Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_031421.5(TTC25):c.425_426insT (p.Lys142fs)	TTC25		Ciliary dyskinesia, primary, 35	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000254128	17	40092753 - 40092754	17	41936500 - 41936501	254128	248579	rs886037889	NC_000017.11:41936500::T
NM_031421.5(TTC25):c.114+1G>T	TTC25		Ciliary dyskinesia, primary, 35	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000254127	17	40087091	17	41930838	254127	248578	rs886037888	NC_000017.11:41930837:G:T
NM_003076.5(SMARCD1):c.1507C>T (p.Arg503Ter)	SMARCD1	R503*, R462*	COFFIN-SIRIS SYNDROME 11	Pathogenic(Last reviewed: Feb 19, 2020)	no assertion criteria provided	VCV000812683	12	50492742	12	50098959	812683	800934		NC_000012.12:50098958:C:T
NM_003076.5(SMARCD1):c.1483T>C (p.Phe495Leu)	SMARCD1	F495L, F454L	COFFIN-SIRIS SYNDROME 11	Pathogenic(Last reviewed: Feb 19, 2020)	no assertion criteria provided	VCV000812682	12	50492587	12	50098804	812682	800933		NC_000012.12:50098803:T:C
NM_003076.5(SMARCD1):c.1457G>A (p.Trp486Ter)	SMARCD1	W486*, W445*	COFFIN-SIRIS SYNDROME 11	Pathogenic(Last reviewed: Feb 19, 2020)	no assertion criteria provided	VCV000812681	12	50492561	12	50098778	812681	800932		NC_000012.12:50098777:G:A
NM_003076.5(SMARCD1):c.1336A>G (p.Arg446Gly)	SMARCD1	R446G	COFFIN-SIRIS SYNDROME 11	Pathogenic(Last reviewed: Feb 19, 2020)	no assertion criteria provided	VCV000812680	12	50490699	12	50096916	812680	800931		NC_000012.12:50096915:A:G
NM_003076.5(SMARCD1):c.990C>G (p.Asp330Glu)	SMARCD1	D330E	COFFIN-SIRIS SYNDROME 11	Pathogenic(Last reviewed: Feb 19, 2020)	no assertion criteria provided	VCV000812679	12	50484140	12	50090357	812679	800930		NC_000012.12:50090356:C:G
KLHL10, IVS3, 4-BP DEL, +121	KLHL10		Spermatogenic failure 11	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000040010					40010	48523		
NM_152467.5(KLHL10):c.937G>A (p.Ala313Thr)	KLHL10	A313T, A225T	Spermatogenic failure 11	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000040009	17	40001630	17	41845378	40009	48522	rs370756367	NC_000017.11:41845377:G:A
NM_005702.4(ERAL1):c.707A>T (p.Asn236Ile)	ERAL1	N236I, N235I	Perrault syndrome 6	Pathogenic(Last reviewed: Jul 10, 2017)	no assertion criteria provided	VCV000430638	17	27185500	17	28858482	430638	424018	rs1131692170	NC_000017.11:28858481:A:T
NM_004569.5(PIGH):c.307T>C (p.Ser103Pro)	PIGH	S103P	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17	Pathogenic(Last reviewed: Jun 22, 2018)	no assertion criteria provided	VCV000545631	14	68060543	14	67593826	545631	536131	rs776038451	NC_000014.9:67593825:A:G
NM_004569.5(PIGH):c.1A>T (p.Met1Leu)	PIGH	M1L	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17	Pathogenic(Last reviewed: Jun 22, 2018)	no assertion criteria provided	VCV000545630	14	68066920	14	67600203	545630	536130	rs761543313	NC_000014.9:67600202:T:A
NM_015544.3(TMEM98):c.236_263+6del	TMEM98		Nanophthalmos 4	Pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	VCV000224332	17	31260294 - 31260327	17	32933276 - 32933309	224332	226068	rs869312734	NC_000017.11:32933275:GGAGAATGAAGACTGGATCGAAGATGCCTCGTAAGG:GG
NM_015544.3(TMEM98):c.587A>C (p.His196Pro)	TMEM98	H196P	Nanophthalmos 4	Pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	VCV000224331	17	31267917	17	32940899	224331	226067	rs869312733	NC_000017.11:32940898:A:C
NM_015544.3(TMEM98):c.577G>C (p.Ala193Pro)	TMEM98	A193P	Nanophthalmos 4	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000155721	17	31267907	17	32940889	155721	165475	rs587777690	NC_000017.11:32940888:G:C
NM_004302.5(ACVR1B):c.1262-502_1392+24del	ACVR1B		Carcinoma of pancreas	Pathogenic(Last reviewed: Mar 13, 2001)	no assertion criteria provided	VCV000008228	12	52385141 - 52385797	12	51991357 - 51992013	8228	23267	rs1555162597	
NM_004302.5(ACVR1B):c.1159_1163del (p.Asp387fs)	ACVR1B	D428fs, D387fs, D335fs	Carcinoma of pancreas	Pathogenic(Last reviewed: Mar 13, 2001)	no assertion criteria provided	VCV000008227	12	52380624 - 52380628	12	51986840 - 51986844	8227	23266	rs387906389	NC_000012.12:51986839:GATGA:
NM_002283.4(KRT85):c.1448_1449del (p.Pro483fs)	KRT85	P483fs, P271fs	Ectodermal dysplasia, 'pure' hair-nail type	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000102444	12	52754712 - 52754713	12	52360928 - 52360929	102444	108186	rs1565766888	NC_000012.12:52360927:AG:
NM_001030001.4(RPS29):c.149T>C (p.Ile50Thr)	RPS29	I50T, I47T	Diamond-Blackfan anemia 13	Pathogenic(Last reviewed: Jul 3, 2014)	no assertion criteria provided	VCV000140739	14	50052681	14	49585963	140739	150452	rs587777569	NC_000014.9:49585962:A:G
NM_001030001.4(RPS29):c.91A>T (p.Ile31Phe)	RPS29	I31F, I28F	Diamond-Blackfan anemia 13	Pathogenic(Last reviewed: Jul 3, 2014)	no assertion criteria provided	VCV000140738	14	50052739	14	49586021	140738	150451	rs587777568	NC_000014.9:49586020:T:A
NM_176818.3(GATC):c.233T>G (p.Met78Arg)	GATC	M78R	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42|Cardiomyopathy, mitochondrial	Pathogenic(Last reviewed: May 13, 2018)	criteria provided, single submitter	VCV000559417	12	120884611	12	120446808	559417	550147	rs1370579526	NC_000012.12:120446807:T:G
NM_181534.4(KRT25):c.712G>T (p.Val238Leu)	KRT25	V238L	Autosomal Recessive Hypotrichosis with Woolly Hair|Autosomal recessive woolly hair 3	Pathogenic(Last reviewed: Feb 20, 2016)	criteria provided, single submitter	VCV000242934	17	38907536	17	40751284	242934	244036	rs879253749	NC_000017.11:40751283:C:A
NM_181534.4(KRT25):c.950T>C (p.Leu317Pro)	KRT25	L317P	Hypotrichosis 8|Autosomal recessive woolly hair 3	Pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000217303	17	38907213	17	40750961	217303	213953	rs766783183	NC_000017.11:40750960:A:G
ICR, 3,101-BP DEL	PERCC1		DIARRHEA 11, MALABSORPTIVE, CONGENITAL	Pathogenic(Last reviewed: Nov 14, 2019)	no assertion criteria provided	VCV000694449					694449	682373		
ICR, 7013-BP DEL	PERCC1		DIARRHEA 11, MALABSORPTIVE, CONGENITAL	Pathogenic(Last reviewed: Nov 14, 2019)	no assertion criteria provided	VCV000694448					694448	682372		
NM_001933.5(DLST):c.1121G>A (p.Gly374Glu)	DLST	G374E	PARAGANGLIOMAS 7	Pathogenic(Last reviewed: Jun 24, 2019)	no assertion criteria provided	VCV000635133	14	75367830	14	74901127	635133	622968	rs1270341616	NC_000014.9:74901126:G:A
NM_006160.4(NEUROD2):c.401T>C (p.Met134Thr)	NEUROD2	M134T	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72	Pathogenic(Last reviewed: Apr 4, 2019)	no assertion criteria provided	VCV000625140	17	37762452	17	39606199	625140	613485	rs1567841596	NC_000017.11:39606198:A:G
NM_006160.4(NEUROD2):c.388G>C (p.Glu130Gln)	NEUROD2	E130Q	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72	Pathogenic(Last reviewed: Apr 4, 2019)	no assertion criteria provided	VCV000625139	17	37762465	17	39606212	625139	613484	rs1323339153	NC_000017.11:39606211:C:G
NM_173596.3(SLC39A5):c.911T>C (p.Met304Thr)	SLC39A5	M304T	Myopia 24, autosomal dominant	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000143992	12	56629450	12	56235666	143992	153722	rs587777625	NC_000012.12:56235665:T:C
NM_173596.3(SLC39A5):c.141C>G (p.Tyr47Ter)	SLC39A5	Y47*	Myopia 24, autosomal dominant	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000143991	12	56625199	12	56231415	143991	153721	rs199624584	NC_000012.12:56231414:C:G
NM_148897.3(SDR9C7):c.551A>G (p.Asp184Gly)	SDR9C7	D184G	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000807680	12	57324019	12	56930235	807680	798659		NC_000012.12:56930234:T:C
NM_001330288.2(SMARCC2):c.2779A>G (p.Met927Val)	SMARCC2	M896V, M927V	COFFIN-SIRIS SYNDROME 8	Pathogenic(Last reviewed: Apr 5, 2019)	no assertion criteria provided	VCV000623251	12	56561915	12	56168131	623251	612214	rs1565896447	NC_000012.12:56168130:T:C
NM_001330288.2(SMARCC2):c.723G>A (p.Trp241Ter)	SMARCC2	W241*	COFFIN-SIRIS SYNDROME 8	Pathogenic(Last reviewed: Apr 5, 2019)	no assertion criteria provided	VCV000623250	12	56575605	12	56181821	623250	612213	rs1565917836	NC_000012.12:56181820:C:T
NM_001330288.2(SMARCC2):c.1922T>C (p.Leu641Pro)	SMARCC2	L610P, L641P	COFFIN-SIRIS SYNDROME 8	Pathogenic(Last reviewed: Mar 19, 2019)	no assertion criteria provided	VCV000623249	12	56566216	12	56172432	623249	612212	rs1565903367	NC_000012.12:56172431:A:G
NM_148897.3(SDR9C7):c.214C>T (p.Arg72Trp)	SDR9C7	R72W	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13	Pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000430712	12	57327832	12	56934048	430712	424251	rs530109812	NC_000012.12:56934047:G:A
NM_005205.4(COX6A2):c.127T>C (p.Cys43Arg)	COX6A2	C43R	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Jul 29, 2019)	no assertion criteria provided	VCV000638272	16	31439419	16	31428098	638272	626054		NC_000016.10:31428097:A:G
NM_005205.4(COX6A2):c.117C>A (p.Ser39Arg)	COX6A2	S39R	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Jul 29, 2019)	no assertion criteria provided	VCV000638271	16	31439429	16	31428108	638271	626053		NC_000016.10:31428107:G:T
NM_001330288.2(SMARCC2):c.1311-3C>G	SMARCC2		COFFIN-SIRIS SYNDROME 8	Pathogenic(Last reviewed: Mar 19, 2019)	no assertion criteria provided	VCV000623248	12	56571880	12	56178096	623248	612211	rs1206884190	NC_000012.12:56178095:G:C
NM_001330288.2(SMARCC2):c.1926+2T>C	SMARCC2		COFFIN-SIRIS SYNDROME 8	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000623247	12	56566210	12	56172426	623247	612210	rs1565903353	NC_000012.12:56172425:A:G
NM_148897.3(SDR9C7):c.599T>C (p.Ile200Thr)	SDR9C7	I200T	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000430711	12	57323299	12	56929515	430711	424250	rs770729222	NC_000012.12:56929514:A:G
NM_013251.4(TAC3):c.61del (p.Ala21fs)	TAC3	A21fs	Hypogonadotropic hypogonadism 10 with or without anosmia	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000066083	12	57409521	12	57015737	66083	76985	rs398122393	NC_000012.12:57015736:CCCC:CCC
NM_013251.4(TAC3):c.269T>C (p.Met90Thr)	TAC3	M90T	not provided|Hypogonadotropic hypogonadism 10 without anosmia	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000014027	12	57406629	12	57012845	14027	29066	rs121918123	NC_000012.12:57012844:A:G
NM_148897.3(SDR9C7):c.658C>T (p.Arg220Ter)	SDR9C7	R220*	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13|Congenital ichthyosis of skin	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488591	12	57323240	12	56929456	488591	481459	rs774363396	NC_000012.12:56929455:G:A
MIR184, 57C-T	MIR184		EDICT syndrome	Pathogenic(Last reviewed: Jan 25, 2012)	no assertion criteria provided	VCV000031007					31007	39964		
NM_017988.4:c.1624dupG	SCYL2		ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM	Pathogenic(Last reviewed: Feb 6, 2020)	no assertion criteria provided	VCV000810844					810844	799092		
NM_017988.4:c.106C>T	SCYL2	R36*	ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM	Pathogenic(Last reviewed: Feb 6, 2020)	no assertion criteria provided	VCV000810843					810843	799091		
NM_033198.4(PIGS):c.468+1G>C	PIGS		GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	Pathogenic(Last reviewed: Oct 11, 2018)	no assertion criteria provided	VCV000585257	17	26890448	17	28563430	585257	576306	rs1567616570	NC_000017.11:28563429:C:G
NM_033198.4(PIGS):c.1316_1352delinsGGTTGCT (p.Thr439_Lys451delinsArgLeuLeu)	PIGS		GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	Pathogenic(Last reviewed: Oct 11, 2018)	no assertion criteria provided	VCV000585255	17	26881909 - 26881945	17	28554891 - 28554927	585255	576304	rs1567614073	NC_000017.11:28554890:TTGCCCAGAAGCTGCGCCAGGGAGGTAAGGGTGGTGG:AGCAACC
GRCh38/hg38 12q13.2(chr12:55845043-55851177)	MMP19		Cavitary optic disc anomalies	Pathogenic(Last reviewed: Jan 12, 2015)	no assertion criteria provided	VCV000208981	12	56238827 - 56244961	12	55845043 - 55851177	208981	205536		
GRCh38/hg38 12q13.2(chr12:55845043-55851177)x4	MMP19		Cavitary optic disc anomalies	Pathogenic	no assertion criteria provided	VCV000180748	12	56238827 - 56244961	12	55845043 - 55851177	180748	178906		
NM_014515.6(CNOT2):c.946A>T (p.Lys316Ter)	CNOT2	K316*	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NASAL SPEECH, DYSMORPHIC FACIES, AND VARIABLE SKELETAL ANOMALIES	Pathogenic(Last reviewed: Oct 4, 2019)	no assertion criteria provided	VCV000691600	12	70732268	12	70338488	691600	679320		NC_000012.12:70338487:A:T
CNOT2, 85-KB DEL	CNOT2		INTELLECTUAL DEVELOPMENTAL DISORDER WITH NASAL SPEECH, DYSMORPHIC FACIES, AND VARIABLE SKELETAL ANOMALIES	Pathogenic(Last reviewed: Oct 4, 2019)	no assertion criteria provided	VCV000691599					691599	679319		
NM_003483.4(HMGA2):c.189del (p.Ala64fs)	HMGA2	A64fs	Russell-Silver syndrome	Pathogenic	no assertion criteria provided	VCV000253035	12	66221858	12	65828078	253035	247442	rs1114167320	NC_000012.12:65828077:A:
NM_003483.4(HMGA2):c.193C>T (p.Gln65Ter)	HMGA2	Q65*	Russell-Silver syndrome	Pathogenic	no assertion criteria provided	VCV000253034	12	66221862	12	65828082	253034	247441	rs1114167319	NC_000012.12:65828081:C:T
NM_006576.3(AVIL):c.404G>A (p.Arg135Gln)	AVIL	R135Q	NEPHROTIC SYNDROME, TYPE 21|Steroid-resistant nephrotic syndrome	Pathogenic(Last reviewed: Sep 25, 2019)	no assertion criteria provided	VCV000684650	12	58204845	12	57811062	684650	672262		NC_000012.12:57811061:C:T
NM_006576.3(AVIL):c.1337G>A (p.Arg446His)	AVIL	R446H	NEPHROTIC SYNDROME, TYPE 21|Steroid-resistant nephrotic syndrome	Pathogenic(Last reviewed: Sep 25, 2019)	no assertion criteria provided	VCV000684649	12	58201268	12	57807485	684649	672260		NC_000012.12:57807484:C:T
NM_006576.3(AVIL):c.1273C>A (p.Leu425Met)	AVIL	L425M	NEPHROTIC SYNDROME, TYPE 21|Steroid-resistant nephrotic syndrome	Pathogenic(Last reviewed: Sep 25, 2019)	no assertion criteria provided	VCV000684648	12	58201432	12	57807649	684648	672261		NC_000012.12:57807648:G:T
NM_004822.3(NTN1):c.1802G>C (p.Cys601Ser)	NTN1	C601S	MIRROR MOVEMENTS 4	Pathogenic(Last reviewed: Jan 9, 2019)	no assertion criteria provided	VCV000599326	17	9143272	17	9239955	599326	590601	rs1567750187	NC_000017.11:9239954:G:C
NM_004822.3(NTN1):c.1801T>C (p.Cys601Arg)	NTN1	C601R	MIRROR MOVEMENTS 4	Pathogenic(Last reviewed: Jan 8, 2019)	no assertion criteria provided	VCV000599324	17	9143271	17	9239954	599324	590599	rs1567750186	NC_000017.11:9239953:T:C
NM_001129820.1(SLFN14):c.667C>T (p.Arg223Trp)	SLFN14	R223W	Platelet-type bleeding disorder 20	Pathogenic(Last reviewed: Apr 22, 2016)	no assertion criteria provided	VCV000225536	17	33884415	17	35557396	225536	227443	rs757188030	NC_000017.11:35557395:G:A
NM_001129820.1(SLFN14):c.652A>G (p.Lys218Glu)	SLFN14	K218E	Platelet-type bleeding disorder 20	Pathogenic(Last reviewed: Apr 22, 2016)	no assertion criteria provided	VCV000225535	17	33884430	17	35557411	225535	227442	rs869320716	NC_000017.11:35557410:T:C
NM_004822.3(NTN1):c.1549_1551ATC[1] (p.Ile518del)	NTN1	I518del	MIRROR MOVEMENTS 4	Pathogenic(Last reviewed: Jan 9, 2019)	no assertion criteria provided	VCV000599325	17	9143018 - 9143020	17	9239701 - 9239703	599325	590600	rs1567749982	NC_000017.11:9239700:CATCATC:CATC
NM_001129820.1(SLFN14):c.657A>T (p.Lys219Asn)	SLFN14	K219N	Abnormal bleeding|Thrombocytopenia|Platelet-type bleeding disorder 20	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2016)	no assertion criteria provided	VCV000225534	17	33884425	17	35557406	225534	227441	rs869320715	NC_000017.11:35557405:T:A
NM_001129820.1(SLFN14):c.659T>A (p.Val220Asp)	SLFN14	V220D	Abnormal bleeding|Thrombocytopenia|Platelet-type bleeding disorder 20	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2016)	no assertion criteria provided	VCV000225533	17	33884423	17	35557404	225533	227440	rs869320714	NC_000017.11:35557403:A:T
SERPINA6, 121G-A	SERPINA6		Corticosteroid-binding globulin deficiency	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000016976					16976	32015		
NM_001946.4(DUSP6):c.229T>A (p.Phe77Ile)	DUSP6	F77I	Hypogonadotropic hypogonadism 19 with or without anosmia	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050857	12	89745588	12	89351811	50857	59843	rs587776978	NC_000012.12:89351810:A:T
NM_001946.4(DUSP6):c.566A>G (p.Asn189Ser)	DUSP6	N189S	Hypogonadotropic hypogonadism 19 with or without anosmia	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050854	12	89744637	12	89350860	50854	59840	rs143946794	NC_000012.12:89350859:T:C
NM_001756.4(SERPINA6):c.1165G>A (p.Asp389Asn)	SERPINA6	D367N, D389N	Corticosteroid-binding globulin deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	no assertion criteria provided	VCV000016975	14	94770808	14	94304471	16975	32014	rs28929488	NC_000014.9:94304470:C:T
NM_002480.3(PPP1R12A):c.2033_2034del (p.Glu677_Ser678insTer)	PPP1R12A		GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME	Pathogenic(Last reviewed: Mar 19, 2020)	no assertion criteria provided	VCV000827964	12	80192331 - 80192332	12	79798551 - 79798552	827964	816297		NC_000012.12:79798550:AGA:A
NM_002480.3(PPP1R12A):c.1189del (p.Thr397fs)	PPP1R12A	T310fs, T397fs	GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME	Pathogenic(Last reviewed: Mar 19, 2020)	no assertion criteria provided	VCV000827963	12	80211224	12	79817444	827963	816296		NC_000012.12:79817443:TT:T
NM_002480.3(PPP1R12A):c.1510C>T (p.Arg504Ter)	PPP1R12A	R504*, R417*	GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME	Pathogenic(Last reviewed: Mar 19, 2020)	no assertion criteria provided	VCV000827962	12	80202303	12	79808523	827962	816295		NC_000012.12:79808522:G:A
NM_004855.5(PIGB):c.1162G>C (p.Ala388Pro)	PIGB	A388P	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 80	Pathogenic(Last reviewed: Sep 13, 2019)	no assertion criteria provided	VCV000689515	15	55642935	15	55350737	689515	677193		NC_000015.10:55350736:G:C
NM_004480.4(FUT8):c.454C>T (p.Arg152Ter)	FUT8	R315*, R152*	Congenital disorder of glycosylation with defective fucosylation 1	Pathogenic(Last reviewed: Feb 20, 2019)	no assertion criteria provided	VCV000545468	14	66188600	14	65721882	545468	535728	rs1334593208	NC_000014.9:65721881:C:T
NM_004480.4(FUT8):c.770+5G>T	FUT8		Congenital disorder of glycosylation with defective fucosylation 1	Pathogenic(Last reviewed: Feb 20, 2019)	no assertion criteria provided	VCV000545467	14	66191046	14	65724328	545467	535727	rs1555388034	NC_000014.9:65724327:G:T
NM_004480.4(FUT8):c.520C>G (p.Arg174Gly)	FUT8	R337G, R174G	Congenital disorder of glycosylation with defective fucosylation 1	Pathogenic(Last reviewed: Feb 20, 2019)	no assertion criteria provided	VCV000545466	14	66188666	14	65721948	545466	535726	rs1297536872	NC_000014.9:65721947:C:G
NM_007035.3(KERA):c.320T>G (p.Ile107Arg)	KERA	I107R	Cornea plana 2	Pathogenic(Last reviewed: Apr 21, 2016)	no assertion criteria provided	VCV000225521	12	91449739	12	91055962	225521	227428	rs757611751	NC_000012.12:91055961:A:C
NM_007035.3(KERA):c.937C>T (p.Arg313Ter)	KERA	R313*	Cornea plana 2	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000006522	12	91445245	12	91051468	6522	21561	rs121917863	NC_000012.12:91051467:G:A
NM_007035.3(KERA):c.644C>A (p.Thr215Lys)	KERA	T215K	Cornea plana 2	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000006521	12	91449415	12	91055638	6521	21560	rs121917862	NC_000012.12:91055637:G:T
NM_007035.3(KERA):c.520C>T (p.Gln174Ter)	KERA	Q174*	Cornea plana 2	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000006520	12	91449539	12	91055762	6520	21559	rs121917860	NC_000012.12:91055761:G:A
NM_007035.3(KERA):c.740A>G (p.Asn247Ser)	KERA	N247S	Cornea plana 2	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000006519	12	91449319	12	91055542	6519	21558	rs121917858	NC_000012.12:91055541:T:C
NM_004480.4(FUT8):c.226C>T (p.Arg76Ter)	FUT8	R239*, R76*	not provided|Congenital disorder of glycosylation with defective fucosylation 1	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000545465	14	66136078	14	65669360	545465	535725	rs1460811017	NC_000014.9:65669359:C:T
NM_001177676.2(GPR68):c.221T>C (p.Leu74Pro)	GPR68	L74P	Amelogenesis imperfecta, hypomaturation type IIA6|Amelogenesis imperfecta	Pathogenic(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000268086	14	91701174	14	91234830	268086	263524	rs1057517672	NC_000014.9:91234829:A:G
NM_001177676.2(GPR68):c.667_668del (p.Lys223fs)	GPR68	K223fs	Amelogenesis imperfecta, hypomaturation type IIA6|Amelogenesis imperfecta	Pathogenic(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000268085	14	91700727 - 91700728	14	91234383 - 91234384	268085	263523	rs1057517671	NC_000014.9:91234382:TT:
NM_001177676.2(GPR68):c.386_835del (p.Phe129_Asn278del)	GPR68		Amelogenesis imperfecta, hypomaturation type IIA6|Amelogenesis imperfecta	Pathogenic(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000268084	14	91700560 - 91701009	14	91234216 - 91234665	268084	263522	rs1555409827	
NM_007035.3(KERA):c.835C>T (p.Arg279Ter)	KERA	R279*	Cornea plana 2	Pathogenic/Likely pathogenic(Last reviewed: Apr 21, 2016)	no assertion criteria provided	VCV000056550	12	91449224	12	91055447	56550	71189	rs386833986	NC_000012.12:91055446:G:A
NM_020547.3(AMHR2):c.994C>T (p.Arg332Ter)	AMHR2	R332*	Male pseudohermaphroditism	Pathogenic	no assertion criteria provided	VCV000689555	12	53823263	12	53429479	689555	677242		NC_000012.12:53429478:C:T
NM_015154.3(MESD):c.607_611del (p.Thr203fs)	MESD	T203fs	OSTEOGENESIS IMPERFECTA, TYPE XX	Pathogenic(Last reviewed: Oct 25, 2019)	no assertion criteria provided	VCV000692265	15	81271654 - 81271658	15	80979313 - 80979317	692265	680077		NC_000015.10:80979312:TTTGTTTT:TTT
NM_015154.3(MESD):c.631_632del (p.Lys211fs)	MESD	K211fs	OSTEOGENESIS IMPERFECTA, TYPE XX	Pathogenic(Last reviewed: Oct 25, 2019)	no assertion criteria provided	VCV000692264	15	81271633 - 81271634	15	80979292 - 80979293	692264	680076		NC_000015.10:80979291:TTTTTTTT:TTTTTT
NM_015154.3(MESD):c.676C>T (p.Arg226Ter)	MESD	R226*	OSTEOGENESIS IMPERFECTA, TYPE XX	Pathogenic(Last reviewed: Oct 25, 2019)	no assertion criteria provided	VCV000692263	15	81271589	15	80979248	692263	680075		NC_000015.10:80979247:G:A
NM_015154.3(MESD):c.632dup (p.Lys212fs)	MESD		OSTEOGENESIS IMPERFECTA, TYPE XX	Pathogenic(Last reviewed: Oct 25, 2019)	no assertion criteria provided	VCV000692262	15	81271632 - 81271633	15	80979291 - 80979292	692262	680074		NC_000015.10:80979291:TTTTTTTT:TTTTTTTTT
NM_002532.6(NUP88):c.1899_1901del (p.Glu634del)	NUP88	E634del, E650del	FETAL AKINESIA DEFORMATION SEQUENCE 4	Pathogenic(Last reviewed: Apr 16, 2019)	no assertion criteria provided	VCV000625470	17	5290721 - 5290723	17	5387401 - 5387403	625470	613775	rs776532930	NC_000017.11:5387400:TCTT:T
NM_002532.6(NUP88):c.1525C>T (p.Arg509Ter)	NUP88	R509*	FETAL AKINESIA DEFORMATION SEQUENCE 4	Pathogenic(Last reviewed: Apr 16, 2019)	no assertion criteria provided	VCV000625469	17	5292240	17	5388920	625469	613774	rs774070092	NC_000017.11:5388919:G:A
NM_002532.6(NUP88):c.1300G>T (p.Asp434Tyr)	NUP88	D434Y	FETAL AKINESIA DEFORMATION SEQUENCE 4	Pathogenic(Last reviewed: Apr 16, 2019)	no assertion criteria provided	VCV000625468	17	5298293	17	5394973	625468	613773	rs1567568217	NC_000017.11:5394972:C:A
NM_001145112.1(PATL2):c.1224+2T>C	PATL2		OOCYTE MATURATION DEFECT 4	Pathogenic(Last reviewed: Dec 22, 2017)	no assertion criteria provided	VCV000444050	15	44961176	15	44668978	444050	437692	rs1555385717	NC_000015.10:44668977:A:G
NM_001145112.1(PATL2):c.223-14_223-2del	PATL2		OOCYTE MATURATION DEFECT 4	Pathogenic(Last reviewed: Oct 24, 2017)	no assertion criteria provided	VCV000444049	15	44966430 - 44966442	15	44674232 - 44674244	444049	437691		NC_000015.10:44674231:TGGAACAGGAGGG:
NM_152464.3(TMEM199):c.376-1G>A	TMEM199		TMEM199-CDG	Pathogenic(Last reviewed: Feb 29, 2016)	no assertion criteria provided	VCV000223001	17	26687551	17	28360528	223001	224174	rs869025587	NC_000017.11:28360527:G:A
AMHR2, IVS2DS, G-T, +1	AMHR2		Persistent mullerian duct syndrome, type II	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000008626					8626	23665		
NM_152464.3(TMEM199):c.40G>C (p.Ala14Pro)	TMEM199	A14P	TMEM199-CDG	Pathogenic(Last reviewed: Feb 29, 2016)	no assertion criteria provided	VCV000223000	17	26684733	17	28357710	223000	224173	rs869025586	NC_000017.11:28357709:G:C
NM_020547.3(AMHR2):c.1217G>A (p.Arg406Gln)	AMHR2	R406Q	Persistent mullerian duct syndrome, type II	Pathogenic(Last reviewed: Aug 15, 2009)	no assertion criteria provided	VCV000008629	12	53823691	12	53429907	8629	23668	rs137853104	NC_000012.12:53429906:G:A
AMHR2, 1-BP DEL, 1692A	AMHR2		Persistent mullerian duct syndrome, type II	Pathogenic(Last reviewed: Aug 15, 2009)	no assertion criteria provided	VCV000008628					8628	23667		
AMHR2, 27-BP DEL, NT6331	AMHR2		Persistent mullerian duct syndrome, type II	Pathogenic(Last reviewed: Aug 15, 2009)	no assertion criteria provided	VCV000008627					8627	23666		
NM_005593.3(MYF5):c.23_32del (p.Gln8fs)	MYF5	Q8fs	OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES|Scoliosis|Abnormality of the ribs|External ophthalmoplegia	Pathogenic(Last reviewed: Oct 26, 2018)	no assertion criteria provided	VCV000523663	12	81110863 - 81110872	12	80717084 - 80717093	523663	514311	rs1555216163	NC_000012.12:80717083:CCAGTTCTCACC:CC
NM_001330283.1(PATL2):c.-10T>A	PATL2	Y186*	OOCYTE MATURATION DEFECT 4	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000444048	15	44964312	15	44672114	444048	437690	rs752734259	NC_000015.10:44672113:A:T
NM_152464.3(TMEM199):c.20C>A (p.Ala7Glu)	TMEM199	A7E	TMEM199-CDG|Congenital disorders of glycosylation type II	Pathogenic(Last reviewed: Feb 29, 2016)	no assertion criteria provided	VCV000218965	17	26684713	17	28357690	218965	216017	rs369488804	NC_000017.11:28357689:C:A
NM_152464.3(TMEM199):c.92G>C (p.Arg31Pro)	TMEM199	R31P	TMEM199-CDG|Congenital disorders of glycosylation type II	Pathogenic(Last reviewed: Feb 29, 2016)	no assertion criteria provided	VCV000218964	17	26684785	17	28357762	218964	216010	rs782531869	NC_000017.11:28357761:G:C
NM_057088.3(KRT3):c.1508G>C (p.Arg503Pro)	KRT3	R503P	Meesmann corneal dystrophy 2|not provided	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000066749	12	53185017	12	52791233	66749	77646	rs60410063	NC_000012.12:52791232:C:G
NM_057088.3(KRT3):c.1493A>T (p.Glu498Val)	KRT3	E498V	Meesmann corneal dystrophy 2|not provided	Pathogenic(Last reviewed: Sep 15, 2008)	no assertion criteria provided	VCV000066748	12	53185032	12	52791248	66748	77645	rs267607431	NC_000012.12:52791247:T:A
NM_057088.3(KRT3):c.1525G>A (p.Glu509Lys)	KRT3	E509K	Meesmann corneal dystrophy 2|not provided	Pathogenic(Last reviewed: Jun 1, 1997)	no assertion criteria provided	VCV000014632	12	53185000	12	52791216	14632	29671	rs57872071	NC_000012.12:52791215:C:T
NM_005593.3(MYF5):c.283C>T (p.Arg95Cys)	MYF5	R95C	OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES|Scoliosis|Abnormality of the ribs|External ophthalmoplegia	Pathogenic(Last reviewed: Oct 26, 2018)	no assertion criteria provided	VCV000523662	12	81111125	12	80717346	523662	514310	rs1565864693	NC_000012.12:80717345:C:T
NM_014233.4(UBTF):c.628G>A (p.Glu210Lys)	UBTF	E210K	UBTF E210K Neuroregression Syndrome|UBTF-Related Disorder|Infantile or childhood onset neurodegenerative disease, global developmental delay, and intellectual disability|Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000437909	17	42290219	17	44212851	437909	431537	rs1555582065	NC_000017.11:44212850:C:T
NM_004136.4(IREB2):c.1329_1331del (p.Ser444del)	IREB2	S194del, S387del, S444del	NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOSIS AND MICROCYTIC ANEMIA	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694294	15	78775691 - 78775693	15	78483349 - 78483351	694294	682170		NC_000015.10:78483348:CATC:C
NM_004136.4(IREB2):c.2353G>A (p.Gly785Arg)	IREB2	G785R, G535R, G728R	NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOSIS AND MICROCYTIC ANEMIA	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694293	15	78786279	15	78493937	694293	682169		NC_000015.10:78493936:G:A
NM_003460.2(ZP2):c.1115G>C (p.Cys372Ser)	ZP2	C372S	OOCYTE MATURATION DEFECT 6	Pathogenic(Last reviewed: Aug 21, 2019)	no assertion criteria provided	VCV000689402	16	21213597	16	21202276	689402	676994		NC_000016.10:21202275:C:G
NM_003460.2(ZP2):c.1691_1694dup (p.Cys566fs)	ZP2		OOCYTE MATURATION DEFECT 6	Pathogenic(Last reviewed: Mar 8, 2019)	no assertion criteria provided	VCV000619597	16	21212689 - 21212690	16	21201368 - 21201369	619597	610995	rs1567212569	NC_000016.10:21201368:CCATCCA:CCATCCATCCA
NM_003460.2(ZP2):c.1695-2A>G	ZP2		OOCYTE MATURATION DEFECT 6	Pathogenic(Last reviewed: Mar 8, 2019)	no assertion criteria provided	VCV000619596	16	21211201	16	21199880	619596	610994	rs1156454797	NC_000016.10:21199879:T:C
NM_005475.2(SH2B3):c.603_607del (p.Arg202fs)	SH2B3	R202fs	Myelofibrosis	Pathogenic(Last reviewed: Aug 12, 2010)	no assertion criteria provided	VCV000030444	12	111856549 - 111856553	12	111418745 - 111418749	30444	39401	rs587776885	NC_000012.12:111418744:GCTGCGCT:GCT
NM_004373.4(COX6A1):c.247-7_247-3del	COX6A1		Charcot-Marie-Tooth disease, recessive intermediate d	Pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000156370	12	120878247 - 120878251	12	120440444 - 120440448	156370	166149	rs587777783	NC_000012.12:120440443:CACTCCAC:CAC
NM_005276.4(GPD1):c.751dup (p.Thr251fs)	GPD1		not provided	Pathogenic(Last reviewed: Jun 26, 2015)	criteria provided, single submitter	VCV000419206	12	50501487 - 50501488	12	50107704 - 50107705	419206	408692	rs1555188332	NC_000012.12:50107704:A:AA
NM_005276.4(GPD1):c.686G>C (p.Arg229Pro)	GPD1	R229Q, R229P, R206P	Hypertriglyceridemia, transient infantile	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157542	12	50501423	12	50107640	157542	167405	rs199673455	NC_000012.12:50107639:G:C
NM_005276.4(GPD1):c.361-1G>C	GPD1		Hypertriglyceridemia, transient infantile	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000029741	12	50500070	12	50106287	29741	38696	rs200327418	NC_000012.12:50106286:G:C
NM_000982.3(RPL21):c.95G>A (p.Arg32Gln)	RPL21	R32Q	Hypotrichosis 12	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000139638	13	27828384	13	27254247	139638	143259	rs587777527	NC_000013.11:27254246:G:A
NC_000017.11:g.12269251_12706280del	MYOCD		Prune belly syndrome|MEGABLADDER, CONGENITAL	Pathogenic(Last reviewed: Dec 23, 2019)	no assertion criteria provided	VCV000689482					689482	677119		
NM_001146312.2(MYOCD):c.1053_1054del (p.Asn351fs)	MYOCD	N351fs	Prune belly syndrome|MEGABLADDER, CONGENITAL	Pathogenic(Last reviewed: Dec 23, 2019)	no assertion criteria provided	VCV000689481	17	12649316 - 12649317	17	12745999 - 12746000	689481	677117		NC_000017.11:12745998:ACA:A
NM_001146312.2(MYOCD):c.343C>T (p.Arg115Ter)	MYOCD	R115*	Prune belly syndrome|MEGABLADDER, CONGENITAL	Pathogenic(Last reviewed: Dec 23, 2019)	no assertion criteria provided	VCV000689480	17	12626253	17	12722936	689480	677115		NC_000017.11:12722935:C:T
NM_005208.4(CRYBA1):c.607_608del (p.Gln203fs)	CRYBA1	Q203fs	Cataract, congenital zonular, with sutural opacities	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560445	17	27581326 - 27581327	17	29254308 - 29254309	560445	551584	rs1567671947	NC_000017.11:29254307:CA:
NM_001025356.3(ANO6):c.1387-1G>T	ANO6		not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000449565	12	45795577	12	45401794	449565	444999	rs374664255	NC_000012.12:45401793:G:T
NM_006982.3(ALX1):c.661-1G>C	ALX1		Frontonasal dysplasia 3	Pathogenic(Last reviewed: Mar 16, 2020)	no assertion criteria provided	VCV000827658	12	85694932	12	85301154	827658	815862		NC_000012.12:85301153:G:C
NM_005739.4(RASGRP1):c.1910_1911insAG (p.Ala638fs)	RASGRP1		IMMUNODEFICIENCY 64	Pathogenic(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000666281	15	38786931 - 38786932	15	38494730 - 38494731	666281	653838		NC_000015.10:38494730::CT
NM_005739.4(RASGRP1):c.964A>T (p.Lys322Ter)	RASGRP1	K322*	IMMUNODEFICIENCY 64	Pathogenic(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000666280	15	38803807	15	38511606	666280	653837		NC_000015.10:38511605:T:A
NM_005739.4(RASGRP1):c.641C>T (p.Thr214Ile)	RASGRP1	T214I	IMMUNODEFICIENCY 64	Pathogenic(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000666279	15	38808432	15	38516231	666279	653836		NC_000015.10:38516230:G:A
NM_005739.4(RASGRP1):c.771G>A (p.Trp257Ter)	RASGRP1	W257*	IMMUNODEFICIENCY 64	Pathogenic(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000666278	15	38805062	15	38512861	666278	653835		NC_000015.10:38512860:C:T
NM_005739.4(RASGRP1):c.736C>T (p.Arg246Ter)	RASGRP1	R246*	IMMUNODEFICIENCY 64	Pathogenic(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000666277	15	38805097	15	38512896	666277	653834		NC_000015.10:38512895:G:A
NM_006982.3(ALX1):c.531+1G>A	ALX1		Frontonasal dysplasia 3	Pathogenic(Last reviewed: May 14, 2010)	no assertion criteria provided	VCV000008111	12	85677655	12	85283877	8111	23150	rs587776684	NC_000012.12:85283876:G:A
SYCP3, 1-BP DEL, 643A	SYCP3			Pathogenic(Last reviewed: Nov 22, 2003)	no assertion criteria provided	VCV000005371					5371	20410		
NM_001218.5(CA12):c.908-1G>A	CA12		Hyperchlorhidrosis, isolated	Pathogenic(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	VCV000218369	15	63619433	15	63327234	218369	215094	rs148438059	NC_000015.10:63327233:C:T
NM_001218.5(CA12):c.363C>A (p.His121Gln)	CA12	H121Q, H61Q	Hyperchlorhidrosis, isolated	Pathogenic(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	VCV000218368	15	63637742	15	63345543	218368	215096	rs775067652	NC_000015.10:63345542:G:T
NM_001218.5(CA12):c.859_860insACCT (p.Thr287fs)	CA12		Hyperchlorhidrosis, isolated	Pathogenic(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	VCV000218367	15	63631032 - 63631033	15	63338833 - 63338834	218367	215095	rs879253800	NC_000015.10:63338833::AGGT
ANO6, IVS12AS, G-T, -1	ANO6		SCOTT SYNDROME	Pathogenic(Last reviewed: Dec 9, 2010)	no assertion criteria provided	VCV000030740					30740	39697		
NM_001218.5(CA12):c.427G>A (p.Glu143Lys)	CA12	E143K, E83K	Hyperchlorhidrosis, isolated	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000018442	15	63637678	15	63345479	18442	33481	rs267606694	NC_000015.10:63345478:C:T
CRYBA1, 3-BP DEL, 278GGA	CRYBA1		Cataract, congenital zonular, with sutural opacities	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	VCV000016952					16952	31991		
NG_021364.1:g.81245_89166del	CFAP251		SPERMATOGENIC FAILURE 33|SPERMATOGENIC FAILURE 18	Pathogenic(Last reviewed: Oct 22, 2018)	no assertion criteria provided	VCV000586974					586974	578020		
NM_144668.6(CFAP251):c.123del (p.Asp42fs)	CFAP251	D42fs	SPERMATOGENIC FAILURE 33|Non-syndromic male infertility due to sperm motility disorder|Male infertility with teratozoospermia due to single gene mutation	Pathogenic(Last reviewed: Oct 22, 2018)	no assertion criteria provided	VCV000548450	12	122359331	12	121921425	548450	538934	rs749163856	NC_000012.12:121921424:AAAA:AAA
NM_144668.6(CFAP251):c.331G>T (p.Glu111Ter)	CFAP251	E111*	SPERMATOGENIC FAILURE 33|Non-syndromic male infertility due to sperm motility disorder|Male infertility with teratozoospermia due to single gene mutation	Pathogenic(Last reviewed: Oct 22, 2018)	no assertion criteria provided	VCV000548449	12	122359542	12	121921636	548449	538933	rs199671406	NC_000012.12:121921635:G:T
NM_144668.6(CFAP251):c.1588_1589del (p.Leu530fs)	CFAP251	L530fs	SPERMATOGENIC FAILURE 33|asthenozoospermia|multiple morphologic abnormalities of the sperm flagellum|dysplasia of the mitochondrial sheath	Pathogenic(Last reviewed: Oct 22, 2018)	no assertion criteria provided	VCV000545693	12	122395032 - 122395033	12	121957126 - 121957127	545693	536185	rs1565912409	NC_000012.12:121957125:CT:
NM_194279.4(ISCA2):c.334A>G (p.Ser112Gly)	ISCA2	S112G	Multiple mitochondrial dysfunctions syndrome 4	Pathogenic(Last reviewed: Jun 15, 2018)	no assertion criteria provided	VCV000523611	14	74961572	14	74494869	523611	514262	rs767352340	NC_000014.9:74494868:A:G
NM_001320198.2(KRT86):c.353C>A (p.Ala118Glu)	KRT86	A118E	Beaded hair|not provided	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000007614	12	52696053	12	52302269	7614	22653	rs60612575	NC_000012.12:52302268:C:A
NM_001320198.2(KRT86):c.1204G>C (p.Glu402Gln)	KRT86	E402Q	Beaded hair|not provided	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000007613	12	52700021	12	52306237	7613	22652	rs60687604	NC_000012.12:52306236:G:C
NM_001320198.2(KRT86):c.340A>G (p.Asn114Asp)	KRT86	N114D	Beaded hair|not provided	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000007612	12	52696040	12	52302256	7612	22651	rs61091894	NC_000012.12:52302255:A:G
NM_005639.3(SYT1):c.1113C>G (p.Asn371Lys)	SYT1	N371K, N368K	Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome|SYT1-associated neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000590281	12	79842748	12	79448968	590281	581223	rs144900171	NC_000012.12:79448967:C:G
NM_005639.3(SYT1):c.1098C>A (p.Asp366Glu)	SYT1	D366E, D363E	Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome|SYT1-associated neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000590280	12	79842733	12	79448953	590280	581222	rs1565962725	NC_000012.12:79448952:C:A
NM_005639.3(SYT1):c.911A>G (p.Asp304Gly)	SYT1	D304G, D301G	Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome|SYT1-associated neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000590279	12	79747382	12	79353602	590279	581221	rs1565922395	NC_000012.12:79353601:A:G
NM_005208.4(CRYBA1):c.215+1G>T	CRYBA1		Cataract, congenital zonular, with sutural opacities	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000572809	17	27577319	17	29250301	572809	570831	rs1264025914	NC_000017.11:29250300:G:T
NM_001320198.2(KRT86):c.1239G>T (p.Glu413Asp)	KRT86	E413D	Beaded hair|not provided	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000007610	12	52700056	12	52306272	7610	22649	rs121909130	NC_000012.12:52306271:G:T
NM_005639.3(SYT1):c.908T>A (p.Met303Lys)	SYT1	M303K, M300K	SYT1-associated neurodevelopmental disorder|Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000590278	12	79747379	12	79353599	590278	581220	rs1565922388	NC_000012.12:79353598:T:A
NM_001320198.2(KRT86):c.1204G>A (p.Glu402Lys)	KRT86	E402K	not provided|Beaded hair	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000007611	12	52700021	12	52306237	7611	22650	rs60687604	NC_000012.12:52306236:G:A
NM_003136.4(SRP54):c.821G>A (p.Gly274Asp)	SRP54	G274D, G225D	NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000810690	14	35483043	14	35013837	810690	798976		NC_000014.9:35013836:G:A
NM_003136.4(SRP54):c.668C>A (p.Ala223Asp)	SRP54	A223D, A174D	NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000810689	14	35482583	14	35013377	810689	798975		NC_000014.9:35013376:C:A
NM_003136.4(SRP54):c.337G>C (p.Gly113Arg)	SRP54	G113R, G64R	NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000810688	14	35476570	14	35007364	810688	798974		NC_000014.9:35007363:G:C
NM_032808.7(LINGO1):c.863A>G (p.Tyr288Cys)	LINGO1	Y288C, Y282C	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64	Pathogenic(Last reviewed: Aug 29, 2018)	no assertion criteria provided	VCV000560184	15	77907386	15	77615044	560184	551235	rs750612085	NC_000015.10:77615043:T:C
NM_032808.7(LINGO1):c.869G>A (p.Arg290His)	LINGO1	R290H, R284H	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64	Pathogenic(Last reviewed: Aug 29, 2018)	no assertion criteria provided	VCV000560183	15	77907380	15	77615038	560183	551234	rs757077698	NC_000015.10:77615037:C:T
NM_003805.5(CRADD):c.491T>G (p.Phe164Cys)	CRADD	F164C	Mental retardation, autosomal recessive 34	Pathogenic(Last reviewed: Dec 19, 2016)	no assertion criteria provided	VCV000372192	12	94243938	12	93850162	372192	359097	rs370916968	NC_000012.12:93850161:T:G
NM_003805.5(CRADD):c.508C>T (p.Arg170Cys)	CRADD	R170C	Mental retardation, autosomal recessive 34	Pathogenic(Last reviewed: Dec 19, 2016)	no assertion criteria provided	VCV000372190	12	94243955	12	93850179	372190	359095	rs749655461	NC_000012.12:93850178:C:T
NM_173812.5(DPY19L2):c.1218+1G>A	DPY19L2		Spermatogenic failure 9	Pathogenic(Last reviewed: Aug 15, 2012)	no assertion criteria provided	VCV000101509	12	64011083	12	63617303	101509	107255	rs868256749	NC_000012.12:63617302:C:T
NM_173812.5(DPY19L2):c.892C>T (p.Arg298Cys)	DPY19L2	R298C	Spermatogenic failure 9	Pathogenic(Last reviewed: Aug 15, 2012)	no assertion criteria provided	VCV000101508	12	64017881	12	63624101	101508	107254	rs587777206	NC_000012.12:63624100:G:A
NG_031909.1:g.(12232_26209)_(29173_47048)del	DPY19L2		Spermatogenic failure 9	Pathogenic(Last reviewed: Aug 15, 2012)	no assertion criteria provided	VCV000101507					101507	107253		
NM_173812.5(DPY19L2):c.1183del (p.Ser395fs)	DPY19L2	S395fs	Spermatogenic failure 9	Pathogenic(Last reviewed: Aug 15, 2012)	no assertion criteria provided	VCV000101506	12	64011119	12	63617339	101506	107252	rs751879424	NC_000012.12:63617338:A:
NM_173812.5(DPY19L2):c.2038A>T (p.Lys680Ter)	DPY19L2	K680*	Spermatogenic failure 9	Pathogenic(Last reviewed: Aug 15, 2012)	no assertion criteria provided	VCV000101505	12	63963092	12	63569312	101505	107251	rs587777205	NC_000012.12:63569311:T:A
NM_173812.5(DPY19L2):c.869G>A (p.Arg290His)	DPY19L2	R290H	Spermatogenic failure 9	Pathogenic(Last reviewed: Aug 15, 2012)	no assertion criteria provided	VCV000101504	12	64017904	12	63624124	101504	107250	rs147579680	NC_000012.12:63624123:C:T
NM_005555.4(KRT6B):c.510_512CAA[2] (p.Asn172del)	KRT6B	N172del	not provided	Pathogenic(Last reviewed: Apr 10, 2015)	criteria provided, single submitter	VCV000066600	12	52845345 - 52845347	12	52451561 - 52451563	66600	77497	rs267607472	NC_000012.12:52451560:TTGTTGTTG:TTGTTG
NM_005555.4(KRT6B):c.1381G>A (p.Glu461Lys)	KRT6B	E461K	not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000066599	12	52841605	12	52447821	66599	77496	rs267607473	NC_000012.12:52447820:C:T
ASCL1, 24-BP DEL, NT108	ASCL1		Haddad syndrome	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000018334					18334	33373		
NM_005555.4(KRT6B):c.1406T>G (p.Leu469Arg)	KRT6B	L469R	Pachyonychia congenita 4	Pathogenic(Last reviewed: Mar 6, 2020)	no assertion criteria provided	VCV000816696	12	52841580	12	52447796	816696	804902		NC_000012.12:52447795:A:C
NM_003805.5(CRADD):c.509G>A (p.Arg170His)	CRADD	R170H	Mental retardation, autosomal recessive 34	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	no assertion criteria provided	VCV000372191	12	94243956	12	93850180	372191	359096	rs141179774	NC_000012.12:93850179:G:A
NM_001021.6(RPS17):c.159T>G (p.Tyr53Ter)	RPS17	Y53*	Diamond-Blackfan anemia 4	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000100625	15	82823390	15	82538982	100625	106497	rs6991	NC_000015.10:82538981:A:C
RPS17, 2.9-KB DEL	RPS17		Diamond-Blackfan anemia 4	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000088976					88976	94532		
NM_003805.5(CRADD):c.382G>C (p.Gly128Arg)	CRADD	G128R	Mental retardation, autosomal recessive 34	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030360	12	94243829	12	93850053	30360	39317	rs387906861	NC_000012.12:93850052:G:C
NC_000012.12:g.(?_63595966)_(63596037_?)del	DPY19L2		not provided	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000831821	12	63989746 - 63989817			831821	820513		
ASCL1, 15-BP DEL, NT111	ASCL1		Congenital central hypoventilation	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000018333					18333	33372		
NM_001021.6(RPS17):c.199_200AG[1] (p.Gly68fs)	RPS17		Diamond-Blackfan anemia 4	Pathogenic(Last reviewed: Jun 25, 2009)	no assertion criteria provided	VCV000013000	15	82823347 - 82823348	15	82538939 - 82538940	13000	28039	rs116840812	NC_000015.10:82538938:CTCT:CT
NM_001021.6(RPS17):c.2T>G (p.Met1Arg)	RPS17	M1R	Diamond-Blackfan anemia 4	Pathogenic(Last reviewed: Jun 25, 2009)	no assertion criteria provided	VCV000012999	15	82824835	15	82540427	12999	28038	rs116840811	NC_000015.10:82540426:A:C
DPY19L2, DEL	DPY19L2		Spermatogenic failure 9	Pathogenic(Last reviewed: Aug 15, 2012)	no assertion criteria provided	VCV000031083	12	63952693 - 64062354	12	63558913 - 63669201	31083	40040		
NM_001291424.1(SH2B3):c.577G>A (p.Glu193Lys)	SH2B3	E193K, E395K	Thrombocythemia 1|Primary familial polycythemia due to EPO receptor mutation	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000619973	12	111885295	12	111447491	619973	611368	rs148636776	NC_000012.12:111447490:G:A
NM_003136.4(SRP54):c.343A>G (p.Thr115Ala)	SRP54	T115A, T66A	Shwachman-Diamond syndrome 1|NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000430851	14	35476576	14	35007370	430851	424393	rs1555354200	NC_000014.9:35007369:A:G
NM_005269.3(GLI1):c.337C>T (p.Arg113Ter)	GLI1	R113*, R72*	POLYDACTYLY, POSTAXIAL, TYPE A8	Pathogenic(Last reviewed: Sep 17, 2018)	no assertion criteria provided	VCV000561215	12	57858599	12	57464816	561215	552353	rs748321474	NC_000012.12:57464815:C:T
NM_005269.3(GLI1):c.1930C>T (p.Gln644Ter)	GLI1	Q644*, Q603*, Q516*	POLYDACTYLY, POSTAXIAL, TYPE A8	Pathogenic(Last reviewed: Sep 17, 2018)	no assertion criteria provided	VCV000561214	12	57864453	12	57470670	561214	552352	rs1565601979	NC_000012.12:57470669:C:T
NM_005269.3(GLI1):c.2340G>A (p.Trp780Ter)	GLI1	W780*, W739*, W652*	POLYDACTYLY, POSTAXIAL, TYPE A8	Pathogenic(Last reviewed: Sep 18, 2018)	no assertion criteria provided	VCV000561213	12	57864863	12	57471080	561213	552351	rs1309855392	NC_000012.12:57471079:G:A
NM_001212.4(C1QBP):c.562_564del (p.Tyr188del)	C1QBP	Y188del	Combined oxidative phosphorylation deficiency 33	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000441246	17	5337001 - 5337003	17	5433681 - 5433683	441246	434878	rs755568057	NC_000017.11:5433680:ATAAT:AT
NM_001212.4(C1QBP):c.823C>T (p.Leu275Phe)	C1QBP	L275F	Combined oxidative phosphorylation deficiency 33	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000441245	17	5336361	17	5433041	441245	434877	rs1555532484	NC_000017.11:5433040:G:A
NM_001212.4(C1QBP):c.739G>T (p.Gly247Trp)	C1QBP	G247W	Combined oxidative phosphorylation deficiency 33	Pathogenic(Last reviewed: Oct 12, 2017)	no assertion criteria provided	VCV000441244	17	5336445	17	5433125	441244	434876	rs1394499137	NC_000017.11:5433124:C:A
NM_001212.4(C1QBP):c.824T>C (p.Leu275Pro)	C1QBP	L275P	Combined oxidative phosphorylation deficiency 33	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000441243	17	5336360	17	5433040	441243	434875	rs1555532483	NC_000017.11:5433039:A:G
NM_001212.4(C1QBP):c.612C>G (p.Phe204Leu)	C1QBP	F204L	Combined oxidative phosphorylation deficiency 33	Pathogenic(Last reviewed: Oct 12, 2017)	no assertion criteria provided	VCV000441242	17	5336700	17	5433380	441242	434874	rs767427194	NC_000017.11:5433379:G:C
NM_001212.4(C1QBP):c.557G>C (p.Cys186Ser)	C1QBP	C186S	Combined oxidative phosphorylation deficiency 33	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000441241	17	5337008	17	5433688	441241	434873	rs748497469	NC_000017.11:5433687:C:G
NM_017799.4(TMEM260):c.1698_1701del (p.Tyr567fs)	TMEM260	Y567fs	Structural heart defects and renal anomalies syndrome	Pathogenic(Last reviewed: May 12, 2017)	no assertion criteria provided	VCV000426076	14	57099860 - 57099863	14	56633142 - 56633145	426076	414517	rs1085307449	NC_000014.9:56633141:TATCTAT:TAT
NM_017799.4(TMEM260):c.1393C>T (p.Gln465Ter)	TMEM260	Q465*	Structural heart defects and renal anomalies syndrome	Pathogenic(Last reviewed: May 12, 2017)	no assertion criteria provided	VCV000426075	14	57088415	14	56621697	426075	414516	rs201956469	NC_000014.9:56621696:C:T
NM_001651.4(AQP5):c.367A>G (p.Asn123Asp)	AQP5	N123D	Palmoplantar keratoderma, Bothnian type	Pathogenic(Last reviewed: Aug 8, 2013)	no assertion criteria provided	VCV000065482	12	50357278	12	49963495	65482	76393	rs398123057	NC_000012.12:49963494:A:G
NM_001651.4(AQP5):c.529A>T (p.Ile177Phe)	AQP5	I177F	Palmoplantar keratoderma, Bothnian type	Pathogenic(Last reviewed: Aug 8, 2013)	no assertion criteria provided	VCV000065481	12	50357875	12	49964092	65481	76392	rs398123056	NC_000012.12:49964091:A:T
NM_001651.4(AQP5):c.562C>T (p.Arg188Cys)	AQP5	R188C	Palmoplantar keratoderma, Bothnian type	Pathogenic(Last reviewed: Aug 8, 2013)	no assertion criteria provided	VCV000065479	12	50357908	12	49964125	65479	76390	rs368292687	NC_000012.12:49964124:C:T
NM_005639.3(SYT1):c.1103T>C (p.Ile368Thr)	SYT1	I365T, I368T	not provided|SYT1-associated neurodevelopmental disorder|Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431484	12	79842738	12	79448958	431484	424991	rs1135402761	NC_000012.12:79448957:T:C
NM_001320198.2(KRT86):c.1237G>A (p.Glu413Lys)	KRT86	E413K	Beaded hair|not provided	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000007609	12	52700054	12	52306270	7609	22648	rs121909129	NC_000012.12:52306269:G:A
NM_003136.4(SRP54):c.677G>A (p.Gly226Glu)	SRP54	G226E, G177E	Shwachman-Diamond syndrome 1|NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000430850	14	35482592	14	35013386	430850	424395	rs1555354750	NC_000014.9:35013385:G:A
NM_005555.4(KRT6B):c.1414G>A (p.Glu472Lys)	KRT6B	E472K	not provided|Pachyonychia congenita 4	Pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, single submitter	VCV000014633	12	52841572	12	52447788	14633	29672	rs60627726	NC_000012.12:52447787:C:T
fragile site, folic acid type, rare, fra(12)(q13.1)	DIP2B		Mental retardation, fra12a type	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000000970	12	50898787 - 50898807			970	16009		
PABPN1, (GCG)n REPEAT EXPANSION, (GCG)7	PABPN1		Oculopharyngeal muscular dystrophy	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000007367					7367	22406		
NM_173086.5(KRT6C):c.510_512CAA[2] (p.Asn172del)	KRT6C	N172del	not provided|Palmoplantar keratoderma, nonepidermolytic, focal	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000126525	12	52867004 - 52867006	12	52473220 - 52473222	126525	132049	rs267607474	NC_000012.12:52473219:TTGTTGTTG:TTGTTG
NM_173086.5(KRT6C):c.1384_1410del (p.Ile462_Glu470del)	KRT6C		Palmoplantar keratoderma, nonepidermolytic, focal|not provided	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000066966	12	52863468 - 52863494	12	52469684 - 52469710	66966	77863	rs267607475	NC_000012.12:52469683:CTCCAGCAGCTTGCGGTAGGTGGCGATCTCCA:CTCCA
BEAN1, 2.5- TO 3.8-KB INS	BEAN1			Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000000733					733	15772		
NM_173086.5(KRT6C):c.1414G>A (p.Glu472Lys)	KRT6C	E472K	Palmoplantar keratoderma, nonepidermolytic, focal or diffuse|not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000126527	12	52863464	12	52469680	126527	132051	rs587777292	NC_000012.12:52469679:C:T
NM_001271885.1(AAGAB):c.-255+566C>T	AAGAB	Q21*	not provided	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000620111	15	67546909	15	67254571	620111	611798	rs1567037561	NC_000015.10:67254570:G:A
NM_014232.3:c.135_137del	VAMP2		NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS	Pathogenic(Last reviewed: Feb 1, 2020)	no assertion criteria provided	VCV000810679	17	8065071 - 8065073	17	8161753 - 8161755	810679	798965		NC_000017.11:8161752:ATGATG:ATG
NM_014232.3:c.128_130del	VAMP2		NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS	Pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000810678					810678	798964		
NM_014232.3(VAMP2):c.230T>C (p.Phe77Ser)	VAMP2	F77S, F79S	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS	Pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000810677	17	8064978	17	8161660	810677	798963		NC_000017.11:8161659:A:G
NM_014232.3(VAMP2):c.233A>C (p.Glu78Ala)	VAMP2	E78A, E80A	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS	Pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000810676	17	8064975	17	8161657	810676	798962		NC_000017.11:8161656:T:G
NM_014232.3(VAMP2):c.223T>C (p.Ser75Pro)	VAMP2	S75P, S77P	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS	Pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000810675	17	8064985	17	8161667	810675	798961		NC_000017.11:8161666:A:G
NM_001260.3(CDK8):c.669A>G (p.Ile223Met)	CDK8	I223M, I50M	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Jan 27, 2020)	no assertion criteria provided	VCV000805985	13	26967526	13	26393389	805985	794321		NC_000013.11:26393388:A:G
NM_001260.2:c.578T>G	CDK8	V193G	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Jan 28, 2020)	no assertion criteria provided	VCV000805984					805984	794320		
NM_001260.3(CDK8):c.88G>A (p.Gly30Ser)	CDK8	G30S	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Jan 27, 2020)	no assertion criteria provided	VCV000805983	13	26828866	13	26254729	805983	794319		NC_000013.11:26254728:G:A
NM_001260.3(CDK8):c.85C>G (p.Arg29Gly)	CDK8	R29G	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Jan 27, 2020)	no assertion criteria provided	VCV000805982	13	26828863	13	26254726	805982	794318		NC_000013.11:26254725:C:G
NM_001260.3(CDK8):c.185C>T (p.Ser62Leu)	CDK8	S62L	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Jan 27, 2020)	no assertion criteria provided	VCV000805981	13	26911760	13	26337623	805981	794317		NC_000013.11:26337622:C:T
NM_014232.2:c.[128_130delTGG]	VAMP2		Severe neurodevelopmental delay	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666257	17	8065078 - 8065080	17	8161760 - 8161762	666257	653823		NC_000017.11:8161759:CCACCACC:CCACC
NM_001079537.2(TRAPPC6B):c.124C>T (p.Arg42Ter)	TRAPPC6B	R42*	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY	Pathogenic(Last reviewed: Mar 26, 2018)	no assertion criteria provided	VCV000488424	14	39628712	14	39159508	488424	481280	rs377626365	NC_000014.9:39159507:G:A
NM_001079537.2(TRAPPC6B):c.150-2A>G	TRAPPC6B		NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY	Pathogenic(Last reviewed: Mar 13, 2018)	no assertion criteria provided	VCV000488423	14	39627608	14	39158404	488423	481279	rs1347223331	NC_000014.9:39158403:T:C
NM_001271885.1(AAGAB):c.543+1G>A	AAGAB		Keratosis palmoplantaris papulosa	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039737	15	67495885	15	67203547	39737	48336	rs753247583	NC_000015.10:67203546:C:T
NM_001271885.1(AAGAB):c.-127_-124del	AAGAB	F67fs	Keratosis palmoplantaris papulosa	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039736	15	67529028 - 67529031	15	67236690 - 67236693	39736	48335	rs1567027610	NC_000015.10:67236689:AAGAAA:AA
NM_001271885.1(AAGAB):c.146del (p.Gly49fs)	AAGAB	G158fs, G49fs	Keratosis palmoplantaris papulosa	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039735	15	67524214	15	67231876	39735	48334	rs781596375	NC_000015.10:67231875:CC:C
NM_001271885.1(AAGAB):c.43C>T (p.Arg15Ter)	AAGAB	R124*, R15*	Keratosis palmoplantaris papulosa	Pathogenic(Last reviewed: Oct 5, 2012)	no assertion criteria provided	VCV000039733	15	67528398	15	67236060	39733	48332	rs200564757	NC_000015.10:67236059:G:A
NM_001025195.2(CES1):c.783del (p.Asp261fs)	CES1	D260fs, D261fs	DRUG METABOLISM, ALTERED, CES1-RELATED	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000017603	16	55854302	16	55820390	17603	32642	rs778068631	NC_000016.10:55820389:A:
NM_001260.3(CDK8):c.185C>A (p.Ser62Ter)	CDK8	S62*	Ebstein anomaly of the tricuspid valve|Stillbirth|Abnormal facial shape|Congenital diaphragmatic hernia|Ventriculomegaly|Common atrium|Abnormal heart morphology	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000631491	13	26911760	13	26337623	631491	619854	rs1565977796	NC_000013.11:26337622:C:A
NM_001271885.1(AAGAB):c.19_20AG[1] (p.Arg7fs)	AAGAB		Keratosis palmoplantaris papulosa	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039734	15	67528758 - 67528759	15	67236420 - 67236421	39734	48333	rs1567027297	NC_000015.10:67236419:CTCT:CT
NM_001271885.1(AAGAB):c.154C>T (p.Arg52Ter)	AAGAB	R161*, R52*	Keratosis palmoplantaris papulosa	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039732	15	67524206	15	67231868	39732	48331	rs746488412	NC_000015.10:67231867:G:A
NM_001025195.2(CES1):c.428G>A (p.Gly143Glu)	CES1	G143E, G142E	DRUG METABOLISM, ALTERED, CES1-RELATED	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000017602	16	55857573	16	55823661	17602	32641	rs121912777	NC_000016.10:55823660:C:T
NM_024496.4(IRF2BPL):c.599_608del (p.Pro200fs)	IRF2BPL	P200fs	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803038	14	77493528 - 77493537	14	77027185 - 77027194	803038	791423		NC_000014.9:77027184:GTTGGTTTGGG:G
NM_024496.4(IRF2BPL):c.499C>T (p.Gln167Ter)	IRF2BPL	Q167*	not provided	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000620458	14	77493637	14	77027294	620458	611788	rs1566786613	NC_000014.9:77027293:G:A
IRF2BPL, 2-BP DEL, 2135GT	IRF2BPL		NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES	Pathogenic(Last reviewed: Apr 10, 2019)	no assertion criteria provided	VCV000599203					599203	590380		
NM_024496.4(IRF2BPL):c.962del (p.Ala321fs)	IRF2BPL	A321fs	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES	Pathogenic(Last reviewed: Apr 10, 2019)	no assertion criteria provided	VCV000599202	14	77493174	14	77026831	599202	590379	rs1566786207	NC_000014.9:77026830:G:
NM_024496.4(IRF2BPL):c.1254G>C (p.Lys418Asn)	IRF2BPL	K418N	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES	Pathogenic(Last reviewed: Dec 20, 2018)	no assertion criteria provided	VCV000559612	14	77492882	14	77026539	559612	550333	rs201073695	NC_000014.9:77026538:C:G
NM_024496.4(IRF2BPL):c.1115C>G (p.Pro372Arg)	IRF2BPL	P372R	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES	Pathogenic(Last reviewed: Dec 20, 2018)	no assertion criteria provided	VCV000559611	14	77493021	14	77026678	559611	550332	rs1555377336	NC_000014.9:77026677:G:C
NM_024496.4(IRF2BPL):c.376C>T (p.Gln126Ter)	IRF2BPL	Q126*	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES	Pathogenic(Last reviewed: Dec 20, 2018)	no assertion criteria provided	VCV000559610	14	77493760	14	77027417	559610	550331	rs1555377483	NC_000014.9:77027416:G:A
NM_024496.4(IRF2BPL):c.379C>T (p.Gln127Ter)	IRF2BPL	Q127*	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES	Pathogenic(Last reviewed: Dec 20, 2018)	no assertion criteria provided	VCV000559609	14	77493757	14	77027414	559609	550330	rs1292724234	NC_000014.9:77027413:G:A
NM_012106.4(ARL2BP):c.207+1G>T	ARL2BP		Retinitis pigmentosa 82 with or without situs inversus	Pathogenic(Last reviewed: Aug 8, 2018)	no assertion criteria provided	VCV000559501	16	57282556	16	57248644	559501	550225	rs199830550	NC_000016.10:57248643:G:T
NM_001190919.1(THRA):c.1110+83C>G	THRA	P398R	Hypothyroidism, congenital, nongoitrous, 6	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000192273	17	38245669	17	40089416	192273	190073	rs876657396	NC_000017.11:40089415:C:G
NM_001190919.1(THRA):c.1110+97G>A	THRA	E403K	Hypothyroidism, congenital, nongoitrous, 6	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000192272	17	38245683	17	40089430	192272	190072	rs876657395	NC_000017.11:40089429:G:A
NM_001190919.1(THRA):c.1110+66C>A	THRA	C392*	Hypothyroidism, congenital, nongoitrous, 6	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000192271	17	38245652	17	40089399	192271	190071	rs876657394	NC_000017.11:40089398:C:A
NM_012106.4(ARL2BP):c.134T>G (p.Met45Arg)	ARL2BP	M45R	Retinitis pigmentosa 82 with or without situs inversus	Pathogenic(Last reviewed: Aug 8, 2013)	no assertion criteria provided	VCV000065474	16	57282482	16	57248570	65474	76386	rs398123053	NC_000016.10:57248569:T:G
NM_001190919.1(THRA):c.1110G>C (p.Lys370Asn)	THRA	K370N	Hypothyroidism, congenital, nongoitrous, 6	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000029914	17	38245586	17	40089333	29914	38869	rs137853163	NC_000017.11:40089332:G:C
NM_001190919.1(THRA):c.134G>T (p.Ser45Ile)	THRA	E403*, S45I	Hypothyroidism, congenital, nongoitrous, 6	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000029913	17	38233773	17	40077520	29913	38868	rs137853162	NC_000017.11:40077519:G:T
NM_012106.4(ARL2BP):c.38+2T>G	ARL2BP		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812223	16	57279319	16	57245407	812223	800700		NC_000016.10:57245406:T:G
NM_005208.4(CRYBA1):c.269_271GAG[1] (p.Gly91del)	CRYBA1	G91del	Cataract, congenital zonular, with sutural opacities|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000425127	17	27579135 - 27579137	17	29252117 - 29252119	425127	413461	rs1064797219	NC_000017.11:29252116:GAGGAG:GAG
NM_024496.4(IRF2BPL):c.562C>T (p.Arg188Ter)	IRF2BPL	R188*	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES|IRF2BPL-related condition	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000559608	14	77493574	14	77027231	559608	550329	rs1345176461	NC_000014.9:77027230:G:A
NM_012106.4(ARL2BP):c.101-1G>C	ARL2BP		Retinitis pigmentosa 82 with or without situs inversus|Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000065473	16	57282448	16	57248536	65473	76385	rs879255568	NC_000016.10:57248535:G:C
MIR140, 24A-G	MIR140		SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	Pathogenic(Last reviewed: Oct 9, 2019)	no assertion criteria provided	VCV000691804					691804	679519		
NM_000223.4(KRT12):c.395T>C (p.Leu132Pro)	KRT12	L132P	Meesmann corneal dystrophy 1	Pathogenic(Last reviewed: Feb 4, 2020)	no assertion criteria provided	VCV000254686	17	39023044	17	40866792	254686	249262	rs886038212	NC_000017.11:40866791:A:G
NM_000223.4(KRT12):c.386T>C (p.Met129Thr)	KRT12	M129T	not provided|Meesmann corneal dystrophy 1	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000007927	17	39023053	17	40866801	7927	22966	rs28936695	NC_000017.11:40866800:A:G
NM_000223.4(KRT12):c.419T>G (p.Leu140Arg)	KRT12	L140R	not provided|Meesmann corneal dystrophy 1	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000007926	17	39023020	17	40866768	7926	22965	rs58918655	NC_000017.11:40866767:A:C
NM_000223.4(KRT12):c.1285T>G (p.Tyr429Asp)	KRT12	Y429D	not provided|Meesmann corneal dystrophy 1	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000007925	17	39019406	17	40863154	7925	22964	rs58162394	NC_000017.11:40863153:A:C
NM_000223.4(KRT12):c.404G>T (p.Arg135Ile)	KRT12	R135I	not provided|Meesmann corneal dystrophy 1	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000007924	17	39023035	17	40866783	7924	22963	rs57218384	NC_000017.11:40866782:C:A
NM_000223.4(KRT12):c.403A>G (p.Arg135Gly)	KRT12	R135G	not provided|Meesmann corneal dystrophy 1	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000007923	17	39023036	17	40866784	7923	22962	rs58410481	NC_000017.11:40866783:T:C
NM_000223.4(KRT12):c.427G>C (p.Val143Leu)	KRT12	V143L	not provided|Meesmann corneal dystrophy 1	Pathogenic(Last reviewed: Jun 1, 1997)	no assertion criteria provided	VCV000007922	17	39023012	17	40866760	7922	22961	rs58343600	NC_000017.11:40866759:C:G
NM_000223.4(KRT12):c.404G>C (p.Arg135Thr)	KRT12	R135T	Meesmann corneal dystrophy 1|not provided	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000007921	17	39023035	17	40866783	7921	22960	rs57218384	NC_000017.11:40866782:C:G
NM_003394.4(WNT10B):c.817dup (p.Ala273fs)	WNT10B		Split-hand/foot malformation 6	Pathogenic(Last reviewed: Sep 27, 2018)	no assertion criteria provided	VCV000634647	12	49360230 - 49360231	12	48966447 - 48966448	634647	622518	rs1555177994	NC_000012.12:48966447:CCCCC:CCCCCC
NM_003394.4(WNT10B):c.817del (p.Ala273fs)	WNT10B	A273fs	Split-hand/foot malformation 6	Pathogenic(Last reviewed: Sep 27, 2018)	no assertion criteria provided	VCV000634645	12	49360231	12	48966448	634645	622517	rs1555177994	NC_000012.12:48966447:CCCCC:CCCC
NM_015932.6(POMP):c.342_348delinsACC (p.Phe114fs)	POMP		PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2	Pathogenic(Last reviewed: Jul 17, 2018)	no assertion criteria provided	VCV000548960	13	29246553 - 29246559	13	28672416 - 28672422	548960	539442	rs1555257076	NC_000013.11:28672415:TGAGGAT:ACC
NM_003394.4(WNT10B):c.786G>A (p.Trp262Ter)	WNT10B	W262*	Tooth agenesis, selective, 8	Pathogenic(Last reviewed: Aug 16, 2016)	no assertion criteria provided	VCV000253058	12	49360262	12	48966479	253058	247469	rs766021478	NC_000012.12:48966478:C:T
NM_003394.4(WNT10B):c.632G>A (p.Arg211Gln)	WNT10B	R211Q	Tooth agenesis, selective, 8	Pathogenic(Last reviewed: Aug 16, 2016)	no assertion criteria provided	VCV000253057	12	49361808	12	48968025	253057	247468	rs779326570	NC_000012.12:48968024:C:T
NM_173849.2(GSC):c.355+1G>C	GSC		Short stature, auditory canal atresia, mandibular hypoplasia, and skeletal abnormalities	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000126524	14	95235997	14	94769660	126524	132048	rs587777290	NC_000014.9:94769659:C:G
NM_173849.2(GSC):c.196_212del (p.Gly66fs)	GSC	G66fs	Short stature, auditory canal atresia, mandibular hypoplasia, and skeletal abnormalities	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000126522	14	95236141 - 95236157	14	94769804 - 94769820	126522	132046	rs587777288	NC_000014.9:94769803:GCCGGGAGGCCCGCGCCGCCGGG:GCCGGG
NM_003394.4(WNT10B):c.458_461dup (p.Asp155fs)	WNT10B		Split-hand/foot malformation 6	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000030237	12	49361978 - 49361979	12	48968195 - 48968196	30237	39193		NC_000012.12:48968195:TGCT:TGCTTGCT
NM_005977.4(RNF6):c.731G>A (p.Gly244Asp)	RNF6	G244D	Esophageal squamous cell carcinoma, somatic	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000005702	13	26789288	13	26215151	5702	20741	rs121434524	NC_000013.11:26215150:C:T
NM_005977.4(RNF6):c.724G>A (p.Ala242Thr)	RNF6	A242T	Esophageal squamous cell carcinoma, somatic	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000005701	13	26789295	13	26215158	5701	20740	rs121434523	NC_000013.11:26215157:C:T
NM_005977.4(RNF6):c.305G>A (p.Arg102Lys)	RNF6	R102K	Esophageal squamous cell carcinoma, somatic	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000005700	13	26789714	13	26215577	5700	20739	rs121434522	NC_000013.11:26215576:C:T
NM_015932.5(POMP):c.-95del	POMP		Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	Pathogenic(Last reviewed: Apr 9, 2010)	no assertion criteria provided	VCV000000116	13	29233226	13	28659089	116	15155	rs112368783	
NM_003394.4(WNT10B):c.689_691ACA[2] (p.Asn232del)	WNT10B	N232del	Split-hand/foot malformation 6	Pathogenic(Last reviewed: Oct 7, 2019)	no assertion criteria provided	VCV000599263	12	49361743 - 49361745	12	48967960 - 48967962	599263	590508	rs776938956	NC_000012.12:48967959:TGTTGTTGT:TGTTGT
NM_015932.6(POMP):c.340_344dup (p.Glu115fs)	POMP		PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2	Pathogenic(Last reviewed: Jul 17, 2018)	no assertion criteria provided	VCV000548959	13	29246548 - 29246549	13	28672411 - 28672412	548959	539441	rs1555257075	NC_000013.11:28672411:GATTTGA:GATTTGATTTGA
NM_173849.2(GSC):c.400C>T (p.Gln134Ter)	GSC	Q134*	Short stature, auditory canal atresia, mandibular hypoplasia, and skeletal abnormalities	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000126523	14	95235510	14	94769173	126523	132047	rs587777289	NC_000014.9:94769172:G:A
NM_003394.4(WNT10B):c.994C>T (p.Arg332Trp)	WNT10B	R332W	Split-hand/foot malformation 6	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000007630	12	49360054	12	48966271	7630	22669	rs121918349	NC_000012.12:48966270:G:A
NM_015932.6(POMP):c.334_335del (p.Ile112fs)	POMP	I112fs	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2	Pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	VCV000522801	13	29246544 - 29246545	13	28672407 - 28672408	522801	513446	rs1555257073	NC_000013.11:28672406:TAT:T
NM_001797.4(CDH11):c.696C>G (p.Tyr232Ter)	CDH11	Y232*, Y106*	Brachioskeletogenital syndrome	Pathogenic(Last reviewed: Apr 27, 2018)	no assertion criteria provided	VCV000523099	16	65025786	16	64991883	523099	513723	rs1555515924	NC_000016.10:64991882:G:C
NM_001797.4(CDH11):c.1116_1117delinsGATCATCAG (p.Ile372fs)	CDH11		Brachioskeletogenital syndrome	Pathogenic(Last reviewed: Apr 27, 2018)	no assertion criteria provided	VCV000523098	16	65016087 - 65016088	16	64982184 - 64982185	523098	513722	rs1555514463	NC_000016.10:64982183:AG:CTGATGATC
NM_001031679.3(MSRB3):c.55C>T (p.Arg19Ter)	MSRB3	R19*	Deafness, autosomal recessive 74	Pathogenic(Last reviewed: Jan 7, 2011)	no assertion criteria provided	VCV000031056	12	65702414	12	65308634	31056	40013	rs149258390	NC_000012.12:65308633:C:T
NM_001031679.3(MSRB3):c.391-1G>A	MSRB3		Deafness, autosomal recessive 74	Pathogenic	criteria provided, single submitter	VCV000562077	12	65856934	12	65463154	562077	553269	rs751906778	NC_000012.12:65463153:G:A
NM_001797.4(CDH11):c.999+1G>T	CDH11		Brachioskeletogenital syndrome	Pathogenic(Last reviewed: Apr 27, 2018)	no assertion criteria provided	VCV000523097	16	65022059	16	64988156	523097	513721	rs1555515331	NC_000016.10:64988155:C:A
NM_001031679.3(MSRB3):c.244T>G (p.Cys82Gly)	MSRB3	C89G, C82G	Deafness, autosomal recessive 74	Pathogenic(Last reviewed: Jan 7, 2011)	no assertion criteria provided	VCV000031055	12	65722364	12	65328584	31055	40012	rs387907088	NC_000012.12:65328583:T:G
NM_001029.5(RPS26):c.219C>G (p.Tyr73Ter)	RPS26	Y73*	not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000489313	12	56437184	12	56043400	489313	482027	rs150229551	NC_000012.12:56043399:C:G
NM_000937.5(POLR2A):c.3371T>C (p.Leu1124Pro)	POLR2A	L1124P	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000691501	17	7411700	17	7508381	691501	679187		NC_000017.11:7508380:T:C
NM_000937.5(POLR2A):c.2207C>T (p.Thr736Met)	POLR2A	T736M	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000691500	17	7404906	17	7501587	691500	679186		NC_000017.11:7501586:C:T
NM_000937.5(POLR2A):c.2203C>T (p.Gln735Ter)	POLR2A	Q735*	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000691499	17	7404902	17	7501583	691499	679185		NC_000017.11:7501582:C:T
NM_000937.5(POLR2A):c.2098C>T (p.Gln700Ter)	POLR2A	Q700*	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000691498	17	7404655	17	7501336	691498	679184		NC_000017.11:7501335:C:T
NM_000937.5(POLR2A):c.1370T>C (p.Ile457Thr)	POLR2A	I457T	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000691497	17	7402392	17	7499073	691497	679183		NC_000017.11:7499072:T:C
NM_003562.5(SLC25A11):c.107_108del (p.Thr36fs)	SLC25A11	T36fs, T25fs	PARAGANGLIOMAS 6	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000635130	17	4842495 - 4842496	17	4939200 - 4939201	635130	622965	rs1374026152	NC_000017.11:4939199:TGT:T
NM_003562.5(SLC25A11):c.421G>A (p.Glu141Lys)	SLC25A11	E141K, E130K, E90K	PARAGANGLIOMAS 6	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000635129	17	4842098	17	4938803	635129	622964	rs1567651815	NC_000017.11:4938802:C:T
NM_003562.5(SLC25A11):c.708C>T (p.Ala236=)	SLC25A11	A236A	PARAGANGLIOMAS 6	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000635128	17	4841478	17	4938183	635128	622963	rs1567650874	NC_000017.11:4938182:G:A
NM_003562.5(SLC25A11):c.439A>G (p.Met147Val)	SLC25A11	M147V, M136V, M96V	PARAGANGLIOMAS 6	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000635127	17	4842080	17	4938785	635127	622962	rs1203876038	NC_000017.11:4938784:T:C
NM_003562.5(SLC25A11):c.715C>A (p.Pro239Thr)	SLC25A11	P239T, P228T, P188T	PARAGANGLIOMAS 6	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000635126	17	4841471	17	4938176	635126	622961	rs1567650859	NC_000017.11:4938175:G:T
NM_001029.5(RPS26):c.1A>C (p.Met1Leu)	RPS26	M1L	Bone marrow hypocellularity	Pathogenic	criteria provided, single submitter	VCV000598993	12	56435951	12	56042167	598993	590067	rs143951267	NC_000012.12:56042166:A:C
NM_004184.4(WARS1):c.770A>G (p.His257Arg)	WARS1	H257R, H216R		Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000441278	14	100813139	14	100346802	441278	434934	rs770003315	NC_000014.9:100346801:T:C
NM_004527.4(MEOX1):c.250C>T (p.Gln84Ter)	MEOX1	Q84*	Klippel-Feil syndrome 2, autosomal recessive	Pathogenic(Last reviewed: Sep 28, 2013)	no assertion criteria provided	VCV000162132	17	41738653	17	43661285	162132	171847	rs713993044	NC_000017.11:43661284:G:A
NM_001424.6(EMP2):c.28G>A (p.Ala10Thr)	EMP2	A10T	Nephrotic syndrome, type 10	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139533	16	10641447	16	10547590	139533	143177	rs587777482	NC_000016.10:10547589:C:T
NM_001424.6(EMP2):c.21C>G (p.Phe7Leu)	EMP2	F7L	Nephrotic syndrome, type 10	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139532	16	10641454	16	10547597	139532	143176	rs730882194	NC_000016.10:10547596:G:C
NM_001424.6(EMP2):c.184C>T (p.Gln62Ter)	EMP2	Q62*	Nephrotic syndrome, type 10	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139531	16	10631917	16	10538060	139531	143175	rs587777481	NC_000016.10:10538059:G:A
NM_004527.4(MEOX1):c.664C>T (p.Arg222Ter)	MEOX1	R222*, P164L, R107*	Klippel-Feil syndrome 2, autosomal recessive	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039508	17	41719379	17	43642011	39508	48107	rs772798486	NC_000017.11:43642010:G:A
NM_004527.4(MEOX1):c.94del (p.Ala32fs)	MEOX1	A32fs	Klippel-Feil syndrome 2, autosomal recessive	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039507	17	41738809	17	43661441	39507	48106	rs1567750527	NC_000017.11:43661440:CCCC:CCC
NM_001029.5(RPS26):c.3+1G>A	RPS26		Diamond-Blackfan anemia 10	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000006126	12	56435954	12	56042170	6126	21165	rs148622862	NC_000012.12:56042169:G:A
NM_001029.5(RPS26):c.31dup (p.Ala11fs)	RPS26		Diamond-Blackfan anemia 10	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000006125	12	56436235 - 56436236	12	56042451 - 56042452	6125	21164	rs786200892	NC_000012.12:56042451:G:GG
NM_001029.5(RPS26):c.97G>A (p.Asp33Asn)	RPS26	D33N	Diamond-Blackfan anemia 10	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000006124	12	56436302	12	56042518	6124	21163	rs267607023	NC_000012.12:56042517:G:A
NM_001029.5(RPS26):c.1A>T (p.Met1Leu)	RPS26	M1L	Diamond-Blackfan anemia 10	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000006123	12	56435951	12	56042167	6123	21162	rs143951267	NC_000012.12:56042166:A:T
NM_001029.5(RPS26):c.55C>T (p.Gln19Ter)	RPS26	Q19*	Diamond-Blackfan anemia 10	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212066	12	56436260	12	56042476	212066	207984	rs797045919	NC_000012.12:56042475:C:T
NM_001029.5(RPS26):c.4-2A>T	RPS26		Diamond-Blackfan anemia 10|Diamond-Blackfan anemia 15 with mandibulofacial dysostosis	Pathogenic(Last reviewed: May 19, 2015)	criteria provided, single submitter	VCV000187850	12	56436207	12	56042423	187850	185741	rs786203998	NC_000012.12:56042422:A:T
NM_001029.5(RPS26):c.259C>T (p.Arg87Ter)	RPS26	R87*	Diamond-Blackfan anemia 10|Diamond-Blackfan anemia 15 with mandibulofacial dysostosis	Pathogenic(Last reviewed: May 19, 2015)	criteria provided, single submitter	VCV000187849	12	56437224	12	56043440	187849	185740	rs148942765	NC_000012.12:56043439:C:T
NM_001029.5(RPS26):c.1A>G (p.Met1Val)	RPS26	M1V	Diamond-Blackfan anemia 10	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000006122	12	56435951	12	56042167	6122	21161	rs143951267	NC_000012.12:56042166:A:G
NM_031293.3(PMFBP1):c.2278_2281del (p.Lys760fs)	PMFBP1	K760fs, K615fs	SPERMATOGENIC FAILURE 31	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000807468	16	72159277 - 72159280	16	72125378 - 72125381	807468	798703		NC_000016.10:72125377:TCTTT:T
NM_031293.3(PMFBP1):c.327T>A (p.Tyr109Ter)	PMFBP1	Y109*	SPERMATOGENIC FAILURE 31	Pathogenic(Last reviewed: Mar 11, 2019)	no assertion criteria provided	VCV000619947	16	72188197	16	72154298	619947	611344	rs759127010	NC_000016.10:72154297:A:T
NM_031293.3(PMFBP1):c.2561_2562del (p.Lys854fs)	PMFBP1	K709fs, K854fs	SPERMATOGENIC FAILURE 31	Pathogenic(Last reviewed: Mar 12, 2019)	no assertion criteria provided	VCV000619946	16	72158693 - 72158694	16	72124794 - 72124795	619946	611343	rs772371753	NC_000016.10:72124793:TTTT:TT
NM_031293.3(PMFBP1):c.2092del (p.Ala698fs)	PMFBP1	A698fs, A553fs	SPERMATOGENIC FAILURE 31	Pathogenic(Last reviewed: Sep 7, 2018)	no assertion criteria provided	VCV000560419	16	72160028	16	72126129	560419	551502	rs1567621034	NC_000016.10:72126128:C:
NM_031293.3(PMFBP1):c.2725C>T (p.Arg909Ter)	PMFBP1	R909*, R764*	SPERMATOGENIC FAILURE 31	Pathogenic(Last reviewed: Sep 7, 2018)	no assertion criteria provided	VCV000560418	16	72156856	16	72122957	560418	551501	rs140352254	NC_000016.10:72122956:G:A
NM_031293.3(PMFBP1):c.1462C>T (p.Gln488Ter)	PMFBP1	Q488*, Q343*	SPERMATOGENIC FAILURE 31	Pathogenic(Last reviewed: Sep 7, 2018)	no assertion criteria provided	VCV000560417	16	72164607	16	72130708	560417	551500	rs777263062	NC_000016.10:72130707:G:A
NM_133368.3(RSPRY1):c.121G>T (p.Gly41Cys)	RSPRY1	G41C	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	Pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000218886	16	57238691	16	57204779	218886	215643	rs864309652	NC_000016.10:57204778:G:T
NM_133368.3(RSPRY1):c.1279dup (p.Thr427fs)	RSPRY1		Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	Pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000218885	16	57264627 - 57264628	16	57230715 - 57230716	218885	215642	rs864309651	NC_000016.10:57230715:A:AA
NM_152336.4(AGBL1):c.3107G>C (p.Cys1036Ser)	AGBL1	C990S, C1036S	Corneal dystrophy, Fuchs endothelial, 8	Pathogenic(Last reviewed: Oct 3, 2013)	no assertion criteria provided	VCV000088758	15	87217553	15	86674322	88758	94339	rs181958589	NC_000015.10:86674321:G:C
NM_005853.6(IRX5):c.1362_1368delinsGT (p.Lys455fs)	IRX5		Hamamy syndrome	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374379	16	54967695 - 54967701	16	54933783 - 54933789	374379	361220	rs1057518725	NC_000016.10:54933782:TAAAGAC:GT
NM_005853.6(IRX5):c.448G>C (p.Ala150Pro)	IRX5	A150P	Hamamy syndrome	Pathogenic(Last reviewed: May 13, 2012)	no assertion criteria provided	VCV000031911	16	54966608	16	54932696	31911	40567	rs387907198	NC_000016.10:54932695:G:C
NM_005853.6(IRX5):c.498C>A (p.Asn166Lys)	IRX5	N166K	Hamamy syndrome	Pathogenic(Last reviewed: May 13, 2012)	no assertion criteria provided	VCV000031910	16	54966658	16	54932746	31910	40566	rs786200931	NC_000016.10:54932745:C:A
NM_001085.4(SERPINA3):c.233T>C (p.Leu78Pro)	SERPINA3	L55P, L78P	ANTICHYMOTRYPSIN BOCHUM 1	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	VCV000018049	14	95081011	14	94614674	18049	33088	rs1800463	NC_000014.9:94614673:T:C
NM_014990.3(RALGAPA1):c.3227A>G (p.Asn1076Ser)	RALGAPA1	N1535S, N1582S, N1076S, N1089S, N1123S	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION|Generalized hypotonia|Respiratory distress|Feeding difficulties|Infantile spasms	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000691798	14	36143795	14	35674589	691798	679513		NC_000014.9:35674588:T:C
NM_014990.3(RALGAPA1):c.5732C>G (p.Ser1911Ter)	RALGAPA1	S1911*, S1958*, S2370*, S1924*, S2417*	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION|Generalized hypotonia|Respiratory distress|Feeding difficulties|Infantile spasms	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000691797	14	36041884	14	35572678	691797	679512		NC_000014.9:35572677:G:C
NM_014990.3(RALGAPA1):c.610G>T (p.Glu204Ter)	RALGAPA1	E204*	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION|Generalized hypotonia|Respiratory distress|Feeding difficulties|Infantile spasms	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000691796	14	36226052	14	35756846	691796	679511		NC_000014.9:35756845:C:A
NM_014990.3(RALGAPA1):c.4992del (p.Phe1664fs)	RALGAPA1	F1711fs, F2123fs, F2170fs, F1664fs, F1677fs	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION|Generalized hypotonia|Respiratory distress|Feeding difficulties|Infantile spasms	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000691795	14	36096643	14	35627437	691795	679510		NC_000014.9:35627436:AAA:AA
NM_014990.3(RALGAPA1):c.1126C>T (p.Arg376Ter)	RALGAPA1	R376*	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION|Generalized hypotonia|Respiratory distress|Feeding difficulties|Infantile spasms	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000691794	14	36217916	14	35748710	691794	679509		NC_000014.9:35748709:G:A
NM_032656.4(DHX37):c.1399C>T (p.Leu467=)	DHX37	L467V	NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES	Pathogenic(Last reviewed: Jan 22, 2020)	no assertion criteria provided	VCV000804277	12	125453089	12	124968543	804277	792633		NC_000012.12:124968542:G:A
NM_016194.4(GNB5):c.1032C>A (p.Tyr344Ter)	GNB5	Y344*, Y302*	not provided	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000450608	15	52416814	15	52124617	450608	445389	rs749597091	NC_000015.10:52124616:G:T
NM_014055.4(IFT81):c.723_724del (p.Arg242fs)	IFT81	R242fs	not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000834402	12	110574606 - 110574607	12	110136801 - 110136802	834402	839293		NC_000012.12:110136800:AAA:A
Single allele	IFT81		SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY	Pathogenic(Last reviewed: Jul 3, 2018)	no assertion criteria provided	VCV000560182	12	110576651 - 110589026			560182	550898		
NM_016617.4(UFM1):c.241C>T (p.Arg81Cys)	UFM1	R81C, R79C, R99C	LEUKODYSTROPHY, HYPOMYELINATING, 14	Pathogenic(Last reviewed: Aug 7, 2018)	no assertion criteria provided	VCV000559446	13	38934898	13	38360761	559446	550170	rs1033946108	NC_000013.11:38360760:C:T
NM_016194.4(GNB5):c.1120C>T (p.Arg374Ter)	GNB5	R332*, R374*	Intellectual developmental disorder with cardiac arrhythmia	Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	VCV000268099	15	52416726	15	52124529	268099	263625	rs773902879	NC_000015.10:52124528:G:A
NM_016194.4(GNB5):c.375G>A (p.Gln125=)	GNB5		Intellectual developmental disorder with cardiac arrhythmia	Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	VCV000268098	15	52446137	15	52153940	268098	263624	rs886041054	NC_000015.10:52153939:C:T
NM_021044.4(DHH):c.1086del (p.Leu363fs)	DHH	L363fs	46,XY gonadal dysgenesis, complete, dhh-related	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000005012	12	49483747	12	49089964	5012	20051		NC_000012.12:49089963:C:
NM_021044.4(DHH):c.485T>C (p.Leu162Pro)	DHH	L162P	46,XY gonadal dysgenesis, complete, dhh-related	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000005011	12	49484991	12	49091208	5011	20050	rs111033589	NC_000012.12:49091207:A:G
NM_014055.4(IFT81):c.1213C>T (p.Arg405Ter)	IFT81	R405*, R95*	not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000864626	12	110618251	12	110180446	864626	839298		NC_000012.12:110180445:C:T
NM_021044.4(DHH):c.371G>A (p.Arg124Gln)	DHH	R124Q	46,XY gonadal dysgenesis, partial, with minifascicular neuropathy	Pathogenic	criteria provided, single submitter	VCV000560406	12	49485105	12	49091322	560406	551459	rs1565573892	NC_000012.12:49091321:C:T
NM_016194.4(GNB5):c.348_352del (p.Asp116fs)	GNB5	D116fs, D74fs	not provided|Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia|Intellectual developmental disorder with cardiac arrhythmia	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000426541	15	52446160 - 52446164	15	52153963 - 52153967	426541	415438	rs1085307675	NC_000015.10:52153962:TCTTATCTT:TCTT
NM_016194.4(GNB5):c.375+3A>G	GNB5		Intellectual developmental disorder with cardiac arrhythmia	Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	VCV000268101	15	52446134	15	52153937	268101	263627	rs766004901	NC_000015.10:52153936:T:C
NM_016194.4(GNB5):c.375+1G>T	GNB5		Intellectual developmental disorder with cardiac arrhythmia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000268100	15	52446136	15	52153939	268100	263626	rs886041055	NC_000015.10:52153938:C:A
NM_021044.4(DHH):c.2T>C (p.Met1Thr)	DHH	M1T	46,XY gonadal dysgenesis, partial, with minifascicular neuropathy	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000005010	12	49488294	12	49094511	5010	20049	rs104894346	NC_000012.12:49094510:A:G
NM_032656.4(DHX37):c.278G>A (p.Arg93Gln)	DHX37	R93Q	NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES|Neurodevelopmental delay|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2020)	no assertion criteria provided	VCV000691927	12	125467168	12	124982622	691927	679686		NC_000012.12:124982621:C:T
NM_032656.4(DHX37):c.2191G>A (p.Val731Met)	DHX37	V731M	NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES|Neurodevelopmental delay|Intellectual disability|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2020)	no assertion criteria provided	VCV000691926	12	125441648	12	124957102	691926	679682		NC_000012.12:124957101:C:T
NM_021044.4(DHH):c.528C>G (p.Tyr176Ter)	DHH	Y176*	46,XY sex reversal, type 7	Pathogenic	no assertion criteria provided	VCV000561189	12	49484948	12	49091165	561189	552295	rs1565573786	NC_000012.12:49091164:G:C
NM_032656.4(DHX37):c.500_501inv (p.Glu167Ala)	DHX37	E167S	NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES|Neurodevelopmental delay|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000691928	12	125465273 - 125465274	12	124980727 - 124980728	691928	679685		NC_000012.12:124980727:TC:GA
NM_021044.4(DHH):c.1011del (p.Asn337fs)	DHH	N337fs	46,XY sex reversal, type 7	Pathogenic	criteria provided, single submitter	VCV000561188	12	49483822	12	49090039	561188	552294	rs1565572949	NC_000012.12:49090038:G:
NM_021044.4(DHH):c.528C>A (p.Tyr176Ter)	DHH	Y176*	46,XY sex reversal, type 7	Pathogenic	criteria provided, single submitter	VCV000561187	12	49484948	12	49091165	561187	552293	rs1565573786	NC_000012.12:49091164:G:T
NM_001286704.1(UFM1):c.-273_-271delTCA	UFM1		LEUKODYSTROPHY, HYPOMYELINATING, 14|not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000495149	13	38923902 - 38923904	13	38349765 - 38349767	495149	486703	rs747359907	
NM_007374.3(SIX6):c.-227_572+235del	SIX6		Congenital cornea plana|Congenital cataract|Microphthalmia|Sclerocornea	Pathogenic	criteria provided, single submitter	VCV000637953	14	60975886 - 60976919	14	60509168 - 60510201	637953	625774		
NM_007374.3(SIX6):c.547G>C (p.Asp183His)	SIX6	D183H	Congenital cataract|Nystagmus|Sclerocornea|Microcornea	Pathogenic	criteria provided, single submitter	VCV000637058	14	60976663	14	60509945	637058	624881		NC_000014.9:60509944:G:C
NM_017807.4(OSGEP):c.838C>T (p.Arg280Cys)	OSGEP	R280C	GALLOWAY-MOWAT SYNDROME 3	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000444892	14	20915805	14	20447646	444892	438534	rs374322839	NC_000014.9:20447645:G:A
NM_017807.4(OSGEP):c.839G>A (p.Arg280His)	OSGEP	R280H	GALLOWAY-MOWAT SYNDROME 3	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000444890	14	20915804	14	20447645	444890	438532	rs144732839	NC_000014.9:20447644:C:T
NM_017807.4(OSGEP):c.530G>C (p.Gly177Ala)	OSGEP	G177A	GALLOWAY-MOWAT SYNDROME 3	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000444888	14	20917150	14	20448991	444888	438530	rs778931753	NC_000014.9:20448990:C:G
NM_181783.4(TMTC3):c.3G>A (p.Met1Ile)	TMTC3	M1I	Lissencephaly 8	Pathogenic(Last reviewed: Dec 17, 2016)	no assertion criteria provided	VCV000372277	12	88542095	12	88148318	372277	359185	rs1057517698	NC_000012.12:88148317:G:A
NM_181783.4(TMTC3):c.199C>G (p.His67Asp)	TMTC3	H67D, H7D	Lissencephaly 8	Pathogenic(Last reviewed: Dec 17, 2016)	no assertion criteria provided	VCV000372276	12	88547077	12	88153300	372276	359184	rs754200057	NC_000012.12:88153299:C:G
NM_181783.4(TMTC3):c.1959_1960insTT (p.Arg654fs)	TMTC3		Lissencephaly 8	Pathogenic(Last reviewed: Dec 17, 2016)	no assertion criteria provided	VCV000372275	12	88588639 - 88588640	12	88194862 - 88194863	372275	359183	rs1057519417	NC_000012.12:88194862:T:TTT
NM_181783.4(TMTC3):c.2617C>T (p.Gln873Ter)	TMTC3	Q873*, Q813*, Q642*, Q784*, Q800*	Lissencephaly 8	Pathogenic(Last reviewed: Dec 17, 2016)	no assertion criteria provided	VCV000372274	12	88589298	12	88195521	372274	359182	rs1057517697	NC_000012.12:88195520:C:T
NM_181783.4(TMTC3):c.1462del (p.Arg488fs)	TMTC3	R415fs, R428fs, R488fs, R257fs, R399fs	Lissencephaly 8	Pathogenic(Last reviewed: Dec 17, 2016)	no assertion criteria provided	VCV000372273	12	88582648	12	88188871	372273	359181	rs1057517696	NC_000012.12:88188870:AA:A
NM_020810.3(TRMT5):c.1156A>G (p.Met386Val)	TRMT5	M386V, M413V, M414V	Combined oxidative phosphorylation deficiency 26	Pathogenic(Last reviewed: Dec 27, 2017)	no assertion criteria provided	VCV000372248	14	61442481	14	60975763	372248	359153	rs1057517685	NC_000014.9:60975762:T:C
NM_007374.3(SIX6):c.110T>C (p.Leu37Pro)	SIX6	L37P	Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000189378	14	60976226	14	60509508	189378	187260	rs786204851	NC_000014.9:60509507:T:C
NM_020810.3(TRMT5):c.872G>A (p.Arg291His)	TRMT5	R291H, R319H, R318H	Combined oxidative phosphorylation deficiency 26	Pathogenic(Last reviewed: Dec 27, 2017)	no assertion criteria provided	VCV000372247	14	61442765	14	60976047	372247	359152	rs746738473	NC_000014.9:60976046:C:T
NM_001165967.2(HES7):c.400_409dup (p.Arg137fs)	HES7		Spondylocostal dysostosis 5	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000091404	17	8025172 - 8025173	17	8121854 - 8121855	91404	96881	rs398122970	NC_000017.11:8121854:GGGGCGGTTTGGGGCG:GGGGCGGTTTGGGGCGGTTTGGGGCG
NM_001165967.2(HES7):c.172A>G (p.Ile58Val)	HES7	I58V	Spondylocostal dysostosis 5	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000030698	17	8025715	17	8122397	30698	39655	rs387906979	NC_000017.11:8122396:T:C
NM_001165967.2(HES7):c.571G>T (p.Asp191Tyr)	HES7	D186Y, D191Y	Spondylocostal dysostosis 5	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000030697	17	8025011	17	8121693	30697	39654	rs387906978	NC_000017.11:8121692:C:A
NM_017807.4(OSGEP):c.974G>A (p.Arg325Gln)	OSGEP	R325Q	GALLOWAY-MOWAT SYNDROME 3	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000444886	14	20915433	14	20447274	444886	438528	rs753237335	NC_000014.9:20447273:C:T
NM_001165967.2(HES7):c.73C>T (p.Arg25Trp)	HES7	R25W	Spondylocostal dysostosis 4, autosomal recessive|Spondylocostal dysostosis 5	Pathogenic(Last reviewed: Jan 17, 2013)	no assertion criteria provided	VCV000030696	17	8026414	17	8123096	30696	39653	rs113994160	NC_000017.11:8123095:G:A
NM_017807.4(OSGEP):c.740G>A (p.Arg247Gln)	OSGEP	R247Q	GALLOWAY-MOWAT SYNDROME 3	Pathogenic(Last reviewed: Oct 30, 2017)	no assertion criteria provided	VCV000444893	14	20916116	14	20447957	444893	438535	rs773173317	NC_000014.9:20447956:C:T
NM_145059.3(FCSK):c.2980A>C (p.Lys994Gln)	FCSK	K994Q	Congenital disorder of glycosylation with defective fucosylation 2	Pathogenic(Last reviewed: Feb 22, 2019)	no assertion criteria provided	VCV000619035	16	70513133	16	70479230	619035	610433	rs199515460	NC_000016.10:70479229:A:C
NM_016417.3(GLRX5):c.86_93dup (p.Ala32fs)	GLRX5		Spasticity, childhood-onset, with hyperglycinemia	Pathogenic(Last reviewed: Jul 26, 2018)	no assertion criteria provided	VCV000224513	14	96001505 - 96001506	14	95535168 - 95535169	224513	226291	rs869320758	NC_000014.9:95535168:CGGGCGTGCGGGCG:CGGGCGTGCGGGCGTGCGGGCG
NM_016417.3(GLRX5):c.443T>C (p.Leu148Ser)	GLRX5	L148S	Sideroblastic anemia 3, pyridoxine-refractory	Pathogenic(Last reviewed: Jul 26, 2018)	no assertion criteria provided	VCV000224511	14	96010431	14	95544094	224511	226289	rs765487627	NC_000014.9:95544093:T:C
NM_006364.4(SEC23A):c.2104A>G (p.Met702Val)	SEC23A	M702V	Craniolenticulosutural dysplasia	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000039521	14	39509974	14	39040770	39521	48120	rs138568622	NC_000014.9:39040769:T:C
NM_000239.2(LYZ):c.223T>A (p.Phe75Ile)	LYZ	F57I, F75I	Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000014377	12	69743974	12	69350194	14377	29416	rs121913549	NC_000012.12:69350193:T:A
NM_000239.2(LYZ):c.244T>C (p.Trp82Arg)	LYZ	W64R, W82R	Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000014376	12	69743995	12	69350215	14376	29415	rs387906536	NC_000012.12:69350214:T:C
NM_016417.3(GLRX5):c.148_150AAG[1] (p.Lys51del)	GLRX5	K51del	Spasticity, childhood-onset, with hyperglycinemia	Pathogenic(Last reviewed: Mar 17, 2016)	no assertion criteria provided	VCV000224512	14	96001573 - 96001575	14	95535236 - 95535238	224512	226290	rs869320757	NC_000014.9:95535235:GAAGAAG:GAAG
NM_016417.3(GLRX5):c.301A>C (p.Lys101Gln)	GLRX5	K101Q	Sideroblastic anemia 3, pyridoxine-refractory	Pathogenic(Last reviewed: Jul 26, 2018)	no assertion criteria provided	VCV000224510	14	96010289	14	95543952	224510	226288	rs869312752	NC_000014.9:95543951:A:C
NM_005022.3(PFN1):c.350A>G (p.Glu117Gly)	PFN1	E117G	Amyotrophic lateral sclerosis 18	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000037037	17	4849268	17	4945973	37037	45723	rs140547520	NC_000017.11:4945972:T:C
NM_005022.3(PFN1):c.353G>T (p.Gly118Val)	PFN1	G118V	Amyotrophic lateral sclerosis 18	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000037036	17	4849265	17	4945970	37036	45722	rs387907266	NC_000017.11:4945969:C:A
NM_005022.3(PFN1):c.341T>C (p.Met114Thr)	PFN1	M114T	Amyotrophic lateral sclerosis 18	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000037035	17	4849277	17	4945982	37035	45721	rs387907265	NC_000017.11:4945981:A:G
NM_005022.3(PFN1):c.211T>G (p.Cys71Gly)	PFN1	C71G	Amyotrophic lateral sclerosis 18	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000037034	17	4850037	17	4946742	37034	45720	rs387907264	NC_000017.11:4946741:A:C
NM_000239.2(LYZ):c.221T>C (p.Ile74Thr)	LYZ	I56T, I74T	Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: Apr 8, 1993)	no assertion criteria provided	VCV000014374	12	69743972	12	69350192	14374	29413	rs121913547	NC_000012.12:69350191:T:C
NM_016417.3(GLRX5):c.294A>G (p.Gln98=)	GLRX5	Q98Q	Sideroblastic anemia 3, pyridoxine-refractory	Pathogenic(Last reviewed: Aug 15, 2007)	no assertion criteria provided	VCV000001606	14	96001720	14	95535383	1606	16645	rs121908584	NC_000014.9:95535382:A:G
NM_006364.4(SEC23A):c.1144T>C (p.Phe382Leu)	SEC23A	F382L	Craniolenticulosutural dysplasia	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000001228	14	39536460	14	39067256	1228	16267	rs118204000	NC_000014.9:39067255:A:G
NM_000239.2(LYZ):c.244T>A (p.Trp82Arg)	LYZ	W64R, W82R	Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000014378	12	69743995	12	69350215	14378	29417	rs387906536	NC_000012.12:69350214:T:A
NM_000239.2(LYZ):c.199G>C (p.Asp67His)	LYZ	D67H	Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000014375	12	69743950	12	69350170	14375	29414	rs387906535	NC_000012.12:69350169:G:C
NM_181789.4(GLDN):c.1435C>T (p.Arg479Ter)	GLDN	R479*, R355*	Lethal congenital contracture syndrome 11	Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	VCV000268109	15	51696730	15	51404533	268109	263635	rs368085516	NC_000015.10:51404532:C:T
NM_181789.4(GLDN):c.541+1G>A	GLDN		Lethal congenital contracture syndrome 11	Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	VCV000268108	15	51676090	15	51383893	268108	263634	rs886041057	NC_000015.10:51383892:G:A
NM_181789.4(GLDN):c.1240C>T (p.Arg414Ter)	GLDN	R414*, R290*	Lethal congenital contracture syndrome 11	Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	VCV000268107	15	51696535	15	51404338	268107	263633	rs539703340	NC_000015.10:51404337:C:T
NM_181789.4(GLDN):c.95C>A (p.Ala32Glu)	GLDN	A32E	Lethal congenital contracture syndrome 11	Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	VCV000268106	15	51633976	15	51341779	268106	263632	rs779432560	NC_000015.10:51341778:C:A
NM_181789.4(GLDN):c.1423G>C (p.Ala475Pro)	GLDN	A475P, A351P	Lethal congenital contracture syndrome 11	Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	VCV000268105	15	51696718	15	51404521	268105	263631	rs764239923	NC_000015.10:51404520:G:C
NM_181789.4(GLDN):c.758del (p.Pro253fs)	GLDN	P129fs, P253fs	Lethal congenital contracture syndrome 11	Pathogenic(Last reviewed: Nov 9, 2016)	no assertion criteria provided	VCV000268104	15	51689732	15	51397535	268104	263630	rs886041056	NC_000015.10:51397534:CCCCC:CCCC
NM_004998.4(MYO1E):c.2085T>G (p.Tyr695Ter)	MYO1E	Y695*	Focal segmental glomerulosclerosis 6	Pathogenic(Last reviewed: Jul 28, 2011)	no assertion criteria provided	VCV000030192	15	59466404	15	59174205	30192	39148	rs778868018	NC_000015.10:59174204:A:C
NM_004998.4(MYO1E):c.475G>C (p.Ala159Pro)	MYO1E	A159P	Focal segmental glomerulosclerosis 6	Pathogenic(Last reviewed: Jul 28, 2011)	no assertion criteria provided	VCV000030191	15	59523936	15	59231737	30191	39147	rs387906807	NC_000015.10:59231736:C:G
NM_022916.6(VPS33A):c.1492C>T (p.Arg498Trp)	VPS33A	R498W, R391W, R487W, R482W	Mucopolysaccharidosis-plus syndrome	Pathogenic(Last reviewed: Jan 20, 2017)	no assertion criteria provided	VCV000374985	12	122717464	12	122232917	374985	361893	rs767748011	NC_000012.12:122232916:G:A
NM_019887.6(DIABLO):c.377C>T (p.Ser126Leu)	DIABLO	S126L, S82L, S29L, S73L, S53L	not provided|Deafness, autosomal dominant 64	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000030449	12	122701355	12	122216808	30449	39406	rs387906893	NC_000012.12:122216807:G:A
NM_019074.4(DLL4):c.1397G>A (p.Cys466Tyr)	DLL4	C466Y	Adams-Oliver syndrome 6	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523592	15	41228582	15	40936384	523592	514255	rs1247027543	NC_000015.10:40936383:G:A
NM_019074.4(DLL4):c.1310G>C (p.Cys437Ser)	DLL4	C437S	Adams-Oliver syndrome 6	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523591	15	41228495	15	40936297	523591	514254	rs1555393125	NC_000015.10:40936296:G:C
NM_019074.4(DLL4):c.1825C>T (p.Gln609Ter)	DLL4	Q609*	Adams-Oliver syndrome 6	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523582	15	41229010	15	40936812	523582	514256	rs1555393182	NC_000015.10:40936811:C:T
NM_019074.4(DLL4):c.583T>C (p.Phe195Leu)	DLL4	F195L	Adams-Oliver syndrome	Pathogenic	criteria provided, single submitter	VCV000204376	15	41223889	15	40931691	204376	200764	rs796065351	NC_000015.10:40931690:T:C
NM_019074.4(DLL4):c.1365C>G (p.Cys455Trp)	DLL4	C455W	Adams-Oliver syndrome	Pathogenic	criteria provided, single submitter	VCV000204370	15	41228550	15	40936352	204370	200768	rs796065345	NC_000015.10:40936351:C:G
NM_019074.4(DLL4):c.361G>C (p.Ala121Pro)	DLL4	A121P	Adams-Oliver syndrome 6|Adams-Oliver syndrome	Pathogenic	criteria provided, single submitter	VCV000204375	15	41222847	15	40930649	204375	200762	rs796065350	NC_000015.10:40930648:G:C
NM_019074.4(DLL4):c.556C>T (p.Arg186Cys)	DLL4	R186C	Adams-Oliver syndrome 6|Adams-Oliver syndrome	Pathogenic	criteria provided, single submitter	VCV000204373	15	41223862	15	40931664	204373	200763	rs796065348	NC_000015.10:40931663:C:T
NM_019074.4(DLL4):c.1168T>C (p.Cys390Arg)	DLL4	C390R	Adams-Oliver syndrome 6|Adams-Oliver syndrome	Pathogenic	criteria provided, single submitter	VCV000204372	15	41227243	15	40935045	204372	200766	rs796065347	NC_000015.10:40935044:T:C
NM_019074.4(DLL4):c.1169G>A (p.Cys390Tyr)	DLL4	C390Y	Adams-Oliver syndrome 6|Adams-Oliver syndrome	Pathogenic	criteria provided, single submitter	VCV000204371	15	41227244	15	40935046	204371	200767	rs796065346	NC_000015.10:40935045:G:A
NM_019074.4(DLL4):c.1672C>T (p.Arg558Ter)	DLL4	R558*	Adams-Oliver syndrome 6|Adams-Oliver syndrome	Pathogenic	criteria provided, single submitter	VCV000204369	15	41228857	15	40936659	204369	200770	rs61750844	NC_000015.10:40936658:C:T
NM_019074.4(DLL4):c.1660C>T (p.Gln554Ter)	DLL4	Q554*	Adams-Oliver syndrome 6|Adams-Oliver syndrome	Pathogenic	criteria provided, single submitter	VCV000204368	15	41228845	15	40936647	204368	200769	rs796065344	NC_000015.10:40936646:C:T
NM_025237.3(SOST):c.61G>A (p.Val21Met)	SOST	V21M	Craniodiaphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000031592	17	41836049	17	43758681	31592	40277	rs387907169	NC_000017.11:43758680:C:T
NM_025237.3(SOST):c.61G>T (p.Val21Leu)	SOST	V21L	Craniodiaphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000031593	17	41836049	17	43758681	31593	40278		NC_000017.11:43758680:C:A
NM_025237.3(SOST):c.376C>T (p.Arg126Ter)	SOST	R126*	Sclerosteosis 1	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000004786	17	41832976	17	43755608	4786	19825	rs104894645	NC_000017.11:43755607:G:A
NM_025237.3(SOST):c.372G>A (p.Trp124Ter)	SOST	W124*	Sclerosteosis 1	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000004785	17	41832980	17	43755612	4785	19824	rs104894644	NC_000017.11:43755611:C:T
NM_025237.3(SOST):c.70C>T (p.Gln24Ter)	SOST	Q24*	Sclerosteosis 1	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000004783	17	41836040	17	43758672	4783	19822	rs387906320	NC_000017.11:43758671:G:A
NM_181789.4(GLDN):c.1305G>A (p.Trp435Ter)	GLDN	W435*, W311*	Lethal congenital contracture syndrome 11|Flexion contracture|Congenital contracture|Breathing dysregulation|Polyhydramnios	Pathogenic/Likely pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488521	15	51696600	15	51404403	488521	481389	rs775011495	NC_000015.10:51404402:G:A
SOST, IVS1DS, A-T, +3 AND/OR IVS1AS, A-C, -67	SOST		Sclerosteosis 1	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000004784					4784	19823		
NM_153218.4(LACC1):c.128_129del (p.Cys43fs)	LACC1	C43fs	JUVENILE ARTHRITIS	Pathogenic(Last reviewed: Feb 28, 2020)	no assertion criteria provided	VCV000814026	13	44455248 - 44455249	13	43881112 - 43881113	814026	802255		NC_000013.11:43881111:TGT:T
NM_153218.4(LACC1):c.988_990del (p.Ile330del)	LACC1	I330del, I74del	JUVENILE ARTHRITIS	Pathogenic(Last reviewed: Feb 28, 2020)	no assertion criteria provided	VCV000814025	13	44462973 - 44462975	13	43888837 - 43888839	814025	802254		NC_000013.11:43888836:ATT:
NM_153218.4(LACC1):c.1240C>T (p.Arg414Ter)	LACC1	R414*, R158*	JUVENILE ARTHRITIS	Pathogenic(Last reviewed: Feb 28, 2020)	no assertion criteria provided	VCV000814024	13	44464356	13	43890220	814024	802253		NC_000013.11:43890219:C:T
NM_153218.4(LACC1):c.3G>A (p.Met1Ile)	LACC1	M1I	JUVENILE ARTHRITIS	Pathogenic(Last reviewed: Feb 29, 2020)	no assertion criteria provided	VCV000814023	13	44455124	13	43880988	814023	802252		NC_000013.11:43880987:G:A
NM_153218.4(LACC1):c.827del (p.Thr276fs)	LACC1	T20fs, T276fs	JUVENILE ARTHRITIS	Pathogenic(Last reviewed: Feb 28, 2020)	no assertion criteria provided	VCV000814022	13	44457992	13	43883856	814022	802251		NC_000013.11:43883855:C:
NM_014669.5(NUP93):c.1537+1G>A	NUP93		Nephrotic syndrome, type 12	Pathogenic(Last reviewed: Apr 6, 2016)	no assertion criteria provided	VCV000224967	16	56867319	16	56833407	224967	226848	rs138909849	NC_000016.10:56833406:G:A
NM_014669.5(NUP93):c.1326del (p.Lys442fs)	NUP93	K319fs, K442fs	Nephrotic syndrome, type 12	Pathogenic(Last reviewed: Apr 6, 2016)	no assertion criteria provided	VCV000224966	16	56866281	16	56832369	224966	226847	rs869320695	NC_000016.10:56832368:G:
NM_014669.5(NUP93):c.1886A>G (p.Tyr629Cys)	NUP93	Y629C, Y506C	Nephrotic syndrome, type 12	Pathogenic(Last reviewed: Apr 6, 2016)	no assertion criteria provided	VCV000224965	16	56870616	16	56836704	224965	226846	rs757674160	NC_000016.10:56836703:A:G
NM_014669.5(NUP93):c.1772G>T (p.Gly591Val)	NUP93	G591V, G468V	Nephrotic syndrome, type 12	Pathogenic(Last reviewed: May 30, 2018)	no assertion criteria provided	VCV000224964	16	56868680	16	56834768	224964	226845	rs145473779	NC_000016.10:56834767:G:T
NM_014301.4(ISCU):c.74G>A (p.Gly25Glu)	ISCU	G50E, G25E	Myopathy with lactic acidosis, hereditary	Pathogenic(Last reviewed: Mar 3, 2016)	no assertion criteria provided	VCV000000783	12	108958089	12	108564313	783	15822	rs267607190	NC_000012.12:108564312:G:A
NM_014301.4(ISCU):c.343+382G>C	ISCU		Myopathy with lactic acidosis, hereditary	Pathogenic(Last reviewed: Mar 3, 2016)	no assertion criteria provided	VCV000223141	12	108961426	12	108567650	223141	224867	rs767000507	NC_000012.12:108567649:G:C
NM_207581.4(DUOXA2):c.8_9TG[3] (p.Trp4fs)	DUOXA2		not provided	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000504016	15	45406810 - 45406811	15	45114612 - 45114613	504016	495335	rs1555414714	NC_000015.10:45114612:TGTG:TGTGTG
NM_207581.4(DUOXA2):c.414C>G (p.Tyr138Ter)	DUOXA2	Y138*	Thyroglobulin synthesis defect	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000547935	15	45408787	15	45116589	547935	538443	rs1555415049	NC_000015.10:45116588:C:G
NM_000422.3(KRT17):c.960+5G>A	KRT17		Anonychia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523369	17	39777213	17	41620961	523369	514082	rs370554150	NC_000017.11:41620960:C:T
NM_207581.4(DUOXA2):c.738C>G (p.Tyr246Ter)	DUOXA2	Y246*	Thyroglobulin synthesis defect	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000000444	15	45409472	15	45117274	444	15483	rs4774518	NC_000015.10:45117273:C:G
NM_001920.5(DCN):c.962del (p.Lys321fs)	DCN	K174fs, K212fs, K134fs, K321fs	Congenital Stromal Corneal Dystrophy	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000126374	12	91539953	12	91146176	126374	131908	rs587777258	NC_000012.12:91146175:TTTTT:TTTT
NM_024006.6(VKORC1):c.292C>T (p.Arg98Trp)	VKORC1	R98W, A61V, R126W	Vitamin K-dependent clotting factors, combined deficiency of, 2	Pathogenic(Last reviewed: Feb 5, 2004)	no assertion criteria provided	VCV000002206	16	31102655	16	31091334	2206	17245	rs72547528	NC_000016.10:31091333:G:A
NM_207581.4(DUOXA2):c.413dup (p.Tyr138Ter)	DUOXA2		Thyroglobulin synthesis defect	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225344	15	45408785 - 45408786	15	45116587 - 45116588	225344	227369	rs778410503	NC_000015.10:45116587:A:AA
NM_001920.5(DCN):c.947del (p.Gly316fs)	DCN	G129fs, G207fs, G316fs, G169fs	Congenital Stromal Corneal Dystrophy	Pathogenic(Last reviewed: Feb 2, 2012)	no assertion criteria provided	VCV000065663	12	91539968	12	91146191	65663	76571	rs397515545	NC_000012.12:91146190:CC:C
NM_000422.3(KRT17):c.274A>C (p.Asn92His)	KRT17	N92H	not provided|Steatocystoma multiplex	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000014589	17	39780488	17	41624236	14589	29628	rs28928896	NC_000017.11:41624235:T:G
NM_000422.3(KRT17):c.304G>A (p.Val102Met)	KRT17	V102M	not provided|Pachyonychia congenita 2	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000014599	17	39780458	17	41624206	14599	29638	rs59977263	NC_000017.11:41624205:C:T
NM_000422.3(KRT17):c.284T>A (p.Leu95Gln)	KRT17	L95Q	not provided|Pachyonychia congenita 2	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000014595	17	39780478	17	41624226	14595	29634	rs28928899	NC_000017.11:41624225:A:T
NM_000422.3(KRT17):c.281G>C (p.Arg94Pro)	KRT17	R94P	not provided|Pachyonychia congenita 2	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000014594	17	39780481	17	41624229	14594	29633	rs28928897	NC_000017.11:41624228:C:G
NM_000422.3(KRT17):c.263T>C (p.Met88Thr)	KRT17	M88T	not provided|Pachyonychia congenita 2	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000014592	17	39780499	17	41624247	14592	29631	rs28928898	NC_000017.11:41624246:A:G
NM_000422.3(KRT17):c.292T>G (p.Tyr98Asp)	KRT17	Y98D	not provided|Pachyonychia congenita 2	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000014588	17	39780470	17	41624218	14588	29627	rs28933088	NC_000017.11:41624217:A:C
NM_024006.6(VKORC1):c.196G>A (p.Val66Met)	VKORC1	V66M	Warfarin response	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000692018	16	31104720	16	31093399	692018	679794		NC_000016.10:31093398:C:T
NM_000422.3(KRT17):c.287_289CCT[1] (p.Ser97del)	KRT17	S97del	Pachyonychia congenita 2|not provided	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000265321	17	39780470 - 39780472	17	41624218 - 41624220	265321	260166	rs121912478	NC_000017.11:41624217:AGGAGG:AGG
NM_001920.5(DCN):c.967del (p.Ser323fs)	DCN	S176fs, S214fs, S323fs, S136fs	Congenital Stromal Corneal Dystrophy	Pathogenic(Last reviewed: Feb 2, 2012)	no assertion criteria provided	VCV000016870	12	91539948	12	91146171	16870	31909	rs80338741	NC_000012.12:91146170:AA:A
NM_000422.3(KRT17):c.296T>C (p.Leu99Pro)	KRT17	L99P	not provided|Pachyonychia congenita 2	Pathogenic(Last reviewed: Jun 9, 2015)	criteria provided, single submitter	VCV000014598	17	39780466	17	41624214	14598	29637	rs28933089	NC_000017.11:41624213:A:G
NM_000422.3(KRT17):c.284T>C (p.Leu95Pro)	KRT17	L95P	not provided|Pachyonychia congenita 2	Pathogenic(Last reviewed: May 14, 2015)	criteria provided, single submitter	VCV000014596	17	39780478	17	41624226	14596	29635	rs28928899	NC_000017.11:41624225:A:G
NM_000422.3(KRT17):c.281_295del (p.Arg94_Tyr98del)	KRT17		not provided|Pachyonychia congenita 2	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000014593	17	39780467 - 39780481	17	41624215 - 41624229	14593	29632	rs57674130	NC_000017.11:41624214:GGTAGGAGGCCAGGCGGT:GGT
NM_000422.3(KRT17):c.274A>G (p.Asn92Asp)	KRT17	N92D	not provided|Pachyonychia congenita 2	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000014586	17	39780488	17	41624236	14586	29625	rs28928896	NC_000017.11:41624235:T:C
NM_024006.6(VKORC1):c.172A>G (p.Arg58Gly)	VKORC1	R58G	Warfarin response	Pathogenic(Last reviewed: Feb 5, 2004)	no assertion criteria provided	VCV000002209	16	31105879	16	31094558	2209	17248	rs104894541	NC_000016.10:31094557:T:C
NM_024006.6(VKORC1):c.134T>C (p.Val45Ala)	VKORC1	V45A	Warfarin response	Pathogenic(Last reviewed: Feb 5, 2004)	no assertion criteria provided	VCV000002208	16	31105917	16	31094596	2208	17247	rs104894540	NC_000016.10:31094595:A:G
NM_024006.6(VKORC1):c.85G>T (p.Val29Leu)	VKORC1	V29L	Warfarin response	Pathogenic(Last reviewed: Feb 5, 2004)	no assertion criteria provided	VCV000002207	16	31105966	16	31094645	2207	17246	rs104894539	NC_000016.10:31094644:C:A
NM_130466.4(UBE3B):c.256del (p.Leu86fs)	UBE3B	L86fs	not provided	Pathogenic(Last reviewed: Jul 27, 2016)	criteria provided, single submitter	VCV000280737	12	109921759	12	109483954	280737	264457	rs771222229	NC_000012.12:109483953:CC:C
NM_130466.4(UBE3B):c.941-1G>A	UBE3B		not provided	Pathogenic(Last reviewed: Jul 27, 2016)	criteria provided, single submitter	VCV000280736	12	109937437	12	109499632	280736	264495	rs886041886	NC_000012.12:109499631:G:A
NM_130466.4(UBE3B):c.2923-1G>T	UBE3B		Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802889	12	109971270	12	109533465	802889	791191		NC_000012.12:109533464:G:T
NM_130466.4(UBE3B):c.2568+1G>A	UBE3B		Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000488631	12	109962309	12	109524504	488631	481499	rs1555269815	NC_000012.12:109524503:G:A
NM_014994.3(MAPKBP1):c.2809C>T (p.Gln937Ter)	MAPKBP1	Q943*, Q937*	Nephronophthisis 20	Pathogenic(Last reviewed: May 22, 2017)	no assertion criteria provided	VCV000374920	15	42113872	15	41821674	374920	361825	rs752616462	NC_000015.10:41821673:C:T
NM_014994.3(MAPKBP1):c.2426-1G>A	MAPKBP1		Nephronophthisis 20	Pathogenic(Last reviewed: May 22, 2017)	no assertion criteria provided	VCV000374919	15	42111792	15	41819594	374919	361824	rs1057519306	NC_000015.10:41819593:G:A
NM_014994.3(MAPKBP1):c.1613G>A (p.Arg538Gln)	MAPKBP1	R544Q, R538Q	Nephronophthisis 20	Pathogenic(Last reviewed: May 22, 2017)	no assertion criteria provided	VCV000374918	15	42109135	15	41816937	374918	361823	rs1057519305	NC_000015.10:41816936:G:A
NM_014994.3(MAPKBP1):c.1300C>T (p.Arg434Ter)	MAPKBP1	R440*, R434*	Nephronophthisis 20	Pathogenic(Last reviewed: Jan 25, 2018)	no assertion criteria provided	VCV000374917	15	42107586	15	41815388	374917	361822	rs202001274	NC_000015.10:41815387:C:T
NM_014994.3(MAPKBP1):c.4375C>T (p.Arg1459Ter)	MAPKBP1	R1465*, R1459*, R1182*	Nephronophthisis 20	Pathogenic(Last reviewed: May 22, 2017)	no assertion criteria provided	VCV000374916	15	42117482	15	41825284	374916	361821	rs1057519304	NC_000015.10:41825283:C:T
NM_014994.3(MAPKBP1):c.592C>T (p.Arg198Ter)	MAPKBP1	R198*	Nephronophthisis 20	Pathogenic(Last reviewed: May 22, 2017)	no assertion criteria provided	VCV000374915	15	42104807	15	41812609	374915	361820	rs1057519303	NC_000015.10:41812608:C:T
NM_001888.5(CRYM):c.941A>C (p.Lys314Thr)	CRYM	K314T	Deafness, autosomal dominant 40	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000016935	16	21270106	16	21258785	16935	31974	rs104894512	NC_000016.10:21258784:T:G
NM_001888.5(CRYM):c.945A>T (p.Ter315Tyr)	CRYM	*315Y	Deafness, autosomal dominant 40	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000016934	16	21270102	16	21258781	16934	31973	rs104894509	NC_000016.10:21258780:T:A
NM_130466.4(UBE3B):c.351T>G (p.Tyr117Ter)	UBE3B	Y117*	Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000829809	12	109924284	12	109486479	829809	818141		NC_000012.12:109486478:T:G
NM_130466.4(UBE3B):c.2172dup (p.Ile725fs)	UBE3B		Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000829808	12	109959045 - 109959046	12	109521240 - 109521241	829808	818142		NC_000012.12:109521240:GGG:GGGG
NM_130466.4(UBE3B):c.2180A>C (p.Gln727Pro)	UBE3B	Q727P	Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000050237	12	109959056	12	109521251	50237	59391	rs398123023	NC_000012.12:109521250:A:C
NM_130466.4(UBE3B):c.545-2A>G	UBE3B		Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000050236	12	109927722	12	109489917	50236	59390	rs398123022	NC_000012.12:109489916:A:G
NM_130466.4(UBE3B):c.1741+2T>C	UBE3B		Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000050234	12	109947521	12	109509716	50234	59388	rs398123020	NC_000012.12:109509715:T:C
NM_130466.4(UBE3B):c.2219_2220AG[2] (p.Arg741fs)	UBE3B		Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000050235	12	109959095 - 109959096	12	109521290 - 109521291	50235	59389	rs398123021	NC_000012.12:109521289:AGAGAG:AGAG
ISCU, IVS5, G-C, +382	ISCU		Myopathy with lactic acidosis, hereditary	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000000782					782	15821		
NM_001920.5(DCN):c.941del (p.Pro314fs)	DCN	P167fs, P314fs, P205fs, P127fs	Congenital Stromal Corneal Dystrophy	Pathogenic(Last reviewed: Feb 2, 2012)	no assertion criteria provided	VCV000021302	12	91539974	12	91146197	21302	34154	rs80338742	NC_000012.12:91146196:GGG:GG
NM_003403.5(YY1):c.385del (p.Asp129fs)	YY1	D129fs	not provided	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000817604	14	100705965	14	100239628	817604	805777		NC_000014.9:100239627:GG:G
NM_003403.5(YY1):c.860_864del (p.Ile287fs)	YY1	I287fs	not provided	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000432981	14	100741049 - 100741053	14	100274712 - 100274716	432981	426048	rs1555370811	NC_000014.9:100274711:AAATTAAA:AAA
NM_001070.5(TUBG1):c.991A>C (p.Thr331Pro)	TUBG1	T331P	Cortical dysplasia, complex, with other brain malformations 4	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000065399	17	40766425	17	42614407	65399	76332	rs398123047	NC_000017.11:42614406:A:C
NM_001070.5(TUBG1):c.275A>G (p.Tyr92Cys)	TUBG1	Y92C	Cortical dysplasia, complex, with other brain malformations 4	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000065398	17	40762553	17	42610535	65398	76331	rs398123046	NC_000017.11:42610534:A:G
NM_001070.5(TUBG1):c.1160T>C (p.Leu387Pro)	TUBG1	L387P	Cortical dysplasia, complex, with other brain malformations 4	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000065397	17	40766863	17	42614845	65397	76330	rs398123045	NC_000017.11:42614844:T:C
NM_003403.5(YY1):c.535A>T (p.Lys179Ter)	YY1	K179*		Pathogenic(Last reviewed: Jul 7, 2017)	no assertion criteria provided	VCV000430621	14	100706116	14	100239779	430621	423704	rs1131692046	NC_000014.9:100239778:A:T
NM_003403.5(YY1):c.1030C>T (p.Gln344Ter)	YY1	Q344*		Pathogenic(Last reviewed: Jul 7, 2017)	no assertion criteria provided	VCV000430620	14	100742953	14	100276616	430620	423703	rs1131692045	NC_000014.9:100276615:C:T
NM_003403.5(YY1):c.1096C>G (p.Leu366Val)	YY1	L366V		Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000430619	14	100743788	14	100277451	430619	423702	rs1131692044	NC_000014.9:100277450:C:G
NM_003403.5(YY1):c.1097T>C (p.Leu366Pro)	YY1	L366P		Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000430618	14	100743789	14	100277452	430618	423701	rs1131692163	NC_000014.9:100277451:T:C
NM_003403.5(YY1):c.1138G>T (p.Asp380Tyr)	YY1	D380Y		Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000430617	14	100743830	14	100277493	430617	423700	rs1131692043	NC_000014.9:100277492:G:T
NM_000422.3(KRT17):c.280C>T (p.Arg94Cys)	KRT17	R94C	not provided|Steatocystoma multiplex|Pachyonychia congenita 2	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000014591	17	39780482	17	41624230	14591	29630	rs58730926	NC_000017.11:41624229:G:A
NM_000422.3(KRT17):c.281G>A (p.Arg94His)	KRT17	R94H	not provided|Steatocystoma multiplex|Pachyonychia congenita 2	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000014590	17	39780481	17	41624229	14590	29629	rs28928897	NC_000017.11:41624228:C:T
NM_001013838.3(CARMIL2):c.2536_2548del (p.Leu846fs)	CARMIL2	L810fs, L846fs	Severe combined immunodeficiency due to CARMIL2 deficiency	Pathogenic(Last reviewed: Sep 28, 2018)	no assertion criteria provided	VCV000565284	16	67685694 - 67685706	16	67651791 - 67651803	565284	556468	rs1567632829	NC_000016.10:67651790:GCCTCCCGGAGCTGC:GC
NM_001013838.3(CARMIL2):c.1574T>A (p.Leu525Gln)	CARMIL2	L525Q, L489Q	Severe combined immunodeficiency due to CARMIL2 deficiency	Pathogenic(Last reviewed: Sep 28, 2018)	no assertion criteria provided	VCV000565279	16	67682860	16	67648957	565279	556463	rs1567629943	NC_000016.10:67648956:T:A
NM_001013838.3(CARMIL2):c.1590C>A (p.Asn530Lys)	CARMIL2	N530K, N494K	Congenital combined immunodeficiency|Chronic colitis	Pathogenic	criteria provided, single submitter	VCV000562177	16	67682876	16	67648973	562177	553351	rs1567629968	NC_000016.10:67648972:C:A
NM_018648.3(NOP10):c.122_135delinsCACC (p.Tyr41fs)	NOP10		Dyskeratosis congenita autosomal recessive 1	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000651009	15	34634229 - 34634242	15	34342028 - 34342041	651009	643100		NC_000015.10:34342027:TCGGTGTCGAGAGT:GGTG
NM_001013838.3(CARMIL2):c.2557C>T (p.Gln853Ter)	CARMIL2	Q853*, Q817*	Severe combined immunodeficiency due to CARMIL2 deficiency	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000565280	16	67685717	16	67651814	565280	556464	rs1567632864	NC_000016.10:67651813:C:T
NM_001013838.3(CARMIL2):c.871+1G>T	CARMIL2		Combined T and B cell immunodeficiency|Severe combined immunodeficiency due to CARMIL2 deficiency	Pathogenic(Last reviewed: Sep 28, 2018)	no assertion criteria provided	VCV000266036	16	67681506	16	67647603	266036	260859	rs886041044	NC_000016.10:67647602:G:T
NM_001013838.3(CARMIL2):c.490dup (p.Ala164fs)	CARMIL2		Combined T and B cell immunodeficiency|Severe combined immunodeficiency due to CARMIL2 deficiency	Pathogenic(Last reviewed: Oct 1, 2018)	no assertion criteria provided	VCV000266035	16	67680638 - 67680639	16	67646735 - 67646736	266035	260858	rs886041043	NC_000016.10:67646735:GG:GGG
NM_018648.3(NOP10):c.100C>T (p.Arg34Trp)	NOP10	R34W	Dyskeratosis congenita autosomal recessive 1	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000004279	15	34634264	15	34342063	4279	19318	rs121908092	NC_000015.10:34342062:G:A
NM_016194.4(GNB5):c.368C>T (p.Ser123Leu)	GNB5	S81L, S123L	Intellectual developmental disorder with cardiac arrhythmia|Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia|Attention deficit hyperactivity disorder|Global developmental delay|Delayed speech and language development|Intellectual developmental disorder with cardiac arrhythmia|Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000254029	15	52446144	15	52153947	254029	248477	rs761399728	NC_000015.10:52153946:G:A
GRCh37/hg19 15q14(chr15:37328530-37383148)x1	MEIS2		not provided	Pathogenic(Last reviewed: Jun 5, 2018)	no assertion criteria provided	VCV000686274	15	37328530 - 37383148			686274	673866		
GRCh37/hg19 15q14(chr15:37299667-37409497)x1	MEIS2		not provided	Pathogenic(Last reviewed: Jun 26, 2018)	no assertion criteria provided	VCV000685290	15	37299667 - 37409497			685290	672882		
NM_170675.5(MEIS2):c.424G>T (p.Glu142Ter)	MEIS2	E129*, E142*, E54*	not provided	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000620448	15	37387779	15	37095578	620448	611792	rs1567294240	NC_000015.10:37095577:C:A
NM_170675.5(MEIS2):c.978-2A>G	MEIS2		not provided	Pathogenic(Last reviewed: Apr 10, 2017)	no assertion criteria provided	VCV000545068	15	37188889	15	36896688	545068	535328	rs1555418998	NC_000015.10:36896687:T:C
NM_133443.4(GPT2):c.181G>T (p.Glu61Ter)	GPT2	E61*	not provided	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000280442	16	46918808	16	46884896	280442	264947	rs886041649	NC_000016.10:46884895:G:T
NM_014712.3(SETD1A):c.4175G>A (p.Arg1392His)	SETD1A	R1392H	EPILEPSY, EARLY-ONSET, WITH OR WITHOUT DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Apr 9, 2020)	no assertion criteria provided	VCV000834093	16	30991282	16	30979961	834093	822343		NC_000016.10:30979960:G:A
NM_014712.3(SETD1A):c.4105G>A (p.Gly1369Arg)	SETD1A	G1369R	EPILEPSY, EARLY-ONSET, WITH OR WITHOUT DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Apr 8, 2020)	no assertion criteria provided	VCV000834092	16	30991212	16	30979891	834092	822342		NC_000016.10:30979890:G:A
NM_014712.3(SETD1A):c.806A>G (p.Gln269Arg)	SETD1A	Q269R	EPILEPSY, EARLY-ONSET, WITH OR WITHOUT DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Apr 8, 2020)	no assertion criteria provided	VCV000834091	16	30975581	16	30964260	834091	822341		NC_000016.10:30964259:A:G
NM_014712.3(SETD1A):c.2737C>T (p.Arg913Cys)	SETD1A	R913C	EPILEPSY, EARLY-ONSET, WITH OR WITHOUT DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Apr 8, 2020)	no assertion criteria provided	VCV000834090	16	30978876	16	30967555	834090	822340		NC_000016.10:30967554:C:T
NM_001034852.3(SMOC1):c.709G>T (p.Glu237Ter)	SMOC1	E237*		Pathogenic(Last reviewed: Sep 1, 2018)	no assertion criteria provided	VCV000562133	14	70477515	14	70010798	562133	553308	rs1566709754	NC_000014.9:70010797:G:T
NM_170675.5(MEIS2):c.825dup (p.Arg276fs)	MEIS2		Cleft palate, cardiac defects, and mental retardation	Pathogenic(Last reviewed: Oct 13, 2017)	no assertion criteria provided	VCV000559625	15	37329089 - 37329090	15	37036888 - 37036889	559625	550369	rs1555456994	NC_000015.10:37036888:TTTTTT:TTTTTTT
NM_001034852.3(SMOC1):c.367T>C (p.Ser123Pro)	SMOC1	S123P		Pathogenic	no assertion criteria provided	VCV000427815	14	70420238	14	69953521	427815	418799	rs1114167455	NC_000014.9:69953520:T:C
NM_170675.5(MEIS2):c.611C>G (p.Ser204Ter)	MEIS2	S204*, S191*, S116*	Cleft palate, cardiac defects, and mental retardation	Pathogenic(Last reviewed: Aug 26, 2019)	no assertion criteria provided	VCV000427215	15	37385810	15	37093609	427215	415884	rs749346955	NC_000015.10:37093608:G:C
NG_029108.1:g.120078_181902dup	MEIS2		Cleft palate, cardiac defects, and mental retardation	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000427214					427214	415883		
NM_133443.4(GPT2):c.1210C>T (p.Arg404Ter)	GPT2	R404*, R304*	Mental retardation, autosomal recessive 49	Pathogenic(Last reviewed: Sep 22, 2016)	no assertion criteria provided	VCV000254655	16	46956326	16	46922414	254655	249203	rs115352435	NC_000016.10:46922413:C:T
NM_172240.3(POC1B):c.810+1G>T	POC1B		Cone-rod dystrophy 20	Pathogenic(Last reviewed: Aug 7, 2014)	no assertion criteria provided	VCV000155771	12	89864137	12	89470360	155771	165523	rs587777694	NC_000012.12:89470359:C:A
NM_172240.3(POC1B):c.199_201del (p.Gln67del)	POC1B	Q67del, Q25del	Cone-rod dystrophy 20	Pathogenic(Last reviewed: Aug 7, 2014)	no assertion criteria provided	VCV000155770	12	89891019 - 89891021	12	89497242 - 89497244	155770	165522	rs587777693	NC_000012.12:89497241:CTGC:C
NM_001034852.3(SMOC1):c.857G>A (p.Arg286His)	SMOC1	R286H		Pathogenic	no assertion criteria provided	VCV000562137	14	70477663	14	70010946	562137	553310	rs1365818420	NC_000014.9:70010945:G:A
NM_001034852.3(SMOC1):c.378+1G>T	SMOC1			Pathogenic	no assertion criteria provided	VCV000562135	14	70420250	14	69953533	562135	553307	rs751356341	NC_000014.9:69953532:G:T
NM_014712.3(SETD1A):c.1938C>G (p.Tyr646Ter)	SETD1A	Y646*	Schizophrenia	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000224654	16	30977140	16	30965819	224654	226433	rs770913157	NC_000016.10:30965818:C:G
NM_014712.3(SETD1A):c.2171dup (p.Ala725fs)	SETD1A		Schizophrenia	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000224653	16	30977372 - 30977373	16	30966051 - 30966052	224653	226434	rs869312832	NC_000016.10:30966051:C:CC
NM_014712.3(SETD1A):c.2209C>T (p.Gln737Ter)	SETD1A	Q737*	Schizophrenia	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000224652	16	30977411	16	30966090	224652	226435	rs869312831	NC_000016.10:30966089:C:T
NM_014712.3(SETD1A):c.1272del (p.Tyr425fs)	SETD1A	Y425fs	Schizophrenia	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000224651	16	30976335	16	30965014	224651	226432	rs869312830	NC_000016.10:30965013:C:
NM_014712.3(SETD1A):c.518-2A>G	SETD1A		Schizophrenia	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000224650	16	30974752	16	30963431	224650	226431	rs869312829	NC_000016.10:30963430:A:G
NM_133443.4(GPT2):c.459C>G (p.Ser153Arg)	GPT2	S153R, S53R	Mental retardation, autosomal recessive 49	Pathogenic(Last reviewed: Mar 3, 2015)	no assertion criteria provided	VCV000187856	16	46940770	16	46906858	187856	185748	rs786203999	NC_000016.10:46906857:C:G
NM_001034852.3(SMOC1):c.378+1G>A	SMOC1			Pathogenic(Last reviewed: Jan 7, 2011)	no assertion criteria provided	VCV000030728	14	70420250	14	69953533	30728	39685		NC_000014.9:69953532:G:A
NM_001034852.3(SMOC1):c.664+1G>A	SMOC1			Pathogenic(Last reviewed: Jan 7, 2011)	no assertion criteria provided	VCV000030727	14	70461198	14	69994481	30727	39684	rs863223317	NC_000014.9:69994480:G:A
NM_001034852.3(SMOC1):c.718C>T (p.Gln240Ter)	SMOC1	Q240*		Pathogenic(Last reviewed: Jan 7, 2011)	no assertion criteria provided	VCV000030726	14	70477524	14	70010807	30726	39683	rs376672665	NC_000014.9:70010806:C:T
NM_170675.5(MEIS2):c.992_994GAA[2] (p.Arg333del)	MEIS2	R320del, R333del	MEIS2-related disorder|Cleft palate, cardiac defects, and mental retardation|not provided	Pathogenic(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	VCV000224962	15	37188865 - 37188867	15	36896664 - 36896666	224962	226843	rs879255264	NC_000015.10:36896663:TTCTTCTTCT:TTCTTCT
NM_172240.3(POC1B):c.317G>C (p.Arg106Pro)	POC1B	R106P, R64P	Cone-rod dystrophy 20	Pathogenic	criteria provided, single submitter	VCV000155769	12	89885848	12	89492071	155769	165521	rs76216585	NC_000012.12:89492070:C:G
NM_012064.4(MIP):c.698G>A (p.Arg233Lys)	MIP	R233K	not provided	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000432015	12	56845158	12	56451374	432015	426009	rs1555179699	NC_000012.12:56451373:C:T
NM_012064.4(MIP):c.631G>T (p.Gly211Ter)	MIP	G211*	Congenital cataract	Pathogenic(Last reviewed: Jul 29, 2016)	no assertion criteria provided	VCV000252956	12	56845225	12	56451441	252956	247354	rs1114167315	NC_000012.12:56451440:C:A
NM_012064.4(MIP):c.623del (p.Pro208fs)	MIP	P208fs	Cataract 15, multiple types	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000474241	12	56845233	12	56451449	474241	462635	rs1555179713	NC_000012.12:56451448:GGG:GG
NM_012064.4(MIP):c.508dup (p.Leu170fs)	MIP		Cataract 15, multiple types	Pathogenic(Last reviewed: Dec 16, 2015)	no assertion criteria provided	VCV000377392	12	56847391 - 56847392	12	56453607 - 56453608	377392	364277	rs1057519616	NC_000012.12:56453607:GGG:GGGG
NM_012064.4(MIP):c.597_598insGGGAACATTCCACT (p.Asn200fs)	MIP		Congenital cataract	Pathogenic(Last reviewed: Jan 9, 2015)	no assertion criteria provided	VCV000217345	12	56846864 - 56846865	12	56453080 - 56453081	217345	213989	rs864309696	NC_000012.12:56453080:AGTG:AGTGGAATGTTCCCAGTG
NM_012064.4(MIP):c.97C>T (p.Arg33Cys)	MIP	R33C	Congenital cataract	Pathogenic(Last reviewed: Jan 9, 2015)	no assertion criteria provided	VCV000217342	12	56848301	12	56454517	217342	213990	rs864309693	NC_000012.12:56454516:G:A
NM_012064.4(MIP):c.401A>G (p.Glu134Gly)	MIP	E134G	Cataract 15, multiple types	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000014355	12	56847499	12	56453715	14355	29394	rs121917869	NC_000012.12:56453714:T:C
NM_012064.4(MIP):c.413C>G (p.Thr138Arg)	MIP	T138R	Cataract 15, multiple types	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000014354	12	56847487	12	56453703	14354	29393	rs121917867	NC_000012.12:56453702:G:C
NM_138576.4(BCL11B):c.1878_1884del (p.Gly630fs)	BCL11B	G559fs, G630fs, G558fs, G629fs	not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000817903	14	99641289 - 99641295	14	99174952 - 99174958	817903	805804		NC_000014.9:99174951:CGCCGCACGC:CGC
NM_138576.4(BCL11B):c.1743_1746del (p.Gly582fs)	BCL11B	G511fs, G582fs, G510fs, G581fs	not provided	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000817648	14	99641427 - 99641430	14	99175090 - 99175093	817648	805805		NC_000014.9:99175089:GCCG:
NM_138576.4(BCL11B):c.81dup (p.Ala28fs)	BCL11B		not provided	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000817183	14	99724153 - 99724154	14	99257816 - 99257817	817183	805806		NC_000014.9:99257816:GG:GGG
NM_006383.4(CIB2):c.97C>T (p.Arg33Ter)	CIB2	R33*	not provided	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000816953	15	78403608	15	78111266	816953	805842		NC_000015.10:78111265:G:A
NM_138576.4(BCL11B):c.1500dup (p.Gly501fs)	BCL11B		INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000807550	14	99641672 - 99641673	14	99175335 - 99175336	807550	798684		NC_000014.9:99175335:GGG:GGGG
NM_138576.4(BCL11B):c.2048del (p.Ser683fs)	BCL11B	S612fs, S682fs, S611fs, S683fs	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000807549	14	99641125	14	99174788	807549	798683		NC_000014.9:99174787:C:
NM_000977.3(RPL13):c.548G>C (p.Arg183Pro)	RPL13	R183P, R136P	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ISIDOR-TOUTAIN TYPE	Pathogenic(Last reviewed: Jan 7, 2020)	no assertion criteria provided	VCV000804147	16	89629362	16	89562954	804147	792532		NC_000016.10:89562953:G:C
NM_000977.3(RPL13):c.548G>T (p.Arg183Leu)	RPL13	R183L, R136L	Spondyloepimetaphyseal dysplasia	Pathogenic(Last reviewed: Apr 22, 2019)	no assertion criteria provided	VCV000689803	16	89629362	16	89562954	689803	677481		NC_000016.10:89562953:G:T
NM_138576.4(BCL11B):c.1495G>T (p.Glu499Ter)	BCL11B	E499*, E427*, E428*, E498*	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES	Pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	VCV000560178	14	99641678	14	99175341	560178	550894	rs1555376234	NC_000014.9:99175340:C:A
NM_138576.4(BCL11B):c.242del (p.Cys81fs)	BCL11B	C81fs, C80fs	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES	Pathogenic(Last reviewed: Feb 4, 2019)	no assertion criteria provided	VCV000560177	14	99723993	14	99257656	560177	550893	rs1555384300	NC_000014.9:99257655:C:
NM_138576.4(BCL11B):c.2671del (p.Ala891fs)	BCL11B	A820fs, A890fs, A891fs, A819fs	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES	Pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	VCV000560176	14	99640502	14	99174165	560176	550892	rs1555376017	NC_000014.9:99174164:CC:C
NM_138576.4(BCL11B):c.2449_2456dup (p.Gly820fs)	BCL11B		INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES	Pathogenic(Last reviewed: Aug 29, 2018)	no assertion criteria provided	VCV000560175	14	99640716 - 99640717	14	99174379 - 99174380	560175	550891	rs1555376035	NC_000014.9:99174379:GTGTGGCT:GTGTGGCTGTGTGGCT
NM_006383.4(CIB2):c.368T>C (p.Ile123Thr)	CIB2	I123T, I74T, I80T, I128T	Deafness, autosomal recessive 48	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039687	15	78398255	15	78105913	39687	48286	rs397515412	NC_000015.10:78105912:A:G
NM_006383.4(CIB2):c.297C>G (p.Cys99Trp)	CIB2	C99W, C104W, C50W, C56W	Deafness, autosomal recessive 48	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039686	15	78401626	15	78109284	39686	48285	rs370965183	NC_000015.10:78109283:G:C
NM_006383.4(CIB2):c.272T>C (p.Phe91Ser)	CIB2	F91S, F96S, F42S, F48S	Deafness, autosomal recessive 48	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039685	15	78401651	15	78109309	39685	48284	rs397515411	NC_000015.10:78109308:A:G
NM_024580.6(EFL1):c.2645T>A (p.Met882Lys)	EFL1	M882K, M831K, M619K	SHWACHMAN-DIAMOND SYNDROME 2	Pathogenic(Last reviewed: Apr 19, 2018)	no assertion criteria provided	VCV000522583	15	82444150	15	82151809	522583	513197	rs1316615934	NC_000015.10:82151808:A:T
NM_000977.3(RPL13):c.477+1G>A	RPL13		SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ISIDOR-TOUTAIN TYPE|Spondyloepimetaphyseal dysplasia	Pathogenic(Last reviewed: Jan 6, 2020)	no assertion criteria provided	VCV000689802	16	89628800	16	89562392	689802	677478		NC_000016.10:89562391:G:A
NM_000977.3(RPL13):c.477+2T>C	RPL13		SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ISIDOR-TOUTAIN TYPE|Spondyloepimetaphyseal dysplasia	Pathogenic(Last reviewed: Jan 6, 2020)	no assertion criteria provided	VCV000689801	16	89628801	16	89562393	689801	677480		NC_000016.10:89562392:T:C
NM_000977.3(RPL13):c.477+1G>T	RPL13		SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ISIDOR-TOUTAIN TYPE|Spondyloepimetaphyseal dysplasia	Pathogenic(Last reviewed: Jan 7, 2020)	no assertion criteria provided	VCV000689800	16	89628800	16	89562392	689800	677479		NC_000016.10:89562391:G:T
NM_138576.4(BCL11B):c.2421C>G (p.Asn807Lys)	BCL11B	N807K, N736K, N735K, N806K	Immunodeficiency 49|INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000560174	14	99640752	14	99174415	560174	550890	rs888230251	NC_000014.9:99174414:G:C
NM_138576.4(BCL11B):c.1323T>G (p.Asn441Lys)	BCL11B	N441K, N370K, N440K, N369K	Immunodeficiency 49|Congenital combined immunodeficiency	Pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	VCV000254673	14	99641850	14	99175513	254673	249216	rs750610248	NC_000014.9:99175512:A:C
NM_012064.4(MIP):c.638del (p.Gly213fs)	MIP	G213fs	Cataract 15, multiple types	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000050960	12	56845218	12	56451434	50960	65630	rs398122378	NC_000012.12:56451433:CCCCC:CCCC
NM_023936.2(MRPS34):c.322-10G>A	MRPS34		Combined oxidative phosphorylation deficiency 32	Pathogenic(Last reviewed: Sep 15, 2017)	no assertion criteria provided	VCV000438633	16	1822657	16	1772656	438633	432254	rs563189672	NC_000016.10:1772655:C:T
NM_033419.5(PGAP3):c.726G>A (p.Trp242Ter)	PGAP3	W242*, W191*, W221*	not provided	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000620568	17	37829477	17	39673224	620568	611853	rs1567870911	NC_000017.11:39673223:C:T
NM_001128126.3(AP4S1):c.294+1G>C	AP4S1		not provided	Pathogenic(Last reviewed: Jul 7, 2016)	no assertion criteria provided	VCV000545037	14	31542180	14	31072974	545037	535327	rs886041127	NC_000014.9:31072973:G:C
NM_033419.5(PGAP3):c.694+1G>A	PGAP3		not provided	Pathogenic(Last reviewed: Nov 25, 2016)	criteria provided, single submitter	VCV000373293	17	37829766	17	39673513	373293	360242	rs144574243	NC_000017.11:39673512:C:T
NM_033419.5(PGAP3):c.842T>C (p.Leu281Pro)	PGAP3	L281P, L230P, L260P	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000224648	17	37829361	17	39673108	224648	226424	rs869312817	NC_000017.11:39673107:A:G
NM_033419.5(PGAP3):c.511T>C (p.Cys171Arg)	PGAP3	C171R, C120R, C150R	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000224647	17	37830292	17	39674039	224647	226426	rs869312816	NC_000017.11:39674038:A:G
NM_033419.5(PGAP3):c.861G>T (p.Trp287Cys)	PGAP3	W287C, W236C, W266C	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000224641	17	37829342	17	39673089	224641	226422	rs869312813	NC_000017.11:39673088:C:A
NC_000014.8:g.(?_31535393)_(31542189_?)del	AP4S1		Spastic paraplegia	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000645361	14	31535393 - 31542189	14	31066187 - 31072983	645361	652306		
NM_001173467.3(SP7):c.946C>T (p.Arg316Cys)	SP7	R316C, R298C	Osteogenesis imperfecta type 12	Pathogenic(Last reviewed: Aug 31, 2018)	no assertion criteria provided	VCV000560212	12	53722280	12	53328496	560212	551264	rs1565789682	NC_000012.12:53328495:G:A
NM_033419.5(PGAP3):c.432+1G>A	PGAP3		Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522978	17	37840849	17	39684596	522978	513643	rs1555610241	NC_000017.11:39684595:C:T
NM_033419.5(PGAP3):c.280del (p.Trp94fs)	PGAP3	W94fs	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000496676	17	37841002	17	39684749	496676	488160	rs1555610292	NC_000017.11:39684748:A:
NM_181503.3(EXOSC8):c.5C>T (p.Ala2Val)	EXOSC8	A2V	Pontocerebellar hypoplasia, type 1c	Pathogenic(Last reviewed: Jul 3, 2014)	no assertion criteria provided	VCV000157609	13	37574947	13	37000810	157609	167469	rs606231285	NC_000013.11:37000809:C:T
NM_033419.5(PGAP3):c.314C>G (p.Pro105Arg)	PGAP3	P105R	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000125440	17	37840968	17	39684715	125440	130978	rs371549948	NC_000017.11:39684714:G:C
NM_033419.5(PGAP3):c.275G>A (p.Gly92Asp)	PGAP3	G92D	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000125437	17	37842179	17	39685926	125437	130975	rs587777251	NC_000017.11:39685925:C:T
SP7, 1-BP DEL, 1052A	SP7		Osteogenesis imperfecta type 12	Pathogenic(Last reviewed: Jul 9, 2010)	no assertion criteria provided	VCV000030597					30597	39554		
NM_001128126.3(AP4S1):c.43C>T (p.Arg15Ter)	AP4S1	R15*	Spastic paraplegia	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000577104	14	31535445	14	31066239	577104	572777	rs754944359	NC_000014.9:31066238:C:T
NM_033419.5(PGAP3):c.845A>G (p.Asp282Gly)	PGAP3	D282G, D261G, D231G	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000224644	17	37829358	17	39673105	224644	226423	rs869312814	NC_000017.11:39673104:T:C
Single allele	SLC52A1		Maternal riboflavin deficiency	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210044					210044	206636		
SLC52A1, 1.9-KB DEL	SLC52A1		Maternal riboflavin deficiency	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000039608					39608	48207		
NM_033419.5(PGAP3):c.851A>G (p.His284Arg)	PGAP3	H284R, H233R, H263R	Global developmental delay|Severe global developmental delay|Infantile axial hypotonia|Cleft palate|Low-set ears|Seizures|Low posterior hairline|Profound global developmental delay|Congenital diaphragmatic hernia|Agenesis of maxillary lateral incisor	Pathogenic	criteria provided, single submitter	VCV000599004	17	37829352	17	39673099	599004	590083	rs776720232	NC_000017.11:39673098:T:C
NM_033419.5(PGAP3):c.439dup (p.Leu147fs)	PGAP3		Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000224646	17	37830925 - 37830926	17	39674672 - 39674673	224646	226427	rs869312815	NC_000017.11:39674672:GGG:GGGG
NM_001128126.3(AP4S1):c.124C>T (p.Arg42Ter)	AP4S1	R42*	Spastic paraplegia 52, autosomal recessive	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030658	14	31535526	14	31066320	30658	39615	rs387906970	NC_000014.9:31066319:C:T
NM_001128126.3(AP4S1):c.138+3_138+6del	AP4S1		Spastic paraplegia 52, autosomal recessive	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000234925	14	31535539 - 31535542	14	31066333 - 31066336	234925	236722	rs876661295	NC_000014.9:31066332:AAGTAAGT:AAGT
NM_005557.4(KRT16):c.362T>G (p.Met121Arg)	KRT16	M121R	not provided	Pathogenic(Last reviewed: Dec 31, 2015)	criteria provided, single submitter	VCV000419351	17	39768579	17	41612327	419351	409923	rs28928894	NC_000017.11:41612326:A:C
NM_005557.4(KRT16):c.383T>C (p.Leu128Pro)	KRT16	L128P	not provided	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	VCV000265486	17	39768558	17	41612306	265486	260164	rs28928895	NC_000017.11:41612305:A:G
NM_005557.4(KRT16):c.379C>G (p.Arg127Gly)	KRT16	R127G	not provided	Pathogenic(Last reviewed: May 11, 2015)	criteria provided, single submitter	VCV000265217	17	39768562	17	41612310	265217	260165	rs59856285	NC_000017.11:41612309:G:C
NM_024339.5(THOC6):c.611A>C (p.Gln204Pro)	THOC6	Q204P, Q180P	Beaulieu-Boycott-Innes syndrome	Pathogenic(Last reviewed: Sep 14, 2018)	no assertion criteria provided	VCV000561206	16	3076892	16	3026891	561206	552313	rs1567416845	NC_000016.10:3026890:A:C
NM_001805.3(CEBPE):c.391C>T (p.Arg131Ter)	CEBPE	R131*	Specific granule deficiency 1	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000530667	14	23587910	14	23118701	530667	528042	rs760325316	NC_000014.9:23118700:G:A
NM_024824.5(ZC3H14):c.460C>T (p.Arg154Ter)	ZC3H14	R154*, R120*	Mental retardation, autosomal recessive 56	Pathogenic(Last reviewed: Sep 20, 2016)	no assertion criteria provided	VCV000254278	14	89038950	14	88572606	254278	248811	rs886037950	NC_000014.9:88572605:C:T
NM_005557.4(KRT16):c.371T>A (p.Leu124His)	KRT16	L124H	not provided	Pathogenic(Last reviewed: Jan 26, 2016)	criteria provided, single submitter	VCV000066605	17	39768570	17	41612318	66605	77502	rs58293603	NC_000017.11:41612317:A:T
NM_024339.5(THOC6):c.136G>A (p.Gly46Arg)	THOC6	G46R, G22R	Beaulieu-Boycott-Innes syndrome	Pathogenic(Last reviewed: Apr 26, 2013)	no assertion criteria provided	VCV000064681	16	3075805	16	3025804	64681	75616	rs587777030	NC_000016.10:3025803:G:A
NM_005557.4(KRT16):c.1244_1270delinsGGC (p.Ala415_Glu424delinsGlyGln)	KRT16		Palmoplantar keratoderma, nonepidermolytic, focal	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000014610	17	39766593 - 39766619	17	41610341 - 41610367	14610	29649	rs1555573633	NC_000017.11:41610340:CGCCCTCCAGCAGGCGGCGGTAGGTGG:GCC
NM_002929.3(GRK1):c.1172C>A (p.Pro391His)	GRK1	P391H	Oguchi disease 2	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000013012	13	114434294	13	113731321	13012	28051	rs570621429	NC_000013.11:113731320:C:A
GRK1, 4-BP DEL	GRK1		Oguchi disease 2	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000013011					13011	28050		
NM_002929.3(GRK1):c.1139T>A (p.Val380Asp)	GRK1	V380D	Oguchi disease 2	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000013010	13	114434261	13	113731288	13010	28049	rs777094000	NC_000013.11:113731287:T:A
CEBPE, 1-BP INS, 1113A	CEBPE		Specific granule deficiency 1	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000008855					8855	23894		
CEBPE, 5-BP DEL, NT224	CEBPE		Specific granule deficiency 1	Pathogenic(Last reviewed: Jun 7, 1999)	no assertion criteria provided	VCV000008854					8854	23893		
NM_024339.5(THOC6):c.135C>A (p.Tyr45Ter)	THOC6	Y45*, Y21*	Beaulieu-Boycott-Innes syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2018)	no assertion criteria provided	VCV000561207	16	3075804	16	3025803	561207	552314	rs772533643	NC_000016.10:3025802:C:A
NM_005557.4(KRT16):c.373_374delinsGG (p.Asn125Gly)	KRT16	N125G	Pachyonychia congenita 1	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000156024	17	39768567 - 39768568	17	41612315 - 41612316	156024	165833	rs587777717	NC_000017.11:41612314:TT:CC
GRK1, EX5DEL	GRK1		Oguchi disease 2	Pathogenic(Last reviewed: Jan 6, 1998)	no assertion criteria provided	VCV000013009					13009	28048		
NM_005557.4(KRT16):c.383T>A (p.Leu128Gln)	KRT16	L128Q	Pachyonychia congenita 1|not provided	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000014609	17	39768558	17	41612306	14609	29648	rs28928895	NC_000017.11:41612305:A:T
NM_005557.4(KRT16):c.371T>G (p.Leu124Arg)	KRT16	L124R	Pachyonychia congenita 1|not provided	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000014606	17	39768570	17	41612318	14606	29645	rs58293603	NC_000017.11:41612317:A:C
NM_005557.4(KRT16):c.365A>C (p.Gln122Pro)	KRT16	Q122P	Pachyonychia congenita 1|not provided	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000014605	17	39768576	17	41612324	14605	29644	rs59349773	NC_000017.11:41612323:T:G
NM_005557.4(KRT16):c.380G>C (p.Arg127Pro)	KRT16	R127P	Pachyonychia congenita 1|not provided	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000014604	17	39768561	17	41612309	14604	29643	rs57424749	NC_000017.11:41612308:C:G
NM_033419.5(PGAP3):c.402dup (p.Met135fs)	PGAP3		Hyperphosphatasia with mental retardation syndrome 4|not provided	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224640	17	37840879 - 37840880	17	39684626 - 39684627	224640	226428	rs869312812	NC_000017.11:39684626:GGGGG:GGGGGG
NM_005557.4(KRT16):c.373A>G (p.Asn125Asp)	KRT16	N125D	Pachyonychia congenita 1|not provided	Pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, single submitter	VCV000066608	17	39768568	17	41612316	66608	77505	rs58608173	NC_000017.11:41612315:T:C
NM_005557.4(KRT16):c.362T>C (p.Met121Thr)	KRT16	M121T	Pachyonychia congenita 1|not provided	Pathogenic(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	VCV000014608	17	39768579	17	41612327	14608	29647	rs28928894	NC_000017.11:41612326:A:G
NM_005557.4(KRT16):c.386_388CCT[1] (p.Ser130del)	KRT16	S130del	Pachyonychia congenita 1|not provided	Pathogenic(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	VCV000014603	17	39768550 - 39768552	17	41612298 - 41612300	14603	29642	rs58181827	NC_000017.11:41612297:AGGAGG:AGG
NM_016013.4(NDUFAF1):c.532del (p.Thr178fs)	NDUFAF1	T178fs	not provided	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	VCV000419281	15	41688726	15	41396528	419281	409218	rs1064793767	NC_000015.10:41396527:T:
NM_016013.4(NDUFAF1):c.2T>C (p.Met1Thr)	NDUFAF1	M1T	not provided	Pathogenic(Last reviewed: Jul 31, 2014)	criteria provided, single submitter	VCV000214732	15	41689256	15	41397058	214732	211697	rs863224089	NC_000015.10:41397057:A:G
NM_032271.3(TRAF7):c.1111C>G (p.Arg371Gly)	TRAF7	R371G	CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Oct 31, 2018)	no assertion criteria provided	VCV000587688	16	2223813	16	2173812	587688	578646	rs1567252659	NC_000016.10:2173811:C:G
NM_032271.3(TRAF7):c.1036A>G (p.Lys346Glu)	TRAF7	K346E	CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Oct 31, 2018)	no assertion criteria provided	VCV000587687	16	2223505	16	2173504	587687	578645	rs1567252467	NC_000016.10:2173503:A:G
NM_032271.3(TRAF7):c.1801A>G (p.Thr601Ala)	TRAF7	T601A	CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Oct 31, 2018)	no assertion criteria provided	VCV000587686	16	2226104	16	2176103	587686	578644	rs1567254067	NC_000016.10:2176102:A:G
NM_016013.4(NDUFAF1):c.733G>A (p.Gly245Arg)	NDUFAF1	G245R	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000030625	15	41687083	15	41394885	30625	39582	rs376344575	NC_000015.10:41394884:C:T
NM_016013.4(NDUFAF1):c.631C>T (p.Arg211Cys)	NDUFAF1	R211C	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000030624	15	41687185	15	41394987	30624	39581	rs387906958	NC_000015.10:41394986:G:A
NM_016013.4(NDUFAF1):c.758A>G (p.Lys253Arg)	NDUFAF1	K253R	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11	Pathogenic(Last reviewed: Jul 11, 2007)	no assertion criteria provided	VCV000030623	15	41687058	15	41394860	30623	39580	rs387906957	NC_000015.10:41394859:T:C
NM_016013.4(NDUFAF1):c.619A>C (p.Thr207Pro)	NDUFAF1	T207P	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11	Pathogenic(Last reviewed: Jul 11, 2007)	no assertion criteria provided	VCV000030622	15	41687197	15	41394999	30622	39579	rs387906956	NC_000015.10:41394998:T:G
NM_006383.4(CIB2):c.192G>C (p.Glu64Asp)	CIB2	E64D, E21D	Usher syndrome, type 1J|	Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000039688	15	78403513	15	78111171	39688	48287	rs145415848	NC_000015.10:78111170:C:G
NM_005557.4(KRT16):c.395T>C (p.Leu132Pro)	KRT16	L132P	not provided|Pachyonychia congenita 1	Pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	VCV000014600	17	39768546	17	41612294	14600	29639	rs60944949	NC_000017.11:41612293:A:G
NM_002742.3(PRKD1):c.896T>G (p.Leu299Trp)	PRKD1	L299W, L307W, L211W	Congenital heart defects and ectodermal dysplasia	Pathogenic(Last reviewed: Feb 24, 2017)	no assertion criteria provided	VCV000375741	14	30107911	14	29638705	375741	362626	rs1057519636	NC_000014.9:29638704:A:C
NM_002742.3(PRKD1):c.1774G>A (p.Gly592Arg)	PRKD1	G592R, G600R, G504R	Congenital heart defects and ectodermal dysplasia	Pathogenic(Last reviewed: Feb 24, 2017)	no assertion criteria provided	VCV000375740	14	30095714	14	29626508	375740	362625	rs1057519635	NC_000014.9:29626507:C:T
NM_000196.4(HSD11B2):c.77_78del (p.Arg25_Ser26insTer)	HSD11B2		Apparent mineralocorticoid excess	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000031132	16	67465228 - 67465229	16	67431325 - 67431326	31132	40089	rs794726684	NC_000016.10:67431324:CA:
NM_000196.4(HSD11B2):c.1012T>C (p.Tyr338His)	HSD11B2	Y338H	Apparent mineralocorticoid excess	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000031131	16	67470700	16	67436797	31131	40088	rs387907117	NC_000016.10:67436796:T:C
NM_000196.4(HSD11B2):c.664+14C>T	HSD11B2		Apparent mineralocorticoid excess	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000031130	16	67470059	16	67436156	31130	40087	rs376023420	NC_000016.10:67436155:C:T
NM_000196.4(HSD11B2):c.895_897del (p.Tyr299del)	HSD11B2	Y299del	Apparent mineralocorticoid excess	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	VCV000012102	16	67470581 - 67470583	16	67436678 - 67436680	12102	27141	rs794726670	NC_000016.10:67436677:ACTAC:AC
NM_000196.4(HSD11B2):c.835C>T (p.Arg279Cys)	HSD11B2	R279C	Apparent mineralocorticoid excess	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000012098	16	67470523	16	67436620	12098	27137	rs28934594	NC_000016.10:67436619:C:T
NM_000196.3(HSD11B2):c.1010_1012delGCT (p.Arg337_Tyr338delinsHis)	HSD11B2		Apparent mineralocorticoid excess	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000012097	16	67470698 - 67470700	16	67436795 - 67436797	12097	27136	rs397509434	NC_000016.10:67436794:GCT:
NM_000196.4(HSD11B2):c.623G>A (p.Arg208His)	HSD11B2	R208H	Apparent mineralocorticoid excess	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000012096	16	67470004	16	67436101	12096	27135	rs28934592	NC_000016.10:67436100:G:A
NM_000229.2(LCAT):c.524-22T>C	LCAT		Fish-eye disease	Pathogenic(Last reviewed: Jul 15, 1996)	no assertion criteria provided	VCV000003674	16	67976512	16	67942609	3674	18713	rs794726664	NC_000016.10:67942608:A:G
NM_000229.2(LCAT):c.463A>G (p.Asn155Asp)	LCAT	N131D, N155D	Fish-eye disease	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000003673	16	67976634	16	67942731	3673	18712	rs121908057	NC_000016.10:67942730:T:C
NM_000229.2(LCAT):c.969_971CCT[1] (p.Leu325del)	LCAT	L300del, L324del, L325del	Fish-eye disease	Pathogenic(Last reviewed: Jul 1, 1993)	no assertion criteria provided	VCV000003672	16	67974156 - 67974158	16	67940253 - 67940255	3672	18711	rs121908056	NC_000016.10:67940252:AGGAGG:AGG
NM_000229.2(LCAT):c.321C>A (p.Tyr107Ter)	LCAT	Y83*, Y107*	Norum disease	Pathogenic(Last reviewed: Feb 1, 1993)	no assertion criteria provided	VCV000003671	16	67976870	16	67942967	3671	18710	rs121908055	NC_000016.10:67942966:G:T
NM_000229.2(LCAT):c.1034C>T (p.Thr345Met)	LCAT	T321M, T345M	Norum disease	Pathogenic(Last reviewed: Feb 1, 1993)	no assertion criteria provided	VCV000003670	16	67974096	16	67940193	3670	18709	rs28940888	NC_000016.10:67940192:G:A
NM_000229.2(LCAT):c.1197dup (p.Gln400fs)	LCAT	Q376T	Norum disease	Pathogenic(Last reviewed: Feb 1, 1993)	no assertion criteria provided	VCV000003669	16	67973932 - 67973933	16	67940029 - 67940030	3669	18708	rs794726663	NC_000016.10:67940029:T:TT
NM_000229.2(LCAT):c.475C>T (p.Arg159Trp)	LCAT	R135W, R159W	Norum disease	Pathogenic(Last reviewed: Feb 1, 1993)	no assertion criteria provided	VCV000003668	16	67976622	16	67942719	3668	18707	rs28940887	NC_000016.10:67942718:G:A
NM_000229.2(LCAT):c.698T>C (p.Leu233Pro)	LCAT	L209P, L233P	Norum disease	Pathogenic(Last reviewed: Feb 1, 1993)	no assertion criteria provided	VCV000003666	16	67976316	16	67942413	3666	18705	rs28942087	NC_000016.10:67942412:A:G
NM_000229.2(LCAT):c.1112C>T (p.Thr371Met)	LCAT	T347M, T371M	Fish-eye disease	Pathogenic(Last reviewed: Feb 1, 1992)	no assertion criteria provided	VCV000003664	16	67974018	16	67940115	3664	18703	rs121908053	NC_000016.10:67940114:G:A
LCAT, 1-BP INS, C, EXON 1	LCAT		Norum disease	Pathogenic(Last reviewed: Dec 31, 1991)	no assertion criteria provided	VCV000003661					3661	18700		
NM_000229.2(LCAT):c.756C>A (p.Asn252Lys)	LCAT	N228K, N252K	Norum disease	Pathogenic(Last reviewed: Sep 28, 1991)	no assertion criteria provided	VCV000003659	16	67974374	16	67940471	3659	18698	rs121908049	NC_000016.10:67940470:G:T
NM_000229.2(LCAT):c.491_493dup (p.Ala165_Ala166insGly)	LCAT		Norum disease	Pathogenic(Last reviewed: Sep 28, 1991)	no assertion criteria provided	VCV000003658	16	67976603 - 67976604	16	67942700 - 67942701	3658	18697	rs794726662	NC_000016.10:67942700:CGC:CGCCGC
NM_000229.2(LCAT):c.951G>A (p.Met317Ile)	LCAT	M293I, M317I	Norum disease	Pathogenic(Last reviewed: Jul 31, 1991)	no assertion criteria provided	VCV000003657	16	67974179	16	67940276	3657	18696	rs121908048	NC_000016.10:67940275:C:T
NM_000229.2(LCAT):c.1210A>G (p.Met404Val)	LCAT	M404V	Norum disease	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000626358	16	67973920	16	67940017	626358	614690	rs779114194	NC_000016.10:67940016:T:C
NM_000229.2(LCAT):c.997G>A (p.Val333Met)	LCAT	V333M	Norum disease	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000626357	16	67974133	16	67940230	626357	614689	rs776035233	NC_000016.10:67940229:C:T
NM_000196.4(HSD11B2):c.667G>A (p.Asp223Asn)	HSD11B2	D223N	Apparent mineralocorticoid excess	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000012101	16	67470154	16	67436251	12101	27140	rs121917833	NC_000016.10:67436250:G:A
NM_000196.4(HSD11B2):c.680C>T (p.Pro227Leu)	HSD11B2	P227L	Apparent mineralocorticoid excess, mild	Pathogenic(Last reviewed: Oct 26, 1999)	no assertion criteria provided	VCV000012099	16	67470167	16	67436264	12099	27138	rs121917782	NC_000016.10:67436263:C:T
NM_000196.4(HSD11B2):c.1009C>T (p.Arg337Cys)	HSD11B2	R337C	Apparent mineralocorticoid excess	Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000012095	16	67470697	16	67436794	12095	27134	rs121917781	NC_000016.10:67436793:C:T
NM_000229.2(LCAT):c.827T>A (p.Met276Lys)	LCAT	M252K, M276K	Norum disease	Pathogenic(Last reviewed: Sep 14, 1992)	no assertion criteria provided	VCV000003665	16	67974303	16	67940400	3665	18704	rs121908054	NC_000016.10:67940399:A:T
NM_000229.2(LCAT):c.440C>T (p.Thr147Ile)	LCAT	I123T, T123I, T147I	Fish-eye disease	Pathogenic(Last reviewed: Feb 1, 1992)	no assertion criteria provided	VCV000003660	16	67976657	16	67942754	3660	18699	rs121908050	NC_000016.10:67942753:G:A
NM_000229.2(LCAT):c.508T>C (p.Trp170Arg)	LCAT	W147R, W170R	Norum disease	Pathogenic(Last reviewed: Jul 1, 1990)	no assertion criteria provided	VCV000003656	16	67976589	16	67942686	3656	18695	rs267607211	NC_000016.10:67942685:A:G
NM_023936.2(MRPS34):c.94C>T (p.Gln32Ter)	MRPS34	Q32*	Combined oxidative phosphorylation deficiency 32|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438635	16	1823027	16	1773026	438635	432256	rs763672163	NC_000016.10:1773025:G:A
NM_023936.1(MRPS34):c.321+1G>T	MRPS34		Combined oxidative phosphorylation deficiency 32|Leigh syndrome	Pathogenic(Last reviewed: Sep 15, 2017)	no assertion criteria provided	VCV000430586	16	1822799	16	1772798	430586	423234	rs1161932777	NC_000016.10:1772797:C:A
NM_153490.3(KRT13):c.332T>C (p.Leu111Pro)	KRT13	L111P	White sponge nevus 2|not provided	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000066751	17	39661471	17	41505219	66751	77648	rs59897026	NC_000017.11:41505218:A:G
NM_000196.4(HSD11B2):c.637C>T (p.Arg213Cys)	HSD11B2	R213C	Apparent mineralocorticoid excess	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000012094	16	67470018	16	67436115	12094	27133	rs28934591	NC_000016.10:67436114:C:T
NM_153490.3(KRT13):c.356T>C (p.Leu119Pro)	KRT13	L15P, L119P	not provided|White sponge nevus 2	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000014629	17	39661447	17	41505195	14629	29668	rs60440396	NC_000017.11:41505194:A:G
NM_032271.3(TRAF7):c.1964G>A (p.Arg655Gln)	TRAF7	R655Q	CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000587685	16	2226351	16	2176350	587685	578643	rs1331463984	NC_000016.10:2176349:G:A
NM_006888.6(CALM1):c.268T>C (p.Phe90Leu)	CALM1	F90L, F54L, F91L	Long QT syndrome 14	Pathogenic(Last reviewed: Jan 28, 2014)	no assertion criteria provided	VCV000183232	14	90870295	14	90403951	183232	181365	rs730882253	NC_000014.9:90403950:T:C
NM_006888.6(CALM1):c.389A>G (p.Asp130Gly)	CALM1	D130G, D94G, D131G	Long QT syndrome 14	Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	VCV000183230	14	90870826	14	90404482	183230	181363	rs730882252	NC_000014.9:90404481:A:G
NM_006888.6(CALM1):c.394G>A (p.Asp132Asn)	CALM1	D96N, D132N, D133N	Long QT syndrome 14|Ventricular tachycardia, catecholaminergic polymorphic, 4	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000639902	14	90870831	14	90404487	639902	642781		NC_000014.9:90404486:G:A
NM_006888.6(CALM1):c.426C>G (p.Phe142Leu)	CALM1	F142L, F143L, F106L	Long QT syndrome 14	Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	VCV000183231	14	90871037	14	90404693	183231	181364	rs199744595	NC_000014.9:90404692:C:G
NM_000942.4(PPIB):c.343+1G>A	PPIB		not provided	Pathogenic(Last reviewed: Oct 31, 2016)	criteria provided, single submitter	VCV000031845	15	64452302	15	64160103	31845	40505	rs137853867	NC_000015.10:64160102:C:T
NM_002635.4(SLC25A3):c.158-237G>A	SLC25A3	G72E	Mitochondrial phosphate carrier deficiency	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000009149	12	98989268	12	98595490	9149	24188	rs104894375	NC_000012.12:98595489:G:A
NM_000942.4(PPIB):c.313G>A (p.Gly105Arg)	PPIB	G105R	Osteogenesis imperfecta type 9|not provided	Pathogenic(Last reviewed: Dec 7, 2015)	no assertion criteria provided	VCV000031844	15	64452333	15	64160134	31844	40504	rs137853866	NC_000015.10:64160133:C:T
NM_000942.4(PPIB):c.120del (p.Val42fs)	PPIB	V42fs	Osteogenesis imperfecta type 9|not provided	Pathogenic(Last reviewed: Apr 15, 2011)	no assertion criteria provided	VCV000031843	15	64455066	15	64162867	31843	40503	rs137853865	NC_000015.10:64162866:GGG:GG
NM_005557.4(KRT16):c.379C>T (p.Arg127Cys)	KRT16	R127C	Palmoplantar keratoderma, nonepidermolytic, focal|not provided|Pachyonychia congenita 1	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000014601	17	39768562	17	41612310	14601	29640	rs59856285	NC_000017.11:41612309:G:A
NM_002635.4(SLC25A3):c.158-303A>G	SLC25A3		not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000215165	12	98989202	12	98595424	215165	211657	rs745305932	NC_000012.12:98595423:A:G
NM_000942.4(PPIB):c.26T>G (p.Met9Arg)	PPIB	M9R	not provided|Osteogenesis imperfecta type 9	Pathogenic(Last reviewed: May 20, 2010)	no assertion criteria provided	VCV000016927	15	64455160	15	64162961	16927	31966	rs137853864	NC_000015.10:64162960:A:C
NM_001206979.2(NR1H4):c.547C>T (p.Arg183Ter)	NR1H4	R183*, R193*	not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000498806	12	100926337	12	100532559	498806	490230	rs1555335324	NC_000012.12:100532558:C:T
NM_052988.5(CDK10):c.608+1G>A	CDK10		AL KAISSI SYNDROME	Pathogenic(Last reviewed: Sep 29, 2017)	no assertion criteria provided	VCV000440757	16	89759876	16	89693468	440757	434384	rs771066826	NC_000016.10:89693467:G:A
NM_052988.5(CDK10):c.139del (p.Glu47fs)	CDK10	E47fs	AL KAISSI SYNDROME	Pathogenic(Last reviewed: Sep 29, 2017)	no assertion criteria provided	VCV000440756	16	89755711	16	89689303	440756	434383	rs1555516716	NC_000016.10:89689302:G:
CDK10, EX2-3DEL	CDK10		AL KAISSI SYNDROME	Pathogenic(Last reviewed: Oct 2, 2017)	no assertion criteria provided	VCV000440755					440755	434382		
NM_052988.5(CDK10):c.609-1G>A	CDK10		AL KAISSI SYNDROME	Pathogenic(Last reviewed: Sep 29, 2017)	no assertion criteria provided	VCV000440754	16	89760580	16	89694172	440754	434381	rs767176610	NC_000016.10:89694171:G:A
NR1H4, 31.7-KB DEL	NR1H4		Cholestasis, progressive familial intrahepatic, 5	Pathogenic(Last reviewed: Jul 27, 2016)	no assertion criteria provided	VCV000253139					253139	247551		
NM_012232.6(CAVIN1):c.471+1G>T	CAVIN1		Lipodystrophy, congenital generalized, type 4	Pathogenic(Last reviewed: Sep 1, 2010)	no assertion criteria provided	VCV000030330	17	40574644	17	42422626	30330	39286	rs866504928	NC_000017.11:42422625:C:A
NM_012232.6(CAVIN1):c.478_481dup (p.Lys161fs)	CAVIN1		Lipodystrophy, congenital generalized, type 4	Pathogenic(Last reviewed: Sep 1, 2010)	no assertion criteria provided	VCV000030328	17	40557396 - 40557397	17	42405378 - 42405379	30328	39284	rs1567776514	NC_000017.11:42405378:TCACT:TCACTCACT
NM_012232.6(CAVIN1):c.135del (p.Lys45fs)	CAVIN1	K45fs	Lipodystrophy, congenital generalized, type 4	Pathogenic(Last reviewed: Sep 1, 2010)	no assertion criteria provided	VCV000030327	17	40574981	17	42422963	30327	39283	rs1567782493	NC_000017.11:42422962:C:
NM_012232.6(CAVIN1):c.362dup (p.Lys122fs)	CAVIN1		Lipodystrophy, congenital generalized, type 4	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000006604	17	40574753 - 40574754	17	42422735 - 42422736	6604	21643	rs1489315815	NC_000017.11:42422735:A:AA
NM_012232.6(CAVIN1):c.526del (p.Glu176fs)	CAVIN1	E176fs	Lipodystrophy, congenital generalized, type 4	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000006602	17	40557352	17	42405334	6602	21641	rs1567776490	NC_000017.11:42405333:CC:C
NM_012232.6(CAVIN1):c.696dup (p.Lys233fs)	CAVIN1		Lipodystrophy, congenital generalized, type 4	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000006601	17	40557181 - 40557182	17	42405163 - 42405164	6601	21640	rs1427062799	NC_000017.11:42405163:G:GG
Single allele	NR1H4		Cholestasis, progressive familial intrahepatic 1	Pathogenic(Last reviewed: Dec 17, 2015)	criteria provided, single submitter	VCV000219163	12	100886254 - 100917988	12	100492476 - 100524210	219163	217182		
NM_012232.6(CAVIN1):c.518_521del (p.Lys173fs)	CAVIN1	K173fs	Lipodystrophy, congenital generalized, type 4	Pathogenic(Last reviewed: Sep 1, 2010)	no assertion criteria provided	VCV000030329	17	40557357 - 40557360	17	42405339 - 42405342	30329	39285	rs1207466199	NC_000017.11:42405338:TCTTTC:TC
NM_012232.6(CAVIN1):c.160del (p.Val54fs)	CAVIN1	V54fs	Lipodystrophy, congenital generalized, type 4	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000006603	17	40574956	17	42422938	6603	21642	rs1567782465	NC_000017.11:42422937:CC:C
NM_001206979.2(NR1H4):c.419_420insAAA (p.Asn140_Ala141insLys)	NR1H4		Cholestasis, progressive familial intrahepatic, 5|Cholestasis, progressive familial intrahepatic 1	Pathogenic(Last reviewed: Dec 17, 2015)	criteria provided, single submitter	VCV000219162	12	100904893 - 100904894	12	100511115 - 100511116	219162	217180	rs879255644	NC_000012.12:100511115:AA:AAAAA
NM_001005273.2(CHD3):c.3362G>C (p.Arg1121Pro)	CHD3	R1121P, R1180P	SNIJDERS BLOK-CAMPEAU SYNDROME|Intellectual disability	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549736	17	7806037	17	7902719	549736	540503	rs1567860112	NC_000017.11:7902718:G:C
NM_001005273.2(CHD3):c.2954G>A (p.Arg985Gln)	CHD3	R985Q, R1044Q	SNIJDERS BLOK-CAMPEAU SYNDROME|Intellectual disability	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549733	17	7804025	17	7900707	549733	540500	rs1567856331	NC_000017.11:7900706:G:A
NM_001206979.2(NR1H4):c.526C>T (p.Arg176Ter)	NR1H4	R176*, R186*	Cholestasis, progressive familial intrahepatic, 5|Cholestasis, progressive familial intrahepatic 1	Pathogenic(Last reviewed: Dec 17, 2015)	criteria provided, single submitter	VCV000219164	12	100926316	12	100532538	219164	217181	rs113090017	NC_000012.12:100532537:C:T
NM_005554.4(KRT6A):c.490C>T (p.Arg164Cys)	KRT6A	R164C	not provided	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000452212	12	52886483	12	52492699	452212	445047	rs1318088507	NC_000012.12:52492698:G:A
NM_005554.4(KRT6A):c.511A>C (p.Asn171His)	KRT6A	N171H	not provided	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000419468	12	52886462	12	52492678	419468	408714	rs62635294	NC_000012.12:52492677:T:G
NM_005554.4(KRT6A):c.529_531del (p.Phe177del)	KRT6A	F177del	not provided	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000418765	12	52886442 - 52886444	12	52492658 - 52492660	418765	408713	rs1064793417	NC_000012.12:52492657:GAAG:G
NM_004434.3(EML1):c.1567C>T (p.Arg523Ter)	EML1	R523*, R542*	Band heterotopia	Pathogenic(Last reviewed: Jul 9, 2018)	no assertion criteria provided	VCV000548146	14	100380588	14	99914251	548146	538630	rs1555404109	NC_000014.9:99914250:C:T
NM_004434.3(EML1):c.673T>C (p.Trp225Arg)	EML1	W225R, W244R	Band heterotopia	Pathogenic(Last reviewed: Sep 19, 2016)	no assertion criteria provided	VCV000254260	14	100361091	14	99894754	254260	248786	rs886037937	NC_000014.9:99894753:T:C
NM_004434.3(EML1):c.727A>G (p.Thr243Ala)	EML1	T243A, T262A	Band heterotopia	Pathogenic(Last reviewed: Sep 19, 2016)	no assertion criteria provided	VCV000254259	14	100363531	14	99897194	254259	248785	rs886037936	NC_000014.9:99897193:A:G
NM_004434.3(EML1):c.412C>T (p.Arg138Ter)	EML1	R138*, R157*	Band heterotopia	Pathogenic(Last reviewed: Sep 19, 2016)	no assertion criteria provided	VCV000254258	14	100344850	14	99878513	254258	248784	rs886037935	NC_000014.9:99878512:C:T
NM_005554.4(KRT6A):c.508C>T (p.Leu170Phe)	KRT6A	L170F	not provided	Pathogenic(Last reviewed: Feb 3, 2016)	criteria provided, single submitter	VCV000066584	12	52886465	12	52492681	66584	77481	rs57448541	NC_000012.12:52492680:G:A
NM_005554.4(KRT6A):c.487G>A (p.Glu163Lys)	KRT6A	E163K	not provided	Pathogenic(Last reviewed: Apr 19, 2016)	criteria provided, single submitter	VCV000066579	12	52886486	12	52492702	66579	77476	rs267607464	NC_000012.12:52492701:C:T
NM_005554.4(KRT6A):c.1393T>C (p.Tyr465His)	KRT6A	Y465H	not provided	Pathogenic(Last reviewed: Apr 10, 2015)	criteria provided, single submitter	VCV000066572	12	52882143	12	52488359	66572	77469	rs267607463	NC_000012.12:52488358:A:G
NM_005554.4(KRT6A):c.1387G>C (p.Ala463Pro)	KRT6A	A463P	not provided	Pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	VCV000066570	12	52882149	12	52488365	66570	77467	rs267607462	NC_000012.12:52488364:C:G
NM_005554.4(KRT6A):c.1385T>A (p.Ile462Asn)	KRT6A	I462N	not provided	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000066568	12	52882151	12	52488367	66568	77465	rs57629991	NC_000012.12:52488366:A:T
NM_005554.4(KRT6A):c.1381G>T (p.Glu461Ter)	KRT6A	E461*	Pachyonychia congenita 3	Pathogenic(Last reviewed: Mar 19, 2020)	no assertion criteria provided	VCV000827961	12	52882155	12	52488371	827961	816294		NC_000012.12:52488370:C:A
NM_005554.4(KRT6A):c.1460-2A>C	KRT6A		Pachyonychia congenita 3	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000156022	12	52881741	12	52487957	156022	165831	rs113369052	NC_000012.12:52487956:T:G
NM_005554.4(KRT6A):c.511A>T (p.Asn171Tyr)	KRT6A	N171Y	not provided|Pachyonychia congenita 3	Pathogenic(Last reviewed: Jul 24, 2014)	no assertion criteria provided	VCV000066586	12	52886462	12	52492678	66586	77483	rs62635294	NC_000012.12:52492677:T:A
NM_005554.4(KRT6A):c.521T>C (p.Phe174Ser)	KRT6A	F174S	not provided|Pachyonychia congenita 3	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000066591	12	52886452	12	52492668	66591	77488	rs61145796	NC_000012.12:52492667:A:G
NM_005554.4(KRT6A):c.511A>G (p.Asn171Asp)	KRT6A	N171D	not provided|Pachyonychia congenita 3	Pathogenic(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	VCV000066585	12	52886462	12	52492678	66585	77482	rs62635294	NC_000012.12:52492677:T:C
NM_005554.4(KRT6A):c.1406T>C (p.Leu469Pro)	KRT6A	L469P	not provided|Pachyonychia congenita 3	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000066576	12	52882130	12	52488346	66576	77473	rs57052654	NC_000012.12:52488345:A:G
NM_005554.4(KRT6A):c.1406T>G (p.Leu469Arg)	KRT6A	L469R	not provided|Pachyonychia congenita 3	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000014637	12	52882130	12	52488346	14637	29676	rs57052654	NC_000012.12:52488345:A:C
NM_005554.4(KRT6A):c.520T>G (p.Phe174Val)	KRT6A	F174V	not provided|Pachyonychia congenita 3	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000014635	12	52886453	12	52492669	14635	29674	rs28933087	NC_000012.12:52492668:A:C
NM_005554.4(KRT6A):c.1414G>A (p.Glu472Lys)	KRT6A	E472K	not provided|Pachyonychia congenita 3	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000014636	12	52882122	12	52488338	14636	29675	rs60554162	NC_000012.12:52488337:C:T
NM_014444.5(TUBGCP4):c.1380G>A (p.Trp460Ter)	TUBGCP4	W461*, W460*	Microcephaly and chorioretinopathy, autosomal recessive, 3	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803072	15	43690339	15	43398141	803072	791449		NC_000015.10:43398140:G:A
NM_015355.4(SUZ12):c.1826dup (p.Glu610fs)	SUZ12		not provided	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000631551	17	30323846 - 30323847	17	31996827 - 31996828	631551	619937	rs1567840389	NC_000017.11:31996827:GG:GGG
NM_015355.4(SUZ12):c.1794+1G>A	SUZ12		not provided	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000631549	17	30322782	17	31995763	631549	619939	rs1242271427	NC_000017.11:31995762:G:A
NM_016630.7(SPG21):c.736C>T (p.Arg246Ter)	SPG21	R246*, R219*	not provided	Pathogenic(Last reviewed: Jun 26, 2015)	criteria provided, single submitter	VCV000372515	15	65257735	15	64965394	372515	360212	rs369957508	NC_000015.10:64965393:G:A
NM_014444.5(TUBGCP4):c.726delinsAA (p.Leu243fs)	TUBGCP4		not provided	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000265616	15	43677991	15	43385793	265616	260067	rs886039671	NC_000015.10:43385792:C:AA
NM_015355.4(SUZ12):c.1960C>T (p.Arg654Ter)	SUZ12	R654*, R631*	IMAGAWA-MATSUMOTO SYNDROME	Pathogenic(Last reviewed: Feb 21, 2020)	no assertion criteria provided	VCV000812718	17	30325762	17	31998743	812718	800969		NC_000017.11:31998742:C:T
NM_015355.4(SUZ12):c.1807T>C (p.Phe603Leu)	SUZ12	F603L, F580L	IMAGAWA-MATSUMOTO SYNDROME	Pathogenic(Last reviewed: Feb 21, 2020)	no assertion criteria provided	VCV000812717	17	30323829	17	31996810	812717	800968		NC_000017.11:31996809:T:C
NM_015355.4(SUZ12):c.844_845del (p.Ala282fs)	SUZ12	A259fs, A282fs	IMAGAWA-MATSUMOTO SYNDROME	Pathogenic(Last reviewed: Feb 21, 2020)	no assertion criteria provided	VCV000812716	17	30303560 - 30303561	17	31976541 - 31976542	812716	800967		NC_000017.11:31976540:GC:
NM_016630.7(SPG21):c.119dup (p.Ser41fs)	SPG21		Mast syndrome	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000573980	15	65273307 - 65273308	15	64980969 - 64980970	573980	569033	rs1332886505	NC_000015.10:64980969:C:CC
NM_001290018.1(PRMT7):c.1713C>A (p.Cys571Ter)	PRMT7	C571*, C521*, C572*	Insulin resistance|Acanthosis nigricans|Abnormal facial shape|Intellectual disability, severe|Skeletal dysplasia|Renal hypoplasia (disease)|Abnormality of the dentition|Self-injurious behavior|Hyperlipidemia|Short metacarpal|Lumbar hyperlordosis|Obesity|Brachydactyly|Hepatic steatosis|Short stature	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523434	16	68389688	16	68355785	523434	514065	rs1251713297	NC_000016.10:68355784:C:A
NM_019023.4(PRMT7):c.1239_1246dup (p.Val416fs)	PRMT7		Short stature, brachydactyly, intellectual developmental disability, and seizures	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000522593	16	68381160 - 68381161	16	68347257 - 68347258	522593	513207	rs1567721991	NC_000016.10:68347257:GCTCTCCG:GCTCTCCGGCTCTCCG
NM_019023.4(PRMT7):c.429_430AG[1] (p.Glu144fs)	PRMT7		Short stature, brachydactyly, intellectual developmental disability, and seizures	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000522559	16	68371399 - 68371400	16	68337496 - 68337497	522559	513171	rs1567690011	NC_000016.10:68337495:AGAG:AG
NM_015355.4(SUZ12):c.1829A>T (p.Glu610Val)	SUZ12	E610V, E587V	IMAGAWA-MATSUMOTO SYNDROME	Pathogenic(Last reviewed: Feb 21, 2020)	no assertion criteria provided	VCV000430647	17	30323851	17	31996832	430647	424180	rs1131692177	NC_000017.11:31996831:A:T
PRMT7, 15,309-BP DEL	PRMT7		Short stature, brachydactyly, intellectual developmental disability, and seizures	Pathogenic(Last reviewed: May 18, 2017)	no assertion criteria provided	VCV000427216					427216	415885		
NM_019023.4(PRMT7):c.1159A>G (p.Arg387Gly)	PRMT7	R387G, R337G	Short stature, brachydactyly, intellectual developmental disability, and seizures	Pathogenic(Last reviewed: Oct 17, 2016)	no assertion criteria provided	VCV000266023	16	68380151	16	68346248	266023	260846	rs762515973	NC_000016.10:68346247:A:G
NM_019023.4(PRMT7):c.95G>C (p.Arg32Thr)	PRMT7	R32T	Short stature, brachydactyly, intellectual developmental disability, and seizures	Pathogenic(Last reviewed: Oct 17, 2016)	no assertion criteria provided	VCV000266022	16	68349977	16	68316074	266022	260845	rs149170494	NC_000016.10:68316073:G:C
NM_019023.4(PRMT7):c.1480T>C (p.Trp494Arg)	PRMT7	W494R, W444R	Short stature, brachydactyly, intellectual developmental disability, and seizures	Pathogenic(Last reviewed: Oct 17, 2016)	no assertion criteria provided	VCV000266021	16	68386217	16	68352314	266021	260844	rs751670999	NC_000016.10:68352313:T:C
NM_019023.4(PRMT7):c.1276-1G>A	PRMT7		Short stature, brachydactyly, intellectual developmental disability, and seizures	Pathogenic(Last reviewed: Oct 17, 2016)	no assertion criteria provided	VCV000266020	16	68381533	16	68347630	266020	260843	rs886039897	NC_000016.10:68347629:G:A
NM_014444.5(TUBGCP4):c.298del (p.Tyr100fs)	TUBGCP4	Y100fs	Microcephaly and chorioretinopathy, autosomal recessive, 3	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000190126	15	43668790	15	43376592	190126	187958	rs794726856	NC_000015.10:43376591:TT:T
NM_014444.2(TUBGCP4):c.1732-?_*544+?del	TUBGCP4		Microcephaly and chorioretinopathy, autosomal recessive, 3	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000190125					190125	187957		
KRT10, 1-BP INS, 1325C	KRT10		Bullous ichthyosiform erythroderma	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000029766					29766	38721		
NM_000421.4(KRT10):c.1449dup (p.Gly484fs)	KRT10		Erythroderma, ichthyosiform, congenital reticular	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000014583	17	38975337 - 38975338	17	40819085 - 40819086	14583	29622	rs587776817	NC_000017.11:40819085:GG:GGG
KRT10, ARG10LEU	KRT10	R10L	Bullous ichthyosiform erythroderma	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000014570					14570	29609		
NM_015355.4(SUZ12):c.344_347TTAC[1] (p.Tyr117fs)	SUZ12		not provided	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000631552	17	30267462 - 30267465	17	31940443 - 31940446	631552	619936		NC_000017.11:31940442:CTTACTTAC:CTTAC
NM_019023.4(PRMT7):c.1056-1G>T	PRMT7		Short stature, brachydactyly, intellectual developmental disability, and seizures	Pathogenic(Last reviewed: Oct 17, 2016)	no assertion criteria provided	VCV000266024	16	68380047	16	68346144	266024	260847	rs201824659	NC_000016.10:68346143:G:T
KRT10, ARG10CYS	KRT10	R10C	Bullous ichthyosiform erythroderma	Pathogenic(Last reviewed: Feb 1, 1994)	no assertion criteria provided	VCV000014574					14574	29613		
KRT10, ARG10HIS	KRT10	R10H	Bullous ichthyosiform erythroderma	Pathogenic(Last reviewed: Feb 1, 1994)	no assertion criteria provided	VCV000014568					14568	29607		
NM_014444.5(TUBGCP4):c.579dup (p.Gly194fs)	TUBGCP4		Microcephaly and chorioretinopathy, autosomal recessive, 3	Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	VCV000190124	15	43675557 - 43675558	15	43383359 - 43383360	190124	187956	rs794726855	NC_000015.10:43383359:T:TT
NM_016630.7(SPG21):c.322G>C (p.Ala108Pro)	SPG21	A108P, A81P	Mast syndrome	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000127082	15	65267070	15	64974732	127082	132593	rs587777315	NC_000015.10:64974731:C:G
NM_000421.4(KRT10):c.1560_1561del (p.Gly521fs)	KRT10	G521fs	not provided|Erythroderma, ichthyosiform, congenital reticular	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000014584	17	38975226 - 38975227	17	40818974 - 40818975	14584	29623	rs267607384	NC_000017.11:40818973:CGC:C
NM_016630.7(SPG21):c.601dup (p.Thr201fs)	SPG21		Mast syndrome	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000002490	15	65261659 - 65261660	15	64969322 - 64969323	2490	17529	rs387906275	NC_000015.10:64969322:T:TT
NM_000422.3(KRT17):c.275A>G (p.Asn92Ser)	KRT17	N92S	not provided|Pachyonychia congenita 2|Pachyonychia congenita syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014587	17	39780487	17	41624235	14587	29626	rs59151893	NC_000017.11:41624234:T:C
NM_005554.4(KRT6A):c.513C>A (p.Asn171Lys)	KRT6A	N171K	not provided|Pachyonychia congenita 3	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000066589	12	52886460	12	52492676	66589	77486	rs59685571	NC_000012.12:52492675:G:T
NM_005554.4(KRT6A):c.512A>G (p.Asn171Ser)	KRT6A	N171S	not provided|Pachyonychia congenita 3	Pathogenic(Last reviewed: Dec 11, 2015)	criteria provided, single submitter	VCV000066588	12	52886461	12	52492677	66588	77485	rs58556099	NC_000012.12:52492676:T:C
NM_001005273.2(CHD3):c.3515G>A (p.Arg1172Gln)	CHD3	R1172Q, R1231Q	Intellectual disability|SNIJDERS BLOK-CAMPEAU SYNDROME	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549743	17	7806609	17	7903291	549743	540510	rs1567861501	NC_000017.11:7903290:G:A
NM_005852.4(CHD3):c.3477C>A (p.Asn1159Lys)	CHD3	N1159K, N1218K	Marfanoid habitus and intellectual disability|SNIJDERS BLOK-CAMPEAU SYNDROME|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000549739	17	7806361	17	7903043	549739	540506	rs754919272	NC_000017.11:7903042:C:A
NM_001005273.2(CHD3):c.3472T>C (p.Trp1158Arg)	CHD3	W1158R, W1217R	Intellectual disability|SNIJDERS BLOK-CAMPEAU SYNDROME	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549738	17	7806356	17	7903038	549738	540505	rs1567860891	NC_000017.11:7903037:T:C
NM_001005273.2(CHD3):c.2745G>T (p.Leu915Phe)	CHD3	L915F, L974F	Intellectual disability|SNIJDERS BLOK-CAMPEAU SYNDROME	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549730	17	7803670	17	7900352	549730	540497	rs1567855669	NC_000017.11:7900351:G:T
NM_019023.4(PRMT7):c.322G>T (p.Glu108Ter)	PRMT7	E108*, E58*	Short stature, brachydactyly, intellectual developmental disability, and seizures|not provided|Insulin resistance|Acanthosis nigricans|Abnormal facial shape|Intellectual disability, severe|Skeletal dysplasia|Renal hypoplasia (disease)|Abnormality of the dentition|Self-injurious behavior|Hyperlipidemia|Short metacarpal|Lumbar hyperlordosis|Obesity|Brachydactyly|Hepatic steatosis|Short stature	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523435	16	68363008	16	68329105	523435	514064	rs1014959895	NC_000016.10:68329104:G:T
NM_002666.5(PLIN1):c.1191_1192del (p.Val398fs)	PLIN1	V398fs	Familial partial lipodystrophy 4	Pathogenic(Last reviewed: Feb 24, 2011)	no assertion criteria provided	VCV000029828	15	90210184 - 90210185	15	89666953 - 89666954	29828	38783	rs1567075667	NC_000015.10:89666952:CT:
NM_002666.5(PLIN1):c.1210-1G>T	PLIN1		Familial partial lipodystrophy 4	Pathogenic(Last reviewed: Feb 24, 2011)	no assertion criteria provided	VCV000029827	15	90209174	15	89665943	29827	38782	rs1567075176	NC_000015.10:89665942:C:A
NM_001005273.2(CHD3):c.3505C>T (p.Arg1169Trp)	CHD3	R1169W, R1228W	Intellectual disability|SNIJDERS BLOK-CAMPEAU SYNDROME	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000549741	17	7806599	17	7903281	549741	540508	rs1567861468	NC_000017.11:7903280:C:T
NM_001145026.2(PTPRQ):c.1359+2T>C	PTPRQ		not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000597495	12	80878386	12	80484607	597495	588556	rs377572771	NC_000012.12:80484606:T:C
NM_001145026.2(PTPRQ):c.5156_5157AT[1] (p.Ile1720fs)	PTPRQ		Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560907	12	81007608 - 81007609	12	80613829 - 80613830	560907	552023	rs1565819402	NC_000012.12:80613828:ATAT:AT
NM_001145026.2(PTPRQ):c.6739-1G>A	PTPRQ		Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560906	12	81072380	12	80678601	560906	552024	rs1565855932	NC_000012.12:80678600:G:A
NM_015972.4(POLR1D):c.170dup (p.Tyr57Ter)	POLR1D		not provided	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000546551	13	28197154 - 28197155	13	27623017 - 27623018	546551	536863	rs1555271308	NC_000013.11:27623017:A:AA
NM_001145026.2(PTPRQ):c.3867_3871del (p.Tyr1289_Lys1291delinsTer)	PTPRQ		not provided	Pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000499563	12	80936650 - 80936654	12	80542871 - 80542875	499563	490987	rs1419144846	NC_000012.12:80542870:TATATTATA:TATA
NM_001145026.2(PTPRQ):c.5390-1G>T	PTPRQ		not provided	Pathogenic(Last reviewed: Feb 17, 2016)	criteria provided, single submitter	VCV000285868	12	81013932	12	80620153	285868	270105	rs886043240	NC_000012.12:80620152:G:T
NM_001372.4(DNAH9):c.10127dup (p.Leu3376fs)	DNAH9		CILIARY DYSKINESIA, PRIMARY, 40	Pathogenic(Last reviewed: Jan 29, 2019)	no assertion criteria provided	VCV000617525	17	11774986 - 11774987	17	11871669 - 11871670	617525	608893	rs867177356	NC_000017.11:11871669:TT:TTT
NM_001372.4(DNAH9):c.3354-1G>T	DNAH9		CILIARY DYSKINESIA, PRIMARY, 40	Pathogenic(Last reviewed: Jan 29, 2020)	no assertion criteria provided	VCV000617524	17	11583073	17	11679756	617524	608892	rs969193071	NC_000017.11:11679755:G:T
NM_001372.4(DNAH9):c.1970+4A>G	DNAH9		CILIARY DYSKINESIA, PRIMARY, 40	Pathogenic(Last reviewed: Jan 29, 2020)	no assertion criteria provided	VCV000617523	17	11548020	17	11644703	617523	608891	rs368341716	NC_000017.11:11644702:A:G
NM_001372.4(DNAH9):c.8251C>T (p.Gln2751Ter)	DNAH9	Q2751*	CILIARY DYSKINESIA, PRIMARY, 40	Pathogenic(Last reviewed: Jan 29, 2019)	no assertion criteria provided	VCV000617521	17	11700941	17	11797624	617521	608889	rs1567808990	NC_000017.11:11797623:C:T
NM_001372.4(DNAH9):c.8708-2A>G	DNAH9		CILIARY DYSKINESIA, PRIMARY, 40	Pathogenic(Last reviewed: Jan 29, 2019)	no assertion criteria provided	VCV000617520	17	11725235	17	11821918	617520	608888	rs143007518	NC_000017.11:11821917:A:G
NM_001372.4(DNAH9):c.10193G>T (p.Arg3398Leu)	DNAH9	R3398L	CILIARY DYSKINESIA, PRIMARY, 40	Pathogenic(Last reviewed: Jan 29, 2019)	no assertion criteria provided	VCV000617519	17	11775054	17	11871737	617519	608887	rs763238622	NC_000017.11:11871736:G:T
NM_001372.4(DNAH9):c.12367G>A (p.Asp4123Asn)	DNAH9	D4123N, D435N	CILIARY DYSKINESIA, PRIMARY, 40	Pathogenic(Last reviewed: Jan 29, 2019)	no assertion criteria provided	VCV000617518	17	11837266	17	11933949	617518	608886	rs1267599270	NC_000017.11:11933948:G:A
NM_024598.3(USB1):c.489_492del (p.Asn163fs)	USB1	N163fs, N112fs	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496761	16	58048213 - 58048216	16	58014309 - 58014312	496761	488203	rs777667891	NC_000016.10:58014308:CAATCAA:CAA
NM_024598.3(USB1):c.609+1G>A	USB1		Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496760	16	58051344	16	58017440	496760	488202	rs1555498581	NC_000016.10:58017439:G:A
NM_024598.3(USB1):c.518T>G (p.Leu173Arg)	USB1	L173R, L122R, L155R	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496759	16	58051252	16	58017348	496759	488201	rs1555498563	NC_000016.10:58017347:T:G
NM_024598.3(USB1):c.450-2A>G	USB1		Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496758	16	58048175	16	58014271	496758	488200	rs1555498396	NC_000016.10:58014270:A:G
NM_024598.3(USB1):c.415C>T (p.Gln139Ter)	USB1	Q139*, Q88*	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496757	16	58043982	16	58010078	496757	488199	rs1555498129	NC_000016.10:58010077:C:T
NM_024598.3(USB1):c.334dup (p.Arg112fs)	USB1		Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496756	16	58043896 - 58043897	16	58009992 - 58009993	496756	488198	rs1555498117	NC_000016.10:58009992:CCCCC:CCCCCC
NM_024598.3(USB1):c.267T>A (p.Tyr89Ter)	USB1	Y89*, Y38*	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496755	16	58043834	16	58009930	496755	488197	rs771096742	NC_000016.10:58009929:T:A
NM_024598.3(USB1):c.266-1G>A	USB1		Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496754	16	58043832	16	58009928	496754	488196	rs1555498092	NC_000016.10:58009927:G:A
NM_024598.3(USB1):c.265+2T>G	USB1		Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496753	16	58036551	16	58002647	496753	488195	rs1555497680	NC_000016.10:58002646:T:G
NM_024598.3(USB1):c.258T>A (p.Tyr86Ter)	USB1	Y86*, Y35*	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496752	16	58036542	16	58002638	496752	488194	rs199820065	NC_000016.10:58002637:T:A
NM_024598.3(USB1):c.232C>T (p.Arg78Ter)	USB1	R78*, R27*	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496751	16	58036516	16	58002612	496751	488193	rs374559185	NC_000016.10:58002611:C:T
NM_024598.3(USB1):c.176_177del (p.Gly59fs)	USB1	G59fs, G8fs	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496750	16	58036458 - 58036459	16	58002554 - 58002555	496750	488192	rs759761915	NC_000016.10:58002553:GGGG:GG
NM_024598.3(USB1):c.693+1G>T	USB1		Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496749	16	58052960	16	58019056	496749	488191	rs1292827495	NC_000016.10:58019055:G:T
NM_024598.3(USB1):c.673C>T (p.Gln225Ter)	USB1	Q207*, Q174*, Q225*	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496748	16	58052939	16	58019035	496748	488190	rs1459714680	NC_000016.10:58019034:C:T
NM_024598.3(USB1):c.623A>G (p.His208Arg)	USB1	H157R, H190R, H208R	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496747	16	58052889	16	58018985	496747	488189	rs1249059283	NC_000016.10:58018984:A:G
NM_024598.3(USB1):c.541C>T (p.Gln181Ter)	USB1	Q130*, Q181*, Q163*	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496746	16	58051275	16	58017371	496746	488188	rs1555498573	NC_000016.10:58017370:C:T
NM_024598.3(USB1):c.531del (p.His179fs)	USB1	H128fs, H161fs, H179fs	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496745	16	58051265	16	58017361	496745	488187	rs1555498565	NC_000016.10:58017360:A:
NM_005881.4(BCKDK):c.671G>C (p.Arg224Pro)	BCKDK	R224P	Branched-chain keto acid dehydrogenase kinase deficiency	Pathogenic(Last reviewed: Oct 19, 2012)	no assertion criteria provided	VCV000039745	16	31122037	16	31110716	39745	48344	rs147210405	NC_000016.10:31110715:G:C
NM_005881.3c.222delG	BCKDK		Branched-chain keto acid dehydrogenase kinase deficiency	Pathogenic(Last reviewed: Oct 19, 2012)	no assertion criteria provided	VCV000039744					39744	48343		
NM_005881.4(BCKDK):c.466C>T (p.Arg156Ter)	BCKDK	R156*	Branched-chain keto acid dehydrogenase kinase deficiency	Pathogenic(Last reviewed: Oct 19, 2012)	no assertion criteria provided	VCV000039743	16	31121568	16	31110247	39743	48342	rs397514573	NC_000016.10:31110246:C:T
NM_001145026.2(PTPRQ):c.6475C>T (p.Arg2159Ter)	PTPRQ	R2159*	Pain|Hearing impairment|Pes planus|Unsteady gait|Progressive inability to walk|Pes cavus|Impaired vibration sensation in the lower limbs	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523416	12	81064144	12	80670365	523416	514025	rs1445287184	NC_000012.12:80670364:C:T
NM_001195302.2(USB1):c.450-3012del	USB1	T116fs, T167fs	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000496744	16	58048223	16	58014319	496744	488186	rs1555498399	NC_000016.10:58014318:AAAA:AAA
NM_015972.4(POLR1D):c.163C>G (p.Leu55Val)	POLR1D	L55V	Treacher Collins syndrome 2	Pathogenic(Last reviewed: Sep 1, 2014)	no assertion criteria provided	VCV000156464	13	28197148	13	27623011	156464	166231	rs587777841	NC_000013.11:27623010:C:G
NM_001145026.2(PTPRQ):c.837T>A (p.Tyr279Ter)	PTPRQ	Y279*, Y497*	Deafness, autosomal recessive 84	Pathogenic(Last reviewed: Apr 9, 2010)	no assertion criteria provided	VCV000156333	12	80849348	12	80460829	156333	166113	rs183258549	NC_000012.12:80460828:T:A
NM_001145026.2(PTPRQ):c.715A>G (p.Arg239Gly)	PTPRQ	R239G, R457G	Deafness, autosomal recessive 84	Pathogenic(Last reviewed: Apr 9, 2010)	no assertion criteria provided	VCV000156332	12	80849470	12	80460707	156332	166112	rs281865414	NC_000012.12:80460706:A:G
NM_015972.4(POLR1D):c.88_89dup (p.Gln31fs)	POLR1D		Treacher Collins syndrome 2	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000031054	13	28197072 - 28197073	13	27622935 - 27622936	31054	40011		NC_000013.11:27622935:GT:GTGT
NM_015972.4(POLR1D):c.262_263dup (p.Thr89fs)	POLR1D		Treacher Collins syndrome 2	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000031053	13	28197246 - 28197247	13	27623109 - 27623110	31053	40010		NC_000013.11:27623109:GG:GGGG
POLR1D, 2-BP DEL, 326CA	POLR1D		Treacher Collins syndrome 2	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000031052					31052	40009		
NM_015972.4(POLR1D):c.152T>G (p.Leu51Arg)	POLR1D	L51R	Treacher Collins syndrome 2	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000031051	13	28197137	13	27623000	31051	40008		NC_000013.11:27622999:T:G
NM_015972.4(POLR1D):c.139G>A (p.Glu47Lys)	POLR1D	E47K	Treacher Collins syndrome 2	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000031050	13	28197124	13	27622987	31050	40007		NC_000013.11:27622986:G:A
NM_015972.4(POLR1D):c.259C>T (p.Arg87Ter)	POLR1D	R87*	Treacher Collins syndrome 2	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000031049	13	28197244	13	27623107	31049	40006		NC_000013.11:27623106:C:T
NM_024598.3(USB1):c.502A>G (p.Arg168Gly)	USB1	R168G, R117G	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000000203	16	58048229	16	58014325	203	15242	rs137853971	NC_000016.10:58014324:A:G
NM_024598.3(USB1):c.504-2A>C	USB1		Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000000201	16	58051236	16	58017332	201	15240	rs137853970	NC_000016.10:58017331:A:C
NM_024598.3(USB1):c.179del (p.Pro60fs)	USB1	P60fs, P9fs	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000018399	16	58036462	16	58002558	18399	33438	rs786205051	NC_000016.10:58002557:CC:C
NM_024598.3(USB1):c.683_693+1del	USB1		Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000000202	16	58052949 - 58052960	16	58019045 - 58019056	202	15241	rs137853972	NC_000016.10:58019044:AGGAACTACAGG:
NM_024598.3(USB1):c.243G>A (p.Trp81Ter)	USB1	W81*, W30*	Poikiloderma with neutropenia	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000156347	16	58036527	16	58002623	156347	166127	rs137853973	NC_000016.10:58002622:G:A
NM_000785.4(CYP27B1):c.1357C>T (p.Arg453Cys)	CYP27B1	R453C	Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802871	12	58157450	12	57763667	802871	791268		NC_000012.12:57763666:G:A
NM_000785.4(CYP27B1):c.171dup (p.Leu58fs)	CYP27B1		not provided	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000595816	12	58160653 - 58160654	12	57766870 - 57766871	595816	586878	rs763437121	NC_000012.12:57766870:CCCCCCC:CCCCCCCC
NM_014239.4(EIF2B2):c.3G>T (p.Met1Ile)	EIF2B2	M1I	not provided	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000280422	14	75469696	14	75002993	280422	264604	rs767933078	NC_000014.9:75002992:G:T
NM_000785.4(CYP27B1):c.1286G>C (p.Arg429Pro)	CYP27B1	R429P	not provided	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000265095	12	58157521	12	57763738	265095	260032	rs568165874	NC_000012.12:57763737:C:G
NM_000785.4(CYP27B1):c.96_97del (p.Ala33fs)	CYP27B1	A33fs	not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000843900	12	58160728 - 58160729	12	57766945 - 57766946	843900	840186		NC_000012.12:57766944:CT:
NM_000785.4(CYP27B1):c.1375C>T (p.Arg459Cys)	CYP27B1	R459C	Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522958	12	58157432	12	57763649	522958	513614	rs555068245	NC_000012.12:57763648:G:A
NM_014239.4(EIF2B2):c.818A>G (p.Lys273Arg)	EIF2B2	K273R	Premature ovarian insufficiency	Pathogenic(Last reviewed: Jan 15, 2017)	no assertion criteria provided	VCV000495050	14	75473404	14	75006701	495050	486605	rs113994016	NC_000014.9:75006700:A:G
NM_001102.4(ACTN1):c.2255G>A (p.Arg752Gln)	ACTN1	R752Q	Platelet-type bleeding disorder 15	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000042030	14	69346704	14	68879987	42030	51195	rs387907347	NC_000014.9:68879986:C:T
NM_001102.4(ACTN1):c.94C>A (p.Gln32Lys)	ACTN1	Q32K	Platelet-type bleeding disorder 15	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000042029	14	69445680	14	68978963	42029	51194	rs387907346	NC_000014.9:68978962:G:T
IGHG2, 1-BP INS, 1793G	IGHG2		Immunoglobulin IgG2 deficiency	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000014808					14808	29847		
NM_014239.4(EIF2B2):c.512C>T (p.Ser171Phe)	EIF2B2	S171F	Ovarioleukodystrophy	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000004339	14	75471518	14	75004815	4339	19378	rs104894428	NC_000014.9:75004814:C:T
NM_014239.4(EIF2B2):c.547C>T (p.Arg183Ter)	EIF2B2	R183*	Ovarioleukodystrophy	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000004338	14	75471553	14	75004850	4338	19377	rs104894427	NC_000014.9:75004849:C:T
NM_000785.4(CYP27B1):c.1165C>G (p.Arg389Gly)	CYP27B1	R389G	Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000001672	12	58157931	12	57764148	1672	16711	rs118204010	NC_000012.12:57764147:G:C
NM_000785.4(CYP27B1):c.386+1G>A	CYP27B1		Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000001671	12	58159789	12	57766006	1671	16710		NC_000012.12:57766005:C:T
CYP27B1, 5-BP DEL/6-BP INS	CYP27B1		Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000001670					1670	16709		
NM_000785.4(CYP27B1):c.589+1G>A	CYP27B1		Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000001667	12	58159079	12	57765296	1667	16706	rs761780097	NC_000012.12:57765295:C:T
NM_000785.4(CYP27B1):c.962C>G (p.Thr321Arg)	CYP27B1	T321R	Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000001666	12	58158538	12	57764755	1666	16705	rs118204007	NC_000012.12:57764754:G:C
CYP27B1, 7-BP DUP	CYP27B1		Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000001665					1665	16704		
NM_000785.4(CYP27B1):c.693del (p.Thr232fs)	CYP27B1	T232fs	Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000001663	12	58158891	12	57765108	1663	16702	rs387906259	NC_000012.12:57765107:GG:G
NM_000785.4(CYP27B1):c.631del (p.Glu211fs)	CYP27B1	E211fs	Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000001662	12	58158953	12	57765170	1662	16701	rs387906258	NC_000012.12:57765169:CC:C
NM_000785.4(CYP27B1):c.1144C>T (p.Pro382Ser)	CYP27B1	P382S	Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Mar 5, 1998)	no assertion criteria provided	VCV000001661	12	58157952	12	57764169	1661	16700	rs28934607	NC_000012.12:57764168:G:A
NM_000785.4(CYP27B1):c.1004G>C (p.Arg335Pro)	CYP27B1	R335P	Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Mar 5, 1998)	no assertion criteria provided	VCV000001660	12	58158293	12	57764510	1660	16699	rs28934606	NC_000012.12:57764509:C:G
NM_000785.4(CYP27B1):c.374G>A (p.Gly125Glu)	CYP27B1	G125E	Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Mar 5, 1998)	no assertion criteria provided	VCV000001659	12	58159802	12	57766019	1659	16698	rs28934605	NC_000012.12:57766018:C:T
NM_020843.4(SCAPER):c.2377C>T (p.Gln793Ter)	SCAPER	Q547*, Q665*, Q793*, Q659*, Q799*	INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA|not provided	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000620525	15	76995214	15	76702873	620525	611800	rs1239725461	NC_000015.10:76702872:G:A
NM_000785.4(CYP27B1):c.305G>A (p.Gly102Glu)	CYP27B1	G102E	not provided|Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000380287	12	58159871	12	57766088	380287	372536	rs1057520815	NC_000012.12:57766087:C:T
NM_014239.4(EIF2B2):c.254T>A (p.Val85Glu)	EIF2B2	V85E	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000040180	14	75470068	14	75003365	40180	48677	rs397514648	NC_000014.9:75003364:T:A
NM_000785.4(CYP27B1):c.1226C>T (p.Thr409Ile)	CYP27B1	T409I	Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000001668	12	58157581	12	57763798	1668	16707	rs118204008	NC_000012.12:57763797:G:A
NM_020843.4(SCAPER):c.2806del (p.Thr935_Leu936insTer)	SCAPER		Neurological speech impairment|Pigmentary retinopathy|Obesity|Brachydactyly|Short stature|Intellectual disability	Pathogenic	criteria provided, single submitter	VCV000548448	15	76866531	15	76574190	548448	538932	rs1567499068	NC_000015.10:76574189:GGG:GG
NM_014239.4(EIF2B2):c.922G>A (p.Val308Met)	EIF2B2	V308M	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000522641	14	75475757	14	75009054	522641	513345	rs372548739	NC_000014.9:75009053:G:A
NM_020843.3(SCAPER):c.1859_1861del (p.Glu620del)	SCAPER	E620del	Rod-cone dystrophy|Intellectual disability, moderate|INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2018)	no assertion criteria provided	VCV000427856	15	77046154 - 77046156	15	76753813 - 76753815	427856	418812	rs1395475624	NC_000015.10:76753812:CTTCTTCTTCTT:CTTCTTCTT
NM_020843.4(SCAPER):c.3656G>A (p.Ser1219Asn)	SCAPER	S1219N, S1085N, S1225N, S1091N, S973N	Rod-cone dystrophy|Intellectual disability, moderate|INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2018)	no assertion criteria provided	VCV000427855	15	76673768	15	76381427	427855	418811	rs1305542291	NC_000015.10:76381426:C:T
NM_020843.3(SCAPER):c.2973_2976del (p.Ile991Metfs)	SCAPER		INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA|Attention deficit hyperactivity disorder|Rod-cone dystrophy|Intellectual disability, moderate	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000417685	15	76763655 - 76763658	15	76471314 - 76471317	417685	404617	rs1555447569	NC_000015.10:76471313:ATTGATTG:ATTG
NM_001102.4(ACTN1):c.2212C>T (p.Arg738Trp)	ACTN1	R738W	Macrothrombocytopenia|Platelet-type bleeding disorder 15	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000042032	14	69346747	14	68880030	42032	51197	rs387907349	NC_000014.9:68880029:G:A
NM_000785.4(CYP27B1):c.1027C>T (p.Leu343Phe)	CYP27B1	L343F	Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000001673	12	58158270	12	57764487	1673	16712	rs118204011	NC_000012.12:57764486:G:A
NM_000785.4(CYP27B1):c.262del (p.Val88fs)	CYP27B1	V88fs	not provided|Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000001664	12	58159914	12	57766131	1664	16703	rs387906260	NC_000012.12:57766130:C:
NM_001102.4(ACTN1):c.136C>T (p.Arg46Trp)	ACTN1	R46W	Macrothrombocytopenia|Thrombocytopenia	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000626995	14	69392359	14	68925642	626995	615564		NC_000014.9:68925641:G:A
NM_000785.4(CYP27B1):c.566A>G (p.Glu189Gly)	CYP27B1	E189G	Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000001674	12	58159103	12	57765320	1674	16713	rs118204012	NC_000012.12:57765319:T:C
NM_001102.4(ACTN1):c.673G>A (p.Glu225Lys)	ACTN1	E225K	Macrothrombocytopenia|Platelet-type bleeding disorder 15	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000042033	14	69371375	14	68904658	42033	51198	rs387907350	NC_000014.9:68904657:C:T
NM_001102.4(ACTN1):c.137G>A (p.Arg46Gln)	ACTN1	R46Q	Macrothrombocytopenia|Platelet-type bleeding disorder 15	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000042031	14	69392358	14	68925641	42031	51196	rs387907348	NC_000014.9:68925640:C:T
NM_006984.5(CLDN10):c.2T>C (p.Met1Thr)	CLDN10	M1T	HELIX SYNDROME	Pathogenic(Last reviewed: Nov 20, 2018)	no assertion criteria provided	VCV000438638	13	96205009	13	95552755	438638	432259	rs930701747	NC_000013.11:95552754:T:C
NM_006984.5(CLDN10):c.392C>T (p.Ser131Leu)	CLDN10	S131L, S129L, S110L	HELIX SYNDROME	Pathogenic(Last reviewed: Feb 26, 2018)	no assertion criteria provided	VCV000438637	13	96212645	13	95560391	438637	432258	rs1555299783	NC_000013.11:95560390:C:T
NM_006984.5(CLDN10):c.144C>G (p.Asn48Lys)	CLDN10	N48K	HELIX SYNDROME	Pathogenic(Last reviewed: Sep 15, 2017)	no assertion criteria provided	VCV000438636	13	96205151	13	95552897	438636	432257	rs759408749	NC_000013.11:95552896:C:G
NM_005886.3(KATNB1):c.432+1G>A	KATNB1		Lissencephaly 6, with microcephaly	Pathogenic(Last reviewed: Dec 17, 2014)	no assertion criteria provided	VCV000180641	16	57785215	16	57751303	180641	178803	rs879255519	NC_000016.10:57751302:G:A
NM_005886.3(KATNB1):c.97G>T (p.Gly33Trp)	KATNB1	G33W	Lissencephaly 6, with microcephaly	Pathogenic(Last reviewed: Dec 17, 2014)	no assertion criteria provided	VCV000180640	16	57775655	16	57741743	180640	178802	rs730880259	NC_000016.10:57741742:G:T
NM_005886.3(KATNB1):c.1A>G (p.Met1Val)	KATNB1	M1V	Lissencephaly 6, with microcephaly	Pathogenic(Last reviewed: Dec 17, 2014)	no assertion criteria provided	VCV000180639	16	57771156	16	57737244	180639	178801	rs879255518	NC_000016.10:57737243:A:G
NM_005886.3(KATNB1):c.447del (p.Val150fs)	KATNB1	V150fs	Lissencephaly 6, with microcephaly	Pathogenic(Last reviewed: Dec 17, 2014)	no assertion criteria provided	VCV000180638	16	57785566	16	57751654	180638	178800	rs879255517	NC_000016.10:57751653:CC:C
NM_005886.3(KATNB1):c.1619T>G (p.Leu540Arg)	KATNB1	L540R	Lissencephaly 6, with microcephaly	Pathogenic(Last reviewed: Dec 17, 2014)	no assertion criteria provided	VCV000180637	16	57789805	16	57755893	180637	178799	rs730880258	NC_000016.10:57755892:T:G
NM_005886.3(KATNB1):c.1604C>T (p.Ser535Leu)	KATNB1	S535L	Lissencephaly 6, with microcephaly	Pathogenic(Last reviewed: Dec 17, 2014)	no assertion criteria provided	VCV000180636	16	57789790	16	57755878	180636	178798	rs730880257	NC_000016.10:57755877:C:T
NM_001270974.2(HYDIN):c.3786-1G>T	HYDIN		Ciliary dyskinesia, primary, 5	Pathogenic(Last reviewed: Aug 8, 2013)	no assertion criteria provided	VCV000065472	16	71025300	16	70991397	65472	76384	rs373501414	NC_000016.10:70991396:C:A
NM_001270974.2(HYDIN):c.3985G>T (p.Val1329Leu)	HYDIN	V1329L	Kartagener syndrome|Ciliary dyskinesia, primary, 5	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000039698	16	71022036	16	70988133	39698	48297	rs397515413	NC_000016.10:70988132:C:A
NM_001102.4(ACTN1):c.313G>A (p.Val105Ile)	ACTN1	V105I	Macrothrombocytopenia|Platelet-type bleeding disorder 15	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042028	14	69387750	14	68921033	42028	51193	rs387907345	NC_000014.9:68921032:C:T
NM_001270974.2(HYDIN):c.922A>T (p.Lys308Ter)	HYDIN	K307*, K308*, K335*, K325*	Ciliary dyskinesia, primary, 5|Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000039699	16	71171175	16	71137272	39699	48298	rs397515414	NC_000016.10:71137271:T:A
NM_004870.4(MPDU1):c.221T>C (p.Leu74Ser)	MPDU1	L74S	MPDU1-CDG	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000005871	17	7489315	17	7585997	5871	20910	rs104894589	NC_000017.11:7585996:T:C
MPDU1, 1-BP DEL, 511C	MPDU1		MPDU1-CDG	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000005870					5870	20909		
NM_004870.4(MPDU1):c.356T>C (p.Leu119Pro)	MPDU1	L119P	MPDU1-CDG	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000005868	17	7490063	17	7586745	5868	20907	rs104894587	NC_000017.11:7586744:T:C
NM_033124.5(CCDC65):c.658G>T (p.Glu220Ter)	CCDC65	E220*, E77*	Ciliary dyskinesia, primary, 27	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000649817	12	49312106	12	48918323	649817	641147		NC_000012.12:48918322:G:T
NM_033124.5(CCDC65):c.718C>T (p.Arg240Ter)	CCDC65	R240*, R97*	Ciliary dyskinesia, primary, 27	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000644753	12	49312166	12	48918383	644753	641148		NC_000012.12:48918382:C:T
NC_000013.10:g.(?_91350605)_(91351391_?)del	MIR17HG		Feingold syndrome 2	Pathogenic(Last reviewed: Apr 27, 2015)	criteria provided, single submitter	VCV000433155	13	91350605 - 91351391	13	90698351 - 90699137	433155	426722		
NM_005554.4(KRT6A):c.510_512CAA[2] (p.Asn172del)	KRT6A	N172del	not provided|Pachyonychia congenita 3	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000014634	12	52886455 - 52886457	12	52492671 - 52492673	14634	29673	rs606231214	NC_000012.12:52492670:TTGTTGTTG:TTGTTG
NM_005557.4(KRT16):c.374A>G (p.Asn125Ser)	KRT16	N125S	Palmoplantar keratoderma, nonepidermolytic, focal|Pachyonychia congenita 1|not provided|Pachyonychia congenita 1|Palmoplantar keratoderma, nonepidermolytic, focal	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014602	17	39768567	17	41612315	14602	29641	rs60723330	NC_000017.11:41612314:T:C
NM_033124.5(CCDC65):c.494del (p.Glu165fs)	CCDC65	E22fs, E165fs	Ciliary dyskinesia, primary, 27|Cough|Clinodactyly of the 5th finger|Anomalous origin of coronary artery from the pulmonary artery	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000474640	12	49310776	12	48916993	474640	462979	rs1555174708	NC_000012.12:48916992:A:
NM_025233.7(COASY):c.394C>T (p.Gln132Ter)	COASY	Q132*, Q161*	not provided	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000620212	17	40715034	17	42563016	620212	611855	rs1567903711	NC_000017.11:42563015:C:T
NM_139242.4(MTFMT):c.91C>T (p.Arg31Ter)	MTFMT	R31*	Combined oxidative phosphorylation deficiency 15	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000488549	15	65321861	15	65029523	488549	481417	rs1555404423	NC_000015.10:65029522:G:A
NM_207037.2(TCF12):c.1876C>T (p.Arg626Ter)	TCF12	R626*, R366*, R432*, R544*, R614*, R625*, R407*, R456*, R568*, R602*	Craniosynostosis 3	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374377	15	57565358	15	57273160	374377	361216	rs758543580	NC_000015.10:57273159:C:T
NC_000017.11:g.(?_42562392)_(42565988_?)del	COASY		Neurodegeneration with brain iron accumulation 6	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000832522	17	40714410 - 40718006			832522	821043		
NM_207037.2(TCF12):c.786dup (p.Ser263fs)	TCF12		Craniosynostosis 3	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000692240	15	57524587 - 57524588	15	57232389 - 57232390	692240	680054		NC_000015.10:57232389:AA:AAA
NM_025233.7(COASY):c.641C>T (p.Ala214Val)	COASY	A214V, A243V	Neurodegeneration with brain iron accumulation 6	Pathogenic(Last reviewed: Jan 9, 2019)	no assertion criteria provided	VCV000599340	17	40715281	17	42563263	599340	590637	rs1567904066	NC_000017.11:42563262:C:T
NM_207037.2(TCF12):c.1642_1645del (p.Glu548fs)	TCF12	E354fs, E466fs, E548fs, E288fs, E329fs, E536fs, E378fs, E547fs, E490fs, E524fs	Craniosynostosis 3	Pathogenic(Last reviewed: Oct 14, 2015)	criteria provided, single submitter	VCV000436958	15	57555366 - 57555369	15	57263168 - 57263171	436958	429708	rs1555412971	NC_000015.10:57263167:AAAGAAA:AAA
NM_139242.4(MTFMT):c.219_222del (p.Glu74fs)	MTFMT	E74fs	Combined oxidative phosphorylation deficiency 15	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000435899	15	65319366 - 65319369	15	65027028 - 65027031	435899	429712	rs777725264	NC_000015.10:65027027:TTCTTT:TT
NM_207037.2(TCF12):c.1488_1489CT[3] (p.Val498fs)	TCF12		not provided	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000377099	15	57554311 - 57554312	15	57262113 - 57262114	377099	363977	rs1057520132	NC_000015.10:57262113:CTCT:CTCTCT
NM_139242.4(MTFMT):c.878G>A (p.Ser293Asn)	MTFMT	S293N	Combined oxidative phosphorylation deficiency 15	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000133324	15	65298465	15	65006127	133324	137061	rs587777418	NC_000015.10:65006126:C:T
NM_207037.2(TCF12):c.1838G>A (p.Arg613His)	TCF12	R613H, R353H, R612H, R419H, R443H, R531H, R555H, R394H, R589H, R601H	Craniosynostosis 3	Pathogenic(Last reviewed: Sep 2, 2013)	criteria provided, single submitter	VCV000127272	15	57565320	15	57273122	127272	132729	rs730880016	NC_000015.10:57273121:G:A
NM_207037.2(TCF12):c.1366dup (p.Ile456fs)	TCF12		Craniosynostosis 3	Pathogenic(Last reviewed: Sep 2, 2013)	criteria provided, single submitter	VCV000127271	15	57545564 - 57545565	15	57253366 - 57253367	127271	132728	rs730880326	NC_000015.10:57253366:A:AA
NM_207037.2(TCF12):c.1071del (p.Ser358fs)	TCF12	S122fs, S139fs, S188fs, S300fs, S370fs, S358fs	Craniosynostosis 3	Pathogenic(Last reviewed: Sep 2, 2013)	criteria provided, single submitter	VCV000127270	15	57535705	15	57243507	127270	132727	rs730880015	NC_000015.10:57243506:G:
NM_207037.2(TCF12):c.998_999CA[1] (p.Gln334fs)	TCF12		Craniosynostosis 3	Pathogenic(Last reviewed: Sep 2, 2013)	criteria provided, single submitter	VCV000127269	15	57526268 - 57526269	15	57234070 - 57234071	127269	132726	rs730880017	NC_000015.10:57234069:CACA:CA
NM_025233.7(COASY):c.175C>T (p.Gln59Ter)	COASY	Q59*, Q88*	Neurodegeneration with brain iron accumulation 6	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000100663	17	40714815	17	42562797	100663	106535	rs587777136	NC_000017.11:42562796:C:T
NM_207037.2(TCF12):c.1912C>G (p.Gln638Glu)	TCF12	Q638E, Q614E, Q637E, Q419E, Q580E, Q378E, Q444E, Q626E, Q468E, Q556E	Craniosynostosis 3	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000055917	15	57565394	15	57273196	55917	70559	rs886037641	NC_000015.10:57273195:C:G
NM_207037.2(TCF12):c.1035+3G>C	TCF12		Craniosynostosis 3	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000055916	15	57526308	15	57234110	55916	70558	rs886037640	NC_000015.10:57234109:G:C
NM_207037.2(TCF12):c.1963G>T (p.Glu655Ter)	TCF12	E656*, E655*, E461*, E654*, E597*, E631*, E436*, E573*, E643*, E395*, E485*	Craniosynostosis 3	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000055915	15	57565445	15	57273247	55915	70557	rs886037639	NC_000015.10:57273246:G:T
NM_207037.2(TCF12):c.1646del (p.Lys549fs)	TCF12	K355fs, K467fs, K537fs, K289fs, K330fs, K379fs, K491fs, K525fs, K548fs, K549fs	Craniosynostosis 3	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000055914	15	57555370	15	57263172	55914	70556	rs886037638	NC_000015.10:57263171:AAAA:AAA
NM_207037.2(TCF12):c.722C>G (p.Ser241Ter)	TCF12	S241*, S22*, S71*, S183*, S253*	Craniosynostosis 3	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000055913	15	57524525	15	57232327	55913	70555	rs398122381	NC_000015.10:57232326:C:G
NM_207037.2(TCF12):c.1491dup (p.Val498fs)	TCF12		Craniosynostosis 3	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000055912	15	57554314 - 57554315	15	57262116 - 57262117	55912	70554	rs886037637	NC_000015.10:57262116:T:TT
NM_207037.2(TCF12):c.842C>G (p.Ser281Ter)	TCF12	S281*, S111*, S293*, S45*, S223*, S62*	Craniosynostosis 3	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000055911	15	57524926	15	57232728	55911	70553	rs886037636	NC_000015.10:57232727:C:G
NM_139242.4(MTFMT):c.382C>T (p.Arg128Ter)	MTFMT	R128*	Combined oxidative phosphorylation deficiency 15	Pathogenic(Last reviewed: Sep 7, 2011)	no assertion criteria provided	VCV000039828	15	65319206	15	65026868	39828	48427	rs397514613	NC_000015.10:65026867:G:A
NM_025233.7(COASY):c.1547_1548AG[1] (p.Ser517fs)	COASY		PONTOCEREBELLAR HYPOPLASIA, TYPE 12	Pathogenic(Last reviewed: Jan 9, 2019)	no assertion criteria provided	VCV000599342	17	40717738 - 40717739	17	42565720 - 42565721	599342	590639	rs766482965	NC_000017.11:42565719:AGAG:AG
NM_025233.7(COASY):c.1486-3C>G	COASY		PONTOCEREBELLAR HYPOPLASIA, TYPE 12	Pathogenic(Last reviewed: Jan 9, 2019)	no assertion criteria provided	VCV000599341	17	40717674	17	42565656	599341	590638	rs577714887	NC_000017.11:42565655:C:G
NM_139242.4(MTFMT):c.1100_1101del (p.Phe367fs)	MTFMT	F367fs	Mitochondrial oxidative phosphorylation disorder	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000506018	15	65295469 - 65295470	15	65003131 - 65003132	506018	497470	rs754222633	NC_000015.10:65003130:AAA:A
NM_139242.4(MTFMT):c.452C>T (p.Pro151Leu)	MTFMT	P151L	Combined oxidative phosphorylation deficiency 15	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000120309	15	65316100	15	65023762	120309	125903	rs587777244	NC_000015.10:65023761:G:A
NM_025233.7(COASY):c.1495C>T (p.Arg499Cys)	COASY	R499C, R528C	Neurodegeneration with brain iron accumulation 6	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000100662	17	40717686	17	42565668	100662	106534	rs140709867	NC_000017.11:42565667:C:T
GRCh37/hg19 15q21.3(chr15:57367491-57456139)x1	TCF12		See cases	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000638114	15	57367491 - 57456139			638114	625935		
NM_139242.4(MTFMT):c.73C>T (p.Gln25Ter)	MTFMT	Q25*	not provided|Combined oxidative phosphorylation deficiency 15	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000133325	15	65321879	15	65029541	133325	137062	rs587777419	NC_000015.10:65029540:G:A
NM_139242.4(MTFMT):c.374C>T (p.Ser125Leu)	MTFMT	S125L	Combined oxidative phosphorylation deficiency 15	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000039829	15	65319214	15	65026876	39829	48428	rs397514614	NC_000015.10:65026875:G:A
NM_003632.3(CNTNAP1):c.2344C>T (p.Arg782Ter)	CNTNAP1	R782*	not provided	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000817524	17	40843529	17	42691511	817524	805947		NC_000017.11:42691510:C:T
NM_003632.3(CNTNAP1):c.3475-2A>C	CNTNAP1		not provided	Pathogenic(Last reviewed: Oct 27, 2015)	criteria provided, single submitter	VCV000430068	17	40849290	17	42697272	430068	422168	rs1131691767	NC_000017.11:42697271:A:C
NM_003632.3(CNTNAP1):c.1282C>T (p.Arg428Ter)	CNTNAP1	R428*	not provided	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000379825	17	40839975	17	42687957	379825	375017	rs778961637	NC_000017.11:42687956:C:T
NM_003632.3(CNTNAP1):c.2668C>T (p.Arg890Ter)	CNTNAP1	R890*	Lethal congenital contracture syndrome 7	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000692016	17	40844654	17	42692636	692016	679798		NC_000017.11:42692635:C:T
NM_015133.5(MAPK8IP3):c.65del (p.Gly22fs)	MAPK8IP3	G22fs	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES	Pathogenic(Last reviewed: May 23, 2019)	no assertion criteria provided	VCV000632561	16	1756404	16	1706403	632561	620947	rs1567128142	NC_000016.10:1706402:GG:G
NM_003632.3(CNTNAP1):c.1677G>A (p.Trp559Ter)	CNTNAP1	W559*	Congenital hypomyelinating neuropathy 3	Pathogenic(Last reviewed: Nov 27, 2018)	no assertion criteria provided	VCV000590918	17	40841587	17	42689569	590918	581862	rs756896276	NC_000017.11:42689568:G:A
NM_003632.3(CNTNAP1):c.635T>C (p.Leu212Pro)	CNTNAP1	L212P	Congenital hypomyelinating neuropathy 3	Pathogenic(Last reviewed: Nov 27, 2018)	no assertion criteria provided	VCV000590912	17	40837358	17	42685340	590912	581856	rs1567969825	NC_000017.11:42685339:T:C
NM_014321.4(ORC6):c.1A>G (p.Met1Val)	ORC6	M1V	Meier-Gorlin syndrome 3	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000436124	16	46723618	16	46689706	436124	429811	rs777153067	NC_000016.10:46689705:A:G
NM_014321.4(ORC6):c.449+5G>A	ORC6		Meier-Gorlin syndrome 3	Pathogenic(Last reviewed: Aug 26, 2016)	no assertion criteria provided	VCV000253273	16	46727099	16	46693187	253273	247699	rs572314014	NC_000016.10:46693186:G:A
NM_002461.3(MVD):c.875A>G (p.Asn292Ser)	MVD	N292S	Porokeratosis 7, multiple types	Pathogenic(Last reviewed: Jul 23, 2015)	no assertion criteria provided	VCV000253040	16	88721629	16	88655221	253040	247451	rs755948940	NC_000016.10:88655220:T:C
NM_003632.3(CNTNAP1):c.2993-1_2995del	CNTNAP1		Lethal congenital contracture syndrome 7	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000189262	17	40847537 - 40847540	17	42695519 - 42695522	189262	187147	rs786204800	NC_000017.11:42695518:AGATA:A
NM_003632.3(CNTNAP1):c.3009dup (p.Glu1004Ter)	CNTNAP1		Lethal congenital contracture syndrome 7	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000189261	17	40847552 - 40847553	17	42695534 - 42695535	189261	187146	rs786204799	NC_000017.11:42695534:TTT:TTTT
NM_006432.4(NPC2):c.3G>C (p.Met1Ile)	NPC2	M1I		Pathogenic	no assertion criteria provided	VCV000132902	14	74959975	14	74493272	132902	136651	rs483352893	NC_000014.9:74493271:C:G
NM_014321.4(ORC6):c.695A>C (p.Tyr232Ser)	ORC6	Y232S	Meier-Gorlin syndrome 3	Pathogenic(Last reviewed: Feb 27, 2011)	no assertion criteria provided	VCV000030656	16	46731433	16	46697521	30656	39613	rs387906969	NC_000016.10:46697520:A:C
NM_006432.5(NPC2):c.210_213dup (p.Ala72fs)	NPC2			Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000856293	14	74951267 - 74951268	14	74484564 - 74484565	856293	841724		NC_000014.9:74484564:CTTGCT:CTTGCTTGCT
NC_000014.9:g.(?_74480264)_(74493284_?)del	NPC2			Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000831251	14	74946967 - 74959987			831251	820646		
NM_003632.3(CNTNAP1):c.69C>G (p.Tyr23Ter)	CNTNAP1	Y23*	Fetal akinesia sequence|Arthrogryposis multiplex congenita	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000692274	17	40835840	17	42683822	692274	680118		NC_000017.11:42683821:C:G
NM_006432.5(NPC2):c.79dup (p.Cys27fs)	NPC2			Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000643285	14	74959898 - 74959899	14	74493195 - 74493196	643285	642685		NC_000014.9:74493195:A:AA
NM_003632.3(CNTNAP1):c.2290C>T (p.Arg764Cys)	CNTNAP1	R764C	Congenital hypomyelinating neuropathy 3	Pathogenic(Last reviewed: Nov 28, 2018)	no assertion criteria provided	VCV000590914	17	40843475	17	42691457	590914	581858	rs761805324	NC_000017.11:42691456:C:T
NM_003632.3(CNTNAP1):c.2011C>T (p.Gln671Ter)	CNTNAP1	Q671*	Congenital hypomyelinating neuropathy 3	Pathogenic(Last reviewed: Nov 27, 2018)	no assertion criteria provided	VCV000590913	17	40842912	17	42690894	590913	581857	rs1567973088	NC_000017.11:42690893:C:T
NM_014321.4(ORC6):c.598_601AGAA[1] (p.Lys201fs)	ORC6		Meier-Gorlin syndrome 3	Pathogenic(Last reviewed: Aug 26, 2019)	no assertion criteria provided	VCV000253274	16	46729964 - 46729967	16	46696052 - 46696055	253274	247700	rs879255692	NC_000016.10:46696051:AGAAAGAA:AGAA
NM_002461.3(MVD):c.746T>C (p.Phe249Ser)	MVD	F249S	Porokeratosis 7, multiple types	Pathogenic(Last reviewed: Jul 23, 2015)	no assertion criteria provided	VCV000253039	16	88721758	16	88655350	253039	247450	rs761991070	NC_000016.10:88655349:A:G
NM_003632.3(CNTNAP1):c.1869G>A (p.Trp623Ter)	CNTNAP1	W623*	Congenital hypomyelinating neuropathy 3	Pathogenic(Last reviewed: Nov 27, 2018)	no assertion criteria provided	VCV000242387	17	40842770	17	42690752	242387	237756	rs878853221	NC_000017.11:42690751:G:A
NM_003632.3(CNTNAP1):c.967T>C (p.Cys323Arg)	CNTNAP1	C323R	Congenital hypomyelinating neuropathy 3	Pathogenic(Last reviewed: Nov 28, 2018)	no assertion criteria provided	VCV000242386	17	40838987	17	42686969	242386	237757	rs768554986	NC_000017.11:42686968:T:C
NM_006432.4(NPC2):c.295T>C (p.Cys99Arg)	NPC2	C99R		Pathogenic(Last reviewed: Jul 22, 2008)	no assertion criteria provided	VCV000021458	14	74951186	14	74484483	21458	34310	rs80358264	NC_000014.9:74484482:A:G
NPC2, 1-BP DEL, 111A	NPC2			Pathogenic(Last reviewed: Dec 22, 2000)	no assertion criteria provided	VCV000008478					8478	23517		
NM_006432.4(NPC2):c.27del (p.Leu10fs)	NPC2	L10fs		Pathogenic(Last reviewed: Jul 22, 2008)	no assertion criteria provided	VCV000021457	14	74959951	14	74493248	21457	34309	rs80358267	NC_000014.9:74493247:C:
NM_006432.4(NPC2):c.141C>A (p.Cys47Ter)	NPC2	C47*		Pathogenic(Last reviewed: Jun 25, 2014)	no assertion criteria provided	VCV000021456	14	74953081	14	74486378	21456	34308	rs80358263	NC_000014.9:74486377:G:T
NM_003632.3(CNTNAP1):c.1561dup (p.Leu521fs)	CNTNAP1		not provided|Lethal congenital contracture syndrome 7	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000254173	17	40840997 - 40840998	17	42688979 - 42688980	254173	248652	rs1555642784	NC_000017.11:42688979:C:CC
NM_006432.4(NPC2):c.82+2T>C	NPC2			Pathogenic(Last reviewed: Nov 11, 2014)	no assertion criteria provided	VCV000242903	14	74959894	14	74493191	242903	244008	rs879253740	NC_000014.9:74493190:A:G
NM_014321.4(ORC6):c.257_258del (p.Ser85_Phe86insTer)	ORC6		Meier-Gorlin syndrome 3	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000030655	16	46726353 - 46726354	16	46692441 - 46692442	30655	39612	rs786205258	NC_000016.10:46692440:TTTT:TT
NM_006432.4(NPC2):c.115G>A (p.Val39Met)	NPC2	V39M		Pathogenic(Last reviewed: Jul 22, 2008)	no assertion criteria provided	VCV000008483	14	74953107	14	74486404	8483	23522	rs80358261	NC_000014.9:74486403:C:T
NM_006432.4(NPC2):c.199T>C (p.Ser67Pro)	NPC2	S67P		Pathogenic(Last reviewed: Jul 22, 2008)	no assertion criteria provided	VCV000008482	14	74951282	14	74484579	8482	23521	rs11694	NC_000014.9:74484578:A:G
NM_003632.3(CNTNAP1):c.2901_2902del (p.Cys968fs)	CNTNAP1	C968fs	Lethal congenital contracture syndrome 7|not provided	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000204313	17	40845463 - 40845464	17	42693445 - 42693446	204313	200707	rs751050956	NC_000017.11:42693444:CT:
NM_000785.4(CYP27B1):c.1312_1318CCCACCC[3] (p.Phe443fs)	CYP27B1		Vitamin D-dependent rickets, type 1|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279798	12	58157481 - 58157482	12	57763698 - 57763699	279798	264701	rs780950819	NC_000012.12:57763698:GGGTGGGGGGTGGG:GGGTGGGGGGTGGGGGGTGGG
NM_201631.4(TGM5):c.1001+2_1001+3del	TGM5		not provided	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000420028	15	43533047 - 43533048	15	43240849 - 43240850	420028	409231	rs748610718	NC_000015.10:43240848:CAC:C
NM_001288767.2(ARMC5):c.1379T>C (p.Leu460Pro)	ARMC5	L365P, L460P, L397P	Acth-independent macronodular adrenal hyperplasia 2	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000144058	16	31473962	16	31462641	144058	153793	rs587777663	NC_000016.10:31462640:T:C
ARMC5, 1-BP DEL, G	ARMC5		Acth-independent macronodular adrenal hyperplasia 2	Pathogenic(Last reviewed: Nov 28, 2013)	no assertion criteria provided	VCV000144056					144056	153791		
NM_001288767.2(ARMC5):c.1928T>C (p.Leu643Pro)	ARMC5	L548P, L643P, L580P	Acth-independent macronodular adrenal hyperplasia 2	Pathogenic(Last reviewed: Nov 28, 2013)	no assertion criteria provided	VCV000144055	16	31475987	16	31464666	144055	153790	rs587777661	NC_000016.10:31464665:T:C
NM_001288767.2(ARMC5):c.541C>T (p.Gln181Ter)	ARMC5	Q86*, Q181*, Q118*	Acth-independent macronodular adrenal hyperplasia 2	Pathogenic(Last reviewed: Nov 28, 2013)	no assertion criteria provided	VCV000144054	16	31471101	16	31459780	144054	153789	rs587777660	NC_000016.10:31459779:C:T
NM_201631.4(TGM5):c.1811_1815delinsTCCTTCA (p.Ser604fs)	TGM5		Peeling skin syndrome 2	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000157571	15	43527027 - 43527031	15	43234829 - 43234833	157571	167433	rs606231278	NC_000015.10:43234828:ACTGC:TGAAGGA
NM_001288767.2(ARMC5):c.2062C>T (p.Arg688Trp)	ARMC5	R593W, R688W, R625W	Acth-independent macronodular adrenal hyperplasia 2	Pathogenic(Last reviewed: Jun 6, 2014)	no assertion criteria provided	VCV000144057	16	31476121	16	31464800	144057	153792	rs587777662	NC_000016.10:31464799:C:T
NM_001288767.2(ARMC5):c.2977C>T (p.Arg993Trp)	ARMC5	R898W, R993W, R930W	Acth-independent macronodular adrenal hyperplasia 2	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000144053	16	31478094	16	31466773	144053	153788	rs587777659	NC_000016.10:31466772:C:T
NM_001288767.2(ARMC5):c.1084C>T (p.Arg362Ter)	ARMC5	R267*, R362*, R299*	Acth-independent macronodular adrenal hyperplasia 2	Pathogenic(Last reviewed: Jun 6, 2014)	no assertion criteria provided	VCV000144052	16	31473667	16	31462346	144052	153787	rs369721476	NC_000016.10:31462345:C:T
NM_201631.4(TGM5):c.1335G>C (p.Lys445Asn)	TGM5	K445N, K363N	Peeling skin syndrome 2	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000157567	15	43531025	15	43238827	157567	167429	rs606231276	NC_000015.10:43238826:C:G
NM_000226.4(KRT9):c.478C>T (p.Leu160Phe)	KRT9	L160F	not provided|Palmoplantar keratoderma, epidermolytic, with knuckle pads	Pathogenic(Last reviewed: Jul 30, 2003)	no assertion criteria provided	VCV000003008	17	39727767	17	41571515	3008	18047	rs28940896	NC_000017.11:41571514:G:A
NM_201631.4(TGM5):c.640del (p.Leu214fs)	TGM5	L132fs, L214fs	Peeling skin syndrome 1|Peeling skin syndrome 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000157570	15	43545748	15	43253550	157570	167432	rs606231277	NC_000015.10:43253549:G:
NM_000226.4(KRT9):c.482A>T (p.Asn161Ile)	KRT9	N161I	not provided|Palmoplantar keratoderma, epidermolytic, with knuckle pads	Pathogenic(Last reviewed: Jul 30, 2003)	no assertion criteria provided	VCV000003009	17	39727763	17	41571511	3009	18048	rs56707768	NC_000017.11:41571510:T:A
NM_000226.4(KRT9):c.511G>A (p.Val171Met)	KRT9	V171M	Epidermolytic palmoplantar keratoderma|not provided	Pathogenic(Last reviewed: Jul 30, 2003)	no assertion criteria provided	VCV000003007	17	39727734	17	41571482	3007	18046	rs57019720	NC_000017.11:41571481:C:T
NM_000226.4(KRT9):c.470T>C (p.Met157Thr)	KRT9	M157T	not provided|Epidermolytic palmoplantar keratoderma	Pathogenic(Last reviewed: Jul 30, 2003)	no assertion criteria provided	VCV000003006	17	39727775	17	41571523	3006	18045	rs59510579	NC_000017.11:41571522:A:G
NM_000226.4(KRT9):c.478C>G (p.Leu160Val)	KRT9	L160V	not provided|Epidermolytic palmoplantar keratoderma	Pathogenic(Last reviewed: Jul 30, 2003)	no assertion criteria provided	VCV000003005	17	39727767	17	41571515	3005	18044	rs28940896	NC_000017.11:41571514:G:C
NM_000226.4(KRT9):c.503T>C (p.Leu168Ser)	KRT9	L168S	not provided|Epidermolytic palmoplantar keratoderma	Pathogenic(Last reviewed: Jul 30, 2003)	no assertion criteria provided	VCV000003004	17	39727742	17	41571490	3004	18043	rs61157095	NC_000017.11:41571489:A:G
NM_000226.4(KRT9):c.483T>A (p.Asn161Lys)	KRT9	N161K	not provided|Epidermolytic palmoplantar keratoderma	Pathogenic(Last reviewed: Jul 30, 2003)	no assertion criteria provided	VCV000003000	17	39727762	17	41571510	3000	18039	rs57536312	NC_000017.11:41571509:A:T
NM_000226.4(KRT9):c.515A>C (p.Gln172Pro)	KRT9	Q172P	not provided|Epidermolytic palmoplantar keratoderma	Pathogenic(Last reviewed: Jul 30, 2003)	no assertion criteria provided	VCV000002998	17	39727730	17	41571478	2998	18037	rs59878153	NC_000017.11:41571477:T:G
NM_003632.3(CNTNAP1):c.2015G>A (p.Trp672Ter)	CNTNAP1	W672*	Congenital hypomyelinating neuropathy 3|Distal arthrogryposis type 1A	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560980	17	40842916	17	42690898	560980	552203	rs1567973091	NC_000017.11:42690897:G:A
NM_014321.4(ORC6):c.2T>C (p.Met1Thr)	ORC6	M1T	not provided|Meier-Gorlin syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000253272	16	46723619	16	46689707	253272	247698	rs146795505	NC_000016.10:46689706:T:C
NM_201631.4(TGM5):c.255del (p.Ser86fs)	TGM5	S86fs	Peeling skin syndrome 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000631730	15	43552431	15	43260233	631730	620514	rs778322388	NC_000015.10:43260232:GGGG:GGG
NM_201631.4(TGM5):c.763T>C (p.Trp255Arg)	TGM5	W255R, W173R	Peeling skin syndrome 2	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000157568	15	43545056	15	43252858	157568	167430	rs115677373	NC_000015.10:43252857:A:G
NM_000226.4(KRT9):c.481A>T (p.Asn161Tyr)	KRT9	N161Y	not provided|Epidermolytic palmoplantar keratoderma	Pathogenic(Last reviewed: Jul 30, 2003)	no assertion criteria provided	VCV000002999	17	39727764	17	41571512	2999	18038	rs59296273	NC_000017.11:41571511:T:A
NM_003041.4(SLC5A2):c.1291del (p.Val431fs)	SLC5A2	V431fs	Familial renal glucosuria	Pathogenic(Last reviewed: Nov 27, 2017)	no assertion criteria provided	VCV000522538	16	31500210	16	31488889	522538	513129	rs1555496083	NC_000016.10:31488888:GG:G
NM_003041.4(SLC5A2):c.416G>A (p.Arg139His)	SLC5A2	R139H	Familial renal glucosuria	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522721	16	31497162	16	31485841	522721	513357	rs1378076282	NC_000016.10:31485840:G:A
NM_018052.5(VAC14):c.1748C>T (p.Ser583Leu)	VAC14	S583L, S349L	Striatonigral degeneration, childhood-onset	Pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	VCV000253143	16	70732628	16	70698725	253143	247555	rs879255645	NC_000016.10:70698724:G:A
NM_018052.5(VAC14):c.1744G>T (p.Ala582Ser)	VAC14	A582S, A348S	Striatonigral degeneration, childhood-onset	Pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	VCV000253142	16	70732632	16	70698729	253142	247554	rs749094914	NC_000016.10:70698728:C:A
NM_018052.5(VAC14):c.1528+1G>A	VAC14		Striatonigral degeneration, childhood-onset	Pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	VCV000253141	16	70778325	16	70744422	253141	247553	rs879255555	NC_000016.10:70744421:C:T
NM_003041.4(SLC5A2):c.265G>A (p.Ala89Thr)	SLC5A2	A89T	Familial renal glucosuria	Pathogenic(Last reviewed: Aug 2, 2016)	no assertion criteria provided	VCV000253135	16	31496206	16	31484885	253135	247547	rs886037850	NC_000016.10:31484884:G:A
NM_003041.4(SLC5A2):c.294C>A (p.Phe98Leu)	SLC5A2	F98L	Familial renal glucosuria	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000029882	16	31496235	16	31484914	29882	38837	rs398122802	NC_000016.10:31484913:C:A
NM_003041.4(SLC5A2):c.1435C>G (p.Arg479Gly)	SLC5A2	R479G	Familial renal glucosuria	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000029881	16	31500355	16	31489034	29881	38836	rs387906682	NC_000016.10:31489033:C:G
NM_003041.4(SLC5A2):c.127-16C>A	SLC5A2		Familial renal glucosuria	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000029880	16	31495978	16	31484657	29880	38835	rs398122801	NC_000016.10:31484656:C:A
NM_003041.3(SLC5A2):c.500delA (p.Gln167Argfs)	SLC5A2	Q167fs	Familial renal glucosuria	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000012906	16	31497522	16	31486201	12906	27945	rs267607067	NC_000016.10:31486200:A:
NM_003041.4(SLC5A2):c.1320G>A (p.Trp440Ter)	SLC5A2	W440*	Familial renal glucosuria	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000012904	16	31500240	16	31488919	12904	27943	rs121918621	NC_000016.10:31488918:G:A
NM_001414.4(EIF2B1):c.715T>G (p.Phe239Val)	EIF2B1	F239V	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000217282	12	124107221	12	123622674	217282	213929	rs863225052	NC_000012.12:123622673:A:C
NM_001414.4(EIF2B1):c.824A>G (p.Tyr275Cys)	EIF2B1	Y275C	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000217281	12	124106397	12	123621850	217281	213928	rs758746181	NC_000012.12:123621849:T:C
NM_001414.4(EIF2B1):c.328A>G (p.Lys110Glu)	EIF2B1	K110E	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000217279	12	124114757	12	123630210	217279	213926	rs863225050	NC_000012.12:123630209:T:C
BMP4, 1-BP DUP, 171C	BMP4		Microphthalmia with brain and digit anomalies	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000029617					29617	38571		
BMP4, DEL	BMP4		Microphthalmia with brain and digit anomalies	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000029615					29615	38569		
NM_001202.6(BMP4):c.1037C>T (p.Ala346Val)	BMP4	A346V, A283V, A393V	Orofacial cleft 11	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000017702	14	54416940	14	53950222	17702	32741	rs121912766	NC_000014.9:53950221:G:A
NM_001202.6(BMP4):c.278A>G (p.Glu93Gly)	BMP4	E93G, E140G, E30G	Microphthalmia with brain and digit anomalies	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000017701	14	54418663	14	53951945	17701	32740	rs121912765	NC_000014.9:53951944:T:C
BMP4, 2-BP DEL, 226AG	BMP4		Microphthalmia with brain and digit anomalies	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000017700					17700	32739		
NM_194279.4(ISCA2):c.229G>A (p.Gly77Ser)	ISCA2	G77S	not provided|Multiple mitochondrial dysfunctions syndrome 4|Multiple mitochondrial dysfunctions syndrome|Muscular hypotonia of the trunk|High CSF lactic acid|Global developmental delay|Optic atrophy|Neurodegeration|Death in infancy|Spastic tetraplegia|Failure to thrive	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000183353	14	74961032	14	74494329	183353	181441	rs730882246	NC_000014.9:74494328:G:A
NM_139242.4(MTFMT):c.994C>T (p.Arg332Ter)	MTFMT	R332*	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27|not provided|Combined oxidative phosphorylation deficiency 15	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000039830	15	65295576	15	65003238	39830	48429	rs200286768	NC_000015.10:65003237:G:A
NM_003041.4(SLC5A2):c.885+5G>A	SLC5A2		Familial renal glucosuria	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000632249	16	31499085	16	31487764	632249	620875	rs200228142	NC_000016.10:31487763:G:A
NM_001414.4(EIF2B1):c.610_612GGA[1] (p.Gly205del)	EIF2B1	G205del	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Aug 19, 2015)	no assertion criteria provided	VCV000217280	12	124109346 - 124109348	12	123624799 - 123624801	217280	213927	rs863225051	NC_000012.12:123624798:TCCTCC:TCC
NM_001414.4(EIF2B1):c.833C>G (p.Pro278Arg)	EIF2B1	P278R	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Aug 19, 2015)	no assertion criteria provided	VCV000217278	12	124106388	12	123621841	217278	213925	rs863225049	NC_000012.12:123621840:G:C
NM_001414.4(EIF2B1):c.547G>T (p.Val183Phe)	EIF2B1	V183F	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Aug 19, 2015)	no assertion criteria provided	VCV000217277	12	124110976	12	123626429	217277	213924	rs863225048	NC_000012.12:123626428:C:A
NM_001414.4(EIF2B1):c.622A>T (p.Asn208Tyr)	EIF2B1	N208Y	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Aug 19, 2015)	no assertion criteria provided	VCV000004124	12	124109339	12	123624792	4124	19163	rs113994007	NC_000012.12:123624791:T:A
NM_006888.6(CALM1):c.161A>T (p.Asn54Ile)	CALM1	N53I, N54I, N18I, N55I	Ventricular tachycardia, catecholaminergic polymorphic, 4|Catecholaminergic polymorphic ventricular tachycardia type 1	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2014)	no assertion criteria provided	VCV000039757	14	90867729	14	90401385	39757	48356	rs267607276	NC_000014.9:90401384:A:T
NM_000226.4(KRT9):c.482A>G (p.Asn161Ser)	KRT9	N161S	not provided|Epidermolytic palmoplantar keratoderma	Pathogenic(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	VCV000003003	17	39727763	17	41571511	3003	18042	rs56707768	NC_000017.11:41571510:T:C
NM_000226.4(KRT9):c.469A>G (p.Met157Val)	KRT9	M157V	not provided|Epidermolytic palmoplantar keratoderma	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000003002	17	39727776	17	41571524	3002	18041	rs58597584	NC_000017.11:41571523:T:C
NM_001202.6(BMP4):c.592C>T (p.Arg198Ter)	BMP4	R198*, R245*, R135*	Microphthalmia with brain and digit anomalies|Orofacial cleft 11	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000029616	14	54417385	14	53950667	29616	38570	rs387906597	NC_000014.9:53950666:G:A
NM_001321075.3(DLG4):c.1292del (p.Phe431fs)	DLG4	F371fs, F404fs, F431fs, F428fs, F471fs, F474fs	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000817726	17	7099548	17	7196229	817726	805987		NC_000017.11:7196228:AAA:AA
NM_001321075.3(DLG4):c.326del (p.Gly109fs)	DLG4	G149fs, G106fs, G152fs, G109fs, G49fs, G82fs	not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000817274	17	7107020	17	7203701	817274	805989		NC_000017.11:7203700:CC:C
NM_001321075.3(DLG4):c.525dup (p.Gly176fs)	DLG4		not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000817065	17	7106628 - 7106629	17	7203309 - 7203310	817065	805988		NC_000017.11:7203309:T:TT
NM_001365.4(DLG4):c.1249C>T (p.Gln417Ter)	DLG4	Q417*, Q314*, Q374*, Q371*, Q414*, Q347*	not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000620405	17	7099858	17	7196539	620405	611878	rs1567532079	NC_000017.11:7196538:G:A
NM_001365.4(DLG4):c.1618C>T (p.Arg540Ter)	DLG4	R540*, R494*, R497*, R437*, R537*, R470*	not provided	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000620100	17	7097309	17	7193990	620100	611877	rs1567528092	NC_000017.11:7193989:G:A
NM_001365.4(DLG4):c.1283del (p.Thr428fs)	DLG4	T382fs, T385fs, T325fs, T358fs, T425fs, T428fs	not provided	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000523996	17	7099824	17	7196505	523996	514733	rs1555522077	NC_000017.11:7196504:G:
NM_016122.3(CEP83):c.1067_1068insTA (p.Glu356fs)	CEP83		not provided	Pathogenic(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	VCV000420205	12	94761958 - 94761959	12	94368182 - 94368183	420205	408775	rs1064794347	NC_000012.12:94368182:T:TAT
NM_001321075.3(DLG4):c.925C>T (p.Arg309Ter)	DLG4	R352*, R349*, R282*, R309*, R249*, R306*	INTELLECTUAL DEVELOPMENTAL DISORDER 62	Pathogenic(Last reviewed: Feb 28, 2020)	no assertion criteria provided	VCV000813881	17	7100234	17	7196915	813881	802110		NC_000017.11:7196914:G:A
NM_001321075.3(DLG4):c.1102C>T (p.Arg368Ter)	DLG4	R411*, R408*, R308*, R365*, R341*, R368*	INTELLECTUAL DEVELOPMENTAL DISORDER 62	Pathogenic(Last reviewed: Feb 27, 2020)	no assertion criteria provided	VCV000813880	17	7099876	17	7196557	813880	802109		NC_000017.11:7196556:G:A
NM_016122.3(CEP83):c.1131dup (p.Arg378fs)	CEP83		Nephronophthisis 18	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000854978	12	94761894 - 94761895	12	94368118 - 94368119	854978	840461		NC_000012.12:94368118:T:TT
NM_016122.3(CEP83):c.1234_1237del (p.Lys412fs)	CEP83	K308fs, K337fs, K412fs	Nephronophthisis 18	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000836554	12	94761676 - 94761679	12	94367900 - 94367903	836554	840459		NC_000012.12:94367899:CTTTC:C
NM_016122.3(CEP83):c.907C>T (p.Arg303Ter)	CEP83	R228*, R303*, R124*, R199*	Nephronophthisis 18	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000656543	12	94769688	12	94375912	656543	641505		NC_000012.12:94375911:G:A
NM_016122.3(CEP83):c.1888C>T (p.Arg630Ter)	CEP83	R630*, R555*, R526*	Nephronophthisis 18	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000578457	12	94703807	12	94310031	578457	568206	rs1207804224	NC_000012.12:94310030:G:A
NM_016122.3(CEP83):c.1530C>A (p.Cys510Ter)	CEP83	C510*, C406*, C435*	Nephronophthisis 18	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139546	12	94727305	12	94333529	139546	143190	rs587777488	NC_000012.12:94333528:G:T
NM_016122.3(CEP83):c.625C>T (p.Arg209Ter)	CEP83	R209*, R105*, R134*, R30*	Nephronophthisis 18	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139545	12	94772743	12	94378967	139545	143189	rs369483167	NC_000012.12:94378966:G:A
NM_016122.3(CEP83):c.1532G>C (p.Arg511Pro)	CEP83	R511P, R436P, R407P	Nephronophthisis 18	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139544	12	94727303	12	94333527	139544	143188	rs587777487	NC_000012.12:94333526:C:G
NM_016122.3(CEP83):c.2072_2074AAC[1] (p.Gln692del)	CEP83	Q692del	Nephronophthisis 18	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139543	12	94702618 - 94702620	12	94308842 - 94308844	139543	143187	rs879255576	NC_000012.12:94308841:GTTGTT:GTT
NM_016122.3(CEP83):c.241C>T (p.Gln81Ter)	CEP83	Q81*	Nephronophthisis 18	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139542	12	94805556	12	94411780	139542	143186	rs368619022	NC_000012.12:94411779:G:A
NM_016122.3(CEP83):c.335_352del (p.Pro112_Leu117del)	CEP83		Nephronophthisis 18	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139541	12	94797011 - 94797028	12	94403235 - 94403252	139541	143185	rs879255575	NC_000012.12:94403234:GCAATTCCAATTTTTGTGG:G
NM_016122.3(CEP83):c.121C>T (p.Arg41Ter)	CEP83	R41*	Nephronophthisis 18	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139540	12	94806146	12	94412370	139540	143184	rs587777486	NC_000012.12:94412369:G:A
NM_015133.5(MAPK8IP3):c.1732C>T (p.Arg578Cys)	MAPK8IP3	R578C, R572C, R579C	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000632564	16	1812844	16	1762843	632564	620950	rs1567203083	NC_000016.10:1762842:C:T
NM_006432.4(NPC2):c.358C>T (p.Pro120Ser)	NPC2	P120S		Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000008486	14	74951123	14	74484420	8486	23525	rs104894458	NC_000014.9:74484419:G:A
X57331.1:g.275C>A	IGHM		Agammaglobulinemia, non-Bruton type	Pathogenic(Last reviewed: Apr 15, 2016)	no assertion criteria provided	VCV000427234					427234	416155		
NM_015114.3(ANKLE2):c.601G>T (p.Gly201Trp)	ANKLE2	G201W	Microcephaly 16, primary, autosomal recessive	Pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV000635194	12	133331300	12	132754714	635194	623028	rs1185537869	NC_000012.12:132754713:C:A
NM_005154.5(USP8):c.2153C>G (p.Ser718Cys)	USP8	S718C, S612C	Pituitary dependent hypercortisolism	Pathogenic(Last reviewed: Nov 18, 2014)	no assertion criteria provided	VCV000161993	15	50782641	15	50490444	161993	171719	rs672601308	NC_000015.10:50490443:C:G
IGHM, 2-BP DEL, AA	IGHM		Agammaglobulinemia, non-Bruton type	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000014812					14812	29851		
NM_000617.3(SLC11A2):c.635G>T (p.Gly212Val)	SLC11A2	G212V, G241V, G208V	Anemia, hypochromic microcytic, with iron overload 1	Pathogenic(Last reviewed: May 15, 2006)	no assertion criteria provided	VCV000009078	12	51392997	12	50999214	9078	24117	rs121918367	NC_000012.12:50999213:C:A
SLC11A2, 3-BP DEL, 428GTG	SLC11A2		Anemia, hypochromic microcytic, with iron overload 1	Pathogenic(Last reviewed: May 15, 2006)	no assertion criteria provided	VCV000009077					9077	24116		
NM_000617.3(SLC11A2):c.1246C>T (p.Arg416Cys)	SLC11A2	R416C, R445C, R412C	Anemia, hypochromic microcytic, with iron overload 1	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000009076	12	51386074	12	50992291	9076	24115	rs121918366	NC_000012.12:50992290:G:A
SLC11A2, 3-BP DEL, 310CTT	SLC11A2		Anemia, hypochromic microcytic, with iron overload 1	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000009075					9075	24114		
IGHM, 75-KB DEL	IGHM		Agammaglobulinemia, non-Bruton type	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000014809					14809	29848		
IGHM, IVS4AS, G-A, -1	IGHM		Agammaglobulinemia, non-Bruton type	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000014810					14810	29849		
NM_005154.5(USP8):c.2159C>G (p.Pro720Arg)	USP8	P720R, P614R	Pituitary dependent hypercortisolism	Pathogenic(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000161995	15	50782647	15	50490450	161995	171721	rs672601311	NC_000015.10:50490449:C:G
NM_005154.5(USP8):c.2152T>C (p.Ser718Pro)	USP8	S718P, S612P	Pituitary dependent hypercortisolism	Pathogenic(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000161992	15	50782640	15	50490443	161992	171718	rs672601307	NC_000015.10:50490442:T:C
NM_005154.5(USP8):c.2152_2154TCC[1] (p.Ser719del)	USP8	S719del, S613del	Pituitary dependent hypercortisolism	Pathogenic(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000161991	15	50782639 - 50782641	15	50490442 - 50490444	161991	171720	rs672601306	NC_000015.10:50490441:CTCCTCC:CTCC
NM_015114.3(ANKLE2):c.2344C>T (p.Gln782Ter)	ANKLE2	Q782*	Microcephaly|Microcephaly 16, primary, autosomal recessive	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	VCV000218245	12	133306404	12	132729818	218245	214881	rs201785518	NC_000012.12:132729817:G:A
NC_000014.9:g.(?_50267733)_(50269350_?)del	L2HGDH		L-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000831656	14	50734451 - 50736068			831656	820624		
NM_002150.3(HPD):c.158dup (p.Ser54fs)	HPD		Tyrosinemia type 3|Hawkinsinuria	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000642856	12	122295273 - 122295274	12	121857367 - 121857368	642856	640666		NC_000012.12:121857367:CC:CCC
NM_002150.3(HPD):c.43C>T (p.Arg15Ter)	HPD	R15*	Tyrosinemia type 3|Hawkinsinuria	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000570062	12	122295713	12	121857807	570062	565098	rs775747384	NC_000012.12:121857806:G:A
NM_024884.3(L2HGDH):c.530del (p.Pro177fs)	L2HGDH	P177fs	L-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000567343	14	50760843	14	50294125	567343	568081	rs766538932	NC_000014.9:50294124:GG:G
NC_000012.11:g.(?_122281596)_(122285140_?)del	HPD		Hawkinsinuria|Tyrosinemia type 3	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000529472	12	122281596 - 122285140	12	121843690 - 121847234	529472	526618		
NM_002282.3(KRT83):c.811del (p.Ser271fs)	KRT83	S271fs	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 5	Pathogenic(Last reviewed: Mar 12, 2019)	no assertion criteria provided	VCV000446111	12	52710747	12	52316963	446111	439459	rs753293188	NC_000012.12:52316962:T:
NM_002282.3(KRT83):c.1252G>A (p.Glu418Lys)	KRT83	E418K	Beaded hair	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000446110	12	52709687	12	52315903	446110	439458	rs1438087533	NC_000012.12:52315902:C:T
NM_024884.3(L2HGDH):c.1015del (p.Arg339fs)	L2HGDH	R339fs	L-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Jun 13, 2016)	criteria provided, single submitter	VCV000435701	14	50734520	14	50267802	435701	429566	rs1555328749	NC_000014.9:50267801:T:
NM_024884.3(L2HGDH):c.465del (p.Gly156fs)	L2HGDH	G156fs	L-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Jul 22, 2015)	criteria provided, single submitter	VCV000211348	14	50760908	14	50294190	211348	208101	rs797045678	NC_000014.9:50294189:TTT:TT
NM_024884.3(L2HGDH):c.1003C>T (p.Arg335Ter)	L2HGDH	R335*	L-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000030793	14	50734532	14	50267814	30793	39750	rs387907013	NC_000014.9:50267813:G:A
NM_002272.4(KRT4):c.1303G>A (p.Glu435Lys)	KRT4	E449K, E435K		Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000016920	12	53201471	12	52807687	16920	31959	rs62642055	NC_000012.12:52807686:C:T
NM_002272.4(KRT4):c.419_420insCAA (p.Gln140delinsHisLys)	KRT4			Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000016919	12	53207423 - 53207424	12	52813639 - 52813640	16919	31958	rs587776845	NC_000012.12:52813639:T:TTGT
NM_002272.4(KRT4):c.432_434CAA[2] (p.Asn146del)	KRT4	N146del		Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000016918	12	53207403 - 53207405	12	52813619 - 52813621	16918	31957	rs587776844	NC_000012.12:52813618:TTGTTGTTG:TTGTTG
NM_024884.3(L2HGDH):c.164G>A (p.Gly55Asp)	L2HGDH	G55D	L-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Nov 15, 2004)	no assertion criteria provided	VCV000001610	14	50769712	14	50302994	1610	16649	rs118204021	NC_000014.9:50302993:C:T
NM_024884.3(L2HGDH):c.906+1G>T	L2HGDH		L-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Nov 15, 2004)	no assertion criteria provided	VCV000001609	14	50735880	14	50269162	1609	16648	rs786200870	NC_000014.9:50269161:C:A
NM_024884.3(L2HGDH):c.905C>T (p.Pro302Leu)	L2HGDH	P302L	L-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Nov 15, 2004)	no assertion criteria provided	VCV000001607	14	50735882	14	50269164	1607	16646	rs118204020	NC_000014.9:50269163:G:A
NM_002150.3(HPD):c.774T>G (p.Tyr258Ter)	HPD	Y258*, Y219*	Tyrosinemia type 3	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000001574	12	122284825	12	121846919	1574	16613	rs137852866	NC_000012.12:121846918:A:C
NM_002150.3(HPD):c.479A>G (p.Tyr160Cys)	HPD	Y160C, Y121C	Tyrosinemia type 3	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000001573	12	122287632	12	121849726	1573	16612	rs137852865	NC_000012.12:121849725:T:C
NM_024884.3(L2HGDH):c.829C>T (p.Arg277Ter)	L2HGDH	R277*	L-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000863865	14	50735958	14	50269240	863865	841539		NC_000014.9:50269239:G:A
NM_145064.3(STAC3):c.997-1G>T	STAC3		Bailey-Bloch congenital myopathy	Pathogenic(Last reviewed: Jun 18, 2019)	no assertion criteria provided	VCV000691283	12	57637694	12	57243911	691283	678969		NC_000012.12:57243910:C:A
NM_024884.3(L2HGDH):c.208C>T (p.Arg70Ter)	L2HGDH	R70*	L-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000580563	14	50769668	14	50302950	580563	568936	rs937345512	NC_000014.9:50302949:G:A
NM_002150.3(HPD):c.600C>G (p.Tyr200Ter)	HPD	Y200*, Y161*	Tyrosinemia type 3	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000001575	12	122285117	12	121847211	1575	16614	rs137852867	NC_000012.12:121847210:G:C
NM_145064.3(STAC3):c.761_762CT[1] (p.Leu255fs)	STAC3		Bailey-Bloch congenital myopathy	Pathogenic(Last reviewed: Jun 18, 2019)	no assertion criteria provided	VCV000559850	12	57638360 - 57638363	12	57244577 - 57244580	559850	550572	rs773050511	NC_000012.12:57244576:AGAGAG:AG
NM_024884.3(L2HGDH):c.1115del (p.Met372fs)	L2HGDH	M372fs	L-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000001608	14	50732157	14	50265439	1608	16647	rs786200869	NC_000014.9:50265438:A:
NM_002150.3(HPD):c.75G>A (p.Trp25Ter)	HPD	W25*	Tyrosinemia type 3|Hawkinsinuria|Tyrosinemia type 3	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000529468	12	122295681	12	121857775	529468	527273	rs367674632	NC_000012.12:121857774:C:T
NM_024884.3(L2HGDH):c.256+1G>A	L2HGDH		not provided|L-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379781	14	50769619	14	50302901	379781	376074	rs150299874	NC_000014.9:50302900:C:T
GRCh37/hg19 14q22.3(chr14:57130786-57577796)x1	OTX2		not provided	Pathogenic(Last reviewed: Jan 2, 2019)	no assertion criteria provided	VCV000815661	14	57130786 - 57577796			815661	803870		
NM_021728.4(OTX2):c.534C>A (p.Cys178Ter)	OTX2	C170*, C178*	not provided	Pathogenic(Last reviewed: May 18, 2016)	criteria provided, single submitter	VCV000288042	14	57268813	14	56802095	288042	272279	rs886043793	NC_000014.9:56802094:G:T
NM_021728.4(OTX2):c.296C>A (p.Ala99Asp)	OTX2	A91D, A99D	Anophthalmia	Pathogenic(Last reviewed: Apr 1, 2017)	no assertion criteria provided	VCV000430900	14	57269051	14	56802333	430900	424445	rs1555350254	NC_000014.9:56802332:G:T
NM_021728.4(OTX2):c.698A>G (p.Asn233Ser)	OTX2	N233S, N225S	Pituitary hormone deficiency, combined 6	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000030023	14	57268649	14	56801931	30023	38978	rs370761964	NC_000014.9:56801930:T:C
SUOX, 1-BP DEL, 1244G	SUOX		Sulfite oxidase deficiency, isolated	Pathogenic(Last reviewed: Jul 15, 2005)	no assertion criteria provided	VCV000003824					3824	18863		
SUOX, SER370TYR	SUOX	S370Y	Sulfite oxidase deficiency, isolated	Pathogenic(Last reviewed: Dec 26, 1997)	no assertion criteria provided	VCV000003822					3822	18861		
NM_021728.4(OTX2):c.596del (p.Gly199fs)	OTX2	G199fs, G191fs	Anophthalmia-microphthalmia syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000842588	14	57268751	14	56802033	842588	841563		NC_000014.9:56802032:CC:C
NM_021728.4(OTX2):c.811del (p.Thr271fs)	OTX2	T263fs, T271fs		Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812111	14	57268536	14	56801818	812111	800363		NC_000014.9:56801817:TTT:TT
NM_021728.4(OTX2):c.749del (p.Gly250fs)	OTX2	G242fs, G250fs		Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000666555	14	57268598	14	56801880	666555	654138		NC_000014.9:56801879:CCC:CC
NM_001032386.2(SUOX):c.1280_1281delinsAC (p.Ser427Tyr)	SUOX	S370Y	Sulfite oxidase deficiency	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000623470	12	56398453 - 56398454	12	56004669 - 56004670	623470	610991	rs1565799723	NC_000012.12:56004668:CG:AC
NM_001032386.2(SUOX):c.1200C>G (p.Tyr400Ter)	SUOX	Y400*	Sulfite oxidase deficiency	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000619593	12	56398373	12	56004589	619593	610990	rs747461754	NC_000012.12:56004588:C:G
NM_021728.4(OTX2):c.781_784del (p.Thr261fs)	OTX2	T253fs, T261fs		Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000545433	14	57268563 - 57268566	14	56801845 - 56801848	545433	535705	rs1555350156	NC_000014.9:56801844:TGGTTG:TG
NM_021728.4(OTX2):c.289C>T (p.Arg97Ter)	OTX2	R97*, R89*		Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000190250	14	57269058	14	56802340	190250	188074	rs104894464	NC_000014.9:56802339:G:A
NM_021728.4(OTX2):c.316del (p.Gln106fs)	OTX2	Q106fs, Q98fs		Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000190249	14	57269031	14	56802313	190249	188073	rs786205884	NC_000014.9:56802312:G:
NM_021728.4(OTX2):c.586G>T (p.Gly196Ter)	OTX2	G188*, G196*		Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000030027	14	57268761	14	56802043	30027	38982	rs397514463	NC_000014.9:56802042:C:A
NM_021728.4(OTX2):c.245_260del (p.Lys82fs)	OTX2	K82fs, K74fs		Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000030026	14	57270919 - 57270934	14	56804201 - 56804216	30026	38981	rs1566624472	NC_000014.9:56804200:TCGGGCAAGTTGATTTTC:TC
NM_021728.4(OTX2):c.437C>G (p.Ser146Ter)	OTX2	S138*, S146*		Pathogenic(Last reviewed: Nov 21, 2009)	no assertion criteria provided	VCV000030025	14	57268910	14	56802192	30025	38980	rs786205879	NC_000014.9:56802191:G:C
NM_021728.4(OTX2):c.426_427CT[3] (p.Ser144fs)	OTX2			Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000030024	14	57268917 - 57268918	14	56802199 - 56802200	30024	38979	rs1566623121	NC_000014.9:56802199:AGAG:AGAGAG
NM_001032386.2(SUOX):c.1388C>T (p.Ser463Phe)	SUOX	S463F	Sulfite oxidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000623385	12	56398561	12	56004777	623385	612297	rs1565799921	NC_000012.12:56004776:C:T
NM_001032386.2(SUOX):c.520del (p.Asp174fs)	SUOX	D174fs	Sulfite oxidase deficiency	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000619592	12	56397693	12	56003909	619592	610989	rs1565798380	NC_000012.12:56003908:G:
NM_021728.4(OTX2):c.673del (p.Ala225fs)	OTX2	A217fs, A225fs		Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561071	14	57268674	14	56801956	561071	552178	rs1566622571	NC_000014.9:56801955:CCCC:CCC
NM_021728.4(OTX2):c.561T>A (p.Tyr187Ter)	OTX2	Y179*, Y187*		Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000009518	14	57268786	14	56802068	9518	24557	rs104894465	NC_000014.9:56802067:A:T
NM_021728.4(OTX2):c.81del (p.Ser28fs)	OTX2	S28fs		Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000009517	14	57272094	14	56805376	9517	24556	rs786205874	NC_000014.9:56805375:GGGG:GGG
NM_021728.4(OTX2):c.289C>G (p.Arg97Gly)	OTX2	R89G, R97G		Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000009516	14	57269058	14	56802340	9516	24555	rs104894464	NC_000014.9:56802339:G:C
NM_021728.4(OTX2):c.487_488dup (p.Ser164fs)	OTX2			Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000009515	14	57268858 - 57268859	14	56802140 - 56802141	9515	24554	rs786205873	NC_000014.9:56802140:GC:GCGC
NM_172337.2(OTX2):c.402dup (p.Ser135Leufs)	OTX2		not provided|	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000500507	14	57268920 - 57268921	14	56802202 - 56802203	500507	491931	rs1555350223	NC_000014.9:56802202:GGGGGG:GGGGGGG
NM_021728.4(OTX2):c.294A>T (p.Arg98Ser)	OTX2	R90S, R98S		Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000030028	14	57269053	14	56802335	30028	38983	rs1566623392	NC_000014.9:56802334:T:A
NM_001032386.2(SUOX):c.1589G>A (p.Gly530Asp)	SUOX	G530D	Sulfite oxidase deficiency|Sulfite oxidase deficiency, isolated	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000003823	12	56398762	12	56004978	3823	18862	rs121908009	NC_000012.12:56004977:G:A
NM_001032386.2(SUOX):c.794C>A (p.Ala265Asp)	SUOX	A265D	Sulfite oxidase deficiency|Sulfite oxidase deficiency, isolated	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000003821	12	56397967	12	56004183	3821	18860	rs121908008	NC_000012.12:56004182:C:A
NM_130466.4(UBE3B):c.61G>T (p.Glu21Ter)	UBE3B	E21*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225041	12	109921417	12	109483612	225041	226931	rs775981553	NC_000012.12:109483611:G:T
NM_000781.3(CYP11A1):c.358C>T (p.Arg120Ter)	CYP11A1	R120*	not provided	Pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	VCV000379354	15	74640308	15	74347967	379354	374330	rs776056840	NC_000015.10:74347966:G:A
NM_000781.3(CYP11A1):c.425+1G>A	CYP11A1		not provided	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000280582	15	74640240	15	74347899	280582	264877	rs886041759	NC_000015.10:74347898:C:T
NM_000781.3(CYP11A1):c.835del (p.Ile279fs)	CYP11A1	I121fs, I279fs	not provided	Pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, single submitter	VCV000265094	15	74635473	15	74343132	265094	260079	rs757299093	NC_000015.10:74343131:T:
NM_017791.3(FLVCR2):c.1289C>T (p.Thr430Met)	FLVCR2	T430M, T225M	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	Pathogenic(Last reviewed: Apr 30, 2018)	no assertion criteria provided	VCV000523100	14	76107351	14	75641008	523100	513724	rs267606825	NC_000014.9:75641007:C:T
NM_014305.4(TGDS):c.892A>G (p.Asn298Asp)	TGDS	N298D, N266D	Catel Manzke syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162460	13	95228658	13	94576404	162460	172135	rs724160005	NC_000013.11:94576403:T:C
NM_014305.4(TGDS):c.268_269GA[1] (p.Lys91fs)	TGDS		Catel Manzke syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162459	13	95243149 - 95243150	13	94590895 - 94590896	162459	172134	rs727502809	NC_000013.11:94590894:TCTCT:TCT
NM_014305.4(TGDS):c.294T>G (p.Phe98Leu)	TGDS	F98L, F66L	Catel Manzke syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162458	13	95243126	13	94590872	162458	172133	rs727502808	NC_000013.11:94590871:A:C
NM_000781.3(CYP11A1):c.665T>C (p.Leu222Pro)	CYP11A1	L222P, L64P	Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000029625	15	74636294	15	74343953	29625	38579	rs387906601	NC_000015.10:74343952:A:G
NM_000781.3(CYP11A1):c.1244T>A (p.Val415Glu)	CYP11A1	V415E, V257E	Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000017523	15	74631102	15	74338761	17523	32562	rs121912814	NC_000015.10:74338760:A:T
NM_000781.3(CYP11A1):c.422T>G (p.Leu141Trp)	CYP11A1	L141W	Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000017522	15	74640244	15	74347903	17522	32561	rs121912813	NC_000015.10:74347902:A:C
CYP11A1, 1-BP INS, IVS3, T	CYP11A1		Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000017521					17521	32560		
NM_000781.3(CYP11A1):c.1076C>T (p.Ala359Val)	CYP11A1	A359V, A201V	Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000017520	15	74632009	15	74339668	17520	32559	rs121912812	NC_000015.10:74339667:G:A
NM_000781.3(CYP11A1):c.566C>T (p.Ala189Val)	CYP11A1	A189V, A31V	Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000017518	15	74637444	15	74345103	17518	32557	rs121912811	NC_000015.10:74345102:G:A
NM_000781.3(CYP11A1):c.1057C>T (p.Arg353Trp)	CYP11A1	R353W, R195W	Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000017517	15	74632028	15	74339687	17517	32556	rs72547508	NC_000015.10:74339686:G:A
CYP11A1, 6-BP INS	CYP11A1		Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000017516					17516	32555		
NM_017791.3(FLVCR2):c.1341+2T>C	FLVCR2		Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000001093	14	76107405	14	75641062	1093	16132	rs780523767	NC_000014.9:75641061:T:C
NM_017791.3(FLVCR2):c.977C>T (p.Ala326Val)	FLVCR2	A326V, A121V	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000001092	14	76099996	14	75633653	1092	16131	rs267606824	NC_000014.9:75633652:C:T
NM_017791.3(FLVCR2):c.1192C>G (p.Leu398Val)	FLVCR2	L398V, L193V	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000001089	14	76105762	14	75639419	1089	16128	rs267606822	NC_000014.9:75639418:C:G
NM_017791.3(FLVCR2):c.1289C>G (p.Thr430Arg)	FLVCR2	T430R, T225R	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000001087	14	76107351	14	75641008	1087	16126	rs267606825	NC_000014.9:75641007:C:G
NM_014305.4(TGDS):c.269A>G (p.Glu90Gly)	TGDS	E90G, E58G	Catel Manzke syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162457	13	95243151	13	94590897	162457	172132	rs724160004	NC_000013.11:94590896:T:C
NM_014305.4(TGDS):c.700T>C (p.Tyr234His)	TGDS	Y234H, Y202H	Catel Manzke syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162456	13	95230384	13	94578130	162456	172131	rs544436734	NC_000013.11:94578129:A:G
CYP11A1, 1-BP DEL, 835A	CYP11A1		Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000017519					17519	32558		
NM_020843.4(SCAPER):c.2023-2A>G	SCAPER		|INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA|Retinitis pigmentosa	Pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000424861	15	77021080	15	76728739	424861	413182	rs1555558169	NC_000015.10:76728738:T:C
NM_014239.4(EIF2B2):c.607_612delinsTG (p.Met203fs)	EIF2B2		Ovarioleukodystrophy|Leukoencephalopathy with vanishing white matter|not provided	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004340	14	75472578 - 75472583	14	75005875 - 75005880	4340	19379	rs113994014	NC_000014.9:75005874:ATGGCT:TG
NC_000014.8:g.(?_57268433)_(57271101_?)del	OTX2		Anophthalmia-microphthalmia syndrome	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000647944	14	57268433 - 57271101	14	56801715 - 56804383	647944	652873		
NM_001032386.2(SUOX):c.98del (p.Asn33fs)	SUOX	N33fs	Sulfite oxidase deficiency	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000529474	12	56396372	12	56002588	529474	527816	rs773937413	NC_000012.12:56002587:AAA:AA
NM_001032386.2(SUOX):c.363dup (p.Pro122fs)	SUOX		Sulfite oxidase deficiency	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000529473	12	56397530 - 56397531	12	56003746 - 56003747	529473	527277	rs1555198521	NC_000012.12:56003746:GGGGGG:GGGGGGG
NM_015665.6(AAAS):c.1332-2A>T	AAAS		not provided	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000596786	12	53701715	12	53307931	596786	587847	rs1565776390	NC_000012.12:53307930:T:A
NM_015665.6(AAAS):c.885G>A (p.Trp295Ter)	AAAS	W295*, W262*	not provided	Pathogenic(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	VCV000429876	12	53702991	12	53309207	429876	421944	rs766542823	NC_000012.12:53309206:C:T
NM_015665.6(AAAS):c.1191dup (p.Glu398fs)	AAAS		not provided	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000429542	12	53702123 - 53702124	12	53308339 - 53308340	429542	421943	rs746305979	NC_000012.12:53308339:T:TT
NM_015665.5(AAAS):c.310_317delTTTGAGTG (p.Phe104Glyfs)	AAAS		not provided	Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	VCV000280691	12	53709201 - 53709208	12	53315417 - 53315424	280691	264533	rs886041850	NC_000012.12:53315416:CACTCAAACACT:CACT
NM_015665.6(AAAS):c.1066_1067del (p.Leu356fs)	AAAS	L356fs, L323fs	not provided	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000264992	12	53702529 - 53702530	12	53308745 - 53308746	264992	260028	rs763216820	NC_000012.12:53308744:AG:
NM_015665.6(AAAS):c.1159C>T (p.Gln387Ter)	AAAS	Q387*, Q354*	not provided	Pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, single submitter	VCV000264990	12	53702241	12	53308457	264990	260026	rs763820204	NC_000012.12:53308456:G:A
NM_015665.6(AAAS):c.936-1G>C	AAAS		not provided	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000264989	12	53702805	12	53309021	264989	260030	rs369629444	NC_000012.12:53309020:C:G
NM_015665.6(AAAS):c.57_58del (p.Tyr19_Glu20delinsTer)	AAAS		not provided	Pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	VCV000264988	12	53715192 - 53715193	12	53321408 - 53321409	264988	260031	rs552637666	NC_000012.12:53321407:CA:
NM_002408.4(MGAT2):c.799G>C (p.Asp267His)	MGAT2	D267H	Congenital disorder of glycosylation, type IIa	Pathogenic	no assertion criteria provided	VCV000617661	14	50088785	14	49622067	617661	609066	rs1566505013	NC_000014.9:49622066:G:C
NM_002408.4(MGAT2):c.91C>T (p.Gln31Ter)	MGAT2	Q31*	Congenital disorder of glycosylation, type IIa	Pathogenic	no assertion criteria provided	VCV000617658	14	50088077	14	49621359	617658	609062	rs1310787426	NC_000014.9:49621358:C:T
NM_002408.4(MGAT2):c.753dup (p.Ala252fs)	MGAT2		Congenital disorder of glycosylation, type IIa	Pathogenic	no assertion criteria provided	VCV000617657	14	50088738 - 50088739	14	49622020 - 49622021	617657	609061	rs1566504935	NC_000014.9:49622020:T:TT
NM_002408.4(MGAT2):c.1120C>T (p.His374Tyr)	MGAT2	H374Y	Congenital disorder of glycosylation, type IIa	Pathogenic	no assertion criteria provided	VCV000617656	14	50089106	14	49622388	617656	609060	rs776531113	NC_000014.9:49622387:C:T
NM_015665.6(AAAS):c.938T>C (p.Val313Ala)	AAAS	V313A, V280A	Glucocorticoid deficiency with achalasia	Pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000202169	12	53702802	12	53309018	202169	198632	rs773601814	NC_000012.12:53309017:A:G
NM_000119.3(EPB42):c.950del (p.Arg317fs)	EPB42	R287fs, R317fs	Spherocytosis type 5	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000132636	15	43500946	15	43208748	132636	136385	rs515726213	NC_000015.10:43208747:C:
NM_000119.3(EPB42):c.949C>T (p.Arg317Cys)	EPB42	R317C, R287C	Spherocytosis type 5	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000132635	15	43500947	15	43208749	132635	136384	rs515726212	NC_000015.10:43208748:G:A
NM_000119.3(EPB42):c.920C>T (p.Thr307Ile)	EPB42	T307I, T277I	Spherocytosis type 5	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000132634	15	43501474	15	43209276	132634	136383	rs515726211	NC_000015.10:43209275:G:A
NM_000119.3(EPB42):c.523G>T (p.Asp175Tyr)	EPB42	D175Y, D145Y	Spherocytosis type 5	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000132633	15	43503730	15	43211532	132633	136382	rs143682977	NC_000015.10:43211531:C:A
NM_015665.6(AAAS):c.251G>A (p.Trp84Ter)	AAAS	W84*	Glucocorticoid deficiency with achalasia	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000005048	12	53714349	12	53320565	5048	20087	rs754637718	NC_000012.12:53320564:C:T
NM_015665.6(AAAS):c.1288C>T (p.Leu430Phe)	AAAS	L430F, L397F	Glucocorticoid deficiency with achalasia	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000005047	12	53701879	12	53308095	5047	20086	rs121918551	NC_000012.12:53308094:G:A
NM_015665.6(AAAS):c.1087+1G>A	AAAS		Glucocorticoid deficiency with achalasia	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000005046	12	53702508	12	53308724	5046	20085	rs1035139364	NC_000012.12:53308723:C:T
NM_015665.6(AAAS):c.400-2A>G	AAAS		Glucocorticoid deficiency with achalasia	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000005042	12	53708926	12	53315142	5042	20081	rs1565781382	NC_000012.12:53315141:T:C
NM_015665.6(AAAS):c.980dup (p.Ser328fs)	AAAS		Glucocorticoid deficiency with achalasia	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000005041	12	53702759 - 53702760	12	53308975 - 53308976	5041	20080	rs387906326	NC_000012.12:53308975:A:AA
NM_006432.4(NPC2):c.352G>T (p.Glu118Ter)	NPC2	E118*		Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008480	14	74951129	14	74484426	8480	23519	rs80358266	NC_000014.9:74484425:C:A
NM_015665.6(AAAS):c.688C>T (p.Arg230Ter)	AAAS	R197*, R230*	not provided	Pathogenic(Last reviewed: May 9, 2019)	criteria provided, single submitter	VCV000841221	12	53708083	12	53314299	841221	840079		NC_000012.12:53314298:G:A
NM_000119.2(EPB42):c.1747G>T (p.Glu583Ter)	EPB42	E583*, E553*	Spherocytosis type 5	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000013237	15	43495435	15	43203237	13237	28276	rs115998465	NC_000015.10:43203236:C:A
NM_000119.2(EPB42):c.922+1G>A	EPB42		Spherocytosis type 5	Pathogenic(Last reviewed: Jul 1, 1995)	no assertion criteria provided	VCV000013236	15	43501471	15	43209273	13236	28275	rs266257355	NC_000015.10:43209272:C:T
NM_000119.2(EPB42):c.265delG (p.Val89Trpfs)	EPB42	V89fs, V59fs	Spherocytosis type 5	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000013234	15	43508487	15	43216289	13234	28273	rs266257354	NC_000015.10:43216288:CC:C
NM_002408.4(MGAT2):c.1017T>A (p.Cys339Ter)	MGAT2	C339*	Congenital disorder of glycosylation, type IIa	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000006992	14	50089003	14	49622285	6992	22031	rs104894449	NC_000014.9:49622284:T:A
NM_002408.4(MGAT2):c.952A>G (p.Asn318Asp)	MGAT2	N318D	Congenital disorder of glycosylation, type IIa	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000006991	14	50088938	14	49622220	6991	22030	rs104894448	NC_000014.9:49622219:A:G
NM_002408.4(MGAT2):c.785A>G (p.His262Arg)	MGAT2	H262R	Congenital disorder of glycosylation, type IIa	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000006990	14	50088771	14	49622053	6990	22029	rs104894447	NC_000014.9:49622052:A:G
NM_002408.3(MGAT2):c.869C>T (p.Ser290Phe)	MGAT2	S290F	Congenital disorder of glycosylation, type IIa	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000006989	14	50088855	14	49622137	6989	22028	rs104894446	NC_000014.9:49622136:C:T
NM_015665.6(AAAS):c.934C>T (p.Arg312Ter)	AAAS	R312*, R279*	Glucocorticoid deficiency with achalasia	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000005039	12	53702942	12	53309158	5039	20078	rs121918547	NC_000012.12:53309157:G:A
NM_000119.2(EPB42):c.929G>A (p.Arg310Gln)	EPB42	R310Q, R280Q	Spherocytosis type 5	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000013235	15	43500967	15	43208769	13235	28274	rs121917734	NC_000015.10:43208768:C:T
NM_004589.4(SCO1):c.261del (p.Ser88fs)	SCO1	S88fs	not provided	Pathogenic(Last reviewed: Apr 17, 2015)	criteria provided, single submitter	VCV000418798	17	10600564	17	10697247	418798	409826	rs770131276	NC_000017.11:10697246:GGGG:GGG
NM_004589.4(SCO1):c.551del (p.Val184fs)	SCO1	V184fs	not provided	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000280792	17	10596092	17	10692775	280792	264662	rs766454175	NC_000017.11:10692774:A:
NM_004589.4(SCO1):c.394G>A (p.Gly132Ser)	SCO1	G132S	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000120177	17	10596249	17	10692932	120177	125785	rs587777220	NC_000017.11:10692931:C:T
NM_004589.4(SCO1):c.521C>T (p.Pro174Leu)	SCO1	P174L	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000006178	17	10596122	17	10692805	6178	21217	rs104894630	NC_000017.11:10692804:G:A
NM_004589.3(SCO1):c.363_364del (p.Lys122Valfs)	SCO1		not provided|Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000006177	17	10599057 - 10599058	17	10695740 - 10695741	6177	21216	rs587776629	NC_000017.11:10695739:CTCTCT:CTCT
NM_015665.6(AAAS):c.1140_1143TCTG[1] (p.Ser382fs)	AAAS		Glucocorticoid deficiency with achalasia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000264993	12	53702253 - 53702256	12	53308469 - 53308472	264993	260027	rs770214071	NC_000012.12:53308468:CAGACAGA:CAGA
NM_152328.4(ADSS1):c.919del (p.Ile307fs)	ADSS1	I307fs, I102fs, I350fs	Myopathy, distal, 5	Pathogenic(Last reviewed: Jul 15, 2016)	no assertion criteria provided	VCV000243026	14	105208310	14	104741973	243026	244108	rs559454746	NC_000014.9:104741972:A:
NM_000423.3(KRT2):c.556A>G (p.Asn186Asp)	KRT2	N192D, N186D	Ichthyosis bullosa of Siemens	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000009315	12	53045371	12	52651587	9315	24354	rs137852631	NC_000012.12:52651586:T:C
NM_152328.4(ADSS1):c.741del (p.Lys248fs)	ADSS1	K291fs, K248fs, K43fs	Fetal akinesia sequence|Arthrogryposis multiplex congenita	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000692295	14	105207522	14	104741185	692295	680113		NC_000014.9:104741184:CCCCCCC:CCCCCC
NM_000423.3(KRT2):c.542A>C (p.Gln181Pro)	KRT2	Q187P, Q181P	Ichthyosis bullosa of Siemens	Pathogenic(Last reviewed: Sep 1, 1994)	no assertion criteria provided	VCV000009311	12	53045385	12	52651601	9311	24350	rs57510142	NC_000012.12:52651600:T:G
NM_000423.3(KRT2):c.558C>A (p.Asn186Lys)	KRT2	N192K, N186K	not provided|Ichthyosis bullosa of Siemens	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000009316	12	53045369	12	52651585	9316	24355	rs137852632	NC_000012.12:52651584:G:T
NM_000423.3(KRT2):c.1426G>A (p.Glu476Lys)	KRT2	E482K, E476K	not provided|Ichthyosis bullosa of Siemens	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000009314	12	53040567	12	52646783	9314	24353	rs56829062	NC_000012.12:52646782:C:T
NM_000423.3(KRT2):c.556A>T (p.Asn186Tyr)	KRT2	N192Y, N186Y	not provided|Ichthyosis bullosa of Siemens	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000009313	12	53045371	12	52651587	9313	24352	rs137852631	NC_000012.12:52651586:T:A
NM_000423.3(KRT2):c.1435A>C (p.Thr479Pro)	KRT2	T485P, T479P	not provided|Ichthyosis bullosa of Siemens	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000009312	12	53040558	12	52646774	9312	24351	rs137852630	NC_000012.12:52646773:T:G
NM_199165.2(ADSS1):c.910G>A (p.Asp304Asn)	ADSS1	D304N, D261N, D56N	Myopathy, distal, 5	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000243025	14	105207568	14	104741231	243025	244107	rs140614802	NC_000014.9:104741230:G:A
NM_000423.3(KRT2):c.1461G>T (p.Glu487Asp)	KRT2	E493D, E487D	not provided|Ichthyosis bullosa of Siemens	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000009309	12	53040532	12	52646748	9309	24348	rs137852628	NC_000012.12:52646747:C:A
NM_006346.4(PIBF1):c.1801C>T (p.Arg601Ter)	PIBF1	R601*, R630*	JOUBERT SYNDROME 33	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000807653	13	73505373	13	72931235	807653	798669		NC_000013.11:72931234:C:T
NM_006346.4(PIBF1):c.1453C>T (p.Gln485Ter)	PIBF1	Q485*, Q514*	JOUBERT SYNDROME 33	Pathogenic	no assertion criteria provided	VCV000599034	13	73468052	13	72893914	599034	590163	rs539010725	NC_000013.11:72893913:C:T
NM_005982.4(SIX1):c.329G>A (p.Arg110Gln)	SIX1	R110Q	not provided	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000420132	14	61115579	14	60648861	420132	409142	rs1064794308	NC_000014.9:60648860:C:T
NM_004278.4(PIGL):c.60G>A (p.Trp20Ter)	PIGL	W20*	not provided	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000265641	17	16120600	17	16217286	265641	260151	rs886039691	NC_000017.11:16217285:G:A
NM_006346.4(PIBF1):c.1918A>T (p.Ile640Phe)	PIBF1	I640F, I669F	JOUBERT SYNDROME 33|Cephalocele	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632607	13	73539496	13	72965358	632607	621032	rs911707459	NC_000013.11:72965357:A:T
PIBF1, EX6-9 DEL	PIBF1		JOUBERT SYNDROME 33	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000446200					446200	439560		
NM_006346.4(PIBF1):c.1910A>C (p.Asp637Ala)	PIBF1	D637A, D666A	JOUBERT SYNDROME 33	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000446198	13	73539488	13	72965350	446198	439558	rs987735817	NC_000013.11:72965349:A:C
NM_004278.4(PIGL):c.427-1G>A	PIGL			Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030547	17	16216860	17	16313546	30547	39504	rs770084126	NC_000017.11:16313545:G:A
NM_004278.4(PIGL):c.652C>T (p.Gln218Ter)	PIGL	Q218*		Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030546	17	16221214	17	16317900	30546	39503	rs139004722	NC_000017.11:16317899:C:T
NM_004278.4(PIGL):c.274del (p.Leu92fs)	PIGL	L92fs		Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030545	17	16137323	17	16234009	30545	39502	rs758633805	NC_000017.11:16234008:C:
LPAR6, 2-BP DEL, 373AA	LPAR6		Hypotrichosis 8	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000001825					1825	16864		
NM_138638.5(CFL2):c.338del (p.Ser113fs)	CFL2	S96fs, S113fs	Nemaline myopathy 7	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000800930	14	35182316	14	34713110	800930	788881		NC_000014.9:34713109:C:
NM_006346.4(PIBF1):c.1508A>G (p.Tyr503Cys)	PIBF1	Y503C, Y532C	JOUBERT SYNDROME 33|JOUBERT SYNDROME 33|Cephalocele	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000598934	13	73482688	13	72908550	598934	590021	rs144610914	NC_000013.11:72908549:A:G
NM_005982.4(SIX1):c.373G>A (p.Glu125Lys)	SIX1	E125K	Deafness, autosomal dominant 23	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000208361	14	61115535	14	60648817	208361	204589	rs797044960	NC_000014.9:60648816:C:T
NM_005982.4(SIX1):c.50T>A (p.Val17Glu)	SIX1	V17E	Melnick-Fraser syndrome	Pathogenic(Last reviewed: Jun 20, 2013)	no assertion criteria provided	VCV000065698	14	61115858	14	60649140	65698	76606	rs397515562	NC_000014.9:60649139:A:T
NM_005982.4(SIX1):c.334C>T (p.Arg112Cys)	SIX1	R112C	Melnick-Fraser syndrome	Pathogenic(Last reviewed: Jun 20, 2013)	no assertion criteria provided	VCV000065697	14	61115574	14	60648856	65697	76605	rs397515561	NC_000014.9:60648855:G:A
NM_005982.4(SIX1):c.317T>G (p.Val106Gly)	SIX1	V106G	Melnick-Fraser syndrome	Pathogenic(Last reviewed: Jun 20, 2013)	no assertion criteria provided	VCV000065696	14	61115591	14	60648873	65696	76604	rs397515560	NC_000014.9:60648872:A:C
NM_005982.4(SIX1):c.364T>A (p.Trp122Arg)	SIX1	W122R	Branchiootic syndrome 3	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000008311	14	61115544	14	60648826	8311	23350	rs121909770	NC_000014.9:60648825:A:T
NC_000014.8:g.(?_35179578)_(35182892_?)del	CFL2		Nemaline myopathy 7	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000657372	14	35179578 - 35182892	14	34710372 - 34713686	657372	652860		
NC_000014.8:g.(?_35182051)_(35183766_?)del	CFL2		Nemaline myopathy 7	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000583485	14	35182051 - 35183766	14	34712845 - 34714560	583485	572600		
NM_005982.4(SIX1):c.328C>T (p.Arg110Trp)	SIX1	R110W	Branchiootic syndrome 3	Pathogenic(Last reviewed: Aug 27, 2009)	no assertion criteria provided	VCV000008309	14	61115580	14	60648862	8309	23348	rs80356459	NC_000014.9:60648861:G:A
NM_002408.4(MGAT2):c.711G>C (p.Lys237Asn)	MGAT2	K237N	Abnormal glycosylation (CDG IIa)|Abnormal facial shape|Global developmental delay|Congenital disorder of glycosylation, type IIa	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000030270	14	50088697	14	49621979	30270	39226	rs730882218	NC_000014.9:49621978:G:C
NM_015665.6(AAAS):c.1432C>T (p.Arg478Ter)	AAAS	R478*, R445*	not provided|Glucocorticoid deficiency with achalasia	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000005040	12	53701482	12	53307698	5040	20079	rs121918548	NC_000012.12:53307697:G:A
NM_138638.5(CFL2):c.103G>A (p.Ala35Thr)	CFL2	A35T, A18T	Nemaline myopathy 7	Pathogenic(Last reviewed: Mar 15, 2012)	no assertion criteria provided	VCV000008160	14	35182668	14	34713462	8160	23199	rs80358250	NC_000014.9:34713461:C:T
NM_021005.4(NR2F2):c.1029_1035del (p.Cys343fs)	NR2F2	C210fs, C343fs, C190fs	not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000817184	15	96880633 - 96880639	15	96337404 - 96337410	817184	805855		NC_000015.10:96337403:TGTGCTTTG:TG
NM_021005.4(NR2F2):c.247G>T (p.Gly83Ter)	NR2F2	G83*	Congenital heart defects, multiple types, 4	Pathogenic(Last reviewed: Nov 2, 2017)	no assertion criteria provided	VCV000446122	15	96875581	15	96332352	446122	439469	rs1555447012	NC_000015.10:96332351:G:T
NM_021005.4(NR2F2):c.856dup (p.Val286fs)	NR2F2		not provided	Pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, single submitter	VCV000280543	15	96877716 - 96877717	15	96334487 - 96334488	280543	264906	rs886041730	NC_000015.10:96334487:GG:GGG
NM_021005.4(NR2F2):c.970+1G>A	NR2F2		Congenital heart defects, multiple types, 4	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	VCV000128235	15	96877833	15	96334604	128235	133690	rs587777374	NC_000015.10:96334603:G:A
NM_021005.4(NR2F2):c.210_212GCA[6] (p.Gln75dup)	NR2F2		Congenital heart defects, multiple types, 4	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	VCV000128234	15	96875542 - 96875543	15	96332313 - 96332314	128234	133689	rs780808943	NC_000015.10:96332313:AGCAGCAGCAGCAGCA:AGCAGCAGCAGCAGCAGCA
NM_021005.4(NR2F2):c.614A>T (p.Asn205Ile)	NR2F2	N205I, N72I, N52I	Congenital heart defects, multiple types, 4	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	VCV000128233	15	96877476	15	96334247	128233	133688	rs587777372	NC_000015.10:96334246:A:T
LPAR6, 4-BP INS, 69CATG	LPAR6		Autosomal recessive woolly hair 1, with or without hypotrichosis|Hypotrichosis 8	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000001826					1826	16865		
NM_021005.4(NR2F2):c.217C>T (p.Gln73Ter)	NR2F2	Q73*	Congenital heart defects, multiple types, 4	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000848589	15	96875551	15	96332322	848589	842943		NC_000015.10:96332321:C:T
NM_014239.4(EIF2B2):c.638A>G (p.Glu213Gly)	EIF2B2	E213G	Ovarioleukodystrophy|Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000004336	14	75472609	14	75005906	4336	19375	rs104894425	NC_000014.9:75005905:A:G
NM_000785.4(CYP27B1):c.1166G>A (p.Arg389His)	CYP27B1	R389H	not provided|Vitamin D-dependent rickets, type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001669	12	58157930	12	57764147	1669	16708	rs118204009	NC_000012.12:57764146:C:T
NM_021005.4(NR2F2):c.1022C>A (p.Ser341Tyr)	NR2F2	S341Y, S208Y, S188Y	Congenital heart defects, multiple types, 4|not provided	Pathogenic(Last reviewed: May 26, 2017)	criteria provided, single submitter	VCV000128232	15	96880628	15	96337399	128232	133687	rs587777371	NC_000015.10:96337398:C:A
NM_020312.4(COQ9):c.521+1del	COQ9		Coenzyme Q10 deficiency, primary, 5	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000192296	16	57490559	16	57456647	192296	190089	rs786205897	NC_000016.10:57456646:G:
NM_005982.4(SIX1):c.397_399del (p.Glu133del)	SIX1	E133del	Branchiootic syndrome 3|Deafness, autosomal dominant 23	Pathogenic(Last reviewed: Aug 27, 2009)	no assertion criteria provided	VCV000008310	14	61115509 - 61115511	14	60648791 - 60648793	8310	23349	rs80356460	NC_000014.9:60648790:CTCCT:CT
NM_006565.4(CTCF):c.1990C>T (p.Gln664Ter)	CTCF	Q664*, Q336*	Mental retardation, autosomal dominant 21	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803262	16	67670745	16	67636842	803262	791631		NC_000016.10:67636841:C:T
NM_006565.4(CTCF):c.1916dup (p.Pro640fs)	CTCF		not provided	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000546453	16	67670670 - 67670671	16	67636767 - 67636768	546453	536911	rs1555536759	NC_000016.10:67636767:A:AA
NM_006565.4(CTCF):c.313_314dup (p.Gln106fs)	CTCF		not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000504066	16	67645047 - 67645048	16	67611144 - 67611145	504066	495384	rs1555534093	NC_000016.10:67611144:GA:GAGA
NM_006565.4(CTCF):c.1814del (p.Lys605fs)	CTCF	K277fs, K605fs	not provided	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000422876	16	67663412	16	67629509	422876	409662	rs1064796062	NC_000016.10:67629508:AA:A
NM_006565.4(CTCF):c.610dup (p.Thr204fs)	CTCF		not provided	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000280869	16	67645338 - 67645339	16	67611435 - 67611436	280869	264719	rs886041997	NC_000016.10:67611435:AAAAAAA:AAAAAAAA
NM_006565.4(CTCF):c.1670_1674del (p.Val556_Cys557insTer)	CTCF		not provided	Pathogenic(Last reviewed: Jul 28, 2016)	criteria provided, single submitter	VCV000280753	16	67662421 - 67662425	16	67628518 - 67628522	280753	264964	rs886041901	NC_000016.10:67628517:TCTGTTCT:TCT
NM_001478.5(B4GALNT1):c.292C>T (p.Arg98Ter)	B4GALNT1	R98*	Spastic paraplegia	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000653998	12	58025074	12	57631291	653998	641324		NC_000012.12:57631290:G:A
NM_006565.4(CTCF):c.773_776del (p.Lys258fs)	CTCF	K258fs	Mental retardation, autosomal dominant 21	Pathogenic(Last reviewed: Aug 29, 2018)	no assertion criteria provided	VCV000625526	16	67645507 - 67645510	16	67611604 - 67611607	625526	613830	rs1567608876	NC_000016.10:67611603:AAAAA:A
NM_032790.3(ORAI1):c.141_142insCCGCCGCCGCAGCGGGGACGGGGAGCCCCCGGGGGCC (p.Ser48fs)	ORAI1		Combined immunodeficiency due to ORAI1 deficiency	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000470188	12	122064794 - 122064795	12	121626888 - 121626889	470188	462211	rs1555322558	NC_000012.12:121626888::CCGCCGCCGCAGCGGGGACGGGGAGCCCCCGGGGGCC
NM_032790.3(ORAI1):c.290C>G (p.Ser97Cys)	ORAI1	S97C	Myopathy, tubular aggregate, 2	Pathogenic(Last reviewed: Oct 4, 2017)	no assertion criteria provided	VCV000440860	12	122064943	12	121627037	440860	434505	rs1555322610	NC_000012.12:121627036:C:G
NM_032790.3(ORAI1):c.581T>C (p.Leu194Pro)	ORAI1	L194P	Combined immunodeficiency due to ORAI1 deficiency	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000192288	12	122079224	12	121641318	192288	190081	rs782753385	NC_000012.12:121641317:T:C
NM_032790.3(ORAI1):c.412C>T (p.Leu138Phe)	ORAI1	L138F	Myopathy, tubular aggregate, 2	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000189257	12	122079055	12	121641149	189257	187139	rs786204797	NC_000012.12:121641148:C:T
NM_032790.3(ORAI1):c.292G>A (p.Gly98Ser)	ORAI1	G98S	Myopathy, tubular aggregate, 2	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000189256	12	122064945	12	121627039	189256	187138	rs786204796	NC_000012.12:121627038:G:A
NM_006565.4(CTCF):c.1186dup (p.Arg396fs)	CTCF		Mental retardation, autosomal dominant 21	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000088637	16	67654695 - 67654696	16	67620792 - 67620793	88637	94226	rs879255571	NC_000016.10:67620792:AAAA:AAAAA
NM_006565.4(CTCF):c.375dup (p.Val126fs)	CTCF		Mental retardation, autosomal dominant 21	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000088636	16	67645109 - 67645110	16	67611206 - 67611207	88636	94225	rs879255570	NC_000016.10:67611206:T:TT
NM_001478.5(B4GALNT1):c.1298A>C (p.Asp433Ala)	B4GALNT1	D433A, D378A	Hereditary spastic paraplegia 26	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000060527	12	58021487	12	57627704	60527	75110	rs879255242	NC_000012.12:57627703:T:G
NM_001478.5(B4GALNT1):c.395del (p.Pro132fs)	B4GALNT1	P132fs, P77fs	Hereditary spastic paraplegia 26	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000060523	12	58024858	12	57631075	60523	75106	rs766591558	NC_000012.12:57631074:GGGG:GGG
NM_032790.3(ORAI1):c.308C>A (p.Ala103Glu)	ORAI1	A103E	Combined immunodeficiency due to ORAI1 deficiency	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000192287	12	122078951	12	121641045	192287	190080	rs786205890	NC_000012.12:121641044:C:A
NM_032790.3(ORAI1):c.261dup (p.Ala88fs)	ORAI1		Combined immunodeficiency due to ORAI1 deficiency	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000192286	12	122064911 - 122064912	12	121627005 - 121627006	192286	190079	rs878853261	NC_000012.12:121627005:AAA:AAAA
NM_032790.3(ORAI1):c.734C>T (p.Pro245Leu)	ORAI1	P245L	Myopathy, tubular aggregate, 2	Pathogenic(Last reviewed: Mar 18, 2014)	no assertion criteria provided	VCV000139640	12	122079377	12	121641471	139640	143261	rs587777528	NC_000012.12:121641470:C:T
NM_001478.5(B4GALNT1):c.1445dup (p.Asp482fs)	B4GALNT1		Spastic paraplegia	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000852385	12	58020683 - 58020684	12	57626900 - 57626901	852385	840152		NC_000012.12:57626900:T:TT
NM_001478.5(B4GALNT1):c.358C>T (p.Gln120Ter)	B4GALNT1	Q120*	Hereditary spastic paraplegia 26|not provided	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000060526	12	58025008	12	57631225	60526	75109	rs879255241	NC_000012.12:57631224:G:A
NM_001478.5(B4GALNT1):c.682C>T (p.Arg228Ter)	B4GALNT1	R228*, R173*	Hereditary spastic paraplegia 26	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000060524	12	58023965	12	57630182	60524	75107	rs398122382	NC_000012.12:57630181:G:A
NM_032790.3(ORAI1):c.271C>T (p.Arg91Trp)	ORAI1	R91W	Combined immunodeficiency due to ORAI1 deficiency	Pathogenic(Last reviewed: Mar 21, 2008)	no assertion criteria provided	VCV000001283	12	122064924	12	121627018	1283	16322	rs118203993	NC_000012.12:121627017:C:T
NM_006565.4(CTCF):c.1699C>T (p.Arg567Trp)	CTCF	R567W, R239W	not provided|Mental retardation, autosomal dominant 21	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000088638	16	67662453	16	67628550	88638	94227	rs879255516	NC_000016.10:67628549:C:T
NM_005726.6(TSFM):c.399del (p.Lys133fs)	TSFM	K133fs	not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000854965	12	58180858	12	57787075	854965	840187		NC_000012.12:57787074:AAAA:AAA
NM_170682.4(P2RX2):c.1057G>C (p.Gly353Arg)	P2RX2	G353R, G281R, G261R, G319R, G329R	Deafness, autosomal dominant 41	Pathogenic(Last reviewed: Jan 25, 2014)	no assertion criteria provided	VCV000155763	12	133198121	12	132621535	155763	165516	rs202138002	NC_000012.12:132621534:G:C
NM_170682.4(P2RX2):c.178G>T (p.Val60Leu)	P2RX2	V60L, R37L	Deafness, autosomal dominant 41	Pathogenic(Last reviewed: Feb 5, 2013)	no assertion criteria provided	VCV000155762	12	133196029	12	132619443	155762	165515	rs587777692	NC_000012.12:132619442:G:T
NM_130468.3(CHST14):c.567del (p.Phe190fs)	CHST14	F190fs	not provided	Pathogenic(Last reviewed: May 18, 2015)	criteria provided, single submitter	VCV000193484	15	40763979	15	40471780	193484	190648	rs794726956	NC_000015.10:40471779:G:
NM_130468.4(CHST14):c.797dup (p.Tyr266Ter)	CHST14		Ehlers-Danlos syndrome, musculocontractural type	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000816708	15	40764208 - 40764209	15	40472009 - 40472010	816708	804914		NC_000015.10:40472009:A:AA
NM_001040667.3(HSF4):c.965dup (p.Pro323fs)	HSF4			Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000567423	16	67201726 - 67201727	16	67167823 - 67167824	567423	570347	rs776129797	NC_000016.10:67167823:CCCCCCC:CCCCCCCC
NM_130468.3(CHST14):c.821G>C (p.Arg274Pro)	CHST14	R274P	Ehlers-Danlos syndrome, musculocontractural type	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000050992	15	40764233	15	40472034	50992	65663	rs397514706	NC_000015.10:40472033:G:C
NM_130468.3(CHST14):c.981_1000dup (p.Glu334fs)	CHST14		Ehlers-Danlos syndrome, musculocontractural type	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000018421	15	40764391 - 40764392	15	40472192 - 40472193	18421	33460	rs1555410785	NC_000015.10:40472192:GGTACCGGCCAGCCAGCCCCG:GGTACCGGCCAGCCAGCCCCGGTACCGGCCAGCCAGCCCCG
NM_001040667.3(HSF4):c.256A>G (p.Ile86Val)	HSF4	I87V, I86V		Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000007095	16	67199645	16	67165742	7095	22134	rs121909050	NC_000016.10:67165741:A:G
NM_001040667.3(HSF4):c.56C>A (p.Ala19Asp)	HSF4	A20D, A19D		Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000007094	16	67198770	16	67164867	7094	22133	rs121909049	NC_000016.10:67164866:C:A
NM_001040667.3(HSF4):c.341T>C (p.Leu114Pro)	HSF4	L115P, L114P		Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000007092	16	67199730	16	67165827	7092	22131	rs121909048	NC_000016.10:67165826:T:C
NM_005726.6(TSFM):c.557T>A (p.Leu186Ter)	TSFM	L207*, L186*	not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000845374	12	58186842	12	57793059	845374	840188		NC_000012.12:57793058:T:A
NC_000012.12:g.(?_57791955)_(57796593_?)del	TSFM		not provided	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000831748	12	58185738 - 58190376			831748	820512		
NM_001040667.3(HSF4):c.89del (p.Asp30fs)	HSF4	D30fs		Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000459609	16	67198803	16	67164900	459609	466795	rs1555549755	NC_000016.10:67164899:A:
NM_130468.3(CHST14):c.453dup (p.Cys152fs)	CHST14		Ehlers-Danlos syndrome, musculocontractural type	Pathogenic(Last reviewed: Nov 8, 2017)	no assertion criteria provided	VCV000446173	15	40763864 - 40763865	15	40471665 - 40471666	446173	439521	rs1555410747	NC_000015.10:40471665:C:CC
NM_001040667.3(HSF4):c.355C>T (p.Arg119Cys)	HSF4	R120C, R119C		Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000007093	16	67199744	16	67165841	7093	22132	rs28937573	NC_000016.10:67165840:C:T
NM_130468.3(CHST14):c.866G>C (p.Cys289Ser)	CHST14	C289S	Ehlers-Danlos syndrome, musculocontractural type	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000002342	15	40764278	15	40472079	2342	17381	rs267606731	NC_000015.10:40472078:G:C
NM_130468.3(CHST14):c.205A>T (p.Lys69Ter)	CHST14	K69*	Ehlers-Danlos syndrome, musculocontractural type	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000002341	15	40763617	15	40471418	2341	17380	rs267606730	NC_000015.10:40471417:A:T
NM_130466.4(UBE3B):c.2990G>C (p.Arg997Pro)	UBE3B	R997P	Kaufman oculocerebrofacial syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000208729	12	109971338	12	109533533	208729	205272	rs539407162	NC_000012.12:109533532:G:C
NM_130468.3(CHST14):c.527_530delinsGACAG (p.Val176fs)	CHST14		not provided|Ehlers-Danlos syndrome, musculocontractural type	Pathogenic/Likely pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000653458	15	40763939 - 40763942	15	40471740 - 40471743	653458	643159		NC_000015.10:40471739:TGGA:GACAG
NM_130468.3(CHST14):c.842C>T (p.Pro281Leu)	CHST14	P281L	Ehlers-Danlos syndrome, musculocontractural type	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000002340	15	40764254	15	40472055	2340	17379	rs267606729	NC_000015.10:40472054:C:T
NM_130468.3(CHST14):c.638G>C (p.Arg213Pro)	CHST14	R213P	Ehlers-Danlos syndrome, musculocontractural type	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000002337	15	40764050	15	40471851	2337	17376	rs121908257	NC_000015.10:40471850:G:C
GRCh37/hg19 12q24.31(chr12:123738222-123738503)	C12orf65		Combined oxidative phosphorylation deficiency 7	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000813299	12	123738222 - 123738503			813299	801553		
NM_152269.5(C12orf65):c.33dup (p.Pro12fs)	C12orf65		Combined oxidative phosphorylation deficiency 7|Spastic paraplegia	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000859045	12	123738253 - 123738254	12	123253706 - 123253707	859045	839377		NC_000012.12:123253706:A:AA
NM_152269.5(C12orf65):c.-28-1489_283-968del	C12orf65		Neurodevelopmental disorder	Pathogenic(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635867	12	123736705 - 123740392	12	123252158 - 123255845	635867	623680		
NM_152269.5(C12orf65):c.282+2T>A	C12orf65		Spastic paraplegia 55, autosomal recessive	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000144069	12	123738505	12	123253958	144069	153819	rs587777668	NC_000012.12:123253957:T:A
NM_152269.5(C12orf65):c.413_417del (p.Lys138fs)	C12orf65	K138fs	Spastic paraplegia 55, autosomal recessive	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000144068	12	123741488 - 123741492	12	123256941 - 123256945	144068	153818	rs587777667	NC_000012.12:123256940:AAAACAA:AA
NM_130468.3(CHST14):c.145del (p.Ala48_Val49insTer)	CHST14		Ehlers-Danlos syndrome, musculocontractural type|not provided	Pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	VCV000002336	15	40763556	15	40471357	2336	17375	rs397518432	NC_000015.10:40471356:GG:G
NM_152269.5(C12orf65):c.307del (p.Gln103fs)	C12orf65	Q103fs	Combined oxidative phosphorylation deficiency 7|Spastic paraplegia	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000834522	12	123741384	12	123256837	834522	839378		NC_000012.12:123256836:C:
NM_001302652.2(COA8):c.328_330GAA[1] (p.Glu111del)	COA8	E124del	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000156424	14	104040448 - 104040450	14	103574111 - 103574113	156424	166198	rs587777787	NC_000014.9:103574110:AAGAAGAA:AAGAA
NM_032374.4(COA8):c.163-1G>A	COA8		Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000156422	14	104037959	14	103571622	156422	166196	rs587777785	
NM_001302652.2(COA8):c.196C>T (p.Arg66Ter)	COA8	R79*, R66*	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000156421	14	104038032	14	103571695	156421	166195	rs587777784	NC_000014.9:103571694:C:T
NM_152269.5(C12orf65):c.346del (p.Lys115_Val116insTer)	C12orf65		Spastic paraplegia 55, autosomal recessive	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000091408	12	123741423	12	123256876	91408	96885	rs398122972	NC_000012.12:123256875:G:
NM_152269.5(C12orf65):c.415C>T (p.Gln139Ter)	C12orf65	Q139*	Spastic paraplegia 55, autosomal recessive	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000088864	12	123741492	12	123256945	88864	94433	rs398122365	NC_000012.12:123256944:C:T
NM_152269.5(C12orf65):c.96_99dup (p.Pro34fs)	C12orf65		Spastic paraplegia|Combined oxidative phosphorylation deficiency 7|not provided	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214192	12	123738316 - 123738317	12	123253769 - 123253770	214192	211578	rs863223926	NC_000012.12:123253769:ATCC:ATCCATCC
NM_152269.5(C12orf65):c.394C>T (p.Arg132Ter)	C12orf65	R132*	not provided|Spastic paraplegia 55, autosomal recessive	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000039582	12	123741471	12	123256924	39582	48181	rs397514539	NC_000012.12:123256923:C:T
NM_001318526.2(TRAPPC2L):c.-10G>T	TRAPPC2L	D37Y, D7Y	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS	Pathogenic(Last reviewed: Feb 22, 2019)	no assertion criteria provided	VCV000619097	16	88925102	16	88858694	619097	610495	rs766510287	NC_000016.10:88858693:G:T
NM_080911.3(UNG):c.685C>T (p.Arg229Ter)	UNG	R229*, R220*		Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000578381	12	109541300	12	109103495	578381	571184	rs772214871	NC_000012.12:109103494:C:T
UNG, 2-BP DEL, 497AT	UNG			Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000012293					12293	27332		
UNG, 2-BP DEL, 639TA	UNG			Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000012291					12291	27330		
UNG, 1-BP DEL, 462C	UNG			Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000012290					12290	27329		
NM_001383.5(DPH1):c.274del (p.Glu92fs)	DPH1	E97fs, E92fs	not provided	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000664140	17	1937131	17	2033837	664140	645401		NC_000017.11:2033836:GG:G
NM_080911.3(UNG):c.752T>C (p.Phe251Ser)	UNG	F251S, F242S		Pathogenic(Last reviewed: Jun 20, 2005)	no assertion criteria provided	VCV000012292	12	109541367	12	109103562	12292	27331	rs104894380	NC_000012.12:109103561:T:C
NM_001383.4(DPH1):c.17T>A (p.Met6Lys)	DPH1	M6K	not provided|Developmental delay with short stature, dysmorphic features, and sparse hair	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000218949	17	1933465	17	2030171	218949	215783	rs757167361	NC_000017.11:2030170:T:A
NM_001383.4(DPH1):c.701T>C (p.Leu234Pro)	DPH1	L234P, L223P, L94P	Developmental delay with short stature, dysmorphic features, and sparse hair|Cerebellar vermis hypoplasia|Dandy-Walker syndrome|Global developmental delay|Hydrocephalus	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2015)	no assertion criteria provided	VCV000183359	17	1943054	17	2039760	183359	181451	rs730882250	NC_000017.11:2039759:T:C
NM_145064.3(STAC3):c.851G>C (p.Trp284Ser)	STAC3	W284S, W245S, W98S	Bailey-Bloch congenital myopathy	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000088744	12	57638105	12	57244322	88744	94325	rs140291094	NC_000012.12:57244321:C:G
GRCh37/hg19 15q23(chr15:72194247-72249034)x1	MYO9A		not provided	Pathogenic(Last reviewed: Sep 29, 2017)	no assertion criteria provided	VCV000686724	15	72194247 - 72249034			686724	674316		
NM_005262.3(GFER):c.373C>T (p.Gln125Ter)	GFER	Q125*	not provided	Pathogenic(Last reviewed: Sep 26, 2012)	criteria provided, single submitter	VCV000214471	16	2034862	16	1984861	214471	211704	rs771809901	NC_000016.10:1984860:C:T
MYO9A, ASP1698GLY (rs150726107)	MYO9A	D1698G	MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC	Pathogenic(Last reviewed: Nov 29, 2018)	no assertion criteria provided	VCV000590982					590982	581927		
MYO9A, ARG2283HIS (rs142345927)	MYO9A	R2283H	MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC	Pathogenic(Last reviewed: Nov 29, 2018)	no assertion criteria provided	VCV000590981					590981	581926		
MYO9A, ARG1517HIS (rs149046541)	MYO9A	R1517H	MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC	Pathogenic(Last reviewed: Nov 29, 2018)	no assertion criteria provided	VCV000590980					590980	581925		
NM_014239.4(EIF2B2):c.599G>T (p.Gly200Val)	EIF2B2	G200V	not provided|Leukoencephalopathy with vanishing white matter	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208575	14	75472570	14	75005867	208575	205176	rs113994012	NC_000014.9:75005866:G:T
NM_005262.3(GFER):c.217del (p.Ala73fs)	GFER	A73fs	not provided|Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000559178	16	2034434	16	1984433	559178	550030	rs1555486560	NC_000016.10:1984432:GGG:GG
NM_001100913.3(PACS2):c.625G>A (p.Glu209Lys)	PACS2	E209K, E142K	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66|Intellectual disability|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495141	14	105834449	14	105368112	495141	486695	rs1555408401	NC_000014.9:105368111:G:A
NM_000423.3(KRT2):c.1459G>A (p.Glu487Lys)	KRT2	E493K, E487K	not provided|Ichthyosis exfoliativa|Ichthyosis bullosa of Siemens	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000009310	12	53040534	12	52646750	9310	24349	rs137852629	NC_000012.12:52646749:C:T
NM_032856.5(WDR73):c.566_567AC[1] (p.Thr190fs)	WDR73		not provided	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000817321	15	85189016 - 85189017	15	84645785 - 84645786	817321	805846		NC_000015.10:84645784:GTGT:GT
NM_032856.5(WDR73):c.750_751del (p.Cys251fs)	WDR73	C251fs	not provided	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000817296	15	85188834 - 85188835	15	84645603 - 84645604	817296	805845		NC_000015.10:84645602:AAA:A
NM_032856.5(WDR73):c.42-1G>C	WDR73		Seizures|Dyskinesia	Pathogenic	no assertion criteria provided	VCV000812997	15	85196931	15	84653700	812997	801158		NC_000015.10:84653699:C:G
NM_032856.5(WDR73):c.706_719dup (p.Ser240fs)	WDR73		Galloway-Mowat syndrome 1	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000807718	15	85188865 - 85188866	15	84645634 - 84645635	807718	798689		NC_000015.10:84645634:CTGGGCCCAGGGCCCTGG:CTGGGCCCAGGGCCCTGGGCCCAGGGCCCTGG
NM_025193.4(HSD3B7):c.268_281del (p.Val90fs)	HSD3B7	V90fs	not provided	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000593981	16	30997470 - 30997483	16	30986149 - 30986162	593981	585044	rs1567370784	NC_000016.10:30986148:GGTAGACGTGTTTGG:G
NM_025193.4(HSD3B7):c.453del (p.Pro150_Tyr151insTer)	HSD3B7		not provided	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000593957	16	30997947	16	30986626	593957	585020	rs1567371518	NC_000016.10:30986625:C:
NM_025193.4(HSD3B7):c.166+1G>A	HSD3B7		not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000593800	16	30997146	16	30985825	593800	584863	rs530793570	NC_000016.10:30985824:G:A
NM_025193.4(HSD3B7):c.196del (p.Asp66fs)	HSD3B7	D66fs	not provided	Pathogenic(Last reviewed: Oct 28, 2016)	criteria provided, single submitter	VCV000498040	16	30997395	16	30986074	498040	489464	rs1555492659	NC_000016.10:30986073:GGGGG:GGGG
NM_025193.4(HSD3B7):c.890del (p.Phe297fs)	HSD3B7	F297fs	not provided	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000286890	16	30999283	16	30987962	286890	271127	rs886043511	NC_000016.10:30987961:TT:T
NM_032856.5(WDR73):c.681T>A (p.Cys227Ter)	WDR73	C227*	Dystonia	Pathogenic	no assertion criteria provided	VCV000812996	15	85188904	15	84645673	812996	801157		NC_000015.10:84645672:A:T
NM_005419.4(STAT2):c.1999C>T (p.Arg667Ter)	STAT2	R667*, R663*	Immunodeficiency 44	Pathogenic(Last reviewed: Oct 7, 2018)	criteria provided, single submitter	VCV000578415	12	56740271	12	56346487	578415	566961	rs1565648608	NC_000012.12:56346486:G:A
NM_032387.5(WNK4):c.3505A>G (p.Lys1169Glu)	WNK4	K1169E, K833E	Pseudohypoaldosteronism type 2B	Pathogenic(Last reviewed: Feb 16, 2017)	no assertion criteria provided	VCV000375699	17	40948214	17	42796196	375699	362588	rs193922737	NC_000017.11:42796195:A:G
NM_032387.5(WNK4):c.1690G>C (p.Asp564His)	WNK4	D564H, D228H	Pseudohypoaldosteronism type 2B	Pathogenic(Last reviewed: Feb 16, 2017)	no assertion criteria provided	VCV000375698	17	40939509	17	42787491	375698	362587	rs193922736	NC_000017.11:42787490:G:C
NM_032387.5(WNK4):c.1682C>T (p.Pro561Leu)	WNK4	P561L, P225L	Pseudohypoaldosteronism type 2B	Pathogenic(Last reviewed: Feb 16, 2017)	no assertion criteria provided	VCV000375697	17	40939501	17	42787483	375697	362586	rs193922735	NC_000017.11:42787482:C:T
NM_032387.5(WNK4):c.1679A>G (p.Glu560Gly)	WNK4	E560G, E224G	Pseudohypoaldosteronism type 2B	Pathogenic(Last reviewed: Feb 16, 2017)	no assertion criteria provided	VCV000375696	17	40939498	17	42787480	375696	362585	rs193922734	NC_000017.11:42787479:A:G
NM_005419.4(STAT2):c.1836C>A (p.Cys612Ter)	STAT2	C612*, C608*	Immunodeficiency 44	Pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000218141	12	56740628	12	56346844	218141	214789	rs781522558	NC_000012.12:56346843:G:T
NM_005419.4(STAT2):c.381+5G>C	STAT2		Immunodeficiency 44	Pathogenic(Last reviewed: Feb 19, 2013)	no assertion criteria provided	VCV000218140	12	56749487	12	56355703	218140	214788	rs281874770	NC_000012.12:56355702:C:G
NM_032856.3(WDR73):c.400_401delAG (p.Trp136Alafs)	WDR73		Galloway-Mowat syndrome 1	Pathogenic(Last reviewed: Jun 29, 2015)	no assertion criteria provided	VCV000208466	15	85189531 - 85189532	15	84646300 - 84646301	208466	204987	rs767086146	NC_000015.10:84646299:CTCTC:CTC
NM_032856.3(WDR73):c.703C>T (p.Gln235Ter)	WDR73	Q235*	Galloway-Mowat syndrome 1	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000208465	15	85188882	15	84645651	208465	204986	rs797044992	NC_000015.10:84645650:G:A
NM_032856.3(WDR73):c.129T>G (p.Tyr43Ter)	WDR73	Y43*	Galloway-Mowat syndrome 1	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162610	15	85196014	15	84652783	162610	172286	rs727502863	NC_000015.10:84652782:A:C
NM_025193.4(HSD3B7):c.322+1G>T	HSD3B7			Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000002883	16	30997526	16	30986205	2883	17922	rs387906288	NC_000016.10:30986204:G:T
NM_032856.3(WDR73):c.940C>T (p.Gln314Ter)	WDR73	Q314*	Galloway-Mowat syndrome 1	Pathogenic(Last reviewed: Jun 29, 2015)	no assertion criteria provided	VCV000208469	15	85186898	15	84643667	208469	204990	rs797044994	NC_000015.10:84643666:G:A
NM_005262.3(GFER):c.586C>T (p.Arg196Cys)	GFER	R196C	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay|Mitochondrial diseases	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000426097	16	2035997	16	1985996	426097	414710	rs370475970	NC_000016.10:1985995:C:T
NM_032387.5(WNK4):c.1691A>C (p.Asp564Ala)	WNK4	D564A, D228A	Pseudohypoaldosteronism type 2B	Pathogenic(Last reviewed: Feb 16, 2017)	no assertion criteria provided	VCV000007662	17	40939510	17	42787492	7662	22701	rs137853094	NC_000017.11:42787491:A:C
NM_032387.5(WNK4):c.1684G>A (p.Glu562Lys)	WNK4	E562K, E226K	Pseudohypoaldosteronism type 2B	Pathogenic(Last reviewed: Feb 16, 2017)	no assertion criteria provided	VCV000007661	17	40939503	17	42787485	7661	22700	rs137853093	NC_000017.11:42787484:G:A
NM_025193.4(HSD3B7):c.45_46del (p.Gly17fs)	HSD3B7	G17fs	|not provided	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000002885	16	30997024 - 30997025	16	30985703 - 30985704	2885	17924	rs786200876	NC_000016.10:30985702:AG:
NM_025193.4(HSD3B7):c.439G>A (p.Glu147Lys)	HSD3B7	E147K	|not provided	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000002884	16	30997933	16	30986612	2884	17923	rs104894518	NC_000016.10:30986611:G:A
NM_025193.4(HSD3B7):c.294dup (p.Lys99fs)	HSD3B7		|not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000002882	16	30997494 - 30997495	16	30986173 - 30986174	2882	17921	rs397514443	NC_000016.10:30986173:CCC:CCCC
NM_025193.4(HSD3B7):c.1039_1040del (p.Leu347fs)	HSD3B7	L347fs		Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000002881	16	30999433 - 30999434	16	30988112 - 30988113	2881	17920	rs397514442	NC_000016.10:30988111:CT:
NM_032856.3(WDR73):c.888del (p.Phe296Leufs)	WDR73	F296fs	Galloway-Mowat syndrome 1|not provided	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000225244	15	85186950	15	84643719	225244	227158	rs869320712	NC_000015.10:84643718:AAAA:AAA
NM_032856.3(WDR73):c.1039C>T (p.His347Tyr)	WDR73	H347Y	Galloway-Mowat syndrome 1	Pathogenic(Last reviewed: Jun 29, 2015)	no assertion criteria provided	VCV000208467	15	85186799	15	84643568	208467	204988	rs754099015	NC_000015.10:84643567:G:A
NM_032856.3(WDR73):c.766dup (p.Arg256Profs)	WDR73		Galloway-Mowat syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162611	15	85188818 - 85188819	15	84645587 - 84645588	162611	172287	rs727502864	NC_000015.10:84645587:GGGGG:GGGGGG
NM_005251.3(FOXC2):c.902_923del (p.Leu301fs)	FOXC2	L301fs	not provided	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000524132	16	86601835 - 86601856	16	86568229 - 86568250	524132	514701	rs1555531360	NC_000016.10:86568228:GCCGCCGCTGGCGCTGCCCTACGCCGCCGC:GCCGCCGC
NM_005251.3(FOXC2):c.712C>T (p.Gln238Ter)	FOXC2	Q238*	not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000523810	16	86601653	16	86568047	523810	514700	rs1555531333	NC_000016.10:86568046:C:T
NM_018082.6(POLR3B):c.2084-6A>G	POLR3B		not provided	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	VCV000419962	12	106848274	12	106454496	419962	408505	rs747912710	NC_000012.12:106454495:A:G
NM_018082.6(POLR3B):c.2777A>G (p.Asp926Gly)	POLR3B	D926G, D868G	not provided	Pathogenic(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	VCV000419234	12	106889896	12	106496118	419234	408507	rs1064793739	NC_000012.12:106496117:A:G
NM_018082.6(POLR3B):c.2774C>T (p.Pro925Leu)	POLR3B	P925L, P867L	Cerebellar hypoplasia with endosteal sclerosis	Pathogenic(Last reviewed: Dec 21, 2016)	no assertion criteria provided	VCV000375248	12	106889893	12	106496115	375248	361949	rs775141057	NC_000012.12:106496114:C:T
NM_005251.3(FOXC2):c.988dup (p.Gln330fs)	FOXC2		not provided	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000280261	16	86601927 - 86601928	16	86568321 - 86568322	280261	264646	rs886041497	NC_000016.10:86568321:CC:CCC
NM_138387.3(G6PC3):c.911dup (p.Gln305fs)	G6PC3		Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827706	17	42153275 - 42153276	17	44075907 - 44075908	827706	815934		NC_000017.11:44075907:CCCCCC:CCCCCCC
NM_138387.3(G6PC3):c.199_218+1del	G6PC3		Dursun syndrome	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000691994	17	42148527 - 42148547	17	44071159 - 44071179	691994	679830		NC_000017.11:44071158:AGTGGCTCAACCTCATCTTCAAGTGG:AGTGG
NM_138387.3(G6PC3):c.207dup (p.Ile70fs)	G6PC3		Dursun syndrome	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000691992	17	42148539 - 42148540	17	44071171 - 44071172	691992	679799		NC_000017.11:44071171:C:CC
NM_005251.3(FOXC2):c.1006dup (p.Met336fs)	FOXC2		Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus	Pathogenic(Last reviewed: Dec 15, 2004)	no assertion criteria provided	VCV000007258	16	86601946 - 86601947	16	86568340 - 86568341	7258	22297	rs1567571636	NC_000016.10:86568340:A:AA
NM_138387.3(G6PC3):c.565C>T (p.Arg189Ter)	G6PC3	P149L, R189*	Severe congenital neutropenia 4, autosomal recessive	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000653016	17	42152707	17	44075339	653016	646075		NC_000017.11:44075338:C:T
NM_005251.3(FOXC2):c.1205C>T (p.Pro402Leu)	FOXC2	P402L	Distichiasis-lymphedema syndrome	Pathogenic(Last reviewed: Jan 2, 2019)	no assertion criteria provided	VCV000599244	16	86602146	16	86568540	599244	590468	rs1567571823	NC_000016.10:86568539:C:T
NM_018082.6(POLR3B):c.2774C>A (p.Pro925Gln)	POLR3B	P925Q, P867Q	Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism	Pathogenic	no assertion criteria provided	VCV000375867	12	106889893	12	106496115	375867	362748	rs775141057	NC_000012.12:106496114:C:A
NM_138387.3(G6PC3):c.935dup (p.Asn313fs)	G6PC3		Severe congenital neutropenia 4, autosomal recessive	Pathogenic(Last reviewed: Jan 18, 2015)	no assertion criteria provided	VCV000189784	17	42153301 - 42153302	17	44075933 - 44075934	189784	187653	rs797044567	NC_000017.11:44075933:TTTT:TTTTT
NM_138387.3(G6PC3):c.829C>T (p.Gln277Ter)	G6PC3	G277*, Q277*	Severe congenital neutropenia 4, autosomal recessive	Pathogenic(Last reviewed: Jan 18, 2015)	no assertion criteria provided	VCV000189783	17	42153199	17	44075831	189783	187652	rs148559256	NC_000017.11:44075830:C:T
NM_005251.3(FOXC2):c.509del (p.Lys170fs)	FOXC2	K170fs	Distichiasis-lymphedema syndrome	Pathogenic(Last reviewed: May 15, 2001)	no assertion criteria provided	VCV000007256	16	86601446	16	86567840	7256	22295	rs1567571276	NC_000016.10:86567839:AAAAA:AAAA
NM_005251.3(FOXC2):c.1331del (p.Gln444fs)	FOXC2	Q444fs	Distichiasis-lymphedema syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000007252	16	86602272	16	86568666	7252	22291		NC_000016.10:86568665:A:
NM_005251.3(FOXC2):c.1090_1093dup (p.Pro365fs)	FOXC2		Distichiasis-lymphedema syndrome	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000007250	16	86602029 - 86602030	16	86568423 - 86568424	7250	22289	rs1567571702	NC_000016.10:86568423:CGGCC:CGGCCGGCC
NM_138387.3(G6PC3):c.346A>G (p.Met116Val)	G6PC3	M116V	Dursun syndrome	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000001042	17	42152068	17	44074700	1042	16081	rs267606834	NC_000017.11:44074699:A:G
G6PC3, 1-BP DUP, 935T	G6PC3		Severe congenital neutropenia 4, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000001041					1041	16080		
NM_138387.3(G6PC3):c.784G>C (p.Gly262Arg)	G6PC3	G262R	Severe congenital neutropenia 4, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000001040	17	42153154	17	44075786	1040	16079	rs118203971	NC_000017.11:44075785:G:C
NM_138387.3(G6PC3):c.141C>G (p.Tyr47Ter)	G6PC3	Y47*	Severe congenital neutropenia 4, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000001039	17	42148474	17	44071106	1039	16078	rs118203970	NC_000017.11:44071105:C:G
NM_138387.3(G6PC3):c.554T>C (p.Leu185Pro)	G6PC3	L185P	Severe congenital neutropenia 4, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000001038	17	42152696	17	44075328	1038	16077	rs118203969	NC_000017.11:44075327:T:C
NM_018191.4(RCBTB1):c.1164G>T (p.Leu388Phe)	RCBTB1	L388F, L195F	Retinitis pigmentosa|Retinal dystrophy with or without extraocular anomalies	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	no assertion criteria provided	VCV000253020	13	50118881	13	49544745	253020	247424	rs879255547	NC_000013.11:49544744:C:A
NM_018191.4(RCBTB1):c.973C>T (p.His325Tyr)	RCBTB1	H325Y, H132Y	Retinitis pigmentosa|RETINAL DYSTROPHY WITH EXTRAOCULAR ANOMALIES	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	no assertion criteria provided	VCV000253018	13	50123666	13	49549530	253018	247426	rs200826424	NC_000013.11:49549529:G:A
NM_018191.4(RCBTB1):c.930G>T (p.Trp310Cys)	RCBTB1	W310C, W117C	Retinitis pigmentosa|RETINAL DYSTROPHY WITH EXTRAOCULAR ANOMALIES	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	no assertion criteria provided	VCV000253017	13	50123709	13	49549573	253017	247427	rs772592456	NC_000013.11:49549572:C:A
NM_018191.4(RCBTB1):c.919G>A (p.Val307Met)	RCBTB1	V307M, V114M	Retinitis pigmentosa|Retinal dystrophy with or without extraocular anomalies	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	no assertion criteria provided	VCV000253016	13	50123720	13	49549584	253016	247428	rs368217569	NC_000013.11:49549583:C:T
NM_018082.6(POLR3B):c.2570+1G>A	POLR3B		Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000620581	12	106853147	12	106459369	620581	611987	rs753943393	NC_000012.12:106459368:G:A
NM_005251.3(FOXC2):c.1258C>T (p.Gln420Ter)	FOXC2	Q420*	Distichiasis-lymphedema syndrome	Pathogenic(Last reviewed: Jan 2, 2019)	no assertion criteria provided	VCV000599245	16	86602199	16	86568593	599245	590469	rs1567571863	NC_000016.10:86568592:C:T
NM_005251.3(FOXC2):c.602_681delinsACAAA (p.Ala201_Thr226delinsAsp)	FOXC2		Distichiasis-lymphedema syndrome	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000007259	16	86601543 - 86601622	16	86567937 - 86568016	7259	22298	rs1567571360	
NM_005251.3(FOXC2):c.588dup (p.Thr197fs)	FOXC2		Distichiasis-lymphedema syndrome	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000007255	16	86601527 - 86601528	16	86567921 - 86567922	7255	22294	rs1567571345	NC_000016.10:86567921:CC:CCC
NM_138387.3(G6PC3):c.130C>T (p.Pro44Ser)	G6PC3	F44S, P44S	Severe congenital neutropenia 4, autosomal recessive	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, single submitter	VCV000189781	17	42148463	17	44071095	189781	187650	rs775224457	NC_000017.11:44071094:C:T
NM_018082.6(POLR3B):c.2686A>T (p.Lys896Ter)	POLR3B	K896*, K838*	Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000031167	12	106857371	12	106463593	31167	40124	rs267608685	NC_000012.12:106463592:A:T
NM_018082.6(POLR3B):c.1533del (p.Ile511fs)	POLR3B	I453fs, I511fs	Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000031165	12	106826163	12	106432385	31165	40122	rs267608684	NC_000012.12:106432384:TT:T
NM_018082.6(POLR3B):c.1508C>A (p.Thr503Lys)	POLR3B	T503K, T445K	Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000031164	12	106826139	12	106432361	31164	40121	rs267608683	NC_000012.12:106432360:C:A
NM_018082.6(POLR3B):c.2778C>G (p.Asp926Glu)	POLR3B	D926E, D868E	Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000031163	12	106889897	12	106496119	31163	40120	rs267608689	NC_000012.12:106496118:C:G
NM_018082.6(POLR3B):c.2303G>A (p.Arg768His)	POLR3B	R768H, R710H	Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000031161	12	106850925	12	106457147	31161	40118	rs267608687	NC_000012.12:106457146:G:A
NM_018082.6(POLR3B):c.1857-2A>C	POLR3B		Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000031160	12	106831457	12	106437679	31160	40117	rs267608686	NC_000012.12:106437678:A:C
NM_005251.3(FOXC2):c.914_921del (p.Tyr305fs)	FOXC2	Y305fs	Distichiasis-lymphedema syndrome	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000007257	16	86601855 - 86601862	16	86568249 - 86568256	7257	22296	rs1567571564	NC_000016.10:86568248:ACGCCGCC:
NM_138387.3(G6PC3):c.758G>A (p.Arg253His)	G6PC3	R253H	Severe congenital neutropenia 4, autosomal recessive	Pathogenic(Last reviewed: Jan 18, 2015)	no assertion criteria provided	VCV000001037	17	42153128	17	44075760	1037	16076	rs118203968	NC_000017.11:44075759:G:A
NM_020529.2(NFKBIA):c.33G>A (p.Trp11Ter)	NFKBIA	W11*	not provided	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000452693	14	35873818	14	35404612	452693	445229	rs1555342918	NC_000014.9:35404611:C:T
NM_020529.2(NFKBIA):c.25C>T (p.Gln9Ter)	NFKBIA	Q9*	not provided	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000280143	14	35873826	14	35404620	280143	264537	rs886041411	NC_000014.9:35404619:G:A
NM_000294.3(PHKG2):c.657del (p.Cys219fs)	PHKG2	C219fs	Glycogen storage disease IXc	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803250	16	30767697	16	30756376	803250	791583		NC_000016.10:30756375:T:
NM_000294.3(PHKG2):c.783del (p.Ser262fs)	PHKG2	S262fs	Glycogen storage disease IXc	Pathogenic(Last reviewed: Nov 11, 2019)	no assertion criteria provided	VCV000694642	16	30767822	16	30756501	694642	682740		NC_000016.10:30756500:CC:C
NM_020529.2(NFKBIA):c.95G>A (p.Ser32Asn)	NFKBIA	S32N	Ectodermal dysplasia and immunodeficiency 2	Pathogenic(Last reviewed: Nov 15, 2018)	no assertion criteria provided	VCV000590311	14	35873756	14	35404550	590311	581252	rs28933100	NC_000014.9:35404549:C:T
NM_020529.2(NFKBIA):c.96C>G (p.Ser32Arg)	NFKBIA	S32R	Ectodermal dysplasia and immunodeficiency 2	Pathogenic(Last reviewed: Nov 15, 2018)	no assertion criteria provided	VCV000590310	14	35873755	14	35404549	590310	581251	rs1566591082	NC_000014.9:35404548:G:C
NM_020529.2(NFKBIA):c.94A>G (p.Ser32Gly)	NFKBIA	S32G	Ectodermal dysplasia and immunodeficiency 2	Pathogenic(Last reviewed: Nov 15, 2018)	no assertion criteria provided	VCV000590309	14	35873757	14	35404551	590309	581250	rs1566591086	NC_000014.9:35404550:T:C
NM_020529.2(NFKBIA):c.110T>A (p.Met37Lys)	NFKBIA	M37K	Ectodermal dysplasia and immunodeficiency 2	Pathogenic(Last reviewed: Nov 15, 2018)	no assertion criteria provided	VCV000590307	14	35873741	14	35404535	590307	581248	rs1566591073	NC_000014.9:35404534:A:T
NM_020529.2(NFKBIA):c.110T>G (p.Met37Arg)	NFKBIA	M37R	Ectodermal dysplasia and immunodeficiency 2	Pathogenic(Last reviewed: Nov 15, 2018)	no assertion criteria provided	VCV000590306	14	35873741	14	35404535	590306	581247	rs1566591073	NC_000014.9:35404534:A:C
NM_001352020.1(LMF1):c.1336+55G>A	LMF1	W464*, W247*, W331*, W355*		Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000143993	16	919908	16	869908	143993	153723	rs587777626	NC_000016.10:869907:C:T
NM_001289910.1(IDH2):c.262C>G (p.Arg88Gly)	IDH2	R140G, R88G, R10G	D-2-hydroxyglutaric aciduria 2	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000014717	15	90631935	15	90088703	14717	29756	rs267606870	NC_000015.10:90088702:G:C
NM_020529.2(NFKBIA):c.40G>T (p.Glu14Ter)	NFKBIA	E14*	Ectodermal dysplasia and immunodeficiency 2	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000014005	14	35873811	14	35404605	14005	29044	rs121913665	NC_000014.9:35404604:C:A
NM_022773.3(LMF1):c.1317C>G (p.Tyr439Ter)	LMF1	Y439*, Y222*, Y306*, Y330*		Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000000792	16	919982	16	869982	792	15831	rs121909397	NC_000016.10:869981:G:C
NM_020529.2(NFKBIA):c.107C>A (p.Ser36Tyr)	NFKBIA	S36Y	Ectodermal dysplasia and immunodeficiency 2	Pathogenic(Last reviewed: Nov 15, 2018)	no assertion criteria provided	VCV000590308	14	35873744	14	35404538	590308	581249	rs1566591076	NC_000014.9:35404537:G:T
NM_000294.3(PHKG2):c.553C>T (p.Arg185Ter)	PHKG2	R185*	Glycogen storage disease IXc	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000577568	16	30764875	16	30753554	577568	568095	rs1270523244	NC_000016.10:30753553:C:T
NM_000294.3(PHKG2):c.250del (p.Val84fs)	PHKG2	V84fs	Glycogen storage disease IXc	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000566399	16	30762580	16	30751259	566399	570252	rs1567260747	NC_000016.10:30751258:GG:G
NM_000294.3(PHKG2):c.316_317GT[1] (p.Val106_Phe107insTer)	PHKG2		Glycogen storage disease IXc	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000538173	16	30762914 - 30762915	16	30751593 - 30751594	538173	530000	rs1555467052	NC_000016.10:30751592:GTGT:GT
NM_000294.3(PHKG2):c.671_672delinsAA (p.Phe224Ter)	PHKG2		Glycogen storage disease IXc	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000538172	16	30767711 - 30767712	16	30756390 - 30756391	538172	530429	rs1555467557	NC_000016.10:30756389:TC:AA
NM_174916.3(UBR1):c.4107T>A (p.Cys1369Ter)	UBR1	C1369*	Johanson-Blizzard syndrome	Pathogenic(Last reviewed: Sep 30, 2014)	criteria provided, single submitter	VCV000208624	15	43276138	15	42983940	208624	205177	rs797045112	NC_000015.10:42983939:A:T
NM_020529.2(NFKBIA):c.95G>T (p.Ser32Ile)	NFKBIA	S32I	Ectodermal dysplasia and immunodeficiency 2	Pathogenic(Last reviewed: Sep 6, 2004)	no assertion criteria provided	VCV000014003	14	35873756	14	35404550	14003	29042	rs28933100	NC_000014.9:35404549:C:A
NM_000294.3(PHKG2):c.677T>G (p.Leu226Arg)	PHKG2	L225R, L226R	Glycogen storage disease IXc	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000013631	16	30767717	16	30756396	13631	28670	rs137853592	NC_000016.10:30756395:T:G
NM_000294.3(PHKG2):c.433C>T (p.His145Tyr)	PHKG2	H144Y, H145Y	Glycogen storage disease IXc	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000013630	16	30764755	16	30753434	13630	28669	rs137853591	NC_000016.10:30753433:C:T
NM_000294.3(PHKG2):c.317T>A (p.Val106Glu)	PHKG2	V106E	Glycogen storage disease IXc	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000013627	16	30762915	16	30751594	13627	28666	rs137853589	NC_000016.10:30751593:T:A
NM_000294.3(PHKG2):c.566G>A (p.Gly189Glu)	PHKG2	G189E	Glycogen storage disease IXc	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000013626	16	30767512	16	30756191	13626	28665	rs137853588	NC_000016.10:30756190:G:A
NM_174916.3(UBR1):c.2839+5G>A	UBR1		Johanson-Blizzard syndrome	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000004681	15	43314895	15	43022697	4681	19720		NC_000015.10:43022696:C:T
NM_174916.3(UBR1):c.1537C>T (p.Gln513Ter)	UBR1	Q513*	Johanson-Blizzard syndrome	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000004680	15	43340592	15	43048394	4680	19719	rs119477055	NC_000015.10:43048393:G:A
UBR1, IVS20DS, T-C, +2	UBR1		Johanson-Blizzard syndrome	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000004679					4679	19718		
NM_174916.3(UBR1):c.407A>G (p.His136Arg)	UBR1	H136R	Johanson-Blizzard syndrome	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000004678	15	43374846	15	43082648	4678	19717	rs119477054	NC_000015.10:43082647:T:C
NM_018082.6(POLR3B):c.1648C>T (p.Arg550Ter)	POLR3B	R550*, R492*	Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000031162	12	106827517	12	106433739	31162	40119	rs267608688	NC_000012.12:106433738:C:T
NM_020312.4(COQ9):c.730C>T (p.Arg244Ter)	COQ9	R244*	Coenzyme Q10 deficiency, primary, 5	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000000431	16	57493495	16	57459583	431	15470	rs267606751	NC_000016.10:57459582:C:T
NM_000294.3(PHKG2):c.926G>A (p.Arg309Gln)	PHKG2	R309Q	Mauriac syndrome|not provided	Pathogenic(Last reviewed: Jan 19, 2016)	criteria provided, single submitter	VCV000253061	16	30768035	16	30756714	253061	247472	rs572115942	NC_000016.10:30756713:G:A
NM_174916.3(UBR1):c.1440-1G>A	UBR1		Johanson-Blizzard syndrome	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000031918	15	43340690	15	43048492	31918	40574		NC_000015.10:43048491:C:T
NM_000294.3(PHKG2):c.277del (p.Leu93fs)	PHKG2	L93fs	Glycogen storage disease IXc	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000013629	16	30762873	16	30751552	13629	28668		NC_000016.10:30751551:CCC:CC
PHKG2, 1-BP INS	PHKG2		Glycogen storage disease IXc	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000013625					13625	28664		
NM_020529.2(NFKBIA):c.32G>A (p.Trp11Ter)	NFKBIA	W11*	Inherited Immunodeficiency Diseases|Ectodermal dysplasia and immunodeficiency 2	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000014004	14	35873819	14	35404613	14004	29043	rs121913664	NC_000014.9:35404612:C:T
GRCh37/hg19 16q24.2(chr16:87969915-87970056)	CA5A		Carbonic anhydrase VA deficiency, hyperammonemia due to	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000813300	16	87969915 - 87970056			813300	801554		
NM_002465.4(MYBPC1):c.739T>C (p.Tyr247His)	MYBPC1	Y247H, Y196H, Y203H, Y209H, Y210H, Y222H	MYOPATHY, CONGENITAL, WITH TREMOR	Pathogenic(Last reviewed: Aug 22, 2019)	no assertion criteria provided	VCV000689419	12	102036270	12	101642492	689419	677011		NC_000012.12:101642491:T:C
NM_002465.4(MYBPC1):c.952C>T (p.Arg318Ter)	MYBPC1	R318*, R267*, R280*, R281*, R274*, R293*	Lethal congenital contracture syndrome 4	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039766	12	102038561	12	101644783	39766	48365	rs397515422	NC_000012.12:101644782:C:T
NM_002465.4(MYBPC1):c.706T>C (p.Trp236Arg)	MYBPC1	W236R, W185R, W192R, W198R, W199R, W211R	Distal arthrogryposis type 1B	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000029800	12	102036237	12	101642459	29800	38755	rs387906657	NC_000012.12:101642458:T:C
NC_000016.10:g.(?_87904766)_(87904924_?)del	CA5A		Carbonic anhydrase VA deficiency, hyperammonemia due to	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000832389	16	87938372 - 87938530			832389	820900		
NC_000016.9:g.(?_87969895)_(87970076_?)del	CA5A		Carbonic anhydrase VA deficiency, hyperammonemia due to	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000584317	16	87969895 - 87970076	16	87936289 - 87936470	584317	567550		
NM_001739.2(CA5A):c.94C>T (p.Arg32Ter)	CA5A	R32*	Carbonic anhydrase VA deficiency, hyperammonemia due to	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000570252	16	87969963	16	87936357	570252	570611	rs767402215	NC_000016.10:87936356:G:A
NM_000294.3(PHKG2):c.130C>T (p.Arg44Ter)	PHKG2	R44*	not provided|Glycogen storage disease IXc	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000013628	16	30762461	16	30751140	13628	28667	rs137853590	NC_000016.10:30751139:C:T
NM_001739.2(CA5A):c.697T>C (p.Ser233Pro)	CA5A	S233P	Carbonic anhydrase VA deficiency, hyperammonemia due to	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000127087	16	87925482	16	87891876	127087	132597	rs587777316	NC_000016.10:87891875:A:G
NC_000016.10:g.(?_87888109)_(87891974_?)del	CA5A		Carbonic anhydrase VA deficiency, hyperammonemia due to	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000832363	16	87921715 - 87925580			832363	820899		
NM_002465.4(MYBPC1):c.742G>A (p.Glu248Lys)	MYBPC1	E223K, E248K, E211K, E197K, E210K, E204K	MYOPATHY, CONGENITAL, WITH TREMOR|not provided	Pathogenic(Last reviewed: May 6, 2016)	criteria provided, single submitter	VCV000225889	12	102036273	12	101642495	225889	227702	rs564856283	NC_000012.12:101642494:G:A
NM_001739.1(CA5A):c.619-3421_774+502del (p.Asp207_Gln258del)	CA5A		Carbonic anhydrase VA deficiency, hyperammonemia due to	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000127089	16	87924903 - 87928981	16	87891297 - 87895395	127089	132599		
NM_032387.5(WNK4):c.1693C>G (p.Gln565Glu)	WNK4	Q565E, Q229E	Pseudohypoaldosteronism type 2B	Pathogenic(Last reviewed: Feb 16, 2017)	no assertion criteria provided	VCV000007660	17	40939512	17	42787494	7660	22699	rs137853092	NC_000017.11:42787493:C:G
NM_004773.4(ZNHIT3):c.92C>T (p.Ser31Leu)	ZNHIT3	S31L	PEHO syndrome	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000427725	17	34842784	17	36486940	427725	417248	rs148890852	NC_000017.11:36486939:C:T
NM_003701.4(TNFSF11):c.828_829del (p.Val277fs)	TNFSF11	V204fs, V277fs		Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000006975	13	43180928 - 43180929	13	42606792 - 42606793	6975	22014	rs863223288	NC_000013.11:42606791:CG:
NM_003701.4(TNFSF11):c.596T>A (p.Met199Lys)	TNFSF11	M199K, M126K		Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000006974	13	43180696	13	42606560	6974	22013	rs121909072	NC_000013.11:42606559:T:A
TNFSF11, 5-BP DEL, IVS7+4	TNFSF11			Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000006973					6973	22012		
NM_001172696.1(TSFM):c.997C>T	TSFM	R333W, R312W	not provided|Combined oxidative phosphorylation deficiency 3	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000005379	12	58190322	12	57796539	5379	20418	rs121909485	NC_000012.12:57796538:C:T
NM_001319945.2(G6PC3):c.210del (p.Phe71fs)	G6PC3	F71fs	Severe congenital neutropenia 4, autosomal recessive	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000189782	17	42148543	17	44071175	189782	187651	rs769441127	NC_000017.11:44071174:C:
NM_153006.3(NAGS):c.1313del (p.Gly438fs)	NAGS	G438fs	not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801409	17	42084998	17	44007630	801409	789789		NC_000017.11:44007629:GGGGGG:GGGGG
NM_153006.3(NAGS):c.1323C>G (p.Tyr441Ter)	NAGS	Y441*	not provided	Pathogenic(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	VCV000284268	17	42085013	17	44007645	284268	268505	rs886042831	NC_000017.11:44007644:C:G
NM_014254.3(RXYLT1):c.92del (p.Arg31fs)	RXYLT1	R31fs	not provided	Pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	VCV000265345	12	64173832	12	63780052	265345	260033	rs886039490	NC_000012.12:63780051:G:
NM_014254.3(RXYLT1):c.649del (p.Arg217fs)	RXYLT1	R217fs	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000583374	12	64196088	12	63802308	583374	568164	rs948674144	NC_000012.12:63802307:AAAA:AAA
NM_014254.3(RXYLT1):c.139del (p.Ala47fs)	RXYLT1	A47fs	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10	Pathogenic(Last reviewed: Apr 26, 2013)	no assertion criteria provided	VCV000050607	12	64173875	12	63780095	50607	59641	rs397514696	NC_000012.12:63780094:GGGGG:GGGG
NM_014254.3(RXYLT1):c.1018C>T (p.Arg340Ter)	RXYLT1	R340*, R80*	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10	Pathogenic(Last reviewed: Apr 26, 2013)	no assertion criteria provided	VCV000050606	12	64202558	12	63808778	50606	59640	rs397514695	NC_000012.12:63808777:C:T
NM_014254.3(RXYLT1):c.279del (p.Gly94fs)	RXYLT1	G94fs	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039607	12	64174906	12	63781126	39607	48206	rs397514546	NC_000012.12:63781125:AAA:AA
NM_014254.3(RXYLT1):c.795del (p.Arg266fs)	RXYLT1	R266fs, R6fs	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039603	12	64199065	12	63805285	39603	48202	rs397514543	NC_000012.12:63805284:G:
NM_198217.2(ING1):c.443C>A (p.Ala148Asp)	ING1	A192D, A148D, A335D, A175D, A123D	Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: Jun 15, 2000)	no assertion criteria provided	VCV000008069	13	111372014	13	110719667	8069	23108	rs121909252	NC_000013.11:110719666:C:A
NM_198217.2(ING1):c.515A>G (p.Asn172Ser)	ING1	N216S, N172S, N147S, N199S, N359S	Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: Jun 15, 2000)	no assertion criteria provided	VCV000008068	13	111372086	13	110719739	8068	23107	rs121909251	NC_000013.11:110719738:A:G
NM_198217.2(ING1):c.512G>C (p.Cys171Ser)	ING1	C215S, C171S, C358S, C146S, C198S	Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: Jun 15, 2000)	no assertion criteria provided	VCV000008067	13	111372083	13	110719736	8067	23106	rs121909250	NC_000013.11:110719735:G:C
NM_014254.3(RXYLT1):c.997G>A (p.Gly333Arg)	RXYLT1	G333R, G73R	not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000854859	12	64202537	12	63808757	854859	840204		NC_000012.12:63808756:G:A
NM_153006.3(NAGS):c.34del (p.Ala12fs)	NAGS	A12fs	Hyperammonemia, type III	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000851292	17	42082063	17	44004695	851292	845482		NC_000017.11:44004694:GGG:GG
NM_153006.3(NAGS):c.570G>A (p.Trp190Ter)	NAGS	W190*	Hyperammonemia, type III	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000529424	17	42083148	17	44005780	529424	531138	rs755257734	NC_000017.11:44005779:G:A
NM_153006.3(NAGS):c.1307dup (p.Thr439fs)	NAGS		Hyperammonemia, type III	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002430	17	42084996 - 42084997	17	44007628 - 44007629	2430	17469	rs730880303	NC_000017.11:44007628:T:TT
NM_153006.3(NAGS):c.916-2A>T	NAGS		Hyperammonemia, type III	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002429	17	42083895	17	44006527	2429	17468	rs730880267	NC_000017.11:44006526:A:T
NM_014254.3(RXYLT1):c.641del (p.Phe214fs)	RXYLT1	F214fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000597876	12	64196082	12	63802302	597876	588937	rs1354951198	NC_000012.12:63802301:TT:T
NM_153006.3(NAGS):c.1299G>C (p.Glu433Asp)	NAGS	E433D	Hyperammonemia, type III	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000002434	17	42084989	17	44007621	2434	17473	rs104894607	NC_000017.11:44007620:G:C
NM_153006.3(NAGS):c.1450T>C (p.Trp484Arg)	NAGS	W484R	Hyperammonemia, type III	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000002433	17	42085140	17	44007772	2433	17472	rs104894606	NC_000017.11:44007771:T:C
NM_153006.3(NAGS):c.1289T>C (p.Leu430Pro)	NAGS	L430P	Hyperammonemia, type III	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000002432	17	42084979	17	44007611	2432	17471	rs104894605	NC_000017.11:44007610:T:C
NM_153006.3(NAGS):c.971G>A (p.Trp324Ter)	NAGS	W324*	Hyperammonemia, type III	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002428	17	42083952	17	44006584	2428	17467	rs104894604	NC_000017.11:44006583:G:A
NM_002465.4(MYBPC1):c.788T>G (p.Leu263Arg)	MYBPC1	L263R, L219R, L225R, L226R, L212R, L238R	MYOPATHY, CONGENITAL, WITH TREMOR|not provided|MYBPC1-related condition	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000635215	12	102036319	12	101642541	635215	623048	rs1565943228	NC_000012.12:101642540:T:G
NM_014254.3(RXYLT1):c.123_150del (p.Leu43fs)	RXYLT1	L43fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000452154	12	64173856 - 64173883	12	63780076 - 63780103	452154	445075	rs748590408	NC_000012.12:63780075:CCCCGCGGGGCCTCAGGAAGGGGGCGGCCCCCGCG:CCCCGCG
NM_153006.3(NAGS):c.835G>A (p.Ala279Thr)	NAGS	A279T	Hyperammonemia, type III	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000002431	17	42083525	17	44006157	2431	17470	rs121912591	NC_000017.11:44006156:G:A
NM_153006.3(NAGS):c.1025del (p.Arg342fs)	NAGS	R342fs	Hyperammonemia, type III	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000002427	17	42084006	17	44006638	2427	17466	rs730880266	NC_000017.11:44006637:G:
NM_001289910.1(IDH2):c.360G>C (p.Arg120Ser)	IDH2	R120S, R172S, R42S	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375985	15	90631837	15	90088605	375985	362864	rs1057519736	NC_000015.10:90088604:C:G
NM_012448.4(STAT5B):c.1102del (p.Gln368fs)	STAT5B	Q368fs	Laron syndrome with immunodeficiency	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000840661	17	40370236	17	42218218	840661	845329		NC_000017.11:42218217:GGGGGGGG:GGGGGGG
NM_012448.3(STAT5B):c.530A>C (p.Gln177Pro)	STAT5B	Q177P	Laron syndrome with immunodeficiency	Pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	VCV000522611	17	40375420	17	42223402	522611	513224	rs1555549674	NC_000017.11:42223401:T:G
NM_012448.3(STAT5B):c.1433C>T (p.Ala478Val)	STAT5B	A478V	Laron syndrome with immunodeficiency	Pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	VCV000517661	17	40368072	17	42216054	517661	508752	rs1555548678	NC_000017.11:42216053:G:A
NM_012448.3(STAT5B):c.1421A>G (p.Gln474Arg)	STAT5B	Q474R	Laron syndrome with immunodeficiency	Pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	VCV000492931	17	40368084	17	42216066	492931	485862	rs1555548680	NC_000017.11:42216065:T:C
STAT5B, 1-BP DEL, EXON 13/INTRON 13 JUNCTION	STAT5B		Laron syndrome with immunodeficiency	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000005698					5698	20737		
NM_012448.3(STAT5B):c.454C>T (p.Arg152Ter)	STAT5B	R152*	Laron syndrome with immunodeficiency	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000005697	17	40375496	17	42223478	5697	20736	rs121908502	NC_000017.11:42223477:G:A
STAT5B, 1-BP INS, 1191G	STAT5B		Laron syndrome with immunodeficiency	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000005695					5695	20734		
NM_012448.3(STAT5B):c.1888G>C (p.Ala630Pro)	STAT5B	A630P	Laron syndrome with immunodeficiency	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000005694	17	40362207	17	42210189	5694	20733	rs121908501	NC_000017.11:42210188:C:G
NM_012448.3(STAT5B):c.1102dup (p.Gln368fs)	STAT5B		Laron syndrome with immunodeficiency	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000579749	17	40370235 - 40370236	17	42218217 - 42218218	579749	571115	rs761761205	NC_000017.11:42218217:GGGGGGGG:GGGGGGGGG
NM_152269.5(C12orf65):c.210del (p.Gly72fs)	C12orf65	G72fs	not provided|Combined oxidative phosphorylation deficiency 7	Pathogenic/Likely pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000054	12	123738431	12	123253884	54	15093	rs576462794	NC_000012.12:123253883:A:
NM_001039.4(SCNN1G):c.146_149dup (p.Leu51fs)	SCNN1G		not provided	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000280615	16	23197735 - 23197736	16	23186414 - 23186415	280615	264937	rs886041786	NC_000016.10:23186414:CGGCCG:CGGCCGGCCG
NM_001012759.3(CTU2):c.282+5G>A	CTU2		MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME	Pathogenic	no assertion criteria provided	VCV000637954	16	88776695	16	88710287	637954	625775		NC_000016.10:88710286:G:A
NM_001012759.3(CTU2):c.1514_1517del (p.Ile505fs)	CTU2	I505fs, D485fs, I418fs, I576fs	MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME	Pathogenic	no assertion criteria provided	VCV000635411	16	88781622 - 88781625	16	88715214 - 88715217	635411	623375		NC_000016.10:88715213:TGATTGA:TGA
NM_001012759.3(CTU2):c.188T>C (p.Leu63Pro)	CTU2	L63P	MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME	Pathogenic	no assertion criteria provided	VCV000635410	16	88776390	16	88709982	635410	623374		NC_000016.10:88709981:T:C
NM_001012759.3(CTU2):c.1206dup (p.Ala403fs)	CTU2		MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME	Pathogenic	no assertion criteria provided	VCV000635409	16	88780998 - 88780999	16	88714590 - 88714591	635409	623373		NC_000016.10:88714590:T:TT
NM_001039.4(SCNN1G):c.1749_1753del (p.Glu583fs)	SCNN1G	E583fs	LIDDLE SYNDROME 2	Pathogenic(Last reviewed: Sep 27, 2018)	no assertion criteria provided	VCV000565277	16	23226589 - 23226593	16	23215268 - 23215272	565277	556461	rs1567270184	NC_000016.10:23215267:AGCTC:
SCNN1G, ASN530SER	SCNN1G	N530S	LIDDLE SYNDROME 2	Pathogenic(Last reviewed: Sep 27, 2018)	no assertion criteria provided	VCV000565276					565276	556460		
SCNN1G, GLN567TER	SCNN1G	Q567*	LIDDLE SYNDROME 2	Pathogenic(Last reviewed: Sep 12, 2018)	no assertion criteria provided	VCV000561163					561163	552269		
NM_001039.4(SCNN1G):c.1627del (p.Val543fs)	SCNN1G	V543fs		Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000008827	16	23226467	16	23215146	8827	23866		NC_000016.10:23215145:G:
NM_001039.4(SCNN1G):c.318-1G>A	SCNN1G			Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000008826	16	23200691	16	23189370	8826	23865	rs1567262640	NC_000016.10:23189369:G:A
NM_001039.4(SCNN1G):c.1570-1G>A	SCNN1G			Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000008825	16	23226409	16	23215088	8825	23864		NC_000016.10:23215087:G:A
NM_001039.4(SCNN1G):c.1718G>A (p.Trp573Ter)	SCNN1G	W574*, W573*	LIDDLE SYNDROME 2	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000008824	16	23226558	16	23215237	8824	23863	rs137853342	NC_000016.10:23215236:G:A
NM_001012759.3(CTU2):c.873G>A (p.Thr291=)	CTU2	T247T	MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME	Pathogenic(Last reviewed: Oct 5, 2018)	no assertion criteria provided	VCV000585016	16	88779855	16	88713447	585016	576071	rs769481947	NC_000016.10:88713446:G:A
NM_014365.2(HSPB8):c.422A>T (p.Lys141Met)	HSPB8	K141M	Charcot-Marie-Tooth disease, type 2L	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000560412	12	119624884	12	119187079	560412	551465	rs1565929090	NC_000012.12:119187078:A:T
NM_032229.3(SLITRK6):c.541C>T (p.Arg181Ter)	SLITRK6	R181*	Deafness and myopia	Pathogenic(Last reviewed: Nov 24, 2014)	no assertion criteria provided	VCV000088862	13	86370103	13	85795968	88862	94431	rs587777071	NC_000013.11:85795967:G:A
NM_032229.3(SLITRK6):c.890C>A (p.Ser297Ter)	SLITRK6	S297*	Deafness and myopia	Pathogenic(Last reviewed: Nov 24, 2014)	no assertion criteria provided	VCV000088861	13	86369754	13	85795619	88861	94430	rs587777070	NC_000013.11:85795618:G:T
NM_015665.6(AAAS):c.1331+1G>A	AAAS		Glucocorticoid deficiency with achalasia|not provided	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000264994	12	53701835	12	53308051	264994	260025	rs150511103	NC_000012.12:53308050:C:T
NM_032229.3(SLITRK6):c.1240C>T (p.Gln414Ter)	SLITRK6	Q414*	Deafness and myopia	Pathogenic(Last reviewed: Nov 24, 2014)	no assertion criteria provided	VCV000088860	13	86369404	13	85795269	88860	94429	rs587777069	NC_000013.11:85795268:G:A
NM_001242883.1(NAXD):c.57-5216_57-5213del	NAXD	A20fs, A38fs	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	Pathogenic(Last reviewed: Feb 12, 2019)	no assertion criteria provided	VCV000617759	13	111274567 - 111274570	13	110622220 - 110622223	617759	609157	rs773887880	NC_000013.11:110622219:AGAAAGA:AGA
NM_001242883.1(NAXD):c.57-5083G>A	NAXD	G63S, G81S	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	Pathogenic(Last reviewed: Feb 12, 2019)	no assertion criteria provided	VCV000617758	13	111274703	13	110622356	617758	609156	rs1566614549	NC_000013.11:110622355:G:A
NM_001242882.1(NAXD):c.948_949insTT (p.Ala317fs)	NAXD		Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	Pathogenic(Last reviewed: Feb 12, 2019)	no assertion criteria provided	VCV000617757	13	111290833 - 111290834	13	110638486 - 110638487	617757	609155	rs778824382	NC_000013.11:110638486::TT
NM_001242882.1(NAXD):c.839+1G>T	NAXD		Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	Pathogenic(Last reviewed: Feb 12, 2019)	no assertion criteria provided	VCV000617756	13	111289597	13	110637250	617756	609154	rs1566623786	NC_000013.11:110637249:G:T
NM_001242882.1(NAXD):c.922C>T (p.Arg308Cys)	NAXD	R308C, R326C, R216C, S371L	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	Pathogenic(Last reviewed: Feb 12, 2019)	no assertion criteria provided	VCV000617755	13	111290807	13	110638460	617755	609153	rs767778853	NC_000013.11:110638459:C:T
NM_000934.3(SERPINF2):c.1231G>A (p.Val411Met)	SERPINF2	V384M, V347M, V411M	Alpha-2-plasmin inhibitor deficiency	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000000276	17	1657583	17	1754289	276	15315	rs121965062	NC_000017.11:1754288:G:A
NM_000934.3(SERPINF2):c.561_565del (p.Lys189fs)	SERPINF2	K125fs, K189fs	Abnormal bleeding	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000626930	17	1650652 - 1650656	17	1747358 - 1747362	626930	615565		NC_000017.11:1747357:GGCAA:
NM_000934.3(SERPINF2):c.525_527AGA[1] (p.Glu176del)	SERPINF2	E137del, E112del, E176del	Alpha-2-plasmin inhibitor deficiency	Pathogenic(Last reviewed: Oct 25, 1989)	no assertion criteria provided	VCV000000275	17	1650615 - 1650617	17	1747321 - 1747323	275	15314	rs121965061	NC_000017.11:1747320:AAGAAGA:AAGA
SERPINF2, 1-BP INS, 1438C	SERPINF2		Alpha-2-plasmin inhibitor deficiency	Pathogenic(Last reviewed: May 1, 1989)	no assertion criteria provided	VCV000000274					274	15313		
NM_014365.2(HSPB8):c.421A>G (p.Lys141Glu)	HSPB8	K141E	Charcot-Marie-Tooth disease|Distal hereditary motor neuronopathy type 2A	Pathogenic(Last reviewed: Apr 30, 2015)	no assertion criteria provided	VCV000002618	12	119624883	12	119187078	2618	17657	rs104894351	NC_000012.12:119187077:A:G
NM_022067.4(VIPAS39):c.1184G>A (p.Trp395Ter)	VIPAS39	W395*, W346*	Arthrogryposis, renal dysfunction, and cholestasis 2	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522399	14	77896106	14	77429763	522399	513104	rs1555364979	NC_000014.9:77429762:C:T
NM_001082538.3(TCTN1):c.1454G>A (p.Trp485Ter)	TCTN1	W429*, W471*, W485*, W307*, W436*, W376*	Joubert syndrome 13	Pathogenic(Last reviewed: Apr 11, 2019)	no assertion criteria provided	VCV000829835	12	111082894	12	110645089	829835	818295		NC_000012.12:110645088:G:A
NM_002768.5(CHMP1A):c.28-13G>A	CHMP1A		Pontocerebellar hypoplasia type 8	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039838	16	89718067	16	89651659	39838	48437	rs398122918	NC_000016.10:89651658:C:T
NM_001361.5(DHODH):c.595C>T (p.Arg199Cys)	DHODH	R199C	Miller syndrome	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000016808	16	72055100	16	72021201	16808	31847	rs267606769	NC_000016.10:72021200:C:T
NM_001361.5(DHODH):c.611del (p.Leu204fs)	DHODH	L204fs	Miller syndrome	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000016807	16	72055116	16	72021217	16807	31846		NC_000016.10:72021216:T:
NM_001361.5(DHODH):c.730C>T (p.Arg244Trp)	DHODH	R244W	Miller syndrome	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000016806	16	72056285	16	72022386	16806	31845	rs267606768	NC_000016.10:72022385:C:T
NM_001361.5(DHODH):c.605G>A (p.Gly202Asp)	DHODH	G202D	Miller syndrome	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000016805	16	72055110	16	72021211	16805	31844	rs267606767	NC_000016.10:72021210:G:A
NM_001361.5(DHODH):c.605G>C (p.Gly202Ala)	DHODH	G202A	Miller syndrome	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000016804	16	72055110	16	72021211	16804	31843	rs267606767	NC_000016.10:72021210:G:C
NM_001361.5(DHODH):c.1036C>T (p.Arg346Trp)	DHODH	R346W	Miller syndrome	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000016800	16	72057435	16	72023536	16800	31839	rs201947120	NC_000016.10:72023535:C:T
NM_022067.4(VIPAS39):c.2T>G (p.Met1Arg)	VIPAS39	M1R	Arthrogryposis, renal dysfunction, and cholestasis 2	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000000115	14	77920444	14	77454101	115	15154	rs267607172	NC_000014.9:77454100:A:C
NM_022067.4(VIPAS39):c.871C>T (p.Gln291Ter)	VIPAS39	Q291*, Q242*	Arthrogryposis, renal dysfunction, and cholestasis 2	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000000114	14	77902228	14	77435885	114	15153	rs267607171	NC_000014.9:77435884:G:A
NM_022067.4(VIPAS39):c.658C>T (p.Arg220Ter)	VIPAS39	R220*, R171*	Arthrogryposis, renal dysfunction, and cholestasis 2	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000000113	14	77908979	14	77442636	113	15152	rs200370925	NC_000014.9:77442635:G:A
NM_022067.4(VIPAS39):c.749_753del (p.Thr250fs)	VIPAS39	T201fs, T250fs	Arthrogryposis, renal dysfunction, and cholestasis 2	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000000112	14	77907418 - 77907422	14	77441075 - 77441079	112	15151	rs794726653	NC_000014.9:77441074:TTCTGTTCT:TTCT
NM_022067.4(VIPAS39):c.535C>T (p.Gln179Ter)	VIPAS39	Q179*, Q130*	Arthrogryposis, renal dysfunction, and cholestasis 2	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000000111	14	77910654	14	77444311	111	15150	rs267607173	NC_000014.9:77444310:G:A
NM_022067.4(VIPAS39):c.1179+1G>A	VIPAS39		Arthrogryposis, renal dysfunction, and cholestasis 1	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635327	14	77900184	14	77433841	635327	623179		NC_000014.9:77433840:C:T
NM_022067.4(VIPAS39):c.20del (p.Asp7fs)	VIPAS39	D7fs	Arthrogryposis, renal dysfunction, and cholestasis 1	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635326	14	77920426	14	77454083	635326	623160		NC_000014.9:77454082:T:
NM_002768.5(CHMP1A):c.346G>A (p.Glu116Lys)	CHMP1A	E116K, R109Q	Pontocerebellar hypoplasia type 1A	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522948	16	89713646	16	89647238	522948	513639	rs1064794609	NC_000016.10:89647237:C:T
NM_001082538.3(TCTN1):c.898C>T (p.Arg300Ter)	TCTN1	R300*, R286*, R122*, R240*, R244*	Joubert syndrome 13	Pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	VCV000221983	12	111078242	12	110640437	221983	223671	rs751962801	NC_000012.12:110640436:C:T
NM_001082538.3(TCTN1):c.843+1del	TCTN1		Joubert syndrome 13	Pathogenic(Last reviewed: Feb 19, 2014)	criteria provided, single submitter	VCV000212386	12	111074306	12	110636501	212386	207936	rs797046039	NC_000012.12:110636500:GG:G
NM_001082538.3(TCTN1):c.436dup (p.Ile146fs)	TCTN1		Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000862398	12	111064260 - 111064261	12	110626455 - 110626456	862398	839311		NC_000012.12:110626455:A:AA
NM_001082538.3(TCTN1):c.902_929dup (p.Leu311_Val312insGlyGlyHisTer)	TCTN1		Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000834702	12	111078240 - 111078241	12	110640435 - 110640436	834702	839313		NC_000012.12:110640435:CCGACGGGAGGACACTGATGTGCTGCAGCCGAC:CCGACGGGAGGACACTGATGTGCTGCAGCCGACGGGAGGACACTGATGTGCTGCAGCCGAC
NC_000012.12:g.(?_110626342)_(110642409_?)del	TCTN1		Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000833489	12	111064147 - 111080214			833489	820443		
NM_014365.2(HSPB8):c.423G>C (p.Lys141Asn)	HSPB8	K141N	Charcot-Marie-Tooth disease|Distal hereditary motor neuronopathy type 2A	Pathogenic(Last reviewed: Apr 30, 2015)	no assertion criteria provided	VCV000002617	12	119624885	12	119187080	2617	17656	rs104894345	NC_000012.12:119187079:G:C
NM_001082538.3(TCTN1):c.843+1G>C	TCTN1		Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000834796	12	111074307	12	110636502	834796	852654		NC_000012.12:110636501:G:C
NM_001082538.3(TCTN1):c.221-2A>G	TCTN1		Joubert syndrome 13	Pathogenic(Last reviewed: Mar 29, 2012)	no assertion criteria provided	VCV000030803	12	111057639	12	110619834	30803	39760	rs367543065	NC_000012.12:110619833:A:G
NM_032382.4(COG8):c.1687_1688del (p.Phe563fs)	COG8	F563fs	Congenital disorder of glycosylation type 2H	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000003649	16	69364893 - 69364894	16	69330990 - 69330991	3649	18688	rs766244312	NC_000016.10:69330989:AAAA:AA
COG8, IVS3DS, G-A, +3	COG8		Congenital disorder of glycosylation type 2H	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000003648					3648	18687		
NM_032382.4(COG8):c.1611C>G (p.Tyr537Ter)	COG8	Y537*	Congenital disorder of glycosylation type 2H	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000003647	16	69364970	16	69331067	3647	18686	rs121434387	NC_000016.10:69331066:G:C
NM_002768.5(CHMP1A):c.88C>T (p.Gln30Ter)	CHMP1A	Q30*, A23V	not provided|Pontocerebellar hypoplasia type 8	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039837	16	89717994	16	89651586	39837	48436	rs397515426	NC_000016.10:89651585:G:A
NM_152269.5(C12orf65):c.248del (p.Val83fs)	C12orf65	V83fs	Combined oxidative phosphorylation deficiency 7|Spastic paraplegia 55, autosomal recessive|Epileptic encephalopathy|Abnormality of brain morphology	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000000053	12	123738469	12	123253922	53	15092	rs587776508	NC_000012.12:123253921:T:
NM_001082538.3(TCTN1):c.342-2A>G	TCTN1		Typical Joubert syndrome MRI findings|Global developmental delay|Joubert syndrome 13	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000183312	12	111064165	12	110626360	183312	181433	rs730882221	NC_000012.12:110626359:A:G
NM_004727.3(SLC24A1):c.2968A>C (p.Ser990Arg)	SLC24A1	S990R, S317R, S960R, S972R	Congenital stationary night blindness, type 1D	Pathogenic(Last reviewed: Feb 13, 2018)	no assertion criteria provided	VCV000489400	15	65945064	15	65652726	489400	482301	rs1555407654	NC_000015.10:65652725:A:C
NM_004727.3(SLC24A1):c.3291_3294del (p.Val1099fs)	SLC24A1	V1069fs, V1099fs, V1081fs, V426fs	Congenital stationary night blindness, type 1D	Pathogenic(Last reviewed: Feb 12, 2018)	no assertion criteria provided	VCV000489399	15	65946407 - 65946410	15	65654069 - 65654072	489399	482300	rs766780281	NC_000015.10:65654068:TATCT:T
NM_004727.3(SLC24A1):c.1691_1693del (p.Phe564del)	SLC24A1	F564del	Congenital stationary night blindness, type 1D	Pathogenic(Last reviewed: Feb 12, 2018)	no assertion criteria provided	VCV000489398	15	65918107 - 65918109	15	65625769 - 65625771	489398	482299	rs1555403793	NC_000015.10:65625768:CTTCT:CT
NM_004727.3(SLC24A1):c.2401G>T (p.Glu801Ter)	SLC24A1	E801*, E128*, E783*	Congenital stationary night blindness, type 1D	Pathogenic(Last reviewed: Feb 9, 2018)	no assertion criteria provided	VCV000489397	15	65942888	15	65650550	489397	482298	rs1410075831	NC_000015.10:65650549:G:T
SLC24A1, 2-BP DEL, EXON 2	SLC24A1		Congenital stationary night blindness, type 1D	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000030373					30373	39330		
NM_004727.3(SLC24A1):c.95T>A (p.Leu32Ter)	SLC24A1	L32*	Retinitis pigmentosa	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560509	15	65916513	15	65624175	560509	551578	rs1566945534	NC_000015.10:65624174:T:A
NM_001080442.3(SLC38A8):c.445C>T (p.Gln149Ter)	SLC38A8	Q149*	not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000817539	16	84067018	16	84033413	817539	805895		NC_000016.10:84033412:G:A
NM_001080442.3(SLC38A8):c.837del (p.Val280fs)	SLC38A8	V280fs	not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000817244	16	84050861	16	84017256	817244	805894		NC_000016.10:84017255:TT:T
NM_194318.4(B3GLCT):c.1067_1082del (p.Ile356fs)	B3GLCT	I356fs	not provided	Pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, single submitter	VCV000194286	13	31891704 - 31891719	13	31317567 - 31317582	194286	191449	rs794727108	NC_000013.11:31317566:ATCTCCAGGCTCCAGCA:A
NM_194318.4(B3GLCT):c.1065-1G>A	B3GLCT		not provided	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	VCV000194287	13	31891702	13	31317565	194287	191450	rs371904655	NC_000013.11:31317564:G:A
NM_001080442.2(SLC38A8):c.842_844CTG[1] (p.Ala282del)	SLC38A8	A282del	Foveal hypoplasia 2 and optic nerve misrouting with or without anterior segment dysgenesis	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000125448	16	84050851 - 84050853	16	84017246 - 84017248	125448	130986	rs587777257	NC_000016.10:84017245:CAGCAG:CAG
NM_001080442.2(SLC38A8):c.598C>T (p.Gln200Ter)	SLC38A8	Q200*	Foveal hypoplasia 2 and optic nerve misrouting with or without anterior segment dysgenesis	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000125447	16	84065506	16	84031901	125447	130985	rs149592537	NC_000016.10:84031900:G:A
NM_194318.4(B3GLCT):c.1098T>A (p.Tyr366Ter)	B3GLCT	Y366*	Peters plus syndrome	Pathogenic(Last reviewed: Feb 17, 2011)	no assertion criteria provided	VCV000021865	13	31891736	13	31317599	21865	34717	rs80338852	NC_000013.11:31317598:T:A
NM_001080442.2(SLC38A8):c.490_491del (p.Leu164fs)	SLC38A8	L164fs	Foveal hypoplasia|Foveal hypoplasia 2	Pathogenic	criteria provided, single submitter	VCV000691946	16	84066972 - 84066973	16	84033367 - 84033368	691946	679693		NC_000016.10:84033366:AG:
NM_001080442.2(SLC38A8):c.697G>A (p.Glu233Lys)	SLC38A8	E233K	Foveal hypoplasia 2	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000125446	16	84056488	16	84022883	125446	130984	rs372929441	NC_000016.10:84022882:C:T
NM_001080442.2(SLC38A8):c.1234G>A (p.Gly412Arg)	SLC38A8	G412R	FOVEAL HYPOPLASIA 2 WITH OPTIC NERVE MISROUTING	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000125445	16	84043463	16	84009858	125445	130983	rs587777256	NC_000016.10:84009857:C:T
NM_001080442.2(SLC38A8):c.1002del (p.Ser336fs)	SLC38A8	S336fs	FOVEAL HYPOPLASIA 2 WITH OPTIC NERVE MISROUTING AND ANTERIOR SEGMENT DYSGENESIS	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000125444	16	84050284	16	84016679	125444	130982	rs587777255	NC_000016.10:84016678:CCCCC:CCCC
NM_001080442.2(SLC38A8):c.707T>A (p.Val236Asp)	SLC38A8	V236D	FOVEAL HYPOPLASIA 2 WITH OPTIC NERVE MISROUTING AND ANTERIOR SEGMENT DYSGENESIS	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000125443	16	84056478	16	84022873	125443	130981	rs587777254	NC_000016.10:84022872:A:T
NM_194318.4(B3GLCT):c.1178G>A (p.Gly393Glu)	B3GLCT	G393E	Peters plus syndrome	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000001268	13	31891816	13	31317679	1268	16307	rs267606675	NC_000013.11:31317678:G:A
NM_194318.4(B3GLCT):c.230dup (p.Leu77fs)	B3GLCT		Peters plus syndrome	Pathogenic(Last reviewed: Oct 15, 2008)	no assertion criteria provided	VCV000001267	13	31803389 - 31803390	13	31229252 - 31229253	1267	16306		NC_000013.11:31229252:TT:TTT
NM_001080442.2(SLC38A8):c.95T>G (p.Ile32Ser)	SLC38A8	I32S	Foveal hypoplasia|Foveal hypoplasia 2	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000125442	16	84075668	16	84042063	125442	130980	rs587777253	NC_000016.10:84042062:A:C
NM_194318.4(B3GLCT):c.347+5G>A	B3GLCT		Peters plus syndrome	Pathogenic(Last reviewed: Feb 17, 2011)	no assertion criteria provided	VCV000001265	13	31821241	13	31247104	1265	16304	rs80338850	NC_000013.11:31247103:G:A
NM_194318.4(B3GLCT):c.459+1G>A	B3GLCT		Peters plus syndrome|not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000449340	13	31822104	13	31247967	449340	445137	rs767361165	NC_000013.11:31247966:G:A
NM_152641.4(ARID2):c.4316_4317CA[1] (p.Gln1440fs)	ARID2		not provided	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000818059	12	46246221 - 46246222	12	45852438 - 45852439	818059	805736		NC_000012.12:45852437:ACACA:ACA
NM_001145358.2(SIN3A):c.763del (p.Gln255fs)	SIN3A	Q255fs	not provided	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000817978	15	75704078	15	75411737	817978	805841		NC_000015.10:75411736:GGG:GG
NM_152641.4(ARID2):c.4017_4018del (p.Asn1340fs)	ARID2	N1340fs	not provided	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000817958	12	46245922 - 46245923	12	45852139 - 45852140	817958	805735		NC_000012.12:45852138:AGA:A
NM_001372076.1(PAX9):c.543dup (p.Ile182fs)	PAX9		not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000817799	14	37132638 - 37132639	14	36663433 - 36663434	817799	805797		NC_000014.9:36663433:CC:CCC
NM_152641.4(ARID2):c.2114del (p.Ser705fs)	ARID2	S705fs	COFFIN-SIRIS SYNDROME 6	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000807541	12	46244020	12	45850237	807541	798654		NC_000012.12:45850236:G:
NM_152641.4(ARID2):c.5346T>G (p.Tyr1782Ter)	ARID2	Y1782*	COFFIN-SIRIS SYNDROME 6	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802839	12	46287487	12	45893704	802839	791235		NC_000012.12:45893703:T:G
GRCh37/hg19 12q12(chr12:46079151-46258348)x1	ARID2		not provided	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000684972	12	46079151 - 46258348			684972	672564		
NM_152641.4(ARID2):c.5260C>T (p.Arg1754Ter)	ARID2	R1754*	not provided	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000620566	12	46287315	12	45893532	620566	611766	rs1565642121	NC_000012.12:45893531:C:T
NM_152641.4(ARID2):c.2521C>T (p.Gln841Ter)	ARID2	Q841*	COFFIN-SIRIS SYNDROME 6	Pathogenic(Last reviewed: May 9, 2018)	no assertion criteria provided	VCV000545705	12	46244427	12	45850644	545705	536197	rs1555154946	NC_000012.12:45850643:C:T
NM_152641.4(ARID2):c.905dup (p.Asn302fs)	ARID2		not provided	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000504247	12	46230654 - 46230655	12	45836871 - 45836872	504247	495528	rs1555152246	NC_000012.12:45836871:AA:AAA
NM_152641.4(ARID2):c.415del (p.Ser139fs)	ARID2	S139fs	not provided	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000504143	12	46205331	12	45811548	504143	495735	rs1555148625	NC_000012.12:45811547:T:
NM_001145358.2(SIN3A):c.1675C>T (p.Arg559Ter)	SIN3A	R559*	not provided	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000489302	15	75693133	15	75400792	489302	482078	rs1555444879	NC_000015.10:75400791:G:A
NM_001145358.2(SIN3A):c.2675G>A (p.Trp892Ter)	SIN3A	W892*	not provided	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000489258	15	75684759	15	75392418	489258	482076	rs1555443627	NC_000015.10:75392417:C:T
NM_001145358.2(SIN3A):c.2844_2847del (p.Lys948fs)	SIN3A	K948fs	not provided	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000450996	15	75684587 - 75684590	15	75392246 - 75392249	450996	445424	rs1555443581	NC_000015.10:75392245:TTCTTT:TT
NM_001145358.2(SIN3A):c.2809_2810del (p.Lys937fs)	SIN3A	K937fs	not provided	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000450723	15	75684624 - 75684625	15	75392283 - 75392284	450723	445425	rs1555443600	NC_000015.10:75392282:TT:
NM_001145358.2(SIN3A):c.3400del (p.Arg1134fs)	SIN3A	R1134fs	not provided	Pathogenic(Last reviewed: May 29, 2017)	criteria provided, single submitter	VCV000432491	15	75668197	15	75375856	432491	426121	rs1555441161	NC_000015.10:75375855:GG:G
NM_152641.4(ARID2):c.2758C>T (p.Gln920Ter)	ARID2	Q920*	not provided	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000432360	12	46244664	12	45850881	432360	425975	rs1555155026	NC_000012.12:45850880:C:T
NM_006194.3(PAX9):c.3G>A (p.Met1Ile)	PAX9	M1I	Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Jun 24, 2017)	no assertion criteria provided	VCV000430692	14	37131297	14	36662092	430692	424223	rs1131692057	NC_000014.9:36662091:G:A
NM_001145358.2(SIN3A):c.2689C>T (p.Arg897Ter)	SIN3A	R897*	not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000424338	15	75684745	15	75392404	424338	409348	rs1064796919	NC_000015.10:75392403:G:A
NM_006194.3(PAX9):c.114_117dup (p.Cys40fs)	PAX9		not provided	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000418946	14	37132207 - 37132208	14	36663002 - 36663003	418946	409122	rs1555316699	NC_000014.9:36663002:CCGACCG:CCGACCGACCG
NM_152641.4(ARID2):c.2872C>T (p.Gln958Ter)	ARID2	Q958*	not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000392199	12	46244778	12	45850995	392199	375131	rs1057524391	NC_000012.12:45850994:C:T
NM_006194.3(PAX9):c.325_331dup (p.Val111fs)	PAX9		not provided	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, single submitter	VCV000373036	14	37132417 - 37132418	14	36663212 - 36663213	373036	360100	rs1057518159	NC_000014.9:36663212:GGCGGACGGCG:GGCGGACGGCGGACGGCG
NM_152641.4(ARID2):c.1338_1341del (p.Leu446fs)	ARID2	L446fs	not provided	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000280731	12	46233119 - 46233122	12	45839336 - 45839339	280731	264614	rs886041882	NC_000012.12:45839335:AGTG:
NM_000126.4(ETFA):c.625C>T (p.Arg209Ter)	ETFA	R209*, R160*	not provided	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000265123	15	76578017	15	76285676	265123	260080	rs199763682	NC_000015.10:76285675:G:A
NM_152641.4(ARID2):c.1708del (p.Cys570fs)	ARID2	C570fs	not provided	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000252984	12	46242746	12	45848963	252984	247387	rs879255529	NC_000012.12:45848962:T:
NM_006194.3(PAX9):c.336C>G (p.Cys112Trp)	PAX9	C112W	Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Mar 20, 2017)	no assertion criteria provided	VCV000155939	14	37132433	14	36663228	155939	165743	rs587776350	NC_000014.9:36663227:C:G
NM_000126.4(ETFA):c.625del (p.Arg209fs)	ETFA	R209fs, R160fs	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000853348	15	76578017	15	76285676	853348	842711		NC_000015.10:76285675:G:
NC_000015.10:g.(?_76311340)_(76311398_?)del	ETFA		Glutaric aciduria, type 2	Pathogenic(Last reviewed: Nov 9, 2019)	criteria provided, single submitter	VCV000833247	15	76603681 - 76603739			833247	820737		
NM_000126.4(ETFA):c.52C>T (p.Arg18Ter)	ETFA	R18*	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000666198	15	76588066	15	76295725	666198	643553		NC_000015.10:76295724:G:A
NM_001145358.2(SIN3A):c.2019T>G (p.Tyr673Ter)	SIN3A	Y673*	not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000653960	15	75688673	15	75396332	653960	643548		NC_000015.10:75396331:A:C
NM_000126.4(ETFA):c.624del (p.Arg209fs)	ETFA	R209fs, R160fs	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000648977	15	76578018	15	76285677	648977	643549		NC_000015.10:76285676:A:
NM_000126.4(ETFA):c.493_494GT[1] (p.Ser167fs)	ETFA		Glutaric aciduria, type 2	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000459956	15	76578778 - 76578779	15	76286437 - 76286438	459956	465428	rs1298299792	NC_000015.10:76286436:ACAC:AC
NM_152641.4(ARID2):c.5305C>T (p.Arg1769Ter)	ARID2	R1769*	not provided	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000451913	12	46287446	12	45893663	451913	445001	rs774801990	NC_000012.12:45893662:C:T
ARID2, 105-KB DEL, EX3-5DEL	ARID2		COFFIN-SIRIS SYNDROME 6	Pathogenic(Last reviewed: Dec 13, 2017)	no assertion criteria provided	VCV000448921					448921	442510		
NM_152641.4(ARID2):c.156del (p.Arg53fs)	ARID2	R53fs	COFFIN-SIRIS SYNDROME 6	Pathogenic(Last reviewed: Dec 13, 2017)	no assertion criteria provided	VCV000448920	12	46123889	12	45730106	448920	442509	rs1555139310	NC_000012.12:45730105:CC:C
NM_152641.4(ARID2):c.3411_3412del (p.Gly1139fs)	ARID2	G1139fs	COFFIN-SIRIS SYNDROME 6	Pathogenic(Last reviewed: Dec 13, 2017)	no assertion criteria provided	VCV000448919	12	46245317 - 46245318	12	45851534 - 45851535	448919	442508	rs1555155252	NC_000012.12:45851533:AG:
NM_152641.4(ARID2):c.4441del (p.His1481fs)	ARID2	H1481fs	COFFIN-SIRIS SYNDROME 6	Pathogenic(Last reviewed: Dec 14, 2017)	no assertion criteria provided	VCV000448917	12	46246347	12	45852564	448917	204044	rs796052241	NC_000012.12:45852563:C:
NM_006194.3(PAX9):c.59C>T (p.Pro20Leu)	PAX9	P20L	Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Jan 18, 2017)	no assertion criteria provided	VCV000375454	14	37132156	14	36662951	375454	362221	rs1555316697	NC_000014.9:36662950:C:T
PAX9, 1-BP INS, 190G	PAX9		Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000013780					13780	28819		
PAX9, 3-BP DEL, 24-BP INS, NT619	PAX9		Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000013778					13778	28817		
NM_006194.3(PAX9):c.792_793insC (p.Val265fs)	PAX9		Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000013776	14	37145423 - 37145424	14	36676218 - 36676219	13776	28815		NC_000014.9:36676218::C
NM_006194.3(PAX9):c.83G>C (p.Arg28Pro)	PAX9	R28P	Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000013773	14	37132180	14	36662975	13773	28812	rs28933971	NC_000014.9:36662974:G:C
PAX9, 288-BP INS	PAX9		Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000013772					13772	28811		
PAX9, DEL	PAX9		Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000013769					13769	28808		
NM_006194.3(PAX9):c.340A>T (p.Lys114Ter)	PAX9	K114*	Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000013768	14	37132437	14	36663232	13768	28807	rs104894467	NC_000014.9:36663231:A:T
ETFA, IVS11DS, 1-BP DEL, +1G	ETFA		Glutaric acidemia IIA	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000002597					2597	17636		
ETFA, 3-BP DEL, NT808	ETFA		Glutaric acidemia IIA	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000002596					2596	17635		
NM_000126.4(ETFA):c.346G>A (p.Gly116Arg)	ETFA	G116R, G67R	Glutaric acidemia IIA	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000002595	15	76584777	15	76292436	2595	17634	rs119458971	NC_000015.10:76292435:C:T
NM_006194.3(PAX9):c.180C>A (p.Tyr60Ter)	PAX9	Y60*	Partial congenital absence of teeth	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000526772	14	37132277	14	36663072	526772	528503	rs1555316704	NC_000014.9:36663071:C:A
NM_001145358.2(SIN3A):c.3114_3115CA[2] (p.Gln1040fs)	SIN3A		Witteveen-kolk syndrome	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431101	15	75676681 - 75676682	15	75384340 - 75384341	431101	424624	rs1135401768	NC_000015.10:75384339:TGTGTGT:TGTGT
NM_001145358.2(SIN3A):c.3310C>T (p.Arg1104Ter)	SIN3A	R1104*	Witteveen-kolk syndrome	Pathogenic(Last reviewed: Aug 12, 2016)	no assertion criteria provided	VCV000253074	15	75673043	15	75380702	253074	247485	rs879255621	NC_000015.10:75380701:G:A
NM_001145358.2(SIN3A):c.2949_2950GA[3] (p.Glu985fs)	SIN3A		Witteveen-kolk syndrome	Pathogenic(Last reviewed: Aug 12, 2016)	no assertion criteria provided	VCV000253073	15	75682058 - 75682059	15	75389717 - 75389718	253073	247484	rs886037847	NC_000015.10:75389716:TCTCTCTC:TCTCTC
NM_001145358.2(SIN3A):c.1759del (p.Ser587fs)	SIN3A	S587fs	Witteveen-kolk syndrome	Pathogenic(Last reviewed: Aug 12, 2016)	no assertion criteria provided	VCV000253072	15	75692476	15	75400135	253072	247483	rs879255620	NC_000015.10:75400134:AAA:AA
NM_001145357.1(SIN3A):c.1010_1013del (p.Lys337Serfs)	SIN3A		Witteveen-kolk syndrome	Pathogenic(Last reviewed: Aug 12, 2016)	no assertion criteria provided	VCV000253071	15	75702623 - 75702626	15	75410282 - 75410285	253071	247482	rs879255619	NC_000015.10:75410281:TCTTTCT:TCT
NM_001145358.2(SIN3A):c.803dup (p.Leu269fs)	SIN3A		Witteveen-kolk syndrome	Pathogenic(Last reviewed: Aug 12, 2016)	no assertion criteria provided	VCV000253070	15	75704037 - 75704038	15	75411696 - 75411697	253070	247481	rs879255618	NC_000015.10:75411696:GGGGG:GGGGGG
NM_006194.3(PAX9):c.139C>T (p.Arg47Trp)	PAX9	R47W	Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000013781	14	37132236	14	36663031	13781	28820	rs121917720	NC_000014.9:36663030:C:T
NM_006194.3(PAX9):c.151G>A (p.Gly51Ser)	PAX9	G51S	Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000013779	14	37132248	14	36663043	13779	28818	rs104894469	NC_000014.9:36663042:G:A
PAX9, 1A-G	PAX9		Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000013777					13777	28816		
NM_006194.3(PAX9):c.76C>T (p.Arg26Trp)	PAX9	R26W	Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000013774	14	37132173	14	36662968	13774	28813	rs28933972	NC_000014.9:36662967:C:T
NM_006194.3(PAX9):c.62T>C (p.Leu21Pro)	PAX9	L21P	Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000013771	14	37132159	14	36662954	13771	28810	rs28933970	NC_000014.9:36662953:T:C
PAX9, 1-BP INS, 219G	PAX9		Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Feb 13, 2004)	no assertion criteria provided	VCV000013767					13767	28806		
NM_000126.4(ETFA):c.470T>G (p.Val157Gly)	ETFA	V157G, V108G	Glutaric acidemia IIA	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000002593	15	76578804	15	76286463	2593	17632	rs119458969	NC_000015.10:76286462:A:C
NM_001145358.2(SIN3A):c.848dup (p.His283fs)	SIN3A		Witteveen-kolk syndrome	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000560386	15	75703992 - 75703993	15	75411651 - 75411652	560386	551435	rs1567368243	NC_000015.10:75411651:T:TT
NM_152641.4(ARID2):c.2536del (p.Val846fs)	ARID2	V846fs	not provided|COFFIN-SIRIS SYNDROME 6	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000207823	12	46244442	12	45850659	207823	204042	rs796052240	NC_000012.12:45850658:G:
NM_000326.5(RLBP1):c.333T>G (p.Tyr111Ter)	RLBP1	Y111*	Retinal dystrophy	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000866938	15	89760364	15	89217133	866938	856823		NC_000015.10:89217132:A:C
NM_000538.3(RFXAP):c.323T>A (p.Leu108Ter)	RFXAP	L108*	Bare lymphocyte syndrome 2	Pathogenic(Last reviewed: May 25, 2014)	no assertion criteria provided	VCV000208152	13	37393817	13	36819680	208152	204413	rs754240018	NC_000013.11:36819679:T:A
NM_000538.3(RFXAP):c.127C>T (p.Gln43Ter)	RFXAP	Q43*	Bare lymphocyte syndrome 2	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000566425	13	37393621	13	36819484	566425	568511	rs1313207845	NC_000013.11:36819483:C:T
RLBP1, IVS3, T-C, +2	RLBP1		Newfoundland rod-cone dystrophy	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000013098					13098	28137		
NM_000538.3(RFXAP):c.163C>T (p.Gln55Ter)	RFXAP	Q53*, Q55*	Bare Lymphocyte Syndrome, Type II, Complementation Group D	Pathogenic(Last reviewed: Sep 11, 1997)	no assertion criteria provided	VCV000007652	13	37393657	13	36819520	7652	22691	rs137853098	NC_000013.11:36819519:C:T
RFXAP, 1-BP INS, 505G	RFXAP		Bare Lymphocyte Syndrome, Type II, Complementation Group D	Pathogenic(Last reviewed: Mar 3, 1997)	no assertion criteria provided	VCV000007650					7650	22689		
RFXAP, 1-BP INS, 413G	RFXAP		Bare Lymphocyte Syndrome, Type II, Complementation Group D	Pathogenic(Last reviewed: Mar 3, 1997)	no assertion criteria provided	VCV000007649					7649	22688		
NM_000326.5(RLBP1):c.282del (p.Phe95fs)	RLBP1	F95fs	not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000844049	15	89760415	15	89217184	844049	842744		NC_000015.10:89217183:G:
NM_000485.3(APRT):c.400+2dup	APRT		Adenine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000203396	16	88876475 - 88876476	16	88810067 - 88810068	203396	199814	rs745594160	NC_000016.10:88810067:A:AA
NM_000485.3(APRT):c.448G>T (p.Val150Phe)	APRT	V150F	Adenine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000041012	16	88876201	16	88809793	41012	49434	rs281860266	NC_000016.10:88809792:C:A
APRT, 254-BP DEL AND 8-BP INS	APRT		Adenine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000018301					18301	33340		
NM_000485.3(APRT):c.329T>C (p.Leu110Pro)	APRT	L110P	Adenine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000018300	16	88876549	16	88810141	18300	33339	rs104894508	NC_000016.10:88810140:A:G
NM_000485.3(APRT):c.194A>T (p.Asp65Val)	APRT	D65V	Adenine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000018297	16	88876958	16	88810550	18297	33336	rs104894506	NC_000016.10:88810549:T:A
NM_000485.3(APRT):c.518_520TCT[1] (p.Phe174del)	APRT	F174del	Adenine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Nov 1, 1987)	no assertion criteria provided	VCV000018294	16	88876126 - 88876128	16	88809718 - 88809720	18294	33333	rs121912681	NC_000016.10:88809717:AGAAGAAG:AGAAG
NC_000015.10:g.(?_89210285)_(89211901_?)del	RLBP1		not provided	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, single submitter	VCV000833369	15	89753516 - 89755132			833369	820740		
NM_000326.5(RLBP1):c.79del (p.Thr27fs)	RLBP1	T27fs	Retinitis punctata albescens|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 13, 2017)	no assertion criteria provided	VCV000635160	15	89761858	15	89218627	635160	623000	rs1567124404	NC_000015.10:89218626:TT:T
NM_000485.3(APRT):c.542G>C (p.Ter181Ser)	APRT	*181S	Adenine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000018302	16	88876107	16	88809699	18302	33341	rs387906584	NC_000016.10:88809698:C:G
NM_000485.3(APRT):c.258_261dup (p.Lys88fs)	APRT		Adenine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000018299	16	88876890 - 88876891	16	88810482 - 88810483	18299	33338	rs281860265	NC_000016.10:88810482:TCGG:TCGGTCGG
NM_000485.3(APRT):c.294G>A (p.Trp98Ter)	APRT	W98*	Adenine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000018298	16	88876858	16	88810450	18298	33337	rs104894507	NC_000016.10:88810449:C:T
NM_004727.3(SLC24A1):c.754_755del (p.Met252fs)	SLC24A1	M252fs	Retinitis pigmentosa|Congenital stationary night blindness, type 1D|Retinal dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000560508	15	65917172 - 65917173	15	65624834 - 65624835	560508	551579	rs777989874	NC_000015.10:65624833:AT:
NM_000326.5(RLBP1):c.141+2T>C	RLBP1		RLBP1-Related Disorders|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503712	15	89761794	15	89218563	503712	495363	rs760650165	NC_000015.10:89218562:A:G
RLBP1, 324G-A	RLBP1		Retinitis punctata albescens|Newfoundland rod-cone dystrophy	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000013099					13099	28138		
NM_000326.5(RLBP1):c.452G>A (p.Arg151Gln)	RLBP1	R150Q, R151Q	Retinitis punctata albescens|Pigmentary retinal dystrophy	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000013097	15	89758364	15	89215133	13097	28136	rs137853290	NC_000015.10:89215132:C:T
RFXAP, 1-BP DEL, 484G	RFXAP		Bare Lymphocyte Syndrome, Type II, Complementation Group D	Pathogenic(Last reviewed: Sep 11, 1997)	no assertion criteria provided	VCV000007651					7651	22690		
NM_006177.5(NRL):c.544C>T (p.Gln182Ter)	NRL	Q182*, Q77*	not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000620329	14	24550615	14	24081406	620329	611783	rs901811301	NC_000014.9:24081405:G:A
NM_006177.5(NRL):c.104dup (p.Thr36fs)	NRL		Retinitis pigmentosa 27	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560472	14	24551953 - 24551954	14	24082744 - 24082745	560472	551571	rs1566561006	NC_000014.9:24082744:GGGGGG:GGGGGGG
NM_001206999.2(CIT):c.689A>T (p.Asp230Val)	CIT	D230V	Microcephaly 17, primary, autosomal recessive	Pathogenic(Last reviewed: Sep 2, 2016)	no assertion criteria provided	VCV000254136	12	120270639	12	119832835	254136	248603	rs886037894	NC_000012.12:119832834:T:A
NM_001206999.2(CIT):c.376A>C (p.Lys126Gln)	CIT	K126Q	Microcephaly 17, primary, autosomal recessive	Pathogenic(Last reviewed: Sep 2, 2016)	no assertion criteria provided	VCV000254135	12	120295365	12	119857561	254135	248602	rs886037893	NC_000012.12:119857560:T:G
NM_001206999.2(CIT):c.317G>T (p.Gly106Val)	CIT	G106V	Microcephaly 17, primary, autosomal recessive	Pathogenic(Last reviewed: Sep 2, 2016)	no assertion criteria provided	VCV000254134	12	120295424	12	119857620	254134	248601	rs886037892	NC_000012.12:119857619:C:A
NM_001143992.2(WRAP53):c.1118del (p.Leu373fs)	WRAP53	L373fs	Dyskeratosis congenita, autosomal recessive, 3	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638511	17	7605824	17	7702506	638511	626262		NC_000017.11:7702505:T:
NM_006177.5(NRL):c.91C>T (p.Arg31Ter)	NRL	R31*	Enhanced s-cone syndrome	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000369652	14	24551967	14	24082758	369652	353881	rs762991211	NC_000014.9:24082757:G:A
NM_001206999.2(CIT):c.753+3A>T	CIT		Microcephaly 17, primary, autosomal recessive	Pathogenic(Last reviewed: Sep 2, 2016)	no assertion criteria provided	VCV000254139	12	120270572	12	119832768	254139	248606	rs886037895	NC_000012.12:119832767:T:A
NM_001206999.2(CIT):c.473C>G (p.Pro158Arg)	CIT	P158R	Primary autosomal recessive microcephaly	Pathogenic	no assertion criteria provided	VCV000252994	12	120288021	12	119850217	252994	247395	rs879255524	NC_000012.12:119850216:G:C
NM_001206999.2(CIT):c.412C>T (p.Gln138Ter)	CIT	Q138*	Primary autosomal recessive microcephaly	Pathogenic	no assertion criteria provided	VCV000252993	12	120295329	12	119857525	252993	247396	rs879255523	NC_000012.12:119857524:G:A
NM_006177.5(NRL):c.479T>C (p.Leu160Pro)	NRL	L160P, L55P	Retinal degeneration, autosomal recessive, clumped pigment type	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000014044	14	24550680	14	24081471	14044	29083	rs104894463	NC_000014.9:24081470:A:G
NM_001354768.3(NRL):c.444_445insGCTGCGGG (p.Leu149fs)	NRL		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812356	14	24550714 - 24550715	14	24081505 - 24081506	812356	800586		NC_000014.9:24081505:C:CCCGCAGCC
NM_001143992.2(WRAP53):c.1303G>A (p.Gly435Arg)	WRAP53	G435R	Dyskeratosis congenita, autosomal recessive, 3	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000041251	17	7606345	17	7703027	41251	49675	rs281865550	NC_000017.11:7703026:G:A
NM_001143992.2(WRAP53):c.1126C>T (p.His376Tyr)	WRAP53	H376Y	Dyskeratosis congenita, autosomal recessive, 3	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000030976	17	7605832	17	7702514	30976	39933	rs281865549	NC_000017.11:7702513:C:T
NM_001143992.2(WRAP53):c.1192C>T (p.Arg398Trp)	WRAP53	R398W	Dyskeratosis congenita, autosomal recessive, 3	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000030975	17	7606088	17	7702770	30975	39932	rs281865548	NC_000017.11:7702769:C:T
NM_000485.3(APRT):c.321+2dup	APRT		Adenine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000018295	16	88876828 - 88876829	16	88810420 - 88810421	18295	33334	rs281860263	NC_000016.10:88810420:A:AA
NM_001206999.2(CIT):c.29_38del (p.Asn10fs)	CIT	N10fs	Microcephaly 17, primary, autosomal recessive|Primary autosomal recessive microcephaly	Pathogenic(Last reviewed: Sep 2, 2016)	no assertion criteria provided	VCV000221283	12	120313935 - 120313944	12	119876131 - 119876140	221283	222995	rs879253817	NC_000012.12:119876130:TCCAAAGGATTCC:TCC
NM_001165960.1(ALOXE3):c.1492del (p.Ile498fs)	ALOXE3	I365fs, I498fs, I366fs	not provided	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000817655	17	8013708	17	8110390	817655	806002		NC_000017.11:8110389:T:
NM_014319.5(LEMD3):c.785_792dup (p.Asp265fs)	LEMD3		not provided	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000817380	12	65564158 - 65564159	12	65170378 - 65170379	817380	805754		NC_000012.12:65170378:AGAGGAAGAG:AGAGGAAGAGAGGAAGAG
NM_001165960.1(ALOXE3):c.1725C>A (p.Tyr575Ter)	ALOXE3	Y443*, Y575*, Y442*	not provided	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000620330	17	8013297	17	8109979	620330	611881	rs1567999245	NC_000017.11:8109978:G:T
NM_001165960.1(ALOXE3):c.2026C>T (p.Gln676Ter)	ALOXE3	Q544*, Q676*, Q543*	not provided	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000449286	17	8011840	17	8108522	449286	445918	rs781631629	NC_000017.11:8108521:G:A
NM_014319.5(LEMD3):c.1873C>T (p.Arg625Ter)	LEMD3	R625*, R624*	not provided	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000381745	12	65632546	12	65238766	381745	373252	rs749951964	NC_000012.12:65238765:C:T
NM_001165960.1(ALOXE3):c.2182-2A>G	ALOXE3		not provided	Pathogenic(Last reviewed: May 26, 2015)	criteria provided, single submitter	VCV000379699	17	8006813	17	8103495	379699	378843	rs139375856	NC_000017.11:8103494:T:C
NM_001165960.1(ALOXE3):c.1027C>T (p.Arg343Ter)	ALOXE3	R343*, R211*, R210*	not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000072354	17	8017851	17	8114533	72354	83245	rs141340759	NC_000017.11:8114532:G:A
NM_014319.5(LEMD3):c.2639C>G (p.Thr880Ser)	LEMD3	T879S, T880S	Cerebral arteriovenous malformation	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000545103	12	65640008	12	65246228	545103	535373	rs1555196298	NC_000012.12:65246227:C:G
NM_000618.5(IGF1):c.292C>T (p.Arg98Trp)	IGF1	R98W, R82W	Growth delay due to insulin-like growth factor type 1 deficiency	Pathogenic	no assertion criteria provided	VCV000127243	12	102813397	12	102419619	127243	132700	rs587779350	NC_000012.12:102419618:G:A
NM_001165960.1(ALOXE3):c.1676T>C (p.Leu559Pro)	ALOXE3	L427P, L559P, L426P	Autosomal recessive congenital ichthyosis 3	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000039551	17	8013435	17	8110117	39551	48150	rs1355284797	NC_000017.11:8110116:A:G
NM_001165960.1(ALOXE3):c.1238G>T (p.Gly413Val)	ALOXE3	G281V, G413V, G280V	Autosomal recessive congenital ichthyosis 3	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000039548	17	8014792	17	8111474	39548	48147	rs786205120	NC_000017.11:8111473:C:A
NM_000618.5(IGF1):c.274G>A (p.Val92Met)	IGF1	V44M, V76M, V92M	Growth delay due to insulin-like growth factor type 1 deficiency	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000014789	12	102813415	12	102419637	14789	29828	rs121912430	NC_000012.12:102419636:C:T
IGF1, MUTATION IN POLYADENYLATION SIGNAL, T-A	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000014788					14788	29827		
IGF1, EX4-5DEL	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Pathogenic(Last reviewed: Oct 31, 1996)	no assertion criteria provided	VCV000014787					14787	29826		
NM_001165960.1(ALOXE3):c.1582C>A (p.Arg528Ser)	ALOXE3	R396S, R528S, R395S	Autosomal recessive congenital ichthyosis 3	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000003409	17	8013529	17	8110211	3409	18448	rs121434234	NC_000017.11:8110210:G:T
NM_001165960.1(ALOXE3):c.1894G>T (p.Val632Phe)	ALOXE3	V500F, V632F, V499F	Autosomal recessive congenital ichthyosis 3	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000003407	17	8012556	17	8109238	3407	18446	rs121434232	NC_000017.11:8109237:C:A
NM_014319.5(LEMD3):c.1522+1G>A	LEMD3		Dermatofibrosis lenticularis disseminata, isolated	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000002760	12	65564899	12	65171119	2760	17799	rs1565776684	NC_000012.12:65171118:G:A
NM_014319.5(LEMD3):c.2564G>A (p.Trp855Ter)	LEMD3	W855*, W854*	Dermatofibrosis lenticularis disseminata	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000002758	12	65639711	12	65245931	2758	17797	rs267607216	NC_000012.12:65245930:G:A
LEMD3, 1941+5delG	LEMD3		Osteopoikilosis	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000002756					2756	17795		
LEMD3, 1-BP DUP, 1185T	LEMD3		Dermatofibrosis lenticularis disseminata	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000002754					2754	17793		
LEMD3, 3-BP DEL/1-BP INS	LEMD3		Dermatofibrosis lenticularis disseminata	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000002753					2753	17792		
NM_014319.5(LEMD3):c.457C>T (p.Gln153Ter)	LEMD3	Q153*	Osteopoikilosis	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000002752	12	65563833	12	65170053	2752	17791		NC_000012.12:65170052:C:T
NM_001165960.1(ALOXE3):c.1230C>A (p.Tyr410Ter)	ALOXE3	Y278*, Y410*, Y277*	Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633811	17	8014800	17	8111482	633811	622255	rs765682032	NC_000017.11:8111481:G:T
NM_001165960.1(ALOXE3):c.702T>A (p.Tyr234Ter)	ALOXE3	Y102*, Y234*	Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633810	17	8020140	17	8116822	633810	622256	rs1568005543	NC_000017.11:8116821:A:T
NM_014319.5(LEMD3):c.1801G>T (p.Glu601Ter)	LEMD3	E601*, E600*	Dermatofibrosis lenticularis disseminata	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000620578	12	65632474	12	65238694	620578	611979	rs1565799131	NC_000012.12:65238693:G:T
NM_001165960.1(ALOXE3):c.830G>A (p.Arg277His)	ALOXE3	R145H, R277H	Autosomal recessive congenital ichthyosis 3	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000039550	17	8018925	17	8115607	39550	48149	rs745480657	NC_000017.11:8115606:C:T
LEMD3, 1609C-T	LEMD3		Osteopoikilosis with melorheostosis	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000002755					2755	17794		
NM_001165960.1(ALOXE3):c.814C>T (p.Arg272Ter)	ALOXE3	R140*, R272*	Autosomal recessive congenital ichthyosis 3|Ichthyosis (disease)	Pathogenic(Last reviewed: Nov 17, 2015)	no assertion criteria provided	VCV000217301	17	8018941	17	8115623	217301	213955	rs370031870	NC_000017.11:8115622:G:A
LEMD3, 1-BP DUP, 2154A	LEMD3		Osteopoikilosis|Dermatofibrosis lenticularis disseminata	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000002757					2757	17796		
NM_001206999.2(CIT):c.1111+1G>A	CIT		Primary autosomal recessive microcephaly|Microcephaly 17, primary, autosomal recessive	Pathogenic(Last reviewed: Sep 2, 2016)	no assertion criteria provided	VCV000252992	12	120260623	12	119822819	252992	247394	rs879255522	NC_000012.12:119822818:C:T
NM_001165960.1(ALOXE3):c.1096C>T (p.Arg366Ter)	ALOXE3	R234*, R366*, R233*	not provided|Autosomal recessive congenital ichthyosis 3	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000003408	17	8015495	17	8112177	3408	18447	rs121434233	NC_000017.11:8112176:G:A
NM_014319.5(LEMD3):c.1963C>T (p.Arg655Ter)	LEMD3	R655*, R654*	Osteopoikilosis with melorheostosis|Dermatofibrosis lenticularis disseminata, isolated	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000002759	12	65633750	12	65239970	2759	17798	rs267607217	NC_000012.12:65239969:C:T
NM_006177.5(NRL):c.223dup (p.Leu75fs)	NRL		not provided|Retinal degeneration, autosomal recessive, clumped pigment type	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000014043	14	24551834 - 24551835	14	24082625 - 24082626	14043	29082	rs763191889	NC_000014.9:24082625:G:GG
NM_006177.5(NRL):c.148T>A (p.Ser50Thr)	NRL	S50T	Retinitis pigmentosa 27	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000014042	14	24551910	14	24082701	14042	29081	rs104894459	NC_000014.9:24082700:A:T
NM_001361.5(DHODH):c.403C>T (p.Arg135Cys)	DHODH	R135C	not provided|Miller syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016801	16	72048540	16	72014641	16801	31840	rs201230446	NC_000016.10:72014640:C:T
NM_052874.5(STX1B):c.165dup (p.Gln56fs)	STX1B		Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000807504	16	31012454 - 31012455	16	31001133 - 31001134	807504	798699		NC_000016.10:31001133:TTTTTT:TTTTTTT
NM_018418.5(SPATA7):c.699_700del (p.Phe233_Ser234insTer)	SPATA7		not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801398	14	88892900 - 88892901	14	88426556 - 88426557	801398	789779		NC_000014.9:88426555:TTTT:TT
NM_018418.5(SPATA7):c.8_19+14del	SPATA7		not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801396	14	88852168 - 88852193	14	88385824 - 88385849	801396	789777		NC_000014.9:88385823:TGGCAGCCGGAGAGGTAAAGGGCAGCTG:TG
GRCh37/hg19 15q26.3(chr15:101061066-101081879)x1	CERS3		not provided	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000686196	15	101061066 - 101081879			686196	673788		
NC_000014.9:g.88362113_88425523delinsTGG	SPATA7		Retinitis pigmentosa, juvenile	Pathogenic(Last reviewed: Dec 13, 2017)	no assertion criteria provided	VCV000635162			14	88362113 - 88425523	635162	622999		
NM_052874.5(STX1B):c.733C>T (p.Arg245Ter)	STX1B	R245*	Seizures	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000590057	16	31004504	16	30993183	590057	579994	rs780843272	NC_000016.10:30993182:G:A
NM_018418.5(SPATA7):c.1373del (p.Val458fs)	SPATA7	V426fs, V458fs	not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000503686	14	88904339	14	88437995	503686	495763	rs753697847	NC_000014.9:88437994:T:
NM_018418.5(SPATA7):c.115_119del (p.Ser39fs)	SPATA7	S39fs	not provided	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000497357	14	88859753 - 88859757	14	88393409 - 88393413	497357	488781	rs1555370458	NC_000014.9:88393408:CTCTTCTCT:CTCT
NM_052874.5(STX1B):c.58del (p.Val20fs)	STX1B	V20fs	not provided	Pathogenic(Last reviewed: Mar 29, 2016)	criteria provided, single submitter	VCV000280465	16	31012897	16	31001576	280465	264938	rs886041666	NC_000016.10:31001575:CC:C
NM_004530.6(MMP2):c.1287del (p.Asn430fs)	MMP2	N380fs, N354fs, N430fs	not provided	Pathogenic(Last reviewed: Dec 10, 2014)	criteria provided, single submitter	VCV000198809	16	55525819	16	55491907	198809	195969	rs794727916	NC_000016.10:55491906:G:
NM_004530.6(MMP2):c.265del (p.Asp90fs)	MMP2	D90fs, D14fs, D40fs	not provided	Pathogenic(Last reviewed: Dec 10, 2014)	criteria provided, single submitter	VCV000195227	16	55516932	16	55483020	195227	192388	rs794727275	NC_000016.10:55483019:C:
NC_000015.10:g.(?_51210798)_(51255741_?)del	CYP19A1		not provided	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000833490	15	51502995 - 51547938			833490	820721		
NM_052874.5(STX1B):c.382del (p.Glu128fs)	STX1B	E128fs	Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000813789	16	31008353	16	30997032	813789	802012		NC_000016.10:30997031:CC:C
NC_000016.9:g.(?_31012229)_(31012944_?)del	STX1B		Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000661190	16	31012229 - 31012944	16	31000908 - 31001623	661190	652846		
NM_052874.5(STX1B):c.404del (p.Ala135fs)	STX1B	A135fs	Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000657728	16	31008331	16	30997010	657728	644611		NC_000016.10:30997009:G:
NM_052874.5(STX1B):c.35_36dup (p.Asp13fs)	STX1B		Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000567167	16	31012918 - 31012919	16	31001597 - 31001598	567167	570129	rs1567379671	NC_000016.10:31001597:TTT:TTTTT
NM_030943.3(AMN):c.318_319CT[3] (p.Asp108fs)	AMN		Megaloblastic anemia|Cobalamin deficiency	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523538	14	103395116 - 103395117	14	102928779 - 102928780	523538	514036	rs1555381324	NC_000014.9:102928779:CTCT:CTCTCT
NM_018418.5(SPATA7):c.19G>A (p.Val7Ile)	SPATA7	V7I	Leber congenital amaurosis	Pathogenic(Last reviewed: May 9, 2017)	no assertion criteria provided	VCV000427873	14	88852181	14	88385837	427873	418826	rs371609982	NC_000014.9:88385836:G:A
NM_018418.5(SPATA7):c.1215G>T (p.Glu405Asp)	SPATA7	E405D, E373D	Leber congenital amaurosis	Pathogenic(Last reviewed: May 9, 2017)	no assertion criteria provided	VCV000427862	14	88903941	14	88437597	427862	418827	rs768028061	NC_000014.9:88437596:G:T
NM_052874.5(STX1B):c.676G>C (p.Gly226Arg)	STX1B	G226R	Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162399	16	31004561	16	30993240	162399	172102	rs727502806	NC_000016.10:30993239:C:G
NM_052874.5(STX1B):c.647T>A (p.Val216Glu)	STX1B	V216E	Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162398	16	31004696	16	30993375	162398	172101	rs724159974	NC_000016.10:30993374:A:T
NM_052874.5(STX1B):c.140C>A (p.Ser47Ter)	STX1B	S47*	Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162397	16	31012480	16	31001159	162397	172100	rs200979563	NC_000016.10:31001158:G:T
CYP19A1, INV, TMOD3 PROMOTER	CYP19A1		Familial gynecomastia, due to increased aromatase activity	Pathogenic(Last reviewed: May 8, 2003)	no assertion criteria provided	VCV000017825					17825	32864		
CYP19A1, INV, CGNL1 PROMOTER	CYP19A1		Familial gynecomastia, due to increased aromatase activity	Pathogenic(Last reviewed: May 8, 2003)	no assertion criteria provided	VCV000017824					17824	32863		
CYP19A1, 1-BP DEL, C, CODON 156	CYP19A1		Aromatase deficiency	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000017822					17822	32861		
MYO5A, 47-BP INS, NT4634	MYO5A		Griscelli syndrome type 1	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000014070					14070	29109		
NM_030943.3(AMN):c.122C>T (p.Thr41Ile)	AMN	T41I	Megaloblastic anemia 1, Norwegian type	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000004770	14	103390126	14	102923789	4770	19809	rs119478058	NC_000014.9:102923788:C:T
NC_000015.10:g.(?_51227769)_(51227943_?)del	CYP19A1		not provided	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000830524	15	51519966 - 51520140			830524	820722		
NM_001290343.2(CERS3):c.731G>A (p.Trp244Ter)	CERS3	W244*, W255*	Autosomal recessive congenital ichthyosis 9	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633803	15	101013136	15	100472931	633803	622244	rs1567644030	NC_000015.10:100472930:C:T
NM_000259.3(MYO5A):c.2012+1G>T	MYO5A		Griscelli syndrome type 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561060	15	52675287	15	52383090	561060	552183	rs769021352	NC_000015.10:52383089:C:A
NM_000259.3(MYO5A):c.4200C>G (p.Ser1400Arg)	MYO5A	S1400R, S1373R	Nystagmus|Cerebellar cortical atrophy|Seizures|Dystonia|Global developmental delay	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242881	15	52632432	15	52340235	242881	243993	rs1114167290	NC_000015.10:52340234:G:C
NM_016111.4(TELO2):c.779C>T (p.Pro260Leu)	TELO2	P260L	You-Hoover-Fong syndrome	Pathogenic	criteria provided, single submitter	VCV000236228	16	1547458	16	1497457	236228	237796	rs369656775	NC_000016.10:1497456:C:T
NM_052874.5(STX1B):c.133_134insGGATGTGCATTG (p.Lys45delinsArgMetCysIleGlu)	STX1B		Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162396	16	31012486 - 31012487	16	31001165 - 31001166	162396	172099	rs1114167275	NC_000016.10:31001165::CAATGCACATCC
NM_052874.5(STX1B):c.166C>T (p.Gln56Ter)	STX1B	Q56*	Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162395	16	31012454	16	31001133	162395	172098	rs724159973	NC_000016.10:31001132:G:A
NM_001290343.2(CERS3):c.43T>C (p.Trp15Arg)	CERS3	W15R, W26R	Autosomal recessive congenital ichthyosis 9	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000064621	15	101042012	15	100501807	64621	75585	rs762679102	NC_000015.10:100501806:A:G
NM_001290343.2(CERS3):c.609+1G>T	CERS3		Autosomal recessive congenital ichthyosis 9	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000055838	15	101016290	15	100476085	55838	70496	rs587776996	NC_000015.10:100476084:C:A
CYP19A1, CYP19A1/TRPM7 FUSION	CYP19A1		Familial gynecomastia, due to increased aromatase activity	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000017827					17827	32866		
NM_004530.6(MMP2):c.1357del (p.Gly454fs)	MMP2	G454fs, G378fs, G404fs	Multicentric osteolysis, nodulosis and arthropathy	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000017112	16	55527089	16	55493177	17112	32151	rs1567378779	NC_000016.10:55493176:CC:C
MYO5A, F-EXON DEL	MYO5A		Griscelli syndrome type 3	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000014071					14071	29110		
NM_000259.3(MYO5A):c.2332C>T (p.Arg778Ter)	MYO5A	R778*	Griscelli syndrome type 1	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000014069	15	52668632	15	52376435	14069	29108	rs764371254	NC_000015.10:52376434:G:A
AMN, IVS3, A-G, -2	AMN		Megaloblastic anemia due to inborn errors of metabolism	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000004771					4771	19810		
NM_018418.5(SPATA7):c.1200_1201del (p.Asn400fs)	SPATA7	N400fs, N368fs	Leber congenital amaurosis 3	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000857630	14	88903925 - 88903926	14	88437581 - 88437582	857630	841889		NC_000014.9:88437580:ATA:A
NM_018418.5(SPATA7):c.1195C>T (p.Gln399Ter)	SPATA7	Q367*, Q399*	Leber congenital amaurosis 3	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000854754	14	88903921	14	88437577	854754	841888		NC_000014.9:88437576:C:T
NM_030943.3(AMN):c.14del (p.Gly5fs)	AMN	G5fs	Megaloblastic anemia 1, Norwegian type|Megaloblastic anemia due to inborn errors of metabolism	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000056749	14	103389037	14	102922700	56749	71388	rs386834168	NC_000014.9:102922699:GGG:GG
SPATA7, 3-BP DEL, 1227CAC	SPATA7		Leber congenital amaurosis 3	Pathogenic(Last reviewed: May 9, 2011)	no assertion criteria provided	VCV000030805					30805	39762		
SPATA7, 4-BP DEL, 265CTCA	SPATA7		Leber congenital amaurosis 3	Pathogenic(Last reviewed: May 9, 2011)	no assertion criteria provided	VCV000030804					30804	39761		
MMP2, 3-BP DEL, 1488TGG	MMP2		Multicentric osteolysis, nodulosis and arthropathy	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000017111					17111	32150		
NM_004530.6(MMP2):c.302G>A (p.Arg101His)	MMP2	R101H, R51H, R25H	Multicentric osteolysis, nodulosis and arthropathy	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000017108	16	55516969	16	55483057	17108	32147	rs121912953	NC_000016.10:55483056:G:A
NM_018418.5(SPATA7):c.1102_1103del (p.Leu368fs)	SPATA7	L368fs, L336fs	SPATA7-Related Disorders|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000631720	14	88899497 - 88899498	14	88433153 - 88433154	631720	620496	rs777069665	NC_000014.9:88433152:TCT:T
NM_018418.5(SPATA7):c.1171C>T (p.Arg391Ter)	SPATA7	R391*, R359*	not provided|Leber congenital amaurosis 3	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000489379	14	88903897	14	88437553	489379	482057	rs374268850	NC_000014.9:88437552:C:T
NM_016111.4(TELO2):c.1826G>A (p.Arg609His)	TELO2	R609H	not provided|You-Hoover-Fong syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, multiple submitters, no conflicts	VCV000236229	16	1552987	16	1502986	236229	237797	rs754162070	NC_000016.10:1502985:G:A
NM_004530.6(MMP2):c.1210G>A (p.Glu404Lys)	MMP2	E404K, E328K, E354K	Multicentric osteolysis, nodulosis and arthropathy	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000017110	16	55525742	16	55491830	17110	32149	rs121912955	NC_000016.10:55491829:G:A
NM_004530.6(MMP2):c.732C>A (p.Tyr244Ter)	MMP2	Y244*, Y168*, Y194*	not provided|Multicentric osteolysis, nodulosis and arthropathy	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000017109	16	55519589	16	55485677	17109	32148	rs121912954	NC_000016.10:55485676:C:A
NM_018418.5(SPATA7):c.1395del (p.Gln465fs)	SPATA7	Q433fs, Q465fs	Leber congenital amaurosis 3	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000001398	14	88904360	14	88438016	1398	16437	rs386834243	NC_000014.9:88438015:AA:A
NM_018418.5(SPATA7):c.1183C>T (p.Arg395Ter)	SPATA7	R395*, R363*	Leber congenital amaurosis 3	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000001397	14	88903909	14	88437565	1397	16436	rs75895925	NC_000014.9:88437564:C:T
NM_002163.4(IRF8):c.671C>T (p.Pro224Leu)	IRF8	P224L, P20L, P234L	Immunodeficiency 32b	Pathogenic(Last reviewed: Jun 8, 2018)	no assertion criteria provided	VCV000545494	16	85952092	16	85918486	545494	535755	rs774835569	NC_000016.10:85918485:C:T
NM_002163.4(IRF8):c.238A>G (p.Thr80Ala)	IRF8	T80A, T90A	Immunodeficiency 32a	Pathogenic(Last reviewed: Jul 14, 2011)	no assertion criteria provided	VCV000056843	16	85942659	16	85909053	56843	71461	rs397514711	NC_000016.10:85909052:A:G
DDHD1, IVS11AS, G-T, -1	DDHD1		Spastic paraplegia 28, autosomal recessive	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039674					39674	48273		
DDHD1, GLN417TER	DDHD1	Q417*	Spastic paraplegia 28, autosomal recessive	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039673					39673	48272		
DDHD1, 1-BP DEL, 1874T	DDHD1		Spastic paraplegia 28, autosomal recessive	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039672					39672	48271		
DDHD1, 1766G-A	DDHD1		Spastic paraplegia 28, autosomal recessive	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039671					39671	48270		
NM_002163.4(IRF8):c.322A>G (p.Lys108Glu)	IRF8	K108E, K118E	Immunodeficiency 32b	Pathogenic(Last reviewed: Sep 18, 2014)	no assertion criteria provided	VCV000056842	16	85942743	16	85909137	56842	71460	rs397514710	NC_000016.10:85909136:A:G
NM_006177.5(NRL):c.151C>T (p.Pro51Ser)	NRL	P51S	not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000195258	14	24551907	14	24082698	195258	192419	rs794727281	NC_000014.9:24082697:G:A
NC_000016.10:g.(?_71569834)_(71576435_?)del	TAT			Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000832602	16	71603737 - 71610338			832602	820870		
NM_000353.3(TAT):c.236-5A>G	TAT			Pathogenic(Last reviewed: Oct 1, 1992)	no assertion criteria provided	VCV000000406	16	71609934	16	71576031	406	15445	rs587776512	NC_000016.10:71576030:T:C
NM_000353.3(TAT):c.177dup (p.Val60fs)	TAT			Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557491	16	71610141 - 71610142	16	71576238 - 71576239	557491	547833	rs1555538156	NC_000016.10:71576238:AA:AAA
NM_018418.5(SPATA7):c.288T>A (p.Cys96Ter)	SPATA7	C96*, C64*	not provided|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000191050	14	88883104	14	88416760	191050	188856	rs767745816	NC_000014.9:88416759:T:A
NM_015665.6(AAAS):c.43C>A (p.Gln15Lys)	AAAS	Q15K	not provided|Glucocorticoid deficiency with achalasia	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005044	12	53715207	12	53321423	5044	20083	rs121918549	NC_000012.12:53321422:G:T
NM_002076.4(GNS):c.26dup (p.Arg10fs)	GNS		not provided	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000504309	12	65153030 - 65153031	12	64759250 - 64759251	504309	495540	rs1555164555	NC_000012.12:64759250:CC:CCC
NM_016123.4(IRAK4):c.518T>A (p.Leu173Ter)	IRAK4	L173*, L49*	Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000858438	12	44166742	12	43772939	858438	839929		NC_000012.12:43772938:T:A
NM_016123.4(IRAK4):c.781del (p.Val261fs)	IRAK4	V261fs, V137fs, V58fs	Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000853817	12	44171497	12	43777694	853817	839931		NC_000012.12:43777693:G:
NM_016123.4(IRAK4):c.869_885del (p.Lys290fs)	IRAK4	K166fs, K87fs, K290fs	Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000846951	12	44172029 - 44172045	12	43778226 - 43778242	846951	839932		NC_000012.12:43778225:TGCAAGATTGCTCAGGGTGCA:TGCA
NM_016123.3(IRAK4):c.88G>T (p.Glu30Ter)	IRAK4	E30*	Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000533523	12	44162002	12	43768199	533523	527705	rs1443126481	NC_000012.12:43768198:G:T
NM_001145256.1(IRAK4):c.-65-898del	IRAK4	G75fs	Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000464933	12	44165082	12	43771279	464933	462177	rs1555167566	NC_000012.12:43771278:GGGG:GGG
NM_002010.3(FGF9):c.184A>G (p.Arg62Gly)	FGF9	R62G	Multiple synostoses syndrome 3	Pathogenic(Last reviewed: Oct 25, 2017)	no assertion criteria provided	VCV000444874	13	22246235	13	21672096	444874	438515	rs1555223925	NC_000013.11:21672095:A:G
NM_016123.3(IRAK4):c.831+5G>T	IRAK4		Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000030610	12	44171552	12	43777749	30610	39567	rs758539498	NC_000012.12:43777748:G:T
NM_002010.3(FGF9):c.296G>A (p.Ser99Asn)	FGF9	S99N	Multiple synostoses syndrome 3	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000008705	13	22255199	13	21681060	8705	23744	rs121918322	NC_000013.11:21681059:G:A
NM_016123.3(IRAK4):c.1189-1G>T	IRAK4		Invasive pneumococcal disease, recurrent isolated, 1	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000003841	12	44180201	12	43786398	3841	18880	rs1565688667	NC_000012.12:43786397:G:T
IRAK4, 2-BP DEL, 620AC	IRAK4		Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency	Pathogenic(Last reviewed: Aug 18, 2003)	no assertion criteria provided	VCV000003840					3840	18879		
NM_016123.3(IRAK4):c.821del (p.Leu274fs)	IRAK4	L274fs, L71fs, L150fs	Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency	Pathogenic(Last reviewed: Mar 28, 2003)	no assertion criteria provided	VCV000003838	12	44171537	12	43777734	3838	18877	rs1565678077	NC_000012.12:43777733:T:
NC_000012.12:g.(?_64739371)_(64747928_?)del	GNS		Mucopolysaccharidosis, MPS-III-D	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000831424	12	65133151 - 65141708			831424	820516		
NM_016123.3(IRAK4):c.547C>T (p.Arg183Ter)	IRAK4	R183*, R59*	Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000567326	12	44166771	12	43772968	567326	571871	rs114951157	NC_000012.12:43772967:C:T
NM_002076.4(GNS):c.1226dup (p.Ser410fs)	GNS		Mucopolysaccharidosis, MPS-III-D	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000002936	12	65116867 - 65116868	12	64723087 - 64723088	2936	17975	rs483352900	NC_000012.12:64723087:C:CC
NM_002076.4(GNS):c.1138_1139insGTCCT (p.Asp380fs)	GNS		Mucopolysaccharidosis, MPS-III-D	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000002935	12	65122797 - 65122798	12	64729017 - 64729018	2935	17974	rs483352899	NC_000012.12:64729017::AGGAC
NM_002076.4(GNS):c.1169del (p.Gln390fs)	GNS	Q390fs	Mucopolysaccharidosis, MPS-III-D	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000002933	12	65122767	12	64728987	2933	17972	rs483352898	NC_000012.12:64728986:T:
NM_002076.4(GNS):c.1168C>T (p.Gln390Ter)	GNS	Q390*	Mucopolysaccharidosis, MPS-III-D	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000002934	12	65122768	12	64728988	2934	17973	rs119461975	NC_000012.12:64728987:G:A
NM_002076.4(GNS):c.1063C>T (p.Arg355Ter)	GNS	R355*	Mucopolysaccharidosis, MPS-III-D	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000002932	12	65130819	12	64737039	2932	17971	rs119461974	NC_000012.12:64737038:G:A
NM_005208.4(CRYBA1):c.215+1G>A	CRYBA1		Cataract, congenital zonular, with sutural opacities|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000521851	17	27577319	17	29250301	521851	512267	rs1264025914	NC_000017.11:29250300:G:A
NM_002076.4(GNS):c.814C>T (p.Gln272Ter)	GNS	Q272*	Mucopolysaccharidosis, MPS-III-D	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000638094	12	65134447	12	64740667	638094	625883		NC_000012.12:64740666:G:A
NM_000270.3(PNP):c.520G>C (p.Ala174Pro)	PNP	A174P	Purine-nucleoside phosphorylase deficiency	Pathogenic(Last reviewed: Oct 4, 2013)	no assertion criteria provided	VCV000013989	14	20943279	14	20475120	13989	29028	rs104894454	NC_000014.9:20475119:G:C
NM_000270.3(PNP):c.285+1G>A	PNP		Purine-nucleoside phosphorylase deficiency	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000013997	14	20942735	14	20474576	13997	29036	rs1566525400	NC_000014.9:20474575:G:A
NM_000270.3(PNP):c.172C>T (p.Arg58Ter)	PNP	R58*	Purine-nucleoside phosphorylase deficiency	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000013996	14	20940627	14	20472468	13996	29035	rs104894460	NC_000014.9:20472467:C:T
NM_000270.3(PNP):c.70C>T (p.Arg24Ter)	PNP	R24*	Purine-nucleoside phosphorylase deficiency	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000013995	14	20940525	14	20472366	13995	29034	rs104894455	NC_000014.9:20472365:C:T
PNP, 1-BP DEL	PNP		Purine-nucleoside phosphorylase deficiency	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000013994					13994	29033		
NM_000270.3(PNP):c.575A>G (p.Tyr192Cys)	PNP	Y192C	Purine-nucleoside phosphorylase deficiency	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000013993	14	20943334	14	20475175	13993	29032	rs104894452	NC_000014.9:20475174:A:G
NM_000270.3(PNP):c.383A>G (p.Asp128Gly)	PNP	D128G	Purine-nucleoside phosphorylase deficiency	Pathogenic(Last reviewed: Oct 1, 1992)	no assertion criteria provided	VCV000013990	14	20943029	14	20474870	13990	29029	rs104894450	NC_000014.9:20474869:A:G
NM_000270.3(PNP):c.265G>A (p.Glu89Lys)	PNP	E89K	Purine-nucleoside phosphorylase deficiency	Pathogenic(Last reviewed: Feb 15, 1987)	no assertion criteria provided	VCV000013988	14	20942714	14	20474555	13988	29027	rs104894453	NC_000014.9:20474554:G:A
NM_018418.5(SPATA7):c.960dup (p.Pro321fs)	SPATA7		Leber congenital amaurosis 3	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000001396	14	88895738 - 88895739	14	88429394 - 88429395	1396	16435	rs386834241	NC_000014.9:88429394:A:AA
Single allele	MIPEP		Combined oxidative phosphorylation deficiency 31	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000584431	13	24436682 - 24443638	13	23862543 - 23869499	584431	575510		
NM_000336.3(SCNN1B):c.1747G>T (p.Glu583Ter)	SCNN1B	E583*	not provided	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000448298	16	23391946	16	23380625	448298	441888	rs1555490554	NC_000016.10:23380624:G:T
NM_001014987.2(LAT):c.44dup (p.Leu16fs)	LAT		Immunodeficiency 52	Pathogenic(Last reviewed: Jun 5, 2017)	no assertion criteria provided	VCV000427751	16	28996781 - 28996782	16	28985460 - 28985461	427751	417545	rs1555524788	NC_000016.10:28985460:T:TT
NM_001014987.2(LAT):c.268_269del (p.Gly90fs)	LAT	G90fs, G89fs, G126fs	Immunodeficiency 52	Pathogenic(Last reviewed: Jun 5, 2017)	no assertion criteria provided	VCV000427750	16	28997722 - 28997723	16	28986401 - 28986402	427750	417544	rs781410769	NC_000016.10:28986400:GGGGG:GGG
NM_020821.3(VPS13C):c.802_805dup (p.Arg269fs)	VPS13C		Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Dec 20, 2019)	no assertion criteria provided	VCV000224604	15	62305257 - 62305258	15	62013058 - 62013059	224604	226382	rs869320761	NC_000015.10:62013058:TCTG:TCTGTCTG
NM_000336.3(SCNN1B):c.863A>G (p.Asn288Ser)	SCNN1B	N288S	Bronchiectasis with or without elevated sweat chloride 1	Pathogenic(Last reviewed: May 28, 2008)	no assertion criteria provided	VCV000008843	16	23379263	16	23367942	8843	23882	rs137852712	NC_000016.10:23367941:A:G
NM_000336.3(SCNN1B):c.1105C>A (p.Pro369Thr)	SCNN1B	P369T	Bronchiectasis with or without elevated sweat chloride 1	Pathogenic(Last reviewed: May 28, 2008)	no assertion criteria provided	VCV000008842	16	23383157	16	23371836	8842	23881	rs137852711	NC_000016.10:23371835:C:A
NM_000336.3(SCNN1B):c.1615G>A (p.Glu539Lys)	SCNN1B	E539K	Bronchiectasis with or without elevated sweat chloride 1	Pathogenic(Last reviewed: Nov 15, 2005)	no assertion criteria provided	VCV000008841	16	23391814	16	23380493	8841	23880	rs137852710	NC_000016.10:23380492:G:A
NM_000336.3(SCNN1B):c.1543-2A>G	SCNN1B		Bronchiectasis with or without elevated sweat chloride 1	Pathogenic(Last reviewed: Nov 15, 2005)	no assertion criteria provided	VCV000008839	16	23391740	16	23380419	8839	23878		NC_000016.10:23380418:A:G
NM_000336.3(SCNN1B):c.800C>T (p.Pro267Leu)	SCNN1B	P267L	Bronchiectasis with or without elevated sweat chloride 1	Pathogenic(Last reviewed: Nov 15, 2005)	no assertion criteria provided	VCV000008838	16	23379200	16	23367879	8838	23877	rs137852709	NC_000016.10:23367878:C:T
NM_000336.3(SCNN1B):c.1847C>G (p.Pro616Arg)	SCNN1B	P616R	Liddle syndrome 1	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000008837	16	23392046	16	23380725	8837	23876	rs387906402	NC_000016.10:23380724:C:G
NM_000336.3(SCNN1B):c.1849C>T (p.Pro617Ser)	SCNN1B	P615S, P617S	Liddle syndrome 1	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000008836	16	23392048	16	23380727	8836	23875	rs137852708	NC_000016.10:23380726:C:T
SCNN1B, 32-BP DEL	SCNN1B		Liddle syndrome 1	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000008835					8835	23874		
SCNN1B, 1-BP INS, 592C	SCNN1B		Liddle syndrome 1	Pathogenic(Last reviewed: Apr 1, 1997)	no assertion criteria provided	VCV000008834					8834	23873		
NM_000336.3(SCNN1B):c.1858T>C (p.Tyr620His)	SCNN1B	Y618H, Y620H	Liddle syndrome 1	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000008833	16	23392057	16	23380736	8833	23872	rs137852707	NC_000016.10:23380735:T:C
NM_000336.3(SCNN1B):c.1790_1791dup (p.Ser598fs)	SCNN1B		not provided	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000586631	16	23391987 - 23391988	16	23380666 - 23380667	586631	577536	rs1567321736	NC_000016.10:23380666:CGC:CGCGC
NM_000336.3(SCNN1B):c.1789del (p.Arg597fs)	SCNN1B	R597fs	not provided	Pathogenic(Last reviewed: Jan 19, 2016)	criteria provided, single submitter	VCV000448299	16	23391983	16	23380662	448299	441889	rs758629218	NC_000016.10:23380661:CCCCCC:CCCCC
NC_000016.10:g.(?_28985376)_(29038755_?)del	LAT		not provided	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000832035	16	28996697 - 29050076			832035	820824		
NM_020821.3(VPS13C):c.806_807insCAGA (p.Arg269fs)	VPS13C		Parkinson disease	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222068	15	62305256 - 62305257	15	62013057 - 62013058	222068	223769	rs879253853	NC_000015.10:62013057::TCTG
NM_005932.4(MIPEP):c.1804G>T (p.Glu602Ter)	MIPEP	E602*	Combined oxidative phosphorylation deficiency 31|Left ventricular noncompaction|Cardiomyopathy|Infantile muscular hypotonia	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000208631	13	24380133	13	23805994	208631	205202	rs114638163	NC_000013.11:23805993:C:A
NM_005050.4(ABCD4):c.1588C>T (p.Gln530Ter)	ABCD4	Q530*, Q267*, Q375*, Q371*, Q426*, Q443*, Q392*, Q488*	Methylmalonic acidemia with homocystinuria, type cblJ	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000583152	14	74754561	14	74287858	583152	569014	rs767795583	NC_000014.9:74287857:G:A
ABCD4, 1456G-T	ABCD4		Methylmalonic acidemia with homocystinuria, type cblJ	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000037322					37322	45897		
NM_005050.4(ABCD4):c.1746_1747insCT (p.Glu583fs)	ABCD4		Methylmalonic acidemia with homocystinuria, type cblJ	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000037320	14	74753409 - 74753410	14	74286706 - 74286707	37320	45895	rs387907315	NC_000014.9:74286706:A:AGA
NM_005050.4(ABCD4):c.542+1G>T	ABCD4		not provided|Methylmalonic acidemia with homocystinuria, type cblJ	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000280107	14	74763035	14	74296332	280107	264602	rs769364566	NC_000014.9:74296331:C:A
NM_005050.4(ABCD4):c.956A>G (p.Tyr319Cys)	ABCD4	Y319C, Y160C, Y164C, Y215C, Y232C, Y181C, Y277C, Y56C	not provided|Methylmalonic acidemia with homocystinuria, type cblJ	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000037319	14	74759326	14	74292623	37319	45894	rs201777056	NC_000014.9:74292622:T:C
NM_020821.3(VPS13C):c.4777del (p.Gln1593fs)	VPS13C	Q1550fs, Q1593fs	Parkinson disease 23, autosomal recessive early-onset|Parkinson disease	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222071	15	62239491	15	61947292	222071	223767	rs869312811	NC_000015.10:61947291:GGG:GG
NM_020821.3(VPS13C):c.4165G>C (p.Gly1389Arg)	VPS13C	G1389R, G1346R	Parkinson disease 23, autosomal recessive early-onset|Parkinson disease	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222070	15	62250807	15	61958608	222070	223768	rs369100678	NC_000015.10:61958607:C:G
NM_020821.3(VPS13C):c.9568G>T (p.Glu3190Ter)	VPS13C	E3190*, E3147*	Parkinson disease 23, autosomal recessive early-onset|Parkinson disease	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222069	15	62174851	15	61882652	222069	223765	rs869312810	NC_000015.10:61882651:C:A
NM_020821.3(VPS13C):c.8445+2T>G	VPS13C		Parkinson disease 23, autosomal recessive early-onset|Parkinson disease	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222067	15	62207830	15	61915631	222067	223766	rs869312809	NC_000015.10:61915630:A:C
NM_000353.3(TAT):c.169C>T (p.Arg57Ter)	TAT	R57*	not provided|	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000402	16	71610150	16	71576247	402	15441	rs118203914	NC_000016.10:71576246:G:A
NM_000419.5(ITGA2B):c.1073G>A (p.Arg358His)	ITGA2B	R327H, R358H	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Oct 19, 2016)	no assertion criteria provided	VCV000002896	17	42460998	17	44383630	2896	17935	rs137852908	NC_000017.11:44383629:C:T
NM_000419.5(ITGA2B):c.414C>A (p.Cys138Ter)	ITGA2B	C138*	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000854735	17	42463079	17	44385711	854735	845495		NC_000017.11:44385710:G:T
NM_000419.5(ITGA2B):c.1346G>A (p.Gly449Asp)	ITGA2B	G418D, G449D	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Feb 11, 1994)	no assertion criteria provided	VCV000691627	17	42458294	17	44380926	691627	679346		NC_000017.11:44380925:C:T
NM_000419.5(ITGA2B):c.2094+2T>C	ITGA2B		Glanzmann thrombasthenia	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000458368	17	42455728	17	44378360	458368	468281	rs1555613692	NC_000017.11:44378359:A:G
NM_000419.5(ITGA2B):c.1878G>C (p.Gln626His)	ITGA2B	Q595H, Q626H	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000002903	17	42457057	17	44379689	2903	17942	rs80277041	NC_000017.11:44379688:C:G
NM_000419.5(ITGA2B):c.2870C>T (p.Ser957Leu)	ITGA2B	S926L, S957L	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000002902	17	42452100	17	44374732	2902	17941	rs80002943	NC_000017.11:44374731:G:A
NM_000419.5(ITGA2B):c.641T>C (p.Leu214Pro)	ITGA2B	L214P	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000002901	17	42462561	17	44385193	2901	17940	rs137852911	NC_000017.11:44385192:A:G
NM_000419.3(ITGA2B):c.1787T>C	ITGA2B	I565T, I596T	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000002900	17	42457148	17	44379780	2900	17939	rs76811038	NC_000017.11:44379779:A:G
NM_000419.5(ITGA2B):c.1063G>A (p.Glu355Lys)	ITGA2B	E324K, E355K	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000002899	17	42461008	17	44383640	2899	17938	rs137852910	NC_000017.11:44383639:C:T
NM_000419.5(ITGA2B):c.1366_1371del (p.Val456_Asp457del)	ITGA2B		Glanzmann thrombasthenia	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000002898	17	42458269 - 42458274	17	44380901 - 44380906	2898	17937	rs780017389	NC_000017.11:44380900:GTCTACG:G
NM_000419.5(ITGA2B):c.818G>A (p.Gly273Asp)	ITGA2B	G273D	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000002894	17	42461935	17	44384567	2894	17933	rs137852907	NC_000017.11:44384566:C:T
NM_000419.5(ITGA2B):c.2602-3C>G	ITGA2B		Glanzmann thrombasthenia	Pathogenic(Last reviewed: Jun 15, 1992)	no assertion criteria provided	VCV000002893	17	42453087	17	44375719	2893	17932	rs763330792	NC_000017.11:44375718:G:C
NM_000419.5(ITGA2B):c.1750C>T (p.Arg584Ter)	ITGA2B	R584*	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Jun 15, 1992)	no assertion criteria provided	VCV000002892	17	42457372	17	44380004	2892	17931	rs137852906	NC_000017.11:44380003:G:A
ITGA2B, 4.5-KB DEL, EX2-9	ITGA2B		Glanzmann thrombasthenia	Pathogenic(Last reviewed: Jan 1, 1991)	no assertion criteria provided	VCV000002890					2890	17929		
NM_000419.5(ITGA2B):c.409-2_419del	ITGA2B		Glanzmann thrombasthenia	Pathogenic(Last reviewed: Apr 15, 1991)	no assertion criteria provided	VCV000002889	17	42463074 - 42463086	17	44385706 - 44385718	2889	17928	rs879255508	NC_000017.11:44385705:GGGGCGCAGGCCTGG:GG
NM_000419.5(ITGA2B):c.2992del (p.Trp998fs)	ITGA2B	W998fs	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627292	17	42451790	17	44374422	627292	615568		NC_000017.11:44374421:A:
NM_000419.5(ITGA2B):c.1440-1G>A	ITGA2B		Glanzmann thrombasthenia	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627239	17	42457859	17	44380491	627239	615748		NC_000017.11:44380490:C:T
NM_000419.5(ITGA2B):c.559del (p.Val187fs)	ITGA2B	V187fs	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627093	17	42462934	17	44385566	627093	615579		NC_000017.11:44385565:C:
NM_000419.5(ITGA2B):c.409-1G>A	ITGA2B		Glanzmann thrombasthenia	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627063	17	42463085	17	44385717	627063	615753		NC_000017.11:44385716:C:T
NM_000419.5(ITGA2B):c.2883del (p.Phe961fs)	ITGA2B	F961fs	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627052	17	42452087	17	44374719	627052	615569		NC_000017.11:44374718:G:
NM_000419.5(ITGA2B):c.1544+1G>A	ITGA2B		Glanzmann thrombasthenia	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000002895	17	42457753	17	44380385	2895	17934	rs879255509	NC_000017.11:44380384:C:T
NM_001519.4(BRF1):c.875C>A (p.Pro292His)	BRF1	P177H, P292H, P265H, P88H, P54H	Cerebellofaciodental syndrome|cerebellar-facial-dental syndrome	Pathogenic(Last reviewed: Jan 5, 2015)	no assertion criteria provided	VCV000161426	14	105693011	14	105226674	161426	171266	rs606231450	NC_000014.9:105226673:G:T
NM_001519.4(BRF1):c.667C>T (p.Arg223Trp)	BRF1	R108W, R223W, R196W, R19W	Cerebellofaciodental syndrome|cerebellar-facial-dental syndrome	Pathogenic(Last reviewed: Jan 5, 2015)	no assertion criteria provided	VCV000161425	14	105707629	14	105241292	161425	171269	rs370270828	NC_000014.9:105241291:G:A
NM_001519.4(BRF1):c.776C>T (p.Thr259Met)	BRF1	T144M, T259M, T232M, T21M, T55M	Cerebellofaciodental syndrome|cerebellar-facial-dental syndrome	Pathogenic(Last reviewed: Jan 5, 2015)	no assertion criteria provided	VCV000161424	14	105695169	14	105228832	161424	171267	rs373957300	NC_000014.9:105228831:G:A
NM_001519.4(BRF1):c.677C>T (p.Ser226Leu)	BRF1	S111L, S226L, S199L, S22L	Cerebellofaciodental syndrome|cerebellar-facial-dental syndrome	Pathogenic(Last reviewed: Jan 5, 2015)	no assertion criteria provided	VCV000161423	14	105707619	14	105241282	161423	171268	rs606231416	NC_000014.9:105241281:G:A
NM_000485.3(APRT):c.407T>C (p.Met136Thr)	APRT	M136T	Adenine phosphoribosyltransferase deficiency|APRT deficiency, Japanese type	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000018296	16	88876242	16	88809834	18296	33335	rs28999113	NC_000016.10:88809833:A:G
NM_015721.3(GEMIN4):c.2452T>C (p.Trp818Arg)	GEMIN4	W818R	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES|Microcephaly|Severe dystonia|Global developmental delay|Congenital cataract	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2015)	no assertion criteria provided	VCV000183310	17	648831	17	745591	183310	181456	rs730882219	NC_000017.11:745590:A:G
NM_000336.3(SCNN1B):c.1852C>T (p.Pro618Ser)	SCNN1B	P618S	not provided	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000805492	16	23392051	16	23380730	805492	793632		NC_000016.10:23380729:C:T
NM_080669.6(SLC46A1):c.981_982del (p.Tyr327_Cys328delinsTer)	SLC46A1		not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801406	17	26731733 - 26731734	17	28404715 - 28404716	801406	789786		NC_000017.11:28404714:AG:
NM_182894.3(VSX2):c.71dup (p.Ala25fs)	VSX2		Anophthalmia - microphthalmia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000221962	14	74706329 - 74706330	14	74239626 - 74239627	221962	223644	rs869025268	NC_000014.9:74239626:GGGGGG:GGGGGGG
NM_080669.6(SLC46A1):c.23dup (p.Glu9fs)	SLC46A1		Congenital defect of folate absorption	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000065752	17	26733109 - 26733110	17	28406091 - 28406092	65752	76660	rs397515574	NC_000017.11:28406091:GGGGGG:GGGGGGG
NM_080669.6(SLC46A1):c.194dup (p.Cys66fs)	SLC46A1		Congenital defect of folate absorption	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000065750	17	26732938 - 26732939	17	28405920 - 28405921	65750	76658	rs80338769	NC_000017.11:28405920:CCCCCCC:CCCCCCCC
NM_080669.6(SLC46A1):c.197_198delinsAA (p.Cys66Ter)	SLC46A1		Congenital defect of folate absorption	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000021744	17	26732935 - 26732936	17	28405917 - 28405918	21744	34596	rs154623632	NC_000017.11:28405916:GC:TT
NM_182894.3(VSX2):c.599G>A (p.Arg200Gln)	VSX2	R200Q	Microphthalmia, cataracts, and iris abnormalities	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000014860	14	74726324	14	74259621	14860	29899	rs121912543	NC_000014.9:74259620:G:A
NM_182894.3(VSX2):c.267del (p.Gln90fs)	VSX2	Q90fs	Microphthalmia, isolated 2	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000849052	14	74706531	14	74239828	849052	841719		NC_000014.9:74239827:G:
NC_000014.8:g.(?_74706255)_(74712001_?)del	VSX2		Microphthalmia, isolated 2	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000645368	14	74706255 - 74712001	14	74239552 - 74245298	645368	652424		
CHX10, IVS1, G-A, -1	VSX2		Microphthalmia, isolated, with coloboma 3	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000014864					14864	29903		
NM_182894.3(VSX2):c.609G>A (p.Trp203Ter)	VSX2	W203*	Retinitis pigmentosa	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560530	14	74726334	14	74259631	560530	551575	rs1566888340	NC_000014.9:74259630:G:A
SLC46A1, 1-BP INS, 17C	SLC46A1		Congenital defect of folate absorption	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000030922					30922	39879		
CHX10, 4-KB DEL, EXON 3	VSX2		Microphthalmia, isolated 2	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000014863					14863	29902		
NM_080669.6(SLC46A1):c.194del (p.Gly65fs)	SLC46A1	G65fs	Congenital defect of folate absorption	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000000851	17	26732939	17	28405921	851	15890	rs80338769	NC_000017.11:28405920:CCCCCCC:CCCCCC
NM_080669.6(SLC46A1):c.466G>T (p.Asp156Tyr)	SLC46A1	D156Y	Congenital defect of folate absorption|not provided	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000065753	17	26732249	17	28405231	65753	76661	rs281875210	NC_000017.11:28405230:C:A
NM_080669.6(SLC46A1):c.204_205del (p.Asn68fs)	SLC46A1	N68fs	Congenital defect of folate absorption	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000030924	17	26732928 - 26732929	17	28405910 - 28405911	30924	39881	rs397515391	NC_000017.11:28405909:GG:
NM_080669.6(SLC46A1):c.439G>C (p.Gly147Arg)	SLC46A1	G147R	not provided|Congenital defect of folate absorption	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000021745	17	26732276	17	28405258	21745	34597	rs80338771	NC_000017.11:28405257:C:G
NM_000270.4(PNP):c.286-18G>A	PNP		Purine-nucleoside phosphorylase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000505116	14	20942914	14	20474755	505116	497661	rs1026474882	NC_000014.9:20474754:G:A
NM_001004127.3(ALG11):c.953A>C (p.Gln318Pro)	ALG11	Q318P	Congenital disorder of glycosylation type 1P	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000031647	13	52598819	13	52024683	31647	40324	rs387907184	NC_000013.11:52024682:A:C
NM_001004127.3(ALG11):c.836A>C (p.Tyr279Ser)	ALG11	Y279S	Congenital disorder of glycosylation type 1P	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000031644	13	52598702	13	52024566	31644	40321	rs387907181	NC_000013.11:52024565:A:C
NM_001004127.3(ALG11):c.623_642del (p.Ser208fs)	ALG11	S208fs	Congenital disorder of glycosylation type 1P	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000031643	13	52598488 - 52598507	13	52024352 - 52024371	31643	40320	rs387907180	NC_000013.11:52024351:TCTGTAGTGAAGAATCAAAAT:T
NM_001004127.3(ALG11):c.257T>C (p.Leu86Ser)	ALG11	L86S	Congenital disorder of glycosylation type 1P	Pathogenic(Last reviewed: Apr 15, 2010)	no assertion criteria provided	VCV000018393	13	52593261	13	52019125	18393	33432	rs267606652	NC_000013.11:52019124:T:C
NM_080669.6(SLC46A1):c.1012G>C (p.Gly338Arg)	SLC46A1	G338R	not provided|Congenital defect of folate absorption	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000030925	17	26731703	17	28404685	30925	39882	rs281875209	NC_000017.11:28404684:C:G
NM_080669.6(SLC46A1):c.1004C>A (p.Ala335Asp)	SLC46A1	A335D	Congenital defect of folate absorption|not provided	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000030923	17	26731711	17	28404693	30923	39880	rs281875208	NC_000017.11:28404692:G:T
NM_080669.6(SLC46A1):c.337C>T (p.Arg113Cys)	SLC46A1	R113C	not provided|Congenital defect of folate absorption	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000000855	17	26732378	17	28405360	855	15894	rs80338770	NC_000017.11:28405359:G:A
NM_080669.6(SLC46A1):c.954C>G (p.Ser318Arg)	SLC46A1	S318R	not provided|Congenital defect of folate absorption	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000000853	17	26731761	17	28404743	853	15892	rs80338772	NC_000017.11:28404742:G:C
NM_000419.5(ITGA2B):c.2148dup (p.Leu717fs)	ITGA2B		Glanzmann thrombasthenia|Macrothrombocytopenia	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000627273	17	42455104 - 42455105	17	44377736 - 44377737	627273	615574		NC_000017.11:44377736:C:CC
NM_000336.3(SCNN1B):c.1847C>T (p.Pro616Leu)	SCNN1B	P616L	Liddle syndrome 1|not provided	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000008831	16	23392046	16	23380725	8831	23870	rs387906402	NC_000016.10:23380724:C:T
NM_001142279.2(RNASEH2B):c.437-1G>A	RNASEH2B		not provided	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000424112	13	51517456	13	50943320	424112	409033	rs777313709	NC_000013.11:50943319:G:A
NC_000015.9:g.(?_55526960)_(55527152_?)del	RAB27A		Griscelli syndrome type 2	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000650701	15	55526960 - 55527152	15	55234762 - 55234954	650701	652686		
NC_000015.9:g.(?_55516067)_(55527152_?)del	RAB27A		Griscelli syndrome type 2	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000641551	15	55516067 - 55527152	15	55223869 - 55234954	641551	652680		
NC_000015.9:g.(?_55516067)_(55516230_?)del	RAB27A		Griscelli syndrome type 2	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000639378	15	55516067 - 55516230	15	55223869 - 55224032	639378	652397		
NM_183235.3(RAB27A):c.2T>C (p.Met1Thr)	RAB27A	M1T	Griscelli syndrome type 2	Pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000436459	15	55527131	15	55234933	436459	429706	rs141281020	NC_000015.10:55234932:A:G
NM_183235.3(RAB27A):c.454G>C (p.Ala152Pro)	RAB27A	A152P	Griscelli syndrome type 2	Pathogenic(Last reviewed: Mar 28, 2003)	no assertion criteria provided	VCV000005987	15	55516100	15	55223902	5987	21026	rs104894499	NC_000015.10:55223901:C:G
NM_183235.3(RAB27A):c.389T>C (p.Leu130Pro)	RAB27A	L130P	Griscelli syndrome type 2	Pathogenic(Last reviewed: Mar 28, 2003)	no assertion criteria provided	VCV000005986	15	55516165	15	55223967	5986	21025	rs104894498	NC_000015.10:55223966:A:G
RAB27A, 550C-T	RAB27A		Griscelli syndrome type 2	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000005984					5984	21023		
NM_183235.3(RAB27A):c.239+3A>G	RAB27A		Griscelli syndrome type 2	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000005983	15	55522596	15	55230398	5983	21022		NC_000015.10:55230397:T:C
NM_183235.3(RAB27A):c.217T>G (p.Trp73Gly)	RAB27A	W73G	Griscelli syndrome type 2	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000005982	15	55522621	15	55230423	5982	21021	rs28938176	NC_000015.10:55230422:A:C
NM_001142279.2(RNASEH2B):c.719C>G (p.Ser240Ter)	RNASEH2B	S240*	Aicardi Goutieres syndrome 2	Pathogenic(Last reviewed: Feb 25, 2018)	criteria provided, single submitter	VCV000582587	13	51523619	13	50949483	582587	566169	rs372632599	NC_000013.11:50949482:C:G
NM_001142279.2(RNASEH2B):c.121del (p.Val41fs)	RNASEH2B	V41fs	Aicardi Goutieres syndrome 2	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000567225	13	51501598	13	50927462	567225	568621	rs1452451283	NC_000013.11:50927461:GG:G
NM_001142279.2(RNASEH2B):c.667G>T (p.Glu223Ter)	RNASEH2B	E223*	Aicardi Goutieres syndrome 2	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000540251	13	51522173	13	50948037	540251	528154	rs1555257383	NC_000013.11:50948036:G:T
Single allele	RAB27A		Griscelli syndrome type 2	Pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, single submitter	VCV000468590			15	55228589 - 55234954	468590	464784		
RAB27A, IVS5, G-C, +1	RAB27A		Griscelli syndrome type 2	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000005989					5989	21028		
RAB27A, 67.5-KB DEL	RAB27A		Griscelli syndrome type 2	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000005985					5985	21024		
NM_001142279.2(RNASEH2B):c.554T>G (p.Val185Gly)	RNASEH2B	V185G	Aicardi Goutieres syndrome 2	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000001263	13	51519606	13	50945470	1263	16302	rs74555752	NC_000013.11:50945469:T:G
NM_001142279.2(RNASEH2B):c.136+1del	RNASEH2B		Aicardi Goutieres syndrome 2	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000566198	13	51501614	13	50927478	566198	567722	rs75186889	NC_000013.11:50927477:GG:G
NM_183235.3(RAB27A):c.18_19del (p.Tyr6_Asp7delinsTer)	RAB27A		not provided|Griscelli syndrome type 2	Pathogenic(Last reviewed: Aug 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000451279	15	55527114 - 55527115	15	55234916 - 55234917	451279	445391	rs1555394745	NC_000015.10:55234915:CA:
NM_001142279.2(RNASEH2B):c.488C>T (p.Thr163Ile)	RNASEH2B	T163I	Aicardi Goutieres syndrome 2	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000650668	13	51517508	13	50943372	650668	642024		NC_000013.11:50943371:C:T
NM_001142279.2(RNASEH2B):c.510+1G>A	RNASEH2B		Aicardi Goutieres syndrome 2	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000650490	13	51517531	13	50943395	650490	652842		NC_000013.11:50943394:G:A
NM_173500.4(TTBK2):c.1304_1305GA[1] (p.Asp436fs)	TTBK2			Pathogenic(Last reviewed: Feb 28, 2019)	no assertion criteria provided	VCV000041375	15	43069331 - 43069332	15	42777133 - 42777134	41375	49799	rs318240735	NC_000015.10:42777132:TCTCT:TCT
NM_183235.3(RAB27A):c.352C>T (p.Gln118Ter)	RAB27A	Q118*	Griscelli syndrome type 2	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000005990	15	55516202	15	55224004	5990	21029	rs104894500	NC_000015.10:55224003:G:A
NM_183235.3(RAB27A):c.51_52CT[1] (p.Ser18fs)	RAB27A		Griscelli syndrome type 2	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000005988	15	55527079 - 55527080	15	55234881 - 55234882	5988	21027		NC_000015.10:55234880:AGAG:AG
NM_080669.6(SLC46A1):c.337C>A (p.Arg113Ser)	SLC46A1	R113S	not provided|Congenital defect of folate absorption	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000000852	17	26732378	17	28405360	852	15891	rs80338770	NC_000017.11:28405359:G:T
NM_006121.4(KRT1):c.591+1G>T	KRT1		not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000451394	12	53073541	12	52679757	451394	445051	rs267607422	NC_000012.12:52679756:C:A
NM_006121.4(KRT1):c.1434G>C (p.Glu478Asp)	KRT1	E478D	not provided	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000391788	12	53070100	12	52676316	391788	372443	rs58949162	NC_000012.12:52676315:C:G
NM_003361.3(UMOD):c.490G>T (p.Glu164Ter)	UMOD	E164*, E197*	Uromodulin-associated kidney disease	Pathogenic	no assertion criteria provided	VCV000370029	16	20360133	16	20348811	370029	354268	rs1057515585	NC_000016.10:20348810:C:A
NM_003361.3(UMOD):c.944G>A (p.Cys315Tyr)	UMOD	C315Y, C348Y	not provided	Pathogenic(Last reviewed: Jun 10, 2013)	criteria provided, single submitter	VCV000094133	16	20359574	16	20348252	94133	100033	rs398123698	NC_000016.10:20348251:C:T
NM_003361.3(UMOD):c.317G>A (p.Cys106Tyr)	UMOD	C106Y, C139Y	Autosomal dominant medullary cystic kidney disease with hyperuricemia	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000807521	16	20360306	16	20348984	807521	798696		NC_000016.10:20348983:C:T
NM_003361.3(UMOD):c.651C>G (p.Cys217Trp)	UMOD	C250W, C217W	Glomerulocystic kidney disease with hyperuricemia and isosthenuria	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000807520	16	20359972	16	20348650	807520	798695		NC_000016.10:20348649:G:C
NM_003361.3(UMOD):c.890G>A (p.Cys297Tyr)	UMOD	C297Y, C330Y	Familial juvenile gout	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803225	16	20359628	16	20348306	803225	791530		NC_000016.10:20348305:C:T
NM_006121.4(KRT1):c.1865dup (p.Val623fs)	KRT1		Erythroderma, ichthyosiform, congenital reticular	Pathogenic(Last reviewed: Mar 16, 2015)	no assertion criteria provided	VCV000548649	12	53069046 - 53069047	12	52675262 - 52675263	548649	539150	rs1555171158	NC_000012.12:52675262:CCCCC:CCCCCC
NM_022463.5(NXN):c.1231_1233GAG[1] (p.Glu412del)	NXN	E304del, E412del	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2	Pathogenic(Last reviewed: Aug 8, 2019)	no assertion criteria provided	VCV000488062	17	704261 - 704263	17	801021 - 801023	488062	481073	rs1555607285	NC_000017.11:801020:CTCCTCC:CTCC
NM_003361.3(UMOD):c.744C>G (p.Cys248Trp)	UMOD	C248W, C281W	not provided	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000287876	16	20359879	16	20348557	287876	272113	rs886043751	NC_000016.10:20348556:G:C
NM_003361.3(UMOD):c.278_289delinsCCGCCTCCT (p.Val93_Gly97delinsAlaAlaSerCys)	UMOD		Autosomal dominant medullary cystic kidney disease with hyperuricemia	Pathogenic(Last reviewed: Jun 30, 2016)	no assertion criteria provided	VCV000242346	16	20360334 - 20360345	16	20349012 - 20349023	242346	243897	rs878855325	NC_000016.10:20349011:CTTCGGGGCAGA:AGGAGGCGG
NM_006121.4(KRT1):c.698C>T (p.Ser233Leu)	KRT1	S233L	not provided	Pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	VCV000066662	12	53072434	12	52678650	66662	77559	rs60297570	NC_000012.12:52678649:G:A
NM_006121.4(KRT1):c.559C>T (p.Leu187Phe)	KRT1	L187F	not provided	Pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	VCV000066648	12	53073574	12	52679790	66648	77545	rs59151464	NC_000012.12:52679789:G:A
DIAPH3, -172G-A	DIAPH3		Auditory neuropathy, autosomal dominant, 1	Pathogenic(Last reviewed: Jul 27, 2010)	no assertion criteria provided	VCV000031218					31218	40175		
KRT1, 1-BP INS, 1752G	KRT1		Epidermolytic hyperkeratosis, late-onset	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000015921					15921	30960		
KRT1, IVS6, G-A, +1	KRT1		Epidermolytic palmoplantar keratoderma	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000015920					15920	30959		
KRT1, 24-BP DEL, NT1376	KRT1		Nonepidermolytic palmoplantar keratoderma	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000015917					15917	30956		
KRT1, IVS1, T-A, +2	KRT1		Nonepidermolytic palmoplantar keratoderma	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000015916					15916	30955		
NM_006121.4(KRT1):c.1424T>C (p.Leu475Pro)	KRT1	L475P	Bullous ichthyosiform erythroderma	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000015915	12	53070110	12	52676326	15915	30954	rs137853225	NC_000012.12:52676325:A:G
NM_006121.4(KRT1):c.931G>C (p.Glu311Gln)	KRT1	E310Q, E311Q	Bullous ichthyosiform erythroderma	Pathogenic(Last reviewed: Aug 21, 1992)	no assertion criteria provided	VCV000015907	12	53071466	12	52677682	15907	30946	rs137853224	NC_000012.12:52677681:C:G
NM_003361.3(UMOD):c.553C>T (p.Arg185Cys)	UMOD	R185C, R218C	not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000586922	16	20360070	16	20348748	586922	577448	rs1567310155	NC_000016.10:20348747:G:A
NM_003361.3(UMOD):c.358T>G (p.Cys120Gly)	UMOD	C120G, C153G	Familial juvenile gout	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000488632	16	20360265	16	20348943	488632	481500	rs1555487621	NC_000016.10:20348942:A:C
NM_006121.4(KRT1):c.623T>C (p.Leu208Pro)	KRT1	L208P	Bullous ichthyosiform erythroderma|not provided	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000066659	12	53072509	12	52678725	66659	77556	rs61616632	NC_000012.12:52678724:A:G
NM_003361.3(UMOD):c.743G>C (p.Cys248Ser)	UMOD	C248S, C281S	Familial juvenile gout	Pathogenic(Last reviewed: May 15, 2010)	no assertion criteria provided	VCV000064644	16	20359880	16	20348558	64644	75598	rs398122388	NC_000016.10:20348557:C:G
KRT1, 1-BP DEL, 1628G	KRT1		Keratosis palmoplantaris striata 3	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000015918					15918	30957		
NM_003361.3(UMOD):c.943T>C (p.Cys315Arg)	UMOD	C315R, C348R	Glomerulocystic kidney disease with hyperuricemia and isosthenuria	Pathogenic(Last reviewed: Dec 15, 2003)	no assertion criteria provided	VCV000012263	16	20359575	16	20348253	12263	27302	rs121917773	NC_000016.10:20348252:A:G
NM_003361.3(UMOD):c.764G>A (p.Cys255Tyr)	UMOD	C255Y, C288Y	Familial juvenile gout	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000012261	16	20359859	16	20348537	12261	27300	rs121917771	NC_000016.10:20348536:C:T
NM_003361.3(UMOD):c.383A>G (p.Asn128Ser)	UMOD	N128S, N161S	Familial juvenile gout	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000012260	16	20360240	16	20348918	12260	27299	rs121917770	NC_000016.10:20348917:T:C
NM_003361.3(UMOD):c.230G>A (p.Cys77Tyr)	UMOD	C77Y, C110Y	Familial juvenile gout	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000012258	16	20360393	16	20349071	12258	27297	rs121917768	NC_000016.10:20349070:C:T
NM_003361.3(UMOD):c.307G>T (p.Gly103Cys)	UMOD	G103C, G136C	Autosomal dominant medullary cystic kidney disease with hyperuricemia	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000012257	16	20360316	16	20348994	12257	27296	rs28934584	NC_000016.10:20348993:C:A
NM_003361.3(UMOD):c.443G>A (p.Cys148Tyr)	UMOD	C148Y, C181Y	Familial juvenile gout	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000012255	16	20360180	16	20348858	12255	27294	rs28934582	NC_000016.10:20348857:C:T
NM_003361.3(UMOD):c.649T>G (p.Cys217Gly)	UMOD	C217G, C250G	Familial juvenile gout	Pathogenic(Last reviewed: Jan 6, 2012)	no assertion criteria provided	VCV000039418	16	20359974	16	20348652	39418	48017	rs28934583	NC_000016.10:20348651:A:C
NM_006121.4(KRT1):c.464T>A (p.Val155Asp)	KRT1	V155D	not provided|Bullous ichthyosiform erythroderma	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000015913	12	53073669	12	52679885	15913	30952	rs57959072	NC_000012.12:52679884:A:T
NM_006121.4(KRT1):c.1435A>T (p.Ile479Phe)	KRT1	I479F	not provided|Ichthyosis, cyclic, with epidermolytic hyperkeratosis	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000015912	12	53070099	12	52676315	15912	30951	rs61218439	NC_000012.12:52676314:T:A
NM_006121.4(KRT1):c.221A>T (p.Lys74Ile)	KRT1	K73I, K74I	Nonepidermolytic palmoplantar keratoderma|not provided	Pathogenic(Last reviewed: Dec 1, 1994)	no assertion criteria provided	VCV000015910	12	53073912	12	52680128	15910	30949	rs57977969	NC_000012.12:52680127:T:A
NM_006121.4(KRT1):c.1445A>G (p.Tyr482Cys)	KRT1	Y481C, Y482C	Bullous ichthyosiform erythroderma|not provided	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000015909	12	53070089	12	52676305	15909	30948	rs58420087	NC_000012.12:52676304:T:C
NM_003361.3(UMOD):c.817G>T (p.Val273Phe)	UMOD	V273F, V306F	Familial juvenile gout	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000012264	16	20359806	16	20348484	12264	27303	rs121917774	NC_000016.10:20348483:C:A
NM_003361.3(UMOD):c.649T>C (p.Cys217Arg)	UMOD	C217R, C250R	Familial juvenile gout	Pathogenic(Last reviewed: Dec 17, 2004)	no assertion criteria provided	VCV000012256	16	20359974	16	20348652	12256	27295	rs28934583	NC_000016.10:20348651:A:G
NM_173500.4(TTBK2):c.1285_1286GA[1] (p.Glu429fs)	TTBK2			Pathogenic(Last reviewed: Jul 22, 2008)	no assertion criteria provided	VCV000000848	15	43069350 - 43069351	15	42777152 - 42777153	848	15887	rs80356539	NC_000015.10:42777151:TCTCT:TCT
NM_003361.3(UMOD):c.610C>G (p.Arg204Gly)	UMOD	R204G, R237G	not provided	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000586923	16	20360013	16	20348691	586923	577447	rs1567310019	NC_000016.10:20348690:G:C
NM_003361.3(UMOD):c.947A>C (p.Gln316Pro)	UMOD	Q316P, Q349P	Familial juvenile gout|Autosomal dominant medullary cystic kidney disease with hyperuricemia	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000441279	16	20359571	16	20348249	441279	434935	rs1555487318	NC_000016.10:20348248:T:G
NM_006121.4(KRT1):c.1609_1610delinsA (p.Gly537fs)	KRT1		not provided|Ichthyosis histrix, curth-macklin type	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000015919	12	53069302 - 53069303	12	52675518 - 52675519	15919	30958	rs59169454	NC_000012.12:52675517:CC:T
NM_006121.4(KRT1):c.564C>A (p.Asn188Lys)	KRT1	N187K, N188K	not provided|Bullous ichthyosiform erythroderma	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000015914	12	53073569	12	52679785	15914	30953	rs59429455	NC_000012.12:52679784:G:T
NM_006121.4(KRT1):c.1436T>C (p.Ile479Thr)	KRT1	I479T	Ichthyosis, cyclic, with epidermolytic hyperkeratosis|not provided	Pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	VCV000015911	12	53070098	12	52676314	15911	30950	rs57837128	NC_000012.12:52676313:A:G
NM_006121.4(KRT1):c.482T>C (p.Leu161Pro)	KRT1	L160P, L161P	Bullous ichthyosiform erythroderma|not provided	Pathogenic(Last reviewed: Sep 4, 1992)	no assertion criteria provided	VCV000015908	12	53073651	12	52679867	15908	30947	rs57695159	NC_000012.12:52679866:A:G
NM_018418.5(SPATA7):c.253C>T (p.Arg85Ter)	SPATA7	R85*, R53*	Leber congenital amaurosis 3|Retinal dystrophy|SPATA7-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030806	14	88883069	14	88416725	30806	39763	rs140287375	NC_000014.9:88416724:C:T
NM_000270.3(PNP):c.701G>C (p.Arg234Pro)	PNP	R234P	Purine-nucleoside phosphorylase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013991	14	20944591	14	20476432	13991	29030	rs104894451	NC_000014.9:20476431:G:C
NM_001139.3(ALOX12B):c.530G>A (p.Trp177Ter)	ALOX12B	W177*	not provided	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000373376	17	7984096	17	8080778	373376	360345	rs959284348	NC_000017.11:8080777:C:T
NM_001139.3(ALOX12B):c.252C>A (p.Cys84Ter)	ALOX12B	C84*	not provided	Pathogenic(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	VCV000280119	17	7989434	17	8086116	280119	264881	rs886041394	NC_000017.11:8086115:G:T
NM_001139.3(ALOX12B):c.242del (p.Pro81fs)	ALOX12B	P81fs	not provided	Pathogenic(Last reviewed: May 25, 2016)	criteria provided, single submitter	VCV000265037	17	7989444	17	8086126	265037	260200	rs886039307	NC_000017.11:8086125:GGG:GG
NM_001139.3(ALOX12B):c.435-2A>G	ALOX12B		Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803318	17	7984296	17	8080978	803318	791844		NC_000017.11:8080977:T:C
NM_001139.3(ALOX12B):c.1859C>A (p.Pro620Gln)	ALOX12B	P620Q	Ichthyosis (disease)	Pathogenic(Last reviewed: Jun 22, 2015)	criteria provided, single submitter	VCV000374101	17	7976533	17	8073215	374101	361028	rs780420901	NC_000017.11:8073214:G:T
NM_001139.3(ALOX12B):c.1350dup (p.Leu451fs)	ALOX12B		Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633827	17	7979986 - 7979987	17	8076668 - 8076669	633827	622246	rs746723399	NC_000017.11:8076668:CCCCCCC:CCCCCCCC
NM_001139.3(ALOX12B):c.286_287dup (p.Tyr97fs)	ALOX12B		Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633825	17	7989398 - 7989399	17	8086080 - 8086081	633825	622251	rs1567985261	NC_000017.11:8086080:ATA:ATATA
NM_001139.3(ALOX12B):c.147+1_353-1del	ALOX12B		Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633823	17	7984506 - 7990613			633823	622265		
NM_001139.3(ALOX12B):c.199A>T (p.Ile67Phe)	ALOX12B	I67F	Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000039547	17	7989487	17	8086169	39547	48146	rs397514533	NC_000017.11:8086168:T:A
NM_001139.3(ALOX12B):c.353-1G>A	ALOX12B		Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000039544	17	7984506	17	8081188	39544	48143		NC_000017.11:8081187:C:T
NM_001139.3(ALOX12B):c.1207C>T (p.His403Tyr)	ALOX12B	H403Y	Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000039543	17	7980376	17	8077058	39543	48142	rs397514531	NC_000017.11:8077057:G:A
NM_001139.3(ALOX12B):c.1180G>A (p.Glu394Lys)	ALOX12B	E394K	Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000039541	17	7980403	17	8077085	39541	48140	rs397514529	NC_000017.11:8077084:C:T
NM_001139.3(ALOX12B):c.2036G>T (p.Arg679Leu)	ALOX12B	R679L	Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000039540	17	7976159	17	8072841	39540	48139	rs397514528	NC_000017.11:8072840:C:A
NM_001139.3(ALOX12B):c.340C>T (p.Arg114Trp)	ALOX12B	R114W	Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000039538	17	7989346	17	8086028	39538	48137	rs397514526	NC_000017.11:8086027:G:A
NM_001139.3(ALOX12B):c.1734C>A (p.His578Gln)	ALOX12B	H578Q	Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000006084	17	7976996	17	8073678	6084	21123	rs137853024	NC_000017.11:8073677:G:T
NM_001139.3(ALOX12B):c.1277T>C (p.Leu426Pro)	ALOX12B	L426P	Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000006083	17	7980060	17	8076742	6083	21122	rs137853023	NC_000017.11:8076741:A:G
NM_001139.3(ALOX12B):c.1389del (p.Phe463fs)	ALOX12B	F463fs	Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000006082	17	7979636	17	8076318	6082	21121	rs387906349	NC_000017.11:8076317:AAA:AA
NM_001139.3(ALOX12B):c.527+2T>G	ALOX12B		Autosomal recessive congenital ichthyosis 2	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000437455	17	7984200	17	8080882	437455	431019	rs1555643304	NC_000017.11:8080881:A:C
NM_003361.3(UMOD):c.898T>G (p.Cys300Gly)	UMOD	C300G, C333G	Familial juvenile gout|Glomerulocystic kidney disease with hyperuricemia and isosthenuria	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000012262	16	20359620	16	20348298	12262	27301	rs121917772	NC_000016.10:20348297:A:C
NM_003361.3(UMOD):c.376T>C (p.Cys126Arg)	UMOD	C126R, C159R	Familial juvenile gout	Pathogenic(Last reviewed: Jan 6, 2012)	no assertion criteria provided	VCV000012259	16	20360247	16	20348925	12259	27298	rs121917769	NC_000016.10:20348924:A:G
NM_183235.3(RAB27A):c.149del (p.Arg50fs)	RAB27A	R50fs	Griscelli syndrome	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000504894	15	55526984	15	55234786	504894	497250	rs770601673	NC_000015.10:55234785:C:
NM_182894.3(VSX2):c.599G>C (p.Arg200Pro)	VSX2	R200P	Microphthalmia, cataracts, and iris abnormalities|Microphthalmia, isolated 2|not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000014861	14	74726324	14	74259621	14861	29900	rs121912543	NC_000014.9:74259620:G:C
NM_033419.5(PGAP3):c.109G>T (p.Glu37Ter)	PGAP3	E37*	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000520887	17	37844159	17	39687906	520887	512275	rs1242562412	NC_000017.11:39687905:C:A
NM_004452.3(ESRRB):c.787G>A (p.Gly263Ser)	ESRRB	G263S	Deafness, autosomal recessive 35	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402255	14	76949102	14	76482759	402255	389246	rs375916159	NC_000014.9:76482758:G:A
NM_004452.3(ESRRB):c.545G>A (p.Arg182His)	ESRRB	R182H	Deafness, autosomal recessive 35	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402254	14	76948389	14	76482046	402254	389245	rs1060499794	NC_000014.9:76482045:G:A
NM_021150.4(GRIP1):c.1177_1180AAGA[1] (p.Lys394fs)	GRIP1		FRASER SYNDROME 3	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000036971	12	66849203 - 66849206	12	66455423 - 66455426	36971	45628	rs397514486	NC_000012.12:66455422:TCTTTCTTT:TCTTT
NM_021150.4(GRIP1):c.2113+1G>C	GRIP1		FRASER SYNDROME 3	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000036970	12	66786456	12	66392676	36970	45627	rs397514485	NC_000012.12:66392675:C:G
NM_004452.3(ESRRB):c.329C>T (p.Ala110Val)	ESRRB	A110V	Deafness, autosomal recessive 35	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000007499	14	76906025	14	76439682	7499	22538	rs121909110	NC_000014.9:76439681:C:T
ESRRB, 7-BP DUP, NT1018	ESRRB		Deafness, autosomal recessive 35	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000007498					7498	22537		
NM_004452.3(ESRRB):c.1024G>T (p.Val342Leu)	ESRRB	V342L	Deafness, autosomal recessive 35	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000007500	14	76958026	14	76491683	7500	22539	rs121909111	NC_000014.9:76491682:G:T
NM_003361.3(UMOD):c.529_555del (p.His177_Arg185del)	UMOD		not provided|Familial juvenile gout	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000012254	16	20360068 - 20360094	16	20348746 - 20348772	12254	27293	rs1555487528	NC_000016.10:20348745:GCGCCAGTACTCGTCCAGGGTGCGGTG:
NM_170665.4(ATP2A2):c.1372G>T (p.Glu458Ter)	ATP2A2	E458*	not provided	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000420103	12	110771901	12	110334096	420103	408519	rs757914881	NC_000012.12:110334095:G:T
NM_170665.4(ATP2A2):c.1429C>T (p.Gln477Ter)	ATP2A2	Q477*	not provided	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000419479	12	110777095	12	110339290	419479	408520	rs1064793900	NC_000012.12:110339289:C:T
NM_170665.4(ATP2A2):c.2384A>G (p.Asn795Ser)	ATP2A2	N795S	not provided	Pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV000379925	12	110781102	12	110343297	379925	374565	rs1057520789	NC_000012.12:110343296:A:G
NM_170665.4(ATP2A2):c.1185-1G>A	ATP2A2		not provided	Pathogenic(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	VCV000379334	12	110770985	12	110333180	379334	372850	rs1057520577	NC_000012.12:110333179:G:A
NM_170665.4(ATP2A2):c.289_290AT[1] (p.Leu98fs)	ATP2A2		not provided	Pathogenic(Last reviewed: May 5, 2016)	criteria provided, single submitter	VCV000280566	12	110729894 - 110729895	12	110292089 - 110292090	280566	264500	rs886041748	NC_000012.12:110292088:ATAT:AT
NM_170665.4(ATP2A2):c.1A>T (p.Met1Leu)	ATP2A2	M1L	not provided	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000280505	12	110719595	12	110281790	280505	264497	rs886041697	NC_000012.12:110281789:A:T
NM_170665.4(ATP2A2):c.2058del (p.Ile686fs)	ATP2A2	I686fs	not provided	Pathogenic(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	VCV000280355	12	110778760	12	110340955	280355	264569	rs886041576	NC_000012.12:110340954:C:
NM_170665.4(ATP2A2):c.2093C>T (p.Ala698Val)	ATP2A2	A698V	Acrokeratosis verruciformis of Hopf	Pathogenic(Last reviewed: Sep 1, 2010)	no assertion criteria provided	VCV000029610	12	110778795	12	110340990	29610	38564	rs387906594	NC_000012.12:110340989:C:T
NM_170665.4(ATP2A2):c.1805C>T (p.Pro602Leu)	ATP2A2	P602L	Acrokeratosis verruciformis of Hopf	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000017799	12	110778507	12	110340702	17799	32838	rs121912737	NC_000012.12:110340701:C:T
NM_170665.4(ATP2A2):c.2682C>A (p.Tyr894Ter)	ATP2A2	Y894*	Darier disease, segmental	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000017797	12	110783128	12	110345323	17797	32836	rs121912735	NC_000012.12:110345322:C:A
NM_170665.4(ATP2A2):c.2258_2260ACA[2] (p.Asn755del)	ATP2A2	N755del	Keratosis follicularis	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000017796	12	110780193 - 110780195	12	110342388 - 110342390	17796	32835	rs1566240208	NC_000012.12:110342387:ACAACAACA:ACAACA
ATP2A2, 18-BP INS, IVS2, -12	ATP2A2		Keratosis follicularis	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000017795					17795	32834		
NM_170665.4(ATP2A2):c.1678T>C (p.Cys560Arg)	ATP2A2	C560R	Keratosis follicularis	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000017794	12	110777443	12	110339638	17794	32833	rs121912734	NC_000012.12:110339637:T:C
NM_170665.4(ATP2A2):c.803G>T (p.Cys268Phe)	ATP2A2	C268F	Darier disease, acral hemorrhagic type	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000017793	12	110765530	12	110327725	17793	32832	rs121912733	NC_000012.12:110327724:G:T
NM_170665.4(ATP2A2):c.544+1G>A	ATP2A2		Keratosis follicularis	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000017791	12	110760878	12	110323073	17791	32830		NC_000012.12:110323072:G:A
NM_170665.4(ATP2A2):c.322C>T (p.Gln108Ter)	ATP2A2	Q108*	Keratosis follicularis	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000017790	12	110729927	12	110292122	17790	32829	rs121912731	NC_000012.12:110292121:C:T
NM_170665.4(ATP2A2):c.392G>A (p.Arg131Gln)	ATP2A2	R131Q	Keratosis follicularis	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000017800	12	110734471	12	110296666	17800	32839	rs121912738	NC_000012.12:110296665:G:A
NM_170665.4(ATP2A2):c.2305G>A (p.Gly769Arg)	ATP2A2	G769R	not provided|Darier disease, segmental	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000017798	12	110780240	12	110342435	17798	32837	rs121912736	NC_000012.12:110342434:G:A
NM_170665.4(ATP2A2):c.2300A>G (p.Asn767Ser)	ATP2A2	N767S	not provided|Darier disease, acral hemorrhagic type	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000017792	12	110780235	12	110342430	17792	32831	rs121912732	NC_000012.12:110342429:A:G
NM_170665.4(ATP2A2):c.68G>A (p.Gly23Glu)	ATP2A2	G23E	Keratosis follicularis|not provided	Pathogenic(Last reviewed: Aug 19, 2015)	criteria provided, single submitter	VCV000017789	12	110719662	12	110281857	17789	32828	rs28929478	NC_000012.12:110281856:G:A
NM_001139.3(ALOX12B):c.1294C>T (p.Arg432Ter)	ALOX12B	R432*	Autosomal recessive congenital ichthyosis 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039539	17	7980043	17	8076725	39539	48138	rs397514527	NC_000017.11:8076724:G:A
NM_004970.2(IGFALS):c.1291del (p.Trp431fs)	IGFALS	W469fs, W431fs	not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000280144	16	1841128	16	1791127	280144	264656	rs755775132	NC_000016.10:1791126:A:
NM_004970.2(IGFALS):c.583_591dup (p.Ser195_Arg197dup)	IGFALS		Acid-labile subunit deficiency	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000008129	16	1841827 - 1841828	16	1791826 - 1791827	8129	23168	rs606231171	NC_000016.10:1791826:GCGCAGGCTGC:GCGCAGGCTGCGCAGGCTGC
NM_004970.2(IGFALS):c.1618T>C (p.Cys540Arg)	IGFALS	C540R, C578R	Acid-labile subunit deficiency	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000008128	16	1840801	16	1790800	8128	23167	rs121909247	NC_000016.10:1790799:A:G
NM_004970.2(IGFALS):c.103del (p.Glu35fs)	IGFALS	E73fs, E35fs	Acid-labile subunit deficiency	Pathogenic(Last reviewed: Feb 5, 2004)	no assertion criteria provided	VCV000008127	16	1842316	16	1792315	8127	23166	rs587776686	NC_000016.10:1792314:CCCCC:CCCC
NM_021939.3(FKBP10):c.392-2A>G	FKBP10		not provided	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000504221	17	39974339	17	41818087	504221	495419	rs1555616334	NC_000017.11:41818086:A:G
NM_021939.3(FKBP10):c.831del (p.Gly278fs)	FKBP10	G278fs	not provided	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000503914	17	39975559	17	41819307	503914	495422	rs137853883	NC_000017.11:41819306:CCCCCCC:CCCCCC
NM_021939.3(FKBP10):c.1399+2T>G	FKBP10		not provided	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000288324	17	39977343	17	41821091	288324	272561	rs886044880	NC_000017.11:41821090:T:G
NM_000376.3(VDR):c.1190A>C (p.His397Pro)	VDR	H397P, H447P	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: May 3, 2016)	no assertion criteria provided	VCV000264697	12	48238623	12	47844840	264697	259277	rs886037890	NC_000012.12:47844839:T:G
NM_000376.3(VDR):c.1171C>A (p.Arg391Ser)	VDR	R391S, R441S	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: May 3, 2016)	no assertion criteria provided	VCV000264696	12	48238642	12	47844859	264696	259278	rs121909800	NC_000012.12:47844858:G:T
NM_021939.3(FKBP10):c.976del (p.Met326fs)	FKBP10	M326fs	Osteogenesis imperfecta, type XI	Pathogenic(Last reviewed: Aug 25, 2016)	no assertion criteria provided	VCV000222952	17	39975840	17	41819588	222952	223011	rs869025223	NC_000017.11:41819587:A:
NM_004119.2(FLT3):c.1773_1793dup (p.Glu598_Tyr599insAspValAspPheArgGluTyr)	FLT3		Myelodysplastic syndrome progressed to acute myeloid leukemia	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000219096	13	28608262 - 28608263	13	28034125 - 28034126	219096	216788	rs864321619	NC_000013.11:28034125:TCATATTCTCTGAAATCAACGT:TCATATTCTCTGAAATCAACGTCATATTCTCTGAAATCAACGT
NM_021939.3(FKBP10):c.948dup (p.Ile317fs)	FKBP10		Osteogenesis imperfecta type 12	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000041899	17	39975811 - 39975812	17	41819559 - 41819560	41899	50336	rs387907325	NC_000017.11:41819559:T:TT
NM_021939.3(FKBP10):c.1207C>T (p.Arg403Ter)	FKBP10	R403*	Osteogenesis imperfecta type 12	Pathogenic(Last reviewed: Nov 22, 2011)	no assertion criteria provided	VCV000039842	17	39976664	17	41820412	39842	48441	rs372896892	NC_000017.11:41820411:C:T
NM_021939.3(FKBP10):c.743dup (p.Gln249fs)	FKBP10		Bruck syndrome 1	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030635	17	39975471 - 39975472	17	41819219 - 41819220	30635	39592	rs1555616552	NC_000017.11:41819219:CCCCCC:CCCCCCC
NM_021939.3(FKBP10):c.1276dup (p.Gln426fs)	FKBP10		Bruck syndrome 1	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030633	17	39977212 - 39977213	17	41820960 - 41820961	30633	39590	rs1567856056	NC_000017.11:41820960:CCCCCC:CCCCCCC
FKBP10, 35-BP DEL, NT122	FKBP10		Osteogenesis imperfecta type 12	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030632					30632	39589		
FKBP10, 8-BP DUP, NT1016	FKBP10		Bruck syndrome 1	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000030631					30631	39588		
NM_004119.2(FLT3):c.1777_1779del (p.Asp593del)	FLT3	D593del	Acute lymphoid leukemia	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	VCV000016278	13	28608277 - 28608279	13	28034140 - 28034142	16278	31317	rs587776834	NC_000013.11:28034139:ATCA:A
NM_000376.3(VDR):c.1036G>A (p.Val346Met)	VDR	V346M, V396M	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000007759	12	48238777	12	47844994	7759	22798	rs267607169	NC_000012.12:47844993:C:T
NM_000376.3(VDR):c.366del (p.Lys123fs)	VDR	K173fs, K123fs	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000007758	12	48251383	12	47857600	7758	22797		NC_000012.12:47857599:GGG:GG
NM_000376.3(VDR):c.1171C>T (p.Arg391Cys)	VDR	R391C, R441C	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000007756	12	48238642	12	47844859	7756	22795	rs121909800	NC_000012.12:47844858:G:A
NM_000376.3(VDR):c.941T>G (p.Ile314Ser)	VDR	I314S, I364S	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000007755	12	48240201	12	47846418	7755	22794	rs121909799	NC_000012.12:47846417:A:C
NM_000376.3(VDR):c.137G>A (p.Gly46Asp)	VDR	G46D, G96D	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000007753	12	48272760	12	47878977	7753	22792	rs121909797	NC_000012.12:47878976:C:T
NM_000376.3(VDR):c.454C>T (p.Gln152Ter)	VDR	Q149*, Q152*, Q202*	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Jul 1, 1993)	no assertion criteria provided	VCV000007751	12	48251295	12	47857512	7751	22790	rs121909795	NC_000012.12:47857511:G:A
NM_000376.3(VDR):c.239G>A (p.Arg80Gln)	VDR	R77Q, R80Q, R130Q	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Apr 1, 1990)	no assertion criteria provided	VCV000007749	12	48258868	12	47865085	7749	22788	rs121909793	NC_000012.12:47865084:C:T
NM_000376.3(VDR):c.985G>A (p.Glu329Lys)	VDR	E329K, E379K	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000007748	12	48240157	12	47846374	7748	22787	rs121909802	NC_000012.12:47846373:C:T
NM_000376.3(VDR):c.98G>A (p.Gly33Asp)	VDR	G33D, G83D	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Dec 23, 1988)	no assertion criteria provided	VCV000007745	12	48272799	12	47879016	7745	22784	rs121909790	NC_000012.12:47879015:C:T
FKBP10, 33-BP DEL, NT321	FKBP10		Osteogenesis imperfecta type 12	Pathogenic(Last reviewed: Apr 9, 2010)	no assertion criteria provided	VCV000003532					3532	18571		
NM_021939.3(FKBP10):c.890_897dup (p.Gly300Ter)	FKBP10		Osteogenesis imperfecta, type XI|Bruck syndrome 1	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000631496	17	39975623 - 39975624	17	41819371 - 41819372	631496	619859	rs1567855132	NC_000017.11:41819371:TGATGGAC:TGATGGACTGATGGAC
NM_021939.3(FKBP10):c.337G>A (p.Glu113Lys)	FKBP10	E113K	Bruck syndrome 1	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000041473	17	39973401	17	41817149	41473	49909	rs397514674	NC_000017.11:41817148:G:A
NM_000376.3(VDR):c.88C>T (p.Arg30Ter)	VDR	R30*, R80*	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000007757	12	48272809	12	47879026	7757	22796	rs121909801	NC_000012.12:47879025:G:A
NM_000376.3(VDR):c.915C>G (p.His305Gln)	VDR	H305Q, H355Q	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Jan 15, 1997)	no assertion criteria provided	VCV000007754	12	48240227	12	47846444	7754	22793	rs121909798	NC_000012.12:47846443:G:C
NM_000376.3(VDR):c.821G>T (p.Arg274Leu)	VDR	R271L, R274L, R324L	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Jul 1, 1993)	no assertion criteria provided	VCV000007752	12	48240526	12	47846743	7752	22791	rs121909796	NC_000012.12:47846742:C:A
NM_000376.3(VDR):c.149G>A (p.Arg50Gln)	VDR	R47Q, R50Q, R100Q	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Sep 1, 1991)	no assertion criteria provided	VCV000007750	12	48258958	12	47865175	7750	22789	rs121909794	NC_000012.12:47865174:C:T
NM_000376.3(VDR):c.885C>A (p.Tyr295Ter)	VDR	Y292*, Y295*, Y345*	Vitamin D-dependent rickets, type 2	Pathogenic(Last reviewed: Dec 1, 1990)	no assertion criteria provided	VCV000007747	12	48240462	12	47846679	7747	22786	rs121909792	NC_000012.12:47846678:G:T
NM_021939.3(FKBP10):c.877_879del (p.Tyr293del)	FKBP10	Y293del	not provided|Bruck syndrome 1	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000208427	17	39975609 - 39975611	17	41819357 - 41819359	208427	204645	rs869320752	NC_000017.11:41819356:ACTAC:AC
NM_021939.3(FKBP10):c.1271_1272delinsA (p.Ala424fs)	FKBP10		Bruck syndrome 1|Osteogenesis imperfecta type 12	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000041425	17	39977213 - 39977214	17	41820961 - 41820962	41425	49863	rs397509383	NC_000017.11:41820960:CC:A
NM_021939.3(FKBP10):c.344G>A (p.Arg115Gln)	FKBP10	R115Q	Bruck syndrome 1	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000030634	17	39973408	17	41817156	30634	39591	rs387906960	NC_000017.11:41817155:G:A
NM_004119.2(FLT3):c.2520_2521insGGATCC (p.Asn841_Tyr842insGlySer)	FLT3		Acute myeloid leukemia	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000016271	13	28592624 - 28592625	13	28018487 - 28018488	16271	31310	rs398122514	NC_000013.11:28018487:GGA:GGATCCGGA
NM_001139.3(ALOX12B):c.1642C>T (p.Arg548Trp)	ALOX12B	R548W	Autosomal recessive congenital ichthyosis 2|not provided|Congenital ichthyosiform erythroderma|Congenital nonbullous ichthyosiform erythroderma	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039545	17	7978925	17	8075607	39545	48144	rs397514532	NC_000017.11:8075606:G:A
NM_004448.3(ERBB2):c.2740G>A (p.Glu914Lys)	ERBB2	E914K, E884K, E899K	Glioma susceptibility 1	Pathogenic(Last reviewed: Sep 30, 2004)	no assertion criteria provided	VCV000013878	17	37881974	17	39725721	13878	28917	rs28933368	NC_000017.11:39725720:G:A
FLT3, INTERNAL TANDEM DUP	FLT3		Leukemia, acute myeloid, reduced survival in	Pathogenic(Last reviewed: Sep 17, 2009)	no assertion criteria provided	VCV000016270					16270	31309		
NM_004448.3(ERBB2):c.2606T>G (p.Leu869Arg)	ERBB2	L839R, L854R, L869R	Lung adenocarcinoma	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000431024	17	37881414	17	39725161	431024	424554	rs1131692237	NC_000017.11:39725160:T:G
NM_004448.3(ERBB2):c.2328_2336dup (p.Val777_Ser779dup)	ERBB2		Lung adenocarcinoma	Pathogenic(Last reviewed: Sep 30, 2004)	no assertion criteria provided	VCV000013876	17	37880998 - 37880999	17	39724745 - 39724746	13876	28915	rs587776805	NC_000017.11:39724745:TGTGGGCTC:TGTGGGCTCTGTGGGCTC
NM_138477.4(CDAN1):c.3024_3025insTT (p.Glu1009fs)	CDAN1		not provided	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000817663	15	43019890 - 43019891	15	42727692 - 42727693	817663	805824		NC_000015.10:42727692::AA
NM_138477.4(CDAN1):c.3145dup (p.Ser1049fs)	CDAN1		not provided	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000504471	15	43018566 - 43018567	15	42726368 - 42726369	504471	495773	rs769679860	NC_000015.10:42726368:A:AA
NM_138477.4(CDAN1):c.1239T>A (p.Tyr413Ter)	CDAN1	Y413*	Congenital dyserythropoietic anemia, type I	Pathogenic(Last reviewed: May 14, 2019)	no assertion criteria provided	VCV000827786	15	43026442	15	42734244	827786	816003		NC_000015.10:42734243:A:T
NM_138477.4(CDAN1):c.1117_1119del (p.Val373del)	CDAN1	V372del, V373del	Congenital dyserythropoietic anemia, type I	Pathogenic(Last reviewed: Jun 15, 2006)	no assertion criteria provided	VCV000003182	15	43027315 - 43027317	15	42735117 - 42735119	3182	18221	rs120074169	NC_000015.10:42735116:AAC:
NM_138477.4(CDAN1):c.1860+5G>A	CDAN1		Congenital dyserythropoietic anemia, type I	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000003181	15	43023404	15	42731206	3181	18220	rs113313967	NC_000015.10:42731205:C:T
NM_138477.4(CDAN1):c.2602T>A (p.Phe868Ile)	CDAN1	F866I, F868I	Congenital dyserythropoietic anemia, type I	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000003180	15	43021264	15	42729066	3180	18219	rs120074168	NC_000015.10:42729065:A:T
NM_183235.3(RAB27A):c.419_420AG[2] (p.Arg141fs)	RAB27A		Griscelli syndrome type 2	Pathogenic(Last reviewed: Nov 17, 2018)	criteria provided, single submitter	VCV000640583	15	55516130 - 55516131	15	55223932 - 55223933	640583	643440		NC_000015.10:55223931:CTCTCT:CTCT
NM_173500.4(TTBK2):c.1329dup (p.Arg444fs)	TTBK2			Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV000000847	15	43069308 - 43069309	15	42777110 - 42777111	847	15886	rs80356538	NC_000015.10:42777110:T:TT
NM_138477.4(CDAN1):c.1796A>G (p.Asn599Ser)	CDAN1	N598S, N599S	Congenital dyserythropoietic anemia, type I	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000003178	15	43023473	15	42731275	3178	18217	rs120074166	NC_000015.10:42731274:T:C
NM_138477.4(CDAN1):c.3124C>T (p.Arg1042Trp)	CDAN1	R1040W, R1042W	Congenital dyserythropoietic anemia, type I	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000003176	15	43018588	15	42726390	3176	18215	rs80338697	NC_000015.10:42726389:G:A
NM_004119.2(FLT3):c.2503_2505del (p.Asp835del)	FLT3	D835del	Acute myeloid leukemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000016277	13	28592640 - 28592642	13	28018503 - 28018505	16277	31316	rs121913486	NC_000013.11:28018502:ATC:
NM_016532.4(INPP5K):c.418G>A (p.Gly140Ser)	INPP5K	G140S, G64S	Muscular dystrophy, congenital, with cataracts and intellectual disability	Pathogenic(Last reviewed: Jul 21, 2017)	no assertion criteria provided	VCV000417783	17	1412608	17	1509314	417783	404684	rs749383757	NC_000017.11:1509313:C:T
NM_016532.4(INPP5K):c.1251_1252del (p.Asn417fs)	INPP5K	N417fs, N341fs	Muscular dystrophy, congenital, with cataracts and intellectual disability	Pathogenic(Last reviewed: Apr 4, 2017)	no assertion criteria provided	VCV000417782	17	1399392 - 1399393	17	1496098 - 1496099	417782	404683	rs1060505040	NC_000017.11:1496097:TGT:T
NM_016532.4(INPP5K):c.805G>A (p.Asp269Asn)	INPP5K	D269N, D193N	Muscular dystrophy, congenital, with cataracts and intellectual disability	Pathogenic(Last reviewed: Apr 4, 2017)	no assertion criteria provided	VCV000417781	17	1401388	17	1498094	417781	404682	rs761612652	NC_000017.11:1498093:C:T
NM_016532.4(INPP5K):c.67G>A (p.Val23Met)	INPP5K	V23M	Muscular dystrophy, congenital, with cataracts and intellectual disability	Pathogenic(Last reviewed: Apr 4, 2017)	no assertion criteria provided	VCV000417780	17	1417251	17	1513957	417780	404681	rs750781027	NC_000017.11:1513956:C:T
NM_016532.4(INPP5K):c.277A>G (p.Met93Val)	INPP5K	M93V, M17V	Muscular dystrophy, congenital, with cataracts and intellectual disability	Pathogenic(Last reviewed: Apr 4, 2017)	no assertion criteria provided	VCV000417779	17	1413078	17	1509784	417779	404680	rs1060505039	NC_000017.11:1509783:T:C
NM_016532.4(INPP5K):c.899A>G (p.Tyr300Cys)	INPP5K	Y300C, Y224C	Muscular dystrophy, congenital, with cataracts and intellectual disability	Pathogenic(Last reviewed: Apr 4, 2017)	no assertion criteria provided	VCV000417778	17	1401294	17	1498000	417778	404679	rs766046008	NC_000017.11:1497999:T:C
NM_016532.4(INPP5K):c.149T>C (p.Ile50Thr)	INPP5K	I50T	Muscular dystrophy, congenital, with cataracts and intellectual disability	Pathogenic(Last reviewed: Apr 4, 2017)	no assertion criteria provided	VCV000417777	17	1417169	17	1513875	417777	404678	rs1060505038	NC_000017.11:1513874:A:G
NM_138477.4(CDAN1):c.3389C>T (p.Pro1130Leu)	CDAN1	P1129L, P1130L	Congenital dyserythropoietic anemia, type I	Pathogenic(Last reviewed: May 14, 2019)	no assertion criteria provided	VCV000003177	15	43017748	15	42725550	3177	18216	rs80338699	NC_000015.10:42725549:G:A
NM_001451.3(FOXF1):c.145C>G (p.Pro49Ala)	FOXF1	P49A		Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800377	16	86544320	16	86510714	800377	788964		NC_000016.10:86510713:C:G
NM_001451.3(FOXF1):c.849_850del (p.Ile285fs)	FOXF1	I285fs		Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800376	16	86545024 - 86545025	16	86511418 - 86511419	800376	788971		NC_000016.10:86511417:TT:
NM_001451.3(FOXF1):c.316T>C (p.Phe106Leu)	FOXF1	F106L		Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800375	16	86544491	16	86510885	800375	788969		NC_000016.10:86510884:T:C
NM_001451.3(FOXF1):c.862C>T (p.Gln288Ter)	FOXF1	Q288*		Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800374	16	86545037	16	86511431	800374	788972		NC_000016.10:86511430:C:T
NM_001451.3(FOXF1):c.294C>A (p.His98Gln)	FOXF1	H98Q		Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800373	16	86544469	16	86510863	800373	788968		NC_000016.10:86510862:C:A
NM_001451.3(FOXF1):c.539C>A (p.Ser180Ter)	FOXF1	S180*		Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800372	16	86544714	16	86511108	800372	788970		NC_000016.10:86511107:C:A
NM_001451.3(FOXF1):c.221T>A (p.Ile74Asn)	FOXF1	I74N		Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800371	16	86544396	16	86510790	800371	788967		NC_000016.10:86510789:T:A
NM_001451.3(FOXF1):c.1139G>C (p.Ter380Ser)	FOXF1	*380S		Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800370	16	86546690	16	86513084	800370	788976		NC_000016.10:86513083:G:C
NM_001451.3(FOXF1):c.191C>A (p.Ser64Ter)	FOXF1	S64*		Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800369	16	86544366	16	86510760	800369	788966		NC_000016.10:86510759:C:A
NM_001451.3(FOXF1):c.899_903dup (p.Gly302fs)	FOXF1			Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800368	16	86545071 - 86545072	16	86511465 - 86511466	800368	788974		NC_000016.10:86511465:CCTGTCC:CCTGTCCTGTCC
NM_001451.3(FOXF1):c.872_879del (p.Leu290_Ser291insTer)	FOXF1			Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800367	16	86545040 - 86545047	16	86511434 - 86511441	800367	788973		NC_000016.10:86511433:CCCCTGTCCCCCTGT:CCCCTGT
NM_001451.3(FOXF1):c.89C>A (p.Ser30Ter)	FOXF1	S30*		Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800366	16	86544264	16	86510658	800366	788963		NC_000016.10:86510657:C:A
NM_001451.3(FOXF1):c.145C>T (p.Pro49Ser)	FOXF1	P49S		Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800365	16	86544320	16	86510714	800365	788965		NC_000016.10:86510713:C:T
NM_001451.3(FOXF1):c.1031_1032del (p.Phe344fs)	FOXF1	F344fs		Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000800364	16	86546581 - 86546582	16	86512975 - 86512976	800364	788975		NC_000016.10:86512974:TTT:T
NM_000693.4(ALDH1A3):c.211G>A (p.Val71Met)	ALDH1A3	V71M	not provided	Pathogenic	no assertion criteria provided	VCV000091908	15	101427783	15	100887578	91908	97386	rs386834230	NC_000015.10:100887577:G:A
NM_000486.6(AQP2):c.153dup (p.Ile52fs)	AQP2		not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000847319	12	50344765 - 50344766	12	49950982 - 49950983	847319	840000		NC_000012.12:49950982:T:TT
NM_000693.4(ALDH1A3):c.265C>T (p.Arg89Cys)	ALDH1A3	R89C	Microphthalmia, isolated 8	Pathogenic(Last reviewed: Feb 7, 2013)	no assertion criteria provided	VCV000040203	15	101427837	15	100887632	40203	48690	rs397514652	NC_000015.10:100887631:C:T
NM_000486.5(AQP2):c.299G>T (p.Gly100Val)	AQP2	G100V	Diabetes insipidus, nephrogenic, autosomal recessive	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000017843	12	50344912	12	49951129	17843	32882	rs104894338	NC_000012.12:49951128:G:T
NM_000486.5(AQP2):c.64C>G (p.Leu22Val)	AQP2	L22V	Diabetes insipidus, nephrogenic, autosomal recessive	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000017838	12	50344677	12	49950894	17838	32877	rs104894336	NC_000012.12:49950893:C:G
NM_000486.5(AQP2):c.203A>G (p.Asn68Ser)	AQP2	N68S	Diabetes insipidus, nephrogenic, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000017834	12	50344816	12	49951033	17834	32873	rs104894331	NC_000012.12:49951032:A:G
FOXF1, 2-BP DEL, 956TT	FOXF1			Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000008465					8465	23504		
FOXF1, 1-BP DUP, 775T	FOXF1			Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000008464					8464	23503		
NM_001451.3(FOXF1):c.1138T>C (p.Ter380Arg)	FOXF1	*380R		Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000008463	16	86546689	16	86513083	8463	23502	rs121909337	NC_000016.10:86513082:T:C
NM_001451.3(FOXF1):c.683_690GCGGCGGC[1] (p.Ala231fs)	FOXF1			Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000692054	16	86544858 - 86544865	16	86511252 - 86511259	692054	679795		NC_000016.10:86511251:GCGGCGGCGCGGCGGC:GCGGCGGC
NM_015202.4(KATNIP):c.4420del (p.Met1474fs)	KATNIP	M1474fs	Joubert syndrome 26	Pathogenic(Last reviewed: Feb 8, 2018)	no assertion criteria provided	VCV000489396	16	27786376	16	27775055	489396	482291	rs1555497891	NC_000016.10:27775054:A:
NM_000486.5(AQP2):c.277C>T (p.Gln93Ter)	AQP2	Q93*	not provided	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000446861	12	50344890	12	49951107	446861	441560	rs770810694	NC_000012.12:49951106:C:T
NM_001451.3(FOXF1):c.225C>A (p.Tyr75Ter)	FOXF1	Y50*, Y75*		Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000008462	16	86544400	16	86510794	8462	23501	rs121909336	NC_000016.10:86510793:C:A
NM_014712.3(SETD1A):c.214del (p.Arg72fs)	SETD1A	R72fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000521559	16	30970475	16	30959154	521559	512198	rs1555488653	NC_000016.10:30959153:A:
NM_001190919.1(THRA):c.1110+27del	THRA	C380fs	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 14, 2014)	criteria provided, single submitter	VCV000520565	17	38245612	17	40089359	520565	512278	rs746765465	NC_000017.11:40089358:CC:C
NM_000486.5(AQP2):c.170A>C (p.Gln57Pro)	AQP2	Q57P	Diabetes insipidus, nephrogenic, autosomal recessive|not provided	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000017842	12	50344783	12	49951000	17842	32881	rs28931580	NC_000012.12:49950999:A:C
NM_138477.2(CDAN1):c.2015C>T (p.Pro672Leu)	CDAN1	P672L	Congenital dyserythropoietic anemia, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003179	15	43022955	15	42730757	3179	18218	rs120074167	NC_000015.10:42730756:G:A
GRCh37/hg19 14q24.3(chr14:76279519-76359171)x1	TTLL5		not provided	Pathogenic(Last reviewed: May 7, 2018)	no assertion criteria provided	VCV000687938	14	76279519 - 76359171			687938	675530		
NM_015072.5(TTLL5):c.2782dup (p.Met928fs)	TTLL5		Cone-rod dystrophy 19	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522428	14	76249668 - 76249669	14	75783325 - 75783326	522428	513103	rs1555345387	NC_000014.9:75783325:A:AA
NM_000526.5(KRT14):c.1194del (p.Glu397_Tyr398insTer)	KRT14		not provided	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000503671	17	39739567	17	41583315	503671	495675	rs1555571791	NC_000017.11:41583314:G:
NM_000526.5(KRT14):c.1163G>A (p.Arg388His)	KRT14	R388H	not provided	Pathogenic(Last reviewed: Sep 6, 2015)	criteria provided, single submitter	VCV000419836	17	39739598	17	41583346	419836	409921	rs58645163	NC_000017.11:41583345:C:T
NM_015072.5(TTLL5):c.1810del (p.Gln604fs)	TTLL5	Q604fs	not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000860044	14	76232504	14	75766161	860044	841797		NC_000014.9:75766160:CCC:CC
NM_015072.5(TTLL5):c.2029C>T (p.Arg677Ter)	TTLL5	R677*	not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000859370	14	76238090	14	75771747	859370	841799		NC_000014.9:75771746:C:T
NM_015072.5(TTLL5):c.3393del (p.Val1133fs)	TTLL5	V1133fs	not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000856502	14	76330076	14	75863733	856502	841813		NC_000014.9:75863732:A:
NM_015072.5(TTLL5):c.2261dup (p.Asp754fs)	TTLL5		not provided	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, single submitter	VCV000852337	14	76241950 - 76241951	14	75775607 - 75775608	852337	841803		NC_000014.9:75775607:A:AA
NM_015072.5(TTLL5):c.3177_3180del (p.Thr1059_Asn1060insTer)	TTLL5		not provided	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000845763	14	76286352 - 76286355	14	75820009 - 75820012	845763	841810		NC_000014.9:75820008:AACAAAC:AAC
NC_000014.9:g.(?_75745095)_(75783530_?)del	TTLL5		not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000832921	14	76211438 - 76249873			832921	820647		
NM_001346754.2(PIGW):c.460A>G (p.Arg154Gly)	PIGW	R154G	Hyperphosphatasia with mental retardation syndrome 5	Pathogenic(Last reviewed: Mar 9, 2018)	no assertion criteria provided	VCV000495299	17	34893410	17	36537561	495299	486796	rs1256773607	NC_000017.11:36537560:A:G
NM_001346754.2(PIGW):c.499A>G (p.Met167Val)	PIGW	M167V	Hyperphosphatasia with mental retardation syndrome 5	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000156157	17	34893449	17	36537600	156157	165956	rs200024253	NC_000017.11:36537599:A:G
NM_001346754.2(PIGW):c.211A>C (p.Thr71Pro)	PIGW	T71P	Hyperphosphatasia with mental retardation syndrome 5	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000156156	17	34893161	17	36537312	156156	165955	rs587777733	NC_000017.11:36537311:A:C
NM_015072.5(TTLL5):c.1627G>T (p.Glu543Ter)	TTLL5	E543*	Cone-rod dystrophy 19	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000139516	14	76231034	14	75764691	139516	143161	rs199882533	NC_000014.9:75764690:G:T
NM_015072.5(TTLL5):c.3354G>A (p.Trp1118Ter)	TTLL5	W1118*	Cone-rod dystrophy 19	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000139515	14	76330037	14	75863694	139515	143160	rs587777471	NC_000014.9:75863693:G:A
NM_015072.5(TTLL5):c.401del (p.Leu134fs)	TTLL5	L134fs	Cone-rod dystrophy 19	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000139514	14	76156564	14	75690221	139514	143159	rs587777470	NC_000014.9:75690220:T:
NM_015072.5(TTLL5):c.1584_1585AG[1] (p.Glu529fs)	TTLL5		Cone-rod dystrophy 19	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000139513	14	76230991 - 76230994	14	75764648 - 75764651	139513	143158	rs587777469	NC_000014.9:75764647:AGAGAG:AG
NM_000526.5(KRT14):c.915G>A (p.Trp305Ter)	KRT14	W305*	not provided	Pathogenic(Last reviewed: Sep 7, 2015)	criteria provided, single submitter	VCV000066382	17	39740024	17	41583772	66382	77279	rs60090257	NC_000017.11:41583771:C:T
NM_000526.5(KRT14):c.815T>C (p.Met272Thr)	KRT14	M272T	not provided	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000066378	17	39740124	17	41583872	66378	77275	rs61371557	NC_000017.11:41583871:A:G
NM_000526.5(KRT14):c.397G>T (p.Val133Leu)	KRT14	V133L	not provided	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000066358	17	39742690	17	41586438	66358	77255	rs61027685	NC_000017.11:41586437:C:A
NM_000526.5(KRT14):c.397G>A (p.Val133Met)	KRT14	V133M	not provided	Pathogenic(Last reviewed: Apr 4, 2015)	criteria provided, single submitter	VCV000066356	17	39742690	17	41586438	66356	77253	rs61027685	NC_000017.11:41586437:C:T
NM_000526.5(KRT14):c.1231G>A (p.Glu411Lys)	KRT14	E411K	not provided	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000066314	17	39739530	17	41583278	66314	77211	rs61664582	NC_000017.11:41583277:C:T
NM_000526.5(KRT14):c.1228C>T (p.Gln410Ter)	KRT14	Q410*	not provided	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000066313	17	39739533	17	41583281	66313	77210	rs267607400	NC_000017.11:41583280:G:A
NM_015072.5(TTLL5):c.2132_2135dup (p.Met712fs)	TTLL5		not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000861699	14	76238192 - 76238193	14	75771849 - 75771850	861699	841800		NC_000014.9:75771849:AGAT:AGATAGAT
NM_015072.5(TTLL5):c.2136+1G>A	TTLL5		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812436	14	76238198	14	75771855	812436	800698		NC_000014.9:75771854:G:A
NM_015072.5(TTLL5):c.1487+1G>A	TTLL5		Retinitis pigmentosa	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560512	14	76211925	14	75745582	560512	551576	rs1566585766	NC_000014.9:75745581:G:A
NM_015072.5(TTLL5):c.1627G>A (p.Glu543Lys)	TTLL5	E543K	Retinal dystrophy|Cone-rod dystrophy 19	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000139517	14	76231034	14	75764691	139517	143162	rs199882533	NC_000014.9:75764690:G:A
NM_000526.5(KRT14):c.19C>T (p.Gln7Ter)	KRT14	Q7*	Naegeli-Franceschetti-Jadassohn syndrome|not provided	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000066333	17	39743068	17	41586816	66333	77230	rs267607391	NC_000017.11:41586815:G:A
NM_000526.5(KRT14):c.92del (p.Ile31fs)	KRT14	I31fs	Epidermolysis bullosa simplex, autosomal recessive|not provided	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000066385	17	39742995	17	41586743	66385	77282	rs60231560	NC_000017.11:41586742:A:
NM_000526.5(KRT14):c.526-2A>C	KRT14		Epidermolysis bullosa simplex, autosomal recessive|not provided	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000066369	17	39741311	17	41585059	66369	77266	rs200779504	NC_000017.11:41585058:T:G
NM_000526.5(KRT14):c.313_314del (p.Ala105fs)	KRT14	A105fs	Epidermolysis bullosa simplex, autosomal recessive|not provided	Pathogenic(Last reviewed: Nov 1, 1994)	no assertion criteria provided	VCV000066337	17	39742773 - 39742774	17	41586521 - 41586522	66337	77234	rs57278315	NC_000017.11:41586520:GC:
NM_000526.5(KRT14):c.1162C>T (p.Arg388Cys)	KRT14	R388C	not provided|Skin fragility with non-scarring blistering|Palmoplantar blistering	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000066306	17	39739599	17	41583347	66306	77203	rs59966597	NC_000017.11:41583346:G:A
NM_000526.5(KRT14):c.1123_1125del (p.Glu375del)	KRT14	E375del	|not provided	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000066301	17	39739636 - 39739638	17	41583384 - 41583386	66301	77198	rs56974573	NC_000017.11:41583383:CTCCT:CT
NM_000526.5(KRT14):c.54C>A (p.Cys18Ter)	KRT14	C18*	not provided|Dermatopathia pigmentosa reticularis	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000014626	17	39743033	17	41586781	14626	29665	rs60831116	NC_000017.11:41586780:G:T
NM_000526.5(KRT14):c.1264G>A (p.Glu422Lys)	KRT14	E422K	not provided|	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000014623	17	39739497	17	41583245	14623	29662	rs58762773	NC_000017.11:41583244:C:T
NM_000526.5(KRT14):c.1256T>A (p.Leu419Gln)	KRT14	L419Q	not provided|	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000014622	17	39739505	17	41583253	14622	29661	rs57364972	NC_000017.11:41583252:A:T
NM_000526.5(KRT14):c.815T>G (p.Met272Arg)	KRT14	M272R	Epidermolysis bullosa simplex, Koebner type|not provided	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000014617	17	39740124	17	41583872	14617	29656	rs61371557	NC_000017.11:41583871:A:C
NM_000526.5(KRT14):c.612T>A (p.Tyr204Ter)	KRT14	Y204*	not provided|Epidermolysis bullosa simplex, autosomal recessive	Pathogenic(Last reviewed: Nov 1, 1994)	no assertion criteria provided	VCV000014616	17	39740662	17	41584410	14616	29655	rs60725382	NC_000017.11:41584409:A:T
NM_000526.5(KRT14):c.431A>C (p.Glu144Ala)	KRT14	E144A	not provided|Epidermolysis bullosa simplex, autosomal recessive	Pathogenic(Last reviewed: Apr 1, 1993)	no assertion criteria provided	VCV000014614	17	39742656	17	41586404	14614	29653	rs57121345	NC_000017.11:41586403:T:G
NM_002582.4(PARN):c.172A>T (p.Lys58Ter)	PARN	K58*	not provided	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000424050	16	14722034	16	14628177	424050	409447	rs1064796768	NC_000016.10:14628176:T:A
GRCh37/hg19 12q24.21(chr12:114995645-115376925)x1	TBX3		See cases	Pathogenic	no assertion criteria provided	VCV000396398	12	114995645 - 115376925			396398	383291		
NM_002582.4(PARN):c.948_949del (p.Val318fs)	PARN	V318fs, V272fs, V257fs	Dyskeratosis congenita, autosomal recessive 6	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803221	16	14680188 - 14680189	16	14586331 - 14586332	803221	791523		NC_000016.10:14586330:AT:
NM_005996.4(TBX3):c.1920_1921dup (p.Pro641fs)	TBX3		Ulnar-mammary syndrome	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000591004	12	115109896 - 115109897	12	114672091 - 114672092	591004	581960	rs1565858163	NC_000012.12:114672091:GC:GCGC
NM_005996.4(TBX3):c.1423C>T (p.Gln475Ter)	TBX3	E475*, Q475*, Q495*	Ulnar-mammary syndrome	Pathogenic(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000417720	12	115112257	12	114674452	417720	404621	rs1060505020	NC_000012.12:114674451:G:A
NM_002582.4(PARN):c.1262A>G (p.Lys421Arg)	PARN	K421R, K360R, K375R	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000190471	16	14674731	16	14580874	190471	188290	rs777090017	NC_000016.10:14580873:T:C
NM_002582.4(PARN):c.529C>T (p.Gln177Ter)	PARN	Q177*, Q116*, Q131*	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000190469	16	14704526	16	14610669	190469	188288	rs876661305	NC_000016.10:14610668:G:A
NM_002582.4(PARN):c.246-2A>G	PARN		Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000190468	16	14721046	16	14627189	190468	188287	rs751381953	NC_000016.10:14627188:T:C
NM_005996.4(TBX3):c.991C>T (p.Gln331Ter)	TBX3	Q331*, Q351*	Ulnar-mammary syndrome	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000031909	12	115114166	12	114676361	31909	40565	rs397514484	NC_000012.12:114676360:G:A
NM_005996.4(TBX3):c.88dup (p.Met30fs)	TBX3		Ulnar-mammary syndrome	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000007990	12	115120917 - 115120918	12	114683112 - 114683113	7990	23029		NC_000012.12:114683112:T:TT
NM_005996.4(TBX3):c.817A>T (p.Lys273Ter)	TBX3	K273*, K293*	Ulnar-mammary syndrome	Pathogenic(Last reviewed: Jul 15, 2002)	no assertion criteria provided	VCV000007989	12	115115449	12	114677644	7989	23028	rs104894376	NC_000012.12:114677643:T:A
NM_005996.4(TBX3):c.657+1G>C	TBX3		Ulnar-mammary syndrome	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000007988	12	115118683	12	114680878	7988	23027		NC_000012.12:114680877:C:G
NM_005996.4(TBX3):c.227del (p.Ile76fs)	TBX3	I76fs	Ulnar-mammary syndrome	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000007987	12	115120779	12	114682974	7987	23026		NC_000012.12:114682973:A:
NM_002582.4(PARN):c.657G>A (p.Trp219Ter)	PARN	W158*, W219*, W173*	Dyskeratosis congenita, autosomal recessive 6|Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000857552	16	14702140	16	14608283	857552	843121		NC_000016.10:14608282:C:T
NM_002582.4(PARN):c.1124_1133del (p.Gln375fs)	PARN	Q314fs, Q375fs, Q329fs	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4|Dyskeratosis congenita, autosomal recessive 6	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000835748	16	14676097 - 14676106	16	14582240 - 14582249	835748	843118		NC_000016.10:14582239:TCGTGGAGTT:
NM_002582.4(PARN):c.24del (p.Phe8fs)	PARN	F8fs	Dyskeratosis congenita, autosomal recessive 6	Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	VCV000436158	16	14723527	16	14629670	436158	429771	rs1555512179	NC_000016.10:14629669:AAAA:AAA
NM_002582.4(PARN):c.1257dup (p.Asn420Ter)	PARN		Dyskeratosis congenita, autosomal recessive 6	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000436157	16	14674735 - 14674736	16	14580878 - 14580879	436157	429765	rs942538351	NC_000016.10:14580878:AAAAAAA:AAAAAAAA
NM_002582.3(PARN):c.962+295_1263-8706del	PARN		Dyskeratosis congenita, autosomal recessive 6	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000219121	16	14658272 - 14679880	16	14564415 - 14586023	219121	216923		
NM_002582.4(PARN):c.1045C>T (p.Arg349Trp)	PARN	R349W, R303W, R288W	Dyskeratosis congenita, autosomal recessive 6	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000219120	16	14678240	16	14584383	219120	216922	rs754368658	NC_000016.10:14584382:G:A
NM_002582.4(PARN):c.659+4_659+7del	PARN		Dyskeratosis congenita, autosomal recessive 6	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000190291	16	14702131 - 14702134	16	14608274 - 14608277	190291	178830	rs759131762	NC_000016.10:14608273:TACTTACTT:TACTT
NM_002582.4(PARN):c.863dup (p.Asn288fs)	PARN		Dyskeratosis congenita, autosomal recessive 6	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000190290	16	14687212 - 14687213	16	14593355 - 14593356	190290	178829	rs786201001	NC_000016.10:14593355:TT:TTT
NM_004448.3(ERBB2):c.2570A>G (p.Asn857Ser)	ERBB2	N857S, N827S, N842S	Neoplasm of ovary|Ovarian Adenocarcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000013880	17	37881378	17	39725125	13880	28919	rs28933370	NC_000017.11:39725124:A:G
NM_002582.4(PARN):c.819_820insTAGAAATCATTTCTAGAGTC (p.Ile274Ter)	PARN		Dyskeratosis congenita, autosomal recessive 6	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000631490	16	14693781 - 14693782	16	14599924 - 14599925	631490	619853		NC_000016.10:14599924:GACTCTAGAAA:GACTCTAGAAATGATTTCTAGACTCTAGAAA
NM_000526.5(KRT14):c.17del (p.Arg6fs)	KRT14	R6fs	Naegeli-Franceschetti-Jadassohn syndrome|not provided	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000066329	17	39743070	17	41586818	66329	77226	rs267607390	NC_000017.11:41586817:C:
NM_000526.5(KRT14):c.1243T>C (p.Tyr415His)	KRT14	Y415H	not provided|	Pathogenic(Last reviewed: Mar 27, 2015)	criteria provided, single submitter	VCV000014621	17	39739518	17	41583266	14621	29660	rs58380626	NC_000017.11:41583265:A:G
NM_000526.5(KRT14):c.356T>C (p.Met119Thr)	KRT14	M119T	not provided|	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000014619	17	39742731	17	41586479	14619	29658	rs28928893	NC_000017.11:41586478:A:G
NM_000526.5(KRT14):c.1151T>C (p.Leu384Pro)	KRT14	L384P	Epidermolysis bullosa simplex, Koebner type|not provided	Pathogenic(Last reviewed: Nov 22, 1991)	no assertion criteria provided	VCV000014611	17	39739610	17	41583358	14611	29650	rs59629244	NC_000017.11:41583357:A:G
NM_002582.4(PARN):c.918+1G>T	PARN		Dyskeratosis congenita, autosomal recessive 6|Dyskeratosis congenita	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000180662	16	14687157	16	14593300	180662	178828	rs756132866	NC_000016.10:14593299:C:A
NM_002582.4(PARN):c.1148C>T (p.Ala383Val)	PARN	A383V, A322V, A337V	Dyskeratosis congenita, autosomal recessive 6|Dyskeratosis congenita	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000180661	16	14676082	16	14582225	180661	178827	rs786200999	NC_000016.10:14582224:G:A
NM_002582.4(PARN):c.563dup (p.Glu189fs)	PARN		Dyskeratosis congenita, autosomal recessive 6|Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4|Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000190470	16	14702971 - 14702972	16	14609114 - 14609115	190470	188289	rs878853260	NC_000016.10:14609114:A:AA
NM_000526.5(KRT14):c.368A>G (p.Asn123Ser)	KRT14	N123S	not provided|	Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	VCV000014628	17	39742719	17	41586467	14628	29667	rs60171927	NC_000017.11:41586466:T:C
GRCh37/hg19 15q21.1(chr15:48545362-48581182)x1	SLC12A1		not provided	Pathogenic(Last reviewed: Apr 21, 2017)	no assertion criteria provided	VCV000688499	15	48545362 - 48581182			688499	676091		
GRCh37/hg19 14q23.3(chr14:67135019-67197722)x1	GPHN		not provided	Pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000686024	14	67135019 - 67197722			686024	673616		
NM_001184832.2(SLC12A1):c.1917C>G (p.Tyr639Ter)	SLC12A1	Y639*	not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000523909	15	48543942	15	48251745	523909	514672	rs375445813	NC_000015.10:48251744:C:G
NM_001184832.2(SLC12A1):c.2873+1G>A	SLC12A1		not provided	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000450686	15	48580714	15	48288517	450686	445333	rs201930377	NC_000015.10:48288516:G:A
NM_000338.3(SLC12A1):c.1687dup (p.Glu563fs)	SLC12A1		not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000847437	15	48541772 - 48541773	15	48249575 - 48249576	847437	842429		NC_000015.10:48249575:GG:GGG
NC_000014.9:g.(?_66508508)_(66681205_?)del	GPHN		Molybdenum cofactor deficiency, complementation group C	Pathogenic(Last reviewed: Nov 24, 2019)	criteria provided, single submitter	VCV000833426	14	66975226 - 67147923			833426	820636		
NC_000014.9:g.(?_67122236)_(67122397_?)del	GPHN		Molybdenum cofactor deficiency, complementation group C	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000833419	14	67588953 - 67589114			833419	820641		
NC_000014.9:g.(?_66508508)_(66508611_?)del	GPHN		Molybdenum cofactor deficiency, complementation group C	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000831995	14	66975226 - 66975329			831995	820635		
NC_000014.9:g.(?_66776444)_(66776541_?)del	GPHN		Molybdenum cofactor deficiency, complementation group C	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000831947	14	67243162 - 67243259			831947	820637		
NC_000014.8:g.(?_67346637)_(67346771_?)del	GPHN		Molybdenum cofactor deficiency, complementation group C	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000655222	14	67346637 - 67346771	14	66879919 - 66880053	655222	652560		
NM_020806.4(GPHN):c.1666C>T (p.Arg556Ter)	GPHN	R556*, R523*	Molybdenum cofactor deficiency, complementation group C	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000653059	14	67589012	14	67122295	653059	642637		NC_000014.9:67122294:C:T
NM_001184832.2(SLC12A1):c.1833del (p.Phe611fs)	SLC12A1	F611fs	Bartter syndrome, type 1, antenatal	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000378051	15	48543854	15	48251657	378051	380142	rs1057520304	NC_000015.10:48251656:TTTTT:TTTT
NM_001184832.2(SLC12A1):c.2494_2495GA[2] (p.Arg833fs)	SLC12A1		Bartter syndrome, type 1, antenatal	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000378050	15	48577310 - 48577311	15	48285113 - 48285114	378050	380141	rs1057520303	NC_000015.10:48285112:AGAGAGA:AGAGA
NM_001184832.2(SLC12A1):c.2787dup (p.Thr931fs)	SLC12A1		Bartter syndrome, type 1, antenatal	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000378049	15	48580626 - 48580627	15	48288429 - 48288430	378049	380140	rs1057520302	NC_000015.10:48288429:C:CC
NM_001184832.2(SLC12A1):c.1883C>A (p.Ala628Asp)	SLC12A1	A628D	Bartter syndrome, type 1, antenatal	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000378048	15	48543908	15	48251711	378048	380139	rs1057520301	NC_000015.10:48251710:C:A
NM_001184832.2(SLC12A1):c.1137del (p.Phe380fs)	SLC12A1	F380fs	Bartter syndrome, type 1, antenatal	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000378047	15	48527123	15	48234926	378047	380138	rs1057520300	NC_000015.10:48234925:C:
NM_001110219.3(GJB6):c.261dup (p.Ala88fs)	GJB6		not provided	Pathogenic(Last reviewed: Sep 17, 2013)	no assertion criteria provided	VCV000095434	13	20797358 - 20797359	13	20223219 - 20223220	95434	101333	rs398124236	NC_000013.11:20223219:T:TT
NM_020806.4(GPHN):c.1838A>C (p.Asp613Ala)	GPHN	D580A, D613A	Molybdenum cofactor deficiency, complementation group C	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000088674	14	67626133	14	67159416	88674	94254	rs397518420	NC_000014.9:67159415:A:C
NM_001184832.2(SLC12A1):c.2095del (p.Asp699fs)	SLC12A1	D699fs	Bartter syndrome, type 1, antenatal	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000008756	15	48551448	15	48259251	8756	23795	rs1057519608	NC_000015.10:48259250:GG:G
NM_001184832.2(SLC12A1):c.629-504A>G	SLC12A1		Bartter syndrome, type 1, antenatal	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000008755	15	48518772	15	48226575	8755	23794	rs774515747	NC_000015.10:48226574:A:G
NM_001184832.2(SLC12A1):c.1875G>A (p.Trp625Ter)	SLC12A1	W625*	Bartter syndrome, type 1, antenatal	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000008754	15	48543900	15	48251703	8754	23793	rs137853159	NC_000015.10:48251702:G:A
NM_001184832.2(SLC12A1):c.814G>T (p.Val272Phe)	SLC12A1	V272F	Bartter syndrome, type 1, antenatal	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000008753	15	48521475	15	48229278	8753	23792	rs137853158	NC_000015.10:48229277:G:T
NM_001184832.2(SLC12A1):c.1942G>A (p.Asp648Asn)	SLC12A1	D648N	Bartter syndrome, type 1, antenatal	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000008752	15	48543967	15	48251770	8752	23791	rs137853157	NC_000015.10:48251769:G:A
NM_020806.4(GPHN):c.65-?_201+?del	GPHN		Molybdenum cofactor deficiency, complementation group C	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000005972	14	66975310 - 67291191	14	66508592 - 66824473	5972	21011		
NC_000014.8:g.(?_67243182)_(67432042_?)del	GPHN		Molybdenum cofactor deficiency, complementation group C	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000584128	14	67243182 - 67432042			584128	567758		
NC_000014.8:g.(?_67243162)_(67391029_?)del	GPHN		Molybdenum cofactor deficiency, complementation group C	Pathogenic(Last reviewed: Nov 18, 2017)	criteria provided, single submitter	VCV000534558	14	67243162 - 67391029			534558	527836		
NM_001110219.3(GJB6):c.110T>A (p.Val37Glu)	GJB6	V37E	Hidrotic ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000005547	13	20797510	13	20223371	5547	20586	rs104894416	NC_000013.11:20223370:A:T
NM_001110219.3(GJB6):c.119C>T (p.Ala40Val)	GJB6	A40V	Deafness, autosomal dominant 3b	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000424855	13	20797501	13	20223362	424855	413171	rs780320724	NC_000013.11:20223361:G:A
NM_001184832.2(SLC12A1):c.1163del (p.Phe388fs)	SLC12A1	F388fs	Bartter syndrome, type 1, antenatal|Nephrolithiasis|Nephrocalcinosis	Pathogenic/Likely pathogenic(Last reviewed: Sep 8, 2017)	no assertion criteria provided	VCV000265999	15	48527143	15	48234946	265999	260799	rs779588655	NC_000015.10:48234945:TTTTTTT:TTTTTT
NM_000526.5(KRT14):c.357G>A (p.Met119Ile)	KRT14	M119I	not provided||Epidermolysis bullosa simplex, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	VCV000014620	17	39742730	17	41586478	14620	29659	rs57358989	NC_000017.11:41586477:C:T
NM_000526.5(KRT14):c.374G>A (p.Arg125His)	KRT14	R125H	|not provided	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000014613	17	39742713	17	41586461	14613	29652	rs58330629	NC_000017.11:41586460:C:T
NM_001077418.3(TMEM231):c.352T>G (p.Leu118Val)	TMEM231	L118V, L171V	Ciliopathy	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812432	16	75579810	16	75545912	812432	800608		NC_000016.10:75545911:A:C
NM_153603.4(COG7):c.1321C>T (p.Gln441Ter)	COG7	Q441*	not provided	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000489365	16	23424857	16	23413536	489365	482093	rs769603091	NC_000016.10:23413535:G:A
NM_002863.5(PYGL):c.1818del (p.Ile606fs)	PYGL	I606fs, I572fs	not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000452643	14	51378705	14	50911987	452643	445237	rs760913598	NC_000014.9:50911986:AA:A
NM_153603.4(COG7):c.323dup (p.Leu108fs)	COG7		not provided	Pathogenic(Last reviewed: Mar 17, 2015)	criteria provided, single submitter	VCV000196587	16	23456480 - 23456481	16	23445159 - 23445160	196587	193748	rs797044712	NC_000016.10:23445159:AA:AAA
NM_002863.5(PYGL):c.1947C>A (p.Tyr649Ter)	PYGL	Y649*, Y615*	not provided	Pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	VCV000194626	14	51378470	14	50911752	194626	191789	rs150547274	NC_000014.9:50911751:G:T
NM_002863.5(PYGL):c.1648dup (p.Leu550fs)	PYGL		not provided	Pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	VCV000194379	14	51378993 - 51378994	14	50912275 - 50912276	194379	191542	rs529502292	NC_000014.9:50912275:GG:GGG
NM_001039958.2(MESP2):c.471dup (p.Ser158fs)	MESP2		not provided	Pathogenic(Last reviewed: Jan 6, 2019)	criteria provided, single submitter	VCV000642227	15	90320055 - 90320056	15	89776824 - 89776825	642227	643628		NC_000015.10:89776824:GGGG:GGGGG
NC_000015.9:g.(?_90319579)_(90321575_?)del	MESP2		not provided	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000642062	15	90319579 - 90321575	15	89776348 - 89778344	642062	652712		
NM_153603.4(COG7):c.1476-1G>T	COG7		COG7 congenital disorder of glycosylation	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000548708	16	23417584	16	23406263	548708	539192	rs1555493029	NC_000016.10:23406262:C:A
NM_001077418.3(TMEM231):c.438+1G>A	TMEM231		Meckel syndrome, type 11	Pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	VCV000437010	16	75579723	16	75545825	437010	429845	rs1415483600	NC_000016.10:75545824:C:T
NM_001077418.3(TMEM231):c.665-11T>C	TMEM231		Joubert Syndrome and Related Disorders	Pathogenic	no assertion criteria provided	VCV000266095	16	75575364	16	75541466	266095	260923	rs886039807	NC_000016.10:75541465:A:G
NM_001077418.3(TMEM231):c.815A>C (p.Gln272Pro)	TMEM231	Q301P, Q325P, Q272P	Meckel syndrome, type 11	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000064620	16	75574028	16	75540130	64620	75584	rs397514754	NC_000016.10:75540129:T:G
NM_001039958.2(MESP2):c.385A>T (p.Ile129Phe)	MESP2	I129F		Pathogenic(Last reviewed: Aug 25, 2009)	no assertion criteria provided	VCV000038909	15	90319973	15	89776742	38909	47512	rs113994157	NC_000015.10:89776741:A:T
NM_001039958.2(MESP2):c.271A>G (p.Lys91Glu)	MESP2	K91E		Pathogenic(Last reviewed: Aug 25, 2009)	no assertion criteria provided	VCV000038908	15	90319859	15	89776628	38908	47511	rs113994156	NC_000015.10:89776627:A:G
NM_002863.5(PYGL):c.2461T>C (p.Tyr821His)	PYGL	Y821H, Y787H	Glycogen storage disease, type VI	Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000021336	14	51372193	14	50905475	21336	34188	rs113993988	NC_000014.9:50905474:A:G
NM_002863.5(PYGL):c.911_914dup (p.Leu305fs)	PYGL		Glycogen storage disease, type VI	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000844532	14	51383764 - 51383765	14	50917046 - 50917047	844532	841550		NC_000014.9:50917046:AAGG:AAGGAAGG
NC_000014.9:g.(?_50909875)_(50912323_?)del	PYGL		Glycogen storage disease, type VI	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV000831481	14	51376593 - 51379041			831481	820628		
NM_002863.5(PYGL):c.508_510delinsTAA (p.Lys170Ter)	PYGL		Glycogen storage disease, type VI	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000827812	14	51398409 - 51398411	14	50931691 - 50931693	827812	816002		NC_000014.9:50931690:CTT:TTA
NM_001077418.3(TMEM231):c.139+47C>A	TMEM231	S83*	Meckel syndrome, type 11|Joubert syndrome 20	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000565503	16	75589922	16	75556024	565503	570534	rs200063331	NC_000016.10:75556023:G:T
NM_002863.5(PYGL):c.298_307del (p.Met100fs)	PYGL	M100fs	Glycogen storage disease, type VI	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548489	14	51404492 - 51404501	14	50937774 - 50937783	548489	539053	rs1555328280	NC_000014.9:50937773:GGTTGATCATGGT:GGT
NM_002863.5(PYGL):c.25_44dup (p.Ser15fs)	PYGL		Glycogen storage disease, type VI	Pathogenic(Last reviewed: Nov 10, 2013)	criteria provided, single submitter	VCV000189242	14	51411077 - 51411078	14	50944359 - 50944360	189242	187131	rs786204785	NC_000014.9:50944359:CTGATCTGCCGCCGCTTCTCCTG:CTGATCTGCCGCCGCTTCTCCTGATCTGCCGCCGCTTCTCCTG
NM_001077416.2(TMEM231):c.74T>A (p.Met25Lys)	TMEM231	Y4*, M25K	Joubert syndrome 20	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039821	16	75590096	16	75556198	39821	48420	rs397514609	NC_000016.10:75556197:A:T
NM_002863.5(PYGL):c.2024C>T (p.Ser675Leu)	PYGL	S675L, S641L	Glycogen storage disease, type VI	Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000021334	14	51376766	14	50910048	21334	34186	rs113993986	NC_000014.9:50910047:G:A
NM_002863.5(PYGL):c.2023T>A (p.Ser675Thr)	PYGL	S675T, S641T	Glycogen storage disease, type VI	Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000021333	14	51376767	14	50910049	21333	34185	rs113993985	NC_000014.9:50910048:A:T
NM_002863.5(PYGL):c.2017G>A (p.Glu673Lys)	PYGL	E673K, E639K	Glycogen storage disease, type VI	Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000021332	14	51376773	14	50910055	21332	34184	rs113993984	NC_000014.9:50910054:C:T
NM_002863.5(PYGL):c.1895A>T (p.Asn632Ile)	PYGL	N632I, N598I	Glycogen storage disease, type VI	Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000021330	14	51378522	14	50911804	21330	34182	rs113993983	NC_000014.9:50911803:T:A
NM_002863.5(PYGL):c.1471C>T (p.Arg491Cys)	PYGL	R491C, R457C	Glycogen storage disease, type VI	Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000021329	14	51381466	14	50914748	21329	34181	rs113993980	NC_000014.9:50914747:G:A
NM_002863.5(PYGL):c.1366G>A (p.Val456Met)	PYGL	V456M, V422M	Glycogen storage disease, type VI	Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000021328	14	51382091	14	50915373	21328	34180	rs113993979	NC_000014.9:50915372:C:T
NM_153603.4(COG7):c.170-7A>G	COG7		COG7 congenital disorder of glycosylation	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000003651	16	23457289	16	23445968	3651	18690	rs1555496968	NC_000016.10:23445967:T:C
NM_000126.4(ETFA):c.797C>T (p.Thr266Met)	ETFA	T266M, T217M	Glutaric acidemia IIA|not provided|Glutaric aciduria, type 2	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002594	15	76566772	15	76274431	2594	17633	rs119458970	NC_000015.10:76274430:G:A
NM_002863.5(PYGL):c.1016A>G (p.Asn339Ser)	PYGL	N338S, N339S, N305S	Glycogen storage disease, type VI	Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000038367	14	51383436	14	50916718	38367	38457	rs113993976	NC_000014.9:50916717:T:C
NM_002863.5(PYGL):c.280C>T (p.Arg94Ter)	PYGL	R94*	Glycogen storage disease, type VI	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000021337	14	51404519	14	50937801	21337	34189	rs113993973	NC_000014.9:50937800:G:A
NM_002863.5(PYGL):c.1131C>G (p.Asn377Lys)	PYGL	N376K, N377K, N343K	Glycogen storage disease, type VI	Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000011995	14	51382651	14	50915933	11995	27034	rs113993977	NC_000014.9:50915932:G:C
NM_002863.5(PYGL):c.529-1G>C	PYGL		Glycogen storage disease, type VI	Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000011993	14	51390819	14	50924101	11993	27032	rs113993974	NC_000014.9:50924100:C:G
NM_001039958.2(MESP2):c.700G>T (p.Glu234Ter)	MESP2	E234*		Pathogenic(Last reviewed: Aug 5, 2010)	no assertion criteria provided	VCV000005186	15	90320288	15	89777057	5186	20225	rs118204035	NC_000015.10:89777056:G:T
NM_001039958.2(MESP2):c.373C>G (p.Leu125Val)	MESP2	L125V		Pathogenic(Last reviewed: Aug 5, 2010)	no assertion criteria provided	VCV000005185	15	90319961	15	89776730	5185	20224	rs71647806	NC_000015.10:89776729:C:G
NM_001110219.3(GJB6):c.14C>T (p.Thr5Met)	GJB6	T5M	Deafness, autosomal dominant 3b	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000005543	13	20797606	13	20223467	5543	20582	rs104894414	NC_000013.11:20223466:G:A
NM_002863.5(PYGL):c.1620+1G>T	PYGL		Glycogen storage disease, type VI	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000849156	14	51379746	14	50913028	849156	852745		NC_000014.9:50913027:C:A
NC_000016.9:g.(?_75573872)_(75579413_?)del	TMEM231		Meckel syndrome, type 11|Joubert syndrome 20	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000473319	16	75573872 - 75579413	16	75539974 - 75545515	473319	465438		
NM_001077418.3(TMEM231):c.664G>A (p.Val222Ile)	TMEM231	V275I, V222I	Meckel-Gruber syndrome|Meckel syndrome, type 11	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000064619	16	75576500	16	75542602	64619	75583	rs397514753	NC_000016.10:75542601:C:T
NM_002863.5(PYGL):c.1195C>T (p.Arg399Ter)	PYGL	R399*, R365*	not provided|Glycogen storage disease, type VI	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000021327	14	51382587	14	50915869	21327	34179	rs113993978	NC_000014.9:50915868:G:A
NM_001039958.2(MESP2):c.500_503dup (p.Gly169fs)	MESP2			Pathogenic(Last reviewed: Jan 17, 2013)	no assertion criteria provided	VCV000005183	15	90320084 - 90320085	15	89776853 - 89776854	5183	20222	rs113994158	NC_000015.10:89776853:CCGACCG:CCGACCGACCG
NM_152443.3(RDH12):c.599A>G (p.Tyr200Cys)	RDH12	Y200C	Retinal dystrophy	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000867114	14	68193848	14	67727131	867114	856790		NC_000014.9:67727130:A:G
NM_152443.3(RDH12):c.446T>C (p.Leu149Pro)	RDH12	L149P	Retinal dystrophy	Pathogenic(Last reviewed: May 27, 2019)	criteria provided, single submitter	VCV000866614	14	68192870	14	67726153	866614	856787		NC_000014.9:67726152:T:C
NM_001013703.4(EIF2AK4):c.4414_4417CAGA[1] (p.Thr1473fs)	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000812872	15	40318202 - 40318205	15	40026001 - 40026004	812872	801155		NC_000015.10:40026000:CAGACAGA:CAGA
NM_001013703.4(EIF2AK4):c.3097C>T (p.Gln1033Ter)	EIF2AK4	Q1033*	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000812866	15	40293363	15	40001162	812866	801149		NC_000015.10:40001161:C:T
NM_001013703.4(EIF2AK4):c.281dup (p.Asn94fs)	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000812858	15	40235601 - 40235602	15	39943400 - 39943401	812858	801141		NC_000015.10:39943400:AAAAAA:AAAAAAA
NM_001013703.4(EIF2AK4):c.145-2A>G	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000812856	15	40231704	15	39939503	812856	801248		NC_000015.10:39939502:A:G
NM_020988.3(GNAO1):c.723+1G>A	GNAO1		Choreoathetosis	Pathogenic	no assertion criteria provided	VCV000812780	16	56370773	16	56336861	812780	801162		NC_000016.10:56336860:G:A
NM_020988.3(GNAO1):c.607G>C (p.Gly203Arg)	GNAO1	G203R	Early infantile epileptic encephalopathy 17	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803257	16	56370656	16	56336744	803257	791625		NC_000016.10:56336743:G:C
NM_020988.3(GNAO1):c.725A>C (p.Asn242Thr)	GNAO1	N242T	not provided	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000427004	16	56385297	16	56351385	427004	415502	rs1085307894	NC_000016.10:56351384:A:C
NM_020988.3(GNAO1):c.724-8G>A	GNAO1		not provided	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000426965	16	56385288	16	56351376	426965	415501	rs1085307876	NC_000016.10:56351375:G:A
NM_020988.3(GNAO1):c.620C>A (p.Ser207Tyr)	GNAO1	S207Y	not provided	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000373477	16	56370669	16	56336757	373477	360290	rs1057518440	NC_000016.10:56336756:C:A
NM_020988.3(GNAO1):c.119G>A (p.Gly40Glu)	GNAO1	G40E	not provided	Pathogenic(Last reviewed: May 17, 2016)	criteria provided, single submitter	VCV000280589	16	56226486	16	56192574	280589	264812	rs886041766	NC_000016.10:56192573:G:A
NM_025215.6(PUS1):c.722del (p.Gly241fs)	PUS1	G241fs, G213fs	not provided	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000852107	12	132426012	12	131941467	852107	839407		NC_000012.12:131941466:GGG:GG
NM_025215.6(PUS1):c.837_838del (p.Ala280fs)	PUS1	A252fs, A280fs	not provided	Pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, single submitter	VCV000846145	12	132426129 - 132426130	12	131941584 - 131941585	846145	839409		NC_000012.12:131941583:TG:
NM_025215.6(PUS1):c.225_226delinsTT (p.Glu75_Glu76delinsAspTer)	PUS1		not provided	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000844870	12	132414602 - 132414603	12	131930057 - 131930058	844870	839406		NC_000012.12:131930056:GG:TT
NM_025215.6(PUS1):c.801C>G (p.Tyr267Ter)	PUS1	Y239*, Y267*	not provided	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000840012	12	132426093	12	131941548	840012	839408		NC_000012.12:131941547:C:G
NM_025215.6(PUS1):c.961_962GA[1] (p.Lys322fs)	PUS1		not provided	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000838402	12	132426252 - 132426253	12	131941707 - 131941708	838402	839410		NC_000012.12:131941706:AGAGA:AGA
NC_000012.12:g.(?_131929713)_(131943596_?)del	PUS1		not provided	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000830734	12	132414258 - 132428141			830734	820456		
NM_025215.6(PUS1):c.1122C>G (p.Tyr374Ter)	PUS1	Y346*, Y374*	Myopathy, lactic acidosis, and sideroblastic anemia 1	Pathogenic(Last reviewed: Oct 8, 2019)	no assertion criteria provided	VCV000691962	12	132426414	12	131941869	691962	679710		NC_000012.12:131941868:C:G
NM_020988.3(GNAO1):c.851T>C (p.Leu284Ser)	GNAO1	L284S	Early infantile epileptic encephalopathy 17	Pathogenic	criteria provided, single submitter	VCV000496687	16	56385423	16	56351511	496687	488166	rs1555508316	NC_000016.10:56351510:T:C
NM_020988.3(GNAO1):c.737A>G (p.Glu246Gly)	GNAO1	E246G	Neurodevelopmental disorder with involuntary movements	Pathogenic(Last reviewed: Jun 2, 2017)	no assertion criteria provided	VCV000427730	16	56385309	16	56351397	427730	417343	rs1114167431	NC_000016.10:56351396:A:G
NM_020988.3(GNAO1):c.625C>G (p.Arg209Gly)	GNAO1	R209G	Neurodevelopmental disorder with involuntary movements	Pathogenic(Last reviewed: Jun 2, 2017)	no assertion criteria provided	VCV000427726	16	56370674	16	56336762	427726	417339	rs886039494	NC_000016.10:56336761:C:G
NM_025215.6(PUS1):c.883C>T (p.Arg295Trp)	PUS1	R295W, R267W	Myopathy, lactic acidosis, and sideroblastic anemia 1	Pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	VCV000221982	12	132426175	12	131941630	221982	223670	rs869025309	NC_000012.12:131941629:C:T
NM_001013703.4(EIF2AK4):c.3766C>T (p.Arg1256Ter)	EIF2AK4	R1256*	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000101528	15	40308709	15	40016508	101528	107271	rs587777207	NC_000015.10:40016507:C:T
NM_001013703.4(EIF2AK4):c.1387C>T (p.Arg463Ter)	EIF2AK4	R463*	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000097069	15	40259914	15	39967713	97069	102968	rs587777107	NC_000015.10:39967712:C:T
NM_001013703.4(EIF2AK4):c.1754G>A (p.Arg585Gln)	EIF2AK4	R585Q	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000097068	15	40265886	15	39973685	97068	102967	rs587777106	NC_000015.10:39973684:G:A
NM_020988.3(GNAO1):c.572_592del (p.Thr191_Phe197del)	GNAO1		Early infantile epileptic encephalopathy 17	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000066114	16	56368740 - 56368760	16	56334828 - 56334848	66114	77011	rs587777056	NC_000016.10:56334827:CCACTTCACATTCAAGAACCTCCACTTCA:CCACTTCA
NM_020988.3(GNAO1):c.521A>G (p.Asp174Gly)	GNAO1	D174G	Early infantile epileptic encephalopathy 17	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000066113	16	56368697	16	56334785	66113	77010	rs587777055	NC_000016.10:56334784:A:G
NM_020988.3(GNAO1):c.836T>A (p.Ile279Asn)	GNAO1	I279N	Early infantile epileptic encephalopathy 17	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000066112	16	56385408	16	56351496	66112	77009	rs587777054	NC_000016.10:56351495:T:A
NM_001099274.3(TINF2):c.862T>C (p.Phe288Leu)	TINF2	F288L, F253L	Aplastic anemia	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038925	14	24709824	14	24240618	38925	47528	rs199422317	NC_000014.9:24240617:A:G
NM_001099274.3(TINF2):c.839del (p.Lys280fs)	TINF2	K245fs, K280fs	Revesz syndrome	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000031542	14	24709847	14	24240641	31542	40214		NC_000014.9:24240640:TT:T
NM_025215.6(PUS1):c.658G>T (p.Glu220Ter)	PUS1	E220*, E192*	Myopathy, lactic acidosis, and sideroblastic anemia 1	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000002537	12	132425950	12	131941405	2537	17576	rs104894372	NC_000012.12:131941404:G:T
RDH12, 1-BP DEL, 776G	RDH12		Retinitis pigmentosa 53	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000002060					2060	17099		
NM_001099274.3(TINF2):c.1010del (p.Gly337fs)	TINF2	G302fs, G337fs	Dyskeratosis congenita	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000579804	14	24709676	14	24240470	579804	572773	rs756029660	NC_000014.9:24240469:CCCCCC:CCCCC
NM_001099274.3(TINF2):c.1090dup (p.Leu364fs)	TINF2		Dyskeratosis congenita	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000575752	14	24709507 - 24709508	14	24240301 - 24240302	575752	567979	rs1566366182	NC_000014.9:24240301:GGGGG:GGGGGG
NM_001013703.4(EIF2AK4):c.4728+1_4728+13delinsTTCT	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426064	15	40324439 - 40324451	15	40032238 - 40032250	426064	414426	rs1085307445	NC_000015.10:40032237:GTAAGTGGCTTTC:TTCT
NM_001013703.4(EIF2AK4):c.4205dup (p.Ser1403fs)	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426063	15	40313130 - 40313131	15	40020929 - 40020930	426063	414425	rs1085307444	NC_000015.10:40020929:T:TT
NM_001013703.4(EIF2AK4):c.4065+1G>C	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426062	15	40309444	15	40017243	426062	414424	rs776140816	NC_000015.10:40017242:G:C
NM_001013703.4(EIF2AK4):c.3576+1G>T	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426061	15	40300397	15	40008196	426061	414423	rs756902589	NC_000015.10:40008195:G:T
NM_001013703.4(EIF2AK4):c.3344C>T (p.Pro1115Leu)	EIF2AK4	P1115L	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426060	15	40295502	15	40003301	426060	414422	rs774906916	NC_000015.10:40003300:C:T
NM_001013703.4(EIF2AK4):c.3244C>T (p.Gln1082Ter)	EIF2AK4	Q1082*	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426059	15	40295402	15	40003201	426059	414421	rs1085307443	NC_000015.10:40003200:C:T
NM_001013703.4(EIF2AK4):c.3159G>A (p.Lys1053=)	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426058	15	40293425	15	40001224	426058	414420	rs1085307442	NC_000015.10:40001223:G:A
NM_001013703.4(EIF2AK4):c.2857C>T (p.Gln953Ter)	EIF2AK4	Q953*	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426057	15	40289255	15	39997054	426057	414419	rs759101551	NC_000015.10:39997053:C:T
NM_001013703.4(EIF2AK4):c.2458C>T (p.Arg820Ter)	EIF2AK4	R820*	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426056	15	40280238	15	39988037	426056	414418	rs774163084	NC_000015.10:39988036:C:T
NM_001013703.4(EIF2AK4):c.2319+1G>A	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426055	15	40270349	15	39978148	426055	414417	rs1085307441	NC_000015.10:39978147:G:A
NM_001013703.4(EIF2AK4):c.2136_2139dup (p.Ser714fs)	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426054	15	40268931 - 40268932	15	39976730 - 39976731	426054	414416	rs751247185	NC_000015.10:39976730:CACT:CACTCACT
NM_001013703.4(EIF2AK4):c.1928T>G (p.Leu643Arg)	EIF2AK4	L643R	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426053	15	40268724	15	39976523	426053	414415	rs757852728	NC_000015.10:39976522:T:G
NM_001013703.4(EIF2AK4):c.1554-4C>A	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426052	15	40265105	15	39972904	426052	414414	rs376877634	NC_000015.10:39972903:C:A
NM_001013703.4(EIF2AK4):c.745C>T (p.Arg249Ter)	EIF2AK4	R249*	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426051	15	40253986	15	39961785	426051	414413	rs202140402	NC_000015.10:39961784:C:T
NM_001013703.4(EIF2AK4):c.352_353TG[1] (p.Cys118fs)	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000426050	15	40235678 - 40235679	15	39943477 - 39943478	426050	414412	rs1085307439	NC_000015.10:39943476:TGTG:TG
NM_020988.3(GNAO1):c.692A>G (p.Tyr231Cys)	GNAO1	Y231C	not provided|Early infantile epileptic encephalopathy 17	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000374381	16	56370741	16	56336829	374381	361222	rs1057518678	NC_000016.10:56336828:A:G
NM_001013703.4(EIF2AK4):c.3406C>T (p.Arg1136Ter)	EIF2AK4	R1136*	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000097067	15	40299265	15	40007064	97067	102966	rs587777105	NC_000015.10:40007063:C:T
NM_001013703.4(EIF2AK4):c.567dup (p.Lys190fs)	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000097066	15	40246157 - 40246158	15	39953956 - 39953957	97066	102965	rs587777104	NC_000015.10:39953956:G:GG
NM_001013703.4(EIF2AK4):c.3802C>T (p.Gln1268Ter)	EIF2AK4	Q1268*	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000097065	15	40308745	15	40016544	97065	102964	rs587777103	NC_000015.10:40016543:C:T
NM_001099274.3(TINF2):c.892del (p.Gln298fs)	TINF2	Q263fs, Q298fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038928	14	24709794	14	24240588	38928	47531	rs199422320	NC_000014.9:24240587:GGG:GG
NM_001099274.3(TINF2):c.871A>G (p.Arg291Gly)	TINF2	R291G, R256G		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038927	14	24709815	14	24240609	38927	47530	rs199422319	NC_000014.9:24240608:T:C
NM_001099274.3(TINF2):c.865_866delinsAG (p.Pro289Ser)	TINF2			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038926	14	24709820 - 24709821	14	24240614 - 24240615	38926	47529	rs199422318	NC_000014.9:24240613:GG:CT
NM_001099274.3(TINF2):c.860T>C (p.Leu287Pro)	TINF2	L287P, L252P		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038924	14	24709826	14	24240620	38924	47527	rs199422316	NC_000014.9:24240619:A:G
NM_001099274.3(TINF2):c.850A>G (p.Thr284Ala)	TINF2	T284A, T249A		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038923	14	24709836	14	24240630	38923	47526	rs199422314	NC_000014.9:24240629:T:C
NM_001099274.3(TINF2):c.849dup (p.Thr284fs)	TINF2			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038922	14	24709836 - 24709837	14	24240630 - 24240631	38922	47525	rs199422315	NC_000014.9:24240630:GGGG:GGGGG
NM_001099274.3(TINF2):c.848C>A (p.Pro283His)	TINF2	P283H, P248H		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038921	14	24709838	14	24240632	38921	47524	rs199422313	NC_000014.9:24240631:G:T
NM_001099274.3(TINF2):c.847C>G (p.Pro283Ala)	TINF2	P283A, P248A		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038919	14	24709839	14	24240633	38919	47522	rs199422311	NC_000014.9:24240632:G:C
NM_001099274.3(TINF2):c.838A>T (p.Lys280Ter)	TINF2	K280*, K245*		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038917	14	24709848	14	24240642	38917	47520	rs121918543	NC_000014.9:24240641:T:A
NM_001099274.3(TINF2):c.826del (p.Arg276fs)	TINF2	R276fs, R241fs	Dyskeratosis congenita, autosomal dominant, 3	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000037090	14	24709860	14	24240654	37090	45765	rs863223324	NC_000014.9:24240653:T:
NM_001099274.3(TINF2):c.811C>T (p.Gln271Ter)	TINF2	Q271*, Q236*	Dyskeratosis congenita, autosomal dominant, 3	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000031543	14	24709875	14	24240669	31543	40215	rs387907154	NC_000014.9:24240668:G:A
NM_001013703.4(EIF2AK4):c.860-1G>A	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000101530	15	40257886	15	39965685	101530	107273	rs886037661	NC_000015.10:39965684:G:A
NM_001013703.4(EIF2AK4):c.1153dup (p.Val385fs)	EIF2AK4		Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000101527	15	40259676 - 40259677	15	39967475 - 39967476	101527	107270	rs775819448	NC_000015.10:39967475:GGGG:GGGGG
NM_001099274.3(TINF2):c.805C>T (p.Gln269Ter)	TINF2	Q269*, Q234*	Dyskeratosis congenita, autosomal dominant, 3	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000031541	14	24709881	14	24240675	31541	40213	rs387907153	NC_000014.9:24240674:G:A
NM_025215.6(PUS1):c.430C>T (p.Arg144Trp)	PUS1	R116W, R144W	Myopathy, lactic acidosis, and sideroblastic anemia 1	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000002536	12	132416846	12	131932301	2536	17575	rs104894371	NC_000012.12:131932300:C:T
NM_001013703.4(EIF2AK4):c.560_564del (p.Lys187fs)	EIF2AK4	K187fs	Pulmonary venoocclusive disease 2, autosomal recessive|not provided	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000280131	15	40246149 - 40246153	15	39953948 - 39953952	280131	264568	rs772487425	NC_000015.10:39953947:AAAAGAA:AA
NM_001013703.4(EIF2AK4):c.3448C>T (p.Arg1150Ter)	EIF2AK4	R1150*	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000101529	15	40300268	15	40008067	101529	107272	rs587777208	NC_000015.10:40008066:C:T
NM_001013703.4(EIF2AK4):c.1392del (p.Arg465fs)	EIF2AK4	R465fs	Pulmonary venoocclusive disease 2, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000097064	15	40259918	15	39967717	97064	102963	rs587777102	NC_000015.10:39967716:TT:T
NM_001099274.3(TINF2):c.847C>T (p.Pro283Ser)	TINF2	P283S, P248S	not provided|	Pathogenic(Last reviewed: Jun 1, 2015)	criteria provided, single submitter	VCV000038920	14	24709839	14	24240633	38920	47523	rs199422311	NC_000014.9:24240632:G:A
NM_152443.3(RDH12):c.464C>T (p.Thr155Ile)	RDH12	T155I	Leber congenital amaurosis 13	Pathogenic(Last reviewed: Dec 15, 2005)	no assertion criteria provided	VCV000002059	14	68193713	14	67726996	2059	17098	rs121434337	NC_000014.9:67726995:C:T
NM_152443.3(RDH12):c.152T>A (p.Ile51Asn)	RDH12	I51N	Leber congenital amaurosis 13	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000002057	14	68191273	14	67724556	2057	17096	rs104894473	NC_000014.9:67724555:T:A
NM_152443.3(RDH12):c.523T>C (p.Ser175Pro)	RDH12	S175P	Leber congenital amaurosis 13	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000002056	14	68193772	14	67727055	2056	17095	rs104894472	NC_000014.9:67727054:T:C
NM_152443.3(RDH12):c.451C>A (p.His151Asn)	RDH12	H151N	Leber congenital amaurosis 13	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000002052	14	68193700	14	67726983	2052	17091	rs104894475	NC_000014.9:67726982:C:A
NM_152443.3(RDH12):c.565C>T (p.Gln189Ter)	RDH12	Q189*	Leber congenital amaurosis 13	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000002048	14	68193814	14	67727097	2048	17087	rs104894470	NC_000014.9:67727096:C:T
NM_001173464.2(KIF21A):c.84C>G (p.Cys28Trp)	KIF21A	C28W	Fibrosis of extraocular muscles, congenital, 1	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000219258	12	39764024	12	39370222	219258	217277	rs864321718	NC_000012.12:39370221:G:C
NM_000369.2(TSHR):c.545+3G>C	TSHR		Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000006461	14	81558955	14	81092611	6461	21500	rs786205080	NC_000014.9:81092610:G:C
NM_000369.2(TSHR):c.1400T>C (p.Leu467Pro)	TSHR	L467P	Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000006459	14	81609802	14	81143458	6459	21498	rs121908885	NC_000014.9:81143457:T:C
NM_000369.2(TSHR):c.1798T>C (p.Cys600Arg)	TSHR	C600R	Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000006458	14	81610200	14	81143856	6458	21497	rs121908884	NC_000014.9:81143855:T:C
NM_000369.2(TSHR):c.1291G>A (p.Gly431Ser)	TSHR	G431S	Hyperthyroidism, nonautoimmune	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000006457	14	81609693	14	81143349	6457	21496	rs121908883	NC_000014.9:81143348:G:A
NM_000369.2(TSHR):c.1430C>T (p.Thr477Ile)	TSHR	T477I	Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000006455	14	81609832	14	81143488	6455	21494	rs121908881	NC_000014.9:81143487:C:T
NM_000369.2(TSHR):c.1915C>T (p.Pro639Ser)	TSHR	P639S	Hyperthyroidism, nonautoimmune	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000006454	14	81610317	14	81143973	6454	21493	rs121908880	NC_000014.9:81143972:C:T
NM_000369.2(TSHR):c.548A>G (p.Lys183Arg)	TSHR	K183R	Hyperthyroidism, familial gestational	Pathogenic(Last reviewed: Dec 17, 1998)	no assertion criteria provided	VCV000006453	14	81562985	14	81096641	6453	21492	rs121908879	NC_000014.9:81096640:A:G
NM_000369.2(TSHR):c.842G>A (p.Ser281Asn)	TSHR	S281N	Hyperthyroidism, nonautoimmune	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000006452	14	81606172	14	81139828	6452	21491	rs121908873	NC_000014.9:81139827:G:A
NM_000369.2(TSHR):c.1514G>A (p.Ser505Asn)	TSHR	S505N	Hyperthyroidism, nonautoimmune	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000006450	14	81609916	14	81143572	6450	21489	rs121908876	NC_000014.9:81143571:G:A
NM_000369.2(TSHR):c.2015G>A (p.Cys672Tyr)	TSHR	C672Y	Hyperthyroidism, nonautoimmune	Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000006449	14	81610417	14	81144073	6449	21488	rs121908875	NC_000014.9:81144072:G:A
TSHR, 18-BP DEL, 4-BP INS	TSHR		Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000006447					6447	21486		
NM_000369.2(TSHR):c.842G>T (p.Ser281Ile)	TSHR	S281I	Thyroid adenoma, hyperfunctioning	Pathogenic(Last reviewed: Sep 15, 1997)	no assertion criteria provided	VCV000006446	14	81606172	14	81139828	6446	21485	rs121908873	NC_000014.9:81139827:G:T
NM_000369.2(TSHR):c.1575C>A (p.Phe525Leu)	TSHR	F525L	Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000006443	14	81609977	14	81143633	6443	21482	rs121908870	NC_000014.9:81143632:C:A
NM_000369.2(TSHR):c.1228G>A (p.Asp410Asn)	TSHR	D410N	Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000006441	14	81609630	14	81143286	6441	21480	rs121908868	NC_000014.9:81143285:G:A
NM_000369.2(TSHR):c.970C>T (p.Gln324Ter)	TSHR	Q324*	Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000006440	14	81609372	14	81143028	6440	21479	rs121908867	NC_000014.9:81143027:C:T
NM_000369.2(TSHR):c.326G>A (p.Arg109Gln)	TSHR	R109Q	Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Apr 1, 1997)	no assertion criteria provided	VCV000006438	14	81554306	14	81087962	6438	21477	rs121908865	NC_000014.9:81087961:G:A
NM_000369.2(TSHR):c.1897G>C (p.Asp633His)	TSHR	D633H	THYROID CARCINOMA WITH THYROTOXICOSIS, SOMATIC	Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	VCV000006437	14	81610299	14	81143955	6437	21476	rs28937584	NC_000014.9:81143954:G:C
NM_000369.2(TSHR):c.1358T>C (p.Met453Thr)	TSHR	M453T	Hyperthyroidism, nonautoimmune	Pathogenic(Last reviewed: Sep 26, 2018)	no assertion criteria provided	VCV000006436	14	81609760	14	81143416	6436	21475	rs121908864	NC_000014.9:81143415:T:C
NM_000369.2(TSHR):c.500T>A (p.Ile167Asn)	TSHR	I167N	Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Jan 19, 1995)	no assertion criteria provided	VCV000006434	14	81558907	14	81092563	6434	21473	rs121908862	NC_000014.9:81092562:T:A
NM_000369.2(TSHR):c.1867_1868delGCinsAT (p.Ala623Ile)	TSHR	A623I	Thyroid adenoma, hyperfunctioning	Pathogenic(Last reviewed: Oct 14, 1993)	no assertion criteria provided	VCV000006432	14	81610269 - 81610270	14	81143925 - 81143926	6432	21471	rs121908860	NC_000014.9:81143924:GC:AT
NM_000369.2(TSHR):c.1856A>G (p.Asp619Gly)	TSHR	D619G	Thyroid adenoma, hyperfunctioning	Pathogenic(Last reviewed: Oct 14, 1993)	no assertion criteria provided	VCV000006431	14	81610258	14	81143914	6431	21470	rs121908859	NC_000014.9:81143913:A:G
TSHR, 2-BP DEL, 654AC	TSHR		Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000006460					6460	21499		
NM_000369.2(TSHR):c.1526T>C (p.Val509Ala)	TSHR	V509A	Hyperthyroidism, nonautoimmune	Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000006448	14	81609928	14	81143584	6448	21487	rs121908874	NC_000014.9:81143583:T:C
NM_000369.2(TSHR):c.1170T>G (p.Cys390Trp)	TSHR	C390W	Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000006444	14	81609572	14	81143228	6444	21483	rs121908871	NC_000014.9:81143227:T:G
NM_000369.2(TSHR):c.484C>G (p.Pro162Ala)	TSHR	P162A	Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000006435	14	81558891	14	81092547	6435	21474	rs121908863	NC_000014.9:81092546:C:G
NM_001173464.2(KIF21A):c.2841G>A (p.Met947Ile)	KIF21A	M947I, M934I, M911I	Fibrosis of extraocular muscles, congenital, 3b	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000002442	12	39726408	12	39332606	2442	17481	rs267607200	NC_000012.12:39332605:C:T
NM_001173464.2(KIF21A):c.2840T>G (p.Met947Arg)	KIF21A	M947R, M934R, M911R	Fibrosis of extraocular muscles, congenital, 1	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000002441	12	39726409	12	39332607	2441	17480	rs121912590	NC_000012.12:39332606:A:C
NM_001173464.2(KIF21A):c.2839A>G (p.Met947Val)	KIF21A	M947V, M934V, M911V	Fibrosis of extraocular muscles, congenital, 1	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000002440	12	39726410	12	39332608	2440	17479	rs121912589	NC_000012.12:39332607:T:C
NM_001173464.2(KIF21A):c.3029T>C (p.Ile1010Thr)	KIF21A	I1010T, I997T, I974T	Fibrosis of extraocular muscles, congenital, 1	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000002438	12	39726038	12	39332236	2438	17477	rs121912587	NC_000012.12:39332235:A:G
NM_004115.3(FGF14):c.487del (p.Arg163fs)	FGF14	R163fs, R100fs, R116fs, R129fs, R103fs, R131fs, R168fs, R79fs, R101fs		Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000008116	13	102379082	13	101726732	8116	23155	rs587776685	NC_000013.11:101726731:T:
NM_004115.3(FGF14):c.434T>C (p.Phe145Ser)	FGF14	F145S, F150S, F113S, F82S, F83S, F111S, F98S, F61S, F85S		Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000008115	13	102379135	13	101726785	8115	23154	rs104894393	NC_000013.11:101726784:A:G
NM_001173464.2(KIF21A):c.1067T>C (p.Met356Thr)	KIF21A	M356T	Fibrosis of extraocular muscles, congenital, 1	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000002439	12	39752128	12	39358326	2439	17478	rs121912588	NC_000012.12:39358325:A:G
NM_000226.4(KRT9):c.487C>T (p.Arg163Trp)	KRT9	R163W	not provided|Palmoplantar keratoderma, epidermolytic, with knuckle pads|Epidermolytic palmoplantar keratoderma|Palmoplantar keratoderma	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002997	17	39727758	17	41571506	2997	18036	rs59616921	NC_000017.11:41571505:G:A
NM_152443.3(RDH12):c.164C>T (p.Thr55Met)	RDH12	T55M	Leber congenital amaurosis 13|Leber congenital amaurosis	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000805928	14	68191285	14	67724568	805928	794252		NC_000014.9:67724567:C:T
NM_020988.3(GNAO1):c.709G>A (p.Glu237Lys)	GNAO1	E237K	Neurodevelopmental disorder with involuntary movements|Early infantile epileptic encephalopathy 17|not provided|Dyskinesia|Chorea	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420523	16	56370758	16	56336846	420523	409653	rs1064794533	NC_000016.10:56336845:G:A
NM_175929.2(FGF14):c.544A>T (p.Lys182Ter)	FGF14	K177*, K182*, K93*, K130*, K143*, K117*, K145*, K114*, K115*		Pathogenic(Last reviewed: Sep 24, 2019)	no assertion criteria provided	VCV000489406	13	102379040	13	101726690	489406	482339	rs1555370787	NC_000013.11:101726689:T:A
NM_000369.2(TSHR):c.928C>T (p.Arg310Cys)	TSHR	R310C	Hypothyroidism, congenital, nongoitrous, 1|not specified	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000006456	14	81609330	14	81142986	6456	21495	rs121908882	NC_000014.9:81142985:C:T
NM_000369.2(TSHR):c.1887G>T (p.Leu629Phe)	TSHR	L629F	Thyroid adenoma, hyperfunctioning|Hyperthyroidism, nonautoimmune	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000006451	14	81610289	14	81143945	6451	21490	rs121908877	NC_000014.9:81143944:G:T
NM_000369.2(TSHR):c.1891T>C (p.Phe631Leu)	TSHR	F631L	Hyperthyroidism, nonautoimmune|Thyroid adenoma, hyperfunctioning	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000006433	14	81610293	14	81143949	6433	21472	rs121908861	NC_000014.9:81143948:T:C
NM_001329943.3(KIAA0586):c.908del (p.Pro303fs)	KIAA0586	P163fs, P259fs, P356fs, P303fs, P218fs, P288fs	not provided	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000497058	14	58915156	14	58448438	497058	488482	rs1555378721	NC_000014.9:58448437:CCC:CC
NM_001329943.3(KIAA0586):c.787C>T (p.Gln263Ter)	KIAA0586	Q263*, Q316*, Q219*, Q123*, Q178*, Q248*	not provided	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000423877	14	58910873	14	58444155	423877	409139	rs985118235	NC_000014.9:58444154:C:T
NM_001329943.3(KIAA0586):c.2353C>T (p.Arg785Ter)	KIAA0586	R709*, R838*, R770*, R700*, R785*, R645*, R741*	not provided	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000418265	14	58934551	14	58467833	418265	409140	rs1064793157	NC_000014.9:58467832:C:T
NM_001329943.3(KIAA0586):c.1656G>A (p.Gln552=)	KIAA0586		Short-rib thoracic dysplasia 14 with polydactyly	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208813	14	58925263	14	58458545	208813	205374	rs762081862	NC_000014.9:58458544:G:A
NM_001329943.3(KIAA0586):c.194C>G (p.Ser65Ter)	KIAA0586	S77*, S65*, S50*	Short-rib thoracic dysplasia 14 with polydactyly	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208812	14	58895176	14	58428458	208812	205373	rs797045119	NC_000014.9:58428457:C:G
NM_001329943.3(KIAA0586):c.3668C>G (p.Ser1223Ter)	KIAA0586	S1083*, S1179*, S1147*, S1223*, S1276*, S1138*, S1208*	Joubert syndrome 23|Short-rib thoracic dysplasia 14 with polydactyly	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000854917	14	58955479	14	58488761	854917	841568		NC_000014.9:58488760:C:G
NM_001329943.3(KIAA0586):c.1804C>T (p.Gln602Ter)	KIAA0586	Q655*, Q517*, Q558*, Q587*, Q462*, Q602*	Short-rib thoracic dysplasia 14 with polydactyly|Joubert syndrome 23	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000565469	14	58926708	14	58459990	565469	566507	rs1566827747	NC_000014.9:58459989:C:T
NM_001329943.3(KIAA0586):c.643C>T (p.Gln215Ter)	KIAA0586	Q268*, Q215*, Q200*, Q75*, Q130*, Q171*	Joubert syndrome 23	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000217669	14	58910729	14	58444011	217669	214344	rs201097695	NC_000014.9:58444010:C:T
NM_001329943.3(KIAA0586):c.1571_1575del (p.Leu524fs)	KIAA0586	L524fs, L384fs, L439fs, L480fs, L509fs, L577fs	Joubert syndrome 23	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000217668	14	58924684 - 58924688	14	58457966 - 58457970	217668	214346	rs863225203	NC_000014.9:58457965:TTATCT:T
NM_001329943.3(KIAA0586):c.1271_1274delinsGA (p.Glu424fs)	KIAA0586		Joubert syndrome 23	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000217666	14	58923437 - 58923440	14	58456719 - 58456722	217666	214345	rs869312856	NC_000014.9:58456718:AGCT:GA
NM_001077418.3(TMEM231):c.664+4A>G	TMEM231		Meckel syndrome, type 11|Meckel syndrome, type 11|Joubert syndrome 20	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000437009	16	75576496	16	75542598	437009	429844	rs760426025	NC_000016.10:75542597:T:C
NM_153603.4(COG7):c.169+4A>C	COG7		COG7 congenital disorder of glycosylation	Pathogenic(Last reviewed: Aug 21, 2019)	no assertion criteria provided	VCV000003650	16	23464143	16	23452822	3650	18689	rs1555497568	NC_000016.10:23452821:T:G
NC_000014.8:g.(?_58910652)_(58917484_?)del	KIAA0586		Short-rib thoracic dysplasia 14 with polydactyly|Joubert syndrome 23	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000583841	14	58910652 - 58917484	14	58443934 - 58450766	583841	566189		
NM_001329943.3(KIAA0586):c.2504_2508del (p.Leu835fs)	KIAA0586	L695fs, L759fs, L820fs, L835fs, L791fs, L888fs, L750fs	Joubert syndrome 23|Short-rib thoracic dysplasia 14 with polydactyly	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000542183	14	58937392 - 58937396	14	58470674 - 58470678	542183	528586	rs1410766981	NC_000014.9:58470673:TGTCT:
NM_001329943.3(KIAA0586):c.790C>T (p.Gln264Ter)	KIAA0586	Q264*, Q317*, Q179*, Q220*, Q249*, Q124*	Joubert syndrome 23	Pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	VCV000369671	14	58910876	14	58444158	369671	353908	rs1057516038	NC_000014.9:58444157:C:T
NM_001329943.3(KIAA0586):c.1538A>T (p.Asp513Val)	KIAA0586	D566V, D373V, D428V, D469V, D498V, D513V	Joubert syndrome 23	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000204597	14	58924652	14	58457934	204597	200987	rs796052129	NC_000014.9:58457933:A:T
NM_001329943.3(KIAA0586):c.1000C>T (p.Gln334Ter)	KIAA0586	Q387*, Q194*, Q249*, Q290*, Q319*, Q334*	Joubert syndrome 23	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000204595	14	58917335	14	58450617	204595	200985	rs796052128	NC_000014.9:58450616:C:T
NM_001173464.2(KIF21A):c.2861G>A (p.Arg954Gln)	KIF21A	R954Q, R941Q, R918Q	Fibrosis of extraocular muscles, congenital, 3b|Fibrosis of extraocular muscles, congenital, 1	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000002437	12	39726206	12	39332404	2437	17476	rs121912586	NC_000012.12:39332403:C:T
NM_001329943.3(KIAA0586):c.38dup (p.Ile14fs)	KIAA0586		Short-rib thoracic dysplasia 14 with polydactyly|Short-rib thoracic dysplasia 14 with polydactyly|Joubert syndrome 23	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000575236	14	58895012 - 58895013	14	58428294 - 58428295	575236	568950	rs745949846	NC_000014.9:58428294:AAAAAAAA:AAAAAAAAA
NM_001329943.3(KIAA0586):c.789dup (p.Gln264fs)	KIAA0586		not provided|Joubert syndrome 23|Short-rib thoracic dysplasia 14 with polydactyly	Pathogenic/Likely pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000524064	14	58910873 - 58910874	14	58444155 - 58444156	524064	514662	rs1203751352	NC_000014.9:58444155:AA:AAA
NM_001329943.3(KIAA0586):c.831C>T (p.Leu277=)	KIAA0586		Joubert syndrome 23|Short-rib thoracic dysplasia 14 with polydactyly	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000475455	14	58915081	14	58448363	475455	463307	rs780520735	NC_000014.9:58448362:C:T
NM_001329943.3(KIAA0586):c.4032del (p.Arg1344fs)	KIAA0586	R1259fs, R1268fs, R1329fs, R1344fs, R1300fs, R1204fs, R1397fs	Joubert syndrome 23|Joubert Syndrome and Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000266098	14	58965542	14	58498824	266098	260917	rs886039809	NC_000014.9:58498823:A:
NM_007129.5(ZIC2):c.494dup (p.His166fs)	ZIC2		not provided	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000451180	13	100634811 - 100634812	13	99982557 - 99982558	451180	445164	rs1555332225	NC_000013.11:99982557:A:AA
NM_007129.5(ZIC2):c.637C>T (p.Gln213Ter)	ZIC2	Q213*	not provided	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000450157	13	100634955	13	99982701	450157	445165	rs753776168	NC_000013.11:99982700:C:T
NM_007129.5(ZIC2):c.725_728del (p.Ala242fs)	ZIC2	A242fs	not provided	Pathogenic(Last reviewed: Sep 8, 2015)	criteria provided, single submitter	VCV000419833	13	100635043 - 100635046	13	99982789 - 99982792	419833	409052	rs1064794138	NC_000013.11:99982788:CCTT:
NM_007129.5(ZIC2):c.1097dup (p.Phe367fs)	ZIC2		not provided	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000280364	13	100637220 - 100637221	13	99984966 - 99984967	280364	264527	rs886041583	NC_000013.11:99984966:A:AA
NM_007129.5(ZIC2):c.1317del (p.Leu440fs)	ZIC2	L440fs	Holoprosencephaly 5	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000811286	13	100637651	13	99985397	811286	799754		NC_000013.11:99985396:GGGG:GGG
NM_014918.5(CHSY1):c.96del (p.Glu33fs)	CHSY1	E33fs	Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030715	15	101791566	15	101251361	30715	39672		NC_000015.10:101251360:GG:G
NM_014918.5(CHSY1):c.205C>T (p.Gln69Ter)	CHSY1	Q69*	Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030712	15	101791457	15	101251252	30712	39669	rs387906984	NC_000015.10:101251251:G:A
NM_014918.5(CHSY1):c.14del (p.Gly5fs)	CHSY1	G5fs	Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030711	15	101791648	15	101251443	30711	39668	rs1567112402	NC_000015.10:101251442:CC:C
NM_018082.5(POLR3B):c.1568T>A	POLR3B	V523E, V465E	Hypomyelinating leukodystrophy 7|Hypogonadotropic hypogonadism 7 with or without anosmia|Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism|Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism|Cerebellar hypoplasia with endosteal sclerosis|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031166	12	106826199	12	106432421	31166	40123	rs138249161	NC_000012.12:106432420:T:A
NM_007129.5(ZIC2):c.321del (p.Tyr108fs)	ZIC2	Y108fs	Holoprosencephaly 5	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000545578	13	100634638	13	99982384	545578	536082	rs1555332212	NC_000013.11:99982383:CC:C
NM_007129.5(ZIC2):c.1076-2A>T	ZIC2		Holoprosencephaly 5	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, single submitter	VCV000468364	13	100637198	13	99984944	468364	463710	rs1555332361	NC_000013.11:99984943:A:T
NM_007129.5(ZIC2):c.1085_1131del (p.Pro362fs)	ZIC2	P362fs	Holoprosencephaly 5	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, single submitter	VCV000437335	13	100637206 - 100637252	13	99984952 - 99984998	437335	429512	rs1555332362	NC_000013.11:99984951:AGCCGTTCCAGTGTGAGTTTGAGGGCTGCGACCGGCGCTTCGCCAACAGC:AGC
NM_007129.3:c.1148_1464del	ZIC2		Holoprosencephaly 5	Pathogenic	criteria provided, single submitter	VCV000397658					397658	384631		
NM_007129.5(ZIC2):c.1093_1094TG[1] (p.Cys365_Glu366delinsTer)	ZIC2		Holoprosencephaly 5	Pathogenic	criteria provided, single submitter	VCV000397656	13	100637216 - 100637217	13	99984962 - 99984963	397656	384629	rs1060499562	NC_000013.11:99984961:GTGTG:GTG
NM_007129.5(ZIC2):c.793C>T (p.Gln265Ter)	ZIC2	Q265*	Holoprosencephaly 5	Pathogenic	criteria provided, single submitter	VCV000397655	13	100635111	13	99982857	397655	384628	rs1060499563	NC_000013.11:99982856:C:T
NM_007129.5(ZIC2):c.1097_1098del (p.Glu366fs)	ZIC2	E366fs	Holoprosencephaly 5	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000397654	13	100637220 - 100637221	13	99984966 - 99984967	397654	384627	rs1060499564	NC_000013.11:99984965:GAG:G
NM_014918.5(CHSY1):c.1616C>G (p.Pro539Arg)	CHSY1	P539R	Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030714	15	101718386	15	101178181	30714	39671	rs387906985	NC_000015.10:101178180:G:C
NM_014918.5(CHSY1):c.321-3C>G	CHSY1		Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030713	15	101775785	15	101235580	30713	39670	rs1567106459	NC_000015.10:101235579:G:C
CHSY1, 30-BP DEL, NT55	CHSY1		Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030710					30710	39667		
ZIC2, 2-BP DEL, 180AC	ZIC2		Holoprosencephaly 5	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000006641					6641	21680		
NM_152443.3(RDH12):c.316C>T (p.Arg106Ter)	RDH12	R106*	Leber congenital amaurosis 13	Pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000835782	14	68191944	14	67725227	835782	841681		NC_000014.9:67725226:C:T
NM_152443.3(RDH12):c.609C>A (p.Ser203Arg)	RDH12	S203R	Leber congenital amaurosis 13	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000663830	14	68193858	14	67727141	663830	642640		NC_000014.9:67727140:C:A
NM_020988.3(GNAO1):c.118G>T (p.Gly40Trp)	GNAO1	G40W	not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280526	16	56226265	16	56192353	280526	264953	rs886041715	NC_000016.10:56192352:G:T
NM_001099274.3(TINF2):c.844C>A (p.Arg282Ser)	TINF2	R282S, R247S	|Dyskeratosis congenita, autosomal dominant, 3	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000005626	14	24709842	14	24240636	5626	20665	rs121918545	NC_000014.9:24240635:G:T
NM_001099274.3(TINF2):c.838A>G (p.Lys280Glu)	TINF2	K280E, K245E	|Dyskeratosis congenita, autosomal dominant, 3	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000005624	14	24709848	14	24240642	5624	20663	rs121918543	NC_000014.9:24240641:T:C
NM_007129.5(ZIC2):c.1091_1092del (p.Gln364fs)	ZIC2	Q364fs	Holoprosencephaly 5	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065492	13	100637215 - 100637216	13	99984961 - 99984962	65492	76400	rs397515500	NC_000013.11:99984960:AG:
NM_007129.5(ZIC2):c.936del (p.Lys312fs)	ZIC2	K312fs	Holoprosencephaly 5	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065487	13	100635254	13	99983000	65487	76395	rs397515499	NC_000013.11:99982999:G:
NM_007129.5(ZIC2):c.397_403del (p.Gly133fs)	ZIC2	G133fs	Holoprosencephaly 5	Pathogenic(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000030298	13	100634710 - 100634716	13	99982456 - 99982462	30298	39254		NC_000013.11:99982455:CGGGCGGCGGGC:CGGGC
NM_007129.5(ZIC2):c.1042_1048del (p.Glu348fs)	ZIC2	E348fs	Holoprosencephaly 5	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000006640	13	100635358 - 100635364	13	99983104 - 99983110	6640	21679	rs397515365	NC_000013.11:99983103:CCGAGAACC:CC
NM_007129.5(ZIC2):c.1318dup (p.Leu440fs)	ZIC2		Holoprosencephaly 5	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000006638	13	100637654 - 100637655	13	99985400 - 99985401	6638	21677	rs397515364	NC_000013.11:99985400:C:CC
NM_007129.4(ZIC2):c.177_178ins56	ZIC2		Holoprosencephaly 5	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000006637	13	100634495 - 100634496	13	99982241 - 99982242	6637	21676		
NM_001039958.2(MESP2):c.307G>T (p.Glu103Ter)	MESP2	E103*	not provided|	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005184	15	90319895	15	89776664	5184	20223	rs71647808	NC_000015.10:89776663:G:T
NM_001329943.3(KIAA0586):c.3144G>A (p.Pro1048=)	KIAA0586		Joubert syndrome 23|Short-rib thoracic dysplasia 14 with polydactyly|Joubert syndrome 23	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217667	14	58949430	14	58482712	217667	214347	rs540255320	NC_000014.9:58482711:G:A
NM_001329943.3(KIAA0586):c.704_705del (p.Gln235fs)	KIAA0586	Q150fs, Q235fs, Q288fs, Q191fs, Q95fs, Q220fs	Rod-cone dystrophy|Intellectual disability|Congenital cerebellar hypoplasia|Joubert syndrome 23	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000204596	14	58910790 - 58910791	14	58444072 - 58444073	204596	200986	rs770566897	NC_000014.9:58444071:AA:
NM_152443.3(RDH12):c.250C>T (p.Arg84Ter)	RDH12	R84*	Leber congenital amaurosis 13|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488802	14	68191878	14	67725161	488802	482052	rs1349849938	NC_000014.9:67725160:C:T
NM_015087.5(SPART):c.696del (p.Phe232fs)	SPART	F232fs	not provided	Pathogenic(Last reviewed: Jun 9, 2015)	criteria provided, single submitter	VCV000419124	13	36909272	13	36335135	419124	409022	rs770560051	NC_000013.11:36335134:AAAAAAAA:AAAAAAA
NM_015087.5(SPART):c.1369C>T (p.Arg457Ter)	SPART	R457*	not provided	Pathogenic(Last reviewed: Jun 9, 2015)	criteria provided, single submitter	VCV000379832	13	36888478	13	36314341	379832	373823	rs200373703	NC_000013.11:36314340:G:A
NM_006086.4(TUBB3):c.1172G>T (p.Arg391Leu)	TUBB3	R319L, R391L	not provided	Pathogenic(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	VCV000265354	16	90002031	16	89935623	265354	260146	rs886039497	NC_000016.10:89935622:G:T
NM_001318918.1(GLIS2):c.775+1G>T	GLIS2		Nephronophthisis	Pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	VCV000242364	16	4385395	16	4335394	242364	243911	rs878855335	NC_000016.10:4335393:G:T
NM_006086.4(TUBB3):c.1162A>G (p.Met388Val)	TUBB3	M388V, M316V	Cortical dysplasia, complex, with other brain malformations 1	Pathogenic(Last reviewed: Sep 22, 2016)	no assertion criteria provided	VCV000236243	16	90002021	16	89935613	236243	237806	rs878853279	NC_000016.10:89935612:A:G
NM_006086.4(TUBB3):c.185G>A (p.Arg62Gln)	TUBB3	R62Q	Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000219254	16	89999894	16	89933486	219254	217278	rs864321714	NC_000016.10:89933485:G:A
NM_006086.4(TUBB3):c.967A>G (p.Met323Val)	TUBB3	M323V, M251V	Cortical dysplasia, complex, with other brain malformations 1	Pathogenic(Last reviewed: Nov 15, 2010)	no assertion criteria provided	VCV000030272	16	90001826	16	89935418	30272	39228	rs878853256	NC_000016.10:89935417:A:G
NM_015087.5(SPART):c.388C>T (p.Gln130Ter)	SPART	Q130*	Troyer syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000863112	13	36909580	13	36335443	863112	840877		NC_000013.11:36335442:G:A
NM_015087.5(SPART):c.685C>T (p.Gln229Ter)	SPART	Q229*	Troyer syndrome	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000572922	13	36909283	13	36335146	572922	567565	rs748835312	NC_000013.11:36335145:G:A
NM_006086.4(TUBB3):c.905C>T (p.Ala302Val)	TUBB3	A302V, A230V	Cortical dysplasia, complex, with other brain malformations 1	Pathogenic(Last reviewed: Nov 15, 2010)	no assertion criteria provided	VCV000030275	16	90001764	16	89935356	30275	39231	rs878853258	NC_000016.10:89935355:C:T
GLIS2, IVS5DS, G-T, +1	GLIS2		Nephronophthisis 7	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000002213					2213	17252		
NM_006086.4(TUBB3):c.689C>T (p.Ser230Leu)	TUBB3	S230L, S158L	not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280212	16	90001548	16	89935140	280212	264989	rs886041459	NC_000016.10:89935139:C:T
c.1228G>A	TUBB3	E410K	Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement	Pathogenic(Last reviewed: Dec 4, 2015)	no assertion criteria provided	VCV000224784					224784	226603		
NM_006086.4(TUBB3):c.1138C>T (p.Arg380Cys)	TUBB3	R308C, R380C	not provided|Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	VCV000219257	16	90001997	16	89935589	219257	217281	rs864321717	NC_000016.10:89935588:C:T
NM_006086.4(TUBB3):c.211G>A (p.Gly71Arg)	TUBB3	G91R, G71R	not provided|Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000219255	16	89999920	16	89933512	219255	217279	rs864321715	NC_000016.10:89933511:G:A
NM_006086.4(TUBB3):c.613G>A (p.Glu205Lys)	TUBB3	E205K, E133K	Cortical dysplasia, complex, with other brain malformations 1	Pathogenic(Last reviewed: Feb 4, 2016)	criteria provided, single submitter	VCV000030274	16	90001472	16	89935064	30274	39230	rs878853257	NC_000016.10:89935063:G:A
NM_006086.4(TUBB3):c.1249G>C (p.Asp417His)	TUBB3	D417H, D345H	Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000006965	16	90002108	16	89935700	6965	22004	rs267607164	NC_000016.10:89935699:G:C
NM_001318918.1(GLIS2):c.523T>C (p.Cys175Arg)	GLIS2	C175R	Nephronophthisis 7|Nephronophthisis	Pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	VCV000127160	16	4385061	16	4335060	127160	132658	rs587777353	NC_000016.10:4335059:T:C
NM_006086.4(TUBB3):c.1249G>A (p.Asp417Asn)	TUBB3	D417N, D345N	Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000006966	16	90002108	16	89935700	6966	22005	rs267607164	NC_000016.10:89935699:G:A
NM_001083614.2(EARS2):c.684C>A (p.Tyr228Ter)	EARS2	Y228*	Combined oxidative phosphorylation deficiency 12	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803228	16	23546483	16	23535162	803228	791561		NC_000016.10:23535161:G:T
NM_001308211.1(EARS2):c.1194C>G (p.Tyr398Ter)	EARS2	Y398*	not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000488831	16	23541092	16	23529771	488831	482094	rs369291371	NC_000016.10:23529770:G:C
NM_002615.7(SERPINF1):c.295C>T (p.Arg99Ter)	SERPINF1	R99*	not provided	Pathogenic(Last reviewed: Apr 16, 2017)	criteria provided, single submitter	VCV000426454	17	1674334	17	1771040	426454	415540	rs1085307634	NC_000017.11:1771039:C:T
NM_002615.7(SERPINF1):c.651G>A (p.Trp217Ter)	SERPINF1	W217*, W30*	Osteogenesis imperfecta, type VI	Pathogenic	criteria provided, single submitter	VCV000684390	17	1678359	17	1775065	684390	671986		NC_000017.11:1775064:G:A
NM_002615.7(SERPINF1):c.1217_1253del (p.Leu406fs)	SERPINF1	L406fs, L219fs	Osteogenesis imperfecta, type VI	Pathogenic	criteria provided, single submitter	VCV000684387	17	1680691 - 1680727	17	1777397 - 1777433	684387	671987		NC_000017.11:1777396:CAGGGGCCCTTCTCTTCATTGGCAAGATTCTGGACCCCAGGGGCCC:CAGGGGCCC
NM_002615.7(SERPINF1):c.1152_1170del (p.Phe384fs)	SERPINF1	F197fs, F384fs	Osteogenesis imperfecta, type VI	Pathogenic	criteria provided, single submitter	VCV000224879	17	1680628 - 1680646	17	1777334 - 1777352	224879	226723	rs869312908	NC_000017.11:1777333:TCACCTTCCCGCTGGACTATCACCTT:TCACCTT
NM_002615.7(SERPINF1):c.-9+2dup	SERPINF1		Osteogenesis imperfecta, type VI	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000041893	17	1665408 - 1665409	17	1762114 - 1762115	41893	50330	rs398122519	NC_000017.11:1762114:T:TT
NM_002615.7(SERPINF1):c.119_120del (p.Val40fs)	SERPINF1	V40fs	Osteogenesis imperfecta, type VI	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000041892	17	1673179 - 1673180	17	1769885 - 1769886	41892	50329	rs398122518	NC_000017.11:1769884:GTG:G
NM_001308211.1(EARS2):c.500G>A (p.Cys167Tyr)	EARS2	C167Y	Combined oxidative phosphorylation deficiency 12	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000039792	16	23546667	16	23535346	39792	48391	rs397514594	NC_000016.10:23535345:C:T
NM_001308211.1(EARS2):c.286G>A (p.Glu96Lys)	EARS2	E96K	Combined oxidative phosphorylation deficiency 12	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000039791	16	23563479	16	23552158	39791	48390	rs397514593	NC_000016.10:23552157:C:T
NM_001308211.1(EARS2):c.610G>A (p.Gly204Ser)	EARS2	G204S	Combined oxidative phosphorylation deficiency 12	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000039790	16	23546557	16	23535236	39790	48389	rs397514592	NC_000016.10:23535235:C:T
NM_001308211.1(EARS2):c.502A>G (p.Arg168Gly)	EARS2	R168G	Combined oxidative phosphorylation deficiency 12	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000039788	16	23546665	16	23535344	39788	48387	rs397514591	NC_000016.10:23535343:T:C
SERPINF1, 2-BP DUP, 324CT	SERPINF1		Osteogenesis imperfecta, type VI	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000029840					29840	38795		
NM_001308211.1(EARS2):c.320G>A (p.Arg107His)	EARS2	R107H	not provided|Combined oxidative phosphorylation deficiency 12	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449533	16	23556000	16	23544679	449533	445541	rs1021330566	NC_000016.10:23544678:C:T
NM_001083614.1(EARS2):c.1547G>A (p.Arg516Gln)	EARS2	R516Q	Combined oxidative phosphorylation deficiency 12|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265109	16	23535717	16	23524396	265109	260092	rs201727231	NC_000016.10:23524395:C:T
NM_001308211.1(EARS2):c.193A>G (p.Lys65Glu)	EARS2	K65E	Combined oxidative phosphorylation deficiency 12	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000039793	16	23563572	16	23552251	39793	48392	rs397514595	NC_000016.10:23552250:T:C
NM_002615.7(SERPINF1):c.1132C>T (p.Gln378Ter)	SERPINF1	Q378*, Q191*	not provided|Osteogenesis imperfecta, type VI	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000031853	17	1680615	17	1777321	31853	40513	rs193302873	NC_000017.11:1777320:C:T
NM_002615.7(SERPINF1):c.696C>G (p.Tyr232Ter)	SERPINF1	Y232*, Y45*	Osteogenesis imperfecta, type VI|not provided	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000031851	17	1678404	17	1775110	31851	40511	rs193302872	NC_000017.11:1775109:C:G
NM_004119.2(FLT3):c.2506A>C (p.Ile836Leu)	FLT3	I836L	Acute myeloid leukemia	Pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000375970	13	28592639	13	28018502	375970	362849	rs1057519726	NC_000013.11:28018501:T:G
NM_006086.4(TUBB3):c.785G>A (p.Arg262His)	TUBB3	R190H, R262H	not provided|Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000219256	16	90001644	16	89935236	219256	217280	rs864321716	NC_000016.10:89935235:G:A
NM_002615.7(SERPINF1):c.653del (p.Val218fs)	SERPINF1	V31fs, V218fs	not provided|Osteogenesis imperfecta, type VI	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000041894	17	1678361	17	1775067	41894	50331	rs398122520	NC_000017.11:1775066:T:
NM_002435.3(MPI):c.166C>T (p.Arg56Ter)	MPI	R36*, R6*, R56*	MPI-CDG	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000851479	15	75183741	15	74891400	851479	842706		NC_000015.10:74891399:C:T
NM_002435.3(MPI):c.631del (p.Glu211fs)	MPI	E191fs, E161fs, E211fs	MPI-CDG	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000843069	15	75185621	15	74893280	843069	842707		NC_000015.10:74893279:GG:G
MPI, 1-BP INS, 166C	MPI		MPI-CDG	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000014348					14348	29387		
NM_002435.3(MPI):c.413T>C (p.Met138Thr)	MPI	M138T, M88T, M118T	MPI-CDG	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000014347	15	75185069	15	74892728	14347	29386	rs104894495	NC_000015.10:74892727:T:C
NM_002435.3(MPI):c.305C>T (p.Ser102Leu)	MPI	S102L, S52L, S82L	MPI-CDG	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000014346	15	75183880	15	74891539	14346	29385	rs104894494	NC_000015.10:74891538:C:T
NM_002435.3(MPI):c.1253G>A (p.Arg418His)	MPI	R418H, R357H, R368H, R398H	MPI-CDG	Pathogenic	criteria provided, single submitter	VCV000218095	15	75190052	15	74897711	218095	214750	rs863225087	NC_000015.10:74897710:G:A
NM_002435.3(MPI):c.1205A>G (p.Glu402Gly)	MPI	E402G, E341G, E352G, E382G	MPI-CDG	Pathogenic	criteria provided, single submitter	VCV000218094	15	75190004	15	74897663	218094	214749	rs863225086	NC_000015.10:74897662:A:G
NM_002435.3(MPI):c.884G>A (p.Arg295His)	MPI	R295H, R245H, R234H, R275H	MPI-CDG	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000014349	15	75189391	15	74897050	14349	29388	rs28928906	NC_000015.10:74897049:G:A
NM_183235.3(RAB27A):c.550C>T (p.Arg184Ter)	RAB27A	R184*	Griscelli syndrome type 2	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000436458	15	55497821	15	55205623	436458	429705	rs200956636	NC_000015.10:55205622:G:A
NM_004448.3(ERBB2):c.2331_2339dup (p.Gly778_Pro780dup)	ERBB2		Non-small cell lung cancer	Pathogenic(Last reviewed: Jul 24, 2013)	criteria provided, single submitter	VCV000044992	17	37881001 - 37881002	17	39724748 - 39724749	44992	54159	rs397516981	NC_000017.11:39724748:GGGCTCCCC:GGGCTCCCCGGGCTCCCC
NM_004448.3(ERBB2):c.2326G>A (p.Gly776Ser)	ERBB2	G776S, G746S, G761S	Neoplasm of stomach|Adenocarcinoma of stomach|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000013879	17	37880997	17	39724744	13879	28918	rs28933369	NC_000017.11:39724743:G:A
NM_003673.3(TCAP):c.66G>A (p.Trp22Ter)	TCAP	W22*	not provided	Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	VCV000290645	17	37821678	17	39665425	290645	274882	rs141019458	NC_000017.11:39665424:G:A
NM_003673.3(TCAP):c.103G>T (p.Glu35Ter)	TCAP	E35*	not provided	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000286261	17	37821715	17	39665462	286261	270498	rs779699520	NC_000017.11:39665461:G:T
NM_003673.3(TCAP):c.90_91del (p.Ser31fs)	TCAP	S31fs	Elevated serum creatine phosphokinase	Pathogenic	no assertion criteria provided	VCV000446463	17	37821701 - 37821702	17	39665448 - 39665449	446463	439919	rs1555606976	NC_000017.11:39665447:TGT:T
NM_003673.3(TCAP):c.110_110+1del	TCAP		Autosomal recessive limb-girdle muscular dystrophy type 2G	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000005526	17	37821720 - 37821721	17	39665467 - 39665468	5526	20565	rs786205076	NC_000017.11:39665466:GGGG:GG
NM_003673.3(TCAP):c.410C>T (p.Thr137Ile)	TCAP	T137I	Dilated cardiomyopathy 1N	Pathogenic(Last reviewed: Dec 7, 2004)	no assertion criteria provided	VCV000189787	17	37822268	17	39666015	189787	187657	rs773317399	NC_000017.11:39666014:C:T
NM_152443.3(RDH12):c.437T>A (p.Val146Asp)	RDH12	V146D	Leber congenital amaurosis 13	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000841398	14	68192861	14	67726144	841398	841682		NC_000014.9:67726143:T:A
NM_152443.3(RDH12):c.210dup (p.Arg71fs)	RDH12		not provided|Retinal dystrophy|Leber congenital amaurosis 13	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197878	14	68191837 - 68191838	14	67725120 - 67725121	197878	195039	rs797044761	NC_000014.9:67725120:C:CC
NM_152443.3(RDH12):c.658+1G>A	RDH12		Retinitis pigmentosa|Leber congenital amaurosis 13	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000002058	14	68193908	14	67727191	2058	17097	rs387906272	NC_000014.9:67727190:G:A
NM_006086.4(TUBB3):c.904G>A (p.Ala302Thr)	TUBB3	A302T, A230T	not provided|Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000006964	16	90001763	16	89935355	6964	22003	rs267607163	NC_000016.10:89935354:G:A
NM_002435.3(MPI):c.166dup (p.Arg56fs)	MPI		MPI-CDG	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188967	15	75183736 - 75183737	15	74891395 - 74891396	188967	186941	rs786204593	NC_000015.10:74891395:CCCCC:CCCCCC
NM_021954.4(GJA3):c.466A>C (p.Lys156Gln)	GJA3	K156Q	Congenital cataract	Pathogenic(Last reviewed: Jul 29, 2016)	no assertion criteria provided	VCV000252945	13	20716962	13	20142823	252945	247355	rs1114167308	NC_000013.11:20142822:T:G
NM_021954.4(GJA3):c.56C>T (p.Thr19Met)	GJA3	T19M	Congenital cataract	Pathogenic(Last reviewed: Jul 29, 2016)	no assertion criteria provided	VCV000252944	13	20717372	13	20143233	252944	247356	rs1114167307	NC_000013.11:20143232:G:A
NM_021954.4(GJA3):c.260C>T (p.Thr87Met)	GJA3	T87M	Congenital cataract	Pathogenic(Last reviewed: Jan 9, 2015)	no assertion criteria provided	VCV000217334	13	20717168	13	20143029	217334	213991	rs864309687	NC_000013.11:20143028:G:A
NM_021954.4(GJA3):c.427G>A (p.Gly143Arg)	GJA3	G143R	Zonular pulverulent cataract 3	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000050945	13	20717001	13	20142862	50945	65608	rs398122937	NC_000013.11:20142861:C:T
NM_021954.4(GJA3):c.616T>A (p.Phe206Ile)	GJA3	F206I	Zonular pulverulent cataract 3	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000050944	13	20716812	13	20142673	50944	65607	rs397514704	NC_000013.11:20142672:A:T
NM_021954.4(GJA3):c.563A>T (p.Asn188Ile)	GJA3	N188I	Zonular pulverulent cataract 3	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000050943	13	20716865	13	20142726	50943	65606	rs140332366	NC_000013.11:20142725:T:A
NM_021954.4(GJA3):c.5G>A (p.Gly2Asp)	GJA3	G2D	Zonular pulverulent cataract 3	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000050942	13	20717423	13	20143284	50942	65605	rs397514703	NC_000013.11:20143283:C:T
NM_021954.4(GJA3):c.563A>C (p.Asn188Thr)	GJA3	N188T	Zonular pulverulent cataract 3	Pathogenic(Last reviewed: Sep 14, 2004)	no assertion criteria provided	VCV000050941	13	20716865	13	20142726	50941	65604	rs140332366	NC_000013.11:20142725:T:G
NM_021954.4(GJA3):c.227G>A (p.Arg76His)	GJA3	R76H	Zonular pulverulent cataract 3	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000016981	13	20717201	13	20143062	16981	32020	rs121917827	NC_000013.11:20143061:C:T
NM_021954.4(GJA3):c.560C>T (p.Pro187Leu)	GJA3	P187L	Zonular pulverulent cataract 3	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000016980	13	20716868	13	20142729	16980	32019	rs121917825	NC_000013.11:20142728:G:A
NM_021954.4(GJA3):c.188A>G (p.Asn63Ser)	GJA3	N63S	Zonular pulverulent cataract 3	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000016978	13	20717240	13	20143101	16978	32017	rs121917823	NC_000013.11:20143100:T:C
NM_021954.4(GJA3):c.1137dup (p.Ser380fs)	GJA3		Zonular pulverulent cataract 3	Pathogenic(Last reviewed: Dec 9, 2005)	no assertion criteria provided	VCV000016979	13	20716290 - 20716291	13	20142151 - 20142152	16979	32018		NC_000013.11:20142151:G:GG
NM_000286.3(PEX12):c.86T>G (p.Leu29Ter)	PEX12	L29*	not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000595654	17	33904955	17	35577936	595654	586716	rs1567731767	NC_000017.11:35577935:A:C
NM_000286.3(PEX12):c.51_54dup (p.Ser19fs)	PEX12		not provided	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000280211	17	33904986 - 33904987	17	35577967 - 35577968	280211	264766	rs886041458	NC_000017.11:35577967:TGGCTGG:TGGCTGGCTGG
NM_000286.3(PEX12):c.31del (p.Ala11fs)	PEX12	A11fs	Peroxisome biogenesis disorder 3A	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000847311	17	33905010	17	35577991	847311	845242		NC_000017.11:35577990:C:
NM_000286.3(PEX12):c.765_766dup (p.Phe256fs)	PEX12		Peroxisome biogenesis disorder 3A	Pathogenic(Last reviewed: Nov 18, 2019)	no assertion criteria provided	VCV000375474	17	33903114 - 33903115	17	35576095 - 35576096	375474	362280	rs1057519507	NC_000017.11:35576095:ATA:ATATA
NM_000286.3(PEX12):c.273A>T (p.Arg91Ser)	PEX12	R91S	Peroxisomal biogenesis disorder 3b	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000007778	17	33904464	17	35577445	7778	22817	rs28936698	NC_000017.11:35577444:T:A
PEX12, IVS1DS, G-T, +1	PEX12		Peroxisomal biogenesis disorder 3b	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000007777					7777	22816		
NM_000286.3(PEX12):c.24_25CA[1] (p.Thr9fs)	PEX12		Peroxisomal biogenesis disorder 3b	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000007776	17	33905014 - 33905015	17	35577995 - 35577996	7776	22815		NC_000017.11:35577994:TGTG:TG
NM_000286.3(PEX12):c.691A>T (p.Lys231Ter)	PEX12	K231*	Peroxisome biogenesis disorder 3A	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000007773	17	33903190	17	35576171	7773	22812	rs104894616	NC_000017.11:35576170:T:A
PEX12, 4-BP DEL, 684TAGT	PEX12		Peroxisome biogenesis disorder 3A	Pathogenic(Last reviewed: Apr 1, 1997)	no assertion criteria provided	VCV000007772					7772	22811		
PEX12, 1-BP INS, 744T	PEX12		Peroxisome biogenesis disorder 3A	Pathogenic(Last reviewed: Apr 1, 1997)	no assertion criteria provided	VCV000007771					7771	22810		
PEX12, 4-BP INS, 733GCCT	PEX12		Peroxisome biogenesis disorder 3A	Pathogenic(Last reviewed: Apr 1, 1997)	no assertion criteria provided	VCV000007770					7770	22809		
NM_000286.3(PEX12):c.604C>T (p.Arg202Ter)	PEX12	R202*	Peroxisome biogenesis disorder 3A|Infantile Refsum's disease	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000551647	17	33904133	17	35577114	551647	548350	rs61752105	NC_000017.11:35577113:G:A
NM_021954.4(GJA3):c.130G>A (p.Val44Met)	GJA3	V44M	Zonular pulverulent cataract 3	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000639312	13	20717298	13	20143159	639312	641579		NC_000013.11:20143158:C:T
NM_015087.5(SPART):c.1110del (p.Lys370fs)	SPART	K370fs	not provided|Troyer syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003457	13	36903553	13	36329416	3457	18496	rs1060499524	NC_000013.11:36329415:TTT:TT
NM_000336.3(SCNN1B):c.1696C>T (p.Arg566Ter)	SCNN1B	R564*, R566*	Liddle syndrome 1|not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008830	16	23391895	16	23380574	8830	23869	rs137852704	NC_000016.10:23380573:C:T
GRCh37/hg19 16q23.1(chr16:77319898-77463907)x1	ADAMTS18		not provided	Pathogenic(Last reviewed: Apr 17, 2017)	no assertion criteria provided	VCV000688462	16	77319898 - 77463907			688462	676054		
GRCh37/hg19 16q23.1(chr16:77302151-77323245)x1	ADAMTS18		not provided	Pathogenic(Last reviewed: Feb 21, 2018)	no assertion criteria provided	VCV000686598	16	77302151 - 77323245			686598	674190		
GRCh37/hg19 16q23.1(chr16:77319898-77463907)x1	ADAMTS18		not provided	Pathogenic(Last reviewed: Dec 26, 2017)	no assertion criteria provided	VCV000686184	16	77319898 - 77463907			686184	673776		
GRCh37/hg19 16q23.1(chr16:77306614-77373261)x1	ADAMTS18		not provided	Pathogenic(Last reviewed: Jul 31, 2017)	no assertion criteria provided	VCV000686064	16	77306614 - 77373261			686064	673656		
NM_015386.3(COG4):c.844+2T>A	COG4		not provided	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000449595	16	70543817	16	70509914	449595	445608	rs1555497029	NC_000016.10:70509913:A:T
NM_199355.4(ADAMTS18):c.3473C>G (p.Ser1158Ter)	ADAMTS18	S1158*, S986*	not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000836407	16	77323238	16	77289341	836407	844298		NC_000016.10:77289340:G:C
NM_199355.4(ADAMTS18):c.97C>T (p.Gln33Ter)	ADAMTS18	Q33*	Microcornea, myopic chorioretinal atrophy, and telecanthus	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000066042	16	77468396	16	77434499	66042	76948	rs397515469	NC_000016.10:77434498:G:A
NM_015386.3(COG4):c.599_600del (p.Lys200fs)	COG4	K196fs, K58fs, K200fs	Congenital disorder of glycosylation type 2J	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000862921	16	70546280 - 70546281	16	70512377 - 70512378	862921	844240		NC_000016.10:70512376:TTT:T
NM_015386.3(COG4):c.1840G>T (p.Glu614Ter)	COG4	E614*, E472*, E589*	not provided|Delayed gross motor development	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000599648	16	70516712	16	70482809	599648	590984	rs1048764460	NC_000016.10:70482808:C:A
NM_015386.3(COG4):c.1546G>C (p.Gly516Arg)	COG4	G516R, G374R, G512R	SAUL-WILSON SYNDROME	Pathogenic(Last reviewed: Nov 29, 2018)	no assertion criteria provided	VCV000585271	16	70530270	16	70496367	585271	576321	rs1555575860	NC_000016.10:70496366:C:G
NM_015386.3(COG4):c.6del (p.Thr3fs)	COG4	T3fs	Congenital disorder of glycosylation type 2J	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000571433	16	70557441	16	70523538	571433	570516	rs937887233	NC_000016.10:70523537:CCCC:CCC
NM_199355.4(ADAMTS18):c.605T>C (p.Leu202Pro)	ADAMTS18	L202P, C29R	Microcornea, myopic chorioretinal atrophy, and telecanthus	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000066041	16	77401511	16	77367614	66041	76947	rs397515468	NC_000016.10:77367613:A:G
NM_199355.4(ADAMTS18):c.2065G>T (p.Glu689Ter)	ADAMTS18	E689*, E517*	Microcornea, myopic chorioretinal atrophy, and telecanthus	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000066040	16	77356331	16	77322434	66040	76946	rs397515467	NC_000016.10:77322433:C:A
NM_199355.4(ADAMTS18):c.1731C>G (p.Cys577Trp)	ADAMTS18	C577W, C405W	Microcornea, myopic chorioretinal atrophy, and telecanthus	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000066039	16	77369781	16	77335884	66039	76945	rs148319220	NC_000016.10:77335883:G:C
NM_015386.3(COG4):c.2318T>G (p.Leu773Arg)	COG4	L773R, L631R, L748R	Congenital disorder of glycosylation type 2J	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000031928	16	70514965	16	70481062	31928	40585	rs387907203	NC_000016.10:70481061:A:C
NM_015386.3(COG4):c.697G>T (p.Glu233Ter)	COG4	E233*, E91*, E229*	Congenital disorder of glycosylation type 2J	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000031927	16	70546183	16	70512280	31927	40584	rs387907202	NC_000016.10:70512279:C:A
COG4, 400-KB DEL	COG4		Congenital disorder of glycosylation type 2J	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000003653					3653	18692		
NM_000286.3(PEX12):c.744dup (p.Thr249fs)	PEX12		Infantile Refsum's disease|Peroxisome biogenesis disorder 3A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553741	17	33903136 - 33903137	17	35576117 - 35576118	553741	548344	rs61752108	NC_000017.11:35576117:A:AA
GRCh37/hg19 14q32.2(chr14:97265342-97334742)x1	VRK1		not provided	Pathogenic(Last reviewed: Feb 20, 2018)	no assertion criteria provided	VCV000686393	14	97265342 - 97334742			686393	673985		
NM_003384.3(VRK1):c.156T>A (p.Tyr52Ter)	VRK1	Y52*	Pontocerebellar hypoplasia type 1	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000861842	14	97299964	14	96833627	861842	842068		NC_000014.9:96833626:T:A
NM_003384.3(VRK1):c.9del (p.Arg3_Val4insTer)	VRK1		Pontocerebellar hypoplasia type 1	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000847284	14	97299817	14	96833480	847284	842067		NC_000014.9:96833479:T:
NM_003384.3(VRK1):c.660T>A (p.Cys220Ter)	VRK1	C220*	Pontocerebellar hypoplasia type 1	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000846403	14	97321644	14	96855307	846403	842074		NC_000014.9:96855306:T:A
NC_000014.9:g.(?_96846085)_(96847354_?)del	VRK1		Pontocerebellar hypoplasia type 1	Pathogenic(Last reviewed: Jun 30, 2019)	criteria provided, single submitter	VCV000832438	14	97312422 - 97313691			832438	820662		
NC_000014.8:g.(?_97277006)_(97327082_?)del	VRK1		Pontocerebellar hypoplasia type 1	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000657389	14	97277006 - 97327082	14	96810669 - 96860745	657389	652569		
NM_003384.3(VRK1):c.1066A>T (p.Lys356Ter)	VRK1	K356*	Pontocerebellar hypoplasia type 1	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000654056	14	97327070	14	96860733	654056	642980		NC_000014.9:96860732:A:T
NM_003384.3(VRK1):c.362_365del (p.Lys121fs)	VRK1	K121fs	Pontocerebellar hypoplasia type 1	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000644618	14	97313668 - 97313671	14	96847331 - 96847334	644618	642973		NC_000014.9:96847330:AAAAA:A
NC_000014.8:g.(?_97322457)_(97327082_?)del	VRK1		Pontocerebellar hypoplasia type 1	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000643149	14	97322457 - 97327082	14	96856120 - 96860745	643149	652900		
NC_000014.8:g.(?_97312412)_(97313701_?)del	VRK1		Pontocerebellar hypoplasia type 1	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000584083	14	97312412 - 97313701	14	96846075 - 96847364	584083	567774		
NM_003384.3(VRK1):c.6del (p.Arg3fs)	VRK1	R3fs	Pontocerebellar hypoplasia type 1	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000533538	14	97299814	14	96833477	533538	528555	rs780789145	NC_000014.9:96833476:T:
NM_003384.3(VRK1):c.637T>C (p.Tyr213His)	VRK1	Y213H	Pontocerebellar hypoplasia type 1A|EMG: neuropathic changes|Microcephaly-complex motor and sensory axonal neuropathy syndrome	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000812546	14	97321621	14	96855284	812546	800787		NC_000014.9:96855283:T:C
NM_003384.3(VRK1):c.265C>T (p.Arg89Ter)	VRK1	R89*	Pontocerebellar hypoplasia type 1A	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000533537	14	97312480	14	96846143	533537	528946	rs772263867	NC_000014.9:96846142:C:T
NM_003384.3(VRK1):c.879_882AAAC[1] (p.Lys295fs)	VRK1		Pontocerebellar hypoplasia type 1A	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	VCV000464942	14	97322913 - 97322916	14	96856576 - 96856579	464942	463934	rs779282547	NC_000014.9:96856575:AAACAAAC:AAAC
NM_002863.5(PYGL):c.1768+1G>A	PYGL		Glycogen storage disease, type VI	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011992	14	51378873	14	50912155	11992	27031	rs113993982	NC_000014.9:50912154:C:T
NM_015386.3(COG4):c.2197C>T (p.Arg733Trp)	COG4	R729W, R712W, R733W, R591W, R708W	Congenital disorder of glycosylation type 2J|Delayed gross motor development	Pathogenic(Last reviewed: Jul 30, 2018)	no assertion criteria provided	VCV000003652	16	70515300	16	70481397	3652	18691	rs267606740	NC_000016.10:70481396:G:A
NM_003384.3(VRK1):c.976C>T (p.Gln326Ter)	VRK1	Q326*	Pontocerebellar hypoplasia type 1A|Pontocerebellar hypoplasia type 1	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000619220	14	97326980	14	96860643	619220	610618	rs1566713184	NC_000014.9:96860642:C:T
NM_025152.3(NUBPL):c.774dup (p.Ala259fs)	NUBPL		not provided	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000817927	14	32315756 - 32315757	14	31846550 - 31846551	817927	805794		NC_000014.9:31846550:T:TT
GRCh37/hg19 14q12(chr14:32117154-32214183)x1	NUBPL		not provided	Pathogenic(Last reviewed: May 10, 2017)	no assertion criteria provided	VCV000685158	14	32117154 - 32214183			685158	672750		
NM_005360.5(MAF):c.208dup (p.Ser70fs)	MAF		not provided	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000452100	16	79633591 - 79633592	16	79599694 - 79599695	452100	445627	rs1555530054	NC_000016.10:79599694:AA:AAA
NM_025152.3(NUBPL):c.201_202insG (p.Gln68fs)	NUBPL		not provided	Pathogenic(Last reviewed: Feb 7, 2014)	criteria provided, single submitter	VCV000214884	14	32031366 - 32031367	14	31562160 - 31562161	214884	211666	rs749681373	NC_000014.9:31562160::G
NM_025152.3(NUBPL):c.726C>G (p.Phe242Leu)	NUBPL	F242L, F146L, F59L	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000635348	14	32315709	14	31846503	635348	623182		NC_000014.9:31846502:C:G
NM_001481.3(GAS8):c.1069C>T (p.Gln357Ter)	GAS8	Q357*, Q332*, Q274*, Q165*	Ciliary dyskinesia, primary, 33	Pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000219124	16	90106765	16	90040357	219124	216926	rs566755911	NC_000016.10:90040356:C:T
NM_001481.3(GAS8):c.1000C>T (p.Arg334Ter)	GAS8	R334*, R309*, R142*, R251*	Ciliary dyskinesia, primary, 33	Pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000219123	16	90104245	16	90037837	219123	216925	rs755553133	NC_000016.10:90037836:C:T
NM_001481.3(GAS8):c.927C>A (p.Cys309Ter)	GAS8	C309*, C284*, C226*, C117*	Ciliary dyskinesia, primary, 33	Pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000219122	16	90104172	16	90037764	219122	216924	rs748688175	NC_000016.10:90037763:C:A
NM_005360.5(MAF):c.908A>C (p.Gln303Pro)	MAF	Q303P	Cataract 21, multiple types	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000190236	16	79632892	16	79598995	190236	188065	rs786205222	NC_000016.10:79598994:T:G
NM_005360.5(MAF):c.895C>A (p.Arg299Ser)	MAF	R299S	Cataract 21, multiple types	Pathogenic(Last reviewed: Oct 18, 2007)	no assertion criteria provided	VCV000190235	16	79632905	16	79599008	190235	188064	rs786205221	NC_000016.10:79599007:G:T
NM_005360.5(MAF):c.185C>G (p.Thr62Arg)	MAF	T62R	Ayme-gripp syndrome	Pathogenic	no assertion criteria provided	VCV000162517	16	79633615	16	79599718	162517	172186	rs727502771	NC_000016.10:79599717:G:C
NM_025152.3(NUBPL):c.579A>C (p.Leu193Phe)	NUBPL	L193F, L97F, L10F	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21	Pathogenic(Last reviewed: Apr 23, 2013)	no assertion criteria provided	VCV000050217	14	32257051	14	31787845	50217	59377	rs552722349	NC_000014.9:31787844:A:C
NM_025152.3(NUBPL):c.693+1G>A	NUBPL		MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21	Pathogenic(Last reviewed: Apr 23, 2013)	no assertion criteria provided	VCV000050216	14	32295921	14	31826715	50216	59376	rs751631278	NC_000014.9:31826714:G:A
NM_025152.3(NUBPL):c.667_668insCCTTGTGCTG (p.Glu223delinsAlaLeuCysTer)	NUBPL		MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21	Pathogenic(Last reviewed: Apr 23, 2013)	no assertion criteria provided	VCV000050214	14	32295888 - 32295889	14	31826682 - 31826683	50214	59374	rs879255565	NC_000014.9:31826682:GTGCTG:GTGCTGCCTTGTGCTG
NM_005360.5(MAF):c.890A>G (p.Lys297Arg)	MAF	K297R	Cataract 21, multiple types	Pathogenic(Last reviewed: Mar 15, 2006)	no assertion criteria provided	VCV000013232	16	79632910	16	79599013	13232	28271	rs121917736	NC_000016.10:79599012:T:C
NC_000016.10:g.(?_79594440)_(79599922_?)del	MAF		Ayme-gripp syndrome|Cataract 21, multiple types	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000830955	16	79628337 - 79633819			830955	820885		
NM_005360.5(MAF):c.863G>C (p.Arg288Pro)	MAF	R288P	Cataract 21, multiple types	Pathogenic(Last reviewed: Mar 16, 2012)	no assertion criteria provided	VCV000013231	16	79632937	16	79599040	13231	28270	rs121917735	NC_000016.10:79599039:C:G
NM_152443.3(RDH12):c.377C>T (p.Ala126Val)	RDH12	A126V	Retinal dystrophy|Retinitis pigmentosa|Retinitis pigmentosa 53	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV000002061	14	68192801	14	67726084	2061	17100	rs202126574	NC_000014.9:67726083:C:T
NM_005360.5(MAF):c.176C>T (p.Pro59Leu)	MAF	P59L	Ayme-gripp syndrome	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000162516	16	79633624	16	79599727	162516	172187	rs727502770	NC_000016.10:79599726:G:A
NM_000419.5(ITGA2B):c.3076C>T (p.Arg1026Trp)	ITGA2B	R995W, R1026W	Thrombocytopenia|Glanzmann thrombasthenia|Platelet-type bleeding disorder 16	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000050233	17	42449776	17	44372408	50233	59387	rs766503255	NC_000017.11:44372407:G:A
NM_005360.5(MAF):c.176C>A (p.Pro59His)	MAF	P59H	Ayme-gripp syndrome	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000162515	16	79633624	16	79599727	162515	172188	rs727502770	NC_000016.10:79599726:G:T
NM_005360.5(MAF):c.172A>G (p.Thr58Ala)	MAF	T58A	Ayme-gripp syndrome	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000162513	16	79633628	16	79599731	162513	172190	rs727502767	NC_000016.10:79599730:T:C
NM_005360.5(MAF):c.161C>T (p.Ser54Leu)	MAF	S54L	Ayme-gripp syndrome	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000162512	16	79633639	16	79599742	162512	172191	rs727502766	NC_000016.10:79599741:G:A
NM_003673.4(TCAP):c.136_137del (p.Gln46fs)	TCAP	Q46fs	Dilated cardiomyopathy 1N|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000835598	17	37821994 - 37821995	17	39665741 - 39665742	835598	845252		NC_000017.11:39665740:CA:
NM_030928.4(CDT1):c.832+1G>A	CDT1		Meier-Gorlin syndrome 4	Pathogenic(Last reviewed: Mar 28, 2013)	criteria provided, single submitter	VCV000128664	16	88872278	16	88805870	128664	134113	rs587780305	NC_000016.10:88805869:G:A
NM_030928.4(CDT1):c.196G>A (p.Ala66Thr)	CDT1	A66T	Meier-Gorlin syndrome 4	Pathogenic(Last reviewed: Feb 27, 2011)	no assertion criteria provided	VCV000030501	16	88870435	16	88804027	30501	39458	rs387906918	NC_000016.10:88804026:G:A
CDT1, IVS2DS, G-C, +1	CDT1		Meier-Gorlin syndrome 4	Pathogenic(Last reviewed: Feb 27, 2011)	no assertion criteria provided	VCV000030500					30500	39457		
NM_030928.4(CDT1):c.1560C>G (p.Tyr520Ter)	CDT1	Y520*	Meier-Gorlin syndrome 4	Pathogenic(Last reviewed: Feb 27, 2011)	no assertion criteria provided	VCV000030499	16	88874605	16	88808197	30499	39456	rs147914553	NC_000016.10:88808196:C:G
NM_030928.4(CDT1):c.1402G>A (p.Glu468Lys)	CDT1	E468K	Meier-Gorlin syndrome 4	Pathogenic(Last reviewed: Feb 27, 2011)	no assertion criteria provided	VCV000030502	16	88873815	16	88807407	30502	39459	rs200652608	NC_000016.10:88807406:G:A
NM_004119.2(FLT3):c.2508C>G (p.Ile836Met)	FLT3	I836M	Acute myeloid leukemia	Pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000375969	13	28592637	13	28018500	375969	362848	rs121913232	NC_000013.11:28018499:G:C
NM_006086.4(TUBB3):c.1228G>A (p.Glu410Lys)	TUBB3	E410K, E338K	Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement|Cortical dysplasia, complex, with other brain malformations 1	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000006967	16	90002087	16	89935679	6967	22006	rs267607165	NC_000016.10:89935678:G:A
NM_005360.5(MAF):c.881G>A (p.Arg294Gln)	MAF	R294Q	Ayme-gripp syndrome|Cataract 21, multiple types	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000664291	16	79632919	16	79599022	664291	645006		NC_000016.10:79599021:C:T
NM_021954.4(GJA3):c.176C>T (p.Pro59Leu)	GJA3	P59L	Zonular pulverulent cataract 3|Congenital cataract	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000217339	13	20717252	13	20143113	217339	213992	rs864309691	NC_000013.11:20143112:G:A
NM_022369.4(STRA6):c.582_583insTTGGCAGAGGGCAGAGTGT (p.Pro195fs)	STRA6		not provided	Pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	VCV000418507	15	74487657 - 74487658	15	74195316 - 74195317	418507	409345	rs1064793275	NC_000015.10:74195316:ACACTCTGCCCTCTGCCA:ACACTCTGCCCTCTGCCAAACACTCTGCCCTCTGCCA
NM_019109.4(ALG1):c.69del (p.Gly22_Trp23insTer)	ALG1		not provided	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000373810	16	5121918	16	5071917	373810	360282	rs1057518625	NC_000016.10:5071916:GG:G
NM_019109.4(ALG1):c.115del (p.Val39fs)	ALG1	V39fs	not provided	Pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, single submitter	VCV000281338	16	5121964	16	5071963	281338	265575	rs886042130	NC_000016.10:5071962:GG:G
NM_000289.6(PFKM):c.1929_1933del (p.Leu643_Tyr644insTer)	PFKM		Glycogen storage disease, type VII	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000660611	12	48537875 - 48537879	12	48144092 - 48144096	660611	641143		NC_000012.12:48144091:CTGTACT:CT
NM_022369.4(STRA6):c.1913G>C (p.Arg638Pro)	STRA6	R638P, R653P, R675P, R629P, R677P	Anophthalmia - microphthalmia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000221967	15	74472512	15	74180171	221967	223647	rs144691445	NC_000015.10:74180170:C:G
NM_022369.4(STRA6):c.1313A>G (p.Gln438Arg)	STRA6	Q438R, Q477R, Q453R, Q429R, Q475R	Anophthalmia - microphthalmia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000221966	15	74474789	15	74182448	221966	223649	rs869025269	NC_000015.10:74182447:T:C
NM_022369.4(STRA6):c.1735C>G (p.Pro579Ala)	STRA6	P579A, P616A, P618A, P594A, P570A	Anophthalmia - microphthalmia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000221927	15	74473228	15	74180887	221927	223648	rs372931895	NC_000015.10:74180886:G:C
NM_022369.4(STRA6):c.1385del (p.Asn462fs)	STRA6	N501fs, N462fs, N477fs, N453fs, N499fs	not provided	Pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, multiple submitters, no conflicts	VCV000194560	15	74474717	15	74182376	194560	191723	rs794727153	NC_000015.10:74182375:TT:T
NM_000289.6(PFKM):c.116G>T (p.Arg39Leu)	PFKM	R39L, R110L, R10L, R142L, R47L, R87L	Glycogen storage disease, type VII	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000001157	12	48524176	12	48130393	1157	16196	rs121918193	NC_000012.12:48130392:G:T
NM_000289.6(PFKM):c.1628A>C (p.Asp543Ala)	PFKM	D543A, D614A, D501A, D514A, D591A, D493A, D512A, D646A, D551A	Glycogen storage disease, type VII	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000001155	12	48535824	12	48142041	1155	16194	rs121918194	NC_000012.12:48142040:A:C
NM_000289.6(PFKM):c.428-2A>C	PFKM		Glycogen storage disease, type VII	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000001153	12	48527096	12	48133313	1153	16192		NC_000012.12:48133312:A:C
NM_022369.4(STRA6):c.961A>C (p.Thr321Pro)	STRA6	T321P, T312P, T336P, T358P, T360P	Microphthalmia syndromic 9	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000001138	15	74481585	15	74189244	1138	16177	rs118203962	NC_000015.10:74189243:T:G
NM_022369.4(STRA6):c.269C>T (p.Pro90Leu)	STRA6	P90L, P105L, P127L, P129L	Microphthalmia syndromic 9	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000001137	15	74488486	15	74196145	1137	16176	rs118203961	NC_000015.10:74196144:G:A
NM_022369.4(STRA6):c.1931C>T (p.Thr644Met)	STRA6	T644M, T681M, T683M, T659M, T635M	Microphthalmia syndromic 9	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000001136	15	74472494	15	74180153	1136	16175	rs118203960	NC_000015.10:74180152:G:A
NM_022369.4(STRA6):c.147del (p.Gly50fs)	STRA6	G50fs, G89fs, G65fs, G87fs	Microphthalmia syndromic 9	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000001134	15	74490126	15	74197785	1134	16173	rs606231125	NC_000015.10:74197784:GGG:GG
NM_022369.4(STRA6):c.878C>T (p.Pro293Leu)	STRA6	P293L, P330L, P332L, P308L, P284L	Microphthalmia syndromic 9	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000001133	15	74483230	15	74190889	1133	16172	rs118203958	NC_000015.10:74190888:G:A
NM_000289.6(PFKM):c.292C>T (p.Arg98Ter)	PFKM	R169*, R201*, R69*, R146*, R48*, R98*, R106*	Glycogen storage disease, type VII	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000844552	12	48526705	12	48132922	844552	839965		NC_000012.12:48132921:C:T
NM_019109.5(ALG1):c.1063del (p.Leu355fs)	ALG1	L244fs, L355fs	ALG1-CDG	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000653599	16	5131044	16	5081043	653599	644744		NC_000016.10:5081042:CCCCC:CCCC
NM_022369.4(STRA6):c.1676dup (p.Asp560fs)	STRA6		Microphthalmia syndromic 9	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000572841	15	74473643 - 74473644	15	74181302 - 74181303	572841	573538	rs1567177198	NC_000015.10:74181302:A:AA
NM_022369.4(STRA6):c.113+3_113+4del	STRA6		Microphthalmia syndromic 9	Pathogenic(Last reviewed: Nov 20, 2017)	no assertion criteria provided	VCV000446174	15	74494492 - 74494493	15	74202151 - 74202152	446174	439522	rs1555457882	NC_000015.10:74202150:TT:
NM_022369.4(STRA6):c.1521-1G>A	STRA6		Microphthalmia syndromic 9	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000088764	15	74473800	15	74181459	88764	94345	rs397518484	NC_000015.10:74181458:C:T
NM_022369.4(STRA6):c.1678G>C (p.Asp560His)	STRA6	D560H, D597H, D551H, D575H, D599H	Microphthalmia syndromic 9	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000040078	15	74473642	15	74181301	40078	48591	rs397514638	NC_000015.10:74181300:C:G
NM_019109.4(ALG1):c.1188T>A (p.Cys396Ter)	ALG1	C396*, C285*	ALG1-CDG	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000030538	16	5133683	16	5083682	30538	39495	rs387906927	NC_000016.10:5083681:T:A
NM_019109.4(ALG1):c.1129A>G (p.Met377Val)	ALG1	M377V, M266V	ALG1-CDG	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000030536	16	5132616	16	5082615	30536	39493	rs387906925	NC_000016.10:5082614:A:G
NM_019109.4(ALG1):c.450C>G (p.Ser150Arg)	ALG1	S150R, S39R	ALG1-CDG	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000004726	16	5125448	16	5075447	4726	19765	rs121908340	NC_000016.10:5075446:C:G
NM_019109.4(ALG1):c.1025A>C (p.Gln342Pro)	ALG1	E342P, Q342P, Q231P	ALG1-CDG	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000004725	16	5131010	16	5081009	4725	19764	rs267606651	NC_000016.10:5081008:A:C
NM_000289.6(PFKM):c.2058G>T (p.Trp686Cys)	PFKM	W686C, W757C, W636C, W644C, W789C, W655C, W657C, W734C, W694C	Glycogen storage disease, type VII	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000001159	12	48538879	12	48145096	1159	16198	rs121918196	NC_000012.12:48145095:G:T
NM_022369.4(STRA6):c.69G>A (p.Trp23Ter)	STRA6	W23*, W38*, W60*, W62*	Microphthalmia syndromic 9	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000001142	15	74494540	15	74202199	1142	16181	rs267607096	NC_000015.10:74202198:C:T
NM_022369.4(STRA6):c.50_52delinsCC (p.Asp17fs)	STRA6		Microphthalmia syndromic 9	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000001139	15	74494557 - 74494559	15	74202216 - 74202218	1139	16178	rs606231126	NC_000015.10:74202215:AGT:GG
NM_000289.6(PFKM):c.283C>T (p.Arg95Ter)	PFKM	R95*, R166*, R143*, R198*, R45*, R103*, R66*	Glycogen storage disease, type VII	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000001158	12	48526696	12	48132913	1158	16197	rs121918195	NC_000012.12:48132912:C:T
NM_000289.6(PFKM):c.116G>C (p.Arg39Pro)	PFKM	R39P, R110P, R47P, R10P, R142P, R87P	Glycogen storage disease, type VII	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000001154	12	48524176	12	48130393	1154	16193	rs121918193	NC_000012.12:48130392:G:C
NM_000289.6(PFKM):c.1341+1G>T	PFKM		Glycogen storage disease, type VII	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000001152	12	48534655	12	48140872	1152	16191		NC_000012.12:48140871:G:T
NM_022369.4(STRA6):c.35_36dup (p.Gly13fs)	STRA6		Microphthalmia syndromic 9	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000001141	15	74494572 - 74494573	15	74202231 - 74202232	1141	16180	rs1555457919	NC_000015.10:74202231:GGGGG:GGGGGGG
NM_001330504.1(ALG1):c.-30C>T	ALG1	Q102*	ALG1-CDG|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000432180	16	5123171	16	5073170	432180	426173	rs780107088	NC_000016.10:5073169:C:T
NM_019109.4(ALG1):c.1188-2A>G	ALG1		not provided|Congenital disorder of glycosylation	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	VCV000194107	16	5133681	16	5083680	194107	191270	rs794727073	NC_000016.10:5083679:A:G
NM_019109.4(ALG1):c.15C>A (p.Cys5Ter)	ALG1	C5*	not provided|Congenital disorder of glycosylation	Pathogenic(Last reviewed: Mar 27, 2015)	criteria provided, single submitter	VCV000193419	16	5121865	16	5071864	193419	190583	rs752922461	NC_000016.10:5071863:C:A
PFKM, IVS5DS, G-A, +1	PFKM		Glycogen storage disease, type VII	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000001156					1156	16195		
NM_000286.3(PEX12):c.530_532AAC[1] (p.Gln178del)	PEX12	Q178del	Peroxisome biogenesis disorder 3A|Infantile Refsum's disease|Peroxisome biogenesis disorder 3A	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000437449	17	33904202 - 33904204	17	35577183 - 35577185	437449	430999	rs61752102	NC_000017.11:35577182:GTTGTTGT:GTTGT
NM_020751.3(COG6):c.726del (p.Cys242fs)	COG6	C242fs	Congenital disorder of glycosylation type 2L	Pathogenic	no assertion criteria provided	VCV000816813	13	40256339	13	39682202	816813	805024		NC_000013.11:39682201:T:
GRCh37/hg19 13q14.11(chr13:40329397-40380244)x1	COG6		not provided	Pathogenic(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000688225	13	40329397 - 40380244			688225	675817		
NM_020751.3(COG6):c.1075-1G>T	COG6		not provided	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000194109	13	40268770	13	39694633	194109	191272	rs781641023	NC_000013.11:39694632:G:T
NM_020751.3(COG6):c.112A>T (p.Lys38Ter)	COG6	K38*	not provided	Pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	VCV000193438	13	40229975	13	39655838	193438	190602	rs794726950	NC_000013.11:39655837:A:T
NM_020751.3(COG6):c.1239dup (p.Phe414fs)	COG6		Congenital disorder of glycosylation type 2L	Pathogenic(Last reviewed: Mar 5, 2018)	no assertion criteria provided	VCV000493010	13	40273709 - 40273710	13	39699572 - 39699573	493010	485966	rs1555277827	NC_000013.11:39699572:A:AA
NM_020751.3(COG6):c.1A>G (p.Met1Val)	COG6	M1V	Congenital disorder of glycosylation type 2L	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000487579	13	40229864	13	39655727	487579	480626	rs752232501	NC_000013.11:39655726:A:G
NM_020751.3(COG6):c.388C>T (p.Gln130Ter)	COG6	Q130*	Congenital disorder of glycosylation type 2L	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000487578	13	40239251	13	39665114	487578	480625	rs1259563970	NC_000013.11:39665113:C:T
NM_020751.3(COG6):c.785A>G (p.Tyr262Cys)	COG6	Y262C	Congenital disorder of glycosylation type 2L	Pathogenic(Last reviewed: Sep 15, 2010)	no assertion criteria provided	VCV000493009	13	40256398	13	39682261	493009	485965	rs756826030	NC_000013.11:39682260:A:G
NM_020751.3(COG6):c.511C>T (p.Arg171Ter)	COG6	R171*	Congenital disorder of glycosylation type 2L	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000493007	13	40251687	13	39677550	493007	485963	rs200177031	NC_000013.11:39677549:C:T
NM_020751.3(COG6):c.1535T>G (p.Leu512Ter)	COG6	L512*	Shaheen syndrome|Congenital disorder of glycosylation type 2L|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000432111	13	40293915	13	39719778	432111	426044	rs1292534396	NC_000013.11:39719777:T:G
NM_005360.5(MAF):c.173C>T (p.Thr58Ile)	MAF	T58I	Ayme-gripp syndrome|not provided	Pathogenic(Last reviewed: Apr 1, 2016)	criteria provided, single submitter	VCV000162514	16	79633627	16	79599730	162514	172189	rs727502769	NC_000016.10:79599729:G:A
NM_000289.6(PFKM):c.1413-2A>G	PFKM		Glycogen storage disease, type VII|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000597689	12	48535521	12	48141738	597689	588750	rs1430517061	NC_000012.12:48141737:A:G
NM_001330504.1(ALG1):c.854+1G>A	ALG1		not provided|Congenital disorder of glycosylation	Pathogenic(Last reviewed: Apr 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000095934	16	5132675	16	5082674	95934	101830	rs374928784	NC_000016.10:5082673:G:A
NM_032436.4(CHAMP1):c.2079del (p.Ser694fs)	CHAMP1	S694fs	not provided	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000817883	13	115091396	13	114325921	817883	805767		NC_000013.11:114325920:C:
NM_032436.4(CHAMP1):c.1214_1222delinsA (p.Ser405_His408delinsTer)	CHAMP1		not provided	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000817568	13	115090531 - 115090539	13	114325056 - 114325064	817568	805765		NC_000013.11:114325055:CTCCTGAAC:A
NM_032436.4(CHAMP1):c.2127T>G (p.Tyr709Ter)	CHAMP1	Y709*	not provided	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000523879	13	115091444	13	114325969	523879	514653	rs1555379968	NC_000013.11:114325968:T:G
NM_032436.4(CHAMP1):c.730delinsGC (p.Ser244fs)	CHAMP1		not provided	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000503867	13	115090047	13	114324572	503867	495565	rs1555379525	NC_000013.11:114324571:T:GC
NM_032436.4(CHAMP1):c.403C>T (p.Gln135Ter)	CHAMP1	Q135*	not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000430233	13	115089720	13	114324245	430233	421955	rs1131691845	NC_000013.11:114324244:C:T
NM_032436.4(CHAMP1):c.1850dup (p.Lys618fs)	CHAMP1		not provided	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000280855	13	115091164 - 115091165	13	114325689 - 114325690	280855	264510	rs886041988	NC_000013.11:114325689:AAA:AAAA
NM_032436.4(CHAMP1):c.1544G>A (p.Trp515Ter)	CHAMP1	W515*	not provided	Pathogenic(Last reviewed: Oct 16, 2015)	criteria provided, single submitter	VCV000217907	13	115090861	13	114325386	217907	214568	rs863225075	NC_000013.11:114325385:G:A
NM_032436.4(CHAMP1):c.1969C>T (p.Gln657Ter)	CHAMP1	Q657*	not provided	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000217916	13	115091286	13	114325811	217916	214571	rs863225074	NC_000013.11:114325810:C:T
NM_032436.4(CHAMP1):c.1945C>T (p.Gln649Ter)	CHAMP1	Q649*	not provided	Pathogenic(Last reviewed: Oct 16, 2015)	criteria provided, single submitter	VCV000217910	13	115091262	13	114325787	217910	214569	rs863225078	NC_000013.11:114325786:C:T
NM_032436.4(CHAMP1):c.540_541CT[1] (p.Ser181fs)	CHAMP1		not provided	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000217909	13	115089857 - 115089858	13	114324382 - 114324383	217909	214566	rs863225077	NC_000013.11:114324381:CTCT:CT
NM_032436.4(CHAMP1):c.1002G>A (p.Trp334Ter)	CHAMP1	W334*	Mental retardation, autosomal dominant 40	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000210049	13	115090319	13	114324844	210049	206661	rs879255261	NC_000013.11:114324843:G:A
NM_000452.3(SLC10A2):c.584_585+1inv	SLC10A2		Bile acid malabsorption, primary	Pathogenic(Last reviewed: Apr 15, 1997)	no assertion criteria provided	VCV000008242	13	103704969 - 103704971	13	103052619 - 103052621	8242	23281	rs387906390	NC_000013.11:103052618:CTT:AAG
NM_032436.4(CHAMP1):c.1044del (p.Pro347_Trp348insTer)	CHAMP1		not provided	Pathogenic(Last reviewed: Oct 16, 2015)	criteria provided, single submitter	VCV000217908	13	115090360	13	114324885	217908	214567	rs863225076	NC_000013.11:114324884:GG:G
NM_032436.4(CHAMP1):c.1866_1867del (p.Asp622fs)	CHAMP1	D622fs	Mental retardation, autosomal dominant 40|intellectual disability with severe speech impairment	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000208417	13	115091182 - 115091183	13	114325707 - 114325708	208417	204640	rs797044963	NC_000013.11:114325706:ACA:A
NM_032436.4(CHAMP1):c.1768C>T (p.Gln590Ter)	CHAMP1	Q590*	Mental retardation, autosomal dominant 40|intellectual disability with severe speech impairment	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000208416	13	115091085	13	114325610	208416	204639	rs200070245	NC_000013.11:114325609:C:T
NM_032436.4(CHAMP1):c.635del (p.Pro212fs)	CHAMP1	P212fs	Mental retardation, autosomal dominant 40|intellectual disability with severe speech impairment	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000208414	13	115089949	13	114324474	208414	204637	rs797044961	NC_000013.11:114324473:CCCC:CCC
NM_005982.4(SIX1):c.386A>G (p.Tyr129Cys)	SIX1	Y129C	Deafness, autosomal dominant 23|Branchiootic syndrome 3|not provided|Melnick-Fraser syndrome|Branchiootic syndrome 3|Deafness, autosomal dominant 23|Melnick-Fraser syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008308	14	61115522	14	60648804	8308	23347	rs104894478	NC_000014.9:60648803:T:C
NM_001289910.1(IDH2):c.263G>T (p.Arg88Leu)	IDH2	R140L, R88L, R10L	Neoplasm of the large intestine|Myelodysplastic syndrome|Squamous cell carcinoma of the head and neck|Multiple myeloma|Acute myeloid leukemia	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375988	15	90631934	15	90088702	375988	362867	rs121913502	NC_000015.10:90088701:C:A
NM_022369.4(STRA6):c.910_911delinsAA (p.Gly304Lys)	STRA6	G304K	not provided|Microphthalmia, isolated, with coloboma 8|Microphthalmia syndromic 9	Pathogenic(Last reviewed: Feb 11, 2015)	criteria provided, single submitter	VCV000039742	15	74483197 - 74483198	15	74190856 - 74190857	39742	48341	rs151341424	NC_000015.10:74190855:CC:TT
NM_018668.4(VPS33B):c.940-2A>G	VPS33B		not provided	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000595362	15	91549016	15	91005786	595362	586424	rs774529051	NC_000015.10:91005785:T:C
NM_018668.4(VPS33B):c.350del (p.Pro117fs)	VPS33B	P90fs, P26fs, P117fs	not provided	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000523950	15	91557041	15	91013811	523950	514682	rs1555459968	NC_000015.10:91013810:GGG:GG
NM_018668.4(VPS33B):c.1246C>T (p.Arg416Ter)	VPS33B	R416*, R325*, R389*	not provided	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000500825	15	91546341	15	91003111	500825	492249	rs780626848	NC_000015.10:91003110:G:A
NM_018668.4(VPS33B):c.1479+1G>A	VPS33B		not provided	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000500321	15	91544618	15	91001388	500321	491745	rs1555458189	NC_000015.10:91001387:C:T
NM_018668.4(VPS33B):c.239+5G>A	VPS33B		not provided	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000500160	15	91560188	15	91016958	500160	491584	rs372769808	NC_000015.10:91016957:C:T
NM_001289149.1(VPS33B):c.-32del	VPS33B	L54fs, L81fs	not provided	Pathogenic(Last reviewed: May 27, 2015)	criteria provided, single submitter	VCV000419058	15	91557661	15	91014431	419058	409394	rs1064793614	NC_000015.10:91014430:AA:A
NM_018668.4(VPS33B):c.1616del (p.Glu539fs)	VPS33B	E448fs, E512fs, E539fs	not provided	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, single submitter	VCV000286653	15	91543171	15	90999941	286653	270890	rs886043445	NC_000015.10:90999940:T:
NM_018668.4(VPS33B):c.1726T>C (p.Cys576Arg)	VPS33B	C576R, C485R, C549R	Arthrogryposis, renal dysfunction, and cholestasis 1	Pathogenic(Last reviewed: Oct 25, 2018)	no assertion criteria provided	VCV000694284	15	91542955	15	90999725	694284	682127		NC_000015.10:90999724:A:G
NM_018668.4(VPS33B):c.151C>T (p.Arg51Ter)	VPS33B	R51*	Arthrogryposis, renal dysfunction, and cholestasis 1	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587506	15	91561061	15	91017831	587506	578522	rs11542638	NC_000015.10:91017830:G:A
NM_018668.4(VPS33B):c.1498G>T (p.Glu500Ter)	VPS33B	E500*, E409*, E473*	Arthrogryposis, renal dysfunction, and cholestasis 1	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000437260	15	91543803	15	91000573	437260	429751	rs751858602	NC_000015.10:91000572:C:A
NM_018668.4(VPS33B):c.1259_1260CA[1] (p.Gln421fs)	VPS33B		Arthrogryposis, renal dysfunction, and cholestasis 1	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000088859	15	91546325 - 91546326	15	91003095 - 91003096	88859	94428	rs398122408	NC_000015.10:91003094:TGTGT:TGT
NM_018668.4(VPS33B):c.240-577_290-156del	VPS33B		Arthrogryposis, renal dysfunction, and cholestasis 1	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000088857	15	91557257 - 91558240	15	91014027 - 91015010	88857	94426	rs1555460030	
NM_018668.4(VPS33B):c.700+1G>A	VPS33B		Arthrogryposis, renal dysfunction, and cholestasis 1	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000002204	15	91550179	15	91006949	2204	17243	rs794726658	NC_000015.10:91006948:C:T
NM_018668.4(VPS33B):c.1594C>T (p.Arg532Ter)	VPS33B	R532*, R441*, R505*	Arthrogryposis, renal dysfunction, and cholestasis 1	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000002201	15	91543193	15	90999963	2201	17240	rs121434383	NC_000015.10:90999962:G:A
NM_001289149.1(VPS33B):c.-123T>C	VPS33B	L30P	Arthrogryposis, renal dysfunction, and cholestasis 1	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000002203	15	91565391	15	91022161	2203	17242	rs121434385	NC_000015.10:91022160:A:G
NM_000486.5(AQP2):c.211G>A (p.Val71Met)	AQP2	V71M	not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000446860	12	50344824	12	49951041	446860	441559	rs149659001	NC_000012.12:49951040:G:A
NM_020751.3(COG6):c.1646G>T (p.Gly549Val)	COG6	G549V	Congenital disorder of glycosylation type 2L	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000030628	13	40297531	13	39723394	30628	39585	rs387906959	NC_000013.11:39723393:G:T
NM_001139.3(ALOX12B):c.1562A>G (p.Tyr521Cys)	ALOX12B	Y521C	Ichthyosis (disease)|Autosomal recessive congenital ichthyosis 2|not provided	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039546	17	7979005	17	8075687	39546	48145	rs199766569	NC_000017.11:8075686:T:C
NM_006086.4(TUBB3):c.784C>T (p.Arg262Cys)	TUBB3	R262C, R190C	not provided|Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000006963	16	90001643	16	89935235	6963	22002	rs267607162	NC_000016.10:89935234:C:T
NM_001040616.3(LINS1):c.809del (p.Phe270fs)	LINS1	F255fs, F21fs, F270fs	not provided	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000817855	15	101114269	15	100574064	817855	805807		NC_000015.10:100574063:AAA:AA
NM_000101.4(CYBA):c.261C>G (p.Tyr87Ter)	CYBA	Y87*	not provided	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000636575	16	88713189	16	88646781	636575	624618		NC_000016.10:88646780:G:C
NM_001004334.3(GPR179):c.779_780dup (p.Pro262Alafs)	GPR179		Congenital stationary night blindness, type 1E	Pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000599074	17	36498892 - 36498893	17	38343009 - 38343010	599074	590325	rs1567728372	NC_000017.11:38343009:GAG:GAGAG
NM_001004334.3(GPR179):c.1543C>T (p.Arg515Ter)	GPR179	R515*	not provided	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000598120	17	36491018	17	38335135	598120	589181	rs980007216	NC_000017.11:38335134:G:A
NM_000101.4(CYBA):c.415del (p.Arg139fs)	CYBA	R139fs	not provided	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000596212	16	88709934	16	88643526	596212	587273	rs1567607736	NC_000016.10:88643525:GGGG:GGG
NM_001040616.3(LINS1):c.1096G>T (p.Glu366Ter)	LINS1	E366*, E117*, E351*	not provided	Pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	VCV000429992	15	101113982	15	100573777	429992	421998	rs1131691716	NC_000015.10:100573776:C:A
NM_001004334.3(GPR179):c.673C>T (p.Gln225Ter)	GPR179	Q225*	not provided	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000287851	17	36499000	17	38343117	287851	272088	rs747682469	NC_000017.11:38343116:G:A
NM_001004334.3(GPR179):c.647dupA (p.Ala217Glyfs)	GPR179		not provided	Pathogenic(Last reviewed: Mar 12, 2016)	criteria provided, single submitter	VCV000286422	17	36499025 - 36499026	17	38343142 - 38343143	286422	270659	rs886043388	NC_000017.11:38343142:T:TT
NM_000101.4(CYBA):c.246del (p.Phe83fs)	CYBA	F83fs	Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000619030	16	88713204	16	88646796	619030	610428	rs1439134665	NC_000016.10:88646795:GGG:GG
NM_000101.4(CYBA):c.288-15C>G	CYBA		Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000619029	16	88712620	16	88646212	619029	610427	rs1567608853	NC_000016.10:88646211:G:C
NM_001040616.3(LINS1):c.1219_1222+1del	LINS1		Mental retardation, autosomal recessive 27	Pathogenic(Last reviewed: Jun 17, 2013)	no assertion criteria provided	VCV000120183	15	101113855 - 101113859	15	100573650 - 100573654	120183	125791	rs587777226	NC_000015.10:100573649:CCTTTC:C
NM_001004334.3(GPR179):c.187del (p.Leu63Serfs)	GPR179	L63fs	Congenital stationary night blindness, type 1E	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000031205	17	36499486	17	38343603	31205	40162	rs794726686	NC_000017.11:38343602:G:
NM_001004334.3(GPR179):c.1784+1G>A	GPR179		Congenital stationary night blindness, type 1E	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000031203	17	36490586	17	38334703	31203	40160	rs773126191	NC_000017.11:38334702:C:T
NM_001004334.3(GPR179):c.598C>T (p.Arg200Ter)	GPR179	R200*	Congenital stationary night blindness, type 1E	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000031202	17	36499075	17	38343192	31202	40159	rs387907138	NC_000017.11:38343191:G:A
NM_001004334.3(GPR179):c.278del (p.Pro93Glnfs)	GPR179	P93fs	Congenital stationary night blindness, type 1E	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000031201	17	36499395	17	38343512	31201	40158	rs794726685	NC_000017.11:38343511:GGGGGG:GGGGG
NM_000101.4(CYBA):c.166del (p.Arg56fs)	CYBA	R56fs	Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000661264	16	88713546	16	88647138	661264	645113		NC_000016.10:88647137:GGGGG:GGGG
NM_000101.4(CYBA):c.21del (p.Met8fs)	CYBA	M8fs	Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000650083	16	88717401	16	88650993	650083	645114		NC_000016.10:88650992:GG:G
NM_001040616.3(LINS1):c.985_988del (p.His328_His329insTer)	LINS1		Mental retardation, autosomal recessive 27	Pathogenic(Last reviewed: Jun 17, 2013)	no assertion criteria provided	VCV000120182	15	101114090 - 101114093	15	100573885 - 100573888	120182	125790	rs587777225	NC_000015.10:100573884:CATG:
NM_000101.4(CYBA):c.155T>C (p.Leu52Pro)	CYBA	L52P	not provided	Pathogenic(Last reviewed: May 18, 2015)	criteria provided, single submitter	VCV000068209	16	88713557	16	88647149	68209	79100	rs179363890	NC_000016.10:88647148:A:G
NM_000101.4(CYBA):c.373G>A (p.Ala125Thr)	CYBA	A125T	Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000002267	16	88709976	16	88643568	2267	17306	rs119103269	NC_000016.10:88643567:C:T
CYBA, 36-BP DEL	CYBA		Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000002266					2266	17305		
NM_000101.4(CYBA):c.7C>T (p.Gln3Ter)	CYBA	Q3*	Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000002264	16	88717415	16	88651007	2264	17303	rs104894511	NC_000016.10:88651006:G:A
NM_000101.4(CYBA):c.287+1G>A	CYBA		Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000002262	16	88713162	16	88646754	2262	17301	rs1567609091	NC_000016.10:88646753:C:T
NM_000101.4(CYBA):c.281A>G (p.His94Arg)	CYBA	H94R	Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000002261	16	88713169	16	88646761	2261	17300	rs104894510	NC_000016.10:88646760:T:C
NM_001004334.3(GPR179):c.799_803delCAGGTinsTGATCTAC (p.Gln267_Leu602delinsTer)	GPR179		Congenital stationary night blindness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000286815	17	36495400 - 36495404	17	38339517 - 38339521	286815	271052	rs886043488	NC_000017.11:38339516:ACCTG:GTAGATCA
NM_001004334.3(GPR179):c.1807C>T (p.His603Tyr)	GPR179	H603Y	Congenital stationary night blindness, type 1E|not provided	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000031200	17	36489899	17	38334016	31200	40157	rs281875234	NC_000017.11:38334015:G:A
NM_000101.4(CYBA):c.269G>A (p.Arg90Gln)	CYBA	R90Q	Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000002258	16	88713181	16	88646773	2258	17297	rs104894513	NC_000016.10:88646772:C:T
CYBA, 1-BP DEL, 272C	CYBA		Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Nov 1, 1990)	no assertion criteria provided	VCV000002257					2257	17296		
nsv513777	CYBA		Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Nov 1, 1990)	no assertion criteria provided	VCV000002256					2256	17295		
NM_018668.4(VPS33B):c.403+2T>A	VPS33B		Arthrogryposis, renal dysfunction, and cholestasis 1	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000317430	15	91553029	15	91009799	317430	340110	rs769333468	NC_000015.10:91009798:A:T
NM_018668.4(VPS33B):c.1312C>T (p.Arg438Ter)	VPS33B	R438*, R347*, R411*	Arthrogryposis, renal dysfunction, and cholestasis 1	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000002202	15	91545373	15	91002143	2202	17241	rs121434384	NC_000015.10:91002142:G:A
NM_000101.4(CYBA):c.26G>A (p.Trp9Ter)	CYBA	W9*	Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000862425	16	88717396	16	88650988	862425	844472		NC_000016.10:88650987:C:T
NC_000016.10:g.(?_88643329)_(88648134_?)del	CYBA		Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV000833221	16	88709737 - 88714542			833221	820908		
NM_001004334.3(GPR179):c.659A>G (p.Tyr220Cys)	GPR179	Y220C	not provided|Congenital stationary night blindness, type 1E	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000031206	17	36499014	17	38343131	31206	40163	rs281875236	NC_000017.11:38343130:T:C
NM_016194.4(GNB5):c.1032C>G (p.Tyr344Ter)	GNB5	Y302*, Y344*	Intellectual developmental disorder with cardiac arrhythmia|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000268102	15	52416814	15	52124617	268102	263628	rs749597091	NC_000015.10:52124616:G:C
NC_000016.10:g.(?_88643329)_(88643581_?)del	CYBA		Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000830689	16	88709737 - 88709989			830689	820907		
NM_001040616.3(LINS1):c.1178T>G (p.Leu393Ter)	LINS1	L393*, L144*, L378*	Mental retardation, autosomal recessive 27|not provided	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280510	15	101113900	15	100573695	280510	264545	rs149644940	NC_000015.10:100573694:A:C
NM_000101.4(CYBA):c.467C>A (p.Pro156Gln)	CYBA	P156Q	Chronic granulomatous disease|Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Feb 11, 2016)	no assertion criteria provided	VCV000002260	16	88709882	16	88643474	2260	17299	rs104894515	NC_000016.10:88643473:G:T
NM_000101.4(CYBA):c.354C>A (p.Ser118Arg)	CYBA	S118R	Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not provided	Pathogenic(Last reviewed: Nov 1, 1990)	no assertion criteria provided	VCV000002259	16	88712539	16	88646131	2259	17298	rs104894514	NC_000016.10:88646130:G:T
GRCh37/hg19 15q21.3(chr15:53871541-53993518)x1	WDR72		not provided	Pathogenic(Last reviewed: May 2, 2017)	no assertion criteria provided	VCV000688610	15	53871541 - 53993518			688610	676202		
NM_182758.4(WDR72):c.1467_1468del (p.Val491fs)	WDR72	V491fs	Amelogenesis imperfecta, hypomaturation type, IIA3	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000161415	15	53994432 - 53994433	15	53702235 - 53702236	161415	171258	rs606231462	NC_000015.10:53702234:AT:
NM_182758.4(WDR72):c.2348C>G (p.Ser783Ter)	WDR72	S783*	Amelogenesis imperfecta, hypomaturation type, IIA3	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000000231	15	53908055	15	53615858	231	15270	rs267607178	NC_000015.10:53615857:G:C
NM_182758.4(WDR72):c.2686C>T (p.Arg896Ter)	WDR72	R896*	Amelogenesis imperfecta, hypomaturation type, IIA3|Renal tubular acidosis, distal, with hemolytic anemia	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000522610	15	53907717	15	53615520	522610	513221	rs557128345	NC_000015.10:53615519:G:A
NM_182758.4(WDR72):c.2522T>A (p.Leu841Gln)	WDR72	L841Q	Renal tubular acidosis, distal, with hemolytic anemia	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000522609	15	53907881	15	53615684	522609	513222	rs768446132	NC_000015.10:53615683:A:T
NM_182758.4(WDR72):c.1777A>G (p.Arg593Gly)	WDR72	R593G	Renal tubular acidosis, distal, with hemolytic anemia	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000522608	15	53957954	15	53665757	522608	513223	rs1376457227	NC_000015.10:53665756:T:C
NM_182758.4(WDR72):c.2857del (p.Ser953fs)	WDR72	S953fs	Amelogenesis imperfecta, hypomaturation type, IIA3	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000000233	15	53905878	15	53613681	233	15272	rs606231351	NC_000015.10:53613680:T:
NM_182758.4(WDR72):c.2934G>A (p.Trp978Ter)	WDR72	W978*	not provided|Amelogenesis imperfecta, hypomaturation type, IIA3	Pathogenic(Last reviewed: Dec 15, 2016)	criteria provided, single submitter	VCV000000232	15	53901728	15	53609531	232	15271	rs143816093	NC_000015.10:53609530:C:T
NM_014252.4(SLC25A15):c.22C>T (p.Gln8Ter)	SLC25A15	Q8*	not provided	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000489127	13	41367384	13	40793248	489127	482043	rs1448259297	NC_000013.11:40793247:C:T
NM_014252.4(SLC25A15):c.208_209delinsTT (p.Ala70Leu)	SLC25A15		not provided	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000419157	13	41373345 - 41373346	13	40799209 - 40799210	419157	409028	rs1064793683	NC_000013.11:40799208:GC:TT
NM_014252.4(SLC25A15):c.847C>T (p.Leu283Phe)	SLC25A15	L283F	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: May 31, 2012)	no assertion criteria provided	VCV000038404	13	41383744	13	40809608	38404	46963	rs202247809	NC_000013.11:40809607:C:T
NM_014252.4(SLC25A15):c.818T>A (p.Met273Lys)	SLC25A15	M273K	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: May 31, 2012)	no assertion criteria provided	VCV000038402	13	41383715	13	40809579	38402	46961	rs202247808	NC_000013.11:40809578:T:A
NM_014252.4(SLC25A15):c.658G>A (p.Gly220Arg)	SLC25A15	G220R	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: May 31, 2012)	no assertion criteria provided	VCV000038401	13	41382609	13	40808473	38401	46960	rs202247805	NC_000013.11:40808472:G:A
NM_014252.4(SLC25A15):c.569G>A (p.Gly190Asp)	SLC25A15	G190D	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: May 31, 2012)	no assertion criteria provided	VCV000038400	13	41381546	13	40807410	38400	46959	rs202247804	NC_000013.11:40807409:G:A
NM_014252.4(SLC25A15):c.44C>A (p.Ala15Glu)	SLC25A15	A15E	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: May 31, 2012)	no assertion criteria provided	VCV000038398	13	41367406	13	40793270	38398	46957	rs202247806	NC_000013.11:40793269:C:A
NM_014252.4(SLC25A15):c.337G>T (p.Gly113Cys)	SLC25A15	G113C	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: May 31, 2012)	no assertion criteria provided	VCV000038397	13	41379276	13	40805140	38397	46956	rs199894905	NC_000013.11:40805139:G:T
NM_014252.4(SLC25A15):c.59del (p.Gly20fs)	SLC25A15	G20fs	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000857237	13	41373195	13	40799059	857237	840891		NC_000013.11:40799058:GG:G
NM_014252.4(SLC25A15):c.408del (p.Met137fs)	SLC25A15	M137fs	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000851641	13	41379346	13	40805210	851641	840893		NC_000013.11:40805209:CC:C
NM_014252.4(SLC25A15):c.514G>T (p.Gly172Ter)	SLC25A15	G172*	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000656435	13	41381491	13	40807355	656435	641941		NC_000013.11:40807354:G:T
NM_014252.4(SLC25A15):c.521C>A (p.Ser174Ter)	SLC25A15	S174*	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000650947	13	41381498	13	40807362	650947	641942		NC_000013.11:40807361:C:A
NM_130466.4(UBE3B):c.1956+1G>A	UBE3B		Inborn genetic diseases	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000521558	12	109949109	12	109511304	521558	511953	rs1304422857	NC_000012.12:109511303:G:A
NM_014252.4(SLC25A15):c.95C>G (p.Thr32Arg)	SLC25A15	T32R	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: May 31, 2012)	no assertion criteria provided	VCV000006000	13	41373232	13	40799096	6000	21039	rs121908536	NC_000013.11:40799095:C:G
NM_014252.4(SLC25A15):c.212T>A (p.Leu71Gln)	SLC25A15	L71Q	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: May 31, 2012)	no assertion criteria provided	VCV000005998	13	41373349	13	40799213	5998	21037	rs121908534	NC_000013.11:40799212:T:A
NM_014252.4(SLC25A15):c.110T>G (p.Met37Arg)	SLC25A15	M37R	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: May 31, 2012)	no assertion criteria provided	VCV000005997	13	41373247	13	40799111	5997	21036	rs121908533	NC_000013.11:40799110:T:G
NM_014252.4(SLC25A15):c.824G>A (p.Arg275Gln)	SLC25A15	R275Q	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: May 31, 2012)	no assertion criteria provided	VCV000005996	13	41383721	13	40809585	5996	21035	rs104894431	NC_000013.11:40809584:G:A
NM_014252.4(SLC25A15):c.446del (p.Ser149fs)	SLC25A15	S149fs	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000567983	13	41379385	13	40805249	567983	568548	rs1566123619	NC_000013.11:40805248:G:
NM_000326.5(RLBP1):c.677T>A (p.Met226Lys)	RLBP1	M225K, M226K	RLBP1-Related Disorders|Retinitis punctata albescens|Retinitis pigmentosa|Retinal dystrophy	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013101	15	89754981	15	89211750	13101	28140	rs137853291	NC_000015.10:89211749:A:T
NM_014252.4(SLC25A15):c.79G>A (p.Gly27Arg)	SLC25A15	G27R	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000005995	13	41373216	13	40799080	5995	21034	rs104894430	NC_000013.11:40799079:G:A
NM_001042355.2(CYLD):c.1672_1673del (p.Leu558fs)	CYLD	L558fs, L561fs	not provided	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000817054	16	50815318 - 50815319	16	50781407 - 50781408	817054	805885		NC_000016.10:50781406:TTT:T
NM_015247.2(CYLD):c.2569C>T (p.Gln857Ter)	CYLD	Q857*, Q854*	Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267255	16	50828222	16	50794311	267255	262134	rs886040894	NC_000016.10:50794310:C:T
NM_015247.2(CYLD):c.2515del (p.Ser839fs)	CYLD	S836fs, S839fs	Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267254	16	50828168	16	50794257	267254	262133	rs886040893	NC_000016.10:50794256:T:
NM_015247.2(CYLD):c.2406_2407del (p.Cys802_Tyr803delinsTer)	CYLD		Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267253	16	50827512 - 50827513	16	50793601 - 50793602	267253	262132	rs886040892	NC_000016.10:50793600:CT:
NM_015247.2(CYLD):c.2390_2391del (p.Met796_Tyr797insTer)	CYLD		Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267252	16	50827495 - 50827496	16	50793584 - 50793585	267252	262131	rs886040891	NC_000016.10:50793583:TAT:T
NM_015247.2(CYLD):c.2350+1G>T	CYLD		Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267251	16	50826617	16	50792706	267251	262130	rs886040890	NC_000016.10:50792705:G:T
NM_015247.2(CYLD):c.2299A>T (p.Lys767Ter)	CYLD	K767*, K764*	Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267249	16	50826565	16	50792654	267249	262128	rs886040888	NC_000016.10:50792653:A:T
NM_015247.2(CYLD):c.2291_2295del (p.Lys764fs)	CYLD	K764fs, K761fs	Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267248	16	50826555 - 50826559	16	50792644 - 50792648	267248	262127	rs886040887	NC_000016.10:50792643:TAAACTA:TA
NM_015247.2(CYLD):c.2242-2A>G	CYLD		Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267247	16	50826506	16	50792595	267247	262126	rs886040886	NC_000016.10:50792594:A:G
NM_015247.2(CYLD):c.2138_2139dup (p.Phe714fs)	CYLD			Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267246	16	50825497 - 50825498	16	50791586 - 50791587	267246	262125	rs886040885	NC_000016.10:50791586:AC:ACAC
NM_015247.2(CYLD):c.2108G>A (p.Arg703Lys)	CYLD	R703K, R700K		Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267245	16	50821763	16	50787852	267245	262124	rs886040884	NC_000016.10:50787851:G:A
NM_015247.2(CYLD):c.1950-2_1953del	CYLD		Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267243	16	50820763 - 50820768	16	50786852 - 50786857	267243	262122	rs886040882	NC_000016.10:50786851:TAGATAT:T
NM_015247.2(CYLD):c.1771A>T (p.Lys591Ter)	CYLD	K591*, K588*	Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267240	16	50816322	16	50782411	267240	262119	rs886040879	NC_000016.10:50782410:A:T
NM_015247.2(CYLD):c.1658_1661del (p.Asn553fs)	CYLD	N550fs, N553fs	Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267237	16	50815294 - 50815297	16	50781383 - 50781386	267237	262116	rs886040876	NC_000016.10:50781382:CAATCA:CA
NM_015247.2(CYLD):c.1599dup (p.Val534fs)	CYLD			Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267236	16	50815234 - 50815235	16	50781323 - 50781324	267236	262115	rs886040875	NC_000016.10:50781323:TTT:TTTT
NM_015247.2(CYLD):c.1537dup (p.Cys513fs)	CYLD			Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267235	16	50815174 - 50815175	16	50781263 - 50781264	267235	262114	rs886040874	NC_000016.10:50781263:T:TT
NM_015247.2(CYLD):c.1363C>T (p.Gln455Ter)	CYLD	Q455*, Q452*	Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267234	16	50813800	16	50779889	267234	262113	rs886040873	NC_000016.10:50779888:C:T
NM_015247.2(CYLD):c.1327C>T (p.Gln443Ter)	CYLD	Q443*, Q440*	Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267233	16	50813764	16	50779853	267233	262112	rs764952788	NC_000016.10:50779852:C:T
NM_015247.2(CYLD):c.987_988dup (p.Gly330fs)	CYLD		Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267231	16	50810153 - 50810154	16	50776242 - 50776243	267231	262110	rs886040871	NC_000016.10:50776242:AG:AGAG
NM_015247.2(CYLD):c.968_977del (p.Ser323fs)	CYLD	S323fs, S320fs		Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267230	16	50810132 - 50810141	16	50776221 - 50776230	267230	262109	rs886040870	NC_000016.10:50776220:TGTCAAGAGGTGT:TGT
NM_015247.2(CYLD):c.911dup (p.Ala305fs)	CYLD		Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267229	16	50788330 - 50788331	16	50754419 - 50754420	267229	262108	rs886040869	NC_000016.10:50754419:CCC:CCCC
NM_015247.2(CYLD):c.831_834del (p.Asp277fs)	CYLD	D277fs	Cylindromatosis, familial	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000267228	16	50788250 - 50788253	16	50754339 - 50754342	267228	262107	rs886040868	NC_000016.10:50754338:GGATGGA:GGA
CYLD, 4-BP DEL, 1950-1GATA	CYLD		Cylindromatosis, familial	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000005262					5262	20301		
NM_015247.2(CYLD):c.1392dup (p.Gly465fs)	CYLD			Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000005261	16	50813828 - 50813829	16	50779917 - 50779918	5261	20300		NC_000016.10:50779917:T:TT
NM_015247.2(CYLD):c.561dup (p.Gln188fs)	CYLD		Cylindromatosis, familial	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000005260	16	50785566 - 50785567	16	50751655 - 50751656	5260	20299		NC_000016.10:50751655:TTTTT:TTTTTT
NM_015247.2(CYLD):c.1826+2T>G	CYLD		Familial multiple trichoepitheliomata	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000005257	16	50816379	16	50782468	5257	20296		NC_000016.10:50782467:T:G
NM_001042355.2(CYLD):c.2229_2230AG[1] (p.Glu744fs)	CYLD		Familial multiple trichoepitheliomata	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000005256	16	50825598 - 50825599	16	50791687 - 50791688	5256	20295		NC_000016.10:50791686:AGAG:AG
CYLD, 1-BP DEL, 2172A	CYLD			Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000005255					5255	20294		
NM_015247.2(CYLD):c.2469+1G>A	CYLD		Cylindromatosis, familial	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000005252	16	50827576	16	50793665	5252	20291		NC_000016.10:50793664:G:A
NM_015247.2(CYLD):c.1112C>A (p.Ser371Ter)	CYLD	S371*, S368*	Cylindromatosis, familial|not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000267232	16	50811826	16	50777915	267232	262111	rs886040872	NC_000016.10:50777914:C:A
NM_000286.3(PEX12):c.334C>T (p.Gln112Ter)	PEX12	Q112*	Peroxisome biogenesis disorder 3A|not provided|Infantile Refsum's disease|Peroxisome biogenesis disorder 3A	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000191074	17	33904403	17	35577384	191074	188880	rs776731688	NC_000017.11:35577383:G:A
NM_000286.3(PEX12):c.894del (p.Lys299_Met300insTer)	PEX12		not provided|Infantile Refsum's disease|Peroxisome biogenesis disorder 3A	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092777	17	33902987	17	35575968	92777	98684	rs398123302	NC_000017.11:35575967:GGG:GG
NM_015247.2(CYLD):c.2240A>G (p.Glu747Gly)	CYLD	E747G, E744G	Familial multiple trichoepitheliomata|	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000005258	16	50825600	16	50791689	5258	20297	rs121908389	NC_000016.10:50791688:A:G
NM_015247.2(CYLD):c.2252del (p.Cys751fs)	CYLD	C748fs, C751fs	Cylindromatosis, familial|	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000005254	16	50826518	16	50792607	5254	20293		NC_000016.10:50792606:G:
NM_015247.2(CYLD):c.2272C>T (p.Arg758Ter)	CYLD	R758*, R755*	Cylindromatosis, familial|not specified	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000005253	16	50826538	16	50792627	5253	20292	rs121908388	NC_000016.10:50792626:C:T
NM_003850.2(SUCLA2):c.887del (p.Gln296fs)	SUCLA2	Q296fs	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802962	13	48528608	13	47954473	802962	791345		NC_000013.11:47954472:T:
NC_000016.9:g.(?_74750291)_(74762108_?)del	FA2H		Spastic paraplegia	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000458208	16	74750291 - 74762108			458208	465548		
NM_024306.5(FA2H):c.821_822del (p.Pro274fs)	FA2H	P274fs	Spastic paraplegia	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000241466	16	74750462 - 74750463	16	74716564 - 74716565	241466	242496	rs878855083	NC_000016.10:74716563:AG:
NM_024306.5(FA2H):c.968C>T (p.Pro323Leu)	FA2H	P323L	Spastic paraplegia 35	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807416	16	74750316	16	74716418	807416	798705		NC_000016.10:74716417:G:A
NM_024306.5(FA2H):c.340_363+8del	FA2H		Spastic paraplegia 35	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803271	16	74773913 - 74773944	16	74740015 - 74740046	803271	791640		NC_000016.10:74740014:CCAGGTACCTTGTCCCAATCCACCACTTTGAACC:CC
NM_003850.2(SUCLA2):c.815A>T (p.Asp272Val)	SUCLA2	D272V	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522686	13	48528680	13	47954545	522686	513339	rs1555256440	NC_000013.11:47954544:T:A
NM_024306.5(FA2H):c.102C>G (p.Tyr34Ter)	FA2H	Y34*	Spastic paraplegia 35	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000488512	16	74808552	16	74774654	488512	481380	rs957683798	NC_000016.10:74774653:G:C
NM_003850.2(SUCLA2):c.850C>T (p.Arg284Cys)	SUCLA2	R284C	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000005978	13	48528645	13	47954510	5978	21017	rs121908538	NC_000013.11:47954509:G:A
NM_003850.2(SUCLA2):c.352G>A (p.Gly118Arg)	SUCLA2	G118R	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000005977	13	48563036	13	47988901	5977	21016	rs121908537	NC_000013.11:47988900:C:T
SUCLA2, 43-BP DEL AND 5-BP INS	SUCLA2		Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000005975					5975	21014		
NM_000101.4(CYBA):c.268C>T (p.Arg90Trp)	CYBA	R90W	not provided|Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000068211	16	88713182	16	88646774	68211	79102	rs179363892	NC_000016.10:88646773:G:A
NM_000101.4(CYBA):c.70G>A (p.Gly24Arg)	CYBA	G24R	Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000002265	16	88714511	16	88648103	2265	17304	rs28941476	NC_000016.10:88648102:C:T
NG_017070.1:g.(39810_52446)_(66877_?)del	FA2H		Spastic paraplegia 35	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000031625	16	74746853 - 74773920	16	74712955 - 74740022	31625	40303		
NM_024306.5(FA2H):c.707T>C (p.Phe236Ser)	FA2H	F236S	Spastic paraplegia 35	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000031624	16	74752965	16	74719067	31624	40302	rs387907172	NC_000016.10:74719066:A:G
NM_024306.5(FA2H):c.159_176del (p.Arg53_Ile58del)	FA2H		Spastic paraplegia 35	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000030871	16	74808478 - 74808495	16	74774580 - 74774597	30871	39828	rs759947457	NC_000016.10:74774579:CTGATGTCCTGGCCCGCCCTG:CTG
NM_024306.5(FA2H):c.103G>T (p.Asp35Tyr)	FA2H	D35Y	Spastic paraplegia 35	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000001044	16	74808551	16	74774653	1044	16083	rs121918217	NC_000016.10:74774652:C:A
NM_024306.5(FA2H):c.786+1G>A	FA2H		Spastic paraplegia 35	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000001043	16	74752885	16	74718987	1043	16082	rs1567633766	NC_000016.10:74718986:C:T
NM_014252.4(SLC25A15):c.538G>A (p.Glu180Lys)	SLC25A15	E180K	not provided|Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	VCV000005993	13	41381515	13	40807379	5993	21032	rs104894424	NC_000013.11:40807378:G:A
NM_001165960.1(ALOXE3):c.2285C>T (p.Pro762Leu)	ALOXE3	P762L, P630L, P629L	Autosomal recessive congenital ichthyosis|Autosomal recessive congenital ichthyosis 3|not provided	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279677	17	8006708	17	8103390	279677	264886	rs147149459	NC_000017.11:8103389:G:A
NM_003850.2(SUCLA2):c.751G>A (p.Asp251Asn)	SUCLA2	D251N	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000066034	13	48542781	13	47968646	66034	76940	rs397515462	NC_000013.11:47968645:C:T
NM_024306.5(FA2H):c.510_511del (p.Tyr170_Ser171delinsTer)	FA2H		Spastic paraplegia 35	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000030873	16	74760225 - 74760226	16	74726327 - 74726328	30873	39830	rs587776891	NC_000016.10:74726326:TGT:T
NM_003850.2(SUCLA2):c.534+1G>A	SUCLA2		Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	Pathogenic(Last reviewed: May 26, 2009)	no assertion criteria provided	VCV000005976	13	48562675	13	47988540	5976	21015	rs113994161	NC_000013.11:47988539:C:T
ASPA, EX4DEL	ASPA		Spongy degeneration of central nervous system	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000002613					2613	17652		
ASPA, 1-BP DEL, 32T	ASPA		Spongy degeneration of central nervous system	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000002611					2611	17650		
ASPA, 4-BP DEL, 876AGAA	ASPA		Spongy degeneration of central nervous system	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000002610					2610	17649		
NM_003922.4(HERC1):c.1183C>T (p.Gln395Ter)	HERC1	Q395*	not provided	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000853776	15	64050412	15	63758213	853776	842576		NC_000015.10:63758212:G:A
NM_007347.5(AP4E1):c.2743_2744insTATGT (p.His915fs)	AP4E1		Spastic paraplegia	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000569155	15	51289919 - 51289920	15	50997722 - 50997723	569155	573416	rs754944429	NC_000015.10:50997722::TATGT
NM_003922.4(HERC1):c.13559G>A (p.Gly4520Glu)	HERC1	G4520E	Macrocephaly, dysmorphic facies, and psychomotor retardation	Pathogenic(Last reviewed: Aug 4, 2016)	no assertion criteria provided	VCV000243011	15	63915976	15	63623777	243011	244092	rs769677823	NC_000015.10:63623776:C:T
NM_003922.4(HERC1):c.2625G>A (p.Trp875Ter)	HERC1	W875*	Macrocephaly, dysmorphic facies, and psychomotor retardation	Pathogenic(Last reviewed: Aug 4, 2016)	no assertion criteria provided	VCV000243010	15	64026944	15	63734745	243010	244091	rs879253786	NC_000015.10:63734744:C:T
NM_021728.4(OTX2):c.226C>T (p.Arg76Ter)	OTX2	R68*, R76*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280496	14	57270953	14	56804235	280496	264818	rs773157352	NC_000014.9:56804234:G:A
NM_003922.4(HERC1):c.9748C>T (p.Arg3250Ter)	HERC1	R3250*	Macrocephaly, dysmorphic facies, and psychomotor retardation|Megalencephaly with thick corpus callosum, cerebellar atrophy, and intellectual disability	Pathogenic(Last reviewed: Feb 3, 2015)	criteria provided, single submitter	VCV000188045	15	63948409	15	63656210	188045	185937	rs753780877	NC_000015.10:63656209:G:A
AP4E1, VAL454FS	AP4E1		Spastic paraplegia 51, autosomal recessive	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000030661					30661	39618		
AP4E1, 4-BP DEL, IVS5DS, 542+1GTAA	AP4E1		Spastic paraplegia 51, autosomal recessive	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030660					30660	39617		
NM_024306.5(FA2H):c.460C>T (p.Arg154Cys)	FA2H	R154C	not provided|Spastic paraplegia 35	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000030872	16	74761188	16	74727290	30872	39829	rs387907040	NC_000016.10:74727289:G:A
F10, GLU32GLN	F10	E32Q	Factor X deficiency	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000012065					12065	27104		
Factor X Ketchikan	F10	E14G	Factor X deficiency	Pathogenic(Last reviewed: Feb 1, 1995)	no assertion criteria provided	VCV000012064					12064	27103		
F10, GLU7GLY	F10	E7G	Factor X deficiency	Pathogenic(Last reviewed: Nov 8, 1996)	no assertion criteria provided	VCV000012063					12063	27102		
F10, SER334PRO	F10	S334P	Factor X deficiency	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000012060					12060	27099		
F10, PRO343SER	F10	P343S	Factor X deficiency	Pathogenic(Last reviewed: Jan 15, 1991)	no assertion criteria provided	VCV000012057					12057	27096		
F10, GLU14LYS	F10	E14K	Factor X deficiency	Pathogenic(Last reviewed: Jul 15, 1990)	no assertion criteria provided	VCV000012055					12055	27094		
NM_000504.4(F10):c.814del (p.Ile271_Leu272insTer)	F10		Factor X deficiency	Pathogenic(Last reviewed: Oct 1, 1989)	no assertion criteria provided	VCV000012054	13	113801758	13	113147444	12054	27093	rs387906506	NC_000013.11:113147443:CC:C
NM_000504.4(F10):c.1096C>T (p.Arg366Cys)	F10	R366C, R322C	Factor X deficiency	Pathogenic(Last reviewed: Oct 1, 1989)	no assertion criteria provided	VCV000012053	13	113803460	13	113149146	12053	27092	rs104894392	NC_000013.11:113149145:C:T
F10, THR318MET	F10	T318M	Factor X deficiency	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000031081					31081	40038		
F10, ASP282ASN	F10	D282N	Factor X deficiency	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000012062					12062	27101		
NM_000504.4(F10):c.859A>T (p.Arg287Trp)	F10	R287W, R243W	Factor X deficiency	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000012059	13	113801804	13	113147490	12059	27098	rs121964948	NC_000013.11:113147489:A:T
F10, G-A, -20	F10		Factor X deficiency	Pathogenic(Last reviewed: Mar 15, 1993)	no assertion criteria provided	VCV000012058					12058	27097		
F10, VAL298MET	F10	V298M	Factor X deficiency	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000012056					12056	27095		
F10, GLY249ARG	F10	G249R	Factor x deficiency, autosomal dominant	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000012066					12066	27105		
NM_020988.3(GNAO1):c.626G>T (p.Arg209Leu)	GNAO1	R209L	Early infantile epileptic encephalopathy 17|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431699	16	56370675	16	56336763	431699	425224	rs797044878	NC_000016.10:56336762:G:T
NM_020988.3(GNAO1):c.680C>T (p.Ala227Val)	GNAO1	A227V	not provided|Early infantile epileptic encephalopathy 17|Neurodevelopmental disorder with involuntary movements|Early infantile epileptic encephalopathy|Early infantile epileptic encephalopathy 17	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211088	16	56370729	16	56336817	211088	208289	rs797045599	NC_000016.10:56336816:C:T
NM_003593.2(FOXN1):c.1366_1369dup (p.His457fs)	FOXN1			Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000862162	17	26861953 - 26861954	17	28534935 - 28534936	862162	844823		NC_000017.11:28534935:CTTGC:CTTGCTTGC
NM_003593.2(FOXN1):c.189del (p.Pro65fs)	FOXN1	P65fs		Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000854460	17	26851586	17	28524568	854460	844808		NC_000017.11:28524567:G:
NM_003593.2(FOXN1):c.490del (p.Asp164fs)	FOXN1	D164fs		Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000839513	17	26851886	17	28524868	839513	844811		NC_000017.11:28524867:GG:G
NM_003593.2(FOXN1):c.1376C>A (p.Ser459Ter)	FOXN1	S459*		Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000837219	17	26861965	17	28534947	837219	844824		NC_000017.11:28534946:C:A
NM_003593.2(FOXN1):c.1418del (p.Pro473fs)	FOXN1	P473fs	T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Mar 13, 2020)	no assertion criteria provided	VCV000827578	17	26862005	17	28534987	827578	815782		NC_000017.11:28534986:CCC:CC
NM_003593.2(FOXN1):c.1089_1103del (p.Trp363_Pro368delinsCys)	FOXN1		T-lymphocyte deficiency	Pathogenic(Last reviewed: Mar 13, 2020)	no assertion criteria provided	VCV000827575	17	26861510 - 26861524	17	28534492 - 28534506	827575	815779		NC_000017.11:28534491:GAAGAGGAAAGATCC:
NM_003593.2(FOXN1):c.933_936dup (p.Asp313fs)	FOXN1		T-lymphocyte deficiency	Pathogenic(Last reviewed: Mar 13, 2020)	no assertion criteria provided	VCV000827574	17	26861352 - 26861353	17	28534334 - 28534335	827574	815778		NC_000017.11:28534334:CACCC:CACCCACCC
NM_003593.2(FOXN1):c.562del (p.Ser188fs)	FOXN1	S188fs		Pathogenic(Last reviewed: Mar 13, 2020)	no assertion criteria provided	VCV000827573	17	26851959	17	28524941	827573	815777		NC_000017.11:28524940:A:
NM_003593.2(FOXN1):c.728_729dup (p.Pro244fs)	FOXN1			Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000663245	17	26856138 - 26856139	17	28529120 - 28529121	663245	645407		NC_000017.11:28529120:ATA:ATATA
NM_003593.2(FOXN1):c.1086dup (p.Trp363fs)	FOXN1			Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000639621	17	26861502 - 26861503	17	28534484 - 28534485	639621	645415		NC_000017.11:28534484:AAAAA:AAAAAA
NM_001369369.1(FOXN1):c.1445_1449delinsCCA (p.Arg482fs)	FOXN1			Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000576959	17	26862034 - 26862038	17	28535016 - 28535020	576959	570825	rs1567887558	NC_000017.11:28535015:GGGCC:CCA
NM_003593.2(FOXN1):c.1420C>T (p.Gln474Ter)	FOXN1	Q474*		Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000660886	17	26862009	17	28534991	660886	645421		NC_000017.11:28534990:C:T
NM_002768.5(CHMP1A):c.108C>T (p.Ala36=)	CHMP1A	P30S	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 12, 2014)	criteria provided, single submitter	VCV000520606	16	89715903	16	89649495	520606	512251	rs764358419	NC_000016.10:89649494:G:A
NM_003593.2(FOXN1):c.958C>T (p.Arg320Trp)	FOXN1	R320W	|T-CELL LYMPHOPENIA, INFANTILE, WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Mar 13, 2020)	no assertion criteria provided	VCV000827572	17	26861379	17	28534361	827572	815776		NC_000017.11:28534360:C:T
NM_017775.4(TTC19):c.304C>T (p.Arg102Ter)	TTC19	R102*	not provided	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000489153	17	15903551	17	16000237	489153	482117	rs961191529	NC_000017.11:16000236:C:T
NM_017775.4(TTC19):c.194G>A (p.Trp65Ter)	TTC19	W65*	not provided	Pathogenic(Last reviewed: Sep 18, 2012)	criteria provided, single submitter	VCV000215300	17	15903441	17	16000127	215300	211790	rs779592523	NC_000017.11:16000126:G:A
NM_017775.4(TTC19):c.817G>T (p.Glu273Ter)	TTC19	E273*, E166*	Mitochondrial complex III deficiency, nuclear type 2	Pathogenic(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	VCV000437076	17	15928471	17	16025157	437076	429927	rs1555530551	NC_000017.11:16025156:G:T
NM_017775.4(TTC19):c.-42G>T	TTC19		not provided	Pathogenic(Last reviewed: Jun 25, 2013)	criteria provided, single submitter	VCV000215308	17	15903121	17	15999807	215308	211787	rs769078093	NC_000017.11:15999806:G:T
NM_017775.4(TTC19):c.829C>T (p.Gln277Ter)	TTC19	Q277*, Q170*	Mitochondrial complex III deficiency, nuclear type 2	Pathogenic(Last reviewed: Jan 7, 2014)	no assertion criteria provided	VCV000102440	17	15928483	17	16025169	102440	108182	rs794726692	NC_000017.11:16025168:C:T
TTC19, 4-BP DEL, 964GGCT	TTC19		Mitochondrial complex III deficiency, nuclear type 2	Pathogenic(Last reviewed: Dec 25, 2013)	no assertion criteria provided	VCV000102439					102439	108181		
TTC19, TRP186TER	TTC19	W186*	Mitochondrial complex III deficiency, nuclear type 2	Pathogenic(Last reviewed: Dec 25, 2013)	no assertion criteria provided	VCV000102438					102438	108180		
NM_017775.4(TTC19):c.517C>T (p.Gln173Ter)	TTC19	Q173*, Q66*	Mitochondrial complex III deficiency, nuclear type 2	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000031074	17	15907199	17	16003885	31074	40031	rs387907094	NC_000017.11:16003884:C:T
NM_017775.4(TTC19):c.656T>G (p.Leu219Ter)	TTC19	L219*, L112*	Mitochondrial complex III deficiency, nuclear type 2	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000031073	17	15909862	17	16006548	31073	40030	rs747166010	NC_000017.11:16006547:T:G
NM_001136473.1(LITAF):c.*69G>A	LITAF	V144M	Charcot-Marie-Tooth disease, type 1C	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000006061	16	11643549	16	11549693	6061	21100	rs121908615	NC_000016.10:11549692:C:T
NM_001136473.1(LITAF):c.364C>G (p.Leu122Val)	LITAF	L122V	Charcot-Marie-Tooth disease, type 1C	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000006060	16	11647402	16	11553546	6060	21099	rs104894522	NC_000016.10:11553545:G:C
NM_017775.4(TTC19):c.601_604del (p.Gly201fs)	TTC19	G201fs, G94fs	Mitochondrial complex III deficiency, nuclear type 2|not provided	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000102437	17	15909804 - 15909807	17	16006490 - 16006493	102437	108179	rs794726691	NC_000017.11:16006489:GCTGGCT:GCT
NM_001136473.1(LITAF):c.346T>G (p.Trp116Gly)	LITAF	W116G	Charcot-Marie-Tooth disease, type 1C	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000006059	16	11647420	16	11553564	6059	21098	rs104894521	NC_000016.10:11553563:A:C
NM_000289.6(PFKM):c.2003del (p.Pro668fs)	PFKM	P618fs, P676fs, P626fs, P739fs, P637fs, P639fs, P668fs, P716fs, P771fs	Glycogen storage disease|Glycogen storage disease, type VII	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000632192	12	48538822	12	48145039	632192	620443	rs767095759	NC_000012.12:48145038:CCC:CC
NM_001330504.1(ALG1):c.917_918insTG (p.Ala307fs)	ALG1		Congenital disorder of glycosylation|not provided|ALG1-CDG	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000424339	16	5133745 - 5133746	16	5083744 - 5083745	424339	409644	rs746019074	NC_000016.10:5083744::TG
NM_001770.5(CD19):c.1653_*9delins23	CD19		Common variable immunodeficiency 3	Pathogenic(Last reviewed: Sep 13, 2016)	no assertion criteria provided	VCV000254197	16	28950266 - 28950293	16	28938945 - 28938972	254197	248712		
NM_001770.5(CD19):c.1464del (p.Ser489fs)	CD19	S489fs	Common variable immunodeficiency 3	Pathogenic(Last reviewed: Sep 13, 2016)	no assertion criteria provided	VCV000254196	16	28949121	16	28937800	254196	248711	rs886037921	NC_000016.10:28937799:CCCC:CCC
NM_001770.5(CD19):c.156G>C (p.Trp52Cys)	CD19	W52C	Common variable immunodeficiency 3	Pathogenic(Last reviewed: Sep 13, 2016)	no assertion criteria provided	VCV000254195	16	28943734	16	28932413	254195	248710	rs886037920	NC_000016.10:28932412:G:C
NM_001770.5(CD19):c.947-1G>T	CD19		Common variable immunodeficiency 3	Pathogenic(Last reviewed: Sep 13, 2016)	no assertion criteria provided	VCV000254194	16	28947473	16	28936152	254194	248709	rs1567506566	NC_000016.10:28936151:G:T
CD19, 2-BP DEL, 1384GA	CD19		Common variable immunodeficiency 3	Pathogenic(Last reviewed: May 4, 2006)	no assertion criteria provided	VCV000018055					18055	33094		
CD19, 1-BP INS, 972A	CD19		Common variable immunodeficiency 3	Pathogenic(Last reviewed: May 4, 2006)	no assertion criteria provided	VCV000018054					18054	33093		
NM_015247.2(CYLD):c.2806C>T (p.Arg936Ter)	CYLD	R936*, R933*	Cylindromatosis, familial|Familial multiple trichoepitheliomata|	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000005259	16	50830354	16	50796443	5259	20298	rs121908390	NC_000016.10:50796442:C:T
NM_014249.4(NR2E3):c.309C>A (p.Cys103Ter)	NR2E3	C103*	Retinal dystrophy	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000867206	15	72104169	15	71811829	867206	856816		NC_000015.10:71811828:C:A
NM_014249.4(NR2E3):c.290G>A (p.Arg97His)	NR2E3	R97H	Retinal dystrophy	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000867089	15	72104150	15	71811810	867089	856815		NC_000015.10:71811809:G:A
NM_014249.4(NR2E3):c.747+1G>C	NR2E3		Enhanced s-cone syndrome	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812354	15	72104852	15	71812512	812354	800699		NC_000015.10:71812511:G:C
NM_014249.4(NR2E3):c.804G>A (p.Trp268Ter)	NR2E3	W268*	not provided	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000864656	15	72105785	15	71813445	864656	842651		NC_000015.10:71813444:G:A
NM_014249.4(NR2E3):c.449dup (p.Ala151fs)	NR2E3		not provided	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000863414	15	72104389 - 72104390	15	71812049 - 71812050	863414	842648		NC_000015.10:71812049:CCCCC:CCCCCC
NM_014249.4(NR2E3):c.301C>T (p.Gln101Ter)	NR2E3	Q101*	not provided	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000661687	15	72104161	15	71811821	661687	643520		NC_000015.10:71811820:C:T
NM_014249.4(NR2E3):c.722_723TC[1] (p.Ser242fs)	NR2E3		Cone-rod dystrophy	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560471	15	72104826 - 72104827	15	71812486 - 71812487	560471	551580	rs750740765	NC_000015.10:71812485:TCTC:TC
NM_014249.4(NR2E3):c.1171_1172del (p.Phe391fs)	NR2E3	F391fs	Leber congenital amaurosis	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560470	15	72109960 - 72109961	15	71817619 - 71817620	560470	551581	rs574936510	NC_000015.10:71817618:TTTTT:TTT
NM_014249.4(NR2E3):c.200_208del (p.Cys67_Gly69del)	NR2E3		Enhanced s-cone syndrome	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000005531	15	72103899 - 72103907	15	71811559 - 71811567	5531	20570	rs1567159701	NC_000015.10:71811558:CGGCTGCAGCGGCT:CGGCT
NM_014249.4(NR2E3):c.806_807CT[1] (p.Leu270fs)	NR2E3		not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000860177	15	72105786 - 72105787	15	71813446 - 71813447	860177	842652		NC_000015.10:71813445:TCTCT:TCT
NM_014249.4(NR2E3):c.143_144delinsAGTGTGCCTCCAGTGCCTCGCTCCA (p.Arg48fs)	NR2E3		Retinitis pigmentosa 37	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000183143	15	72103847 - 72103848	15	71811507 - 71811508	183143	181279	rs730882149	NC_000015.10:71811506:GC:AGTGTGCCTCCAGTGCCTCGCTCCA
NM_014249.4(NR2E3):c.1034_1038del (p.Ala344_Leu345insTer)	NR2E3		Retinitis pigmentosa 37	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000005534	15	72106392 - 72106396	15	71814051 - 71814055	5534	20573	rs1567160967	NC_000015.10:71814050:TGCAG:
NM_000286.3(PEX12):c.625C>T (p.Gln209Ter)	PEX12	Q209*	Peroxisome biogenesis disorder 3A|Infantile Refsum's disease|Peroxisome biogenesis disorder 3A|Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555548	17	33904112	17	35577093	555548	548348	rs61752106	NC_000017.11:35577092:G:A
NM_014249.4(NR2E3):c.827_843del (p.Pro276fs)	NR2E3	P276fs	not provided	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000849239	15	72105807 - 72105823	15	71813467 - 71813483	849239	842653		NC_000015.10:71813466:CCTCTGCTGGCACCGCCC:C
NM_014249.4(NR2E3):c.1038G>C (p.Gln346His)	NR2E3	Q346H	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812355	15	72106396	15	71814055	812355	800592		NC_000015.10:71814054:G:C
NM_016123.3(IRAK4):c.877C>T (p.Gln293Ter)	IRAK4	Q293*, Q169*, Q90*	Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003839	12	44172041	12	43778238	3839	18878	rs121908002	NC_000012.12:43778237:C:T
NM_001289910.1(IDH2):c.262C>T (p.Arg88Trp)	IDH2	R140W, R88W, R10W	Myelodysplastic syndrome|Acute myeloid leukemia|Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine|Multiple myeloma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375989	15	90631935	15	90088703	375989	362868	rs267606870	NC_000015.10:90088702:G:A
NM_001289910.1(IDH2):c.359G>T (p.Arg120Met)	IDH2	R120M, R172M, R42M	Neoplasm of the large intestine|Acute myeloid leukemia|Neoplasm of brain|Brainstem glioma|Hepatocellular carcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375986	15	90631838	15	90088606	375986	362865	rs121913503	NC_000015.10:90088605:C:A
NM_144508.5(KNL1):c.5184dup (p.Ile1729fs)	KNL1		Primary autosomal recessive microcephaly 4	Pathogenic(Last reviewed: Oct 26, 2015)	criteria provided, single submitter	VCV000217515	15	40917645 - 40917646	15	40625447 - 40625448	217515	214161	rs863225127	NC_000015.10:40625447:T:TT
NM_001793.6(CDH3):c.307C>T (p.Arg103Ter)	CDH3	R103*, R48*	Retinal dystrophy	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000866071	16	68712097	16	68678194	866071	856861		NC_000016.10:68678193:C:T
NM_001793.6(CDH3):c.747C>A (p.Tyr249Ter)	CDH3	Y194*, Y249*	Hypotrichosis with juvenile macular dystrophy	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812255	16	68713757	16	68679854	812255	800604		NC_000016.10:68679853:C:A
NM_001793.6(CDH3):c.1063G>T (p.Asp355Tyr)	CDH3	D300Y, D355Y		Pathogenic(Last reviewed: Jan 18, 2017)	no assertion criteria provided	VCV000666276	16	68716271	16	68682368	666276	653833		NC_000016.10:68682367:G:T
NM_001793.6(CDH3):c.1795+1G>C	CDH3			Pathogenic(Last reviewed: Jan 18, 2017)	no assertion criteria provided	VCV000666275	16	68721640	16	68687737	666275	653832		NC_000016.10:68687736:G:C
NM_001793.6(CDH3):c.895C>T (p.Gln299Ter)	CDH3	Q299*, Q244*	not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000594037	16	68714898	16	68680995	594037	585100	rs866290802	NC_000016.10:68680994:C:T
NM_001793.6(CDH3):c.1085G>A (p.Trp362Ter)	CDH3	W362*, W307*	not provided	Pathogenic(Last reviewed: Sep 9, 2016)	criteria provided, single submitter	VCV000291181	16	68716293	16	68682390	291181	275418	rs755910254	NC_000016.10:68682389:G:A
NM_001793.6(CDH3):c.2059dup (p.Leu687fs)	CDH3		not provided	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000850589	16	68729210 - 68729211	16	68695307 - 68695308	850589	844115		NC_000016.10:68695307:CCCC:CCCCC
NC_000015.10:g.72708224_72722485del	BBS4		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812225	15	73000565 - 73014826			812225	800593		
NM_001793.6(CDH3):c.1508G>A (p.Arg503His)	CDH3	R503H, R448H		Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000017639	16	68719191	16	68685288	17639	32678	rs121434542	NC_000016.10:68685287:G:A
NM_033028.5(BBS4):c.76+1G>T	BBS4		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585186	15	72987570	15	72695229	585186	576239	rs1465437164	NC_000015.10:72695228:G:T
NM_033028.5(BBS4):c.657del (p.Lys220fs)	BBS4	K48fs, K220fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585185	15	73021971	15	72729630	585185	576241	rs1567427651	NC_000015.10:72729629:G:
NM_033028.5(BBS4):c.157-3C>G	BBS4		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585184	15	73004582	15	72712241	585184	576240	rs1567412639	NC_000015.10:72712240:C:G
NM_033028.4(BBS4):c.157-?_220+?del	BBS4		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585183					585183	576238		
NM_033028.5(BBS4):c.960T>A (p.Tyr320Ter)	BBS4	Y320*, Y297*, Y148*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000531832	15	73023991	15	72731650	531832	529619	rs770891152	NC_000015.10:72731649:T:A
NC_000015.9:g.(?_72978559)_(72978602_?)del	BBS4		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000462943			15	72686218 - 72686261	462943	464791		
NM_033028.5(BBS4):c.638T>A (p.Leu213Ter)	BBS4	L213*, L41*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jul 9, 2016)	criteria provided, single submitter	VCV000412298	15	73020331	15	72727990	412298	400330	rs1060503692	NC_000015.10:72727989:T:A
NM_033028.5(BBS4):c.513T>A (p.Tyr171Ter)	BBS4	Y171*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000412296	15	73016922	15	72724581	412296	400329	rs367882912	NC_000015.10:72724580:T:A
NM_033028.5(BBS4):c.172C>T (p.Gln58Ter)	BBS4	Q58*	Bardet-Biedl syndrome	Pathogenic	no assertion criteria provided	VCV000266089	15	73004600	15	72712259	266089	260918	rs886039802	NC_000015.10:72712258:C:T
NM_033028.5(BBS4):c.1226del (p.Ser409fs)	BBS4	S237fs, S409fs, S386fs	Bardet-Biedl syndrome	Pathogenic	no assertion criteria provided	VCV000266087	15	73028285	15	72735944	266087	260919	rs886039800	NC_000015.10:72735943:G:
NM_033028.5(BBS4):c.406-2A>G	BBS4		Bardet-Biedl syndrome 4	Pathogenic(Last reviewed: Oct 5, 2015)	no assertion criteria provided	VCV000217435	15	73015133	15	72722792	217435	214078	rs113994191	NC_000015.10:72722791:A:G
NM_033028.5(BBS4):c.406-2A>C	BBS4		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 13, 2009)	no assertion criteria provided	VCV000021730	15	73015133	15	72722792	21730	34582	rs113994191	NC_000015.10:72722791:A:C
NM_001793.6(CDH3):c.965A>T (p.Asn322Ile)	CDH3	N322I, N267I	EEM syndrome	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000017640	16	68714968	16	68681065	17640	32679	rs121434543	NC_000016.10:68681064:A:T
NM_033028.5(BBS4):c.1091C>A (p.Ala364Glu)	BBS4	A364E, A192E, A341E	Bardet-Biedl syndrome 4	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000009148	15	73027508	15	72735167	9148	24187	rs28938468	NC_000015.10:72735166:C:A
NC_000015.9:g.(?_73002021)_(73004668_?)del	BBS4		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000657391	15	73002021 - 73004668	15	72709680 - 72712327	657391	652541		
NC_000015.9:g.(?_73007612)_(73009211_?)del	BBS4		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000639863	15	73007612 - 73009211	15	72715271 - 72716870	639863	652543		
NM_033028.5(BBS4):c.341del (p.Leu114fs)	BBS4	L114fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000579105	15	73009124	15	72716783	579105	573506	rs750258633	NC_000015.10:72716782:TTTT:TTT
NM_001793.6(CDH3):c.981del (p.Met327fs)	CDH3	M272fs, M327fs	Hypotrichosis with juvenile macular dystrophy|	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000017638	16	68714984	16	68681081	17638	32677	rs724159984	NC_000016.10:68681080:G:
NM_033028.5(BBS4):c.220+1G>C	BBS4		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000021729	15	73004649	15	72712308	21729	34581	rs113994190	NC_000015.10:72712307:G:C
NM_021939.3(FKBP10):c.831dup (p.Gly278fs)	FKBP10		Short stature|Kyphosis|Recurrent fractures|Osteogenesis imperfecta type 12|Osteogenesis imperfecta, type XI|not provided|Bruck syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438659	17	39975558 - 39975559	17	41819306 - 41819307	438659	432334	rs137853883	NC_000017.11:41819306:CCCCCCC:CCCCCCCC
NM_004119.2(FLT3):c.2504A>C (p.Asp835Ala)	FLT3	D835A	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375973	13	28592641	13	28018504	375973	362852	rs121909646	NC_000013.11:28018503:T:G
NM_144508.5(KNL1):c.6045G>A (p.Met2015Ile)	KNL1	M2041I, M2015I	Primary autosomal recessive microcephaly 4	Pathogenic	criteria provided, single submitter	VCV000039707	15	40939223	15	40647025	39707	48306		NC_000015.10:40647024:G:A
NM_033028.5(BBS4):c.77-216del	BBS4		Bardet-Biedl syndrome 4|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 13, 2009)	no assertion criteria provided	VCV000009146	15	73001821	15	72709480	9146	24185	rs113994189	NC_000015.10:72709479:AAAAA:AAAA
NM_033028.5(BBS4):c.884G>C (p.Arg295Pro)	BBS4	R295P, R123P, R272P	Bardet-Biedl syndrome 4|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000009145	15	73023915	15	72731574	9145	24184	rs121434632	NC_000015.10:72731573:G:C
NM_000161.3(GCH1):c.26_27insTCT (p.Ala10_Glu11insLeu)	GCH1		GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803029	14	55369355 - 55369356	14	54902637 - 54902638	803029	791414		NC_000014.9:54902637::AGA
NM_000161.3(GCH1):c.646C>T (p.Arg216Ter)	GCH1	R216*	GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803028	14	55310842	14	54844124	803028	791413		NC_000014.9:54844123:G:A
GRCh37/hg19 14q22.2(chr14:55329585-55355031)x1	GCH1		not provided	Pathogenic(Last reviewed: Oct 18, 2017)	no assertion criteria provided	VCV000685932	14	55329585 - 55355031			685932	673524		
NM_000161.3(GCH1):c.510-1G>C	GCH1		not provided	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000449757	14	55313849	14	54847131	449757	445239	rs1555358604	NC_000014.9:54847130:C:G
NM_000161.3(GCH1):c.626+1G>T	GCH1		not provided	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000449485	14	55312485	14	54845767	449485	445238	rs1555358507	NC_000014.9:54845766:C:A
NM_000161.3(GCH1):c.159G>A (p.Trp53Ter)	GCH1	W53*	not provided	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000280517	14	55369223	14	54902505	280517	264600	rs886041708	NC_000014.9:54902504:C:T
NM_000161.3(GCH1):c.631_632del (p.Met211fs)	GCH1	M211fs	not provided	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000265173	14	55310856 - 55310857	14	54844138 - 54844139	265173	260057	rs886039379	NC_000014.9:54844137:AT:
NM_000161.3(GCH1):c.126dup (p.Glu43fs)	GCH1		Dystonia	Pathogenic	no assertion criteria provided	VCV000560371	14	55369255 - 55369256	14	54902537 - 54902538	560371	551413	rs1566687487	NC_000014.9:54902537:GGG:GGGG
NM_000161.3(GCH1):c.752G>C (p.Ter251Ser)	GCH1		not provided	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000447377	14	55310736	14	54844018	447377	441650	rs201255606	NC_000014.9:54844017:C:G
NM_000161.3(GCH1):c.662T>C (p.Met221Thr)	GCH1	M221T	Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000009281	14	55310826	14	54844108	9281	24320	rs104894434	NC_000014.9:54844107:A:G
GCH1, 1-BP DEL, 351A	GCH1		Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000009280					9280	24319		
NM_000151.4(G6PC):c.563-3C>G	G6PC		Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803397	17	41062929	17	42910912	803397	791751		NC_000017.11:42910911:C:G
NM_000151.4(G6PC):c.388_400del (p.Met130fs)	G6PC	M130fs	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Sep 5, 2018)	no assertion criteria provided	VCV000560550	17	41059587 - 41059599	17	42907570 - 42907582	560550	551628	rs1567705064	NC_000017.11:42907569:ATGGTCACATCTA:
NM_000161.3(GCH1):c.510-1G>A	GCH1		not provided	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, single submitter	VCV000447375	14	55313849	14	54847131	447375	441652	rs1555358604	NC_000014.9:54847130:C:T
NM_000161.3(GCH1):c.595C>G (p.Pro199Ala)	GCH1	P199A	Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000009292	14	55312517	14	54845799	9292	24331	rs137852633	NC_000014.9:54845798:G:C
NM_000161.3(GCH1):c.633G>A (p.Met211Ile)	GCH1	M211I	GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Apr 28, 1995)	no assertion criteria provided	VCV000009287	14	55310855	14	54844137	9287	24326	rs104894443	NC_000014.9:54844136:C:T
NM_000161.3(GCH1):c.473del (p.Pro158fs)	GCH1	P158fs	Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000848233	14	55326435	14	54859717	848233	841560		NC_000014.9:54859716:GG:G
NC_000014.9:g.(?_54859671)_(54865446_?)del	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000832851	14	55326389 - 55332164			832851	820629		
NM_000151.4(G6PC):c.209G>A (p.Trp70Ter)	G6PC	W70*	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic	criteria provided, single submitter	VCV000813495	17	41053102	17	42901085	813495	801733		NC_000017.11:42901084:G:A
NM_000161.3(GCH1):c.76del (p.Asp26fs)	GCH1	D26fs	GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000647643	14	55369306	14	54902588	647643	642518		NC_000014.9:54902587:CCC:CC
NM_000161.3(GCH1):c.1A>G (p.Met1Val)	GCH1	M1V	GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000642685	14	55369381	14	54902663	642685	642519		NC_000014.9:54902662:T:C
NM_000161.3(GCH1):c.127_130dup (p.Ala44fs)	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000641586	14	55369251 - 55369252	14	54902533 - 54902534	641586	642517		NC_000014.9:54902533:CCTC:CCTCCCTC
NM_000161.3(GCH1):c.248dup (p.Glu84fs)	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000640887	14	55369133 - 55369134	14	54902415 - 54902416	640887	642515		NC_000014.9:54902415:CCC:CCCC
NM_000161.3(GCH1):c.532A>T (p.Arg178Ter)	GCH1	R178*	GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000640160	14	55313826	14	54847108	640160	642512		NC_000014.9:54847107:T:A
NM_000161.3(GCH1):c.220_223del (p.Ala74fs)	GCH1	A74fs	Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000573159	14	55369159 - 55369162	14	54902441 - 54902444	573159	568949	rs1566687321	NC_000014.9:54902440:AGGC:
NM_000161.3(GCH1):c.186_197delinsA (p.Asp63fs)	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Nov 18, 2017)	criteria provided, single submitter	VCV000529414	14	55369185 - 55369196	14	54902467 - 54902478	529414	528685	rs1555362845	NC_000014.9:54902466:AGCTCGTTATCC:T
NM_000161.3(GCH1):c.541+1G>C	GCH1		Dystonia 5	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000465762	14	55313816	14	54847098	465762	463824	rs1555358599	NC_000014.9:54847097:C:G
NM_000161.3(GCH1):c.278dup (p.Thr94fs)	GCH1		Dystonia 5	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000465759	14	55369103 - 55369104	14	54902385 - 54902386	465759	464175	rs1555362835	NC_000014.9:54902385:TT:TTT
NM_000161.3(GCH1):c.1A>T (p.Met1Leu)	GCH1	M1L	Dystonia 5	Pathogenic(Last reviewed: Jul 2, 2016)	criteria provided, single submitter	VCV000465758	14	55369381	14	54902663	465758	464177	rs1555362907	NC_000014.9:54902662:T:A
NM_000151.4(G6PC):c.551G>T (p.Gly184Val)	G6PC	G184V, W158C	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000374125	17	41061424	17	42909407	374125	361015	rs104894569	NC_000017.11:42909406:G:T
NM_000151.4(G6PC):c.497T>G (p.Val166Gly)	G6PC	V166G, C140W	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Oct 31, 1997)	no assertion criteria provided	VCV000012010	17	41061370	17	42909353	12010	27049	rs104894571	NC_000017.11:42909352:T:G
NM_000151.4(G6PC):c.551G>A (p.Gly184Glu)	G6PC	G184E, W158*	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000012007	17	41061424	17	42909407	12007	27046	rs104894569	NC_000017.11:42909406:G:A
NM_000151.4(G6PC):c.230+4A>G	G6PC		Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000012002	17	41053127	17	42901110	12002	27041	rs587776757	NC_000017.11:42901109:A:G
GCH1, DEL	GCH1		Dystonia 5	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000009291					9291	24330		
NM_000161.3(GCH1):c.551G>A (p.Arg184His)	GCH1	R184H	GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Dec 30, 2014)	criteria provided, single submitter	VCV000009290	14	55312561	14	54845843	9290	24329	rs104894445	NC_000014.9:54845842:C:T
GCH1, IVS5, G-A, +1	GCH1		Dystonia 5	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000009289					9289	24328		
NM_000161.3(GCH1):c.142C>T (p.Gln48Ter)	GCH1	Q48*	Dystonia 5	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000009288	14	55369240	14	54902522	9288	24327	rs104894444	NC_000014.9:54902521:G:A
NM_000161.3(GCH1):c.404T>A (p.Ile135Lys)	GCH1	I135K	Dystonia 5	Pathogenic(Last reviewed: Feb 25, 1999)	no assertion criteria provided	VCV000009285	14	55332094	14	54865376	9285	24324	rs104894441	NC_000014.9:54865375:A:T
NM_000161.3(GCH1):c.586G>T (p.Ala196Ser)	GCH1	A196S	Dystonia 5	Pathogenic(Last reviewed: Mar 10, 1999)	no assertion criteria provided	VCV000009284	14	55312526	14	54845808	9284	24323	rs104894436	NC_000014.9:54845807:C:A
GCH1, IVS2, G-C, +1	GCH1		Dystonia 5	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000009279					9279	24318		
NM_000161.3(GCH1):c.431A>C (p.His144Pro)	GCH1	H144P	Dystonia 5	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000009278	14	55332067	14	54865349	9278	24317	rs104894440	NC_000014.9:54865348:T:G
NM_000161.3(GCH1):c.3G>C (p.Met1Ile)	GCH1	M1I	Dystonia 5	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000009277	14	55369379	14	54902661	9277	24316	rs104894439	NC_000014.9:54902660:C:G
GCH1, IVS2, A-G, -2	GCH1		Dystonia 5	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	VCV000009276					9276	24315		
GCH1, IVS1, A-G, -2	GCH1		Dystonia 5	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	VCV000009275					9275	24314		
GCH1, 2-BP INS	GCH1		Dystonia 5	Pathogenic(Last reviewed: Apr 28, 1995)	no assertion criteria provided	VCV000009273					9273	24312		
NM_000161.3(GCH1):c.401A>T (p.Asp134Val)	GCH1	D134V	Dystonia 5	Pathogenic(Last reviewed: Apr 28, 1995)	no assertion criteria provided	VCV000009272	14	55332097	14	54865379	9272	24311	rs104894437	NC_000014.9:54865378:T:A
NM_000161.3(GCH1):c.262C>T (p.Arg88Trp)	GCH1	R88W	Dystonia 5	Pathogenic(Last reviewed: Apr 28, 1995)	no assertion criteria provided	VCV000009271	14	55369120	14	54902402	9271	24310	rs104894433	NC_000014.9:54902401:G:A
NM_152443.3(RDH12):c.506G>A (p.Arg169Gln)	RDH12	R169Q	Leber congenital amaurosis 13|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000623219	14	68193755	14	67727038	623219	612157	rs971610277	NC_000014.9:67727037:G:A
NM_152443.3(RDH12):c.524C>T (p.Ser175Leu)	RDH12	S175L	Leber congenital amaurosis 13|Leber congenital amaurosis	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000559527	14	68193773	14	67727056	559527	550250	rs116733939	NC_000014.9:67727055:C:T
NM_001099274.3(TINF2):c.845G>A (p.Arg282His)	TINF2	R282H, R247H	Revesz syndrome|Dyskeratosis congenita, autosomal dominant, 3	Pathogenic(Last reviewed: Nov 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000005625	14	24709841	14	24240635	5625	20664	rs121918544	NC_000014.9:24240634:C:T
NM_152443.3(RDH12):c.146C>T (p.Thr49Met)	RDH12	T49M	Cone-rod degeneration|Leber congenital amaurosis 13	Pathogenic(Last reviewed: Nov 24, 2019)	criteria provided, single submitter	VCV000002049	14	68191267	14	67724550	2049	17088	rs28940314	NC_000014.9:67724549:C:T
NM_001793.6(CDH3):c.830del (p.Gly277fs)	CDH3	G222fs, G277fs	EEM syndrome|Macular dystrophy	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000017641	16	68713839	16	68679936	17641	32680	rs724159985	NC_000016.10:68679935:GG:G
NM_000151.4(G6PC):c.384C>G (p.Tyr128Ter)	G6PC	Y128*	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000841886	17	41059583	17	42907566	841886	845355		NC_000017.11:42907565:C:G
NC_000017.11:g.(?_42900800)_(42904229_?)del	G6PC		Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000831758	17	41052817 - 41056246			831758	821044		
NC_000014.8:g.(?_55332035)_(55332164_?)del	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000652965	14	55332035 - 55332164	14	54865317 - 54865446	652965	652318		
NM_000161.3(GCH1):c.509+1_509+3delinsTGTGAG	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000641360	14	55326396 - 55326398	14	54859678 - 54859680	641360	652355		NC_000014.9:54859677:TAC:CTCACA
NM_000151.4(G6PC):c.255C>A (p.Tyr85Ter)	G6PC	Y85*	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000543553	17	41055972	17	42903955	543553	531275	rs748363083	NC_000017.11:42903954:C:A
NM_000151.4(G6PC):c.258G>A (p.Trp86Ter)	G6PC	W86*	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided	Pathogenic(Last reviewed: May 28, 2017)	criteria provided, single submitter	VCV000502134	17	41055975	17	42903958	502134	493558	rs142917638	NC_000017.11:42903957:G:A
NC_000014.8:g.(?_55332025)_(55332174_?)del	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000465757	14	55332025 - 55332174	14	54865307 - 54865456	465757	463966		
NM_000151.4(G6PC):c.136del (p.Leu46fs)	G6PC	L46fs	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic/Likely pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371379	17	41053028	17	42901011	371379	358439	rs1057517227	NC_000017.11:42901010:CC:C
NM_000161.3(GCH1):c.602G>A (p.Gly201Glu)	GCH1	G201E	Dystonia 5	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000009274	14	55312510	14	54845792	9274	24313	rs104894438	NC_000014.9:54845791:C:T
GRCh37/hg19 17p12(chr17:13879079-14013128)x1	COX10		not provided	Pathogenic(Last reviewed: Dec 6, 2017)	no assertion criteria provided	VCV000688021	17	13879079 - 14013128			688021	675613		
NM_021615.5(CHST6):c.172C>T (p.Gln58Ter)	CHST6	Q58*	not provided	Pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, single submitter	VCV000497526	16	75513555	16	75479657	497526	488950	rs756036451	NC_000016.10:75479656:G:A
NM_000017.4(ACADS):c.319_321delinsTGC (p.Arg107Cys)	ACADS		not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000421618	12	121174897 - 121174899	12	120737094 - 120737096	421618	408538	rs1064795254	NC_000012.12:120737093:CGT:TGC
NM_000017.4(ACADS):c.238del (p.Leu80fs)	ACADS	L80fs	not provided	Pathogenic(Last reviewed: May 14, 2015)	criteria provided, single submitter	VCV000419056	12	121174816	12	120737013	419056	408537	rs1064793612	NC_000012.12:120737012:C:
GRCh37/hg19 17p12(chr17:14110043-14111913)x1	COX10		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253545	17	14110043 - 14111913			253545	247993		
NM_021615.5(CHST6):c.277C>A (p.Arg93Ser)	CHST6	R93S	Macular corneal dystrophy, type II	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000005079	16	75513450	16	75479552	5079	20118	rs121917826	NC_000016.10:75479551:G:T
NM_021615.5(CHST6):c.827T>C (p.Leu276Pro)	CHST6	L276P	Macular corneal dystrophy Type I	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000005078	16	75512900	16	75479002	5078	20117	rs121917824	NC_000016.10:75479001:A:G
NM_021615.5(CHST6):c.329A>G (p.Tyr110Cys)	CHST6	Y110C	Macular corneal dystrophy Type I	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000005077	16	75513398	16	75479500	5077	20116	rs72547544	NC_000016.10:75479499:T:C
NM_021615.5(CHST6):c.304T>G (p.Cys102Gly)	CHST6	C102G	Macular corneal dystrophy Type I	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000005076	16	75513423	16	75479525	5076	20115	rs121917822	NC_000016.10:75479524:A:C
CHST6, DELETION OF 5-PRIME REGION	CHST6		Macular corneal dystrophy, type II	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000005074					5074	20113		
CHST6, REPLACEMENT OF 5-PRIME REGION	CHST6		Macular corneal dystrophy, type II	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000005073					5073	20112		
NM_021615.5(CHST6):c.609C>A (p.Asp203Glu)	CHST6	D203E	Macular corneal dystrophy Type I	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000005072	16	75513118	16	75479220	5072	20111	rs28937878	NC_000016.10:75479219:G:T
NM_021615.5(CHST6):c.892C>T (p.Gln298Ter)	CHST6	Q298*	Macular corneal dystrophy Type I	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000320606	16	75512835	16	75478937	320606	344037	rs886052321	NC_000016.10:75478936:G:A
NM_001303.4(COX10):c.2T>C (p.Met1Thr)	COX10	M1T	Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000007527	17	13972924	17	14069607	7527	22566	rs387906383	NC_000017.11:14069606:T:C
NM_001303.4(COX10):c.1007A>G (p.Asp336Gly)	COX10	D336G	Leigh syndrome due to mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Oct 15, 2003)	no assertion criteria provided	VCV000007526	17	14110205	17	14206888	7526	22565	rs104894557	NC_000017.11:14206887:A:G
NM_001303.4(COX10):c.674C>T (p.Pro225Leu)	COX10	P225L	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Oct 15, 2003)	no assertion criteria provided	VCV000007524	17	14063243	17	14159926	7524	22563	rs104894556	NC_000017.11:14159925:C:T
NM_001303.4(COX10):c.587C>A (p.Thr196Lys)	COX10	T196K	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Oct 15, 2003)	no assertion criteria provided	VCV000007523	17	14005522	17	14102205	7523	22562	rs104894555	NC_000017.11:14102204:C:A
NM_001303.4(COX10):c.612C>A (p.Asn204Lys)	COX10	N204K	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000007522	17	14005547	17	14102230	7522	22561	rs104894560	NC_000017.11:14102229:C:A
NM_000017.4(ACADS):c.369C>G (p.Tyr123Ter)	ACADS	Y123*	not provided|Deficiency of butyryl-CoA dehydrogenase	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000370525	12	121175167	12	120737364	370525	358096	rs749491616	NC_000012.12:120737363:C:G
NM_000017.4(ACADS):c.988_990delinsTGT (p.Arg330Cys)	ACADS		not provided|Deficiency of butyryl-CoA dehydrogenase	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000203569	12	121176677 - 121176679	12	120738874 - 120738876	203569	200240	rs796051906	NC_000012.12:120738873:CGC:TGT
NM_000017.4(ACADS):c.1112G>T (p.Gly371Val)	ACADS	G371V, G367V	Deficiency of butyryl-CoA dehydrogenase|not provided	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000203563	12	121177124	12	120739321	203563	200246	rs796051905	NC_000012.12:120739320:G:T
NM_000017.4(ACADS):c.682_683del (p.Glu228fs)	ACADS	E224fs, E228fs	Deficiency of butyryl-CoA dehydrogenase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2014)	criteria provided, multiple submitters, no conflicts	VCV000189093	12	121176139 - 121176140	12	120738336 - 120738337	189093	187077	rs786204691	NC_000012.12:120738335:AGA:A
NM_001303.4(COX10):c.1007A>T (p.Asp336Val)	COX10	D336V	Leigh syndrome due to mitochondrial complex IV deficiency|Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000007525	17	14110205	17	14206888	7525	22564	rs104894557	NC_000017.11:14206887:A:T
NM_021615.5(CHST6):c.521A>G (p.Lys174Arg)	CHST6	K174R	Macular corneal dystrophy Type I	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000005071	16	75513206	16	75479308	5071	20110	rs28937877	NC_000016.10:75479307:T:C
NC_000014.9:g.(?_54902311)_(54902702_?)del	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000832331	14	55369029 - 55369420			832331	820630		
NM_000151.4(G6PC):c.518T>C (p.Leu173Pro)	G6PC	L173P	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000640818	17	41061391	17	42909374	640818	645915		NC_000017.11:42909373:T:C
NC_000014.8:g.(?_55369019)_(55369401_?)del	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000529416	14	55369019 - 55369401	14	54902301 - 54902683	529416	527839		
NM_000161.3(GCH1):c.344-1G>A	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000529413	14	55332155	14	54865437	529413	528680	rs1555360050	NC_000014.9:54865436:C:T
NM_000161.3(GCH1):c.344-1G>C	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000465761	14	55332155	14	54865437	465761	464169	rs1555360050	NC_000014.9:54865436:C:G
NM_000151.4(G6PC):c.150_151del (p.Trp50fs)	G6PC	W50fs	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic/Likely pathogenic(Last reviewed: Mar 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370671	17	41053043 - 41053044	17	42901026 - 42901027	370671	358440	rs1057516674	NC_000017.11:42901025:GT:
NM_014336.5(AIPL1):c.211G>T (p.Val71Phe)	AIPL1	V32F, V49F, V71F, V59F	Leber congenital amaurosis	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812219	17	6337304	17	6433984	812219	800611		NC_000017.11:6433983:C:A
NM_014336.5(AIPL1):c.215G>A (p.Trp72Ter)	AIPL1	W33*, W50*, W60*, W72*	Leber congenital amaurosis	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812218	17	6337300	17	6433980	812218	800610		NC_000017.11:6433979:C:T
NM_014336.5(AIPL1):c.815G>C (p.Arg272Pro)	AIPL1	R272P, R250P, R260P, R248P, R209P, R212P, R233P	Leber congenital amaurosis	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000635995	17	6329120	17	6425800	635995	623891		NC_000017.11:6425799:C:G
NM_014336.5(AIPL1):c.99del (p.Ile34fs)	AIPL1	I34fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812220	17	6337416	17	6434096	812220	800612		NC_000017.11:6434095:C:
NM_000286.3(PEX12):c.538C>T (p.Arg180Ter)	PEX12	R180*	Peroxisomal biogenesis disorder 3b|Infantile Refsum's disease|Peroxisome biogenesis disorder 3A|Peroxisome biogenesis disorder 3A	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007774	17	33904199	17	35577180	7774	22813	rs61752103	NC_000017.11:35577179:G:A
NM_014336.5(AIPL1):c.547G>T (p.Gly183Ter)	AIPL1	G161*, G175*, G144*, G120*, G183*, G123*, G171*	Leber congenital amaurosis 4	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000848588	17	6330296	17	6426976	848588	845918		NC_000017.11:6426975:C:A
NM_014336.5(AIPL1):c.617T>A (p.Ile206Asn)	AIPL1	I206N, I198N, I146N, I194N, I143N, I167N, I184N	not provided|Leber congenital amaurosis 4	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000065710	17	6330226	17	6426906	65710	76618	rs62637011	NC_000017.11:6426905:A:T
NM_014336.5(AIPL1):c.589G>C (p.Ala197Pro)	AIPL1	A197P, A175P, A134P, A158P, A185P, A137P, A189P	not provided|Leber congenital amaurosis 4	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000065709	17	6330254	17	6426934	65709	76617	rs62637010	NC_000017.11:6426933:C:G
NM_005905.6(SMAD9):c.127A>G (p.Lys43Glu)	SMAD9	K43E	Primary pulmonary hypertension 2	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000056969	13	37453700	13	36879563	56969	71564	rs397514715	NC_000013.11:36879562:T:C
NM_005905.6(SMAD9):c.606C>A (p.Cys202Ter)	SMAD9	C202*	Primary pulmonary hypertension 2	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000006515	13	37446859	13	36872722	6515	21554	rs121918359	NC_000013.11:36872721:G:T
NM_001329943.3(KIAA0586):c.1254-1G>C	KIAA0586		Joubert syndrome 23|Short-rib thoracic dysplasia 14 with polydactyly|Joubert syndrome 23|not provided	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204594	14	58923419	14	58456701	204594	200984	rs757350052	NC_000014.9:58456700:G:C
NM_001451.2(FOXF1):c.(?_15)_(*58_?)del	FOXF1		Idiopathic and/or familial pulmonary arterial hypertension	Pathogenic(Last reviewed: Oct 26, 2015)	criteria provided, single submitter	VCV000228348	16	86544190 - 86546749	16	86510584 - 86513143	228348	230608		
NM_033028.5(BBS4):c.1106+2T>A	BBS4		Bardet-Biedl syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280217	15	73027525	15	72735184	280217	264628	rs886041464	NC_000015.10:72735183:T:A
NM_000151.4(G6PC):c.356A>T (p.His119Leu)	G6PC	H119L	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000863144	17	41059555	17	42907538	863144	845354		NC_000017.11:42907537:A:T
NM_000151.4(G6PC):c.228G>C (p.Lys76Asn)	G6PC	K76N	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000855275	17	41053121	17	42901104	855275	845352		NC_000017.11:42901103:G:C
NM_000161.3(GCH1):c.626+1G>A	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000529415	14	55312485	14	54845767	529415	528574	rs1555358507	NC_000014.9:54845766:C:T
NM_001127217.2(SMAD9):c.880C>T (p.Arg294Ter)	SMAD9	R294*, R257*	Primary pulmonary hypertension 2|not provided	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000056970	13	37439797	13	36865660	56970	71565	rs397514716	NC_000013.11:36865659:G:A
NM_014336.5(AIPL1):c.1008_1009AG[1] (p.Glu337fs)	AIPL1		Leber congenital amaurosis 4|not provided	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000005566	17	6328924 - 6328925	17	6425604 - 6425605	5566	20605	rs62637016	NC_000017.11:6425603:CTCT:CT
NM_003321.5(TUFM):c.162del (p.Thr53_Tyr54insTer)	TUFM		Combined oxidative phosphorylation deficiency 4	Pathogenic(Last reviewed: Dec 5, 2016)	no assertion criteria provided	VCV000372183	16	28857318	16	28845997	372183	359088	rs1057518743	NC_000016.10:28845996:G:
NM_003321.5(TUFM):c.440T>A (p.Leu147His)	TUFM	L147H	Combined oxidative phosphorylation deficiency 4	Pathogenic(Last reviewed: Dec 5, 2016)	no assertion criteria provided	VCV000372182	16	28856351	16	28845030	372182	359087	rs1057518742	NC_000016.10:28845029:A:T
NC_000012.11:g.57892346A>G	MARS1	Y344C	Interstitial lung and liver disease	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000192373	12	57892346	12	57498563	192373	187251	rs766466297	NC_000012.12:57498562:A:G
NM_004990.4(MARS1):c.1568T>C (p.Ile523Thr)	MARS1	I523T	Interstitial lung and liver disease	Pathogenic(Last reviewed: Oct 8, 2013)	no assertion criteria provided	VCV000068464	12	57905819	12	57512036	68464	79356	rs201555303	NC_000012.12:57512035:T:C
NM_003321.5(TUFM):c.1016G>A (p.Arg339Gln)	TUFM	R339Q, R311Q	Combined oxidative phosphorylation deficiency 4	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000007275	16	28855329	16	28844008	7275	22314	rs121434452	NC_000016.10:28844007:C:T
NM_004990.4(MARS1):c.1814A>T (p.Asp605Val)	MARS1	D605V	Interstitial lung and liver disease|Pulmonary alveolar proteinosis	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000189365	12	57906594	12	57512811	189365	187254	rs756021768	NC_000012.12:57512810:A:T
NM_000526.5(KRT14):c.373C>T (p.Arg125Cys)	KRT14	R125C	not provided||Epidermolysis bullosa simplex	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014612	17	39742714	17	41586462	14612	29651	rs60399023	NC_000017.11:41586461:G:A
NM_014336.5(AIPL1):c.715T>C (p.Cys239Arg)	AIPL1	C239R, C176R, C179R, C200R, C217R, C227R, C215R, C231R	Leber congenital amaurosis 4|not provided	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000005567	17	6330004	17	6426684	5567	20606	rs62637012	NC_000017.11:6426683:A:G
NM_001482.3(GATM):c.778C>T (p.Arg260Ter)	GATM	R260*, R131*	not provided	Pathogenic(Last reviewed: Sep 24, 2012)	criteria provided, single submitter	VCV000205617	15	45658604	15	45366406	205617	202851	rs775933965	NC_000015.10:45366405:G:A
NM_004990.4(MARS1):c.2398C>A (p.Pro800Thr)	MARS1	P800T	Charcot-Marie-Tooth disease, axonal, type 2u|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 30, 2015)	no assertion criteria provided	VCV000187857	12	57909709	12	57515926	187857	185749	rs781249411	NC_000012.12:57515925:C:A
NM_018139.2(DNAAF2):c.1203dup (p.Thr402fs)	DNAAF2		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000650880	14	50100664 - 50100665	14	49633946 - 49633947	650880	642461		NC_000014.9:49633946:A:AA
NM_001482.3(GATM):c.216G>A (p.Trp72Ter)	GATM	W72*	Arginine:glycine amidinotransferase deficiency	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000572733	15	45668871	15	45376673	572733	573320	rs1566842679	NC_000015.10:45376672:C:T
NM_018139.2(DNAAF2):c.484C>T (p.Gln162Ter)	DNAAF2	Q162*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000525367	14	50101384	14	49634666	525367	528170	rs1555328087	NC_000014.9:49634665:G:A
NM_018139.2(DNAAF2):c.1433dup (p.Ser479fs)	DNAAF2		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000525361	14	50100434 - 50100435	14	49633716 - 49633717	525361	528521	rs1555327928	NC_000014.9:49633716:CCCC:CCCCC
NM_018139.2(DNAAF2):c.804C>G (p.Tyr268Ter)	DNAAF2	Y268*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000454914	14	50101064	14	49634346	454914	463773	rs1555328022	NC_000014.9:49634345:G:C
NM_018139.2(DNAAF2):c.696_702del (p.Ala233fs)	DNAAF2	A233fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000454905	14	50101166 - 50101172	14	49634448 - 49634454	454905	464265	rs1555328047	NC_000014.9:49634447:GGGGGCTG:G
NM_018139.2(DNAAF2):c.226_232dup (p.Leu78fs)	DNAAF2		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000454904	14	50101635 - 50101636	14	49634917 - 49634918	454904	464098	rs1555328130	NC_000014.9:49634917:GCACATGGC:GCACATGGCACATGGC
NM_018139.2(DNAAF2):c.388G>T (p.Glu130Ter)	DNAAF2	E130*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000411173	14	50101480	14	49634762	411173	399667	rs752795172	NC_000014.9:49634761:C:A
NM_018139.2(DNAAF2):c.1156_1159dup (p.Glu387fs)	DNAAF2		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 24, 2016)	criteria provided, single submitter	VCV000411172	14	50100708 - 50100709	14	49633990 - 49633991	411172	400405	rs902156961	NC_000014.9:49633990:CCCCC:CCCCCCCCC
NM_018139.2(DNAAF2):c.31del (p.Glu11fs)	DNAAF2	E11fs	Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000208993	14	50101837	14	49635119	208993	205562	rs797045146	NC_000014.9:49635118:CC:C
NM_001482.3(GATM):c.608A>C (p.Tyr203Ser)	GATM	Y203S, Y74S	Arginine:glycine amidinotransferase deficiency	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000055921	15	45660335	15	45368137	55921	70563	rs397514709	NC_000015.10:45368136:T:G
NM_018139.2(DNAAF2):c.822_828AGCCCCG[3] (p.Val279fs)	DNAAF2		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000454915	14	50101032 - 50101033	14	49634314 - 49634315	454915	463247	rs777108430	NC_000014.9:49634314:CGGGGCTCGGGGCT:CGGGGCTCGGGGCTCGGGGCT
NM_001482.3(GATM):c.505C>T (p.Arg169Ter)	GATM	R169*, R40*	Arginine:glycine amidinotransferase deficiency	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000055919	15	45660438	15	45368240	55919	70561	rs397514708	NC_000015.10:45368239:G:A
NM_001482.3(GATM):c.1111dup (p.Met371fs)	GATM		Arginine:glycine amidinotransferase deficiency	Pathogenic(Last reviewed: Dec 10, 2015)	no assertion criteria provided	VCV000055918	15	45656145 - 45656146	15	45363947 - 45363948	55918	70560	rs397515542	NC_000015.10:45363947:T:TT
NM_001482.3(GATM):c.484+1G>T	GATM		Arginine:glycine amidinotransferase deficiency	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000021299	15	45661523	15	45369325	21299	34151	rs80338738	NC_000015.10:45369324:C:A
NM_018139.2(DNAAF2):c.1199_1214dupACGATACCTGCGTGGC (p.Gly406Argfs)	DNAAF2		Kartagener syndrome|Ciliary dyskinesia, primary, 10	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000208847	14	50100653 - 50100654	14	49633935 - 49633936	208847	205407	rs397515341	NC_000014.9:49633935:GCCACGCAGGTATCGTG:GCCACGCAGGTATCGTGCCACGCAGGTATCGTG
NM_018139.2(DNAAF2):c.23C>A (p.Ser8Ter)	DNAAF2	S8*	Ciliary dyskinesia, primary, 10|Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000000529	14	50101845	14	49635127	529	15568	rs137853191	NC_000014.9:49635126:G:T
NM_000151.4(G6PC):c.262del (p.Val88fs)	G6PC	V88fs	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000643470	17	41055977	17	42903960	643470	645913		NC_000017.11:42903959:GGG:GG
NM_000151.4(G6PC):c.969C>A (p.Tyr323Ter)	G6PC	Y323*	not provided|Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000188777	17	41063338	17	42911321	188777	186978	rs780226142	NC_000017.11:42911320:C:A
NM_006612.6(KIF1C):c.2478del (p.Ala828fs)	KIF1C	A828fs	Ataxia, spastic, 2, autosomal recessive	Pathogenic(Last reviewed: Aug 25, 2016)	no assertion criteria provided	VCV000265862	17	4925854	17	5022559	265862	260578	rs1131690773	NC_000017.11:5022558:A:
NC_000017.10:g.(4907452_4914761)_(4918508_4926045)del	KIF1C		Ataxia, spastic, 2, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000101069	17	4907452 - 4926045			101069	106834		
NM_006612.6(KIF1C):c.2191C>T (p.Arg731Ter)	KIF1C	R731*	Ataxia, spastic, 2, autosomal recessive	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000101066	17	4925567	17	5022272	101066	106831	rs587777197	NC_000017.11:5022271:C:T
NM_000017.4(ACADS):c.1031A>G (p.Glu344Gly)	ACADS	E344G, E340G	Deficiency of butyryl-CoA dehydrogenase	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030612	12	121176944	12	120739141	30612	39569	rs387906950	NC_000012.12:120739140:A:G
NM_014252.4(SLC25A15):c.535C>T (p.Arg179Ter)	SLC25A15	R179*	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000005994	13	41381512	13	40807376	5994	21033	rs104894429	NC_000013.11:40807375:C:T
NM_001482.3(GATM):c.446G>A (p.Trp149Ter)	GATM	W149*, W20*	Arginine:glycine amidinotransferase deficiency	Pathogenic(Last reviewed: Aug 18, 2011)	no assertion criteria provided	VCV000007302	15	45661562	15	45369364	7302	22341	rs80338737	NC_000015.10:45369363:C:T
NM_001127713.1(ATL1):c.1204T>C (p.Phe402Leu)	ATL1	F402L	not provided	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000452665	14	51094833	14	50628115	452665	445236	rs1555365850	NC_000014.9:50628114:T:C
NM_015915.5(ATL1):c.1223T>C (p.Met408Thr)	ATL1	M408T	Hereditary spastic paraplegia 3A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803026	14	51094852	14	50628134	803026	791411		NC_000014.9:50628133:T:C
NM_015915.5(ATL1):c.488T>C (p.Val163Ala)	ATL1	V163A	Hereditary spastic paraplegia 3A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803025	14	51058323	14	50591605	803025	791410		NC_000014.9:50591604:T:C
NM_015915.5(ATL1):c.596T>A (p.Leu199Gln)	ATL1	L199Q	Hereditary spastic paraplegia 3A	Pathogenic(Last reviewed: Feb 20, 2014)	no assertion criteria provided	VCV000208489	14	51062316	14	50595598	208489	205019	rs797045004	NC_000014.9:50595597:T:A
NM_001127713.1(ATL1):c.1519dupA (Ile507Asnfs)	ATL1		Hereditary spastic paraplegia 3A	Pathogenic(Last reviewed: Sep 21, 2010)	no assertion criteria provided	VCV000021528	14	51095146 - 51095147	14	50628428 - 50628429	21528	34380	rs863223314	NC_000014.9:50628428:AA:AAA
NC_000014.9:g.(?_50560256)_(50632349_?)del	ATL1		Hereditary spastic paraplegia 3A	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000831440	14	51026974 - 51099067			831440	820625		
NM_001127713.1(ATL1):c.1306_1308del (p.Asn436del)	ATL1	N436del	Hereditary spastic paraplegia 3A	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000004354	14	51094935 - 51094937	14	50628217 - 50628219	4354	19393		NC_000014.9:50628216:AAT:
ATL1, 1-BP INS, 1688A	ATL1		Hereditary spastic paraplegia 3A	Pathogenic(Last reviewed: Dec 24, 2002)	no assertion criteria provided	VCV000004350					4350	19389		
NM_001127713.1(ATL1):c.776C>A (p.Ser259Tyr)	ATL1	S259Y	Hereditary spastic paraplegia 3A	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004347	14	51081143	14	50614425	4347	19386	rs119476047	NC_000014.9:50614424:C:A
NM_001127713.1(ATL1):c.470T>G (p.Leu157Trp)	ATL1	L157W	Hereditary spastic paraplegia 3A	Pathogenic(Last reviewed: Sep 21, 2010)	no assertion criteria provided	VCV000004353	14	51058305	14	50591587	4353	19392	rs119476051	NC_000014.9:50591586:T:G
NM_001127713.1(ATL1):c.773A>G (p.His258Arg)	ATL1	H258R	Hereditary spastic paraplegia 3A	Pathogenic(Last reviewed: Sep 21, 2010)	no assertion criteria provided	VCV000004348	14	51081140	14	50614422	4348	19387	rs119476048	NC_000014.9:50614421:A:G
NM_001127713.1(ATL1):c.1160T>C (p.Leu387Ser)	ATL1	L387S	Hereditary spastic paraplegia 3A	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000659129	14	51094789	14	50628071	659129	642490		NC_000014.9:50628070:T:C
NM_000293.3(PHKB):c.2457del (p.Glu820fs)	PHKB	E813fs, E820fs	not provided	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000817385	16	47703154	16	47669243	817385	805884		NC_000016.10:47669242:AA:A
NM_000293.3(PHKB):c.2326C>T (p.Gln776Ter)	PHKB	Q776*, Q769*	not provided	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000620526	16	47697635	16	47663724	620526	611824	rs149244943	NC_000016.10:47663723:C:T
NM_000293.3(PHKB):c.307C>T (p.Arg103Ter)	PHKB	R103*, R96*	not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000426940	16	47536903	16	47502992	426940	415494	rs145166656	NC_000016.10:47502991:C:T
NM_014249.4(NR2E3):c.310C>T (p.Arg104Trp)	NR2E3	R104W	not provided	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000846973	15	72104170	15	71811830	846973	842646		NC_000015.10:71811829:C:T
NC_000016.9:g.(?_47703106)_(47703348_?)del	PHKB		Glycogen storage disease IXb	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000583761	16	47703106 - 47703348	16	47669195 - 47669437	583761	567507		
NM_000293.3(PHKB):c.1257T>A (p.Tyr419Ter)	PHKB	Y418*, Y419*, Y412*	Glycogen storage disease IXb	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000013620	16	47630336	16	47596425	13620	28659	rs121918021	NC_000016.10:47596424:T:A
NM_000293.3(PHKB):c.306-2A>G	PHKB		Glycogen storage disease IXb	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000013619	16	47536900	16	47502989	13619	28658	rs797044442	NC_000016.10:47502988:A:G
PHKB, 1-BP INS	PHKB		Glycogen storage disease IXb	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000013617					13617	28656		
NM_004960.4(FUS):c.1022_1023del (p.Ser340_Phe341insTer)	FUS		not provided	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000817574	16	31201069 - 31201070	16	31189748 - 31189749	817574	805882		NC_000016.10:31189747:TTTT:TT
NM_004960.3(FUS):c.1510_1514dup (p.Phe506fs)	FUS		not provided	Pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	VCV000280602	16	31202399 - 31202400	16	31191078 - 31191079	280602	264702	rs886041776	NC_000016.10:31191078:GGTGG:GGTGGGGTGG
NM_004960.3(FUS):c.1504_1505del (p.Asp502fs)	FUS	D501fs, D502fs, D498fs	not provided	Pathogenic(Last reviewed: Mar 6, 2016)	criteria provided, single submitter	VCV000280356	16	31202394 - 31202395	16	31191073 - 31191074	280356	264941	rs886041577	NC_000016.10:31191072:GA:
NM_004960.3(FUS):c.1572G>C (p.Arg524Ser)	FUS	R524S, R520S, R523S	not provided	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000280109	16	31202750	16	31191429	280109	264704	rs886041389	NC_000016.10:31191428:G:C
NM_004960.3(FUS):c.868C>T (p.Gln290Ter)	FUS	Q290*, Q286*, Q289*	Tremor, hereditary essential, 4	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037070	16	31200479	16	31189158	37070	45746	rs387907274	NC_000016.10:31189157:C:T
NM_004960.3(FUS):c.1551C>G (p.His517Gln)	FUS	H517Q, H513Q, H516Q	Amyotrophic lateral sclerosis 6, autosomal recessive	Pathogenic(Last reviewed: Feb 27, 2009)	no assertion criteria provided	VCV000016221	16	31202729	16	31191408	16221	31260	rs121909667	NC_000016.10:31191407:C:G
NM_001170634.1(FUS):c.1504_1505AG[3] (p.Gly503fs)	FUS		Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000665141	16	31202396 - 31202397	16	31191075 - 31191076	665141	644622		NC_000016.10:31191075:AGAG:AGAGAG
NM_004960.3(FUS):c.616G>A (p.Gly206Ser)	FUS	G206S, G205S, G202S	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Aug 31, 2010)	no assertion criteria provided	VCV000029708	16	31196352	16	31185031	29708	38663	rs387906628	NC_000016.10:31185030:G:A
NM_004960.3(FUS):c.1570A>T (p.Arg524Trp)	FUS	R524W, R520W, R523W	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000016228	16	31202748	16	31191427	16228	31267	rs267606833	NC_000016.10:31191426:A:T
NM_004960.3(FUS):c.1553G>A (p.Arg518Lys)	FUS	R518K, R514K, R517K	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Feb 27, 2009)	no assertion criteria provided	VCV000016223	16	31202731	16	31191410	16223	31262	rs121909669	NC_000016.10:31191409:G:A
NM_004960.3(FUS):c.1520G>A (p.Gly507Asp)	FUS	G507D, G506D, G503D	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000016226	16	31202410	16	31191089	16226	31265	rs267606831	NC_000016.10:31191088:G:A
NM_004960.3(FUS):c.1562G>A (p.Arg521His)	FUS	R521H, R517H, R520H	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Feb 27, 2009)	no assertion criteria provided	VCV000016225	16	31202740	16	31191419	16225	31264	rs121909671	NC_000016.10:31191418:G:A
NM_000161.3(GCH1):c.541+1G>T	GCH1		not provided|GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000489338	14	55313816	14	54847098	489338	482050	rs1555358599	NC_000014.9:54847097:C:A
NM_000151.4(G6PC):c.161A>C (p.Gln54Pro)	G6PC	Q54P	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371101	17	41053054	17	42901037	371101	358441	rs1057517008	NC_000017.11:42901036:A:C
NM_000151.4(G6PC):c.1022T>A (p.Ile341Asn)	G6PC	I341D, I341N	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000012009	17	41063391	17	42911374	12009	38395	rs387906505	NC_000017.11:42911373:T:A
NM_004960.3(FUS):c.1483C>T (p.Arg495Ter)	FUS	R495*, R494*, R491*	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Aug 31, 2010)	no assertion criteria provided	VCV000029707	16	31202373	16	31191052	29707	38662	rs387906627	NC_000016.10:31191051:C:T
NM_000293.3(PHKB):c.1969C>T (p.Gln657Ter)	PHKB	Q656*, Q657*, Q650*	Glycogen storage disease IXb	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013618	16	47684830	16	47650919	13618	28657	rs34667348	NC_000016.10:47650918:C:T
NM_001127713.1(ATL1):c.1246C>T (p.Arg416Cys)	ATL1	R416C	Hereditary spastic paraplegia 3A	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000030582	14	51094875	14	50628157	30582	39539	rs387906941	NC_000014.9:50628156:C:T
NM_004960.3(FUS):c.1394-2del	FUS		Amyotrophic lateral sclerosis type 6|not provided	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447355	16	31202282	16	31190961	447355	441905	rs1555509569	NC_000016.10:31190960:A:
NM_004960.3(FUS):c.646C>T (p.Arg216Cys)	FUS	R216C, R212C, R215C	Tremor, hereditary essential, 4|Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000016227	16	31196382	16	31185061	16227	31266	rs267606832	NC_000016.10:31185060:C:T
NM_014336.5(AIPL1):c.265T>C (p.Cys89Arg)	AIPL1	C89R, C67R, C77R, C50R	Leber congenital amaurosis 4	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000574505	17	6337250	17	6433930	574505	569528	rs1264794214	NC_000017.11:6433929:A:G
NM_020988.3(GNAO1):c.133G>C (p.Gly45Arg)	GNAO1	G45R	Inborn genetic diseases	Pathogenic	criteria provided, single submitter	VCV000225047	16	56226500	16	56192588	225047	226954	rs869312939	NC_000016.10:56192587:G:C
NM_152443.3(RDH12):c.451C>G (p.His151Asp)	RDH12	H151D	Leber congenital amaurosis 13|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000002054	14	68193700	14	67726983	2054	17093	rs104894475	NC_000014.9:67726982:C:G
NM_152443.3(RDH12):c.379G>T (p.Gly127Ter)	RDH12	G127*	Retinitis pigmentosa|Leber congenital amaurosis 13	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000002051	14	68192803	14	67726086	2051	17090	rs104894474	NC_000014.9:67726085:G:T
NM_152443.3(RDH12):c.184C>T (p.Arg62Ter)	RDH12	R62*	Retinal dystrophy|Leber congenital amaurosis 13	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002050	14	68191305	14	67724588	2050	17089	rs104894471	NC_000014.9:67724587:C:T
NM_000286.3(PEX12):c.268_271del (p.Lys90fs)	PEX12	K90fs	Peroxisome biogenesis disorders, Zellweger syndrome spectrum|not provided|Peroxisome biogenesis disorder 3A|Peroxisome biogenesis disorder 3A|Infantile Refsum's disease	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000501646	17	33904466 - 33904469	17	35577447 - 35577450	501646	493070	rs61752100	NC_000017.11:35577446:TCTTT:T
NM_005682.7(ADGRG1):c.811C>T (p.Arg271Ter)	ADGRG1	R271*, R101*, R96*, R219*, R276*	not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000620113	16	57689353	16	57655441	620113	611827	rs768441855	NC_000016.10:57655440:C:T
NM_005682.7(ADGRG1):c.235C>T (p.Arg79Ter)	ADGRG1	R79*, R84*, R27*	not provided	Pathogenic(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	VCV000430049	16	57685282	16	57651370	430049	422101	rs780718243	NC_000016.10:57651369:C:T
NM_005682.7(ADGRG1):c.367C>T (p.Gln123Ter)	ADGRG1	Q123*, Q71*, Q128*	not provided	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000381530	16	57685414	16	57651502	381530	375227	rs1047016803	NC_000016.10:57651501:C:T
NM_201525.4(ADGRG1):c.1656C>A (p.Tyr552Ter)	ADGRG1	Y551*, Y558*, Y383*, Y388*, Y557*, Y377*, Y552*, Y500*	not provided	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000859444	16	57694780	16	57660868	859444	844042		NC_000016.10:57660867:C:A
NM_201525.4(ADGRG1):c.1473del (p.Tyr492fs)	ADGRG1	Y498fs, Y317fs, Y328fs, Y440fs, Y491fs, Y497fs, Y492fs, Y323fs	not provided	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000835987	16	57693508	16	57659596	835987	844041		NC_000016.10:57659595:GGGG:GGG
NC_000016.10:g.(?_57650278)_(57663592_?)del	ADGRG1		not provided	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000831304	16	57684190 - 57697504			831304	820843		
NM_005682.7(ADGRG1):c.407T>A (p.Leu136Ter)	ADGRG1	L141*, L84*, L136*	not provided	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000662811	16	57685454	16	57651542	662811	644794		NC_000016.10:57651541:T:A
NM_005682.7(ADGRG1):c.59del (p.Val20fs)	ADGRG1	V20fs	not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000639515	16	57684258	16	57650346	639515	644793		NC_000016.10:57650345:T:
NM_201525.4(ADGRG1):c.898C>T (p.Gln300Ter)	ADGRG1	Q300*, Q130*, Q305*, Q125*, Q248*	Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Sep 26, 2018)	no assertion criteria provided	VCV000617503	16	57689440	16	57655528	617503	608863	rs1567782714	NC_000016.10:57655527:C:T
NM_201525.4(ADGRG1):c.1583dup (p.Ala529fs)	ADGRG1		Global developmental delay|Generalized weakness of limb muscles|Pachygyria|Intellectual disability, moderate|Generalized seizures|Strabismus|Visual impairment	Pathogenic(Last reviewed: Apr 30, 2017)	no assertion criteria provided	VCV000544681	16	57694706 - 57694707	16	57660794 - 57660795	544681	535226	rs1567815105	NC_000016.10:57660794:T:TT
NM_031427.4(DNAL1):c.486G>A (p.Trp162Ter)	DNAL1	W162*, W123*	Ciliary dyskinesia, primary, 16	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000406527	14	74156172	14	73689469	406527	400253	rs372572996	NC_000014.9:73689468:G:A
NM_201525.4(ADGRG1):c.1216del (p.Leu406fs)	ADGRG1	L231fs, L354fs, L411fs, L236fs, L405fs, L406fs	Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211093	16	57691332	16	57657420	211093	208293	rs797045600	NC_000016.10:57657419:CC:C
NM_201525.4(ADGRG1):c.620+1G>A	ADGRG1		Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158634	16	57687248	16	57653336	158634	169281	rs587783660	NC_000016.10:57653335:G:A
NM_201525.4(ADGRG1):c.265C>T (p.His89Tyr)	ADGRG1	H89Y, H37Y, H94Y	Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158628	16	57685312	16	57651400	158628	169275	rs587783658	NC_000016.10:57651399:C:T
NM_201525.4(ADGRG1):c.1952G>A (p.Trp651Ter)	ADGRG1	W657*, W487*, W650*, W656*, W482*, W476*, W599*, W651*	Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Feb 17, 2014)	criteria provided, single submitter	VCV000158627	16	57697382	16	57663470	158627	169303	rs587783657	NC_000016.10:57663469:G:A
NM_201525.4(ADGRG1):c.1515T>G (p.Tyr505Ter)	ADGRG1	Y511*, Y336*, Y341*, Y453*, Y510*, Y330*, Y504*, Y505*	Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158621	16	57693553	16	57659641	158621	169297	rs587783655	NC_000016.10:57659640:T:G
NM_201525.4(ADGRG1):c.1442T>C (p.Leu481Pro)	ADGRG1	L487P, L429P, L480P, L486P, L312P, L306P, L317P, L481P	Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158619	16	57693480	16	57659568	158619	169295	rs587783653	NC_000016.10:57659567:T:C
NM_201525.4(ADGRG1):c.-36+10587_-36+10601del	ADGRG1		Polymicrogyria, bilateral perisylvian, autosomal recessive	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000127079	16	57673286 - 57673300	16	57639374 - 57639388	127079	132590	rs587777312	NC_000016.10:57639373:CAACGGTTGCCAGGGCAACGGTTGCCAGGG:CAACGGTTGCCAGGG
NM_201525.4(ADGRG1):c.263A>G (p.Tyr88Cys)	ADGRG1	Y88C, Y93C, Y36C	Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Mar 26, 2004)	no assertion criteria provided	VCV000005833	16	57685310	16	57651398	5833	20872	rs121908466	NC_000016.10:57651397:A:G
NM_201525.4(ADGRG1):c.1036T>A (p.Cys346Ser)	ADGRG1	C346S, C345S, C351S, C171S, C176S, C294S	Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Mar 26, 2004)	no assertion criteria provided	VCV000005830	16	57690156	16	57656244	5830	20869	rs121908463	NC_000016.10:57656243:T:A
NM_201525.4(ADGRG1):c.112C>T (p.Arg38Trp)	ADGRG1	R38W, R43W	Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Mar 26, 2004)	no assertion criteria provided	VCV000005829	16	57685159	16	57651247	5829	20868	rs121908462	NC_000016.10:57651246:C:T
NM_201525.4(ADGRG1):c.621-1G>C	ADGRG1		Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Mar 26, 2004)	no assertion criteria provided	VCV000005827	16	57687897	16	57653985	5827	20866	rs587776624	NC_000016.10:57653984:G:C
NM_201525.4(ADGRG1):c.1167+3G>C	ADGRG1		Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Mar 26, 2004)	no assertion criteria provided	VCV000005826	16	57690532	16	57656620	5826	20865	rs587776623	NC_000016.10:57656619:G:C
NM_004448.3(ERBB2):c.2333_2334insGCTCCCCAG (p.Ser779_Pro780insLeuProSer)	ERBB2		Neoplasm of the breast	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375993	17	37881003 - 37881004	17	39724750 - 39724751	375993	362872	rs1057519737	NC_000017.11:39724750:G:GGCTCCCCAG
NM_004448.3(ERBB2):c.2264_2278del (p.Leu755_Thr759del)	ERBB2		Neoplasm of the breast	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375990	17	37880219 - 37880233	17	39723966 - 39723980	375990	362869	rs1131692241	NC_000017.11:39723965:TTGAGGGAAAACACAT:T
NC_000014.8:g.(?_74138225)_(74138320_?)del	DNAL1		Ciliary dyskinesia, primary, 16	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000662859	14	74138225 - 74138320	14	73671522 - 73671617	662859	652875		
NM_031427.4(DNAL1):c.384del (p.Asp129fs)	DNAL1	D90fs, D129fs	Ciliary dyskinesia, primary, 16	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000406536	14	74154078	14	73687375	406536	399716	rs1060501178	NC_000014.9:73687374:AAAA:AAA
NM_201525.4(ADGRG1):c.671del (p.Asp224fs)	ADGRG1	D172fs, D54fs, D224fs, D229fs, D49fs	not provided	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372729	16	57687948	16	57654036	372729	360291	rs1057517949	NC_000016.10:57654035:A:
NM_201525.4(ADGRG1):c.10C>T (p.Gln4Ter)	ADGRG1	Q4*	Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Apr 17, 2014)	criteria provided, single submitter	VCV000189231	16	57684209	16	57650297	189231	187126	rs786204777	NC_000016.10:57650296:C:T
NM_001173464.2(KIF21A):c.2860C>T (p.Arg954Trp)	KIF21A	R954W, R941W, R918W	Fibrosis of extraocular muscles, congenital, 3b|Fibrosis of extraocular muscles, congenital, 1|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002436	12	39726207	12	39332405	2436	17475	rs121912585	NC_000012.12:39332404:G:A
NM_201525.4(ADGRG1):c.944_945dup (p.Val316fs)	ADGRG1		Polymicrogyria, bilateral frontoparietal|not provided	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000211096	16	57689830 - 57689831	16	57655918 - 57655919	211096	208292	rs797045602	NC_000016.10:57655918:TT:TTTT
NM_201525.4(ADGRG1):c.272G>C (p.Cys91Ser)	ADGRG1	C91S, C39S, C96S	not provided|Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Sep 13, 2016)	criteria provided, single submitter	VCV000005832	16	57685319	16	57651407	5832	20871	rs121908465	NC_000016.10:57651406:G:C
NM_001127713.1(ATL1):c.1065C>A (p.Asn355Lys)	ATL1	N355K	Hereditary sensory neuropathy type 1D|Charcot-Marie-Tooth disease|Penetrating foot ulcers|Distal lower limb muscle weakness|Osteomyelitis leading to amputation due to slow healing fractures|Distal sensory impairment	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000030579	14	51089912	14	50623194	30579	39536	rs1555365597	NC_000014.9:50623193:C:A
NM_031427.4(DNAL1):c.449A>G (p.Asn150Ser)	DNAL1	N150S, N111S	Ciliary dyskinesia, primary, 16|Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000030816	14	74156135	14	73689432	30816	39773	rs387907021	NC_000014.9:73689431:A:G
NM_000161.3(GCH1):c.323G>A (p.Gly108Asp)	GCH1	G108D	GTP cyclohydrolase I deficiency|Dystonia 5|Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000009282	14	55369059	14	54902341	9282	24321	rs104894435	NC_000014.9:54902340:C:T
NM_012213.3(MLYCD):c.946C>T (p.Gln316Ter)	MLYCD	Q316*	not provided	Pathogenic(Last reviewed: Jun 1, 2015)	criteria provided, single submitter	VCV000379914	16	83945970	16	83912365	379914	377826	rs962135951	NC_000016.10:83912364:C:T
NM_001128159.3(VPS53):c.1556+5G>A	VPS53		Pontocerebellar hypoplasia, type 2e	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000139445	17	465738	17	562498	139445	143137	rs587777466	NC_000017.11:562497:C:T
NM_012213.3(MLYCD):c.680_685dup (p.Arg229_Arg230insLeuLys)	MLYCD		not provided	Pathogenic(Last reviewed: Jan 21, 2013)	no assertion criteria provided	VCV000095504	16	83941768 - 83941769	16	83908163 - 83908164	95504	101403	rs398124254	NC_000016.10:83908163:TGAAGC:TGAAGCTGAAGC
NM_012213.3(MLYCD):c.1064_1065del (p.Phe355fs)	MLYCD	F355fs	Deficiency of malonyl-CoA decarboxylase	Pathogenic(Last reviewed: Aug 27, 1999)	no assertion criteria provided	VCV000004058	16	83948675 - 83948676	16	83915070 - 83915071	4058	19097	rs1567636915	NC_000016.10:83915069:TTT:T
NM_012213.3(MLYCD):c.640_641+2del	MLYCD		Deficiency of malonyl-CoA decarboxylase	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000004057	16	83940700 - 83940703	16	83907095 - 83907098	4057	19096	rs1294168838	NC_000016.10:83907094:AGTGAGT:AGT
NC_000016.9:g.(?_83932730)_(83949114_?)del	MLYCD		Deficiency of malonyl-CoA decarboxylase	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000584161	16	83932730 - 83949114	16	83899125 - 83915509	584161	569400		
MLYCD, 25-BP DEL, NT84	MLYCD		Deficiency of malonyl-CoA decarboxylase	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000004061					4061	19100		
NM_012213.3(MLYCD):c.119T>C (p.Met40Thr)	MLYCD	M40T	Deficiency of malonyl-CoA decarboxylase	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000004060	16	83932868	16	83899263	4060	19099	rs28937908	NC_000016.10:83899262:T:C
NM_012213.3(MLYCD):c.949-14A>G	MLYCD		Deficiency of malonyl-CoA decarboxylase	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000004056	16	83948547	16	83914942	4056	19095	rs761146008	NC_000016.10:83914941:A:G
NM_014249.4(NR2E3):c.767C>A (p.Ala256Glu)	NR2E3	A256E	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000438229	15	72105748	15	71813408	438229	431787	rs377257254	NC_000015.10:71813407:C:A
NM_133443.4(GPT2):c.70C>T (p.Gln24Ter)	GPT2	Q24*	Mental retardation, autosomal recessive 49|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000522105	16	46918697	16	46884785	522105	512212	rs1437184398	NC_000016.10:46884784:C:T
NM_004960.3(FUS):c.1561C>T (p.Arg521Cys)	FUS	R521C, R517C, R520C	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Aug 31, 2010)	no assertion criteria provided	VCV000016224	16	31202739	16	31191418	16224	31263	rs121909668	NC_000016.10:31191417:C:T
NM_001128159.3(VPS53):c.2084A>G (p.Gln695Arg)	VPS53	Q695R, Q497R, Q666R	Pontocerebellar hypoplasia, type 2e	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000139444	17	436083	17	532843	139444	143136	rs587777465	NC_000017.11:532842:T:C
NM_000017.4(ACADS):c.164C>T (p.Pro55Leu)	ACADS	P55L	Deficiency of butyryl-CoA dehydrogenase	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030611	12	121164946	12	120727143	30611	39568	rs147442301	NC_000012.12:120727142:C:T
NM_000017.4(ACADS):c.307_309GAG[1] (p.Glu104del)	ACADS	E104del	not provided|Deficiency of butyryl-CoA dehydrogenase	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000003833	12	121174884 - 121174886	12	120737081 - 120737083	3833	18872	rs387906308	NC_000012.12:120737080:GGAGGAG:GGAG
NM_012213.3(MLYCD):c.560C>G (p.Ser187Ter)	MLYCD	S148*, S187*	Deficiency of malonyl-CoA decarboxylase|not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000004055	16	83940623	16	83907018	4055	19094	rs104894528	NC_000016.10:83907017:C:G
NM_152641.4(ARID2):c.3442_3445del (p.Leu1148fs)	ARID2	L1148fs	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000521536	12	46245346 - 46245349	12	45851563 - 45851566	521536	511993	rs1555155263	NC_000012.12:45851562:ACTTAC:AC
NM_031427.4(DNAL1):c.224_230del (p.Ile74_Leu75insTer)	DNAL1		Ciliary dyskinesia, primary, 16|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228252	14	74138259 - 74138265	14	73671556 - 73671562	228252	230536	rs876657637	NC_000014.9:73671555:TTATCTTT:T
NM_001163673.1(WDR81):c.1059_1060del (p.Gly354fs)	WDR81	G1557fs, G330fs, G354fs, G506fs	Microlissencephaly	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000635849	17	1636999 - 1637000	17	1733705 - 1733706	635849	623663		NC_000017.11:1733704:AG:
NM_001163673.1(WDR81):c.59-1864del	WDR81	T1186fs, T135fs	not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000423034	17	1631810	17	1728516	423034	409843	rs1064796183	NC_000017.11:1728515:C:
NM_001163673.1(WDR81):c.59-3857C>T	WDR81	Q522*	not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000392796	17	1629817	17	1726523	392796	375966	rs1057524638	NC_000017.11:1726522:C:T
NM_001163673.1(WDR81):c.59-2854C>T	WDR81	P856L	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000031611	17	1630820	17	1727526	31611	40295	rs587776906	NC_000017.11:1727525:C:T
NM_000289.6(PFKM):c.237+1G>A	PFKM		Glycogen storage disease, type VII|Rhabdomyolysis	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189239	12	48525177	12	48131394	189239	187120	rs202143236	NC_000012.12:48131393:G:A
NM_001127713.1(ATL1):c.650G>A (p.Arg217Gln)	ATL1	R217Q	Hereditary spastic paraplegia 3A	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000004349	14	51079996	14	50613278	4349	19388	rs119476049	NC_000014.9:50613277:G:A
NM_001163673.1(WDR81):c.59-2135C>T	WDR81	Q1096*, Q45*	not provided|HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2018)	no assertion criteria provided	VCV000191291	17	1631539	17	1728245	191291	189094	rs770279237	NC_000017.11:1728244:C:T
NM_153700.2(STRC):c.4837G>T (p.Glu1613Ter)	STRC	E1613*	not provided	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	VCV000499237	15	43893077	15	43600879	499237	490661	rs769443188	NC_000015.10:43600878:C:A
15q15.3 deletion	STRC		Deafness, autosomal dominant 16	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000236065					236065	237629		
NM_153700.2(STRC):c.259C>T (p.Gln87Ter)	STRC	Q87*	Rare genetic deafness	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000666998	15	43910360	15	43618162	666998	654775		NC_000015.10:43618161:G:A
NM_153700.2(STRC):c.4375+1G>A	STRC		Rare genetic deafness	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000666997	15	43896193	15	43603995	666997	654768		NC_000015.10:43603994:C:T
NM_153700.2(STRC):c.379C>T (p.Arg127Ter)	STRC	R127*	Rare genetic deafness	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000505325	15	43910240	15	43618042	505325	497466	rs771264491	NC_000015.10:43618041:G:A
NM_153700.2(STRC):c.3493C>T (p.Gln1165Ter)	STRC	Q1165*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000228403	15	43902515	15	43610317	228403	230571	rs876657726	NC_000015.10:43610316:G:A
NM_153700.2(STRC):c.3217C>T (p.Arg1073Ter)	STRC	R1073*	Rare genetic deafness	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000228402	15	43903435	15	43611237	228402	230574	rs876657725	NC_000015.10:43611236:G:A
NM_153700.2(STRC):c.1086C>A (p.Tyr362Ter)	STRC	Y362*	Rare genetic deafness	Pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	VCV000228401	15	43908678	15	43616480	228401	230579	rs876657724	NC_000015.10:43616479:G:T
NM_153700.2(STRC):c.3484del (p.Trp1162fs)	STRC	W1162fs	Rare genetic deafness	Pathogenic(Last reviewed: Apr 11, 2014)	criteria provided, single submitter	VCV000179717	15	43902524	15	43610326	179717	175972	rs727505074	NC_000015.10:43610325:A:
NM_153700.2(STRC):c.4796_4800del (p.Cys1599fs)	STRC	C1599fs	Rare genetic deafness	Pathogenic(Last reviewed: Mar 15, 2014)	criteria provided, single submitter	VCV000165302	15	43893114 - 43893118	15	43600916 - 43600920	165302	175964	rs727503442	NC_000015.10:43600915:TCCAC:
15q15.3 deletion	STRC		Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Nov 24, 2019)	no assertion criteria provided	VCV000813830					813830	802083		
NM_153700.2(STRC):c.(?_4443)_(4845_?)-68del	STRC		Rare genetic deafness	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000228400	15	43892948 - 43895542	15	43600750 - 43603344	228400	230552		
NM_153700.2(STRC):c.(?_4376)-190_(4845_?)-68del	STRC		Rare genetic deafness	Pathogenic(Last reviewed: Nov 28, 2014)	criteria provided, single submitter	VCV000180122	15	43892948 - 43895799	15	43600750 - 43603601	180122	175771		
NM_153700.2(STRC):c.4195G>T (p.Glu1399Ter)	STRC	E1399*	Rare genetic deafness	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000165310	15	43896582	15	43604384	165310	176112	rs371513959	NC_000015.10:43604383:C:A
NC_000015.9:g.(?_43892732)_(43897597_?)del	STRC		Rare genetic deafness	Pathogenic(Last reviewed: Jan 6, 2014)	criteria provided, single submitter	VCV000165297	15	43892732 - 43897597	15	43600534 - 43605399	165297	176096		
NC_000015.9:g.(?_43892732)_(43893212_?)del	STRC		Rare genetic deafness	Pathogenic(Last reviewed: Mar 4, 2014)	criteria provided, single submitter	VCV000165296	15	43892732 - 43893212	15	43600534 - 43601014	165296	175911		
NC_000015.10:g.(?_43599438)_(43608225_43613711)del	STRC		Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004345			15	43599438 - 43613711	4345	19384		
NM_153700.2(STRC):c.2171_2174del (p.Val724fs)	STRC	V724fs	Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004344	15	43906634 - 43906637	15	43614436 - 43614439	4344	19383	rs786200883	NC_000015.10:43614435:CAAACA:CA
NM_153700.2(STRC):c.3156dup (p.Cys1053fs)	STRC		Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004343	15	43903495 - 43903496	15	43611297 - 43611298	4343	19382	rs786200882	NC_000015.10:43611297:G:GG
NM_153700.2(STRC):c.3670C>T (p.Arg1224Ter)	STRC	R1224*	Rare genetic deafness	Pathogenic(Last reviewed: Nov 28, 2014)	criteria provided, single submitter	VCV000165315	15	43900289	15	43608091	165315	176115	rs727503444	NC_000015.10:43608090:G:A
NM_153700.2(STRC):c.4402C>T (p.Arg1468Ter)	STRC	R1468*	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000179758	15	43895583	15	43603385	179758	176111	rs377480477	NC_000015.10:43603384:G:A
NM_153700.2(STRC):c.4701+1G>A	STRC		Deafness, autosomal recessive 16|Rare genetic deafness	Pathogenic(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	VCV000165305	15	43893593	15	43601395	165305	175965	rs199839039	NC_000015.10:43601394:C:T
NM_001193333.2(CORO1A):c.670_673GTGC[1] (p.Arg225fs)	CORO1A		Immunodeficiency 8	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000663029	16	30198735 - 30198738	16	30187414 - 30187417	663029	644593		NC_000016.10:30187413:CGTGCGTGC:CGTGC
NM_001193333.2(CORO1A):c.400G>A (p.Val134Met)	CORO1A	V134M	Immunodeficiency 8	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000064645	16	30198215	16	30186894	64645	75599	rs397514755	NC_000016.10:30186893:G:A
NM_007074.3(CORO1A):c.1078delC	CORO1A	Q360fs	Immunodeficiency 8	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000157509	16	30199693	16	30188372	157509	167370	rs606231256	NC_000016.10:30188371:CC:C
NM_007074.3(CORO1A):c.248_249del	CORO1A	P83fs	Immunodeficiency 8	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000040886	16	30197968 - 30197969	16	30186647 - 30186648	40886	49379	rs606231246	NC_000016.10:30186646:CT:
NM_033028.5(BBS4):c.157-2A>G	BBS4		Bardet-Biedl syndrome 4|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000009147	15	73004583	15	72712242	9147	24186	rs113994192	NC_000015.10:72712241:A:G
NM_201631.4(TGM5):c.104G>A (p.Arg35Gln)	TGM5	R35Q	Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449109	15	43552684	15	43260486	449109	445319	rs749224503	NC_000015.10:43260485:C:T
NM_000424.4(KRT5):c.1409dup (p.Tyr470Ter)	KRT5		not provided	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000816993	12	52910450 - 52910451	12	52516666 - 52516667	816993	805751		NC_000012.12:52516666:T:TT
NM_000424.4(KRT5):c.1363G>T (p.Glu455Ter)	KRT5	E455*	not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000620350	12	52910497	12	52516713	620350	611773	rs1294665232	NC_000012.12:52516712:C:A
NM_000424.4(KRT5):c.495G>C (p.Arg165Ser)	KRT5	R165S	not provided	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000432952	12	52913586	12	52519802	432952	425998	rs267607456	NC_000012.12:52519801:C:G
NM_000424.4(KRT5):c.1A>G (p.Met1Val)	KRT5	M1V	not provided	Pathogenic(Last reviewed: Aug 22, 2015)	criteria provided, single submitter	VCV000419591	12	52914080	12	52520296	419591	408715	rs1064793977	NC_000012.12:52520295:T:C
NM_000424.4(KRT5):c.472G>T (p.Asp158Tyr)	KRT5	D158Y	not provided	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000379242	12	52913609	12	52519825	379242	372442	rs763608512	NC_000012.12:52519824:C:A
NM_031220.4(PITPNM3):c.274C>T (p.Arg92Ter)	PITPNM3	R92*, R56*	Cerebral arteriovenous malformation	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000545101	17	6406847	17	6503527	545101	535374	rs1555556099	NC_000017.11:6503526:G:A
NM_000424.4(KRT5):c.538G>C (p.Ala180Pro)	KRT5	A180P	not provided	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000066257	12	52913543	12	52519759	66257	77154	rs267607451	NC_000012.12:52519758:C:G
NM_000424.4(KRT5):c.502G>A (p.Glu168Lys)	KRT5	E168K	not provided	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000066248	12	52913579	12	52519795	66248	77145	rs58619430	NC_000012.12:52519794:C:T
NM_000424.4(KRT5):c.1411C>T (p.Arg471Cys)	KRT5	R471C	not provided	Pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000066213	12	52910449	12	52516665	66213	77110	rs267607448	NC_000012.12:52516664:G:A
NM_000424.4(KRT5):c.1400T>C (p.Ile467Thr)	KRT5	I467T	not provided	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000066210	12	52910460	12	52516676	66210	77107	rs60271599	NC_000012.12:52516675:A:G
NM_006009.4(TUBA1A):c.381C>A (p.Asp127Glu)	TUBA1A	D127E, D92E	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625521	12	49579768	12	49185985	625521	613808	rs1565627390	NC_000012.12:49185984:G:T
NM_006009.4(TUBA1A):c.172G>C (p.Ala58Pro)	TUBA1A	A58P, A23P	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625520	12	49580448	12	49186665	625520	613818	rs1565627718	NC_000012.12:49186664:C:G
NM_006009.4(TUBA1A):c.565C>G (p.Leu189Val)	TUBA1A	L189V, L154V	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625519	12	49579584	12	49185801	625519	613799	rs113208258	NC_000012.12:49185800:G:C
NM_006009.4(TUBA1A):c.215C>G (p.Pro72Arg)	TUBA1A	P72R, P37R	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625518	12	49580405	12	49186622	625518	613814	rs1565627677	NC_000012.12:49186621:G:C
NM_006009.4(TUBA1A):c.473C>T (p.Ser158Leu)	TUBA1A	S158L, S123L	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625517	12	49579676	12	49185893	625517	613803	rs1565627324	NC_000012.12:49185892:G:A
NM_006009.4(TUBA1A):c.214C>T (p.Pro72Ser)	TUBA1A	P72S, P37S	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625516	12	49580406	12	49186623	625516	613815	rs1565627680	NC_000012.12:49186622:G:A
NM_006009.4(TUBA1A):c.302A>G (p.Asn101Ser)	TUBA1A	N101S, N66S	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625515	12	49580166	12	49186383	625515	613812	rs1565627526	NC_000012.12:49186382:T:C
NM_006009.4(TUBA1A):c.1112T>A (p.Val371Glu)	TUBA1A	V371E, V336E	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625514	12	49579037	12	49185254	625514	613783	rs1565626988	NC_000012.12:49185253:A:T
NM_006009.4(TUBA1A):c.1307G>A (p.Gly436Asp)	TUBA1A	G436D, G401D	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625512	12	49578842	12	49185059	625512	613777	rs1565626851	NC_000012.12:49185058:C:T
NM_006009.4(TUBA1A):c.518C>T (p.Pro173Leu)	TUBA1A	P173L, P138L	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625511	12	49579631	12	49185848	625511	613801	rs1565627304	NC_000012.12:49185847:G:A
NM_006009.4(TUBA1A):c.320A>G (p.His107Arg)	TUBA1A	H107R, H72R	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625510	12	49580148	12	49186365	625510	613811	rs1565627517	NC_000012.12:49186364:T:C
NM_006009.4(TUBA1A):c.449C>T (p.Thr150Ile)	TUBA1A	T150I, T115I	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625509	12	49579700	12	49185917	625509	613804	rs1565627339	NC_000012.12:49185916:G:A
NM_006009.4(TUBA1A):c.352G>C (p.Val118Leu)	TUBA1A	V118L, V83L	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625508	12	49580116	12	49186333	625508	613809	rs863224938	NC_000012.12:49186332:C:G
NM_006009.4(TUBA1A):c.175G>A (p.Gly59Ser)	TUBA1A	G59S, G24S	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625507	12	49580445	12	49186662	625507	613817	rs1565627712	NC_000012.12:49186661:C:T
NM_006009.4(TUBA1A):c.161G>A (p.Ser54Asn)	TUBA1A	S54N, S19N	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625506	12	49580459	12	49186676	625506	613821	rs1565627740	NC_000012.12:49186675:C:T
NM_006009.4(TUBA1A):c.1186G>T (p.Asp396Tyr)	TUBA1A	D396Y, D361Y	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625505	12	49578963	12	49185180	625505	613781	rs1565626951	NC_000012.12:49185179:C:A
NM_006009.4(TUBA1A):c.1225G>A (p.Val409Ile)	TUBA1A	V409I, V374I	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625504	12	49578924	12	49185141	625504	613780	rs1565626928	NC_000012.12:49185140:C:T
NM_006009.4(TUBA1A):c.337G>A (p.Glu113Lys)	TUBA1A	E113K, E78K	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625503	12	49580131	12	49186348	625503	613810	rs769889742	NC_000012.12:49186347:C:T
NM_006009.4(TUBA1A):c.1160C>T (p.Ala387Val)	TUBA1A	A387V, A352V	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625502	12	49578989	12	49185206	625502	613782	rs1565626959	NC_000012.12:49185205:G:A
NM_006009.4(TUBA1A):c.599G>A (p.Cys200Tyr)	TUBA1A	C200Y, C165Y	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625501	12	49579550	12	49185767	625501	613798	rs1565627260	NC_000012.12:49185766:C:T
NM_006009.4(TUBA1A):c.652G>T (p.Asp218Tyr)	TUBA1A	D218Y, D183Y	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625499	12	49579497	12	49185714	625499	613796	rs1057517858	NC_000012.12:49185713:C:A
NM_006009.4(TUBA1A):c.1306G>C (p.Gly436Arg)	TUBA1A	G436R, G401R	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625497	12	49578843	12	49185060	625497	613778	rs1565626860	NC_000012.12:49185059:C:G
NM_006009.4(TUBA1A):c.1007A>G (p.Lys336Arg)	TUBA1A	K336R, K301R	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625496	12	49579142	12	49185359	625496	613785	rs1565627040	NC_000012.12:49185358:T:C
NM_006009.4(TUBA1A):c.433A>G (p.Thr145Ala)	TUBA1A	T145A, T110A	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625494	12	49579716	12	49185933	625494	613805	rs1565627349	NC_000012.12:49185932:T:C
NM_006009.4(TUBA1A):c.26T>C (p.Val9Ala)	TUBA1A	V9A	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625491	12	49580594	12	49186811	625491	613824	rs1565627795	NC_000012.12:49186810:A:G
NM_006009.4(TUBA1A):c.1285G>C (p.Glu429Gln)	TUBA1A	E429Q, E394Q	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625488	12	49578864	12	49185081	625488	613779	rs1565626872	NC_000012.12:49185080:C:G
NM_006009.4(TUBA1A):c.978A>C (p.Lys326Asn)	TUBA1A	K326N, K291N	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625487	12	49579171	12	49185388	625487	613787	rs1565627058	NC_000012.12:49185387:T:G
NM_006009.4(TUBA1A):c.274C>G (p.Leu92Val)	TUBA1A	L92V, L57V	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625486	12	49580194	12	49186411	625486	613813	rs1565627548	NC_000012.12:49186410:G:C
NM_006009.4(TUBA1A):c.908T>G (p.Val303Gly)	TUBA1A	V303G, V268G	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625485	12	49579241	12	49185458	625485	613788	rs1565627104	NC_000012.12:49185457:A:C
NM_006009.4(TUBA1A):c.4C>A (p.Arg2Ser)	TUBA1A	R2S	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625482	12	49580616	12	49186833	625482	613825	rs1565627805	NC_000012.12:49186832:G:T
NM_006009.4(TUBA1A):c.74G>T (p.Cys25Phe)	TUBA1A	C25F	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625481	12	49580546	12	49186763	625481	613822	rs1565627777	NC_000012.12:49186762:C:A
NM_006009.4(TUBA1A):c.703G>T (p.Val235Leu)	TUBA1A	V235L, V200L	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625478	12	49579446	12	49185663	625478	613793	rs1565627190	NC_000012.12:49185662:C:A
NM_006009.4(TUBA1A):c.481T>C (p.Tyr161His)	TUBA1A	Y161H, Y126H	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625477	12	49579668	12	49185885	625477	613802	rs587784488	NC_000012.12:49185884:A:G
NM_006009.4(TUBA1A):c.998C>T (p.Ala333Val)	TUBA1A	A333V, A298V	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625476	12	49579151	12	49185368	625476	613786	rs1565627046	NC_000012.12:49185367:G:A
NM_006009.4(TUBA1A):c.209T>C (p.Leu70Ser)	TUBA1A	L70S, L35S	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625475	12	49580411	12	49186628	625475	613816	rs1565627684	NC_000012.12:49186627:A:G
NM_006009.4(TUBA1A):c.629A>G (p.Tyr210Cys)	TUBA1A	Y210C, Y175C	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625474	12	49579520	12	49185737	625474	613797	rs1565627253	NC_000012.12:49185736:T:C
NM_006009.4(TUBA1A):c.163G>A (p.Glu55Lys)	TUBA1A	E55K, E20K	Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625472	12	49580457	12	49186674	625472	613820	rs1565627735	NC_000012.12:49186673:C:T
KRT5, 1-BP DEL, 1635G	KRT5			Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000014651					14651	29690		
NM_000424.4(KRT5):c.20T>C (p.Val7Ala)	KRT5	V7A	Epidermolysis bullosa simplex, Koebner type	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000014646	12	52914061	12	52520277	14646	29685	rs121912474	NC_000012.12:52520276:A:G
NM_153700.2:c.3499_4701+1del	STRC		Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000692158					692158	679904		
NM_000424.4(KRT5):c.1414A>T (p.Lys472Ter)	KRT5	K472*	not provided|Epidermolysis bullosa simplex, generalized, with severe palmoplantar keratosis	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000014654	12	52910446	12	52516662	14654	29693	rs57348201	NC_000012.12:52516661:T:A
NM_000424.4(KRT5):c.1429G>T (p.Glu477Ter)	KRT5	E477*	not provided|Epidermolysis bullosa simplex, Dowling-Meara type, with severe palmoplantar keratoderma	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000014653	12	52910431	12	52516647	14653	29692	rs59190510	NC_000012.12:52516646:C:A
NM_006009.4(TUBA1A):c.1168C>G (p.Arg390Gly)	TUBA1A	R390G, R355G	not provided|Tubulinopathies	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000450183	12	49578981	12	49185198	450183	445034	rs1064793286	NC_000012.12:49185197:G:C
NM_006009.4(TUBA1A):c.1096G>A (p.Gly366Arg)	TUBA1A	G366R, G331R	not provided|Tubulinopathies	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449342	12	49579053	12	49185270	449342	445035	rs1555162299	NC_000012.12:49185269:C:T
NM_006009.4(TUBA1A):c.1177C>T (p.His393Tyr)	TUBA1A	H393Y, H358Y	Tubulinopathy|Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000438298	12	49578972	12	49185189	438298	431921	rs1555162288	NC_000012.12:49185188:G:A
NM_006009.4(TUBA1A):c.641G>T (p.Arg214Leu)	TUBA1A	R214L, R179L	Tubulinopathies|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000432708	12	49579508	12	49185725	432708	425989	rs1057517843	NC_000012.12:49185724:C:A
NM_006009.4(TUBA1A):c.1148C>A (p.Ala383Asp)	TUBA1A	A383D, A348D	Tubulinopathies|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000427202	12	49579001	12	49185218	427202	415338	rs587784482	NC_000012.12:49185217:G:T
NM_006009.4(TUBA1A):c.190C>T (p.Arg64Trp)	TUBA1A	R64W, R29W	Tubulinopathies|not provided	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420581	12	49580430	12	49186647	420581	408690	rs1064794568	NC_000012.12:49186646:G:A
NM_006009.4(TUBA1A):c.1168C>T (p.Arg390Cys)	TUBA1A	R390C, R355C	Tubulinopathies|not provided	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418531	12	49578981	12	49185198	418531	408687	rs1064793286	NC_000012.12:49185197:G:A
NM_006009.4(TUBA1A):c.79G>C (p.Glu27Gln)	TUBA1A	E27Q	Tubulinopathies|not provided	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381537	12	49580541	12	49186758	381537	372337	rs1057521064	NC_000012.12:49186757:C:G
NM_006009.4(TUBA1A):c.17C>G (p.Ser6Cys)	TUBA1A	S6C	Tubulinopathies|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379329	12	49580603	12	49186820	379329	373114	rs1057520574	NC_000012.12:49186819:G:C
NM_006009.4(TUBA1A):c.367C>T (p.Arg123Cys)	TUBA1A	R123C, R88C	Tubulinopathies|not provided	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265378	12	49580101	12	49186318	265378	260022	rs886039513	NC_000012.12:49186317:G:A
NM_006009.4(TUBA1A):c.790C>G (p.Arg264Gly)	TUBA1A	R264G, R229G	Tubulinopathies|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265283	12	49579359	12	49185576	265283	260021	rs137853043	NC_000012.12:49185575:G:C
NM_000424.4(KRT5):c.555+1G>A	KRT5		|not provided	Pathogenic(Last reviewed: May 12, 2015)	criteria provided, single submitter	VCV000265218	12	52913525	12	52519741	265218	260024	rs886039403	NC_000012.12:52519740:C:T
NM_000424.4(KRT5):c.991C>T (p.Arg331Cys)	KRT5	R331C	|not provided	Pathogenic(Last reviewed: Apr 9, 2016)	criteria provided, single submitter	VCV000066298	12	52911475	12	52517691	66298	77195	rs61297109	NC_000012.12:52517690:G:A
NM_000424.4(KRT5):c.1252G>A (p.Glu418Lys)	KRT5	E418K	Epidermolysis bullosa simplex, autosomal recessive|not provided	Pathogenic(Last reviewed: Jun 28, 2002)	no assertion criteria provided	VCV000014658	12	52910608	12	52516824	14658	29697	rs121912476	NC_000012.12:52516823:C:T
NM_000424.4(KRT5):c.556G>T (p.Val186Leu)	KRT5	V186L	not provided|Epidermolysis bullosa simplex, Koebner type	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000014652	12	52912944	12	52519160	14652	29691	rs121912475	NC_000012.12:52519159:C:A
NM_000424.4(KRT5):c.541T>C (p.Ser181Pro)	KRT5	S181P	not provided|	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000014650	12	52913540	12	52519756	14650	29689	rs60715293	NC_000012.12:52519755:A:G
NM_000424.4(KRT5):c.14C>A (p.Ser5Ter)	KRT5	S5*	not provided|Dowling-Degos disease 1	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000014647	12	52914067	12	52520283	14647	29686	rs58751565	NC_000012.12:52520282:G:T
NM_000424.4(KRT5):c.523C>T (p.Leu175Phe)	KRT5	L174F, L175F	|not provided	Pathogenic(Last reviewed: Aug 1, 1996)	no assertion criteria provided	VCV000014645	12	52913558	12	52519774	14645	29684	rs57890479	NC_000012.12:52519773:G:A
NM_000424.4(KRT5):c.579C>G (p.Asn193Lys)	KRT5	N193K	|not provided	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000014644	12	52912921	12	52519137	14644	29683	rs60586163	NC_000012.12:52519136:G:C
NM_000424.4(KRT5):c.519G>C (p.Lys173Asn)	KRT5	K173N	not provided|Epidermolysis bullosa simplex, Koebner type	Pathogenic(Last reviewed: Mar 1, 1995)	no assertion criteria provided	VCV000014643	12	52913562	12	52519778	14643	29682	rs58163069	NC_000012.12:52519777:C:G
NM_000424.4(KRT5):c.987C>A (p.Asn329Lys)	KRT5	N329K	|not provided	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000014642	12	52911479	12	52517695	14642	29681	rs59730172	NC_000012.12:52517694:G:T
NM_000424.4(KRT5):c.1424A>G (p.Glu475Gly)	KRT5	E475G	not provided|	Pathogenic(Last reviewed: Mar 19, 1992)	no assertion criteria provided	VCV000014638	12	52910436	12	52516652	14638	29677	rs61348633	NC_000012.12:52516651:T:C
NM_006565.4(CTCF):c.1456C>T (p.Gln486Ter)	CTCF	Q486*, Q158*	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000521891	16	67660556	16	67626653	521891	512222	rs1555535739	NC_000016.10:67626652:C:T
NM_006565.4(CTCF):c.75C>A (p.Tyr25Ter)	CTCF	Y25*	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000521865	16	67644810	16	67610907	521865	512218	rs1555534067	NC_000016.10:67610906:C:A
NM_006565.4(CTCF):c.615_618del (p.Lys206fs)	CTCF	K206fs	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 6, 2016)	criteria provided, single submitter	VCV000521287	16	67645347 - 67645350	16	67611444 - 67611447	521287	512219	rs1555534147	NC_000016.10:67611443:AAAGAAA:AAA
GRCh37/hg19 13q31.3(chr13:94120662-94430587)x1	GPC6		not provided	Pathogenic(Last reviewed: Jun 30, 2017)	no assertion criteria provided	VCV000687181	13	94120662 - 94430587			687181	674773		
GRCh37/hg19 13q31.3(chr13:94097218-94204671)x1	GPC6		not provided	Pathogenic(Last reviewed: Jul 28, 2017)	no assertion criteria provided	VCV000685089	13	94097218 - 94204671			685089	672681		
NM_024589.2(ROGDI):c.334C>T (p.Gln112Ter)	ROGDI	Q112*	not provided	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000504177	16	4850501	16	4800500	504177	495621	rs372097881	NC_000016.10:4800499:G:A
NM_024589.2(ROGDI):c.532-2A>T	ROGDI		Kohlschutter's syndrome	Pathogenic(Last reviewed: Sep 13, 2019)	no assertion criteria provided	VCV000031228	16	4848187	16	4798186	31228	40185	rs786205119	NC_000016.10:4798185:T:A
NM_024589.2(ROGDI):c.302_308dup (p.Glu104fs)	ROGDI		Kohlschutter's syndrome	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000654553	16	4850526 - 4850527	16	4800525 - 4800526	654553	644705		NC_000016.10:4800525:CGGAAGGCG:CGGAAGGCGGAAGGCG
NC_000016.9:g.(?_4847441)_(4852592_?)del	ROGDI		Kohlschutter's syndrome	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000583558	16	4847441 - 4852592	16	4797440 - 4802591	583558	567509		
NM_024589.2(ROGDI):c.665dup (p.Ala223fs)	ROGDI		Kohlschutter's syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000530797	16	4847968 - 4847969	16	4797967 - 4797968	530797	530316	rs1039568775	NC_000016.10:4797967:CCCCC:CCCCCC
NM_024589.2(ROGDI):c.340C>T (p.Gln114Ter)	ROGDI	Q114*	Kohlschutter's syndrome	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000461607	16	4849779	16	4799778	461607	466481	rs1555491350	NC_000016.10:4799777:G:A
NM_024589.2(ROGDI):c.469C>T (p.Arg157Ter)	ROGDI	R157*	Kohlschutter's syndrome	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000031229	16	4848632	16	4798631	31229	40186	rs387907146	NC_000016.10:4798630:G:A
NM_024589.2(ROGDI):c.227_228CT[1] (p.Leu77fs)	ROGDI		Kohlschutter's syndrome	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000031225	16	4851293 - 4851294	16	4801292 - 4801293	31225	40182	rs764899074	NC_000016.10:4801291:AGAG:AG
NM_005708.3(GPC6):c.712_877dup	GPC6			Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000005553			13	94011504 - 94038749	5553	20592		
NC_000013.11:g.94252984_94352299del99316insCTA	GPC6			Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000005551	13	94905238 - 95004553	13	94252984 - 94352299	5551	20590		
NC_000013.11:g.93997007_94063501del66495insATAAATCACTTAGAGATGT	GPC6			Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000005550	13	94649261 - 94715755	13	93997007 - 94063501	5550	20589		
NM_005708.5(GPC6):c.778del (p.Leu260fs)	GPC6	L260fs		Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000005549	13	94680049	13	94027795	5549	20588	rs863223282	NC_000013.11:94027794:C:
NM_024589.2(ROGDI):c.45+37_46-30del	ROGDI		Kohlschutter's syndrome	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000041466	16	4852484 - 4852491	16	4802483 - 4802490	41466	49902	rs786205125	NC_000016.10:4802482:GCCCCGCCGCCCCGCCG:GCCCCGCCG
NM_024589.2(ROGDI):c.507del (p.Glu170fs)	ROGDI	E170fs	Kohlschutter's syndrome	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000041465	16	4848594	16	4798593	41465	49901	rs786205124	NC_000016.10:4798592:GGGG:GGG
NM_024589.2(ROGDI):c.531+5G>C	ROGDI		Kohlschutter's syndrome	Pathogenic(Last reviewed: Oct 1, 1974)	no assertion criteria provided	VCV000031227	16	4848565	16	4798564	31227	40184	rs749657986	NC_000016.10:4798563:C:G
NM_006009.4(TUBA1A):c.368G>A (p.Arg123His)	TUBA1A	R123H, R88H	Tubulinopathies|Lissencephaly 3	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000437122	12	49580100	12	49186317	437122	429435	rs1555162456	NC_000012.12:49186316:C:T
NM_006009.4(TUBA1A):c.1105G>A (p.Ala369Thr)	TUBA1A	A369T, A334T	Tubulinopathies|Lissencephaly 3	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212488	12	49579044	12	49185261	212488	207972	rs797046071	NC_000012.12:49185260:C:T
NM_006009.4(TUBA1A):c.986A>G (p.Asn329Ser)	TUBA1A	N329S, N294S	Tubulinopathies|Lissencephaly 3	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000160167	12	49579163	12	49185380	160167	168990	rs587784495	NC_000012.12:49185379:T:C
NM_006009.4(TUBA1A):c.481T>G (p.Tyr161Asp)	TUBA1A	Y161D, Y126D	Tubulinopathies|Lissencephaly 3	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000160158	12	49579668	12	49185885	160158	168997	rs587784488	NC_000012.12:49185884:A:C
NM_000424.4(KRT5):c.418dup (p.Ile140fs)	KRT5		not provided|Dowling-Degos disease 1	Pathogenic(Last reviewed: Jul 1, 2010)	no assertion criteria provided	VCV000066235	12	52913662 - 52913663	12	52519878 - 52519879	66235	77132	rs61348424	NC_000012.12:52519878:T:TT
NM_153700.2(STRC):c.4219-1G>A	STRC		|Deafness-infertility syndrome|Deafness, autosomal recessive 16|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000505435	15	43896351	15	43604153	505435	497248	rs748854592	NC_000015.10:43604152:C:T
NM_153700.2(STRC):c.4057C>T	STRC	Q1353*	Deafness, autosomal recessive 16|not provided	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000242391	15	43896918	15	43604720	242391	237617	rs774312182	NC_000015.10:43604719:G:A
NC_000015.9:g.(?_43891870)_(43910920_?)del	STRC		Rare genetic deafness	Pathogenic(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	VCV000165295	15	43891870 - 43910920	15	43599672 - 43618722	165295	175952		
NM_024589.2(ROGDI):c.506_507dup (p.Glu170fs)	ROGDI		Kohlschutter's syndrome	Pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000453294	16	4848593 - 4848594	16	4798592 - 4798593	453294	446891	rs786205124	NC_000016.10:4798592:GGGG:GGGGGG
NM_024589.2(ROGDI):c.286C>T (p.Gln96Ter)	ROGDI	Q96*	Kohlschutter's syndrome	Pathogenic(Last reviewed: Dec 23, 2015)	criteria provided, single submitter	VCV000031226	16	4850549	16	4800548	31226	40183	rs387907145	NC_000016.10:4800547:G:A
NM_024589.2(ROGDI):c.117+1G>A	ROGDI		Kohlschutter's syndrome	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000565630	16	4852382	16	4802381	565630	574076	rs570952151	NC_000016.10:4802380:C:T
NM_000151.4(G6PC):c.189G>A (p.Trp63Ter)	G6PC	W63*	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188966	17	41053082	17	42901065	188966	186977	rs764920787	NC_000017.11:42901064:G:A
NM_000151.4(G6PC):c.1012G>T (p.Val338Phe)	G6PC	V338F	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188945	17	41063381	17	42911364	188945	186979	rs367727229	NC_000017.11:42911363:G:T
NM_000151.4(G6PC):c.370G>A (p.Ala124Thr)	G6PC	A124T	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012006	17	41059569	17	42907552	12006	27045	rs104894568	NC_000017.11:42907551:G:A
NM_002968.2(SALL1):c.814C>T (p.Gln272Ter)	SALL1	Q272*, Q175*	not provided	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000488838	16	51175319	16	51141408	488838	482101	rs1555475342	NC_000016.10:51141407:G:A
NM_002968.2(SALL1):c.1380_1381del (p.Ser460fs)	SALL1	S363fs, S460fs	not provided	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000424424	16	51174752 - 51174753	16	51140841 - 51140842	424424	409647	rs1064796960	NC_000016.10:51140840:CAC:C
NM_002968.2(SALL1):c.1393C>T (p.Gln465Ter)	SALL1	Q465*, Q368*	not provided	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000373187	16	51174740	16	51140829	373187	360289	rs1057518273	NC_000016.10:51140828:G:A
NM_002968.2(SALL1):c.1763dup (p.Gly589fs)	SALL1		not provided	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000373123	16	51174369 - 51174370	16	51140458 - 51140459	373123	360179	rs1057518232	NC_000016.10:51140458:GGGGGG:GGGGGGG
NM_002968.2(SALL1):c.727C>T (p.Gln243Ter)	SALL1	Q243*, Q146*	not provided	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000291272	16	51175406	16	51141495	291272	275509	rs886044708	NC_000016.10:51141494:G:A
NM_002968.2(SALL1):c.3099_3105dup (p.Arg1036fs)	SALL1		not provided	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000280886	16	51173027 - 51173028	16	51139116 - 51139117	280886	264951	rs886042011	NC_000016.10:51139116:ATTGCAAA:ATTGCAAATTGCAAA
NM_001127892.1(SALL1):c.577_578TC[3] (p.Gln194fs)	SALL1		not provided	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000279887	16	51175261 - 51175262	16	51141350 - 51141351	279887	264711	rs886041236	NC_000016.10:51141350:GAGA:GAGAGA
NM_002968.3(SALL1):c.2686_2689dup (p.Val897fs)	SALL1		Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000807481	16	51173443 - 51173444	16	51139532 - 51139533	807481	798700		NC_000016.10:51139532:CATCC:CATCCATCC
NM_002968.2(SALL1):c.3005_3008del (p.Ala1002fs)	SALL1	A1002fs, A905fs	Townes syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000663219	16	51173125 - 51173128	16	51139214 - 51139217	663219	644745		NC_000016.10:51139213:CAAGCA:CA
NM_002968.3(SALL1):c.1324del (p.Ser442fs)	SALL1	S345fs, S442fs	Townes syndrome	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000648831	16	51174809	16	51140898	648831	644746		NC_000016.10:51140897:AA:A
NM_002968.2(SALL1):c.2356del (p.Arg786fs)	SALL1	R689fs, R786fs	Townes syndrome	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000528881	16	51173777	16	51139866	528881	530025	rs1555475106	NC_000016.10:51139865:GG:G
NM_002968.2(SALL1):c.866T>A (p.Leu289Ter)	SALL1	L289*, L192*	Townes syndrome	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000528879	16	51175267	16	51141356	528879	530032	rs1555475334	NC_000016.10:51141355:A:T
NM_002968.2(SALL1):c.2256del (p.Tyr753fs)	SALL1	Y656fs, Y753fs	Townes syndrome	Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	VCV000459258	16	51173877	16	51139966	459258	466492	rs1555475120	NC_000016.10:51139965:G:
NM_002968.2(SALL1):c.1214dup (p.Leu406fs)	SALL1		Townes syndrome	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000459257	16	51174918 - 51174919	16	51141007 - 51141008	459257	465770	rs1555475275	NC_000016.10:51141007:GGG:GGGG
NM_001127892.1(SALL1):c.1530del (p.Leu511fs)	SALL1	L511fs, L608fs	Townes-Brocks-branchiootorenal-like syndrome	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000007432	16	51174312	16	51140401	7432	22471		NC_000016.10:51140400:CCC:CC
NM_001287.6(CLCN7):c.1617+119G>A	CLCN7			Pathogenic	criteria provided, single submitter	VCV000827681	16	1500379	16	1450378	827681	815881		NC_000016.10:1450377:C:T
NM_001287.6(CLCN7):c.857G>A (p.Arg286Gln)	CLCN7	R286Q, R262Q		Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000438670	16	1506173	16	1456172	438670	432314	rs760956030	NC_000016.10:1456171:C:T
NM_002968.2(SALL1):c.1108_1109del (p.Val370fs)	SALL1	V273fs, V370fs	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, single submitter	VCV000426114	16	51175024 - 51175025	16	51141113 - 51141114	426114	414718	rs1085307143	NC_000016.10:51141112:AC:
NM_001287.6(CLCN7):c.643G>A (p.Gly215Arg)	CLCN7	G215R, G191R		Pathogenic(Last reviewed: Jun 20, 2013)	no assertion criteria provided	VCV000065635	16	1509140	16	1459139	65635	76543	rs397515539	NC_000016.10:1459138:C:T
SALL1, 2-BP DEL, 3414AT	SALL1		Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Dec 15, 2007)	no assertion criteria provided	VCV000007437					7437	22476		
NM_001127892.1(SALL1):c.704del (p.Pro235fs)	SALL1	P235fs, P332fs	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Dec 15, 2007)	no assertion criteria provided	VCV000007436	16	51175138	16	51141227	7436	22475		NC_000016.10:51141226:GG:G
NM_002968.2(SALL1):c.1256T>A (p.Leu419Ter)	SALL1	L419*, L322*	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: May 15, 2007)	no assertion criteria provided	VCV000007435	16	51174877	16	51140966	7435	22474	rs137853084	NC_000016.10:51140965:A:T
NM_001127892.1(SALL1):c.501_502del (p.Leu167fs)	SALL1	L167fs, L264fs	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Aug 15, 2001)	no assertion criteria provided	VCV000007433	16	51175340 - 51175341	16	51141429 - 51141430	7433	22472		NC_000016.10:51141428:GC:
NM_001127892.1(SALL1):c.1054_1055CA[1] (p.His352fs)	SALL1		Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000007431	16	51174785 - 51174786	16	51140874 - 51140875	7431	22470		NC_000016.10:51140873:TGTGT:TGT
NM_002968.2(SALL1):c.1115C>G (p.Ser372Ter)	SALL1	S372*, S275*	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007429	16	51175018	16	51141107	7429	22468	rs104894535	NC_000016.10:51141106:G:C
NM_001287.6(CLCN7):c.781A>T (p.Ile261Phe)	CLCN7	I261F, I237F		Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000006865	16	1507296	16	1457295	6865	21904	rs121434436	NC_000016.10:1457294:T:A
NM_001287.6(CLCN7):c.2297T>C (p.Leu766Pro)	CLCN7	L766P, L742P		Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000006862	16	1497041	16	1447040	6862	21901	rs121434434	NC_000016.10:1447039:A:G
NM_001287.6(CLCN7):c.2285G>A (p.Arg762Gln)	CLCN7	R762Q, R738Q		Pathogenic(Last reviewed: Jan 26, 2001)	no assertion criteria provided	VCV000006861	16	1497053	16	1447052	6861	21900	rs121434433	NC_000016.10:1447051:C:T
NM_001287.6(CLCN7):c.1663C>T (p.Gln555Ter)	CLCN7	Q555*, Q531*		Pathogenic(Last reviewed: Jan 26, 2001)	no assertion criteria provided	VCV000006860	16	1499283	16	1449282	6860	21899	rs121434432	NC_000016.10:1449281:G:A
NM_001287.6(CLCN7):c.2250+1G>T	CLCN7			Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000585308	16	1497392	16	1447391	585308	576355	rs1567263375	NC_000016.10:1447390:C:A
NC_000016.9:g.(?_51171003)_(51185172_?)del	SALL1		Townes syndrome	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000528884	16	51171003 - 51185172	16	51137092 - 51151261	528884	529570		
NM_002968.2(SALL1):c.958C>T (p.Gln320Ter)	SALL1	Q320*, Q223*	Townes syndrome	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000528880	16	51175175	16	51141264	528880	530030	rs1555475319	NC_000016.10:51141263:G:A
NM_002968.2(SALL1):c.3414_3415del (p.Cys1139fs)	SALL1	C1042fs, C1139fs	not provided|Townes syndrome	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000418466	16	51172718 - 51172719	16	51138807 - 51138808	418466	409645	rs1064793257	NC_000016.10:51138806:AT:
NM_001287.6(CLCN7):c.2144A>G (p.Tyr715Cys)	CLCN7	Y715C, Y691C	HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT|not provided	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000372326	16	1497499	16	1447498	372326	360150	rs1057517718	NC_000016.10:1447497:T:C
NM_001127892.1(SALL1):c.986_987del (p.Arg329fs)	SALL1	R426fs, R329fs	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007430	16	51174855 - 51174856	16	51140944 - 51140945	7430	22469		NC_000016.10:51140943:TCT:T
NM_002968.2(SALL1):c.1115C>A (p.Ser372Ter)	SALL1	S372*, S275*	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007427	16	51175018	16	51141107	7427	22466	rs104894535	NC_000016.10:51141106:G:T
NM_001127892.1(SALL1):c.979del (p.Gln327fs)	SALL1	Q327fs, Q424fs	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007426	16	51174863	16	51140952	7426	22465		NC_000016.10:51140951:GGG:GG
NM_001040616.3(LINS1):c.1394+1G>T	LINS1		Inborn genetic diseases	Pathogenic(Last reviewed: Jan 25, 2013)	criteria provided, single submitter	VCV000225032	15	101112098	15	100571893	225032	226943	rs869312932	NC_000015.10:100571892:C:A
CLCN7, 2-BP DEL, 2423AG	CLCN7			Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000006864					6864	21903		
NM_001271620.2(ZNF423):c.2985dup (p.Asn996fs)	ZNF423		not provided	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000280335	16	49669897 - 49669898	16	49635986 - 49635987	280335	264636	rs886041561	NC_000016.10:49635986:GGGGG:GGGGGG
NM_001271620.2(ZNF423):c.3649C>T (p.His1217Tyr)	ZNF423	H1277Y, H1217Y, H1160Y	Joubert syndrome 19	Pathogenic(Last reviewed: Aug 3, 2012)	no assertion criteria provided	VCV000037289	16	49525212	16	49491301	37289	45862		NC_000016.10:49491300:G:A
NM_001271620.2(ZNF423):c.1338del (p.Asn447fs)	ZNF423	N507fs, N390fs, N447fs	Joubert syndrome 19	Pathogenic(Last reviewed: Aug 3, 2012)	no assertion criteria provided	VCV000037288	16	49671545	16	49637634	37288	45861		NC_000016.10:49637633:GGGG:GGG
NM_006009.4(TUBA1A):c.167C>T (p.Thr56Met)	TUBA1A	T56M, T21M	Tubulinopathies|Lissencephaly 3	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000625513	12	49580453	12	49186670	625513	613819	rs1565627727	NC_000012.12:49186669:G:A
NM_006009.4(TUBA1A):c.1169G>A (p.Arg390His)	TUBA1A	R390H, R355H	Tubulinopathies|Lissencephaly 3	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488628	12	49578980	12	49185197	488628	481496	rs1064796460	NC_000012.12:49185196:C:T
NM_006009.4(TUBA1A):c.920C>T (p.Pro307Leu)	TUBA1A	P307L, P272L	Tubulinopathies|Lissencephaly 3	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000438589	12	49579229	12	49185446	438589	432218	rs1555162325	NC_000012.12:49185445:G:A
NM_006009.4(TUBA1A):c.352G>A (p.Val118Met)	TUBA1A	V118M, V83M	Lissencephaly 3|Tubulinopathies	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217023	12	49580116	12	49186333	217023	213622	rs863224938	NC_000012.12:49186332:C:T
NM_006009.4(TUBA1A):c.808G>T (p.Ala270Ser)	TUBA1A	A270S, A235S	Lissencephaly 3|Tubulinopathies	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000160164	12	49579341	12	49185558	160164	168992	rs587784494	NC_000012.12:49185557:C:A
NM_006009.4(TUBA1A):c.1274T>A (p.Met425Lys)	TUBA1A	M425K, M390K	Lissencephaly 3|Tubulinopathies	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000160148	12	49578875	12	49185092	160148	168980	rs587784484	NC_000012.12:49185091:A:T
NM_006009.4(TUBA1A):c.1205G>T (p.Arg402Leu)	TUBA1A	R402L, R367L	Lissencephaly 3|Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000160147	12	49578944	12	49185161	160147	168981	rs137853044	NC_000012.12:49185160:C:A
NM_000424.4(KRT5):c.1388T>C (p.Leu463Pro)	KRT5	L462P, L463P	not provided|Epidermolysis bullosa simplex, Koebner type	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000014639	12	52910472	12	52516688	14639	29678	rs57599352	NC_000012.12:52516687:A:G
NM_006009.4(TUBA1A):c.1190T>C (p.Leu397Pro)	TUBA1A	L397P, L362P	Tubulinopathies|Lissencephaly 3	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000007075	12	49578959	12	49185176	7075	22114	rs137853048	NC_000012.12:49185175:A:G
NM_001127713.1(ATL1):c.467C>T (p.Thr156Ile)	ATL1	T156I	Hereditary spastic paraplegia 3A|not provided	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021531	14	51058302	14	50591584	21531	34383	rs137852657	NC_000014.9:50591583:C:T
NM_001163673.1(WDR81):c.59-4576G>A	WDR81	G282E	Hydranencephaly|Neonatal death|Severe brain malformation|Severe cerebellar hypoplasia|HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2018)	no assertion criteria provided	VCV000183290	17	1629098	17	1725804	183290	181450	rs730882206	NC_000017.11:1725803:G:A
NM_012452.3(TNFRSF13B):c.198C>A (p.Cys66Ter)	TNFRSF13B	C66*	Common variable immunodeficiency 2	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000840923	17	16855761	17	16952447	840923	844739		NC_000017.11:16952446:G:T
NM_012452.2(TNFRSF13B):c.95_96dupGA	TNFRSF13B		Common variable immunodeficiency 2	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000647108	17	16855862 - 16855863	17	16952548 - 16952549	647108	645339		NC_000017.11:16952548:TCTC:TCTCTC
NM_012452.2(TNFRSF13B):c.431C>A (p.Ser144Ter)	TNFRSF13B	S144*	Common variable immunodeficiency 2	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000005307	17	16852066	17	16948752	5307	20346	rs104894650	NC_000017.11:16948751:G:T
NM_012452.2(TNFRSF13B):c.227_231delGCAAG	TNFRSF13B		Common variable immunodeficiency 2	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000657940	17	16852266 - 16852270	17	16948952 - 16948956	657940	645336		NC_000017.11:16948951:CTTGCCTTGC:CTTGC
NM_012452.2(TNFRSF13B):c.572dup (p.Asp191fs)	TNFRSF13B		Common variable immunodeficiency 2	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000582925	17	16843698 - 16843699	17	16940384 - 16940385	582925	574315	rs769165409	NC_000017.11:16940384:T:TT
NM_012452.2(TNFRSF13B):c.49del (p.Gln17fs)	TNFRSF13B	Q17fs	Common variable immunodeficiency 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000538707	17	16875341	17	16972027	538707	530604	rs1555550717	NC_000017.11:16972026:GG:G
TNFRSF13B, 1-BP INS, 204A	TNFRSF13B		Immunoglobulin A deficiency 2|Common variable immunodeficiency 2	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000005305					5305	20344		
NM_014249.4(NR2E3):c.226C>T (p.Arg76Trp)	NR2E3	R76W	not provided|Enhanced s-cone syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000005529	15	72103930	15	71811590	5529	20568	rs104894492	NC_000015.10:71811589:C:T
NM_153700.2(STRC):c.4027C>T (p.Gln1343Ter)	STRC	Q1343*	Deafness, autosomal recessive 16|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000448908	15	43896948	15	43604750	448908	442483	rs144948296	NC_000015.10:43604749:G:A
NM_012452.2(TNFRSF13B):c.61+1G>T	TNFRSF13B		Common variable immunodeficiency 2	Pathogenic(Last reviewed: Sep 22, 2018)	criteria provided, single submitter	VCV000647267	17	16875328	17	16972014	647267	652888		NC_000017.11:16972013:C:A
NM_012452.2(TNFRSF13B):c.581_582delCCinsAA (p.Ser194Ter)	TNFRSF13B	S194*	Common variable immunodeficiency 2	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000005306	17	16843689 - 16843690	17	16940375 - 16940376	5306	20345	rs121908379	NC_000017.11:16940374:GG:TT
NM_002225.5(IVD):c.1231C>T (p.Arg411Trp)	IVD	R411W, R381W, R395W, R440W	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803069	15	40710421	15	40418222	803069	791446		NC_000015.10:40418221:C:T
NM_002225.5(IVD):c.1206del (p.Ile402fs)	IVD	I386fs, I402fs, I431fs, I372fs	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803068	15	40710396	15	40418197	803068	791445		NC_000015.10:40418196:A:
NM_002225.5(IVD):c.1009C>G (p.Arg337Gly)	IVD	R321G, R337G, R366G, R307G	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803067	15	40708325	15	40416126	803067	791444		NC_000015.10:40416125:C:G
NM_002225.5(IVD):c.960G>T (p.Gln320His)	IVD	Q320H, Q290H, Q304H, Q349H	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000627426	15	40707681	15	40415482	627426	615781	rs367814475	NC_000015.10:40415481:G:T
NM_002225.5(IVD):c.650del (p.Pro217fs)	IVD	P201fs, P217fs, P187fs, P246fs	not provided	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000593628	15	40703852	15	40411653	593628	584692	rs1364046355	NC_000015.10:40411652:CC:C
NM_002225.5(IVD):c.1108C>T (p.Gln370Ter)	IVD	Q373*, Q370*, Q399*, Q340*, Q354*	not provided	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000286660	15	40708531	15	40416332	286660	270897	rs368705240	NC_000015.10:40416331:C:T
NM_002225.5(IVD):c.870del (p.Pro291fs)	IVD	P320fs, P261fs, P291fs, P275fs	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000854919	15	40707168	15	40414969	854919	842285		NC_000015.10:40414968:GGGGGG:GGGGG
NM_002225.5(IVD):c.61_67del (p.Leu21fs)	IVD	L21fs	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000851748	15	40698085 - 40698091	15	40405884 - 40405890	851748	842281		NC_000015.10:40405883:GCCGCTTGCCG:GCCG
NM_002225.5(IVD):c.243G>A (p.Trp81Ter)	IVD	W81*, W110*, W51*, W65*	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000653100	15	40700146	15	40407947	653100	650373		NC_000015.10:40407946:G:A
NM_002225.5(IVD):c.1175G>A (p.Arg392His)	IVD	R392H, R362H, R421H, R376H	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623383	15	40710365	15	40418166	623383	612307	rs982218848	NC_000015.10:40418165:G:A
IVD, 90-BP DEL, NT145	IVD		Isovaleric acidemia, type II	Pathogenic(Last reviewed: Feb 5, 1992)	no assertion criteria provided	VCV000003565					3565	18604		
IVD, 1-BP DEL, 1177T	IVD		Isovaleric acidemia, type III	Pathogenic(Last reviewed: Jul 1, 1991)	no assertion criteria provided	VCV000003564					3564	18603		
NM_002225.5(IVD):c.125T>C (p.Leu42Pro)	IVD	L13P, L45P, L42P	Isovaleric acidemia, type I	Pathogenic(Last reviewed: Jul 1, 1991)	no assertion criteria provided	VCV000003562	15	40698153	15	40405952	3562	18601	rs121434284	NC_000015.10:40405951:T:C
NC_000015.9:g.(?_40698000)_(40700209_?)del	IVD		Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000830632	15	40698000 - 40700209			830632	820757		
NM_002225.5(IVD):c.397_398del (p.Cys133fs)	IVD	C103fs, C117fs, C133fs, C162fs	not provided|Isovaleryl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000094054	15	40702937 - 40702938	15	40410738 - 40410739	94054	99956	rs398123682	NC_000015.10:40410737:TG:
NM_012452.2(TNFRSF13B):c.492C>G (p.Tyr164Ter)	TNFRSF13B	Y164*	Common variable immunodeficiency 2|Immunoglobulin A deficiency 2	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000203368	17	16843779	17	16940465	203368	199804	rs72553882	NC_000017.11:16940464:G:C
NM_002225.5(IVD):c.1069_1070TG[1] (p.Ala358fs)	IVD		Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000844890	15	40708492 - 40708493	15	40416293 - 40416294	844890	842288		NC_000015.10:40416292:TGTG:TG
NM_002225.5(IVD):c.1183C>T (p.Arg395Ter)	IVD	R395*, R379*, R424*, R365*	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000571005	15	40710373	15	40418174	571005	567013	rs398123681	NC_000015.10:40418173:C:T
NM_002225.5(IVD):c.102_103del (p.Val35fs)	IVD	V35fs	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371578	15	40698130 - 40698131	15	40405929 - 40405930	371578	358294	rs1057517379	NC_000015.10:40405928:CG:
NM_002225.5(IVD):c.1174C>T (p.Arg392Cys)	IVD	R395C, R392C, R362C, R421C, R376C	Isovaleryl-CoA dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, multiple submitters, no conflicts	VCV000265202	15	40710364	15	40418165	265202	260065	rs371427844	NC_000015.10:40418164:C:T
NM_002225.5(IVD):c.784+1G>A	IVD		Isovaleryl-CoA dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000198480	15	40705287	15	40413088	198480	195641	rs763471771	NC_000015.10:40413087:G:A
NM_014252.4(SLC25A15):c.553_555TTC[3] (p.Phe188del)	SLC25A15	F188del	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005992	13	41381530 - 41381532	13	40807394 - 40807396	5992	21031	rs202247803	NC_000013.11:40807393:TTCTTCTTCTTC:TTCTTCTTC
NM_000424.4(KRT5):c.508G>A (p.Glu170Lys)	KRT5	E170K	|Epidermolysis bullosa simplex, autosomal recessive|not provided	Pathogenic(Last reviewed: Jun 8, 2016)	criteria provided, single submitter	VCV000014657	12	52913573	12	52519789	14657	29696	rs59115483	NC_000012.12:52519788:C:T
NM_000424.4(KRT5):c.482T>G (p.Ile161Ser)	KRT5	I161S	not provided|	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000014640	12	52913599	12	52519815	14640	29679	rs58058996	NC_000012.12:52519814:A:C
NM_006009.4(TUBA1A):c.1256C>T (p.Ser419Leu)	TUBA1A	S419L, S384L	Tubulinopathies|Lissencephaly 3	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000007074	12	49578893	12	49185110	7074	22113	rs137853047	NC_000012.12:49185109:G:A
NM_006009.4(TUBA1A):c.787C>A (p.Pro263Thr)	TUBA1A	P263T, P228T	Tubulinopathies|Lissencephaly 3	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000007073	12	49579362	12	49185579	7073	22112	rs137853046	NC_000012.12:49185578:G:T
NM_006009.4(TUBA1A):c.562A>C (p.Ile188Leu)	TUBA1A	I188L, I153L	Tubulinopathies|Lissencephaly 3	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000007072	12	49579587	12	49185804	7072	22111	rs137853045	NC_000012.12:49185803:T:G
NC_000015.10:g.(?_40418110)_(40418283_?)del	IVD		Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000830813	15	40710309 - 40710482			830813	820694		
NM_002225.5(IVD):c.381del (p.Ala128fs)	IVD	A112fs, A128fs, A157fs, A98fs	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000459924	15	40702921	15	40410722	459924	465017	rs769048174	NC_000015.10:40410721:T:
NM_002225.5(IVD):c.232C>T (p.Arg78Ter)	IVD	R81*, R78*, R62*	Isovaleryl-CoA dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, multiple submitters, no conflicts	VCV000370807	15	40699924	15	40407723	370807	358297	rs765815516	NC_000015.10:40407722:C:T
NM_002225.5(IVD):c.870dup (p.Pro291fs)	IVD		Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000459932	15	40707167 - 40707168	15	40414968 - 40414969	459932	464758	rs759159766	NC_000015.10:40414968:GGGGGG:GGGGGGG
NM_001355436.2(SPTB):c.4267C>T (p.Arg1423Ter)	SPTB	R1423*	not specified	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000812019	14	65246649	14	64779931	812019	799773		NC_000014.9:64779930:G:A
NM_001355436.2(SPTB):c.3128G>A (p.Trp1043Ter)	SPTB	W1043*	not specified	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000811791	14	65253555	14	64786837	811791	799776		NC_000014.9:64786836:C:T
NM_001355436.2(SPTB):c.4058del (p.Lys1353fs)	SPTB	K1353fs	not specified	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000811255	14	65249216	14	64782498	811255	799774		NC_000014.9:64782497:TTTT:TTT
NM_001355436.2(SPTB):c.6157G>C (p.Ala2053Pro)	SPTB	A2053P	Elliptocytosis 3	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000012831	14	65234443	14	64767725	12831	27870	rs121918645	NC_000014.9:64767724:C:G
NM_001355436.2(SPTB):c.5623C>T (p.Gln1875Ter)	SPTB	Q1875*	Spherocytosis type 2	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000544817	14	65237778	14	64771060	544817	535255	rs1555367359	NC_000014.9:64771059:G:A
NM_001355436.2(SPTB):c.2863C>T (p.Arg955Ter)	SPTB	R955*	Spherocytosis type 2	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000544812	14	65253820	14	64787102	544812	535258	rs1555369657	NC_000014.9:64787101:G:A
NM_001355436.2(SPTB):c.5794_5798+6del	SPTB		Hemolytic anemia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523359	14	65237597 - 65237607	14	64770879 - 64770889	523359	514047	rs1555367318	NC_000014.9:64770878:CCTCACCTGGGCCTC:CCTC
NM_001355436.2(SPTB):c.6095T>C (p.Leu2032Pro)	SPTB	L2032P	Hereditary spherocytosis	Pathogenic(Last reviewed: Feb 3, 2018)	no assertion criteria provided	VCV000522602	14	65234505	14	64767787	522602	513215	rs1555366607	NC_000014.9:64767786:A:G
NM_001355436.2(SPTB):c.1912del (p.Arg638fs)	SPTB	R638fs	Spherocytosis type 2	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000012842	14	65260469	14	64793751	12842	27881	rs863223304	NC_000014.9:64793750:G:
NM_001355436.2(SPTB):c.6191G>C (p.Arg2064Pro)	SPTB	R2064P	Elliptocytosis 3	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000012840	14	65234409	14	64767691	12840	27879	rs121918650	NC_000014.9:64767690:C:G
NM_001355436.2(SPTB):c.6177del (p.Ser2060fs)	SPTB	S2060fs	Elliptocytosis 3	Pathogenic(Last reviewed: Oct 15, 1992)	no assertion criteria provided	VCV000012834	14	65234423	14	64767705	12834	27873		NC_000014.9:64767704:GG:G
NM_001355436.2(SPTB):c.4063G>T (p.Glu1355Ter)	SPTB	E1355*	Hereditary spherocytosis	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000624571	14	65249211	14	64782493	624571	613404	rs1566754467	NC_000014.9:64782492:C:A
NM_001355436.2(SPTB):c.1331_1338del (p.Leu444fs)	SPTB	L444fs	Spherocytosis type 2	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000544810	14	65263278 - 65263285	14	64796560 - 64796567	544810	535259	rs1555370967	NC_000014.9:64796559:GGCCACGAGGC:GGC
NM_001355436.2(SPTB):c.604T>C (p.Trp202Arg)	SPTB	W202R	Spherocytosis type 2	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000012835	14	65268515	14	64801797	12835	27874	rs121918646	NC_000014.9:64801796:A:G
NM_001355436.2(SPTB):c.6133_6134GA[3] (p.Lys2046fs)	SPTB		Elliptocytosis 3	Pathogenic(Last reviewed: Jul 15, 1991)	no assertion criteria provided	VCV000012833	14	65234463 - 65234464	14	64767745 - 64767746	12833	27872	rs863223303	NC_000014.9:64767745:TCTC:TCTCTC
NM_001355436.2(SPTB):c.6269+3G>T	SPTB		Elliptocytosis 3	Pathogenic(Last reviewed: Jul 1, 1991)	no assertion criteria provided	VCV000012832	14	65234018	14	64767300	12832	27871	rs863223302	NC_000014.9:64767299:C:A
NM_001355436.2(SPTB):c.5266C>T (p.Arg1756Ter)	SPTB	R1756*	Spherocytosis type 2	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000012843	14	65239585	14	64772867	12843	27882	rs267607086	NC_000014.9:64772866:G:A
NM_001355436.2(SPTB):c.1A>G (p.Met1Val)	SPTB	M1V	Spherocytosis type 2|not specified	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000012841	14	65289812	14	64823094	12841	27880	rs121918651	NC_000014.9:64823093:T:C
SPTB, EX22-23DEL	SPTB		Spherocytosis type 2	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000012838					12838	27877		
NM_001287.6(CLCN7):c.2299C>T (p.Arg767Trp)	CLCN7	R767W, R743W	|	Pathogenic(Last reviewed: Jun 20, 2013)	no assertion criteria provided	VCV000006863	16	1497039	16	1447038	6863	21902	rs121434435	NC_000016.10:1447037:G:A
NM_201525.4(ADGRG1):c.739_745del (p.Gln247fs)	ADGRG1	Q247fs, Q77fs, Q195fs, Q72fs, Q252fs	not provided|Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005828	16	57688015 - 57688021	16	57654103 - 57654109	5828	20867	rs587776625	NC_000016.10:57654102:CCAGGACC:C
NM_052845.4(MMAB):c.568C>G (p.Arg190Gly)	MMAB	R190G	not provided	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000279853	12	109998861	12	109561056	279853	264665	rs398124434	NC_000012.12:109561055:G:C
NM_001355436.2(SPTB):c.6053C>G (p.Ala2018Gly)	SPTB	A2018G	Hereditary pyropoikilocytosis|Elliptocytosis 3	Pathogenic(Last reviewed: Oct 25, 1993)	no assertion criteria provided	VCV000012836	14	65234547	14	64767829	12836	27875	rs121918647	NC_000014.9:64767828:G:C
NM_052845.4(MMAB):c.563T>G (p.Val188Gly)	MMAB	V188G	Vitamin B12-responsive methylmalonic acidemia type cblB	Pathogenic(Last reviewed: May 18, 2014)	no assertion criteria provided	VCV000225186	12	109998866	12	109561061	225186	227103	rs869320654	NC_000012.12:109561060:A:C
NM_024339.5(THOC6):c.259C>T (p.Arg87Ter)	THOC6	R87*, R63*	Beaulieu-Boycott-Innes syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 9, 2015)	criteria provided, single submitter	VCV000520614	16	3076102	16	3026101	520614	512191	rs763344375	NC_000016.10:3026100:C:T
NM_004448.3(ERBB2):c.2686C>T (p.Arg896Cys)	ERBB2	R866C, R881C, R896C	Neoplasm of the breast	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375995	17	37881616	17	39725363	375995	362874	rs758222990	NC_000017.11:39725362:C:T
NM_052845.4(MMAB):c.468G>A (p.Trp156Ter)	MMAB	W156*	Vitamin B12-responsive methylmalonic acidemia type cblB	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000834947	12	109999276	12	109561471	834947	839255		NC_000012.12:109561470:C:T
NM_052845.4(MMAB):c.585-2A>C	MMAB		Vitamin B12-responsive methylmalonic acidemia type cblB	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000550985	12	109996962	12	109559157	550985	546633	rs1555274254	NC_000012.12:109559156:T:G
NM_052845.4(MMAB):c.567_569CCG[3] (p.Arg191dup)	MMAB		Vitamin B12-responsive methylmalonic acidemia type cblB	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000218327	12	109998856 - 109998857	12	109561051 - 109561052	218327	215034	rs864309512	NC_000012.12:109561051:CGGCGGC:CGGCGGCGGC
NM_052845.4(MMAB):c.290G>A (p.Gly97Glu)	MMAB	G97E	Vitamin B12-responsive methylmalonic acidemia type cblB	Pathogenic(Last reviewed: Sep 1, 2010)	no assertion criteria provided	VCV000218326	12	110006575	12	109568770	218326	215033	rs864309511	NC_000012.12:109568769:C:T
NM_052845.4(MMAB):c.573_577del (p.Ala192fs)	MMAB	A192fs	Vitamin B12-responsive methylmalonic acidemia type cblB	Pathogenic(Last reviewed: Dec 15, 2002)	no assertion criteria provided	VCV000003097	12	109998852 - 109998856	12	109561047 - 109561051	3097	18136	rs1555274497	NC_000012.12:109561046:CGGCCCGGC:CGGC
NM_024306.5(FA2H):c.565C>T (p.Arg189Ter)	FA2H	R189*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 2, 2013)	criteria provided, single submitter	VCV000208728	16	74760171	16	74726273	208728	205295	rs765086319	NC_000016.10:74726272:G:A
NM_002225.5(IVD):c.1199A>G (p.Tyr400Cys)	IVD	Y403C, Y400C, Y370C, Y429C, Y384C	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2016)	criteria provided, multiple submitters, no conflicts	VCV000371390	15	40710389	15	40418190	371390	358301	rs773560012	NC_000015.10:40418189:A:G
NM_002225.3(IVD):c.507delG (p.Glu169Aspfs)	IVD		not provided|Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094056	15	40703500	15	40411301	94056	99958	rs398123684	NC_000015.10:40411300:G:
NM_002225.5(IVD):c.596G>T (p.Gly199Val)	IVD	G170V, G202V, G183V, G228V, G169V, G199V	not provided|Isovaleric acidemia, type I|Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	VCV000003563	15	40703799	15	40411600	3563	18602	rs121434285	NC_000015.10:40411599:G:T
NM_052845.4(MMAB):c.287T>C (p.Ile96Thr)	MMAB	I96T	Vitamin B12-responsive methylmalonic acidemia type cblB	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000218323	12	110006578	12	109568773	218323	215030	rs864309509	NC_000012.12:109568772:A:G
NC_000014.9:g.(?_22812880)_(22813418_?)del	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Jun 2, 2019)	criteria provided, single submitter	VCV000833005	14	23282089 - 23282627			833005	820609		
NC_000014.8:g.(?_23242799)_(23282627_?)del	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000643157	14	23242799 - 23282627	14	22773590 - 22813418	643157	652858		
GRCh37/hg19 14q11.2(chr14:23242388-23245542)	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625743	14	23242388 - 23245542			625743	614047		
NM_001126105.2(SLC7A7):c.1395del (p.Glu465fs)	SLC7A7	E465fs	Lysinuric protein intolerance	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000579224	14	23243176	14	22773967	579224	566296	rs1290445670	NC_000014.9:22773966:TT:T
NM_001126105.2(SLC7A7):c.1095+2del	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000437441	14	23244651	14	22775442	437441	430998	rs1555320639	NC_000014.9:22775441:A:
SLC7A7, EX6-11, DEL	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000006215					6215	21254		
NM_005262.3(GFER):c.566C>G (p.Ser189Ter)	GFER	S189*	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000521763	16	2035977	16	1985976	521763	512179	rs373135339	NC_000016.10:1985975:C:G
NM_003982.4(SLC7A7):c.1383_1384del (p.Ile461fs)	SLC7A7	I461fs	Lysinuric protein intolerance	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000859540	14	23243187 - 23243188	14	22773978 - 22773979	859540	841180		NC_000014.9:22773977:TG:
NM_003982.4(SLC7A7):c.725G>A (p.Trp242Ter)	SLC7A7	W242*	Lysinuric protein intolerance	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000850645	14	23248047	14	22778838	850645	841187		NC_000014.9:22778837:C:T
NC_000014.9:g.(?_22778783)_(22780061_?)del	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000832882	14	23247992 - 23249270			832882	820608		
NM_001126106.2(SLC7A7):c.1122C>A (p.Cys374Ter)	SLC7A7	C374*	Lysinuric protein intolerance	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561110	14	23243686	14	22774477	561110	552172	rs771254387	NC_000014.9:22774476:G:T
NM_001126105.2(SLC7A7):c.1A>C (p.Met1Leu)	SLC7A7	M1L	Lysinuric protein intolerance	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000006208	14	23282607	14	22813398	6208	21247	rs121908676	NC_000014.9:22813397:T:G
SLC7A7, 455-BP DEL, NT197	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000006206					6206	21245		
NM_001330504.1(ALG1):c.854+3A>G	ALG1		ALG1-CDG|not provided|Congenital disorder of glycosylation	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224118	16	5132677	16	5082676	224118	225848	rs369160589	NC_000016.10:5082675:A:G
NM_006009.4(TUBA1A):c.1169G>C (p.Arg390Pro)	TUBA1A	R390P, R355P	Lissencephaly 3|Tubulinopathies|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423490	12	49578980	12	49185197	423490	408686	rs1064796460	NC_000012.12:49185196:C:G
NM_006009.4(TUBA1A):c.1148C>T (p.Ala383Val)	TUBA1A	A383V, A348V	Lissencephaly 3|Tubulinopathies|Abnormality of neuronal migration	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000160143	12	49579001	12	49185218	160143	168985	rs587784482	NC_000012.12:49185217:G:A
NM_000424.4(KRT5):c.1429G>A (p.Glu477Lys)	KRT5	E477K	not provided||	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000021174	12	52910431	12	52516647	21174	34026	rs59190510	NC_000012.12:52516646:C:T
NM_000424.4(KRT5):c.1649del (p.Gly550fs)	KRT5	G550fs	not provided|Epidermolysis bullosa simplex with migratory circinate erythema	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000014655	12	52908850	12	52515066	14655	29694	rs61126080	NC_000012.12:52515065:CCCCCC:CCCCC
NC_000014.9:g.(?_22773590)_(22780071_?)del	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000832683	14	23242799 - 23249280			832683	820606		
NC_000014.9:g.(?_22773212)_(22780061_?)del	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000831197	14	23242421 - 23249270			831197	820605		
NM_001126106.2(SLC7A7):c.895-2_895delinsCCATT	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000646821	14	23245145 - 23245147	14	22775936 - 22775938	646821	652583		NC_000014.9:22775935:TCT:AATGG
NM_001126105.2(SLC7A7):c.1402C>T (p.Arg468Ter)	SLC7A7	R468*	Lysinuric protein intolerance	Pathogenic	criteria provided, single submitter	VCV000056359	14	23243169	14	22773960	56359	70998	rs386833807	NC_000014.9:22773959:G:A
NM_052845.4(MMAB):c.454G>T (p.Glu152Ter)	MMAB	E152*	Vitamin B12-responsive methylmalonic acidemia type cblB	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551214	12	109999290	12	109561485	551214	546844	rs557884699	NC_000012.12:109561484:C:A
NM_052845.4(MMAB):c.563_577dup (p.Val188_Ala192dup)	MMAB		not provided|Vitamin B12-responsive methylmalonic acidemia type cblB	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000203822	12	109998851 - 109998852	12	109561046 - 109561047	203822	200227	rs1555274496	NC_000012.12:109561046:CGGCCCGGCGGCACACGGCCCGGC:CGGCCCGGCGGCACACGGCCCGGCGGCACACGGCCCGGC
NM_001126105.2(SLC7A7):c.713C>T (p.Ser238Phe)	SLC7A7	S238F	Lysinuric protein intolerance	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000056376	14	23248059	14	22778850	56376	71015	rs386833823	NC_000014.9:22778849:G:A
NM_001126105.2(SLC7A7):c.625+1G>A	SLC7A7		Lysinuric protein intolerance	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000056374	14	23249134	14	22779925	56374	71013	rs386833822	NC_000014.9:22779924:C:T
NM_001126105.2(SLC7A7):c.149T>A (p.Met50Lys)	SLC7A7	M50K	Lysinuric protein intolerance	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000056363	14	23282459	14	22813250	56363	71002	rs386833811	NC_000014.9:22813249:A:T
NM_001126106.2(SLC7A7):c.1387del (p.Val463fs)	SLC7A7	V463fs	Lysinuric protein intolerance	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000056358	14	23243184	14	22773975	56358	70997	rs386833806	NC_000014.9:22773974:C:
SLC7A7, IVS6AS, A-T, -2	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000006205					6205	21244		
NM_002225.5(IVD):c.550+1G>A	IVD		not provided|Isovaleryl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372389	15	40703553	15	40411354	372389	360185	rs377147994	NC_000015.10:40411353:G:A
NM_002225.5(IVD):c.149G>C (p.Arg50Pro)	IVD	R53P, R50P, R34P	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188922	15	40699841	15	40407640	188922	186929	rs2229311	NC_000015.10:40407639:G:C
NM_000017.4(ACADS):c.988C>T (p.Arg330Cys)	ACADS	R330C, R326C	not provided|Deficiency of butyryl-CoA dehydrogenase	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203557	12	121176677	12	120738874	203557	200239	rs140853839	NC_000012.12:120738873:C:T
GRCh37/hg19 16p12.2(chr16:21740273-21807834)x1	OTOA		not provided	Pathogenic(Last reviewed: Dec 29, 2017)	no assertion criteria provided	VCV000689312	16	21740273 - 21807834			689312	676904		
GRCh37/hg19 16p12.2(chr16:21742365-21807834)x1	OTOA		not provided	Pathogenic(Last reviewed: Jul 18, 2017)	no assertion criteria provided	VCV000687324	16	21742365 - 21807834			687324	674916		
GRCh37/hg19 16p12.2(chr16:21742365-21784278)x1	OTOA		not provided	Pathogenic(Last reviewed: Sep 22, 2017)	no assertion criteria provided	VCV000687216	16	21742365 - 21784278			687216	674808		
GRCh37/hg19 16p12.2(chr16:21742365-21784278)x1	OTOA		not provided	Pathogenic(Last reviewed: Jun 29, 2017)	no assertion criteria provided	VCV000685246	16	21742365 - 21784278			685246	672838		
NM_012158.3(FBXL3):c.1072T>C (p.Cys358Arg)	FBXL3	C358R	Mental retardation, short stature, facial anomalies, and joint dislocations	Pathogenic(Last reviewed: Apr 15, 2019)	no assertion criteria provided	VCV000625421	13	77581495	13	77007360	625421	613735	rs1566225872	NC_000013.11:77007359:A:G
NM_002755.3(MAP2K1):c.371C>G (p.Pro124Arg)	MAP2K1	P124R	not provided	Pathogenic(Last reviewed: Jun 11, 2015)	criteria provided, single submitter	VCV000372636	15	66729163	15	66436825	372636	360217	rs397516792	NC_000015.10:66436824:C:G
NM_002755.3(MAP2K1):c.383_384delinsTT (p.Gly128Val)	MAP2K1		Rasopathy	Pathogenic(Last reviewed: Nov 4, 2012)	criteria provided, single submitter	VCV000040745	15	66729175 - 66729176	15	66436837 - 66436838	40745	49215	rs730880508	NC_000015.10:66436836:GC:TT
NM_002755.3(MAP2K1):c.355C>T (p.His119Tyr)	MAP2K1	H119Y	not provided	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000040741	15	66729147	15	66436809	40741	49211	rs730880503	NC_000015.10:66436808:C:T
NM_144672.4(OTOA):c.1765del (p.Gln589fs)	OTOA	Q265fs, Q589fs, Q510fs	Deafness, autosomal recessive 22	Pathogenic(Last reviewed: Aug 8, 2019)	no assertion criteria provided	VCV000684616	16	21730783	16	21719462	684616	672206		NC_000016.10:21719461:CC:C
NM_012158.3(FBXL3):c.884del (p.Leu295fs)	FBXL3	L295fs	Mental retardation, short stature, facial anomalies, and joint dislocations	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000625420	13	77581683	13	77007548	625420	613734	rs764008859	NC_000013.11:77007547:AAAAAAAAA:AAAAAAAA
NM_012158.3(FBXL3):c.445C>T (p.Arg149Ter)	FBXL3	R149*	Mental retardation, short stature, facial anomalies, and joint dislocations	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000625419	13	77592761	13	77018626	625419	613733	rs374431043	NC_000013.11:77018625:G:A
NM_144672.4(OTOA):c.268-2A>G	OTOA		Rare genetic deafness	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000505849	16	21696549	16	21685228	505849	497686	rs770892393	NC_000016.10:21685227:A:G
NM_144672.4(OTOA):c.1025A>T (p.Asp342Val)	OTOA	D342V, D18V, D263V	Deafness, autosomal recessive 22	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402269	16	21716534	16	21705213	402269	389247	rs1060499804	NC_000016.10:21705212:A:T
NM_144672.4(OTOA):c.755G>A (p.Trp252Ter)	OTOA	W252*, W173*	not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252785	16	21709111	16	21697790	252785	247114	rs879255431	NC_000016.10:21697789:G:A
NM_144672.4(OTOA):c.1688+1G>T	OTOA		Rare genetic deafness	Pathogenic(Last reviewed: Sep 9, 2014)	criteria provided, single submitter	VCV000164824	16	21730513	16	21719192	164824	175925	rs727503350	NC_000016.10:21719191:G:T
NM_002755.3(MAP2K1):c.388T>A (p.Tyr130Asn)	MAP2K1	Y130N	Cardiofaciocutaneous syndrome 3	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000636238	15	66729180	15	66436842	636238	624057		NC_000015.10:66436841:T:A
NM_144672.3(OTOA):c.(?_-46)_(2431_?)+58del	OTOA		Rare genetic deafness	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000505764	16	21689790 - 21747769	16	21678469 - 21736448	505764	497253		
NM_002755.3(MAP2K1):c.305A>G (p.Glu102Gly)	MAP2K1	E102G	Cardiofaciocutaneous syndrome 3	Pathogenic(Last reviewed: May 14, 2015)	no assertion criteria provided	VCV000190378	15	66729097	15	66436759	190378	188202	rs797044593	NC_000015.10:66436758:A:G
NM_144672.4(OTOA):c.1879C>T (p.Pro627Ser)	OTOA	P627S, P548S, P303S	Deafness, autosomal recessive 22	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000100655	16	21734298	16	21722977	100655	106527	rs587777133	NC_000016.10:21722976:C:T
NM_144672.4(OTOA):c.1352G>A (p.Gly451Asp)	OTOA	G451D, G127D, G372D	Deafness, autosomal recessive 22	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000100654	16	21726337	16	21715016	100654	106526	rs200656442	NC_000016.10:21715015:G:A
OTOA, 500-KB DEL	OTOA		Deafness, autosomal recessive 22	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000003561					3561	18600		
NM_144672.4(OTOA):c.746_751delinsA (p.Ser249fs)	OTOA		Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228383	16	21709102 - 21709107	16	21697781 - 21697786	228383	230618	rs876657716	NC_000016.10:21697780:CTGCTT:A
NM_144672.4(OTOA):c.1880+1G>A	OTOA		Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000164826	16	21734300	16	21722979	164826	175926	rs148690740	NC_000016.10:21722978:G:A
NM_144672.3(OTOA):c.(?_2302)_(2431_?)del (p.(?))	OTOA		Rare genetic deafness	Pathogenic(Last reviewed: Feb 27, 2014)	criteria provided, single submitter	VCV000164814	16	21747582 - 21747711	16	21736261 - 21736390	164814	175913		
NM_144672.4(OTOA):c.1320+2T>C	OTOA		Deafness, autosomal recessive 22	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000003560	16	21721426	16	21710105	3560	18599	rs1567381218	NC_000016.10:21710104:T:C
NM_002968.2(SALL1):c.967C>T (p.Gln323Ter)	SALL1	Q323*, Q226*	Townes-Brocks-branchiootorenal-like syndrome|Townes-Brocks syndrome 1|Townes syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007434	16	51175166	16	51141255	7434	22473	rs104894538	NC_000016.10:51141254:G:A
NC_000014.9:g.(?_22773212)_(22776328_?)del	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000830609	14	23242421 - 23245537			830609	820604		
NC_000014.8:g.(?_23242819)_(23245527_?)del	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000583991	14	23242819 - 23245527	14	22773610 - 22776318	583991	567763		
NC_000014.8:g.(?_23242799)_(23245547_?)del	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000529506	14	23242799 - 23245547	14	22773590 - 22776338	529506	527837		
NM_001126105.2(SLC7A7):c.1381_1384dup (p.Arg462fs)	SLC7A7		Lysinuric protein intolerance	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2018)	no assertion criteria provided	VCV000056357	14	23243186 - 23243187	14	22773977 - 22773978	56357	70996	rs386833805	NC_000014.9:22773977:TGAT:TGATTGAT
NM_001126105.2(SLC7A7):c.1005_1008del (p.Phe335Leufs)	SLC7A7	F335fs	Lysinuric protein intolerance	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000056346	14	23244740 - 23244743	14	22775531 - 22775534	56346	70985	rs386833794	NC_000014.9:22775530:AAAGAAA:AAA
NM_001126106.2(SLC7A7):c.726G>A (p.Trp242Ter)	SLC7A7	W242*	Lysinuric protein intolerance	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000006214	14	23248046	14	22778837	6214	21253	rs121908679	NC_000014.9:22778836:C:T
NM_014080.4(DUOX2):c.1085_1103dup (p.Val369fs)	DUOX2		not provided	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000501281	15	45402115 - 45402116	15	45109917 - 45109918	501281	492705	rs1555414044	NC_000015.10:45109917:CTGAGAGCTTGGGAGCTTT:CTGAGAGCTTGGGAGCTTTCTGAGAGCTTGGGAGCTTT
NM_014080.4(DUOX2):c.3329G>A (p.Arg1110Gln)	DUOX2	R1110Q	not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000420157	15	45391946	15	45099748	420157	409244	rs368488511	NC_000015.10:45099747:C:T
NM_014080.4(DUOX2):c.3516-1G>C	DUOX2		not provided	Pathogenic(Last reviewed: Apr 17, 2015)	criteria provided, single submitter	VCV000379375	15	45390257	15	45098059	379375	374088	rs764517475	NC_000015.10:45098058:C:G
NM_014080.4(DUOX2):c.2907dup (p.Thr970fs)	DUOX2		not provided	Pathogenic(Last reviewed: Sep 2, 2016)	criteria provided, single submitter	VCV000280847	15	45393416 - 45393417	15	45101218 - 45101219	280847	264626	rs775863038	NC_000015.10:45101218:CC:CCC
NM_014080.4(DUOX2):c.2665G>T (p.Glu889Ter)	DUOX2	E889*	not provided	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000649026	15	45394177	15	45101979	649026	643281		NC_000015.10:45101978:C:A
NM_001363711.2(DUOX2):c.513+1G>C	DUOX2		Thyroid dyshormonogenesis 6	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638519	15	45403965	15	45111767	638519	626316		NC_000015.10:45111766:C:G
NM_001363711.2(DUOX2):c.1126C>T (p.Arg376Trp)	DUOX2	R376W	Thyroid dyshormonogenesis 6	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000004065	15	45402093	15	45109895	4065	19104	rs119472029	NC_000015.10:45109894:G:A
NM_001363711.2(DUOX2):c.2056C>T (p.Gln686Ter)	DUOX2	Q686*	Thyroid dyshormonogenesis 6	Pathogenic(Last reviewed: Jul 11, 2002)	no assertion criteria provided	VCV000004063	15	45398415	15	45106217	4063	19102	rs119472027	NC_000015.10:45106216:G:A
NM_001363711.2(DUOX2):c.1300C>T (p.Arg434Ter)	DUOX2	R434*	Thyroid dyshormonogenesis 6	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000004062	15	45401085	15	45108887	4062	19101	rs119472026	NC_000015.10:45108886:G:A
NM_144672.4(OTOA):c.828del (p.Ser277fs)	OTOA	S198fs, S277fs	Deafness, autosomal recessive 22|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000402235	16	21709183	16	21697862	402235	389206	rs751447996	NC_000016.10:21697861:TT:T
NM_002755.3(MAP2K1):c.157T>C (p.Phe53Leu)	MAP2K1	F53L	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375977	15	66727441	15	66435103	375977	362856	rs1057519728	NC_000015.10:66435102:T:C
NM_001363711.2(DUOX2):c.2524C>T (p.Arg842Ter)	DUOX2	R842*	Thyroid dyshormonogenesis 6|not provided	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000004064	15	45396374	15	45104176	4064	19103	rs119472028	NC_000015.10:45104175:G:A
NM_012452.2(TNFRSF13B):c.431C>G (p.Ser144Ter)	TNFRSF13B	S144*	Common variable immunodeficiency 2|not specified|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265340	17	16852066	17	16948752	265340	260152	rs104894650	NC_000017.11:16948751:G:C
GRCh37/hg19 15q21.1(chr15:49011048-49079652)x1	CEP152		not provided	Pathogenic(Last reviewed: Dec 29, 2017)	no assertion criteria provided	VCV000688942	15	49011048 - 49079652			688942	676534		
NM_001040436.3(YARS2):c.842del (p.Lys281fs)	YARS2	K281fs	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000423483	12	32906957	12	32754023	423483	408636	rs768344665	NC_000012.12:32754022:TTT:TT
NM_001194998.2(CEP152):c.693_694CT[1] (p.Ser232fs)	CEP152		not provided	Pathogenic(Last reviewed: Aug 3, 2015)	criteria provided, single submitter	VCV000419487	15	49085654 - 49085655	15	48793457 - 48793458	419487	409309	rs1064793906	NC_000015.10:48793456:AGAG:AG
NM_001194998.2(CEP152):c.2038C>T (p.Gln680Ter)	CEP152	Q680*	not provided	Pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	VCV000265076	15	49059641	15	48767444	265076	260076	rs886039327	NC_000015.10:48767443:G:A
NM_001194998.2(CEP152):c.2598G>A (p.Trp866Ter)	CEP152	W866*	not provided	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000644237	15	49052428	15	48760231	644237	643419		NC_000015.10:48760230:C:T
NM_001040436.3(YARS2):c.1303A>G (p.Ser435Gly)	YARS2	S435G	Myopathy, lactic acidosis, and sideroblastic anemia 2	Pathogenic(Last reviewed: Jan 16, 2014)	no assertion criteria provided	VCV000102436	12	32900269	12	32747335	102436	108178	rs587777215	NC_000012.12:32747334:T:C
NM_001040436.3(YARS2):c.1078C>T (p.Arg360Ter)	YARS2	R360*	Myopathy, lactic acidosis, and sideroblastic anemia 2	Pathogenic(Last reviewed: Dec 17, 2013)	no assertion criteria provided	VCV000102435	12	32903678	12	32750744	102435	108177	rs587777214	NC_000012.12:32750743:G:A
NM_001040436.3(YARS2):c.572G>A (p.Gly191Asp)	YARS2	G191D	Myopathy, lactic acidosis, and sideroblastic anemia 2	Pathogenic(Last reviewed: Dec 17, 2013)	no assertion criteria provided	VCV000102434	12	32908237	12	32755303	102434	108176	rs11539445	NC_000012.12:32755302:C:T
NM_001194998.2(CEP152):c.3212del (p.Leu1071fs)	CEP152	L1071fs	Primary autosomal recessive microcephaly 9	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000434736	15	49048233	15	48756036	434736	429684	rs1555418825	NC_000015.10:48756035:AAAA:AAA
NM_001194998.2(CEP152):c.3014_3015delinsT (p.Lys1005fs)	CEP152		Primary autosomal recessive microcephaly 9	Pathogenic(Last reviewed: Oct 14, 2013)	criteria provided, single submitter	VCV000210686	15	49048430 - 49048431	15	48756233 - 48756234	210686	208201	rs869312853	NC_000015.10:48756232:TT:A
NM_001040436.3(YARS2):c.359dup (p.Asp121fs)	YARS2		Myopathy, lactic acidosis, and sideroblastic anemia 2	Pathogenic(Last reviewed: Apr 1, 2014)	criteria provided, single submitter	VCV000209208	12	32908449 - 32908450	12	32755515 - 32755516	209208	205771	rs797045077	NC_000012.12:32755515:CCC:CCCC
NM_001194998.2(CEP152):c.3016del (p.Thr1006fs)	CEP152	T1006fs	Primary autosomal recessive microcephaly 9	Pathogenic(Last reviewed: Oct 14, 2013)	criteria provided, single submitter	VCV000158250	15	49048429	15	48756232	158250	169144	rs587783423	NC_000015.10:48756231:TTTTTT:TTTTT
NM_001194998.2(CEP152):c.2679del (p.Ser894fs)	CEP152	S894fs	Primary autosomal recessive microcephaly 9	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158244	15	49052347	15	48760150	158244	169150	rs587783421	NC_000015.10:48760149:G:
NM_001194998.2(CEP152):c.1155del (p.Thr386fs)	CEP152	T386fs	Primary autosomal recessive microcephaly 9	Pathogenic(Last reviewed: Apr 24, 2013)	criteria provided, single submitter	VCV000158223	15	49081016	15	48788819	158223	169169	rs587783414	NC_000015.10:48788818:G:
NM_001194998.2(CEP152):c.2694+1G>T	CEP152		Seckel syndrome 5	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000031032	15	49052331	15	48760134	31032	39989	rs1349385657	NC_000015.10:48760133:C:A
NM_001194998.2(CEP152):c.261+1G>C	CEP152		Seckel syndrome 5	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000031030	15	49089857	15	48797660	31030	39987	rs966888627	NC_000015.10:48797659:C:G
NM_001040436.3(YARS2):c.1147_1164dup (p.Val383_Glu388dup)	YARS2		Mitochondrial diseases	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000426099	12	32902980 - 32902981	12	32750046 - 32750047	426099	414707	rs775256289	NC_000012.12:32750046:CTCCTGATCAGACATGACCTCC:CTCCTGATCAGACATGACCTCCTGATCAGACATGACCTCC
NM_001040436.3(YARS2):c.1106G>A (p.Cys369Tyr)	YARS2	C369Y	Mitochondrial diseases	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000426098	12	32903039	12	32750105	426098	414708	rs1365700579	NC_000012.12:32750104:C:T
NM_001101362.2(KBTBD13):c.742C>A (p.Arg248Ser)	KBTBD13	R248S	Nemaline myopathy 6	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000031063	15	65369895	15	65077557	31063	40020	rs200549195	NC_000015.10:65077556:C:A
NM_014249.4(NR2E3):c.481del (p.Thr161fs)	NR2E3	T161fs	Retinal dystrophy|Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000636047	15	72104426	15	71812086	636047	623884		NC_000015.10:71812085:A:
NM_012062.5(DNM1L):c.763_764dup (p.Lys256fs)	DNM1L		Optic atrophy 5|Encephalopathy due to defective mitochondrial and peroxisomal fission 1	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000689730	12	32873619 - 32873620	12	32720685 - 32720686	689730	677437		NC_000012.12:32720685:AA:AAAA
NM_012062.5(DNM1L):c.251-1532dup	DNM1L		Encephalopathy due to defective mitochondrial and peroxisomal fission 1	Pathogenic(Last reviewed: Aug 25, 2016)	no assertion criteria provided	VCV000253263	12	32858768 - 32858769	12	32705834 - 32705835	253263	247685	rs879255686	NC_000012.12:32705834:A:AA
NM_001040436.3(YARS2):c.137G>A (p.Gly46Asp)	YARS2	G46D	not provided|Myopathy, lactic acidosis, and sideroblastic anemia 2	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000102433	12	32908672	12	32755738	102433	108175	rs587777213	NC_000012.12:32755737:C:T
NM_001101362.2(KBTBD13):c.1222C>T (p.Arg408Cys)	KBTBD13	R408C	Nemaline myopathy 6	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000031062	15	65370375	15	65078037	31062	40019	rs387907090	NC_000015.10:65078036:C:T
NM_001101362.2(KBTBD13):c.1170G>C (p.Lys390Asn)	KBTBD13	K390N	Nemaline myopathy 6	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000031061	15	65370323	15	65077985	31061	40018		NC_000015.10:65077984:G:C
NM_012062.5(DNM1L):c.575C>A (p.Ala192Glu)	DNM1L	A192E, A205E	Optic atrophy 5	Pathogenic(Last reviewed: Nov 8, 2017)	no assertion criteria provided	VCV000446170	12	32866261	12	32713327	446170	439517	rs1555119216	NC_000012.12:32713326:C:A
NM_012062.5(DNM1L):c.5A>C (p.Glu2Ala)	DNM1L	E2A	Optic atrophy 5	Pathogenic(Last reviewed: Nov 8, 2017)	no assertion criteria provided	VCV000446169	12	32832302	12	32679368	446169	439516	rs1555229948	NC_000012.12:32679367:A:C
NM_012062.5(DNM1L):c.346_347del (p.Glu116fs)	DNM1L	E129fs, E116fs	Encephalopathy due to defective mitochondrial and peroxisomal fission 1	Pathogenic(Last reviewed: Aug 25, 2016)	no assertion criteria provided	VCV000253264	12	32861134 - 32861135	12	32708200 - 32708201	253264	247686	rs879255687	NC_000012.12:32708199:AGA:A
NM_012062.5(DNM1L):c.106A>G (p.Ser36Gly)	DNM1L	S36G	Encephalopathy due to defective mitochondrial and peroxisomal fission 1|not provided	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000253266	12	32854352	12	32701418	253266	247688	rs879255688	NC_000012.12:32701417:A:G
NM_000424.4(KRT5):c.980T>C (p.Met327Thr)	KRT5	M327T	|not provided|Epidermolysis bullosa simplex, autosomal recessive|Epidermolysis bullosa simplex, Koebner type|Epidermolysis bullosa simplex with migratory circinate erythema|Dowling-Degos disease 1|||Epidermolysis bullosa simplex with mottled pigmentation	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014641	12	52911486	12	52517702	14641	29680	rs58072617	NC_000012.12:52517701:A:G
NM_002755.3(MAP2K1):c.790C>T (p.Pro264Ser)	MAP2K1	P264S	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375983	15	66777424	15	66485086	375983	362862	rs1057519734	NC_000015.10:66485085:C:T
NM_002755.3(MAP2K1):c.332T>G (p.Ile111Ser)	MAP2K1	I111S	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375979	15	66729124	15	66436786	375979	362858	rs1057519730	NC_000015.10:66436785:T:G
NM_003982.4(SLC7A7):c.895-2A>T	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000816701	14	23245147	14	22775938	816701	804907		NC_000014.9:22775937:T:A
NM_001126105.2(SLC7A7):c.625+1G>C	SLC7A7		Lysinuric protein intolerance	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000056375	14	23249134	14	22779925	56375	71014	rs386833822	NC_000014.9:22779924:C:G
NM_001126105.2(SLC7A7):c.1185_1188del (p.Ser396fs)	SLC7A7	S396fs	Lysinuric protein intolerance	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000056352	14	23243620 - 23243623	14	22774411 - 22774414	56352	70991	rs386833800	NC_000014.9:22774410:AGAAAG:AG
NM_003673.3(TCAP):c.26_33dup (p.Glu12fs)	TCAP		not provided|Dilated cardiomyopathy 1N|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448649	17	37821635 - 37821636	17	39665382 - 39665383	448649	441954	rs778568339	NC_000017.11:39665382:CGAGGTGTCG:CGAGGTGTCGAGGTGTCG
NC_000012.11:g.(?_111348623)_(111348979_?)del	MYL2		Familial hypertrophic cardiomyopathy 10	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000417460	12	111348623 - 111348979	12	110910819 - 110911175	417460	398419		
NM_002755.3(MAP2K1):c.607G>A (p.Glu203Lys)	MAP2K1	E203K	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375982	15	66774131	15	66481793	375982	362861	rs1057519733	NC_000015.10:66481792:G:A
NM_002755.3(MAP2K1):c.158T>C (p.Phe53Ser)	MAP2K1	F53S	Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 3|not provided	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000013350	15	66727442	15	66435104	13350	28389	rs121908594	NC_000015.10:66435103:T:C
NM_000286.3(PEX12):c.126+1G>T	PEX12		not provided|Peroxisome biogenesis disorder 3A|Peroxisome biogenesis disorders, Zellweger syndrome spectrum|Infantile Refsum's disease	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371718	17	33904914	17	35577895	371718	358427	rs144259891	NC_000017.11:35577894:C:A
NM_031885.4(BBS2):c.535-2A>G	BBS2		not provided	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000499851	16	56543948	16	56510036	499851	491275	rs1555523398	NC_000016.10:56510035:T:C
NM_031885.4(BBS2):c.1099dup (p.Leu367fs)	BBS2		not provided	Pathogenic(Last reviewed: Jan 26, 2015)	criteria provided, single submitter	VCV000193747	16	56535390 - 56535391	16	56501478 - 56501479	193747	190910	rs797044632	NC_000016.10:56501478:G:GG
NM_031885.4(BBS2):c.1546C>T (p.Gln516Ter)	BBS2	Q516*	Bardet-Biedl syndrome 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803258	16	56532462	16	56498550	803258	791626		NC_000016.10:56498549:G:A
NM_004204.4(PIGQ):c.690-2A>G	PIGQ		EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 77	Pathogenic(Last reviewed: Jun 15, 2014)	no assertion criteria provided	VCV000140458	16	625837	16	575837	140458	150142	rs587777543	NC_000016.10:575836:A:G
BBS2, THR560ILE	BBS2	T560I	Bardet-biedl syndrome 2/4, digenic	Pathogenic(Last reviewed: Sep 21, 2001)	no assertion criteria provided	VCV000004582					4582	19621		
BBS2, LEU168FS, TER170	BBS2		Bardet-biedl syndrome 2/6, digenic	Pathogenic(Last reviewed: Sep 21, 2001)	no assertion criteria provided	VCV000004581					4581	19620		
NM_031885.3(BBS2):c.472del (p.Val158Leufs)	BBS2		Bardet-biedl syndrome 1/2, digenic	Pathogenic(Last reviewed: Sep 21, 2001)	no assertion criteria provided	VCV000004580	16	56544833	16	56510921	4580	19619	rs587777826	NC_000016.10:56510920:CC:C
BBS2, ASP170FS, TER171	BBS2		Bardet-biedl syndrome 1/2, digenic	Pathogenic(Last reviewed: Sep 21, 2001)	no assertion criteria provided	VCV000004574					4574	19613		
NM_031885.5(BBS2):c.774del (p.Asn258fs)	BBS2	N258fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: May 11, 2019)	criteria provided, single submitter	VCV000854709	16	56539892	16	56505980	854709	844017		NC_000016.10:56505979:A:
NM_031885.5(BBS2):c.1843dup (p.Ala615fs)	BBS2		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000838085	16	56530945 - 56530946	16	56497033 - 56497034	838085	844005		NC_000016.10:56497033:CC:CCC
NM_031885.5(BBS2):c.1486_1489del (p.Ile496fs)	BBS2	I496fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000836947	16	56533728 - 56533731	16	56499816 - 56499819	836947	844011		NC_000016.10:56499815:TGATTG:TG
NM_031885.4(BBS2):c.1062C>G (p.Asn354Lys)	BBS2	N354K	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000625448	16	56536247	16	56502335	625448	613755	rs1567576202	NC_000016.10:56502334:G:C
NM_031885.4(BBS2):c.522T>A (p.Asp174Glu)	BBS2	D174E	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585182	16	56544783	16	56510871	585182	576242	rs767373822	NC_000016.10:56510870:A:T
NC_000016.9:g.(?_56518653)_(56545216_?)del	BBS2		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Aug 12, 2017)	criteria provided, single submitter	VCV000462944	16	56518653 - 56545216			462944	465687		
NC_000016.9:g.(56519651_56530879)_(56536720_56539861)del	BBS2		Bardet-Biedl syndrome	Pathogenic	no assertion criteria provided	VCV000266085	16	56519651 - 56539861	16	56485739 - 56505949	266085	260920		
NM_031885.4(BBS2):c.263del (p.Gly88fs)	BBS2	G88fs	Bardet-Biedl syndrome 2	Pathogenic(Last reviewed: Oct 5, 2015)	no assertion criteria provided	VCV000217434	16	56548447	16	56514535	217434	214079	rs869025206	NC_000016.10:56514534:CC:C
ERCC5, 1-BP DEL, 2170A	ERCC5		Xeroderma pigmentosum group g/Cockayne syndrome	Pathogenic(Last reviewed: Jul 1, 1993)	no assertion criteria provided	VCV000016569					16569	31608		
NM_031885.4(BBS2):c.118-1G>C	BBS2		Bardet-Biedl syndrome 2	Pathogenic(Last reviewed: Sep 21, 2001)	no assertion criteria provided	VCV000004579	16	56548593	16	56514681	4579	19618	rs587777825	NC_000016.10:56514680:C:G
BBS2, CYS210FS, TER246	BBS2		Bardet-Biedl syndrome 2	Pathogenic(Last reviewed: Sep 21, 2001)	no assertion criteria provided	VCV000004575					4575	19614		
NM_031885.4(BBS2):c.940del (p.Ile314fs)	BBS2	I314fs	Bardet-Biedl syndrome 2	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004568	16	56536585	16	56502673	4568	19607	rs587777824	NC_000016.10:56502672:TTT:TT
NM_031885.4(BBS2):c.472-2A>G	BBS2		Bardet-Biedl syndrome 2	Pathogenic(Last reviewed: Oct 5, 2012)	no assertion criteria provided	VCV000030550	16	56544835	16	56510923	30550	39507	rs137854887	NC_000016.10:56510922:T:C
ERCC5, 1-BP DEL, 2972T	ERCC5		Cerebrooculofacioskeletal syndrome 3	Pathogenic(Last reviewed: Apr 27, 2007)	no assertion criteria provided	VCV000016568					16568	31607		
NM_031885.4(BBS2):c.416G>T (p.Gly139Val)	BBS2	G139V	Bardet-Biedl syndrome 2	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000004584	16	56545126	16	56511214	4584	19623	rs121908181	NC_000016.10:56511213:C:A
NM_001110219.3(GJB6):c.263C>T (p.Ala88Val)	GJB6	A88V	Deafness, autosomal dominant 3b|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Hidrotic ectodermal dysplasia syndrome|Hidrotic ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000005545	13	20797357	13	20223218	5545	20584	rs28937872	NC_000013.11:20223217:G:A
NM_031885.4(BBS2):c.1290dup (p.His431fs)	BBS2		Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636152	16	56534872 - 56534873	16	56500960 - 56500961	636152	624003		NC_000016.10:56500960:T:TT
NM_004204.4(PIGQ):c.619C>T (p.Arg207Ter)	PIGQ	R207*	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 77|Intractable seizure|Global developmental delay|Optic atrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2015)	no assertion criteria provided	VCV000183339	16	624693	16	574693	183339	181445	rs730882240	NC_000016.10:574692:C:T
NM_000432.3(MYL2):c.283C>G (p.Pro95Ala)	MYL2	P94R, P95A	Familial hypertrophic cardiomyopathy 10	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000014066	12	111351120	12	110913316	14066	29105	rs121913658	NC_000012.12:110913315:G:C
NM_001126106.2(SLC7A7):c.1228C>T (p.Arg410Ter)	SLC7A7	R410*	Lysinuric protein intolerance	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000006212	14	23243580	14	22774371	6212	21251	rs121908678	NC_000014.9:22774370:G:A
NM_001126106.2(SLC7A7):c.1001T>G (p.Leu334Arg)	SLC7A7	L334R	Lysinuric protein intolerance	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000006209	14	23244747	14	22775538	6209	21248	rs72552272	NC_000014.9:22775537:A:C
NM_001089.3(ABCA3):c.817_821del (p.Tyr273fs)	ABCA3	Y273fs	Surfactant metabolism dysfunction, pulmonary, 3	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000619285	16	2369634 - 2369638	16	2319633 - 2319637	619285	610685	rs775903641	NC_000016.10:2319632:GTGTAG:G
NM_001089.3(ABCA3):c.4909+1G>A	ABCA3		Surfactant metabolism dysfunction, pulmonary, 3	Pathogenic(Last reviewed: Mar 25, 2004)	no assertion criteria provided	VCV000008016	16	2327879	16	2277878	8016	23055	rs1567335355	NC_000016.10:2277877:C:T
NM_001089.3(ABCA3):c.1702A>G (p.Asn568Asp)	ABCA3	N568D	Surfactant metabolism dysfunction, pulmonary, 3	Pathogenic(Last reviewed: Mar 25, 2004)	no assertion criteria provided	VCV000008015	16	2349443	16	2299442	8015	23054	rs121909184	NC_000016.10:2299441:T:C
NM_001089.3(ABCA3):c.4772A>C (p.Gln1591Pro)	ABCA3	Q1591P	Surfactant metabolism dysfunction, pulmonary, 3	Pathogenic(Last reviewed: Mar 25, 2004)	no assertion criteria provided	VCV000008014	16	2328017	16	2278016	8014	23053	rs28936691	NC_000016.10:2278015:T:G
NM_001089.3(ABCA3):c.4658T>C (p.Leu1553Pro)	ABCA3	L1553P	Surfactant metabolism dysfunction, pulmonary, 3	Pathogenic(Last reviewed: Mar 25, 2004)	no assertion criteria provided	VCV000008013	16	2328349	16	2278348	8013	23052	rs121909183	NC_000016.10:2278347:A:G
NM_001089.3(ABCA3):c.302T>C (p.Leu101Pro)	ABCA3	L101P	Surfactant metabolism dysfunction, pulmonary, 3	Pathogenic(Last reviewed: Mar 25, 2004)	no assertion criteria provided	VCV000008012	16	2376028	16	2326027	8012	23051	rs121909182	NC_000016.10:2326026:A:G
NM_001089.3(ABCA3):c.3426G>A (p.Trp1142Ter)	ABCA3	W1142*	Surfactant metabolism dysfunction, pulmonary, 3	Pathogenic(Last reviewed: Mar 25, 2004)	no assertion criteria provided	VCV000008011	16	2335500	16	2285499	8011	23050	rs121909181	NC_000016.10:2285498:C:T
NM_031885.4(BBS2):c.1705C>T (p.Gln569Ter)	BBS2	Q569*	Bardet-Biedl syndrome|Bardet-Biedl syndrome 2	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551008	16	56531747	16	56497835	551008	548025	rs1555521501	NC_000016.10:56497834:G:A
NM_031885.4(BBS2):c.1780C>T (p.Arg594Ter)	BBS2	R594*	Bardet-Biedl syndrome|Bardet-Biedl syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550489	16	56531672	16	56497760	550489	548023	rs762047808	NC_000016.10:56497759:G:A
NM_031885.4(BBS2):c.1770del (p.Phe590fs)	BBS2	F590fs	Bardet-Biedl syndrome|Bardet-Biedl syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035755	16	56531682	16	56497770	35755	44419	rs193922711	NC_000016.10:56497769:AAAA:AAA
NM_032520.5(GNPTG):c.436_446del (p.Asn146fs)	GNPTG	N146fs	not provided	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000501897	16	1412229 - 1412239	16	1362228 - 1362238	501897	493321	rs1555451874	NC_000016.10:1362227:GCAACCGGCTGGC:GC
NM_032520.5(GNPTG):c.714del (p.Phe239fs)	GNPTG	F239fs	not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000861787	16	1412713	16	1362712	861787	843085		NC_000016.10:1362711:GGGG:GGG
NM_032520.5(GNPTG):c.365G>A (p.Trp122Ter)	GNPTG	W122*	not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000835923	16	1412086	16	1362085	835923	843077		NC_000016.10:1362084:G:A
NC_000016.9:g.(?_1401957)_(1413102_?)del	GNPTG		not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000665655	16	1401957 - 1413102	16	1351956 - 1363101	665655	653095		
NM_032520.5(GNPTG):c.639del (p.Phe213fs)	GNPTG	F213fs		Pathogenic(Last reviewed: Jul 5, 2012)	no assertion criteria provided	VCV000021723	16	1412637	16	1362636	21723	34575	rs193302858	NC_000016.10:1362635:TTTTT:TTTT
NM_032520.5(GNPTG):c.619_620insT (p.Lys207fs)	GNPTG			Pathogenic(Last reviewed: Jul 5, 2012)	no assertion criteria provided	VCV000021722	16	1412621 - 1412622	16	1362620 - 1362621	21722	34574	rs193302857	NC_000016.10:1362620::T
NM_032520.5(GNPTG):c.610-2A>G	GNPTG			Pathogenic(Last reviewed: Jul 5, 2012)	no assertion criteria provided	VCV000021721	16	1412610	16	1362609	21721	34573	rs193302855	NC_000016.10:1362608:A:G
NM_032520.5(GNPTG):c.610-1G>T	GNPTG			Pathogenic(Last reviewed: Jul 5, 2012)	no assertion criteria provided	VCV000021720	16	1412611	16	1362610	21720	34572	rs193302854	NC_000016.10:1362609:G:T
NM_032520.5(GNPTG):c.608_609insC (p.Gln203fs)	GNPTG			Pathogenic(Last reviewed: Jul 5, 2012)	no assertion criteria provided	VCV000021718	16	1412534 - 1412535	16	1362533 - 1362534	21718	34570	rs1555451988	NC_000016.10:1362533::C
NM_032520.5(GNPTG):c.523dup (p.Leu175fs)	GNPTG			Pathogenic(Last reviewed: Jul 5, 2012)	no assertion criteria provided	VCV000021717	16	1412317 - 1412318	16	1362316 - 1362317	21717	34569	rs193302851	NC_000016.10:1362316:C:CC
NM_032520.5(GNPTG):c.379_391del (p.Asp127fs)	GNPTG	D127fs		Pathogenic(Last reviewed: Jul 5, 2012)	no assertion criteria provided	VCV000021716	16	1412099 - 1412111	16	1362098 - 1362110	21716	34568	rs193302850	NC_000016.10:1362097:TGACGCCTGCCGTT:T
NM_032520.5(GNPTG):c.318-1G>C	GNPTG			Pathogenic(Last reviewed: Jul 5, 2012)	no assertion criteria provided	VCV000021714	16	1412038	16	1362037	21714	34566	rs193302847	NC_000016.10:1362036:G:C
NM_032520.5(GNPTG):c.527-10G>A	GNPTG			Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000030685	16	1412443	16	1362442	30685	39642		NC_000016.10:1362441:G:A
NM_032520.5(GNPTG):c.609+28_610-16del	GNPTG			Pathogenic(Last reviewed: Jul 5, 2012)	no assertion criteria provided	VCV000021719	16	1412563 - 1412596	16	1362562 - 1362595	21719	34571	rs193302853	NC_000016.10:1362561:GTGGGCCTGGCTGGGAGCTGGGTGCTGCCCCTGC:
GNPTG, IVS8AS, G-T, -1	GNPTG			Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000002801					2801	17840		
GNPTG, 1-BP DEL, 639T	GNPTG			Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000002800					2800	17839		
GNPTG, IVS8AS, A-G, -2	GNPTG			Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000002798					2798	17837		
GNPTG, 1-BP INS	GNPTG			Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000002794					2794	17833		
NM_002225.4(IVD):c.149G>A (p.Arg50His)	IVD	R53H, R50H	Isovaleryl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370843	15	40699841	15	40407640	370843	358296	rs2229311	NC_000015.10:40407639:G:A
NM_002225.3(IVD):c.1188delT (p.Leu397Phefs)	IVD		Isovaleryl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188993	15	40710369	15	40418168	188993	186932	rs786204613	NC_000015.10:40418167:TTT:TT
NM_002225.5(IVD):c.456+2T>C	IVD		Isovaleryl-CoA dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094055	15	40702998	15	40410799	94055	99957	rs398123683	NC_000015.10:40410798:T:C
NM_032520.5(GNPTG):c.328G>T (p.Glu110Ter)	GNPTG	E110*		Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000554488	16	1412049	16	1362048	554488	547729	rs763678034	NC_000016.10:1362047:G:T
NM_032520.5(GNPTG):c.445del (p.Ala149fs)	GNPTG	A149fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039080	16	1412239	16	1362238	39080	47683	rs281864956	NC_000016.10:1362237:GG:G
NM_032520.5(GNPTG):c.640_667del (p.Glu214fs)	GNPTG	E214fs		Pathogenic(Last reviewed: Jul 5, 2012)	no assertion criteria provided	VCV000002796	16	1412642 - 1412669	16	1362641 - 1362668	2796	17835	rs193302859	NC_000016.10:1362640:GAGGATGCTGGCTACTTAAAGACCCCAG:
NM_032520.4(GNPTG):c.611delG (p.Gly204Alafs)	GNPTG			Pathogenic(Last reviewed: Jul 5, 2012)	no assertion criteria provided	VCV000002795	16	1412611	16	1362610	2795	17834	rs193302856	NC_000016.10:1362609:GGG:GG
NM_052867.4(NALCN):c.3490-2A>G	NALCN		not provided	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000546191	13	101736157	13	101083806	546191	536859	rs1333710212	NC_000013.11:101083805:T:C
NM_052867.4(NALCN):c.1068dup (p.Gly357fs)	NALCN		not provided	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000545938	13	101936349 - 101936350	13	101283998 - 101283999	545938	536418	rs1255534617	NC_000013.11:101283998:A:AA
NM_052867.4(NALCN):c.306T>G (p.Tyr102Ter)	NALCN	Y102*	not provided	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000489026	13	102030990	13	101378639	489026	482037	rs527789070	NC_000013.11:101378638:A:C
NM_052867.4(NALCN):c.4750_4751AG[1] (p.Arg1584fs)	NALCN		not provided	Pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000423000	13	101714322 - 101714323	13	101061970 - 101061971	423000	408781	rs1064796154	NC_000013.11:101061969:CTCT:CT
NM_052867.4(NALCN):c.1776T>G (p.Ser592Arg)	NALCN	S592R, S563R	not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000421882	13	101828714	13	101176363	421882	408782	rs1064795423	NC_000013.11:101176362:A:C
NM_052867.4(NALCN):c.2008C>T (p.Gln670Ter)	NALCN	Q670*, Q641*	not provided	Pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000391479	13	101795541	13	101143190	391479	373579	rs972964381	NC_000013.11:101143189:G:A
NM_052867.4(NALCN):c.965T>C (p.Ile322Thr)	NALCN	I322T	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic	no assertion criteria provided	VCV000375370	13	101944423	13	101292072	375370	362156	rs1057519433	NC_000013.11:101292071:A:G
NM_052867.4(NALCN):c.1639A>G (p.Met547Val)	NALCN	M547V, M518V	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic	no assertion criteria provided	VCV000375369	13	101844393	13	101192042	375369	362155	rs1057519432	NC_000013.11:101192041:T:C
NC_000013.11:g.101089704G>T	NALCN		Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000816891					816891	805103		
NM_052867.4(NALCN):c.537del (p.Ile178_Trp179insTer)	NALCN		Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684711	13	102029158	13	101376807	684711	672274		NC_000013.11:101376806:CC:C
NM_052867.4(NALCN):c.2758del (p.Ile920fs)	NALCN	I891fs, I949fs, I920fs	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684710	13	101756777	13	101104426	684710	672271		NC_000013.11:101104425:T:
NM_052867.4(NALCN):c.321G>A (p.Trp107Ter)	NALCN	W107*	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684709	13	102030975	13	101378624	684709	672275		NC_000013.11:101378623:C:T
NM_052867.4(NALCN):c.4150C>T (p.Arg1384Ter)	NALCN	R1384*, R1413*, R1355*	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684708	13	101725983	13	101073631	684708	672267		NC_000013.11:101073630:G:A
NM_052867.4(NALCN):c.2889+3_2889+6del	NALCN		Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684707	13	101756640 - 101756643	13	101104289 - 101104292	684707	672305		NC_000013.11:101104288:ACTTAC:AC
NM_052867.4(NALCN):c.4333A>T (p.Ile1445Leu)	NALCN	I1445L, I1416L, I1474L	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684706	13	101720383	13	101068031	684706	672265		NC_000013.11:101068030:T:A
NM_052867.4(NALCN):c.2435dup (p.Glu813fs)	NALCN		Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684705	13	101760069 - 101760070	13	101107718 - 101107719	684705	672273		NC_000013.11:101107718:TTTTTTT:TTTTTTTT
NM_052867.4(NALCN):c.3556C>T (p.Gln1186Ter)	NALCN	Q1186*, Q1215*, Q1157*	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684704	13	101736089	13	101083738	684704	672268		NC_000013.11:101083737:G:A
NM_052867.4(NALCN):c.4103+2T>C	NALCN		Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684703	13	101726863	13	101074512	684703	672304		NC_000013.11:101074511:A:G
NM_052867.4(NALCN):c.4281C>A (p.Phe1427Leu)	NALCN	F1427L, F1456L, F1398L	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684702	13	101721096	13	101068744	684702	672266		NC_000013.11:101068743:G:T
NM_052867.4(NALCN):c.2629del (p.Gln877fs)	NALCN	Q877fs, Q906fs, Q848fs	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684700	13	101757252	13	101104901	684700	672272		NC_000013.11:101104900:G:
NM_052867.4(NALCN):c.3022C>T (p.Arg1008Ter)	NALCN	R1037*, R1008*, R979*	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684699	13	101755558	13	101103207	684699	672270		NC_000013.11:101103206:G:A
NM_052867.4(NALCN):c.4236C>A (p.Tyr1412Ter)	NALCN	Y1412*, Y1441*, Y1383*	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522758	13	101721141	13	101068789	522758	513325	rs1158771233	NC_000013.11:101068788:G:T
NM_052867.4(NALCN):c.1733A>G (p.Tyr578Cys)	NALCN	Y578C, Y549C	not provided	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000254646	13	101844299	13	101191948	254646	249193	rs786203988	NC_000013.11:101191947:T:C
NM_052867.4(NALCN):c.934C>A (p.Leu312Ile)	NALCN	L312I	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000235837	13	101944583	13	101292232	235837	237490	rs878853134	NC_000013.11:101292231:G:T
NM_052867.4(NALCN):c.979G>A (p.Glu327Lys)	NALCN	E327K	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000235836	13	101944409	13	101292058	235836	237489	rs878853133	NC_000013.11:101292057:C:T
NM_052867.4(NALCN):c.1534T>G (p.Phe512Val)	NALCN	F512V, F483V	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000235835	13	101881836	13	101229485	235835	237488	rs878853132	NC_000013.11:101229484:A:C
NM_052867.4(NALCN):c.1538C>A (p.Thr513Asn)	NALCN	T513N, T484N	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000235834	13	101881832	13	101229481	235834	237487	rs878853131	NC_000013.11:101229480:G:T
NM_052867.4(NALCN):c.3017T>C (p.Val1006Ala)	NALCN	V1006A, V977A, V1035A	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000235833	13	101755563	13	101103212	235833	237486	rs878853130	NC_000013.11:101103211:A:G
NM_052867.4(NALCN):c.3050T>C (p.Ile1017Thr)	NALCN	I1017T, I1046T, I988T	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000235832	13	101755530	13	101103179	235832	237485	rs878853129	NC_000013.11:101103178:A:G
NM_052867.4(NALCN):c.3493A>C (p.Thr1165Pro)	NALCN	T1165P, T1136P, T1194P	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000235831	13	101736152	13	101083801	235831	237484	rs878853128	NC_000013.11:101083800:T:G
NM_052867.4(NALCN):c.4338T>G (p.Ile1446Met)	NALCN	I1446M, I1417M, I1475M	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000235830	13	101720378	13	101068026	235830	237483	rs878853127	NC_000013.11:101068025:A:C
NM_052867.4(NALCN):c.3390G>A (p.Pro1130=)	NALCN		Abnormal pattern of respiration|Intellectual disability, severe|Seizures|Cachexia|Strabismus	Pathogenic(Last reviewed: Dec 31, 2015)	criteria provided, single submitter	VCV000222073	13	101742197	13	101089846	222073	223771	rs869312873	NC_000013.11:101089845:C:T
NM_052867.4(NALCN):c.3860G>T (p.Trp1287Leu)	NALCN	W1287L, W1258L, W1316L	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Oct 3, 2013)	no assertion criteria provided	VCV000088687	13	101733903	13	101081552	88687	94267	rs587777068	NC_000013.11:101081551:C:A
NM_052867.4(NALCN):c.1924C>T (p.Gln642Ter)	NALCN	Q642*, Q613*	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065422	13	101797163	13	101144812	65422	76352	rs587777038	NC_000013.11:101144811:G:A
NM_052867.4(NALCN):c.1526T>C (p.Leu509Ser)	NALCN	L509S, L480S	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000187774	13	101881844	13	101229493	187774	185672	rs786203987	NC_000013.11:101229492:A:G
NM_052867.4(NALCN):c.1768C>T (p.Leu590Phe)	NALCN	L590F, L561F	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000187773	13	101828722	13	101176371	187773	185671	rs786203986	NC_000013.11:101176370:G:A
NM_052867.4(NALCN):c.938T>G (p.Val313Gly)	NALCN	V313G	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000187772	13	101944579	13	101292228	187772	185670	rs786203985	NC_000013.11:101292227:A:C
NM_052867.4(NALCN):c.530A>C (p.Gln177Pro)	NALCN	Q177P	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000187771	13	102029165	13	101376814	187771	185669	rs786203984	NC_000013.11:101376813:T:G
NM_052867.4(NALCN):c.3056dup (p.Leu1019fs)	NALCN		not provided|Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000684701	13	101755523 - 101755524	13	101103172 - 101103173	684701	672269		NC_000013.11:101103172:AAAAAAA:AAAAAAAA
NM_052867.4(NALCN):c.1489del (p.Tyr497fs)	NALCN	Y497fs, Y468fs	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1|not provided	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000088686	13	101881881	13	101229530	88686	94266	rs869025188	NC_000013.11:101229529:A:
NM_031885.4(BBS2):c.700C>T (p.Arg234Ter)	BBS2	R234*	Bardet-Biedl syndrome 2|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554001	16	56540049	16	56506137	554001	548043	rs779690256	NC_000016.10:56506136:G:A
NM_031885.4(BBS2):c.1814C>G (p.Ser605Ter)	BBS2	S605*	Bardet-Biedl syndrome 2|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553335	16	56530975	16	56497063	553335	547788	rs201063733	NC_000016.10:56497062:G:C
NM_006009.4(TUBA1A):c.641G>A (p.Arg214His)	TUBA1A	R214H, R179H	Lissencephaly 3|not provided|Tubulinopathies	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372542	12	49579508	12	49185725	372542	359970	rs1057517843	NC_000012.12:49185724:C:T
NM_006009.4(TUBA1A):c.1226T>C (p.Val409Ala)	TUBA1A	V409A, V374A	|Lissencephaly|Cryptorchidism|not provided|Tubulinopathies|Lissencephaly 3	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208490	12	49578923	12	49185140	208490	205017	rs797045005	NC_000012.12:49185139:A:G
NM_052867.4(NALCN):c.1733A>C (p.Tyr578Ser)	NALCN	Y578S, Y549S	not provided|Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	VCV000187775	13	101844299	13	101191948	187775	185673	rs786203988	NC_000013.11:101191947:T:G
NM_032520.5(GNPTG):c.607dup (p.Gln203fs)	GNPTG		|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553164	16	1412527 - 1412528	16	1362526 - 1362527	553164	547990	rs756225251	NC_000016.10:1362526:CCCCCC:CCCCCCC
NM_032520.5(GNPTG):c.333G>A (p.Trp111Ter)	GNPTG	W111*	|not provided	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000002797	16	1412054	16	1362053	2797	17836	rs137852884	NC_000016.10:1362052:G:A
NM_000137.4(FAH):c.1003_1004del (p.Val335fs)	FAH	V335fs	Tyrosinemia type I	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803110	15	80472507 - 80472508	15	80180165 - 80180166	803110	791487		NC_000015.10:80180164:TGT:T
NM_000137.3(FAH):c.82_83del (p.Pro28fs)	FAH	P28fs	Tyrosinemia type I	Pathogenic(Last reviewed: Nov 23, 2018)	no assertion criteria provided	VCV000635516	15	80450402 - 80450403	15	80158060 - 80158061	635516	623379		NC_000015.10:80158059:CC:
NM_000137.4(FAH):c.221del (p.Gly74fs)	FAH	G74fs	Tyrosinemia type I	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000862144	15	80452124	15	80159782	862144	842736		NC_000015.10:80159781:GGG:GG
NM_000137.4(FAH):c.1180+1G>A	FAH		Tyrosinemia type I	Pathogenic	criteria provided, single submitter	VCV000813493	15	80473502	15	80181160	813493	801728		NC_000015.10:80181159:G:A
NM_000137.4(FAH):c.982C>T (p.Gln328Ter)	FAH	Q328*	Tyrosinemia type I	Pathogenic	criteria provided, single submitter	VCV000813492	15	80472487	15	80180145	813492	801727		NC_000015.10:80180144:C:T
NM_000137.3(FAH):c.835del (p.Gln279fs)	FAH	Q279fs	Tyrosinemia type I	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000551130	15	80465484	15	80173142	551130	547601	rs1555441703	NC_000015.10:80173141:C:
NM_000137.3(FAH):c.698A>T (p.Asp233Val)	FAH	D233V	Tyrosinemia type I	Pathogenic(Last reviewed: Aug 25, 2011)	no assertion criteria provided	VCV000021057	15	80464582	15	80172240	21057	33909	rs80338897	NC_000015.10:80172239:A:T
NM_000137.3(FAH):c.836A>G (p.Gln279Arg)	FAH	Q279R	Tyrosinemia type I	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000011875	15	80465485	15	80173143	11875	26914	rs121965078	NC_000015.10:80173142:A:G
NM_000137.3(FAH):c.47A>T (p.Asn16Ile)	FAH	N16I	Tyrosinemia type I	Pathogenic(Last reviewed: Oct 1, 1992)	no assertion criteria provided	VCV000011865	15	80445443	15	80153101	11865	26904	rs121965073	NC_000015.10:80153100:A:T
NC_000015.10:g.(?_80177527)_(80186219_?)del	FAH		Tyrosinemia type I	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000830521	15	80469869 - 80478561			830521	820739		
NM_000137.4(FAH):c.978dup (p.Leu327fs)	FAH		Tyrosinemia type I	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000656983	15	80472482 - 80472483	15	80180140 - 80180141	656983	643565		NC_000015.10:80180140:G:GG
NM_000137.3(FAH):c.553+2_553+3del	FAH		Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000552185	15	80460491 - 80460492	15	80168149 - 80168150	552185	547864	rs1555441272	NC_000015.10:80168148:TGTG:TG
NM_000137.3(FAH):c.706+2T>G	FAH		Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000550532	15	80464592	15	80172250	550532	547873	rs1555441597	NC_000015.10:80172249:T:G
NM_000137.3(FAH):c.963C>A (p.Tyr321Ter)	FAH	Y321*	Tyrosinemia type I|not provided	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000291075	15	80472468	15	80180126	291075	275312	rs886044640	NC_000015.10:80180125:C:A
NM_001089.3(ABCA3):c.128G>A (p.Arg43His)	ABCA3	R43H	Primary interstitial lung disease specific to childhood due to pulmonary surfactant protein anomalies	Pathogenic(Last reviewed: Feb 26, 2015)	criteria provided, single submitter	VCV000228321	16	2376202	16	2326201	228321	230630	rs754714105	NC_000016.10:2326200:C:T
GRCh37/hg19 12q21.31(chr12:80632582-80728257)x1	OTOGL		not provided	Pathogenic(Last reviewed: Apr 25, 2017)	no assertion criteria provided	VCV000688084	12	80632582 - 80728257			688084	675676		
GRCh37/hg19 12q21.31(chr12:80632582-80724853)x1	OTOGL		not provided	Pathogenic(Last reviewed: Jun 13, 2017)	no assertion criteria provided	VCV000685526	12	80632582 - 80724853			685526	673118		
NM_173591.3(OTOGL):c.3076C>T (p.Gln1026Ter)	OTOGL	Q1026*, Q981*	not provided	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000291087	12	80696453	12	80302673	291087	275324	rs886044647	NC_000012.12:80302672:C:T
NM_173591.3(OTOGL):c.6095-1G>A	OTOGL		Deafness, autosomal recessive 84b	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000522356	12	80752450	12	80358670	522356	512934	rs952235302	NC_000012.12:80358669:G:A
NM_173591.3(OTOGL):c.(?_6305)-71_*(79_?)del	OTOGL		Rare genetic deafness	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000517528	12	80761270 - 80771907	12	80367490 - 80378127	517528	497408		
NM_173591.3(OTOGL):c.5314del (p.Ser1772fs)	OTOGL	S1727fs, S1772fs	Rare genetic deafness	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000505326	12	80746148	12	80352368	505326	497655	rs772723774	NC_000012.12:80352367:TTT:TT
NM_173591.3(OTOGL):c.3054dup (p.Leu1019fs)	OTOGL		Rare genetic deafness	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000505260	12	80696424 - 80696425	12	80302644 - 80302645	505260	497430	rs764178233	NC_000012.12:80302644:TTTTTTT:TTTTTTTT
NC_000012.11:g.(?_80671950)_(80730309_?)del	OTOGL		Rare genetic deafness	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000505207	12	80671950 - 80730309	12	80278170 - 80336529	505207	497628		
NM_173591.3(OTOGL):c.948del (p.Leu316fs)	OTOGL	L316fs	Rare genetic deafness	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000228385	12	80633142	12	80239362	228385	230353	rs766753922	NC_000012.12:80239361:G:
NM_173591.3(OTOGL):c.4987C>T (p.Arg1663Ter)	OTOGL	R1663*, R1618*	Rare genetic deafness	Pathogenic(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	VCV000228384	12	80733008	12	80339228	228384	230401	rs759174628	NC_000012.12:80339227:C:T
NM_173591.3(OTOGL):c.5238+5G>A	OTOGL		Deafness, autosomal recessive 84b	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039780	12	80735947	12	80342167	39780	48379	rs902734999	NC_000012.12:80342166:G:A
NM_173591.3(OTOGL):c.547C>T (p.Arg183Ter)	OTOGL	R183*	Deafness, autosomal recessive 84b	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039779	12	80623121	12	80229341	39779	48378	rs397514588	NC_000012.12:80229340:C:T
NM_173591.3(OTOGL):c.1430del (p.Val477fs)	OTOGL	V477fs	Deafness, autosomal recessive 84b	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039778	12	80648835	12	80255055	39778	48377	rs1233562246	NC_000012.12:80255054:T:
NM_000137.3(FAH):c.1025C>T (p.Pro342Leu)	FAH	P342L	Tyrosinemia type I	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000551024	15	80472530	15	80180188	551024	547617	rs779040832	NC_000015.10:80180187:C:T
NM_000137.3(FAH):c.1210G>A (p.Gly404Ser)	FAH	G404S	Tyrosinemia type I	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000459903	15	80478501	15	80186159	459903	465319	rs1297118863	NC_000015.10:80186158:G:A
NM_000137.3(FAH):c.1090G>T (p.Glu364Ter)	FAH	E364*	Tyrosinemia type I	Pathogenic	criteria provided, single submitter	VCV000011867	15	80473411	15	80181069	11867	26906	rs121965076	NC_000015.10:80181068:G:T
NM_173591.3(OTOGL):c.1558C>T (p.Gln520Ter)	OTOGL	Q520*	not provided|Deafness, autosomal recessive 84b	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000503724	12	80648963	12	80255183	503724	495308	rs371465450	NC_000012.12:80255182:C:T
NM_201525.4(ADGRG1):c.1408C>T (p.Arg470Ter)	ADGRG1	R476*, R470*, R295*, R301*, R418*, R469*, R306*, R475*	not provided|Polymicrogyria, bilateral frontoparietal|Polymicrogyria, bilateral perisylvian, autosomal recessive|Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158618	16	57693446	16	57659534	158618	169294	rs587783652	NC_000016.10:57659533:C:T
NM_001040436.3(YARS2):c.156C>G (p.Phe52Leu)	YARS2	F52L	Myopathy, lactic acidosis, and sideroblastic anemia 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001056	12	32908653	12	32755719	1056	16095	rs267607180	NC_000012.12:32755718:G:C
NM_032520.5(GNPTG):c.196C>T (p.Arg66Ter)	GNPTG	R66*		Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000021713	16	1411761	16	1361760	21713	34565	rs193302848	NC_000016.10:1361759:C:T
NM_004119.2(FLT3):c.2503G>A (p.Asp835Asn)	FLT3	D835N	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000016274	13	28592642	13	28018505	16274	31313	rs121913488	NC_000013.11:28018504:C:T
NM_173591.3(OTOGL):c.1913G>A (p.Trp638Ter)	OTOGL	W638*	Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000498660	12	80655799	12	80262019	498660	490084	rs377708973	NC_000012.12:80262018:G:A
NM_002968.2(SALL1):c.826C>T (p.Arg276Ter)	SALL1	R276*, R179*	Townes syndrome|Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000007428	16	51175307	16	51141396	7428	22467	rs104894537	NC_000016.10:51141395:G:A
NM_000137.4(FAH):c.1063-1G>A	FAH		Tyrosinemia type I	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000848070	15	80473383	15	80181041	848070	852784		NC_000015.10:80181040:G:A
NM_000137.3(FAH):c.709C>T (p.Arg237Ter)	FAH	R237*	Tyrosinemia type I	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000437463	15	80465358	15	80173016	437463	431016	rs769550316	NC_000015.10:80173015:C:T
NM_031885.4(BBS2):c.1909_1910del (p.Met637fs)	BBS2	M637fs	Bardet-Biedl syndrome|Retinal dystrophy|Bardet-Biedl syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552850	16	56530879 - 56530880	16	56496967 - 56496968	552850	547755	rs1555521379	NC_000016.10:56496966:AT:
NM_031885.4(BBS2):c.565C>T (p.Arg189Ter)	BBS2	R189*	Bardet-Biedl syndrome 2|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550801	16	56543916	16	56510004	550801	547762	rs1273181642	NC_000016.10:56510003:G:A
NM_052867.4(NALCN):c.3542G>A (p.Arg1181Gln)	NALCN	R1181Q, R1210Q, R1152Q	Intellectual disability with episodic ataxia and congenital arthrogryposis|Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	VCV000188046	13	101736103	13	101083752	188046	185938	rs786201003	NC_000013.11:101083751:C:T
NM_003978.5(PSTPIP1):c.865G>C (p.Asp289His)	PSTPIP1	D289H, D280H, D354H	Behcet's syndrome	Pathogenic(Last reviewed: Nov 23, 2016)	no assertion criteria provided	VCV000280942	15	77325229	15	77032888	280942	265179	rs774164456	NC_000015.10:77032887:G:C
NM_003978.5(PSTPIP1):c.748G>C (p.Glu250Gln)	PSTPIP1	E250Q, E241Q, E315Q	Pyogenic arthritis-pyoderma gangrenosum-acne syndrome	Pathogenic(Last reviewed: Apr 15, 2002)	no assertion criteria provided	VCV000004434	15	77324645	15	77032304	4434	19473	rs28939089	NC_000015.10:77032303:G:C
NM_002087.3(GRN):c.1073_1074dup (p.Ala359fs)	GRN		not provided	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000586216	17	42429056 - 42429057	17	44351688 - 44351689	586216	577637	rs1567887567	NC_000017.11:44351688:AA:AAAA
NM_002087.3(GRN):c.599-1G>A	GRN		not provided	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000447476	17	42428058	17	44350690	447476	441958	rs1555611154	NC_000017.11:44350689:G:A
NM_002087.3(GRN):c.1465_1469dup (p.Lys491fs)	GRN		not provided	Pathogenic(Last reviewed: Oct 20, 2016)	criteria provided, single submitter	VCV000447472	17	42429759 - 42429760	17	44352391 - 44352392	447472	441963	rs1555611439	NC_000017.11:44352391:AACGT:AACGTAACGT
NM_002087.3(GRN):c.102del (p.Gly35fs)	GRN	G35fs	not provided	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000098125	17	42426631	17	44349263	98125	104017	rs63751073	NC_000017.11:44349262:CCCC:CCC
GRN, IVS7AS, A-G, -2	GRN		Primary progressive aphasia	Pathogenic(Last reviewed: Sep 11, 2007)	no assertion criteria provided	VCV000016017					16017	31056		
NM_002087.3(GRN):c.709-4_713del	GRN			Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807613	17	42428397 - 42428405	17	44351029 - 44351037	807613	798715		NC_000017.11:44351028:CCACTCAGGCCAC:CCAC
NM_002087.3(GRN):c.424dup (p.Met142fs)	GRN			Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000807612	17	42427669 - 42427670	17	44350301 - 44350302	807612	798714		NC_000017.11:44350301:A:AA
NM_002087.3(GRN):c.349+1G>C	GRN			Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807611	17	42427120	17	44349752	807611	798713		NC_000017.11:44349751:G:C
NM_002087.3(GRN):c.146G>A (p.Trp49Ter)	GRN	W49*		Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807610	17	42426801	17	44349433	807610	798712		NC_000017.11:44349432:G:A
NM_002087.3(GRN):c.918C>A (p.Cys306Ter)	GRN	C306*		Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000807426	17	42428813	17	44351445	807426	798716		NC_000017.11:44351444:C:A
NM_002087.3(GRN):c.87dup (p.Cys30fs)	GRN		Frontotemporal dementia	Pathogenic	no assertion criteria provided	VCV000203459	17	42426617 - 42426618	17	44349249 - 44349250	203459	199866	rs794729672	NC_000017.11:44349249:CC:CCC
NM_002087.3(GRN):c.1212C>A (p.Cys404Ter)	GRN	C404*	Frontotemporal dementia	Pathogenic	no assertion criteria provided	VCV000203457	17	42429415	17	44352047	203457	199870	rs193026789	NC_000017.11:44352046:C:A
GRN, 1-BP DEL, 998G	GRN		Primary progressive aphasia	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000016015					16015	31054		
NM_002087.3(GRN):c.232dup (p.Ser78fs)	GRN		Frontotemporal dementia	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599618	17	42426886 - 42426887	17	44349518 - 44349519	599618	590954	rs1567885658	NC_000017.11:44349518:T:TT
NM_002087.3(GRN):c.385dup (p.Ser129fs)	GRN		Frontotemporal dementia	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599617	17	42427630 - 42427631	17	44350262 - 44350263	599617	590956	rs1567886206	NC_000017.11:44350262:A:AA
NM_002087.3(GRN):c.560del (p.Leu187fs)	GRN	L187fs	Frontotemporal dementia	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599615	17	42427907	17	44350539	599615	590959	rs1567886478	NC_000017.11:44350538:T:
NM_002087.3(GRN):c.1446C>A (p.Cys482Ter)	GRN	C482*	Frontotemporal dementia	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599613	17	42429741	17	44352373	599613	590963	rs1567888461	NC_000017.11:44352372:C:A
NM_002087.3(GRN):c.776dup (p.Cys260fs)	GRN		Frontotemporal dementia	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599612	17	42428470 - 42428471	17	44351102 - 44351103	599612	590961	rs1567887015	NC_000017.11:44351102:AA:AAA
NM_002087.3(GRN):c.753_754TG[5] (p.Asp254fs)	GRN		Frontotemporal dementia	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599610	17	42428448 - 42428449	17	44351080 - 44351081	599610	590960	rs63751035	NC_000017.11:44351080:TGTGTGTG:TGTGTGTGTG
NM_002087.3(GRN):c.522_523insTGTGAAGACAGGGTGCACTGCTGTC (p.His175fs)	GRN		Frontotemporal dementia	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599609	17	42427869 - 42427870	17	44350501 - 44350502	599609	590958	rs1567886445	NC_000017.11:44350501::TGTGAAGACAGGGTGCACTGCTGTC
NM_002087.3(GRN):c.1072C>T (p.Gln358Ter)	GRN	Q358*	not provided	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000447470	17	42429056	17	44351688	447470	441961	rs1555611293	NC_000017.11:44351687:C:T
NM_002087.3(GRN):c.907del (p.Ala303fs)	GRN	A303fs		Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000437406	17	42428798	17	44351430	437406	430968	rs1555611256	NC_000017.11:44351429:GGGGG:GGGG
NM_002087.3(GRN):c.1246dup (p.Cys416fs)	GRN		Frontotemporal dementia	Pathogenic	no assertion criteria provided	VCV000203458	17	42429448 - 42429449	17	44352080 - 44352081	203458	199871	rs794729671	NC_000017.11:44352080:T:TT
NM_002087.3(GRN):c.882T>G (p.Tyr294Ter)	GRN	Y294*	Frontotemporal dementia	Pathogenic	no assertion criteria provided	VCV000203456	17	42428777	17	44351409	203456	199869	rs794729670	NC_000017.11:44351408:T:G
NM_002087.3(GRN):c.462+1G>C	GRN		Frontotemporal dementia	Pathogenic	no assertion criteria provided	VCV000203455	17	42427709	17	44350341	203455	199867	rs794729669	NC_000017.11:44350340:G:C
GRN, IVS6AS, G-A, -1	GRN			Pathogenic(Last reviewed: Oct 27, 2009)	no assertion criteria provided	VCV000029743					29743	38698		
GRN, 1-BP DEL, 154A	GRN			Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000016022					16022	31061		
NM_002087.3(GRN):c.835+1G>A	GRN			Pathogenic(Last reviewed: Aug 24, 2006)	no assertion criteria provided	VCV000016012	17	42428532	17	44351164	16012	31051	rs606231221	NC_000017.11:44351163:G:A
NM_000137.3(FAH):c.1027G>T (p.Gly343Trp)	FAH	G343W	Tyrosinemia type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000576751	15	80472532	15	80180190	576751	567293	rs970505762	NC_000015.10:80180189:G:T
NM_000137.3(FAH):c.707-1G>A	FAH		Tyrosinemia type I	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558607	15	80465355	15	80173013	558607	548270	rs149052294	NC_000015.10:80173012:G:A
NM_000137.3(FAH):c.192+1G>T	FAH		Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Feb 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189085	15	80450513	15	80158171	189085	186942	rs786204683	NC_000015.10:80158170:G:T
NM_000137.3(FAH):c.456G>A (p.Trp152Ter)	FAH	W152*	Tyrosinemia type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092445	15	80460394	15	80168052	92445	98354	rs370686447	NC_000015.10:80168051:G:A
NM_002087.3(GRN):c.991C>T (p.Gln331Ter)	GRN	Q331*	|Ceroid lipofuscinosis, neuronal, 11	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000569790	17	42428975	17	44351607	569790	571532	rs1567887496	NC_000017.11:44351606:C:T
NM_002087.3(GRN):c.80dup (p.Val28fs)	GRN		|Ceroid lipofuscinosis, neuronal, 11	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000540277	17	42426609 - 42426610	17	44349241 - 44349242	540277	531144	rs1392550887	NC_000017.11:44349241:CCC:CCCC
NM_002087.3(GRN):c.898C>T (p.Gln300Ter)	GRN	Q300*	not provided	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000447479	17	42428793	17	44351425	447479	441960	rs1555611253	NC_000017.11:44351424:C:T
NM_002087.4(GRN):c.1402C>T (p.Gln468Ter)	GRN	Q468*	not provided|	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000098184	17	42429605	17	44352237	98184	104076	rs63749908	NC_000017.11:44352236:C:T
NM_002087.4(GRN):c.264G>A (p.Glu88=)	GRN		not provided|	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000098130	17	42426919	17	44349551	98130	104022	rs63751166	NC_000017.11:44349550:G:A
GRN, IVS6AS, A-G, -2	GRN			Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000016019					16019	31058		
NM_032520.5(GNPTG):c.344_346ACA[1] (p.Asn116del)	GNPTG	N116del	|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000021715	16	1412063 - 1412065	16	1362062 - 1362064	21715	34567	rs193302849	NC_000016.10:1362061:CAACAACA:CAACA
NC_000016.9:g.(?_21689836)_(21771861_?)del	OTOA		Rare genetic deafness	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000178863	16	21689836 - 21771861	16	21678515 - 21760540	178863	176001		
NM_002755.4(MAP2K1):c.383G>T (p.Gly128Val)	MAP2K1	G128V	Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000013352	15	66729175	15	66436837	13352	28391	rs121908596	NC_000015.10:66436836:G:T
NM_002087.3(GRN):c.1144dup (p.Thr382Asnfs)	GRN		not provided|	Pathogenic(Last reviewed: Jul 10, 2007)	no assertion criteria provided	VCV000098169	17	42429127 - 42429128	17	44351759 - 44351760	98169	104061	rs63749905	NC_000017.11:44351759:A:AA
GRN, 1-BP DEL, 102C	GRN			Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000016021					16021	31060		
NM_002087.3(GRN):c.93_96dup (p.Asp33fs)	GRN			Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000016010	17	42426621 - 42426622	17	44349253 - 44349254	16010	31049	rs606231220	NC_000017.11:44349253:CTGCCTG:CTGCCTGCCTG
NM_002087.4(GRN):c.3G>A (p.Met1Ile)	GRN	M1I	not provided|	Pathogenic(Last reviewed: Aug 24, 2006)	no assertion criteria provided	VCV000016009	17	42426535	17	44349167	16009	31048	rs63750331	NC_000017.11:44349166:G:A
GRN, IVS0DS, G-C, +5	GRN			Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000016006					16006	31045		
NM_031885.4(BBS2):c.814C>T (p.Arg272Ter)	BBS2	R272*	Bardet-Biedl syndrome 2|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552219	16	56536711	16	56502799	552219	548029	rs764164384	NC_000016.10:56502798:G:A
NM_001363711.2(DUOX2):c.1588A>T (p.Lys530Ter)	DUOX2	K530*	not provided|Thyroid dyshormonogenesis 6	Pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000287079	15	45399648	15	45107450	287079	271316	rs180671269	NC_000015.10:45107449:T:A
NM_001363711.2(DUOX2):c.602dup (p.Gln202fs)	DUOX2		not provided|Thyroid dyshormonogenesis 6	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279800	15	45403694 - 45403695	15	45111496 - 45111497	279800	264574	rs567500345	NC_000015.10:45111496:CCCCCC:CCCCCCC
NM_001127713.1(ATL1):c.757G>A (p.Val253Ile)	ATL1	V253I	Hereditary spastic paraplegia 3A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220424	14	51081124	14	50614406	220424	222372	rs864622520	NC_000014.9:50614405:G:A
NM_002087.4(GRN):c.328C>T (p.Arg110Ter)	GRN	R110*	|not provided	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098134	17	42427098	17	44349730	98134	104026	rs63750411	NC_000017.11:44349729:C:T
NM_002087.4(GRN):c.2T>C (p.Met1Thr)	GRN	M1T	not provided|	Pathogenic(Last reviewed: Aug 24, 2006)	no assertion criteria provided	VCV000016008	17	42426534	17	44349166	16008	31047	rs63751006	NC_000017.11:44349165:T:C
NM_139276.2(STAT3):c.1139+1G>T	STAT3		not provided	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000636714	17	40481764	17	42329746	636714	624814		NC_000017.11:42329745:C:A
NM_020778.4(ALPK3):c.1134del (p.Ile379fs)	ALPK3	I379fs	not provided	Pathogenic(Last reviewed: Jan 3, 2017)	criteria provided, single submitter	VCV000422956	15	85383038	15	84839807	422956	409358	rs1064796122	NC_000015.10:84839806:G:
NM_003150.4(STAT3):c.709_712del (p.Asp237fs)	STAT3	D237fs	not provided	Pathogenic(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	VCV000418817	17	40489538 - 40489541	17	42337520 - 42337523	418817	409934	rs1064793452	NC_000017.11:42337519:CGTCCGT:CGT
NM_139276.2(STAT3):c.1397A>G (p.Asn466Ser)	STAT3	N466S	not provided	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000418505	17	40477048	17	42325030	418505	409932	rs1057521091	NC_000017.11:42325029:T:C
NM_139276.2(STAT3):c.1840A>G (p.Ser614Gly)	STAT3	S614G	not provided	Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	VCV000265440	17	40475070	17	42323052	265440	260168	rs886039546	NC_000017.11:42323051:T:C
NC_000015.10:g.84857208dup	ALPK3		CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689738	15	85400438 - 85400439	15	84857207 - 84857208	689738	677448		NC_000015.10:84857207:T:TT
NM_020778.5(ALPK3):c.2237del (p.Gly746fs)	ALPK3	G948fs, G746fs	not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000648292	15	85400204	15	84856973	648292	643566		NC_000015.10:84856972:GGG:GG
NM_020778.4(ALPK3):c.3544G>T (p.Gly1182Ter)	ALPK3	G1182*	not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000648290	15	85400907	15	84857676	648290	643567		NC_000015.10:84857675:G:T
NM_020778.4(ALPK3):c.3792G>A (p.Trp1264Ter)	ALPK3	W1264*	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27	Pathogenic(Last reviewed: Jul 12, 2018)	no assertion criteria provided	VCV000548941	15	85401155	15	84857924	548941	539428	rs1555435531	NC_000015.10:84857923:G:A
NM_020778.4(ALPK3):c.5294G>A (p.Trp1765Ter)	ALPK3	W1765*	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27	Pathogenic(Last reviewed: Jul 12, 2018)	no assertion criteria provided	VCV000548940	15	85407861	15	84864630	548940	539427	rs1555436118	NC_000015.10:84864629:G:A
NM_020778.4(ALPK3):c.4736-1G>A	ALPK3		CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27	Pathogenic(Last reviewed: Jul 12, 2018)	no assertion criteria provided	VCV000548939	15	85405865	15	84862634	548939	539426	rs762110595	NC_000015.10:84862633:G:A
NM_139276.2(STAT3):c.1260T>G (p.Asn420Lys)	STAT3	N420K	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	VCV000224849	17	40481449	17	42329431	224849	226687	rs869312893	NC_000017.11:42329430:A:C
NM_139276.2(STAT3):c.1057G>T (p.Val353Phe)	STAT3	V353F	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	VCV000224847	17	40483542	17	42331524	224847	226688	rs869312891	NC_000017.11:42331523:C:A
NM_003150.4(STAT3):c.1974G>C (p.Lys658Asn)	STAT3	K658N	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000144032	17	40474427	17	42322409	144032	153771	rs587777650	NC_000017.11:42322408:C:G
NM_003150.4(STAT3):c.1938C>G (p.Asn646Lys)	STAT3	N646K	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000144031	17	40474463	17	42322445	144031	153770	rs587777649	NC_000017.11:42322444:G:C
NM_003150.4(STAT3):c.1175A>G (p.Lys392Arg)	STAT3	K392R	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000144030	17	40481630	17	42329612	144030	153769	rs587777648	NC_000017.11:42329611:T:C
NM_139276.2(STAT3):c.2107G>A (p.Ala703Thr)	STAT3	A703T, A702T	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	VCV000224850	17	40469237	17	42317219	224850	226684	rs869312894	NC_000017.11:42317218:C:T
NM_139276.2(STAT3):c.1032G>C (p.Gln344His)	STAT3	Q344H	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	VCV000224843	17	40485708	17	42333690	224843	226689	rs869312887	NC_000017.11:42333689:C:G
NM_003150.4(STAT3):c.1166C>T (p.Thr389Ile)	STAT3	T389I	Hyper-IgE recurrent infection syndrome 1, autosomal dominant	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000064689	17	40481639	17	42329621	64689	75618	rs397514766	NC_000017.11:42329620:G:A
NM_003150.4(STAT3):c.1145G>T (p.Arg382Leu)	STAT3	R383L, R382L	Hyper-IgE recurrent infection syndrome 1, autosomal dominant	Pathogenic(Last reviewed: Oct 18, 2007)	no assertion criteria provided	VCV000018307	17	40481660	17	42329642	18307	33346	rs113994136	NC_000017.11:42329641:C:A
NM_139276.2(STAT3):c.1853G>A (p.Gly618Asp)	STAT3	G618D	Hyper-IgE recurrent infection syndrome 1, autosomal dominant	Pathogenic	no assertion criteria provided	VCV000430904	17	40475057	17	42323039	430904	424450	rs1555563871	NC_000017.11:42323038:C:T
NM_139276.2(STAT3):c.1261G>A (p.Gly421Arg)	STAT3	G421R	not provided|Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000224844	17	40481448	17	42329430	224844	226686	rs869312888	NC_000017.11:42329429:C:T
NM_139276.2(STAT3):c.1268G>A (p.Arg423Gln)	STAT3	R423Q	Hyper-IgE recurrent infection syndrome 1, autosomal dominant	Pathogenic(Last reviewed: Jun 7, 2012)	no assertion criteria provided	VCV000018306	17	40481441	17	42329423	18306	33345	rs113994137	NC_000017.11:42329422:C:T
NM_000431.4(MVK):c.643C>T (p.Arg215Ter)	MVK	R215*, R163*	not provided	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000234379	12	110024570	12	109586765	234379	231821	rs758026399	NC_000012.12:109586764:C:T
NM_000431.4(MVK):c.630G>A (p.Trp210Ter)	MVK	W158*, W210*	Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812112	12	110023929	12	109586124	812112	800362		NC_000012.12:109586123:G:A
NM_000431.4(MVK):c.380C>T (p.Pro127Leu)	MVK	P127L	Mevalonic aciduria	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812109	12	110019208	12	109581403	812109	800361		NC_000012.12:109581402:C:T
NM_000431.4(MVK):c.545T>A (p.Leu182Ter)	MVK	L182*, L130*	|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000573681	12	110023844	12	109586039	573681	565034	rs1566147222	NC_000012.12:109586038:T:A
NM_000431.4(MVK):c.1039+1G>A	MVK			Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000217749	12	110032987	12	109595182	217749	214395	rs104895362	NC_000012.12:109595181:G:A
NM_000431.4(MVK):c.122T>C (p.Leu41Pro)	MVK	L41P		Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039728	12	110013846	12	109576041	39728	48327	rs397514571	NC_000012.12:109576040:T:C
NM_000431.4(MVK):c.764T>C (p.Leu255Pro)	MVK	L255P, L203P		Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039724	12	110028662	12	109590857	39724	48323	rs397514570	NC_000012.12:109590856:T:C
NM_000431.4(MVK):c.494C>T (p.Pro165Leu)	MVK	P165L	Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000011933	12	110019322	12	109581517	11933	26972	rs121917790	NC_000012.12:109581516:C:T
NM_000431.4(MVK):c.902A>C (p.Asn301Thr)	MVK	N301T, N249T	Mevalonic aciduria	Pathogenic(Last reviewed: Jul 5, 1992)	no assertion criteria provided	VCV000011928	12	110032849	12	109595044	11928	26967	rs121917789	NC_000012.12:109595043:A:C
NM_000431.4(MVK):c.1094T>C (p.Phe365Ser)	MVK	F365S, F313S		Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000039730	12	110034285	12	109596480	39730	48329	rs398122911	NC_000012.12:109596479:T:C
NM_000431.4(MVK):c.1039+2T>C	MVK			Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039729	12	110032988	12	109595183	39729	48328	rs398122910	NC_000012.12:109595182:T:C
NM_139276.2(STAT3):c.1988C>T (p.Thr663Ile)	STAT3	T663I	not provided|Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000224845	17	40474413	17	42322395	224845	226685	rs869312889	NC_000017.11:42322394:G:A
NM_139276.2(STAT3):c.1243G>A (p.Glu415Lys)	STAT3	E415K	Autoimmune disease, multisystem, infantile-onset, 1|Hyper-IgE recurrent infection syndrome 1, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, multiple submitters, no conflicts	VCV000036784	17	40481466	17	42329448	36784	45445	rs193922717	NC_000017.11:42329447:C:T
NM_000431.4(MVK):c.709A>T (p.Thr237Ser)	MVK	T237S, T185S	Hyperimmunoglobulin D with periodic fever|not provided	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000097612	12	110028607	12	109590802	97612	103504	rs104895366	NC_000012.12:109590801:A:T
NM_000431.4(MVK):c.564G>A (p.Trp188Ter)	MVK	W188*, W136*	not provided|Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Mar 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000097597	12	110023863	12	109586058	97597	103489	rs104895311	NC_000012.12:109586057:G:A
NM_000431.4(MVK):c.442G>A (p.Ala148Thr)	MVK	A148T	Hyperimmunoglobulin D with periodic fever|not provided	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000097592	12	110019270	12	109581465	97592	103484	rs104895298	NC_000012.12:109581464:G:A
NM_000431.3(MVK):c.421dupG (p.Ala141Glyfs)	MVK		Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000088837	12	110019245 - 110019246	12	109581440 - 109581441	88837	94406	rs104895323	NC_000012.12:109581440:GGGG:GGGGG
NM_000431.4(MVK):c.16_34del (p.Leu6fs)	MVK	L6fs	Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000011935	12	110012643 - 110012661	12	109574838 - 109574856	11935	26974	rs104895334	NC_000012.12:109574837:CTACTGGTGTCTGCTCCGG:
NM_002435.3(MPI):c.656G>A (p.Arg219Gln)	MPI	R219Q, R169Q, R199Q	MPI-CDG	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014345	15	75185647	15	74893306	14345	29384	rs104894489	NC_000015.10:74893305:G:A
NM_000424.4(KRT5):c.74C>T (p.Pro25Leu)	KRT5	P25L	not provided|Epidermolysis bullosa simplex with mottled pigmentation	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000014648	12	52914007	12	52520223	14648	29687	rs57499817	NC_000012.12:52520222:G:A
NM_032520.5(GNPTG):c.318-1G>A	GNPTG		not provided|	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000453175	16	1412038	16	1362037	453175	445491	rs193302847	NC_000016.10:1362036:G:A
NM_000431.4(MVK):c.58C>A (p.His20Asn)	MVK	H20N	Mevalonic aciduria||Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Sep 29, 2018)	criteria provided, single submitter	VCV000649235	12	110012685	12	109574880	649235	640599		NC_000012.12:109574879:C:A
NM_052845.4(MMAB):c.197-1G>T	MMAB		Methylmalonic acidemia|Vitamin B12-responsive methylmalonic acidemia type cblB	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000219008	12	110006669	12	109568864	219008	216059	rs763935916	NC_000012.12:109568863:C:A
NM_052845.4(MMAB):c.568C>T (p.Arg190Cys)	MMAB	R190C	Vitamin B12-responsive methylmalonic acidemia type cblB|not provided	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000096244	12	109998861	12	109561056	96244	102138	rs398124434	NC_000012.12:109561055:G:A
NM_139276.2(STAT3):c.1311C>A (p.His437Gln)	STAT3	H437Q	STAT3 gain of function|Hyper-IgE recurrent infection syndrome 1, autosomal dominant	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000664121	17	40478188	17	42326170	664121	645893		NC_000017.11:42326169:G:T
NM_139276.2(STAT3):c.2117T>C (p.Leu706Pro)	STAT3	L706P, L705P	not provided|Hyper-IgE recurrent infection syndrome 1, autosomal dominant|STAT3 gain of function	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429592	17	40469227	17	42317209	429592	422166	rs1131691476	NC_000017.11:42317208:A:G
NM_139276.2(STAT3):c.454C>T (p.Arg152Trp)	STAT3	R152W	STAT3 gain of function|Hyper-IgE recurrent infection syndrome 1, autosomal dominant|Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224846	17	40491346	17	42339328	224846	226690	rs869312890	NC_000017.11:42339327:G:A
NM_005163.2(AKT1):c.1303A>C (p.Thr435Pro)	AKT1	T435P	Cowden syndrome 6	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000040163	14	105237142	14	104770805	40163	48663	rs397514645	NC_000014.9:104770804:T:G
NM_005163.2(AKT1):c.73C>T (p.Arg25Cys)	AKT1	R25C	Cowden syndrome 6	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000040162	14	105246527	14	104780190	40162	48662	rs397514644	NC_000014.9:104780189:G:A
NM_002087.3(GRN):c.592_593del (p.Arg198fs)	GRN	R198fs	not provided	Pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000447475	17	42427939 - 42427940	17	44350571 - 44350572	447475	441957	rs1555611136	NC_000017.11:44350570:AG:
NM_002087.4(GRN):c.373C>T (p.Gln125Ter)	GRN	Q125*	not provided|	Pathogenic(Last reviewed: Aug 24, 2006)	no assertion criteria provided	VCV000016007	17	42427619	17	44350251	16007	31046	rs63750077	NC_000017.11:44350250:C:T
NM_003150.4(STAT3):c.1384_1386GTG[1] (p.Val463del)	STAT3	V463del	not provided|Hyper-IgE recurrent infection syndrome 1, autosomal dominant	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000018303	17	40477056 - 40477058	17	42325038 - 42325040	18303	33342	rs113994138	NC_000017.11:42325037:CACCAC:CAC
NM_000161.3(GCH1):c.607G>A (p.Gly203Arg)	GCH1	G203R	GTP cyclohydrolase I deficiency|Dystonia 5|not provided	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381665	14	55312505	14	54845787	381665	373875	rs988395114	NC_000014.9:54845786:C:T
NM_000151.4(G6PC):c.724C>T (p.Gln242Ter)	G6PC	Q242*	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021061	17	41063093	17	42911076	21061	33913	rs80356485	NC_000017.11:42911075:C:T
NM_005163.2(AKT1):c.49_50delinsAG (p.Glu17Arg)	AKT1		Proteus syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000800567	14	105246550 - 105246551	14	104780213 - 104780214	800567	789168		NC_000014.9:104780212:TC:CT
NM_000431.4(MVK):c.830G>A (p.Arg277His)	MVK	R277H, R225H	Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria||Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000097631	12	110029107	12	109591302	97631	103523	rs104895352	NC_000012.12:109591301:G:A
NM_000431.4(MVK):c.608T>C (p.Val203Ala)	MVK	V203A, V151A	not provided|Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria||Hyperimmunoglobulin D with periodic fever	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000097601	12	110023907	12	109586102	97601	103493	rs104895332	NC_000012.12:109586101:T:C
NM_000017.4(ACADS):c.1138C>T (p.Arg380Trp)	ACADS	R356W, R380W, R376W	not provided|Deficiency of butyryl-CoA dehydrogenase	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003837	12	121177150	12	120739347	3837	18876	rs28940875	NC_000012.12:120739346:C:T
NM_000017.4(ACADS):c.136C>T (p.Arg46Trp)	ACADS	R46W	Deficiency of butyryl-CoA dehydrogenase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003825	12	121164918	12	120727115	3825	18864	rs121908003	NC_000012.12:120727114:C:T
NM_012463.4(ATP6V0A2):c.304C>T (p.Gln102Ter)	ATP6V0A2	Q102*	not provided	Pathogenic(Last reviewed: Jul 17, 2014)	criteria provided, single submitter	VCV000197291	12	124209210	12	123724663	197291	194452	rs794727643	NC_000012.12:123724662:C:T
NM_012463.4(ATP6V0A2):c.825+2T>C	ATP6V0A2		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000095526	12	124220173	12	123735626	95526	101425	rs398124257	NC_000012.12:123735625:T:C
NM_012463.4(ATP6V0A2):c.1514+1G>A	ATP6V0A2		not provided	Pathogenic(Last reviewed: Aug 2, 2012)	criteria provided, single submitter	VCV000095519	12	124229332	12	123744785	95519	101418	rs374480381	NC_000012.12:123744784:G:A
ATP6V0A2, 1-BP INS, 100A	ATP6V0A2		Cutis laxa with osteodystrophy	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039453					39453	48052		
NM_012463.4(ATP6V0A2):c.2356_2362del (p.Gly786fs)	ATP6V0A2	G786fs	Cutis laxa with osteodystrophy	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039452	12	124241423 - 124241429	12	123756876 - 123756882	39452	48051	rs1566294545	NC_000012.12:123756875:TGGCGTCT:T
NM_012463.4(ATP6V0A2):c.840del (p.Glu281fs)	ATP6V0A2	E281fs	Cutis laxa with osteodystrophy	Pathogenic(Last reviewed: Sep 23, 2010)	no assertion criteria provided	VCV000021502	12	124221619	12	123737072	21502	34354	rs80356754	NC_000012.12:123737071:CC:C
NM_012463.4(ATP6V0A2):c.732-2A>G	ATP6V0A2		Cutis laxa with osteodystrophy	Pathogenic(Last reviewed: Sep 23, 2010)	no assertion criteria provided	VCV000021501	12	124220076	12	123735529	21501	34353	rs80356753	NC_000012.12:123735528:A:G
NM_012463.4(ATP6V0A2):c.353_354del (p.Leu118fs)	ATP6V0A2	L118fs	Cutis laxa with osteodystrophy	Pathogenic(Last reviewed: Sep 23, 2010)	no assertion criteria provided	VCV000021500	12	124209259 - 124209260	12	123724712 - 123724713	21500	34352	rs80356752	NC_000012.12:123724711:TG:
NM_012463.4(ATP6V0A2):c.2176-3_2176-2del	ATP6V0A2		Cutis laxa with osteodystrophy	Pathogenic(Last reviewed: Sep 23, 2010)	no assertion criteria provided	VCV000021496	12	124238964 - 124238965	12	123754417 - 123754418	21496	34348	rs367543007	NC_000012.12:123754416:CA:
NM_012463.4(ATP6V0A2):c.1324G>T (p.Glu442Ter)	ATP6V0A2	E442*	Cutis laxa with osteodystrophy	Pathogenic(Last reviewed: Sep 23, 2010)	no assertion criteria provided	VCV000021494	12	124228882	12	123744335	21494	34346	rs80356755	NC_000012.12:123744334:G:T
NM_012463.4(ATP6V0A2):c.1062dup (p.Ser355fs)	ATP6V0A2		ALG9 congenital disorder of glycosylation	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000840755	12	124228351 - 124228352	12	123743804 - 123743805	840755	839380		NC_000012.12:123743804:CCCC:CCCCC
NM_012463.4(ATP6V0A2):c.1929del (p.Gln645fs)	ATP6V0A2	Q645fs	Cutis laxa with osteodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000021495	12	124233326	12	123748779	21495	34347	rs80356756	NC_000012.12:123748778:A:
NM_012463.4(ATP6V0A2):c.2293C>T (p.Gln765Ter)	ATP6V0A2	Q765*	Cutis laxa with osteodystrophy	Pathogenic(Last reviewed: Sep 23, 2010)	no assertion criteria provided	VCV000000844	12	124239084	12	123754537	844	15883	rs80356758	NC_000012.12:123754536:C:T
NM_000326.5(RLBP1):c.700C>T (p.Arg234Trp)	RLBP1	R234W	RLBP1-Related Disorders|Retinitis punctata albescens|Retinitis pigmentosa|Bothnia retinal dystrophy	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000013100	15	89754025	15	89210794	13100	28139	rs28933990	NC_000015.10:89210793:G:A
NM_002087.3(GRN):c.753_754TG[3] (p.Cys253_Asp254delinsTer)	GRN		Frontotemporal dementia|not provided|	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000098152	17	42428449 - 42428450	17	44351081 - 44351082	98152	104044	rs63751035	NC_000017.11:44351080:TGTGTGTG:TGTGTG
NM_012463.4(ATP6V0A2):c.294+1G>A	ATP6V0A2		Cutis laxa with osteodystrophy|Wrinkly skin syndrome	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000021499	12	124206996	12	123722449	21499	34351	rs80356751	NC_000012.12:123722448:G:A
NM_032520.4(GNPTG):c.499dup (p.Leu167Profs)	GNPTG		not provided|	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000437454	16	1412288 - 1412289	16	1362287 - 1362288	437454	431017	rs756959430	NC_000016.10:1362287:CCCCCC:CCCCCCC
NM_000431.4(MVK):c.59A>C (p.His20Pro)	MVK	H20P	Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000011931	12	110012686	12	109574881	11931	26970	rs104895295	NC_000012.12:109574880:A:C
NM_001194998.2(CEP152):c.794A>C (p.Gln265Pro)	CEP152	Q265P	Seckel syndrome 5|Primary autosomal recessive microcephaly 9|CEP152-Related Disorders|Primary autosomal recessive microcephaly 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000055	15	49085556	15	48793359	55	15094	rs267606717	NC_000015.10:48793358:T:G
NM_003593.2(FOXN1):c.763C>T (p.Arg255Ter)	FOXN1	R255*	T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT|	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000008757	17	26856175	17	28529157	8757	23796	rs104894562	NC_000017.11:28529156:C:T
GRCh37/hg19 16q24.3(chr16:89066987-89174140)x1	ACSF3		not provided	Pathogenic(Last reviewed: May 30, 2018)	no assertion criteria provided	VCV000688696	16	89066987 - 89174140			688696	676288		
NM_174917.5(ACSF3):c.1446_1447del (p.Tyr482_Lys483delinsTer)	ACSF3		not provided	Pathogenic(Last reviewed: May 21, 2015)	criteria provided, single submitter	VCV000419126	16	89211753 - 89211754	16	89145345 - 89145346	419126	409783	rs1064793662	NC_000016.10:89145344:ACA:A
NM_174917.5(ACSF3):c.589G>A (p.Ala197Thr)	ACSF3	A197T	not provided	Pathogenic(Last reviewed: Feb 28, 2014)	criteria provided, single submitter	VCV000203607	16	89167678	16	89101270	203607	200308	rs761573352	NC_000016.10:89101269:G:A
NM_174917.5(ACSF3):c.1A>G (p.Met1Val)	ACSF3	M1V	not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000203603	16	89167090	16	89100682	203603	200302	rs370382601	NC_000016.10:89100681:A:G
NM_001243279.3(ACSF3):c.246del (p.Cys83fs)	ACSF3	C83fs	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000855742	16	89167335	16	89100927	855742	844482		NC_000016.10:89100926:C:
NM_001243279.3(ACSF3):c.803del (p.Pro268fs)	ACSF3	P3fs, P268fs	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000851516	16	89169147	16	89102739	851516	844485		NC_000016.10:89102738:CC:C
NM_001243279.3(ACSF3):c.1310G>A (p.Trp437Ter)	ACSF3	W437*, W172*	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000844844	16	89199614	16	89133206	844844	844486		NC_000016.10:89133205:G:A
NM_001243279.3(ACSF3):c.1535G>A (p.Trp512Ter)	ACSF3	W247*, W512*	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000843811	16	89212379	16	89145971	843811	844487		NC_000016.10:89145970:G:A
NM_001243279.3(ACSF3):c.286G>T (p.Glu96Ter)	ACSF3	E96*	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000842479	16	89167375	16	89100967	842479	844483		NC_000016.10:89100966:G:T
NM_001243279.3(ACSF3):c.1602dup (p.Glu535fs)	ACSF3		Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, single submitter	VCV000840232	16	89212443 - 89212444	16	89146035 - 89146036	840232	844489		NC_000016.10:89146035:AAA:AAAA
NM_001243279.3(ACSF3):c.305del (p.Cys102fs)	ACSF3	C102fs	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000657796	16	89167394	16	89100986	657796	645124		NC_000016.10:89100985:G:
NM_001243279.3(ACSF3):c.675del (p.Leu226fs)	ACSF3	L226fs	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000653700	16	89169018	16	89102610	653700	645129		NC_000016.10:89102609:GGG:GG
NM_174917.5(ACSF3):c.828G>A (p.Trp276Ter)	ACSF3	W276*, W11*	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000646673	16	89178505	16	89112097	646673	645132		NC_000016.10:89112096:G:A
NM_174917.5(ACSF3):c.451G>T (p.Glu151Ter)	ACSF3	E151*	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000642668	16	89167540	16	89101132	642668	645127		NC_000016.10:89101131:G:T
NM_174917.5(ACSF3):c.689G>A (p.Trp230Ter)	ACSF3	W230*	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000642486	16	89169034	16	89102626	642486	645131		NC_000016.10:89102625:G:A
NM_174917.5(ACSF3):c.1300C>T (p.Arg434Ter)	ACSF3	R169*, R434*	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000639703	16	89199604	16	89133196	639703	645133		NC_000016.10:89133195:C:T
ACSF3, LYS462THR AND GLY465_GLY470 DEL	ACSF3	K462T	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Aug 14, 2011)	no assertion criteria provided	VCV000031142					31142	40099		
NM_174917.5(ACSF3):c.593T>G (p.Met198Arg)	ACSF3	M198R	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Aug 14, 2011)	no assertion criteria provided	VCV000031141	16	89167682	16	89101274	31141	40098	rs387907121	NC_000016.10:89101273:T:G
NM_174917.5(ACSF3):c.728C>T (p.Pro243Leu)	ACSF3	P243L	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Aug 14, 2011)	no assertion criteria provided	VCV000031140	16	89169073	16	89102665	31140	40097	rs140986055	NC_000016.10:89102664:C:T
NM_174917.5(ACSF3):c.1073C>T (p.Thr358Ile)	ACSF3	T358I, T93I	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Aug 14, 2011)	no assertion criteria provided	VCV000031139	16	89180842	16	89114434	31139	40096	rs387907120	NC_000016.10:89114433:C:T
NM_174917.5(ACSF3):c.1412G>A (p.Arg471Gln)	ACSF3	R471Q, R206Q	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Aug 14, 2011)	no assertion criteria provided	VCV000031138	16	89211720	16	89145312	31138	40095	rs387907119	NC_000016.10:89145311:G:A
NM_001243279.3(ACSF3):c.424C>T (p.Gln142Ter)	ACSF3	Q142*	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000839825	16	89167513	16	89101105	839825	844484		NC_000016.10:89101104:C:T
NM_012463.4(ATP6V0A2):c.78dup (p.Ser27fs)	ATP6V0A2		ALG9 congenital disorder of glycosylation|not provided	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000286400	12	124197189 - 124197190	12	123712642 - 123712643	286400	270637	rs745590426	NC_000012.12:123712642:C:CC
NM_012463.4(ATP6V0A2):c.187C>T (p.Arg63Ter)	ATP6V0A2	R63*	not provided|Cutis laxa with osteodystrophy	Pathogenic(Last reviewed: Aug 30, 2013)	criteria provided, single submitter	VCV000000845	12	124203239	12	123718692	845	15884	rs80356750	NC_000012.12:123718691:C:T
NM_174917.5(ACSF3):c.1405C>T (p.Arg469Ter)	ACSF3	R469*, R204*	Combined malonic and methylmalonic aciduria	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000569646	16	89211713	16	89145305	569646	570613	rs748382994	NC_000016.10:89145304:C:T
NM_174917.5(ACSF3):c.1567C>T (p.Arg523Ter)	ACSF3	R523*, R258*	Combined malonic and methylmalonic aciduria	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000031135	16	89212411	16	89146003	31135	40092	rs387907118	NC_000016.10:89146002:C:T
NM_000137.3(FAH):c.1A>G (p.Met1Val)	FAH	M1V	not provided|Tyrosinemia type I	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372766	15	80445397	15	80153055	372766	360304	rs1057517972	NC_000015.10:80153054:A:G
NM_174917.5(ACSF3):c.1608G>A (p.Trp536Ter)	ACSF3	W536*, W271*	not provided|Combined malonic and methylmalonic aciduria	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379920	16	89212452	16	89146044	379920	377918	rs201954387	NC_000016.10:89146043:G:A
NM_001136473.1(LITAF):c.344C>A (p.Thr115Asn)	LITAF	T115N	Charcot-Marie-Tooth disease, type 1C|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006058	16	11647422	16	11553566	6058	21097	rs104894520	NC_000016.10:11553565:G:T
NM_020988.3(GNAO1):c.607G>A (p.Gly203Arg)	GNAO1	G203R	Early infantile epileptic encephalopathy 17|Neurodevelopmental disorder with involuntary movements|Early infantile epileptic encephalopathy 17|Early infantile epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066115	16	56370656	16	56336744	66115	77012	rs587777057	NC_000016.10:56336743:G:A
NM_174917.5(ACSF3):c.1502-2A>G	ACSF3		Combined malonic and methylmalonic aciduria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000598729	16	89212344	16	89145936	598729	589790	rs1188774860	NC_000016.10:89145935:A:G
NC_000016.10:g.(?_89693)_(100529_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000832843	16	139691 - 150527			832843	820916		
NC_000016.10:g.(?_138130)_(138287_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000832358	16	188129 - 188286			832358	820764		
NC_000016.9:g.(?_148123)_(188286_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000832174	16	148123 - 188286			832174	820972		
NC_000016.9:g.(?_136684)_(188286_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000583997	16	136684 - 188286			583997	570737		
NC_000016.9:g.(?_160503)_(162794_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000542816	16	160503 - 162794			542816	530819		
NC_000016.9:g.(?_136684)_(162794_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000830471	16	136684 - 162794			830471	820970		
NM_000431.4(MVK):c.346T>C (p.Tyr116His)	MVK	Y116H	not provided|Mevalonic aciduria||Hyperimmunoglobulin D with periodic fever|Hyperimmunoglobulin D with periodic fever	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000097581	12	110017726	12	109579921	97581	103473	rs104895382	NC_000012.12:109579920:T:C
NM_000431.3(MVK):c.72dupT (p.Gly25Trpfs)	MVK		Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria||Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000088836	12	110012698 - 110012699	12	109574893 - 109574894	88836	94405	rs104895322	NC_000012.12:109574893:T:TT
NM_000431.3(MVK):c.417dupC (p.Gly140Argfs)	MVK		Mevalonic aciduria|not provided||Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000039727	12	110019239 - 110019240	12	109581434 - 109581435	39727	48326	rs104895373	NC_000012.12:109581434:CCCCCC:CCCCCCC
NM_000431.4(MVK):c.604G>A (p.Gly202Arg)	MVK	G202R, G150R	Mevalonic aciduria||Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039726	12	110023903	12	109586098	39726	48325	rs104895301	NC_000012.12:109586097:G:A
NM_003239.5(TGFB3):c.171del (p.Glu58fs)	TGFB3	E58fs	Flexion contracture	Pathogenic	no assertion criteria provided	VCV000816840	14	76447066	14	75980723	816840	805025		NC_000014.9:75980722:A:
NM_003239.4(TGFB3):c.106A>T (p.Lys36Ter)	TGFB3	K36*	not provided	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000489086	14	76447131	14	75980788	489086	482054	rs1555361451	NC_000014.9:75980787:T:A
NM_014249.4(NR2E3):c.194_202del (p.Asn65_Cys67del)	NR2E3		Retinitis pigmentosa 37|Enhanced s-cone syndrome|Retinal dystrophy|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551852	15	72103893 - 72103901	15	71811553 - 71811561	551852	547531	rs1555454566	NC_000015.10:71811552:CTGCAACGGCTGCA:CTGCA
NM_003239.5(TGFB3):c.109A>T (p.Lys37Ter)	TGFB3	K37*	Loeys-Dietz syndrome 4	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000862476	14	76447128	14	75980785	862476	841833		NC_000014.9:75980784:T:A
NC_000014.9:g.(?_75958692)_(75980923_?)del	TGFB3		Loeys-Dietz syndrome 4	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000832288	14	76425035 - 76447266			832288	820650		
NM_003239.4(TGFB3):c.989G>A (p.Trp330Ter)	TGFB3	W330*	Loeys-Dietz syndrome 4	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000477652	14	76427357	14	75961014	477652	464504	rs1555360222	NC_000014.9:75961013:C:T
NM_003239.4(TGFB3):c.321dup (p.Phe108fs)	TGFB3		Loeys-Dietz syndrome 5	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000441282	14	76446915 - 76446916	14	75980572 - 75980573	441282	434940	rs1555361385	NC_000014.9:75980572:TTT:TTTT
NM_003239.4(TGFB3):c.883_884del (p.Gly295fs)	TGFB3	G295fs	Loeys-Dietz syndrome 4	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000410268	14	76429701 - 76429702	14	75963358 - 75963359	410268	400296	rs1060502826	NC_000014.9:75963357:CCCCCC:CCCC
NM_003239.4(TGFB3):c.704del (p.Asn235fs)	TGFB3	N235fs	Loeys-Dietz syndrome 5	Pathogenic(Last reviewed: Apr 7, 2015)	no assertion criteria provided	VCV000203491	14	76431981	14	75965638	203491	199891	rs875989817	NC_000014.9:75965637:TT:T
NM_003239.4(TGFB3):c.754+2T>C	TGFB3		Loeys-Dietz syndrome 5	Pathogenic(Last reviewed: Apr 7, 2015)	no assertion criteria provided	VCV000203489	14	76431929	14	75965586	203489	199889	rs875989816	NC_000014.9:75965585:A:G
NM_003239.4(TGFB3):c.1226G>A (p.Cys409Tyr)	TGFB3	C409Y	Loeys-Dietz syndrome 5	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000091862	14	76425543	14	75959200	91862	97339	rs398122984	NC_000014.9:75959199:C:T
NM_003239.4(TGFB3):c.*495C>T	TGFB3		Arrhythmogenic right ventricular dysplasia, familial 1	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000012475	14	76425035	14	75958692	12475	27514	rs387906514	NC_000014.9:75958691:G:A
NM_031885.4(BBS2):c.534+1G>T	BBS2		Bardet-Biedl syndrome 2|Retinitis pigmentosa 74|Bardet-Biedl syndrome 2|Retinal dystrophy|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553927	16	56544770	16	56510858	553927	547812	rs773862084	NC_000016.10:56510857:C:A
NM_031885.4(BBS2):c.1438C>T (p.Arg480Ter)	BBS2	R480*	Bardet-Biedl syndrome 2|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553353	16	56533779	16	56499867	553353	547792	rs778090540	NC_000016.10:56499866:G:A
NM_031885.4(BBS2):c.661del (p.Leu221fs)	BBS2	L221fs	Bardet-Biedl syndrome 2|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000208564	16	56540088	16	56506176	208564	205180	rs770258677	NC_000016.10:56506175:GGG:GG
NM_003239.4(TGFB3):c.1034C>G (p.Ser345Ter)	TGFB3	S345*	Loeys-Dietz syndrome 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000410269	14	76427312	14	75960969	410269	399925	rs1060502827	NC_000014.9:75960968:G:C
NM_002087.4(GRN):c.1252C>T (p.Arg418Ter)	GRN	R418*	not provided|	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098177	17	42429455	17	44352087	98177	104069	rs63751180	NC_000017.11:44352086:C:T
NM_002087.4(GRN):c.911G>A (p.Trp304Ter)	GRN	W304*	not provided	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000098162	17	42428806	17	44351438	98162	104054	rs63751177	NC_000017.11:44351437:G:A
NM_002087.4(GRN):c.138+1G>A	GRN		not provided||Ceroid lipofuscinosis, neuronal, 11	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000098126	17	42426671	17	44349303	98126	104018	rs63749844	NC_000017.11:44349302:G:A
NM_002087.4(GRN):c.26C>A (p.Ala9Asp)	GRN	A9D	not provided|	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000016013	17	42426558	17	44349190	16013	31052	rs63751243	NC_000017.11:44349189:C:A
NM_006432.4(NPC2):c.58G>T (p.Glu20Ter)	NPC2	E20*	Niemann-Pick disease, type C|	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008477	14	74959920	14	74493217	8477	23516	rs80358260	NC_000014.9:74493216:C:A
HBA2, METHYLATION SILENCING DUE TO ANTISENSE TRANSCRIPT	HBA2		Alpha-thalassemia, zf type	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000015680					15680	30719		
Single allele	HBA2		alpha Thalassemia	Pathogenic(Last reviewed: Dec 29, 2016)	no assertion criteria provided	VCV000375752					375752	362638		
NM_006445.4(PRPF8):c.6901C>T (p.Pro2301Ser)	PRPF8	P2301S	Retinal dystrophy	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV000867220	17	1554203	17	1650909	867220	856865		NC_000017.11:1650908:G:A
NM_006445.4(PRPF8):c.7000T>A (p.Tyr2334Asn)	PRPF8	Y2334N	Retinal dystrophy	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000865924	17	1554104	17	1650810	865924	856862		NC_000017.11:1650809:A:T
NM_001256269.2(KIF22):c.242G>T (p.Arg81Leu)	KIF22	R149L, R81L	Spondyloepimetaphyseal dysplasia with joint laxity, type 2	Pathogenic(Last reviewed: Dec 9, 2011)	no assertion criteria provided	VCV000030336	16	29809965	16	29798644	30336	39292	rs193922922	NC_000016.10:29798643:G:T
PRPF8, ARG2310SER	PRPF8	R2310S	Retinitis pigmentosa 13	Pathogenic(Last reviewed: Dec 2, 2011)	no assertion criteria provided	VCV000030667					30667	39624		
NM_001256269.2(KIF22):c.238C>T (p.Pro80Ser)	KIF22	P148S, P80S	Spondyloepimetaphyseal dysplasia with joint laxity, type 2	Pathogenic(Last reviewed: Dec 9, 2011)	no assertion criteria provided	VCV000030333	16	29809961	16	29798640	30333	39289	rs193922920	NC_000016.10:29798639:C:T
NM_006445.4(PRPF8):c.6912C>G (p.Phe2304Leu)	PRPF8	F2304L	Retinitis pigmentosa 13	Pathogenic(Last reviewed: Jul 15, 2001)	no assertion criteria provided	VCV000003359	17	1554192	17	1650898	3359	18398	rs121434240	NC_000017.11:1650897:G:C
NM_006445.4(PRPF8):c.6901C>A (p.Pro2301Thr)	PRPF8	P2301T	Retinitis pigmentosa 13	Pathogenic(Last reviewed: Jul 15, 2001)	no assertion criteria provided	VCV000003358	17	1554203	17	1650909	3358	18397	rs121434239	NC_000017.11:1650908:G:T
NM_006445.4(PRPF8):c.3391_3393AAG[1] (p.Lys1132del)	PRPF8		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812382	17	1577090 - 1577092	17	1673796 - 1673798	812382	800609		NC_000017.11:1673795:CTTCTT:CTT
NM_006445.4(PRPF8):c.6353C>T (p.Ser2118Phe)	PRPF8	S2118F	Retinitis pigmentosa 13	Pathogenic(Last reviewed: Dec 2, 2011)	no assertion criteria provided	VCV000030666	17	1556852	17	1653558	30666	39623	rs387906971	NC_000017.11:1653557:G:A
NM_004239.4(TRIP11):c.3477del (p.Gln1160fs)	TRIP11	Q1159fs, Q1160fs	Achondrogenesis, type IA	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000847890	14	92470843	14	92004499	847890	841907		NC_000014.9:92004498:AA:A
NM_004239.4(TRIP11):c.986_987GA[1] (p.Asp330fs)	TRIP11		Achondrogenesis, type IA	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000648142	14	92480756 - 92480757	14	92014412 - 92014413	648142	642786		NC_000014.9:92014411:TCTCT:TCT
NM_004239.4(TRIP11):c.2300_2303TCAA[1] (p.Asn768fs)	TRIP11		Achondrogenesis, type IA	Pathogenic(Last reviewed: Feb 27, 2019)	no assertion criteria provided	VCV000619115	14	92472013 - 92472016	14	92005669 - 92005672	619115	610510	rs1294029121	NC_000014.9:92005668:TTGATTGA:TTGA
NM_004239.4(TRIP11):c.1622del (p.Lys541fs)	TRIP11	K541fs, K540fs	Osteochondrodysplasia	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000619114	14	92472698	14	92006354	619114	610509	rs1420691965	NC_000014.9:92006353:TTTTTTT:TTTTTT
NM_004239.4(TRIP11):c.4813_4814AG[1] (p.Glu1606fs)	TRIP11		Osteochondrodysplasia	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000619111	14	92465658 - 92465661	14	91999314 - 91999317	619111	610506	rs1429820082	NC_000014.9:91999313:CTCTCT:CT
NM_004239.4(TRIP11):c.2993_2994del (p.Lys998fs)	TRIP11	K997fs, K998fs	Osteochondrodysplasia	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000619108	14	92471326 - 92471327	14	92004982 - 92004983	619108	610503	rs1566859649	NC_000014.9:92004981:TTTT:TT
NM_004239.4(TRIP11):c.2557C>T (p.Arg853Ter)	TRIP11	R853*, R852*	Achondrogenesis, type IA	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000583332	14	92471763	14	92005419	583332	569067	rs1053206465	NC_000014.9:92005418:G:A
NM_004239.4(TRIP11):c.615_616CT[1] (p.Asn205_Ser206insTer)	TRIP11		Achondrogenesis, type IA	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000581029	14	92484065 - 92484066	14	92017721 - 92017722	581029	568337	rs1566867763	NC_000014.9:92017720:AGAG:AG
NM_004239.4(TRIP11):c.3352_3353del (p.Glu1118fs)	TRIP11	E1118fs, E1117fs	Achondrogenesis, type IA	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000579327	14	92470967 - 92470968	14	92004623 - 92004624	579327	572972	rs1566859264	NC_000014.9:92004622:TCT:T
NM_004239.4(TRIP11):c.1280T>A (p.Leu427Ter)	TRIP11	L427*, L426*	Achondrogenesis, type IA	Pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000572495	14	92477364	14	92011020	572495	568334	rs34761938	NC_000014.9:92011019:A:T
NM_004239.4(TRIP11):c.4557+1G>T	TRIP11		Goldblatt hypertension	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000522813	14	92469762	14	92003418	522813	513449	rs1555386022	NC_000014.9:92003417:C:A
NM_004239.4(TRIP11):c.2038G>T (p.Glu680Ter)	TRIP11	E680*, E679*	Goldblatt hypertension	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000522812	14	92472282	14	92005938	522812	513450	rs1400419650	NC_000014.9:92005937:C:A
NM_004239.4(TRIP11):c.202-2A>G	TRIP11		Achondrogenesis, type IA	Pathogenic(Last reviewed: Jan 21, 2010)	no assertion criteria provided	VCV000005510	14	92491766	14	92025422	5510	20549	rs863223281	NC_000014.9:92025421:T:C
NP_004230.2(TRIP11):p.Trp1224Ter	TRIP11	W1224*	Achondrogenesis, type IA	Pathogenic(Last reviewed: Jan 21, 2010)	no assertion criteria provided	VCV000005509					5509	20548		
NM_004239.4(TRIP11):c.4127C>A (p.Ser1376Ter)	TRIP11	S1375*, S1376*	Achondrogenesis, type IA	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000692173	14	92470193	14	92003849	692173	679926		NC_000014.9:92003848:G:T
NM_004239.4(TRIP11):c.3671G>A (p.Trp1224Ter)	TRIP11	W1223*, W1224*	Achondrogenesis, type IA	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000692167	14	92470649	14	92004305	692167	679928		NC_000014.9:92004304:C:T
NM_004239.4(TRIP11):c.3478C>T (p.Gln1160Ter)	TRIP11	Q1159*, Q1160*	Achondrogenesis, type IA	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000692166	14	92470842	14	92004498	692166	679929		NC_000014.9:92004497:G:A
NM_006445.4(PRPF8):c.6929G>A (p.Arg2310Lys)	PRPF8	R2310K	Retinal dystrophy|Retinitis pigmentosa 13	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000003357	17	1554175	17	1650881	3357	18396	rs121434238	NC_000017.11:1650880:C:T
NM_006445.4(PRPF8):c.6926A>G (p.His2309Arg)	PRPF8	H2309R	Retinal dystrophy|Retinitis pigmentosa 13	Pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000003355	17	1554178	17	1650884	3355	18394	rs121434236	NC_000017.11:1650883:T:C
NM_004239.4(TRIP11):c.2128_2129del (p.Ile710fs)	TRIP11	I710fs, I709fs	Achondrogenesis, type IA|Osteochondrodysplasia	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000619113	14	92472191 - 92472192	14	92005847 - 92005848	619113	610508	rs1566860640	NC_000014.9:92005846:ATA:A
NM_001256269.2(KIF22):c.242G>A (p.Arg81Gln)	KIF22	R149Q, R81Q	not provided|Spondyloepimetaphyseal dysplasia with joint laxity, type 2	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000030335	16	29809965	16	29798644	30335	39291	rs193922922	NC_000016.10:29798643:G:A
NM_006445.4(PRPF8):c.6926A>C (p.His2309Pro)	PRPF8	H2309P	Retinal dystrophy|Retinitis pigmentosa 13	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000003356	17	1554178	17	1650884	3356	18395	rs121434236	NC_000017.11:1650883:T:G
NM_014967.5(FAN1):c.1899del (p.Cys633fs)	FAN1	C633fs	not provided	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000817020	15	31210454	15	30918251	817020	805819		NC_000015.10:30918250:T:
NM_006939.4(SOS2):c.800T>C (p.Met267Thr)	SOS2	M267T	not provided	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000373114	14	50649239	14	50182521	373114	360159	rs797045167	NC_000014.9:50182520:A:G
NM_024685.4(BBS10):c.1315del (p.Gln439fs)	BBS10	Q439fs	Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802873	12	76740450	12	76346670	802873	791277		NC_000012.12:76346669:GG:G
NM_024685.4(BBS10):c.1871C>G (p.Ser624Ter)	BBS10	S624*	Bardet-Biedl syndrome 10	Pathogenic	no assertion criteria provided	VCV000684438	12	76739894	12	76346114	684438	672028		NC_000012.12:76346113:G:C
NM_014967.5(FAN1):c.1102C>T (p.Gln368Ter)	FAN1	Q368*	Interstitial nephritis, karyomegalic	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000437428	15	31197968	15	30905765	437428	430984	rs778075842	NC_000015.10:30905764:C:T
NM_024685.4(BBS10):c.1677C>G (p.Tyr559Ter)	BBS10	Y559*	Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000371499	12	76740088	12	76346308	371499	358109	rs375413604	NC_000012.12:76346307:G:C
NM_024685.4(BBS10):c.1202G>A (p.Gly401Glu)	BBS10	G401E	Bardet-Biedl syndrome 10	Pathogenic	no assertion criteria provided	VCV000068063	12	76740563	12	76346783	68063	78954	rs199474722	NC_000012.12:76346782:C:T
NM_005236.2(ERCC4):c.1730dup (p.Tyr577Ter)	ERCC4		Xeroderma pigmentosum, type F/Cockayne syndrome	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000055828	16	14029518 - 14029519	16	13935661 - 13935662	55828	70486	rs397509404	NC_000016.10:13935661:A:AA
NM_005236.2(ERCC4):c.706T>C (p.Cys236Arg)	ERCC4	C236R	Xeroderma pigmentosum, type F/Cockayne syndrome	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000055827	16	14022006	16	13928149	55827	70485	rs397509403	NC_000016.10:13928148:T:C
NM_014967.5(FAN1):c.1375+1G>A	FAN1		Interstitial nephritis, karyomegalic	Pathogenic(Last reviewed: Jul 8, 2012)	no assertion criteria provided	VCV000037099	15	31200462	15	30908259	37099	45774	rs1305708707	NC_000015.10:30908258:G:A
NM_005236.2(ERCC4):c.458G>C (p.Arg153Pro)	ERCC4	R153P	XFE progeroid syndrome	Pathogenic(Last reviewed: Dec 21, 2006)	no assertion criteria provided	VCV000016581	16	14020487	16	13926630	16581	31620	rs121913050	NC_000016.10:13926629:G:C
BBS10, SER303 FS	BBS10		Bardet-biedl syndrome 1/10, digenic	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000001330					1330	16369		
NC_000012.12:g.(?_76345803)_(76348368_?)del	BBS10		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, single submitter	VCV000830774	12	76739583 - 76742148			830774	820520		
NM_024685.4(BBS10):c.1676dup (p.Tyr559Ter)	BBS10		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000625446	12	76740088 - 76740089	12	76346308 - 76346309	625446	613753	rs1565809478	NC_000012.12:76346308:T:TT
NM_024685.4(BBS10):c.724del (p.Gln242fs)	BBS10	Q242fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585180	12	76741041	12	76347261	585180	576235	rs1565809995	NC_000012.12:76347260:G:
NM_024685.4(BBS10):c.559_561del (p.His187del)	BBS10	H187del	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585179	12	76741204 - 76741206	12	76347424 - 76347426	585179	576236	rs781421232	NC_000012.12:76347423:ATGAT:AT
NM_024685.4(BBS10):c.198G>T (p.Arg66Ser)	BBS10	R66S	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585178	12	76741567	12	76347787	585178	576237	rs1565810301	NC_000012.12:76347786:C:A
NM_024685.4(BBS10):c.1143T>G (p.Tyr381Ter)	BBS10	Y381*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585177	12	76740622	12	76346842	585177	576231	rs1340165752	NC_000012.12:76346841:A:C
NM_024685.4(BBS10):c.118A>T (p.Lys40Ter)	BBS10	K40*	Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000552187	12	76742021	12	76348241	552187	547266	rs202228478	NC_000012.12:76348240:T:A
NM_024685.4(BBS10):c.1138dup (p.Arg380fs)	BBS10		Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: Jun 13, 2016)	criteria provided, single submitter	VCV000434488	12	76740626 - 76740627	12	76346846 - 76346847	434488	429451	rs1555202645	NC_000012.12:76346846:TTTT:TTTTT
NM_024685.4(BBS10):c.1495G>T (p.Glu499Ter)	BBS10	E499*	Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, single submitter	VCV000434487	12	76740270	12	76346490	434487	429449	rs898539189	NC_000012.12:76346489:C:A
NM_024685.4(BBS10):c.257_261del (p.Phe86fs)	BBS10	F86fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000406219	12	76741504 - 76741508	12	76347724 - 76347728	406219	399558	rs1060500996	NC_000012.12:76347723:AATAAA:A
NM_024685.4(BBS10):c.1547del (p.Thr516fs)	BBS10	T516fs	Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: Oct 5, 2015)	no assertion criteria provided	VCV000217440	12	76740218	12	76346438	217440	214076	rs869025211	NC_000012.12:76346437:G:
NM_024685.4(BBS10):c.1024dup (p.Ile342fs)	BBS10		Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: Oct 5, 2015)	no assertion criteria provided	VCV000217439	12	76740740 - 76740741	12	76346960 - 76346961	217439	214077	rs869025210	NC_000012.12:76346960:T:TT
NM_024685.4(BBS10):c.1856_1865del (p.Lys619fs)	BBS10	K619fs	Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: Oct 5, 2015)	no assertion criteria provided	VCV000217438	12	76739900 - 76739909	12	76346120 - 76346129	217438	214075	rs869025209	NC_000012.12:76346119:TGGCATTTTTTGGCAT:TGGCAT
NM_014967.5(FAN1):c.1234+2T>A	FAN1		Interstitial nephritis, karyomegalic	Pathogenic(Last reviewed: Jul 8, 2012)	no assertion criteria provided	VCV000037095	15	31198102	15	30905899	37095	45770	rs767435461	NC_000015.10:30905898:T:A
NM_024685.4(BBS10):c.1244del (p.His415fs)	BBS10	H415fs	Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000558108	12	76740521	12	76346741	558108	547213	rs760642305	NC_000012.12:76346740:T:
NM_024685.4(BBS10):c.83_84delinsAG (p.Cys28Ter)	BBS10		Bardet-Biedl syndrome 10|not provided	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000432908	12	76742055 - 76742056	12	76348275 - 76348276	432908	426020	rs1555202801	NC_000012.12:76348274:GC:CT
NM_006939.4(SOS2):c.800T>A (p.Met267Lys)	SOS2	M267K	Noonan syndrome 9	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000209092	14	50649239	14	50182521	209092	205689	rs797045167	NC_000014.9:50182520:A:T
NM_005236.2(ERCC4):c.689T>C (p.Leu230Pro)	ERCC4	L230P	Fanconi anemia, complementation group Q	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000055826	16	14021989	16	13928132	55826	70484	rs397509402	NC_000016.10:13928131:T:C
NM_005236.2(ERCC4):c.2371_2398dup (p.Ile800fs)	ERCC4		Fanconi anemia, complementation group Q	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000055825	16	14041823 - 14041824	16	13947966 - 13947967	55825	70483	rs397509401	NC_000016.10:13947966:CTTACACTTCACTTCCCCAGACTACGGA:CTTACACTTCACTTCCCCAGACTACGGACTTACACTTCACTTCCCCAGACTACGGA
NM_005236.2(ERCC4):c.2304_2307del	ERCC4		Xeroderma pigmentosum, group F	Pathogenic(Last reviewed: Sep 6, 1996)	no assertion criteria provided	VCV000016579	16	14041753 - 14041756	16	13947896 - 13947899	16579	31618	rs869025184	NC_000016.10:13947895:TCTCTCTC:TCTC
NM_024685.4(BBS10):c.931T>G (p.Ser311Ala)	BBS10	S311A	Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000001331	12	76740834	12	76347054	1331	16370	rs137852837	NC_000012.12:76347053:A:C
NM_000431.4(MVK):c.1162C>T (p.Arg388Ter)	MVK	R388*, R336*	not provided|Mevalonic aciduria||Hyperimmunoglobulin D with periodic fever|Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000097572	12	110034353	12	109596548	97572	103464	rs104895360	NC_000012.12:109596547:C:T
NM_000431.4(MVK):c.928G>A (p.Val310Met)	MVK	V310M, V258M	Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever||Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|not provided	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011934	12	110032875	12	109595070	11934	26973	rs104895319	NC_000012.12:109595069:G:A
NM_002470.4(MYH3):c.1141+131_3256del	MYH3		CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1B	Pathogenic(Last reviewed: Feb 27, 2020)	no assertion criteria provided	VCV000634845	17	10542273 - 10548893	17	10638956 - 10645576	634845	622714		
NM_002470.4(MYH3):c.1160A>G (p.Tyr387Cys)	MYH3	Y387C	ARTHROGRYPOSIS, DISTAL, TYPE 2B3	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000631471	17	10548001	17	10644684	631471	619825	rs1567559027	NC_000017.11:10644683:T:C
NM_002470.4(MYH3):c.2590_2592del (p.Leu864del)	MYH3	L864del	ARTHROGRYPOSIS, DISTAL, TYPE 2B3	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000014142	17	10543403 - 10543405	17	10640086 - 10640088	14142	29181	rs879255230	NC_000017.11:10640085:GAG:
NM_002470.4(MYH3):c.2474T>A (p.Val825Asp)	MYH3	V825D	Freeman-Sheldon syndrome	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000014141	17	10543521	17	10640204	14141	29180	rs121913620	NC_000017.11:10640203:A:T
NM_002470.4(MYH3):c.2014C>T (p.Arg672Cys)	MYH3	R672C	Freeman-Sheldon syndrome	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000014139	17	10544635	17	10641318	14139	29178	rs121913618	NC_000017.11:10641317:G:A
NM_002470.4(MYH3):c.1411-391_1411-219del	MYH3		Spondylocarpotarsal synostosis syndrome|Contractures, pterygia, and variable skeletal fusions syndrome 1A	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000587704	17	10546532 - 10546704	17	10643215 - 10643387	587704	578661	rs1567558314	
NM_002470.4(MYH3):c.3214_3216dup (p.Asn1072dup)	MYH3		Contractures, pterygia, and variable skeletal fusions syndrome 1A	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000235829	17	10542392 - 10542393	17	10639075 - 10639076	235829	237491	rs878853126	NC_000017.11:10639075:ATT:ATTATT
NM_002470.4(MYH3):c.3224A>C (p.Gln1075Pro)	MYH3	Q1075P	Contractures, pterygia, and variable skeletal fusions syndrome 1A	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000203471	17	10542385	17	10639068	203471	199883	rs796051884	NC_000017.11:10639067:T:G
NM_002470.4(MYH3):c.2015G>A (p.Arg672His)	MYH3	R672H	Freeman-Sheldon syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000014138	17	10544634	17	10641317	14138	29177	rs121913617	NC_000017.11:10641316:C:T
NM_024685.4(BBS10):c.1804G>C (p.Val602Leu)	BBS10	V602L	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000860963	12	76739961	12	76346181	860963	840279		NC_000012.12:76346180:C:G
NM_005236.2(ERCC4):c.388+1164_792+795del	ERCC4		XFE progeroid syndrome|Hutchinson-Gilford syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2019)	no assertion criteria provided	VCV000625138					625138	613483		
NM_024685.4(BBS10):c.235dup (p.Thr79fs)	BBS10		Bardet-Biedl syndrome 10|Retinal dystrophy	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554591	12	76741529 - 76741530	12	76347749 - 76347750	554591	547264	rs760693838	NC_000012.12:76347749:TTTTTTT:TTTTTTTT
NM_024685.4(BBS10):c.646dup (p.Asp216fs)	BBS10		Bardet-Biedl syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419326	12	76741118 - 76741119	12	76347338 - 76347339	419326	408746	rs1555202695	NC_000012.12:76347338:C:CC
NM_024685.4(BBS10):c.1506_1507AT[2] (p.Ile504fs)	BBS10		Bardet-Biedl syndrome 10|not provided	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000288255	12	76740254 - 76740255	12	76346474 - 76346475	288255	272492	rs886043841	NC_000012.12:76346473:ATATAT:ATAT
NM_024685.4(BBS10):c.197+1G>T	BBS10		not provided|Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: Oct 14, 2015)	criteria provided, single submitter	VCV000283884	12	76741941	12	76348161	283884	268121	rs886042729	NC_000012.12:76348160:C:A
NM_024685.4(BBS10):c.531C>A (p.Tyr177Ter)	BBS10	Y177*	Bardet-Biedl syndrome 10|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	VCV000216124	12	76741234	12	76347454	216124	213012	rs863224522	NC_000012.12:76347453:G:T
NM_002470.4(MYH3):c.1748A>C (p.Tyr583Ser)	MYH3	Y583S	Freeman-Sheldon syndrome	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000694360	17	10545874	17	10642557	694360	682258		NC_000017.11:10642556:T:G
NM_002470.4(MYH3):c.141T>G (p.Tyr47Ter)	MYH3	Y47*	CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1B|Spondylocarpotarsal synostosis syndrome|Contractures, pterygia, and variable skeletal fusions syndrome 1A	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000587703	17	10558241	17	10654924	587703	578664	rs1567564042	NC_000017.11:10654923:A:C
NM_002470.4(MYH3):c.1581+1G>A	MYH3		Spondylocarpotarsal synostosis syndrome|Contractures, pterygia, and variable skeletal fusions syndrome 1A|Contractures, pterygia, and variable skeletal fusions syndrome 1A	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000587702	17	10546142	17	10642825	587702	578660	rs1350968647	NC_000017.11:10642824:C:T
NM_002470.4(MYH3):c.4647+1G>A	MYH3		Spondylocarpotarsal synostosis syndrome|Contractures, pterygia, and variable skeletal fusions syndrome 1A|CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1B	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000587701	17	10536907	17	10633590	587701	578659	rs1567552713	NC_000017.11:10633589:C:T
NM_000295.5(SERPINA1):c.833T>C (p.Leu278Pro)	SERPINA1	L278P	Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000626306	14	94847292	14	94380955	626306	614635	rs1566753480	NC_000014.9:94380954:A:G
NM_000295.5(SERPINA1):c.585_586delinsA (p.Asp195fs)	SERPINA1		Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000626303	14	94848989 - 94848990	14	94382652 - 94382653	626303	614638	rs1566756379	NC_000014.9:94382651:AA:T
NM_000295.5(SERPINA1):c.244G>C (p.Ala82Pro)	SERPINA1	A82P	Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000626298	14	94849331	14	94382994	626298	614640	rs113817720	NC_000014.9:94382993:C:G
NM_000295.5(SERPINA1):c.227T>C (p.Phe76Ser)	SERPINA1	F76S	Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Dec 8, 2014)	no assertion criteria provided	VCV000444040	14	94849348	14	94383011	444040	437684	rs1555369172	NC_000014.9:94383010:A:G
NM_000295.5(SERPINA1):c.1del (p.Met1fs)	SERPINA1	M1fs	Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Dec 8, 2014)	no assertion criteria provided	VCV000444039	14	94849574	14	94383237	444039	437686	rs1555369299	NC_000014.9:94383236:TT:T
NM_000295.5(SERPINA1):c.1158del (p.Glu387fs)	SERPINA1	E387fs	Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Dec 8, 2014)	no assertion criteria provided	VCV000444037	14	94844885	14	94378548	444037	437676	rs764325655	NC_000014.9:94378547:GGGGGGG:GGGGGG
NM_000295.5(SERPINA1):c.1072_1073del (p.Val357_His358insTer)	SERPINA1		Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Dec 8, 2014)	no assertion criteria provided	VCV000444035	14	94844970 - 94844971	14	94378633 - 94378634	444035	437678	rs1555367892	NC_000014.9:94378632:TG:
NM_000295.5(SERPINA1):c.1064_1066= (p.Lys355_Ala356=)	SERPINA1		Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Dec 8, 2014)	no assertion criteria provided	VCV000444034	14	94844977 - 94845799	14	94378640 - 94379462	444034	437679	rs1555367896	
NM_000295.5(SERPINA1):c.866dup (p.Asn289fs)	SERPINA1		Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000440499	14	94847258 - 94847259	14	94380921 - 94380922	440499	434121	rs1555368557	NC_000014.9:94380921:TTTT:TTTTT
NM_001127701.1(SERPINA1):c.647-1delG	SERPINA1		Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000440496	14	94847478	14	94381141	440496	434124	rs1555368758	NC_000014.9:94381140:CC:C
NM_000295.5(SERPINA1):c.1226T>C (p.Met409Thr)	SERPINA1	M409T	Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000440487	14	94844817	14	94378480	440487	434114	rs1488213352	NC_000014.9:94378479:A:G
NM_000295.5(SERPINA1):c.288_291del (p.His97fs)	SERPINA1	H97fs	Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Jul 10, 2014)	no assertion criteria provided	VCV000370034	14	94849284 - 94849287	14	94382947 - 94382950	370034	354274	rs1057516212	NC_000014.9:94382946:GTGAGTG:GTG
NC_000016.9:g.(?_14014013)_(14042214_?)del	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Pathogenic(Last reviewed: Aug 4, 2018)	criteria provided, single submitter	VCV000661743	16	14014013 - 14042214	16	13920156 - 13948357	661743	652453		
NM_024685.4(BBS10):c.1407T>G (p.Tyr469Ter)	BBS10	Y469*	Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000632669	12	76740358	12	76346578	632669	621383	rs1356713858	NC_000012.12:76346577:A:C
NC_000016.9:g.(?_14021879)_(14022098_?)del	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000541254	16	14021879 - 14022098	16	13928022 - 13928241	541254	529246		
NM_024685.4(BBS10):c.164T>C (p.Leu55Pro)	BBS10	L55P	Bardet-Biedl syndrome 10|Bardet-Biedl syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522272	12	76741975	12	76348195	522272	512858	rs1460517643	NC_000012.12:76348194:A:G
NM_000151.4(G6PC):c.229T>C (p.Trp77Arg)	G6PC	W77R	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012001	17	41053122	17	42901105	12001	27040	rs104894566	NC_000017.11:42901104:T:C
NM_178452.6(DNAAF1):c.1876A>T (p.Lys626Ter)	DNAAF1	K390*, K626*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000663190	16	84209716	16	84176110	663190	645076		NC_000016.10:84176109:A:T
NM_178452.6(DNAAF1):c.1906C>T (p.Arg636Ter)	DNAAF1	R636*, R400*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000569853	16	84209746	16	84176140	569853	570565	rs748869874	NC_000016.10:84176139:C:T
NM_178452.6(DNAAF1):c.1937del (p.Leu646fs)	DNAAF1	L410fs, L646fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000525389	16	84209777	16	84176171	525389	530869	rs1555527001	NC_000016.10:84176170:T:
NM_178452.6(DNAAF1):c.934_940del (p.Arg312fs)	DNAAF1	R60fs, R312fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000525219	16	84199455 - 84199461	16	84165849 - 84165855	525219	530350	rs1233603821	NC_000016.10:84165848:GAGCAGGGAGC:GAGC
NM_178452.6(DNAAF1):c.715del (p.Ser239fs)	DNAAF1	S239fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000455006	16	84189328	16	84155723	455006	466820	rs758650222	NC_000016.10:84155722:A:
NM_178452.6(DNAAF1):c.1814dup (p.Asn605fs)	DNAAF1		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, single submitter	VCV000455002	16	84209651 - 84209652	16	84176045 - 84176046	455002	466844	rs1555526915	NC_000016.10:84176045:AAA:AAAA
NM_178452.6(DNAAF1):c.1645-2A>C	DNAAF1		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000455001	16	84208273	16	84174667	455001	466828	rs764066045	NC_000016.10:84174666:A:C
NM_178452.6(DNAAF1):c.145_146AT[1] (p.Ile49fs)	DNAAF1		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000455000	16	84182632 - 84182633	16	84149027 - 84149028	455000	467116	rs1555519999	NC_000016.10:84149026:ATAT:AT
NM_178452.6(DNAAF1):c.1012del (p.Arg338fs)	DNAAF1	R86fs, R338fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000454995	16	84199537	16	84165931	454995	467119	rs762843285	NC_000016.10:84165930:A:
NM_001146051.1(HSDL1):c.-7464_-2089del	DNAAF1		Ciliary dyskinesia, primary, 13	Pathogenic(Last reviewed: Sep 15, 2011)	no assertion criteria provided	VCV000065498	16	84180705 - 84186080	16	84147100 - 84152475	65498	76406		
QOgranite falls allele	SERPINA1		Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000217816					217816	214472		
NM_004239.4(TRIP11):c.790C>T (p.Arg264Ter)	TRIP11	R264*, R263*	Achondrogenesis, type IA|Goldblatt hypertension	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000005508	14	92482073	14	92015729	5508	20547	rs267607138	NC_000014.9:92015728:G:A
NC_000016.9:g.(?_84182592)_(84183967_?)del	DNAAF1		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000663406	16	84182592 - 84183967	16	84148987 - 84150362	663406	653163		
NM_178452.6(DNAAF1):c.1300_1322del (p.Gly434fs)	DNAAF1	G434fs, G198fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000525404	16	84203730 - 84203752	16	84170124 - 84170146	525404	530352	rs745495583	NC_000016.10:84170123:GGACGGAGATGGAGAGCCAGAGGGGAC:GGAC
NM_178452.6(DNAAF1):c.190C>T (p.Gln64Ter)	DNAAF1	Q64*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000410278	16	84182677	16	84149072	410278	401360	rs1060502829	NC_000016.10:84149071:C:T
NM_178452.6(DNAAF1):c.1349dup (p.Pro451fs)	DNAAF1		Ciliary dyskinesia, primary, 13|Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000000263	16	84203778 - 84203779	16	84170172 - 84170173	263	15302	rs397515339	NC_000016.10:84170172:CCCCC:CCCCCC
NM_000295.5(SERPINA1):c.841G>T (p.Glu281Ter)	SERPINA1	E281*	Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000859309	14	94847284	14	94380947	859309	841913		NC_000014.9:94380946:C:A
NM_000295.5(SERPINA1):c.538C>T (p.Gln180Ter)	SERPINA1	Q180*	Alpha-1-antitrypsin deficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000219364	14	94849037	14	94382700	219364	221054	rs864622051	NC_000014.9:94382699:G:A
NM_002087.3(GRN):c.768_769dup (p.Gln257fs)	GRN		not provided|	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000803427	17	42428463 - 42428464	17	44351095 - 44351096	803427	791781		NC_000017.11:44351095:CC:CCCC
NM_002087.3(GRN):c.708+1G>A	GRN		Frontotemporal dementia|not provided|	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203460	17	42428169	17	44350801	203460	199868	rs63749817	NC_000017.11:44350800:G:A
NM_000359.3(TGM1):c.1437dup (p.Ile480fs)	TGM1		not provided	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000817199	14	24725248 - 24725249	14	24256042 - 24256043	817199	805786		NC_000014.9:24256042:GG:GGG
NM_000359.3(TGM1):c.882_888del (p.Asp294fs)	TGM1	D294fs	not provided	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000817048	14	24729006 - 24729012	14	24259800 - 24259806	817048	805787		NC_000014.9:24259799:CCCGTGG:
NM_020366.3(RPGRIP1):c.1615_1624del (p.Glu539fs)	RPGRIP1	E539fs	Cone-rod degeneration	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812424	14	21790015 - 21790024	14	21321856 - 21321865	812424	800581		NC_000014.9:21321855:GGAACTGGAGG:G
NM_000359.3(TGM1):c.586C>T (p.Gln196Ter)	TGM1	Q196*	not provided	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000620502	14	24729827	14	24260621	620502	611784	rs1566380103	NC_000014.9:24260620:G:A
NM_020366.3(RPGRIP1):c.1468-2A>G	RPGRIP1		not provided	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000498452	14	21789416	14	21321257	498452	489876	rs751342895	NC_000014.9:21321256:A:G
NM_000359.3(TGM1):c.427C>G (p.Arg143Gly)	TGM1	R143G	not provided	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000452009	14	24730982	14	24261776	452009	445220	rs531650682	NC_000014.9:24261775:G:C
NM_000359.3(TGM1):c.1094A>G (p.Tyr365Cys)	TGM1	Y365C	not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000427008	14	24728346	14	24259140	427008	415394	rs756732717	NC_000014.9:24259139:T:C
NM_020366.3(RPGRIP1):c.3565C>T (p.Arg1189Ter)	RPGRIP1	R1189*	not provided	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000381684	14	21813304	14	21345145	381684	375915	rs752175052	NC_000014.9:21345144:C:T
NM_000359.3(TGM1):c.1082T>C (p.Ile361Thr)	TGM1	I361T	not provided	Pathogenic(Last reviewed: Jun 26, 2015)	criteria provided, single submitter	VCV000372535	14	24728358	14	24259152	372535	360046	rs1057517837	NC_000014.9:24259151:A:G
NM_020366.3(RPGRIP1):c.2668C>T (p.Arg890Ter)	RPGRIP1	R890*	not provided	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000280091	14	21794290	14	21326131	280091	264783	rs780587095	NC_000014.9:21326130:C:T
NM_020366.3(RPGRIP1):c.3749-2A>G	RPGRIP1		not provided	Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	VCV000195835	14	21819261	14	21351102	195835	192996	rs376517859	NC_000014.9:21351101:A:G
NM_000359.3(TGM1):c.1621A>C (p.Thr541Pro)	TGM1	T541P	Lamellar ichthyosis	Pathogenic	no assertion criteria provided	VCV000127067	14	24724594	14	24255388	127067	132580	rs587779765	NC_000014.9:24255387:T:G
NM_000359.3(TGM1):c.1019G>A (p.Gly340Glu)	TGM1	G340E	Autosomal recessive congenital ichthyosis 1	Pathogenic	criteria provided, single submitter	VCV000813833	14	24728421	14	24259215	813833	802085	rs867950920	NC_000014.9:24259214:C:T
NM_000359.3(TGM1):c.1409del (p.Phe470fs)	TGM1	F470fs	not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000664642	14	24725277	14	24256071	664642	642341		NC_000014.9:24256070:AA:A
NC_000014.8:g.(?_24723348)_(24725293_?)dup	TGM1		not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000646967	14	24723348 - 24725293	14	24254142 - 24256087	646967	652550		
NM_020366.3(RPGRIP1):c.564A>G (p.Glu188=)	RPGRIP1		Leber congenital amaurosis	Pathogenic(Last reviewed: May 9, 2017)	no assertion criteria provided	VCV000427869	14	21770720	14	21302561	427869	418825	rs574462207	NC_000014.9:21302560:A:G
NM_020366.3(RPGRIP1):c.2759_2760insT (p.Gln920fs)	RPGRIP1		Leber congenital amaurosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803005	14	21795830 - 21795831	14	21327671 - 21327672	803005	791390		NC_000014.9:21327671::T
NM_000359.3(TGM1):c.1054C>G (p.Pro352Ala)	TGM1	P352A	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000694521	14	24728386	14	24259180	694521	682508		NC_000014.9:24259179:G:C
NM_000359.3(TGM1):c.131G>A (p.Trp44Ter)	TGM1	W44*	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633816	14	24731428	14	24262222	633816	622243	rs1566381457	NC_000014.9:24262221:C:T
NM_000359.3(TGM1):c.1928-1G>A	TGM1		Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633793	14	24724031	14	24254825	633793	622263	rs112419023	NC_000014.9:24254824:C:T
NM_000359.3(TGM1):c.1521del (p.Gln508fs)	TGM1	Q508fs	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633792	14	24724694	14	24255488	633792	622235	rs1566377068	NC_000014.9:24255487:CC:C
NM_000359.3(TGM1):c.1298+1G>A	TGM1		Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633791	14	24727740	14	24258534	633791	622264	rs1566378425	NC_000014.9:24258533:C:T
NM_000359.3(TGM1):c.1307A>G (p.His436Arg)	TGM1	H436R	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633789	14	24727586	14	24258380	633789	622238	rs1381998109	NC_000014.9:24258379:T:C
NM_020366.3(RPGRIP1):c.799C>T (p.Arg267Ter)	RPGRIP1	R267*	Leber congenital amaurosis 6	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560507	14	21771701	14	21303542	560507	551569	rs554396590	NC_000014.9:21303541:C:T
NM_020366.3(RPGRIP1):c.2554C>T (p.Arg852Ter)	RPGRIP1	R852*	not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000501219	14	21794176	14	21326017	501219	492643	rs1429786931	NC_000014.9:21326016:C:T
NM_020366.3(RPGRIP1):c.2356C>T (p.Gln786Ter)	RPGRIP1	Q786*	Leber congenital amaurosis 6	Pathogenic(Last reviewed: Sep 18, 2014)	no assertion criteria provided	VCV000156388	14	21793531	14	21325372	156388	166169	rs587783019	NC_000014.9:21325371:C:T
NM_020366.3(RPGRIP1):c.832C>T (p.Arg278Ter)	RPGRIP1	R278*	Leber congenital amaurosis 6	Pathogenic(Last reviewed: Sep 18, 2014)	no assertion criteria provided	VCV000156387	14	21775921	14	21307762	156387	166168	rs587783018	NC_000014.9:21307761:C:T
NM_020366.3(RPGRIP1):c.3565_3571del (p.Arg1189fs)	RPGRIP1	R1189fs	Leber congenital amaurosis 6	Pathogenic(Last reviewed: Sep 18, 2014)	no assertion criteria provided	VCV000156381	14	21813299 - 21813305	14	21345140 - 21345146	156381	166162	rs587783012	NC_000014.9:21345139:AAGGCCGAAGGC:AAGGC
NM_020366.3(RPGRIP1):c.1892A>T (p.His631Leu)	RPGRIP1	H631L	Leber congenital amaurosis 6	Pathogenic(Last reviewed: Sep 18, 2014)	no assertion criteria provided	VCV000156380	14	21792906	14	21324747	156380	166161	rs535922252	NC_000014.9:21324746:A:T
NM_000359.3(TGM1):c.1331dup (p.Arg445fs)	TGM1		Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000039535	14	24727561 - 24727562	14	24258355 - 24258356	39535	48134	rs398122903	NC_000014.9:24258355:TT:TTT
NM_000359.3(TGM1):c.1923_1927+2del	TGM1		Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000039534	14	24724176 - 24724182	14	24254970 - 24254976	39534	48133	rs398122902	NC_000014.9:24254969:ACAGGCC:
NM_000359.3(TGM1):c.614T>A (p.Leu205Gln)	TGM1	L204Q, L205Q	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000039526	14	24729799	14	24260593	39526	48125	rs878853259	NC_000014.9:24260592:A:T
NM_000359.3(TGM1):c.305A>T (p.Asp102Val)	TGM1	D101V, D102V	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000039525	14	24731254	14	24262048	39525	48124	rs398122901	NC_000014.9:24262047:T:A
TGM1, -86C-T	TGM1		Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000039524					39524	48123		
NM_000359.3(TGM1):c.1304_1308del (p.Phe435fs)	TGM1	F435fs	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000039522	14	24727585 - 24727589	14	24258379 - 24258383	39522	48121	rs398122900	NC_000014.9:24258378:ATGGAA:A
NM_000359.3(TGM1):c.866A>C (p.Asn289Thr)	TGM1	N288T, N289T	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000012498	14	24729156	14	24259950	12498	27537	rs121918730	NC_000014.9:24259949:T:G
NM_000359.3(TGM1):c.425G>C (p.Arg142Pro)	TGM1	R142P	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000012494	14	24730984	14	24261778	12494	27533		NC_000014.9:24261777:C:G
NM_000359.3(TGM1):c.1175G>A (p.Gly392Asp)	TGM1	G392D	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000012493	14	24727864	14	24258658	12493	27532	rs121918726	NC_000014.9:24258657:C:T
TGM1, 1-BP DEL, 9008A	TGM1		Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000012490					12490	27529		
NM_000359.3(TGM1):c.1147G>A (p.Val383Met)	TGM1	V382M, V383M	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000012488	14	24728293	14	24259087	12488	27527	rs121918722	NC_000014.9:24259086:C:T
NM_000359.3(TGM1):c.479C>G (p.Ser160Cys)	TGM1	S160C	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000012482	14	24730930	14	24261724	12482	27521	rs121918728	NC_000014.9:24261723:G:C
TGM1, 1-BP DEL, 4640T	TGM1		Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jan 27, 1995)	no assertion criteria provided	VCV000012478					12478	27517		
NM_024685.4(BBS10):c.1552C>T (p.Gln518Ter)	BBS10	Q518*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000863841	12	76740213	12	76346433	863841	840283		NC_000012.12:76346432:G:A
NM_024685.4(BBS10):c.598A>T (p.Lys200Ter)	BBS10	K200*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000837298	12	76741167	12	76347387	837298	840291		NC_000012.12:76347386:T:A
NM_024685.4(BBS10):c.445dup (p.Leu149fs)	BBS10		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000661491	12	76741319 - 76741320	12	76347539 - 76347540	661491	641390		NC_000012.12:76347539:GG:GGG
NM_024685.4(BBS10):c.999T>A (p.Cys333Ter)	BBS10	C333*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000576535	12	76740766	12	76346986	576535	572052	rs1565809867	NC_000012.12:76346985:A:T
NM_024685.4(BBS10):c.1452_1455del (p.Gln484fs)	BBS10	Q484fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000571128	12	76740310 - 76740313	12	76346530 - 76346533	571128	567065	rs1565809597	NC_000012.12:76346529:TGTTTG:TG
NM_024685.4(BBS10):c.1767C>A (p.Tyr589Ter)	BBS10	Y589*	Bardet-Biedl syndrome 10|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000560964	12	76739998	12	76346218	560964	552165	rs1565809409	NC_000012.12:76346217:G:T
NM_005236.2(ERCC4):c.1731del (p.Arg576_Tyr577insTer)	ERCC4		Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, group F	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000541251	16	14029520	16	13935663	541251	529467	rs1555468482	NC_000016.10:13935662:C:
NM_024685.4(BBS10):c.2030del (p.Gly677fs)	BBS10	G677fs	Bardet-Biedl syndrome 10|Bardet-Biedl syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000423236	12	76739735	12	76345955	423236	408745	rs1064796315	NC_000012.12:76345954:CC:C
NM_005236.2(ERCC4):c.1484_1488del (p.Thr495fs)	ERCC4	T495fs	Pre-B-cell acute lymphoblastic leukemia|Fanconi anemia, complementation group Q	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000055823	16	14029271 - 14029275	16	13935414 - 13935418	55823	70481	rs397509400	NC_000016.10:13935413:AACTCAA:AA
NC_000014.9:g.(?_21317696)_(21320177_?)del	RPGRIP1		Cone-rod dystrophy 13|Leber congenital amaurosis 6	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000832960	14	21785855 - 21788336			832960	820600		
NM_020366.3(RPGRIP1):c.895_896del (p.Glu299fs)	RPGRIP1	E299fs	Leber congenital amaurosis 6	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000814018	14	21775983 - 21775984	14	21307824 - 21307825	814018	802247		NC_000014.9:21307823:AGA:A
NC_000014.9:g.21348213_21348216AGAA[1]	RPGRIP1		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812428	14	21816370 - 21816373	14	21348211 - 21348214	812428	800585		NC_000014.9:21348210:AAAGAAAGAA:AAAGAA
NM_020366.3(RPGRIP1):c.2974del (p.Arg992fs)	RPGRIP1	R992fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812427	14	21796659	14	21328500	812427	800584		NC_000014.9:21328499:AAA:AA
NM_020366.3(RPGRIP1):c.2935C>T (p.Gln979Ter)	RPGRIP1	Q979*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812426	14	21796622	14	21328463	812426	800583		NC_000014.9:21328462:C:T
NM_020366.3(RPGRIP1):c.2017C>T (p.Gln673Ter)	RPGRIP1	Q673*	Leber congenital amaurosis 6|Cone-rod dystrophy 13	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000578421	14	21793031	14	21324872	578421	566290	rs1566341956	NC_000014.9:21324871:C:T
NM_020366.3(RPGRIP1):c.3467_3468insCT (p.Thr1156_Glu1157insTer)	RPGRIP1		Leber congenital amaurosis 6	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522702	14	21811322 - 21811323	14	21343163 - 21343164	522702	513343	rs776698746	NC_000014.9:21343163::CT
NM_000359.3(TGM1):c.184G>T (p.Gly62Ter)	TGM1	G62*	not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000280810	14	24731375	14	24262169	280810	264694	rs886041950	NC_000014.9:24262168:C:A
NM_000359.3(TGM1):c.132G>A (p.Trp44Ter)	TGM1	W44*	not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jun 8, 2016)	criteria provided, single submitter	VCV000265597	14	24731427	14	24262221	265597	260055	rs886039654	NC_000014.9:24262220:C:T
NM_000359.3(TGM1):c.2278C>T (p.Arg760Ter)	TGM1	R670*, R760*	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000039536	14	24718695	14	24249489	39536	48135	rs398122904	NC_000014.9:24249488:G:A
NM_000359.3(TGM1):c.826T>A (p.Tyr276Asn)	TGM1	Y276N	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000039527	14	24729196	14	24259990	39527	48126	rs397514523	NC_000014.9:24259989:A:T
RPGRIP1, 1-BP DEL, LYS342	RPGRIP1		Leber congenital amaurosis 6	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000004985					4985	20024		
RPGRIP1, 1-BP INS, GLN893	RPGRIP1		Leber congenital amaurosis 6	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000004984					4984	20023		
RPGRIP1, 1-BP DEL, ASP1176	RPGRIP1		Leber congenital amaurosis 6	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000004982					4982	20021		
NM_178452.6(DNAAF1):c.524T>G (p.Leu175Arg)	DNAAF1	L175R	Ciliary dyskinesia, primary, 13|Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000000267	16	84188353	16	84154748	267	15306	rs267607227	NC_000016.10:84154747:T:G
NM_178452.6(DNAAF1):c.508dup (p.Glu170fs)	DNAAF1		Ciliary dyskinesia, primary, 13|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, single submitter	VCV000000266	16	84188335 - 84188336	16	84154730 - 84154731	266	15305	rs786205052	NC_000016.10:84154730:GG:GGG
NM_178452.6(DNAAF1):c.792C>A (p.Tyr264Ter)	DNAAF1	Y264*, Y12*	Ciliary dyskinesia, primary, 13|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000000265	16	84193330	16	84159725	265	15304	rs267607226	NC_000016.10:84159724:C:A
NM_152594.3(SPRED1):c.1015C>T (p.Gln339Ter)	SPRED1	Q339*	not provided	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000592540	15	38643545	15	38351344	592540	583577	rs1566876895	NC_000015.10:38351343:C:T
NC_000015.10:g.(?_38299363)_(38324819_?)del	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000831554	15	38591564 - 38617020			831554	820689		
NM_152594.3(SPRED1):c.306_307dup (p.Phe103fs)	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000650362	15	38614539 - 38614540	15	38322338 - 38322339	650362	643118		NC_000015.10:38322338:GT:GTGT
NM_152594.3(SPRED1):c.900dup (p.Lys301Ter)	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000640306	15	38643429 - 38643430	15	38351228 - 38351229	640306	643123		NC_000015.10:38351228:T:TT
NM_152594.3(SPRED1):c.301_307del (p.Leu101fs)	SPRED1	L101fs	Legius syndrome	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000578285	15	38614533 - 38614539	15	38322332 - 38322338	578285	566981	rs1566867246	NC_000015.10:38322331:GTCTTACGT:GT
NM_152594.3(SPRED1):c.234dup (p.Asp79fs)	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000573472	15	38614462 - 38614463	15	38322261 - 38322262	573472	573217	rs1566867209	NC_000015.10:38322261:AAAAAA:AAAAAAA
NM_152594.3(SPRED1):c.384dup (p.Glu129fs)	SPRED1		Legius syndrome	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000568389	15	38616967 - 38616968	15	38324766 - 38324767	568389	566991	rs1566868022	NC_000015.10:38324766:CCCC:CCCCC
NM_152594.3(SPRED1):c.1044_1046delinsC (p.Arg349fs)	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000565472	15	38643574 - 38643576	15	38351373 - 38351375	565472	573221	rs1566876929	NC_000015.10:38351372:TAG:C
NM_152594.3(SPRED1):c.103G>T (p.Gly35Ter)	SPRED1	G35*	Legius syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547791	15	38591644	15	38299443	547791	538027	rs1555389690	NC_000015.10:38299442:G:T
NM_152594.3(SPRED1):c.7_20del (p.Glu3fs)	SPRED1	E3fs	Legius syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547789	15	38545392 - 38545405	15	38253191 - 38253204	547789	538025	rs1555386651	NC_000015.10:38253190:CGAGGAGACGGCGAC:C
NM_152594.3(SPRED1):c.340_341AG[1] (p.Gly115fs)	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Feb 10, 2018)	criteria provided, single submitter	VCV000536687	15	38614574 - 38614575	15	38322373 - 38322374	536687	529257	rs1555391061	NC_000015.10:38322372:AGAG:AG
NM_152594.3(SPRED1):c.423+2T>C	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000505193	15	38617012	15	38324811	505193	497043	rs1555391161	NC_000015.10:38324810:T:C
NM_152594.3(SPRED1):c.1095_1098AGTT[1] (p.Ser367fs)	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000468788	15	38643625 - 38643628	15	38351424 - 38351427	468788	464988	rs1555392783	NC_000015.10:38351423:AGTTAGTT:AGTT
NC_000015.9:g.(?_38591574)_(38649450_?)del	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000417474	15	38591574 - 38649450	15	38299373 - 38357249	417474	400528		
NM_152594.3(SPRED1):c.421C>T (p.Gln141Ter)	SPRED1	Q141*	Legius syndrome	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000409627	15	38617008	15	38324807	409627	400555	rs1060502505	NC_000015.10:38324806:C:T
NM_152594.3(SPRED1):c.1045_1046del (p.Arg349fs)	SPRED1	R349fs	Legius syndrome	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000030784	15	38643575 - 38643576	15	38351374 - 38351375	30784	39741	rs1566876941	NC_000015.10:38351373:AG:
NM_152594.3(SPRED1):c.131T>A (p.Val44Asp)	SPRED1	V44D	Legius syndrome	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000001816	15	38591672	15	38299471	1816	16855	rs121434318	NC_000015.10:38299470:T:A
NM_152594.3(SPRED1):c.784A>T (p.Arg262Ter)	SPRED1	R262*	Legius syndrome	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000001815	15	38643314	15	38351113	1815	16854	rs121434317	NC_000015.10:38351112:A:T
NM_152594.3(SPRED1):c.643C>T (p.Gln215Ter)	SPRED1	Q215*	Legius syndrome	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001812	15	38641683	15	38349482	1812	16851	rs121434314	NC_000015.10:38349481:C:T
NM_152594.3(SPRED1):c.423+1G>A	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001811	15	38617011	15	38324810	1811	16850	rs1566868058	NC_000015.10:38324809:G:A
NM_020366.3(RPGRIP1):c.3238+1G>A	RPGRIP1		Leber congenital amaurosis 6	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000814008	14	21798547	14	21330388	814008	802189		NC_000014.9:21330387:G:A
NM_020366.3(RPGRIP1):c.1468-263G>C	RPGRIP1		Leber congenital amaurosis 6	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000814006	14	21789155	14	21320996	814006	802186		NC_000014.9:21320995:G:C
NM_020366.3(RPGRIP1):c.800+1G>A	RPGRIP1		not provided|Leber congenital amaurosis 1	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000803002	14	21771703	14	21303544	803002	791387		NC_000014.9:21303543:G:A
NM_020366.3(RPGRIP1):c.801-25_843del	RPGRIP1		Leber congenital amaurosis 6	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000587394	14	21775863 - 21775930	14	21307704 - 21307771	587394	578347	rs1566674809	
NM_000359.3(TGM1):c.316C>T (p.Arg106Ter)	TGM1	R106*	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000558256	14	24731243	14	24262037	558256	547465	rs773303931	NC_000014.9:24262036:G:A
NM_000359.3(TGM1):c.566dup (p.Ser190fs)	TGM1		Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000555976	14	24729846 - 24729847	14	24260640 - 24260641	555976	547455	rs1211601030	NC_000014.9:24260640:CCCCCC:CCCCCCC
NM_000359.3(TGM1):c.1224_1225CA[1] (p.Thr409fs)	TGM1		Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000555175	14	24727812 - 24727813	14	24258606 - 24258607	555175	547304	rs1555306113	NC_000014.9:24258605:TGTGT:TGT
NM_000359.3(TGM1):c.1417G>A (p.Gly473Ser)	TGM1	G473S	not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372536	14	24725269	14	24256063	372536	360147	rs904122716	NC_000014.9:24256062:C:T
NM_000359.3(TGM1):c.1363T>C (p.Trp455Arg)	TGM1	W455R	Ichthyosis (disease)|Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Nov 17, 2015)	no assertion criteria provided	VCV000217304	14	24727530	14	24258324	217304	213952	rs863223405	NC_000014.9:24258323:A:G
NM_020366.3(RPGRIP1):c.154C>T (p.Arg52Ter)	RPGRIP1	R52*	Cone-rod dystrophy 13|not provided	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000195355	14	21762904	14	21294745	195355	192516	rs192003551	NC_000014.9:21294744:C:T
NM_020366.3(RPGRIP1):c.2775G>A (p.Trp925Ter)	RPGRIP1	W925*	not provided|Leber congenital amaurosis	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095949	14	21795846	14	21327687	95949	101845	rs398124354	NC_000014.9:21327686:G:A
NM_000359.3(TGM1):c.857G>A (p.Arg286Gln)	TGM1	R286Q	Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000012495	14	24729165	14	24259959	12495	27534	rs121918727	NC_000014.9:24259958:C:T
RPGRIP1, 3-BP DEL, 3835GAG	RPGRIP1		Leber congenital amaurosis 6	Pathogenic(Last reviewed: May 15, 2005)	no assertion criteria provided	VCV000004989					4989	20028		
NM_002470.4(MYH3):c.-9+1G>A	MYH3		CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1B|Spondylocarpotarsal synostosis syndrome|Contractures, pterygia, and variable skeletal fusions syndrome 1A|Contractures, pterygia, and variable skeletal fusions syndrome 1A	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000587706	17	10559406	17	10656089	587706	578665	rs557849165	NC_000017.11:10656088:C:T
NM_152594.3(SPRED1):c.395dup (p.Asn132fs)	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000848498	15	38616976 - 38616977	15	38324775 - 38324776	848498	842242		NC_000015.10:38324775:AAAAAA:AAAAAAA
NC_000015.10:g.(?_38253186)_(38253227_?)del	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000832303	15	38545387 - 38545428			832303	820688		
NM_152594.3(SPRED1):c.1151del (p.Glu384fs)	SPRED1	E384fs	Legius syndrome	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000642469	15	38643681	15	38351480	642469	643125		NC_000015.10:38351479:A:
NM_152594.3(SPRED1):c.800G>A (p.Trp267Ter)	SPRED1	W267*	Legius syndrome	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000641432	15	38643330	15	38351129	641432	643122		NC_000015.10:38351128:G:A
NM_031885.4(BBS2):c.1237C>T (p.Arg413Ter)	BBS2	R413*	Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 2|Retinitis pigmentosa 74|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370943	16	56534926	16	56501014	370943	358376	rs147030232	NC_000016.10:56501013:G:A
NM_031885.4(BBS2):c.1864C>T (p.Arg622Ter)	BBS2	R622*	Bardet-Biedl syndrome|not provided|Bardet-Biedl syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000284737	16	56530925	16	56497013	284737	268974	rs201196733	NC_000016.10:56497012:G:A
NM_031885.4(BBS2):c.646C>T (p.Arg216Ter)	BBS2	R216*	Bardet-Biedl syndrome 2|Bardet-biedl syndrome 2/6, digenic|Retinal dystrophy|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004583	16	56540103	16	56506191	4583	19622	rs121908180	NC_000016.10:56506190:G:A
NC_000015.9:g.(?_38545381)_(38643871_?)del	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000584323	15	38545381 - 38643871	15	38253180 - 38351670	584323	568569		
NM_152594.3(SPRED1):c.676C>T (p.Gln226Ter)	SPRED1	Q226*	Legius syndrome	Pathogenic(Last reviewed: Sep 9, 2018)	criteria provided, single submitter	VCV000536686	15	38641716	15	38349515	536686	529263	rs1555392609	NC_000015.10:38349514:C:T
NM_152594.3(SPRED1):c.973C>T (p.Arg325Ter)	SPRED1	R325*	Legius syndrome	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000374301	15	38643503	15	38351302	374301	361214	rs1057518683	NC_000015.10:38351301:C:T
NM_152594.3(SPRED1):c.637C>T (p.Gln213Ter)	SPRED1	Q213*	Legius syndrome	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000001814	15	38641677	15	38349476	1814	16853	rs121434316	NC_000015.10:38349475:C:T
NM_020366.3(RPGRIP1):c.2465_2468dup (p.Ala824fs)	RPGRIP1		Cone-rod dystrophy 13|Leber congenital amaurosis 6|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000857229	14	21794086 - 21794087	14	21325927 - 21325928	857229	841171		NC_000014.9:21325927:CATA:CATACATA
NM_000359.3(TGM1):c.1166G>C (p.Arg389Pro)	TGM1	R389P	not provided	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000838484	14	24727873	14	24258667	838484	841350		NC_000014.9:24258666:C:G
NM_020366.3(RPGRIP1):c.3617+1G>A	RPGRIP1		Leber congenital amaurosis 6|Cone-rod dystrophy 13	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587410	14	21813357	14	21345198	587410	578511	rs771116776	NC_000014.9:21345197:G:A
NM_000359.3(TGM1):c.802del (p.Val268fs)	TGM1	V268fs	not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556211	14	24729220	14	24260014	556211	547449	rs1322979131	NC_000014.9:24260013:C:
NM_000359.3(TGM1):c.1042C>T (p.Arg348Ter)	TGM1	R348*	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000556205	14	24728398	14	24259192	556205	547816	rs1296165092	NC_000014.9:24259191:G:A
NM_000359.3(TGM1):c.160C>T (p.Arg54Ter)	TGM1	R54*	Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000554786	14	24731399	14	24262193	554786	547149	rs140000324	NC_000014.9:24262192:G:A
NM_000359.3(TGM1):c.232C>T (p.Arg78Ter)	TGM1	R78*	Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000449511	14	24731327	14	24262121	449511	445221	rs760429286	NC_000014.9:24262120:G:A
NM_000359.3(TGM1):c.379C>T (p.Arg127Ter)	TGM1	R127*	not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000279910	14	24731030	14	24261824	279910	264686	rs886041250	NC_000014.9:24261823:G:A
NM_020366.3(RPGRIP1):c.2480G>T (p.Arg827Leu)	RPGRIP1	R827L	not provided|Cone-rod dystrophy 13	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000004986	14	21794102	14	21325943	4986	20025	rs28937883	NC_000014.9:21325942:G:T
NM_178452.6(DNAAF1):c.811C>T (p.Arg271Ter)	DNAAF1	R271*, R19*	Ciliary dyskinesia, primary, 13|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000000264	16	84193349	16	84159744	264	15303	rs267607225	NC_000016.10:84159743:C:T
NM_152594.3(SPRED1):c.1149_1152del (p.Gly385fs)	SPRED1	G385fs	Legius syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000646826	15	38643679 - 38643682	15	38351478 - 38351481	646826	643124		NC_000015.10:38351477:AGAG:
NM_152594.3(SPRED1):c.304dup (p.Thr102fs)	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000536688	15	38614537 - 38614538	15	38322336 - 38322337	536688	529256	rs1555391053	NC_000015.10:38322336:A:AA
NM_152594.3(SPRED1):c.921_922CT[1] (p.Ser308fs)	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000468800	15	38643451 - 38643452	15	38351250 - 38351251	468800	464981	rs1555392759	NC_000015.10:38351249:CTCT:CT
NM_024685.4(BBS10):c.473C>A (p.Ser158Ter)	BBS10	S158*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000853587	12	76741292	12	76347512	853587	840292		NC_000012.12:76347511:G:T
NM_000382.3(ALDH3A2):c.946del (p.Thr316fs)	ALDH3A2	T316fs, T123fs	Sjgren-Larsson syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803334	17	19566650	17	19663337	803334	791687		NC_000017.11:19663336:AA:A
NM_000231.2(SGCG):c.230dup (p.Leu78fs)	SGCG		not provided	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000597326	13	23808782 - 23808783	13	23234643 - 23234644	597326	588387	rs1432706111	NC_000013.11:23234643:GG:GGG
NM_000382.3(ALDH3A2):c.480T>G (p.Tyr160Ter)	ALDH3A2	Y160*	not provided	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000545956	17	19559687	17	19656374	545956	536484	rs1555533541	NC_000017.11:19656373:T:G
NM_000382.3(ALDH3A2):c.103C>T (p.Gln35Ter)	ALDH3A2	Q35*	Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000438265	17	19552387	17	19649074	438265	431883		NC_000017.11:19649073:C:T
NM_000382.3(ALDH3A2):c.371_373del (p.Gly124del)	ALDH3A2	G124del	Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000438263	17	19555075 - 19555077	17	19651762 - 19651764	438263	431884		NC_000017.11:19651761:AGGAG:AG
NM_000382.3(ALDH3A2):c.631A>G (p.Lys211Glu)	ALDH3A2	K211E, K18E	Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000438262	17	19559838	17	19656525	438262	431885		NC_000017.11:19656524:A:G
NM_000382.3(ALDH3A2):c.1202G>A (p.Gly401Glu)	ALDH3A2	G401E, G208E	not provided	Pathogenic(Last reviewed: Apr 15, 2015)	criteria provided, single submitter	VCV000379490	17	19568355	17	19665042	379490	374885	rs1010078101	NC_000017.11:19665041:G:A
NM_000231.2(SGCG):c.385+2T>G	SGCG		not provided	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000290553	13	23824858	13	23250719	290553	274790	rs200206447	NC_000013.11:23250718:T:G
NM_000231.2(SGCG):c.599del (p.Ser200fs)	SGCG	S200fs	not provided	Pathogenic(Last reviewed: Jun 22, 2016)	criteria provided, single submitter	VCV000288297	13	23894796	13	23320657	288297	272534	rs886043860	NC_000013.11:23320656:G:
NM_000231.2(SGCG):c.386-2A>G	SGCG		not provided	Pathogenic(Last reviewed: Oct 13, 2015)	criteria provided, single submitter	VCV000283980	13	23853496	13	23279357	283980	268217	rs886042757	NC_000013.11:23279356:A:G
NM_000231.2(SGCG):c.452_458del (p.Leu150_Phe151insTer)	SGCG		not provided	Pathogenic(Last reviewed: Sep 18, 2015)	criteria provided, single submitter	VCV000283032	13	23853563 - 23853569	13	23279424 - 23279430	283032	267269	rs886042540	NC_000013.11:23279423:TTTACTGT:T
NM_000382.3(ALDH3A2):c.191T>A (p.Val64Asp)	ALDH3A2	V64D	not provided	Pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000265458	17	19554897	17	19651584	265458	260157	rs72547556	NC_000017.11:19651583:T:A
NM_000382.3(ALDH3A2):c.386-2A>T	ALDH3A2		not provided	Pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	VCV000265030	17	19555858	17	19652545	265030	260159	rs886039305	NC_000017.11:19652544:A:T
NM_000382.3(ALDH3A2):c.374_378del (p.Ala125fs)	ALDH3A2	A125fs	not provided	Pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000265029	17	19555080 - 19555084	17	19651767 - 19651771	265029	260158	rs886039304	NC_000017.11:19651766:CCATC:
NM_000231.2(SGCG):c.735dup (p.Lys246fs)	SGCG		not provided	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	VCV000198699	13	23898536 - 23898537	13	23324397 - 23324398	198699	195860	rs797044783	NC_000013.11:23324397:CCC:CCCC
NC_000017.11:g.(?_19663323)_(19663509_?)del	ALDH3A2		not provided	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000831853	17	19566636 - 19566822			831853	820992		
NM_000382.3(ALDH3A2):c.50C>A (p.Ser17Ter)	ALDH3A2	S17*	Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Feb 7, 2020)	criteria provided, single submitter	VCV000816625	17	19552334	17	19649021	816625	804830		NC_000017.11:19649020:C:A
NM_000382.3(ALDH3A2):c.837T>G (p.Tyr279Ter)	ALDH3A2	Y279*, Y86*	Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623290	17	19564478	17	19661165	623290	612318		NC_000017.11:19661164:T:G
NM_000382.3(ALDH3A2):c.908G>T (p.Gly303Val)	ALDH3A2	G303V, G110V	Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522786	17	19564549	17	19661236	522786	513368		NC_000017.11:19661235:G:T
GRCh37/hg19 17p11.2(chr17:19494823-19563018)x0	ALDH3A2		See cases	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000443131	17	19494823 - 19563018			443131	436793		
NM_000231.2(SGCG):c.158T>C (p.Leu53Pro)	SGCG	L53P	not provided	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000289650	13	23777991	13	23203852	289650	273887	rs781760379	NC_000013.11:23203851:T:C
NM_000231.2(SGCG):c.690T>A (p.Ser230Arg)	SGCG	S230R	Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: May 9, 2016)	no assertion criteria provided	VCV000226415	13	23894887	13	23320748	226415	228218	rs875989949	NC_000013.11:23320747:T:A
NM_000382.3(ALDH3A2):c.641G>A (p.Cys214Tyr)	ALDH3A2	C214Y, C21Y	Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000001639	17	19559848	17	19656535	1639	16678		NC_000017.11:19656534:G:A
NM_000382.3(ALDH3A2):c.809del (p.Gly270fs)	ALDH3A2	G77fs, G270fs	Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000001637	17	19564449	17	19661136	1637	16676		NC_000017.11:19661135:GG:G
NM_000382.3(ALDH3A2):c.521del (p.Leu174fs)	ALDH3A2	L174fs	Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000001636	17	19559728	17	19656415	1636	16675		NC_000017.11:19656414:T:
NM_000231.3(SGCG):c.533C>G (p.Ser178Ter)	SGCG	S178*, S196*	Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000860561	13	23869581	13	23295442	860561	840582		NC_000013.11:23295441:C:G
NM_000231.3(SGCG):c.496C>T (p.Arg166Ter)	SGCG	R166*, R184*	Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000859443	13	23853608	13	23279469	859443	840581		NC_000013.11:23279468:C:T
NM_000231.3(SGCG):c.167G>A (p.Trp56Ter)	SGCG	W56*, W74*	Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000856157	13	23778000	13	23203861	856157	840580		NC_000013.11:23203860:G:A
NM_000231.3(SGCG):c.649A>T (p.Lys217Ter)	SGCG	K217*, K235*	Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000839948	13	23894846	13	23320707	839948	840584		NC_000013.11:23320706:A:T
NC_000013.11:g.(?_23203685)_(23203899_?)del	SGCG		Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000832832	13	23777824 - 23778038			832832	820548		
NM_000231.2(SGCG):c.333del (p.Thr112fs)	SGCG	T112fs	Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000694029	13	23824804	13	23250665	694029	681848		NC_000013.11:23250664:G:
NM_000231.2(SGCG):c.241_297+1169del	SGCG		Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Mar 9, 2019)	criteria provided, single submitter	VCV000664767	13	23808791 - 23810016	13	23234652 - 23235877	664767	652283		
NC_000017.10:g.(?_19552275)_(19578895_?)del	ALDH3A2		not provided	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000662844	17	19552275 - 19578895	17	19648962 - 19675582	662844	653343		
NM_000231.2(SGCG):c.342dup (p.Ala115fs)	SGCG		Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000651443	13	23824812 - 23824813	13	23250673 - 23250674	651443	641583		NC_000013.11:23250673:T:TT
NC_000013.10:g.(?_23667335)_(23778038_?)del	SGCG		Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000644834	13	23667335 - 23778038	13	23093196 - 23203899	644834	652352		
NM_000382.3(ALDH3A2):c.1309A>T (p.Lys437Ter)	ALDH3A2	K437*, K244*	not provided|Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000619024	17	19575135	17	19671822	619024	610422	rs1567607328	NC_000017.11:19671821:A:T
NC_000013.10:g.(?_23777814)_(23853637_?)del	SGCG		Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000530810	13	23777814 - 23853637	13	23203675 - 23279498	530810	527427		
NM_000382.2(ALDH3A2):c.153+5_386-408delins19	ALDH3A2		Sjgren-Larsson syndrome	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000495851			17	19649129 - 19652139	495851	487677		
NM_000382.3(ALDH3A2):c.574dup (p.Ile192fs)	ALDH3A2		Sjgren-Larsson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280660	17	19559777 - 19559778	17	19656464 - 19656465	280660	264755	rs772967175	NC_000017.11:19656464:AAAA:AAAAA
SGCG, 2-BP DEL, 793TG	SGCG		Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000002007					2007	17046		
SGCG, 2-BP DEL, 801TC	SGCG		Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000002005					2005	17044		
NM_000382.3(ALDH3A2):c.941_943delinsGGGCTAAAAGTACTGTTGGGG (p.Ala314_Pro315delinsGlyAlaLysSerThrValGlyAla)	ALDH3A2		Sjgren-Larsson syndrome	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000001638	17	19566646 - 19566648	17	19663333 - 19663335	1638	16677		NC_000017.11:19663332:CCC:GGGCTAAAAGTACTGTTGGGG
NM_000382.3(ALDH3A2):c.385+2T>C	ALDH3A2		not provided	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000844940	17	19555093	17	19651780	844940	852695		NC_000017.11:19651779:T:C
NM_000382.3(ALDH3A2):c.683G>A (p.Arg228His)	ALDH3A2	R228H, R35H	not provided	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000653859	17	19561060	17	19657747	653859	645400		NC_000017.11:19657746:G:A
NM_000231.2(SGCG):c.579-2A>G	SGCG		not provided|Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic/Likely pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000392545	13	23894774	13	23320635	392545	372663	rs754415994	NC_000013.11:23320634:A:G
NM_000382.3(ALDH3A2):c.798+1del	ALDH3A2		Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371195	17	19561175	17	19657862	371195	358403		NC_000017.11:19657861:GG:G
NM_000382.3(ALDH3A2):c.1108-1G>C	ALDH3A2		Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000370452	17	19568260	17	19664947	370452	358407		NC_000017.11:19664946:G:C
NM_000231.2(SGCG):c.87dup (p.Gly30fs)	SGCG		Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000002008	13	23777919 - 23777920	13	23203780 - 23203781	2008	17047		NC_000013.11:23203780:T:TT
NM_020366.3(RPGRIP1):c.3618-1_3621del	RPGRIP1		Leber congenital amaurosis 6|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: May 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000814005	14	21816326 - 21816330	14	21348167 - 21348171	814005	802190		NC_000014.9:21348166:TTTAGTTTA:TTTA
NM_020366.3(RPGRIP1):c.2718dup (p.Asn907Ter)	RPGRIP1		Leber congenital amaurosis 6|not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000560506	14	21795785 - 21795786	14	21327626 - 21327627	560506	551570	rs776289402	NC_000014.9:21327626:TTTT:TTTTT
NM_020366.3(RPGRIP1):c.2941C>T (p.Arg981Ter)	RPGRIP1	R981*	Leber congenital amaurosis 1|Leber congenital amaurosis	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000438163	14	21796628	14	21328469	438163	431776	rs780667159	NC_000014.9:21328468:C:T
NM_000359.3(TGM1):c.876+2T>C	TGM1		not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372533	14	24729144	14	24259938	372533	360189	rs151054393	NC_000014.9:24259937:A:G
NM_000359.3(TGM1):c.398_407dup (p.Tyr136Ter)	TGM1		Ichthyosis (disease)|not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372530	14	24731001 - 24731002	14	24261795 - 24261796	372530	360090	rs1057517836	NC_000014.9:24261795:TACTCATACT:TACTCATACTTACTCATACT
NM_000359.3(TGM1):c.377G>A (p.Arg126His)	TGM1	R126H	Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000279909	14	24731032	14	24261826	279909	264796	rs200491579	NC_000014.9:24261825:C:T
TGM1, IVS5, A-G, -2	TGM1		Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000012479					12479	27518		
NM_020366.3(RPGRIP1):c.194G>A (p.Trp65Ter)	RPGRIP1	W65*	Leber congenital amaurosis|Leber congenital amaurosis 6	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000004983	14	21762944	14	21294785	4983	20022	rs137853124	NC_000014.9:21294784:G:A
GRCh37/hg19 12q24.21(chr12:114756557-114871208)x1	TBX5		not provided	Pathogenic(Last reviewed: Apr 26, 2019)	no assertion criteria provided	VCV000815554	12	114756557 - 114871208			815554	803763		
NM_000192.3(TBX5):c.408C>G (p.Tyr136Ter)	TBX5	Y136*, Y86*	not provided	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000620372	12	114836480	12	114398675	620372	611761	rs104894379	NC_000012.12:114398674:G:C
NM_000192.3(TBX5):c.756-1G>C	TBX5		not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000594035	12	114804197	12	114366392	594035	585098	rs1565927906	NC_000012.12:114366391:C:G
NM_000192.3(TBX5):c.473_476del (p.Leu158fs)	TBX5	L108fs, L158fs	not provided	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000503839	12	114836412 - 114836415	12	114398607 - 114398610	503839	495511	rs1555226305	NC_000012.12:114398606:TTGA:
NM_000192.3(TBX5):c.587C>G (p.Ser196Ter)	TBX5	S196*, S146*	not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000488731	12	114832622	12	114394817	488731	482010	rs886041247	NC_000012.12:114394816:G:C
NM_000192.3(TBX5):c.164_165del (p.Lys55fs)	TBX5	K55fs, K5fs	not provided	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000452461	12	114839708 - 114839709	12	114401903 - 114401904	452461	444922	rs1555226588	NC_000012.12:114401902:TTT:T
NM_000192.3(TBX5):c.300del (p.Lys99_Tyr100insTer)	TBX5		not provided	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000452157	12	114837380	12	114399575	452157	444921	rs1555226412	NC_000012.12:114399574:G:
NM_000192.3(TBX5):c.1078C>T (p.Gln360Ter)	TBX5	Q360*, Q310*	not provided	Pathogenic(Last reviewed: Aug 31, 2015)	criteria provided, single submitter	VCV000419717	12	114793816	12	114356011	419717	408525	rs1064794062	NC_000012.12:114356010:G:A
NM_000192.3(TBX5):c.178G>T (p.Glu60Ter)	TBX5	E60*, E10*	not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000419668	12	114839695	12	114401890	419668	408526	rs1064794030	NC_000012.12:114401889:C:A
NM_000192.3(TBX5):c.202del (p.His68fs)	TBX5	H68fs, H18fs	not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000373079	12	114839671	12	114401866	373079	359939	rs1057518199	NC_000012.12:114401865:GG:G
NM_000192.3(TBX5):c.710G>C (p.Arg237Pro)	TBX5	R237P, R187P	not provided	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000372783	12	114823326	12	114385521	372783	360073	rs104894378	NC_000012.12:114385520:C:G
NM_000192.3(TBX5):c.670C>T (p.Gln224Ter)	TBX5	Q224*, Q174*	not provided	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000372527	12	114823366	12	114385561	372527	359937	rs1057517833	NC_000012.12:114385560:G:A
NM_000192.3(TBX5):c.466del (p.Gln156fs)	TBX5	Q106fs, Q156fs	not provided	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000280392	12	114836422	12	114398617	280392	264674	rs886041606	NC_000012.12:114398616:GG:G
NM_000192.3(TBX5):c.611dup (p.His204fs)	TBX5		not provided	Pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV000213830	12	114832597 - 114832598	12	114394792 - 114394793	213830	210205	rs863223786	NC_000012.12:114394792:T:TT
NM_000192.3(TBX5):c.468_484del (p.Lys157fs)	TBX5	K107fs, K157fs	not provided	Pathogenic(Last reviewed: May 22, 2014)	criteria provided, single submitter	VCV000213829	12	114836404 - 114836420	12	114398599 - 114398615	213829	210206	rs863223785	NC_000012.12:114398598:TGGTGAGCTTGAGTTTCTGG:TGG
NM_000192.3(TBX5):c.421_443delinsCCAGGA (p.Ser141fs)	TBX5		not provided	Pathogenic(Last reviewed: Aug 4, 2016)	criteria provided, single submitter	VCV000213828	12	114836445 - 114836467	12	114398640 - 114398662	213828	210208	rs863223784	NC_000012.12:114398639:CAATGCGCCCCGGTGGCGGGGGA:TCCTGG
NM_000192.3(TBX5):c.420_432del (p.Asp140fs)	TBX5	D140fs, D90fs	not provided	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	VCV000213827	12	114836456 - 114836468	12	114398651 - 114398663	213827	210210	rs863223783	NC_000012.12:114398650:GGTGGCGGGGGAG:
NM_000192.3(TBX5):c.1126C>T (p.Gln376Ter)	TBX5	Q376*, Q326*	not provided	Pathogenic(Last reviewed: Sep 11, 2015)	criteria provided, single submitter	VCV000213821	12	114793768	12	114355963	213821	210202	rs863223778	NC_000012.12:114355962:G:A
NM_000192.3(TBX5):c.142C>T (p.Gln48Ter)	TBX5	Q48*	not provided	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000213820	12	114841562	12	114403757	213820	210220	rs863223777	NC_000012.12:114403756:G:A
NM_000192.3(TBX5):c.755G>A (p.Ser252Asn)	TBX5	S252N, S202N	not provided	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	VCV000213819	12	114823281	12	114385476	213819	210204	rs863223776	NC_000012.12:114385475:C:T
NM_000192.3(TBX5):c.373G>C (p.Gly125Arg)	TBX5	G125R, G75R	not provided	Pathogenic(Last reviewed: May 13, 2015)	criteria provided, single submitter	VCV000213816	12	114836515	12	114398710	213816	210212	rs863223773	NC_000012.12:114398709:C:G
NM_000192.3(TBX5):c.338G>A (p.Arg113Lys)	TBX5	R113K, R63K	not provided	Pathogenic	no assertion criteria provided	VCV000139591	12	114837342	12	114399537	139591	143216	rs483353129	NC_000012.12:114399536:C:T
NM_181486.4(TBX5):c.246del (p.Met83fs)	TBX5	M33fs, M83fs	Aortic valve disease 2	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000862164	12	114837434	12	114399629	862164	839333		NC_000012.12:114399628:CC:C
NM_181486.4(TBX5):c.69del (p.Cys24fs)	TBX5	C24fs	Aortic valve disease 2	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000857821	12	114841635	12	114403830	857821	839336		NC_000012.12:114403829:GGG:GG
NM_181486.4(TBX5):c.154G>T (p.Glu52Ter)	TBX5	E2*, E52*	Aortic valve disease 2	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000835086	12	114839719	12	114401914	835086	839335		NC_000012.12:114401913:C:A
NM_181486.4(TBX5):c.538del (p.Gln180fs)	TBX5	Q130fs, Q180fs	Holt-Oram syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802896	12	114832671	12	114394866	802896	791198		NC_000012.12:114394865:GG:G
NC_000012.11:g.(?_114839621)_(114839735_?)del	TBX5		Aortic valve disease 2	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000661191	12	114839621 - 114839735	12	114401816 - 114401930	661191	652365		
NM_000192.3(TBX5):c.163_172del (p.Lys55fs)	TBX5	K55fs, K5fs	Aortic valve disease 2	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000656872	12	114839701 - 114839710	12	114401896 - 114401905	656872	640643		NC_000012.12:114401895:GAAACACTTTGA:GA
NC_000012.11:g.(?_114839611)_(114839745_?)del	TBX5		Aortic valve disease 2	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000652398	12	114839611 - 114839745	12	114401806 - 114401940	652398	652165		
NM_000192.3:c.(510+1_511-1)_(663+1_664-1)del	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633773					633773	622206		
NM_000192.3(TBX5):c.261C>A (p.Tyr87Ter)	TBX5	Y87*, Y37*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633772	12	114837419	12	114399614	633772	622188	rs767197919	NC_000012.12:114399613:G:T
NM_000192.3(TBX5):c.943C>T (p.Gln315Ter)	TBX5	Q315*, Q265*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633771	12	114804009	12	114366204	633771	622160	rs1565927645	NC_000012.12:114366203:G:A
NM_000192.3(TBX5):c.674T>G (p.Leu225Ter)	TBX5	L225*, L175*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633770	12	114823362	12	114385557	633770	622172	rs1565935432	NC_000012.12:114385556:A:C
NM_000192.3(TBX5):c.1074del (p.Pro359fs)	TBX5	P359fs, P309fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633769	12	114793820	12	114356015	633769	622157	rs1565923863	NC_000012.12:114356014:A:
NM_000192.3(TBX5):c.73_74insT (p.Asp25fs)	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633768	12	114841630 - 114841631	12	114403825 - 114403826	633768	622194	rs1565943328	NC_000012.12:114403825::A
NM_000192.3(TBX5):c.933C>G (p.Tyr311Ter)	TBX5	Y311*, Y261*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633765	12	114804019	12	114366214	633765	622161	rs1565927664	NC_000012.12:114366213:G:C
NM_000192.3(TBX5):c.978del (p.Glu328fs)	TBX5	E278fs, E328fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633764	12	114803974	12	114366169	633764	622159	rs1565927614	NC_000012.12:114366168:CC:C
NM_000192.3(TBX5):c.336del (p.His112fs)	TBX5	H112fs, H62fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633763	12	114837344	12	114399539	633763	622186	rs1565941434	NC_000012.12:114399538:G:
NM_000192.3:c.946C>T	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633760					633760	622205		
NM_000192.3(TBX5):c.924del (p.Asn309fs)	TBX5	N259fs, N309fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633759	12	114804028	12	114366223	633759	622162	rs1565927673	NC_000012.12:114366222:GGG:GG
NM_000192.3:c.(362+1_363-1)_(510+1_511-1)del	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633758					633758	622204		
NM_000192.3(TBX5):c.119C>A (p.Ser40Ter)	TBX5	S40*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633757	12	114841585	12	114403780	633757	622193	rs903933027	NC_000012.12:114403779:G:T
NM_000192.3(TBX5):c.559_572dup (p.Asn191fs)	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633756	12	114832636 - 114832637	12	114394831 - 114394832	633756	622176	rs1565939303	NC_000012.12:114394831:TTTTCATCCGCTTT:TTTTCATCCGCTTTTTTTCATCCGCTTT
NM_000192.3(TBX5):c.295A>T (p.Lys99Ter)	TBX5	K99*, K49*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633755	12	114837385	12	114399580	633755	622187	rs1565941529	NC_000012.12:114399579:T:A
NM_000192.3(TBX5):c.703G>T (p.Gly235Ter)	TBX5	G235*, G185*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633754	12	114823333	12	114385528	633754	622168	rs1565935397	NC_000012.12:114385527:C:A
NM_000192.3(TBX5):c.457dup (p.Val153fs)	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633753	12	114836430 - 114836431	12	114398625 - 114398626	633753	622183	rs1565940930	NC_000012.12:114398625:C:CC
NM_000192.3(TBX5):c.426del (p.Ala143fs)	TBX5	A143fs, A93fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633750	12	114836462	12	114398657	633750	622184	rs1565941003	NC_000012.12:114398656:GGGGG:GGGG
NM_000192.3:c.(?_-667)_(*1602_?)del	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633749					633749	622203		
NM_000192.3:c.67_81delins	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633748					633748	622202		
NM_000192.3(TBX5):c.496del (p.Asp166fs)	TBX5	D116fs, D166fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633747	12	114836392	12	114398587	633747	622182	rs1565940860	NC_000012.12:114398586:CC:C
NM_000192.3:c.1033_1034dupGA	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633746					633746	622201	rs1565923899	
NM_000192.3(TBX5):c.680_683del (p.Ile227fs)	TBX5	I177fs, I227fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633744	12	114823353 - 114823356	12	114385548 - 114385551	633744	622170	rs1565935410	NC_000012.12:114385547:TCAATC:TC
NM_000192.3(TBX5):c.845C>T (p.Ser282Phe)	TBX5	S282F, S232F	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633743	12	114804107	12	114366302	633743	622164	rs1565927794	NC_000012.12:114366301:G:A
NM_000192.3:c.(663+1_664-1)_(755+1_756-1)del	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633742					633742	622200		
NM_000192.3(TBX5):c.1203G>A (p.Trp401Ter)	TBX5	W401*, W351*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633741	12	114793691	12	114355886	633741	622155	rs377649723	NC_000012.12:114355885:C:T
NM_000192.3:c.(?_-667)_(755+1_756-1)dup	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633740					633740	622199		
NM_080717.3(TBX5):c.483_484TA[1] (p.Ile162fs)	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633739	12	114832573 - 114832574	12	114394768 - 114394769	633739	622174	rs1565939204	NC_000012.12:114394767:TATA:TA
NM_000192.3(TBX5):c.728_729del (p.Glu243fs)	TBX5	E193fs, E243fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633738	12	114823307 - 114823308	12	114385502 - 114385503	633738	622166	rs1565935345	NC_000012.12:114385501:CTC:C
NM_000192.3(TBX5):c.1346del (p.Gln449fs)	TBX5	Q399fs, Q449fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633737	12	114793548	12	114355743	633737	622152	rs1565923488	NC_000012.12:114355742:T:
NM_000192.3:c.(663+1_664-1)_(755+1_756-1)dup	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633736					633736	622198		
NM_000192.3(TBX5):c.500del (p.Pro167fs)	TBX5	P117fs, P167fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633735	12	114836388	12	114398583	633735	622181	rs1565940856	NC_000012.12:114398582:GGG:GG
NM_000192.3:c.(?_-38)_(242+1_243-1)dup	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633733					633733	622197		
NM_000192.3(TBX5):c.537C>A (p.Tyr179Ter)	TBX5	Y179*, Y129*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633732	12	114832672	12	114394867	633732	622177	rs1565939337	NC_000012.12:114394866:G:T
NM_000192.3(TBX5):c.1084C>T (p.Gln362Ter)	TBX5	Q362*, Q312*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633731	12	114793810	12	114356005	633731	622156	rs765204502	NC_000012.12:114356004:G:A
NM_000192.3(TBX5):c.342C>A (p.Tyr114Ter)	TBX5	Y114*, Y64*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633730	12	114837338	12	114399533	633730	622185	rs1565941422	NC_000012.12:114399532:G:T
NM_000192.3(TBX5):c.1045G>T (p.Glu349Ter)	TBX5	E349*, E299*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633729	12	114793849	12	114356044	633729	622158	rs1565923887	NC_000012.12:114356043:C:A
NM_000192.3(TBX5):c.713dup (p.Ser239fs)	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633728	12	114823322 - 114823323	12	114385517 - 114385518	633728	622167	rs1565935383	NC_000012.12:114385517:CCCC:CCCCC
NM_000192.3(TBX5):c.879T>A (p.Cys293Ter)	TBX5	C293*, C243*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633725	12	114804073	12	114366268	633725	622163	rs1565927740	NC_000012.12:114366267:A:T
NM_000192.3:c.(362+1_363-1)_(*1602_?)del	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633724					633724	622196		
NM_000192.3(TBX5):c.1303del (p.Leu435fs)	TBX5	L435fs, L385fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633723	12	114793591	12	114355786	633723	622153	rs1565923537	NC_000012.12:114355785:GGGG:GGG
NM_000192.3(TBX5):c.1269C>G (p.Tyr423Ter)	TBX5	Y423*, Y373*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633722	12	114793625	12	114355820	633722	622154	rs756049331	NC_000012.12:114355819:G:C
NM_000192.3:c.(982+1_983-1)_(*1602_?)del	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000633719					633719	622195		
NM_000192.3(TBX5):c.390del (p.Met131fs)	TBX5	M131fs, M81fs	Aortic valve disease 2	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000577533	12	114836498	12	114398693	577533	565056	rs1565941046	NC_000012.12:114398692:GG:G
NM_000192.3(TBX5):c.246_249del (p.Met83fs)	TBX5	M33fs, M83fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Sep 23, 2015)	no assertion criteria provided	VCV000561217	12	114837431 - 114837434	12	114399626 - 114399629	561217	552355	rs1565941587	NC_000012.12:114399625:CATCC:C
NM_000192.3(TBX5):c.595dup (p.Thr199fs)	TBX5		Aortic valve disease 2	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000543962	12	114832613 - 114832614	12	114394808 - 114394809	543962	526920	rs1555226005	NC_000012.12:114394808:T:TT
NM_000192.3(TBX5):c.432dup (p.Gly145fs)	TBX5		Aortic valve disease 2	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000543961	12	114836455 - 114836456	12	114398650 - 114398651	543961	527252	rs1555226322	NC_000012.12:114398650:GG:GGG
NM_000192.3(TBX5):c.1158dup (p.Ser387fs)	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000488620	12	114793735 - 114793736	12	114355930 - 114355931	488620	481488	rs1064795870	NC_000012.12:114355930:GGGGGG:GGGGGGG
NM_000192.3(TBX5):c.629_632dup (p.Ile212fs)	TBX5		Aortic valve disease 2	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000477658	12	114832576 - 114832577	12	114394771 - 114394772	477658	462429	rs1555225989	NC_000012.12:114394771:AACG:AACGAACG
NC_000012.11:g.(?_114793317)_(114841723_?)del	TBX5		Aortic valve disease 2	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000477653	12	114793317 - 114841723			477653	462123		
NM_000192.3(TBX5):c.40C>A (p.Pro14Thr)	TBX5	P14T	not provided	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000446369	12	114841664	12	114403859	446369	439810	rs773397553	NC_000012.12:114403858:G:T
NM_000192.3(TBX5):c.278dup (p.Leu94fs)	TBX5		Aortic valve disease 2	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000411102	12	114837401 - 114837402	12	114399596 - 114399597	411102	398842	rs1555226420	NC_000012.12:114399596:CCC:CCCC
NM_000192.3(TBX5):c.443G>A (p.Trp148Ter)	TBX5	W148*, W98*	Aortic valve disease 2	Pathogenic(Last reviewed: May 22, 2016)	criteria provided, single submitter	VCV000411100	12	114836445	12	114398640	411100	398968	rs1060503154	NC_000012.12:114398639:C:T
NM_000192.3(TBX5):c.958del (p.Ile320fs)	TBX5	I270fs, I320fs	Aortic valve disease 2	Pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	VCV000237218	12	114803994	12	114366189	237218	241240	rs878853750	NC_000012.12:114366188:TTT:TT
GRCh38/hg38 12q24.21(chr12:114390252-114394865)x1	TBX5		See cases	Pathogenic(Last reviewed: Sep 12, 2011)	no assertion criteria provided	VCV000148683	12	114828057 - 114832670	12	114390252 - 114394865	148683	158434		
NM_181486.4(TBX5):c.727del (p.Glu243fs)	TBX5	E193fs, E243fs	Aortic valve disease 2	Pathogenic(Last reviewed: Mar 10, 2019)	criteria provided, single submitter	VCV000846539	12	114823309	12	114385504	846539	839329		NC_000012.12:114385503:CC:C
NC_000012.12:g.(?_114394721)_(114394913_?)del	TBX5		Aortic valve disease 2	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000831407	12	114832526 - 114832718			831407	820445		
NM_000192.3(TBX5):c.926_927del (p.Asn309fs)	TBX5	N309fs, N259fs	Aortic valve disease 2	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000659191	12	114804025 - 114804026	12	114366220 - 114366221	659191	640641		NC_000012.12:114366219:GT:
GRCh37/hg19 12q24.21(chr12:114791609-114793234)	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625740	12	114791609 - 114793234			625740	614044		
NM_000192.3(TBX5):c.1221C>G (p.Tyr407Ter)	TBX5	Y407*, Y357*	Secundum atrial septal defect|Ventricular septal defect|Mitral regurgitation	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000495227	12	114793673	12	114355868	495227	485953	rs1555223259	NC_000012.12:114355867:G:C
TBX5, 48-KB DUP, EX2-9DUP	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jan 11, 2017)	no assertion criteria provided	VCV000374841					374841	361746		
NM_000192.3(TBX5):c.408C>A (p.Tyr136Ter)	TBX5	Y136*, Y86*	Holt-Oram syndrome	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000007999	12	114836480	12	114398675	7999	23038	rs104894379	NC_000012.12:114398674:G:T
NM_000192.3(TBX5):c.161T>C (p.Ile54Thr)	TBX5	I54T, I4T	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 5, 2000)	no assertion criteria provided	VCV000007998	12	114839712	12	114401907	7998	23037	rs104894384	NC_000012.12:114401906:A:G
NM_000192.3(TBX5):c.145C>A (p.Gln49Lys)	TBX5	Q49K	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 5, 2000)	no assertion criteria provided	VCV000007997	12	114841559	12	114403754	7997	23036	rs104894383	NC_000012.12:114403753:G:T
NM_000192.3(TBX5):c.416del (p.Pro139fs)	TBX5	P89fs, P139fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 5, 2000)	no assertion criteria provided	VCV000007996	12	114836472	12	114398667	7996	23035		NC_000012.12:114398666:GGG:GG
NM_000192.3(TBX5):c.238G>A (p.Gly80Arg)	TBX5	G80R, G30R	Holt-Oram syndrome	Pathogenic(Last reviewed: Mar 16, 1999)	no assertion criteria provided	VCV000007994	12	114839635	12	114401830	7994	23033	rs104894381	NC_000012.12:114401829:C:T
TBX5, 1491C-T	TBX5		Holt-Oram syndrome	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000007991					7991	23030		
NM_000231.2(SGCG):c.195+1G>C	SGCG		not provided|Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000283707	13	23778029	13	23203890	283707	267944	rs200502077	NC_000013.11:23203889:G:C
NM_194318.4(B3GLCT):c.660+1G>A	B3GLCT		not provided|Peters plus syndrome	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001264	13	31843415	13	31269278	1264	16303	rs80338851	NC_000013.11:31269277:G:A
NM_000192.3(TBX5):c.362+2T>C	TBX5		Aortic valve disease 2	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000665547	12	114837316	12	114399511	665547	652207		NC_000012.12:114399510:A:G
NM_000192.3(TBX5):c.1104C>G (p.Tyr368Ter)	TBX5	Y368*, Y318*	Aortic valve disease 2	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000567672	12	114793790	12	114355985	567672	571275	rs1565923835	NC_000012.12:114355984:G:C
NM_000192.3(TBX5):c.105del (p.Ser36fs)	TBX5	S36fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Oct 17, 2014)	criteria provided, single submitter	VCV000369677	12	114841599	12	114403794	369677	353903	rs1057516042	NC_000012.12:114403793:GGGGG:GGGG
NM_000192.3(TBX5):c.444G>A (p.Trp148Ter)	TBX5	W148*, W98*	Atrial septal defect 1|Holt-Oram syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000235885	12	114836444	12	114398639	235885	237520	rs1555226315	NC_000012.12:114398638:C:T
NM_152594.3(SPRED1):c.326_329dup (p.Arg110delinsSerTer)	SPRED1		Legius syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000636663	15	38614558 - 38614559	15	38322357 - 38322358	636663	624494		NC_000015.10:38322357:GCTAG:GCTAGCTAG
NM_152594.3(SPRED1):c.1053del (p.Lys351fs)	SPRED1	K351fs	Legius syndrome	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000581681	15	38643580	15	38351379	581681	569323	rs1566876954	NC_000015.10:38351378:AAAA:AAA
NM_152594.3(SPRED1):c.796_797del (p.Met266fs)	SPRED1	M266fs	Legius syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220172	15	38643326 - 38643327	15	38351125 - 38351126	220172	222418	rs864622410	NC_000015.10:38351124:AT:
NM_152594.3(SPRED1):c.70C>T (p.Arg24Ter)	SPRED1	R24*	Legius syndrome	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000001810	15	38591611	15	38299410	1810	16849	rs121434313	NC_000015.10:38299409:C:T
NM_000295.5(SERPINA1):c.1130dup (p.Leu377fs)	SERPINA1		Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000552891	14	94844912 - 94844913	14	94378575 - 94378576	552891	547383	rs763023697	NC_000014.9:94378575:AAAAA:AAAAAA
NM_001127701.1(SERPINA1):c.552delC (p.Tyr184Terfs)	SERPINA1	Y160*	PI Q0(GRANITE FALLS)|Alpha-1-antitrypsin deficiency	Pathogenic, other(Last reviewed: Jul 15, 2016)	no assertion criteria provided	VCV000017976	14	94849023	14	94382686	17976	33015	rs267606950	NC_000014.9:94382685:G:
NM_181486.4(TBX5):c.239G>A (p.Gly80Glu)	TBX5	G80E, G30E	Aortic valve disease 2	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000861408	12	114839634	12	114401829	861408	839334		NC_000012.12:114401828:C:T
NM_181486.4(TBX5):c.663+1G>A	TBX5		Aortic valve disease 2	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000849438	12	114832545	12	114394740	849438	851476		NC_000012.12:114394739:C:T
NM_000192.3(TBX5):c.868C>T (p.Gln290Ter)	TBX5	Q290*, Q240*	Aortic valve disease 2|Holt-Oram syndrome	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000569967	12	114804084	12	114366279	569967	566343	rs1565927747	NC_000012.12:114366278:G:A
NM_000192.3(TBX5):c.456del (p.Val153fs)	TBX5	V103fs, V153fs	Aortic valve disease 2|not provided	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000377113	12	114836432	12	114398627	377113	363991	rs1057520136	NC_000012.12:114398626:G:
NM_000192.3(TBX5):c.205G>T (p.Glu69Ter)	TBX5	E69*, E19*	not provided|Holt-Oram syndrome	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000007992	12	114839668	12	114401863	7992	23031	rs104894377	NC_000012.12:114401862:C:A
NM_006009.4(TUBA1A):c.1204C>T (p.Arg402Cys)	TUBA1A	R402C, R367C	Lissencephaly 3|not provided|Tubulinopathies|Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000160146	12	49578945	12	49185162	160146	168982	rs587784483	NC_000012.12:49185161:G:A
NM_006009.4(TUBA1A):c.1265G>A (p.Arg422His)	TUBA1A	R422H, R387H	not provided|Tubulinopathies|Lissencephaly 3	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007077	12	49578884	12	49185101	7077	22116	rs137853050	NC_000012.12:49185100:C:T
NM_006009.4(TUBA1A):c.1205G>A (p.Arg402His)	TUBA1A	R402H, R367H	Tubulinopathies|Lissencephaly 3	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007071	12	49578944	12	49185161	7071	22110	rs137853044	NC_000012.12:49185160:C:T
NM_000382.3(ALDH3A2):c.710G>A (p.Cys237Tyr)	ALDH3A2	C237Y, C44Y	Sjgren-Larsson syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000631767	17	19561087	17	19657774	631767	620576		NC_000017.11:19657773:G:A
NM_000382.3(ALDH3A2):c.1291_1292del (p.Lys431fs)	ALDH3A2	K238fs, K431fs	Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495850	17	19575116 - 19575117	17	19671803 - 19671804	495850	487679		NC_000017.11:19671802:AAA:A
NM_000382.3(ALDH3A2):c.798+1_798+6del	ALDH3A2		not provided|Sjgren-Larsson syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371540	17	19561176 - 19561181	17	19657863 - 19657868	371540	358402		NC_000017.11:19657862:GTTTGT:
NM_000382.3(ALDH3A2):c.25_50del (p.Arg9fs)	ALDH3A2	R9fs	Sjgren-Larsson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371103	17	19552305 - 19552330	17	19648992 - 19649017	371103	358393		NC_000017.11:19648991:GGTCCGACAGGCGTTCCTGTCCGGCCGGTC:GGTC
SGCG, 1-BP DEL, 525T	SGCG		Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Aug 12, 2000)	no assertion criteria provided	VCV000002004					2004	17043		
NM_000382.3(ALDH3A2):c.1307_1311dup (p.Leu438fs)	ALDH3A2		not provided|Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000001642	17	19575131 - 19575132	17	19671818 - 19671819	1642	16681	rs387906257	NC_000017.11:19671818:AACAAA:AACAAAACAAA
NM_001128126.3(AP4S1):c.229G>T (p.Glu77Ter)	AP4S1	E77*	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000521910	14	31542114	14	31072908	521910	512097	rs568176223	NC_000014.9:31072907:G:T
NM_000137.3(FAH):c.520C>T (p.Arg174Ter)	FAH	R174*	not provided|Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188751	15	80460458	15	80168116	188751	186943	rs781496816	NC_000015.10:80168115:C:T
NM_020366.3(RPGRIP1):c.1892A>G (p.His631Arg)	RPGRIP1	H273R, H631R	Retinal dystrophy|Cone-rod dystrophy 13|Leber congenital amaurosis 6	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000834237	14	21792906	14	21324747	834237	841170		NC_000014.9:21324746:A:G
NM_000359.3(TGM1):c.1074C>G (p.Ser358Arg)	TGM1	S358R	not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553856	14	24728366	14	24259160	553856	547314	rs779287673	NC_000014.9:24259159:G:C
NM_000359.3(TGM1):c.790C>T (p.Arg264Trp)	TGM1	R264W	not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372532	14	24729232	14	24260026	372532	360057	rs201868387	NC_000014.9:24260025:G:A
NM_001363711.2(DUOX2):c.1462G>A (p.Gly488Arg)	DUOX2	G488R	Familial thyroid dyshormonogenesis|Nongoitrous Euthyroid Hyperthyrotropinemia|Thyroid dyshormonogenesis 6	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000225342	15	45400357	15	45108159	225342	227368	rs191759494	NC_000015.10:45108158:C:T
NM_177550.4(SLC13A5):c.1227dup (p.Ile410fs)	SLC13A5		not provided	Pathogenic(Last reviewed: Nov 24, 2016)	criteria provided, single submitter	VCV000373238	17	6596410 - 6596411	17	6693091 - 6693092	373238	360342	rs1057518299	NC_000017.11:6693091:G:GG
NM_177550.4(SLC13A5):c.511del (p.Glu171fs)	SLC13A5	E128fs, E171fs, E154fs	not provided	Pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	VCV000372505	17	6607233	17	6703914	372505	360470	rs1057517820	NC_000017.11:6703913:CC:C
NC_000017.11:g.(?_6686187)_(6713353_?)del	SLC13A5		Epileptic encephalopathy, early infantile, 25	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000830864	17	6589506 - 6616672			830864	821149		
NM_177550.4(SLC13A5):c.308G>A (p.Trp103Ter)	SLC13A5	W103*, W60*	Epileptic encephalopathy, early infantile, 25	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000652323	17	6610021	17	6706702	652323	646596		NC_000017.11:6706701:C:T
NM_001143838.3(SLC13A5):c.1438-1196G>C	SLC13A5	D524H, D481H, D507H	Epileptic encephalopathy, early infantile, 25	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000218174	17	6590853	17	6687534	218174	214826	rs863225448	NC_000017.11:6687533:C:G
NM_177550.4(SLC13A5):c.1207_1217dup (p.Pro407fs)	SLC13A5		Epileptic encephalopathy, early infantile, 25	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000218172	17	6596420 - 6596421	17	6693101 - 6693102	218172	214824	rs863225447	NC_000017.11:6693101:ACTTTCTCCTG:ACTTTCTCCTGACTTTCTCCTG
NM_177550.4(SLC13A5):c.1022G>A (p.Trp341Ter)	SLC13A5	W341*, W298*, W324*	Epileptic encephalopathy, early infantile, 25	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000218171	17	6599078	17	6695759	218171	214823	rs150203483	NC_000017.11:6695758:C:T
NM_152594.3(SPRED1):c.46C>T (p.Arg16Ter)	SPRED1	R16*	Legius syndrome|not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372718	15	38591587	15	38299386	372718	360244	rs1057517941	NC_000015.10:38299385:C:T
NM_152594.3(SPRED1):c.1149_1150AG[1] (p.Glu384fs)	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000241989	15	38643679 - 38643680	15	38351478 - 38351479	241989	242038	rs878855228	NC_000015.10:38351477:AGAG:AG
NM_152594.3(SPRED1):c.190C>T (p.Arg64Ter)	SPRED1	R64*	Legius syndrome	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001813	15	38591731	15	38299530	1813	16852	rs121434315	NC_000015.10:38299529:C:T
NM_152594.3(SPRED1):c.349C>T (p.Arg117Ter)	SPRED1	R117*	Legius syndrome	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000001809	15	38614583	15	38322382	1809	16848	rs121434312	NC_000015.10:38322381:C:T
NM_024685.4(BBS10):c.766C>T (p.Arg256Ter)	BBS10	R256*	Bardet-Biedl syndrome|Bardet-Biedl syndrome 10	Pathogenic/Likely pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551609	12	76740999	12	76347219	551609	547241	rs1156913215	NC_000012.12:76347218:G:A
NM_024685.4(BBS10):c.1391C>G (p.Ser464Ter)	BBS10	S464*	Bardet-Biedl syndrome|Bardet-Biedl syndrome 10	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370512	12	76740374	12	76346594	370512	358113	rs759682922	NC_000012.12:76346593:G:C
NM_014844.5(TECPR2):c.2495_2498dup (p.Cys834fs)	TECPR2		not provided	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000503675	14	102904458 - 102904459	14	102438121 - 102438122	503675	495745	rs1364819755	NC_000014.9:102438121:TGTT:TGTTTGTT
NM_014844.5(TECPR2):c.774del (p.Asp259fs)	TECPR2	D259fs	not provided	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000450815	14	102891448	14	102425111	450815	445179	rs772483312	NC_000014.9:102425110:AAAA:AAA
NM_014844.5(TECPR2):c.1028_1032del (p.Lys343fs)	TECPR2	K343fs	not provided	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000450814	14	102894661 - 102894665	14	102428324 - 102428328	450814	445180	rs1359602238	NC_000014.9:102428323:GAAAGGA:GA
NM_014844.5(TECPR2):c.240_241TG[1] (p.Val81fs)	TECPR2		not provided	Pathogenic(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	VCV000285656	14	102873695 - 102873696	14	102407358 - 102407359	285656	269893	rs886043167	NC_000014.9:102407357:TGTG:TG
NC_000014.9:g.(?_102376712)_(102376950_?)del	TECPR2		Spastic paraplegia 49, autosomal recessive	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000830697	14	102843049 - 102843287			830697	820594		
NM_014844.5(TECPR2):c.1568del (p.Ser523fs)	TECPR2	S523fs	Spastic paraplegia 49, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000548608	14	102900722	14	102434385	548608	539052	rs1555451465	NC_000014.9:102434384:C:
NM_177550.4(SLC13A5):c.1280C>T (p.Ser427Leu)	SLC13A5	S427L, S384L, S410L	Epileptic encephalopathy, early infantile, 25	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000218170	17	6594255	17	6690936	218170	214822	rs548065551	NC_000017.11:6690935:G:A
NM_000192.3(TBX5):c.593dup (p.Asn198fs)	TBX5		Holt-Oram syndrome|Aortic valve disease 2	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633726	12	114832615 - 114832616	12	114394810 - 114394811	633726	622175	rs1565939215	NC_000012.12:114394810:TTTTTT:TTTTTTT
NM_006662.3(SRCAP):c.7273_7274AC[1] (p.Pro2426fs)	SRCAP		not provided	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000817041	16	30748633 - 30748634	16	30737312 - 30737313	817041	805878		NC_000016.10:30737311:CACAC:CAC
NM_006662.3(SRCAP):c.8427T>A (p.Cys2809Ter)	SRCAP	C2809*	not provided	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000816969	16	30749788	16	30738467	816969	805879		NC_000016.10:30738466:T:A
NM_006662.3(SRCAP):c.7096_7102del (p.Ala2366fs)	SRCAP	A2366fs	not provided	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000523967	16	30748453 - 30748459	16	30737132 - 30737138	523967	514692	rs1555465917	NC_000016.10:30737131:GGGGGCTGGGG:GGGG
NM_006662.3(SRCAP):c.7255C>T (p.Gln2419Ter)	SRCAP	Q2419*	not provided	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000504077	16	30748616	16	30737295	504077	495609	rs1555465928	NC_000016.10:30737294:C:T
NM_006662.3(SRCAP):c.8242C>T (p.Arg2748Ter)	SRCAP	R2748*	not provided	Pathogenic(Last reviewed: Sep 8, 2015)	criteria provided, single submitter	VCV000427015	16	30749603	16	30738282	427015	415489	rs1085307899	NC_000016.10:30738281:C:T
NM_006662.3(SRCAP):c.833del (p.Pro278fs)	SRCAP	P278fs	not provided	Pathogenic(Last reviewed: May 18, 2016)	criteria provided, single submitter	VCV000280616	16	30721029	16	30709708	280616	264784	rs886041787	NC_000016.10:30709707:CCCCC:CCCC
NM_002470.4(MYH3):c.533C>T (p.Thr178Ile)	MYH3	T178I	Freeman-Sheldon syndrome|ARTHROGRYPOSIS, DISTAL, TYPE 2B3	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000014140	17	10553691	17	10650374	14140	29179	rs121913619	NC_000017.11:10650373:G:A
NM_014249.4(NR2E3):c.311G>A (p.Arg104Gln)	NR2E3	R104Q	Retinitis pigmentosa|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438228	15	72104171	15	71811831	438228	431786	rs766096417	NC_000015.10:71811830:G:A
NM_006662.3(SRCAP):c.7287C>A (p.Cys2429Ter)	SRCAP	C2429*	Floating-Harbor syndrome	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689791	16	30748648	16	30737327	689791	677449		NC_000016.10:30737326:C:A
NM_006662.3(SRCAP):c.7993C>T (p.Gln2665Ter)	SRCAP	Q2665*	Floating-Harbor syndrome	Pathogenic(Last reviewed: Nov 15, 2013)	criteria provided, single submitter	VCV000160038	16	30749354	16	30738033	160038	169201	rs587784444	NC_000016.10:30738032:C:T
NM_006662.3(SRCAP):c.7000C>T (p.Gln2334Ter)	SRCAP	Q2334*	Floating-Harbor syndrome	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000144049	16	30747937	16	30736616	144049	153784	rs587777656	NC_000016.10:30736615:C:T
NM_006662.3(SRCAP):c.7863dup (p.Gln2622fs)	SRCAP		Floating-Harbor syndrome	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039978	16	30749223 - 30749224	16	30737902 - 30737903	39978	48498	rs587776938	NC_000016.10:30737902:G:GG
NM_006662.3(SRCAP):c.7549del (p.Gln2517fs)	SRCAP	Q2517fs	Floating-Harbor syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030910	16	30748908	16	30737587	30910	39867	rs199469466	NC_000016.10:30737586:CCC:CC
NM_003978.5(PSTPIP1):c.748G>A (p.Glu250Lys)	PSTPIP1	E250K, E241K, E315K	Pyogenic arthritis-pyoderma gangrenosum-acne syndrome|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000097810	15	77324645	15	77032304	97810	103702	rs28939089	NC_000015.10:77032303:G:A
NM_003361.3(UMOD):c.707C>T (p.Pro236Leu)	UMOD	P236L, P269L	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000521547	16	20359916	16	20348594	521547	512180	rs1447458978	NC_000016.10:20348593:G:A
NM_001297.5(CNGB1):c.2527dup (p.Leu843fs)	CNGB1		Retinal dystrophy	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000866553	16	57938744 - 57938745	16	57904840 - 57904841	866553	856851		NC_000016.10:57904840:GGG:GGGG
NM_001297.5(CNGB1):c.2495A>G (p.Tyr832Cys)	CNGB1	Y826C, Y832C	Retinal dystrophy	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000866552	16	57938777	16	57904873	866552	856852		NC_000016.10:57904872:T:C
NM_001297.5(CNGB1):c.1373-1G>A	CNGB1		Retinal dystrophy	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000865777	16	57965783	16	57931879	865777	857281		NC_000016.10:57931878:C:T
GRCh37/hg19 16q21(chr16:57935248-57958159)x1	CNGB1		not provided	Pathogenic(Last reviewed: Jun 20, 2017)	no assertion criteria provided	VCV000686664	16	57935248 - 57958159			686664	674256		
NM_001297.5(CNGB1):c.315G>A (p.Trp105Ter)	CNGB1	W105*	not provided	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000489134	16	57996944	16	57963040	489134	482103	rs1420628245	NC_000016.10:57963039:C:T
NM_001297.5(CNGB1):c.2128C>T (p.Gln710Ter)	CNGB1	Q710*, Q704*	not provided	Pathogenic(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	VCV000287054	16	57951210	16	57917306	287054	271291	rs754786301	NC_000016.10:57917305:G:A
NM_001297.5(CNGB1):c.2556dup (p.Lys853fs)	CNGB1		not provided	Pathogenic(Last reviewed: Oct 21, 2014)	criteria provided, single submitter	VCV000195947	16	57938715 - 57938716	16	57904811 - 57904812	195947	193108	rs797044693	NC_000016.10:57904811:GGGG:GGGGG
NC_000016.10:g.(?_57903822)_(57911875_?)del	CNGB1		not provided	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000830985	16	57937726 - 57945779			830985	820846		
NC_000016.10:g.(?_57917268)_(57917476_?)del	CNGB1		not provided	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000830804	16	57951172 - 57951380			830804	820847		
PI NULL(PROCIDA)	SERPINA1		Alpha-1-antitrypsin deficiency|PI NULL(PROCIDA)	Pathogenic, other(Last reviewed: Jul 15, 2016)	no assertion criteria provided	VCV000017979					17979	33018		
NM_001297.5(CNGB1):c.3462+1G>A	CNGB1		Retinitis pigmentosa 45	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000008898	16	57921758	16	57887854	8898	23937	rs1567360969	NC_000016.10:57887853:C:T
NM_001297.5(CNGB1):c.2978G>T (p.Gly993Val)	CNGB1	G993V, G987V	Retinitis pigmentosa 45	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000008897	16	57931817	16	57897913	8897	23936	rs121918532	NC_000016.10:57897912:C:A
NM_001297.5(CNGB1):c.1896C>A (p.Cys632Ter)	CNGB1	C632*, C626*	not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000852025	16	57953064	16	57919160	852025	844062		NC_000016.10:57919159:G:T
NM_001297.5(CNGB1):c.2320G>A (p.Glu774Lys)	CNGB1	E774K, E768K	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812285	16	57946883	16	57912979	812285	800602		NC_000016.10:57912978:C:T
NM_001297.5(CNGB1):c.1122-2A>T	CNGB1		Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803261	16	57974227	16	57940323	803261	791629		NC_000016.10:57940322:T:A
NM_004960.3(FUS):c.1561C>G (p.Arg521Gly)	FUS	R521G, R520G, R517G	Amyotrophic lateral sclerosis type 6|Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000016222	16	31202739	16	31191418	16222	31261	rs121909668	NC_000016.10:31191417:C:G
NM_002087.4(GRN):c.836-1G>C	GRN		not provided||Ceroid lipofuscinosis, neuronal, 11	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000098157	17	42428730	17	44351362	98157	104049	rs63751296	NC_000017.11:44351361:G:C
NM_001297.5(CNGB1):c.2166+1G>A	CNGB1		Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636011	16	57951171	16	57917267	636011	623937		NC_000016.10:57917266:C:T
NM_001297.5(CNGB1):c.2508C>A (p.Tyr836Ter)	CNGB1	Y836*, Y830*	not provided	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420589	16	57938764	16	57904860	420589	409658	rs1064794573	NC_000016.10:57904859:G:T
NM_000231.2(SGCG):c.752del (p.Thr251fs)	SGCG	T251fs	not provided|Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000283952	13	23898556	13	23324417	283952	268189	rs886042749	NC_000013.11:23324416:C:
NM_004608.3(TBX6):c.221dup (p.Thr75fs)	TBX6		Spondylocostal dysostosis 5	Pathogenic(Last reviewed: Feb 19, 2018)	no assertion criteria provided	VCV000599077	16	30102210 - 30102211	16	30090889 - 30090890	599077	590322	rs1567342899	NC_000016.10:30090889:CCC:CCCC
NM_004608.3(TBX6):c.418C>T (p.Leu140Phe)	TBX6	L140F	Scoliosis	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000694414	16	30100467	16	30089146	694414	682338		NC_000016.10:30089145:G:A
NM_004608.3(TBX6):c.473_475dup (p.Glu159_Pro160insGly)	TBX6		Scoliosis	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000694406	16	30100409 - 30100410	16	30089088 - 30089089	694406	682335		NC_000016.10:30089088:CCC:CCCCCC
NM_004608.3(TBX6):c.356G>A (p.Arg119His)	TBX6	R119H	Scoliosis	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000694403	16	30100529	16	30089208	694403	682339		NC_000016.10:30089207:C:T
NM_004608.3(TBX6):c.1311A>T (p.Ter437Cys)	TBX6	*437C	Spondylocostal dysostosis 5	Pathogenic(Last reviewed: Apr 15, 2013)	no assertion criteria provided	VCV000100633	16	30097546	16	30086225	100633	106505	rs587777113	NC_000016.10:30086224:T:A
NM_153026.3(PRICKLE1):c.1414T>C (p.Tyr472His)	PRICKLE1	Y472H	Progressive myoclonus epilepsy with ataxia	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000030730	12	42858422	12	42464620	30730	39687	rs281865564	NC_000012.12:42464619:A:G
NM_001297.5(CNGB1):c.1958-1G>A	CNGB1		Retinal dystrophy|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000803260	16	57951381	16	57917477	803260	791628		NC_000016.10:57917476:C:T
NM_020366.3(RPGRIP1):c.2440C>T (p.Arg814Ter)	RPGRIP1	R814*	Cone-rod dystrophy 13|Leber congenital amaurosis 6|Leber congenital amaurosis 6|Leber congenital amaurosis	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000585296	14	21794062	14	21325903	585296	576338	rs759940113	NC_000014.9:21325902:C:T
NM_000359.3(TGM1):c.788G>A (p.Trp263Ter)	TGM1	W263*	not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419403	14	24729234	14	24260028	419403	409111	rs367699137	NC_000014.9:24260027:C:T
NM_000359.3(TGM1):c.1166G>A (p.Arg389His)	TGM1	R388H, R389H	Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000012489	14	24727873	14	24258667	12489	27528	rs121918723	NC_000014.9:24258666:C:T
NM_001256269.2(KIF22):c.239C>T (p.Pro80Leu)	KIF22	P148L, P80L	not provided|Spondyloepimetaphyseal dysplasia with joint laxity, type 2	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030334	16	29809962	16	29798641	30334	39290	rs193922921	NC_000016.10:29798640:C:T
NM_014844.5(TECPR2):c.1319del (p.Leu440fs)	TECPR2	L440fs	not provided|Spastic paraplegia 49, autosomal recessive	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374308	14	102898367	14	102432030	374308	361210	rs750908377	NC_000014.9:102432029:T:
NM_002225.3(IVD):c.367G>A (p.Gly123Arg)	IVD	G123R	not provided|Isovaleryl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000167199	15	40702898	15	40410699	167199	177782	rs142761835	NC_000015.10:40410698:G:A
NM_152594.3(SPRED1):c.52C>T (p.Arg18Ter)	SPRED1	R18*	Legius syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000536693	15	38591593	15	38299392	536693	529252	rs750777752	NC_000015.10:38299391:C:T
NM_020686.6(ABAT):c.638T>G (p.Phe213Cys)	ABAT	F213C	Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000635255	16	8862084	16	8768227	635255	623087	rs1567312671	NC_000016.10:8768226:T:G
NM_020686.6(ABAT):c.168+1G>A	ABAT		Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000635252	16	8839956	16	8746099	635252	623089	rs1567300736	NC_000016.10:8746098:G:A
NM_020686.6(ABAT):c.1460T>C (p.Leu487Pro)	ABAT	L502P, L487P	Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Sep 12, 2017)	no assertion criteria provided	VCV000438387	16	8875244	16	8781387	438387	432015	rs1555494322	NC_000016.10:8781386:T:C
NM_020686.6(ABAT):c.817-2A>G	ABAT		Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Sep 12, 2017)	no assertion criteria provided	VCV000438386	16	8866635	16	8772778	438386	432014	rs1555492932	NC_000016.10:8772777:A:G
NM_000663.3(ABAT):c.199-?_316+?del	ABAT		Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000438385					438385	432013		
ABAT, 3-PRIME DELETION	ABAT		Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000016217					16217	31256		
NM_004608.3(TBX6):c.1179_1180del (p.Gly395fs)	TBX6	G395fs	Spondylocostal dysostosis 5	Pathogenic(Last reviewed: Nov 15, 2015)	criteria provided, single submitter	VCV000252362	16	30097677 - 30097678	16	30086356 - 30086357	252362	246742	rs879253857	NC_000016.10:30086355:CT:
NM_004608.3(TBX6):c.1169dup (p.His391fs)	TBX6		Spondylocostal dysostosis 5	Pathogenic(Last reviewed: Nov 15, 2015)	criteria provided, single submitter	VCV000243054	16	30097687 - 30097688	16	30086366 - 30086367	243054	244133	rs879253776	NC_000016.10:30086366:GG:GGG
NM_004608.3(TBX6):c.704dup (p.Met236fs)	TBX6		Spondylocostal dysostosis 5	Pathogenic(Last reviewed: Nov 15, 2015)	criteria provided, single submitter	VCV000243053	16	30100077 - 30100078	16	30088756 - 30088757	243053	244134	rs758051786	NC_000016.10:30088756:CCCCCCC:CCCCCCCC
NM_020686.6(ABAT):c.1393G>C (p.Gly465Arg)	ABAT	G465R	Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000635254	16	8875177	16	8781320	635254	623088	rs781555217	NC_000016.10:8781319:G:C
NM_020686.6(ABAT):c.454C>T (p.Pro152Ser)	ABAT	P152S	Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000635253	16	8858601	16	8764744	635253	623086	rs1567310537	NC_000016.10:8764743:C:T
NM_000663.4(ABAT):c.199-?_316+?del	ABAT		Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000162037					162037	171756		
NM_031885.4(BBS2):c.175C>T (p.Gln59Ter)	BBS2	Q59*	Bardet-Biedl syndrome|Bardet-Biedl syndrome 2	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004571	16	56548535	16	56514623	4571	19610	rs121908176	NC_000016.10:56514622:G:A
NM_001297.5(CNGB1):c.3139_3142dup (p.Ala1048fs)	CNGB1		Retinal dystrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000437975	16	57931400 - 57931401	16	57897496 - 57897497	437975	431791	rs756806434	NC_000016.10:57897496:CCACC:CCACCCACC
NM_001297.5(CNGB1):c.2185C>T (p.Arg729Ter)	CNGB1	R729*, R723*	Retinal dystrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000437971	16	57950065	16	57916161	437971	431795	rs1352458826	NC_000016.10:57916160:G:A
NM_001297.5(CNGB1):c.3150del (p.Phe1051fs)	CNGB1	F1045fs, F1051fs	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280141	16	57931393	16	57897489	280141	264814	rs753353134	NC_000016.10:57897488:CCC:CC
NM_139276.2(STAT3):c.1979T>C (p.Met660Thr)	STAT3	M660T	STAT3 gain of function|Hyper-IgE recurrent infection syndrome 1, autosomal dominant|not provided|Hyper-IgE syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265261	17	40474422	17	42322404	265261	260167	rs886039434	NC_000017.11:42322403:A:G
NM_024685.4(BBS10):c.1677del (p.Ser558_Tyr559insTer)	BBS10		Bardet-Biedl syndrome 10|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496471	12	76740088	12	76346308	496471	487588	rs1555202584	NC_000012.12:76346307:G:
NM_020686.6(ABAT):c.275G>A (p.Arg92Gln)	ABAT	R92Q	Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000162036	16	8844355	16	8750498	162036	171753	rs724159992	NC_000016.10:8750497:G:A
NM_020686.6(ABAT):c.1433T>C (p.Leu478Pro)	ABAT	L478P	Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000162035	16	8875217	16	8781360	162035	171755	rs724159991	NC_000016.10:8781359:T:C
NM_020686.6(ABAT):c.631C>T (p.Leu211Phe)	ABAT	L211F	Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162034	16	8862077	16	8768220	162034	171754	rs724159990	NC_000016.10:8768219:C:T
NM_004608.3(TBX6):c.266dup (p.Val91fs)	TBX6		Spondylocostal dysostosis 5	Pathogenic(Last reviewed: Nov 15, 2015)	criteria provided, single submitter	VCV000188055	16	30102165 - 30102166	16	30090844 - 30090845	188055	185947	rs786204040	NC_000016.10:30090844:GGG:GGGG
NM_004608.3(TBX6):c.1250dup (p.Leu419fs)	TBX6		Spondylocostal dysostosis 5	Pathogenic(Last reviewed: Nov 15, 2015)	criteria provided, single submitter	VCV000188054	16	30097606 - 30097607	16	30086285 - 30086286	188054	185946	rs786204039	NC_000016.10:30086285:AA:AAA
NM_004608.3(TBX6):c.844C>T (p.Arg282Ter)	TBX6	R282*	Spondylocostal dysostosis 5	Pathogenic(Last reviewed: Nov 15, 2015)	criteria provided, single submitter	VCV000188052	16	30098168	16	30086847	188052	185944	rs201620629	NC_000016.10:30086846:G:A
NM_015335.5(MED13L):c.401dup (p.Met135fs)	MED13L		not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000817901	12	116534551 - 116534552	12	116096746 - 116096747	817901	805726		NC_000012.12:116096746:A:AA
NM_015335.5(MED13L):c.34del (p.Ala12fs)	MED13L	A12fs	not provided	Pathogenic(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000817639	12	116714903	12	116277098	817639	805727		NC_000012.12:116277097:CCCC:CCC
NM_015335.5(MED13L):c.4076G>A (p.Trp1359Ter)	MED13L	W1359*	not provided	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000817519	12	116424952	12	115987147	817519	805724		NC_000012.12:115987146:C:T
NM_015335.5(MED13L):c.1941_1948del (p.Pro648fs)	MED13L	P648fs	not provided	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000817457	12	116446270 - 116446277	12	116008465 - 116008472	817457	805725		NC_000012.12:116008464:CTGGAGGCCTG:CTG
NM_015335.5(MED13L):c.4410_4411TG[1] (p.Val1471fs)	MED13L		not provided	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000817395	12	116422103 - 116422104	12	115984298 - 115984299	817395	805723		NC_000012.12:115984297:CACA:CA
GRCh37/hg19 12q24.21(chr12:116528514-116605811)x1	MED13L		not provided	Pathogenic(Last reviewed: Jun 7, 2018)	no assertion criteria provided	VCV000815559	12	116528514 - 116605811			815559	803768		
GRCh37/hg19 12q24.21(chr12:116503127-116558092)x1	MED13L		not provided	Pathogenic(Last reviewed: Oct 16, 2018)	no assertion criteria provided	VCV000815558	12	116503127 - 116558092			815558	803767		
NC_000012.12:g.116019851_116019852del	MED13L	K250fs	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000807443	12	116457655 - 116457656	12	116019850 - 116019851	807443	798652		NC_000012.12:116019849:TCT:T
NM_015335.4(MED13L):c.4060C>T (p.Gln1354Ter)	MED13L	Q1354*	not provided	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000620328	12	116424968	12	115987163	620328	611763	rs1565995054	NC_000012.12:115987162:G:A
NM_015335.4(MED13L):c.5866C>T (p.Gln1956Ter)	MED13L	Q1956*	not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000620310	12	116409907	12	115972102	620310	611762	rs1565985681	NC_000012.12:115972101:G:A
GRCh37/hg19 12q24.21(chr12:116481669-116569556)x1	MED13L		not provided	Pathogenic(Last reviewed: Sep 20, 2017)	no assertion criteria provided	VCV000563902	12	116481669 - 116569556			563902	555086		
NM_015335.4(MED13L):c.4609C>T (p.Gln1537Ter)	MED13L	Q1537*	not provided	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000546033	12	116421268	12	115983463	546033	536402	rs1555243400	NC_000012.12:115983462:G:A
NM_015335.4(MED13L):c.626-2A>G	MED13L		not provided	Pathogenic(Last reviewed: Nov 2, 2017)	no assertion criteria provided	VCV000545095	12	116457779	12	116019974	545095	535323	rs1555249664	NC_000012.12:116019973:T:C
NM_015335.4(MED13L):c.73-1G>A	MED13L		not provided	Pathogenic(Last reviewed: Jun 8, 2017)	no assertion criteria provided	VCV000545076	12	116675511	12	116237706	545076	535324	rs1555225472	NC_000012.12:116237705:C:T
NM_015335.4(MED13L):c.3909_3910TG[1] (p.Val1304fs)	MED13L		not provided	Pathogenic(Last reviewed: Apr 13, 2017)	no assertion criteria provided	VCV000545069	12	116428847 - 116428848	12	115991042 - 115991043	545069	535322	rs1555244975	NC_000012.12:115991041:CACA:CA
NM_015335.4(MED13L):c.878del (p.Pro293fs)	MED13L	P293fs	not provided	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000524009	12	116457160	12	116019355	524009	514634	rs1555249561	NC_000012.12:116019354:GGG:GG
NM_015335.4(MED13L):c.1992_1993AG[1] (p.Glu665fs)	MED13L		not provided	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000504183	12	116446221 - 116446224	12	116008416 - 116008419	504183	495290	rs1555247800	NC_000012.12:116008415:CTCTCT:CT
NM_015335.4(MED13L):c.3469C>T (p.Gln1157Ter)	MED13L	Q1157*	not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000489304	12	116429290	12	115991485	489304	482012	rs1555245108	NC_000012.12:115991484:G:A
NM_015335.4(MED13L):c.1A>G (p.Met1Val)	MED13L	M1V	not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000430179	12	116714936	12	116277131	430179	421904	rs1131691818	NC_000012.12:116277130:T:C
NM_015335.4(MED13L):c.4403dup (p.Thr1470fs)	MED13L		not provided	Pathogenic(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	VCV000430063	12	116422112 - 116422113	12	115984307 - 115984308	430063	421902	rs1131691764	NC_000012.12:115984307:CCC:CCCC
NM_015335.4(MED13L):c.6073dup (p.Met2025fs)	MED13L		not provided	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000429444	12	116406896 - 116406897	12	115969091 - 115969092	429444	421901	rs1131691386	NC_000012.12:115969091:T:TT
NM_015335.4(MED13L):c.2907_2910CTGT[1] (p.Leu971fs)	MED13L		not provided	Pathogenic(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000423751	12	116434363 - 116434366	12	115996558 - 115996561	423751	408531	rs1064796611	NC_000012.12:115996557:ACAGACAG:ACAG
NM_015335.4(MED13L):c.5589-1G>A	MED13L		not provided	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000423638	12	116413119	12	115975314	423638	408528	rs1064796543	NC_000012.12:115975313:C:T
NM_015335.4(MED13L):c.4716del (p.Pro1573fs)	MED13L	P1573fs	not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000422943	12	116421161	12	115983356	422943	408530	rs1064796113	NC_000012.12:115983355:A:
NM_015335.4(MED13L):c.1186del (p.Met396fs)	MED13L	M396fs	not provided	Pathogenic(Last reviewed: Aug 16, 2015)	criteria provided, single submitter	VCV000419645	12	116450696	12	116012891	419645	408535	rs1064794013	NC_000012.12:116012890:TTT:TT
NM_015335.4(MED13L):c.2524C>T (p.Arg842Ter)	MED13L	R842*	not provided	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	VCV000418865	12	116440853	12	116003048	418865	408534	rs1064793483	NC_000012.12:116003047:G:A
NM_015335.4(MED13L):c.5083dup (p.Ser1695fs)	MED13L		not provided	Pathogenic(Last reviewed: Apr 2, 2015)	criteria provided, single submitter	VCV000418802	12	116420280 - 116420281	12	115982475 - 115982476	418802	408529	rs1555243086	NC_000012.12:115982475:AA:AAA
NM_015335.4(MED13L):c.4051C>T (p.Gln1351Ter)	MED13L	Q1351*	not provided	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000392058	12	116424977	12	115987172	392058	374595	rs1057524341	NC_000012.12:115987171:G:A
NM_015335.4(MED13L):c.4452del (p.Phe1484fs)	MED13L	F1484fs	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic	no assertion criteria provided	VCV000375612	12	116422064	12	115984259	375612	362426	rs1555243582	NC_000012.12:115984258:AAA:AA
NM_015335.4(MED13L):c.5150_5151AT[1] (p.Met1718fs)	MED13L		Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic	no assertion criteria provided	VCV000375611	12	116420211 - 116420212	12	115982406 - 115982407	375611	362425	rs1555243059	NC_000012.12:115982405:ATAT:AT
NM_015335.4(MED13L):c.4956-2A>C	MED13L		Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Aug 24, 2015)	no assertion criteria provided	VCV000374334	12	116420410	12	115982605	374334	361202	rs1057518705	NC_000012.12:115982604:T:G
NM_015335.4(MED13L):c.1992dup (p.Glu665fs)	MED13L		not provided	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000373445	12	116446225 - 116446226	12	116008420 - 116008421	373445	360083	rs1057518424	NC_000012.12:116008420:T:TT
NM_015335.4(MED13L):c.4577del (p.Pro1526fs)	MED13L	P1526fs	not provided	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000373164	12	116421300	12	115983495	373164	360025	rs1057518262	NC_000012.12:115983494:GG:G
NM_015335.4(MED13L):c.5285del (p.Leu1762fs)	MED13L	L1762fs	not provided	Pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, single submitter	VCV000286125	12	116418634	12	115980829	286125	270362	rs886043314	NC_000012.12:115980828:A:
NM_015335.4(MED13L):c.6284dup (p.Ala2096fs)	MED13L		not provided	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000280413	12	116403989 - 116403990	12	115966184 - 115966185	280413	264509	rs886041624	NC_000012.12:115966184:A:AA
NM_015335.4(MED13L):c.1336C>T (p.Gln446Ter)	MED13L	Q446*	not provided	Pathogenic(Last reviewed: Jan 28, 2016)	criteria provided, single submitter	VCV000280267	12	116446882	12	116009077	280267	264587	rs886041503	NC_000012.12:116009076:G:A
NM_015335.4(MED13L):c.5278C>T (p.Arg1760Ter)	MED13L	R1760*	not provided	Pathogenic(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	VCV000280198	12	116418641	12	115980836	280198	264462	rs886041448	NC_000012.12:115980835:G:A
NM_015335.4(MED13L):c.2590A>T (p.Met864Leu)	MED13L	M864L	not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000265523	12	116435015	12	115997210	265523	260010	rs886039599	NC_000012.12:115997209:T:A
NM_015335.4(MED13L):c.5444del (p.Thr1815fs)	MED13L	T1815fs	not provided	Pathogenic(Last reviewed: Aug 10, 2015)	criteria provided, single submitter	VCV000252696	12	116413464	12	115975659	252696	247070	rs879255407	NC_000012.12:115975658:G:
NM_015335.4(MED13L):c.6485C>T (p.Thr2162Met)	MED13L	T2162M	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	VCV000224153	12	116401227	12	115963422	224153	225881	rs869312707	NC_000012.12:115963421:G:A
NM_015335.4(MED13L):c.124dup (p.Asp42fs)	MED13L		Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Feb 10, 2015)	criteria provided, single submitter	VCV000224115	12	116675458 - 116675459	12	116237653 - 116237654	224115	225845	rs869312875	NC_000012.12:116237653:CCCC:CCCCC
NM_015335.4(MED13L):c.263G>A (p.Trp88Ter)	MED13L	W88*	Transposition of the great arteries, dextro-looped 1	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000801022	12	116675320	12	116237515	801022	789405		NC_000012.12:116237514:C:T
NM_015335.4(MED13L):c.1109_1110del (p.Pro370fs)	MED13L	P370fs	not provided	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000633535	12	116452979 - 116452980	12	116015174 - 116015175	633535	621970	rs1566011496	NC_000012.12:116015173:TG:
NM_015335.4(MED13L):c.6260del (p.Pro2087fs)	MED13L	P2087fs	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic	no assertion criteria provided	VCV000626269	12	116404014	12	115966209	626269	614607	rs1565982697	NC_000012.12:115966208:GG:G
GRCh37/hg19 12q24.21(chr12:116622732-116685976)	MED13L		Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625741	12	116622732 - 116685976			625741	614045		
GRCh37/hg19 12q24.21(chr12:116446308-116638445)	MED13L		Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625563	12	116446308 - 116638445			625563	613867		
NM_015335.4(MED13L):c.5502del (p.His1834fs)	MED13L	H1834fs	Transposition of the great arteries, dextro-looped 1|Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000620030	12	116413406	12	115975601	620030	611409	rs1565987758	NC_000012.12:115975600:G:
NM_015335.4(MED13L):c.3519_3521delinsT (p.Tyr1174fs)	MED13L		Transposition of the great arteries, dextro-looped 1	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000570875	12	116429238 - 116429240	12	115991433 - 115991435	570875	566356	rs1565997261	NC_000012.12:115991432:TAG:A
NM_015335.4(MED13L):c.601C>T (p.Gln201Ter)	MED13L	Q201*	Transposition of the great arteries, dextro-looped 1	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000568975	12	116460285	12	116022480	568975	565077	rs1029377279	NC_000012.12:116022479:G:A
NM_015335.4(MED13L):c.2316_2317del (p.Met772fs)	MED13L	M772fs	Transposition of the great arteries, dextro-looped 1	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000567731	12	116444138 - 116444139	12	116006333 - 116006334	567731	571282	rs1566005476	NC_000012.12:116006332:ACA:A
NM_015335.4(MED13L):c.2107C>T (p.Gln703Ter)	MED13L	Q703*	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000545567	12	116445347	12	116007542	545567	536069	rs1555247672	NC_000012.12:116007541:G:A
NM_015335.4(MED13L):c.1971del (p.Asp657fs)	MED13L	D657fs	Motor delay|Vesicoureteral reflux|Delayed speech and language development|Strabismus	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523512	12	116446247	12	116008442	523512	514016	rs1555247805	NC_000012.12:116008441:A:
NM_015335.4(MED13L):c.516_517delinsAT (p.His172_Gly173delinsGlnTer)	MED13L		Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000520431	12	116460369 - 116460370	12	116022564 - 116022565	520431	511031	rs1555250044	NC_000012.12:116022563:CA:AT
NM_015335.4(MED13L):c.2059C>T (p.Gln687Ter)	MED13L	Q687*	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: May 9, 2016)	criteria provided, single submitter	VCV000433184	12	116445395	12	116007590	433184	426745	rs1555247699	NC_000012.12:116007589:G:A
NM_015335.4(MED13L):c.5173C>T (p.Gln1725Ter)	MED13L	Q1725*	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431108	12	116420191	12	115982386	431108	424631	rs1135401765	NC_000012.12:115982385:G:A
NM_015335.4(MED13L):c.2399dup (p.Thr801fs)	MED13L		Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431100	12	116443743 - 116443744	12	116005938 - 116005939	431100	424623	rs1135401766	NC_000012.12:116005938:A:AA
NM_015335.4(MED13L):c.607dup (p.Ser203fs)	MED13L		Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Feb 5, 2016)	no assertion criteria provided	VCV000221562	12	116460278 - 116460279	12	116022473 - 116022474	221562	223291	rs869025291	NC_000012.12:116022473:AA:AAA
NM_015335.4(MED13L):c.5947_5948TC[1] (p.Gln1984fs)	MED13L		Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Feb 5, 2016)	no assertion criteria provided	VCV000221560	12	116408516 - 116408517	12	115970711 - 115970712	221560	223289	rs869025289	NC_000012.12:115970710:GAGA:GA
NC_000012.12:g.(?_115982183)_(116022795_?)del	MED13L		Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000221558	12	116419988 - 116460600	12	115982183 - 116022795	221558	223287		
NM_015335.4(MED13L):c.480-1G>T	MED13L		Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000221557	12	116460407	12	116022602	221557	223286	rs869025288	NC_000012.12:116022601:C:A
NM_015335.4(MED13L):c.1704_1705AG[2] (p.Ser570fs)	MED13L		Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000221555	12	116446509 - 116446510	12	116008704 - 116008705	221555	223284	rs869025286	NC_000012.12:116008703:CTCTCT:CTCT
GRCh38/hg38 12q24.21(chr12:116019418-116054358)x1	MED13L		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000057607	12	116457223 - 116492163	12	116019418 - 116054358	57607	72202		
NM_015335.4(MED13L):c.6068A>G (p.Asp2023Gly)	MED13L	D2023G	Transposition of the great arteries, dextro-looped 1	Pathogenic(Last reviewed: Dec 9, 2003)	no assertion criteria provided	VCV000002108	12	116406902	12	115969097	2108	17147	rs121918333	NC_000012.12:115969096:T:C
NC_000012.12:g.(?_115961246)_(116096772_?)del	MED13L		Transposition of the great arteries, dextro-looped 1	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000833087	12	116399051 - 116534577			833087	820446		
NM_015335.4(MED13L):c.4077G>A (p.Trp1359Ter)	MED13L	W1359*	Transposition of the great arteries, dextro-looped 1	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000572855	12	116424951	12	115987146	572855	565058	rs1565995034	NC_000012.12:115987145:C:T
NM_015335.4(MED13L):c.5588+1G>A	MED13L		Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431140	12	116413319	12	115975514	431140	424659	rs1135401810	NC_000012.12:115975513:C:T
NM_015335.4(MED13L):c.2504del (p.Pro835fs)	MED13L	P835fs	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000427896	12	116440873	12	116003068	427896	418972	rs1555246952	NC_000012.12:116003067:GG:G
GRCh37/hg19 12q24.21(chr12:116064267-116750726)x1	MED13L		not provided	Pathogenic(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000424638	12	116012278 - 116783516			424638	411539		
NC_000013.11:g.(?_23320627)_(23320770_?)del	SGCG		Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000830386	13	23894766 - 23894909			830386	820549		
NM_000382.3(ALDH3A2):c.471+1del	ALDH3A2		Sjgren-Larsson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189163	17	19555945	17	19652632	189163	186956		NC_000017.11:19652631:GG:G
NM_000382.3(ALDH3A2):c.1157A>G (p.Asn386Ser)	ALDH3A2	N386S, N193S	not provided|Sjgren-Larsson syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001644	17	19568310	17	19664997	1644	16683		NC_000017.11:19664996:A:G
NM_015335.4(MED13L):c.3765del (p.Cys1256fs)	MED13L	C1256fs	not provided|Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000221561	12	116428994	12	115991189	221561	223290	rs147976828	NC_000012.12:115991188:GGG:GG
NM_000295.5(SERPINA1):c.1108_1115delinsAAAAACA (p.Glu370fs)	SERPINA1		Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000219353	14	94844928 - 94844935	14	94378591 - 94378598	219353	221044	rs864622043	NC_000014.9:94378590:GCAGCTTC:TGTTTTT
NM_000295.5(SERPINA1):c.1158dup (p.Glu387fs)	SERPINA1		Alpha-1-antitrypsin deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188845	14	94844884 - 94844885	14	94378547 - 94378548	188845	186924	rs764325655	NC_000014.9:94378547:GGGGGGG:GGGGGGGG
NM_001127701.1(SERPINA1):c.272G>A (p.Gly91Glu)	SERPINA1	G67E, G91E	Alpha-1-antitrypsin deficiency|PI M(MINERAL SPRINGS)	Pathogenic, other(Last reviewed: Jul 15, 2016)	no assertion criteria provided	VCV000017966	14	94849303	14	94382966	17966	33005	rs28931568	NC_000014.9:94382965:C:T
NM_052845.4(MMAB):c.291-1G>A	MMAB		Vitamin B12-responsive methylmalonic acidemia type cblB|not provided	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219004	12	110002982	12	109565177	219004	216058	rs199971687	NC_000012.12:109565176:C:T
NM_052845.4(MMAB):c.700C>T (p.Gln234Ter)	MMAB	Q234*	Methylmalonic acidemia|Vitamin B12-responsive methylmalonic acidemia type cblB|not provided	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203820	12	109994886	12	109557081	203820	200226	rs369296618	NC_000012.12:109557080:G:A
NM_004863.3(SPTLC2):c.544G>C (p.Ala182Pro)	SPTLC2	A182P	Hereditary sensory and autonomic neuropathy type IC	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000208302	14	78043197	14	77576854	208302	204570	rs864621998	NC_000014.9:77576853:C:G
NM_004863.3(SPTLC2):c.1510A>T (p.Ile504Phe)	SPTLC2	I504F	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC, SEVERE	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000004799	14	77984440	14	77518097	4799	19838	rs267607091	NC_000014.9:77518096:T:A
NM_004863.3(SPTLC2):c.1075G>A (p.Val359Met)	SPTLC2	V359M	NEUROPATHY, HEREDITARY SENSORY, TYPE IC	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000004798	14	78021744	14	77555401	4798	19837	rs267607090	NC_000014.9:77555400:C:T
NM_015335.4(MED13L):c.6118_6125del (p.Gly2040fs)	MED13L	G2040fs	Mental retardation and distinctive facial features with or without cardiac defects|Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000221556	12	116406845 - 116406852	12	115969040 - 115969047	221556	223285	rs869025287	NC_000012.12:115969039:AATATGCCAATAT:AATAT
t(12;19)(q24.21;q12)	MED13L		Developmental delay|Flat occiput|Camptodactyly|Intellectual disability, mild|Wide nasal bridge|Equinovarus deformity|Smooth philtrum|Bulbous nose|Hirsutism|Robin sequence|Scoliosis|Hypertelorism|Metatarsus adductus|Strabismus	Pathogenic	criteria provided, single submitter	VCV000218934					218934	215768		
NM_000192.3(TBX5):c.668C>T (p.Thr223Met)	TBX5	T223M, T173M	Holt-Oram syndrome|not provided|Aortic valve disease 2	Pathogenic(Last reviewed: Nov 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449105	12	114823368	12	114385563	449105	444920	rs1555225344	NC_000012.12:114385562:G:A
NM_004119.2(FLT3):c.2505T>G (p.Asp835Glu)	FLT3	D835E	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375971	13	28592640	13	28018503	375971	362850	rs121913487	NC_000013.11:28018502:A:C
NM_001297.5(CNGB1):c.2544dup (p.Leu849fs)	CNGB1		not provided|Retinal dystrophy	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000236511	16	57938727 - 57938728	16	57904823 - 57904824	236511	238079	rs760430056	NC_000016.10:57904823:CCCCCC:CCCCCCC
NM_004863.3(SPTLC2):c.547C>T (p.Arg183Trp)	SPTLC2	R183W	Hereditary sensory and autonomic neuropathy type IC	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000487224	14	78043194	14	77576851	487224	463539	rs775437084	NC_000014.9:77576850:G:A
NM_003239.4(TGFB3):c.899G>A (p.Arg300Gln)	TGFB3	R300Q	Loeys-Dietz syndrome 5|not provided|Loeys-Dietz syndrome 4	Pathogenic/Likely pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143945	14	76429686	14	75963343	143945	153683	rs587777617	NC_000014.9:75963342:C:T
NM_052867.4(NALCN):c.2203C>T (p.Arg735Ter)	NALCN	R735*, R706*, R764*	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 17, 2014)	criteria provided, single submitter	VCV000225108	13	101763567	13	101111216	225108	226935	rs757674263	NC_000013.11:101111215:G:A
NM_052867.4(NALCN):c.4197+1G>A	NALCN		Inborn genetic diseases	Pathogenic(Last reviewed: Apr 17, 2014)	criteria provided, single submitter	VCV000225072	13	101725935	13	101073583	225072	226934	rs869312952	NC_000013.11:101073582:C:T
NM_182758.4(WDR72):c.708G>A (p.Trp236Ter)	WDR72	W236*	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	VCV000521052	15	54004972	15	53712775	521052	512148	rs1266819147	NC_000015.10:53712774:C:T
NM_021615.5(CHST6):c.599T>G (p.Leu200Arg)	CHST6	L200R	Macular corneal dystrophy Type I|Macular corneal dystrophy, type II	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005075	16	75513128	16	75479230	5075	20114	rs28937879	NC_000016.10:75479229:A:C
NM_006888.6(CALM1):c.293A>G (p.Asn98Ser)	CALM1	N97S, N98S, N62S, N99S	Ventricular tachycardia, catecholaminergic polymorphic, 4|Catecholaminergic polymorphic ventricular tachycardia|Long QT syndrome 14|Ventricular tachycardia, catecholaminergic polymorphic, 4|Catecholaminergic polymorphic ventricular tachycardia type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039758	14	90870730	14	90404386	39758	48357	rs267607277	NC_000014.9:90404385:A:G
NM_000359.3(TGM1):c.427C>T (p.Arg143Cys)	TGM1	R143C	not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372531	14	24730982	14	24261776	372531	360191	rs531650682	NC_000014.9:24261775:G:A
NM_000137.3(FAH):c.786G>A (p.Trp262Ter)	FAH	W262*	Tyrosinemia type I	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011873	15	80465435	15	80173093	11873	26912	rs80338899	NC_000015.10:80173092:G:A
GRCh37/hg19 12q24.21(chr12:116443463-116457804)x1	MED13L		See cases	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000816513	12	116443463 - 116457804			816513	804718		
NM_020686.6(ABAT):c.659G>A (p.Arg220Lys)	ABAT	R220K	Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000016216	16	8862105	16	8768248	16216	31255	rs121434578	NC_000016.10:8768247:G:A
NM_014844.5(TECPR2):c.3416del (p.Leu1139fs)	TECPR2	L1139fs	Spastic paraplegia 49, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039675	14	102918740	14	102452403	39675	48274	rs751970061	NC_000014.9:102452402:T:
NM_017882.3(CLN6):c.198+1G>A	CLN6		not provided	Pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, single submitter	VCV000265681	15	68510873	15	68218535	265681	260078	rs886039727	NC_000015.10:68218534:C:T
NM_017882.3(CLN6):c.665+1G>A	CLN6		not provided	Pathogenic(Last reviewed: May 5, 2014)	criteria provided, single submitter	VCV000205171	15	68501974	15	68209636	205171	202873	rs796052356	NC_000015.10:68209635:C:T
NM_017882.3(CLN6):c.486+2T>C	CLN6		not provided	Pathogenic(Last reviewed: Oct 18, 2013)	criteria provided, single submitter	VCV000205170	15	68504011	15	68211673	205170	202875	rs796052355	NC_000015.10:68211672:A:G
NM_017882.3(CLN6):c.297+1G>A	CLN6		not provided	Pathogenic(Last reviewed: Jun 19, 2012)	criteria provided, single submitter	VCV000205164	15	68506627	15	68214289	205164	202883	rs796052351	NC_000015.10:68214288:C:T
NM_017882.3(CLN6):c.250T>A (p.Tyr84Asn)	CLN6	Y84N		Pathogenic	no assertion criteria provided	VCV000560343	15	68506675	15	68214337	560343	551392	rs1567096598	NC_000015.10:68214336:A:T
NM_017882.3(CLN6):c.552dup (p.Phe185fs)	CLN6			Pathogenic	no assertion criteria provided	VCV000560341	15	68502087 - 68502088	15	68209749 - 68209750	560341	551391	rs1567095153	NC_000015.10:68209749:GGGG:GGGGG
NM_017882.3(CLN6):c.837del (p.Trp279fs)	CLN6	W279fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803104	15	68500577	15	68208239	803104	791481		NC_000015.10:68208238:CC:C
NM_017882.3(CLN6):c.83G>A (p.Arg28Lys)	CLN6	R28K		Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623397	15	68521840	15	68229502	623397	612357	rs1381427322	NC_000015.10:68229501:C:T
NM_017882.3(CLN6):c.542+5G>T	CLN6			Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000004085	15	68503596	15	68211258	4085	19124	rs786205066	NC_000015.10:68211257:C:A
NM_017882.3(CLN6):c.663C>G (p.Tyr221Ter)	CLN6	Y221*		Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000004084	15	68501977	15	68209639	4084	19123	rs104894486	NC_000015.10:68209638:G:C
NM_017882.3(CLN6):c.7del (p.Ala3fs)	CLN6	A3fs		Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000004080	15	68521916	15	68229578	4080	19119	rs786205065	NC_000015.10:68229577:CC:C
NM_017882.3(CLN6):c.368G>A (p.Gly123Asp)	CLN6	G123D		Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000004079	15	68504131	15	68211793	4079	19118	rs104894484	NC_000015.10:68211792:C:T
NM_017882.3(CLN6):c.511_513TAT[1] (p.Tyr172del)	CLN6	Y171del, Y172del		Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000004078	15	68503627 - 68503629	15	68211289 - 68211291	4078	19117	rs121908079	NC_000015.10:68211288:ATAATA:ATA
NM_017882.3(CLN6):c.542G>A (p.Trp181Ter)	CLN6	W181*	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000840152	15	68503601	15	68211263	840152	842631		NC_000015.10:68211262:C:T
NC_000015.10:g.(?_68208120)_(68229604_?)del	CLN6		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000833141	15	68500458 - 68521942			833141	820731		
NC_000015.9:g.(?_68521830)_(68521932_?)del	CLN6		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000665626	15	68521830 - 68521932	15	68229492 - 68229594	665626	652537		
NM_017882.3(CLN6):c.185G>A (p.Arg62His)	CLN6	R62H		Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000523022	15	68510887	15	68218549	523022	513633	rs751486476	NC_000015.10:68218548:C:T
NM_017882.3(CLN6):c.268_271dup (p.Val91fs)	CLN6			Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000004086	15	68506653 - 68506654	15	68214315 - 68214316	4086	19125	rs786205067	NC_000015.10:68214315:CGTT:CGTTCGTT
NC_000015.9:g.(?_68521820)_(68521942_?)del	CLN6		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000651807	15	68521820 - 68521942	15	68229482 - 68229604	651807	652535		
NM_017882.3(CLN6):c.200T>C (p.Leu67Pro)	CLN6	L67P	not provided|Adult neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000030599	15	68506725	15	68214387	30599	39556	rs154774633	NC_000015.10:68214386:A:G
NM_001478.5(B4GALNT1):c.263dup (p.Leu89fs)	B4GALNT1		Hereditary spastic paraplegia 26|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000060525	12	58025102 - 58025103	12	57631319 - 57631320	60525	75108	rs745744124	NC_000012.12:57631319:CCCCCCCC:CCCCCCCCC
NM_001297.5(CNGB1):c.952C>T (p.Gln318Ter)	CNGB1	Q318*, Q312*	Retinal dystrophy|not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093705	16	57984367	16	57950463	93705	99608	rs372504780	NC_000016.10:57950462:G:A
NM_000432.3(MYL2):c.403-1G>C	MYL2		Familial hypertrophic cardiomyopathy 10|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031768	12	111348980	12	110911176	31768	40428	rs199474813	NC_000012.12:110911175:C:G
NM_000382.3(ALDH3A2):c.529C>T (p.Arg177Ter)	ALDH3A2	R177*	not provided|Sjgren-Larsson syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265027	17	19559736	17	19656423	265027	260160	rs72547561	NC_000017.11:19656422:C:T
NM_002087.3(GRN):c.813_816del (p.Thr272fs)	GRN	T272fs	Primary progressive aphasia||not provided|Ceroid lipofuscinosis, neuronal, 11	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000016020	17	42428507 - 42428510	17	44351139 - 44351142	16020	31059	rs63749877	NC_000017.11:44351138:CTCACT:CT
NM_017882.3(CLN6):c.17G>C (p.Arg6Thr)	CLN6	R6T	not provided|Adult neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000030602	15	68521906	15	68229568	30602	39559	rs154774636	NC_000015.10:68229567:C:G
NM_006939.4(SOS2):c.1127C>G (p.Thr376Ser)	SOS2	T376S	Noonan syndrome 9|not provided|Noonan syndrome	Pathogenic(Last reviewed: Apr 27, 2016)	criteria provided, single submitter	VCV000209091	14	50628269	14	50161551	209091	205688	rs869320687	NC_000014.9:50161550:G:C
PI NULL(HONG KONG 1)	SERPINA1		Alpha-1-antitrypsin deficiency|PI Q0(HONG KONG 1)|PI NULL(HONG KONG 1)	Pathogenic, other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000017980	14	94845838 - 94845839	14	94379501 - 94379502	17980	33019	rs1057519610	NC_000014.9:94379500:GAGAG:GAG
NM_000286.3(PEX12):c.730_733dup (p.Leu245fs)	PEX12		not provided|Infantile Refsum's disease|Peroxisome biogenesis disorder 3A|Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic/Likely pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371737	17	33903147 - 33903148	17	35576128 - 35576129	371737	358425	rs61752107	NC_000017.11:35576128:AGGCA:AGGCAGGCA
NM_024537.2(CARS2):c.752C>T	CARS2	P251L	Combined oxidative phosphorylation deficiency 27	Pathogenic(Last reviewed: Mar 18, 2015)	no assertion criteria provided	VCV000218178	13	111329354	13	110677007	218178	167502	rs557671802	NC_000013.11:110677006:G:A
NM_024537.2(CARS2):c.649_651delGAG	CARS2	E217del	Combined oxidative phosphorylation deficiency 27	Pathogenic(Last reviewed: Mar 18, 2015)	no assertion criteria provided	VCV000218177	13	111335402 - 111335404	13	110683055 - 110683057	218177	167501	rs753472937	NC_000013.11:110683054:CTC:
NM_000359.3(TGM1):c.872G>A (p.Gly291Asp)	TGM1	G291D	not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265269	14	24729150	14	24259944	265269	260054	rs780990272	NC_000014.9:24259943:C:T
NM_000359.3(TGM1):c.1223_1227del (p.Asp408fs)	TGM1	D408fs	Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039537	14	24727812 - 24727816	14	24258606 - 24258610	39537	48136	rs398122905	NC_000014.9:24258605:TGTGT:
NM_139276.2(STAT3):c.2147C>T (p.Thr716Met)	STAT3	T716M, T715M	STAT3 gain of function|Hyper-IgE recurrent infection syndrome 1, autosomal dominant|not provided|Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224848	17	40468917	17	42316899	224848	226683	rs869312892	NC_000017.11:42316898:G:A
NM_017882.2(CLN6):c.316dupC (p.Arg106Profs)	CLN6			Pathogenic(Last reviewed: Jun 25, 2017)	criteria provided, single submitter	VCV000004081	15	68504182 - 68504183	15	68211844 - 68211845	4081	19120	rs397515352	NC_000015.10:68211844:GGGGGG:GGGGGGG
NM_001297.5(CNGB1):c.2284C>T (p.Arg762Cys)	CNGB1	R756C, R762C	not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000812286	16	57949173	16	57915269	812286	800603		NC_000016.10:57915268:G:A
GRCh37/hg19 13q22.3(chr13:77574552-77575350)x1	CLN5		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253413	13	77574552 - 77575350			253413	247861		
NM_006493.2(CLN5):c.116C>A (p.Ser39Ter)	CLN5	S39*	not provided	Pathogenic(Last reviewed: Jan 7, 2014)	criteria provided, single submitter	VCV000205138	13	77566202	13	76992067	205138	202771	rs61504484	NC_000013.11:76992066:C:A
NM_006493.4:c.679C>T	CLN5		Neurodevelopmental disorder	Pathogenic(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635925					635925	623738		
NM_006493.4(CLN5):c.77G>A (p.Trp26Ter)	CLN5	W75*, W26*		Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000553399	13	77566310	13	76992175	553399	547098	rs764790770	NC_000013.11:76992174:G:A
NC_000013.11:g.76992002del	CLN5			Pathogenic	criteria provided, single submitter	VCV000813489	13	77566134	13	76991999	813489	801722		NC_000013.11:76991998:GGGG:GGG
NM_006493.4(CLN5):c.83G>A (p.Trp28Ter)	CLN5	W28*	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000863685	13	77566316	13	76992181	863685	841008		NC_000013.11:76992180:G:A
NM_006493.4(CLN5):c.112_113insATCCGGGCTGG (p.Val38fs)	CLN5		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000527726	13	77566342 - 77566343	13	76992207 - 76992208	527726	528169	rs1555273604	NC_000013.11:76992207:TGG:TGGATCCGGGCTGG
NC_000013.11:g.(?_76995053)_(76996137_?)del	CLN5		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000833329	13	77569188 - 77570272			833329	820591		
NM_000231.2(SGCG):c.581T>C (p.Leu194Ser)	SGCG	L194S	not provided|Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000281085	13	23894778	13	23320639	281085	265322	rs547818652	NC_000013.11:23320638:T:C
NM_000382.3(ALDH3A2):c.551C>T (p.Thr184Met)	ALDH3A2	T184M	Sjgren-Larsson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188768	17	19559758	17	19656445	188768	186957	rs72547562	NC_000017.11:19656444:C:T
NM_000512.5(GALNS):c.1228G>T (p.Glu410Ter)	GALNS	E410*, E416*, E225*	not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000620097	16	88891189	16	88824781	620097	611831	rs1567519109	NC_000016.10:88824780:C:A
NM_000512.5(GALNS):c.899-66_907delinsACTCAGTG	GALNS		not provided	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000497336	16	88898501 - 88898575	16	88832093 - 88832167	497336	488760	rs1555520916	
NM_000512.5(GALNS):c.871G>T (p.Ala291Ser)	GALNS	A291S, A106S, A297S	not provided	Pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	VCV000379921	16	88901648	16	88835240	379921	375752	rs118204448	NC_000016.10:88835239:C:A
NM_000512.5(GALNS):c.1485C>G (p.Asn495Lys)	GALNS	N495K, N501K, N310K	not provided	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000265170	16	88880931	16	88814523	265170	260135	rs886039377	NC_000016.10:88814522:G:C
NM_000512.5(GALNS):c.463G>A (p.Gly155Arg)	GALNS	G155R, G161R	not provided	Pathogenic(Last reviewed: Jun 13, 2013)	criteria provided, single submitter	VCV000093178	16	88904133	16	88837725	93178	99085	rs398123438	NC_000016.10:88837724:C:T
NM_000512.4(GALNS):c.405_422+1del19	GALNS		not provided	Pathogenic(Last reviewed: Jun 13, 2013)	criteria provided, single submitter	VCV000093177	16	88907399 - 88907417	16	88840991 - 88841009	93177	99084	rs398123437	
NM_000512.5(GALNS):c.1559G>A (p.Trp520Ter)	GALNS	W520*, W335*, W526*	not provided	Pathogenic(Last reviewed: Dec 14, 2012)	criteria provided, single submitter	VCV000093171	16	88880857	16	88814449	93171	99078	rs372893383	NC_000016.10:88814448:C:T
NM_000512.5(GALNS):c.1175C>T (p.Ala392Val)	GALNS	A392V, A207V, A398V	not provided	Pathogenic(Last reviewed: Mar 28, 2013)	criteria provided, single submitter	VCV000093163	16	88891242	16	88824834	93163	99070	rs398123430	NC_000016.10:88824833:G:A
NM_000512.5(GALNS):c.1171A>G (p.Met391Val)	GALNS	M391V, M397V, M206V	not provided	Pathogenic(Last reviewed: Jun 13, 2013)	criteria provided, single submitter	VCV000093162	16	88891246	16	88824838	93162	99069	rs398123429	NC_000016.10:88824837:T:C
NM_000512.5(GALNS):c.491A>C (p.Asn164Thr)	GALNS	N164T, N170T	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803280	16	88904105	16	88837697	803280	791650		NC_000016.10:88837696:T:G
NM_000512.5(GALNS):c.1474G>A (p.Ala492Thr)	GALNS	A492T, A498T, A307T	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000800974	16	88884423	16	88818015	800974	788903		NC_000016.10:88818014:C:T
NM_000512.4(GALNS):c.413T>C (p.Val138Ala)	GALNS	A138V, V138A, V144A	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: May 30, 2018)	no assertion criteria provided	VCV000000699	16	88907409	16	88841001	699	15738	rs118204436	NC_000016.10:88841000:A:G
NM_000512.5(GALNS):c.1192del (p.His398fs)	GALNS	H213fs, H398fs, H404fs	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000849188	16	88891225	16	88824817	849188	844476		NC_000016.10:88824816:G:
NC_000016.10:g.(?_88837602)_(88842849_?)del	GALNS		Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000831954	16	88904010 - 88909257			831954	820912		
NC_000016.10:g.(?_88822569)_(88842849_?)del	GALNS		Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000831598	16	88888977 - 88909257			831598	820910		
NC_000016.10:g.(?_88826682)_(88826858_?)del	GALNS		Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000830431	16	88893090 - 88893266			830431	820911		
NC_000016.9:g.(?_88907380)_(88909257_?)del	GALNS		Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000655224	16	88907380 - 88909257	16	88840972 - 88842849	655224	653170		
NM_000512.5(GALNS):c.489del (p.Asn164fs)	GALNS	N164fs, N170fs	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000643109	16	88904107	16	88837699	643109	645119		NC_000016.10:88837698:GGGGG:GGGG
NM_000512.5(GALNS):c.331C>T (p.Gln111Ter)	GALNS	Q111*, Q117*	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000569803	16	88907491	16	88841083	569803	574202	rs200374326	NC_000016.10:88841082:G:A
NM_000512.5(GALNS):c.952A>G (p.Met318Val)	GALNS	M318V, M133V, M324V	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000523005	16	88898456	16	88832048	523005	513638	rs537013895	NC_000016.10:88832047:T:C
NM_000512.5(GALNS):c.1502G>A (p.Cys501Tyr)	GALNS	C316Y, C501Y, C507Y	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522756	16	88880914	16	88814506	522756	513364	rs948490589	NC_000016.10:88814505:C:T
NM_000512.5(GALNS):c.898+1G>C	GALNS		Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Mar 24, 2016)	no assertion criteria provided	VCV000224783	16	88901620	16	88835212	224783	226602	rs761850746	NC_000016.10:88835211:C:G
NM_000512.5(GALNS):c.542A>G (p.Tyr181Cys)	GALNS	Y181C, Y187C	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Feb 14, 2016)	criteria provided, single submitter	VCV000192298	16	88904054	16	88837646	192298	190091	rs786205899	NC_000016.10:88837645:T:C
NM_000512.5(GALNS):c.1019G>A (p.Gly340Asp)	GALNS	G340D, G346D, G155D	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000018403	16	88893230	16	88826822	18403	33442	rs267606838	NC_000016.10:88826821:C:T
NM_000512.5(GALNS):c.178G>A (p.Asp60Asn)	GALNS	D60N, D66N	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000000714	16	88909180	16	88842772	714	15753	rs118204447	NC_000016.10:88842771:C:T
GALNS, 1-BP DEL, 1374T	GALNS		Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000000712					712	15751		
NM_000512.5(GALNS):c.689G>A (p.Trp230Ter)	GALNS	W230*, W45*, W236*	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000000711	16	88902202	16	88835794	711	15750	rs118204449	NC_000016.10:88835793:C:T
NM_000512.5(GALNS):c.205T>G (p.Phe69Val)	GALNS	F69V, F75V	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000000710	16	88909153	16	88842745	710	15749	rs118204445	NC_000016.10:88842744:A:C
NM_000512.5(GALNS):c.871G>A (p.Ala291Thr)	GALNS	A291T, A106T, A297T	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000000707	16	88901648	16	88835240	707	15746	rs118204448	NC_000016.10:88835239:C:T
NM_000512.5(GALNS):c.280C>G (p.Arg94Gly)	GALNS	R94G, R100G	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000000705	16	88908344	16	88841936	705	15744	rs118204441	NC_000016.10:88841935:G:C
NM_000512.5(GALNS):c.1417C>T (p.Gln473Ter)	GALNS	Q473*, Q479*, Q288*	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000000704	16	88884480	16	88818072	704	15743	rs118204439	NC_000016.10:88818071:G:A
GALNS, 2-BP DEL, 1343CA	GALNS		Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Sep 1, 1992)	no assertion criteria provided	VCV000000702					702	15741		
NM_000512.5(GALNS):c.1460A>G (p.Asn487Ser)	GALNS	N487S, N302S, N493S	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000000701	16	88884437	16	88818029	701	15740	rs118204440	NC_000016.10:88818028:T:C
NM_000512.5(GALNS):c.612C>G (p.Asn204Lys)	GALNS	N204K, N210K, N19K	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Sep 1, 1992)	no assertion criteria provided	VCV000000698	16	88902630	16	88836222	698	15737	rs118204435	NC_000016.10:88836221:G:C
NM_000512.5(GALNS):c.1364+1G>A	GALNS		Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000645753	16	88888996	16	88822588	645753	652775		NC_000016.10:88822587:C:T
NM_000512.5(GALNS):c.1000C>T (p.Gln334Ter)	GALNS	Q334*, Q149*, Q340*	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000619963	16	88898408	16	88832000	619963	611356	rs1567526805	NC_000016.10:88831999:G:A
NM_000512.5(GALNS):c.121-2A>G	GALNS		Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000572428	16	88909239	16	88842831	572428	570616	rs1567538216	NC_000016.10:88842830:T:C
NM_000512.5(GALNS):c.776G>A (p.Arg259Gln)	GALNS	R259Q, R265Q, R74Q	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000000706	16	88901743	16	88835335	706	15745	rs118204442	NC_000016.10:88835334:C:T
NM_000512.5(GALNS):c.935C>G (p.Thr312Ser)	GALNS	T312S, T127S, T318S	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000000713	16	88898473	16	88832065	713	15752	rs118204446	NC_000016.10:88832064:G:C
NM_017882.3(CLN6):c.393_394CT[1] (p.Ser132fs)	CLN6		Neuronal ceroid lipofuscinosis||not provided	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000004082	15	68504103 - 68504104	15	68211765 - 68211766	4082	19121	rs774543080	NC_000015.10:68211764:AGAG:AG
NM_000303.3(PMM2):c.367C>T (p.Arg123Ter)	PMM2	R123*	not provided	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000429981	16	8904955	16	8811098	429981	422115	rs191295403	NC_000016.10:8811097:C:T
NM_000303.3(PMM2):c.157C>T (p.Gln53Ter)	PMM2	Q53*	not provided	Pathogenic(Last reviewed: May 20, 2015)	criteria provided, single submitter	VCV000379715	16	8895746	16	8801889	379715	377845	rs1057520708	NC_000016.10:8801888:C:T
NM_000303.3(PMM2):c.310C>G (p.Leu104Val)	PMM2	L104V	not provided	Pathogenic(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	VCV000379257	16	8900227	16	8806370	379257	375565	rs770458492	NC_000016.10:8806369:C:G
NM_000303.3(PMM2):c.394A>T (p.Ile132Phe)	PMM2	I132F	Congenital disorder of glycosylation, type Ia	Pathogenic	no assertion criteria provided	VCV000818203	16	8904982	16	8811125	818203	806409		NC_000016.10:8811124:A:T
NM_000303.3(PMM2):c.97C>T (p.Gln33Ter)	PMM2	Q33*	Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803211	16	8895686	16	8801829	803211	791648		NC_000016.10:8801828:C:T
NM_000303.3(PMM2):c.355T>C (p.Phe119Leu)	PMM2	F119L	Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	VCV000371231	16	8904943	16	8811086	371231	358383	rs1057517110	NC_000016.10:8811085:T:C
NM_000303.3(PMM2):c.653A>T (p.His218Leu)	PMM2	H218L	Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Apr 21, 2011)	no assertion criteria provided	VCV000021144	16	8941594	16	8847737	21144	33996	rs80338705	NC_000016.10:8847736:A:T
NM_000512.5(GALNS):c.898+1G>A	GALNS		Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000528323	16	88901620	16	88835212	528323	530498	rs761850746	NC_000016.10:88835211:C:T
NM_000512.5(GALNS):c.860C>T (p.Ser287Leu)	GALNS	S287L, S102L, S293L	Mucopolysaccharidosis, MPS-IV-A|not provided	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265169	16	88901659	16	88835251	265169	260136	rs770053354	NC_000016.10:88835250:G:A
NM_000512.5(GALNS):c.477G>A (p.Trp159Ter)	GALNS	W159*, W165*	not provided|Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000093179	16	88904119	16	88837711	93179	99086	rs398123439	NC_000016.10:88837710:C:T
NM_024685.4(BBS10):c.909_912del (p.Ser303fs)	BBS10	S303fs	not provided|Bardet-Biedl syndrome|Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432013	12	76740853 - 76740856	12	76347073 - 76347076	432013	426019	rs780059308	NC_000012.12:76347072:CTGACT:CT
NM_000303.3(PMM2):c.561G>A (p.Trp187Ter)	PMM2	W187*	Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000854121	16	8906885	16	8813028	854121	844462		NC_000016.10:8813027:G:A
NC_000016.10:g.(?_8797873)_(8847835_?)del	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000832784	16	8891730 - 8941692			832784	820902		
NC_000016.10:g.(?_8804742)_(8804853_?)del	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000830707	16	8898599 - 8898710			830707	820903		
NC_000016.10:g.(?_8804742)_(8806417_?)del	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000830700	16	8898599 - 8900274			830700	820904		
NC_000016.10:g.(?_8797873)_(8797958_?)del	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000830581	16	8891730 - 8891815			830581	820901		
NM_000303.3(PMM2):c.55del (p.Ala19fs)	PMM2	A19fs	Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000659079	16	8891794	16	8797937	659079	645098		NC_000016.10:8797936:G:
NM_000303.3(PMM2):c.463C>T (p.Gln155Ter)	PMM2	Q155*	Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000656436	16	8905510	16	8811653	656436	645099		NC_000016.10:8811652:C:T
NC_000016.9:g.(?_8891730)_(8906973_?)del	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000639371	16	8891730 - 8906973	16	8797873 - 8813116	639371	652882		
NC_000016.9:g.(?_8898599)_(8906983_?)del	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000530391	16	8898599 - 8906983	16	8804742 - 8813126	530391	529859		
PMM2, 28-KB DEL	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000007726					7726	22765		
NM_000303.3(PMM2):c.669C>G (p.Asp223Glu)	PMM2	D223E	Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000007714	16	8941610	16	8847753	7714	22753	rs104894531	NC_000016.10:8847752:C:G
NM_000303.3(PMM2):c.349G>C (p.Gly117Arg)	PMM2	G117R	Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000007713	16	8904937	16	8811080	7713	22752	rs104894530	NC_000016.10:8811079:G:C
NM_000137.3(FAH):c.1009G>A (p.Gly337Ser)	FAH	E337S, G337S	Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011869	15	80472514	15	80180172	11869	26908	rs80338900	NC_000015.10:80180171:G:A
NM_032436.4(CHAMP1):c.1952C>G (p.Ser651Ter)	CHAMP1	S651*	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000521832	13	115091269	13	114325794	521832	512060	rs1555379911	NC_000013.11:114325793:C:G
NM_000303.3(PMM2):c.-167G>T	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000656718	16	8891573	16	8797716	656718	653316		NC_000016.10:8797715:G:T
NM_000303.3(PMM2):c.109C>T (p.Gln37Ter)	PMM2	Q37*	Congenital disorder of glycosylation, type Ia	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000632947	16	8895698	16	8801841	632947	621550	rs764353860	NC_000016.10:8801840:C:T
NM_000303.3(PMM2):c.677C>G (p.Thr226Ser)	PMM2	T226S	Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Apr 21, 2011)	no assertion criteria provided	VCV000007722	16	8941618	16	8847761	7722	22761	rs80338706	NC_000016.10:8847760:C:G
NM_000303.3(PMM2):c.95T>G (p.Leu32Arg)	PMM2	L32R	Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Oct 29, 2015)	no assertion criteria provided	VCV000007721	16	8895684	16	8801827	7721	22760	rs104894533	NC_000016.10:8801826:T:G
NM_001099274.3(TINF2):c.844C>T (p.Arg282Cys)	TINF2	R282C, R247C	|Dyskeratosis congenita, autosomal dominant, 3|not provided|Dyskeratosis congenita	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005627	14	24709842	14	24240636	5627	20666	rs121918545	NC_000014.9:24240635:G:A
NC_000016.10:g.(?_8804742)_(8813116_?)del	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000830598	16	8898599 - 8906973			830598	820905		
NM_000303.3(PMM2):c.190del (p.Tyr64fs)	PMM2	Y64fs	Congenital disorder of glycosylation, type Ia	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554804	16	8898635	16	8804778	554804	548557	rs1339004837	NC_000016.10:8804777:T:
NM_000303.3(PMM2):c.324del (p.Ile110fs)	PMM2	I110fs	not provided|Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000503676	16	8900241	16	8806384	503676	495633	rs1555449314	NC_000016.10:8806383:G:
NM_000303.3(PMM2):c.511dup (p.Thr171fs)	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370217	16	8905557 - 8905558	16	8811700 - 8811701	370217	358386	rs1057516323	NC_000016.10:8811700:A:AA
NM_000303.3(PMM2):c.256-1G>C	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000007727	16	8900172	16	8806315	7727	22766	rs757394782	NC_000016.10:8806314:G:C
NM_000512.5(GALNS):c.498del (p.Phe167fs)	GALNS	F167fs, F173fs	Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000633232	16	88904098	16	88837690	633232	621553	rs772656696	NC_000016.10:88837689:G:
NM_000512.5(GALNS):c.421T>A (p.Trp141Arg)	GALNS	W141R, W147R	not provided|Mucopolysaccharidosis, MPS-IV-A	Pathogenic/Likely pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000197149	16	88907401	16	88840993	197149	194310	rs794727625	NC_000016.10:88840992:A:T
NM_000512.5(GALNS):c.485C>T (p.Ser162Phe)	GALNS	S162F, S168F	Mucopolysaccharidosis, MPS-IV-A|not provided	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000709	16	88904111	16	88837703	709	15748	rs118204444	NC_000016.10:88837702:G:A
NM_018668.4(VPS33B):c.832dup (p.Leu278fs)	VPS33B		Inborn genetic diseases	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000521757	15	91549621 - 91549622	15	91006391 - 91006392	521757	512160	rs1442840881	NC_000015.10:91006391:G:GG
NM_003978.5(PSTPIP1):c.688G>A (p.Ala230Thr)	PSTPIP1	A230T, A221T, A295T	not provided|Pyogenic arthritis-pyoderma gangrenosum-acne syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004435	15	77323566	15	77031225	4435	19474	rs121908130	NC_000015.10:77031224:G:A
NM_002755.3(MAP2K1):c.362G>C (p.Cys121Ser)	MAP2K1	C121S	Lung adenocarcinoma|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000375980	15	66729154	15	66436816	375980	362859	rs1057519731	NC_000015.10:66436815:G:C
NM_000359.3(TGM1):c.428G>A (p.Arg143His)	TGM1	R142H, R143H	Ichthyosis (disease)|Autosomal recessive congenital ichthyosis 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012481	14	24730981	14	24261775	12481	27520	rs121918719	NC_000014.9:24261774:C:T
NM_000151.4(G6PC):c.562G>A (p.Gly188Ser)	G6PC	G188S, R162K	not provided|Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214465	17	41061435	17	42909418	214465	211810	rs80356482	NC_000017.11:42909417:G:A
NM_000303.3(PMM2):c.548T>C (p.Phe183Ser)	PMM2	F183S	Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000651739	16	8906872	16	8813015	651739	645101		NC_000016.10:8813014:T:C
NM_000303.3(PMM2):c.392del (p.Pro131fs)	PMM2	P131fs	not provided|Congenital disorder of glycosylation, type Ia	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000545732	16	8904977	16	8811120	545732	536476	rs1555449607	NC_000016.10:8811119:CCCC:CCC
NM_000810.4(GABRA5):c.1238C>T (p.Ser413Phe)	GABRA5	S413F	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 79	Pathogenic(Last reviewed: Sep 4, 2019)	no assertion criteria provided	VCV000689393	15	27193229	15	26948082	689393	676985		NC_000015.10:26948081:C:T
NM_000810.4(GABRA5):c.880G>T (p.Val294Phe)	GABRA5	V294F	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 79	Pathogenic(Last reviewed: Sep 4, 2019)	no assertion criteria provided	VCV000689392	15	27188364	15	26943217	689392	676984		NC_000015.10:26943216:G:T
NM_000810.4(GABRA5):c.880G>C (p.Val294Leu)	GABRA5	V294L	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 79	Pathogenic(Last reviewed: Sep 4, 2019)	no assertion criteria provided	VCV000689391	15	27188364	15	26943217	689391	676983		NC_000015.10:26943216:G:C
NM_000512.5(GALNS):c.230C>G (p.Pro77Arg)	GALNS	P83R, P77R	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000856567	16	88909128	16	88842720	856567	844479		NC_000016.10:88842719:G:C
NM_000512.5(GALNS):c.280C>T (p.Arg94Cys)	GALNS	R94C, R100C	Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000651205	16	88908344	16	88841936	651205	645122		NC_000016.10:88841935:G:A
NM_000512.5(GALNS):c.139G>A (p.Gly47Arg)	GALNS	G47R, G53R	Mucopolysaccharidosis, MPS-IV-A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000281018	16	88909219	16	88842811	281018	265255	rs199638097	NC_000016.10:88842810:C:T
NM_014336.5(AIPL1):c.784G>A (p.Gly262Ser)	AIPL1	G262S, G238S, G254S, G240S, G199S, G223S, G250S, G202S	not provided|Leber congenital amaurosis 4	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000065711	17	6329935	17	6426615	65711	76619	rs142326926	NC_000017.11:6426614:C:T
NM_001365088.1(SLC12A6):c.337C>T (p.Arg113Ter)	SLC12A6	R54*, R104*, R98*, R113*, R62*	not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000835797	15	34553201	15	34261000	835797	842230		NC_000015.10:34260999:G:A
NM_001365088.1(SLC12A6):c.250dup (p.His84fs)	SLC12A6		Agenesis of the corpus callosum with peripheral neuropathy	Pathogenic(Last reviewed: Oct 21, 2014)	no assertion criteria provided	VCV000374347	15	34628631 - 34628632	15	34336430 - 34336431	374347	361213	rs1057518713	NC_000015.10:34336430:G:GG
NM_001365088.1(SLC12A6):c.745+1G>T	SLC12A6		Agenesis of the corpus callosum with peripheral neuropathy	Pathogenic	criteria provided, single submitter	VCV000813435	15	34548429	15	34256228	813435	801723		NC_000015.10:34256227:C:A
NM_001365088.1(SLC12A6):c.379G>T (p.Glu127Ter)	SLC12A6	E127*, E76*, E118*, E112*, E68*	Agenesis of the corpus callosum with peripheral neuropathy	Pathogenic(Last reviewed: May 12, 2014)	criteria provided, single submitter	VCV000159897	15	34553159	15	34260958	159897	169120	rs199747285	NC_000015.10:34260957:C:A
NM_001365088.1(SLC12A6):c.1478_1485del (p.Phe493fs)	SLC12A6	F442fs, F484fs, F478fs, F434fs, F493fs	Agenesis of the corpus callosum with peripheral neuropathy	Pathogenic(Last reviewed: Jun 12, 2014)	no assertion criteria provided	VCV000136177	15	34543107 - 34543114	15	34250906 - 34250913	136177	139889	rs515726218	NC_000015.10:34250905:AGAGGGAAAGA:AGA
NM_001365088.1(SLC12A6):c.2032dup (p.Tyr678fs)	SLC12A6		Agenesis of the corpus callosum with peripheral neuropathy	Pathogenic(Last reviewed: Jun 12, 2014)	no assertion criteria provided	VCV000136176	15	34536184 - 34536185	15	34243983 - 34243984	136176	139888	rs515726217	NC_000015.10:34243983:A:AA
NM_001365088.1(SLC12A6):c.1584_1585delinsG (p.Phe529fs)	SLC12A6		Agenesis of the corpus callosum with peripheral neuropathy	Pathogenic(Last reviewed: Jun 12, 2014)	no assertion criteria provided	VCV000136175	15	34542838 - 34542839	15	34250637 - 34250638	136175	139887	rs515726216	NC_000015.10:34250636:AG:C
NM_005664.4(MKRN3):c.1095G>T (p.Arg365Ser)	MKRN3	R365S	Precocious puberty, central, 2	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000056903	15	23812024	15	23566877	56903	71509	rs879255240	NC_000015.10:23566876:G:T
NM_005664.4(MKRN3):c.1172dup (p.Tyr391Ter)	MKRN3		Precocious puberty, central, 2	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000056902	15	23812100 - 23812101	15	23566953 - 23566954	56902	71508	rs879255239	NC_000015.10:23566953:A:AA
NM_005664.4(MKRN3):c.637del (p.Arg213fs)	MKRN3	R213fs	Precocious puberty, central, 2	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000056901	15	23811565	15	23566418	56901	71507	rs879255238	NC_000015.10:23566417:CC:C
NM_005664.4(MKRN3):c.982C>T (p.Arg328Cys)	MKRN3	R328C	Precocious puberty, central, 2	Pathogenic(Last reviewed: Sep 7, 2017)	no assertion criteria provided	VCV000438339	15	23811911	15	23566764	438339	431967	rs1264639964	NC_000015.10:23566763:C:T
NM_005664.4(MKRN3):c.482dup (p.Ala162fs)	MKRN3		Precocious puberty, central, 2	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000056904	15	23811404 - 23811405	15	23566257 - 23566258	56904	71510	rs763195944	NC_000015.10:23566257:CCCCCCC:CCCCCCCC
NM_000303.3(PMM2):c.640-9T>G	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000632945	16	8941572	16	8847715	632945	621848	rs370160676	NC_000016.10:8847714:T:G
NM_005249.5(FOXG1):c.221_228delinsAGCCGCCCCC (p.Pro74fs)	FOXG1		not provided	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000818039	14	29236706 - 29236713	14	28767500 - 28767507	818039	805789		NC_000014.9:28767499:CGCCGCCG:AGCCGCCCCC
NM_005249.5(FOXG1):c.758_761dup (p.Tyr254Ter)	FOXG1		not provided	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000817582	14	29237241 - 29237242	14	28768035 - 28768036	817582	805793		NC_000014.9:28768035:AACTA:AACTAACTA
NM_005249.5(FOXG1):c.178_280del (p.Pro60fs)	FOXG1	P60fs	not provided	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000817446	14	29236657 - 29236759	14	28767451 - 28767553	817446	805788		
NM_005249.5(FOXG1):c.552del (p.Phe184fs)	FOXG1	F184fs	not provided	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV000817320	14	29237037	14	28767831	817320	805792		NC_000014.9:28767830:C:
NM_005249.5(FOXG1):c.526_529dup (p.Gly177fs)	FOXG1		not provided	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000817174	14	29237009 - 29237010	14	28767803 - 28767804	817174	805791		NC_000014.9:28767803:GAACG:GAACGAACG
NM_005249.5(FOXG1):c.777del (p.Ser260fs)	FOXG1	S260fs	Rett syndrome, congenital variant	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000807603	14	29237262	14	28768056	807603	798673		NC_000014.9:28768055:G:
NM_005249.5(FOXG1):c.85del (p.Gln29fs)	FOXG1	Q29fs	Rett syndrome, congenital variant	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803012	14	29236569	14	28767363	803012	791397		NC_000014.9:28767362:CC:C
GRCh37/hg19 14q12(chr14:28484920-29691434)x1	FOXG1		not provided	Pathogenic(Last reviewed: Dec 28, 2017)	no assertion criteria provided	VCV000686451	14	28484920 - 29691434			686451	674043		
NM_000430.4(PAFAH1B1):c.62C>G (p.Ser21Ter)	PAFAH1B1	S21*	not provided	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000620336	17	2568695	17	2665401	620336	611845	rs1567554574	NC_000017.11:2665400:C:G
NM_005249.5(FOXG1):c.770T>C (p.Leu257Pro)	FOXG1	L257P	not provided	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000545092	14	29237255	14	28768049	545092	535326	rs1555321353	NC_000014.9:28768048:T:C
NM_005249.5(FOXG1):c.855del (p.Phe286fs)	FOXG1	F286fs	not provided	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000524039	14	29237339	14	28768133	524039	514660	rs1555321366	NC_000014.9:28768132:CC:C
NM_005249.5(FOXG1):c.958del (p.Arg320fs)	FOXG1	R320fs	not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000503880	14	29237439	14	28768233	503880	495318	rs1555321382	NC_000014.9:28768232:CCCCC:CCCC
NM_005249.5(FOXG1):c.506dup (p.Lys170fs)	FOXG1		not provided	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000503690	14	29236985 - 29236986	14	28767779 - 28767780	503690	495577	rs1452295073	NC_000014.9:28767779:GGGGGG:GGGGGGG
NM_005249.5(FOXG1):c.385G>T (p.Glu129Ter)	FOXG1	E129*	not provided	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000452952	14	29236870	14	28767664	452952	445224	rs1555321264	NC_000014.9:28767663:G:T
NM_005249.5(FOXG1):c.538G>T (p.Glu180Ter)	FOXG1	E180*	not provided	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000432583	14	29237023	14	28767817	432583	426067	rs1555321302	NC_000014.9:28767816:G:T
NM_005249.5(FOXG1):c.436G>T (p.Glu146Ter)	FOXG1	E146*	not provided	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000432581	14	29236921	14	28767715	432581	426066	rs1555321279	NC_000014.9:28767714:G:T
NM_005249.5(FOXG1):c.676C>T (p.Gln226Ter)	FOXG1	Q226*	not provided	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000429702	14	29237161	14	28767955	429702	421988	rs1131691540	NC_000014.9:28767954:C:T
NM_005249.5(FOXG1):c.585_586delinsTT (p.Gln196Ter)	FOXG1		not provided	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000424541	14	29237070 - 29237071	14	28767864 - 28767865	424541	409115	rs1064797030	NC_000014.9:28767863:GC:TT
NM_005249.5(FOXG1):c.1058dup (p.Asn353fs)	FOXG1		not provided	Pathogenic(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	VCV000423084	14	29237541 - 29237542	14	28768335 - 28768336	423084	409119	rs1555321400	NC_000014.9:28768335:AA:AAA
NM_000430.4(PAFAH1B1):c.957_961delinsATCTTAAT (p.Ile320_Lys321delinsSerTer)	PAFAH1B1		not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000419614	17	2579855 - 2579859	17	2676561 - 2676565	419614	409853	rs1064793990	NC_000017.11:2676560:TATTA:ATCTTAAT
NM_005249.5(FOXG1):c.703del (p.Leu235fs)	FOXG1	L235fs	not provided	Pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, single submitter	VCV000418863	14	29237186	14	28767980	418863	409116	rs1064793481	NC_000014.9:28767979:CCC:CC
NM_005249.5(FOXG1):c.460G>T (p.Glu154Ter)	FOXG1	E154*	not provided	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	VCV000379912	14	29236945	14	28767739	379912	373078	rs1057520780	NC_000014.9:28767738:G:T
NM_005249.5(FOXG1):c.406G>T (p.Glu136Ter)	FOXG1	E136*	not provided	Pathogenic(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	VCV000379607	14	29236891	14	28767685	379607	373077	rs1057520663	NC_000014.9:28767684:G:T
NM_005249.5(FOXG1):c.1160_1161delinsGTC (p.Ser387fs)	FOXG1		not provided	Pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, single submitter	VCV000373076	14	29237645 - 29237646	14	28768439 - 28768440	373076	360096	rs1057518196	NC_000014.9:28768438:CG:GTC
NM_005249.5(FOXG1):c.511G>T (p.Glu171Ter)	FOXG1	E171*	not provided	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	VCV000372562	14	29236996	14	28767790	372562	360094	rs1057517859	NC_000014.9:28767789:G:T
NM_005249.5(FOXG1):c.797T>A (p.Ile266Asn)	FOXG1	I266N	not provided	Pathogenic(Last reviewed: May 17, 2016)	criteria provided, single submitter	VCV000280561	14	29237282	14	28768076	280561	264586	rs886041744	NC_000014.9:28768075:T:A
NM_000430.4(PAFAH1B1):c.1159+5del	PAFAH1B1		not provided	Pathogenic(Last reviewed: Sep 7, 2016)	criteria provided, single submitter	VCV000280461	17	2583619	17	2680325	280461	265009	rs886041664	NC_000017.11:2680324:G:
NM_000430.4(PAFAH1B1):c.337C>T (p.Arg113Ter)	PAFAH1B1	R113*	not provided	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000280047	17	2570430	17	2667136	280047	265007	rs886041341	NC_000017.11:2667135:C:T
NM_000430.4(PAFAH1B1):c.826G>T (p.Glu276Ter)	PAFAH1B1	E276*	not provided	Pathogenic(Last reviewed: Jun 26, 2016)	criteria provided, single submitter	VCV000265609	17	2577508	17	2674214	265609	260162	rs886039665	NC_000017.11:2674213:G:T
GRCh37/hg19 17p13.3(chr17:2497629-2585485)x1	PAFAH1B1		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253538	17	2497629 - 2585485			253538	247986		
GRCh37/hg19 17p13.3(chr17:2496180-2498568)x1	PAFAH1B1		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253420	17	2496180 - 2498568			253420	247868		
NM_005249.5(FOXG1):c.821G>A (p.Arg274Gln)	FOXG1	R274Q	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000224139	14	29237306	14	28768100	224139	225868	rs869312700	NC_000014.9:28768099:G:A
NM_005249.5(FOXG1):c.1402_1405del (p.Ser468fs)	FOXG1	S468fs	not provided	Pathogenic(Last reviewed: Nov 14, 2014)	criteria provided, single submitter	VCV000205512	14	29237884 - 29237887	14	28768678 - 28768681	205512	202844	rs796052486	NC_000014.9:28768677:CTGTCTG:CTG
NM_005249.5(FOXG1):c.225_226delinsACCG (p.Pro77fs)	FOXG1		not provided	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	VCV000205511	14	29236710 - 29236711	14	28767504 - 28767505	205511	202807	rs796052485	NC_000014.9:28767503:GC:ACCG
NM_005249.5(FOXG1):c.399del (p.Pro134fs)	FOXG1	P134fs	not provided	Pathogenic(Last reviewed: Jul 28, 2014)	criteria provided, single submitter	VCV000205503	14	29236882	14	28767676	205503	202816	rs796052477	NC_000014.9:28767675:GGG:GG
NM_005249.5(FOXG1):c.383dup (p.Glu129fs)	FOXG1		not provided	Pathogenic(Last reviewed: Aug 12, 2013)	criteria provided, single submitter	VCV000205502	14	29236865 - 29236866	14	28767659 - 28767660	205502	202814	rs796052476	NC_000014.9:28767659:GGG:GGGG
NM_005249.5(FOXG1):c.239dup (p.Ala81fs)	FOXG1		not provided	Pathogenic(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	VCV000205500	14	29236719 - 29236720	14	28767513 - 28767514	205500	202808	rs796052474	NC_000014.9:28767513:CCCCC:CCCCCC
NM_005249.5(FOXG1):c.136dup (p.Gln46fs)	FOXG1		not provided	Pathogenic(Last reviewed: Jan 31, 2014)	criteria provided, single submitter	VCV000205496	14	29236616 - 29236617	14	28767410 - 28767411	205496	202796	rs587783629	NC_000014.9:28767410:CCCCC:CCCCCC
NM_005249.5(FOXG1):c.708C>A (p.Asn236Lys)	FOXG1	N236K	not provided	Pathogenic(Last reviewed: Dec 2, 2013)	criteria provided, single submitter	VCV000205492	14	29237193	14	28767987	205492	202833	rs796052468	NC_000014.9:28767986:C:A
NM_005249.5(FOXG1):c.667C>T (p.Gln223Ter)	FOXG1	Q223*	not provided	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000205488	14	29237152	14	28767946	205488	202827	rs796052465	NC_000014.9:28767945:C:T
NM_005249.5(FOXG1):c.651C>G (p.Tyr217Ter)	FOXG1	Y217*	not provided	Pathogenic(Last reviewed: Jun 11, 2014)	criteria provided, single submitter	VCV000205487	14	29237136	14	28767930	205487	202826	rs796052464	NC_000014.9:28767929:C:G
NM_005249.5(FOXG1):c.586C>T (p.Gln196Ter)	FOXG1	Q196*	not provided	Pathogenic(Last reviewed: Nov 27, 2012)	criteria provided, single submitter	VCV000205486	14	29237071	14	28767865	205486	202824	rs796052463	NC_000014.9:28767864:C:T
NM_005249.5(FOXG1):c.217C>T (p.Gln73Ter)	FOXG1	Q73*	not provided	Pathogenic(Last reviewed: Dec 17, 2013)	criteria provided, single submitter	VCV000205480	14	29236702	14	28767496	205480	202805	rs796052458	NC_000014.9:28767495:C:T
NM_000430.4(PAFAH1B1):c.907_910del (p.Lys303fs)	PAFAH1B1	K303fs	not provided	Pathogenic(Last reviewed: May 13, 2015)	criteria provided, single submitter	VCV000199021	17	2579802 - 2579805	17	2676508 - 2676511	199021	196181	rs587784292	NC_000017.11:2676507:AAAAAAA:AAA
NM_005249.5(FOXG1):c.648_655del (p.Tyr217fs)	FOXG1	Y217fs	not provided	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000167091	14	29237131 - 29237138	14	28767925 - 28767932	167091	177722	rs727503934	NC_000014.9:28767924:CCTTACTACC:CC
NM_005249.5(FOXG1):c.1414_1417del (p.Ser472fs)	FOXG1	S472fs	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000855075	14	29237896 - 29237899	14	28768690 - 28768693	855075	841360		NC_000014.9:28768689:CTGTCTG:CTG
NM_000430.4(PAFAH1B1):c.743_746dup (p.Ala250fs)	PAFAH1B1		not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000839922	17	2577424 - 2577425	17	2674130 - 2674131	839922	844802		NC_000017.11:2674130:TGAT:TGATTGAT
NM_005249.5(FOXG1):c.982_989dup (p.Ser332fs)	FOXG1		Rett syndrome, congenital variant	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000661764	14	29237464 - 29237465	14	28768258 - 28768259	661764	642348		NC_000014.9:28768258:ACAACGGCAC:ACAACGGCACAACGGCAC
NM_005249.5(FOXG1):c.214C>T (p.Gln72Ter)	FOXG1	Q72*	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000487210	14	29236699	14	28767493	487210	464033	rs1555321237	NC_000014.9:28767492:C:T
NM_005249.5(FOXG1):c.506del (p.Gly169fs)	FOXG1	G169fs	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Apr 22, 2017)	criteria provided, single submitter	VCV000471470	14	29236986	14	28767780	471470	463729	rs1452295073	NC_000014.9:28767779:GGGGGG:GGGGG
NM_005249.5(FOXG1):c.500del (p.Glu167fs)	FOXG1	E167fs	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000471469	14	29236985	14	28767779	471469	463725	rs1555321294	NC_000014.9:28767778:A:
NM_005249.5(FOXG1):c.505_506delinsC (p.Gly169fs)	FOXG1		Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, single submitter	VCV000435241	14	29236990 - 29236991	14	28767784 - 28767785	435241	429553	rs786205003	NC_000014.9:28767783:GG:C
GRCh37/hg19 14q12(chr14:27188661-29723971)x1	FOXG1		See cases	Pathogenic	no assertion criteria provided	VCV000394265	14	27188661 - 29723971			394265	381158		
NM_005249.5(FOXG1):c.969del (p.Ser323fs)	FOXG1	S323fs	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Mar 4, 2009)	no assertion criteria provided	VCV000189622	14	29237454	14	28768248	189622	187413	rs786205011	NC_000014.9:28768247:C:
NM_005249.5(FOXG1):c.788_792del (p.Asp263fs)	FOXG1	D263fs	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Mar 18, 2014)	no assertion criteria provided	VCV000189621	14	29237272 - 29237276	14	28768066 - 28768070	189621	187412	rs786205010	NC_000014.9:28768065:GACGTG:G
NM_005249.5(FOXG1):c.700T>C (p.Ser234Pro)	FOXG1	S234P	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Sep 26, 2011)	no assertion criteria provided	VCV000189619	14	29237185	14	28767979	189619	187410	rs786205008	NC_000014.9:28767978:T:C
NM_005249.5(FOXG1):c.689G>A (p.Arg230His)	FOXG1	R230H	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Feb 15, 2013)	no assertion criteria provided	VCV000189618	14	29237174	14	28767968	189618	187409	rs786205007	NC_000014.9:28767967:G:A
NM_005249.5(FOXG1):c.552dup (p.Ser185fs)	FOXG1		Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jul 13, 2010)	no assertion criteria provided	VCV000189615	14	29237036 - 29237037	14	28767830 - 28767831	189615	187404	rs786205004	NC_000014.9:28767830:C:CC
NM_005249.5(FOXG1):c.136C>T (p.Gln46Ter)	FOXG1	Q46*	not provided	Pathogenic(Last reviewed: Jun 12, 2013)	no assertion criteria provided	VCV000189610	14	29236621	14	28767415	189610	187398	rs786205000	NC_000014.9:28767414:C:T
NM_005249.5(FOXG1):c.1248C>G (p.Tyr416Ter)	FOXG1	Y416*	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jul 13, 2010)	no assertion criteria provided	VCV000189609	14	29237733	14	28768527	189609	187415	rs786204999	NC_000014.9:28768526:C:G
NM_005249.5(FOXG1):c.1200C>A (p.Tyr400Ter)	FOXG1	Y400*	not provided	Pathogenic(Last reviewed: Jun 12, 2013)	no assertion criteria provided	VCV000189608	14	29237685	14	28768479	189608	187414	rs138747073	NC_000014.9:28768478:C:A
NM_005249.5(FOXG1):c.765G>T (p.Trp255Cys)	FOXG1	W255C	Rett syndrome, congenital variant	Pathogenic(Last reviewed: May 4, 2015)	criteria provided, single submitter	VCV000158601	14	29237250	14	28768044	158601	169060	rs121913678	NC_000014.9:28768043:G:T
NM_005249.5(FOXG1):c.762C>G (p.Tyr254Ter)	FOXG1	Y254*	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158600	14	29237247	14	28768041	158600	169059	rs587783642	NC_000014.9:28768040:C:G
NM_005249.5(FOXG1):c.170_179del (p.His57fs)	FOXG1	H57fs	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Feb 10, 2014)	criteria provided, single submitter	VCV000158589	14	29236653 - 29236662	14	28767447 - 28767456	158589	169048	rs587783631	NC_000014.9:28767446:CCACCCGCCGCC:CC
NM_005249.5(FOXG1):c.135_136dup (p.Gln46fs)	FOXG1		Rett syndrome, congenital variant	Pathogenic(Last reviewed: May 6, 2014)	criteria provided, single submitter	VCV000158587	14	29236616 - 29236617	14	28767410 - 28767411	158587	169046	rs587783629	NC_000014.9:28767410:CCCCC:CCCCCCC
GRCh38/hg38 17p13.3(chr17:2592886-2609006)x1	PAFAH1B1		See cases	Pathogenic(Last reviewed: Dec 2, 2011)	no assertion criteria provided	VCV000148924	17	2496180 - 2512300	17	2592886 - 2609006	148924	158675		
FOXG1, 1-BP DUP, 460G	FOXG1		Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000029815					29815	38770		
FOXG1, 1-BP DEL, 969C	FOXG1		Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000013868					13868	28907		
NM_000430.4(PAFAH1B1):c.722G>C (p.Arg241Pro)	PAFAH1B1	R241P	Subcortical band heterotopia	Pathogenic(Last reviewed: Oct 28, 2003)	no assertion criteria provided	VCV000008080	17	2577404	17	2674110	8080	23119	rs121434488	NC_000017.11:2674109:G:C
NM_005249.5(FOXG1):c.762C>A (p.Tyr254Ter)	FOXG1	Y254*	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000651666	14	29237247	14	28768041	651666	642347		NC_000014.9:28768040:C:A
NM_000430.4(PAFAH1B1):c.177del (p.Arg60fs)	PAFAH1B1	R60fs	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: May 14, 2018)	no assertion criteria provided	VCV000559651	17	2569368	17	2666074	559651	550371	rs1555526309	NC_000017.11:2666073:TT:T
NM_000430.4(PAFAH1B1):c.568+1G>A	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	VCV000436137	17	2573626	17	2670332	436137	429955	rs1555526733	NC_000017.11:2670331:G:A
NM_000430.4(PAFAH1B1):c.514dup (p.Met172fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Sep 11, 2015)	criteria provided, single submitter	VCV000436136	17	2573570 - 2573571	17	2670276 - 2670277	436136	429954	rs1555526718	NC_000017.11:2670276:A:AA
t(9;14)(q22.31;q12)	FOXG1		Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000426096	14	29738715 - 29739465			426096	414700		
NM_000430.4(PAFAH1B1):c.933dup (p.Leu312fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211836	17	2579830 - 2579831	17	2676536 - 2676537	211836	208387	rs797045872	NC_000017.11:2676536:G:GG
NM_000430.4(PAFAH1B1):c.911del (p.Ser304fs)	PAFAH1B1	S304fs	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: May 22, 2013)	criteria provided, single submitter	VCV000211835	17	2579809	17	2676515	211835	208386	rs797045871	NC_000017.11:2676514:G:
NM_000430.4(PAFAH1B1):c.829dup (p.His277fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211834	17	2577510 - 2577511	17	2674216 - 2674217	211834	208385	rs797045870	NC_000017.11:2674216:C:CC
NM_000430.4(PAFAH1B1):c.771_772TG[1] (p.Val258fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211833	17	2577453 - 2577454	17	2674159 - 2674160	211833	208384	rs797045869	NC_000017.11:2674158:TGTG:TG
NM_000430.4(PAFAH1B1):c.770_772delinsTGACCCA (p.Thr257fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Dec 18, 2014)	criteria provided, single submitter	VCV000211832	17	2577452 - 2577454	17	2674158 - 2674160	211832	208383	rs797045868	NC_000017.11:2674157:CTG:TGACCCA
NM_000430.4(PAFAH1B1):c.728_732dup (p.Asp245fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211831	17	2577406 - 2577407	17	2674112 - 2674113	211831	208382	rs797045867	NC_000017.11:2674112:CAAATCAA:CAAATCAAATCAA
NM_000430.4(PAFAH1B1):c.71_72dup (p.Glu25fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211830	17	2568702 - 2568703	17	2665408 - 2665409	211830	208372	rs797045866	NC_000017.11:2665408:TAT:TATAT
NM_000430.4(PAFAH1B1):c.667dup (p.Thr223fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211828	17	2576044 - 2576045	17	2672750 - 2672751	211828	208380	rs797045864	NC_000017.11:2672750:AAA:AAAA
NM_000430.4(PAFAH1B1):c.537dup (p.Gln180fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211826	17	2573590 - 2573591	17	2670296 - 2670297	211826	208378	rs587784271	NC_000017.11:2670296:TTTT:TTTTT
NM_000430.4(PAFAH1B1):c.347dup (p.His117fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: May 1, 2013)	criteria provided, single submitter	VCV000211823	17	2570436 - 2570437	17	2667142 - 2667143	211823	208375	rs797045859	NC_000017.11:2667142:TTTT:TTTTT
NM_000430.4(PAFAH1B1):c.288_289dup (p.Arg97fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211821	17	2570378 - 2570379	17	2667084 - 2667085	211821	208374	rs797045858	NC_000017.11:2667084:CCCC:CCCCCC
NM_000430.4(PAFAH1B1):c.190_192+5dup	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211820	17	2569381 - 2569382	17	2666087 - 2666088	211820	208373	rs797045857	NC_000017.11:2666087:AAGGTAAC:AAGGTAACAAGGTAAC
NM_000430.4(PAFAH1B1):c.1018dup (p.Trp340fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211818	17	2583472 - 2583473	17	2680178 - 2680179	211818	208389	rs797045855	NC_000017.11:2680178:T:TT
NM_000430.4(PAFAH1B1):c.1003-30_1032del	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211817	17	2583426 - 2583485	17	2680132 - 2680191	211817	208388	rs1555527743	
NM_000430.4(PAFAH1B1):c.910del (p.Ser304fs)	PAFAH1B1	S304fs	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: May 22, 2013)	criteria provided, single submitter	VCV000159551	17	2579802	17	2676508	159551	169379	rs587784292	NC_000017.11:2676507:AAAAAAA:AAAAAA
NM_000430.4(PAFAH1B1):c.900+1G>A	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159549	17	2577583	17	2674289	159549	169378	rs587784290	NC_000017.11:2674288:G:A
NM_000430.4(PAFAH1B1):c.851G>A (p.Trp284Ter)	PAFAH1B1	W284*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159548	17	2577533	17	2674239	159548	169376	rs587784289	NC_000017.11:2674238:G:A
NM_000430.4(PAFAH1B1):c.84T>G (p.Tyr28Ter)	PAFAH1B1	Y28*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159547	17	2568717	17	2665423	159547	169337	rs369259961	NC_000017.11:2665422:T:G
NM_000430.4(PAFAH1B1):c.841T>C (p.Cys281Arg)	PAFAH1B1	C281R	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159546	17	2577523	17	2674229	159546	169375	rs587784288	NC_000017.11:2674228:T:C
NM_000430.4(PAFAH1B1):c.730C>T (p.Gln244Ter)	PAFAH1B1	Q244*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159544	17	2577412	17	2674118	159544	169373	rs587784286	NC_000017.11:2674117:C:T
NM_000430.4(PAFAH1B1):c.72T>G (p.Tyr24Ter)	PAFAH1B1	Y24*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159543	17	2568705	17	2665411	159543	169336	rs587784285	NC_000017.11:2665410:T:G
NM_000430.4(PAFAH1B1):c.675C>G (p.Tyr225Ter)	PAFAH1B1	Y225*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159539	17	2577357	17	2674063	159539	169369	rs587784282	NC_000017.11:2674062:C:G
NM_000430.4(PAFAH1B1):c.671G>A (p.Gly224Asp)	PAFAH1B1	G224D	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159538	17	2576051	17	2672757	159538	169366	rs587784281	NC_000017.11:2672756:G:A
NM_000430.4(PAFAH1B1):c.664C>T (p.Gln222Ter)	PAFAH1B1	Q222*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159535	17	2576044	17	2672750	159535	169365	rs587784278	NC_000017.11:2672749:C:T
NM_000430.4(PAFAH1B1):c.658del (p.Glu220fs)	PAFAH1B1	E220fs	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159534	17	2576036	17	2672742	159534	169364	rs587784277	NC_000017.11:2672741:GGG:GG
NM_000430.4(PAFAH1B1):c.657G>A (p.Trp219Ter)	PAFAH1B1	W219*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159533	17	2576037	17	2672743	159533	169363	rs587784276	NC_000017.11:2672742:G:A
NM_000430.4(PAFAH1B1):c.645_646TA[1] (p.Ile216fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159532	17	2576025 - 2576026	17	2672731 - 2672732	159532	169362	rs587784275	NC_000017.11:2672730:TATA:TA
NM_000430.4(PAFAH1B1):c.644_651del (p.Thr215fs)	PAFAH1B1	T215fs	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159531	17	2576018 - 2576025	17	2672724 - 2672731	159531	169361	rs587784274	NC_000017.11:2672723:ATAAAACTATAAAA:ATAAAA
NM_000430.4(PAFAH1B1):c.632C>G (p.Ser211Ter)	PAFAH1B1	S211*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159530	17	2576012	17	2672718	159530	169360	rs587784273	NC_000017.11:2672717:C:G
NM_000430.4(PAFAH1B1):c.56T>G (p.Leu19Arg)	PAFAH1B1	L19R	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159529	17	2568689	17	2665395	159529	169335	rs587784272	NC_000017.11:2665394:T:G
NM_000430.4(PAFAH1B1):c.537del (p.Gln180fs)	PAFAH1B1	Q180fs	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159527	17	2573591	17	2670297	159527	169358	rs587784271	NC_000017.11:2670296:TTTT:TTT
NM_000430.4(PAFAH1B1):c.524_528del (p.Lys175fs)	PAFAH1B1	K175fs	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159526	17	2573579 - 2573583	17	2670285 - 2670289	159526	169357	rs587784270	NC_000017.11:2670284:TAAACTA:TA
NM_000430.4(PAFAH1B1):c.460C>T (p.Gln154Ter)	PAFAH1B1	Q154*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159524	17	2573517	17	2670223	159524	169355	rs587784269	NC_000017.11:2670222:C:T
NM_000430.4(PAFAH1B1):c.453_454CT[1] (p.Ser152fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159523	17	2573510 - 2573511	17	2670216 - 2670217	159523	169354	rs587784268	NC_000017.11:2670215:CTCT:CT
NM_000430.4(PAFAH1B1):c.405G>A (p.Trp135Ter)	PAFAH1B1	W135*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159521	17	2573462	17	2670168	159521	169352	rs587784266	NC_000017.11:2670167:G:A
NM_000430.4(PAFAH1B1):c.3G>A (p.Met1Ile)	PAFAH1B1	M1I	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159520	17	2541585	17	2638291	159520	169332	rs587784265	NC_000017.11:2638290:G:A
NM_000430.4(PAFAH1B1):c.399+1G>A	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159519	17	2570493	17	2667199	159519	169351	rs587784264	NC_000017.11:2667198:G:A
NM_000430.4(PAFAH1B1):c.386A>T (p.Asp129Val)	PAFAH1B1	D129V	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159517	17	2570479	17	2667185	159517	169349	rs587784263	NC_000017.11:2667184:A:T
NM_000430.4(PAFAH1B1):c.37C>T (p.Arg13Ter)	PAFAH1B1	R13*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159516	17	2568670	17	2665376	159516	169334	rs587784262	NC_000017.11:2665375:C:T
NM_000430.4(PAFAH1B1):c.371T>A (p.Val124Asp)	PAFAH1B1	V124D	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159515	17	2570464	17	2667170	159515	169348	rs587784261	NC_000017.11:2667169:T:A
NM_000430.4(PAFAH1B1):c.33-3C>T	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159514	17	2568663	17	2665369	159514	169333	rs587784260	NC_000017.11:2665368:C:T
NM_000430.4(PAFAH1B1):c.192G>C (p.Lys64Asn)	PAFAH1B1	K64N	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159511	17	2569384	17	2666090	159511	169342	rs587784257	NC_000017.11:2666089:G:C
NM_000430.4(PAFAH1B1):c.192+1G>T	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159510	17	2569385	17	2666091	159510	169344	rs587784256	NC_000017.11:2666090:G:T
NM_000430.4(PAFAH1B1):c.192+1G>A	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159509	17	2569385	17	2666091	159509	169343	rs587784256	NC_000017.11:2666090:G:A
NM_000430.4(PAFAH1B1):c.163T>A (p.Trp55Arg)	PAFAH1B1	W55R	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159507	17	2569355	17	2666061	159507	169341	rs587784254	NC_000017.11:2666060:T:A
NM_000430.4(PAFAH1B1):c.152del (p.Leu51fs)	PAFAH1B1	L51fs	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159506	17	2569341	17	2666047	159506	169340	rs587784253	NC_000017.11:2666046:TTTT:TTT
NM_000430.4(PAFAH1B1):c.136_137del (p.Lys46fs)	PAFAH1B1	K46fs	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159505	17	2569325 - 2569326	17	2666031 - 2666032	159505	169339	rs587784252	NC_000017.11:2666030:AAAAA:AAA
NM_000430.4(PAFAH1B1):c.1233A>C (p.Ter411Cys)	PAFAH1B1	*411C	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159504	17	2585096	17	2681802	159504	169399	rs587784251	NC_000017.11:2681801:A:C
NM_000430.4(PAFAH1B1):c.1201G>C (p.Asp401His)	PAFAH1B1	D401H	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159502	17	2585064	17	2681770	159502	169398	rs587784249	NC_000017.11:2681769:G:C
NM_000430.4(PAFAH1B1):c.1196G>C (p.Ser399Thr)	PAFAH1B1	S399T	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159501	17	2585059	17	2681765	159501	169397	rs587784248	NC_000017.11:2681764:G:C
NM_000430.4(PAFAH1B1):c.1165C>T (p.His389Tyr)	PAFAH1B1	H389Y	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159498	17	2585028	17	2681734	159498	169394	rs587784245	NC_000017.11:2681733:C:T
NM_000430.4(PAFAH1B1):c.1159G>T (p.Asp387Tyr)	PAFAH1B1	D387Y	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159497	17	2583614	17	2680320	159497	169392	rs587784244	NC_000017.11:2680319:G:T
NM_000430.4(PAFAH1B1):c.1159+2T>A	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159496	17	2583616	17	2680322	159496	169393	rs587784243	NC_000017.11:2680321:T:A
NM_000430.4(PAFAH1B1):c.1135C>T (p.His379Tyr)	PAFAH1B1	H379Y	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159495	17	2583590	17	2680296	159495	169391	rs587784242	NC_000017.11:2680295:C:T
NM_000430.4(PAFAH1B1):c.1111C>T (p.Arg371Ter)	PAFAH1B1	R371*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159494	17	2583566	17	2680272	159494	169390	rs587784241	NC_000017.11:2680271:C:T
NM_000430.4(PAFAH1B1):c.1100del (p.Tyr367fs)	PAFAH1B1	Y367fs	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159493	17	2583555	17	2680261	159493	169389	rs587784240	NC_000017.11:2680260:A:
NM_000430.4(PAFAH1B1):c.1064G>A (p.Ser355Asn)	PAFAH1B1	S355N	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159492	17	2583519	17	2680225	159492	169388	rs587784239	NC_000017.11:2680224:G:A
NM_000430.4(PAFAH1B1):c.1063del (p.Ser355fs)	PAFAH1B1	S355fs	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159491	17	2583518	17	2680224	159491	169387	rs587784238	NC_000017.11:2680223:A:
NM_000430.4(PAFAH1B1):c.1024_1031del (p.Arg342fs)	PAFAH1B1	R342fs	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159490	17	2583479 - 2583486	17	2680185 - 2680192	159490	169386	rs587784237	NC_000017.11:2680184:CGTGGAGT:
NM_000430.4(PAFAH1B1):c.1009C>T (p.His337Tyr)	PAFAH1B1	H337Y	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159489	17	2583464	17	2680170	159489	169385	rs587784236	NC_000017.11:2680169:C:T
NM_000430.4(PAFAH1B1):c.1002+5G>A	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159486	17	2579905	17	2676611	159486	169383	rs587784235	NC_000017.11:2676610:G:A
NM_005249.5(FOXG1):c.924G>A (p.Trp308Ter)	FOXG1	W308*	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jul 13, 2010)	no assertion criteria provided	VCV000013871	14	29237409	14	28768203	13871	28910	rs267606827	NC_000014.9:28768202:G:A
NM_005249.5(FOXG1):c.643T>C (p.Phe215Leu)	FOXG1	F215L	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jul 13, 2010)	no assertion criteria provided	VCV000013870	14	29237128	14	28767922	13870	28909	rs267606828	NC_000014.9:28767921:T:C
NM_005249.5(FOXG1):c.765G>A (p.Trp255Ter)	FOXG1	W255*	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Mar 4, 2009)	no assertion criteria provided	VCV000013867	14	29237250	14	28768044	13867	28906	rs121913678	NC_000014.9:28768043:G:A
NM_000430.4(PAFAH1B1):c.830A>C (p.His277Pro)	PAFAH1B1	H277P	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Mar 9, 2004)	no assertion criteria provided	VCV000008082	17	2577512	17	2674218	8082	23121	rs121434490	NC_000017.11:2674217:A:C
NM_000430.4(PAFAH1B1):c.92T>C (p.Phe31Ser)	PAFAH1B1	F31S	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Aug 14, 2001)	no assertion criteria provided	VCV000008078	17	2568725	17	2665431	8078	23117	rs121434486	NC_000017.11:2665430:T:C
NM_000430.4(PAFAH1B1):c.949G>C (p.Asp317His)	PAFAH1B1	D317H	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Aug 14, 2001)	no assertion criteria provided	VCV000008077	17	2579847	17	2676553	8077	23116	rs121434485	NC_000017.11:2676552:G:C
NM_000430.4(PAFAH1B1):c.505T>C (p.Ser169Pro)	PAFAH1B1	S169P	Subcortical band heterotopia	Pathogenic(Last reviewed: Aug 14, 2001)	no assertion criteria provided	VCV000008076	17	2573562	17	2670268	8076	23115	rs121434484	NC_000017.11:2670267:T:C
NM_000430.4(PAFAH1B1):c.991_1002+10del	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000008075	17	2579886 - 2579907	17	2676592 - 2676613	8075	23114	rs1567561137	NC_000017.11:2676591:TGCCTTATGACCCTCGTAAGTTTGC:TGC
NM_005249.5(FOXG1):c.738C>G (p.Tyr246Ter)	FOXG1	Y246*	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000852116	14	29237223	14	28768017	852116	841357		NC_000014.9:28768016:C:G
NM_005249.5(FOXG1):c.1014dup (p.Met339fs)	FOXG1		Rett syndrome, congenital variant	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000836883	14	29237495 - 29237496	14	28768289 - 28768290	836883	841359		NC_000014.9:28768289:CCCC:CCCCC
NM_005249.5(FOXG1):c.301C>T (p.Gln101Ter)	FOXG1	Q101*	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000834510	14	29236786	14	28767580	834510	841355		NC_000014.9:28767579:C:T
NM_005249.5(FOXG1):c.407_458del (p.Glu136fs)	FOXG1	E136fs	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000579194	14	29236884 - 29236935	14	28767678 - 28767729	579194	568018	rs1566445169	
NM_000430.4(PAFAH1B1):c.852G>A (p.Trp284Ter)	PAFAH1B1	W284*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561072	17	2577534	17	2674240	561072	552200	rs1567559851	NC_000017.11:2674239:G:A
NM_005249.5(FOXG1):c.946del (p.Leu316fs)	FOXG1	L316fs	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000538818	14	29237429	14	28768223	538818	528486	rs1555321380	NC_000014.9:28768222:CCC:CC
NM_005249.5(FOXG1):c.505_506delinsT (p.Gly169fs)	FOXG1		Rett syndrome, congenital variant	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000189614	14	29236990 - 29236991	14	28767784 - 28767785	189614	187403	rs786205003	NC_000014.9:28767783:GG:T
NM_000430.4(PAFAH1B1):c.716dup (p.Met239fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Dec 31, 2013)	criteria provided, single submitter	VCV000159542	17	2577397 - 2577398	17	2674103 - 2674104	159542	169372	rs587784284	NC_000017.11:2674103:T:TT
NM_000430.4(PAFAH1B1):c.305dup (p.Tyr102Ter)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	VCV000159513	17	2570397 - 2570398	17	2667103 - 2667104	159513	169347	rs587784259	NC_000017.11:2667103:A:AA
NM_005249.5(FOXG1):c.799G>A (p.Gly267Ser)	FOXG1	G267S	not provided|Rett syndrome, congenital variant	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158602	14	29237284	14	28768078	158602	169061	rs587783643	NC_000014.9:28768077:G:A
NM_005249.5(FOXG1):c.757A>G (p.Asn253Asp)	FOXG1	N253D	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158599	14	29237242	14	28768036	158599	169058	rs587783641	NC_000014.9:28768035:A:G
NM_005249.5(FOXG1):c.298del (p.Gln100fs)	FOXG1	Q100fs	not provided|Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158594	14	29236779	14	28767573	158594	169053	rs587783636	NC_000014.9:28767572:CCCCC:CCCC
NM_005249.5(FOXG1):c.263_278del (p.Arg88fs)	FOXG1	R88fs	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158593	14	29236745 - 29236760	14	28767539 - 28767554	158593	169052	rs587783635	NC_000014.9:28767538:CGCGGGGCGCCCCGGCCGC:CGC
NM_000430.4(PAFAH1B1):c.1050dup (p.Lys351fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000021177	17	2583499 - 2583500	17	2680205 - 2680206	21177	34029	rs113994200	NC_000017.11:2680205:GGGGGG:GGGGGGG
NM_005249.5(FOXG1):c.1200C>G (p.Tyr400Ter)	FOXG1	W400*, Y400*	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jul 13, 2010)	no assertion criteria provided	VCV000013872	14	29237685	14	28768479	13872	28911	rs138747073	NC_000014.9:28768478:C:G
NM_000430.4(PAFAH1B1):c.446A>G (p.His149Arg)	PAFAH1B1	H149R	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Aug 14, 2001)	no assertion criteria provided	VCV000008073	17	2573503	17	2670209	8073	23112	rs121434482	NC_000017.11:2670208:A:G
NM_000192.3(TBX5):c.587C>A (p.Ser196Ter)	TBX5	S196*, S146*	Aortic valve disease 2|not provided|Holt-Oram syndrome	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000279906	12	114832622	12	114394817	279906	264579	rs886041247	NC_000012.12:114394816:G:T
NM_000192.3(TBX5):c.835C>T (p.Arg279Ter)	TBX5	R279*, R229*	Aortic valve disease 2|Holt-Oram syndrome|not provided	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000213832	12	114804117	12	114366312	213832	210203	rs863223788	NC_000012.12:114366311:G:A
NC_000014.9:g.(?_28767260)_(28768769_?)del	FOXG1		Rett syndrome, congenital variant	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000830776	14	29236466 - 29237975			830776	820618		
NM_005249.5(FOXG1):c.624C>A (p.Tyr208Ter)	FOXG1	Y208*	Stereotypy|Global developmental delay|Strabismus|Muscular hypotonia of the trunk|Abnormality of the optic nerve|Rett syndrome, congenital variant	Pathogenic(Last reviewed: Aug 5, 2016)	criteria provided, single submitter	VCV000453289	14	29237109	14	28767903	453289	446889	rs267606826	NC_000014.9:28767902:C:A
NM_005249.5(FOXG1):c.177_186dup (p.Pro63fs)	FOXG1		Rett syndrome, congenital variant|not provided	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000451937	14	29236655 - 29236656	14	28767449 - 28767450	451937	445223	rs1555321206	NC_000014.9:28767449:CCCGCCGCCGCCCGCC:CCCGCCGCCGCCCGCCGCCGCCCGCC
NM_000430.4(PAFAH1B1):c.1159+1G>A	PAFAH1B1		Lissencephaly due to LIS1 mutation|not provided	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, multiple submitters, no conflicts	VCV000379162	17	2583615	17	2680321	379162	374902	rs1057520515	NC_000017.11:2680320:G:A
NM_000430.4(PAFAH1B1):c.441dup (p.Gly148fs)	PAFAH1B1		Lissencephaly due to LIS1 mutation|not provided	Pathogenic(Last reviewed: Aug 11, 2015)	criteria provided, multiple submitters, no conflicts	VCV000211825	17	2573495 - 2573496	17	2670201 - 2670202	211825	208377	rs797045861	NC_000017.11:2670201:AAA:AAAA
NM_000430.4(PAFAH1B1):c.523A>T (p.Lys175Ter)	PAFAH1B1	K175*	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: May 16, 2013)	criteria provided, single submitter	VCV000209180	17	2573580	17	2670286	209180	205783	rs797045061	NC_000017.11:2670285:A:T
NM_000430.4(PAFAH1B1):c.430C>T (p.Arg144Ter)	PAFAH1B1	R144*	Lissencephaly due to LIS1 mutation|not provided	Pathogenic(Last reviewed: Oct 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159522	17	2573487	17	2670193	159522	169353	rs587784267	NC_000017.11:2670192:C:T
NM_000430.4(PAFAH1B1):c.265C>T (p.Arg89Ter)	PAFAH1B1	R89*	Lissencephaly due to LIS1 mutation|not provided	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000159512	17	2570358	17	2667064	159512	169346	rs587784258	NC_000017.11:2667063:C:T
NM_004119.2(FLT3):c.2505T>A (p.Asp835Glu)	FLT3	D835E	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375972	13	28592640	13	28018503	375972	362851	rs121913487	NC_000013.11:28018502:A:T
NM_021939.3(FKBP10):c.1343_1344delTG	FKBP10		Inborn genetic diseases	Pathogenic(Last reviewed: Dec 31, 2014)	criteria provided, single submitter	VCV000208646	17	39977279 - 39977280	17	41821027 - 41821028	208646	205304	rs797044852	NC_000017.11:41821026:TGTGTGTG:TGTGTG
NM_001126108.2(SLC12A3):c.1126del (p.Leu376fs)	SLC12A3	L375fs, L376fs	not provided	Pathogenic(Last reviewed: Jul 6, 2015)	criteria provided, single submitter	VCV000419448	16	56912017	16	56878105	419448	409655	rs1064793879	NC_000016.10:56878104:CCC:CC
NM_000339.3(SLC12A3):c.1743del (p.Met581fs)	SLC12A3	M580fs, M581fs	not provided	Pathogenic(Last reviewed: Mar 29, 2016)	criteria provided, single submitter	VCV000280024	16	56918034	16	56884122	280024	264955	rs754220610	NC_000016.10:56884121:G:
NM_001126108.2(SLC12A3):c.54_55GC[3] (p.Phe20fs)	SLC12A3		not provided	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000851316	16	56899200 - 56899201	16	56865288 - 56865289	851316	844023		NC_000016.10:56865288:GCGC:GCGCGC
NM_001126108.2(SLC12A3):c.1314C>G (p.Tyr438Ter)	SLC12A3	Y437*, Y438*	not provided	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, single submitter	VCV000834760	16	56913118	16	56879206	834760	844025		NC_000016.10:56879205:C:G
NC_000016.10:g.(?_56885255)_(56887103_?)del	SLC12A3		not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000830384	16	56919167 - 56921015			830384	820840		
NM_000339.3(SLC12A3):c.438C>A (p.Cys146Ter)	SLC12A3	C145*, C146*	not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000652156	16	56902217	16	56868305	652156	644769		NC_000016.10:56868304:C:A
NM_000339.3(SLC12A3):c.1188C>A (p.Cys396Ter)	SLC12A3	C396*, C395*	not provided	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000646369	16	56912992	16	56879080	646369	644773		NC_000016.10:56879079:C:A
NM_001126108.2(SLC12A3):c.2576del (p.Cys859fs)	SLC12A3	C867fs, C868fs, C859fs	Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522467	16	56928497	16	56894585	522467	513134	rs1555501632	NC_000016.10:56894584:G:
NM_000339.3(SLC12A3):c.73del (p.Leu25fs)	SLC12A3	L25fs	not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000448399	16	56899220	16	56865308	448399	441906	rs1555499123	NC_000016.10:56865307:C:
NM_001126108.2(SLC12A3):c.1489A>T (p.Lys497Ter)	SLC12A3	K496*, K497*	not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000852297	16	56914087	16	56880175	852297	844026		NC_000016.10:56880174:A:T
NM_001126108.2(SLC12A3):c.237_238dup (p.Arg80fs)	SLC12A3		not provided	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000653276	16	56899381 - 56899382	16	56865469 - 56865470	653276	644767		NC_000016.10:56865469:CCCC:CCCCCC
NC_000016.9:g.(?_56903631)_(56904658_?)del	SLC12A3		not provided	Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV000644830	16	56903631 - 56904658	16	56869719 - 56870746	644830	653138		
NM_001126108.2(SLC12A3):c.2533del (p.Leu845fs)	SLC12A3	L853fs, L845fs, L854fs	not provided	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000586604	16	56928453	16	56894541	586604	577556	rs754378340	NC_000016.10:56894540:CC:C
NM_001126108.2(SLC12A3):c.1276A>T (p.Asn426Tyr)	SLC12A3	N426Y, N425Y	Familial hypokalemia-hypomagnesemia	Pathogenic	no assertion criteria provided	VCV000403666	16	56913080	16	56879168	403666	390646	rs200817545	NC_000016.10:56879167:A:T
NM_001126108.2(SLC12A3):c.1924C>G (p.Arg642Gly)	SLC12A3	R642G, R641G	Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Dec 15, 2014)	criteria provided, single submitter	VCV000397523	16	56919275	16	56885363	397523	384423	rs200697179	NC_000016.10:56885362:C:G
NM_001126108.2(SLC12A3):c.1338del (p.Thr446_Met447insTer)	SLC12A3		Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000279587	16	56913455	16	56879543	279587	263861	rs886041108	NC_000016.10:56879542:CC:C
SLC12A3, 2-BP DEL, 2881AG	SLC12A3		Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Sep 26, 2006)	no assertion criteria provided	VCV000008597					8597	23636		
NM_001126108.2(SLC12A3):c.1868T>C (p.Leu623Pro)	SLC12A3	L623P, L622P	Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000008595	16	56919219	16	56885307	8595	23634	rs121909385	NC_000016.10:56885306:T:C
NM_001126108.2(SLC12A3):c.1889G>T (p.Gly630Val)	SLC12A3	G630V, G629V	Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000008594	16	56919240	16	56885328	8594	23633	rs121909384	NC_000016.10:56885327:G:T
SLC12A3, 3-BP DEL	SLC12A3		Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000008593					8593	23632		
NM_001126108.2(SLC12A3):c.2720+1G>T	SLC12A3		Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000008590	16	56933529	16	56899617	8590	23629		NC_000016.10:56899616:G:T
NM_001126108.2(SLC12A3):c.1964G>T (p.Arg655Leu)	SLC12A3	R653L, R655L, R654L	Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000008589	16	56920314	16	56886402	8589	23628	rs121909380	NC_000016.10:56886401:G:T
NM_001126108.2(SLC12A3):c.625C>T (p.Arg209Trp)	SLC12A3	R209W, R208W	Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000008586	16	56904031	16	56870119	8586	23625	rs28936388	NC_000016.10:56870118:C:T
NM_001126108.2(SLC12A3):c.1261T>C (p.Cys421Arg)	SLC12A3	C421R, C420R	Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000008585	16	56913065	16	56879153	8585	23624	rs28936387	NC_000016.10:56879152:T:C
NC_000016.10:g.(?_56913254)_(56913415_?)del	SLC12A3		not provided	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000831295	16	56947166 - 56947327			831295	820842		
NM_001126108.2(SLC12A3):c.1670-191C>T	SLC12A3		not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000665361	16	56917770	16	56883858	665361	652576		NC_000016.10:56883857:C:T
NM_001126108.2(SLC12A3):c.976del (p.Val326fs)	SLC12A3	V325fs, V326fs	not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000651227	16	56906579	16	56872667	651227	644772		NC_000016.10:56872666:G:
NM_001126108.2(SLC12A3):c.3026G>A (p.Arg1009Gln)	SLC12A3	R1018Q, R1017Q, R1009Q	not provided	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000594235	16	56947277	16	56913365	594235	585298	rs370175770	NC_000016.10:56913364:G:A
NM_005249.5(FOXG1):c.1023C>G (p.Tyr341Ter)	FOXG1	Y341*	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000573079	14	29237508	14	28768302	573079	572775	rs764343290	NC_000014.9:28768301:C:G
NM_000430.4(PAFAH1B1):c.1050del (p.Lys351fs)	PAFAH1B1	K351fs	not provided|Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, multiple submitters, no conflicts	VCV000021176	17	2583500	17	2680206	21176	34028	rs113994200	NC_000017.11:2680205:GGGGGG:GGGGG
NM_000430.4(PAFAH1B1):c.1002+1G>A	PAFAH1B1		Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	VCV000021175	17	2579901	17	2676607	21175	34027	rs113994203	NC_000017.11:2676606:G:A
NM_005249.5(FOXG1):c.624C>G (p.Tyr208Ter)	FOXG1	Y208*	Rett syndrome, congenital variant|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000013869	14	29237109	14	28767903	13869	28908	rs267606826	NC_000014.9:28767902:C:G
NM_001126108.2(SLC12A3):c.2907del (p.Asp969fs)	SLC12A3	D969fs, D977fs, D978fs	not provided	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000863343	16	56938357	16	56904445	863343	844030		NC_000016.10:56904444:C:
NM_001126108.2(SLC12A3):c.2029G>A (p.Val677Met)	SLC12A3	V677M, V676M	not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000860860	16	56920379	16	56886467	860860	844028		NC_000016.10:56886466:G:A
NM_001126108.2(SLC12A3):c.3025C>T (p.Arg1009Ter)	SLC12A3	R1009*, R1017*, R1018*	not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000835523	16	56947276	16	56913364	835523	844031		NC_000016.10:56913363:C:T
NM_001126108.2(SLC12A3):c.283del (p.Gln95fs)	SLC12A3	Q95fs	not provided|Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448955	16	56900982	16	56867070	448955	442544	rs1555499234	NC_000016.10:56867069:C:
NM_004863.3(SPTLC2):c.1151C>T (p.Ser384Phe)	SPTLC2	S384F	Hereditary sensory and autonomic neuropathy type IC|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000637418	14	78021668	14	77555325	637418	625308		NC_000014.9:77555324:G:A
HBA1, 33-BP DEL	HBA1		Alpha plus thalassemia	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000015880					15880	30919		
HBA1, 21-BP INS-DUP	HBA1		Alpha plus thalassemia	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000015879					15879	30918		
NM_001126108.2(SLC12A3):c.1180+2T>C	SLC12A3		not provided	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000842688	16	56912075	16	56878163	842688	852669		NC_000016.10:56878162:T:C
NM_001126108.2(SLC12A3):c.539C>A (p.Thr180Lys)	SLC12A3	T179K, T180K	not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000648571	16	56903674	16	56869762	648571	644771		NC_000016.10:56869761:C:A
NM_001126108.2(SLC12A3):c.473G>A (p.Arg158Gln)	SLC12A3	R157Q, R158Q	not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000647629	16	56902252	16	56868340	647629	644770		NC_000016.10:56868339:G:A
NM_001126108.2(SLC12A3):c.1664C>T (p.Ser555Leu)	SLC12A3	S555L, S554L	not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000642947	16	56916404	16	56882492	642947	644775		NC_000016.10:56882491:C:T
NM_001126108.2(SLC12A3):c.2089_2095del (p.Thr697fs)	SLC12A3	T697fs, T696fs	not provided	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448392	16	56920916 - 56920922	16	56887004 - 56887010	448392	441912	rs771701344	NC_000016.10:56887003:ACCAAGT:
HBA1, 1-BP DEL, 354C	HBA1		alpha Thalassemia	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000015892					15892	30931		
NM_005249.5(FOXG1):c.460del (p.Glu154fs)	FOXG1	E154fs	not provided|Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372563	14	29236939	14	28767733	372563	360091	rs398124204	NC_000014.9:28767732:GGGGGGG:GGGGGG
NM_005249.5(FOXG1):c.730C>T (p.Arg244Cys)	FOXG1	R244C	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000189620	14	29237215	14	28768009	189620	187411	rs786205009	NC_000014.9:28768008:C:T
NM_005249.5(FOXG1):c.256C>T (p.Gln86Ter)	FOXG1	Q86*	not provided|Rett syndrome, congenital variant	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189611	14	29236741	14	28767535	189611	187400	rs398124202	NC_000014.9:28767534:C:T
NM_000430.4(PAFAH1B1):c.22C>T (p.Arg8Ter)	PAFAH1B1	R8*	Lissencephaly due to LIS1 mutation|Subcortical band heterotopia	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	VCV000008081	17	2541604	17	2638310	8081	23120	rs121434489	NC_000017.11:2638309:C:T
NM_000430.4(PAFAH1B1):c.817C>T (p.Arg273Ter)	PAFAH1B1	R273*	Lissencephaly due to LIS1 mutation|not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008074	17	2577499	17	2674205	8074	23113	rs121434483	NC_000017.11:2674204:C:T
NM_000303.3(PMM2):c.580C>T (p.Arg194Ter)	PMM2	R194*	Congenital disorder of glycosylation, type Ia	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000225443	16	8906904	16	8813047	225443	227382	rs199562225	NC_000016.10:8813046:C:T
NM_139241.3(FGD4):c.1877_1881AAAAG[4] (p.Gly631fs)	FGD4		not provided	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000451425	12	32786594 - 32786595	12	32633660 - 32633661	451425	444975	rs751035912	NC_000012.12:32633660:AAGAAAAGAAAAGAAAAG:AAGAAAAGAAAAGAAAAGAAAAG
NM_139241.3(FGD4):c.1329C>A (p.Tyr443Ter)	FGD4	Y443*, Y528*, Y555*, Y195*, Y350*, Y99*, Y259*, Y607*	not provided	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000279806	12	32764208	12	32611274	279806	264610	rs886041200	NC_000012.12:32611273:C:A
NM_139241.3(FGD4):c.1395_1396CA[1] (p.Thr466fs)	FGD4		not provided	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000265144	12	32772688 - 32772689	12	32619754 - 32619755	265144	260015	rs886039361	NC_000012.12:32619753:CACA:CA
NM_139241.3(FGD4):c.952_953del (p.Glu318fs)	FGD4	E225fs, E134fs, E318fs, E482fs, E70fs, E403fs, E430fs	not provided	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000447322	12	32755209 - 32755210	12	32602275 - 32602276	447322	441535	rs771606350	NC_000012.12:32602274:AGA:A
NM_024685.4(BBS10):c.850C>T (p.Gln284Ter)	BBS10	Q284*	Bardet-Biedl syndrome|Bardet-Biedl syndrome 10	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551120	12	76740915	12	76347135	551120	546879	rs758732081	NC_000012.12:76347134:G:A
NM_024685.4(BBS10):c.1044_1045del (p.Pro350fs)	BBS10	P350fs	Bardet-Biedl syndrome 10|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000030817	12	76740720 - 76740721	12	76346940 - 76346941	30817	39774	rs587777837	NC_000012.12:76346939:AAA:A
NM_139241.3(FGD4):c.640del (p.Leu214fs)	FGD4	L30fs, L326fs, L378fs, L214fs, L121fs, L299fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000856785	12	32751470	12	32598536	856785	839850		NC_000012.12:32598535:C:
NM_139241.3(FGD4):c.613C>T (p.Gln205Ter)	FGD4	Q205*, Q290*, Q317*, Q21*, Q369*, Q112*	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000836490	12	32751443	12	32598509	836490	839849		NC_000012.12:32598508:C:T
NM_139241.3(FGD4):c.1043del (p.Pro348fs)	FGD4	P255fs, P164fs, P4fs, P348fs, P460fs, P100fs, P433fs, P512fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000651656	12	32760939	12	32608005	651656	641069		NC_000012.12:32608004:CC:C
NM_139241.3(FGD4):c.2211dup (p.Ala738fs)	FGD4		Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Nov 30, 2018)	no assertion criteria provided	VCV000598939	12	32793376 - 32793377	12	32640442 - 32640443	598939	590026	rs1565942358	NC_000012.12:32640442:A:AA
NM_139241.3(FGD4):c.514del (p.Ala172fs)	FGD4	A257fs, A284fs, A336fs, A79fs, A172fs	Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Nov 30, 2018)	no assertion criteria provided	VCV000598938	12	32735312	12	32582378	598938	590025	rs1565869918	NC_000012.12:32582377:GGGG:GGG
NC_000012.11:g.(?_32729286)_(32772810_?)del	FGD4		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000584336	12	32729286 - 32772810	12	32576352 - 32619876	584336	565005		
NM_139241.3(FGD4):c.991del (p.Gln331fs)	FGD4	Q416fs, Q331fs, Q495fs, Q238fs, Q443fs, Q83fs, Q147fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000570318	12	32755249	12	32602315	570318	566796	rs1393673267	NC_000012.12:32602314:C:
NM_001304480.1(FGD4):c.2199_2200CA[1] (p.Thr734fs)	FGD4		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000543407	12	32786584 - 32786585	12	32633650 - 32633651	543407	527368	rs1555223595	NC_000012.12:32633649:CACA:CA
NM_139241.3(FGD4):c.1729C>T (p.Arg577Ter)	FGD4	R662*, R577*, R689*, R484*, R393*, R741*, R329*, R233*	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000408261	12	32778681	12	32625747	408261	399125	rs778377449	NC_000012.12:32625746:C:T
NM_139241.3(FGD4):c.1698G>H (p.Met566Ile)	FGD4	M222I, M651I, M382I, M473I, M318I, M566I, M730I, M678I	Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000038444	12	32778650	12	32625716	38444	47003	rs281865064	NC_000012.12:32625715:G:H
NC_000012.12:g.(?_32576256)_(32640543_?)del	FGD4		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000831946	12	32729190 - 32793477			831946	820492		
NM_139241.3(FGD4):c.1756G>T (p.Gly586Ter)	FGD4	G586*, G671*, G698*, G242*, G750*, G338*, G402*, G493*	Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001014	12	32778708	12	32625774	1014	16053	rs118203973	NC_000012.12:32625773:G:T
NM_139241.3(FGD4):c.670C>T (p.Arg224Ter)	FGD4	R224*, R309*, R336*, R40*, R131*, R388*	Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001011	12	32751500	12	32598566	1011	16050	rs118203972	NC_000012.12:32598565:C:T
NM_002470.4(MYH3):c.5605_5659-47del	MYH3		Inborn genetic diseases	Pathogenic(Last reviewed: Apr 8, 2014)	criteria provided, single submitter	VCV000208736	17	10533098 - 10533212	17	10629781 - 10629895	208736	205300	rs1555524879	
NM_001126108.2(SLC12A3):c.1387G>A (p.Gly463Arg)	SLC12A3	G463R, G462R	not provided|Familial hypokalemia-hypomagnesemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000319903	16	56913505	16	56879593	319903	325858	rs374163823	NC_000016.10:56879592:G:A
NM_000080.4(CHRNE):c.1096_1105dup (p.Pro369fs)	CHRNE		Myasthenic syndrome, congenital, 4a, slow-channel	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000853401	17	4802606 - 4802607	17	4899311 - 4899312	853401	845585		NC_000017.11:4899311:GGGGCGAGGCGG:GGGGCGAGGCGGGGCGAGGCGG
NM_000080.4(CHRNE):c.1231C>T (p.Gln411Ter)	CHRNE	Q411*	Myasthenic syndrome, congenital, 4a, slow-channel	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000835190	17	4802391	17	4899096	835190	845582		NC_000017.11:4899095:G:A
NM_000080.4(CHRNE):c.1081_1099del (p.Glu361fs)	CHRNE	E361fs	Congenital myasthenic syndrome 4C	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623392	17	4802613 - 4802631	17	4899318 - 4899336	623392	612320	rs1567636493	NC_000017.11:4899317:AGGCGGCCCGGGGGGCCTC:
NM_000080.4(CHRNE):c.1072_1091del (p.Pro358fs)	CHRNE	P358fs	Myasthenic syndrome, congenital, 4a, slow-channel	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000534252	17	4802621 - 4802640	17	4899326 - 4899345	534252	531707	rs932032926	NC_000017.11:4899325:CGGGGGGCCTCGGGCGGCGGCGGGG:CGGGG
NM_000080.3(CHRNE):c.-95G>A	CHRNE		Myasthenic syndrome, congenital, 4a, slow-channel	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000465866	17	4806453	17	4903158	465866	468162	rs990457690	NC_000017.11:4903157:C:T
NM_000080.4(CHRNE):c.1181_1187dup (p.Glu396delinsAspValTer)	CHRNE		Myasthenic syndrome, congenital, 4a, slow-channel	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000465857	17	4802524 - 4802525	17	4899229 - 4899230	465857	467870	rs1423995073	NC_000017.11:4899229:TCAAACA:TCAAACATCAAACA
NM_000080.4(CHRNE):c.1077_1098dup (p.Ser367fs)	CHRNE		Myasthenic syndrome, congenital, 4a, slow-channel	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000465853	17	4802613 - 4802614	17	4899318 - 4899319	465853	467898	rs1555546315	NC_000017.11:4899318:GGCGGCCCGGGGGGCCTCGGGCGGCGGC:GGCGGCCCGGGGGGCCTCGGGCGGCGGCCCGGGGGGCCTCGGGCGGCGGC
NM_000080.4(CHRNE):c.1090dup (p.Arg364fs)	CHRNE		Congenital myasthenic syndrome	Pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	VCV000434765	17	4802621 - 4802622	17	4899326 - 4899327	434765	429984	rs1156634884	NC_000017.11:4899326:GGGGGG:GGGGGGG
NM_000080.4(CHRNE):c.1033-1G>C	CHRNE		not provided	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000420092	17	4802680	17	4899385	420092	410057	rs755303686	NC_000017.11:4899384:C:G
NM_000080.4(CHRNE):c.1291G>C (p.Ala431Pro)	CHRNE	A411P, A431P	Myasthenic syndrome, congenital, 4b, fast-channel	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000018361	17	4802331	17	4899036	18361	33400	rs121909517	NC_000017.11:4899035:C:G
NM_000080.4(CHRNE):c.1161_1162insT (p.Lys388Ter)	CHRNE		Congenital myasthenic syndrome 4C	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000018355	17	4802550 - 4802551	17	4899255 - 4899256	18355	33394	rs886037628	NC_000017.11:4899255::A
NM_000080.4(CHRNE):c.-11-85C>T	CHRNE		Congenital myasthenic syndrome 4C	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000018353	17	4806454	17	4903159	18353	33392	rs748144899	NC_000017.11:4903158:G:A
NM_000080.4(CHRNE):c.1030del (p.His344fs)	CHRNE	H344fs	Congenital myasthenic syndrome 4C	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000018350	17	4802765	17	4899470	18350	33389	rs879253723	NC_000017.11:4899469:GG:G
NM_000080.4(CHRNE):c.1250_1268dup (p.Val424fs)	CHRNE		Myasthenic syndrome, congenital, 4a, slow-channel	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000659043	17	4802353 - 4802354	17	4899058 - 4899059	659043	646147		NC_000017.11:4899058:CAGCAGCGGACCTCGGGGGC:CAGCAGCGGACCTCGGGGGCAGCAGCGGACCTCGGGGGC
NM_000080.4(CHRNE):c.1371del (p.Cys458fs)	CHRNE	C458fs	Myasthenic syndrome, congenital, 4a, slow-channel	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000644142	17	4802142	17	4898847	644142	646145		NC_000017.11:4898846:G:
NM_000080.4(CHRNE):c.1033-2A>T	CHRNE		Congenital myasthenic syndrome 4C	Pathogenic(Last reviewed: Jul 16, 2014)	criteria provided, single submitter	VCV000189225	17	4802681	17	4899386	189225	187128	rs786204773	NC_000017.11:4899385:T:A
NM_001127701.1(SERPINA1):c.347T>A (p.Ile116Asn)	SERPINA1	I92N, I116N	Alpha-1-antitrypsin deficiency|PI NULL(LUDWIGSHAFEN)|PI Q0(LUDWIGSHAFEN)	Pathogenic, other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000017987	14	94849228	14	94382891	17987	33026	rs28931572	NC_000014.9:94382890:A:T
NM_017882.3(CLN6):c.150C>G (p.Tyr50Ter)	CLN6	Y50*	Neuronal ceroid lipofuscinosis||not provided	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068094	15	68510922	15	68218584	68094	78985	rs154774640	NC_000015.10:68218583:G:C
NM_139241.3(FGD4):c.823C>T (p.Arg275Ter)	FGD4	R275*, R360*, R387*, R182*, R27*, R91*, R439*	Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000001016	12	32754344	12	32601410	1016	16055	rs118203974	NC_000012.12:32601409:C:T
NM_000080.4(CHRNE):c.1380G>A (p.Trp460Ter)	CHRNE	W460*	Myasthenic syndrome, congenital, 4a, slow-channel	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000534250	17	4802133	17	4898838	534250	531705	rs1555546096	NC_000017.11:4898837:C:T
NM_000080.4(CHRNE):c.1093del (p.Ala365fs)	CHRNE	A365fs	Myasthenic syndrome, congenital, 4a, slow-channel|not provided	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000285864	17	4802619	17	4899324	285864	270101	rs886043239	NC_000017.11:4899323:CCC:CC
NM_021005.4(NR2F2):c.64C>T (p.Gln22Ter)	NR2F2	Q22*	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 3, 2017)	criteria provided, single submitter	VCV000521441	15	96875398	15	96332169	521441	512168	rs1555446980	NC_000015.10:96332168:C:T
NM_021005.4(NR2F2):c.1097G>C (p.Arg366Pro)	NR2F2	R233P, R366P, R213P	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000521133	15	96880703	15	96337474	521133	512170	rs1555447465	NC_000015.10:96337473:G:C
NM_000430.4(PAFAH1B1):c.162dup (p.Trp55fs)	PAFAH1B1		not provided|Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021181	17	2569346 - 2569347	17	2666052 - 2666053	21181	34033	rs113994198	NC_000017.11:2666052:AAAAAAAA:AAAAAAAAA
NM_000430.4(PAFAH1B1):c.484G>A (p.Gly162Ser)	PAFAH1B1	G162S	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000008079	17	2573541	17	2670247	8079	23118	rs121434487	NC_000017.11:2670246:G:A
PLCG2, LEU848PRO (rs114618894)	PLCG2	L848P	Autoinflammation, antibody deficiency, and immune dysregulation, plcg2-associated	Pathogenic(Last reviewed: Mar 24, 2020)	no assertion criteria provided	VCV000828054					828054	816390		
NM_002661.5(PLCG2):c.2120C>A (p.Ser707Tyr)	PLCG2	S707Y	Autoinflammation, antibody deficiency, and immune dysregulation, plcg2-associated	Pathogenic(Last reviewed: Oct 5, 2012)	no assertion criteria provided	VCV000039696	16	81953154	16	81919549	39696	48295	rs397514562	NC_000016.10:81919548:C:A
PLCG2, 4.8-KB DEL	PLCG2		Familial cold autoinflammatory syndrome 3	Pathogenic(Last reviewed: Jan 26, 2012)	no assertion criteria provided	VCV000030052					30052	39007		
PLCG2, 8.2-KB DEL	PLCG2		Familial cold autoinflammatory syndrome 3	Pathogenic(Last reviewed: Jan 26, 2012)	no assertion criteria provided	VCV000030051					30051	39006		
PLCG2, 5.9-KB DEL	PLCG2		Familial cold autoinflammatory syndrome 3	Pathogenic(Last reviewed: Jan 26, 2012)	no assertion criteria provided	VCV000030050					30050	39005		
NM_000359.3(TGM1):c.968G>A (p.Arg323Gln)	TGM1	R323Q	Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012484	14	24728926	14	24259720	12484	27523	rs121918717	NC_000014.9:24259719:C:T
NM_000512.5(GALNS):c.415G>A (p.Gly139Ser)	GALNS	G139S, G145S	Mucopolysaccharidosis, MPS-IV-A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265167	16	88907407	16	88840999	265167	260138	rs146093755	NC_000016.10:88840998:C:T
FGD4, 893T-G	FGD4		Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001012					1012	16051		
NC_000016.10:g.(?_56902363)_(56904472_?)del	SLC12A3		not provided	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000833511	16	56936275 - 56938384			833511	820841		
NM_001126108.2(SLC12A3):c.626G>A (p.Arg209Gln)	SLC12A3	R208Q, R209Q	not provided	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000805472	16	56904032	16	56870120	805472	793639		NC_000016.10:56870119:G:A
NM_000303.3(PMM2):c.620T>C (p.Phe207Ser)	PMM2	F207S	Congenital disorder of glycosylation, type Ia	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2015)	criteria provided, multiple submitters, no conflicts	VCV000189141	16	8906944	16	8813087	189141	186954	rs532870929	NC_000016.10:8813086:T:C
NM_001365088.1(SLC12A6):c.2023C>T (p.Arg675Ter)	SLC12A6	R675*, R624*, R616*, R660*, R666*	Agenesis of the corpus callosum with peripheral neuropathy|not provided	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005327	15	34536194	15	34243993	5327	20366	rs121908428	NC_000015.10:34243992:G:A
NM_015272.5(RPGRIP1L):c.2451C>G (p.Tyr817Ter)	RPGRIP1L	Y817*	not provided	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000620438	16	53679769	16	53645857	620438	611826	rs145807002	NC_000016.10:53645856:G:C
NM_015272.5(RPGRIP1L):c.2125C>T (p.Arg709Ter)	RPGRIP1L	R709*	not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000596520	16	53686474	16	53652562	596520	587581	rs1037406858	NC_000016.10:53652561:G:A
NM_015272.5(RPGRIP1L):c.2299C>T (p.Gln767Ter)	RPGRIP1L	Q767*	not provided	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000489039	16	53682881	16	53648969	489039	482102	rs1326042797	NC_000016.10:53648968:G:A
NM_015272.5(RPGRIP1L):c.1700-1G>A	RPGRIP1L		not provided	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	VCV000379927	16	53686900	16	53652988	379927	374412	rs1057520790	NC_000016.10:53652987:C:T
NM_015272.5(RPGRIP1L):c.2643_2671del (p.Asn881fs)	RPGRIP1L	N881fs	not provided	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000280658	16	53679549 - 53679577	16	53645637 - 53645665	280658	264715	rs886041824	NC_000016.10:53645636:TGTCATGTGCCAACGAAATCAGAGGCACAT:T
NM_015272.5(RPGRIP1L):c.118C>T (p.Gln40Ter)	RPGRIP1L	Q40*	Joubert syndrome 7	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000438669	16	53730175	16	53696263	438669	432330	rs1555616593	NC_000016.10:53696262:G:A
NM_015272.5(RPGRIP1L):c.3701+1G>T	RPGRIP1L		Joubert syndrome 7	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217695	16	53644878	16	53610966	217695	214350	rs863225219	NC_000016.10:53610965:C:A
NM_015272.5(RPGRIP1L):c.3529C>T (p.Arg1177Ter)	RPGRIP1L	R1097*, R1177*, R1131*, R1143*	Joubert syndrome 7	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217694	16	53653024	16	53619112	217694	214351	rs778533826	NC_000016.10:53619111:G:A
NM_015272.5(RPGRIP1L):c.1243+1G>A	RPGRIP1L		Joubert syndrome 7	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217693	16	53698781	16	53664869	217693	214354	rs863225218	NC_000016.10:53664868:C:T
NM_015272.5(RPGRIP1L):c.1132del (p.Trp378fs)	RPGRIP1L	W378fs	Joubert syndrome 7	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217692	16	53698893	16	53664981	217692	214355	rs863225217	NC_000016.10:53664980:A:
NM_015272.5(RPGRIP1L):c.1721del (p.Tyr574fs)	RPGRIP1L	Y574fs	Joubert syndrome 7	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217691	16	53686878	16	53652966	217691	214353	rs863225216	NC_000016.10:53652965:T:
NM_015272.5(RPGRIP1L):c.2305-1G>A	RPGRIP1L		Joubert syndrome 7	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217690	16	53679916	16	53646004	217690	214352	rs863225215	NC_000016.10:53646003:C:T
NM_015272.5(RPGRIP1L):c.2269del (p.Thr757fs)	RPGRIP1L	T757fs	Joubert syndrome 7	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000001077	16	53682911	16	53648999	1077	16116	rs387906243	NC_000016.10:53648998:TT:T
RPGRIP1L, 1-BP DEL, 1721A	RPGRIP1L		Joubert syndrome 7	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001075					1075	16114		
NM_015272.5(RPGRIP1L):c.1033C>T (p.Gln345Ter)	RPGRIP1L	Q345*	Meckel syndrome type 5	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001073	16	53705492	16	53671580	1073	16112	rs121918202	NC_000016.10:53671579:G:A
NM_015272.5(RPGRIP1L):c.2083G>C (p.Ala695Pro)	RPGRIP1L	A695P	Joubert syndrome 7	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001071	16	53686516	16	53652604	1071	16110	rs121918200	NC_000016.10:53652603:C:G
NM_015272.5(RPGRIP1L):c.1290_1291del (p.Tyr431fs)	RPGRIP1L	Y431fs	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000862715	16	53692743 - 53692744	16	53658831 - 53658832	862715	843988		NC_000016.10:53658830:AC:
NM_015272.5(RPGRIP1L):c.1326_1329del (p.Lys442fs)	RPGRIP1L	K442fs	Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000851426	16	53692705 - 53692708	16	53658793 - 53658796	851426	843987		NC_000016.10:53658792:TTTTTT:TT
NM_015272.5(RPGRIP1L):c.2303C>A (p.Ser768Ter)	RPGRIP1L	S768*	Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000849109	16	53682877	16	53648965	849109	843977		NC_000016.10:53648964:G:T
NM_015272.5(RPGRIP1L):c.3556_3557AC[3] (p.Pro1187fs)	RPGRIP1L		Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000848273	16	53652993 - 53652994	16	53619081 - 53619082	848273	843968		NC_000016.10:53619081:GTGT:GTGTGT
NM_015272.5(RPGRIP1L):c.2466del (p.Phe822fs)	RPGRIP1L	F822fs	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000844309	16	53679754	16	53645842	844309	843975		NC_000016.10:53645841:AAAA:AAA
NM_015272.5(RPGRIP1L):c.1052T>A (p.Leu351Ter)	RPGRIP1L	L351*	Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000840356	16	53705473	16	53671561	840356	843992		NC_000016.10:53671560:A:T
NM_015272.5(RPGRIP1L):c.2760C>A (p.Tyr920Ter)	RPGRIP1L	Y920*	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000834727	16	53675311	16	53641399	834727	843973		NC_000016.10:53641398:G:T
NC_000016.10:g.(?_53619015)_(53622366_?)del	RPGRIP1L		Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000831591	16	53652927 - 53656278			831591	820836		
NC_000016.10:g.(?_53619025)_(53622456_?)del	RPGRIP1L		Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000830842	16	53652937 - 53656368			830842	820837		
NM_015272.5(RPGRIP1L):c.986_987del (p.Lys329fs)	RPGRIP1L	K329fs	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000664390	16	53706824 - 53706825	16	53672912 - 53672913	664390	644755		NC_000016.10:53672911:TTT:T
NM_015272.5(RPGRIP1L):c.1873G>T (p.Gly625Ter)	RPGRIP1L	G625*	Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000660069	16	53686726	16	53652814	660069	644753		NC_000016.10:53652813:C:A
NM_015272.5(RPGRIP1L):c.946C>T (p.Gln316Ter)	RPGRIP1L	Q316*	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000640512	16	53706865	16	53672953	640512	644756		NC_000016.10:53672952:G:A
NM_015272.5(RPGRIP1L):c.196C>T (p.Gln66Ter)	RPGRIP1L	Q66*	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000640372	16	53730097	16	53696185	640372	644757		NC_000016.10:53696184:G:A
NM_015272.5(RPGRIP1L):c.972del (p.Cys325fs)	RPGRIP1L	C325fs	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000530905	16	53706839	16	53672927	530905	530565	rs757594906	NC_000016.10:53672926:G:
NM_015272.5(RPGRIP1L):c.2939del (p.Ile980fs)	RPGRIP1L	I980fs	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000530899	16	53674964	16	53641052	530899	530360	rs1182447072	NC_000016.10:53641051:A:
NM_015272.5(RPGRIP1L):c.2794_2795del (p.Leu932fs)	RPGRIP1L	L932fs	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, single submitter	VCV000406251	16	53675276 - 53675277	16	53641364 - 53641365	406251	401190	rs778824093	NC_000016.10:53641363:AA:
NM_015272.5(RPGRIP1L):c.1072_1073dup (p.Leu358fs)	RPGRIP1L		Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, single submitter	VCV000406250	16	53705451 - 53705452	16	53671539 - 53671540	406250	401974	rs1060501006	NC_000016.10:53671539:AAAA:AAAAAA
NM_015272.5(RPGRIP1L):c.1120del (p.His374fs)	RPGRIP1L	H374fs	Joubert syndrome	Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	VCV000241025	16	53698905	16	53664993	241025	242443	rs878855006	NC_000016.10:53664992:GGG:GG
NM_005249.5(FOXG1):c.256dup (p.Gln86fs)	FOXG1		not provided|Rett syndrome, congenital variant	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189613	14	29236734 - 29236735	14	28767528 - 28767529	189613	187402	rs786205001	NC_000014.9:28767528:CCCCCCC:CCCCCCCC
NM_005249.5(FOXG1):c.256del (p.Gln86fs)	FOXG1	Q86fs	Rett syndrome, congenital variant|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189612	14	29236735	14	28767529	189612	187401	rs786205001	NC_000014.9:28767528:CCCCCCC:CCCCCC
NM_015272.5(RPGRIP1L):c.1945C>T (p.Arg649Ter)	RPGRIP1L	R649*	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000651948	16	53686654	16	53652742	651948	644750		NC_000016.10:53652741:G:A
NM_000382.3(ALDH3A2):c.1293_1294GA[2] (p.Glu433fs)	ALDH3A2		not provided|Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001641	17	19575118 - 19575119	17	19671805 - 19671806	1641	16680	rs387906256	NC_000017.11:19671804:AGAGAGA:AGAGA
GRCh37/hg19 15q26.3(chr15:100629063-100663184)x1	ADAMTS17		not provided	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000688739	15	100629063 - 100663184			688739	676331		
GRCh37/hg19 15q26.3(chr15:100736690-100785790)x1	ADAMTS17		not provided	Pathogenic(Last reviewed: Jul 30, 2018)	no assertion criteria provided	VCV000687803	15	100736690 - 100785790			687803	675395		
GRCh37/hg19 15q26.3(chr15:100492705-100541504)x1	ADAMTS17		not provided	Pathogenic(Last reviewed: Mar 29, 2018)	no assertion criteria provided	VCV000686321	15	100492705 - 100541504			686321	673913		
NC_000015.10:g.(?_100261479)_(100262435_?)del	ADAMTS17		not provided	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV000831110	15	100801684 - 100802640			831110	820664		
NM_139057.4(ADAMTS17):c.873+1G>T	ADAMTS17		Weill-Marchesani syndrome 4	Pathogenic(Last reviewed: Feb 16, 2018)	no assertion criteria provided	VCV000492941	15	100802556	15	100262351	492941	485880	rs1160509052	NC_000015.10:100262350:C:A
NM_139057.4(ADAMTS17):c.652del (p.Asp218fs)	ADAMTS17	D218fs	Weill-Marchesani syndrome 4	Pathogenic(Last reviewed: Feb 16, 2018)	no assertion criteria provided	VCV000492940	15	100821571	15	100281366	492940	485879	rs1555501030	NC_000015.10:100281365:CCC:CC
NM_139057.4(ADAMTS17):c.1721+1G>A	ADAMTS17		Weill-Marchesani syndrome 4	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000003155	15	100672211	15	100132006	3155	18194	rs749116256	NC_000015.10:100132005:C:T
NM_139057.4(ADAMTS17):c.760C>T (p.Gln254Ter)	ADAMTS17	Q254*	Weill-Marchesani syndrome 4	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000003154	15	100821463	15	100281258	3154	18193	rs267606638	NC_000015.10:100281257:G:A
NM_139057.4(ADAMTS17):c.2456-1dup	ADAMTS17		Weill-Marchesani syndrome 4	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000003153	15	100589194 - 100589195	15	100048989 - 100048990	3153	18192	rs387906291	NC_000015.10:100048989:CCCC:CCCCC
NM_002087.3(GRN):c.1414-2A>G	GRN		|Ceroid lipofuscinosis, neuronal, 11|not provided	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000447471	17	42429707	17	44352339	447471	441962	rs1555611412	NC_000017.11:44352338:A:G
NM_001126108.2(SLC12A3):c.2848_2849AG[1] (p.Arg950fs)	SLC12A3		not provided	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000849196	16	56936412 - 56936413	16	56902500 - 56902501	849196	844029		NC_000016.10:56902499:AGAG:AG
NM_000339.3(SLC12A3):c.2532G>A (p.Trp844Ter)	SLC12A3	W844*, W835*, W843*	not provided	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000586603	16	56926950	16	56893038	586603	577555	rs1366655422	NC_000016.10:56893037:G:A
NM_001126108.2(SLC12A3):c.247C>T (p.Arg83Trp)	SLC12A3	R83W	not provided|Familial hypokalemia-hypomagnesemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000319889	16	56899394	16	56865482	319889	325851	rs201255508	NC_000016.10:56865481:C:T
NM_001126108.2(SLC12A3):c.1926-1G>T	SLC12A3		not provided|Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000008587	16	56920275	16	56886363	8587	23626		NC_000016.10:56886362:G:T
NM_001126108.2(SLC12A3):c.2549T>C (p.Leu850Pro)	SLC12A3	L850P, L859P, L858P	not provided|Familial hypokalemia-hypomagnesemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008584	16	56928470	16	56894558	8584	23623	rs121909379	NC_000016.10:56894557:T:C
NM_015272.5(RPGRIP1L):c.1329dup (p.Arg444fs)	RPGRIP1L		Meckel-Gruber syndrome|Joubert syndrome|not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000569914	16	53692704 - 53692705	16	53658792 - 53658793	569914	570303	rs749987648	NC_000016.10:53658792:TTTTTT:TTTTTTT
NM_015272.5(RPGRIP1L):c.2200C>T (p.Arg734Ter)	RPGRIP1L	R734*	Meckel-Gruber syndrome|Joubert syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000421673	16	53682980	16	53649068	421673	409650	rs751128300	NC_000016.10:53649067:G:A
NM_015272.5(RPGRIP1L):c.1489G>T (p.Glu497Ter)	RPGRIP1L	E497*	not provided|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Nov 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279885	16	53691457	16	53657545	279885	264717	rs756821449	NC_000016.10:53657544:C:A
NM_001330504.1(ALG1):c.746C>T (p.Ala249Val)	ALG1	A360V, A249V	not provided|Inborn genetic diseases|Congenital disorder of glycosylation	Pathogenic/Likely pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, multiple submitters, no conflicts	VCV000095931	16	5132566	16	5082565	95931	101827	rs398124348	NC_000016.10:5082564:C:T
NM_002755.3(MAP2K1):c.167A>C (p.Gln56Pro)	MAP2K1	Q56P	Non-small cell lung cancer|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000375978	15	66727451	15	66435113	375978	362857	rs1057519729	NC_000015.10:66435112:A:C
NM_006493.4(CLN5):c.78G>A (p.Trp26Ter)	CLN5	W75*, W26*	|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002565	13	77566311	13	76992176	2565	17604	rs104894385	NC_000013.11:76992175:G:A
NM_015272.5(RPGRIP1L):c.583A>T (p.Lys195Ter)	RPGRIP1L	K195*	not provided|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000591393	16	53721824	16	53687912	591393	582385	rs1277577195	NC_000016.10:53687911:T:A
NM_015272.5(RPGRIP1L):c.1709dup (p.Asp571fs)	RPGRIP1L		Meckel-Gruber syndrome|Joubert syndrome|Joubert syndrome 7	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188192	16	53686889 - 53686890	16	53652977 - 53652978	188192	186227	rs778149316	NC_000016.10:53652977:TTT:TTTT
NM_015272.5(RPGRIP1L):c.1975T>C (p.Ser659Pro)	RPGRIP1L	S659P	Joubert syndrome 7|Joubert syndrome with hepatic defect	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000001080	16	53686624	16	53652712	1080	16119	rs267607020	NC_000016.10:53652711:A:G
NM_015272.5(RPGRIP1L):c.757C>T (p.Gln253Ter)	RPGRIP1L	Q253*	Joubert syndrome 7|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000001070	16	53720364	16	53686452	1070	16109	rs121918199	NC_000016.10:53686451:G:A
NM_177550.4(SLC13A5):c.997C>T (p.Arg333Ter)	SLC13A5	R333*, R290*, R316*	not provided|Seizures|Epileptic encephalopathy, early infantile, 25	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280534	17	6599103	17	6695784	280534	264863	rs773770609	NC_000017.11:6695783:G:A
NM_001304480.1(FGD4):c.2213_2217AAAAG[2] (p.Lys742fs)	FGD4		Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419181	12	32786595 - 32786599	12	32633661 - 32633665	419181	408630	rs751035912	NC_000012.12:32633660:AAGAAAAGAAAAGAAAAG:AAGAAAAGAAAAG
NM_006445.4(PRPF8):c.5804G>A (p.Arg1935His)	PRPF8	R1935H	not provided|Retinal dystrophy|Retinitis pigmentosa 13|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000546782	17	1558827	17	1655533	546782	537271	rs1555550617	NC_000017.11:1655532:C:T
NM_000431.4(MVK):c.1000G>A (p.Ala334Thr)	MVK	A334T, A282T	Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever||Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000011930	12	110032947	12	109595142	11930	26969	rs104895317	NC_000012.12:109595141:G:A
NM_000080.4(CHRNE):c.1323dup (p.Glu442fs)	CHRNE		Myasthenic syndrome, congenital, 4a, slow-channel	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000655554	17	4802298 - 4802299	17	4899003 - 4899004	655554	646146		NC_000017.11:4899003:G:GG
NM_004004.6(GJB2):c.355G>T (p.Glu119Ter)	GJB2	E119*	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560889	13	20763366	13	20189227	560889	552025	rs150529554	NC_000013.11:20189226:C:A
NM_004004.6(GJB2):c.550C>T (p.Arg184Trp)	GJB2	R184W	Hearing loss	Pathogenic(Last reviewed: Nov 10, 2006)	no assertion criteria provided	VCV000560669	13	20763171	13	20189032	560669	551725	rs998045226	NC_000013.11:20189031:G:A
NM_004004.6(GJB2):c.474C>G (p.Tyr158Ter)	GJB2	Y158*	Hearing loss	Pathogenic(Last reviewed: Mar 10, 2017)	no assertion criteria provided	VCV000560668	13	20763247	13	20189108	560668	551726	rs375759781	NC_000013.11:20189107:G:C
NM_004004.6(GJB2):c.66G>T (p.Lys22Asn)	GJB2	K22N	Palmoplantar keratoderma-deafness syndrome	Pathogenic(Last reviewed: Apr 26, 2016)	no assertion criteria provided	VCV000242831	13	20763655	13	20189516	242831	243935	rs879253741	NC_000013.11:20189515:C:A
NM_002206.3(ITGA7):c.427C>T (p.Arg143Ter)	ITGA7	R143*, R46*, R30*	Muscular dystrophy, congenital, due to ITGA7 deficiency	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638329	12	56094926	12	55701142	638329	626218		NC_000012.12:55701141:G:A
NM_004004.6(GJB2):c.526A>G (p.Asn176Asp)	GJB2	N176D	IFAP syndrome with or without BRESHECK syndrome	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000590275	13	20763195	13	20189056	590275	581217	rs781767722	NC_000013.11:20189055:T:C
NM_004004.6(GJB2):c.175G>C (p.Gly59Arg)	GJB2	G59R	Palmoplantar keratoderma-deafness syndrome	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000496215	13	20763546	13	20189407	496215	487604	rs104894410	NC_000013.11:20189406:C:G
NM_004004.6(GJB2):c.400T>C (p.Trp134Arg)	GJB2	W134R	Deafness, autosomal recessive 12	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000236061	13	20763321	13	20189182	236061	237615	rs878853241	NC_000013.11:20189181:A:G
NM_004004.6(GJB2):c.523_533del (p.Pro175fs)	GJB2	P175fs	Rare genetic deafness	Pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	VCV000228350	13	20763188 - 20763198	13	20189049 - 20189059	228350	230433	rs876657693	NC_000013.11:20189048:ACAGTGTTGGGACA:ACA
NM_002206.3(ITGA7):c.1088dup (p.His364fs)	ITGA7		Muscular dystrophy, congenital, due to ITGA7 deficiency	Pathogenic(Last reviewed: Nov 5, 2013)	criteria provided, single submitter	VCV000129291	12	56092270 - 56092271	12	55698486 - 55698487	129291	134737	rs587780362	NC_000012.12:55698486:CCCCCC:CCCCCCC
NM_004004.6(GJB2):c.218A>G (p.His73Arg)	GJB2	H73R	Palmoplantar keratoderma-deafness syndrome	Pathogenic(Last reviewed: Apr 17, 1999)	no assertion criteria provided	VCV000017037	13	20763503	13	20189364	17037	32076	rs121912968	NC_000013.11:20189363:T:C
NM_004004.6(GJB2):c.162C>A (p.Asn54Lys)	GJB2	N54K	Knuckle pads, deafness AND leukonychia syndrome	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000017030	13	20763559	13	20189420	17030	32069	rs104894412	NC_000013.11:20189419:G:T
NM_004004.6(GJB2):c.50C>T (p.Ser17Phe)	GJB2	S17F	Keratitis-ichthyosis-deafness syndrome, autosomal dominant	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000017022	13	20763671	13	20189532	17022	32061	rs28929485	NC_000013.11:20189531:G:A
NM_004004.6(GJB2):c.34G>C (p.Gly12Arg)	GJB2	G12R	Keratitis-ichthyosis-deafness syndrome, autosomal dominant	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000017021	13	20763687	13	20189548	17021	32060	rs104894408	NC_000013.11:20189547:C:G
NM_004004.6(GJB2):c.176G>C (p.Gly59Ala)	GJB2	G59A	Palmoplantar keratoderma-deafness syndrome	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000017015	13	20763545	13	20189406	17015	32054	rs104894404	NC_000013.11:20189405:C:G
NM_004004.6(GJB2):c.487A>C (p.Met163Leu)	GJB2	M163L	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000424854	13	20763234	13	20189095	424854	413167	rs80338949	NC_000013.11:20189094:T:G
NM_004004.6(GJB2):c.172C>G (p.Pro58Ala)	GJB2	P58A	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000424853	13	20763549	13	20189410	424853	413168	rs1064797090	NC_000013.11:20189409:G:C
NM_004004.6(GJB2):c.164C>A (p.Thr55Asn)	GJB2	T55N	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000424852	13	20763557	13	20189418	424852	413169	rs1064797089	NC_000013.11:20189417:G:T
NM_004004.6(GJB2):c.136G>A (p.Asp46Asn)	GJB2	D46N	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000424851	13	20763585	13	20189446	424851	413170	rs1064797088	NC_000013.11:20189445:C:T
NM_004004.6(GJB2):c.465T>A (p.Tyr155Ter)	GJB2	Y155*	not provided	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000195205	13	20763256	13	20189117	195205	192366	rs772264564	NC_000013.11:20189116:A:T
NM_004004.6(GJB2):c.158G>A (p.Cys53Tyr)	GJB2	C53Y	Hearing impairment	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158606	13	20763563	13	20189424	158606	169012	rs587783645	NC_000013.11:20189423:C:T
NM_004004.6(GJB2):c.426C>A (p.Phe142Leu)	GJB2	F142L	Rare genetic deafness	Pathogenic(Last reviewed: Sep 2, 2011)	criteria provided, single submitter	VCV000044750	13	20763295	13	20189156	44750	53917	rs397516877	NC_000013.11:20189155:G:T
NM_004004.6(GJB2):c.175G>A (p.Gly59Ser)	GJB2	G59S	Knuckle pads, deafness AND leukonychia syndrome	Pathogenic(Last reviewed: Jul 30, 2005)	no assertion criteria provided	VCV000017034	13	20763546	13	20189407	17034	32073	rs104894410	NC_000013.11:20189406:C:T
NM_004004.6(GJB2):c.148G>T (p.Asp50Tyr)	GJB2	D50Y	Keratitis-ichthyosis-deafness syndrome, autosomal dominant	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000017028	13	20763573	13	20189434	17028	32067	rs28931594	NC_000013.11:20189433:C:A
NM_000151.4(G6PC):c.508C>T (p.Arg170Ter)	G6PC	R170*, T144M	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Nov 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000522204	17	41061381	17	42909364	522204	512869	rs373345919	NC_000017.11:42909363:C:T
NM_000151.4(G6PC):c.883C>T (p.Arg295Cys)	G6PC	R295C	not provided|Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011999	17	41063252	17	42911235	11999	27038	rs104894563	NC_000017.11:42911234:C:T
NM_002206.3(ITGA7):c.2392C>T (p.Arg798Ter)	ITGA7	R792*, R350*, R705*, R802*, R798*, R689*	Muscular dystrophy, congenital, due to integrin alpha-7 deficiency	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000844274	12	56088080	12	55694296	844274	840089		NC_000012.12:55694295:G:A
NM_002206.3(ITGA7):c.2169_2171del (p.Tyr723_Ser724delinsTer)	ITGA7		Muscular dystrophy, congenital, due to integrin alpha-7 deficiency	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000842929	12	56088587 - 56088589	12	55694803 - 55694805	842929	840094		NC_000012.12:55694802:GAG:
NM_002206.3(ITGA7):c.207G>A (p.Trp69Ter)	ITGA7	W69*	Muscular dystrophy, congenital, due to integrin alpha-7 deficiency	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000838697	12	56096962	12	55703178	838697	840104		NC_000012.12:55703177:C:T
NM_004004.6(GJB2):c.122_124AGG[1] (p.Glu42del)	GJB2	E42del	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000590775	13	20763594 - 20763596	13	20189455 - 20189457	590775	581711	rs1566528901	NC_000013.11:20189454:CCTCCT:CCT
NM_004004.6(GJB2):c.72G>A (p.Trp24Ter)	GJB2	W24*	Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000554744	13	20763649	13	20189510	554744	547102	rs769486081	NC_000013.11:20189509:C:T
NM_002206.3(ITGA7):c.1072dup (p.Tyr358fs)	ITGA7		Muscular dystrophy, congenital, due to integrin alpha-7 deficiency	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000537990	12	56092286 - 56092287	12	55698502 - 55698503	537990	527811	rs750756707	NC_000012.12:55698502:A:AA
NM_002206.3(ITGA7):c.1456C>T (p.Arg486Ter)	ITGA7	R393*, R486*, R490*, R377*, R38*	Muscular dystrophy, congenital, due to integrin alpha-7 deficiency	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000537989	12	56091284	12	55697500	537989	527284	rs372328960	NC_000012.12:55697499:G:A
NM_002206.3(ITGA7):c.1446_1453del (p.Ile483fs)	ITGA7	I374fs, I35fs, I487fs, I390fs, I483fs	Muscular dystrophy, congenital, due to integrin alpha-7 deficiency	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000470565	12	56091287 - 56091294	12	55697503 - 55697510	470565	462612	rs1474512248	NC_000012.12:55697502:GAGCAATAGAG:GAG
NC_000012.11:g.(?_56091459)_(56092721_?)del	ITGA7		Muscular dystrophy, congenital, due to integrin alpha-7 deficiency	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000470560	12	56091459 - 56092721	12	55697675 - 55698937	470560	461788		
NM_004004.5(GJB2):c.592_600delGTGTCTGGAins17 (p.?)	GJB2		not provided	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000447448	13	20763121 - 20763129	13	20188982 - 20188990	447448	441578		
Single allele	GJB2		Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Aug 18, 2016)	no assertion criteria provided	VCV000253027					253027	247434		
NM_004004.6(GJB2):c.314_329del (p.Lys105fs)	GJB2	K105fs	Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211079	13	20763392 - 20763407	13	20189253 - 20189268	211079	208014	rs797045596	NC_000013.11:20189252:TCCCCCTTGATGAACTTCC:TCC
NM_004004.6(GJB2):c.280_284dup (p.Ala96fs)	GJB2		Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Sep 15, 2002)	no assertion criteria provided	VCV000017025	13	20763436 - 20763437	13	20189297 - 20189298	17025	32064	rs886037625	NC_000013.11:20189297:ACGTG:ACGTGACGTG
NM_004004.6(GJB2):c.51_62delinsA (p.Thr18fs)	GJB2		Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000017013	13	20763659 - 20763670	13	20189520 - 20189531	17013	32052	rs886037624	NC_000013.11:20189519:CCAATGCTGGTG:T
NM_002206.3(ITGA7):c.1205del (p.Gly402fs)	ITGA7	G293fs, G309fs, G402fs, G406fs	Muscular dystrophy, congenital, due to integrin alpha-7 deficiency	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000009051	12	56091798	12	55698014	9051	24090	rs1565629479	NC_000012.12:55698013:CCC:CC
ITGA7, IVSDS, T-C, +2	ITGA7		Muscular dystrophy, congenital, due to integrin alpha-7 deficiency	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000009050					9050	24089		
NM_002206.3(ITGA7):c.1506-2A>G	ITGA7		Muscular dystrophy, congenital, due to integrin alpha-7 deficiency	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000009049	12	56091063	12	55697279	9049	24088	rs1565627745	NC_000012.12:55697278:T:C
GRCh37/hg19 13q32.3(chr13:100934274-101067851)x1	PCCA		not provided	Pathogenic(Last reviewed: Sep 11, 2018)	no assertion criteria provided	VCV000688683	13	100934274 - 101067851			688683	676275		
GRCh37/hg19 13q32.3(chr13:100964141-100996801)x1	PCCA		not provided	Pathogenic(Last reviewed: Jul 10, 2018)	no assertion criteria provided	VCV000687853	13	100964141 - 100996801			687853	675445		
GRCh37/hg19 13q32.3(chr13:100934274-101069066)x1	PCCA		not provided	Pathogenic(Last reviewed: May 29, 2018)	no assertion criteria provided	VCV000686944	13	100934274 - 101069066			686944	674536		
GRCh37/hg19 13q32.3(chr13:100934274-101069066)x1	PCCA		not provided	Pathogenic(Last reviewed: May 4, 2018)	no assertion criteria provided	VCV000686309	13	100934274 - 101069066			686309	673901		
NM_000282.4(PCCA):c.1561_1566delinsTATTGCCAATAACC (p.Glu521_Lys522delinsTyrCysGlnTer)	PCCA		not provided	Pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	VCV000496940	13	100992431 - 100992436	13	100340177 - 100340182	496940	488364	rs1555425572	NC_000013.11:100340176:GAGAAG:TATTGCCAATAACC
NM_000282.4(PCCA):c.232-1G>A	PCCA		not provided	Pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	VCV000197126	13	100764246	13	100111992	197126	194287	rs794727620	NC_000013.11:100111991:G:A
NM_000282.4(PCCA):c.1994dup (p.Met666fs)	PCCA		Propionic acidemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802995	13	101167771 - 101167772	13	100515517 - 100515518	802995	791289		NC_000013.11:100515517:CCCC:CCCCC
NM_000282.4(PCCA):c.131delinsATT (p.Cys44fs)	PCCA		Propionic acidemia	Pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000638045	13	100755162	13	100102908	638045	625866		NC_000013.11:100102907:G:ATT
NM_000282.4(PCCA):c.1920del (p.Arg641fs)	PCCA	R278fs, R593fs, R641fs, R567fs, R326fs, R623fs, R308fs, R615fs	Propionic acidemia	Pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000638031	13	101167700	13	100515446	638031	625862		NC_000013.11:100515445:CC:C
NM_000282.4(PCCA):c.1330dup (p.Tyr444fs)	PCCA		Propionic acidemia	Pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000638030	13	100959488 - 100959489	13	100307234 - 100307235	638030	625861		NC_000013.11:100307234:TTT:TTTT
NM_000282.4(PCCA):c.332_333GT[1] (p.Val112fs)	PCCA		Propionic acidemia	Pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000638021	13	100807263 - 100807264	13	100155009 - 100155010	638021	625852		NC_000013.11:100155008:TGTGT:TGT
NM_000282.4(PCCA):c.305del (p.His102fs)	PCCA	H76fs, H102fs	Propionic acidemia	Pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000638020	13	100807237	13	100154983	638020	625851		NC_000013.11:100154982:A:
NM_000282.4(PCCA):c.43G>T (p.Gly15Ter)	PCCA	G15*	Propionic acidemia	Pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000638019	13	100741417	13	100089163	638019	625850		NC_000013.11:100089162:G:T
NM_000282.4(PCCA):c.2T>A (p.Met1Lys)	PCCA	M1K	Propionic acidemia	Pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000638018	13	100741376	13	100089122	638018	625849		NC_000013.11:100089121:T:A
NM_000282.4(PCCA):c.862A>G (p.Arg288Gly)	PCCA	R288G, R262G	Propionic acidemia	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038869	13	100920985	13	100268731	38869	47474	rs121964957	NC_000013.11:100268730:A:G
NM_000282.4(PCCA):c.491T>C (p.Ile164Thr)	PCCA	I164T, I138T	Propionic acidemia	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038868	13	100861608	13	100209354	38868	47473	rs202247815	NC_000013.11:100209353:T:C
NM_000282.4(PCCA):c.412G>A (p.Ala138Thr)	PCCA	A138T, A112T	Propionic acidemia	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038867	13	100807344	13	100155090	38867	47472	rs202247814	NC_000013.11:100155089:G:A
NM_000282.4(PCCA):c.1685C>G (p.Ser562Ter)	PCCA	S562*, S247*, S199*, S488*, S514*, S536*	Propionic acidemia	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038866	13	101020767	13	100368513	38866	47471	rs202247816	NC_000013.11:100368512:C:G
NM_000282.4(PCCA):c.556A>T (p.Lys186Ter)	PCCA	K160*, K186*	Propionic acidemia	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000853682	13	100861673	13	100209419	853682	840488		NC_000013.11:100209418:A:T
NM_000282.4(PCCA):c.451G>T (p.Glu151Ter)	PCCA	E125*, E151*	Propionic acidemia	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000850325	13	100809577	13	100157323	850325	840487		NC_000013.11:100157322:G:T
NM_000282.4(PCCA):c.145del (p.Arg49fs)	PCCA	R49fs	Propionic acidemia	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000843070	13	100755174	13	100102920	843070	840485		NC_000013.11:100102919:CCC:CC
NC_000013.11:g.(?_100209322)_(100235888_?)del	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000833246	13	100861576 - 100888142			833246	820532		
NC_000013.11:g.(?_100268679)_(100268793_?)del	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000831931	13	100920933 - 100921047			831931	820533		
NM_000282.4(PCCA):c.446del (p.Asn149fs)	PCCA	N123fs, N149fs	Propionic acidemia	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000830056	13	100809569	13	100157315	830056	818396		NC_000013.11:100157314:AAAA:AAA
NM_000282.4(PCCA):c.1845+1G>A	PCCA		Propionic acidemia	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000830055	13	101077986	13	100425732	830055	818404		NC_000013.11:100425731:G:A
NM_000282.4(PCCA):c.862_863AG[2] (p.Glu289fs)	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000663694	13	100920985 - 100920986	13	100268731 - 100268732	663694	641516		NC_000013.11:100268730:AGAGAG:AGAG
NM_000282.4(PCCA):c.24_46dup (p.Arg16fs)	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000659677	13	100741393 - 100741394	13	100089139 - 100089140	659677	641512		NC_000013.11:100089139:GGACAGCACCGCTGGTCGCTGCCGGAC:GGACAGCACCGCTGGTCGCTGCCGGACAGCACCGCTGGTCGCTGCCGGAC
NC_000013.10:g.(?_100982795)_(101020848_?)del	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000650714	13	100982795 - 101020848	13	100330541 - 100368594	650714	652268		
NM_000282.4(PCCA):c.656dup (p.Ala220fs)	PCCA		Propionicacidemia	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635308	13	100909865 - 100909866	13	100257611 - 100257612	635308	623158		NC_000013.11:100257611:AA:AAA
NM_000282.4(PCCA):c.843del (p.Asn281fs)	PCCA	N255fs, N281fs	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558720	13	100920966	13	100268712	558720	546745	rs1555400381	NC_000013.11:100268711:T:
NM_000282.4(PCCA):c.1353+5_1353+9del	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Jan 1, 2012)	criteria provided, single submitter	VCV000254165	13	100959516 - 100959520	13	100307262 - 100307266	254165	248623	rs764045674	NC_000013.11:100307261:TTAGTTTA:TTA
NM_000282.3(PCCA):c.183delA	PCCA	T62fs	Propionic acidemia	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000218265	13	100755210	13	100102956	218265	214885	rs879253812	NC_000013.11:100102955:AAAAA:AAAA
NM_000282.4(PCCA):c.548T>G (p.Leu183Ter)	PCCA	L183*, L157*	Propionic acidemia	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000218263	13	100861665	13	100209411	218263	214890	rs879253811	NC_000013.11:100209410:T:G
NM_000282.4(PCCA):c.134_135del (p.Leu45fs)	PCCA	L45fs	Propionic acidemia	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000218261	13	100755165 - 100755166	13	100102911 - 100102912	218261	214884	rs879253809	NC_000013.11:100102910:TA:
NM_000282.4(PCCA):c.467T>A (p.Leu156Ter)	PCCA	L156*, L130*	Propionic acidemia	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000218260	13	100809593	13	100157339	218260	214889	rs760387660	NC_000013.11:100157338:T:A
NM_000282.4(PCCA):c.431G>T (p.Gly144Val)	PCCA	G144V, G118V	Propionic acidemia	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000218259	13	100809557	13	100157303	218259	214888	rs879253808	NC_000013.11:100157302:G:T
NM_000282.4(PCCA):c.184-1G>A	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Jan 1, 2012)	criteria provided, single submitter	VCV000218257	13	100764094	13	100111840	218257	214886	rs879253807	NC_000013.11:100111839:G:A
NM_000282.4(PCCA):c.2062T>C (p.Cys688Arg)	PCCA	C688R, C373R, C640R, C670R, C325R, C614R, C355R, C641R, C615R, C662R	Propionic acidemia	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000218253	13	101179950	13	100527696	218253	214900	rs774949844	NC_000013.11:100527695:T:C
NM_000282.4(PCCA):c.105+1G>A	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000218251	13	100741480	13	100089226	218251	214883	rs879253804	NC_000013.11:100089225:G:A
NM_000282.4(PCCA):c.284A>G (p.Asp95Gly)	PCCA	D95G, D69G	Propionic acidemia	Pathogenic(Last reviewed: Jan 1, 2011)	criteria provided, single submitter	VCV000218248	13	100764299	13	100112045	218248	214887	rs879253801	NC_000013.11:100112044:A:G
PCCA, IVS14, A-G, -1416	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000012025					12025	27064		
NM_000282.4(PCCA):c.862A>T (p.Arg288Ter)	PCCA	R288*, R262*	Propionic acidemia	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000012023	13	100920985	13	100268731	12023	27062	rs121964957	NC_000013.11:100268730:A:T
PCCA, 2-BP INS, 1824IVS, +3	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000012022					12022	27061		
PCCA, 9-BP DEL, 1771IVS, -2	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000012021					12021	27060		
NM_015272.5(RPGRIP1L):c.394A>T (p.Arg132Ter)	RPGRIP1L	R132*	Meckel syndrome type 5|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, single submitter	VCV000001072	16	53726113	16	53692201	1072	16111	rs121918201	NC_000016.10:53692200:T:A
NM_000303.3(PMM2):c.66+1G>T	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000632948	16	8891806	16	8797949	632948	621847	rs937726878	NC_000016.10:8797948:G:T
NM_000303.3(PMM2):c.26G>A (p.Cys9Tyr)	PMM2	C9Y	Congenital disorder of glycosylation, type Ia	Pathogenic/Likely pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007720	16	8891765	16	8797908	7720	22759	rs104894532	NC_000016.10:8797907:G:A
NM_004004.6(GJB2):c.205T>C (p.Phe69Leu)	GJB2	F69L	Noonan syndrome 1	Pathogenic	criteria provided, single submitter	VCV000804361	13	20763516	13	20189377	804361	792700		NC_000013.11:20189376:A:G
NM_004004.6(GJB2):c.327_328delinsA (p.Glu110fs)	GJB2		Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000556762	13	20763393 - 20763394	13	20189254 - 20189255	556762	546785	rs1555341931	NC_000013.11:20189253:CC:T
NM_004004.6(GJB2):c.131G>C (p.Trp44Ser)	GJB2	W44S	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000017031	13	20763590	13	20189451	17031	32070	rs104894413	NC_000013.11:20189450:C:G
NM_004004.6(GJB2):c.535G>A (p.Asp179Asn)	GJB2	D179N	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000017026	13	20763186	13	20189047	17026	32065	rs28931595	NC_000013.11:20189046:C:T
NM_004004.6(GJB2):c.605G>T (p.Cys202Phe)	GJB2	C202F	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000017018	13	20763116	13	20188977	17018	32057	rs104894406	NC_000013.11:20188976:C:A
NM_004004.6(GJB2):c.196G>C (p.Asp66His)	GJB2	D66H	Mutilating keratoderma|Hearing loss	Pathogenic(Last reviewed: May 11, 2015)	no assertion criteria provided	VCV000017012	13	20763525	13	20189386	17012	32051	rs104894403	NC_000013.11:20189385:C:G
NM_000282.4(PCCA):c.1288C>T (p.Arg430Ter)	PCCA	R404*, R430*, R67*, R115*, R356*, R382*	Propionic acidemia	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000851298	13	100959449	13	100307195	851298	840490		NC_000013.11:100307194:C:T
NM_000282.4(PCCA):c.734C>G (p.Ser245Ter)	PCCA	S245*, S219*	Propionic acidemia	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000638024	13	100915000	13	100262746	638024	625855		NC_000013.11:100262745:C:G
NM_000282.4(PCCA):c.415-2A>C	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000632933	13	100809539	13	100157285	632933	621827	rs746286209	NC_000013.11:100157284:A:C
NM_000282.4(PCCA):c.1747-1G>C	PCCA		Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000218250	13	101077886	13	100425632	218250	214897	rs879253803	NC_000013.11:100425631:G:C
NM_000282.4(PCCA):c.600+1G>T	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000218249	13	100861718	13	100209464	218249	214891	rs879253802	NC_000013.11:100209463:G:T
NM_000282.4(PCCA):c.1118T>A (p.Met373Lys)	PCCA	M348K, M347K, M373K, M58K	Propionic acidemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000012024	13	100953766	13	100301512	12024	27063	rs121964958	NC_000013.11:100301511:T:A
NM_000017.4(ACADS):c.1147C>T (p.Arg383Cys)	ACADS	R359C, R383C, R379C	Deficiency of butyryl-CoA dehydrogenase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003829	12	121177159	12	120739356	3829	18868	rs28940872	NC_000012.12:120739355:C:T
NM_000017.4(ACADS):c.529T>C (p.Trp177Arg)	ACADS	W153R, W177R	Deficiency of butyryl-CoA dehydrogenase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003828	12	121175696	12	120737893	3828	18867	rs57443665	NC_000012.12:120737892:T:C
NC_000013.10:g.(?_100764075)_(100764335_?)del	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000654095	13	100764075 - 100764335	13	100111821 - 100112081	654095	652505		
NC_000013.10:g.(?_100764085)_(100764325_?)del	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000650185	13	100764085 - 100764325	13	100111831 - 100112071	650185	652264		
NM_000282.4(PCCA):c.1855C>T (p.Arg619Ter)	PCCA	R619*, R304*, R545*, R256*, R571*, R593*	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553941	13	101101515	13	100449261	553941	547078	rs1194679272	NC_000013.11:100449260:C:T
NM_000282.4(PCCA):c.863G>A (p.Arg288Lys)	PCCA	R288K, R262K	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000218262	13	100920986	13	100268732	218262	214892	rs879253810	NC_000013.11:100268731:G:A
NM_000282.4(PCCA):c.1190_1193del (p.Glu397fs)	PCCA	E371fs, E397fs, E82fs	Propionic acidemia	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000218254	13	100953836 - 100953839	13	100301582 - 100301585	218254	214894	rs879253806	NC_000013.11:100301581:TGAATG:TG
NM_000282.4(PCCA):c.775_779del (p.Leu259fs)	PCCA	L233fs, L259fs	Propionic acidemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000193576	13	100915041 - 100915045	13	100262787 - 100262791	193576	190739	rs794726976	NC_000013.11:100262786:CTAAT:
PCCA, 4-BP DEL, 1824IVS, +3	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000012020					12020	27059		
NM_001126108.2(SLC12A3):c.1963C>T (p.Arg655Cys)	SLC12A3	R655C, R654C	not provided	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000840885	16	56920313	16	56886401	840885	844027		NC_000016.10:56886400:C:T
NM_004004.6(GJB2):c.576del (p.Val193fs)	GJB2	V193fs	not provided	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000644162	13	20763145	13	20189006	644162	641580		NC_000013.11:20189005:T:
NM_004004.6(GJB2):c.11del (p.Gly4fs)	GJB2	G4fs	Deafness, autosomal recessive 1A|not specified	Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496214	13	20763710	13	20189571	496214	487388	rs1555342014	NC_000013.11:20189570:CCCC:CCC
NM_004004.6(GJB2):c.132G>C (p.Trp44Cys)	GJB2	W44C	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000017019	13	20763589	13	20189450	17019	32058	rs104894407	NC_000013.11:20189449:C:G
NM_000282.4(PCCA):c.722del (p.Gly241fs)	PCCA	G215fs, G241fs	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551231	13	100914987	13	100262733	551231	547278	rs745571507	NC_000013.11:100262732:GG:G
NM_000282.4(PCCA):c.1426C>T (p.Arg476Ter)	PCCA	R476*, R161*, R450*, R113*, R402*, R428*	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000218264	13	100962159	13	100309905	218264	214895	rs768703749	NC_000013.11:100309904:C:T
NM_000282.4(PCCA):c.1023dup (p.Lys342Ter)	PCCA		not provided|Propionic acidemia	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092760	13	100925557 - 100925558	13	100273303 - 100273304	92760	98667	rs398123297	NC_000013.11:100273303:T:TT
NM_004004.6(GJB2):c.385G>T (p.Glu129Ter)	GJB2	E129*	Deafness, autosomal recessive 1A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000225223	13	20763336	13	20189197	225223	227136	rs397516875	NC_000013.11:20189196:C:A
GRCh37/hg19 17p13.2(chr17:3547302-3553878)x1	CTNS		not provided	Pathogenic(Last reviewed: Jan 2, 2018)	no assertion criteria provided	VCV000687237	17	3547302 - 3553878			687237	674829		
NM_001031681.2(CTNS):c.516dup (p.Tyr173fs)	CTNS		not provided	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000449354	17	3559833 - 3559834	17	3656539 - 3656540	449354	445763	rs1555563441	NC_000017.11:3656539:CC:CCC
NM_001031681.2(CTNS):c.544T>C (p.Trp182Arg)	CTNS	W182R	Cystinosis	Pathogenic(Last reviewed: Oct 6, 2016)	no assertion criteria provided	VCV000267308	17	3559863	17	3656569	267308	262355	rs764168489	NC_000017.11:3656568:T:C
NM_001031681.2(CTNS):c.397A>T (p.Ile133Phe)	CTNS	I133F, I133P	Cystinosis	Pathogenic(Last reviewed: Oct 6, 2016)	no assertion criteria provided	VCV000267307	17	3558582	17	3655288	267307	262354	rs886040970	NC_000017.11:3655287:A:T
NM_001031681.2(CTNS):c.120del (p.Asn41fs)	CTNS	N41fs	Cystinosis	Pathogenic	no assertion criteria provided	VCV000253209	17	3550795	17	3647501	253209	247624	rs879255616	NC_000017.11:3647500:CC:C
NM_001031681.2(CTNS):c.91dup (p.Val31fs)	CTNS		Cystinosis	Pathogenic	no assertion criteria provided	VCV000253208	17	3550766 - 3550767	17	3647472 - 3647473	253208	247623	rs879255613	NC_000017.11:3647472:G:GG
NM_004937.2:c.661insT	CTNS		Cystinosis	Pathogenic	no assertion criteria provided	VCV000253207					253207	247622		
NM_001031681.2(CTNS):c.255_256CT[1] (p.Ser86fs)	CTNS		Cystinosis	Pathogenic	no assertion criteria provided	VCV000253206	17	3558321 - 3558322	17	3655027 - 3655028	253206	247621	rs879255614	NC_000017.11:3655026:CTCT:CT
NM_001031681.2(CTNS):c.696dup (p.Val233fs)	CTNS		Nephropathic cystinosis	Pathogenic(Last reviewed: Aug 11, 2011)	no assertion criteria provided	VCV000021441	17	3561312 - 3561313	17	3658018 - 3658019	21441	34293	rs113994209	NC_000017.11:3658018:C:CC
NM_001031681.2(CTNS):c.329G>T (p.Gly110Val)	CTNS	G110V	Cystinosis, atypical nephropathic	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000004457	17	3558395	17	3655101	4457	19496	rs121908129	NC_000017.11:3655100:G:T
NM_000282.4(PCCA):c.231+1G>C	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550113	13	100764143	13	100111889	550113	547054	rs972937270	NC_000013.11:100111888:G:C
NM_000282.4(PCCA):c.1788G>A (p.Trp596Ter)	PCCA	W596*, W522*, W548*, W281*, W233*, W570*	Propionic acidemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000195456	13	101077928	13	100425674	195456	192617	rs776496862	NC_000013.11:100425673:G:A
NM_004937.3(CTNS):c.841dup (p.Tyr281fs)	CTNS		Nephropathic cystinosis|Juvenile nephropathic cystinosis|Ocular cystinosis	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000856604	17	3561457 - 3561458	17	3658163 - 3658164	856604	845247		NC_000017.11:3658163:T:TT
NC_000017.11:g.(?_3654988)_(3655362_?)del	CTNS		Ocular cystinosis|Nephropathic cystinosis|Juvenile nephropathic cystinosis	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000831009	17	3558282 - 3558656			831009	821040		
NC_000017.10:g.(?_3550718)_(3552245_?)del	CTNS		Nephropathic cystinosis|Juvenile nephropathic cystinosis|Ocular cystinosis	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000665648	17	3550718 - 3552245	17	3647424 - 3648951	665648	653105		
NC_000017.10:g.(?_3550728)_(3552235_?)del	CTNS		Ocular cystinosis|Nephropathic cystinosis|Juvenile nephropathic cystinosis	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000658450	17	3550728 - 3552235	17	3647434 - 3648941	658450	652641		
NM_004937.3(CTNS):c.429C>A (p.Tyr143Ter)	CTNS	Y143*	Juvenile nephropathic cystinosis|Ocular cystinosis|Nephropathic cystinosis	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000654346	17	3558614	17	3655320	654346	645826		NC_000017.11:3655319:C:A
NC_000017.10:g.(?_3561289)_(3564038_?)del	CTNS		Ocular cystinosis|Nephropathic cystinosis|Juvenile nephropathic cystinosis	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000645871	17	3561289 - 3564038	17	3657995 - 3660744	645871	653107		
NC_000017.10:g.(?_3550738)_(3561469_?)del	CTNS		Ocular cystinosis|Nephropathic cystinosis|Juvenile nephropathic cystinosis	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000584155	17	3550738 - 3561469	17	3647444 - 3658175	584155	574257		
NM_004937.3(CTNS):c.969C>G (p.Asn323Lys)	CTNS	N323K	Juvenile nephropathic cystinosis	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000004456	17	3563268	17	3659974	4456	19495	rs121908128	NC_000017.11:3659973:C:G
CTNS, -303G-T, PROMOTER	CTNS		Ocular cystinosis	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000004453					4453	19492		
CTNS, -295G-C, PROMOTER	CTNS		Nephropathic cystinosis	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000004452					4452	19491		
CTNS, IVS7AS, C-G, -10	CTNS		Juvenile nephropathic cystinosis	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000004448					4448	19487		
NM_001031681.2(CTNS):c.506G>A (p.Gly169Asp)	CTNS	G169D	Nephropathic cystinosis	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000004446	17	3559825	17	3656531	4446	19485	rs121908126	NC_000017.11:3656530:G:A
NM_001031681.2(CTNS):c.58_59TG[1] (p.Cys20_Glu21delinsTer)	CTNS		Nephropathic cystinosis	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000004442	17	3543558 - 3543559	17	3640264 - 3640265	4442	19481	rs1567695026	NC_000017.11:3640263:TGTG:TG
NM_001031681.2(CTNS):c.283G>T (p.Gly95Ter)	CTNS	G95*	Nephropathic cystinosis	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000004441	17	3558349	17	3655055	4441	19480	rs121908124	NC_000017.11:3655054:G:T
NM_000359.3(TGM1):c.832G>A (p.Gly278Arg)	TGM1	G278R	Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012492	14	24729190	14	24259984	12492	27531	rs121918725	NC_000014.9:24259983:C:T
NM_000359.3(TGM1):c.1135G>C (p.Val379Leu)	TGM1	V378L, V379L	Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012486	14	24728305	14	24259099	12486	27525	rs121918720	NC_000014.9:24259098:C:G
NM_001031681.2(CTNS):c.890G>A (p.Trp297Ter)	CTNS	W297*	Nephropathic cystinosis	Pathogenic(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	VCV000551289	17	3563189	17	3659895	551289	548141	rs917630768	NC_000017.11:3659894:G:A
NC_000017.10:g.(?_3539712)_(3560109_?)del	CTNS		Ocular cystinosis|Nephropathic cystinosis|Juvenile nephropathic cystinosis	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000526033	17	3539712 - 3560109	17	3636418 - 3656815	526033	531022		
NM_004937.3(CTNS):c.751_754delinsCG (p.Thr251fs)	CTNS		Ocular cystinosis|Nephropathic cystinosis|Juvenile nephropathic cystinosis	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000526031	17	3561368 - 3561371	17	3658074 - 3658077	526031	530976	rs1555564051	NC_000017.11:3658073:ACCA:CG
NM_001031681.2(CTNS):c.870C>G (p.Tyr290Ter)	CTNS	Y290*	Cystinosis	Pathogenic(Last reviewed: May 15, 2016)	criteria provided, single submitter	VCV000505009	17	3563169	17	3659875	505009	497290	rs776842972	NC_000017.11:3659874:C:G
CTNS, 1-BP INS, -303T, PROMOTER	CTNS		Ocular cystinosis	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000004454					4454	19493		
NM_004937.3(CTNS):c.853-3C>G	CTNS		Ocular cystinosis	Pathogenic(Last reviewed: Aug 11, 2011)	no assertion criteria provided	VCV000004449	17	3563149	17	3659855	4449	19488	rs113994210	NC_000017.11:3659854:C:G
NM_015272.5(RPGRIP1L):c.2413C>T (p.Arg805Ter)	RPGRIP1L	R805*	Joubert syndrome 7|Joubert syndrome with hepatic defect|not provided	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001079	16	53679807	16	53645895	1079	16118	rs145665129	NC_000016.10:53645894:G:A
NM_004937.3(CTNS):c.61+5G>A	CTNS		Juvenile nephropathic cystinosis|Nephropathic cystinosis|Ocular cystinosis	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000836956	17	3543566	17	3640272	836956	851717		NC_000017.11:3640271:G:A
NM_004937.3(CTNS):c.140+1G>T	CTNS		Nephropathic cystinosis|Juvenile nephropathic cystinosis|Ocular cystinosis	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000666181	17	3550817	17	3647523	666181	652939		NC_000017.11:3647522:G:T
NM_001018005.2(TPM1):c.276C>G (p.Ile92Met)	TPM1	I92M, I134M, I56M	not provided	Pathogenic(Last reviewed: Mar 1, 2012)	criteria provided, single submitter	VCV000181684	15	63349219	15	63057020	181684	179761	rs730881157	NC_000015.10:63057019:C:G
NM_001018005.2(TPM1):c.428T>G (p.Ile143Ser)	TPM1	I143S, I107S, I185S	not provided	Pathogenic(Last reviewed: Feb 24, 2012)	criteria provided, single submitter	VCV000181663	15	63351815	15	63059616	181663	179766	rs730881136	NC_000015.10:63059615:T:G
NM_014305.4(TGDS):c.298G>T (p.Ala100Ser)	TGDS	A100S, A68S	Catel Manzke syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000162455	13	95243122	13	94590868	162455	172130	rs140430952	NC_000013.11:94590867:C:A
NM_001018005.2(TPM1):c.742A>G (p.Lys248Glu)	TPM1	K248E, K290E, K212E	Left ventricular noncompaction 9|not provided	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000031901	15	63354814	15	63062615	31901	40561	rs199476319	NC_000015.10:63062614:A:G
NM_001018005.2(TPM1):c.118G>A (p.Glu40Lys)	TPM1	E40K, E82K	Dilated cardiomyopathy 1Y	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000012459	15	63336229	15	63044030	12459	27498	rs104894501	NC_000015.10:63044029:G:A
NM_004937.3(CTNS):c.61_61+2del	CTNS		Ocular cystinosis|Juvenile nephropathic cystinosis|Nephropathic cystinosis	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000852141	17	3543559 - 3543561	17	3640265 - 3640267	852141	852736		NC_000017.11:3640264:GTGGT:GT
NM_001031681.2(CTNS):c.681G>A (p.Glu227=)	CTNS		Nephropathic cystinosis	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000553330	17	3560089	17	3656795	553330	548117	rs778414542	NC_000017.11:3656794:G:A
NM_001031681.2(CTNS):c.853-2A>G	CTNS		Cystinosis|Nephropathic cystinosis	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000496277	17	3563150	17	3659856	496277	487825	rs1475322504	NC_000017.11:3659855:A:G
NM_001031681.2(CTNS):c.519_520del (p.Tyr173_Ser174delinsTer)	CTNS		Nephropathic cystinosis	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	VCV000371212	17	3559837 - 3559838	17	3656543 - 3656544	371212	358430	rs745365232	NC_000017.11:3656542:ACA:A
NM_004004.6(GJB2):c.560_605dup (p.Cys202Ter)	GJB2		Deafness, autosomal recessive 1A|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000627447	13	20763115 - 20763116	13	20188976 - 20188977	627447	615817	rs1566528185	NC_000013.11:20188976:CAAATTCCAGACACTGCAATCATGAACACTGTGAAGACAGTCTTCTC:CAAATTCCAGACACTGCAATCATGAACACTGTGAAGACAGTCTTCTCAAATTCCAGACACTGCAATCATGAACACTGTGAAGACAGTCTTCTC
NM_004004.6(GJB2):c.516G>C (p.Trp172Cys)	GJB2	W172C	Nonsyndromic hearing loss and deafness|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Jul 28, 2019)	reviewed by expert panel	VCV000590799	13	20763205	13	20189066	590799	581737	rs1302739538	NC_000013.11:20189065:C:G
NM_000282.4(PCCA):c.2002G>A (p.Gly668Arg)	PCCA	G668R, G594R, G335R, G650R, G353R, G620R, G642R, G305R	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000218266	13	101167783	13	100515529	218266	214898	rs771438170	NC_000013.11:100515528:G:A
NM_000282.4(PCCA):c.425G>A (p.Gly142Asp)	PCCA	G142D, G116D	Propionic acidemia|not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203880	13	100809551	13	100157297	203880	200253	rs796052019	NC_000013.11:100157296:G:A
NM_000430.4(PAFAH1B1):c.162del (p.Lys54fs)	PAFAH1B1	K54fs	not provided|Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000021180	17	2569347	17	2666053	21180	34032	rs113994198	NC_000017.11:2666052:AAAAAAAA:AAAAAAA
NM_000231.2(SGCG):c.195+4_195+7del	SGCG		Severe autosomal recessive muscular dystrophy of childhood - North African type|not provided	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208611	13	23778028 - 23778031	13	23203889 - 23203892	208611	205173	rs797045106	NC_000013.11:23203888:AGTAAGTA:AGTA
NM_004937.3(CTNS):c.682-1G>T	CTNS		Nephropathic cystinosis|Juvenile nephropathic cystinosis|Ocular cystinosis	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000664004	17	3561298	17	3658004	664004	653266		NC_000017.11:3658003:G:T
NM_004937.3(CTNS):c.206_210del (p.Ile69fs)	CTNS	I69fs	Nephropathic cystinosis|Nephropathic cystinosis|Juvenile nephropathic cystinosis|Ocular cystinosis	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000455787	17	3552206 - 3552210	17	3648912 - 3648916	455787	467996	rs879758262	NC_000017.11:3648911:TCCTT:
NM_004119.2(FLT3):c.2503G>C (p.Asp835His)	FLT3	D835H	Acute myeloid leukemia	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000016273	13	28592642	13	28018505	16273	31312	rs121913488	NC_000013.11:28018504:C:G
NM_024339.5(THOC6):c.824G>A (p.Gly275Asp)	THOC6	G275D, G251D	Beaulieu-Boycott-Innes syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521349	16	3077380	16	3027379	521349	512195	rs200426926	NC_000016.10:3027378:G:A
NM_024339.5(THOC6):c.298T>A (p.Trp100Arg)	THOC6	W100R, W76R	Inborn genetic diseases|Beaulieu-Boycott-Innes syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521347	16	3076141	16	3026140	521347	512192	rs138632121	NC_000016.10:3026139:T:A
NM_001126108.2(SLC12A3):c.1456G>A (p.Asp486Asn)	SLC12A3	D485N, D486N	not provided	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000642516	16	56914054	16	56880142	642516	644774		NC_000016.10:56880141:G:A
NM_001018005.2(TPM1):c.160G>A (p.Glu54Lys)	TPM1	E54K, E96K	Dilated cardiomyopathy 1Y|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012458	15	63336271	15	63044072	12458	27497	rs104894505	NC_000015.10:63044071:G:A
NM_000303.3(PMM2):c.323C>T (p.Ala108Val)	PMM2	A108V	Congenital disorder of glycosylation, type Ia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092800	16	8900240	16	8806383	92800	98707	rs200503569	NC_000016.10:8806382:C:T
NM_004004.6(GJB2):c.257C>G (p.Thr86Arg)	GJB2	T86R	Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000631697	13	20763464	13	20189325	631697	620467	rs1291519904	NC_000013.11:20189324:G:C
NM_004004.6(GJB2):c.9G>A (p.Trp3Ter)	GJB2	W3*	Deafness, autosomal recessive 1A|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000044767	13	20763712	13	20189573	44767	53934	rs111033401	NC_000013.11:20189572:C:T
NM_004937.3(CTNS):c.829dup (p.Thr277fs)	CTNS		Nephropathic cystinosis|Ocular cystinosis|Juvenile nephropathic cystinosis|Nephropathic cystinosis	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551290	17	3561445 - 3561446	17	3658151 - 3658152	551290	548835	rs752919200	NC_000017.11:3658151:A:AA
NC_000017.10:g.(?_3539712)_(3561489_?)del	CTNS		Nephropathic cystinosis|Juvenile nephropathic cystinosis|Ocular cystinosis	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000455786	17	3539712 - 3561489	17	3636418 - 3658195	455786	467343		
NM_001031681.2(CTNS):c.382C>T (p.Gln128Ter)	CTNS	Q128*	Cystinosis|Nephropathic cystinosis	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000267306	17	3558567	17	3655273	267306	262353	rs550254092	NC_000017.11:3655272:C:T
NM_001031681.2(CTNS):c.613G>A (p.Asp205Asn)	CTNS	D205N	Cystinosis|Nephropathic cystinosis	Pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, single submitter	VCV000021440	17	3560021	17	3656727	21440	34292	rs113994208	NC_000017.11:3656726:G:A
GRCh37/hg19 16q23.2(chr16:81380493-81433070)x1	GAN		not provided	Pathogenic(Last reviewed: Dec 8, 2017)	no assertion criteria provided	VCV000686489	16	81380493 - 81433070			686489	674081		
NM_022041.3(GAN):c.633+2T>C	GAN		not provided	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000245920	16	81388362	16	81354757	245920	245007	rs879254001	NC_000016.10:81354756:T:C
NC_000016.10:g.(?_81315104)_(81377606_?)del	GAN		Giant axonal neuropathy 1	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000832850	16	81348709 - 81411211			832850	820887		
NM_022041.3(GAN):c.1373+1G>A	GAN		Giant axonal neuropathy 1	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689762	16	81398716	16	81365111	689762	677453		NC_000016.10:81365110:G:A
NM_022041.3(GAN):c.1157del (p.Lys386fs)	GAN	K386fs	Giant axonal neuropathy 1	Pathogenic(Last reviewed: Nov 12, 2016)	criteria provided, single submitter	VCV000465385	16	81397466	16	81363861	465385	467069	rs1555511861	NC_000016.10:81363860:AAAA:AAA
NM_022041.3(GAN):c.505G>A (p.Glu169Lys)	GAN	E169K	Giant axonal neuropathy 1	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000005038	16	81388232	16	81354627	5038	20077	rs119485095	NC_000016.10:81354626:G:A
NM_022041.3(GAN):c.1429C>T (p.Arg477Ter)	GAN	R477*	Giant axonal neuropathy 1	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000005037	16	81399010	16	81365405	5037	20076	rs119485094	NC_000016.10:81365404:C:T
NM_022041.3(GAN):c.1447C>T (p.Gln483Ter)	GAN	Q483*	Giant axonal neuropathy 1	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000005031	16	81399028	16	81365423	5031	20070	rs119485089	NC_000016.10:81365422:C:T
NM_022041.3(GAN):c.1456G>A (p.Glu486Lys)	GAN	E486K	Giant axonal neuropathy 1	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000005030	16	81399037	16	81365432	5030	20069	rs119485088	NC_000016.10:81365431:G:A
NM_022041.3(GAN):c.43C>A (p.Arg15Ser)	GAN	R15S	Giant axonal neuropathy 1	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000005036	16	81348761	16	81315156	5036	20075	rs119485093	NC_000016.10:81315155:C:A
NM_000282.4(PCCA):c.1899+4_1899+7del	PCCA		not provided|Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000195560	13	101101560 - 101101563	13	100449306 - 100449309	195560	192721	rs794727334	NC_000013.11:100449305:GTAAGTA:GTA
NM_030665.4(RAI1):c.2538del (p.Thr847fs)	RAI1	T847fs	not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000817929	17	17698799	17	17795485	817929	805923		NC_000017.11:17795484:CC:C
NM_030665.4(RAI1):c.2802dup (p.Glu935fs)	RAI1		not provided	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000817786	17	17699062 - 17699063	17	17795748 - 17795749	817786	805924		NC_000017.11:17795748:CC:CCC
NM_030665.4(RAI1):c.3681del (p.Phe1228fs)	RAI1	F1228fs	not provided	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000817206	17	17699942	17	17796628	817206	805925		NC_000017.11:17796627:CC:C
NM_030665.4(RAI1):c.182_185del (p.Gly61fs)	RAI1	G61fs	not provided	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000817187	17	17696442 - 17696445	17	17793128 - 17793131	817187	805922		NC_000017.11:17793127:GGGTGG:GG
NM_030665.4(RAI1):c.1348C>T (p.Gln450Ter)	RAI1	Q450*	not provided	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000620558	17	17697610	17	17794296	620558	611841	rs1567917533	NC_000017.11:17794295:C:T
NM_030665.4(RAI1):c.4432C>T (p.Arg1478Ter)	RAI1	R1478*	not provided	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000546563	17	17700694	17	17797380	546563	536928	rs753540389	NC_000017.11:17797379:C:T
NM_030665.4(RAI1):c.4884del (p.Ser1629fs)	RAI1	S1629fs	not provided	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000524028	17	17701145	17	17797831	524028	514709	rs1555566124	NC_000017.11:17797830:CC:C
NM_030665.4(RAI1):c.2613C>A (p.Tyr871Ter)	RAI1	Y871*	not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000489106	17	17698875	17	17795561	489106	482119	rs1555565533	NC_000017.11:17795560:C:A
NM_030665.4(RAI1):c.3142_3144delinsCT (p.Ala1048fs)	RAI1		not provided	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000453211	17	17699404 - 17699406	17	17796090 - 17796092	453211	445711	rs1555565674	NC_000017.11:17796089:GCC:CT
NM_030665.4(RAI1):c.3398C>G (p.Ser1133Ter)	RAI1	S1133*	not provided	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000452595	17	17699660	17	17796346	452595	445712	rs750335388	NC_000017.11:17796345:C:G
NM_030665.4(RAI1):c.1114dup (p.Tyr372fs)	RAI1		not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000430177	17	17697375 - 17697376	17	17794061 - 17794062	430177	422147	rs1131691817	NC_000017.11:17794061:T:TT
NM_030665.4(RAI1):c.3121del (p.Ala1041fs)	RAI1	A1041fs	not provided	Pathogenic(Last reviewed: Oct 23, 2015)	criteria provided, single submitter	VCV000429828	17	17699380	17	17796066	429828	422148	rs1131691617	NC_000017.11:17796065:GGGG:GGG
NM_030665.4(RAI1):c.5182del (p.Thr1728fs)	RAI1	T1728fs	not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000423074	17	17701444	17	17798130	423074	409846	rs1064796209	NC_000017.11:17798129:A:
NM_030665.4(RAI1):c.3389_3392AGAC[1] (p.Asp1132fs)	RAI1		not provided	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000423003	17	17699651 - 17699654	17	17796337 - 17796340	423003	409845	rs1064796156	NC_000017.11:17796336:AGACAGAC:AGAC
NM_030665.4(RAI1):c.3096del (p.Gln1035fs)	RAI1	Q1035fs	not provided	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000291184	17	17699356	17	17796042	291184	275421	rs886044681	NC_000017.11:17796041:GGG:GG
NM_030665.4(RAI1):c.2275G>T (p.Gly759Ter)	RAI1	G759*	not provided	Pathogenic(Last reviewed: Aug 11, 2016)	criteria provided, single submitter	VCV000280770	17	17698537	17	17795223	280770	265006	rs886041916	NC_000017.11:17795222:G:T
NM_030665.4(RAI1):c.1690_1691del (p.Met564fs)	RAI1	M564fs	not provided	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000265668	17	17697952 - 17697953	17	17794638 - 17794639	265668	260156	rs886039715	NC_000017.11:17794637:AT:
NM_030665.4(RAI1):c.3281C>A (p.Ser1094Ter)	RAI1	S1094*	not provided	Pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, single submitter	VCV000196540	17	17699543	17	17796229	196540	193701	rs376044849	NC_000017.11:17796228:C:A
NM_030665.4(RAI1):c.4678C>T (p.Arg1560Ter)	RAI1	R1560*	not provided	Pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	VCV000167563	17	17700940	17	17797626	167563	177026	rs727504119	NC_000017.11:17797625:C:T
NM_030665.4(RAI1):c.3583A>T (p.Lys1195Ter)	RAI1	K1195*	not provided	Pathogenic(Last reviewed: Apr 21, 2014)	criteria provided, single submitter	VCV000167561	17	17699845	17	17796531	167561	177156	rs727504118	NC_000017.11:17796530:A:T
NM_030665.4(RAI1):c.412del (p.Val138fs)	RAI1	V138fs	not provided	Pathogenic(Last reviewed: Mar 11, 2013)	criteria provided, single submitter	VCV000096189	17	17696671	17	17793357	96189	102083	rs398124419	NC_000017.11:17793356:GGGG:GGG
GRCh37/hg19 17p11.2(chr17:17627289-17627351)x1	RAI1		See cases	Pathogenic	no assertion criteria provided	VCV000394433	17	17627289 - 17627351			394433	381326		
NM_030665.4(RAI1):c.1069_1070insC (p.Ser357fs)	RAI1		Smith-Magenis syndrome	Pathogenic(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000807669	17	17697331 - 17697332	17	17794017 - 17794018	807669	798711		NC_000017.11:17794017::C
NM_030665.4(RAI1):c.4814del (p.Asp1605fs)	RAI1	D1605fs	Smith-Magenis syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803329	17	17701076	17	17797762	803329	791682		NC_000017.11:17797761:A:
NM_030665.4(RAI1):c.2332_2336del (p.Gly778fs)	RAI1	G778fs	Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235845	17	17698592 - 17698596	17	17795278 - 17795282	235845	237501	rs878853142	NC_000017.11:17795277:ATGGCAT:AT
NM_030665.4(RAI1):c.2273G>A (p.Trp758Ter)	RAI1	W758*	Smith-Magenis syndrome	Pathogenic	no assertion criteria provided	VCV000143197	17	17698535	17	17795221	143197	152915	rs527236033	NC_000017.11:17795220:G:A
NM_139241.3(FGD4):c.893T>G (p.Met298Arg)	FGD4	M298R, M383R, M410R, M50R, M205R, M114R, M462R	Charcot-Marie-Tooth disease, type 4H|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000038445	12	32755151	12	32602217	38445	47004	rs63749871	NC_000012.12:32602216:T:G
NM_030665.4(RAI1):c.3188_3191TGAG[1] (p.Glu1065fs)	RAI1		Smith-Magenis syndrome	Pathogenic(Last reviewed: Sep 24, 2018)	no assertion criteria provided	VCV000625530	17	17699450 - 17699453	17	17796136 - 17796139	625530	613831		NC_000017.11:17796135:TGAGTGAG:TGAG
NM_030665.4(RAI1):c.2472dup (p.Leu825fs)	RAI1		Smith-Magenis syndrome	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000522853	17	17698731 - 17698732	17	17795417 - 17795418	522853	513464	rs1555565492	NC_000017.11:17795417:GGG:GGGG
NM_030665.4(RAI1):c.4673dup (p.Arg1559fs)	RAI1		Smith-Magenis syndrome	Pathogenic(Last reviewed: Jun 30, 2017)	no assertion criteria provided	VCV000488447	17	17700933 - 17700934	17	17797619 - 17797620	488447	481322	rs1555566042	NC_000017.11:17797619:AA:AAA
RAI1, 19-BP DEL	RAI1		Smith-Magenis syndrome	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000002952					2952	17991		
NM_030665.4(RAI1):c.3801del (p.Thr1268fs)	RAI1	T1268fs	Smith-Magenis syndrome	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000002951	17	17700059	17	17796745	2951	17990		NC_000017.11:17796744:CCCCC:CCCC
NM_030665.4(RAI1):c.5423G>A (p.Ser1808Asn)	RAI1	S1808N	Smith-Magenis syndrome	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000002949	17	17701685	17	17798371	2949	17988	rs104894633	NC_000017.11:17798370:G:A
RAI1, 29-BP DEL	RAI1		Smith-Magenis syndrome	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000002948					2948	17987		
RAI1, 1-BP DEL, 1308C	RAI1		Smith-Magenis syndrome	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000002947					2947	17986		
RAI1, 1-BP DEL, 4929C	RAI1		Smith-Magenis syndrome	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000002946					2946	17985		
NM_022041.3(GAN):c.601C>T (p.Arg201Ter)	GAN	R201*	Giant axonal neuropathy 1	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000005033	16	81388328	16	81354723	5033	20072	rs119485090	NC_000016.10:81354722:C:T
NM_030665.4(RAI1):c.4685A>G (p.Gln1562Arg)	RAI1	Q1562R	Smith-Magenis syndrome	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000002950	17	17700947	17	17797633	2950	17989	rs104894634	NC_000017.11:17797632:A:G
NM_006662.3(SRCAP):c.7303C>T (p.Arg2435Ter)	SRCAP	R2435*	not provided|Floating-Harbor syndrome	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030909	16	30748664	16	30737343	30909	39866	rs199469465	NC_000016.10:30737342:C:T
NM_000080.4(CHRNE):c.971del (p.Ile324fs)	CHRNE	I324fs	not provided|Congenital myasthenic syndrome 4C|Myasthenic syndrome, congenital, 4a, slow-channel	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000018348	17	4802824	17	4899529	18348	33387	rs879255562	NC_000017.11:4899528:A:
NM_022041.3(GAN):c.1502+1G>T	GAN		Giant axonal neuropathy 1	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000465389	16	81399084	16	81365479	465389	466036	rs1555511978	NC_000016.10:81365478:G:T
NM_004320.6(ATP2A1):c.490C>T (p.Arg164Ter)	ATP2A1	R164*, R39*	Brody myopathy	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000854514	16	28895922	16	28884601	854514	843707		NC_000016.10:28884600:C:T
NC_000016.10:g.(?_28887179)_(28888963_?)del	ATP2A1		Brody myopathy	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000832700	16	28898500 - 28900284			832700	820822		
NM_173201.4(ATP2A1):c.2311G>T (p.Glu771Ter)	ATP2A1	E646*, E771*	Brody myopathy	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000654280	16	28913394	16	28902073	654280	644565		NC_000016.10:28902072:G:T
NM_173201.4(ATP2A1):c.2371C>T (p.Gln791Ter)	ATP2A1	Q791*, Q666*	Brody myopathy	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000644960	16	28913554	16	28902233	644960	644567		NC_000016.10:28902232:C:T
NM_004320.5(ATP2A1):c.53_56TGAG[1] (p.Ser19fs)	ATP2A1		Brody myopathy	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000577343	16	28890044 - 28890047	16	28878723 - 28878726	577343	574013	rs770239154	NC_000016.10:28878722:GTGAGTGAG:GTGAG
NM_173201.4(ATP2A1):c.1491T>G (p.Tyr497Ter)	ATP2A1	Y497*, Y372*	Brody myopathy	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000572734	16	28909392	16	28898071	572734	570229	rs1409892710	NC_000016.10:28898070:T:G
NM_004320.5(ATP2A1):c.909_920delinsACGGCATA (p.Val304fs)	ATP2A1		Brody myopathy	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000464091	16	28899024 - 28899035	16	28887703 - 28887714	464091	466603	rs1555515558	NC_000016.10:28887702:TGTGGCTGCCAT:ACGGCATA
NM_004320.5(ATP2A1):c.2366C>T (p.Pro789Leu)	ATP2A1	P789L, P664L	Brody myopathy	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000017806	16	28913549	16	28902228	17806	32845	rs121918115	NC_000016.10:28902227:C:T
NM_004320.5(ATP2A1):c.440del (p.Pro147fs)	ATP2A1	P22fs, P147fs	Brody myopathy	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000017805	16	28893885	16	28882564	17805	32844		NC_000016.10:28882563:CCC:CC
ATP2A1, IVS3DS, G-C, -2	ATP2A1		Brody myopathy	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000017804					17804	32843		
NM_004320.5(ATP2A1):c.2025C>A (p.Cys675Ter)	ATP2A1	C675*, C550*	Brody myopathy	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000017803	16	28912162	16	28900841	17803	32842	rs121918114	NC_000016.10:28900840:C:A
NM_004320.5(ATP2A1):c.592C>T (p.Arg198Ter)	ATP2A1	R198*, R73*	Brody myopathy	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000017802	16	28898557	16	28887236	17802	32841	rs121918113	NC_000016.10:28887235:C:T
NM_004937.3(CTNS):c.422C>T (p.Ser141Phe)	CTNS	S141F	Ocular cystinosis|Nephropathic cystinosis|Juvenile nephropathic cystinosis	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000651886	17	3558607	17	3655313	651886	645825	rs1436441738	NC_000017.11:3655312:C:T
NM_004937.3(CTNS):c.771_793del (p.Gly258fs)	CTNS	G258fs	Cystinosis|Juvenile nephropathic cystinosis|Nephropathic cystinosis|Ocular cystinosis|Nephropathic cystinosis	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496276	17	3561376 - 3561398	17	3658082 - 3658104	496276	487925	rs759623796	NC_000017.11:3658081:CGTGGCTGCAGTGGGAGTGACCACGTGGCTGCAGT:CGTGGCTGCAGT
NM_004937.3(CTNS):c.646dup (p.Thr216fs)	CTNS		Nephropathic cystinosis|Nephropathic cystinosis|Ocular cystinosis|Juvenile nephropathic cystinosis	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371084	17	3560053 - 3560054	17	3656759 - 3656760	371084	358431	rs893207601	NC_000017.11:3656759:A:AA
NM_001031681.2(CTNS):c.926dup (p.Ser310fs)	CTNS		Cystinosis|Nephropathic cystinosis	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188714	17	3563220 - 3563221	17	3659926 - 3659927	188714	186976	rs786204420	NC_000017.11:3659926:GGGGG:GGGGGG
NM_030665.4(RAI1):c.2962_2965AAGA[1] (p.Lys989fs)	RAI1		not provided|Smith-Magenis syndrome	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431118	17	17699223 - 17699226	17	17795909 - 17795912	431118	424665	rs1135401792	NC_000017.11:17795908:AAAGAAAGA:AAAGA
NC_000016.10:g.(?_28878662)_(28904215_?)del	ATP2A1		Brody myopathy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000833503	16	28889983 - 28915536			833503	820821		
NC_000016.10:g.(?_28878661)_(28904215_?)del	ATP2A1		Brody myopathy	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000831256	16	28889982 - 28915536			831256	820820		
NM_004320.5(ATP2A1):c.2464del (p.Arg822fs)	ATP2A1	R697fs, R822fs	Brody myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000464084	16	28913640	16	28902319	464084	466356	rs751365374	NC_000016.10:28902318:CCCCCCCC:CCCCCCC
NM_139276.2(STAT3):c.1145G>A (p.Arg382Gln)	STAT3	R382Q	Inherited Immunodeficiency Diseases|Hyper-IgE recurrent infection syndrome 1, autosomal dominant|STAT3 gain of function|Hyper-IgE recurrent infection syndrome 1, autosomal dominant	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000018305	17	40481660	17	42329642	18305	33344	rs113994136	NC_000017.11:42329641:C:T
NM_004004.6(GJB2):c.564_565del (p.Lys188fs)	GJB2	K188fs	Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000371691	13	20763156 - 20763157	13	20189017 - 20189018	371691	358129	rs770116143	NC_000013.11:20189016:TCT:T
NM_001018005.2(TPM1):c.479G>A (p.Arg160His)	TPM1	R160H, R202H, R124H	not provided|Primary dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031899	15	63351866	15	63059667	31899	40559	rs199476311	NC_000015.10:63059666:G:A
NM_004320.5(ATP2A1):c.2758C>T (p.Gln920Ter)	ATP2A1	Q920*, Q795*	Brody myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423942	16	28914364	16	28903043	423942	409608	rs897301304	NC_000016.10:28903042:C:T
NM_001127701.1(SERPINA1):c.415G>A (p.Gly139Ser)	SERPINA1	G115S, G139S	Alpha-1-antitrypsin deficiency|PI NULL(DEVON)|PI Q0(DEVON)|PI NULL(NEWPORT)|PI Q0(NEWPORT)	Pathogenic, other(Last reviewed: Jul 15, 2016)	no assertion criteria provided	VCV000017986	14	94849160	14	94382823	17986	33025	rs11558261	NC_000014.9:94382822:C:T
NM_001127701.1(SERPINA1):c.1145T>G (p.Met382Arg)	SERPINA1	M358R, M382R	Alpha-1-antitrypsin deficiency|Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation	Pathogenic(Last reviewed: Dec 8, 2014)	no assertion criteria provided	VCV000017982	14	94844898	14	94378561	17982	33021	rs121912713	NC_000014.9:94378560:A:C
NM_000282.4(PCCA):c.229C>T (p.Arg77Trp)	PCCA	R77W, R51W	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550747	13	100764140	13	100111886	550747	546899	rs141371306	NC_000013.11:100111885:C:T
GRCh37/hg19 16p13.3(chr16:1568217-1570809)	IFT140		Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000813315	16	1568217 - 1570809			813315	801565		
NM_014714.4(IFT140):c.3192del (p.Glu1065fs)	IFT140	E1065fs	Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803144	16	1573907	16	1523906	803144	791525		NC_000016.10:1523905:GGGGG:GGGG
NM_014714.4(IFT140):c.3070G>T (p.Glu1024Ter)	IFT140	E1024*	Retinitis pigmentosa 80	Pathogenic(Last reviewed: Nov 5, 2018)	no assertion criteria provided	VCV000635440	16	1574624	16	1524623	635440	623320		NC_000016.10:1524622:C:A
NM_207361.6(FREM2):c.446_455del (p.Asp149fs)	FREM2	D149fs	not provided	Pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	VCV000523965	13	39261926 - 39261935	13	38687789 - 38687798	523965	514656	rs1555260833	NC_000013.11:38687788:GACCGCGTCCG:G
NM_207361.6(FREM2):c.3890del (p.Ile1297fs)	FREM2	I1297fs	FRASER SYNDROME 2	Pathogenic(Last reviewed: Nov 10, 2017)	no assertion criteria provided	VCV000522532	13	39265371	13	38691234	522532	513101	rs776269575	NC_000013.11:38691233:T:
NM_207361.6(FREM2):c.3103_3104del (p.Leu1036fs)	FREM2	L1036fs	FRASER SYNDROME 2	Pathogenic(Last reviewed: Nov 10, 2017)	no assertion criteria provided	VCV000522531	13	39264583 - 39264584	13	38690446 - 38690447	522531	513100	rs1555261304	NC_000013.11:38690445:GAG:G
NM_014714.4(IFT140):c.2400-2A>G	IFT140		not provided	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000489091	16	1576799	16	1526798	489091	482087	rs1555478654	NC_000016.10:1526797:T:C
NM_014714.4(IFT140):c.3991C>T (p.Gln1331Ter)	IFT140	Q1331*	not provided	Pathogenic(Last reviewed: Feb 27, 2015)	criteria provided, single submitter	VCV000196180	16	1569931	16	1519930	196180	193341	rs794727473	NC_000016.10:1519929:G:A
NM_207361.6(FREM2):c.4063C>T (p.Arg1355Ter)	FREM2	R1355*	Cryptophthalmos, unilateral or bilateral, isolated	Pathogenic(Last reviewed: Apr 10, 2019)	no assertion criteria provided	VCV000625184	13	39265544	13	38691407	625184	613527	rs765324128	NC_000013.11:38691406:C:T
NM_207361.6(FREM2):c.5309G>A (p.Trp1770Ter)	FREM2	W1770*	Cryptophthalmos, unilateral or bilateral, isolated	Pathogenic(Last reviewed: Apr 10, 2019)	no assertion criteria provided	VCV000625183	13	39338486	13	38764349	625183	613526	rs1566133616	NC_000013.11:38764348:G:A
NM_207361.6(FREM2):c.2206C>T (p.Arg736Ter)	FREM2	R736*	Cryptophthalmos, unilateral or bilateral, isolated	Pathogenic(Last reviewed: Apr 10, 2019)	no assertion criteria provided	VCV000625182	13	39263687	13	38689550	625182	613525	rs939534674	NC_000013.11:38689549:C:T
NM_172862.3:c.15del	FREM2		FRASER SYNDROME 2	Pathogenic(Last reviewed: Apr 10, 2019)	no assertion criteria provided	VCV000625181					625181	613524		
NM_207361.6(FREM2):c.6727C>T (p.Arg2243Ter)	FREM2	R2243*	Cryptophthalmia|Abnormality of the anus|Toe syndactyly|Finger syndactyly|Unilateral renal agenesis|Renal hypoplasia/aplasia|Ambiguous genitalia|Cryptotia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523570	13	39425230	13	38851093	523570	514030	rs767978562	NC_000013.11:38851092:C:T
NM_014714.4(IFT140):c.3454-1003_4040+737delinsC	IFT140		Joubert syndrome with Jeune asphyxiating thoracic dystrophy|Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000523185	16	1569145 - 1571812	16	1519144 - 1521811	523185	513806		
NM_014714.4(IFT140):c.4236_4239dup (p.Tyr1414fs)	IFT140		Retinal ciliopathy due to mutation in the retinitis pigmentosa-1 gene	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000523182	16	1561094 - 1561095	16	1511093 - 1511094	523182	513804	rs1555474009	NC_000016.10:1511093:GTAGG:GTAGGTAGG
NM_014714.4(IFT140):c.3141+1G>T	IFT140		Joubert syndrome with Jeune asphyxiating thoracic dystrophy|Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000523180	16	1574552	16	1524551	523180	513807	rs764770536	NC_000016.10:1524550:C:A
NM_014714.4(IFT140):c.2577+25G>A	IFT140		Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000523178	16	1576595	16	1526594	523178	513808	rs1423102192	NC_000016.10:1526593:C:T
NM_014714.4(IFT140):c.2278C>T (p.Arg760Ter)	IFT140	R760*	Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia	Pathogenic(Last reviewed: Nov 22, 2017)	no assertion criteria provided	VCV000446316	16	1608057	16	1558056	446316	439757	rs1555486629	NC_000016.10:1558055:G:A
NM_014714.4(IFT140):c.2815T>C (p.Ser939Pro)	IFT140	S939P	Retinitis pigmentosa 80	Pathogenic(Last reviewed: Nov 22, 2017)	no assertion criteria provided	VCV000446315	16	1575281	16	1525280	446315	439756	rs145549969	NC_000016.10:1525279:A:G
NM_014714.4(IFT140):c.1898_1901del (p.Asn633fs)	IFT140	N633fs	Retinitis pigmentosa 80	Pathogenic(Last reviewed: Nov 22, 2017)	no assertion criteria provided	VCV000446312	16	1616162 - 1616165	16	1566161 - 1566164	446312	439753	rs1555487977	NC_000016.10:1566160:TTATT:T
NM_014714.4(IFT140):c.4196T>C (p.Leu1399Pro)	IFT140	L1399P	Retinitis pigmentosa 80	Pathogenic(Last reviewed: Nov 22, 2017)	no assertion criteria provided	VCV000446311	16	1561138	16	1511137	446311	439752	rs559371453	NC_000016.10:1511136:A:G
NM_207361.6(FREM2):c.5954dup (p.Met1985fs)	FREM2		not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000285788	13	39358879 - 39358880	13	38784742 - 38784743	285788	270025	rs886043213	NC_000013.11:38784742:T:TT
NM_207361.6(FREM2):c.7519+1G>A	FREM2		FRASER SYNDROME 2	Pathogenic(Last reviewed: Feb 15, 2008)	no assertion criteria provided	VCV000001986	13	39433728	13	38859591	1986	17025	rs1566169711	NC_000013.11:38859590:G:A
NM_014714.4(IFT140):c.2177C>T (p.Pro726Leu)	IFT140	P726L	Cranioectodermal dysplasia|Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000523181	16	1612008	16	1562007	523181	513809	rs1417500285	NC_000016.10:1562006:G:A
NM_014714.4(IFT140):c.3939C>A (p.Cys1313Ter)	IFT140	C1313*	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000489108	16	1569983	16	1519982	489108	482086	rs1002670900	NC_000016.10:1519981:G:T
NM_014714.4(IFT140):c.4078T>C (p.Cys1360Arg)	IFT140	C1360R	Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000097052	16	1568321	16	1518320	97052	102954	rs431905520	NC_000016.10:1518319:A:G
NM_207361.6(FREM2):c.5920G>A (p.Glu1974Lys)	FREM2	E1972K	FRASER SYNDROME 2	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000001985	13	39358846	13	38784709	1985	17024	rs121434355	NC_000013.11:38784708:G:A
NM_001126108.2(SLC12A3):c.2191G>A (p.Gly731Arg)	SLC12A3	G731R, G730R	Familial hypokalemia-hypomagnesemia|not provided	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000562347	16	56921849	16	56887937	562347	553531	rs752101663	NC_000016.10:56887936:G:A
NM_014714.4(IFT140):c.3827G>A (p.Gly1276Glu)	IFT140	G1276E	Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000191356	16	1570178	16	1520177	191356	189161	rs779007169	NC_000016.10:1520176:C:T
NM_014714.4(IFT140):c.3916dup (p.Ala1306fs)	IFT140		Jeune thoracic dystrophy|Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000031684	16	1570005 - 1570006	16	1520004 - 1520005	31684	40346	rs587776909	NC_000016.10:1520004:CCCC:CCCCC
NM_004320.5(ATP2A1):c.2464dup (p.Arg822fs)	ATP2A1		Brody myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000464085	16	28913639 - 28913640	16	28902318 - 28902319	464085	466354	rs751365374	NC_000016.10:28902318:CCCCCCCC:CCCCCCCCC
NM_004320.5(ATP2A1):c.1740_1741CT[1] (p.Ser581fs)	ATP2A1		not provided|Brody myopathy	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000446878	16	28909748 - 28909749	16	28898427 - 28898428	446878	441895	rs1421005631	NC_000016.10:28898426:CTCT:CT
NM_173201.4(ATP2A1):c.1184+1G>A	ATP2A1		Brody myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000392313	16	28905565	16	28894244	392313	374322	rs551660089	NC_000016.10:28894243:G:A
NM_000359.3(TGM1):c.877-2A>G	TGM1		Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279911	14	24729019	14	24259813	279911	264584	rs142634031	NC_000014.9:24259812:T:C
NM_020366.3(RPGRIP1):c.1107del (p.Glu370fs)	RPGRIP1	E370fs	Leber congenital amaurosis|Leber congenital amaurosis 6|Cone-rod dystrophy 13|not provided|Leber congenital amaurosis 6	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000099809	14	21780617	14	21312458	99809	105698	rs61751266	NC_000014.9:21312457:AAAAA:AAAA
NM_000359.3(TGM1):c.1187G>A (p.Arg396His)	TGM1	R396H	not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039533	14	24727852	14	24258646	39533	48132	rs121918721	NC_000014.9:24258645:C:T
NM_000359.3(TGM1):c.424C>T (p.Arg142Cys)	TGM1	R142C	Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012483	14	24730985	14	24261779	12483	27522	rs121918716	NC_000014.9:24261778:G:A
NM_014714.4(IFT140):c.1990G>A (p.Glu664Lys)	IFT140	E664K	Retinitis pigmentosa 80|Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031679	16	1614075	16	1564074	31679	40341	rs387907192	NC_000016.10:1564073:C:T
NC_000017.10:g.(?_3539712)_(3561479_?)del	CTNS		Ocular cystinosis|Nephropathic cystinosis|Juvenile nephropathic cystinosis	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000652375	17	3539712 - 3561479	17	3636418 - 3658185	652375	653356		
NM_000303.3(PMM2):c.24del (p.Cys9fs)	PMM2	C9fs	Congenital disorder of glycosylation, type Ia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188744	16	8891763	16	8797906	188744	186952	rs768021123	NC_000016.10:8797905:C:
NM_000303.3(PMM2):c.193G>T (p.Asp65Tyr)	PMM2	D65Y	Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007710	16	8898638	16	8804781	7710	22749	rs104894527	NC_000016.10:8804780:G:T
NM_014714.3(IFT140):c.3454-488_4182+2588dup	IFT140		Joubert syndrome with Jeune asphyxiating thoracic dystrophy|Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia|Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia|Cranioectodermal dysplasia|Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000523177	16	1565629 - 1571297	16	1515628 - 1521296	523177	513805		
NM_024312.5(GNPTAB):c.3281_3282del (p.Asn1093_Cys1094insTer)	GNPTAB		not provided	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000817569	12	102151403 - 102151404	12	101757625 - 101757626	817569	805717		NC_000012.12:101757624:ACA:A
NM_024312.5(GNPTAB):c.377T>A (p.Leu126Ter)	GNPTAB	L126*	not provided	Pathogenic(Last reviewed: May 22, 2014)	criteria provided, single submitter	VCV000197858	12	102179984	12	101786206	197858	195019	rs774506925	NC_000012.12:101786205:A:T
NM_024312.5(GNPTAB):c.3556_3557AG[2] (p.Glu1187fs)	GNPTAB		not provided	Pathogenic(Last reviewed: Jun 9, 2014)	criteria provided, single submitter	VCV000194986	12	102147191 - 102147192	12	101753413 - 101753414	194986	192148	rs781689303	NC_000012.12:101753412:CTCTCT:CTCT
NM_024312.5(GNPTAB):c.732_733del (p.Lys244fs)	GNPTAB	K244fs	not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000096124	12	102173968 - 102173969	12	101780190 - 101780191	96124	102018	rs398124400	NC_000012.12:101780189:TTTTT:TTT
NM_024312.5(GNPTAB):c.2896del (p.Met966fs)	GNPTAB	M966fs	not provided	Pathogenic(Last reviewed: Dec 11, 2012)	criteria provided, single submitter	VCV000096120	12	102155361	12	101761583	96120	102014	rs398124398	NC_000012.12:101761582:T:
NM_024312.5(GNPTAB):c.1298G>A (p.Trp433Ter)	GNPTAB	W433*	not provided	Pathogenic(Last reviewed: Aug 28, 2013)	criteria provided, single submitter	VCV000096117	12	102161925	12	101768147	96117	102011	rs398124397	NC_000012.12:101768146:C:T
NM_024312.5(GNPTAB):c.1034_1035AT[1] (p.Ile346fs)	GNPTAB		not provided	Pathogenic(Last reviewed: Feb 12, 2013)	criteria provided, single submitter	VCV000096116	12	102164260 - 102164261	12	101770482 - 101770483	96116	102010	rs398124396	NC_000012.12:101770481:ATAT:AT
NM_024312.5(GNPTAB):c.1701del (p.Phe568fs)	GNPTAB	F568fs		Pathogenic	criteria provided, single submitter	VCV000813487	12	102158994	12	101765216	813487	801717		NC_000012.12:101765215:G:
NM_024312.5(GNPTAB):c.3094del (p.Thr1032fs)	GNPTAB	T1032fs		Pathogenic	criteria provided, single submitter	VCV000813486	12	102154946	12	101761168	813486	801716		NC_000012.12:101761167:TT:T
NM_024312.5(GNPTAB):c.3488del (p.Thr1163fs)	GNPTAB	T1163fs		Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000623268	12	102147264	12	101753486	623268	612231	rs1566067386	NC_000012.12:101753485:G:
NM_024312.5(GNPTAB):c.100G>C (p.Ala34Pro)	GNPTAB	A34P		Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522908	12	102224354	12	101830576	522908	513608	rs1555277061	NC_000012.12:101830575:C:G
NM_024312.5(GNPTAB):c.2354T>G (p.Leu785Trp)	GNPTAB	L785W	Pseudo-Hurler polydystrophy	Pathogenic	no assertion criteria provided	VCV000100738	12	102158341	12	101764563	100738	106603	rs144060383	NC_000012.12:101764562:A:C
GNPTAB:c.1895C>G	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000065525					65525	76433		
NM_024312.5(GNPTAB):c.3336-1G>C	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000041257	12	102151089	12	101757311	41257	49681	rs397507562	NC_000012.12:101757310:C:G
NM_024312.5(GNPTAB):c.3053A>G (p.Asp1018Gly)	GNPTAB	D1018G		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000041256	12	102154987	12	101761209	41256	49680	rs281865007	NC_000012.12:101761208:T:C
NM_024312.5(GNPTAB):c.2591_2592insG (p.Asn865fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000041255	12	102158103 - 102158104	12	101764325 - 101764326	41255	49679	rs281864997	NC_000012.12:101764325::C
NM_024312.5(GNPTAB):c.2189del (p.Leu730fs)	GNPTAB	L730fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000041254	12	102158506	12	101764728	41254	49678	rs281864988	NC_000012.12:101764727:AAA:AA
NM_024312.5(GNPTAB):c.1402T>A (p.Cys468Ser)	GNPTAB	C468S		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000041253	12	102161821	12	101768043	41253	49677	rs281864979	NC_000012.12:101768042:A:T
NM_024312.5(GNPTAB):c.940C>T (p.Gln314Ter)	GNPTAB	Q314*		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039092	12	102164357	12	101770579	39092	47695	rs281864968	NC_000012.12:101770578:G:A
NM_024312.5(GNPTAB):c.914dup (p.Asp305fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039091	12	102164792 - 102164793	12	101771014 - 101771015	39091	47694	rs281864967	NC_000012.12:101771014:T:TT
NM_024312.5(GNPTAB):c.857dup (p.Asn287fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039090	12	102164849 - 102164850	12	101771071 - 101771072	39090	47693	rs281864966	NC_000012.12:101771071:TT:TTT
NM_024312.5(GNPTAB):c.755_759del (p.Leu251_Ser252insTer)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039089	12	102173942 - 102173946	12	101780164 - 101780168	39089	47692	rs281864965	NC_000012.12:101780163:AGAGGA:A
NM_024312.4:c.750+3A>C	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039088					39088	47691		
NM_024312.5(GNPTAB):c.637-1G>A	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039085	12	102174065	12	101780287	39085	47688	rs281864962	NC_000012.12:101780286:C:T
NM_024312.5(GNPTAB):c.625_629del (p.Arg209fs)	GNPTAB	R209fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039084	12	102174342 - 102174346	12	101780564 - 101780568	39084	47687	rs281864961	NC_000012.12:101780563:CCCCTCC:CC
NM_024312.5(GNPTAB):c.3523_3529del (p.Met1175fs)	GNPTAB	M1175fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039077	12	102147223 - 102147229	12	101753445 - 101753451	39077	47680	rs281865021	NC_000012.12:101753444:GGAACATGGA:GGA
NM_024312.5(GNPTAB):c.3487_3490del (p.Gln1162_Thr1163insTer)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039076	12	102147262 - 102147265	12	101753484 - 101753487	39076	47679	rs281865020	NC_000012.12:101753483:CTGTCTG:CTG
NM_024312.5(GNPTAB):c.3428dup (p.Asn1143fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039072	12	102150995 - 102150996	12	101757217 - 101757218	39072	47675	rs281865017	NC_000012.12:101757217:TTTTTT:TTTTTTT
NM_024312.5(GNPTAB):c.3330dup (p.Tyr1111fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039070	12	102151354 - 102151355	12	101757576 - 101757577	39070	47673	rs281865014	NC_000012.12:101757576:TTT:TTTT
NM_024312.5(GNPTAB):c.3310del (p.Ala1104fs)	GNPTAB	A1104fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039069	12	102151375	12	101757597	39069	47672	rs281865013	NC_000012.12:101757596:C:
NM_024312.5(GNPTAB):c.3249+1G>C	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039068	12	102153807	12	101760029	39068	47671	rs281865012	NC_000012.12:101760028:C:G
NM_024312.5(GNPTAB):c.3232del (p.Tyr1078fs)	GNPTAB	Y1078fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039067	12	102153825	12	101760047	39067	47670	rs281865011	NC_000012.12:101760046:A:
NM_024312.5(GNPTAB):c.3160C>G (p.Leu1054Val)	GNPTAB	L1054V		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039066	12	102153897	12	101760119	39066	47669	rs281865010	NC_000012.12:101760118:G:C
NM_024312.5(GNPTAB):c.3061C>T (p.Gln1021Ter)	GNPTAB	Q1021*		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039064	12	102154979	12	101761201	39064	47667	rs281865008	NC_000012.12:101761200:G:A
NM_024312.5(GNPTAB):c.3002T>C (p.Leu1001Pro)	GNPTAB	L1001P		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039063	12	102155038	12	101761260	39063	47666	rs281865006	NC_000012.12:101761259:A:G
NM_024312.5(GNPTAB):c.2693dup (p.Tyr899fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039057	12	102158001 - 102158002	12	101764223 - 101764224	39057	47660	rs281864999	NC_000012.12:101764223:TTTTTTTT:TTTTTTTTT
NM_024312.5(GNPTAB):c.2664C>G (p.Tyr888Ter)	GNPTAB	Y888*		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039056	12	102158031	12	101764253	39056	47659	rs281864998	NC_000012.12:101764252:G:C
NM_024312.5(GNPTAB):c.2544del (p.Glu849fs)	GNPTAB	E849fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039054	12	102158151	12	101764373	39054	47657	rs281864995	NC_000012.12:101764372:TTTT:TTT
NM_024312.5(GNPTAB):c.2427del (p.Leu810fs)	GNPTAB	L810fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039052	12	102158268	12	101764490	39052	47655	rs281864994	NC_000012.12:101764489:G:
NM_024312.5(GNPTAB):c.2422del (p.Leu808fs)	GNPTAB	L808fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039051	12	102158273	12	101764495	39051	47654	rs281864993	NC_000012.12:101764494:GGGG:GGG
NM_024312.5(GNPTAB):c.2220_2221dup (p.Met741fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039047	12	102158473 - 102158474	12	101764695 - 101764696	39047	47650	rs281864990	NC_000012.12:101764695:TC:TCTC
NM_024312.5(GNPTAB):c.2196G>T (p.Lys732Asn)	GNPTAB	K732N		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039046	12	102158499	12	101764721	39046	47649	rs281864989	NC_000012.12:101764720:C:A
NM_024312.5(GNPTAB):c.2089dup (p.Leu697fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039045	12	102158605 - 102158606	12	101764827 - 101764828	39045	47648	rs281864987	NC_000012.12:101764827:GGGG:GGGGG
NM_024312.5(GNPTAB):c.1999_2000insT (p.Glu667fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039044	12	102158695 - 102158696	12	101764917 - 101764918	39044	47647	rs281864986	NC_000012.12:101764917::A
NM_024312.5(GNPTAB):c.1999G>T (p.Glu667Ter)	GNPTAB	E667*		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039043	12	102158696	12	101764918	39043	47646	rs281864985	NC_000012.12:101764917:C:A
NM_024312.5(GNPTAB):c.1965del (p.Pro655_Ile656insTer)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039042	12	102158730	12	101764952	39042	47645	rs281864984	NC_000012.12:101764951:GGG:GG
NM_024312.5(GNPTAB):c.171del (p.Asp58fs)	GNPTAB	D58fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039039	12	102190487	12	101796709	39039	47642	rs281864951	NC_000012.12:101796708:T:
NM_024312.5(GNPTAB):c.163dup (p.Ser55fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039037	12	102190494 - 102190495	12	101796716 - 101796717	39037	47640	rs281864949	NC_000012.12:101796716:AA:AAA
NM_024312.5(GNPTAB):c.1519C>T (p.Gln507Ter)	GNPTAB	Q507*		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039036	12	102159962	12	101766184	39036	47639	rs281864981	NC_000012.12:101766183:G:A
NM_024312.5(GNPTAB):c.1381T>G (p.Cys461Gly)	GNPTAB	C461G		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039032	12	102161842	12	101768064	39032	47635	rs281864977	NC_000012.12:101768063:A:C
NM_024312.5(GNPTAB):c.1331dup (p.Ser445fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039030	12	102161891 - 102161892	12	101768113 - 101768114	39030	47633	rs281864976	NC_000012.12:101768113:CC:CCC
NM_024312.5(GNPTAB):c.121del (p.Val41fs)	GNPTAB	V41fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039027	12	102190537	12	101796759	39027	47630	rs281864948	NC_000012.12:101796758:CC:C
NM_024312.5(GNPTAB):c.1206dup (p.Ile403fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039025	12	102163876 - 102163877	12	101770098 - 101770099	39025	47628	rs281864972	NC_000012.12:101770098:AAA:AAAA
NM_024312.5(GNPTAB):c.1191_1194dup (p.Ser399fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039024	12	102163888 - 102163889	12	101770110 - 101770111	39024	47627	rs281864971	NC_000012.12:101770110:CAGCC:CAGCCAGCC
NM_024312.4(GNPTAB):c.118-?_203+?dup86	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039023	12	102190455 - 102190540	12	101796677 - 101796762	39023	47626		
NM_024312.5(GNPTAB):c.1001G>T (p.Arg334Leu)	GNPTAB	R334L		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039019	12	102164296	12	101770518	39019	47622	rs281864970	NC_000012.12:101770517:C:A
NM_024312.5(GNPTAB):c.2250del (p.Gln751fs)	GNPTAB	Q751fs	Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000863726	12	102158445	12	101764667	863726	839243		NC_000012.12:101764666:A:
NM_024312.5(GNPTAB):c.2991T>G (p.Tyr997Ter)	GNPTAB	Y997*	|Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000860954	12	102155049	12	101761271	860954	839240		NC_000012.12:101761270:A:C
NM_024312.5(GNPTAB):c.1511del (p.Tyr504fs)	GNPTAB	Y504fs	Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000857819	12	102159970	12	101766192	857819	839247		NC_000012.12:101766191:T:
NM_024312.5(GNPTAB):c.1956dup (p.Val653fs)	GNPTAB		Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000840035	12	102158738 - 102158739	12	101764960 - 101764961	840035	839244		NC_000012.12:101764960:T:TT
NC_000012.12:g.(?_101747144)_(101796782_?)del	GNPTAB		|Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000831427	12	102140922 - 102190560			831427	820438		
NM_024312.5(GNPTAB):c.22A>G (p.Arg8Gly)	GNPTAB	R8G	Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: Jan 8, 2016)	no assertion criteria provided	VCV000684627	12	102224432	12	101830654	684627	672258		NC_000012.12:101830653:T:C
NM_024312.5(GNPTAB):c.2455del (p.Glu819fs)	GNPTAB	E819fs	Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000642316	12	102158240	12	101764462	642316	640580		NC_000012.12:101764461:CC:C
NM_024312.5(GNPTAB):c.571+3A>C	GNPTAB		Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039083	12	102179787	12	101786009	39083	47686	rs281864960	NC_000012.12:101786008:T:G
NM_024312.5(GNPTAB):c.517_518insA (p.Pro173fs)	GNPTAB		Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039082	12	102179843 - 102179844	12	101786065 - 101786066	39082	47685	rs281864957	NC_000012.12:101786065::T
NM_024312.5(GNPTAB):c.44C>A (p.Ser15Tyr)	GNPTAB	S15Y	Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039081	12	102224410	12	101830632	39081	47684	rs281864947	NC_000012.12:101830631:G:T
NM_024312.5(GNPTAB):c.3458A>G (p.Asn1153Ser)	GNPTAB	N1153S	Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039075	12	102147294	12	101753516	39075	47678	rs281865019	NC_000012.12:101753515:T:C
NM_024312.5(GNPTAB):c.2867A>G (p.His956Arg)	GNPTAB	H956R	Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039062	12	102155390	12	101761612	39062	47665	rs281865005	NC_000012.12:101761611:T:C
NM_024312.5(GNPTAB):c.2866C>T (p.His956Tyr)	GNPTAB	H956Y	Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039061	12	102155391	12	101761613	39061	47664	rs281865004	NC_000012.12:101761612:G:A
NM_024312.5(GNPTAB):c.2777A>C (p.Gln926Pro)	GNPTAB	Q926P	Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039060	12	102155480	12	101761702	39060	47663	rs281865002	NC_000012.12:101761701:T:G
NM_024312.5(GNPTAB):c.242G>T (p.Trp81Leu)	GNPTAB	W81L	Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039053	12	102183797	12	101790019	39053	47656	rs281864953	NC_000012.12:101790018:C:A
NM_024312.5(GNPTAB):c.229_231GTT[1] (p.Val78del)	GNPTAB	V78del	Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039050	12	102183805 - 102183807	12	101790027 - 101790029	39050	47653	rs281864952	NC_000012.12:101790026:AACAAC:AAC
NM_024312.5(GNPTAB):c.168T>A (p.Tyr56Ter)	GNPTAB	Y56*	Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039038	12	102190490	12	101796712	39038	47641	rs281864950	NC_000012.12:101796711:A:T
NM_024312.5(GNPTAB):c.1385dup (p.Asp462fs)	GNPTAB		Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039033	12	102161837 - 102161838	12	101768059 - 101768060	39033	47636	rs281864978	NC_000012.12:101768059:T:TT
NM_024312.5(GNPTAB):c.1285-2A>G	GNPTAB		Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039028	12	102161940	12	101768162	39028	47631	rs281864974	NC_000012.12:101768161:T:C
NM_024312.5(GNPTAB):c.1208T>C (p.Ile403Thr)	GNPTAB	I403T	Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039026	12	102163875	12	101770097	39026	47629	rs281864973	NC_000012.12:101770096:A:G
NM_024312.5(GNPTAB):c.1001G>A (p.Arg334Gln)	GNPTAB	R334Q	Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000039018	12	102164296	12	101770518	39018	47621	rs281864970	NC_000012.12:101770517:C:T
NM_024312.5(GNPTAB):c.850del (p.Thr284fs)	GNPTAB	T284fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038434	12	102164857	12	101771079	38434	46993	rs34517004	NC_000012.12:101771078:TTT:TT
NM_024312.5(GNPTAB):c.832C>T (p.Gln278Ter)	GNPTAB	Q278*	Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038433	12	102164875	12	101771097	38433	46992	rs35878526	NC_000012.12:101771096:G:A
NM_024312.4(GNPTAB):c.555_556ins296 (p.?)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038430	12	102179805 - 102179806	12	101786027 - 101786028	38430	46989		
NM_024312.5(GNPTAB):c.3569dup (p.Asn1190fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038428	12	102147182 - 102147183	12	101753404 - 101753405	38428	46987	rs281865039	NC_000012.12:101753404:TTT:TTTT
NM_024312.5(GNPTAB):c.3435-1G>A	GNPTAB		Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038427	12	102147318	12	101753540	38427	46986	rs281865037	NC_000012.12:101753539:C:T
NM_024312.5(GNPTAB):c.3434+1G>A	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038426	12	102150989	12	101757211	38426	46985	rs281865036	NC_000012.12:101757210:C:T
NM_024312.5(GNPTAB):c.3252del (p.Pro1085fs)	GNPTAB	P1085fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038425	12	102151433	12	101757655	38425	46984	rs281865035	NC_000012.12:101757654:T:
NM_024312.5(GNPTAB):c.3249+1G>A	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038424	12	102153807	12	101760029	38424	46983	rs281865012	NC_000012.12:101760028:C:T
NM_024312.5(GNPTAB):c.3231_3234dup (p.Tyr1079fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038423	12	102153822 - 102153823	12	101760044 - 101760045	38423	46982	rs34256381	NC_000012.12:101760044:GTAGG:GTAGGTAGG
NM_024312.5(GNPTAB):c.3145_3146insC (p.Gly1049fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038422	12	102153911 - 102153912	12	101760133 - 101760134	38422	46981	rs281865033	NC_000012.12:101760133::G
NM_024312.5(GNPTAB):c.2918dup (p.Pro974_Glu975insTer)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038421	12	102155121 - 102155122	12	101761343 - 101761344	38421	46980	rs281865032	NC_000012.12:101761343:AA:AAA
NM_024312.5(GNPTAB):c.2659dup (p.Ser887fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038420	12	102158035 - 102158036	12	101764257 - 101764258	38420	46979	rs281865030	NC_000012.12:101764257:T:TT
NM_024312.5(GNPTAB):c.2188delinsAAA (p.Leu730fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038418	12	102158507	12	101764729	38418	46977	rs34161232	NC_000012.12:101764728:A:TTT
NM_024312.5(GNPTAB):c.1985C>G (p.Ala662Gly)	GNPTAB	A662G	Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038416	12	102158710	12	101764932	38416	46975	rs142172397	NC_000012.12:101764931:G:C
NM_024312.4(GNPTAB):c.1738TATA[3] (p.Ser581Ilefs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038415	12	102158953 - 102158954	12	101765175 - 101765176	38415	46974	rs34924076	NC_000012.12:101765175:TATA:TATATATATATA
NM_024312.5(GNPTAB):c.118-2A>G	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038412	12	102190542	12	101796764	38412	46971	rs281865023	NC_000012.12:101796763:T:C
NM_024312.5(GNPTAB):c.1905_1908del (p.Glu637fs)	GNPTAB	E637fs	Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000856935	12	102158787 - 102158790	12	101765009 - 101765012	856935	839245		NC_000012.12:101765008:CCTT:
NM_024312.5(GNPTAB):c.890dup (p.Ser298fs)	GNPTAB		|Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000850178	12	102164816 - 102164817	12	101771038 - 101771039	850178	839249		NC_000012.12:101771038:A:AA
NM_024312.5(GNPTAB):c.1247G>A (p.Trp416Ter)	GNPTAB	W416*	|Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000844609	12	102163836	12	101770058	844609	839248		NC_000012.12:101770057:C:T
NM_024312.5(GNPTAB):c.2249dup (p.Asn750fs)	GNPTAB		not provided|	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000039048	12	102158445 - 102158446	12	101764667 - 101764668	39048	47651	rs281864991	NC_000012.12:101764667:TTTTTT:TTTTTTT
NM_024312.5(GNPTAB):c.2533C>T (p.Gln845Ter)	GNPTAB	Q845*		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038419	12	102158162	12	101764384	38419	46978	rs281865028	NC_000012.12:101764383:G:A
NM_024312.5(GNPTAB):c.1625_1626insC (p.Glu542fs)	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000002770	12	102159069 - 102159070	12	101765291 - 101765292	2770	17809	rs281865027	NC_000012.12:101765291::G
NM_024312.5(GNPTAB):c.2681G>A (p.Trp894Ter)	GNPTAB	W894*		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000002767	12	102158014	12	101764236	2767	17806	rs137852899	NC_000012.12:101764235:C:T
NM_024312.5(GNPTAB):c.3474_3475del (p.His1158fs)	GNPTAB	H1158fs		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000002766	12	102147277 - 102147278	12	101753499 - 101753500	2766	17805	rs281865038	NC_000012.12:101753498:TAT:T
NM_024312.5(GNPTAB):c.3173C>G (p.Ser1058Ter)	GNPTAB	S1058*		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000002765	12	102153884	12	101760106	2765	17804	rs137852898	NC_000012.12:101760105:G:C
NM_024312.5(GNPTAB):c.310C>T (p.Gln104Ter)	GNPTAB	Q104*		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000002763	12	102183729	12	101789951	2763	17802	rs137852896	NC_000012.12:101789950:G:A
NM_024312.5(GNPTAB):c.1220A>C (p.Asp407Ala)	GNPTAB	D407G, D407A	Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000002762	12	102163863	12	101770085	2762	17801	rs137852895	NC_000012.12:101770084:T:G
NM_000192.3(TBX5):c.709C>T (p.Arg237Trp)	TBX5	R237W, R187W	Heart, malformation of|Aortic valve disease 2|Holt-Oram syndrome	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000007995	12	114823327	12	114385522	7995	23034	rs104894382	NC_000012.12:114385521:G:A
NM_024312.5(GNPTAB):c.2404C>T (p.Gln802Ter)	GNPTAB	Q802*	Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000839203	12	102158291	12	101764513	839203	839242		NC_000012.12:101764512:G:A
NM_024312.5(GNPTAB):c.153_156TTTG[1] (p.Phe53fs)	GNPTAB		|Pseudo-Hurler polydystrophy|not provided	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000195376	12	102190498 - 102190501	12	101796720 - 101796723	195376	192537	rs794727302	NC_000012.12:101796719:CAAACAAA:CAAA
NM_024312.5(GNPTAB):c.3326dup (p.Asn1109fs)	GNPTAB		not provided||Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000194787	12	102151358 - 102151359	12	101757580 - 101757581	194787	191950	rs797044663	NC_000012.12:101757580:TTTTT:TTTTTT
NM_024312.5(GNPTAB):c.1906dup (p.Arg636fs)	GNPTAB		|Pseudo-Hurler polydystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000194265	12	102158788 - 102158789	12	101765010 - 101765011	194265	191428	rs747789493	NC_000012.12:101765010:TT:TTT
NM_024312.5(GNPTAB):c.3439_3442TTTG[1] (p.Val1148fs)	GNPTAB		|Pseudo-Hurler polydystrophy|Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	VCV000039074	12	102147306 - 102147309	12	101753528 - 101753531	39074	47677	rs281865018	NC_000012.12:101753527:CAAACAAAC:CAAAC
NM_024312.5(GNPTAB):c.3335+1G>A	GNPTAB			Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000002772	12	102151349	12	101757571	2772	17811	rs34940801	NC_000012.12:101757570:C:T
NM_024312.5(GNPTAB):c.771G>A (p.Leu257=)	GNPTAB		Mucolipidosis III alpha/beta, atypical|Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000002761	12	102173930	12	101780152	2761	17800	rs281865025	NC_000012.12:101780151:C:T
NM_004004.6(GJB2):c.94C>A (p.Arg32Ser)	GJB2	R32S	Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Mutilating keratoderma|Knuckle pads, deafness AND leukonychia syndrome|Deafness, autosomal recessive 1A|Hystrix-like ichthyosis with deafness|Palmoplantar keratoderma-deafness syndrome|Deafness, X-linked 2|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550195	13	20763627	13	20189488	550195	547329	rs371024165	NC_000013.11:20189487:G:T
NM_004004.6(GJB2):c.506G>A (p.Cys169Tyr)	GJB2	C169Y	Deafness, autosomal recessive 1A|Knuckle pads, deafness AND leukonychia syndrome|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Deafness, X-linked 2|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Deafness, autosomal recessive 1A|Hystrix-like ichthyosis with deafness|Mutilating keratoderma|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265481	13	20763215	13	20189076	265481	260039	rs774518779	NC_000013.11:20189075:C:T
NM_001252024.2(TRPM1):c.494-1G>C	TRPM1		Retinal dystrophy	Pathogenic(Last reviewed: Jan 27, 2019)	criteria provided, single submitter	VCV000866281	15	31359391	15	31067188	866281	857271		NC_000015.10:31067187:C:G
NM_001252024.2(TRPM1):c.946A>T (p.Lys316Ter)	TRPM1	K294*, K316*, K333*	Congenital stationary night blindness	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812435	15	31355340	15	31063137	812435	800590		NC_000015.10:31063136:T:A
NM_001252024.2(TRPM1):c.2633G>A (p.Trp878Ter)	TRPM1	W856*, W878*, W895*	Congenital stationary night blindness	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812434	15	31327816	15	31035613	812434	800589		NC_000015.10:31035612:C:T
NM_002420.6(TRPM1):c.2694C>G (p.Tyr898Ter)	TRPM1	Y898*, Y920*, Y937*	not provided	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000620194	15	31325084	15	31032881	620194	611791	rs1567004102	NC_000015.10:31032880:G:C
NM_002420.6(TRPM1):c.3505del (p.Glu1169fs)	TRPM1	E1191fs, E1169fs, E1208fs	not provided	Pathogenic(Last reviewed: Aug 11, 2014)	criteria provided, single submitter	VCV000195958	15	31318400	15	31026197	195958	193119	rs778390089	NC_000015.10:31026196:CCC:CC
NM_001252024.2(TRPM1):c.3123del (p.Ile1041fs)	TRPM1	I1058fs, I1019fs, I1041fs	not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000852361	15	31323190	15	31030987	852361	842112		NC_000015.10:31030986:T:
NC_000015.10:g.(?_31030983)_(31049509_?)del	TRPM1		not provided	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000833317	15	31323186 - 31341712			833317	820675		
NM_001252024.2(TRPM1):c.3017G>A (p.Arg1006His)	TRPM1	R1006H, R1023H, R984H	Congenital stationary night blindness, type 1C	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812113	15	31323296	15	31031093	812113	800364		NC_000015.10:31031092:C:T
NM_002420.6(TRPM1):c.1900C>T (p.Arg634Ter)	TRPM1	R673*, R656*, R634*	not provided	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000645561	15	31334275	15	31042072	645561	643010		NC_000015.10:31042071:G:A
NM_001252024.2(TRPM1):c.1089+3_1089+6del	TRPM1		Congenital stationary night blindness, type 1C	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000030364	15	31354776 - 31354779	15	31062573 - 31062576	30364	39321	rs772011426	NC_000015.10:31062572:ACTTAC:AC
NM_001252024.2(TRPM1):c.2711C>A (p.Ser904Ter)	TRPM1	S882*, S904*, S921*	Congenital stationary night blindness, type 1C	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000030363	15	31325133	15	31032930	30363	39320	rs786205113	NC_000015.10:31032929:G:T
NM_001252024.2(TRPM1):c.97C>T (p.Gln33Ter)	TRPM1	Q11*, Q50*, Q33*	Congenital stationary night blindness, type 1C	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000006226	15	31362416	15	31070213	6226	21265	rs267607141	NC_000015.10:31070212:G:A
NM_001252024.2(TRPM1):c.3171T>A (p.Tyr1057Ter)	TRPM1	Y1035*, Y1074*, Y1057*	Congenital stationary night blindness, type 1C	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000006225	15	31320657	15	31028454	6225	21264	rs267607140	NC_000015.10:31028453:A:T
TRPM1, 1-BP DEL, 412G	TRPM1		Congenital stationary night blindness, type 1C	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000006224					6224	21263		
TRPM1, IVS16DS, T-C, +2	TRPM1		Congenital stationary night blindness, type 1C	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000006223					6223	21262		
TRPM1, 36.4-KB DEL, EX2-7	TRPM1		Congenital stationary night blindness, type 1C	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000006229					6229	21268		
NM_001252024.2(TRPM1):c.281A>G (p.Tyr94Cys)	TRPM1	Y94C, Y111C, Y72C	not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000863108	15	31360294	15	31068091	863108	842132		NC_000015.10:31068090:T:C
XR_001751972.2:n.3575del	SPG7		not provided	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000817991					817991	806285		
NM_003119.4(SPG7):c.87G>A (p.Trp29Ter)	SPG7	W29*	Polyneuropathy	Pathogenic	no assertion criteria provided	VCV000689557	16	89574912	16	89508504	689557	677259		NC_000016.10:89508503:G:A
NM_003119.4(SPG7):c.1192C>T (p.Arg398Ter)	SPG7	R398*	not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000545964	16	89598912	16	89532504	545964	536481	rs1373388852	NC_000016.10:89532503:C:T
NM_003119.4(SPG7):c.1369C>T (p.Arg457Ter)	SPG7	R457*	not provided	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000488804	16	89611100	16	89544692	488804	482113	rs138671904	NC_000016.10:89544691:C:T
NM_003119.4(SPG7):c.416_432del (p.Arg139fs)	SPG7	R139fs	not provided	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000426963	16	89590450 - 89590466	16	89524042 - 89524058	426963	415529	rs1085307874	NC_000016.10:89524041:ACCGAGAGCGGCTGCGCACC:ACC
NM_003119.4(SPG7):c.679C>T (p.Arg227Ter)	SPG7	R227*	not provided	Pathogenic(Last reviewed: May 6, 2016)	criteria provided, single submitter	VCV000280575	16	89592797	16	89526389	280575	264839	rs764791523	NC_000016.10:89526388:C:T
NM_003119.4(SPG7):c.1617del (p.Val540fs)	SPG7	V540fs	not provided	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000265420	16	89614474	16	89548066	265420	260142	rs762795756	NC_000016.10:89548065:CC:C
NM_003119.4(SPG7):c.2189del (p.Asn730fs)	SPG7	K799fs, N730fs	not provided	Pathogenic(Last reviewed: Jun 27, 2014)	criteria provided, single submitter	VCV000215221	16	89623300	16	89556892	215221	211773	rs863224223	NC_000016.10:89556891:AAA:AA
NM_003119.4(SPG7):c.1552+1G>T	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807498	16	89613169	16	89546761	807498	798709		NC_000016.10:89546760:G:T
NM_003119.4(SPG7):c.1727C>G (p.Ser576Trp)	SPG7	S576W	not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000215223	16	89616965	16	89550557	215223	211764	rs151249432	NC_000016.10:89550556:C:G
NM_003119.4(SPG7):c.1171_1172dup (p.Ser392fs)	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000857760	16	89598889 - 89598890	16	89532481 - 89532482	857760	844502		NC_000016.10:89532481:GCG:GCGCG
NC_000016.10:g.(?_89510480)_(89513047_?)del	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000831061	16	89576888 - 89579455			831061	820915		
NM_003119.4(SPG7):c.86G>A (p.Trp29Ter)	SPG7	W29*	Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000646516	16	89574911	16	89508503	646516	645143		NC_000016.10:89508502:G:A
NM_003119.4(SPG7):c.1626_1627TC[1] (p.Leu543fs)	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000411677	16	89614483 - 89614484	16	89548075 - 89548076	411677	401895	rs766155407	NC_000016.10:89548074:CTCTC:CTC
NM_003119.4(SPG7):c.1045_1046delinsAGC (p.Gly349fs)	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: May 31, 2016)	criteria provided, single submitter	VCV000411676	16	89598369 - 89598370	16	89531961 - 89531962	411676	402129	rs1060503425	NC_000016.10:89531960:GG:AGC
NM_003119.3(SPG7):c.1553-?_1779+?del	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000254070					254070	248513		
NM_003119.4(SPG7):c.1408C>T (p.Arg470Ter)	SPG7	R470*	Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Mar 4, 2015)	criteria provided, single submitter	VCV000216088	16	89611139	16	89544731	216088	213228	rs748555510	NC_000016.10:89544730:C:T
SPG7, 5.1-KB DEL	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000006818					6818	21857		
SPG7, 1-BP DEL, 1616C	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000006817					6817	21856		
NM_003119.4(SPG7):c.2075G>C (p.Ser692Thr)	SPG7	S692T	Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Jul 24, 2007)	no assertion criteria provided	VCV000006815	16	89620340	16	89553932	6815	21854	rs121918357	NC_000016.10:89553931:G:C
NM_003119.4(SPG7):c.1739_1741TGG[1] (p.Val581del)	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Mar 14, 2006)	no assertion criteria provided	VCV000006814	16	89616977 - 89616979	16	89550569 - 89550571	6814	21853		NC_000016.10:89550568:TGGTGG:TGG
SPG7, 2-BP DEL, 1-BP INS, 850	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Mar 14, 2006)	no assertion criteria provided	VCV000006813					6813	21852		
SPG7, 1-BP INS, 2228A	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Jun 12, 1998)	no assertion criteria provided	VCV000006811					6811	21850		
SPG7, 2-BP DEL, NT784	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Jun 12, 1998)	no assertion criteria provided	VCV000006810					6810	21849		
NC_000016.9:g.(?_89595865)_(89596007_?)del	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000584118	16	89595865 - 89596007	16	89529457 - 89529599	584118	569409		
NM_003119.4(SPG7):c.850_851delinsC (p.Phe284fs)	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000533735	16	89595976 - 89595977	16	89529568 - 89529569	533735	530501	rs768595656	NC_000016.10:89529567:TT:C
NM_003119.4(SPG7):c.471_472TC[1] (p.Leu158fs)	SPG7		Hereditary spastic paraplegia 7	Pathogenic	criteria provided, single submitter	VCV000217272	16	89590507 - 89590508	16	89524099 - 89524100	217272	213915	rs879253798	NC_000016.10:89524098:CTCTC:CTC
NM_003119.4(SPG7):c.1996G>A (p.Gly666Arg)	SPG7	G666R	Hereditary spastic paraplegia 7	Pathogenic	criteria provided, single submitter	VCV000217271	16	89620261	16	89553853	217271	213918	rs752989523	NC_000016.10:89553852:G:A
NM_003119.4(SPG7):c.2249C>T (p.Pro750Leu)	SPG7	P750L	Hereditary spastic paraplegia 7	Pathogenic	criteria provided, single submitter	VCV000217268	16	89623362	16	89556954	217268	213919	rs879253797	NC_000016.10:89556953:C:T
SPG7, 9.5-KB DEL	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000006812					6812	21851		
NM_024312.5(GNPTAB):c.749dup (p.Asn250fs)	GNPTAB		Mucolipidosis||not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039087	12	102173951 - 102173952	12	101780173 - 101780174	39087	47690	rs281864964	NC_000012.12:101780173:TTTT:TTTTT
NM_024312.5(GNPTAB):c.2693del (p.Lys898fs)	GNPTAB	K898fs	|Pseudo-Hurler polydystrophy|Pseudo-Hurler polydystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039058	12	102158002	12	101764224	39058	47661	rs281864999	NC_000012.12:101764223:TTTTTTTT:TTTTTTT
NM_024312.5(GNPTAB):c.1955_1958TAGT[1] (p.Ser654fs)	GNPTAB		|Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000039041	12	102158733 - 102158736	12	101764955 - 101764958	39041	47644	rs281864983	NC_000012.12:101764954:ACTAACTAA:ACTAA
NM_024312.5(GNPTAB):c.1120T>C (p.Phe374Leu)	GNPTAB	F374L	Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000002775	12	102163963	12	101770185	2775	17814	rs137852900	NC_000012.12:101770184:A:G
NM_002834.5(PTPN11):c.1339del (p.Glu447fs)	PTPN11	E451fs, E447fs, E446fs	Metachondromatosis	Pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV000829985	12	112924392	12	112486588	829985	818296		NC_000012.12:112486587:GG:G
NM_002834.5(PTPN11):c.1530G>T (p.Gln510His)	PTPN11	Q509H, Q510H, Q514H	not specified	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000811634	12	112926910	12	112489106	811634	799666		NC_000012.12:112489105:G:T
NM_080601.3(PTPN11):c.853T>A (p.Phe285Ile)	PTPN11	F285I	not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000636408	12	112910844	12	112473040	636408	624453		NC_000012.12:112473039:T:A
NM_002834.4(PTPN11):c.505del (p.His169fs)	PTPN11	H169fs	not provided	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000561966	12	112891169	12	112453365	561966	552674	rs1566168783	NC_000012.12:112453364:CCC:CC
NM_002834.4(PTPN11):c.1112G>A (p.Trp371Ter)	PTPN11	W371*	not provided	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000504424	12	112919897	12	112482093	504424	495288	rs1555270113	NC_000012.12:112482092:G:A
NM_002834.4(PTPN11):c.180_181delinsAA (p.Asp61Asn)	PTPN11		not provided	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000372703	12	112888164 - 112888165	12	112450360 - 112450361	372703	360019	rs1057517935	NC_000012.12:112450359:TG:AA
NM_002834.4(PTPN11):c.188_189delinsGC (p.Tyr63Cys)	PTPN11		not provided	Pathogenic(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	VCV000372674	12	112888172 - 112888173	12	112450368 - 112450369	372674	360020	rs1057517917	NC_000012.12:112450367:AT:GC
NM_002834.4(PTPN11):c.178G>C (p.Gly60Arg)	PTPN11	G60R	not provided	Pathogenic(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	VCV000372590	12	112888162	12	112450358	372590	360062	rs397507507	NC_000012.12:112450357:G:C
NM_002834.4(PTPN11):c.1051C>T (p.Arg351Ter)	PTPN11	R351*	not provided	Pathogenic(Last reviewed: Jul 23, 2015)	criteria provided, single submitter	VCV000372552	12	112915778	12	112477974	372552	360079	rs923052172	NC_000012.12:112477973:C:T
NM_002834.4(PTPN11):c.845T>C (p.Ile282Thr)	PTPN11	I282T	not provided	Pathogenic(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	VCV000280259	12	112910836	12	112473032	280259	264502	rs886041495	NC_000012.12:112473031:T:C
NM_002834.4(PTPN11):c.1402_1403delinsGA (p.Thr468Glu)	PTPN11		not provided	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000265663	12	112926269 - 112926270	12	112488465 - 112488466	265663	260007	rs886039711	NC_000012.12:112488464:AC:GA
NM_002834.4(PTPN11):c.1520C>A (p.Thr507Lys)	PTPN11	T507K, T511K	not provided	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000265307	12	112926900	12	112489096	265307	260008	rs886039463	NC_000012.12:112489095:C:A
NM_002834.4(PTPN11):c.854T>A (p.Phe285Tyr)	PTPN11	F285Y	not provided	Pathogenic(Last reviewed: Mar 10, 2014)	criteria provided, single submitter	VCV000181499	12	112915455	12	112477651	181499	179449	rs121918463	NC_000012.12:112477650:T:A
NM_002834.4(PTPN11):c.661A>G (p.Ile221Val)	PTPN11	I221V	not provided	Pathogenic(Last reviewed: Jul 8, 2014)	criteria provided, single submitter	VCV000181498	12	112893772	12	112455968	181498	179447	rs397516806	NC_000012.12:112455967:A:G
NM_002834.4(PTPN11):c.226G>C (p.Glu76Gln)	PTPN11	E76Q	not provided	Pathogenic(Last reviewed: Aug 4, 2014)	criteria provided, single submitter	VCV000181496	12	112888210	12	112450406	181496	179445	rs121918464	NC_000012.12:112450405:G:C
NM_002834.4(PTPN11):c.211T>G (p.Phe71Val)	PTPN11	F71V	not provided	Pathogenic(Last reviewed: Jul 17, 2014)	criteria provided, single submitter	VCV000181495	12	112888195	12	112450391	181495	179444	rs397507512	NC_000012.12:112450390:T:G
NM_002834.4(PTPN11):c.172A>T (p.Asn58Tyr)	PTPN11	N58Y	not provided	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000181494	12	112888156	12	112450352	181494	179443	rs397507505	NC_000012.12:112450351:A:T
NM_002834.4(PTPN11):c.1508G>C (p.Gly503Ala)	PTPN11	G503A, G507A	Rasopathy	Pathogenic	no assertion criteria provided	VCV000162464	12	112926888	12	112489084	162464	172138	rs397507546	NC_000012.12:112489083:G:C
NM_002834.4(PTPN11):c.1517_1518delinsCC (p.Gln506Pro)	PTPN11		Rasopathy	Pathogenic(Last reviewed: Jan 1, 2007)	criteria provided, single submitter	VCV000055799	12	112926897 - 112926898	12	112489093 - 112489094	55799	70455	rs397509345	NC_000012.12:112489092:AG:CC
NM_002834.4(PTPN11):c.217A>C (p.Thr73Pro)	PTPN11	T73P	not provided	Pathogenic(Last reviewed: Feb 7, 2013)	criteria provided, single submitter	VCV000040501	12	112888201	12	112450397	40501	48971	rs397507513	NC_000012.12:112450396:A:C
NM_002834.4(PTPN11):c.179_182delinsT (p.Gly60_Asp61delinsVal)	PTPN11		Rasopathy	Pathogenic(Last reviewed: Jan 1, 2006)	criteria provided, single submitter	VCV000040492	12	112888163 - 112888166	12	112450359 - 112450362	40492	48962	rs397507508	NC_000012.12:112450358:GTGA:T
NM_002834.4(PTPN11):c.178G>T (p.Gly60Cys)	PTPN11	G60C	not provided	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000041442	12	112888162	12	112450358	41442	49880	rs397507507	NC_000012.12:112450357:G:T
NG_007459.1:g.45924_60608delinsCA	PTPN11		Metachondromatosis	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000031555	12	112897459 - 112912143	12	112459655 - 112474339	31555	40233		
NM_002834.4(PTPN11):c.1093-1G>T	PTPN11		Metachondromatosis	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000031554	12	112919877	12	112482073	31554	40232	rs398122862	NC_000012.12:112482072:G:T
NM_002834.4(PTPN11):c.295A>T (p.Lys99Ter)	PTPN11	K99*	Metachondromatosis	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000031553	12	112888279	12	112450475	31553	40231	rs387907158	NC_000012.12:112450474:A:T
NM_002834.4(PTPN11):c.643-2A>C	PTPN11		Metachondromatosis	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000031552	12	112893752	12	112455948	31552	40230	rs398122861	NC_000012.12:112455947:A:C
NM_002834.4(PTPN11):c.1315del (p.Leu439fs)	PTPN11	L443fs, L439fs	Metachondromatosis	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000031551	12	112924368	12	112486564	31551	40229	rs398122860	NC_000012.12:112486563:CC:C
NM_002834.4(PTPN11):c.1516C>T (p.Gln506Ter)	PTPN11	Q506*, Q510*	Metachondromatosis	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000031550	12	112926896	12	112489092	31550	40228	rs387907157	NC_000012.12:112489091:C:T
NM_002834.4(PTPN11):c.349_350CT[2] (p.Ser118fs)	PTPN11		Metachondromatosis	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000031549	12	112891014 - 112891015	12	112453210 - 112453211	31549	40227	rs398122859	NC_000012.12:112453209:TCTCTCT:TCTCT
NM_002834.4(PTPN11):c.458_463delinsAAGAACACAGGGGAGAGCA (p.Thr153fs)	PTPN11		Metachondromatosis	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000031548	12	112891124 - 112891129	12	112453320 - 112453325	31548	40226	rs398122858	NC_000012.12:112453319:CTGGTG:AAGAACACAGGGGAGAGCA
NM_002834.4(PTPN11):c.409_413del (p.Val137fs)	PTPN11	V137fs	Metachondromatosis	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000031547	12	112891075 - 112891079	12	112453271 - 112453275	31547	40225	rs398122857	NC_000012.12:112453270:GTACG:
NM_002834.4(PTPN11):c.412C>T (p.Arg138Ter)	PTPN11	R138*	Metachondromatosis	Pathogenic(Last reviewed: Jun 17, 2010)	no assertion criteria provided	VCV000013348	12	112891078	12	112453274	13348	28387	rs267606989	NC_000012.12:112453273:C:T
PTPN11, 11-BP DEL, NT514	PTPN11		Metachondromatosis	Pathogenic(Last reviewed: Jun 17, 2010)	no assertion criteria provided	VCV000013347					13347	28386		
NM_002834.4(PTPN11):c.329A>C (p.Glu110Ala)	PTPN11	E110A	not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040508	12	112888313	12	112450509	40508	48978	rs397507519	NC_000012.12:112450508:A:C
NM_002834.4(PTPN11):c.782T>A (p.Leu261His)	PTPN11	L261H	Rasopathy	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000575203	12	112910773	12	112472969	575203	571258	rs765642157	NC_000012.12:112472968:T:A
NM_002834.4(PTPN11):c.181_183del (p.Asp61del)	PTPN11	D61del	Noonan syndrome 1	Pathogenic(Last reviewed: Feb 25, 2016)	no assertion criteria provided	VCV000222972	12	112888164 - 112888166	12	112450360 - 112450362	222972	224692	rs869025574	NC_000012.12:112450359:TGAT:T
NM_002834.4(PTPN11):c.661del (p.Arg220_Ile221insTer)	PTPN11		Metachondromatosis	Pathogenic(Last reviewed: Sep 7, 2011)	criteria provided, single submitter	VCV000044611	12	112893772	12	112455968	44611	53778	rs397516807	NC_000012.12:112455967:A:
NM_002834.4(PTPN11):c.1402A>C (p.Thr468Pro)	PTPN11	T468P, T472P	Rasopathy|not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040547	12	112926269	12	112488465	40547	49017	rs397507537	NC_000012.12:112488464:A:C
NM_003119.4(SPG7):c.1553-2A>G	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000576145	16	89614409	16	89548001	576145	570640	rs1229749476	NC_000016.10:89548000:A:G
NM_003119.4(SPG7):c.1447C>T (p.Gln483Ter)	SPG7	Q483*	not provided|Hereditary spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000390378	16	89611178	16	89544770	390378	375819	rs562890289	NC_000016.10:89544769:C:T
NM_003119.4(SPG7):c.1675A>T (p.Lys559Ter)	SPG7	K559*	Hereditary spastic paraplegia 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000215215	16	89616913	16	89550505	215215	211763	rs372981030	NC_000016.10:89550504:A:T
NM_001252024.2(TRPM1):c.2695C>T (p.Arg899Ter)	TRPM1	R877*, R916*, R899*	Congenital stationary night blindness, type 1C|Congenital stationary night blindness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000593857	15	31327754	15	31035551	593857	584920	rs1485132228	NC_000015.10:31035550:G:A
GRCh37/hg19 14q31.3(chr14:88399622-88422569)x1	GALC		not provided	Pathogenic(Last reviewed: Jan 16, 2018)	no assertion criteria provided	VCV000688807	14	88399622 - 88422569			688807	676399		
GRCh37/hg19 14q31.3(chr14:88398357-88422853)x1	GALC		not provided	Pathogenic(Last reviewed: Jan 17, 2018)	no assertion criteria provided	VCV000688381	14	88398357 - 88422853			688381	675973		
GRCh37/hg19 14q31.3(chr14:88398357-88422853)x1	GALC		not provided	Pathogenic(Last reviewed: Jan 17, 2018)	no assertion criteria provided	VCV000688380	14	88398357 - 88422853			688380	675972		
GRCh37/hg19 14q31.3(chr14:88398407-88422569)x1	GALC		not provided	Pathogenic(Last reviewed: Jul 9, 2018)	no assertion criteria provided	VCV000688215	14	88398407 - 88422569			688215	675807		
GRCh37/hg19 14q31.3(chr14:88398406-88422853)x1	GALC		not provided	Pathogenic(Last reviewed: Dec 27, 2017)	no assertion criteria provided	VCV000686441	14	88398406 - 88422853			686441	674033		
GRCh37/hg19 14q31.3(chr14:88400251-88422569)x1	GALC		not provided	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000685766	14	88400251 - 88422569			685766	673358		
GRCh37/hg19 14q31.3(chr14:88400285-88422569)x1	GALC		not provided	Pathogenic(Last reviewed: May 16, 2018)	no assertion criteria provided	VCV000685730	14	88400285 - 88422569			685730	673322		
GRCh37/hg19 14q31.3(chr14:88400251-88422569)x1	GALC		not provided	Pathogenic(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000685138	14	88400251 - 88422569			685138	672730		
NM_000153.4(GALC):c.1665C>G (p.Tyr555Ter)	GALC	Y555*, Y529*, Y532*	not provided	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000593833	14	88411902	14	87945558	593833	584896	rs1566972341	NC_000014.9:87945557:G:C
NM_000153.3(GALC):c.1488_1489+2delTGGT	GALC		not provided	Pathogenic(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	VCV000496934	14	88414070 - 88414073	14	87947726 - 87947729	496934	488358	rs1555379355	
NM_000153.4(GALC):c.1075_1084del (p.Lys359fs)	GALC	K359fs, K333fs, K336fs	not provided	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000449484	14	88429805 - 88429814	14	87963461 - 87963470	449484	445259	rs1555381439	NC_000014.9:87963460:CAACTGTCTTCA:CA
NM_000153.4(GALC):c.1399dup (p.Thr467fs)	GALC		not provided	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000373387	14	88414161 - 88414162	14	87947817 - 87947818	373387	360119	rs1057518390	NC_000014.9:87947817:T:TT
NM_000153.4(GALC):c.1161+2T>G	GALC		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000092492	14	88429726	14	87963382	92492	98401	rs398123175	NC_000014.9:87963381:A:C
NM_000153.4(GALC):c.194G>A (p.Gly65Glu)	GALC	G65E	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Jul 28, 2017)	no assertion criteria provided	VCV000433542	14	88459315	14	87992971	433542	427116	rs1555384318	NC_000014.9:87992970:C:T
NM_000153.4(GALC):c.1793G>A (p.Trp598Ter)	GALC	W572*, W575*, W598*	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000837302	14	88407780	14	87941436	837302	841875		NC_000014.9:87941435:C:T
NC_000014.9:g.(?_87992960)_(87993627_?)del	GALC		Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000831740	14	88459304 - 88459971			831740	820658		
NC_000014.9:g.(?_87963374)_(87963521_?)del	GALC		Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000831215	14	88429718 - 88429865			831215	820655		
NM_000153.4(GALC):c.453G>A (p.Trp151Ter)	GALC	W125*, W128*, W151*	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000642301	14	88450867	14	87984523	642301	642773		NC_000014.9:87984522:C:T
NM_000153.4(GALC):c.578T>C (p.Ile193Thr)	GALC	I170T, I193T, I167T	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522714	14	88450742	14	87984398	522714	513346	rs1555383498	NC_000014.9:87984397:A:G
NM_000153.4(GALC):c.331G>A (p.Gly111Ser)	GALC	G111S, G85S, G88S	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: May 27, 2015)	criteria provided, single submitter	VCV000211058	14	88452944	14	87986600	211058	208129	rs756690487	NC_000014.9:87986599:C:T
NM_000153.4(GALC):c.121G>A (p.Gly41Ser)	GALC	G41S	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000030621	14	88459388	14	87993044	30621	39578	rs387906955	NC_000014.9:87993043:C:T
NM_000153.4(GALC):c.953C>G (p.Pro318Arg)	GALC	P318R, P292R, P295R	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030620	14	88431929	14	87965585	30620	39577	rs387906954	NC_000014.9:87965584:G:C
GALC, 1-BP DEL, 1901T	GALC		Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030618					30618	39575		
GALC, IVS13DS, G-A, +1	GALC		Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030617					30617	39574		
GALC, GLY553ARG	GALC	G553R	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030616					30616	39573		
NM_000153.4(GALC):c.433dup (p.Thr145fs)	GALC		Galactosylceramide beta-galactosidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553285	14	88452841 - 88452842	14	87986497 - 87986498	553285	547913	rs1555383679	NC_000014.9:87986497:T:TT
NM_000153.4(GALC):c.129C>G (p.Tyr43Ter)	GALC	Y43*	Galactosylceramide beta-galactosidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370855	14	88459380	14	87993036	370855	358270	rs1057516816	NC_000014.9:87993035:G:C
NM_000153.4(GALC):c.972del (p.Leu324_Met325insTer)	GALC		Galactosylceramide beta-galactosidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370842	14	88431910	14	87965566	370842	358261	rs1057516808	NC_000014.9:87965565:C:
NM_000153.4(GALC):c.1890T>A (p.Tyr630Ter)	GALC	Y630*, Y604*, Y607*	not provided|Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000370392	14	88406270	14	87939926	370392	358250	rs1057516453	NC_000014.9:87939925:A:T
NM_000153.4(GALC):c.946C>T (p.Gln316Ter)	GALC	Q316*, Q290*, Q293*	Galactosylceramide beta-galactosidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370367	14	88431936	14	87965592	370367	358263	rs776368825	NC_000014.9:87965591:G:A
NM_000153.3(GALC):c.243_244dup (p.Ile82Argfs)	GALC		Galactosylceramide beta-galactosidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000286538	14	88454818 - 88454819	14	87988474 - 87988475	286538	270775	rs886043419	NC_000014.9:87988474:TCT:TCTCT
NM_000153.4(GALC):c.1472del (p.Lys491fs)	GALC	K468fs, K465fs, K491fs	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	VCV000188826	14	88414089	14	87947745	188826	186917	rs771489305	NC_000014.9:87947744:TT:T
NM_000153.4(GALC):c.1796T>G (p.Ile599Ser)	GALC	I599S, I573S, I576S	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030615	14	88407777	14	87941433	30615	39572	rs387906953	NC_000014.9:87941432:A:C
NM_000153.4(GALC):c.1153G>T (p.Glu385Ter)	GALC	E385*, E359*, E362*	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000003818	14	88429736	14	87963392	3818	18857	rs121908010	NC_000014.9:87963391:C:A
NM_001365088.1(SLC12A6):c.2436+1del	SLC12A6		Agenesis of the corpus callosum with peripheral neuropathy|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000436730	15	34532861	15	34240660	436730	429644	rs515726215	NC_000015.10:34240659:CC:C
NM_025099.6(CTC1):c.1245del (p.Thr416fs)	CTC1	T416fs	not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000593196	17	8138565	17	8235247	593196	584260	rs1567609103	NC_000017.11:8235246:CCCCCC:CCCCC
NM_025099.6(CTC1):c.1213del (p.Asp405fs)	CTC1	D405fs	Cerebroretinal microangiopathy with calcifications and cysts	Pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	VCV000434858	17	8138597	17	8235279	434858	430035	rs1444923772	NC_000017.11:8235278:CC:C
NM_025099.6(CTC1):c.859C>T (p.Arg287Ter)	CTC1	R287*	Cerebroretinal microangiopathy with calcifications and cysts 1	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000040251	17	8139594	17	8236276	40251	48735	rs397514660	NC_000017.11:8236275:G:A
NM_025099.6(CTC1):c.1058del (p.Ser353fs)	CTC1	S353fs	Cerebroretinal microangiopathy with calcifications and cysts 1	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000031005	17	8139395	17	8236077	31005	39962	rs199473675	NC_000017.11:8236076:G:
NM_025099.6(CTC1):c.3583C>T (p.Arg1195Ter)	CTC1	R1195*	Cerebroretinal microangiopathy with calcifications and cysts 1	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000031003	17	8131569	17	8228251	31003	39960	rs199473682	NC_000017.11:8228250:G:A
NM_025099.6(CTC1):c.1994T>G (p.Val665Gly)	CTC1	V665G	Cerebroretinal microangiopathy with calcifications and cysts 1	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000031002	17	8135745	17	8232427	31002	39959	rs199473676	NC_000017.11:8232426:A:C
NM_025099.6(CTC1):c.3425T>A (p.Leu1142His)	CTC1	L1142H	Cerebroretinal microangiopathy with calcifications and cysts 1	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000031001	17	8131910	17	8228592	31001	39958	rs201455840	NC_000017.11:8228591:A:T
NM_025099.6(CTC1):c.2611G>A (p.Val871Met)	CTC1	V871M	Cerebroretinal microangiopathy with calcifications and cysts 1	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000030997	17	8134652	17	8231334	30997	39954	rs369255297	NC_000017.11:8231333:C:T
NM_025099.6(CTC1):c.1065_1069CCTAT[1] (p.Ser357fs)	CTC1		Dyskeratosis congenita	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000862044	17	8139379 - 8139383	17	8236061 - 8236065	862044	846638		NC_000017.11:8236060:ATAGGATAGGA:ATAGGA
NM_025099.6(CTC1):c.2973T>G (p.Tyr991Ter)	CTC1	Y991*	Dyskeratosis congenita	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000844575	17	8133247	17	8229929	844575	846604		NC_000017.11:8229928:A:C
NM_025099.6(CTC1):c.3099dup (p.Val1034fs)	CTC1		Dyskeratosis congenita	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000653653	17	8132676 - 8132677	17	8229358 - 8229359	653653	647029		NC_000017.11:8229358:A:AA
NM_025099.6(CTC1):c.248_251dup (p.His84fs)	CTC1		Dyskeratosis congenita	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000653432	17	8141893 - 8141894	17	8238575 - 8238576	653432	647050		NC_000017.11:8238575:TGGCTG:TGGCTGGCTG
NM_025099.6(CTC1):c.2996_2997del (p.Pro999fs)	CTC1	P999fs	Dyskeratosis congenita	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000647135	17	8133223 - 8133224	17	8229905 - 8229906	647135	647030		NC_000017.11:8229904:AG:
NM_025099.6(CTC1):c.277C>T (p.Gln93Ter)	CTC1	Q93*	Dyskeratosis congenita	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000580679	17	8141868	17	8238550	580679	574701	rs767991627	NC_000017.11:8238549:G:A
NM_025099.6(CTC1):c.1186C>T (p.Arg396Ter)	CTC1	R396*	Dyskeratosis congenita	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000576930	17	8139169	17	8235851	576930	572478	rs764019241	NC_000017.11:8235850:G:A
NM_025099.6(CTC1):c.3049C>T (p.Gln1017Ter)	CTC1	Q1017*	Dyskeratosis congenita	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000576727	17	8132727	17	8229409	576727	570014	rs1567599296	NC_000017.11:8229408:G:A
NM_025099.6(CTC1):c.440del (p.Ile147fs)	CTC1	I147fs	Dyskeratosis congenita	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000529178	17	8141556	17	8238238	529178	532128	rs1196342305	NC_000017.11:8238237:A:
NM_025099.6(CTC1):c.680C>T (p.Ala227Val)	CTC1	A227V	Cerebroretinal microangiopathy with calcifications and cysts 1	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000031004	17	8140805	17	8237487	31004	39961	rs199473673	NC_000017.11:8237486:G:A
NM_025099.6(CTC1):c.322C>T (p.Arg108Ter)	CTC1	R108*	Dyskeratosis congenita	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000842299	17	8141823	17	8238505	842299	846648		NC_000017.11:8238504:G:A
NM_025099.6(CTC1):c.2831dup (p.His945fs)	CTC1		Dyskeratosis congenita	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000840769	17	8133713 - 8133714	17	8230395 - 8230396	840769	846606		NC_000017.11:8230395:GGGGGG:GGGGGGG
NM_000153.4(GALC):c.2002A>C (p.Thr668Pro)	GALC	T642P, T645P, T668P	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000857343	14	88401132	14	87934788	857343	841873		NC_000014.9:87934787:T:G
GRCh37/hg19 14q31.3(chr14:88391502-88423172)	GALC		Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000830312	14	88391502 - 88423172			830312	818711		
NM_000153.4(GALC):c.599C>A (p.Ser200Ter)	GALC	S200*, S174*, S177*	Galactosylceramide beta-galactosidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189003	14	88448571	14	87982227	189003	186921	rs786204618	NC_000014.9:87982226:G:T
NM_003119.4(SPG7):c.2271del (p.Met757fs)	SPG7	M757fs	Hereditary spastic paraplegia 7	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000522825	16	89623384	16	89556976	522825	513462	rs1217391623	NC_000016.10:89556975:G:
NM_003119.4(SPG7):c.376+1G>T	SPG7		not provided|Hereditary spastic paraplegia 7	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000411682	16	89579446	16	89513038	411682	402128	rs746053679	NC_000016.10:89513037:G:T
NM_003119.4(SPG7):c.976_987+3del	SPG7		not provided|Hereditary spastic paraplegia 7	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000239501	16	89597202 - 89597216	16	89530794 - 89530808	239501	242530	rs878854606	NC_000016.10:89530793:GTGGATTATCTGAAGGTG:GTG
NM_006194.3(PAX9):c.464_465dup (p.Tyr156fs)	PAX9		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000521920	14	37132559 - 37132560	14	36663354 - 36663355	521920	512105	rs1555316743	NC_000014.9:36663354:CCC:CCCCC
NM_002225.3(IVD):c.941C>T (p.Ala314Val)	IVD	A282V, A314V	Isovaleryl-CoA dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000100060	15	40707653	15	40415454	100060	18607	rs28940889	NC_000015.10:40415453:C:T
NM_025099.6(CTC1):c.3019del (p.Leu1007fs)	CTC1	L1007fs	Dyskeratosis congenita	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000843472	17	8132757	17	8229439	843472	846602		NC_000017.11:8229438:GGGG:GGG
NM_002834.4(PTPN11):c.179G>T (p.Gly60Val)	PTPN11	G60V	not provided|Noonan syndrome 1	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000055797	12	112888163	12	112450359	55797	70453	rs397507509	NC_000012.12:112450358:G:T
NM_002834.5(PTPN11):c.768_770dup	PTPN11		Rasopathy|Noonan syndrome 1	Pathogenic(Last reviewed: Feb 12, 2013)	criteria provided, single submitter	VCV000040519	12	112910752 - 112910753	12	112472948 - 112472949	40519	48989	rs397507524	NC_000012.12:112472948:ACAACAACA:ACAACAACAACA
NM_002834.3(PTPN11):c.179_181delGTG (p.Gly60del)	PTPN11	G60del	Noonan syndrome 1	Pathogenic(Last reviewed: Aug 4, 2011)	no assertion criteria provided	VCV000013346	12	112888161 - 112888163	12	112450357 - 112450359	13346	28385	rs80338836	NC_000012.12:112450356:TGGTG:TG
NM_005249.5(FOXG1):c.776C>G (p.Pro259Arg)	FOXG1	P259R	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 20, 2014)	criteria provided, single submitter	VCV000225093	14	29237261	14	28768055	225093	226937	rs869312961	NC_000014.9:28768054:C:G
NM_004937.3(CTNS):c.559_561+24del	CTNS		Nephropathic cystinosis|Juvenile nephropathic cystinosis|Ocular cystinosis|Nephropathic cystinosis	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021442	17	3559867 - 3559893	17	3656573 - 3656599	21442	34294	rs113994211	NC_000017.11:3656572:TGCCCTACATCAAGGTACGGCCTTGCCTGCCCTACATC:TGCCCTACATC
NM_001252024.2(TRPM1):c.362T>C (p.Leu121Pro)	TRPM1	L99P, L121P, L138P	Retinal dystrophy|Congenital stationary night blindness, type 1C|not provided	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006227	15	31360213	15	31068010	6227	21266	rs191205969	NC_000015.10:31068009:A:G
NC_000014.9:g.(?_87934720)_(87950758_?)del	GALC		Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000830496	14	88401064 - 88417102			830496	820653		
NC_000014.8:g.(?_88401056)_(88417112_?)del	GALC		Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000456710	14	88401056 - 88417112	14	87934712 - 87950768	456710	462970		
NM_000153.4(GALC):c.955del (p.Tyr319fs)	GALC	Y319fs, Y293fs, Y296fs	Galactosylceramide beta-galactosidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188767	14	88431927	14	87965583	188767	186918	rs786204454	NC_000014.9:87965582:AA:A
NM_024312.5(GNPTAB):c.342_343CA[1] (p.Thr115fs)	GNPTAB		||Pseudo-Hurler polydystrophy|not provided	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039073	12	102182346 - 102182347	12	101788568 - 101788569	39073	47676	rs281864954	NC_000012.12:101788567:TGTGT:TGT
NM_024312.5(GNPTAB):c.1759C>T (p.Arg587Ter)	GNPTAB	R587*	|Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000039040	12	102158936	12	101765158	39040	47643	rs281864982	NC_000012.12:101765157:G:A
NM_024312.5(GNPTAB):c.1000C>T (p.Arg334Ter)	GNPTAB	R334*	Pseudo-Hurler polydystrophy||Pseudo-Hurler polydystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000039017	12	102164297	12	101770519	39017	47620	rs281864969	NC_000012.12:101770518:G:A
NM_024312.5(GNPTAB):c.2572_2573GA[1] (p.Asn859fs)	GNPTAB		Pseudo-Hurler polydystrophy|Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000002769	12	102158120 - 102158121	12	101764342 - 101764343	2769	17808	rs281865029	NC_000012.12:101764341:TCTCT:TCT
NM_001126108.2(SLC12A3):c.1946C>T (p.Thr649Met)	SLC12A3	T649M, T648M	not provided|Familial hypokalemia-hypomagnesemia	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000632259	16	56920296	16	56886384	632259	620555	rs145337602	NC_000016.10:56886383:C:T
NM_001126108.2(SLC12A3):c.506-1G>A	SLC12A3		not provided|Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448398	16	56903640	16	56869728	448398	441908	rs201555148	NC_000016.10:56869727:G:A
NM_001126108.2(SLC12A3):c.2954G>A (p.Cys985Tyr)	SLC12A3	C994Y, C993Y, C985Y	not provided	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448395	16	56947205	16	56913293	448395	441915	rs199849117	NC_000016.10:56913292:G:A
NM_001126108.2(SLC12A3):c.1180+1G>T	SLC12A3		not provided|Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000437426	16	56912074	16	56878162	437426	430987	rs749098014	NC_000016.10:56878161:G:T
NC_000016.9:g.(?_89574816)_(89575018_?)del	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000658452	16	89574816 - 89575018	16	89508408 - 89508610	658452	653174		
NM_003119.4(SPG7):c.771_772TG[1] (p.Val258fs)	SPG7		Hereditary spastic paraplegia|Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504920	16	89595899 - 89595900	16	89529489 - 89529490	504920	497082	rs768136171	NC_000016.10:89529488:TGTG:TG
NM_003119.4(SPG7):c.2115_2131del (p.Leu706fs)	SPG7	L706fs	Hereditary spastic paraplegia 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000465175	16	89620903 - 89620919	16	89554495 - 89554511	465175	467161	rs748255454	NC_000016.10:89554494:CTGCTGGTGGCCAAGGCCT:CT
NM_003119.4(SPG7):c.376G>C (p.Glu126Gln)	SPG7	E126Q	not provided|Hereditary spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000424654	16	89579445	16	89513037	424654	411589	rs912983346	NC_000016.10:89513036:G:C
NM_003119.4(SPG7):c.988-1G>A	SPG7		Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217270	16	89598311	16	89531903	217270	213916	rs748309520	NC_000016.10:89531902:G:A
NM_144599.5(NIPA1):c.134C>G (p.Thr45Arg)	NIPA1	T45R	Hereditary spastic paraplegia 6	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000002520	15	23086278	15	22786790	2520	17559	rs104894496	NC_000015.10:22786789:C:G
NM_002834.4(PTPN11):c.1471C>G (p.Pro491Ala)	PTPN11	P491A, P495A	Noonan syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2016)	criteria provided, multiple submitters, no conflicts	VCV000181503	12	112926851	12	112489047	181503	179456	rs397507539	NC_000012.12:112489046:C:G
NM_002834.4(PTPN11):c.1530G>C (p.Gln510His)	PTPN11	Q510H, Q514H	not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040567	12	112926910	12	112489106	40567	49037	rs397507550	NC_000012.12:112489105:G:C
NM_000020.3(ACVRL1):c.334C>T (p.Gln112Ter)	ACVRL1	Q112*	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812852	12	52307363	12	51913579	812852	801131		NC_000012.12:51913578:C:T
NM_000020.2(ACVRL1):c.264C>G (p.Tyr88Ter)	ACVRL1	Y88*	not provided	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000618515	12	52307085	12	51913301	618515	609836	rs775754117	NC_000012.12:51913300:C:G
NM_000020.2(ACVRL1):c.870del (p.Arg291fs)	ACVRL1	R291fs	not provided	Pathogenic(Last reviewed: Oct 15, 2017)	criteria provided, single submitter	VCV000617964	12	52309106	12	51915322	617964	609839	rs1565594157	NC_000012.12:51915321:G:
NM_000020.2(ACVRL1):c.1144del (p.Asp382fs)	ACVRL1	D382fs	not provided	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000617962	12	52309914	12	51916130	617962	609845	rs1565595009	NC_000012.12:51916129:GG:G
NM_000020.2(ACVRL1):c.913T>C (p.Ser305Pro)	ACVRL1	S305P	not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000617957	12	52309149	12	51915365	617957	609841	rs1565594238	NC_000012.12:51915364:T:C
NM_000020.2(ACVRL1):c.439C>T (p.Gln147Ter)	ACVRL1	Q147*	not provided	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000523777	12	52307468	12	51913684	523777	514645	rs1555152650	NC_000012.12:51913683:C:T
NM_000020.2(ACVRL1):c.139_140insCG (p.Arg47fs)	ACVRL1		not provided	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000503681	12	52306960 - 52306961	12	51913176 - 51913177	503681	495559	rs1555152455	NC_000012.12:51913176::CG
NM_000020.2(ACVRL1):c.741_742CA[1] (p.Thr248fs)	ACVRL1		not specified	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000439389	12	52308337 - 52308338	12	51914553 - 51914554	439389	433347	rs1555152955	NC_000012.12:51914552:ACACA:ACA
NM_000020.2(ACVRL1):c.265T>C (p.Cys89Arg)	ACVRL1	C89R	not specified	Pathogenic(Last reviewed: Oct 16, 2016)	criteria provided, single submitter	VCV000439381	12	52307086	12	51913302	439381	433344	rs1555152520	NC_000012.12:51913301:T:C
NM_000020.2(ACVRL1):c.525+1G>A	ACVRL1		not specified	Pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	VCV000439380	12	52307555	12	51913771	439380	433343	rs1555152710	NC_000012.12:51913770:G:A
NM_000020.2(ACVRL1):c.626-3C>G	ACVRL1		not specified	Pathogenic(Last reviewed: Oct 1, 2016)	criteria provided, single submitter	VCV000439379	12	52308220	12	51914436	439379	433108	rs1555152899	NC_000012.12:51914435:C:G
NM_000020.2(ACVRL1):c.271del (p.Asp91fs)	ACVRL1	D91fs	not specified	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000439378	12	52307092	12	51913308	439378	433101	rs1555152526	NC_000012.12:51913307:G:
NM_000020.2(ACVRL1):c.1355C>T (p.Pro452Leu)	ACVRL1	P452L	not provided	Pathogenic(Last reviewed: Oct 18, 2017)	criteria provided, single submitter	VCV000439369	12	52312877	12	51919093	439369	433113	rs1555153848	NC_000012.12:51919092:C:T
NM_000020.2(ACVRL1):c.639T>G (p.Tyr213Ter)	ACVRL1	Y213*	not provided	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000432170	12	52308236	12	51914452	432170	425996	rs962224649	NC_000012.12:51914451:T:G
NM_000020.2(ACVRL1):c.295_299del (p.Val99fs)	ACVRL1	V99fs	not provided	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000426959	12	52307115 - 52307119	12	51913331 - 51913335	426959	415349	rs1085307872	NC_000012.12:51913330:CGTGTC:C
NM_000020.2(ACVRL1):c.1027C>T (p.Gln343Ter)	ACVRL1	Q343*	not provided	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000423613	12	52309263	12	51915479	423613	408711	rs1064796530	NC_000012.12:51915478:C:T
NM_000020.2(ACVRL1):c.916del (p.Ala306fs)	ACVRL1	A306fs	not provided	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000422888	12	52309152	12	51915368	422888	408710	rs1064796070	NC_000012.12:51915367:G:
NM_000020.2(ACVRL1):c.1122del (p.Tyr375fs)	ACVRL1	Y375fs	not provided	Pathogenic(Last reviewed: Apr 9, 2014)	criteria provided, single submitter	VCV000212808	12	52309892	12	51916108	212808	210235	rs863223418	NC_000012.12:51916107:GG:G
NM_001077401.2(ACVRL1):c.1029_1030GT[3] (p.Cys345fs)	ACVRL1		not provided	Pathogenic(Last reviewed: Mar 9, 2015)	criteria provided, single submitter	VCV000212807	12	52309264 - 52309265	12	51915480 - 51915481	212807	210234	rs863223417	NC_000012.12:51915480:GTGT:GTGTGT
NM_000020.2(ACVRL1):c.269G>A (p.Cys90Tyr)	ACVRL1	C90Y	not provided	Pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	VCV000212798	12	52307090	12	51913306	212798	210225	rs863223410	NC_000012.12:51913305:G:A
NM_000020.2(ACVRL1):c.152G>A (p.Cys51Tyr)	ACVRL1	C51Y	not provided	Pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, single submitter	VCV000212797	12	52306973	12	51913189	212797	210223	rs863223409	NC_000012.12:51913188:G:A
NM_000020.2(ACVRL1):c.788A>G (p.Asp263Gly)	ACVRL1	D263G	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426016	12	52309024	12	51915240	426016	414387	rs1085307408	NC_000012.12:51915239:A:G
NM_000020.2(ACVRL1):c.1196G>C (p.Trp399Ser)	ACVRL1	W399S	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000008255	12	52309967	12	51916183	8255	23294	rs121909289	NC_000012.12:51916182:G:C
NM_000020.2(ACVRL1):c.1460A>C (p.Lys487Thr)	ACVRL1	K487T	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426039	12	52314625	12	51920841	426039	414410	rs1085307428	NC_000012.12:51920840:A:C
NM_001077401.2(ACVRL1):c.1450delinsTG (p.Arg484fs)	ACVRL1		Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426038	12	52314615	12	51920831	426038	414409	rs1085307427	NC_000012.12:51920830:C:TG
NM_000020.2(ACVRL1):c.1390del (p.Gly463_Leu464insTer)	ACVRL1		Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426033	12	52314554	12	51920770	426033	414404	rs1085307424	NC_000012.12:51920769:CC:C
NM_000020.2(ACVRL1):c.1280A>T (p.Asp427Val)	ACVRL1	D427V	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426029	12	52312802	12	51919018	426029	414400	rs1085307420	NC_000012.12:51919017:A:T
NM_000020.2(ACVRL1):c.1196G>T (p.Trp399Leu)	ACVRL1	W399L	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426027	12	52309967	12	51916183	426027	414398	rs121909289	NC_000012.12:51916182:G:T
NM_000020.2(ACVRL1):c.1195T>C (p.Trp399Arg)	ACVRL1	W399R	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426026	12	52309966	12	51916182	426026	414397	rs1085307418	NC_000012.12:51916181:T:C
NM_000020.2(ACVRL1):c.853C>T (p.Leu285Phe)	ACVRL1	L285F	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426018	12	52309089	12	51915305	426018	414389	rs1085307410	NC_000012.12:51915304:C:T
NM_000020.2(ACVRL1):c.818T>C (p.Leu273Pro)	ACVRL1	L273P	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426017	12	52309054	12	51915270	426017	414388	rs1085307409	NC_000012.12:51915269:T:C
NM_001077401.2(ACVRL1):c.653_654inv (p.Arg218Pro)	ACVRL1		Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426015	12	52308250 - 52308251	12	51914466 - 51914467	426015	414433		NC_000012.12:51914465:GG:CC
NM_000020.2(ACVRL1):c.602A>G (p.Gln201Arg)	ACVRL1	Q201R	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426014	12	52307834	12	51914050	426014	414386	rs1085307407	NC_000012.12:51914049:A:G
NM_000020.2(ACVRL1):c.593T>A (p.Val198Glu)	ACVRL1	V198E	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426013	12	52307825	12	51914041	426013	414385	rs886043123	NC_000012.12:51914040:T:A
NM_000020.3(ACVRL1):c.72_79del (p.Lys25fs)	ACVRL1	K25fs		Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000811218	12	52306891 - 52306898	12	51913107 - 51913114	811218	799694		NC_000012.12:51913106:GTGAAGCCGT:GT
NM_000020.3(ACVRL1):c.1246G>A (p.Gly416Ser)	ACVRL1	G416S		Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000810860	12	52310017	12	51916233	810860	799700		NC_000012.12:51916232:G:A
NM_000020.2(ACVRL1):c.1468C>T (p.Gln490Ter)	ACVRL1	Q490*	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426040	12	52314633	12	51920849	426040	414411	rs1085307429	NC_000012.12:51920848:C:T
NM_000020.2(ACVRL1):c.1436G>C (p.Arg479Pro)	ACVRL1	R479P	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426036	12	52314601	12	51920817	426036	414407	rs1085307426	NC_000012.12:51920816:G:C
NM_000020.2(ACVRL1):c.1433C>A (p.Ala478Asp)	ACVRL1	A478D	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426034	12	52314598	12	51920814	426034	414405	rs1085307425	NC_000012.12:51920813:C:A
NM_000020.2(ACVRL1):c.1388del (p.Gly463fs)	ACVRL1	G463fs	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426032	12	52314552	12	51920768	426032	414403	rs1085307423	NC_000012.12:51920767:GG:G
NM_000020.2(ACVRL1):c.1142T>C (p.Leu381Pro)	ACVRL1	L381P	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426025	12	52309913	12	51916129	426025	414396	rs1085307417	NC_000012.12:51916128:T:C
NM_000020.2(ACVRL1):c.950T>C (p.Ile317Thr)	ACVRL1	I317T	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426021	12	52309186	12	51915402	426021	414392	rs1085307413	NC_000012.12:51915401:T:C
NM_000020.2(ACVRL1):c.936C>G (p.His312Gln)	ACVRL1	H312Q	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426020	12	52309172	12	51915388	426020	414391	rs1085307412	NC_000012.12:51915387:C:G
NM_000020.2(ACVRL1):c.854T>C (p.Leu285Pro)	ACVRL1	L285P	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426019	12	52309090	12	51915306	426019	414390	rs1085307411	NC_000012.12:51915305:T:C
NM_000020.2(ACVRL1):c.37del (p.Leu13fs)	ACVRL1	L13fs	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic	no assertion criteria provided	VCV000426009	12	52306295	12	51912511	426009	414381	rs1085307404	NC_000012.12:51912510:C:
NM_000153.4(GALC):c.1004A>G (p.Tyr335Cys)	GALC	Y312C, Y309C, Y335C	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000651170	14	88431878	14	87965534	651170	642771		NC_000014.9:87965533:T:C
GALC, 30-KB DEL, IVS10	GALC		Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000003819					3819	18858		
NM_000020.3(ACVRL1):c.1153_1157dup (p.Thr387fs)	ACVRL1			Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000859419	12	52309922 - 52309923	12	51916138 - 51916139	859419	840068		NC_000012.12:51916138:GATCCG:GATCCGATCCG
NM_000020.3(ACVRL1):c.1015A>T (p.Lys339Ter)	ACVRL1	K339*		Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000858198	12	52309251	12	51915467	858198	840063		NC_000012.12:51915466:A:T
NM_000020.3(ACVRL1):c.1196G>A (p.Trp399Ter)	ACVRL1	W399*		Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000857852	12	52309967	12	51916183	857852	840071		NC_000012.12:51916182:G:A
NM_000020.3(ACVRL1):c.714del (p.Trp239fs)	ACVRL1	W239fs		Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000841677	12	52308310	12	51914526	841677	840059		NC_000012.12:51914525:CC:C
NM_000020.3(ACVRL1):c.1197G>A (p.Trp399Ter)	ACVRL1	W399*		Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000838981	12	52309968	12	51916184	838981	840072		NC_000012.12:51916183:G:A
NM_000020.3(ACVRL1):c.237del (p.Arg80fs)	ACVRL1	R80fs		Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000838856	12	52307054	12	51913270	838856	840056		NC_000012.12:51913269:GGGGG:GGGG
NM_000020.3(ACVRL1):c.1055del (p.Ala352fs)	ACVRL1	A352fs		Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000838622	12	52309826	12	51916042	838622	840065		NC_000012.12:51916041:C:
NC_000012.12:g.(?_51912465)_(51912545_?)del	ACVRL1			Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000830467	12	52306249 - 52306329			830467	820506		
NM_001077401.2(ACVRL1):c.870_871GA[1] (p.Arg291fs)	ACVRL1			Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000645621	12	52309105 - 52309106	12	51915321 - 51915322	645621	641244		NC_000012.12:51915320:AGAGA:AGA
NM_000020.3(ACVRL1):c.237dup (p.Arg80fs)	ACVRL1			Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000644908	12	52307053 - 52307054	12	51913269 - 51913270	644908	641236		NC_000012.12:51913269:GGGGG:GGGGGG
NM_000020.2(ACVRL1):c.190C>T (p.Gln64Ter)	ACVRL1	Q64*		Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000643072	12	52307011	12	51913227	643072	641235		NC_000012.12:51913226:C:T
NM_000020.2(ACVRL1):c.1378-216C>G	ACVRL1			Pathogenic(Last reviewed: Feb 6, 2019)	no assertion criteria provided	VCV000617664	12	52314327	12	51920543	617664	609067	rs111710113	NC_000012.12:51920542:C:G
NM_000020.2(ACVRL1):c.1048G>C (p.Gly350Arg)	ACVRL1	G350R		Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000583213	12	52309284	12	51915500	583213	566914	rs1565594547	NC_000012.12:51915499:G:C
NM_000020.2(ACVRL1):c.1036_1040del (p.Ile346fs)	ACVRL1	I346fs		Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000581902	12	52309270 - 52309274	12	51915486 - 51915490	581902	565591	rs1565594524	NC_000012.12:51915485:GCATCGC:GC
NM_000020.2(ACVRL1):c.1042del (p.Asp348fs)	ACVRL1	D348fs		Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000569067	12	52309278	12	51915494	569067	566903	rs1565594536	NC_000012.12:51915493:G:
NM_000020.2(ACVRL1):c.145del (p.Ala49fs)	ACVRL1	A49fs		Pathogenic(Last reviewed: Mar 3, 2018)	criteria provided, single submitter	VCV000568436	12	52306961	12	51913177	568436	566902	rs863223415	NC_000012.12:51913176:GGGGGG:GGGGG
NC_000012.11:g.(?_52306863)_(52307574_?)del	ACVRL1			Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000533360	12	52306863 - 52307574	12	51913079 - 51913790	533360	526621		
NC_000012.11:g.(?_52307738)_(52312919_?)del	ACVRL1			Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000533359	12	52307738 - 52312919	12	51913954 - 51919135	533359	526622		
NC_000012.11:g.(?_52307323)_(52312919_?)del	ACVRL1			Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000533358	12	52307323 - 52312919	12	51913539 - 51919135	533358	526620		
NM_000020.2(ACVRL1):c.1147G>T (p.Glu383Ter)	ACVRL1	E383*		Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000533347	12	52309918	12	51916134	533347	527783	rs148057374	NC_000012.12:51916133:G:T
NM_000020.2(ACVRL1):c.58C>T (p.Gln20Ter)	ACVRL1	Q20*		Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000533342	12	52306316	12	51912532	533342	527259	rs1555152345	NC_000012.12:51912531:C:T
NM_000020.2(ACVRL1):c.105del (p.Cys36fs)	ACVRL1	C36fs		Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000495052	12	52306926	12	51913142	495052	486613	rs1555152447	NC_000012.12:51913141:G:
NM_001077401.2(ACVRL1):c.711_713delinsAG (p.Ser238fs)	ACVRL1			Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000464769	12	52308308 - 52308310	12	51914524 - 51914526	464769	462319	rs1555152935	NC_000012.12:51914523:GTC:AG
NM_001077401.2(ACVRL1):c.625+1del	ACVRL1			Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	VCV000464767	12	52307856	12	51914072	464767	463059	rs1555152815	NC_000012.12:51914071:GGG:GG
NM_000020.2(ACVRL1):c.542_545del (p.Asp181fs)	ACVRL1	D181fs		Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000464765	12	52307772 - 52307775	12	51913988 - 51913991	464765	462317	rs1555152771	NC_000012.12:51913987:TGACTG:TG
NM_000020.2(ACVRL1):c.1323_1324dup (p.Val442fs)	ACVRL1			Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000464757	12	52312844 - 52312845	12	51919060 - 51919061	464757	462326	rs1555153830	NC_000012.12:51919060:GG:GGGG
NM_000020.2(ACVRL1):c.1250_1269del (p.Ile417fs)	ACVRL1	I417fs		Pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	VCV000464756	12	52312770 - 52312789	12	51918986 - 51919005	464756	462583	rs1555153796	NC_000012.12:51918985:CATCGTGGAGGACTATAGACCA:CA
NC_000012.11:g.(?_52306239)_(52314697_?)del	ACVRL1			Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000464752	12	52306239 - 52314697			464752	461786		
NM_000020.2(ACVRL1):c.1385C>G (p.Ser462Ter)	ACVRL1	S462*	not provided|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000426031	12	52314550	12	51920766	426031	414402	rs1085307422	NC_000012.12:51920765:C:G
NC_000012.11:g.(?_52314543)_(52317145_?)del	ACVRL1			Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000417555	12	52314543 - 52317145	12	51920759 - 51923361	417555	398802		
NM_001077401.2(ACVRL1):c.525+1del	ACVRL1			Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000411315	12	52307551	12	51913767	411315	399003	rs1060503249	NC_000012.12:51913766:GGGGG:GGGG
NM_000020.2(ACVRL1):c.183del (p.Arg61fs)	ACVRL1	R61fs		Pathogenic(Last reviewed: Jun 26, 2016)	criteria provided, single submitter	VCV000411312	12	52307003	12	51913219	411312	399002	rs1060503246	NC_000012.12:51913218:GG:G
NM_000020.2(ACVRL1):c.889del (p.His297fs)	ACVRL1	H297fs		Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000411311	12	52309122	12	51915338	411311	399769	rs1060503245	NC_000012.12:51915337:CCCC:CCC
NM_000020.2(ACVRL1):c.190del (p.Gln64fs)	ACVRL1	Q64fs		Pathogenic(Last reviewed: Oct 8, 2016)	criteria provided, single submitter	VCV000411306	12	52307007	12	51913223	411306	399504	rs1060503241	NC_000012.12:51913222:CCCCC:CCCC
NM_001077401.2(ACVRL1):c.619_620TG[2] (p.Val208fs)	ACVRL1			Pathogenic(Last reviewed: Dec 24, 2016)	criteria provided, single submitter	VCV000411305	12	52307850 - 52307851	12	51914066 - 51914067	411305	399520	rs1060503240	NC_000012.12:51914065:GTGTGTG:GTGTG
NM_000020.2(ACVRL1):c.41dup (p.Met15fs)	ACVRL1			Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000411301	12	52306298 - 52306299	12	51912514 - 51912515	411301	399503	rs1060503236	NC_000012.12:51912514:T:TT
NM_000020.2(ACVRL1):c.1217G>A (p.Trp406Ter)	ACVRL1	W406*		Pathogenic(Last reviewed: Nov 26, 2016)	criteria provided, single submitter	VCV000411300	12	52309988	12	51916204	411300	399785	rs1060503235	NC_000012.12:51916203:G:A
NM_000020.2(ACVRL1):c.1193T>A (p.Ile398Asn)	ACVRL1	I398N		Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000008248	12	52309964	12	51916180	8248	23287	rs121909286	NC_000012.12:51916179:T:A
NM_000020.3(ACVRL1):c.143_147delinsAGCCT (p.Gly48_Ala49delinsGluPro)	ACVRL1			Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000008247	12	52306964 - 52306968	12	51913180 - 51913184	8247	23286	rs387906392	NC_000012.12:51913179:GGGCC:AGCCT
NM_000020.2(ACVRL1):c.1127T>G (p.Met376Arg)	ACVRL1	M376R		Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000008244	12	52309898	12	51916114	8244	23283	rs28936399	NC_000012.12:51916113:T:G
FANCI, IVS31AS, A-G, -88	FANCI		Fanconi anemia, complementation group I	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000000974					974	16013		
NM_001113378.2(FANCI):c.1674_1690del (p.Ser559fs)	FANCI	S466fs, S559fs	Fanconi anemia	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000846513	15	89826448 - 89826464	15	89283217 - 89283233	846513	842763		NC_000015.10:89283216:CTCTCAGTGCAGTCAGTCTCTCAGTG:CTCTCAGTG
NM_001113378.2(FANCI):c.876_879del (p.His292fs)	FANCI	H292fs, H199fs	Fanconi anemia	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000834648	15	89811749 - 89811752	15	89268518 - 89268521	834648	842755		NC_000015.10:89268517:ACTTA:A
NM_018193.3(FANCI):c.3489_3492dup (p.Tyr1165fs)	FANCI		Fanconi anemia	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000658065	15	89856151 - 89856152	15	89312920 - 89312921	658065	643590		NC_000015.10:89312920:GAAC:GAACGAAC
NM_018193.3(FANCI):c.2815_2819TCCTC[1] (p.Pro941fs)	FANCI		Fanconi anemia	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000651938	15	89844661 - 89844665	15	89301430 - 89301434	651938	643582		NC_000015.10:89301429:CTCCTCTCCTC:CTCCTC
NM_018193.3(FANCI):c.3482del (p.Lys1161fs)	FANCI	K1221fs, K1161fs	Fanconi anemia	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000581414	15	89856144	15	89312913	581414	573565	rs1567179036	NC_000015.10:89312912:AA:A
NM_001113378.1(FANCI):c.3780T>A (p.Tyr1260Ter)	FANCI	Y1260*, Y1200*	Fanconi anemia	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000408248	15	89857902	15	89314671	408248	401235	rs1060501900	NC_000015.10:89314670:T:A
NM_018193.3(FANCI):c.3313del (p.Asp1105fs)	FANCI	D1165fs, D1105fs	Fanconi anemia	Pathogenic(Last reviewed: May 20, 2016)	criteria provided, single submitter	VCV000408200	15	89849380	15	89306149	408200	400419	rs758597713	NC_000015.10:89306148:GG:G
NM_001113378.1(FANCI):c.507G>A (p.Trp169Ter)	FANCI	W169*	Fanconi anemia	Pathogenic(Last reviewed: Jan 30, 2016)	criteria provided, single submitter	VCV000238329	15	89806653	15	89263422	238329	242121	rs878854181	NC_000015.10:89263421:G:A
NM_018193.3(FANCI):c.3444_3445GT[1] (p.Cys1149fs)	FANCI		Fanconi anemia	Pathogenic(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	VCV000219634	15	89850875 - 89850876	15	89307644 - 89307645	219634	222435	rs770318990	NC_000015.10:89307643:TGTGT:TGT
NM_018193.3(FANCI):c.3674G>A (p.Arg1225Gln)	FANCI	R1285Q, R1225Q	Fanconi anemia, complementation group I	Pathogenic(Last reviewed: Apr 20, 2007)	no assertion criteria provided	VCV000000972	15	89858550	15	89315319	972	16011	rs121918163	NC_000015.10:89315318:G:A
FANCI, 2T-C	FANCI		Fanconi anemia, complementation group I	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000000971					971	16010		
NM_000020.3(ACVRL1):c.772+1G>C	ACVRL1			Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000835700	12	52308370	12	51914586	835700	851515		NC_000012.12:51914585:G:C
NC_000012.11:g.(?_52306249)_(52314687_?)del	ACVRL1			Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000657392	12	52306249 - 52314687	12	51912465 - 51920903	657392	652182		
NM_000020.2(ACVRL1):c.270C>A (p.Cys90Ter)	ACVRL1	C90*		Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000654296	12	52307091	12	51913307	654296	641239		NC_000012.12:51913306:C:A
NC_000012.11:g.(?_52314475)_(52314687_?)del	ACVRL1			Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000640986	12	52314475 - 52314687	12	51920691 - 51920903	640986	652385		
NM_000020.2(ACVRL1):c.1246+1G>A	ACVRL1			Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000571573	12	52310018	12	51916234	571573	565603	rs1565595176	NC_000012.12:51916233:G:A
NM_000020.2(ACVRL1):c.526-1G>A	ACVRL1			Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000570721	12	52307757	12	51913973	570721	571903	rs1565593274	NC_000012.12:51913972:G:A
NC_000012.11:g.(?_52314523)_(52314697_?)del	ACVRL1			Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000533361	12	52314523 - 52314697	12	51920739 - 51920913	533361	526625		
NM_000020.2(ACVRL1):c.808_820dup (p.Trp274Ter)	ACVRL1			Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000533341	12	52309043 - 52309044	12	51915259 - 51915260	533341	527781	rs1555153077	NC_000012.12:51915259:AGCACGCAGCTGT:AGCACGCAGCTGTAGCACGCAGCTGT
NM_000020.2(ACVRL1):c.641del (p.Gly214fs)	ACVRL1	G214fs		Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000464768	12	52308237	12	51914453	464768	462575	rs1555152909	NC_000012.12:51914452:GG:G
NM_000020.2(ACVRL1):c.573del (p.Phe192fs)	ACVRL1	F192fs		Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000464766	12	52307802	12	51914018	464766	462572	rs1555152786	NC_000012.12:51914017:CCCC:CCC
NM_000020.2(ACVRL1):c.313+1G>T	ACVRL1			Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000464761	12	52307135	12	51913351	464761	462305	rs1555152548	NC_000012.12:51913350:G:T
NM_001077401.2(ACVRL1):c.1450C>G (p.Arg484Gly)	ACVRL1	R484G	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000426037	12	52314615	12	51920831	426037	414408	rs121909288	NC_000012.12:51920830:C:G
NM_000020.2(ACVRL1):c.822G>A (p.Trp274Ter)	ACVRL1	W274*		Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000236553	12	52309058	12	51915274	236553	241562	rs757645341	NC_000012.12:51915273:G:A
NM_003119.4(SPG7):c.1049_1077del (p.Pro350fs)	SPG7	P350fs	Hereditary spastic paraplegia 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495055	16	89598369 - 89598397	16	89531961 - 89531989	495055	486615	rs775364547	NC_000016.10:89531960:GGCCCCCCCGGCTGTGGGAAGACGCTGCTGGCC:GGCC
NM_024685.4(BBS10):c.1677C>A (p.Tyr559Ter)	BBS10	Y559*	Bardet-Biedl syndrome|Retinal dystrophy|Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000417949	12	76740088	12	76346308	417949	404810	rs375413604	NC_000012.12:76346307:G:T
NM_024685.4(BBS10):c.728_731del (p.Lys243fs)	BBS10	K243fs	Bardet-Biedl syndrome 10|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189071	12	76741034 - 76741037	12	76347254 - 76347257	189071	186852	rs786204671	NC_000012.12:76347253:TCTTTCT:TCT
NM_024685.4(BBS10):c.273C>G (p.Cys91Trp)	BBS10	C91W	Bardet-Biedl syndrome 10|Bardet-Biedl syndrome|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030818	12	76741492	12	76347712	30818	39775	rs148374859	NC_000012.12:76347711:G:C
NM_024312.5(GNPTAB):c.3091C>T (p.Arg1031Ter)	GNPTAB	R1031*	Mucolipidosis||Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000039065	12	102154949	12	101761171	39065	47668	rs281865009	NC_000012.12:101761170:G:A
NM_024312.5(GNPTAB):c.2715+2T>G	GNPTAB		|Pseudo-Hurler polydystrophy|Pseudo-Hurler polydystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039059	12	102157978	12	101764200	39059	47662	rs281865001	NC_000012.12:101764199:A:C
NM_000153.4(GALC):c.136G>T (p.Asp46Tyr)	GALC	D46Y	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633229	14	88459373	14	87993029	633229	621480	rs751975987	NC_000014.9:87993028:C:A
NM_000153.4(GALC):c.430del (p.Ile144fs)	GALC	I121fs, I118fs, I144fs	Galactosylceramide beta-galactosidase deficiency|not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197110	14	88452845	14	87986501	197110	194271	rs775277935	NC_000014.9:87986500:T:
NM_000153.4(GALC):c.169G>A (p.Gly57Ser)	GALC	G57S	Galactosylceramide beta-galactosidase deficiency|not provided	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000193054	14	88459340	14	87992996	193054	190219	rs11623	NC_000014.9:87992995:C:T
NM_000153.4(GALC):c.658C>T (p.Arg220Ter)	GALC	R220*, R194*, R197*	Galactosylceramide beta-galactosidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189024	14	88442796	14	87976452	189024	186920	rs766310671	NC_000014.9:87976451:G:A
NM_000153.4(GALC):c.1630G>A (p.Asp544Asn)	GALC	D544N, D518N, D521N	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, single submitter	VCV000030614	14	88411937	14	87945593	30614	39571	rs387906952	NC_000014.9:87945592:C:T
NM_004004.6(GJB2):c.290dup (p.Tyr97Ter)	GJB2		Deafness, autosomal recessive 1A|not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188821	13	20763430 - 20763431	13	20189291 - 20189292	188821	186858	rs786204491	NC_000013.11:20189291:T:TT
NM_004004.6(GJB2):c.379C>T (p.Arg127Cys)	GJB2	R127C	Rare genetic deafness|Deafness, autosomal dominant 3a|Knuckle pads, deafness AND leukonychia syndrome|Palmoplantar keratoderma-deafness syndrome|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Deafness, autosomal recessive 1A|Deafness, X-linked 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000163514	13	20763342	13	20189203	163514	175763	rs727503066	NC_000013.11:20189202:G:A
NM_000020.3(ACVRL1):c.86del (p.Gly29fs)	ACVRL1	G29fs		Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000847246	12	52306904	12	51913120	847246	840054		NC_000012.12:51913119:GGGG:GGG
NM_000020.2(ACVRL1):c.1046T>C (p.Leu349Pro)	ACVRL1	L349P		Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000662026	12	52309282	12	51915498	662026	641252		NC_000012.12:51915497:T:C
NM_000020.2(ACVRL1):c.651G>A (p.Trp217Ter)	ACVRL1	W217*		Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000655621	12	52308248	12	51914464	655621	641240		NC_000012.12:51914463:G:A
NM_000020.2(ACVRL1):c.625+2T>C	ACVRL1			Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000641790	12	52307859	12	51914075	641790	652332		NC_000012.12:51914074:T:C
NM_000020.2(ACVRL1):c.1336C>T (p.Gln446Ter)	ACVRL1	Q446*	not provided|	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000419979	12	52312858	12	51919074	419979	408712	rs1064794217	NC_000012.12:51919073:C:T
NM_000020.2(ACVRL1):c.841G>T (p.Glu281Ter)	ACVRL1	E281*	not provided|	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000411307	12	52309077	12	51915293	411307	399157	rs779485996	NC_000012.12:51915292:G:T
NM_000020.2(ACVRL1):c.986G>A (p.Arg329His)	ACVRL1	R329H	not provided|	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000212801	12	52309222	12	51915438	212801	210232	rs863223412	NC_000012.12:51915437:G:A
NM_000020.2(ACVRL1):c.1113_1114insG	ACVRL1			Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000008256	12	52309884 - 52309885	12	51916100 - 51916101	8256	23295	rs387906394	NC_000012.12:51916100::G
NM_000020.2(ACVRL1):c.632G>A (p.Gly211Asp)	ACVRL1	G211D	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000008253	12	52308229	12	51914445	8253	23292	rs28936687	NC_000012.12:51914444:G:A
NM_001127701.1(SERPINA1):c.230C>T (p.Ser77Phe)	SERPINA1	S53F, S77F	Alpha-1-antitrypsin deficiency|PI S(IIYAMA)	Pathogenic(Last reviewed: Dec 18, 2014)	criteria provided, single submitter	VCV000017992	14	94849345	14	94383008	17992	33031	rs55819880	NC_000014.9:94383007:G:A
NM_000295.4(SERPINA1):c.721A>T (p.Lys241Ter)	SERPINA1	K217*, K241*	Alpha-1-antitrypsin deficiency|PI NULL(BELLINGHAM)|PI Q0(BELLINGHAM)	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017977	14	94847404	14	94381067	17977	33016	rs199422211	NC_000014.9:94381066:T:A
NM_000282.4(PCCA):c.1284+1G>A	PCCA		not provided|Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279863	13	100955253	13	100302999	279863	264713	rs752761437	NC_000013.11:100302998:G:A
NM_002230.4(JUP):c.188del (p.Gln63fs)	JUP	Q63fs	Naxos disease	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000464030	17	39927919	17	41771667	464030	467865	rs1555606936	NC_000017.11:41771666:T:
NM_002230.4(JUP):c.794G>A (p.Arg265His)	JUP	R265H	Naxos disease	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000212751	17	39923746	17	41767494	212751	209381	rs782440692	NC_000017.11:41767493:C:T
NM_002230.4(JUP):c.1615C>T (p.Gln539Ter)	JUP	Q539*	Naxos disease	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000212750	17	39915005	17	41758753	212750	209380	rs797046139	NC_000017.11:41758752:G:A
NM_002230.4(JUP):c.468G>A (p.Pro156=)	JUP		Naxos disease	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000212749	17	39925670	17	41769418	212749	209379	rs886037753	NC_000017.11:41769417:C:T
NM_002230.4(JUP):c.545C>A (p.Ser182Ter)	JUP	S182*	Naxos disease|Arrhythmogenic right ventricular cardiomyopathy, type 12	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000857898	17	39925383	17	41769131	857898	845316		NC_000017.11:41769130:G:T
NC_000017.11:g.(?_41771637)_(41771864_?)del	JUP		Naxos disease|Arrhythmogenic right ventricular cardiomyopathy, type 12	Pathogenic(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000831627	17	39927889 - 39928116			831627	821042		
NM_002230.4(JUP):c.1455_1462del (p.Val486fs)	JUP	V486fs	Arrhythmogenic right ventricular cardiomyopathy, type 12|Naxos disease	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000659497	17	39919270 - 39919277	17	41763018 - 41763025	659497	645857		NC_000017.11:41763017:GCTTCACG:
NM_002230.4(JUP):c.71C>A (p.Ser24Ter)	JUP	S24*	Naxos disease	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000212748	17	39928036	17	41771784	212748	209378	rs782460555	NC_000017.11:41771783:G:T
NM_002230.4(JUP):c.113_115GCA[3] (p.Ser39dup)	JUP		Arrhythmogenic right ventricular cardiomyopathy, type 12	Pathogenic(Last reviewed: Jul 10, 2008)	no assertion criteria provided	VCV000013600	17	39927988 - 39927989	17	41771736 - 41771737	13600	28639	rs113994176	NC_000017.11:41771736:TGCTGCTG:TGCTGCTGCTG
NM_002230.4(JUP):c.1807del (p.Val603fs)	JUP	V603fs	Naxos disease|Arrhythmogenic right ventricular cardiomyopathy, type 12	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000641938	17	39914003	17	41757751	641938	645855		NC_000017.11:41757750:C:
NM_001605.3(AARS1):c.988C>T (p.Arg330Ter)	AARS1	R330*	Epileptic encephalopathy, early infantile, 29	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000807355	16	70302257	16	70268354	807355	798702		NC_000016.10:70268353:G:A
NM_000432.4(MYL2):c.239C>A (p.Thr80Asn)	MYL2	T80N	Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000155818	12	111352025	12	110914221	155818	165570	rs587782965	NC_000012.12:110914220:G:T
NM_001605.2(AARS1):c.211A>T (p.Asn71Tyr)	AARS1	N71Y	Charcot-Marie-Tooth disease, type 2N	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030155	16	70310991	16	70277088	30155	39111	rs387906792	NC_000016.10:70277087:T:A
NM_000286.3(PEX12):c.886_887CT[1] (p.Leu297fs)	PEX12		Peroxisome biogenesis disorders, Zellweger syndrome spectrum|not provided|Peroxisome biogenesis disorder 3A|Infantile Refsum's disease	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000092776	17	33902992 - 33902993	17	35575973 - 35575974	92776	98683	rs398123301	NC_000017.11:35575972:AGAG:AG
NM_000020.3(ACVRL1):c.1345C>T (p.Pro449Ser)	ACVRL1	P449S		Pathogenic(Last reviewed: May 9, 2019)	criteria provided, single submitter	VCV000856919	12	52312867	12	51919083	856919	840076		NC_000012.12:51919082:C:T
NM_000020.2(ACVRL1):c.1221G>T (p.Glu407Asp)	ACVRL1	E407D		Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000585303	12	52309992	12	51916208	585303	576353	rs1565595129	NC_000012.12:51916207:G:T
NM_000020.2(ACVRL1):c.940C>T (p.His314Tyr)	ACVRL1	H314Y		Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000582561	12	52309176	12	51915392	582561	568116	rs1565594311	NC_000012.12:51915391:C:T
NM_000020.2(ACVRL1):c.540_541insA (p.Asp181fs)	ACVRL1			Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000464763	12	52307772 - 52307773	12	51913988 - 51913989	464763	463054	rs1555152774	NC_000012.12:51913988::A
NM_000020.2(ACVRL1):c.998G>T (p.Ser333Ile)	ACVRL1	S333I	|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212802	12	52309234	12	51915450	212802	210233	rs863223413	NC_000012.12:51915449:G:T
NM_002834.4(PTPN11):c.181G>C (p.Asp61His)	PTPN11	D61H	not provided|Noonan syndrome 3	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040494	12	112888165	12	112450361	40494	48964	rs397507510	NC_000012.12:112450360:G:C
NM_002230.4(JUP):c.2038_2039del (p.Trp680fs)	JUP	W680fs	Naxos disease|not provided	Pathogenic(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	VCV000013599	17	39913674 - 39913675	17	41757422 - 41757423	13599	28638	rs113994177	NC_000017.11:41757421:CA:
NC_000014.8:g.(?_88434659)_(88434854_?)del	GALC		Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000526829	14	88434659 - 88434854	14	87968315 - 87968510	526829	527841		
NM_000153.4(GALC):c.1657G>A (p.Gly553Arg)	GALC	G553R, G530R, G527R	Galactosylceramide beta-galactosidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189113	14	88411910	14	87945566	189113	186915	rs748573754	NC_000014.9:87945565:C:T
NM_004937.3(CTNS):c.971-12G>A	CTNS		Nephropathic cystinosis|Ocular cystinosis|Nephropathic cystinosis|Juvenile nephropathic cystinosis	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000526030	17	3563518	17	3660224	526030	531468	rs375952052	NC_000017.11:3660223:G:A
NM_025099.6(CTC1):c.2959C>T (p.Arg987Trp)	CTC1	R987W	Dyskeratosis congenita|Cerebroretinal microangiopathy with calcifications and cysts 1	Pathogenic(Last reviewed: Feb 18, 2018)	criteria provided, single submitter	VCV000030996	17	8133261	17	8229943	30996	39953	rs202138550	NC_000017.11:8229942:G:A
NM_024312.5(GNPTAB):c.99del (p.Ala34fs)	GNPTAB	A34fs	Pseudo-Hurler polydystrophy||Pseudo-Hurler polydystrophy|	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000496456	12	102224355	12	101830577	496456	487325	rs1408113895	NC_000012.12:101830576:GG:G
NM_024312.5(GNPTAB):c.136C>T (p.Arg46Ter)	GNPTAB	R46*	||Pseudo-Hurler polydystrophy|not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039031	12	102190522	12	101796744	39031	47634	rs78347057	NC_000012.12:101796743:G:A
NM_024312.5(GNPTAB):c.1581del (p.Cys528fs)	GNPTAB	C528fs	|Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000038414	12	102159900	12	101766122	38414	46973	rs36007394	NC_000012.12:101766121:GG:G
NM_001018005.2(TPM1):c.539A>G (p.Glu180Gly)	TPM1	E180G, E222G, E144G	not provided|Familial hypertrophic cardiomyopathy 3	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000012455	15	63353114	15	63060915	12455	27494	rs104894502	NC_000015.10:63060914:A:G
NM_000382.3(ALDH3A2):c.733G>A (p.Asp245Asn)	ALDH3A2	D245N, D52N	not provided|Sjgren-Larsson syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265459	17	19561110	17	19657797	265459	260161	rs72547568	NC_000017.11:19657796:G:A
NM_000231.3(SGCG):c.787G>A (p.Glu263Lys)	SGCG	E263K, E281K	not provided|Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002009	13	23898591	13	23324452	2009	17048	rs104894423	NC_000013.11:23324451:G:A
NM_000231.2(SGCG):c.848G>A (p.Cys283Tyr)	SGCG	C283Y	Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002006	13	23898652	13	23324513	2006	17045	rs104894422	NC_000013.11:23324512:G:A
NM_013382.5(POMT2):c.672del (p.Trp225fs)	POMT2	W225fs	not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000595917	14	77767577	14	77301234	595917	586978	rs1566656247	NC_000014.9:77301233:GGGGG:GGGG
NM_013382.5(POMT2):c.248+2T>C	POMT2		not provided	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000501767	14	77786775	14	77320432	501767	493191	rs1326631351	NC_000014.9:77320431:A:G
NM_013382.5(POMT2):c.639C>A (p.Tyr213Ter)	POMT2	Y213*	not provided	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000500611	14	77769195	14	77302852	500611	492035	rs764878423	NC_000014.9:77302851:G:T
NM_013382.5(POMT2):c.462G>A (p.Trp154Ter)	POMT2	W154*	not provided	Pathogenic(Last reviewed: May 4, 2015)	criteria provided, single submitter	VCV000427146	14	77771120	14	77304777	427146	415405	rs1085307985	NC_000014.9:77304776:C:T
NM_013382.5(POMT2):c.1006+1del	POMT2		not provided	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000422818	14	77765031	14	77298688	422818	409155	rs1064796019	NC_000014.9:77298687:C:
NM_013382.5(POMT2):c.1762C>T (p.Arg588Ter)	POMT2	R588*	not provided	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000378419	14	77746387	14	77280044	378419	373190	rs766169193	NC_000014.9:77280043:G:A
NM_013382.5(POMT2):c.1658dup (p.Asn553fs)	POMT2		not provided	Pathogenic(Last reviewed: Jan 19, 2016)	criteria provided, single submitter	VCV000285471	14	77746801 - 77746802	14	77280458 - 77280459	285471	269708	rs886043110	NC_000014.9:77280458:TT:TTT
NM_013382.5(POMT2):c.1123_1124dup (p.Tyr376fs)	POMT2		not provided	Pathogenic(Last reviewed: Aug 17, 2015)	criteria provided, single submitter	VCV000282447	14	77757715 - 77757716	14	77291372 - 77291373	282447	266684	rs886042401	NC_000014.9:77291372:GTG:GTGTG
NM_013382.5(POMT2):c.1045_1052delinsG (p.Arg349fs)	POMT2		not provided	Pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, single submitter	VCV000281068	14	77762571 - 77762578	14	77296228 - 77296235	281068	265305	rs886042094	NC_000014.9:77296227:GCCATCCG:C
NM_013382.5(POMT2):c.1726-2A>G	POMT2		not provided	Pathogenic(Last reviewed: Feb 17, 2014)	criteria provided, single submitter	VCV000166902	14	77746425	14	77280082	166902	177617	rs727503873	NC_000014.9:77280081:T:C
NM_013382.5(POMT2):c.1484+1G>T	POMT2		not provided	Pathogenic(Last reviewed: Jun 25, 2014)	criteria provided, single submitter	VCV000162599	14	77751823	14	77285480	162599	172249	rs727502857	NC_000014.9:77285479:C:A
NM_013382.5(POMT2):c.924-2A>G	POMT2		not provided	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	VCV000289765	14	77765116	14	77298773	289765	274002	rs886044256	NC_000014.9:77298772:T:C
NM_013382.5(POMT2):c.678del (p.Trp226fs)	POMT2	W226fs	Muscular dystrophy	Pathogenic(Last reviewed: Mar 4, 2015)	criteria provided, single submitter	VCV000211951	14	77767571	14	77301228	211951	208126	rs755660222	NC_000014.9:77301227:CC:C
NM_013382.5(POMT2):c.1577-5_1577-1delinsTGA	POMT2		Muscular dystrophy	Pathogenic(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	VCV000211950	14	77750217 - 77750221	14	77283874 - 77283878	211950	208124	rs797045898	NC_000014.9:77283873:CTAGG:TCA
NM_013382.5(POMT2):c.248+5G>C	POMT2		Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000003234	14	77786772	14	77320429	3234	18273	rs587777816	NC_000014.9:77320428:C:G
NM_013382.5(POMT2):c.737G>A (p.Gly246Asp)	POMT2	G246D	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2	Pathogenic(Last reviewed: May 26, 2009)	no assertion criteria provided	VCV000003228	14	77767512	14	77301169	3228	18267	rs267606966	NC_000014.9:77301168:C:T
NM_013382.5(POMT2):c.1941G>A (p.Trp647Ter)	POMT2	W647*	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2	Pathogenic(Last reviewed: Sep 18, 2007)	no assertion criteria provided	VCV000003223	14	77745163	14	77278820	3223	18262	rs267606963	NC_000014.9:77278819:C:T
NM_013382.5(POMT2):c.673del (p.Trp225fs)	POMT2	W225fs	Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000649496	14	77767576	14	77301233	649496	642748		NC_000014.9:77301232:A:
NM_013382.5(POMT2):c.1293dup (p.Met432fs)	POMT2		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000538734	14	77753125 - 77753126	14	77286782 - 77286783	538734	528387	rs1555352706	NC_000014.9:77286782:GGGGG:GGGGGG
NM_013382.5(POMT2):c.648C>A (p.Cys216Ter)	POMT2	C216*	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000538730	14	77769186	14	77302843	538730	528775	rs147871747	NC_000014.9:77302842:G:T
NM_013382.5(POMT2):c.1445G>T (p.Gly482Val)	POMT2	G482V	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000003236	14	77751863	14	77285520	3236	18275	rs267606968	NC_000014.9:77285519:C:A
POMT2, IVS12AS, G-A, -14	POMT2		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000003235					3235	18274		
NM_013382.5(POMT2):c.2243G>C (p.Trp748Ser)	POMT2	W748S	Limb-girdle muscular dystrophy-dystroglycanopathy, type C2	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000003230	14	77743729	14	77277386	3230	18269	rs267606967	NC_000014.9:77277385:C:G
NM_013382.5(POMT2):c.1117G>T (p.Val373Phe)	POMT2	V373F	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000003226	14	77757723	14	77291380	3226	18265	rs267606965	NC_000014.9:77291379:C:A
NM_013382.5(POMT2):c.1261del (p.Arg421fs)	POMT2	R421fs	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000003220	14	77753158	14	77286815	3220	18259	rs587777815	NC_000014.9:77286814:GGG:GG
NM_019066.5(MAGEL2):c.1808C>A (p.Ser603Ter)	MAGEL2	S603*	not provided	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000817537	15	23891082	15	23645935	817537	805811		NC_000015.10:23645934:G:T
NM_019066.5(MAGEL2):c.2199del (p.Glu734fs)	MAGEL2	E734fs	Schaaf-yang syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803054	15	23890691	15	23645544	803054	791431		NC_000015.10:23645543:TTT:TT
NM_019066.5(MAGEL2):c.2874G>A (p.Trp958Ter)	MAGEL2	W958*	not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000620452	15	23890016	15	23644869	620452	611789	rs1566783684	NC_000015.10:23644868:C:T
NM_019066.5(MAGEL2):c.1762C>T (p.Gln588Ter)	MAGEL2	Q588*	Schaaf-yang syndrome	Pathogenic(Last reviewed: Jun 25, 2018)	no assertion criteria provided	VCV000548683	15	23891128	15	23645981	548683	539166	rs866419580	NC_000015.10:23645980:G:A
NM_019066.5(MAGEL2):c.1761G>A (p.Trp587Ter)	MAGEL2	W587*	Schaaf-yang syndrome	Pathogenic(Last reviewed: Jun 25, 2018)	no assertion criteria provided	VCV000548682	15	23891129	15	23645982	548682	539167	rs1566784441	NC_000015.10:23645981:C:T
NM_019066.5(MAGEL2):c.2982_2983del (p.Glu995fs)	MAGEL2	E995fs	not provided	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000545929	15	23889907 - 23889908	15	23644760 - 23644761	545929	536449	rs1555374125	NC_000015.10:23644759:CA:
NM_019066.5(MAGEL2):c.1927dup (p.Val643fs)	MAGEL2		not provided	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000504272	15	23890962 - 23890963	15	23645815 - 23645816	504272	495591	rs1555374254	NC_000015.10:23645815:CC:CCC
NM_019066.5(MAGEL2):c.2958del (p.Ser987fs)	MAGEL2	S987fs	Schaaf-yang syndrome	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000403667	15	23889932	15	23644785	403667	390647	rs1060499934	NC_000015.10:23644784:CCC:CC
NM_019066.5(MAGEL2):c.2070dup (p.Ala691fs)	MAGEL2		not provided	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000280815	15	23890819 - 23890820	15	23645672 - 23645673	280815	264714	rs886041955	NC_000015.10:23645672:A:AA
NM_019066.5(MAGEL2):c.2163C>A (p.Cys721Ter)	MAGEL2	C721*	not provided	Pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, single submitter	VCV000280384	15	23890727	15	23645580	280384	264558	rs886041598	NC_000015.10:23645579:G:T
NM_019066.5(MAGEL2):c.1996C>T (p.Gln666Ter)	MAGEL2	Q666*	not provided	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000265643	15	23890894	15	23645747	265643	260061	rs752097874	NC_000015.10:23645746:G:A
NM_019066.5(MAGEL2):c.3208G>T (p.Glu1070Ter)	MAGEL2	E1070*	Schaaf-yang syndrome	Pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	VCV000224132	15	23889682	15	23644535	224132	225862	rs869312694	NC_000015.10:23644534:C:A
NC_000015.10:g.23644498del	MAGEL2		Schaaf-yang syndrome	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000816928					816928	805104		
NM_019066.5(MAGEL2):c.188dup (p.Ala64fs)	MAGEL2		Schaaf-yang syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000692038	15	23892701 - 23892702	15	23647554 - 23647555	692038	679792		NC_000015.10:23647554:GG:GGG
NM_019066.5(MAGEL2):c.1621C>T (p.Gln541Ter)	MAGEL2	Q541*	Schaaf-yang syndrome	Pathogenic(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000440466	15	23891269	15	23646122	440466	434104	rs1555374290	NC_000015.10:23646121:G:A
NM_019066.5(MAGEL2):c.2118del (p.Leu708fs)	MAGEL2	L708fs	Schaaf-yang syndrome	Pathogenic(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000440464	15	23890772	15	23645625	440464	434102	rs1555374227	NC_000015.10:23645624:AAAA:AAA
NM_019066.5(MAGEL2):c.1652del (p.Val551fs)	MAGEL2	V551fs	Schaaf-yang syndrome	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000089000	15	23891238	15	23646091	89000	94554	rs398122415	NC_000015.10:23646090:A:
NM_019066.5(MAGEL2):c.1996del (p.Gln666fs)	MAGEL2	Q666fs	Schaaf-yang syndrome	Pathogenic(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000440463	15	23890894	15	23645747	440463	434101	rs770374710	NC_000015.10:23645746:GGGGGGG:GGGGGG
NM_013382.5(POMT2):c.958C>T (p.Gln320Ter)	POMT2	Q320*	Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|not provided	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000289683	14	77765080	14	77298737	289683	273920	rs775932206	NC_000014.9:77298736:G:A
NM_013382.5(POMT2):c.1912C>T (p.Arg638Ter)	POMT2	R638*	not provided|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2	Pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000003218	14	77745192	14	77278849	3218	18257	rs119463989	NC_000014.9:77278848:G:A
NM_000020.2(ACVRL1):c.1377+2T>G	ACVRL1			Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000533354	12	52312901	12	51919117	533354	527505	rs1555153854	NC_000012.12:51919116:T:G
NM_000020.2(ACVRL1):c.914C>T (p.Ser305Phe)	ACVRL1	S305F		Pathogenic(Last reviewed: May 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439382	12	52309150	12	51915366	439382	433111	rs1555153126	NC_000012.12:51915365:C:T
NM_000020.2(ACVRL1):c.406_409del (p.Gly136fs)	ACVRL1	G136fs	|not provided	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212806	12	52307433 - 52307436	12	51913649 - 51913652	212806	210227	rs863223416	NC_000012.12:51913648:TGGGTG:TG
NM_000020.2(ACVRL1):c.145dup (p.Ala49fs)	ACVRL1		|not provided	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212805	12	52306960 - 52306961	12	51913176 - 51913177	212805	210222	rs863223415	NC_000012.12:51913176:GGGGGG:GGGGGGG
NM_000020.2(ACVRL1):c.760_762del (p.Asp254del)	ACVRL1	D254del	|not provided|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000008250	12	52308355 - 52308357	12	51914571 - 51914573	8250	23289	rs387906393	NC_000012.12:51914570:ACGAC:AC
NM_000020.2(ACVRL1):c.150G>T (p.Trp50Cys)	ACVRL1	W150C, W50C		Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000008246	12	52306971	12	51913187	8246	23285	rs121909285	NC_000012.12:51913186:G:T
NM_019066.5(MAGEL2):c.3179_3180AT[1] (p.Ile1061fs)	MAGEL2		Schaaf-yang syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000089002	15	23889708 - 23889709	15	23644561 - 23644562	89002	94556	rs398122417	NC_000015.10:23644560:ATAT:AT
NM_019066.5(MAGEL2):c.1802del (p.Pro601fs)	MAGEL2	P601fs	Schaaf-yang syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000089001	15	23891088	15	23645941	89001	94555	rs398122416	NC_000015.10:23645940:GG:G
NM_013382.5(POMT2):c.1417C>T (p.Arg473Ter)	POMT2	R473*	Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095535	14	77751891	14	77285548	95535	101434	rs368817785	NC_000014.9:77285547:G:A
NM_013382.5(POMT2):c.1057G>A (p.Gly353Ser)	POMT2	G353S	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2	Pathogenic(Last reviewed: May 26, 2009)	no assertion criteria provided	VCV000003231	14	77762566	14	77296223	3231	18270	rs267606970	NC_000014.9:77296222:C:T
NM_013382.5(POMT2):c.551C>T (p.Thr184Met)	POMT2	T184M	Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|not provided	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000003229	14	77769283	14	77302940	3229	18268	rs267606971	NC_000014.9:77302939:G:A
NM_013382.5(POMT2):c.2177G>A (p.Gly726Glu)	POMT2	G726E	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2	Pathogenic(Last reviewed: May 26, 2009)	no assertion criteria provided	VCV000003222	14	77743795	14	77277452	3222	18261	rs267606969	NC_000014.9:77277451:C:T
NM_013382.5(POMT2):c.1006+1G>A	POMT2		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|not provided	Pathogenic(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	VCV000003219	14	77765031	14	77298688	3219	18258	rs533916138	NC_000014.9:77298687:C:T
NM_001113378.1(FANCI):c.1461T>A (p.Tyr487Ter)	FANCI	Y487*	Fanconi anemia|Fanconi anemia, complementation group I	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000408247	15	89824480	15	89281249	408247	400516	rs769248873	NC_000015.10:89281248:T:A
NM_000086.2(CLN3):c.784A>T (p.Lys262Ter)	CLN3	K262*, K184*, K162*, K238*, K208*	not provided	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000420007	16	28495333	16	28484012	420007	409592	rs1064794233	NC_000016.10:28484011:T:A
NM_000086.2(CLN3):c.17del (p.Gly6fs)	CLN3	G6fs	not provided	Pathogenic(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	VCV000285870	16	28503064	16	28491743	285870	270107	rs886043242	NC_000016.10:28491742:CC:C
NM_000086.2(CLN3):c.816_817del (p.Glu273fs)	CLN3	E195fs, E249fs, E273fs, E173fs, E219fs	not provided	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000280317	16	28493967 - 28493968	16	28482646 - 28482647	280317	264622	rs886041546	NC_000016.10:28482645:CCC:C
NM_000086.2(CLN3):c.240del (p.Pro81fs)	CLN3	P27fs, R7fs, P81fs	not provided	Pathogenic(Last reviewed: Dec 19, 2015)	criteria provided, single submitter	VCV000265379	16	28499966	16	28488645	265379	260111	rs748710466	NC_000016.10:28488644:C:
GRCh37/hg19 16p11.2(chr16:28497795-28498122)x1	CLN3		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253522	16	28497795 - 28498122			253522	247970		
GRCh37/hg19 16p11.2(chr16:28497795-28498182)x1	CLN3		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253417	16	28497795 - 28498182			253417	247865		
NM_000086.2(CLN3):c.949C>T (p.Gln317Ter)	CLN3	Q317*, Q217*, Q263*, Q239*, Q293*	not provided	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	VCV000205092	16	28493661	16	28482340	205092	203268	rs796052335	NC_000016.10:28482339:G:A
GRCh37/hg19 16p11.2(chr16:28497668-28497971)	CLN3		Juvenile neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000813302	16	28497668 - 28497971			813302	801555		
NM_000086.2(CLN3):c.494G>A (p.Gly165Glu)	CLN3	G165E, G87E, G141E, G65E, G111E	Ceroid lipofuscinosis, neuronal, 3, protracted	Pathogenic(Last reviewed: Jun 10, 2014)	no assertion criteria provided	VCV000183669	16	28497938	16	28486617	183669	181569	rs786201028	NC_000016.10:28486616:C:T
NM_000086.2(CLN3):c.371_372insT (p.Ser125fs)	CLN3		Juvenile neuronal ceroid lipofuscinosis	Pathogenic	no assertion criteria provided	VCV000100719	16	28498985 - 28498986	16	28487664 - 28487665	100719	106584	rs587779397	NC_000016.10:28487664::A
NM_000086.2(CLN3):c.460+376_677+388del	CLN3		Juvenile neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000666431	16	28497280 - 28498401	16	28485959 - 28487080	666431	653990		
CLN3, IVSDS, G-C, +1/76-BP DEL	CLN3		Juvenile neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Sep 22, 1995)	no assertion criteria provided	VCV000003555					3555	18594		
CLN3, 3-KB DEL, NT928	CLN3		Juvenile neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Sep 22, 1995)	no assertion criteria provided	VCV000003553					3553	18592		
NM_024537.4(CARS2):c.1360dup (p.Ile454fs)	CARS2		Inborn genetic diseases	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000521824	13	111296787 - 111296788	13	110644440 - 110644441	521824	512056	rs1555342802	NC_000013.11:110644440:T:TT
NC_000016.10:g.(?_28477496)_(28491779_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000832292	16	28488817 - 28503100			832292	820818		
NC_000016.10:g.(?_28483996)_(28484128_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Nov 17, 2019)	criteria provided, single submitter	VCV000831057	16	28495317 - 28495449			831057	820819		
NG_008654.2:g.(9642_9761)_(10726_10812)del	CLN3		Retinitis pigmentosa	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000565293	16	28497812 - 28498982	16	28486491 - 28487661	565293	551603		
NC_000016.9:g.(?_28498757)_(28503100_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000527787	16	28498757 - 28503100	16	28487436 - 28491779	527787	529847		
NM_000086.2(CLN3):c.906+2T>A	CLN3		not provided|Juvenile neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000370455	16	28493796	16	28482475	370455	358369	rs771788391	NC_000016.10:28482474:A:T
CLN3, 6-KB DEL	CLN3		Juvenile neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Sep 22, 1995)	no assertion criteria provided	VCV000003554					3554	18593		
NM_001126108.2(SLC12A3):c.2554C>T (p.Arg852Cys)	SLC12A3	R861C, R852C, R860C	Familial hypokalemia-hypomagnesemia|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000437926	16	56928475	16	56894563	437926	431548	rs373899077	NC_000016.10:56894562:C:T
NM_002834.4(PTPN11):c.1506_1507delinsCC (p.Gly503Arg)	PTPN11		Rasopathy	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000571101	12	112926886 - 112926887	12	112489082 - 112489083	571101	571274	rs1566186833	NC_000012.12:112489081:AG:CC
NM_002834.5(PTPN11):c.774G>T (p.Glu258Asp)	PTPN11	E258D, E257D	not specified|Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044613	12	112910765	12	112472961	44613	53780	rs397516809	NC_000012.12:112472960:G:T
NM_002834.4(PTPN11):c.217_218delinsCT (p.Thr73Leu)	PTPN11		Noonan syndrome	Pathogenic(Last reviewed: Apr 2, 2013)	criteria provided, single submitter	VCV000044604	12	112888201 - 112888202	12	112450397 - 112450398	44604	53771	rs397516802	NC_000012.12:112450396:AC:CT
NM_002834.5(PTPN11):c.1472C>A (p.Pro491His)	PTPN11	P491H, P495H, P490H	Noonan syndrome|not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040551	12	112926852	12	112489048	40551	49021	rs397507540	NC_000012.12:112489047:C:A
NM_002834.5(PTPN11):c.178G>A (p.Gly60Ser)	PTPN11	G60S, G59S	not provided|Noonan syndrome	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040490	12	112888162	12	112450358	40490	48960	rs397507507	NC_000012.12:112450357:G:A
NM_000086.2(CLN3):c.1059C>A (p.Cys353Ter)	CLN3	C353*, C253*, C299*, C329*, C275*	Juvenile neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370675	16	28489196	16	28477875	370675	358366	rs1057516677	NC_000016.10:28477874:G:T
NM_000086.2(CLN3):c.105G>A (p.Trp35Ter)	CLN3	W35*	not provided|Juvenile neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000056249	16	28502823	16	28491502	56249	70888	rs386833700	NC_000016.10:28491501:C:T
NM_000153.4(GALC):c.205C>T (p.Arg69Ter)	GALC	R69*, R43*	Galactosylceramide beta-galactosidase deficiency|not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000195020	14	88454858	14	87988514	195020	192182	rs771111145	NC_000014.9:87988513:G:A
NM_000151.4(G6PC):c.809G>T (p.Gly270Val)	G6PC	G270V	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic/Likely pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021063	17	41063178	17	42911161	21063	33915	rs80356483	NC_000017.11:42911160:G:T
NM_000086.2(CLN3):c.569dup (p.Ala191fs)	CLN3		Neuronal ceroid lipofuscinosis|not provided	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457954	16	28497775 - 28497776	16	28486454 - 28486455	457954	466315	rs386833732	NC_000016.10:28486454:CCCCC:CCCCCC
NM_000086.2(CLN3):c.1198-1G>T	CLN3		Juvenile neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000056251	16	28488957	16	28477636	56251	70890	rs386833702	NC_000016.10:28477635:C:A
NM_019066.5(MAGEL2):c.3124C>T (p.Gln1042Ter)	MAGEL2	Q1024*, Q1042*	Schaaf-yang syndrome|not provided	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000089003	15	23889766	15	23644619	89003	94557	rs398122418	NC_000015.10:23644618:G:A
NM_145239.3(PRRT2):c.769_778del (p.Glu257fs)	PRRT2	E257fs	not provided	Pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000280822	16	29825138 - 29825147	16	29813817 - 29813826	280822	264629	rs886041960	NC_000016.10:29813816:GGGGTGGAGGGGGGTG:GGGGTG
NM_145239.3(PRRT2):c.191_207dup (p.Glu70fs)	PRRT2		not provided	Pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	VCV000280549	16	29824562 - 29824563	16	29813241 - 29813242	280549	264770	rs886041735	NC_000016.10:29813241:CCAAGGCTGGGCTGGCTCCA:CCAAGGCTGGGCTGGCTCCAAGGCTGGGCTGGCTCCA
NM_145239.3(PRRT2):c.210_211del (p.Glu70fs)	PRRT2	E70fs	not provided	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000280358	16	29824584 - 29824585	16	29813263 - 29813264	280358	264775	rs886041579	NC_000016.10:29813262:AAA:A
NM_145239.3(PRRT2):c.433dup (p.Arg145fs)	PRRT2		not provided	Pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	VCV000206700	16	29824803 - 29824804	16	29813482 - 29813483	206700	203304	rs796052944	NC_000016.10:29813482:CCCCC:CCCCCC
NM_145239.3(PRRT2):c.213_214CA[1] (p.Thr72fs)	PRRT2		not provided	Pathogenic(Last reviewed: Oct 6, 2014)	criteria provided, single submitter	VCV000206699	16	29824588 - 29824589	16	29813267 - 29813268	206699	203300	rs796052943	NC_000016.10:29813266:CACA:CA
NM_145239.3(PRRT2):c.173del (p.Pro58fs)	PRRT2	P58fs	not provided	Pathogenic(Last reviewed: Feb 12, 2014)	criteria provided, single submitter	VCV000206695	16	29824545	16	29813224	206695	203299	rs796052940	NC_000016.10:29813223:CCCC:CCC
NM_145239.3(PRRT2):c.282_283insC (p.Ser95fs)	PRRT2		Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000853525	16	29824657 - 29824658	16	29813336 - 29813337	853525	843735		NC_000016.10:29813336::C
NM_145239.3(PRRT2):c.776del (p.Gly259fs)	PRRT2	G259fs	Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000835335	16	29825146	16	29813825	835335	843743		NC_000016.10:29813824:GGGGGG:GGGGG
NM_145239.3(PRRT2):c.843G>A (p.Trp281Ter)	PRRT2	W281*	Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000665748	16	29825218	16	29813897	665748	644583		NC_000016.10:29813896:G:A
NM_145239.3(PRRT2):c.848_863del (p.Val283fs)	PRRT2	V283fs	Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000663069	16	29825223 - 29825238	16	29813902 - 29813917	663069	644585		NC_000016.10:29813901:TCAACATCGTGGCCTT:
NM_145239.3(PRRT2):c.106del (p.Gln36fs)	PRRT2	Q36fs	Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000662320	16	29824478	16	29813157	662320	644575		NC_000016.10:29813156:CCCC:CCC
NM_145239.3(PRRT2):c.742dup (p.Ser248fs)	PRRT2		Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000649461	16	29825116 - 29825117	16	29813795 - 29813796	649461	644582		NC_000016.10:29813795:A:AA
NM_145239.3(PRRT2):c.303del (p.Glu102fs)	PRRT2	E102fs	Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000640387	16	29824675	16	29813354	640387	644578		NC_000016.10:29813353:CCCC:CCC
NM_145239.3(PRRT2):c.661C>T (p.Gln221Ter)	PRRT2	Q221*	Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000576805	16	29825036	16	29813715	576805	570237	rs1567379819	NC_000016.10:29813714:C:T
NC_000016.10:g.(?_29813054)_(29813955_?)del	PRRT2		Seizures, benign familial infantile, 2	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000813798					813798	802059		
NM_145239.3(PRRT2):c.697_698del (p.Ser233fs)	PRRT2	S233fs	Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000659554	16	29825072 - 29825073	16	29813751 - 29813752	659554	644581		NC_000016.10:29813750:AG:
NM_145239.3(PRRT2):c.799del (p.Asp267fs)	PRRT2	D267fs	Infantile convulsions and choreoathetosis	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623391	16	29825172	16	29813851	623391	612309	rs1567380076	NC_000016.10:29813850:GGG:GG
NM_145239.3(PRRT2):c.291del (p.Asn98fs)	PRRT2	N98fs	Seizures, benign familial infantile, 2	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039755	16	29824665	16	29813344	39755	48354	rs730882073	NC_000016.10:29813343:CC:C
NM_145239.3(PRRT2):c.629del (p.Pro210fs)	PRRT2	P210fs	Seizures, benign familial infantile, 2	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039754	16	29824998	16	29813677	39754	48353	rs730882067	NC_000016.10:29813676:CCCCCCC:CCCCCC
NM_145239.3(PRRT2):c.562C>T (p.Gln188Ter)	PRRT2	Q188*	Infantile convulsions and choreoathetosis	Pathogenic(Last reviewed: Jul 10, 2012)	no assertion criteria provided	VCV000039753	16	29824937	16	29813616	39753	48352	rs397514578	NC_000016.10:29813615:C:T
NM_145239.3(PRRT2):c.516dup (p.Glu173Ter)	PRRT2		Infantile convulsions and choreoathetosis	Pathogenic(Last reviewed: Jan 26, 2012)	no assertion criteria provided	VCV000031175	16	29824890 - 29824891	16	29813569 - 29813570	31175	40132	rs730882068	NC_000016.10:29813569:T:TT
NM_145239.3(PRRT2):c.879+5G>A	PRRT2	S295N	Seizures, benign familial infantile, 2	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000031173	16	29825259	16	29813938	31173	40130		NC_000016.10:29813937:G:A
NM_000086.2(CLN3):c.790+532_1056+1445del	CLN3		Juvenile neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000632772	16	28491981 - 28494795	16	28480660 - 28483474	632772	621850		
NM_000086.2(CLN3):c.954_962+18del	CLN3		Juvenile neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000056293	16	28493630 - 28493656	16	28482309 - 28482335	56293	70932	rs386833741	NC_000016.10:28482308:TGCCCTCGCTCCTCTTACCAGCGGTATTGC:TGC
NM_000086.2(CLN3):c.622dup (p.Ser208fs)	CLN3		Juvenile neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000056287	16	28497722 - 28497723	16	28486401 - 28486402	56287	70926	rs386833736	NC_000016.10:28486401:A:AA
NM_000086.2(CLN3):c.214C>T (p.Gln72Ter)	CLN3	Q72*, Q18*	Juvenile neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000056258	16	28500619	16	28489298	56258	70897	rs386833709	NC_000016.10:28489297:G:A
NM_000086.2(CLN3):c.1054C>T (p.Gln352Ter)	CLN3	Q352*, Q252*, Q274*, Q328*, Q298*	not provided|Juvenile neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000056246	16	28493428	16	28482107	56246	70885	rs386833697	NC_000016.10:28482106:G:A
NM_145239.3(PRRT2):c.324_325del (p.Ser110fs)	PRRT2	S110fs	not provided|Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Jan 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280888	16	29824699 - 29824700	16	29813378 - 29813379	280888	264624	rs886042013	NC_000016.10:29813377:AG:
NM_145239.3(PRRT2):c.510dup (p.Leu171fs)	PRRT2		Episodic kinesigenic dyskinesia 1	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000065756	16	29824883 - 29824884	16	29813562 - 29813563	65756	76664	rs397515576	NC_000016.10:29813562:TT:TTT
NM_024312.5(GNPTAB):c.3410T>A (p.Leu1137Ter)	GNPTAB	L1137*	|Pseudo-Hurler polydystrophy||Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039071	12	102151014	12	101757236	39071	47674	rs142065232	NC_000012.12:101757235:A:T
NM_024312.5(GNPTAB):c.1399del (p.Asp467fs)	GNPTAB	D467fs	||Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039034	12	102161824	12	101768046	39034	47637	rs397507448	NC_000012.12:101768045:CCCC:CCC
NM_145239.3(PRRT2):c.47_48AG[1] (p.Pro18fs)	PRRT2		Episodic kinesigenic dyskinesia 1	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000813794	16	29824421 - 29824422	16	29813100 - 29813101	813794	802010		NC_000016.10:29813099:GAGAG:GAG
NC_000016.9:g.(?_29824366)_(29825969_?)del	PRRT2		Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000645873	16	29824366 - 29825969	16	29813045 - 29814648	645873	652624		
NM_145239.3(PRRT2):c.535_538del (p.Gln179fs)	PRRT2	Q179fs	Episodic kinesigenic dyskinesia 1	Pathogenic(Last reviewed: Feb 4, 2017)	criteria provided, single submitter	VCV000522556	16	29824907 - 29824910	16	29813586 - 29813589	522556	513169	rs1555502708	NC_000016.10:29813585:AAGCAAG:AAG
NC_000016.9:g.(?_29824356)_(29825979_?)del	PRRT2		Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000468611	16	29824356 - 29825979	16	29813035 - 29814658	468611	464834		
NM_145239.3(PRRT2):c.959C>T (p.Ala320Val)	PRRT2	A320V	Seizures, benign familial infantile, 2|Episodic kinesigenic dyskinesia 1	Pathogenic	criteria provided, single submitter	VCV000440911	16	29825733	16	29814412	440911	434539	rs1301400509	NC_000016.10:29814411:C:T
NM_145239.3(PRRT2):c.650del (p.Arg217fs)	PRRT2	R217fs	Seizures, benign familial infantile, 2	Pathogenic(Last reviewed: Jul 15, 2014)	no assertion criteria provided	VCV000183020	16	29825025	16	29813704	183020	181171	rs730882124	NC_000016.10:29813703:G:
NM_145239.3(PRRT2):c.796C>T (p.Arg266Trp)	PRRT2	R266W	Episodic kinesigenic dyskinesia 1	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000031177	16	29825171	16	29813850	31177	40134	rs387907128	NC_000016.10:29813849:C:T
NM_145239.3(PRRT2):c.972del (p.Val325fs)	PRRT2	V325fs	Episodic kinesigenic dyskinesia 1	Pathogenic(Last reviewed: Nov 20, 2011)	no assertion criteria provided	VCV000031170	16	29825746	16	29814425	31170	40127	rs730882066	NC_000016.10:29814424:A:
NM_145239.3(PRRT2):c.510_513TCTG[1] (p.Ser172fs)	PRRT2		Episodic kinesigenic dyskinesia 1	Pathogenic(Last reviewed: Nov 20, 2011)	no assertion criteria provided	VCV000031169	16	29824885 - 29824888	16	29813564 - 29813567	31169	40126	rs730882065	NC_000016.10:29813563:TCTGTCTG:TCTG
NM_000020.2(ACVRL1):c.924C>A (p.Cys308Ter)	ACVRL1	C308*	not provided|	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000464771	12	52309160	12	51915376	464771	462580	rs1555153131	NC_000012.12:51915375:C:A
NM_000020.2(ACVRL1):c.698C>T (p.Ser233Leu)	ACVRL1	S233L	|not specified	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439385	12	52308295	12	51914511	439385	433109	rs762773076	NC_000012.12:51914510:C:T
NM_000020.2(ACVRL1):c.1377+1G>A	ACVRL1		not provided|	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212794	12	52312900	12	51919116	212794	210236	rs863223406	NC_000012.12:51919115:G:A
NM_000875.5(IGF1R):c.2032dup (p.Ile678fs)	IGF1R		not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000595660	15	99459935 - 99459936	15	98916706 - 98916707	595660	586722	rs1567197213	NC_000015.10:98916706:A:AA
NM_000875.5(IGF1R):c.418dup (p.Ala140fs)	IGF1R		not provided	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000593836	15	99251108 - 99251109	15	98707879 - 98707880	593836	584899	rs746570875	NC_000015.10:98707879:GGGGGG:GGGGGGG
NM_000875.5(IGF1R):c.2578G>T (p.Gly860Ter)	IGF1R	G860*	not provided	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000451669	15	99467197	15	98923968	451669	445484	rs1555462145	NC_000015.10:98923967:G:T
NM_000875.5(IGF1R):c.1590-1G>C	IGF1R		not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000392286	15	99456272	15	98913043	392286	373901	rs1057524426	NC_000015.10:98913042:G:C
NM_000875.5(IGF1R):c.2673del (p.Lys892fs)	IGF1R	K892fs	not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000643286	15	99467803	15	98924574	643286	643757		NC_000015.10:98924573:CC:C
NM_000875.5(IGF1R):c.3454G>A (p.Gly1152Arg)	IGF1R	G1152R, G1151R	Growth delay due to insulin-like growth factor I resistance	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000635846	15	99482586	15	98939357	635846	623659		NC_000015.10:98939356:G:A
NM_000875.5(IGF1R):c.1247+1dup	IGF1R	N417E	Growth delay due to insulin-like growth factor I resistance	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000635844	15	99442848 - 99442849	15	98899619 - 98899620	635844	623662		NC_000015.10:98899619:GGG:GGGG
NM_000875.5(IGF1R):c.904G>T (p.Glu302Ter)	IGF1R	E302*	Growth delay due to insulin-like growth factor I resistance	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000635842	15	99434817	15	98891588	635842	623656		NC_000015.10:98891587:G:T
NM_000875.5(IGF1R):c.384T>C (p.Ile128=)	IGF1R	F112L	Growth delay due to insulin-like growth factor I resistance	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000635841	15	99251080	15	98707851	635841	623655		NC_000015.10:98707850:T:C
NM_145239.3(PRRT2):c.950G>A (p.Ser317Asn)	PRRT2	S317N	Infantile convulsions and choreoathetosis|Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000031172	16	29825724	16	29814403	31172	40129	rs387907125	NC_000016.10:29814402:G:A
NM_001113378.1(FANCI):c.2422A>T (p.Lys808Ter)	FANCI	K808*	Fanconi anemia, complementation group I|Fanconi anemia	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208639	15	89837194	15	89293963	208639	205210	rs375656231	NC_000015.10:89293962:A:T
NC_000016.10:g.(?_28475343)_(28484138_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000833507	16	28486664 - 28495459			833507	820816		
NM_001042432.1(CLN3):c.379del (p.Arg127fs)	CLN3	R127fs, R73fs, R49fs, R103fs, R27fs	Juvenile neuronal ceroid lipofuscinosis|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000056267	16	28498858	16	28487537	56267	70906	rs386833717	NC_000016.10:28487536:GGGGG:GGGG
NM_004937.3(CTNS):c.922G>A (p.Gly308Arg)	CTNS	G308R	Nephropathic cystinosis|Ocular cystinosis|Juvenile nephropathic cystinosis|Cystinosis	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000267310	17	3563221	17	3659927	267310	262357	rs746307931	NC_000017.11:3659926:G:A
NM_004937.3(CTNS):c.198_218del (p.Ile67_Pro73del)	CTNS		Nephropathic cystinosis|Cystinosis	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021438	17	3552198 - 3552218	17	3648904 - 3648924	21438	34290	rs113994204	NC_000017.11:3648903:TATTACTATCCTTGAGCTCCC:
NM_000303.3(PMM2):c.95_96delinsGC (p.Leu32Arg)	PMM2		not provided|Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092807	16	8895684 - 8895685	16	8801827 - 8801828	92807	98714	rs398123312	NC_000016.10:8801826:TA:GC
NM_000303.3(PMM2):c.415G>A (p.Glu139Lys)	PMM2	E139K	not provided|Congenital disorder of glycosylation, type Ia	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021143	16	8905003	16	8811146	21143	33995	rs80338703	NC_000016.10:8811145:G:A
NM_000303.3(PMM2):c.395T>C (p.Ile132Thr)	PMM2	I132T	Congenital disorder of glycosylation, type Ia	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007718	16	8904983	16	8811126	7718	22757	rs80338702	NC_000016.10:8811125:T:C
NM_000303.3(PMM2):c.647A>T (p.Asn216Ile)	PMM2	N216I	Congenital disorder of glycosylation, type Ia|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007707	16	8941588	16	8847731	7707	22746	rs78290141	NC_000016.10:8847730:A:T
NM_145239.3(PRRT2):c.600_603TCAC[1] (p.Ser202fs)	PRRT2		not provided|Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419406	16	29824974 - 29824977	16	29813653 - 29813656	419406	409614	rs1064793851	NC_000016.10:29813652:CTCACTCAC:CTCAC
NM_145239.3(PRRT2):c.748C>T (p.Gln250Ter)	PRRT2	Q250*	Seizures, benign familial infantile, 2|Episodic kinesigenic dyskinesia 1	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000039756	16	29825123	16	29813802	39756	48355	rs397514579	NC_000016.10:29813801:C:T
NM_145239.3(PRRT2):c.487C>T (p.Gln163Ter)	PRRT2	Q163*	Episodic kinesigenic dyskinesia 1|Infantile convulsions and choreoathetosis	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000031176	16	29824862	16	29813541	31176	40133	rs387907127	NC_000016.10:29813540:C:T
PIEZO1, E756DEL	PIEZO1		Xerocytosis	Pathogenic(Last reviewed: Oct 21, 2019)	no assertion criteria provided	VCV000549569					549569	540049		
NM_001142864.4(PIEZO1):c.7289C>T (p.Pro2430Leu)	PIEZO1	P2430L	Lymphedema, hereditary, III	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000223133	16	88782368	16	88715960	223133	224859	rs869025601	NC_000016.10:88715959:G:A
NM_001142864.4(PIEZO1):c.6511G>T (p.Val2171Phe)	PIEZO1	V2171F	Lymphedema, hereditary, III	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000223131	16	88783580	16	88717172	223131	224857	rs370296725	NC_000016.10:88717171:C:A
NM_001142864.4(PIEZO1):c.3796+1G>A	PIEZO1		Lymphedema, hereditary, III	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000223130	16	88792954	16	88726546	223130	224856	rs869025599	NC_000016.10:88726545:C:T
NM_001142864.4(PIEZO1):c.6682C>T (p.Gln2228Ter)	PIEZO1	Q2228*	Lymphedema, hereditary, III	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000223129	16	88783285	16	88716877	223129	224855	rs869025598	NC_000016.10:88716876:G:A
NM_001142864.4(PIEZO1):c.4888G>T (p.Glu1630Ter)	PIEZO1	E1630*	Lymphedema, hereditary, III	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000223128	16	88788693	16	88722285	223128	224854	rs869025597	NC_000016.10:88722284:C:A
NM_001142864.4(PIEZO1):c.4073G>C (p.Arg1358Pro)	PIEZO1	R1358P	Xerocytosis	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000055808	16	88791913	16	88725505	55808	70464	rs587776990	NC_000016.10:88725504:C:G
NM_001142864.4(PIEZO1):c.6674T>G (p.Met2225Arg)	PIEZO1	M2225R	Xerocytosis	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000055805	16	88783293	16	88716885	55805	70461	rs587776987	NC_000016.10:88716884:A:C
NM_003119.4(SPG7):c.1715C>T (p.Ala572Val)	SPG7	A572V	not provided|Hereditary spastic paraplegia 7	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217269	16	89616953	16	89550545	217269	213917	rs72547551	NC_000016.10:89550544:C:T
NM_002834.5(PTPN11):c.598A>T (p.Asn200Tyr)	PTPN11	N200Y, N199Y	not provided|Rasopathy|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000164998	12	112892440	12	112454636	164998	175541	rs727503381	NC_000012.12:112454635:A:T
NM_002834.5(PTPN11):c.923A>C (p.Asn308Thr)	PTPN11	N308T, N307T	Noonan syndrome|not provided	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040535	12	112915524	12	112477720	40535	49005	rs121918455	NC_000012.12:112477719:A:C
NM_002834.4(PTPN11):c.785T>G (p.Leu262Arg)	PTPN11	L262R	Rasopathy|Noonan syndrome 1	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040521	12	112910776	12	112472972	40521	48991	rs397507526	NC_000012.12:112472971:T:G
NM_013382.5(POMT2):c.924-2A>C	POMT2		Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|not provided	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449378	14	77765116	14	77298773	449378	445254	rs886044256	NC_000014.9:77298772:T:G
NM_024685.4(BBS10):c.687del (p.Val230fs)	BBS10	V230fs	Bardet-Biedl syndrome|not provided|Bardet-Biedl syndrome 10	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216123	12	76741078	12	76347298	216123	213011	rs761101213	NC_000012.12:76347297:A:
NM_000153.4(GALC):c.379C>T (p.Arg127Ter)	GALC	R127*, R104*, R101*	not provided|Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429982	14	88452896	14	87986552	429982	421997	rs200532368	NC_000014.9:87986551:G:A
NM_000153.4(GALC):c.850G>A (p.Gly284Ser)	GALC	G284S, G258S, G261S	Global developmental delay|Status epilepticus|Developmental regression|Amblyopia|Neonatal hypoglycemia|Breech presentation|Leukodystrophy|Nystagmus|Small for gestational age|Dysmyelinating leukodystrophy|EMG abnormality|EEG abnormality|Hemiparesis|Progressive visual loss|Loss of ability to walk|Strabismus|Intrauterine growth retardation|EMG: axonal abnormality|Seizures|Galactosylceramide beta-galactosidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000374024	14	88434737	14	87968393	374024	360963	rs377274761	NC_000014.9:87968392:C:T
NM_000153.4(GALC):c.628A>T (p.Arg210Ter)	GALC	R210*, R187*, R184*	not provided|Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000369724	14	88442826	14	87976482	369724	353950	rs202131052	NC_000014.9:87976481:T:A
NM_000153.4(GALC):c.195G>C (p.Gly65=)	GALC		not provided|Galactosylceramide beta-galactosidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280959	14	88459314	14	87992970	280959	265196	rs886042057	NC_000014.9:87992969:C:G
NM_000153.4(GALC):c.749T>C (p.Ile250Thr)	GALC	I250T, I227T, I224T	not provided|Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000265479	14	88442705	14	87976361	265479	260060	rs886039569	NC_000014.9:87976360:A:G
NM_014714.4(IFT140):c.2399+1G>T	IFT140		Retinitis pigmentosa 80|Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia|Retinal dystrophy	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031680	16	1607935	16	1557934	31680	40342	rs376586707	NC_000016.10:1557933:C:A
NM_025099.6(CTC1):c.775G>A (p.Val259Met)	CTC1	V259M	Dyskeratosis congenita|Cerebroretinal microangiopathy with calcifications and cysts 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030998	17	8140710	17	8237392	30998	39955	rs387907080	NC_000017.11:8237391:C:T
NM_001142864.4(PIEZO1):c.7367G>A (p.Arg2456His)	PIEZO1	R2456H	Xerocytosis|not provided	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000055806	16	88782212	16	88715804	55806	70462	rs587776988	NC_000016.10:88715803:C:T
NM_145239.3(PRRT2):c.649C>T (p.Arg217Ter)	PRRT2	R217*	Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000468617	16	29825024	16	29813703	468617	466366	rs77838305	NC_000016.10:29813702:C:T
NC_000016.10:g.(?_28475343)_(28486650_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000833481	16	28486664 - 28497971			833481	820817		
NM_001142864.4(PIEZO1):c.6058G>A (p.Ala2020Thr)	PIEZO1	A2020T	Xerocytosis|not provided	Pathogenic(Last reviewed: Feb 19, 2016)	criteria provided, single submitter	VCV000055807	16	88786583	16	88720175	55807	70463	rs587776989	NC_000016.10:88720174:C:T
NM_139276.2(STAT3):c.1144C>T (p.Arg382Trp)	STAT3	R382W	not provided|Hyper-IgE recurrent infection syndrome 1, autosomal dominant|Hyper-IgE recurrent infection syndrome 1, autosomal dominant|STAT3 gain of function	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000018304	17	40481661	17	42329643	18304	33343	rs113994135	NC_000017.11:42329642:G:A
NM_000020.3(ACVRL1):c.1271C>G (p.Pro424Arg)	ACVRL1	P424R		Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000836149	12	52312793	12	51919009	836149	840073		NC_000012.12:51919008:C:G
NM_001077401.2(ACVRL1):c.1030T>C (p.Cys344Arg)	ACVRL1	C344R	Pulmonary arterial hypertension|	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000656236	12	52309266	12	51915482	656236	641249		NC_000012.12:51915481:T:C
NM_000020.2(ACVRL1):c.1321G>A (p.Val441Met)	ACVRL1	V441M	not provided|	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000617960	12	52312843	12	51919059	617960	609847	rs1565596498	NC_000012.12:51919058:G:A
NM_000020.2(ACVRL1):c.601C>T (p.Gln201Ter)	ACVRL1	Q201*	not provided|	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523779	12	52307833	12	51914049	523779	514646	rs1318446539	NC_000012.12:51914048:C:T
NM_000020.2(ACVRL1):c.1413C>A (p.Cys471Ter)	ACVRL1	C471*		Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000464759	12	52314578	12	51920794	464759	463064	rs1301762186	NC_000012.12:51920793:C:A
NM_004960.3(FUS):c.1504del (p.Asp502fs)	FUS	D501fs, D502fs, D498fs	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, single submitter	VCV000521661	16	31202391	16	31191070	521661	512201	rs1161032867	NC_000016.10:31191069:GGGG:GGG
NC_000015.9:g.68504037_68504039delGAT	CLN6	I154del	Neuronal ceroid lipofuscinosis|	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004083	15	68504036 - 68504038	15	68211698 - 68211700	4083	19122	rs121908080	NC_000015.10:68211697:TGATGATG:TGATG
NM_005902.4(SMAD3):c.871G>T (p.Gly291Ter)	SMAD3	G291*, G247*, G186*, G96*	Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000520182	15	67473791	15	67181453	520182	510661	rs730880215	NC_000015.10:67181452:G:T
NM_005902.4(SMAD3):c.769del (p.Val257fs)	SMAD3	V213fs, V62fs, V152fs, V257fs	not provided	Pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000498755	15	67473689	15	67181351	498755	490179	rs1555413562	NC_000015.10:67181350:G:
NM_005902.4(SMAD3):c.539del (p.Pro180fs)	SMAD3	P136fs, P180fs, P75fs	not specified	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000440289	15	67459120	15	67166782	440289	433932	rs1555412294	NC_000015.10:67166781:CCCC:CCC
NM_005902.4(SMAD3):c.483del (p.Glu162fs)	SMAD3	E162fs, E118fs, E57fs	not provided	Pathogenic(Last reviewed: Sep 11, 2014)	criteria provided, single submitter	VCV000213808	15	67457670	15	67165332	213808	210269	rs863223771	NC_000015.10:67165331:CCCC:CCC
NM_005902.4(SMAD3):c.263dup (p.Tyr88Ter)	SMAD3		not provided	Pathogenic(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	VCV000213807	15	67457288 - 67457289	15	67164950 - 67164951	213807	210255	rs863223770	NC_000015.10:67164950:A:AA
NM_005902.4(SMAD3):c.154G>T (p.Glu52Ter)	SMAD3	E52*	not provided	Pathogenic(Last reviewed: Dec 1, 2014)	criteria provided, single submitter	VCV000213797	15	67358646	15	67066308	213797	210250	rs863223762	NC_000015.10:67066307:G:T
NM_005902.4(SMAD3):c.455del (p.Pro152fs)	SMAD3	P47fs, P108fs, P152fs	not provided	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000213792	15	67457640	15	67165302	213792	210267	rs863223759	NC_000015.10:67165301:CCCCCC:CCCCC
NM_005902.4(SMAD3):c.871+1G>A	SMAD3		Ascending aortic dissection	Pathogenic(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000692110	15	67473792	15	67181454	692110	679854		NC_000015.10:67181453:G:A
NM_001365088.1(SLC12A6):c.3031C>T (p.Arg1011Ter)	SLC12A6	R1011*, R960*, R1002*, R952*, R996*	Agenesis of the corpus callosum with peripheral neuropathy|not provided	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005326	15	34528920	15	34236719	5326	20365	rs121908427	NC_000015.10:34236718:G:A
NC_000015.10:g.(?_67066145)_(67066370_?)del	SMAD3		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000832854	15	67358483 - 67358708			832854	820728		
NC_000015.10:g.(?_67187355)_(67187519_?)del	SMAD3		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000830971	15	67479693 - 67479857			830971	820730		
NM_005902.4(SMAD3):c.904del (p.Glu302fs)	SMAD3	E258fs, E197fs, E302fs, E107fs	Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000653155	15	67477094	15	67184756	653155	643505		NC_000015.10:67184755:GGGG:GGG
NM_005902.4(SMAD3):c.517del (p.Gln173fs)	SMAD3	Q173fs, Q68fs, Q129fs	Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000650869	15	67457704	15	67165366	650869	643501		NC_000015.10:67165365:CCCC:CCC
NM_005902.4(SMAD3):c.946C>T (p.Gln316Ter)	SMAD3	Q121*, Q272*, Q211*, Q316*	Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000642412	15	67477139	15	67184801	642412	643507		NC_000015.10:67184800:C:T
NC_000015.9:g.(?_67479325)_(67479847_?)del	SMAD3		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000583993	15	67479325 - 67479847	15	67186987 - 67187509	583993	569215		
NM_005902.4(SMAD3):c.851_864del (p.Glu284fs)	SMAD3	E89fs, E240fs, E284fs, E179fs	Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000573597	15	67473771 - 67473784	15	67181433 - 67181446	573597	569078	rs1566999621	NC_000015.10:67181432:AGCTGACACGGAGA:
NM_005902.4(SMAD3):c.1009G>T (p.Gly337Ter)	SMAD3	G337*, G232*, G142*, G293*	Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000573480	15	67477202	15	67184864	573480	569088	rs1567002115	NC_000015.10:67184863:G:T
NM_005902.4(SMAD3):c.960_972delinsGACACC (p.Cys320fs)	SMAD3		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000567283	15	67477153 - 67477165	15	67184815 - 67184827	567283	569081	rs1567002059	NC_000015.10:67184814:TAACCAGCGCTAT:GACACC
NM_005902.4(SMAD3):c.246dup (p.Leu83fs)	SMAD3		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000477571	15	67457268 - 67457269	15	67164930 - 67164931	477571	464462	rs1555412069	NC_000015.10:67164930:GGGG:GGGGG
NM_005902.4(SMAD3):c.138del (p.Gln47fs)	SMAD3	Q47fs	Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000477570	15	67358627	15	67066289	477570	465346	rs1555405108	NC_000015.10:67066288:GGGG:GGG
NM_005902.4(SMAD3):c.903_904dup (p.Glu302fs)	SMAD3		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV000405566	15	67477093 - 67477094	15	67184755 - 67184756	405566	400463	rs1060500770	NC_000015.10:67184755:GGGG:GGGGGG
NM_005902.4(SMAD3):c.246_247dup (p.Leu83fs)	SMAD3		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 24, 2016)	criteria provided, single submitter	VCV000405565	15	67457271 - 67457272	15	67164933 - 67164934	405565	400320	rs1555412070	NC_000015.10:67164933:GC:GCGC
NM_024312.5(GNPTAB):c.2715+1G>A	GNPTAB		Pseudo-Hurler polydystrophy|Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002768	12	102157979	12	101764201	2768	17807	rs281865031	NC_000012.12:101764200:C:T
NM_022041.3(GAN):c.851+1G>A	GAN		Giant axonal neuropathy 1|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000246282	16	81390608	16	81357003	246282	245008	rs747291494	NC_000016.10:81357002:G:A
NM_005249.5(FOXG1):c.561C>A (p.Asn187Lys)	FOXG1	N187K	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jun 23, 2016)	criteria provided, multiple submitters, no conflicts	VCV000205485	14	29237046	14	28767840	205485	202823	rs796052462	NC_000014.9:28767839:C:A
NM_005902.4(SMAD3):c.545dup (p.Gly183fs)	SMAD3		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000857614	15	67459124 - 67459125	15	67166786 - 67166787	857614	842622		NC_000015.10:67166786:CCCCC:CCCCCC
NM_005902.4(SMAD3):c.1164_1165TG[1] (p.Val389fs)	SMAD3		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000662651	15	67482760 - 67482761	15	67190422 - 67190423	662651	643511		NC_000015.10:67190421:TGTG:TG
NC_000015.9:g.(?_67457223)_(67482884_?)del	SMAD3		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000639875	15	67457223 - 67482884	15	67164885 - 67190546	639875	652703		
NM_001126108.2(SLC12A3):c.2864G>A (p.Arg955Gln)	SLC12A3	R964Q, R955Q, R963Q	Familial hypokalemia-hypomagnesemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000417864	16	56938314	16	56904402	417864	404825	rs202114767	NC_000016.10:56904401:G:A
NM_004004.5(GJB2):c.592_600delGTGTCTGGAinsCAGTGTTCATGACATTC (p.Val198Glnfs)	GJB2		Deafness, autosomal recessive 1A|Rare genetic deafness|not provided|Hearing loss	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044761	13	20763121 - 20763129	13	20188982 - 20188990	44761	53928	rs111033335	NC_000013.11:20188981:TCCAGACAC:GAATGTCATGAACACTG
NM_002528.7(NTHL1):c.162_163GA[1] (p.Arg55fs)	NTHL1		not provided	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000863401	16	2096318 - 2096319	16	2046317 - 2046318	863401	843283		NC_000016.10:2046316:TCTCT:TCT
NM_002528.7(NTHL1):c.547C>T (p.Gln183Ter)	NTHL1	Q183*, Q73*, Q126*	not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000848942	16	2093706	16	2043705	848942	843246		NC_000016.10:2043704:G:A
NM_002528.7(NTHL1):c.650_653dup (p.Met218fs)	NTHL1		not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000845530	16	2093599 - 2093600	16	2043598 - 2043599	845530	843235		NC_000016.10:2043598:ATAG:ATAGATAG
NC_000016.10:g.(?_2043557)_(2044810_?)del	NTHL1		not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000832200	16	2093558 - 2094811			832200	820785		
NM_002528.7(NTHL1):c.445dup (p.Arg149fs)	NTHL1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000825108	16	2094710 - 2094711	16	2044709 - 2044710	825108	812432		NC_000016.10:2044709:G:GG
NM_002528.7(NTHL1):c.350del (p.Pro117fs)	NTHL1	P117fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000824156	16	2096133	16	2046132	824156	812438		NC_000016.10:2046131:GGGGGGG:GGGGGG
NM_002528.7(NTHL1):c.232del (p.Val78fs)	NTHL1	V78fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, single submitter	VCV000821502	16	2096251	16	2046250	821502	812443		NC_000016.10:2046249:C:
NM_002528.7(NTHL1):c.389_390TC[1] (p.Ser131fs)	NTHL1		not provided	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000665291	16	2094764 - 2094765	16	2044763 - 2044764	665291	644046		NC_000016.10:2044762:GAGAG:GAG
NM_002528.7(NTHL1):c.160C>T (p.Gln54Ter)	NTHL1	Q54*	not provided	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000662775	16	2096323	16	2046322	662775	644082		NC_000016.10:2046321:G:A
NM_002528.7(NTHL1):c.350dup (p.Val119fs)	NTHL1		not provided	Pathogenic(Last reviewed: Nov 16, 2019)	criteria provided, single submitter	VCV000660624	16	2096132 - 2096133	16	2046131 - 2046132	660624	644056		NC_000016.10:2046131:GGGGGGG:GGGGGGGG
NM_002528.7(NTHL1):c.604G>T (p.Glu202Ter)	NTHL1	E145*, E202*, E92*	not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000655543	16	2093649	16	2043648	655543	644011		NC_000016.10:2043647:C:A
NM_002528.7(NTHL1):c.259C>T (p.Gln87Ter)	NTHL1	Q87*	not provided	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000652924	16	2096224	16	2046223	652924	644070		NC_000016.10:2046222:G:A
NM_002528.7(NTHL1):c.409C>T (p.Gln137Ter)	NTHL1	Q27*, Q137*	not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000652003	16	2094747	16	2044746	652003	644042		NC_000016.10:2044745:G:A
NM_002528.7(NTHL1):c.460del (p.Asp154fs)	NTHL1	D154fs, D44fs	not provided	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000651377	16	2094696	16	2044695	651377	644025		NC_000016.10:2044694:CC:C
NM_002528.7(NTHL1):c.433C>T (p.Arg145Ter)	NTHL1	R35*, R145*	not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000647096	16	2094723	16	2044722	647096	644037		NC_000016.10:2044721:G:A
NM_002528.7(NTHL1):c.366C>G (p.Tyr122Ter)	NTHL1	Y12*, Y122*	not provided	Pathogenic(Last reviewed: Nov 17, 2018)	criteria provided, single submitter	VCV000645235	16	2094790	16	2044789	645235	644048		NC_000016.10:2044788:G:C
NM_002528.7(NTHL1):c.356_359dup (p.Arg121fs)	NTHL1		not provided	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000644885	16	2094796 - 2094797	16	2044795 - 2044796	644885	644051		NC_000016.10:2044795:CGTAC:CGTACGTAC
NM_002528.7(NTHL1):c.203del (p.Gly68fs)	NTHL1	G68fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000545879	16	2096280	16	2046279	545879	536454	rs1555492819	NC_000016.10:2046278:CC:C
NM_000282.4(PCCA):c.923dup (p.Leu308fs)	PCCA		Propionic acidemia	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000310846	13	100925451 - 100925452	13	100273197 - 100273198	310846	333273	rs573607437	NC_000013.11:100273197:TTTTTTT:TTTTTTTT
NM_001199107.2(TBC1D24):c.442G>T (p.Glu148Ter)	TBC1D24	E148*	not provided	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000620424	16	2546591	16	2496590	620424	611821	rs763626059	NC_000016.10:2496589:G:T
NM_001199107.2(TBC1D24):c.971C>A (p.Ser324Ter)	TBC1D24	S324*	not provided	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000620365	16	2547716	16	2497715	620365	611822	rs1567412736	NC_000016.10:2497714:C:A
NM_001199107.2(TBC1D24):c.131G>A (p.Trp44Ter)	TBC1D24	W44*	not provided	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000593459	16	2546280	16	2496279	593459	584523	rs1567411053	NC_000016.10:2496278:G:A
NM_001199107.2(TBC1D24):c.619C>T (p.Gln207Ter)	TBC1D24	Q207*	not provided	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000523796	16	2546768	16	2496767	523796	514691	rs770107050	NC_000016.10:2496766:C:T
NM_001199107.2(TBC1D24):c.557del (p.Leu186fs)	TBC1D24	L186fs	not provided	Pathogenic(Last reviewed: Oct 27, 2015)	criteria provided, single submitter	VCV000430018	16	2546706	16	2496705	430018	422085	rs1131691737	NC_000016.10:2496704:T:
NM_001199107.2(TBC1D24):c.1526-2A>C	TBC1D24		not provided	Pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	VCV000429729	16	2550803	16	2500802	429729	422087	rs1131691552	NC_000016.10:2500801:A:C
NM_001199107.2(TBC1D24):c.58C>T (p.Gln20Ter)	TBC1D24	Q20*	not provided	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000419782	16	2546207	16	2496206	419782	409576	rs201257588	NC_000016.10:2496205:C:T
NM_001199107.2(TBC1D24):c.691_700delinsCTT (p.Val231fs)	TBC1D24		not provided	Pathogenic(Last reviewed: Sep 12, 2014)	criteria provided, single submitter	VCV000207516	16	2546840 - 2546849	16	2496839 - 2496848	207516	203237	rs796053407	NC_000016.10:2496838:GTCTTCCTGG:CTT
NM_001199107.2(TBC1D24):c.1079G>A (p.Arg360His)	TBC1D24	R360H, R354H	Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome	Pathogenic(Last reviewed: Aug 9, 2019)	no assertion criteria provided	VCV000652619	16	2548334	16	2498333	652619	653804		NC_000016.10:2498332:G:A
NM_001199107.2(TBC1D24):c.194G>T (p.Arg65Leu)	TBC1D24	R65L	Deafness, autosomal recessive 86	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236046	16	2546343	16	2496342	236046	237618	rs878853232	NC_000016.10:2496341:G:T
NM_001199107.2(TBC1D24):c.1460dup (p.His487fs)	TBC1D24		DOORS syndrome	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000183156	16	2550425 - 2550426	16	2500424 - 2500425	183156	181293	rs797044549	NC_000016.10:2500424:A:AA
NM_001199107.2(TBC1D24):c.313T>C (p.Cys105Arg)	TBC1D24	C105R	DOORS syndrome	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000183153	16	2546462	16	2496461	183153	181289	rs797044547	NC_000016.10:2496460:T:C
NM_001199107.2(TBC1D24):c.1153C>T (p.Gln385Ter)	TBC1D24	Q379*, Q385*	Caused by mutation in the TBC1 domain family, member 24|Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000852959	16	2549368	16	2499367	852959	843668		NC_000016.10:2499366:C:T
NM_001199107.2(TBC1D24):c.1501G>A (p.Gly501Arg)	TBC1D24	G501R, G495R	Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome	Pathogenic(Last reviewed: Aug 9, 2019)	no assertion criteria provided	VCV000652618	16	2550467	16	2500466	652618	653803		NC_000016.10:2500465:G:A
NM_001199107.2(TBC1D24):c.1131C>G (p.Tyr377Ter)	TBC1D24	Y377*, Y371*	Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000569501	16	2548386	16	2498385	569501	570225	rs1567413218	NC_000016.10:2498384:C:G
NM_001199107.2(TBC1D24):c.172del (p.Arg57_Leu58insTer)	TBC1D24		Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000541316	16	2546320	16	2496319	541316	530198	rs1555501140	NC_000016.10:2496318:CC:C
NC_000016.9:g.(?_2546130)_(2550979_?)del	TBC1D24		Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000474299	16	2546130 - 2550979	16	2496129 - 2500978	474299	465533		
NM_001199107.2(TBC1D24):c.468C>A (p.Cys156Ter)	TBC1D24	C156*	Early infantile epileptic encephalopathy 16	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000056847	16	2546617	16	2496616	56847	71465	rs397514714	NC_000016.10:2496615:C:A
NM_001199107.2(TBC1D24):c.686T>C (p.Phe229Ser)	TBC1D24	F229S	Early infantile epileptic encephalopathy 16	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000056846	16	2546835	16	2496834	56846	71464	rs397514713	NC_000016.10:2496833:T:C
NM_001199107.2(TBC1D24):c.751T>C (p.Phe251Leu)	TBC1D24	F251L	Myoclonic epilepsy, familial infantile	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000000050	16	2546900	16	2496899	50	15089	rs267607104	NC_000016.10:2496898:T:C
NM_005902.4(SMAD3):c.874del (p.Arg292fs)	SMAD3	R187fs, R248fs, R292fs, R97fs	Loeys-Dietz syndrome 3	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000694383	15	67477066	15	67184728	694383	682311		NC_000015.10:67184727:AA:A
NM_005902.4(SMAD3):c.266_268GCC[3] (p.Arg90dup)	SMAD3		Loeys-Dietz syndrome 3	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000694381	15	67457291 - 67457292	15	67164953 - 67164954	694381	682307		NC_000015.10:67164953:GCCGCC:GCCGCCGCC
NM_005902.4(SMAD3):c.736del (p.Glu246fs)	SMAD3	E141fs, E202fs, E246fs, E51fs	Loeys-Dietz syndrome 3	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000694380	15	67473653	15	67181315	694380	682310		NC_000015.10:67181314:GGGG:GGG
NM_005902.4(SMAD3):c.54del (p.Gly17_Trp18insTer)	SMAD3		Thoracic aortic aneurysm and aortic dissection|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420915	15	67358545	15	67066207	420915	409322	rs1064794789	NC_000015.10:67066206:GG:G
NM_005902.4(SMAD3):c.427_431del (p.His143fs)	SMAD3	H99fs, H38fs, H143fs	not provided|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000405569	15	67457616 - 67457620	15	67165278 - 67165282	405569	401120	rs1060500773	NC_000015.10:67165277:CCACAC:C
NM_005902.4(SMAD3):c.797C>A (p.Ser266Ter)	SMAD3	S266*, S161*, S71*, S222*	Thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000405537	15	67473717	15	67181379	405537	400459	rs753486471	NC_000015.10:67181378:C:A
NM_005902.4(SMAD3):c.82G>T (p.Glu28Ter)	SMAD3	E28*	not provided|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000213779	15	67358574	15	67066236	213779	210246	rs863223750	NC_000015.10:67066235:G:T
NM_005902.4(SMAD3):c.1081G>T (p.Glu361Ter)	SMAD3	E361*, E166*, E256*, E317*	Loeys-Dietz syndrome 3	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030315	15	67479774	15	67187436	30315	39271	rs387906856	NC_000015.10:67187435:G:T
NM_005902.4(SMAD3):c.836G>A (p.Arg279Lys)	SMAD3	R279K, R174K, R235K, R84K	Loeys-Dietz syndrome 3	Pathogenic(Last reviewed: Sep 2, 2011)	no assertion criteria provided	VCV000030310	15	67473756	15	67181418	30310	39266	rs387906852	NC_000015.10:67181417:G:A
NM_005902.4(SMAD3):c.782C>T (p.Thr261Ile)	SMAD3	T261I, T156I, T217I, T66I	Loeys-Dietz syndrome 3	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000030308	15	67473702	15	67181364	30308	39264	rs387906851	NC_000015.10:67181363:C:T
NM_005902.4(SMAD3):c.741_742del (p.Phe248fs)	SMAD3	F204fs, F143fs, F248fs, F53fs	Loeys-Dietz syndrome 3	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000030307	15	67473661 - 67473662	15	67181323 - 67181324	30307	39263	rs587776880	NC_000015.10:67181322:AT:
NM_002528.7(NTHL1):c.472C>T (p.Gln158Ter)	NTHL1	Q158*, Q48*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000654258	16	2094684	16	2044683	654258	644023		NC_000016.10:2044682:G:A
NM_002528.7(NTHL1):c.366C>A (p.Tyr122Ter)	NTHL1	Y12*, Y122*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000644578	16	2094790	16	2044789	644578	644049		NC_000016.10:2044788:G:T
NM_000086.2(CLN3):c.883G>T (p.Glu295Ter)	CLN3	E295*, E241*, E271*, E195*, E217*	Juvenile neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056290	16	28493821	16	28482500	56290	70929	rs121434286	NC_000016.10:28482499:C:A
NM_000086.2(CLN3):c.461-280_677+382del	CLN3		not provided|Juvenile neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000003552	16	28497286 - 28498251	16	28485965 - 28486930	3552	18591	rs1555468634	
NM_001199107.2(TBC1D24):c.346A>T (p.Lys116Ter)	TBC1D24	K116*	Deafness, autosomal recessive 86|Deafness, autosomal dominant 65	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587507	16	2546495	16	2496494	587507	578528	rs1567411469	NC_000016.10:2496493:A:T
NM_020705.3(TBC1D24):c.966-529GT[2]	TBC1D24		Early infantile epileptic encephalopathy 16	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000056845	16	2547710 - 2547711	16	2497709 - 2497710	56845	71463	rs398122941	NC_000016.10:2497708:GTGTGT:GTGT
NM_001199107.2(TBC1D24):c.439G>C (p.Asp147His)	TBC1D24	D147H	Myoclonic epilepsy, familial infantile	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000000048	16	2546588	16	2496587	48	15087	rs267607103	NC_000016.10:2496586:G:C
NM_002834.4(PTPN11):c.1508G>A (p.Gly503Glu)	PTPN11	G503E, G507E	Rasopathy|LEOPARD syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040561	12	112926888	12	112489084	40561	49031	rs397507546	NC_000012.12:112489083:G:A
NM_002834.5(PTPN11):c.854T>G (p.Phe285Cys)	PTPN11	F285C, F284C	not provided|Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040533	12	112915455	12	112477651	40533	49003	rs121918463	NC_000012.12:112477650:T:G
NM_002834.5(PTPN11):c.846C>G (p.Ile282Met)	PTPN11	I282M, I281M	Noonan syndrome 1|not provided|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040526	12	112910837	12	112473033	40526	48996	rs397507530	NC_000012.12:112473032:C:G
NM_002834.5(PTPN11):c.802G>T (p.Gly268Cys)	PTPN11	G268C, G267C	Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040523	12	112910793	12	112472989	40523	48993	rs397507527	NC_000012.12:112472988:G:T
NM_000153.4(GALC):c.1186C>T (p.Arg396Trp)	GALC	R396W, R373W, R370W	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000456712	14	88417068	14	87950724	456712	464162	rs770485731	NC_000014.9:87950723:G:A
NM_001199107.2(TBC1D24):c.121C>T (p.Gln41Ter)	TBC1D24	Q41*	not provided|Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000391687	16	2546270	16	2496269	391687	377427	rs1057524191	NC_000016.10:2496268:C:T
NM_001199107.2(TBC1D24):c.878G>C (p.Arg293Pro)	TBC1D24	R293P	Deafness, autosomal recessive 86	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000100678	16	2547027	16	2497026	100678	106550	rs199700840	NC_000016.10:2497025:G:C
NM_014249.4(NR2E3):c.166G>A (p.Gly56Arg)	NR2E3	G56R	Retinal dystrophy|Retinitis pigmentosa|not provided|Retinitis pigmentosa 37	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005533	15	72103870	15	71811530	5533	20572	rs121912631	NC_000015.10:71811529:G:A
NM_001142864.4(PIEZO1):c.7477_7482CTGGAG[3] (p.2493_2494LE[3])	PIEZO1		DEHYDRATED HEREDITARY STOMATOCYTOSIS WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA|not provided|Xerocytosis	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000418948	16	88782090 - 88782091	16	88715682 - 88715683	418948	409773	rs587776992	NC_000016.10:88715682:CTCCAGCTCCAGCTCC:CTCCAGCTCCAGCTCCAGCTCC
NM_005902.4(SMAD3):c.668del (p.Pro223fs)	SMAD3	P118fs, P179fs, P223fs, P28fs	Loeys-Dietz syndrome 3	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000694384	15	67473587	15	67181249	694384	682309		NC_000015.10:67181248:CC:C
NC_000015.9:g.(?_67473559)_(67473811_?)del	SMAD3		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000584063	15	67473559 - 67473811	15	67181221 - 67181473	584063	568592		
NM_005902.4(SMAD3):c.401-6G>A	SMAD3		Connective tissue disease|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000213782	15	67457585	15	67165247	213782	210264	rs745672741	NC_000015.10:67165246:G:A
NM_005902.4(SMAD3):c.653del (p.Asn218fs)	SMAD3	N218fs, N23fs, N113fs, N174fs	Loeys-Dietz syndrome 3	Pathogenic(Last reviewed: Sep 2, 2011)	no assertion criteria provided	VCV000030309	15	67462936	15	67170598	30309	39265	rs587776881	NC_000015.10:67170597:AA:A
NM_002528.7(NTHL1):c.685+1G>A	NTHL1		Familial adenomatous polyposis 3|not provided	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000218092	16	2093567	16	2043566	218092	214746	rs372946560	NC_000016.10:2043565:C:T
NM_001199107.2(TBC1D24):c.1079G>T (p.Arg360Leu)	TBC1D24	R360L, R354L	Progressive myoclonus epilepsy with ataxia|Intellectual disability|Neurodevelopmental delay|Periodic paralysis	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000183157	16	2548334	16	2498333	183157	181292	rs765965968	NC_000016.10:2498332:G:T
NM_001199107.2(TBC1D24):c.999G>T (p.Leu333Phe)	TBC1D24	L333F, L327F	DOORS syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000183155	16	2548254	16	2498253	183155	181291	rs797044548	NC_000016.10:2498252:G:T
NM_001199107.2(TBC1D24):c.119G>T (p.Arg40Leu)	TBC1D24	R40L	DOORS syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000183152	16	2546268	16	2496267	183152	181288	rs760474458	NC_000016.10:2496266:G:T
NM_001199107.2(TBC1D24):c.533C>T (p.Ser178Leu)	TBC1D24	S178L	Deafness, autosomal dominant 65|Deafness, autosomal recessive 86	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000133246	16	2546682	16	2496681	133246	136991	rs483352866	NC_000016.10:2496680:C:T
NM_001199107.2(TBC1D24):c.208G>T (p.Asp70Tyr)	TBC1D24	D70Y	Deafness, autosomal recessive 86	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000100677	16	2546357	16	2496356	100677	106549	rs587777147	NC_000016.10:2496355:G:T
NM_001199107.2(TBC1D24):c.1206+5G>A	TBC1D24		DOORS syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000091399	16	2549426	16	2499425	91399	96875	rs398122968	NC_000016.10:2499424:G:A
NM_001199107.2(TBC1D24):c.58C>G (p.Gln20Glu)	TBC1D24	Q20E	DOORS syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000091397	16	2546207	16	2496206	91397	96873	rs201257588	NC_000016.10:2496205:C:G
NM_145239.3(PRRT2):c.718C>T (p.Arg240Ter)	PRRT2	R240*	Infantile convulsions and choreoathetosis|Paroxysmal kinesigenic dyskinesia|not provided	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031174	16	29825093	16	29813772	31174	40131	rs387907126	NC_000016.10:29813771:C:T
NM_001163673.1(WDR81):c.388C>T (p.Arg130Ter)	WDR81	R1333*, R130*, R106*, R282*	Inborn genetic diseases|Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000224836	17	1634392	17	1731098	224836	226676	rs138358708	NC_000017.11:1731097:C:T
NM_000020.3(ACVRL1):c.1451G>T (p.Arg484Leu)	ACVRL1	R484L	|Pulmonary arterial hypertension	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000812855	12	52314616	12	51920832	812855	801134		NC_000012.12:51920831:G:T
NM_000020.3(ACVRL1):c.1132C>T (p.Pro378Ser)	ACVRL1	P378S		Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000811496	12	52309903	12	51916119	811496	799699		NC_000012.12:51916118:C:T
NM_000020.2(ACVRL1):c.206G>T (p.Cys69Phe)	ACVRL1	C69F		Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000533353	12	52307027	12	51913243	533353	527243	rs1318118188	NC_000012.12:51913242:G:T
NM_000020.2(ACVRL1):c.955G>C (p.Gly319Arg)	ACVRL1	G319R	not provided||Primary pulmonary hypertension	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426022	12	52309191	12	51915407	426022	414393	rs1085307414	NC_000012.12:51915406:G:C
NM_000512.5(GALNS):c.901G>T (p.Gly301Cys)	GALNS	G301C, G116C, G307C	Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000708	16	88898507	16	88832099	708	15747	rs118204443	NC_000016.10:88832098:C:A
NM_000512.5(GALNS):c.337A>T (p.Ile113Phe)	GALNS	I113F, I119F	Morquio syndrome|not provided|Mucopolysaccharidosis, MPS-IV-A	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000703	16	88907485	16	88841077	703	15742	rs118204438	NC_000016.10:88841076:T:A
NM_002528.7(NTHL1):c.526-1G>A	NTHL1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000665971	16	2093728	16	2043727	665971	652700		NC_000016.10:2043726:C:T
NM_025152.3(NUBPL):c.311T>C (p.Leu104Pro)	NUBPL	L104P, L8P	Mitochondrial complex I deficiency|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000209179	14	32068514	14	31599308	209179	205774	rs201430951	NC_000014.9:31599307:T:C
NM_001199107.2(TBC1D24):c.118C>T (p.Arg40Cys)	TBC1D24	R40C	DOORS syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000091396	16	2546267	16	2496266	91396	96872	rs398122966	NC_000016.10:2496265:C:T
NM_000303.3(PMM2):c.255+1G>A	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000417920	16	8898701	16	8804844	417920	404826	rs1060499598	NC_000016.10:8804843:G:A
NM_000303.3(PMM2):c.430T>C (p.Phe144Leu)	PMM2	F144L	Congenital disorder of glycosylation, type Ia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000197658	16	8905018	16	8811161	197658	194819	rs150719105	NC_000016.10:8811160:T:C
NM_000303.3(PMM2):c.563A>G (p.Asp188Gly)	PMM2	D188G	Congenital disorder of glycosylation, type Ia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007712	16	8906887	16	8813030	7712	22751	rs80338704	NC_000016.10:8813029:A:G
NM_005902.4(SMAD3):c.277C>T (p.Arg93Ter)	SMAD3	R93*, R49*	not provided|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000213781	15	67457303	15	67164965	213781	210257	rs768713596	NC_000015.10:67164964:C:T
NM_005902.4(SMAD3):c.860G>A (p.Arg287Gln)	SMAD3	R287Q, R182Q, R243Q, R92Q	Connective tissue disease|not provided|Loeys-Dietz syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000180524	15	67473780	15	67181442	180524	178706	rs730880214	NC_000015.10:67181441:G:A
NM_005902.4(SMAD3):c.313del (p.Ala105fs)	SMAD3	A61fs, A105fs	not provided|Loeys-Dietz syndrome 3	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030313	15	67457337	15	67164999	30313	39269	rs587776882	NC_000015.10:67164998:GGG:GG
NM_001198536.1(MEFV):c.*284_*286delinsGTA	MEFV		not provided	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000449657	16	3293405 - 3293407	16	3243405 - 3243407	449657	445573	rs1555458284	NC_000016.10:3243404:CAT:TAC
NM_000243.2(MEFV):c.332G>A (p.Gly111Glu)	MEFV	G111E	Behcet's syndrome	Pathogenic(Last reviewed: Jun 25, 2017)	no assertion criteria provided	VCV000430715	16	3304736	16	3254736	430715	424254	rs751454741	NC_000016.10:3254735:C:T
NM_000243.2(MEFV):c.1099C>G (p.Leu367Val)	MEFV	L367V, L156V	Behcet's syndrome	Pathogenic(Last reviewed: Jan 25, 2017)	no assertion criteria provided	VCV000375253	16	3299592	16	3249592	375253	361954	rs1057519328	NC_000016.10:3249591:G:C
NM_000243.2(MEFV):c.1211A>G (p.His404Arg)	MEFV	H404R, H193R	Behcet's syndrome	Pathogenic(Last reviewed: Jan 25, 2017)	no assertion criteria provided	VCV000375252	16	3299480	16	3249480	375252	361953	rs755659290	NC_000016.10:3249479:T:C
NM_000243.2(MEFV):c.1759+1G>A	MEFV		not provided	Pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	VCV000234363	16	3294253	16	3244253	234363	231935	rs876660996	NC_000016.10:3244252:C:T
NM_000243.2(MEFV):c.826G>T (p.Glu276Ter)	MEFV	E276*	not provided	Pathogenic(Last reviewed: Mar 26, 2013)	criteria provided, single submitter	VCV000234360	16	3304242	16	3254242	234360	231941	rs876660995	NC_000016.10:3254241:C:A
NM_000086.2(CLN3):c.461-279_677+384del	CLN3		Retinitis pigmentosa|Juvenile neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jun 6, 2015)	criteria provided, single submitter	VCV000438235	16	28497284 - 28498250	16	28485963 - 28486929	438235	431856	rs1555468632	
NM_000086.2(CLN3):c.424del (p.Val142fs)	CLN3	V88fs, V118fs, V142fs, V42fs, V64fs	Juvenile neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056269	16	28498813	16	28487492	56269	70908	rs386833720	NC_000016.10:28487491:CC:C
NM_015272.5(RPGRIP1L):c.2050C>T (p.Gln684Ter)	RPGRIP1L	Q684*	Meckel-Gruber syndrome|Joubert syndrome|Joubert syndrome 7|Joubert syndrome with hepatic defect|Meckel syndrome type 5|Joubert syndrome 7	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001076	16	53686549	16	53652637	1076	16115	rs121918204	NC_000016.10:53652636:G:A
NM_024312.5(GNPTAB):c.612_615ACAG[1] (p.Thr206fs)	GNPTAB		|Mucolipidosis||Pseudo-Hurler polydystrophy|not provided	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038432	12	102174352 - 102174355	12	101780574 - 101780577	38432	46991	rs281865024	NC_000012.12:101780573:CTGTCTGTCTG:CTGTCTG
NM_024312.5(GNPTAB):c.1196C>T (p.Ser399Phe)	GNPTAB	S399F	|Pseudo-Hurler polydystrophy|Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000038413	12	102163887	12	101770109	38413	46972	rs281865026	NC_000012.12:101770108:G:A
NM_000243.2(MEFV):c.490A>T (p.Lys164Ter)	MEFV	K164*	Familial Mediterranean fever	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000664924	16	3304578	16	3254578	664924	644639		NC_000016.10:3254577:T:A
NM_001198536.1(MEFV):c.277+2125dup	MEFV		Familial Mediterranean fever	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000650911	16	3304183 - 3304184	16	3254183 - 3254184	650911	644633		NC_000016.10:3254183:GGG:GGGG
NM_000243.2(MEFV):c.65del (p.Glu22fs)	MEFV	E22fs	Familial Mediterranean fever	Pathogenic(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	VCV000644049	16	3306523	16	3256523	644049	644640		NC_000016.10:3256522:T:
NM_000151.4(G6PC):c.562G>C (p.Gly188Arg)	G6PC	G188R, R162T	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012008	17	41061435	17	42909418	12008	27047	rs80356482	NC_000017.11:42909417:G:C
NM_000151.4(G6PC):c.113A>T (p.Asp38Val)	G6PC	D38V	not specified|Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012004	17	41053006	17	42900989	12004	27043	rs104894565	NC_000017.11:42900988:A:T
NM_000137.3(FAH):c.782C>T (p.Pro261Leu)	FAH	P261L	not provided|Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021058	15	80465431	15	80173089	21058	33910	rs80338898	NC_000015.10:80173088:C:T
NM_139242.4(MTFMT):c.626C>T (p.Ser209Leu)	MTFMT	S209L	Leigh syndrome|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27|not provided|Cytochrome C oxidase-negative muscle fibers|Abnormal facial shape|Inability to walk by childhood/adolescence|Poor speech|Short stature|Decreased activity of mitochondrial complex I|Combined oxidative phosphorylation deficiency 15	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039827	15	65313871	15	65021533	39827	48426	rs201431517	NC_000015.10:65021532:G:A
NM_003119.4(SPG7):c.2228T>C (p.Ile743Thr)	SPG7	I743T	Hereditary spastic paraplegia 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000215218	16	89623341	16	89556933	215218	211774	rs752623413	NC_000016.10:89556932:T:C
NM_024685.4(BBS10):c.2119_2120del (p.Thr706_Val707insTer)	BBS10		Retinal dystrophy|Bardet-Biedl syndrome|Bardet-Biedl syndrome 10	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000406221	12	76739645 - 76739646	12	76345865 - 76345866	406221	399055	rs775950661	NC_000012.12:76345864:ACA:A
NM_005236.2(ERCC4):c.1765C>T (p.Arg589Trp)	ERCC4	R589W	Xeroderma pigmentosum, type F/Cockayne syndrome|Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q|XFE progeroid syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000055829	16	14029554	16	13935697	55829	70487	rs147105770	NC_000016.10:13935696:C:T
NM_002834.5(PTPN11):c.209A>G (p.Lys70Arg)	PTPN11	K70R, K69R	not provided|Rasopathy|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044603	12	112888193	12	112450389	44603	53770	rs397516801	NC_000012.12:112450388:A:G
NM_002834.5(PTPN11):c.214G>C (p.Ala72Pro)	PTPN11	A72P, A71P	not provided|Noonan syndrome|Noonan syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040500	12	112888198	12	112450394	40500	48970	rs121918453	NC_000012.12:112450393:G:C
NM_002087.4(GRN):c.709-2A>G	GRN		not provided|||Ceroid lipofuscinosis, neuronal, 11	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098150	17	42428403	17	44351035	98150	104042	rs63750548	NC_000017.11:44351034:A:G
NM_005902.4(SMAD3):c.990dup (p.Val331fs)	SMAD3		not provided|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000213787	15	67477181 - 67477182	15	67184843 - 67184844	213787	210291	rs863223754	NC_000015.10:67184843:CC:CCC
NM_001127701.1(SERPINA1):c.1178C>T (p.Pro393Leu)	SERPINA1	P369L, P393L	PI M(HEERLEN)|not provided|Alpha-1-antitrypsin deficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000017965	14	94844865	14	94378528	17965	33004	rs199422209	NC_000014.9:94378527:G:A
NM_005477.3(HCN4):c.1241C>G (p.Ala414Gly)	HCN4	A414G	Sick sinus syndrome 2, autosomal dominant	Pathogenic(Last reviewed: Aug 26, 2014)	no assertion criteria provided	VCV000374861	15	73624602	15	73332261	374861	361766	rs1057519276	NC_000015.10:73332260:G:C
NM_005477.3(HCN4):c.1438G>C (p.Gly480Arg)	HCN4	G480R	Sick sinus syndrome 2, autosomal dominant	Pathogenic(Last reviewed: Jul 31, 2007)	no assertion criteria provided	VCV000005176	15	73622066	15	73329725	5176	20215	rs121908411	NC_000015.10:73329724:C:G
NM_005477.3(HCN4):c.1657G>A (p.Asp553Asn)	HCN4	D553N	Sick sinus syndrome 2, autosomal dominant	Pathogenic(Last reviewed: Jun 25, 2004)	no assertion criteria provided	VCV000005175	15	73617719	15	73325378	5175	20214	rs104894485	NC_000015.10:73325377:C:T
NM_005477.3(HCN4):c.1631del (p.Pro544fs)	HCN4	P544fs	Sick sinus syndrome 2, autosomal dominant	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000005174	15	73617745	15	73325404	5174	20213	rs1057519015	NC_000015.10:73325403:GGG:GG
NM_005477.3(HCN4):c.2016C>A (p.Ser672Arg)	HCN4	S672R	Sick sinus syndrome 2, autosomal dominant	Pathogenic(Last reviewed: Jan 12, 2006)	no assertion criteria provided	VCV000005173	15	73616557	15	73324216	5173	20212	rs104894488	NC_000015.10:73324215:G:T
NM_005477.3(HCN4):c.1444G>C (p.Gly482Arg)	HCN4	G482R	Sick sinus syndrome 2, autosomal dominant	Pathogenic(Last reviewed: Aug 26, 2014)	no assertion criteria provided	VCV000374859	15	73622060	15	73329719	374859	361764	rs794727637	NC_000015.10:73329718:C:G
NM_005477.3(HCN4):c.1920_1932dup (p.Lys645fs)	HCN4		Sick sinus syndrome 2, autosomal dominant	Pathogenic(Last reviewed: Aug 26, 2014)	no assertion criteria provided	VCV000374858	15	73617341 - 73617342	15	73325000 - 73325001	374858	361763	rs1057519274	NC_000015.10:73325000:GGTGAGCACGCTG:GGTGAGCACGCTGGGTGAGCACGCTG
NM_004004.6(GJB2):c.95G>T (p.Arg32Leu)	GJB2	R32L	Deafness, autosomal recessive 1A|Hearing loss|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000499513	13	20763626	13	20189487	499513	490937	rs111033190	NC_000013.11:20189486:C:A
NM_004004.6(GJB2):c.630_631GT[1] (p.Cys211fs)	GJB2		Hearing impairment|not provided|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158608	13	20763088 - 20763089	13	20188949 - 20188950	158608	169010	rs587783646	NC_000013.11:20188948:ACACA:ACA
NM_000282.4(PCCA):c.937C>T (p.Arg313Ter)	PCCA	R313*, R287*	not provided|Propionic acidemia	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038870	13	100925472	13	100273218	38870	47475	rs138149179	NC_000013.11:100273217:C:T
NM_001126108.2(SLC12A3):c.2938G>A (p.Gly980Arg)	SLC12A3	G989R, G988R, G980R	not provided|Familial hypokalemia-hypomagnesemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000586605	16	56947189	16	56913277	586605	577557	rs34803727	NC_000016.10:56913276:G:A
NM_001126108.2(SLC12A3):c.2856+1G>T	SLC12A3		not provided	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372504	16	56936421	16	56902509	372504	360256	rs199974259	NC_000016.10:56902508:G:T
NM_000359.3(TGM1):c.944G>T (p.Arg315Leu)	TGM1	R315L	Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039531	14	24728950	14	24259744	39531	48130	rs143473912	NC_000014.9:24259743:C:A
NC_000012.12:g.(?_51913089)_(51916243_?)del	ACVRL1			Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000831943	12	52306873 - 52310027			831943	820507		
NM_000020.2(ACVRL1):c.1055C>A (p.Ala352Asp)	ACVRL1	A352D	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not specified|	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426023	12	52309826	12	51916042	426023	414394	rs1085307415	NC_000012.12:51916041:C:A
NM_001077401.2(ACVRL1):c.693_695CTC[1] (p.Ser233del)	ACVRL1	S233del, S232del	not specified|	Pathogenic(Last reviewed: Jun 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000236552	12	52308290 - 52308292	12	51914506 - 51914508	236552	241561	rs387906391	NC_000012.12:51914505:CTCCTC:CTC
NM_000020.2(ACVRL1):c.1232G>C (p.Arg411Pro)	ACVRL1	R411P		Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000008257	12	52310003	12	51916219	8257	23296	rs121909284	NC_000012.12:51916218:G:C
NC_000016.9:g.(?_28497286)_(28498251_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000657904	16	28497286 - 28498251	16	28485965 - 28486930	657904	652837		
NC_000016.9:g.(?_28497668)_(28497971_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000584138	16	28497668 - 28497971	16	28486347 - 28486650	584138	567488		
NC_000016.9:g.(?_28497648)_(28497991_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000457935			16	28486327 - 28486670	457935	464820		
NM_000086.2(CLN3):c.944dup (p.His315fs)	CLN3		Juvenile neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056292	16	28493665 - 28493666	16	28482344 - 28482345	56292	70931	rs386833740	NC_000016.10:28482344:T:TT
NM_000382.3(ALDH3A2):c.943C>T (p.Pro315Ser)	ALDH3A2	P315S, P122S	Sjgren-Larsson syndrome|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001640	17	19566648	17	19663335	1640	16679	rs72547571	NC_000017.11:19663334:C:T
NM_005902.4(SMAD3):c.1102C>T (p.Arg368Ter)	SMAD3	R368*, R324*, R173*, R263*	Cardiovascular phenotype|not provided|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000420088	15	67479795	15	67187457	420088	409327	rs757106110	NC_000015.10:67187456:C:T
NM_006086.4(TUBB3):c.523G>C (p.Val175Leu)	TUBB3	V103L, V175L	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 3, 2015)	criteria provided, single submitter	VCV000520851	16	90001382	16	89934974	520851	512252	rs1555625571	NC_000016.10:89934973:G:C
NM_177550.4(SLC13A5):c.655G>A (p.Gly219Arg)	SLC13A5	G219R, G176R, G202R	Epileptic encephalopathy, early infantile, 25	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140752	17	6606350	17	6703031	140752	150466	rs144332569	NC_000017.11:6703030:C:T
NM_016373.4(WWOX):c.705dup (p.His236fs)	WWOX		Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803276	16	78458862 - 78458863	16	78424965 - 78424966	803276	791645		NC_000016.10:78424965:GGGG:GGGGG
GRCh37/hg19 16q23.1(chr16:78272827-78367613)x1	WWOX		not provided	Pathogenic(Last reviewed: Jun 30, 2017)	no assertion criteria provided	VCV000689191	16	78272827 - 78367613			689191	676783		
GRCh37/hg19 16q23.1(chr16:78308767-78371608)x1	WWOX		not provided	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000689058	16	78308767 - 78371608			689058	676650		
GRCh37/hg19 16q23.1(chr16:78186513-78257627)x1	WWOX		not provided	Pathogenic(Last reviewed: Dec 8, 2017)	no assertion criteria provided	VCV000688386	16	78186513 - 78257627			688386	675978		
GRCh37/hg19 16q23.1(chr16:78413243-78439784)x1	WWOX		not provided	Pathogenic(Last reviewed: Jun 7, 2018)	no assertion criteria provided	VCV000687407	16	78413243 - 78439784			687407	674999		
GRCh37/hg19 16q23.1(chr16:78128313-78151480)x1	WWOX		not provided	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000687039	16	78128313 - 78151480			687039	674631		
GRCh37/hg19 16q23.1-23.2(chr16:79172680-79271549)x1	WWOX		not provided	Pathogenic(Last reviewed: Jun 28, 2017)	no assertion criteria provided	VCV000686651	16	79172680 - 79271549			686651	674243		
GRCh37/hg19 16q23.1(chr16:78374562-78469453)x1	WWOX		not provided	Pathogenic(Last reviewed: May 26, 2017)	no assertion criteria provided	VCV000686530	16	78374562 - 78469453			686530	674122		
GRCh37/hg19 16q23.1(chr16:78402398-78504169)x1	WWOX		not provided	Pathogenic(Last reviewed: Dec 8, 2017)	no assertion criteria provided	VCV000685382	16	78402398 - 78504169			685382	672974		
GRCh37/hg19 16q23.1(chr16:78384724-78504169)x1	WWOX		not provided	Pathogenic(Last reviewed: Jan 18, 2018)	no assertion criteria provided	VCV000685373	16	78384724 - 78504169			685373	672965		
NM_016373.4(WWOX):c.132G>A (p.Trp44Ter)	WWOX	W44*	not provided	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000489204	16	78142344	16	78108447	489204	482106	rs1555535072	NC_000016.10:78108446:G:A
NM_016373.4(WWOX):c.131G>A (p.Trp44Ter)	WWOX	W44*	not provided	Pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, single submitter	VCV000372547	16	78142343	16	78108446	372547	360198	rs1057517846	NC_000016.10:78108445:G:A
NM_016373.4(WWOX):c.410-1G>A	WWOX		not provided	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000265596	16	78198079	16	78164182	265596	260127	rs886039653	NC_000016.10:78164181:G:A
NC_000016.10:g.(?_78099759)_(78432772_?)del	WWOX		Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000832849	16	78133656 - 78466669			832849	820879		
NC_000016.10:g.(?_78099759)_(78099909_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000831561	16	78133656 - 78133806			831561	820877		
NC_000016.10:g.(?_78099759)_(78115174_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Dec 21, 2019)	criteria provided, single submitter	VCV000830545	16	78133656 - 78149071			830545	820878		
GRCh37/hg19 16q23.1(chr16:78458774-78463512)	WWOX		Epileptic encephalopathy, early infantile, 28	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625820	16	78458774 - 78463512			625820	614124		
GRCh37/hg19 16q23.1(chr16:78409180-78431277)	WWOX		Epileptic encephalopathy, early infantile, 28	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625676	16	78409180 - 78431277			625676	613980		
GRCh37/hg19 16q23.1(chr16:78143268-78154701)	WWOX		Epileptic encephalopathy, early infantile, 28	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625675	16	78143268 - 78154701			625675	613979		
NC_000016.9:g.(?_78466365)_(78466669_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000540247	16	78466365 - 78466669	16	78432468 - 78432772	540247	529276		
Single allele	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000473015			16	78318746 - 78386940	473015	464847		
GRCh37/hg19 16q23.1(chr16:78180603-78208482)x0	WWOX		See cases	Pathogenic(Last reviewed: Oct 21, 2014)	no assertion criteria provided	VCV000442240	16	78180603 - 78208482			442240	435902		
NM_016373.4(WWOX):c.749C>G (p.Ser250Ter)	WWOX	S250*, S137*	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000284393	16	78458910	16	78425013	284393	268630	rs368928190	NC_000016.10:78425012:C:G
NM_016373.4(WWOX):c.779C>G (p.Ser260Ter)	WWOX	S260*, S147*	Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000241104	16	78458940	16	78425043	241104	242511	rs878855021	NC_000016.10:78425042:C:G
NM_016373.4(WWOX):c.140C>G (p.Pro47Arg)	WWOX	P47R	Epileptic encephalopathy, early infantile, 28	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000180251	16	78142352	16	78108455	180251	178430	rs730880292	NC_000016.10:78108454:C:G
NM_016373.4(WWOX):c.46_49del (p.Asp16fs)	WWOX	D16fs	Epileptic encephalopathy, early infantile, 28	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000180250	16	78133720 - 78133723	16	78099823 - 78099826	180250	178429	rs730880291	NC_000016.10:78099822:GGACG:G
NM_016373.4(WWOX):c.1005G>A (p.Trp335Ter)	WWOX	W335*, W222*	Epileptic encephalopathy, early infantile, 28	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000180249	16	78466598	16	78432701	180249	178428	rs730880290	NC_000016.10:78432700:G:A
NM_016373.3(WWOX):c.517-?_605+?del	WWOX		Epileptic encephalopathy, early infantile, 28	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000180247	16	78420757 - 78420845	16	78342602 - 78424602	180247	178426		
NM_016373.3(WWOX):c.-366-?_516+?del	WWOX		Epileptic encephalopathy, early infantile, 28	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000180246	16	78133327 - 78198186	16	78099413 - 78164289	180246	178425		
NM_016373.4(WWOX):c.872T>C (p.Leu291Pro)	WWOX	L291P, L178P	Esophageal squamous cell carcinoma, somatic	Pathogenic(Last reviewed: Apr 15, 2002)	no assertion criteria provided	VCV000005203	16	78466465	16	78432568	5203	20242	rs119487098	NC_000016.10:78432567:T:C
NC_000016.10:g.(?_78278583)_(78386968_?)del	WWOX		Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000833164	16	78312480 - 78420865			833164	820880		
NC_000016.10:g.(?_78424850)_(78432772_?)del	WWOX		Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000832198	16	78458747 - 78466669			832198	820884		
NC_000016.9:g.(?_78198060)_(78198206_?)del	WWOX		Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000584160	16	78198060 - 78198206	16	78164163 - 78164309	584160	569817		
NC_000016.9:g.(?_78420737)_(78420865_?)del	WWOX		Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000583631	16	78420737 - 78420865	16	78386840 - 78386968	583631	567543		
NM_016373.4(WWOX):c.139C>A (p.Pro47Thr)	WWOX	P47T	Spinocerebellar ataxia, autosomal recessive 12	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000100649	16	78142351	16	78108454	100649	106521	rs587777128	NC_000016.10:78108453:C:A
NM_016373.4(WWOX):c.107+1G>A	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 28|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000689796	16	78133783	16	78099886	689796	677452		NC_000016.10:78099885:G:A
NM_016373.4(WWOX):c.583G>T (p.Glu195Ter)	WWOX	E195*, E82*	Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000568364	16	78420823	16	78386926	568364	570546	rs1567542020	NC_000016.10:78386925:G:T
NM_016373.4(WWOX):c.214C>T (p.Gln72Ter)	WWOX	Q72*	not provided|Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449920	16	78143716	16	78109819	449920	445615	rs201008667	NC_000016.10:78109818:C:T
NM_016373.4(WWOX):c.255C>G (p.Tyr85Ter)	WWOX	Y85*	not provided	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000419259	16	78148897	16	78115000	419259	409741	rs990150249	NC_000016.10:78114999:C:G
NM_016373.4(WWOX):c.160C>T (p.Arg54Ter)	WWOX	R54*	Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1|Epileptic encephalopathy, early infantile, 28	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000120325	16	78142372	16	78108475	120325	125920	rs587777248	NC_000016.10:78108474:C:T
NM_001136473.1(LITAF):c.334G>A (p.Gly112Ser)	LITAF	G112S	Charcot-Marie-Tooth disease, type 1C|not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006057	16	11647432	16	11553576	6057	21096	rs104894519	NC_000016.10:11553575:C:T
NM_005477.3(HCN4):c.1444G>A (p.Gly482Arg)	HCN4	G482R	Brugada syndrome 8|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197253	15	73622060	15	73329719	197253	194414	rs794727637	NC_000015.10:73329718:C:T
NM_015272.5(RPGRIP1L):c.1843A>C (p.Thr615Pro)	RPGRIP1L	T615P	Joubert syndrome 7|not provided|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001069	16	53686756	16	53652844	1069	16108	rs121918198	NC_000016.10:53652843:T:G
NM_004119.2(FLT3):c.2503G>T (p.Asp835Tyr)	FLT3	D835Y	Acute myeloid leukemia|Acute lymphoid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000016276	13	28592642	13	28018505	16276	31315	rs121913488	NC_000013.11:28018504:C:A
NM_025099.6(CTC1):c.2831del (p.Pro944fs)	CTC1	P944fs	Dyskeratosis congenita|Cerebroretinal microangiopathy with calcifications and cysts 1|Cerebroretinal microangiopathy with calcifications and cysts|not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031000	17	8133714	17	8230396	31000	39957	rs199473677	NC_000017.11:8230395:GGGGGG:GGGGG
NM_025099.6(CTC1):c.724_727del (p.Lys242fs)	CTC1	K242fs	not provided|Dyskeratosis congenita|Cerebroretinal microangiopathy with calcifications and cysts 1	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030995	17	8140758 - 8140761	17	8237440 - 8237443	30995	39952	rs199473674	NC_000017.11:8237439:CTTTCT:CT
NM_016373.4(WWOX):c.790C>T (p.Arg264Ter)	WWOX	R264*, R151*	not provided|Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 28|Malignant tumor of esophagus|Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000241105	16	78458951	16	78425054	241105	242512	rs756762196	NC_000016.10:78425053:C:T
NM_003239.4(TGFB3):c.898C>T (p.Arg300Trp)	TGFB3	R300W	Cardiovascular phenotype|not provided|Loeys-Dietz syndrome 4|Loeys-Dietz syndrome 5	Pathogenic/Likely pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203490	14	76429687	14	75963344	203490	199890	rs796051885	NC_000014.9:75963343:G:A
NM_144599.5(NIPA1):c.316G>C (p.Gly106Arg)	NIPA1	G106R, G31R	Hereditary spastic paraplegia 6	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000002521	15	23060816	15	22812252	2521	17560	rs104894490	NC_000015.10:22812251:G:C
NM_022489.4(INF2):c.254C>G (p.Ser85Trp)	INF2	S85W	Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Jun 3, 2019)	no assertion criteria provided	VCV000829855	14	105167956	14	104701619	829855	818302		NC_000014.9:104701618:C:G
NM_022489.4(INF2):c.217G>A (p.Gly73Ser)	INF2	G73S	Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: May 17, 2018)	no assertion criteria provided	VCV000599131	14	105167919	14	104701582	599131	590306	rs1566777560	NC_000014.9:104701581:G:A
INF2, 9-BP DEL, NT490	INF2		Charcot-Marie-Tooth disease, dominant intermediate E	Pathogenic(Last reviewed: Dec 22, 2011)	no assertion criteria provided	VCV000030869					30869	39826		
NM_022489.4(INF2):c.395T>G (p.Leu132Arg)	INF2	L132R	Charcot-Marie-Tooth disease, dominant intermediate E	Pathogenic(Last reviewed: Dec 22, 2011)	no assertion criteria provided	VCV000030868	14	105169445	14	104703108	30868	39825	rs387907038	NC_000014.9:104703107:T:G
NM_022489.4(INF2):c.311G>T (p.Cys104Phe)	INF2	C104F	Charcot-Marie-Tooth disease, dominant intermediate E	Pathogenic(Last reviewed: Dec 22, 2011)	no assertion criteria provided	VCV000030865	14	105168013	14	104701676	30865	39822	rs387907035	NC_000014.9:104701675:G:T
NM_022489.4(INF2):c.310T>C (p.Cys104Arg)	INF2	C104R	Charcot-Marie-Tooth disease, dominant intermediate E	Pathogenic(Last reviewed: Dec 22, 2011)	no assertion criteria provided	VCV000030864	14	105168012	14	104701675	30864	39821	rs387907034	NC_000014.9:104701674:T:C
NM_022489.4(INF2):c.125T>C (p.Leu42Pro)	INF2	L42P	Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000001054	14	105167827	14	104701490	1054	16093	rs267606880	NC_000014.9:104701489:T:C
NM_022489.4(INF2):c.641G>A (p.Arg214His)	INF2	R214H	Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000001053	14	105169765	14	104703428	1053	16092	rs267606879	NC_000014.9:104703427:G:A
NM_022489.4(INF2):c.556T>C (p.Ser186Pro)	INF2	S186P	Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000001050	14	105169680	14	104703343	1050	16089	rs267606877	NC_000014.9:104703342:T:C
NM_022489.4(INF2):c.490_498del (p.Ala164_Asp166del)	INF2		Focal segmental glomerulosclerosis 5|Charcot-Marie-Tooth disease, dominant intermediate E	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000472868	14	105169532 - 105169540	14	104703195 - 104703203	472868	464026	rs1555373599	NC_000014.9:104703194:CCCTGGACGCCCTGGAC:CCCTGGAC
NM_022489.4(INF2):c.312C>G (p.Cys104Trp)	INF2	C104W	Charcot-Marie-Tooth disease, dominant intermediate E	Pathogenic(Last reviewed: Dec 22, 2011)	no assertion criteria provided	VCV000030866	14	105168014	14	104701677	30866	39823	rs387907036	NC_000014.9:104701676:C:G
NM_022489.4(INF2):c.652C>T (p.Arg218Trp)	INF2	R218W	Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Jan 14, 2019)	no assertion criteria provided	VCV000001052	14	105169776	14	104703439	1052	16091	rs267606878	NC_000014.9:104703438:C:T
NM_000020.3(ACVRL1):c.1428del (p.Ser477fs)	ACVRL1	S477fs		Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000645350	12	52314590	12	51920806	645350	641257		NC_000012.12:51920805:CCCC:CCC
NM_000020.2(ACVRL1):c.1325_1326TG[5] (p.Asp445fs)	ACVRL1			Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000576539	12	52312845 - 52312846	12	51919061 - 51919062	576539	568118	rs1565596508	NC_000012.12:51919061:GTGTGTGTG:GTGTGTGTGTG
NM_022489.4(INF2):c.530G>A (p.Arg177His)	INF2	R177H	Focal segmental glomerulosclerosis 5|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562407	14	105169654	14	104703317	562407	553591	rs1566778651	NC_000014.9:104703316:G:A
NM_004004.6(GJB2):c.132G>A (p.Trp44Ter)	GJB2	W44*	Hearing impairment|not provided|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158605	13	20763589	13	20189450	158605	169013	rs104894407	NC_000013.11:20189449:C:T
NM_022489.4(INF2):c.653G>A (p.Arg218Gln)	INF2	R218Q	Focal segmental glomerulosclerosis 5|not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000001051	14	105169777	14	104703440	1051	16090	rs267607183	NC_000014.9:104703439:G:A
NM_145239.3(PRRT2):c.629dup (p.Ala211fs)	PRRT2		Episodic kinesigenic dyskinesia 1|Infantile convulsions and choreoathetosis|not provided	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031171	16	29824997 - 29824998	16	29813676 - 29813677	31171	40128	rs730882067	NC_000016.10:29813676:CCCCCCC:CCCCCCCC
NM_000018.4(ACADVL):c.1145del (p.Lys382fs)	ACADVL	K306fs, K360fs, K382fs, K405fs	not provided	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000818026	17	7126518	17	7223199	818026	805994		NC_000017.11:7223198:AA:A
NM_000018.4(ACADVL):c.1102_1103del (p.Gln368fs)	ACADVL	Q292fs, Q346fs, Q368fs, Q391fs	not provided	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000618506	17	7126476 - 7126477	17	7223157 - 7223158	618506	610108	rs1567566228	NC_000017.11:7223156:CA:
NM_000018.4(ACADVL):c.1317dup (p.Met440fs)	ACADVL		not provided	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000595610	17	7127178 - 7127179	17	7223859 - 7223860	595610	586672	rs1567567440	NC_000017.11:7223859:T:TT
NM_000018.4(ACADVL):c.1630_1645del (p.Ala544fs)	ACADVL	A567fs, A468fs, A522fs, A544fs	not provided	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000429730	17	7127823 - 7127838	17	7224504 - 7224519	429730	422197	rs1131691553	NC_000017.11:7224503:GCCACTGTGGTGGAGG:
NM_000018.4(ACADVL):c.316_325del (p.Val106fs)	ACADVL	V106fs, V129fs, V30fs, V84fs	not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000373614	17	7124120 - 7124129	17	7220801 - 7220810	373614	360328	rs1057518506	NC_000017.11:7220800:CTGGTGGAGCCTG:CTG
NM_000018.4(ACADVL):c.1730_1740del (p.Ala577fs)	ACADVL	A555fs, A501fs, A600fs, A577fs	not provided	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000373427	17	7128010 - 7128020	17	7224691 - 7224701	373427	360331	rs1057518411	NC_000017.11:7224690:TGCCATGGTGGTG:TG
NM_000018.4(ACADVL):c.869dup (p.Ile291fs)	ACADVL		not provided	Pathogenic(Last reviewed: Sep 19, 2016)	criteria provided, single submitter	VCV000291163	17	7125607 - 7125608	17	7222288 - 7222289	291163	275400	rs886044671	NC_000017.11:7222288:GGGGG:GGGGGG
NM_000018.4(ACADVL):c.507_527del (p.Met169_Gly175del)	ACADVL		not provided	Pathogenic(Last reviewed: Sep 23, 2014)	criteria provided, single submitter	VCV000203597	17	7124877 - 7124897	17	7221558 - 7221578	203597	200321	rs796051920	NC_000017.11:7221557:CGTGGGCATGCATGACCTTGGCGTGGGCAT:CGTGGGCAT
NM_000018.4(ACADVL):c.1316dup (p.Met440fs)	ACADVL		not provided	Pathogenic(Last reviewed: Jun 13, 2014)	criteria provided, single submitter	VCV000203591	17	7127172 - 7127173	17	7223853 - 7223854	203591	200336	rs748077880	NC_000017.11:7223853:GGGGGG:GGGGGGG
NM_000018.4(ACADVL):c.210dup (p.Lys71Ter)	ACADVL		not provided	Pathogenic(Last reviewed: Sep 19, 2014)	criteria provided, single submitter	VCV000203588	17	7123927 - 7123928	17	7220608 - 7220609	203588	200316	rs796051912	NC_000017.11:7220608:T:TT
NM_000018.4(ACADVL):c.1532+1G>A	ACADVL		not provided	Pathogenic(Last reviewed: Apr 14, 2014)	criteria provided, single submitter	VCV000166646	17	7127563	17	7224244	166646	177466	rs727503794	NC_000017.11:7224243:G:A
NM_000018.4(ACADVL):c.911C>T (p.Ala304Val)	ACADVL	A282V, A327V, A228V, A304V	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 1, 2019)	no assertion criteria provided	VCV000867228	17	7126018	17	7222699	867228	857328		NC_000017.11:7222698:C:T
NM_000018.4(ACADVL):c.623-1G>A	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 17, 2018)	criteria provided, single submitter	VCV000811525	17	7125270	17	7221951	811525	800063		NC_000017.11:7221950:G:A
NM_000018.4(ACADVL):c.1194C>A (p.Tyr398Ter)	ACADVL	Y322*, Y376*, Y398*, Y421*	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000810875	17	7126974	17	7223655	810875	800066		NC_000017.11:7223654:C:A
NM_000018.4(ACADVL):c.515T>C (p.Leu172Pro)	ACADVL	L172P, L96P, L150P, L195P	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000807359	17	7124894	17	7221575	807359	798724		NC_000017.11:7221574:T:C
NM_000018.4(ACADVL):c.864del (p.Phe288fs)	ACADVL	F311fs, F212fs, F288fs, F266fs	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522433	17	7125607	17	7222288	522433	513140	rs1555528386	NC_000017.11:7222287:C:
NM_000018.4(ACADVL):c.1389dup (p.Thr464fs)	ACADVL		not provided	Pathogenic(Last reviewed: Oct 5, 2012)	criteria provided, single submitter	VCV000092275	17	7127339 - 7127340	17	7224020 - 7224021	92275	98186	rs398123082	NC_000017.11:7224020:GGGG:GGGGG
NM_000018.4(ACADVL):c.128del (p.Gly43fs)	ACADVL	G43fs, G66fs	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000857574	17	7123502	17	7220183	857574	846140		NC_000017.11:7220182:GGGGG:GGGG
NM_000018.4(ACADVL):c.565_587del (p.Ile189fs)	ACADVL	I113fs, I167fs, I212fs, I189fs	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000856881	17	7124937 - 7124959	17	7221618 - 7221640	856881	846146		NC_000017.11:7221617:CAAAGGCATCCTGCTCTTTGGCACAAAGGC:CAAAGGC
NM_000018.4(ACADVL):c.1611_1627dup (p.Phe543fs)	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000846935	17	7127798 - 7127799	17	7224479 - 7224480	846935	846163		NC_000017.11:7224479:GCAGTACGGGCTCTGGAGCAGT:GCAGTACGGGCTCTGGAGCAGTACGGGCTCTGGAGCAGT
NM_000018.4(ACADVL):c.688dup (p.Thr230fs)	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000844921	17	7125334 - 7125335	17	7222015 - 7222016	844921	846150		NC_000017.11:7222015:AA:AAA
NM_000018.4(ACADVL):c.1508del (p.Gly503fs)	ACADVL	G427fs, G481fs, G526fs, G503fs	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000839947	17	7127537	17	7224218	839947	846161		NC_000017.11:7224217:GG:G
NM_000018.4(ACADVL):c.1368dup (p.Ile457fs)	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000661308	17	7127321 - 7127322	17	7224002 - 7224003	661308	646659		NC_000017.11:7224002:C:CC
NM_000018.4(ACADVL):c.1294G>T (p.Glu432Ter)	ACADVL	E356*, E455*, E410*, E432*	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000660424	17	7127156	17	7223837	660424	646657		NC_000017.11:7223836:G:T
NM_000018.4(ACADVL):c.1064T>C (p.Ile355Thr)	ACADVL	I333T, I279T, I355T, I378T	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000657040	17	7126171	17	7222852	657040	646654		NC_000017.11:7222851:T:C
NM_000018.4(ACADVL):c.1007_1026del (p.Ile336fs)	ACADVL	I314fs, I260fs, I336fs, I359fs	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000581398	17	7126114 - 7126133	17	7222795 - 7222814	581398	569701	rs1567565643	NC_000017.11:7222794:TCCTCAACAATGGAAGGTTT:
NM_000018.4(ACADVL):c.652_682dup (p.Ile228fs)	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000581080	17	7125299 - 7125300	17	7221980 - 7221981	581080	572218	rs746860401	NC_000017.11:7221980:GAGCCCTCAAGCGGGTCAGATGCAGCCTCCA:GAGCCCTCAAGCGGGTCAGATGCAGCCTCCAGAGCCCTCAAGCGGGTCAGATGCAGCCTCCA
NM_000018.4(ACADVL):c.809del (p.Pro270fs)	ACADVL	P248fs, P194fs, P270fs, P293fs	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000572229	17	7125551	17	7222232	572229	574610	rs1567564499	NC_000017.11:7222231:CC:C
NM_000018.4(ACADVL):c.192dup (p.Pro65fs)	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000569888	17	7123830 - 7123831	17	7220511 - 7220512	569888	572212	rs771055189	NC_000017.11:7220511:AAAAAA:AAAAAAA
NM_000018.4(ACADVL):c.103_112del (p.Pro35fs)	ACADVL	P58fs, P35fs	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000541714	17	7123474 - 7123483	17	7220155 - 7220164	541714	531744	rs1329022268	NC_000017.11:7220154:GCCCGGCCCTGCCCGGC:GCCCGGC
NM_000018.4(ACADVL):c.342+1G>C	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000474896	17	7124150	17	7220831	474896	468777	rs780020193	NC_000017.11:7220830:G:C
NM_000018.4(ACADVL):c.1144A>C (p.Lys382Gln)	ACADVL	K382Q, K360Q, K306Q, K405Q	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000001628	17	7126518	17	7223199	1628	16667	rs118204015	NC_000017.11:7223198:A:C
ACADVL, 105-BP DEL	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000001621					1621	16660		
NM_000018.4(ACADVL):c.552del (p.Ile184fs)	ACADVL	I184fs, I108fs, I162fs, I207fs	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000650581	17	7124931	17	7221612	650581	646648		NC_000017.11:7221611:C:
NM_000018.4(ACADVL):c.307_323dup (p.Val109fs)	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000648624	17	7124113 - 7124114	17	7220794 - 7220795	648624	646647		NC_000017.11:7220794:AAAGAGCTGGTGGAGCC:AAAGAGCTGGTGGAGCCAAAGAGCTGGTGGAGCC
NM_000018.4(ACADVL):c.199A>T (p.Lys67Ter)	ACADVL	K67*, K90*	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000617952	17	7123843	17	7220524	617952	610100	rs765432568	NC_000017.11:7220523:A:T
NM_000018.4(ACADVL):c.1882del (p.Gln628fs)	ACADVL	Q552fs, Q606fs, Q628fs, Q651fs	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000811520	17	7128330	17	7225011	811520	800070		NC_000017.11:7225010:C:
NM_000018.4(ACADVL):c.1605+2T>C	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000656452	17	7127714	17	7224395	656452	653503		NC_000017.11:7224394:T:C
NM_000018.4(ACADVL):c.1269+1G>A	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000555644	17	7127050	17	7223731	555644	548679	rs773401248	NC_000017.11:7223730:G:A
NM_000018.4(ACADVL):c.104del (p.Pro35fs)	ACADVL	P35fs, P58fs	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000541718	17	7123480	17	7220161	541718	531746	rs1443151475	NC_000017.11:7220160:CCC:CC
NM_000018.4(ACADVL):c.339C>A (p.Phe113Leu)	ACADVL	F113L, F91L, F136L, F37L	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000474895	17	7124146	17	7220827	474895	467439	rs750653177	NC_000017.11:7220826:C:A
NM_000018.4(ACADVL):c.428_467del (p.Gly143fs)	ACADVL	G143fs, G67fs, G166fs, G121fs	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000422995	17	7124319 - 7124358	17	7221000 - 7221039	422995	410235	rs758144859	NC_000017.11:7220999:GGGCCTTTGGTCTGCAAGTGCCCAGTGAGCTGGGTGGTGTGGGCCTTTG:GGGCCTTTG
NM_000018.4(ACADVL):c.799_802del (p.Val267fs)	ACADVL	V191fs, V245fs, V267fs, V290fs	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000371635	17	7125541 - 7125544	17	7222222 - 7222225	371635	358465	rs761204548	NC_000017.11:7222221:AGTTA:A
NM_000018.4(ACADVL):c.308_309del (p.Lys103fs)	ACADVL	K81fs, K126fs, K27fs, K103fs	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371068	17	7124114 - 7124115	17	7220795 - 7220796	371068	358461	rs1057516979	NC_000017.11:7220794:AAA:A
NM_000018.4(ACADVL):c.996dup (p.Ala333fs)	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370886	17	7126101 - 7126102	17	7222782 - 7222783	370886	358470	rs1057516843	NC_000017.11:7222782:TT:TTT
NM_000018.4(ACADVL):c.65C>A (p.Ser22Ter)	ACADVL	S22*, S45*	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000166638	17	7123443	17	7220124	166638	177423	rs727503788	NC_000017.11:7220123:C:A
NM_001126108.2(SLC12A3):c.1195C>T (p.Arg399Cys)	SLC12A3	R399C, R398C	not provided|Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448391	16	56912999	16	56879087	448391	441911	rs775931992	NC_000016.10:56879086:C:T
NM_017882.3(CLN6):c.214G>T (p.Glu72Ter)	CLN6	E72*	Neuronal ceroid lipofuscinosis||Seizures|not provided	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004077	15	68506711	15	68214373	4077	19116	rs104894483	NC_000015.10:68214372:C:A
NM_000018.4(ACADVL):c.1497_1499CCT[1] (p.Leu502del)	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000854401	17	7127527 - 7127529	17	7224208 - 7224210	854401	846160		NC_000017.11:7224207:CCTCCT:CCT
NM_000018.4(ACADVL):c.266del (p.Pro89fs)	ACADVL	P89fs, P112fs, P13fs, P67fs	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Feb 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552361	17	7123982	17	7220663	552361	548310	rs771808680	NC_000017.11:7220662:CCC:CC
NM_000018.4(ACADVL):c.953C>T (p.Pro318Leu)	ACADVL	P242L, P318L, P341L, P296L	not specified|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439361	17	7126060	17	7222741	439361	433283	rs201676770	NC_000017.11:7222740:C:T
NM_000018.4(ACADVL):c.1807dup (p.Cys603fs)	ACADVL		not provided|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418698	17	7128182 - 7128183	17	7224863 - 7224864	418698	410240	rs1555529088	NC_000017.11:7224863:T:TT
NM_000018.4(ACADVL):c.1804_1805CT[1] (p.Leu602_Cys603insTer)	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000203593	17	7128180 - 7128181	17	7224861 - 7224862	203593	200343	rs796051917	NC_000017.11:7224860:CTCT:CT
NM_000018.3(ACADVL):c.1375dup	ACADVL		not provided|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000203592	17	7127327 - 7127328	17	7224008 - 7224009	203592	200339	rs796051916	NC_000017.11:7224008:CC:CCC
NM_000018.4(ACADVL):c.1372T>C (p.Phe458Leu)	ACADVL	F458L, F481L, F436L, F382L	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000001632	17	7127326	17	7224007	1632	16671	rs118204017	NC_000017.11:7224006:T:C
NM_002087.3(GRN):c.388_391del (p.Gln130fs)	GRN	Q130fs	Frontotemporal dementia|not provided|	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000016011	17	42427631 - 42427634	17	44350263 - 44350266	16011	31050	rs63749801	NC_000017.11:44350262:AGTCAGT:AGT
NM_032436.4(CHAMP1):c.1489C>T (p.Arg497Ter)	CHAMP1	R497*	Inborn genetic diseases|not provided|Mental retardation, autosomal dominant 40	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000210050	13	115090806	13	114325331	210050	206662	rs782397980	NC_000013.11:114325330:C:T
NM_024312.5(GNPTAB):c.1090C>T (p.Arg364Ter)	GNPTAB	R364*	Mucolipidosis|||Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039021	12	102164207	12	101770429	39021	47624	rs200646278	NC_000012.12:101770428:G:A
NM_000018.4(ACADVL):c.277+2T>G	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556238	17	7123997	17	7220678	556238	548628	rs1555527745	NC_000017.11:7220677:T:G
NM_000018.4(ACADVL):c.296_297CA[1] (p.Gln100fs)	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189116	17	7124102 - 7124103	17	7220783 - 7220784	189116	186983	rs786204713	NC_000017.11:7220782:ACACA:ACA
NM_000359.3(TGM1):c.944G>A (p.Arg315His)	TGM1	R315H	Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic(Last reviewed: Dec 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039530	14	24728950	14	24259744	39530	48129	rs143473912	NC_000014.9:24259743:C:T
NM_000359.3(TGM1):c.919C>T (p.Arg307Trp)	TGM1	R306W, R307W	Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012499	14	24728975	14	24259769	12499	27538	rs121918731	NC_000014.9:24259768:G:A
NM_000359.3(TGM1):c.425G>A (p.Arg142His)	TGM1	R141H, R142H	Autosomal recessive congenital ichthyosis 1|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012485	14	24730984	14	24261778	12485	27524	rs121918718	NC_000014.9:24261777:C:T
NM_015346.4(ZFYVE26):c.4359T>A (p.Cys1453Ter)	ZFYVE26	C1453*	Hereditary spastic paraplegia 15	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803037	14	68249510	14	67782793	803037	791422		NC_000014.9:67782792:A:T
NM_015346.4(ZFYVE26):c.4633G>T (p.Glu1545Ter)	ZFYVE26	E1545*	Hereditary spastic paraplegia 15	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803036	14	68246999	14	67780282	803036	791421		NC_000014.9:67780281:C:A
NM_015346.4(ZFYVE26):c.4455del (p.Trp1485fs)	ZFYVE26	W1485fs	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000595101	14	68248164	14	67781447	595101	586163	rs1566881181	NC_000014.9:67781446:CC:C
NM_015346.4(ZFYVE26):c.7060C>T (p.Gln2354Ter)	ZFYVE26	Q2354*	not provided	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000430413	14	68220856	14	67754139	430413	421990	rs1131691949	NC_000014.9:67754138:G:A
NM_015346.4(ZFYVE26):c.5694dup (p.Val1899fs)	ZFYVE26		Spastic paraplegia	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000861470	14	68234516 - 68234517	14	67767799 - 67767800	861470	841695		NC_000014.9:67767799:AAA:AAAA
NM_015346.4(ZFYVE26):c.86G>A (p.Trp29Ter)	ZFYVE26	W29*	Spastic paraplegia	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000857428	14	68282595	14	67815878	857428	841712		NC_000014.9:67815877:C:T
NM_015346.4(ZFYVE26):c.2684_2700dup (p.Arg901fs)	ZFYVE26		Spastic paraplegia	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000854216	14	68257343 - 68257344	14	67790626 - 67790627	854216	841700		NC_000014.9:67790626:CCGAATGGTGCTGCTACCCG:CCGAATGGTGCTGCTACCCGAATGGTGCTGCTACCCG
NM_015346.4(ZFYVE26):c.2083C>T (p.Gln695Ter)	ZFYVE26	Q695*	Spastic paraplegia	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000849692	14	68264896	14	67798179	849692	841703		NC_000014.9:67798178:G:A
NM_015346.4(ZFYVE26):c.4096_4099del (p.Phe1366fs)	ZFYVE26	F1366fs	Spastic paraplegia	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000848122	14	68249770 - 68249773	14	67783053 - 67783056	848122	841697		NC_000014.9:67783052:CAAACA:CA
NM_015346.4(ZFYVE26):c.3447_3466del (p.Met1149fs)	ZFYVE26	M1149fs	Spastic paraplegia	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000848097	14	68251833 - 68251852	14	67785116 - 67785135	848097	841698		NC_000014.9:67785115:AGAAGGTGCCCAAGTAGTCCA:A
NM_015346.4(ZFYVE26):c.3403C>T (p.Gln1135Ter)	ZFYVE26	Q1135*	Spastic paraplegia	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000843451	14	68251896	14	67785179	843451	841699		NC_000014.9:67785178:G:A
NM_015346.4(ZFYVE26):c.529G>T (p.Glu177Ter)	ZFYVE26	E177*	Spastic paraplegia	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000835839	14	68274472	14	67807755	835839	841710		NC_000014.9:67807754:C:A
NM_015346.4(ZFYVE26):c.5358del (p.Ser1787fs)	ZFYVE26	S1787fs	Spastic paraplegia	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000834821	14	68238890	14	67772173	834821	841696		NC_000014.9:67772172:CC:C
NC_000014.9:g.(?_67789325)_(67790783_?)del	ZFYVE26		Spastic paraplegia	Pathogenic(Last reviewed: Jun 14, 2019)	criteria provided, single submitter	VCV000833497	14	68256042 - 68257500			833497	820643		
NC_000014.9:g.(?_67813976)_(67815973_?)del	ZFYVE26		Spastic paraplegia	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000832671	14	68280693 - 68282690			832671	820645		
NC_000014.9:g.(?_67793598)_(67794249_?)del	ZFYVE26		Spastic paraplegia	Pathogenic(Last reviewed: Jul 6, 2019)	criteria provided, single submitter	VCV000830773	14	68260315 - 68260966			830773	820644		
NM_015346.4(ZFYVE26):c.231G>A (p.Trp77Ter)	ZFYVE26	W77*	Spastic paraplegia	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000656900	14	68280745	14	67814028	656900	642665		NC_000014.9:67814027:C:T
NM_015346.4(ZFYVE26):c.837T>G (p.Tyr279Ter)	ZFYVE26	Y279*	Spastic paraplegia	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000652756	14	68274164	14	67807447	652756	642664		NC_000014.9:67807446:A:C
NM_015346.4(ZFYVE26):c.4643C>G (p.Ser1548Ter)	ZFYVE26	S1548*	Spastic paraplegia	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000651290	14	68246989	14	67780272	651290	642653		NC_000014.9:67780271:G:C
NM_015346.4(ZFYVE26):c.1861C>T (p.Gln621Ter)	ZFYVE26	Q621*	Spastic paraplegia	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000650964	14	68265118	14	67798401	650964	642661		NC_000014.9:67798400:G:A
NM_015346.4(ZFYVE26):c.4862_4863AC[1] (p.His1621_Thr1622insTer)	ZFYVE26		Spastic paraplegia	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000647125	14	68244385 - 68244386	14	67777668 - 67777669	647125	642652		NC_000014.9:67777667:GTGTG:GTG
NM_015346.4(ZFYVE26):c.5426G>A (p.Trp1809Ter)	ZFYVE26	W1809*	Spastic paraplegia	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000643788	14	68238822	14	67772105	643788	642651		NC_000014.9:67772104:C:T
NM_015346.4(ZFYVE26):c.3980T>G (p.Leu1327Ter)	ZFYVE26	L1327*	Spastic paraplegia	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000641210	14	68249889	14	67783172	641210	642658		NC_000014.9:67783171:A:C
NM_015346.4(ZFYVE26):c.960G>A (p.Trp320Ter)	ZFYVE26	W320*	not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000586648	14	68273319	14	67806602	586648	577363	rs1177577061	NC_000014.9:67806601:C:T
NM_015346.4(ZFYVE26):c.1933dup (p.Met645fs)	ZFYVE26		not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000586644	14	68265045 - 68265046	14	67798328 - 67798329	586644	577362	rs1566893090	NC_000014.9:67798328:TT:TTT
NM_015346.4(ZFYVE26):c.4114_4115insGAAGGGC (p.Ala1372fs)	ZFYVE26		Spastic paraplegia	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000527985	14	68249754 - 68249755	14	67783037 - 67783038	527985	528704	rs950356390	NC_000014.9:67783037::GCCCTTC
NM_015346.4(ZFYVE26):c.4936C>T (p.Arg1646Ter)	ZFYVE26	R1646*	Spastic paraplegia	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000458286	14	68244314	14	67777597	458286	464458	rs768366199	NC_000014.9:67777596:G:A
NM_015346.4(ZFYVE26):c.5422C>T (p.Gln1808Ter)	ZFYVE26	Q1808*	Hereditary spastic paraplegia 15	Pathogenic(Last reviewed: Oct 6, 2009)	no assertion criteria provided	VCV000030933	14	68238826	14	67772109	30933	39890	rs387907057	NC_000014.9:67772108:G:A
NM_015346.4(ZFYVE26):c.5036del (p.Leu1679fs)	ZFYVE26	L1679fs	Hereditary spastic paraplegia 15	Pathogenic(Last reviewed: Oct 6, 2009)	no assertion criteria provided	VCV000030932	14	68242762	14	67776045	30932	39889		NC_000014.9:67776044:A:
NM_000080.4(CHRNE):c.1353dup (p.Asn452fs)	CHRNE		Myasthenic syndrome, congenital, 4a, slow-channel|not provided|Congenital myasthenic syndrome|Congenital myasthenic syndrome 4C	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000243032	17	4802159 - 4802160	17	4898864 - 4898865	243032	244115	rs773526895	NC_000017.11:4898864:CCCC:CCCCC
NM_015346.4(ZFYVE26):c.1792del (p.Asp598fs)	ZFYVE26	D598fs	Spastic paraplegia	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000864082	14	68265187	14	67798470	864082	841705		NC_000014.9:67798469:CC:C
NM_015346.4(ZFYVE26):c.3139+1G>A	ZFYVE26		Hereditary spastic paraplegia 15	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550192	14	68252830	14	67786113	550192	547557	rs137907310	NC_000014.9:67786112:C:T
NM_015346.4(ZFYVE26):c.6296dup (p.Asn2100fs)	ZFYVE26		Hereditary spastic paraplegia	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000424650	14	68228992 - 68228993	14	67762275 - 67762276	424650	411585	rs1555394376	NC_000014.9:67762275:A:AA
NM_015346.4(ZFYVE26):c.1477C>T (p.Gln493Ter)	ZFYVE26	Q493*	Hereditary spastic paraplegia 15	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000000752	14	68268958	14	67802241	752	15791	rs118204050	NC_000014.9:67802240:G:A
ZFYVE26, 70-BP DEL, NT6702	ZFYVE26		Hereditary spastic paraplegia 15	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000000751					751	15790		
NM_015346.4(ZFYVE26):c.5485-1G>A	ZFYVE26		Hereditary spastic paraplegia 15	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000000750	14	68236448	14	67769731	750	15789		NC_000014.9:67769730:C:T
NM_018668.4(VPS33B):c.1225+5G>C	VPS33B		Arthrogryposis, renal dysfunction, and cholestasis 1|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000088858	15	91548102	15	91004872	88858	94427	rs398122407	NC_000015.10:91004871:C:G
NM_015346.4(ZFYVE26):c.5485-1del	ZFYVE26		not provided|Spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000241051	14	68236448	14	67769731	241051	241869	rs878855013	NC_000014.9:67769730:C:
NM_015346.4(ZFYVE26):c.3373del (p.His1125fs)	ZFYVE26	H1125fs	not provided|Spastic paraplegia	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000241048	14	68251926	14	67785209	241048	241872	rs878855011	NC_000014.9:67785208:GGG:GG
NM_015346.4(ZFYVE26):c.592C>T (p.Arg198Ter)	ZFYVE26	R198*	Spastic paraplegia|Hereditary spastic paraplegia 15	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556397	14	68274409	14	67807692	556397	547356	rs200832994	NC_000014.9:67807691:G:A
NM_015346.4(ZFYVE26):c.4804C>T (p.Arg1602Ter)	ZFYVE26	R1602*	Hereditary spastic paraplegia 15|Spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550774	14	68244446	14	67777729	550774	547530	rs558285072	NC_000014.9:67777728:G:A
NM_000018.4(ACADVL):c.644_647del (p.Phe214_Cys215insTer)	ACADVL		not provided|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370717	17	7125289 - 7125292	17	7221970 - 7221973	370717	358464	rs1057516714	NC_000017.11:7221969:TCTGTCT:TCT
NM_000018.4(ACADVL):c.1357C>T (p.Arg453Ter)	ACADVL	R453*, R431*, R476*, R377*	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000194317	17	7127311	17	7223992	194317	191480	rs794727113	NC_000017.11:7223991:C:T
NM_000018.4(ACADVL):c.1406G>A (p.Arg469Gln)	ACADVL	R469Q, R393Q, R492Q, R447Q	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 25, 2015)	criteria provided, multiple submitters, no conflicts	VCV000092276	17	7127360	17	7224041	92276	98187	rs398123083	NC_000017.11:7224040:G:A
NM_000018.4(ACADVL):c.1246G>A (p.Ala416Thr)	ACADVL	A416T, A340T, A394T, A439T	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001633	17	7127026	17	7223707	1633	16672	rs118204018	NC_000017.11:7223706:G:A
NM_015346.4(ZFYVE26):c.4132C>T (p.Arg1378Ter)	ZFYVE26	R1378*	Hereditary spastic paraplegia 15|Spastic paraplegia	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000458283	14	68249737	14	67783020	458283	464463	rs774809466	NC_000014.9:67783019:G:A
NM_015346.4(ZFYVE26):c.7041C>A (p.Cys2347Ter)	ZFYVE26	C2347*	not provided|Hereditary spastic paraplegia 15|Spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000424005	14	68220875	14	67754158	424005	409145	rs370837940	NC_000014.9:67754157:G:T
NM_052845.4(MMAB):c.571C>T (p.Arg191Trp)	MMAB	R191W	not provided|Vitamin B12-responsive methylmalonic acidemia type cblB	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000218324	12	109998858	12	109561053	218324	215031	rs376128990	NC_000012.12:109561052:G:A
NM_002834.5(PTPN11):c.328G>A (p.Glu110Lys)	PTPN11	E110K, E109K	not provided|Rasopathy|Noonan syndrome|Noonan syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040507	12	112888312	12	112450508	40507	48977	rs397507518	NC_000012.12:112450507:G:A
NM_000153.4(GALC):c.908C>T (p.Ser303Phe)	GALC	S303F, S277F, S280F	not provided|Galactosylceramide beta-galactosidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280957	14	88434679	14	87968335	280957	265194	rs756352952	NC_000014.9:87968334:G:A
NM_000153.4(GALC):c.1592G>A (p.Arg531His)	GALC	R531H, R505H, R508H	Galactosylceramide beta-galactosidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167119	14	88411975	14	87945631	167119	177147	rs200378205	NC_000014.9:87945630:C:T
NM_025099.6(CTC1):c.2951_2953GTT[1] (p.Cys985del)	CTC1	C985del	Cerebroretinal microangiopathy with calcifications and cysts|Cerebroretinal microangiopathy with calcifications and cysts 1|Dyskeratosis congenita	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040250	17	8133264 - 8133266	17	8229946 - 8229948	40250	48734	rs199473679	NC_000017.11:8229945:AACAACAA:AACAA
NM_000086.2(CLN3):c.883G>A (p.Glu295Lys)	CLN3	E295K, E195K, E217K, E271K, E241K	Neuronal ceroid lipofuscinosis|Juvenile neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis, neuronal, 3, protracted|Retinal dystrophy	Pathogenic(Last reviewed: Aug 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003556	16	28493821	16	28482500	3556	18595	rs121434286	NC_000016.10:28482499:C:T
NM_015346.4(ZFYVE26):c.2450del (p.Leu817fs)	ZFYVE26	L817fs	Spastic paraplegia|not provided|Hereditary spastic paraplegia 15	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000430412	14	68260428	14	67793711	430412	421991	rs768176054	NC_000014.9:67793710:AA:A
NM_015346.4(ZFYVE26):c.4181G>A (p.Trp1394Ter)	ZFYVE26	W1394*	Spastic paraplegia|Hereditary spastic paraplegia 15	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000209210	14	68249688	14	67782971	209210	205775	rs370828455	NC_000014.9:67782970:C:T
NM_002755.3(MAP2K1):c.171G>T (p.Lys57Asn)	MAP2K1	K57N	Cutaneous melanoma|Non-small cell lung cancer|Cardio-facio-cutaneous syndrome|Lung adenocarcinoma	Pathogenic/Likely pathogenic(Last reviewed: Mar 3, 2016)	no assertion criteria provided	VCV000223140	15	66727455	15	66435117	223140	224866	rs869025608	NC_000015.10:66435116:G:T
NM_000018.4(ACADVL):c.1468G>C (p.Ala490Pro)	ACADVL	A490P, A513P, A414P, A468P	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000474888	17	7127498	17	7224179	474888	469035	rs759775666	NC_000017.11:7224178:G:C
NM_000018.4(ACADVL):c.1077_1077+1delinsCAC	ACADVL		not provided|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370686	17	7126184 - 7126185	17	7222865 - 7222866	370686	358471	rs1057516686	NC_000017.11:7222864:GG:CAC
NM_000020.3(ACVRL1):c.1331dup (p.Asp445fs)	ACVRL1			Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000836330	12	52312852 - 52312853	12	51919068 - 51919069	836330	840075		NC_000012.12:51919068:T:TT
NM_000020.2(ACVRL1):c.1135G>A (p.Glu379Lys)	ACVRL1	E379K	not provided|	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429940	12	52309906	12	51916122	429940	421939	rs1131691686	NC_000012.12:51916121:G:A
NM_000020.2(ACVRL1):c.1436G>A (p.Arg479Gln)	ACVRL1	R479Q	Primary pulmonary hypertension|	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426035	12	52314601	12	51920817	426035	414406	rs1085307426	NC_000012.12:51920816:G:A
NM_015346.4(ZFYVE26):c.4312C>T (p.Arg1438Ter)	ZFYVE26	R1438*	Hereditary spastic paraplegia 15|Spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000749	14	68249557	14	67782840	749	15788	rs118204049	NC_000014.9:67782839:G:A
NM_000303.3(PMM2):c.255+2T>C	PMM2		Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000321216	16	8898702	16	8804845	321216	326612	rs139716296	NC_000016.10:8804844:T:C
NM_024306.5(FA2H):c.443C>T (p.Pro148Leu)	FA2H	P148L	Spastic paraplegia|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000406877	16	74761205	16	74727307	406877	401348	rs372350326	NC_000016.10:74727306:G:A
NM_001297.5(CNGB1):c.413-1G>A	CNGB1		Retinal dystrophy|Retinitis pigmentosa 45|not provided|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000437976	16	57996515	16	57962611	437976	431798	rs189234741	NC_000016.10:57962610:C:T
NM_001145358.2(SIN3A):c.1657C>T (p.Arg553Ter)	SIN3A	R553*	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000520687	15	75693151	15	75400810	520687	512154	rs1555444885	NC_000015.10:75400809:G:A
NM_004004.6(GJB2):c.148G>A (p.Asp50Asn)	GJB2	D50N	not provided|Hystrix-like ichthyosis with deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Hearing loss	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, multiple submitters, no conflicts	VCV000017020	13	20763573	13	20189434	17020	32059	rs28931594	NC_000013.11:20189433:C:T
NM_000018.4(ACADVL):c.1077+1G>A	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448981	17	7126185	17	7222866	448981	445885	rs140989450	NC_000017.11:7222865:G:A
NM_000018.4(ACADVL):c.385_387GAG[1] (p.Glu130del)	ACADVL	E130del	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001626	17	7124284 - 7124286	17	7220965 - 7220967	1626	16665	rs387906251	NC_000017.11:7220964:GGAGGAG:GGAG
NM_001127464.2(ZNF469):c.10248delG (p.Arg3417Glyfs)	ZNF469	R3445fs	not provided	Pathogenic(Last reviewed: Nov 30, 2015)	criteria provided, single submitter	VCV000265492	16	88504203	16	88437795	265492	260134	rs764470052	NC_000016.10:88437794:GGGGGGGG:GGGGGGG
NM_001367624.1(ZNF469):c.9268C>T (p.Arg3090Ter)	ZNF469	R3062*, R3090*	not provided	Pathogenic(Last reviewed: Jun 8, 2015)	criteria provided, single submitter	VCV000195115	16	88503146	16	88436738	195115	192276	rs764139968	NC_000016.10:88436737:C:T
NM_001367624.1(ZNF469):c.5681A>T (p.Gln1894Leu)	ZNF469	Q1866L, Q1894L	Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126944	16	88499559	16	88433151	126944	132457	rs281865150	NC_000016.10:88433150:A:T
NM_001367624.1(ZNF469):c.337G>A (p.Glu113Lys)	ZNF469	E113K	Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126942	16	88494215	16	88427807	126942	132455	rs281865144	NC_000016.10:88427806:G:A
NM_001127464.2(ZNF469):c.2904_2909delGTCGGG (p.Ser969_Gly970del)	ZNF469		Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126940	16	88496773 - 88496778	16	88430365 - 88430370	126940	132453	rs281865147	NC_000016.10:88430364:GGGGTCGGGGTCGGG:GGGGTCGGG
NM_001367624.1(ZNF469):c.2699C>G (p.Pro900Arg)	ZNF469	P900R	Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126939	16	88496577	16	88430169	126939	132452	rs273585618	NC_000016.10:88430168:C:G
NM_001367624.1(ZNF469):c.2063C>A (p.Thr688Asn)	ZNF469	T688N	Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126938	16	88495941	16	88429533	126938	132451	rs281865146	NC_000016.10:88429532:C:A
NM_001367624.1(ZNF469):c.8996G>T (p.Gly2999Val)	ZNF469	G2971V, G2999V	Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126932	16	88502874	16	88436466	126932	132445	rs273585625	NC_000016.10:88436465:G:T
NM_001367624.1(ZNF469):c.77G>C (p.Ser26Thr)	ZNF469	S26T	Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126931	16	88493955	16	88427547	126931	132444	rs273585616	NC_000016.10:88427546:G:C
NM_001367624.1(ZNF469):c.6809C>A (p.Ser2270Tyr)	ZNF469	S2242Y, S2270Y	Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126929	16	88500687	16	88434279	126929	132442	rs273585624	NC_000016.10:88434278:C:A
NM_001367624.1(ZNF469):c.6179C>A (p.Ser2060Tyr)	ZNF469	S2032Y, S2060Y	Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126928	16	88500057	16	88433649	126928	132441	rs273585623	NC_000016.10:88433648:C:A
NM_001367624.1(ZNF469):c.4447G>T (p.Ala1483Ser)	ZNF469	A1455S, A1483S	Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126925	16	88498325	16	88431917	126925	132438	rs273585620	NC_000016.10:88431916:G:T
NM_001367624.1(ZNF469):c.3119A>C (p.Lys1040Thr)	ZNF469	K1040T	Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126924	16	88496997	16	88430589	126924	132437	rs273585619	NC_000016.10:88430588:A:C
NM_001367624.1(ZNF469):c.290C>T (p.Pro97Leu)	ZNF469	P97L	Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126923	16	88494168	16	88427760	126923	132436	rs273585617	NC_000016.10:88427759:C:T
NM_001367624.1(ZNF469):c.11699C>T (p.Pro3900Leu)	ZNF469	P3872L, P3900L	Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126919	16	88505577	16	88439169	126919	132432	rs273585630	NC_000016.10:88439168:C:T
NM_001367624.1(ZNF469):c.11185G>A (p.Gly3729Ser)	ZNF469	G3701S, G3729S	Keratoconus 1	Pathogenic	no assertion criteria provided	VCV000126918	16	88505063	16	88438655	126918	132431	rs273585629	NC_000016.10:88438654:G:A
NM_001367624.1(ZNF469):c.6444del (p.Gln2149fs)	ZNF469	Q2149fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000291239	16	88500316	16	88433908	291239	275476	rs886044697	NC_000016.10:88433907:GGGGGGG:GGGGGG
NM_001127464.2(ZNF469):c.7554del (p.Ser2519Alafs)	ZNF469	S2547fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265490	16	88501513	16	88435105	265490	260133	rs886039575	NC_000016.10:88435104:CCCC:CCC
NM_001367624.1(ZNF469):c.4258G>T (p.Glu1420Ter)	ZNF469	E1392*, E1420*	Brittle cornea syndrome 1	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000030943	16	88498136	16	88431728	30943	39900	rs387907063	NC_000016.10:88431727:G:T
ZNF469, 1-BP DEL, 9527G	ZNF469		Brittle cornea syndrome 1	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000731					731	15770		
NM_001367624.1(ZNF469):c.10100G>A (p.Cys3367Tyr)	ZNF469	C3339Y, C3367Y	Brittle cornea syndrome 1	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000030942	16	88503978	16	88437570	30942	39899	rs387907062	NC_000016.10:88437569:G:A
NG_012236.2:g.11027del	ZNF469	G2011fs	Brittle cornea syndrome 1	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000730	16	88499905	16	88433497	730	15769		NC_000016.10:88433496:A:
NM_004119.2(FLT3):c.2504A>T (p.Asp835Val)	FLT3	D835V	Acute myeloid leukemia|Acute lymphoid leukemia	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000016272	13	28592641	13	28018504	16272	31311	rs121909646	NC_000013.11:28018503:T:A
NM_005249.5(FOXG1):c.460dup (p.Glu154fs)	FOXG1		Rett syndrome, congenital variant|History of neurodevelopmental disorder|not provided	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095268	14	29236938 - 29236939	14	28767732 - 28767733	95268	101167	rs398124204	NC_000014.9:28767732:GGGGGGG:GGGGGGGG
NM_004448.3(ERBB2):c.2305G>T (p.Asp769Tyr)	ERBB2	D739Y, D754Y, D769Y	Uterine cervical neoplasms|Neoplasm of the breast|Adenocarcinoma of stomach|Carcinoma of esophagus|Transitional cell carcinoma of the bladder	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375992	17	37880261	17	39724008	375992	362871	rs121913468	NC_000017.11:39724007:G:T
NM_004937.3(CTNS):c.1015G>A (p.Gly339Arg)	CTNS	G339R	Juvenile nephropathic cystinosis|Ocular cystinosis|Nephropathic cystinosis|Nephropathic cystinosis	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004455	17	3563574	17	3660280	4455	19494	rs121908127	NC_000017.11:3660279:G:A
NM_004937.3(CTNS):c.414G>A (p.Trp138Ter)	CTNS	W138*	Juvenile nephropathic cystinosis|Ocular cystinosis|Nephropathic cystinosis|not provided|Nephropathic cystinosis	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004443	17	3558599	17	3655305	4443	19482	rs113994205	NC_000017.11:3655304:G:A
NM_013275.6(ANKRD11):c.1477_1478del (p.Arg493fs)	ANKRD11	R493fs	not provided	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000818017	16	89351472 - 89351473	16	89285064 - 89285065	818017	805918		NC_000016.10:89285063:CT:
NM_013275.6(ANKRD11):c.6031_6041del (p.Ser2011fs)	ANKRD11	S2011fs	not provided	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000817986	16	89346909 - 89346919	16	89280501 - 89280511	817986	805903		NC_000016.10:89280500:GGCGCCTCCGAGGCGC:GGCGC
NM_013275.6(ANKRD11):c.2810del (p.Lys937fs)	ANKRD11	K937fs	not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000817956	16	89350140	16	89283732	817956	805915		NC_000016.10:89283731:TTTT:TTT
NM_013275.6(ANKRD11):c.4947_4948dup (p.Lys1650fs)	ANKRD11		not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000817940	16	89348001 - 89348002	16	89281593 - 89281594	817940	805908		NC_000016.10:89281593:TA:TATA
NM_013275.6(ANKRD11):c.5105dup (p.Val1703fs)	ANKRD11		not provided	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000817892	16	89347844 - 89347845	16	89281436 - 89281437	817892	805907		NC_000016.10:89281436:CC:CCC
NM_013275.6(ANKRD11):c.3562_3563insA (p.Arg1188fs)	ANKRD11		not provided	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000817747	16	89349387 - 89349388	16	89282979 - 89282980	817747	805911		NC_000016.10:89282979::T
NM_013275.6(ANKRD11):c.6165del (p.Tyr2056fs)	ANKRD11	Y2056fs	not provided	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000817722	16	89346785	16	89280377	817722	805901		NC_000016.10:89280376:GGG:GG
NM_013275.6(ANKRD11):c.4383_4384GA[3] (p.Lys1464fs)	ANKRD11		not provided	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000817640	16	89348560 - 89348561	16	89282152 - 89282153	817640	805909		NC_000016.10:89282151:TCTCTCTCT:TCTCTCT
NM_013275.6(ANKRD11):c.2944G>T (p.Glu982Ter)	ANKRD11	E982*	not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000817545	16	89350006	16	89283598	817545	805914		NC_000016.10:89283597:C:A
NM_013275.6(ANKRD11):c.5552_5556del (p.Tyr1851fs)	ANKRD11	Y1851fs	not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000817470	16	89347394 - 89347398	16	89280986 - 89280990	817470	805906		NC_000016.10:89280985:GGAGT:
NM_013275.6(ANKRD11):c.3306_3309del (p.Lys1103fs)	ANKRD11	K1103fs	not provided	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000817421	16	89349641 - 89349644	16	89283233 - 89283236	817421	805912		NC_000016.10:89283232:TTTTTTTT:TTTT
NM_013275.6(ANKRD11):c.6067_6081delinsCC (p.Ala2023fs)	ANKRD11		not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000817384	16	89346869 - 89346883	16	89280461 - 89280475	817384	805902		NC_000016.10:89280460:CAGAGCGTACGGGGC:GG
NM_013275.6(ANKRD11):c.7114dup (p.Arg2372fs)	ANKRD11		not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000817353	16	89345835 - 89345836	16	89279427 - 89279428	817353	805899		NC_000016.10:89279427:GGG:GGGG
NM_013275.6(ANKRD11):c.1686del (p.Ser563fs)	ANKRD11	S563fs	not provided	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000817347	16	89351264	16	89284856	817347	805917		NC_000016.10:89284855:G:
NM_013275.6(ANKRD11):c.2536del (p.Ser846fs)	ANKRD11	S846fs	not provided	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000817227	16	89350414	16	89284006	817227	805916		NC_000016.10:89284005:A:
NM_013275.6(ANKRD11):c.6684_6685AG[2] (p.Arg2230fs)	ANKRD11		not provided	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000817165	16	89346261 - 89346262	16	89279853 - 89279854	817165	805900		NC_000016.10:89279852:CTCTCT:CTCT
NM_013275.6(ANKRD11):c.3122C>G (p.Ser1041Ter)	ANKRD11	S1041*	not provided	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000816977	16	89349828	16	89283420	816977	805913		NC_000016.10:89283419:G:C
NM_013275.6(ANKRD11):c.424C>T (p.Gln142Ter)	ANKRD11	Q142*	not provided	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000620520	16	89357210	16	89290802	620520	611837	rs1567592494	NC_000016.10:89290801:G:A
NM_013275.6(ANKRD11):c.7711C>T (p.Gln2571Ter)	ANKRD11	Q2571*	not provided	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000620440	16	89341224	16	89274816	620440	611832	rs1567543920	NC_000016.10:89274815:G:A
NM_013275.6(ANKRD11):c.1996C>T (p.Gln666Ter)	ANKRD11	Q666*	not provided	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000620316	16	89350954	16	89284546	620316	611836	rs747922528	NC_000016.10:89284545:G:A
NM_013275.6(ANKRD11):c.2692C>T (p.Arg898Ter)	ANKRD11	R898*	not provided	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000620276	16	89350258	16	89283850	620276	611834	rs780011005	NC_000016.10:89283849:G:A
NM_013275.6(ANKRD11):c.2283C>G (p.Tyr761Ter)	ANKRD11	Y761*	not provided	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000620269	16	89350667	16	89284259	620269	611835	rs1567578243	NC_000016.10:89284258:G:C
NM_013275.6(ANKRD11):c.7183C>T (p.Gln2395Ter)	ANKRD11	Q2395*	not provided	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000546380	16	89345767	16	89279359	546380	536919	rs1250598768	NC_000016.10:89279358:G:A
NM_013275.6(ANKRD11):c.160C>T (p.Arg54Ter)	ANKRD11	R54*	not provided	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000546032	16	89371680	16	89305272	546032	536480	rs749607205	NC_000016.10:89305271:G:A
NM_013275.6(ANKRD11):c.6677_6680delinsAGA (p.Val2226fs)	ANKRD11		not provided	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000545923	16	89346270 - 89346273	16	89279862 - 89279865	545923	536478	rs1555525476	NC_000016.10:89279861:GGCA:TCT
NM_013275.6(ANKRD11):c.6624_6625del (p.Glu2210fs)	ANKRD11	E2210fs	not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000545919	16	89346325 - 89346326	16	89279917 - 89279918	545919	536479	rs1555525517	NC_000016.10:89279916:CT:
NM_013275.6(ANKRD11):c.6340C>T (p.Gln2114Ter)	ANKRD11	Q2114*	not provided	Pathogenic(Last reviewed: Nov 8, 2016)	no assertion criteria provided	VCV000545049	16	89346610	16	89280202	545049	535332	rs1555525792	NC_000016.10:89280201:G:A
NM_013275.6(ANKRD11):c.3704_3707del (p.Lys1235fs)	ANKRD11	K1235fs	not provided	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000523956	16	89349243 - 89349246	16	89282835 - 89282838	523956	514705	rs1555528354	NC_000016.10:89282834:TGTTT:T
NM_013275.6(ANKRD11):c.6430C>T (p.Gln2144Ter)	ANKRD11	Q2144*	not provided	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000504351	16	89346520	16	89280112	504351	495654	rs1555525685	NC_000016.10:89280111:G:A
NM_013275.6(ANKRD11):c.6513del (p.Val2173fs)	ANKRD11	V2173fs	not provided	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000504035	16	89346437	16	89280029	504035	495645	rs1555525603	NC_000016.10:89280028:GGGGG:GGGG
NM_013275.6(ANKRD11):c.488_501del (p.Lys163fs)	ANKRD11	K163fs	not provided	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000503996	16	89357133 - 89357146	16	89290725 - 89290738	503996	495648	rs1555531390	NC_000016.10:89290724:ACGCTCGTTTCTCT:
NM_013275.6(ANKRD11):c.1124_1128del (p.Thr375fs)	ANKRD11	T375fs	not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000503970	16	89351822 - 89351826	16	89285414 - 89285418	503970	495656	rs1555529864	NC_000016.10:89285413:TTTCGTTTC:TTTC
NM_013275.6(ANKRD11):c.3084del (p.Arg1027_Tyr1028insTer)	ANKRD11		not provided	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000503961	16	89349866	16	89283458	503961	495810	rs1555528719	NC_000016.10:89283457:G:
NM_013275.6(ANKRD11):c.6834_6835TG[1] (p.Val2279fs)	ANKRD11		not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000503853	16	89346113 - 89346114	16	89279705 - 89279706	503853	495651	rs1555525296	NC_000016.10:89279704:CACA:CA
NM_013275.6(ANKRD11):c.4087C>T (p.Arg1363Ter)	ANKRD11	R1363*	not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000488985	16	89348863	16	89282455	488985	482111	rs1364690005	NC_000016.10:89282454:G:A
NM_013275.6(ANKRD11):c.3096del (p.Ser1033fs)	ANKRD11	S1033fs	not provided	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000452988	16	89349854	16	89283446	452988	445674	rs1555528717	NC_000016.10:89283445:GG:G
NM_013275.6(ANKRD11):c.4875del (p.Lys1625fs)	ANKRD11	K1625fs	not provided	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000452532	16	89348075	16	89281667	452532	445672	rs1555527511	NC_000016.10:89281666:C:
NM_013275.6(ANKRD11):c.6249del (p.Ala2084fs)	ANKRD11	A2084fs	not provided	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000451702	16	89346701	16	89280293	451702	445670	rs1555525917	NC_000016.10:89280292:GGG:GG
NM_013275.6(ANKRD11):c.6138del (p.Ala2047fs)	ANKRD11	A2047fs	not provided	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000451268	16	89346812	16	89280404	451268	445671	rs1555526086	NC_000016.10:89280403:GG:G
NM_013275.6(ANKRD11):c.7471-2A>G	ANKRD11		not provided	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000451073	16	89341601	16	89275193	451073	445666	rs1555523580	NC_000016.10:89275192:T:C
NM_013275.6(ANKRD11):c.769G>T (p.Gly257Ter)	ANKRD11	G257*	not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000450131	16	89352570	16	89286162	450131	445677	rs1555530173	NC_000016.10:89286161:C:A
NM_013275.6(ANKRD11):c.1970_1971del (p.Phe657fs)	ANKRD11	F657fs	not provided	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000432651	16	89350979 - 89350980	16	89284571 - 89284572	432651	426194	rs1555529364	NC_000016.10:89284570:AAAA:AA
NM_013275.6(ANKRD11):c.7354C>G (p.Arg2452Gly)	ANKRD11	R2452G	not provided	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000429712	16	89345596	16	89279188	429712	422127	rs1064795497	NC_000016.10:89279187:G:C
NM_013275.6(ANKRD11):c.4205dup (p.Tyr1402Ter)	ANKRD11		not provided	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000426290	16	89348744 - 89348745	16	89282336 - 89282337	426290	415526	rs1085307544	NC_000016.10:89282336:T:TT
NM_013275.6(ANKRD11):c.4933del (p.Leu1645fs)	ANKRD11	L1645fs	not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000424582	16	89348017	16	89281609	424582	409794	rs1064797050	NC_000016.10:89281608:G:
NM_013275.6(ANKRD11):c.6871G>T (p.Glu2291Ter)	ANKRD11	E2291*	not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000424512	16	89346079	16	89279671	424512	409793	rs1064797012	NC_000016.10:89279670:C:A
NM_013275.6(ANKRD11):c.3309del (p.Asp1104fs)	ANKRD11	D1104fs	not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000424134	16	89349641	16	89283233	424134	409795	rs772267579	NC_000016.10:89283232:TTTTTTTT:TTTTTTT
NM_013275.6(ANKRD11):c.600_601dup (p.Gly201fs)	ANKRD11		not provided	Pathogenic(Last reviewed: Jun 19, 2015)	criteria provided, single submitter	VCV000419315	16	89357032 - 89357033	16	89290624 - 89290625	419315	409799	rs1555531314	NC_000016.10:89290624:CT:CTCT
NM_013275.6(ANKRD11):c.2857del (p.Asp953fs)	ANKRD11	D953fs	not provided	Pathogenic(Last reviewed: Jun 1, 2015)	criteria provided, single submitter	VCV000419036	16	89350093	16	89283685	419036	409798	rs1064793599	NC_000016.10:89283684:CC:C
GRCh37/hg19 16q24.3(chr16:89434509-89490401)x1	ANKRD11		See cases	Pathogenic	no assertion criteria provided	VCV000396901	16	89434509 - 89490401			396901	383794		
GRCh37/hg19 16q24.3(chr16:89539973-89570635)x1	ANKRD11		See cases	Pathogenic	no assertion criteria provided	VCV000396573	16	89539973 - 89570635			396573	383466		
GRCh37/hg19 16q24.3(chr16:89296939-89420254)x1	ANKRD11		See cases	Pathogenic	no assertion criteria provided	VCV000396473	16	89296939 - 89420254			396473	383366		
NM_013275.6(ANKRD11):c.7570-1G>A	ANKRD11		not provided	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000379890	16	89341366	16	89274958	379890	375629	rs863223319	NC_000016.10:89274957:C:T
NM_013275.6(ANKRD11):c.7138C>T (p.Gln2380Ter)	ANKRD11	Q2380*	not provided	Pathogenic(Last reviewed: Apr 4, 2015)	criteria provided, single submitter	VCV000379306	16	89345812	16	89279404	379306	377926	rs1057520565	NC_000016.10:89279403:G:A
NM_013275.6(ANKRD11):c.1197_1200AAAG[1] (p.Lys401fs)	ANKRD11		not provided	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000280911	16	89351746 - 89351749	16	89285338 - 89285341	280911	264837	rs886042029	NC_000016.10:89285337:CTTTCTTT:CTTT
NM_013275.6(ANKRD11):c.7234C>T (p.Gln2412Ter)	ANKRD11	Q2412*	not provided	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000280900	16	89345716	16	89279308	280900	264982	rs886042019	NC_000016.10:89279307:G:A
NM_013275.6(ANKRD11):c.5667del (p.Lys1889fs)	ANKRD11	K1889fs	not provided	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000280893	16	89347283	16	89280875	280893	264985	rs886042016	NC_000016.10:89280874:TTTT:TTT
NM_013275.6(ANKRD11):c.7714-2A>G	ANKRD11		not provided	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000280842	16	89337319	16	89270911	280842	264653	rs886041976	NC_000016.10:89270910:T:C
NM_013275.6(ANKRD11):c.7062del (p.Ser2355fs)	ANKRD11	S2355fs	not provided	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000280801	16	89345888	16	89279480	280801	264983	rs886041942	NC_000016.10:89279479:GGGGGG:GGGGG
NM_013275.6(ANKRD11):c.7552C>T (p.Gln2518Ter)	ANKRD11	Q2518*	not provided	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000280739	16	89341518	16	89275110	280739	264735	rs886041889	NC_000016.10:89275109:G:A
NM_013275.6(ANKRD11):c.4372_4375del (p.Glu1458fs)	ANKRD11	E1458fs	not provided	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000280663	16	89348575 - 89348578	16	89282167 - 89282170	280663	264658	rs886041829	NC_000016.10:89282166:TCTCT:T
NM_013275.6(ANKRD11):c.7083dup (p.Thr2362fs)	ANKRD11		not provided	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000280655	16	89345866 - 89345867	16	89279458 - 89279459	280655	264655	rs886041822	NC_000016.10:89279458:GGGGG:GGGGGG
NM_013275.6(ANKRD11):c.2329G>T (p.Glu777Ter)	ANKRD11	E777*	not provided	Pathogenic(Last reviewed: May 9, 2016)	criteria provided, single submitter	VCV000280583	16	89350621	16	89284213	280583	264830	rs886041760	NC_000016.10:89284212:C:A
NM_013275.6(ANKRD11):c.2589dup (p.Asp864fs)	ANKRD11		not provided	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000280537	16	89350360 - 89350361	16	89283952 - 89283953	280537	264826	rs886041724	NC_000016.10:89283952:T:TT
NM_013275.6(ANKRD11):c.5790C>G (p.Tyr1930Ter)	ANKRD11	Y1930*	not provided	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000280353	16	89347160	16	89280752	280353	264738	rs886041574	NC_000016.10:89280751:G:C
NM_013275.6(ANKRD11):c.2719_2730delinsT (p.Arg906_Lys907insTer)	ANKRD11		not provided	Pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, single submitter	VCV000280310	16	89350220 - 89350231	16	89283812 - 89283823	280310	264986	rs886041539	NC_000016.10:89283811:CCTGTCCTTCTT:A
NM_013275.6(ANKRD11):c.2500del (p.Ser834fs)	ANKRD11	S834fs	not provided	Pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	VCV000280247	16	89350450	16	89284042	280247	264661	rs886041486	NC_000016.10:89284041:AAA:AA
NM_013275.6(ANKRD11):c.1801C>T (p.Arg601Ter)	ANKRD11	R601*	not provided	Pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	VCV000280209	16	89351149	16	89284741	280209	264988	rs772229371	NC_000016.10:89284740:G:A
NM_013275.6(ANKRD11):c.1652G>A (p.Trp551Ter)	ANKRD11	W551*	not provided	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000265665	16	89351298	16	89284890	265665	260141	rs886039713	NC_000016.10:89284889:C:T
NM_013275.6(ANKRD11):c.2704G>T (p.Glu902Ter)	ANKRD11	E902*	KBG syndrome	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000807372	16	89350246	16	89283838	807372	798708		NC_000016.10:89283837:C:A
NM_013275.6(ANKRD11):c.2716C>T (p.Arg906Ter)	ANKRD11	R906*	KBG syndrome	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000807371	16	89350234	16	89283826	807371	798707		NC_000016.10:89283825:G:A
NM_013275.6(ANKRD11):c.6805_6806TG[1] (p.Ala2270fs)	ANKRD11		KBG syndrome	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000807370	16	89346142 - 89346143	16	89279734 - 89279735	807370	798706		NC_000016.10:89279733:CACA:CA
NM_013275.6(ANKRD11):c.3425_3431delinsTCCGTCCTG (p.Asp1142fs)	ANKRD11		not provided	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000633514	16	89349519 - 89349525	16	89283111 - 89283117	633514	621982	rs1567573538	NC_000016.10:89283110:GGCAAGT:CAGGACGGA
NM_013275.6(ANKRD11):c.6982dup (p.Arg2328fs)	ANKRD11		not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000450818	16	89345967 - 89345968	16	89279559 - 89279560	450818	445668	rs1555525088	NC_000016.10:89279559:GGGGGG:GGGGGGG
NM_013275.6(ANKRD11):c.5504del (p.Leu1835fs)	ANKRD11	L1835fs	KBG syndrome	Pathogenic	no assertion criteria provided	VCV000375614	16	89347446	16	89281038	375614	362428	rs1057519399	NC_000016.10:89281037:A:
NM_013275.6(ANKRD11):c.3122C>A (p.Ser1041Ter)	ANKRD11	S1041*	KBG syndrome	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374273	16	89349828	16	89283420	374273	361224	rs1057518663	NC_000016.10:89283419:G:T
NM_001256182:c.7545delG	ANKRD11		KBG syndrome	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000246603					246603	245211		
NM_013275.6(ANKRD11):c.5317G>T (p.Glu1773Ter)	ANKRD11	E1773*	Astigmatism|Esotropia|Retrognathia|Intellectual disability|Wide nasal bridge|Hypermetropia|Hypertelorism|Cryptorchidism|Epicanthus|Global developmental delay	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242882	16	89347633	16	89281225	242882	243994	rs1114167291	NC_000016.10:89281224:C:A
NM_013275.6(ANKRD11):c.6792del (p.Ala2265fs)	ANKRD11	A2265fs	KBG syndrome	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000242348	16	89346158	16	89279750	242348	243899	rs878855327	NC_000016.10:89279749:GGGGGGG:GGGGGG
NM_013275.6(ANKRD11):c.6472G>T (p.Glu2158Ter)	ANKRD11	E2158*	KBG syndrome	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000224159	16	89346478	16	89280070	224159	225887	rs869312713	NC_000016.10:89280069:C:A
NM_013275.6(ANKRD11):c.3933_3945del (p.Gly1312_Gln1313insTer)	ANKRD11		KBG syndrome	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000857946	16	89349005 - 89349017	16	89282597 - 89282609	857946	844496		NC_000016.10:89282596:CGGCTCCTGCCCTCGG:CGG
NM_013275.6(ANKRD11):c.3219_3220del (p.Asp1073fs)	ANKRD11	D1073fs	KBG syndrome	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000838272	16	89349730 - 89349731	16	89283322 - 89283323	838272	844497		NC_000016.10:89283321:TGT:T
NM_013275.6(ANKRD11):c.4270del (p.Ser1424fs)	ANKRD11	S1424fs	KBG syndrome	Pathogenic	criteria provided, single submitter	VCV000694706	16	89348680	16	89282272	694706	682827		NC_000016.10:89282271:AAAA:AAA
NM_013275.6(ANKRD11):c.2824_2825AG[1] (p.Arg942fs)	ANKRD11		KBG syndrome	Pathogenic	criteria provided, single submitter	VCV000694698	16	89350121 - 89350124	16	89283713 - 89283716	694698	682828		NC_000016.10:89283712:CTCTCTC:CTC
NM_013275.6(ANKRD11):c.1621C>T (p.Gln541Ter)	ANKRD11	Q541*	KBG syndrome	Pathogenic	criteria provided, single submitter	VCV000694688	16	89351329	16	89284921	694688	682829		NC_000016.10:89284920:G:A
NM_013275.6(ANKRD11):c.1372C>T (p.Arg458Ter)	ANKRD11	R458*	KBG syndrome	Pathogenic	criteria provided, single submitter	VCV000694682	16	89351578	16	89285170	694682	682830		NC_000016.10:89285169:G:A
NM_013275.6(ANKRD11):c.6742C>T (p.Gln2248Ter)	ANKRD11	Q2248*	KBG syndrome	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000691266	16	89346208	16	89279800	691266	678946		NC_000016.10:89279799:G:A
NM_013275.6(ANKRD11):c.618del (p.His206fs)	ANKRD11	H206fs	KBG syndrome	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000666557	16	89355062	16	89288654	666557	654139		NC_000016.10:89288653:G:
NM_013275.6(ANKRD11):c.5682dup (p.Arg1895fs)	ANKRD11		KBG syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000658274	16	89347267 - 89347268	16	89280859 - 89280860	658274	645137		NC_000016.10:89280859:GGGGG:GGGGGG
NM_013275.6(ANKRD11):c.2273_2274del (p.Leu758fs)	ANKRD11	L758fs	KBG syndrome	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000650001	16	89350676 - 89350677	16	89284268 - 89284269	650001	645141		NC_000016.10:89284267:CA:
NM_013275.6(ANKRD11):c.2454dup (p.Asn819Ter)	ANKRD11		KBG syndrome	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000645982	16	89350495 - 89350496	16	89284087 - 89284088	645982	645140		NC_000016.10:89284087:A:AA
NM_013275.6(ANKRD11):c.3708_3709del (p.Lys1237fs)	ANKRD11	K1237fs	KBG syndrome	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000565310	16	89349241 - 89349242	16	89282833 - 89282834	565310	574209	rs1567572265	NC_000016.10:89282832:TCT:T
NM_013275.6(ANKRD11):c.1679C>G (p.Ser560Ter)	ANKRD11	S560*	KBG syndrome	Pathogenic(Last reviewed: Mar 7, 2018)	no assertion criteria provided	VCV000559634	16	89351271	16	89284863	559634	550370	rs1555529551	NC_000016.10:89284862:G:C
NM_013275.6(ANKRD11):c.2404_2407del (p.Leu802fs)	ANKRD11	L802fs	KBG syndrome	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000547949	16	89350543 - 89350546	16	89284135 - 89284138	547949	538461	rs1555529181	NC_000016.10:89284134:TGAGT:T
NM_013275.6(ANKRD11):c.6197_6198delinsAA (p.Phe2066Ter)	ANKRD11		KBG syndrome	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000458786	16	89346752 - 89346753	16	89280344 - 89280345	458786	466885	rs1555525977	NC_000016.10:89280343:GA:TT
NM_013275.6(ANKRD11):c.3632_3633del (p.Lys1211fs)	ANKRD11	K1211fs	KBG syndrome	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000434198	16	89349317 - 89349318	16	89282909 - 89282910	434198	429886	rs1555528400	NC_000016.10:89282908:TTT:T
NM_013275.6(ANKRD11):c.6670G>T (p.Glu2224Ter)	ANKRD11	E2224*	KBG syndrome	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000434197	16	89346280	16	89279872	434197	429885	rs1381957912	NC_000016.10:89279871:C:A
NM_013275.6(ANKRD11):c.6015dup (p.Gly2006fs)	ANKRD11		KBG syndrome	Pathogenic	no assertion criteria provided	VCV000242976	16	89346934 - 89346935	16	89280526 - 89280527	242976	244063	rs879253753	NC_000016.10:89280526:T:TT
NM_013275.6(ANKRD11):c.6210_6211del (p.Lys2070fs)	ANKRD11	K2070fs	KBG syndrome	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000217797	16	89346739 - 89346740	16	89280331 - 89280332	217797	214453	rs863225257	NC_000016.10:89280330:AC:
NM_013275.6(ANKRD11):c.2305del (p.Ser769fs)	ANKRD11	S769fs	KBG syndrome	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030891	16	89350645	16	89284237	30891	39848	rs863223320	NC_000016.10:89284236:A:
NM_013275.6(ANKRD11):c.7571A>G (p.Glu2524Gly)	ANKRD11	E2524G	KBG syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000812187	16	89341364	16	89274956	812187	800673		NC_000016.10:89274955:T:C
NM_013275.6(ANKRD11):c.3138T>A (p.Cys1046Ter)	ANKRD11	C1046*	Autism spectrum disorder	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000589485	16	89349812	16	89283404	589485	580222	rs1567574466	NC_000016.10:89283403:A:T
NM_013275.6(ANKRD11):c.4206C>G (p.Tyr1402Ter)	ANKRD11	Y1402*	KBG syndrome	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000579848	16	89348744	16	89282336	579848	568459	rs749632782	NC_000016.10:89282335:G:C
NM_013275.6(ANKRD11):c.893-1G>C	ANKRD11		KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560944	16	89352058	16	89285650	560944	552196	rs1567583835	NC_000016.10:89285649:C:G
NM_013275.6(ANKRD11):c.867C>A (p.Tyr289Ter)	ANKRD11	Y289*	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560943	16	89352472	16	89286064	560943	552197	rs761636251	NC_000016.10:89286063:G:T
NM_013275.6(ANKRD11):c.5065del (p.Leu1689fs)	ANKRD11	L1689fs	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560942	16	89347885	16	89281477	560942	552191	rs1567566026	NC_000016.10:89281476:GG:G
NM_013275.6(ANKRD11):c.3770_3773del (p.Lys1257fs)	ANKRD11	K1257fs	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560941	16	89349177 - 89349180	16	89282769 - 89282772	560941	552192	rs1567571990	NC_000016.10:89282768:TCTTT:T
NM_013275.6(ANKRD11):c.2047_2048del (p.Lys683fs)	ANKRD11	K683fs	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560940	16	89350902 - 89350903	16	89284494 - 89284495	560940	552193	rs1567579092	NC_000016.10:89284493:TT:
NM_013275.6(ANKRD11):c.1948C>T (p.Gln650Ter)	ANKRD11	Q650*	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560939	16	89351002	16	89284594	560939	552194	rs1567579525	NC_000016.10:89284593:G:A
NM_013275.6(ANKRD11):c.6786_6787insA (p.Pro2263fs)	ANKRD11		KBG syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431147	16	89346163 - 89346164	16	89279755 - 89279756	431147	424663	rs1135401815	NC_000016.10:89279755::T
NM_013275.6(ANKRD11):c.2647G>T (p.Glu883Ter)	ANKRD11	E883*	KBG syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431133	16	89350303	16	89283895	431133	424664	rs1135401804	NC_000016.10:89283894:C:A
NM_013275.6(ANKRD11):c.6212C>G (p.Ser2071Ter)	ANKRD11	S2071*	KBG syndrome	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000375613	16	89346738	16	89280330	375613	362427	rs763407068	NC_000016.10:89280329:G:C
NM_013275.6(ANKRD11):c.5951_5952CA[1] (p.Gln1985fs)	ANKRD11		KBG syndrome	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030892	16	89346996 - 89346997	16	89280588 - 89280589	30892	39849	rs863223321	NC_000016.10:89280587:TGTG:TG
NM_013275.6(ANKRD11):c.7570-1G>C	ANKRD11		KBG syndrome	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030890	16	89341366	16	89274958	30890	39847	rs863223319	NC_000016.10:89274957:C:G
NM_001289910.1(IDH2):c.359G>A (p.Arg120Lys)	IDH2	R120K, R172K, R42K	Hepatocellular carcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Neoplasm of the large intestine|Neoplasm of brain|Brainstem glioma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375987	15	90631838	15	90088606	375987	362866	rs121913503	NC_000015.10:90088605:C:T
NM_013275.6(ANKRD11):c.1977C>G (p.Tyr659Ter)	ANKRD11	Y659*	not provided|KBG syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000489328	16	89350973	16	89284565	489328	482112	rs749201074	NC_000016.10:89284564:G:C
NM_013275.6(ANKRD11):c.2409_2412del (p.Glu805fs)	ANKRD11	E805fs	not provided|KBG syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000426843	16	89350538 - 89350541	16	89284130 - 89284133	426843	415528	rs886039902	NC_000016.10:89284129:TTTTTT:TT
NM_013275.6(ANKRD11):c.3084C>A (p.Tyr1028Ter)	ANKRD11	Y1028*	not provided|KBG syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, multiple submitters, no conflicts	VCV000418939	16	89349866	16	89283458	418939	409797	rs1064793539	NC_000016.10:89283457:G:T
NM_013275.6(ANKRD11):c.3562C>T (p.Arg1188Ter)	ANKRD11	R1188*	not provided|KBG syndrome	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000280480	16	89349388	16	89282980	280480	264823	rs761848111	NC_000016.10:89282979:G:A
NM_000137.3(FAH):c.192G>T (p.Gln64His)	FAH	Q64H	not provided|Tyrosinemia type I	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021054	15	80450512	15	80158170	21054	33906	rs80338894	NC_000015.10:80158169:G:T
NM_000137.3(FAH):c.1069G>T (p.Glu357Ter)	FAH	E357*	Tyrosinemia type I	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011871	15	80473390	15	80181048	11871	26910	rs121965075	NC_000015.10:80181047:G:T
NM_013275.6(ANKRD11):c.3198_3199del (p.His1066fs)	ANKRD11	H1066fs	KBG syndrome	Pathogenic(Last reviewed: Jul 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000619978	16	89349751 - 89349752	16	89283343 - 89283344	619978	611422	rs1567574291	NC_000016.10:89283342:TAT:T
NM_002834.5(PTPN11):c.1502G>A (p.Arg501Lys)	PTPN11	R501K, R505K, R500K	not provided|Noonan syndrome|Rasopathy	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040555	12	112926882	12	112489078	40555	49025	rs397507543	NC_000012.12:112489077:G:A
NM_002834.5(PTPN11):c.781C>T (p.Leu261Phe)	PTPN11	L261F, L260F	Noonan syndrome|Rasopathy|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040520	12	112910772	12	112472968	40520	48990	rs397507525	NC_000012.12:112472967:C:T
NM_000018.4(ACADVL):c.1766_1769TGAG[1] (p.Ser590fs)	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557136	17	7128142 - 7128145	17	7224823 - 7224826	557136	548319	rs1555529048	NC_000017.11:7224822:TGAGTGAG:TGAG
NM_000018.4(ACADVL):c.887_888del (p.Pro296fs)	ACADVL	P274fs, P319fs, P296fs, P220fs	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189008	17	7125994 - 7125995	17	7222675 - 7222676	189008	186986	rs753108198	NC_000017.11:7222674:CT:
NM_000018.4(ACADVL):c.685C>T (p.Arg229Ter)	ACADVL	R229*, R207*, R252*, R153*	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188884	17	7125333	17	7222014	188884	186985	rs786204536	NC_000017.11:7222013:C:T
NM_000018.4(ACADVL):c.1405C>T (p.Arg469Trp)	ACADVL	R469W, R393W, R492W, R447W	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021017	17	7127359	17	7224040	21017	33869	rs113994170	NC_000017.11:7224039:C:T
NC_000016.9:g.(?_89334866)_(89355098_?)del	ANKRD11		KBG syndrome	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000584373	16	89334866 - 89355098	16	89268458 - 89288690	584373	569821		
NM_013275.6(ANKRD11):c.6968_6975del (p.Ala2323fs)	ANKRD11	A2323fs	not provided|KBG syndrome	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000546454	16	89345975 - 89345982	16	89279567 - 89279574	546454	536920	rs1555525115	NC_000016.10:89279566:CTTCGGGGCTTCGG:CTTCGG
NM_022041.3(GAN):c.432C>G (p.Tyr144Ter)	GAN	Y144*	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000521987	16	81388159	16	81354554	521987	512227	rs1555511101	NC_000016.10:81354553:C:G
NM_013275.6(ANKRD11):c.1373_1376GAAA[2] (p.Glu461fs)	ANKRD11		not provided|KBG syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633578	16	89351566 - 89351569	16	89285158 - 89285161	633578	621983		NC_000016.10:89285157:TTTCTTTCTTTC:TTTCTTTC
NM_013275.6(ANKRD11):c.4384dup (p.Arg1462fs)	ANKRD11		not provided|Intellectual disability|KBG syndrome	Pathogenic(Last reviewed: Jan 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280288	16	89348565 - 89348566	16	89282157 - 89282158	280288	264747	rs886041521	NC_000016.10:89282157:T:TT
NM_013275.6(ANKRD11):c.2408_2412del (p.Lys803fs)	ANKRD11	K803fs	KBG syndrome|not provided	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000266033	16	89350538 - 89350542	16	89284130 - 89284134	266033	260852	rs886039902	NC_000016.10:89284129:TTTTTT:T
NM_013275.6(ANKRD11):c.2398_2401del (p.Glu800fs)	ANKRD11	E800fs	KBG syndrome|not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000209131	16	89350549 - 89350552	16	89284141 - 89284144	209131	205782	rs797045027	NC_000016.10:89284140:TTTCTTT:TTT
NM_001077401.2(ACVRL1):c.1450C>T (p.Arg484Trp)	ACVRL1	R484W	not specified|Pulmonary arterial hypertension|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000008252	12	52314615	12	51920831	8252	23291	rs121909288	NC_000012.12:51920830:C:T
NM_001844.5(COL2A1):c.1833+1G>A	COL2A1		Retinal dystrophy	Pathogenic(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000866602	12	48378777	12	47984994	866602	857262		NC_000012.12:47984993:C:T
NM_001844.5(COL2A1):c.504_505delinsA (p.Pro170fs)	COL2A1		not provided	Pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, single submitter	VCV000818081	12	48391415 - 48391416	12	47997632 - 47997633	818081	805740		NC_000012.12:47997631:GG:T
NM_001844.5(COL2A1):c.1525_1527delinsTGTGACC (p.Arg509fs)	COL2A1		not provided	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000817798	12	48380119 - 48380121	12	47986336 - 47986338	817798	805739		NC_000012.12:47986335:TCT:GGTCACA
NM_001844.5(COL2A1):c.2659C>T (p.Arg887Ter)	COL2A1	R887*, R818*	not provided	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000817513	12	48373812	12	47980029	817513	805738		NC_000012.12:47980028:G:A
NM_001844.5(COL2A1):c.3377_3378AG[2] (p.Gly1128fs)	COL2A1		not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000817152	12	48370648 - 48370649	12	47976865 - 47976866	817152	805737		NC_000012.12:47976864:CTCTCTC:CTCTC
NM_001844.5(COL2A1):c.261dup (p.Ile88fs)	COL2A1		not provided	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000817080	12	48393732 - 48393733	12	47999949 - 47999950	817080	805742		NC_000012.12:47999949:GGGG:GGGGG
NM_001844.5(COL2A1):c.1527+135G>A	COL2A1		Stargardt disease	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812294	12	48379984	12	47986201	812294	800697		NC_000012.12:47986200:C:T
NM_001844.5(COL2A1):c.842_843insT (p.Gly282fs)	COL2A1		Retinal detachment	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812293	12	48387804 - 48387805	12	47994021 - 47994022	812293	800575		NC_000012.12:47994021::A
NM_001844.5(COL2A1):c.1399C>T (p.Gln467Ter)	COL2A1	Q467*, Q398*	not provided	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000620239	12	48380638	12	47986855	620239	611769	rs1565683713	NC_000012.12:47986854:G:A
NM_001844.5(COL2A1):c.4008G>A (p.Trp1336Ter)	COL2A1	W1336*, W1267*	not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000620225	12	48368524	12	47974741	620225	611767	rs1565666048	NC_000012.12:47974740:C:T
NM_001844.5(COL2A1):c.2566C>T (p.Gln856Ter)	COL2A1	Q856*, Q787*	not provided	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000620211	12	48374396	12	47980613	620211	611768	rs1565674604	NC_000012.12:47980612:G:A
NM_001844.5(COL2A1):c.1030C>T (p.Arg344Ter)	COL2A1	R344*, R275*	not provided	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000620125	12	48383582	12	47989799	620125	611770	rs1565686896	NC_000012.12:47989798:G:A
NM_001844.5(COL2A1):c.2219dup (p.Gly741fs)	COL2A1		not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000597893	12	48376366 - 48376367	12	47982583 - 47982584	597893	588954	rs1565677720	NC_000012.12:47982583:GGGGGG:GGGGGGG
NM_001844.5(COL2A1):c.3887-1G>C	COL2A1		not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000596739	12	48368646	12	47974863	596739	587800	rs1565666318	NC_000012.12:47974862:C:G
NM_001844.5(COL2A1):c.1123-1G>A	COL2A1		not provided	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000596717	12	48381493	12	47987710	596717	587778	rs1565684864	NC_000012.12:47987709:C:T
NM_001844.5(COL2A1):c.310G>T (p.Gly104Ter)	COL2A1	G104*, G35*	not provided	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000596359	12	48391984	12	47998201	596359	587420	rs764210489	NC_000012.12:47998200:C:A
NM_001844.5(COL2A1):c.2195G>A (p.Gly732Asp)	COL2A1	G732D, G663D	not provided	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000546517	12	48376391	12	47982608	546517	536846	rs1555166457	NC_000012.12:47982607:C:T
NM_001844.5(COL2A1):c.3203G>A (p.Gly1068Glu)	COL2A1	G1068E, G999E	not provided	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000546495	12	48371173	12	47977390	546495	536845	rs1555165195	NC_000012.12:47977389:C:T
NM_001844.5(COL2A1):c.3356del (p.Gly1119fs)	COL2A1	G1119fs, G1050fs	not provided	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000523955	12	48370674	12	47976891	523955	514639	rs1555165110	NC_000012.12:47976890:CC:C
NM_001844.5(COL2A1):c.2490dup (p.Gly831fs)	COL2A1		not provided	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000504463	12	48374724 - 48374725	12	47980941 - 47980942	504463	495531	rs1273496827	NC_000012.12:47980941:GGGGGG:GGGGGGG
NM_001844.5(COL2A1):c.1299_1302del (p.Phe433fs)	COL2A1	F364fs, F433fs	not provided	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000504358	12	48380924 - 48380927	12	47987141 - 47987144	504358	495298	rs1555167439	NC_000012.12:47987140:AGGGA:A
NM_001844.5(COL2A1):c.1556del (p.Gly519fs)	COL2A1	G519fs, G450fs	not provided	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000504238	12	48379720	12	47985937	504238	495550	rs1555167140	NC_000012.12:47985936:CC:C
NM_001844.5(COL2A1):c.1681-1dup	COL2A1		not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000503891	12	48379368 - 48379369	12	47985585 - 47985586	503891	495547	rs1555167067	NC_000012.12:47985585:CCC:CCCC
NM_001844.5(COL2A1):c.3624del (p.Gly1209fs)	COL2A1	G1209fs, G1140fs	not provided	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000503695	12	48369362	12	47975579	503695	495296	rs1555164789	NC_000012.12:47975578:A:
NM_001844.5(COL2A1):c.4328del (p.Gly1443fs)	COL2A1	G1374fs, G1443fs	not provided	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000500253	12	48367326	12	47973543	500253	491677	rs1555164232	NC_000012.12:47973542:CC:C
NM_001844.5(COL2A1):c.4195_4205delinsAGCATTGCC (p.Tyr1399fs)	COL2A1		not provided	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000499269	12	48367984 - 48367994	12	47974201 - 47974211	499269	490693	rs1555164385	NC_000012.12:47974200:TCGTCCAGATA:GGCAATGCT
NM_001844.5(COL2A1):c.1369G>T (p.Glu457Ter)	COL2A1	E457*, E388*	not provided	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000489070	12	48380668	12	47986885	489070	482019	rs1555167368	NC_000012.12:47986884:C:A
NM_001844.5(COL2A1):c.1268G>A (p.Gly423Asp)	COL2A1	G423D, G354D	not provided	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000452953	12	48380958	12	47987175	452953	445010	rs1555167449	NC_000012.12:47987174:C:T
NM_001844.5(COL2A1):c.1537G>A (p.Gly513Ser)	COL2A1	G513S, G444S	not specified	Pathogenic(Last reviewed: Jan 22, 2017)	criteria provided, single submitter	VCV000439509	12	48379739	12	47985956	439509	433419	rs1555167156	NC_000012.12:47985955:C:T
NM_001844.5(COL2A1):c.2814del (p.Gly939fs)	COL2A1	G939fs, G870fs	not provided	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000431967	12	48372461	12	47978678	431967	425978	rs1555165494	NC_000012.12:47978677:A:
NM_001844.5(COL2A1):c.655G>A (p.Gly219Arg)	COL2A1	G219R, G150R	not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000430186	12	48389546	12	47995763	430186	421923	rs1131691822	NC_000012.12:47995762:C:T
NM_001844.5(COL2A1):c.25_26delinsTA (p.Thr9Ter)	COL2A1		not provided	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000429715	12	48398079 - 48398080	12	48004296 - 48004297	429715	421924	rs1131691546	NC_000012.12:48004295:GT:TA
NM_001844.5(COL2A1):c.1105G>C (p.Gly369Arg)	COL2A1	G369R, G300R	not provided	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000426498	12	48383028	12	47989245	426498	415336	rs1085307657	NC_000012.12:47989244:C:G
NM_001844.5(COL2A1):c.2491G>A (p.Gly831Arg)	COL2A1	G831R, G762R	not provided	Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000423853	12	48374724	12	47980941	423853	408660	rs1064796660	NC_000012.12:47980940:C:T
NM_001844.5(COL2A1):c.1330G>A (p.Gly444Ser)	COL2A1	G444S, G375S	not provided	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000423267	12	48380896	12	47987113	423267	408663	rs1064796332	NC_000012.12:47987112:C:T
NM_001844.5(COL2A1):c.1680+1G>C	COL2A1		not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000392907	12	48379510	12	47985727	392907	373083	rs1057524696	NC_000012.12:47985726:C:G
NM_001844.5(COL2A1):c.1925G>T (p.Gly642Val)	COL2A1	G642V, G573V	not provided	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000392715	12	48377886	12	47984103	392715	373290	rs1057524602	NC_000012.12:47984102:C:A
NM_001844.5(COL2A1):c.2818C>T (p.Arg940Ter)	COL2A1	R940*, R871*	not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000391509	12	48372457	12	47978674	391509	373286	rs1057524114	NC_000012.12:47978673:G:A
NM_001844.5(COL2A1):c.3156dup (p.Gly1053fs)	COL2A1		not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000373034	12	48371391 - 48371392	12	47977608 - 47977609	373034	360114	rs1057518157	NC_000012.12:47977608:A:AA
NM_001844.4(COL2A1):c.2465delG (p.Gly822Valfs)	COL2A1		not provided	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000289860	12	48374750	12	47980967	289860	274097	rs886044292	NC_000012.12:47980966:CCC:CC
NM_001844.5(COL2A1):c.297del (p.Gln99fs)	COL2A1	Q30fs, Q99fs	not provided	Pathogenic(Last reviewed: Aug 5, 2016)	criteria provided, single submitter	VCV000289716	12	48392210	12	47998427	289716	273953	rs886044245	NC_000012.12:47998426:TT:T
NM_001844.5(COL2A1):c.714dup (p.Met239fs)	COL2A1		not provided	Pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	VCV000288552	12	48389085 - 48389086	12	47995302 - 47995303	288552	272789	rs886043934	NC_000012.12:47995302:GGG:GGGG
NM_001844.5(COL2A1):c.1071del (p.Pro358fs)	COL2A1	P358fs, P289fs	not provided	Pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, single submitter	VCV000288053	12	48383062	12	47989279	288053	272290	rs886043797	NC_000012.12:47989278:A:
NM_001844.5(COL2A1):c.1023+1G>A	COL2A1		not provided	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000288046	12	48386660	12	47992877	288046	272283	rs886043794	NC_000012.12:47992876:C:T
NM_001844.5(COL2A1):c.3382G>C (p.Gly1128Arg)	COL2A1	G1128R, G1059R	not provided	Pathogenic(Last reviewed: Oct 4, 2015)	criteria provided, single submitter	VCV000283376	12	48370648	12	47976865	283376	267613	rs886042612	NC_000012.12:47976864:C:G
NM_001844.5(COL2A1):c.2536G>A (p.Gly846Arg)	COL2A1	G846R, G777R	not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000280926	12	48374426	12	47980643	280926	264471	rs886042043	NC_000012.12:47980642:C:T
NM_001844.5(COL2A1):c.2618G>A (p.Gly873Glu)	COL2A1	G873E, G804E	not provided	Pathogenic(Last reviewed: Sep 19, 2016)	criteria provided, single submitter	VCV000280883	12	48374344	12	47980561	280883	264621	rs886042009	NC_000012.12:47980560:C:T
NM_001844.5(COL2A1):c.1816G>C (p.Gly606Arg)	COL2A1	G606R, G537R	not provided	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000280805	12	48378795	12	47985012	280805	264479	rs886041945	NC_000012.12:47985011:C:G
NM_001844.5(COL2A1):c.1996-1G>A	COL2A1		not provided	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000280791	12	48377222	12	47983439	280791	264521	rs886041935	NC_000012.12:47983438:C:T
NM_001844.5(COL2A1):c.2825G>A (p.Gly942Asp)	COL2A1	G942D, G873D	not provided	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000280767	12	48372450	12	47978667	280767	264616	rs886041914	NC_000012.12:47978666:C:T
NM_001844.5(COL2A1):c.1546G>A (p.Gly516Ser)	COL2A1	G516S, G447S	not provided	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000280745	12	48379730	12	47985947	280745	264627	rs886041895	NC_000012.12:47985946:C:T
NM_001844.5(COL2A1):c.544C>T (p.Gln182Ter)	COL2A1	Q182*, Q113*	not provided	Pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, single submitter	VCV000280680	12	48390396	12	47996613	280680	264526	rs886041843	NC_000012.12:47996612:G:A
NM_001844.5(COL2A1):c.2617G>T (p.Gly873Trp)	COL2A1	G873W, G804W	not provided	Pathogenic(Last reviewed: Apr 20, 2016)	criteria provided, single submitter	VCV000280522	12	48374345	12	47980562	280522	264623	rs886041713	NC_000012.12:47980561:C:A
NM_001844.5(COL2A1):c.2609G>T (p.Gly870Val)	COL2A1	G870V, G801V	not provided	Pathogenic(Last reviewed: Dec 11, 2015)	criteria provided, single submitter	VCV000280175	12	48374353	12	47980570	280175	264467	rs886041429	NC_000012.12:47980569:C:A
NM_001844.5(COL2A1):c.2813del (p.Pro938fs)	COL2A1	P869fs, P938fs	not provided	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000265430	12	48372462	12	47978679	265430	260019	rs886039543	NC_000012.12:47978678:GGGGGG:GGGGG
NM_001844.5(COL2A1):c.2833G>A (p.Gly945Ser)	COL2A1	G945S, G876S	not provided	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000265429	12	48372442	12	47978659	265429	260018	rs886039542	NC_000012.12:47978658:C:T
NM_001844.5(COL2A1):c.4447_4450del (p.Pro1483fs)	COL2A1	P1414fs, P1483fs	not provided	Pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	VCV000197962	12	48367204 - 48367207	12	47973421 - 47973424	197962	195123	rs794727761	NC_000012.12:47973420:CCGGCC:CC
NM_001844.5(COL2A1):c.3791_3794del (p.Asn1264fs)	COL2A1	N1195fs, N1264fs	not provided	Pathogenic(Last reviewed: Mar 24, 2015)	criteria provided, single submitter	VCV000197923	12	48369192 - 48369195	12	47975409 - 47975412	197923	195084	rs794727748	NC_000012.12:47975408:TGGTTG:TG
NM_001844.5(COL2A1):c.2530C>T (p.Gln844Ter)	COL2A1	Q844*, Q775*	not provided	Pathogenic(Last reviewed: Jan 28, 2015)	criteria provided, single submitter	VCV000197065	12	48374432	12	47980649	197065	194226	rs794727607	NC_000012.12:47980648:G:A
NM_001844.5(COL2A1):c.2015G>C (p.Gly672Ala)	COL2A1	G672A, G603A	not provided	Pathogenic(Last reviewed: Apr 22, 2015)	criteria provided, single submitter	VCV000196679	12	48377202	12	47983419	196679	193840	rs794727546	NC_000012.12:47983418:C:G
NM_001844.5(COL2A1):c.1924G>T (p.Gly642Ter)	COL2A1	G642*, G573*	not provided	Pathogenic(Last reviewed: Feb 9, 2015)	criteria provided, single submitter	VCV000196168	12	48377887	12	47984104	196168	193329	rs794727472	NC_000012.12:47984103:C:A
NM_001844.5(COL2A1):c.1420-2A>C	COL2A1		not provided	Pathogenic(Last reviewed: Nov 22, 2014)	criteria provided, single submitter	VCV000195743	12	48380228	12	47986445	195743	192904	rs794727377	NC_000012.12:47986444:T:G
NM_001844.5(COL2A1):c.1358G>C (p.Gly453Ala)	COL2A1	G453A, G384A	not provided	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000195584	12	48380868	12	47987085	195584	192745	rs794727339	NC_000012.12:47987084:C:G
NM_001844.5(COL2A1):c.1214del (p.Gly405fs)	COL2A1	G336fs, G405fs	not provided	Pathogenic(Last reviewed: Nov 24, 2014)	criteria provided, single submitter	VCV000194937	12	48381401	12	47987618	194937	192099	rs794727225	NC_000012.12:47987617:CC:C
NM_001844.5(COL2A1):c.1056del (p.Ala353fs)	COL2A1	A284fs, A353fs	not provided	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	VCV000194728	12	48383556	12	47989773	194728	191891	rs794727185	NC_000012.12:47989772:GGGG:GGG
NM_001844.5(COL2A1):c.762+1G>A	COL2A1		not provided	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000193849	12	48389037	12	47995254	193849	191012	rs794727026	NC_000012.12:47995253:C:T
NM_001844.5(COL2A1):c.85+1G>C	COL2A1		not provided	Pathogenic(Last reviewed: Jan 8, 2014)	criteria provided, single submitter	VCV000166927	12	48398019	12	48004236	166927	177633	rs727503882	NC_000012.12:48004235:C:G
NM_001844.5(COL2A1):c.1052del (p.Gly351fs)	COL2A1	G282fs, G351fs	not provided	Pathogenic(Last reviewed: Aug 9, 2013)	criteria provided, single submitter	VCV000093786	12	48383560	12	47989777	93786	99688	rs398123628	NC_000012.12:47989776:CC:C
NM_001844.5(COL2A1):c.2320G>A (p.Gly774Ser)	COL2A1	G574S, G705S, G774S	Hypochondrogenesis	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000017357	12	48375925	12	47982142	17357	32396	rs121912867	NC_000012.12:47982141:C:T
NM_001844.5(COL2A1):c.2934del (p.Gln979fs)	COL2A1	Q910fs, Q979fs	not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000854977	12	48372143	12	47978360	854977	839945		NC_000012.12:47978359:A:
NM_001844.5(COL2A1):c.2933del (p.Gly978fs)	COL2A1	G978fs, G909fs	not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000854973	12	48372144	12	47978361	854973	839946		NC_000012.12:47978360:CC:C
NM_001844.5(COL2A1):c.2490del (p.Gly831fs)	COL2A1	G831fs, G762fs	not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000847312	12	48374725	12	47980942	847312	839948		NC_000012.12:47980941:GGGGGG:GGGGG
NM_001844.5(COL2A1):c.3454G>C (p.Gly1152Arg)	COL2A1	G1083R, G1152R	Spondyloepiphyseal dysplasia, stanescu type	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000666308	12	48370332	12	47976549	666308	653883		NC_000012.12:47976548:C:G
NM_001844.5(COL2A1):c.2582G>A (p.Gly861Asp)	COL2A1	G861D, G792D	Skeletal dysplasia	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, single submitter	VCV000492999	12	48374380	12	47980597	492999	485949	rs1209546147	NC_000012.12:47980596:C:T
NM_001844.5(COL2A1):c.1979G>A (p.Gly660Glu)	COL2A1	G660E, G591E		Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000488485	12	48377482	12	47983699	488485	481353	rs1555166729	NC_000012.12:47983698:C:T
NM_001844.5(COL2A1):c.3655G>C (p.Asp1219His)	COL2A1	D1219H, D1150H	Spondyloepiphyseal dysplasia, stanescu type	Pathogenic(Last reviewed: Nov 8, 2017)	no assertion criteria provided	VCV000446168	12	48369331	12	47975548	446168	439515	rs760093841	NC_000012.12:47975547:C:G
NM_001844.5(COL2A1):c.2492G>T (p.Gly831Val)	COL2A1	G831V, G762V	not provided	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000445376	12	48374723	12	47980940	445376	438648	rs1555166013	NC_000012.12:47980939:C:A
NM_001844.5(COL2A1):c.3023G>T (p.Gly1008Val)	COL2A1	G1008V, G939V	Short ribs|Absent vertebral body mineralization	Pathogenic(Last reviewed: Nov 10, 2015)	criteria provided, single submitter	VCV000374042	12	48371881	12	47978098	374042	360945	rs765795867	NC_000012.12:47978097:C:A
NM_001844.5(COL2A1):c.1191_1199dup (p.Ser400_Gly402dup)	COL2A1		Stickler syndrome	Pathogenic	no assertion criteria provided	VCV000162041	12	48381415 - 48381416	12	47987632 - 47987633	162041	171762	rs672601355	NC_000012.12:47987632:GACCCAGGAG:GACCCAGGAGACCCAGGAG
NM_001844.5(COL2A1):c.3357_3358insCT (p.Glu1120fs)	COL2A1		Stickler syndrome	Pathogenic(Last reviewed: Jan 5, 2012)	no assertion criteria provided	VCV000162040	12	48370672 - 48370673	12	47976889 - 47976890	162040	171761	rs672601354	NC_000012.12:47976889::AG
NM_001844.5(COL2A1):c.170G>A (p.Cys57Tyr)	COL2A1	C57Y	Stickler syndrome, type I, nonsyndromic ocular	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000017402	12	48393824	12	48000041	17402	32441	rs121912898	NC_000012.12:48000040:C:T
NM_001844.5(COL2A1):c.141G>A (p.Trp47Ter)	COL2A1	W47*	Stickler syndrome, type I, nonsyndromic ocular	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000017400	12	48393853	12	48000070	17400	32439	rs121912896	NC_000012.12:48000069:C:T
NM_001844.5(COL2A1):c.952G>A (p.Gly318Arg)	COL2A1	G118R, G249R, G318R	Rhegmatogenous retinal detachment, autosomal dominant	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000017396	12	48387258	12	47993475	17396	32435	rs121912894	NC_000012.12:47993474:C:T
NM_001844.5(COL2A1):c.3914G>A (p.Gly1305Asp)	COL2A1	G1105D, G1236D, G1305D	Vitreoretinopathy with phalangeal epiphyseal dysplasia	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000017387	12	48368618	12	47974835	17387	32426	rs121912887	NC_000012.12:47974834:C:T
NM_001844.5(COL2A1):c.3158G>A (p.Gly1053Glu)	COL2A1	G853E, G1053E, G984E	Hypochondrogenesis	Pathogenic(Last reviewed: Nov 5, 1992)	no assertion criteria provided	VCV000017359	12	48371390	12	47977607	17359	32398	rs121912868	NC_000012.12:47977606:C:T
NM_032436.4(CHAMP1):c.1192C>T (p.Arg398Ter)	CHAMP1	R398*	Mental retardation, autosomal dominant 40|Inborn genetic diseases|intellectual disability with severe speech impairment	Pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000208415	13	115090509	13	114325034	208415	204638	rs797044962	NC_000013.11:114325033:C:T
NM_001844.5(COL2A1):c.1129G>A (p.Ala377Thr)	COL2A1	A308T, A377T	Otospondylomegaepiphyseal dysplasia, autosomal dominant	Pathogenic	criteria provided, single submitter	VCV000694725	12	48381486	12	47987703	694725	682820		NC_000012.12:47987702:C:T
NM_001844.5(COL2A1):c.3714C>A (p.Tyr1238Ter)	COL2A1	Y1169*, Y1238*	Otospondylomegaepiphyseal dysplasia, autosomal dominant	Pathogenic	criteria provided, single submitter	VCV000694704	12	48369272	12	47975489	694704	682819		NC_000012.12:47975488:G:T
NM_001844.5(COL2A1):c.2024G>A (p.Gly675Asp)	COL2A1	G675D, G606D	Spondyloepiphyseal dysplasia congenita	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000627589	12	48377193	12	47983410	627589	615941	rs1565679062	NC_000012.12:47983409:C:T
NM_001844.5(COL2A1):c.1420-7_1430del	COL2A1		Otospondylomegaepiphyseal dysplasia, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560983	12	48380216 - 48380233	12	47986433 - 47986450	560983	552161	rs1565683138	NC_000012.12:47986432:CCAGCAGGGCCCTGAGGACCAGCA:CCAGCA
NM_001844.5(COL2A1):c.1114G>A (p.Gly372Arg)	COL2A1	G372R, G303R	Spondyloepiphyseal dysplasia congenita	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547251	12	48383019	12	47989236	547251	537893	rs1555167783	NC_000012.12:47989235:C:T
NM_001844.5(COL2A1):c.2353C>T (p.Arg785Ter)	COL2A1	R785*, R716*	not provided	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000286497	12	48375892	12	47982109	286497	270734	rs886043410	NC_000012.12:47982108:G:A
NM_001844.5(COL2A1):c.3574C>T (p.Arg1192Ter)	COL2A1	R1192*, R1123*	not provided	Pathogenic(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	VCV000283534	12	48369769	12	47975986	283534	267771	rs886042651	NC_000012.12:47975985:G:A
NM_001844.5(COL2A1):c.619G>A (p.Gly207Arg)	COL2A1	G207R, G138R	Spondyloepiphyseal dysplasia, stanescu type	Pathogenic	criteria provided, single submitter	VCV000224878	12	48389693	12	47995910	224878	226722	rs869312907	NC_000012.12:47995909:C:T
NM_001844.5(COL2A1):c.3301G>A (p.Gly1101Arg)	COL2A1	G1101R, G1032R	Spondyloepiphyseal dysplasia congenita	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000208169	12	48370911	12	47977128	208169	204429	rs864621973	NC_000012.12:47977127:C:T
NM_001844.5(COL2A1):c.1637G>T (p.Gly546Val)	COL2A1	G346V, G477V, G546V		Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000017403	12	48379554	12	47985771	17403	32442	rs121912899	NC_000012.12:47985770:C:A
NM_001844.5(COL2A1):c.3886+2T>C	COL2A1		Stickler syndrome, type I, nonsyndromic ocular	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000017399	12	48369098	12	47975315	17399	32438		NC_000012.12:47975314:A:G
NM_001844.5(COL2A1):c.2974A>G (p.Arg992Gly)	COL2A1	R792G, R923G, R992G	Spondylometaphyseal dysplasia	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000017397	12	48372103	12	47978320	17397	32436	rs121912895	NC_000012.12:47978319:T:C
NM_001844.5(COL2A1):c.2149G>A (p.Gly717Ser)	COL2A1	G717S, G648S	Avascular necrosis of the head of femur	Pathogenic(Last reviewed: Jun 2, 2005)	no assertion criteria provided	VCV000017394	12	48376675	12	47982892	17394	32433	rs387906558	NC_000012.12:47982891:C:T
NM_001844.5(COL2A1):c.4314C>A (p.Cys1438Ter)	COL2A1	C1438*, C1369*	Spondyloperipheral dysplasia-short ulna syndrome	Pathogenic(Last reviewed: Aug 30, 2004)	no assertion criteria provided	VCV000017392	12	48367875	12	47974092	17392	32431	rs121912890	NC_000012.12:47974091:G:T
NM_001844.5(COL2A1):c.4413_4416del (p.Gly1472fs)	COL2A1	G1403fs, G1472fs		Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000017390	12	48367238 - 48367241	12	47973455 - 47973458	17390	32429		NC_000012.12:47973454:CCCTCC:CC
NM_001844.5(COL2A1):c.1547G>A (p.Gly516Asp)	COL2A1	G316D, G447D, G516D		Pathogenic(Last reviewed: Apr 30, 2004)	no assertion criteria provided	VCV000017388	12	48379729	12	47985946	17388	32427	rs121912888	NC_000012.12:47985945:C:T
NM_001844.5(COL2A1):c.3517G>C (p.Gly1173Arg)	COL2A1	G973R, G1104R, G1173R	Spondyloepiphyseal dysplasia congenita	Pathogenic(Last reviewed: Jan 31, 2000)	no assertion criteria provided	VCV000017381	12	48369826	12	47976043	17381	32420	rs121912883	NC_000012.12:47976042:C:G
COL2A1, 5-BP DUP	COL2A1		Spondyloperipheral dysplasia-short ulna syndrome	Pathogenic(Last reviewed: May 3, 1996)	no assertion criteria provided	VCV000017380					17380	32419		
NM_001844.5(COL2A1):c.1475G>T (p.Gly492Val)	COL2A1	G292V, G423V, G492V	Spondylometaphyseal dysplasia	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000017378	12	48380171	12	47986388	17378	32417	rs121912881	NC_000012.12:47986387:C:A
NM_001844.5(COL2A1):c.1581+5G>A	COL2A1		Kniest dysplasia	Pathogenic(Last reviewed: Feb 20, 1998)	no assertion criteria provided	VCV000017376	12	48379690	12	47985907	17376	32415		NC_000012.12:47985906:C:T
NM_001844.5(COL2A1):c.2671G>C (p.Gly891Arg)	COL2A1	G691R, G822R, G891R		Pathogenic(Last reviewed: Feb 1, 1995)	no assertion criteria provided	VCV000017372	12	48373800	12	47980017	17372	32411	rs121912879	NC_000012.12:47980016:C:G
NM_001844.5(COL2A1):c.2905G>A (p.Gly969Ser)	COL2A1	G769S, G900S, G969S		Pathogenic(Last reviewed: Jan 27, 1995)	no assertion criteria provided	VCV000017371	12	48372172	12	47978389	17371	32410	rs121912878	NC_000012.12:47978388:C:T
COL2A1, IVS20, A-G, -2	COL2A1		Kniest dysplasia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000017369					17369	32408		
NM_001844.5(COL2A1):c.2725G>T (p.Gly909Cys)	COL2A1	G709C, G840C, G909C	Spondylometaphyseal dysplasia	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000017367	12	48373302	12	47979519	17367	32406	rs121912875	NC_000012.12:47979518:C:A
COL2A1, 45-BP DUP, EX48	COL2A1		Spondyloepiphyseal dysplasia congenita	Pathogenic(Last reviewed: May 1, 1990)	no assertion criteria provided	VCV000017354					17354	32393		
NM_001844.5(COL2A1):c.3220G>A (p.Gly1074Ser)	COL2A1	G943S, G1005S, G1074S	Hypochondrogenesis	Pathogenic(Last reviewed: Nov 5, 1989)	no assertion criteria provided	VCV000017352	12	48371156	12	47977373	17352	32391	rs121912864	NC_000012.12:47977372:C:T
NM_001844.4(COL2A1):c.3490_3597del	COL2A1		Spondyloepiphyseal dysplasia congenita	Pathogenic(Last reviewed: May 26, 1989)	no assertion criteria provided	VCV000017351	12	48369744 - 48370134	12	47975961 - 47976351	17351	32390	rs1555164872	
NM_001844.5(COL2A1):c.3598-1G>A	COL2A1		Stickler syndrome type 1	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000807558	12	48369389	12	47975606	807558	798655		NC_000012.12:47975605:C:T
NM_001844.5(COL2A1):c.2679+1G>A	COL2A1		Stickler syndrome type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802843	12	48373791	12	47980008	802843	791240		NC_000012.12:47980007:C:T
NM_001844.5(COL2A1):c.1924G>A (p.Gly642Arg)	COL2A1	G573R, G642R	COL2A1-related skeletal dysplasia|not specified	Pathogenic/Likely pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000692069	12	48377887	12	47984104	692069	679786		NC_000012.12:47984103:C:T
NM_001844.5(COL2A1):c.3642del (p.Gly1215fs)	COL2A1	G1215fs, G1146fs	Stickler syndrome type 1	Pathogenic(Last reviewed: Feb 27, 2019)	no assertion criteria provided	VCV000635549	12	48369344	12	47975561	635549	623309		NC_000012.12:47975560:A:
NM_001844.5(COL2A1):c.2382del (p.Gly795fs)	COL2A1	G795fs, G726fs	not provided	Pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000289322	12	48375586	12	47981803	289322	273559	rs886044151	NC_000012.12:47981802:A:
NM_001844.5(COL2A1):c.192C>A (p.Cys64Ter)	COL2A1	C64*	not provided|Stickler syndrome, type I, nonsyndromic ocular	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000017401	12	48393802	12	48000019	17401	32440	rs121912897	NC_000012.12:48000018:G:T
NM_001844.5(COL2A1):c.4337del (p.Gly1446fs)	COL2A1	G1377fs, G1446fs	Spondyloperipheral dysplasia-short ulna syndrome	Pathogenic(Last reviewed: Aug 30, 2004)	no assertion criteria provided	VCV000017391	12	48367317	12	47973534	17391	32430	rs1565664375	NC_000012.12:47973533:CCCC:CCC
COL2A1, 2-BP DEL, 4274GT	COL2A1		Stickler syndrome, type I, nonsyndromic ocular	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000017386					17386	32425		
NM_001844.5(COL2A1):c.1266+1del	COL2A1		Kniest dysplasia	Pathogenic(Last reviewed: Mar 3, 1997)	no assertion criteria provided	VCV000017375	12	48381051	12	47987268	17375	32414	rs587776847	NC_000012.12:47987267:C:
NM_001844.5(COL2A1):c.800G>A (p.Gly267Asp)	COL2A1	G67D, G198D, G267D	Stickler syndrome, type I, nonsyndromic ocular	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000017364	12	48388223	12	47994440	17364	32403	rs121912872	NC_000012.12:47994439:C:T
NM_001844.5(COL2A1):c.1060G>A (p.Gly354Arg)	COL2A1	G154R, G285R, G354R	Spondylometaphyseal dysplasia	Pathogenic(Last reviewed: May 3, 1996)	no assertion criteria provided	VCV000017363	12	48383552	12	47989769	17363	32402	rs121912871	NC_000012.12:47989768:C:T
NM_001844.5(COL2A1):c.2908_2909dup (p.Pro971fs)	COL2A1		Stickler syndrome type 1	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000692014	12	48372167 - 48372168	12	47978384 - 47978385	692014	679785		NC_000012.12:47978384:GG:GGGG
NM_001844.5(COL2A1):c.578_579GC[1] (p.Ala194fs)	COL2A1		Stickler syndrome type 1	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000623179	12	48390359 - 48390360	12	47996576 - 47996577	623179	612192		NC_000012.12:47996575:GCGC:GC
NM_001844.5(COL2A1):c.2035A>T (p.Lys679Ter)	COL2A1	K679*, K610*	Stickler syndrome type 1	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000598754	12	48377182	12	47983399	598754	589804	rs1565679039	NC_000012.12:47983398:T:A
NM_001844.5(COL2A1):c.3731del (p.Ala1244fs)	COL2A1	A1175fs, A1244fs	Stickler syndrome type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547263	12	48369255	12	47975472	547263	537881	rs1555164735	NC_000012.12:47975471:G:
NM_001844.5(COL2A1):c.3166-1G>A	COL2A1		Stickler syndrome type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547260	12	48371211	12	47977428	547260	537884	rs1555165204	NC_000012.12:47977427:C:T
NM_001844.5(COL2A1):c.2381del (p.Pro794fs)	COL2A1	P794fs, P725fs	Stickler syndrome type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547258	12	48375587	12	47981804	547258	537886	rs1555166218	NC_000012.12:47981803:GGGGGG:GGGGG
NM_001844.5(COL2A1):c.1177G>A (p.Gly393Ser)	COL2A1	G393S, G324S	Stickler syndrome type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547252	12	48381438	12	47987655	547252	537892	rs1025202963	NC_000012.12:47987654:C:T
NM_001844.5(COL2A1):c.905C>T (p.Ala302Val)	COL2A1	A302V, A233V	not provided|Spondylometaphyseal dysplasia	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000449001	12	48387611	12	47993828	449001	445013	rs1555168505	NC_000012.12:47993827:G:A
NM_001844.5(COL2A1):c.709-2A>G	COL2A1		Stickler syndrome type 1	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000017398	12	48389093	12	47995310	17398	32437		NC_000012.12:47995309:T:C
NM_001844.5(COL2A1):c.1680+1G>A	COL2A1		Stickler syndrome type 1	Pathogenic(Last reviewed: Feb 28, 2000)	no assertion criteria provided	VCV000017382	12	48379510	12	47985727	17382	32421		NC_000012.12:47985726:C:T
COL2A1, 1-BP DEL, EX50	COL2A1		Stickler syndrome type 1	Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000017373					17373	32412		
NM_001844.5(COL2A1):c.908G>A (p.Gly303Asp)	COL2A1	G103D, G234D, G303D	Kniest dysplasia|not provided	Pathogenic(Last reviewed: Oct 2, 2014)	criteria provided, single submitter	VCV000017370	12	48387608	12	47993825	17370	32409	rs121912877	NC_000012.12:47993824:C:T
COL2A1, 1-BP DEL, EX40	COL2A1		Stickler syndrome type 1	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000017358					17358	32397		
NM_181486.4(TBX5):c.710G>A (p.Arg237Gln)	TBX5	R237Q, R187Q	Holt-Oram syndrome|not provided|Aortic valve disease 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007993	12	114823326	12	114385521	7993	23032	rs104894378	NC_000012.12:114385520:C:T
NM_001844.5(COL2A1):c.2101C>T (p.Arg701Ter)	COL2A1	R701*, R632*	Stickler syndrome type 1|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449397	12	48376723	12	47982940	449397	445007	rs1555166555	NC_000012.12:47982939:G:A
NM_001844.5(COL2A1):c.1597C>T (p.Arg533Ter)	COL2A1	R533*, R464*	not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426404	12	48379594	12	47985811	426404	415335	rs1085307608	NC_000012.12:47985810:G:A
NM_001844.5(COL2A1):c.3508G>A (p.Gly1170Ser)	COL2A1	G1170S, G1101S	Avascular necrosis of the head of femur|Coxa plana	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000017393	12	48369835	12	47976052	17393	32432	rs121912891	NC_000012.12:47976051:C:T
COL2A1, IVS17, A-G, -2	COL2A1		Stickler syndrome type 1	Pathogenic(Last reviewed: Jun 14, 1996)	no assertion criteria provided	VCV000017374					17374	32413		
COL2A1, 28-BP DEL	COL2A1		Kniest dysplasia	Pathogenic(Last reviewed: Jul 16, 1999)	no assertion criteria provided	VCV000017362					17362	32401		
NM_001844.5(COL2A1):c.3589G>A (p.Gly1197Ser)	COL2A1	G997S, G1128S, G1197S	not provided|Spondyloepiphyseal dysplasia congenita	Pathogenic/Likely pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000017361	12	48369754	12	47975971	17361	32400	rs121912870	NC_000012.12:47975970:C:T
NM_001844.5(COL2A1):c.4172A>G (p.Tyr1391Cys)	COL2A1	Y1391C, Y1322C	|Spondyloperipheral dysplasia-short ulna syndrome	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000017389	12	48368017	12	47974234	17389	32428	rs121912889	NC_000012.12:47974233:T:C
NM_001844.5(COL2A1):c.1510G>T (p.Gly504Cys)	COL2A1	G304C, G435C, G504C	not provided|Spondylometaphyseal dysplasia	Pathogenic(Last reviewed: Apr 17, 2015)	criteria provided, single submitter	VCV000017377	12	48380136	12	47986353	17377	32416	rs121912880	NC_000012.12:47986352:C:A
NM_001844.5(COL2A1):c.2794C>T (p.Arg932Ter)	COL2A1	R732*, R863*, R932*	not provided|Stickler syndrome type 1	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000017355	12	48372481	12	47978698	17355	32394	rs121912866	NC_000012.12:47978697:G:A
NM_001844.5(COL2A1):c.2155C>T (p.Arg719Cys)	COL2A1	R519C, R650C, R719C	Osteoarthritis with mild chondrodysplasia	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000017353	12	48376669	12	47982886	17353	32392	rs121912865	NC_000012.12:47982885:G:A
NM_032444.4(SLX4):c.4391_4403del (p.Ser1464fs)	SLX4	S1464fs	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803195	16	3639236 - 3639248	16	3589235 - 3589247	803195	791608		NC_000016.10:3589234:CGACAGTCACGGC:
NM_032444.4(SLX4):c.4405del (p.Ser1469fs)	SLX4	S1469fs	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803194	16	3639234	16	3589233	803194	791607		NC_000016.10:3589232:A:
NM_000018.4(ACADVL):c.1843C>T (p.Arg615Ter)	ACADVL	R615*, R539*, R638*, R593*	not provided|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379145	17	7128291	17	7224972	379145	378757	rs1057520507	NC_000017.11:7224971:C:T
NM_000018.4(ACADVL):c.553G>A (p.Gly185Ser)	ACADVL	G185S, G163S, G109S, G208S	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203595	17	7124932	17	7221613	203595	200323	rs545215807	NC_000017.11:7221612:G:A
NM_000018.2(ACADVL):c.343delG (p.Glu115Lysfs)	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001624	17	7124242	17	7220923	1624	16663	rs387906249	NC_000017.11:7220922:GG:G
NM_000018.4(ACADVL):c.1182+1G>A	ACADVL		not provided|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001622	17	7126557	17	7223238	1622	16661	rs113690956	NC_000017.11:7223237:G:A
SLX4, 4,890-BP DEL/2-BP INS	SLX4		Fanconi anemia, complementation group P	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000031026					31026	39983		
NM_032444.4(SLX4):c.514del (p.Leu172fs)	SLX4	L172fs	Fanconi anemia, complementation group P	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000031025	16	3658452	16	3608451	31025	39982	rs1567178071	NC_000016.10:3608450:GG:G
NM_032444.4(SLX4):c.1163+2T>A	SLX4		Fanconi anemia, complementation group P	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000031024	16	3650978	16	3600977	31024	39981	rs773642409	NC_000016.10:3600976:A:T
SLX4, IVS5DS, 1-BP DUP, T, +3	SLX4		Fanconi anemia, complementation group P	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000031023					31023	39980		
NM_032444.4(SLX4):c.1093del (p.Gln365fs)	SLX4	Q365fs	Fanconi anemia, complementation group P	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000031022	16	3651050	16	3601049	31022	39979		NC_000016.10:3601048:GGGGG:GGGG
NM_032444.4(SLX4):c.286del (p.Thr96fs)	SLX4	T96fs	Fanconi anemia, complementation group P	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000031021	16	3658680	16	3608679	31021	39978		NC_000016.10:3608678:TTT:TT
NM_000303.3(PMM2):c.623G>C (p.Gly208Ala)	PMM2	G208A	Congenital disorder of glycosylation, type Ia|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092804	16	8906947	16	8813090	92804	98711	rs398123309	NC_000016.10:8813089:G:C
NM_032444.4(SLX4):c.4133del (p.Pro1378fs)	SLX4	P1378fs	Fanconi anemia	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000861469	16	3639506	16	3589505	861469	843821		NC_000016.10:3589504:GG:G
NM_032444.4(SLX4):c.559C>T (p.Gln187Ter)	SLX4	Q187*	Fanconi anemia	Pathogenic(Last reviewed: Mar 9, 2019)	criteria provided, single submitter	VCV000859189	16	3656676	16	3606675	859189	843857		NC_000016.10:3606674:G:A
NM_032444.4(SLX4):c.3955C>T (p.Gln1319Ter)	SLX4	Q1319*	Fanconi anemia	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000836359	16	3639684	16	3589683	836359	843824		NC_000016.10:3589682:G:A
NC_000016.10:g.(?_3606464)_(3608974_?)del	SLX4		Fanconi anemia	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000831292	16	3656465 - 3658975			831292	820827		
NM_032444.4(SLX4):c.1880_1887del (p.Pro627fs)	SLX4	P627fs	Fanconi anemia	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000639031	16	3646191 - 3646198	16	3596190 - 3596197	639031	644665		NC_000016.10:3596189:GGGCCACGGG:GG
NM_032444.4(SLX4):c.2449del (p.Glu817fs)	SLX4	E817fs	Fanconi anemia	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000576783	16	3641190	16	3591189	576783	568119	rs1567170994	NC_000016.10:3591188:CC:C
NM_032444.4(SLX4):c.59del (p.Leu20fs)	SLX4	L20fs	Fanconi anemia	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000526372	16	3658907	16	3608906	526372	530096	rs1315905872	NC_000016.10:3608905:A:
NM_032444.4(SLX4):c.2137C>T (p.Arg713Ter)	SLX4	R713*	Fanconi anemia	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000526348	16	3644477	16	3594476	526348	530509	rs760126773	NC_000016.10:3594475:G:A
NM_032444.4(SLX4):c.860del (p.Ser287fs)	SLX4	S287fs	Fanconi anemia	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000456341	16	3652209	16	3602208	456341	466455	rs752720263	NC_000016.10:3602207:C:
NC_000016.9:g.(?_3658431)_(3659567_?)del	SLX4		Fanconi anemia	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000417419	16	3658431 - 3659567	16	3608430 - 3609566	417419	401333		
NM_032444.4(SLX4):c.3726_3729del (p.Ser1243fs)	SLX4	S1243fs	Fanconi anemia	Pathogenic(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	VCV000241682	16	3639910 - 3639913	16	3589909 - 3589912	241682	242413	rs878855162	NC_000016.10:3589908:GCTC:
NM_001605.2(AARS1):c.986G>A (p.Arg329His)	AARS1	R329H	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2N	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008466	16	70302259	16	70268356	8466	23505	rs267606621	NC_000016.10:70268355:C:T
NM_152443.3(RDH12):c.295C>A (p.Leu99Ile)	RDH12	L99I	Retinal dystrophy|Leber congenital amaurosis 13|Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002055	14	68191923	14	67725206	2055	17094	rs28940315	NC_000014.9:67725205:C:A
NM_001844.5(COL2A1):c.491del (p.Pro164fs)	COL2A1	P164fs, P95fs	not provided|Stickler syndrome type 1	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000689620	12	48391429	12	47997646	689620	677295		NC_000012.12:47997645:GGGGGG:GGGGG
NM_001844.5(COL2A1):c.719G>A (p.Gly240Asp)	COL2A1	G171D, G240D	not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000663729	12	48389081	12	47995298	663729	641140		NC_000012.12:47995297:C:T
NM_001844.5(COL2A1):c.1999C>T (p.Leu667Phe)	COL2A1	L467F, L598F, L667F	Stickler syndrome, type I, nonsyndromic ocular|Stickler syndrome type 1	Pathogenic(Last reviewed: Sep 11, 2014)	no assertion criteria provided	VCV000017384	12	48377218	12	47983435	17384	32423	rs121912885	NC_000012.12:47983434:G:A
NM_001844.5(COL2A1):c.3138del (p.Gly1047fs)	COL2A1	P846*, G978fs, G1047fs	not provided|Stickler syndrome type 1	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000017365	12	48371410	12	47977627	17365	32404	rs121912873	NC_000012.12:47977626:A:
NM_001844.5(COL2A1):c.625C>T (p.Arg209Ter)	COL2A1	R9*, R140*, R209*	not provided|Stickler syndrome type 1	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000017360	12	48389687	12	47995904	17360	32399	rs121912869	NC_000012.12:47995903:G:A
NM_000369.2(TSHR):c.1349G>A (p.Arg450His)	TSHR	R450H	Congenital hypothyroidism|not provided|Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000225505	14	81609751	14	81143407	225505	227362	rs189261858	NC_000014.9:81143406:G:A
NM_004004.6(GJB2):c.370C>T (p.Gln124Ter)	GJB2	Q124*	Deafness, autosomal recessive 1A|Rare genetic deafness|Hearing loss	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, multiple submitters, no conflicts	VCV000044744	13	20763351	13	20189212	44744	53911	rs397516874	NC_000013.11:20189211:G:A
NM_032444.4(SLX4):c.4862del (p.Leu1621fs)	SLX4	L1621fs	Fanconi anemia	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000578780	16	3633389	16	3583388	578780	570145	rs1567166544	NC_000016.10:3583387:AA:A
NM_201631.4(TGM5):c.337G>T (p.Gly113Cys)	TGM5	G113C	Inborn genetic diseases|Peeling skin syndrome 2|not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006039	15	43552349	15	43260151	6039	21078	rs112292549	NC_000015.10:43260150:C:A
NM_013275.6(ANKRD11):c.3220_3223AAAG[1] (p.Glu1075fs)	ANKRD11		KBG syndrome|not provided	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420179	16	89349723 - 89349726	16	89283315 - 89283318	420179	409796	rs1064794330	NC_000016.10:89283314:CTTTCTTT:CTTT
NM_013275.6(ANKRD11):c.2171_2174CAAA[1] (p.Asn725fs)	ANKRD11		KBG syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265689	16	89350772 - 89350775	16	89284364 - 89284367	265689	260140	rs886039734	NC_000016.10:89284363:TTTGTTTGT:TTTGT
NM_024312.5(GNPTAB):c.1123C>T (p.Arg375Ter)	GNPTAB	R375*	Pseudo-Hurler polydystrophy|not provided||Pseudo-Hurler polydystrophy|GNPTAB-Related Disorders|	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039022	12	102163960	12	101770182	39022	47625	rs397507447	NC_000012.12:101770181:G:A
NM_024312.5(GNPTAB):c.3335+6T>G	GNPTAB		Mucopolysaccharidosis, MPS-III-A||Pseudo-Hurler polydystrophy|Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002773	12	102151344	12	101757566	2773	17812	rs34788341	NC_000012.12:101757565:A:C
NM_000086.2(CLN3):c.1001G>A (p.Arg334His)	CLN3	R334H, R310H, R234H, R256H, R280H	Juvenile neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056244	16	28493481	16	28482160	56244	70883	rs386833695	NC_000016.10:28482159:C:T
NM_003119.4(SPG7):c.861dup (p.Asn288Ter)	SPG7		not provided|Mitochondrial diseases|Hereditary spastic paraplegia 7	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212294	16	89595983 - 89595984	16	89529575 - 89529576	212294	208318	rs797046003	NC_000016.10:89529575:TTTT:TTTTT
NM_002834.5(PTPN11):c.1504T>G (p.Ser502Ala)	PTPN11	S502A, S506A, S501A	not provided|Juvenile myelomonocytic leukemia|Noonan syndrome	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040556	12	112926884	12	112489080	40556	49026	rs121918458	NC_000012.12:112489079:T:G
NM_002834.5(PTPN11):c.1471C>A (p.Pro491Thr)	PTPN11	P491T, P495T, P490T	Rasopathy|Noonan syndrome|not provided|Noonan syndrome 1	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040549	12	112926851	12	112489047	40549	49019	rs397507539	NC_000012.12:112489046:C:A
NM_031885.4(BBS2):c.823C>T (p.Arg275Ter)	BBS2	R275*	Retinitis pigmentosa 74|Bardet-Biedl syndrome 2|not provided|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2|Retinal dystrophy	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004572	16	56536702	16	56502790	4572	19611	rs121908177	NC_000016.10:56502789:G:A
NM_000153.4(GALC):c.1700A>C (p.Tyr567Ser)	GALC	Y567S, Y544S, Y541S	Galactosylceramide beta-galactosidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188969	14	88407873	14	87941529	188969	186914	rs752537626	NC_000014.9:87941528:T:G
NM_005262.3(GFER):c.581G>A (p.Arg194His)	GFER	R194H	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000008691	16	2035992	16	1985991	8691	23730	rs121908192	NC_000016.10:1985990:G:A
NM_004380.3(CREBBP):c.3707_3719delinsCTGTGATCTTGCTGACAGGTATCA (p.Phe1236fs)	CREBBP		not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000817900	16	3801787 - 3801799	16	3751786 - 3751798	817900	805883		NC_000016.10:3751785:CACTTCTCACAGA:TGATACCTGTCAGCAAGATCACAG
NM_001079846.1(CREBBP):c.886dup (p.Gln296fs)	CREBBP		not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000594609	16	3860692 - 3860693	16	3810691 - 3810692	594609	585672	rs1567331357	NC_000016.10:3810691:GGGGG:GGGGGG
NM_001079846.1(CREBBP):c.5553dup (p.Pro1852fs)	CREBBP		not provided	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000524148	16	3779380 - 3779381	16	3729379 - 3729380	524148	514696	rs1555471336	NC_000016.10:3729379:C:CC
NM_001079846.1(CREBBP):c.3930_3943del (p.Gln1311fs)	CREBBP	Q1311fs, Q1349fs	not provided	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000504172	16	3790476 - 3790489	16	3740475 - 3740488	504172	495618	rs1555473890	NC_000016.10:3740474:CAGGGTGATTCTGGC:C
NM_001079846.1(CREBBP):c.6106del (p.Thr2035_Leu2036insTer)	CREBBP		not provided	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000503883	16	3778828	16	3728827	503883	495628	rs1555471086	NC_000016.10:3728826:GGG:GG
NM_001079846.1(CREBBP):c.4395C>G (p.Tyr1465Ter)	CREBBP	Y1503*, Y1465*	not provided	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000497642	16	3786702	16	3736701	497642	489066	rs1555473105	NC_000016.10:3736700:G:C
NM_001079846.1(CREBBP):c.1957C>T (p.Gln653Ter)	CREBBP	Q691*, Q653*	not provided	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000488688	16	3828054	16	3778053	488688	482100	rs1555483689	NC_000016.10:3778052:G:A
NM_001079846.1(CREBBP):c.6079_6085dup (p.Leu2029fs)	CREBBP		not provided	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000430476	16	3778848 - 3778849	16	3728847 - 3728848	430476	422095	rs1131691988	NC_000016.10:3728847:GAGCGCTG:GAGCGCTGAGCGCTG
GRCh37/hg19 16p13.3(chr16:3922991-4004415)x1	CREBBP		See cases	Pathogenic	no assertion criteria provided	VCV000396014	16	3922991 - 4004415			396014	382907		
NM_001079846.1(CREBBP):c.2188C>T (p.Arg730Ter)	CREBBP	R768*, R730*	not provided	Pathogenic(Last reviewed: Apr 19, 2015)	criteria provided, single submitter	VCV000379578	16	3823913	16	3773912	379578	377560	rs1057520652	NC_000016.10:3773911:G:A
NM_001079846.1(CREBBP):c.2545C>T (p.Gln849Ter)	CREBBP	Q887*, Q849*	not provided	Pathogenic(Last reviewed: Apr 2, 2015)	criteria provided, single submitter	VCV000379373	16	3820792	16	3770791	379373	375155	rs1057520589	NC_000016.10:3770790:G:A
NM_001079846.1(CREBBP):c.3495+1G>A	CREBBP		not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000280728	16	3807809	16	3757808	280728	264791	rs886041879	NC_000016.10:3757807:C:T
NM_001079846.1(CREBBP):c.6127C>T (p.Gln2043Ter)	CREBBP	Q2081*, Q2043*	not provided	Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	VCV000280284	16	3778807	16	3728806	280284	264789	rs886041518	NC_000016.10:3728805:G:A
NM_001079846.1(CREBBP):c.2727dup (p.Gln910fs)	CREBBP		not provided	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000280222	16	3820609 - 3820610	16	3770608 - 3770609	280222	264810	rs886041468	NC_000016.10:3770608:TT:TTT
NM_001079846.1(CREBBP):c.5896C>T (p.Arg1966Ter)	CREBBP	R2004*, R1966*	not provided	Pathogenic(Last reviewed: Feb 21, 2016)	criteria provided, single submitter	VCV000265084	16	3779038	16	3729037	265084	260115	rs886039331	NC_000016.10:3729036:G:A
NM_001079846.1(CREBBP):c.3879del (p.Thr1294fs)	CREBBP	T1294fs, T1332fs	not provided	Pathogenic(Last reviewed: Dec 12, 2014)	criteria provided, single submitter	VCV000195820	16	3790540	16	3740539	195820	192981	rs794727391	NC_000016.10:3740538:GG:G
NM_001079846.1(CREBBP):c.2571del (p.Gln859fs)	CREBBP	Q859fs, Q897fs	not provided	Pathogenic(Last reviewed: Oct 20, 2014)	criteria provided, single submitter	VCV000194386	16	3820766	16	3770765	194386	191549	rs794727124	NC_000016.10:3770764:GG:G
NM_001079846.1(CREBBP):c.910del (p.Val304fs)	CREBBP	V304fs	not provided	Pathogenic(Last reviewed: Mar 18, 2013)	criteria provided, single submitter	VCV000095069	16	3860669	16	3810668	95069	100969	rs398124150	NC_000016.10:3810667:CC:C
NM_001079846.1(CREBBP):c.3223C>T (p.Gln1075Ter)	CREBBP	Q1113*, Q1075*	not provided	Pathogenic(Last reviewed: Mar 18, 2013)	criteria provided, single submitter	VCV000095043	16	3808887	16	3758886	95043	100943	rs398124144	NC_000016.10:3758885:G:A
NM_001079846.1(CREBBP):c.1555del (p.Ala519fs)	CREBBP	A557fs, A519fs	not provided	Pathogenic(Last reviewed: Apr 10, 2013)	criteria provided, single submitter	VCV000095027	16	3831212	16	3781211	95027	100927	rs398124139	NC_000016.10:3781210:CCCCC:CCCC
NM_004380.3(CREBBP):c.49del (p.Leu17fs)	CREBBP	L17fs	Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000859497	16	3929869	16	3879868	859497	843871		NC_000016.10:3879867:G:
NM_004380.3(CREBBP):c.1360C>T (p.Gln454Ter)	CREBBP	Q454*, Q416*	Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000853646	16	3832898	16	3782897	853646	843867		NC_000016.10:3782896:G:A
NM_004380.3(CREBBP):c.1941+5G>A	CREBBP		Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000852536	16	3828696	16	3778695	852536	852820		NC_000016.10:3778694:C:T
NM_004380.3(CREBBP):c.2794del (p.Thr932fs)	CREBBP	T932fs, T894fs	Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000846543	16	3820657	16	3770656	846543	843866		NC_000016.10:3770655:TTT:TT
NM_004380.3(CREBBP):c.567del (p.Asn190fs)	CREBBP	N190fs	Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000842619	16	3900529	16	3850528	842619	843868		NC_000016.10:3850527:G:
NC_000016.10:g.(?_3810583)_(3879936_?)del	CREBBP		Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000832520	16	3860584 - 3929937			832520	820834		
NC_000016.10:g.(?_3757268)_(3757396_?)del	CREBBP		Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000832459	16	3807269 - 3807397			832459	820832		
NC_000016.10:g.(?_3791961)_(3792114_?)del	CREBBP		Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000831143	16	3841962 - 3842115			831143	820833		
NM_004380.3(CREBBP):c.1694del (p.Gly565fs)	CREBBP	G527fs, G565fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803205	16	3830862	16	3780861	803205	791618		NC_000016.10:3780860:CC:C
NM_004380.3(CREBBP):c.2322del (p.Asn774fs)	CREBBP	N736fs, N774fs	Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000658712	16	3823893	16	3773892	658712	644682		NC_000016.10:3773891:G:
NM_004380.3(CREBBP):c.1855dup (p.Ala619fs)	CREBBP		Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000658697	16	3828786 - 3828787	16	3778785 - 3778786	658697	644684		NC_000016.10:3778785:C:CC
NM_001079846.1(CREBBP):c.314_315del (p.Gly105fs)	CREBBP	G105fs	Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Dec 15, 2018)	criteria provided, single submitter	VCV000654784	16	3900781 - 3900782	16	3850780 - 3850781	654784	644685		NC_000016.10:3850779:CCC:C
NC_000016.9:g.(?_3830713)_(3831327_?)del	CREBBP		Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000651826	16	3830713 - 3831327	16	3780712 - 3781326	651826	652851		
NM_001079846.1(CREBBP):c.2641C>T (p.Gln881Ter)	CREBBP	Q881*, Q919*	Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000649692	16	3820696	16	3770695	649692	644681		NC_000016.10:3770694:G:A
NM_001079846.1(CREBBP):c.4445A>G (p.Lys1482Arg)	CREBBP	K1520R, K1482R	Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000645503	16	3786652	16	3736651	645503	644679		NC_000016.10:3736650:T:C
NM_001079846.1(CREBBP):c.1891_1892delinsT (p.Lys630_Arg631insTer)	CREBBP		Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000639046	16	3828119 - 3828120	16	3778118 - 3778119	639046	644683		NC_000016.10:3778117:CG:A
NM_001079846.1(CREBBP):c.5056G>A (p.Glu1686Lys)	CREBBP	E1724K, E1686K	Menke-Hennekam syndrome 1	Pathogenic(Last reviewed: Feb 22, 2019)	no assertion criteria provided	VCV000619094	16	3781195	16	3731194	619094	610492	rs1567265131	NC_000016.10:3731193:C:T
NM_001079846.1(CREBBP):c.5014T>C (p.Cys1672Arg)	CREBBP	C1710R, C1672R	Menke-Hennekam syndrome 1	Pathogenic(Last reviewed: Feb 22, 2019)	no assertion criteria provided	VCV000619090	16	3781237	16	3731236	619090	610488	rs1567265203	NC_000016.10:3731235:A:G
NC_000016.9:g.(?_3817701)_(3817930_?)dup	CREBBP		Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000583499	16	3817701 - 3817930	16	3767700 - 3767929	583499	567503		
NM_001079846.1(CREBBP):c.3227del (p.Pro1076fs)	CREBBP	P1076fs, P1114fs	not provided	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000376855	16	3808883	16	3758882	376855	363733	rs1057520072	NC_000016.10:3758881:GG:G
GRCh38/hg38 16p13.3(chr16:3850966-3884581)x1	CREBBP		See cases	Pathogenic(Last reviewed: Nov 26, 2012)	no assertion criteria provided	VCV000155107	16	3900967 - 3934582	16	3850966 - 3884581	155107	164861		
GRCh38/hg38 16p13.3(chr16:3726714-3759009)x1	CREBBP		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000145541	16	3776715 - 3809010	16	3726714 - 3759009	145541	155292		
GRCh38/hg38 16p13.3(chr16:3861794-3904192)x1	CREBBP		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059431	16	3911795 - 3954193	16	3861794 - 3904192	59431	74026		
GRCh38/hg38 16p13.3(chr16:3750305-3769722)x3	CREBBP		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058623	16	3800306 - 3819723	16	3750305 - 3769722	58623	73218		
NM_004380.3(CREBBP):c.5845dup (p.Ala1949fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694832	16	3779202 - 3779203	16	3729201 - 3729202	694832	682870		NC_000016.10:3729201:CC:CCC
NM_004380.3(CREBBP):c.5790dup (p.Thr1931fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694831	16	3779257 - 3779258	16	3729256 - 3729257	694831	682871		NC_000016.10:3729256:GGGGGG:GGGGGGG
NM_004380.3(CREBBP):c.5722del (p.Gln1908fs)	CREBBP	Q1870fs, Q1908fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694830	16	3779326	16	3729325	694830	682872		NC_000016.10:3729324:GGG:GG
NM_004380.3(CREBBP):c.4890+1G>A	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694828	16	3781776	16	3731775	694828	682936		NC_000016.10:3731774:C:T
NM_004380.3(CREBBP):c.4728+2del	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694827	16	3786035	16	3736034	694827	682937		NC_000016.10:3736033:A:
NM_004380.3(CREBBP):c.4644_4646dup (p.Leu1549dup)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694826	16	3786118 - 3786119	16	3736117 - 3736118	694826	682874		NC_000016.10:3736117:AACA:AACAACA
NM_004380.3(CREBBP):c.4458_4459insT (p.His1487fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694822	16	3786752 - 3786753	16	3736751 - 3736752	694822	682878		NC_000016.10:3736751::A
NM_004380.3(CREBBP):c.3832del (p.Glu1278fs)	CREBBP	E1240fs, E1278fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694821	16	3799632	16	3749631	694821	682891		NC_000016.10:3749630:C:
NM_004380.3(CREBBP):c.3779+1G>T	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694820	16	3801726	16	3751725	694820	682940		NC_000016.10:3751724:C:A
NM_004380.3(CREBBP):c.3690T>G (p.Tyr1230Ter)	CREBBP	Y1192*, Y1230*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694817	16	3807297	16	3757296	694817	682893		NC_000016.10:3757295:A:C
NM_004380.3(CREBBP):c.3661_3665del (p.Ile1221fs)	CREBBP	I1183fs, I1221fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694816	16	3807322 - 3807326	16	3757321 - 3757325	694816	682894		NC_000016.10:3757320:GGAATGG:GG
NM_004380.3(CREBBP):c.3659_3660delinsATGGTA (p.Thr1220fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694815	16	3807327 - 3807328	16	3757326 - 3757327	694815	682895		NC_000016.10:3757325:GG:TACCAT
NM_004380.3(CREBBP):c.3625C>T (p.Gln1209Ter)	CREBBP	Q1171*, Q1209*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694814	16	3807362	16	3757361	694814	682896		NC_000016.10:3757360:G:A
NM_004380.3(CREBBP):c.3610-2A>G	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694813	16	3807379	16	3757378	694813	682943		NC_000016.10:3757377:T:C
NM_004380.3(CREBBP):c.3610-1G>C	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694812	16	3807378	16	3757377	694812	682942		NC_000016.10:3757376:C:G
NM_004380.3(CREBBP):c.3432_3433del (p.Gly1145fs)	CREBBP	G1107fs, G1145fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694810	16	3807986 - 3807987	16	3757985 - 3757986	694810	682898		NC_000016.10:3757984:CT:
NM_004380.3(CREBBP):c.2456dup (p.Ser820fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694809	16	3823758 - 3823759	16	3773757 - 3773758	694809	682913		NC_000016.10:3773757:A:AA
NM_004380.3(CREBBP):c.2330del (p.Gly777fs)	CREBBP	G739fs, G777fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694807	16	3823885	16	3773884	694807	682915		NC_000016.10:3773883:CCC:CC
NM_004380.3(CREBBP):c.2159-1G>T	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694806	16	3824695	16	3774694	694806	682945		NC_000016.10:3774693:C:A
NM_004380.3(CREBBP):c.1941+2T>C	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694805	16	3828699	16	3778698	694805	682946		NC_000016.10:3778697:A:G
NM_004380.3(CREBBP):c.1907_1912del (p.Val636_Glu637del)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694804	16	3828730 - 3828735	16	3778729 - 3778734	694804	682916		NC_000016.10:3778728:CTTCCACTT:CTT
NM_004380.3(CREBBP):c.1824-1G>A	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694803	16	3828819	16	3778818	694803	682947		NC_000016.10:3778817:C:T
NM_004380.3(CREBBP):c.1646C>G (p.Ser549Ter)	CREBBP	S511*, S549*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694801	16	3831235	16	3781234	694801	682918		NC_000016.10:3781233:G:C
NM_004380.3(CREBBP):c.1573+1G>A	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694800	16	3832684	16	3782683	694800	682948		NC_000016.10:3782682:C:T
NM_004380.3(CREBBP):c.1549C>T (p.Gln517Ter)	CREBBP	Q479*, Q517*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694799	16	3832709	16	3782708	694799	682919		NC_000016.10:3782707:G:A
NM_004380.3(CREBBP):c.1483C>T (p.Gln495Ter)	CREBBP	Q495*, Q457*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694798	16	3832775	16	3782774	694798	682920		NC_000016.10:3782773:G:A
NM_004380.3(CREBBP):c.1225_1231del (p.Cys409fs)	CREBBP	C409fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694797	16	3842081 - 3842087	16	3792080 - 3792086	694797	682921		NC_000016.10:3792079:ATGCACAATG:ATG
NM_004380.3(CREBBP):c.1216+2T>A	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694796	16	3843385	16	3793384	694796	682949		NC_000016.10:3793383:A:T
NM_004380.3(CREBBP):c.6395_6417del (p.Gly2132fs)	CREBBP	G2094fs, G2132fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694795	16	3778631 - 3778653	16	3728630 - 3728652	694795	682865		NC_000016.10:3728629:CAGGCTGGGCTGCTGGTGCATGCCAGGCTGGG:CAGGCTGGG
NM_004380.3(CREBBP):c.6221_6230del (p.Leu2074fs)	CREBBP	L2036fs, L2074fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694794	16	3778818 - 3778827	16	3728817 - 3728826	694794	682866		NC_000016.10:3728816:GGCGACTTCAGG:GG
NM_004380.3(CREBBP):c.6113_6137dup (p.Ala2047fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694793	16	3778910 - 3778911	16	3728909 - 3728910	694793	682868		NC_000016.10:3728909:GCCTGGGCCTGCATGGATATCACAGGCCTGGGC:GCCTGGGCCTGCATGGATATCACAGGCCTGGGCCTGCATGGATATCACAGGCCTGGGC
NM_004380.3(CREBBP):c.6113_6137del (p.Pro2038fs)	CREBBP	P2000fs, P2038fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694792	16	3778911 - 3778935	16	3728910 - 3728934	694792	682867		NC_000016.10:3728909:GCCTGGGCCTGCATGGATATCACAGGCCTGGGC:GCCTGGGC
NM_004380.3(CREBBP):c.5986del (p.Ala1996fs)	CREBBP	A1958fs, A1996fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694791	16	3779062	16	3729061	694791	682869		NC_000016.10:3729060:CC:C
NM_004380.3(CREBBP):c.4290C>A (p.Tyr1430Ter)	CREBBP	Y1430*, Y1392*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694786	16	3788664	16	3738663	694786	682882		NC_000016.10:3738662:G:T
NM_004380.3(CREBBP):c.4243C>T (p.Gln1415Ter)	CREBBP	Q1377*, Q1415*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694783	16	3789616	16	3739615	694783	682885		NC_000016.10:3739614:G:A
NM_004380.3(CREBBP):c.4174C>T (p.Arg1392Ter)	CREBBP	R1392*, R1354*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694781	16	3789685	16	3739684	694781	682887		NC_000016.10:3739683:G:A
NM_004380.3(CREBBP):c.4078dup (p.Arg1360fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694779	16	3790454 - 3790455	16	3740453 - 3740454	694779	682889		NC_000016.10:3740453:GG:GGG
NM_004380.3(CREBBP):c.3914+1G>A	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694777	16	3795277	16	3745276	694777	682939		NC_000016.10:3745275:C:T
NM_004380.3(CREBBP):c.3366dup (p.Pro1123fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694776	16	3808857 - 3808858	16	3758856 - 3758857	694776	682899		NC_000016.10:3758856:AA:AAA
NM_004380.3(CREBBP):c.3330_3334del (p.Phe1111fs)	CREBBP	F1073fs, F1111fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694775	16	3808890 - 3808894	16	3758889 - 3758893	694775	682900		NC_000016.10:3758888:GGAAAGG:GG
NM_004380.3(CREBBP):c.3292del (p.Thr1097_Leu1098insTer)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694774	16	3808932	16	3758931	694774	682901		NC_000016.10:3758930:GGG:GG
NM_004380.3(CREBBP):c.3168dup (p.Val1057fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694773	16	3817802 - 3817803	16	3767801 - 3767802	694773	682902		NC_000016.10:3767801:TTT:TTTT
NM_004380.3(CREBBP):c.3097A>T (p.Lys1033Ter)	CREBBP	K995*, K1033*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694772	16	3817874	16	3767873	694772	682903		NC_000016.10:3767872:T:A
NM_004380.3(CREBBP):c.3060+1G>T	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694771	16	3819174	16	3769173	694771	682944		NC_000016.10:3769172:C:A
NM_004380.3(CREBBP):c.3058G>T (p.Glu1020Ter)	CREBBP	E1020*, E982*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694770	16	3819177	16	3769176	694770	682904		NC_000016.10:3769175:C:A
NM_004380.3(CREBBP):c.3020_3021dup (p.Pro1008fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694769	16	3819213 - 3819214	16	3769212 - 3769213	694769	682905		NC_000016.10:3769212:CTC:CTCTC
NM_004380.3(CREBBP):c.2911A>T (p.Arg971Ter)	CREBBP	R933*, R971*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694768	16	3819324	16	3769323	694768	682906		NC_000016.10:3769322:T:A
NM_004380.3(CREBBP):c.2910dup (p.Arg971fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694767	16	3819324 - 3819325	16	3769323 - 3769324	694767	682907		NC_000016.10:3769323:G:GG
NM_004380.3(CREBBP):c.2854_2863dup (p.Gln955fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694766	16	3820587 - 3820588	16	3770586 - 3770587	694766	682908		NC_000016.10:3770586:GGGCGTGCAC:GGGCGTGCACGGGCGTGCAC
NM_004380.3(CREBBP):c.2817_2818delinsT (p.Ala940fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694765	16	3820633 - 3820634	16	3770632 - 3770633	694765	682909		NC_000016.10:3770631:CC:A
NM_004380.3(CREBBP):c.2787dup (p.Pro930fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694764	16	3820663 - 3820664	16	3770662 - 3770663	694764	682910		NC_000016.10:3770662:C:CC
NM_004380.3(CREBBP):c.2773C>T (p.Gln925Ter)	CREBBP	Q887*, Q925*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694763	16	3820678	16	3770677	694763	682911		NC_000016.10:3770676:G:A
NM_004380.3(CREBBP):c.2713_2719del (p.Ser905fs)	CREBBP	S867fs, S905fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694762	16	3820732 - 3820738	16	3770731 - 3770737	694762	682912		NC_000016.10:3770730:GCACTGAGC:GC
NM_004380.3(CREBBP):c.1125_1126AG[3] (p.Val377fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694761	16	3843474 - 3843475	16	3793473 - 3793474	694761	682922		NC_000016.10:3793473:CTCTC:CTCTCTC
NM_004380.3(CREBBP):c.1124del (p.Gly375fs)	CREBBP	G375fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694760	16	3843479	16	3793478	694760	682923		NC_000016.10:3793477:CC:C
NM_004380.3(CREBBP):c.1108C>T (p.Arg370Ter)	CREBBP	R370*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000694759	16	3843495	16	3793494	694759	682924		NC_000016.10:3793493:G:A
NM_004380.3(CREBBP):c.1044del (p.Glu349fs)	CREBBP	E349fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694758	16	3843559	16	3793558	694758	682925		NC_000016.10:3793557:A:
NM_004380.3(CREBBP):c.997G>T (p.Gly333Ter)	CREBBP	G333*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694757	16	3843606	16	3793605	694757	682926		NC_000016.10:3793604:C:A
NM_004380.3(CREBBP):c.967_974dup (p.Met325fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694756	16	3860604 - 3860605	16	3810603 - 3810604	694756	682927		NC_000016.10:3810603:ATATTTGG:ATATTTGGATATTTGG
NM_004380.3(CREBBP):c.662_698del (p.Gly221fs)	CREBBP	G221fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694754	16	3900398 - 3900434	16	3850397 - 3850433	694754	682929		NC_000016.10:3850396:CCCTGCATGGCTGGAGTAGGGTACGGCATTCCAGCTCCCCT:CCCT
NM_004380.3(CREBBP):c.613C>T (p.Gln205Ter)	CREBBP	Q205*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694753	16	3900483	16	3850482	694753	682930		NC_000016.10:3850481:G:A
NM_004380.3(CREBBP):c.494_507del (p.Ser165fs)	CREBBP	S165fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694752	16	3900589 - 3900602	16	3850588 - 3850601	694752	682931		NC_000016.10:3850587:TGACGTGGCAGGGCTG:TG
NM_004380.3(CREBBP):c.376G>T (p.Gly126Ter)	CREBBP	G126*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694750	16	3900720	16	3850719	694750	682933		NC_000016.10:3850718:C:A
NM_004380.3(CREBBP):c.243_244insTA (p.Ile82Ter)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694749	16	3900852 - 3900853	16	3850851 - 3850852	694749	682934		NC_000016.10:3850851::TA
NM_004380.3(CREBBP):c.173_185del (p.Asn58fs)	CREBBP	N58fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694748	16	3900911 - 3900923	16	3850910 - 3850922	694748	682935		NC_000016.10:3850909:TCTGGAACAAGGTTC:TC
NM_004380.3(CREBBP):c.6436C>T (p.Gln2146Ter)	CREBBP	Q2108*, Q2146*	Rubinstein-Taybi syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694717	16	3778612	16	3728611	694717	682825		NC_000016.10:3728610:G:A
NM_004380.3(CREBBP):c.4206del (p.Ile1402fs)	CREBBP	I1364fs, I1402fs	Rubinstein-Taybi syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694707	16	3789653	16	3739652	694707	682826		NC_000016.10:3739651:AA:A
NM_001079846.1(CREBBP):c.4558C>T (p.Gln1520Ter)	CREBBP	Q1558*, Q1520*	Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000650876	16	3786093	16	3736092	650876	644678		NC_000016.10:3736091:G:A
GRCh37/hg19 16p13.3(chr16:3794894-3795355)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000619247	16	3794894 - 3795355			619247	610645		
NC_000016.9:g.(?_3799608)_(3821007_?)dup	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000583641	16	3799608 - 3821007	16	3749607 - 3771006	583641	573660		
NM_004380.2(CREBBP):c.-204_85del	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000576111	16	3929833 - 3930121	16	3879832 - 3880120	576111	568137	rs1567386034	
NM_001079846.1(CREBBP):c.1803dup (p.Met602fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000571048	16	3828724 - 3828725	16	3778723 - 3778724	571048	568136	rs1567306142	NC_000016.10:3778723:G:GG
NM_001079846.1(CREBBP):c.3863del (p.Ala1288fs)	CREBBP	A1288fs, A1326fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000566424	16	3794900	16	3744899	566424	574066	rs1567276741	NC_000016.10:3744898:G:
NM_001079846.1(CREBBP):c.1446_1447TC[1] (p.Leu483fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000560708	16	3832695 - 3832696	16	3782694 - 3782695	560708	551791	rs1567309482	NC_000016.10:3782693:GAGAG:GAG
NM_001079846.1(CREBBP):c.2947-1G>T	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548491	16	3817911	16	3767910	548491	539065	rs1555481030	NC_000016.10:3767909:C:A
NM_001079846.1(CREBBP):c.4546A>T (p.Lys1516Ter)	CREBBP	K1554*, K1516*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000545605	16	3786105	16	3736104	545605	536103	rs1567269316	NC_000016.10:3736103:T:A
NM_001079846.1(CREBBP):c.1216+1355_1216+1356del	CREBBP	C427fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000545602	16	3842031 - 3842032	16	3792030 - 3792031	545602	536108	rs1567316655	NC_000016.10:3792029:ACA:A
NM_001079846.1(CREBBP):c.1062dup (p.Gln355fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000545601	16	3843540 - 3843541	16	3793539 - 3793540	545601	536109	rs1567318022	NC_000016.10:3793539:T:TT
NM_001079846.1(CREBBP):c.1827+1G>T	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000545600	16	3828700	16	3778699	545600	536106	rs1555483834	NC_000016.10:3778698:C:A
NM_001079846.1(CREBBP):c.4280G>A (p.Gly1427Glu)	CREBBP	G1465E, G1427E	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000527965	16	3788560	16	3738559	527965	530304	rs1555473491	NC_000016.10:3738558:C:T
NM_001079846.1(CREBBP):c.4900A>T (p.Arg1634Ter)	CREBBP	R1672*, R1634*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527962	16	3781351	16	3731350	527962	529980	rs1555471874	NC_000016.10:3731349:T:A
NM_001079846.1(CREBBP):c.4549G>T (p.Glu1517Ter)	CREBBP	E1555*, E1517*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000527961	16	3786102	16	3736101	527961	529982	rs1555472931	NC_000016.10:3736100:C:A
NM_001079846.1(CREBBP):c.4116dup (p.Gly1373fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000527960	16	3789628 - 3789629	16	3739627 - 3739628	527960	530098	rs1555473668	NC_000016.10:3739627:AAAAAA:AAAAAAA
NM_001079846.1(CREBBP):c.5580_5589del (p.Ser1860fs)	CREBBP	S1860fs, S1898fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000458203	16	3779345 - 3779354	16	3729344 - 3729353	458203	465732	rs1555471323	NC_000016.10:3729343:CTGGGGTGTGCTGGG:CTGGG
NM_001079846.1(CREBBP):c.508C>T (p.Gln170Ter)	CREBBP	Q170*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000458201	16	3900588	16	3850587	458201	465745	rs1555496560	NC_000016.10:3850586:G:A
NM_001079846.1(CREBBP):c.472del (p.Gln158fs)	CREBBP	Q158fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000458200	16	3900624	16	3850623	458200	465750	rs1555496581	NC_000016.10:3850622:G:
NM_001079846.1(CREBBP):c.1333C>T (p.Arg445Ter)	CREBBP	R483*, R445*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000458197	16	3832811	16	3782810	458197	466468	rs1555484797	NC_000016.10:3782809:G:A
NM_001079846.1(CREBBP):c.3800+1G>T	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000434830	16	3795277	16	3745276	434830	429809	rs1555475352	NC_000016.10:3745275:C:A
NG_009873.1:g.(?_5000)_(160068_?)del	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 4, 2015)	criteria provided, single submitter	VCV000375635	16	3775054 - 3930122	16	3725053 - 3880121	375635	362447		
NM_001079846.1(CREBBP):c.86-1G>T	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000210790	16	3901011	16	3851010	210790	208279	rs11644721	NC_000016.10:3851009:C:A
NM_001079846.1(CREBBP):c.827_828dup (p.Gly277fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Aug 8, 2014)	criteria provided, single submitter	VCV000210789	16	3860750 - 3860751	16	3810749 - 3810750	210789	208276	rs797045502	NC_000016.10:3810749:AAA:AAAAA
NM_001079846.1(CREBBP):c.6281_6303dup (p.Gln2102fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jan 23, 2014)	criteria provided, single submitter	VCV000210786	16	3778630 - 3778631	16	3728629 - 3728630	210786	208259	rs797045500	NC_000016.10:3728629:CAGGCTGGGCTGCTGGTGCATGCCAGGCTGGG:CAGGCTGGGCTGCTGGTGCATGCCAGGCTGGGCTGCTGGTGCATGCCAGGCTGGG
NM_001079846.1(CREBBP):c.5993_6002del (p.Pro1998fs)	CREBBP	P1998fs, P2036fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Aug 29, 2014)	criteria provided, single submitter	VCV000210785	16	3778932 - 3778941	16	3728931 - 3728940	210785	208260	rs797045499	NC_000016.10:3728930:ACAGGCCTGG:
NM_001079846.1(CREBBP):c.5822_5823insT (p.Ser1942fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210784	16	3779111 - 3779112	16	3729110 - 3729111	210784	208261	rs797045498	NC_000016.10:3729110::A
NM_001079846.1(CREBBP):c.4913G>A (p.Trp1638Ter)	CREBBP	W1676*, W1638*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Dec 23, 2014)	criteria provided, single submitter	VCV000210781	16	3781338	16	3731337	210781	208264	rs797045495	NC_000016.10:3731336:C:T
NM_001079846.1(CREBBP):c.348_349dup (p.Ala117fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210777	16	3900746 - 3900747	16	3850745 - 3850746	210777	208277	rs797045491	NC_000016.10:3850745:CAC:CACAC
NM_001079846.1(CREBBP):c.3347dup (p.Asp1117fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210776	16	3807957 - 3807958	16	3757956 - 3757957	210776	208268	rs797045490	NC_000016.10:3757956:A:AA
NM_001079846.1(CREBBP):c.3322C>T (p.Gln1108Ter)	CREBBP	Q1146*, Q1108*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	VCV000210775	16	3807983	16	3757982	210775	208269	rs797045489	NC_000016.10:3757981:G:A
NM_001079846.1(CREBBP):c.2963_2971delinsAA (p.Leu988_Ala991delinsTer)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: May 15, 2014)	criteria provided, single submitter	VCV000210774	16	3817886 - 3817894	16	3767885 - 3767893	210774	208270	rs797045488	NC_000016.10:3767884:CTCCTTGCA:TT
NM_001079846.1(CREBBP):c.2T>A (p.Met1Lys)	CREBBP	M1K	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 13, 2014)	criteria provided, single submitter	VCV000210773	16	3929916	16	3879915	210773	208281	rs797045487	NC_000016.10:3879914:A:T
NM_001079846.1(CREBBP):c.282dup (p.Val95fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210772	16	3900813 - 3900814	16	3850812 - 3850813	210772	208278	rs797045486	NC_000016.10:3850812:GGGG:GGGGG
NM_001079846.1(CREBBP):c.2696dup (p.Ser900fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210771	16	3820640 - 3820641	16	3770639 - 3770640	210771	208271	rs797045485	NC_000016.10:3770639:GGGGG:GGGGGG
NM_001079846.1(CREBBP):c.2565_2576delinsCC (p.Ser856fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Dec 26, 2014)	criteria provided, single submitter	VCV000210770	16	3820761 - 3820772	16	3770760 - 3770771	210770	208272	rs797045484	NC_000016.10:3770759:TGCCCGGAAGAC:GG
NM_001079846.1(CREBBP):c.2064dup (p.Met689fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210769	16	3824674 - 3824675	16	3774673 - 3774674	210769	208273	rs797045483	NC_000016.10:3774673:GGGG:GGGGG
NM_004380.2(CREBBP):c.(?_-23)_85+?del	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jun 17, 2014)	criteria provided, single submitter	VCV000210766	16	3929833 - 3929940	16	3879832 - 3879939	210766	208240		
NM_001079846.1(CREBBP):c.953C>A (p.Ser318Ter)	CREBBP	S318*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158403	16	3860626	16	3810625	158403	169265	rs587783516	NC_000016.10:3810624:G:T
NM_001079846.1(CREBBP):c.86-2A>C	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158402	16	3901012	16	3851011	158402	169271	rs587783515	NC_000016.10:3851010:T:G
NM_001079846.1(CREBBP):c.5974C>T (p.Gln1992Ter)	CREBBP	Q2030*, Q1992*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158394	16	3778960	16	3728959	158394	169210	rs587783510	NC_000016.10:3728958:G:A
NM_001079846.1(CREBBP):c.598C>T (p.Gln200Ter)	CREBBP	Q200*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158393	16	3900498	16	3850497	158393	169266	rs587783509	NC_000016.10:3850496:G:A
NM_001079846.1(CREBBP):c.5755del (p.Glu1919fs)	CREBBP	E1957fs, E1919fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158392	16	3779179	16	3729178	158392	169211	rs587783508	NC_000016.10:3729177:CC:C
NM_001079846.1(CREBBP):c.5720_5730del (p.Pro1907fs)	CREBBP	P1945fs, P1907fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158390	16	3779204 - 3779214	16	3729203 - 3729213	158390	169212	rs587783506	NC_000016.10:3729202:CGGGGGTGGGG:
NM_001079846.1(CREBBP):c.5707C>T (p.Gln1903Ter)	CREBBP	Q1941*, Q1903*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	VCV000158388	16	3779227	16	3729226	158388	169215	rs587783505	NC_000016.10:3729225:G:A
NM_001079846.1(CREBBP):c.4678del (p.Ser1560fs)	CREBBP	S1598fs, S1560fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158382	16	3781875	16	3731874	158382	169221	rs587783500	NC_000016.10:3731873:TTTT:TTT
NM_001079846.1(CREBBP):c.4575del (p.Lys1527fs)	CREBBP	K1527fs, K1565fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158380	16	3786076	16	3736075	158380	169223	rs587783499	NC_000016.10:3736074:CC:C
NM_001079846.1(CREBBP):c.4394A>G (p.Tyr1465Cys)	CREBBP	Y1503C, Y1465C	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158377	16	3786703	16	3736702	158377	169226	rs587783497	NC_000016.10:3736701:T:C
NM_001079846.1(CREBBP):c.4330T>G (p.Tyr1444Asp)	CREBBP	Y1482D, Y1444D	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	VCV000158375	16	3786767	16	3736766	158375	169228	rs587783495	NC_000016.10:3736765:A:C
NM_001079846.1(CREBBP):c.4284T>A (p.Tyr1428Ter)	CREBBP	Y1466*, Y1428*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158374	16	3786813	16	3736812	158374	169229	rs147688139	NC_000016.10:3736811:A:T
NM_001079846.1(CREBBP):c.4019+1G>A	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	VCV000158369	16	3790399	16	3740398	158369	169234	rs587783491	NC_000016.10:3740397:C:T
NM_001079846.1(CREBBP):c.3931C>T (p.Gln1311Ter)	CREBBP	Q1349*, Q1311*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158367	16	3790488	16	3740487	158367	169236	rs587783489	NC_000016.10:3740486:G:A
NM_001079846.1(CREBBP):c.3869-2A>G	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Sep 3, 2013)	criteria provided, single submitter	VCV000158364	16	3790552	16	3740551	158364	169239	rs587783486	NC_000016.10:3740550:T:C
NM_001079846.1(CREBBP):c.3499G>T (p.Glu1167Ter)	CREBBP	E1205*, E1167*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158358	16	3807374	16	3757373	158358	169244	rs587783482	NC_000016.10:3757372:C:A
NM_001079846.1(CREBBP):c.3196C>T (p.Gln1066Ter)	CREBBP	Q1104*, Q1066*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158355	16	3808914	16	3758913	158355	169247	rs587783479	NC_000016.10:3758912:G:A
NM_001079846.1(CREBBP):c.316C>T (p.Gln106Ter)	CREBBP	Q106*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jun 27, 2013)	criteria provided, single submitter	VCV000158354	16	3900780	16	3850779	158354	169267	rs587783478	NC_000016.10:3850778:G:A
NM_001079846.1(CREBBP):c.299del (p.Gly100fs)	CREBBP	G100fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158353	16	3900797	16	3850796	158353	169268	rs587783477	NC_000016.10:3850795:CCC:CC
NM_001079846.1(CREBBP):c.286C>T (p.Gln96Ter)	CREBBP	Q96*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158352	16	3900810	16	3850809	158352	169269	rs587783476	NC_000016.10:3850808:G:A
NM_001079846.1(CREBBP):c.2677C>T (p.Gln893Ter)	CREBBP	Q931*, Q893*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158351	16	3820660	16	3770659	158351	169248	rs587783475	NC_000016.10:3770658:G:A
NM_001079846.1(CREBBP):c.2488_2489TC[2] (p.Leu831fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158348	16	3820844 - 3820845	16	3770843 - 3770844	158348	169251	rs587783473	NC_000016.10:3770842:GAGAGA:GAGA
NM_001079846.1(CREBBP):c.2421C>A (p.Cys807Ter)	CREBBP	C845*, C807*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158346	16	3820916	16	3770915	158346	169253	rs587783471	NC_000016.10:3770914:G:T
NM_001079846.1(CREBBP):c.2008_2009del (p.Leu670fs)	CREBBP	L708fs, L670fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	VCV000158345	16	3827649 - 3827650	16	3777648 - 3777649	158345	169254	rs587783470	NC_000016.10:3777647:AG:
NM_001079846.1(CREBBP):c.1912del (p.Gln638fs)	CREBBP	Q638fs, Q676fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158344	16	3828099	16	3778098	158344	169255	rs587783469	NC_000016.10:3778097:G:
NM_001079846.1(CREBBP):c.1707del (p.Lys569fs)	CREBBP	K569fs, K607fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158341	16	3830735	16	3780734	158341	169258	rs587783467	NC_000016.10:3780733:TTT:TT
NM_001079846.1(CREBBP):c.1476del (p.Asn492fs)	CREBBP	N530fs, N492fs	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158339	16	3831291	16	3781290	158339	169259	rs587783465	NC_000016.10:3781289:G:
NM_001079846.1(CREBBP):c.1216+1332G>A	CREBBP	W419*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158337	16	3842055	16	3792054	158337	169261	rs587783463	NC_000016.10:3792053:C:T
NM_001079846.1(CREBBP):c.1063C>T (p.Gln355Ter)	CREBBP	Q355*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158334	16	3843540	16	3793539	158334	169264	rs587783460	NC_000016.10:3793538:G:A
NM_001079846.1(CREBBP):c.3723-2A>T	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 15, 2003)	no assertion criteria provided	VCV000009434	16	3795357	16	3745356	9434	24473	rs1567277287	NC_000016.10:3745355:T:A
CREBBP, 2-BP DEL, NT5222	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000009431					9431	24470		
NM_001079846.1(CREBBP):c.4019G>C (p.Arg1340Pro)	CREBBP	R1378P, R1340P	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000009430	16	3790400	16	3740399	9430	24469	rs121434626	NC_000016.10:3740398:C:G
NM_001079846.1(CREBBP):c.406C>T (p.Gln136Ter)	CREBBP	Q136*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jul 27, 1995)	no assertion criteria provided	VCV000009428	16	3900690	16	3850689	9428	24467	rs121434624	NC_000016.10:3850688:G:A
NC_000016.10:g.(?_3879812)_(3879936_?)del	CREBBP		Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Nov 2, 2019)	criteria provided, single submitter	VCV000831960	16	3929813 - 3929937			831960	820835		
NM_001079846.1(CREBBP):c.3255+1G>A	CREBBP		Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000664200	16	3808854	16	3758853	664200	652563		NC_000016.10:3758852:C:T
NM_004380.3(CREBBP):c.5856dup (p.Pro1953fs)	CREBBP		Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000644368	16	3779191 - 3779192	16	3729190 - 3729191	644368	644677		NC_000016.10:3729190:A:AA
NM_001079846.1(CREBBP):c.5489G>A (p.Arg1830Gln)	CREBBP	R1868Q, R1830Q	not provided|Joint laxity|Downturned corners of mouth|Atrial septal defect|Pectus carinatum|High palate|Thin upper lip vermilion|Cerebral white matter atrophy|Abnormality of the cerebral white matter|Frontal bossing|Generalized hypotonia	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000598959	16	3779445	16	3729444	598959	590076	rs1567263168	NC_000016.10:3729443:C:T
NM_001079846.1(CREBBP):c.5791C>T (p.Gln1931Ter)	CREBBP	Q1969*, Q1931*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000545607	16	3779143	16	3729142	545607	536101	rs1567262537	NC_000016.10:3729141:G:A
NM_001079846.1(CREBBP):c.6130C>T (p.Gln2044Ter)	CREBBP	Q2082*, Q2044*	not provided|Global developmental delay|Scoliosis	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000373943	16	3778804	16	3728803	373943	360998	rs1057518789	NC_000016.10:3728802:G:A
NM_001079846.1(CREBBP):c.4922_4924CCT[1] (p.Ser1642del)	CREBBP	S1680del	Rubinstein-Taybi syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158384	16	3781324 - 3781326	16	3731323 - 3731325	158384	169219	rs587783502	NC_000016.10:3731322:AGGAGGAG:AGGAG
NM_000018.4(ACADVL):c.664G>A (p.Gly222Arg)	ACADVL	G222R, G146R, G245R, G200R	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092289	17	7125312	17	7221993	92289	98200	rs398123091	NC_000017.11:7221992:G:A
NM_004380.3(CREBBP):c.4492C>T (p.Arg1498Ter)	CREBBP	R1498*, R1460*	Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000851163	16	3786719	16	3736718	851163	843865		NC_000016.10:3736717:G:A
NC_000016.10:g.(?_3727698)_(3810799_?)del	CREBBP		Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000832589	16	3777699 - 3860800			832589	820829		
NC_000016.10:g.(?_3727698)_(3793646_?)del	CREBBP		Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000830484	16	3777699 - 3843647			830484	820828		
NM_001079846.1(CREBBP):c.4528_4529GT[1] (p.Leu1511fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000458199	16	3786120 - 3786121	16	3736119 - 3736120	458199	465735	rs1555472938	NC_000016.10:3736118:ACACA:ACA
NM_001079846.1(CREBBP):c.5486G>A (p.Arg1829Gln)	CREBBP	R1867Q, R1829Q	Menke-Hennekam syndrome 1|not provided	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000429336	16	3779448	16	3729447	429336	422096	rs1131691326	NC_000016.10:3729446:C:T
GRCh37/hg19 16p13.3(chr16:3814227-3929941)x1	CREBBP		See cases	Pathogenic(Last reviewed: Oct 14, 2015)	criteria provided, single submitter	VCV000402123	16	3814227 - 3929941			402123	389095		
NM_001079846.1(CREBBP):c.5488C>T (p.Arg1830Trp)	CREBBP	R1868W, R1830W	Menke-Hennekam syndrome 1|not provided	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000265346	16	3779446	16	3729445	265346	260116	rs886039491	NC_000016.10:3729444:G:A
NM_001079846.1(CREBBP):c.5723dup (p.Pro1909fs)	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210783	16	3779210 - 3779211	16	3729209 - 3729210	210783	208262	rs587783507	NC_000016.10:3729209:GGGGGGG:GGGGGGGG
NM_001079846.1(CREBBP):c.3964C>T (p.Arg1322Ter)	CREBBP	R1360*, R1322*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158368	16	3790455	16	3740454	158368	169235	rs587783490	NC_000016.10:3740453:G:A
NM_001079846.1(CREBBP):c.3722+1G>A	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158361	16	3799627	16	3749626	158361	169242	rs200782888	NC_000016.10:3749625:C:T
NM_001079846.1(CREBBP):c.3255+1G>T	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158356	16	3808854	16	3758853	158356	169246	rs587783480	NC_000016.10:3758852:C:A
NM_001079846.1(CREBBP):c.1216+1345C>T	CREBBP	R424*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158338	16	3842042	16	3792041	158338	169260	rs587783464	NC_000016.10:3792040:G:A
NM_001079846.1(CREBBP):c.1156C>T (p.Arg386Ter)	CREBBP	R386*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158335	16	3843447	16	3793446	158335	169263	rs587783461	NC_000016.10:3793445:G:A
NM_001079846.1(CREBBP):c.3868+1G>A	CREBBP		Rubinstein-Taybi syndrome 1|not provided	Pathogenic(Last reviewed: Aug 17, 2015)	criteria provided, multiple submitters, no conflicts	VCV000095046	16	3794894	16	3744893	95046	100946	rs398124145	NC_000016.10:3744892:C:T
NM_001079846.1(CREBBP):c.1069C>T (p.Gln357Ter)	CREBBP	Q357*	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000009429	16	3843534	16	3793533	9429	24468	rs121434625	NC_000016.10:3793532:G:A
NM_001844.5(COL2A1):c.3106C>T (p.Arg1036Ter)	COL2A1	R1036*, R967*	Stickler syndrome type 1|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197503	12	48371798	12	47978015	197503	194664	rs748459670	NC_000012.12:47978014:G:A
NM_001844.5(COL2A1):c.823C>T (p.Arg275Cys)	COL2A1	R75C, R206C, R275C	|Stickler syndrome type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000017368	12	48387824	12	47994041	17368	32407	rs121912876	NC_000012.12:47994040:G:A
NM_001079846.1(CREBBP):c.3722+1G>C	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000568079	16	3799627	16	3749626	568079	570193	rs200782888	NC_000016.10:3749625:C:G
NM_001079846.1(CREBBP):c.1827+1G>A	CREBBP		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000527959	16	3828700	16	3778699	527959	530307	rs1555483834	NC_000016.10:3778698:C:T
NM_001079846.1(CREBBP):c.1216+1312C>T	CREBBP	R413*	Rubinstein-Taybi syndrome 1|not provided	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000434831	16	3842075	16	3792074	434831	429810	rs1302427305	NC_000016.10:3792073:G:A
NM_001079846.1(CREBBP):c.4325A>G (p.Asp1442Gly)	CREBBP	D1480G, D1442G	not provided|Rubinstein-Taybi syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000279963	16	3786772	16	3736771	279963	264634	rs886041286	NC_000016.10:3736770:T:C
NM_001079846.1(CREBBP):c.5723del (p.Pro1908fs)	CREBBP	P1946fs, P1908fs	not provided|Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158391	16	3779211	16	3729210	158391	169213	rs587783507	NC_000016.10:3729209:GGGGGGG:GGGGGG
NM_001271.4(CHD2):c.3702dup (p.Ser1235fs)	CHD2		not provided	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000817391	15	93540290 - 93540291	15	92997060 - 92997061	817391	805853		NC_000015.10:92997060:AAA:AAAA
NM_001271.4(CHD2):c.2674del (p.Gln892fs)	CHD2	Q892fs	not provided	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000817090	15	93521556	15	92978326	817090	805851		NC_000015.10:92978325:CCCCC:CCCC
NM_001271.4(CHD2):c.3700A>T (p.Lys1234Ter)	CHD2	K1234*	not provided	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000816967	15	93540291	15	92997061	816967	805852		NC_000015.10:92997060:A:T
NM_001271.4(CHD2):c.1234G>T (p.Glu412Ter)	CHD2	E412*	not provided	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000620524	15	93489303	15	92946073	620524	611807	rs541056569	NC_000015.10:92946072:G:T
NM_001271.4(CHD2):c.1453C>T (p.Arg485Ter)	CHD2	R485*	not provided	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000620511	15	93492257	15	92949027	620511	611808	rs1567138301	NC_000015.10:92949026:C:T
NM_001271.4(CHD2):c.3548C>A (p.Ser1183Ter)	CHD2	S1183*	not provided	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000620337	15	93536181	15	92992951	620337	611809	rs775406327	NC_000015.10:92992950:C:A
NM_001271.4(CHD2):c.4601G>A (p.Trp1534Ter)	CHD2	W1534*	History of neurodevelopmental disorder	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000589212	15	93555583	15	93012353	589212	580051	rs1567163701	NC_000015.10:93012352:G:A
NM_001271.4(CHD2):c.1052G>A (p.Trp351Ter)	CHD2	W351*	not provided	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000489111	15	93486298	15	92943068	489111	482083	rs1555439557	NC_000015.10:92943067:G:A
NM_001271.4(CHD2):c.3989del (p.Ala1330fs)	CHD2	A1330fs	not provided	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000430540	15	93541832	15	92998602	430540	422067	rs1131692014	NC_000015.10:92998601:C:
NM_001271.4(CHD2):c.982C>T (p.Gln328Ter)	CHD2	Q328*	not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000426731	15	93486228	15	92942998	426731	415462	rs1085307766	NC_000015.10:92942997:C:T
NM_001271.4(CHD2):c.4999C>T (p.Gln1667Ter)	CHD2	Q1667*	not provided	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000389972	15	93563334	15	93020104	389972	373889	rs1057523601	NC_000015.10:93020103:C:T
NM_001271.4(CHD2):c.1809+1G>A	CHD2		not provided	Pathogenic(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000379377	15	93498743	15	92955513	379377	374913	rs1057520592	NC_000015.10:92955512:G:A
NM_001271.4(CHD2):c.1462C>T (p.Gln488Ter)	CHD2	Q488*	not provided	Pathogenic(Last reviewed: Nov 25, 2016)	criteria provided, single submitter	VCV000373127	15	93492266	15	92949036	373127	360146	rs1057518236	NC_000015.10:92949035:C:T
NM_001271.4(CHD2):c.1481G>A (p.Trp494Ter)	CHD2	W494*	not provided	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, single submitter	VCV000280700	15	93492285	15	92949055	280700	264594	rs886041857	NC_000015.10:92949054:G:A
NM_001271.4(CHD2):c.3220del (p.Arg1074fs)	CHD2	R1074fs	not provided	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000280610	15	93527713	15	92984483	280610	264896	rs886041783	NC_000015.10:92984482:C:
NM_001271.4(CHD2):c.3067-2A>G	CHD2		not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000280528	15	93527558	15	92984328	280528	264894	rs886041717	NC_000015.10:92984327:A:G
NM_001271.4(CHD2):c.271G>T (p.Glu91Ter)	CHD2	E91*	not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000280443	15	93467759	15	92924529	280443	264644	rs886041650	NC_000015.10:92924528:G:T
NM_001271.4(CHD2):c.1646_1647AG[3] (p.Glu551fs)	CHD2		not provided	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000280417	15	93496730 - 93496731	15	92953500 - 92953501	280417	264748	rs886041628	NC_000015.10:92953499:AGAGAGAG:AGAGAG
NM_001271.4(CHD2):c.4702_4705AAGA[1] (p.Lys1569fs)	CHD2		not provided	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000280340	15	93557935 - 93557938	15	93014705 - 93014708	280340	264900	rs886041566	NC_000015.10:93014704:AAGAAAGA:AAGA
NM_001271.4(CHD2):c.4413+1G>A	CHD2		not provided	Pathogenic(Last reviewed: Aug 5, 2016)	criteria provided, single submitter	VCV000280318	15	93547982	15	93004752	280318	264898	rs886041547	NC_000015.10:93004751:G:A
NM_001271.4(CHD2):c.693-2A>T	CHD2		not provided	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000265660	15	93485050	15	92941820	265660	260081	rs886039708	NC_000015.10:92941819:A:T
GRCh38/hg38 15q26.1(chr15:92963659-93031241)x1	CHD2		See cases	Pathogenic(Last reviewed: Apr 30, 2011)	no assertion criteria provided	VCV000152929	15	93506889 - 93574471	15	92963659 - 93031241	152929	162680		
NM_001271.4(CHD2):c.3187G>T (p.Glu1063Ter)	CHD2	E1063*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803140	15	93527680	15	92984450	803140	791517		NC_000015.10:92984449:G:T
NM_001271.4(CHD2):c.4003G>T (p.Glu1335Ter)	CHD2	E1335*	Epileptic encephalopathy, childhood-onset	Pathogenic	no assertion criteria provided	VCV000694745	15	93541846	15	92998616	694745	682862		NC_000015.10:92998615:G:T
NM_001271.4(CHD2):c.2674C>T (p.Gln892Ter)	CHD2	Q892*	not provided	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000633517	15	93521560	15	92978330	633517	621979	rs1567149938	NC_000015.10:92978329:C:T
NM_001271.4(CHD2):c.3564C>G (p.Tyr1188Ter)	CHD2	Y1188*	not provided	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000633515	15	93536197	15	92992967	633515	621980	rs2272457	NC_000015.10:92992966:C:G
NM_001271.4(CHD2):c.4829C>T (p.Ala1610Val)	CHD2	A1610V	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433118	15	93558062	15	93014832	433118	426681	rs1555445693	NC_000015.10:93014831:C:T
NM_001271.4(CHD2):c.149G>A (p.Gly50Asp)	CHD2	G50D	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433117	15	93467637	15	92924407	433117	426680	rs1555437424	NC_000015.10:92924406:G:A
NM_001271.4(CHD2):c.1552del (p.Gln518fs)	CHD2	Q518fs	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	VCV000224149	15	93496635	15	92953405	224149	225877	rs869312705	NC_000015.10:92953404:CC:C
NP_001262.3(CHD2):p.Gly1651TrpfsTer16	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218401					218401	215128		
NM_001271.4(CHD2):c.4931_4932del (p.Arg1644fs)	CHD2	R1644fs	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218400	15	93563265 - 93563266	15	93020035 - 93020036	218400	215124	rs864309549	NC_000015.10:93020034:AGA:A
NP_001262.3(CHD2):p.Asn1600Serfs*209	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218397					218397	215127		
NP_001262.3(CHD2):p.Leu1591Xfs	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218396					218396	215126		
NM_001271.4(CHD2):c.4724del (p.Gly1575fs)	CHD2	G1575fs	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218394	15	93557953	15	93014723	218394	215121	rs864309545	NC_000015.10:93014722:GGGGG:GGGG
NM_001271.4(CHD2):c.4256_4274del (p.Lys1419fs)	CHD2	K1419fs	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218393	15	93545517 - 93545535	15	93002287 - 93002305	218393	215120	rs864309544	NC_000015.10:93002286:AAGAAAGAAGTCAAAAGATAAGAAAGA:AAGAAAGA
NP_001262.3(CHD2):p.Glu966SerfsTer2	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218391					218391	215125		
NM_001271.4(CHD2):c.2725C>T (p.Gln909Ter)	CHD2	Q909*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218390	15	93521611	15	92978381	218390	215117	rs864309542	NC_000015.10:92978380:C:T
NM_001271.4(CHD2):c.2567A>G (p.Asp856Gly)	CHD2	D856G	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218389	15	93518170	15	92974940	218389	215116	rs864309541	NC_000015.10:92974939:A:G
NM_001271.4(CHD2):c.2468T>C (p.Leu823Pro)	CHD2	L823P	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218388	15	93515610	15	92972380	218388	215115	rs864309540	NC_000015.10:92972379:T:C
NM_001271.4(CHD2):c.1942C>T (p.Pro648Ser)	CHD2	P648S	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218387	15	93499821	15	92956591	218387	215114	rs864309539	NC_000015.10:92956590:C:T
NM_001271.4(CHD2):c.1808del (p.Lys603fs)	CHD2	K603fs	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218386	15	93498740	15	92955510	218386	215113	rs864309538	NC_000015.10:92955509:AA:A
NM_001271.4(CHD2):c.1642T>C (p.Trp548Arg)	CHD2	W548R	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218385	15	93496726	15	92953496	218385	215112	rs864309537	NC_000015.10:92953495:T:C
NM_001271.4(CHD2):c.1502+1G>A	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218384	15	93492307	15	92949077	218384	215111	rs864309536	NC_000015.10:92949076:G:A
NM_001271.4(CHD2):c.1452dup (p.Arg485fs)	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218383	15	93492254 - 93492255	15	92949024 - 92949025	218383	215110	rs864309535	NC_000015.10:92949024:TT:TTT
NM_001271.4(CHD2):c.335C>G (p.Ser112Ter)	CHD2	S112*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000218382	15	93470514	15	92927284	218382	215109	rs864309534	NC_000015.10:92927283:C:G
NM_001271.4(CHD2):c.2597C>A (p.Ser866Ter)	CHD2	S866*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Jan 5, 2020)	criteria provided, single submitter	VCV000864750	15	93521483	15	92978253	864750	842921		NC_000015.10:92978252:C:A
NM_001271.4(CHD2):c.1895_1896CT[1] (p.Leu633fs)	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000864189	15	93499774 - 93499775	15	92956544 - 92956545	864189	842916		NC_000015.10:92956543:CTCT:CT
NM_001271.4(CHD2):c.1894dup (p.Thr632fs)	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000850653	15	93499769 - 93499770	15	92956539 - 92956540	850653	842915		NC_000015.10:92956539:AAAA:AAAAA
NM_001271.4(CHD2):c.3171_3172del (p.Glu1058fs)	CHD2	E1058fs	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000850311	15	93527664 - 93527665	15	92984434 - 92984435	850311	842924		NC_000015.10:92984433:GG:
NM_001271.4(CHD2):c.1541dup (p.Thr516fs)	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000849422	15	93496623 - 93496624	15	92953393 - 92953394	849422	842914		NC_000015.10:92953393:GG:GGG
NM_001271.4(CHD2):c.3925C>T (p.Gln1309Ter)	CHD2	Q1309*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Mar 17, 2019)	criteria provided, single submitter	VCV000835341	15	93541768	15	92998538	835341	842930		NC_000015.10:92998537:C:T
NC_000015.10:g.(?_92929010)_(92929111_?)del	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000832946	15	93472240 - 93472341			832946	820754		
NC_000015.10:g.(?_92967305)_(93012464_?)del	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: May 9, 2019)	criteria provided, single submitter	VCV000831970	15	93510535 - 93555694			831970	820756		
NC_000015.10:g.(?_92901218)_(92901319_?)del	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000831537	15	93444448 - 93444549			831537	820752		
NC_000015.10:g.(?_92939558)_(92944535_?)del	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000830630	15	93482788 - 93487765			830630	820755		
NM_001271.4(CHD2):c.4174C>T (p.Gln1392Ter)	CHD2	Q1392*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000645522	15	93545443	15	93002213	645522	643743		NC_000015.10:93002212:C:T
NM_001271.4(CHD2):c.5068C>T (p.Arg1690Ter)	CHD2	R1690*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000644061	15	93563403	15	93020173	644061	643750		NC_000015.10:93020172:C:T
NM_001271.4(CHD2):c.739G>T (p.Glu247Ter)	CHD2	E247*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000579480	15	93485098	15	92941868	579480	567444	rs1567135138	NC_000015.10:92941867:G:T
NM_001271.4(CHD2):c.4106C>G (p.Ser1369Ter)	CHD2	S1369*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000578850	15	93543839	15	93000609	578850	569371	rs1567159145	NC_000015.10:93000608:C:G
NM_001271.4(CHD2):c.1382_1383delinsAAGTCTGAA (p.Leu461delinsGlnValTer)	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000569905	15	93492186 - 93492187	15	92948956 - 92948957	569905	573642	rs1567138270	NC_000015.10:92948955:TG:AAGTCTGAA
NM_001271.4(CHD2):c.1135_1138del (p.Gln378_Ile379insTer)	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000569116	15	93487725 - 93487728	15	92944495 - 92944498	569116	569360	rs1567136357	NC_000015.10:92944494:AGATAG:AG
NM_001271.4(CHD2):c.1883T>G (p.Leu628Ter)	CHD2	L628*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000548002	15	93499762	15	92956532	548002	538447	rs1555440885	NC_000015.10:92956531:T:G
NM_001271.4(CHD2):c.1053G>A (p.Trp351Ter)	CHD2	W351*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000541367	15	93487645	15	92944415	541367	529224	rs1555439714	NC_000015.10:92944414:G:A
NM_001271.4(CHD2):c.3409C>T (p.Arg1137Ter)	CHD2	R1137*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000541362	15	93528899	15	92985669	541362	529541	rs773860345	NC_000015.10:92985668:C:T
NM_001271.4(CHD2):c.2785_2801delinsTG (p.Ala929_Val934delinsTer)	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000541361	15	93522422 - 93522438	15	92979192 - 92979208	541361	529238	rs1555442889	NC_000015.10:92979191:GCCAAAAAGAAGATGGT:TG
NM_001271.4(CHD2):c.1081G>T (p.Glu361Ter)	CHD2	E361*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000541360	15	93487673	15	92944443	541360	529208	rs1555439719	NC_000015.10:92944442:G:T
NM_001271.4(CHD2):c.2765dup (p.Glu923fs)	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000474379	15	93522401 - 93522402	15	92979171 - 92979172	474379	465623	rs1555442886	NC_000015.10:92979171:A:AA
NM_001271.4(CHD2):c.879_883del (p.Ser293fs)	CHD2	S293fs	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000411852	15	93486124 - 93486128	15	92942894 - 92942898	411852	401309	rs1060503517	NC_000015.10:92942893:GTGGTG:G
NM_001271.4(CHD2):c.1810-2A>C	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000092096	15	93499687	15	92956457	92096	97527	rs398122999	NC_000015.10:92956456:A:C
CHD2, TRP548ARG	CHD2	W548R	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000060715					60715	75277		
CHD2, ARG1644LYSFSTER22	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000060714					60714	75276		
CHD2, GLY491VALFSTER13	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000060713					60713	75275		
CHD2, GLU1412GLYFSTER64	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000060711					60711	75273		
NM_001271.4(CHD2):c.1809+1del	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Nov 10, 2012)	no assertion criteria provided	VCV000060710	15	93498742	15	92955512	60710	75272	rs397514739	NC_000015.10:92955511:GG:G
NM_004448.3(ERBB2):c.2305G>C (p.Asp769His)	ERBB2	D739H, D754H, D769H	Uterine cervical neoplasms|Neoplasm of the breast|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Carcinoma of esophagus	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375991	17	37880261	17	39724008	375991	362870	rs121913468	NC_000017.11:39724007:G:C
NM_001271.4(CHD2):c.3782G>A (p.Trp1261Ter)	CHD2	W1261*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000863276	15	93540530	15	92997300	863276	842928		NC_000015.10:92997299:G:A
NM_001271.4(CHD2):c.948C>A (p.Tyr316Ter)	CHD2	Y316*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000812180	15	93486194	15	92942964	812180	800671		NC_000015.10:92942963:C:A
NM_001271.4(CHD2):c.3735del (p.Lys1245fs)	CHD2	K1245fs	not provided|History of neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000425077	15	93540316	15	92997086	425077	413411	rs752940775	NC_000015.10:92997085:AAAAAAAAAA:AAAAAAAAA
NM_001271.4(CHD2):c.3214C>T (p.Arg1072Ter)	CHD2	R1072*	not provided|Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280930	15	93527707	15	92984477	280930	264750	rs767106034	NC_000015.10:92984476:C:T
NM_001271.3(CHD2):c.3787dupG (p.Val1263Glyfs)	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224140	15	93540529 - 93540530	15	92997299 - 92997300	224140	225869	rs869312877	NC_000015.10:92997299:GGGGGG:GGGGGGG
NM_000070.3(CAPN3):c.1992+2T>A	CAPN3		not provided	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000596001	15	42701580	15	42409382	596001	587062	rs775217052	NC_000015.10:42409381:T:A
NM_000070.3(CAPN3):c.1855C>T (p.Gln619Ter)	CAPN3	Q619*, Q107*, Q613*	not provided	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000595306	15	42700463	15	42408265	595306	586368	rs1566983844	NC_000015.10:42408264:C:T
NM_000070.3(CAPN3):c.717dup (p.Glu240Ter)	CAPN3		not provided	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000593302	15	42681204 - 42681205	15	42389006 - 42389007	593302	584366	rs776059672	NC_000015.10:42389006:TTTTTT:TTTTTTT
NM_000070.3(CAPN3):c.720dup (p.Ile241fs)	CAPN3		not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000524090	15	42681212 - 42681213	15	42389014 - 42389015	524090	514669	rs1555420639	NC_000015.10:42389014:G:GG
NM_000070.3(CAPN3):c.2235C>A (p.Tyr745Ter)	CAPN3	Y745*, Y80*, Y739*, Y233*, Y653*	not provided	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000499202	15	42702836	15	42410638	499202	490626	rs147774793	NC_000015.10:42410637:C:A
NM_000070.3(CAPN3):c.1127G>A (p.Trp376Ter)	CAPN3	W376*, W328*	not provided	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000498184	15	42689009	15	42396811	498184	489608	rs1555421524	NC_000015.10:42396810:G:A
NM_000070.3(CAPN3):c.2363delinsTCT (p.Arg788fs)	CAPN3		not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000497800	15	42703181	15	42410983	497800	489224	rs1555423219	NC_000015.10:42410982:G:TCT
NM_000070.3(CAPN3):c.1524+2T>C	CAPN3		not provided	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000497572	15	42694010	15	42401812	497572	488996	rs1555422145	NC_000015.10:42401811:T:C
NM_000070.3(CAPN3):c.2115+2T>C	CAPN3		not provided	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000497378	15	42702195	15	42409997	497378	488802	rs1555423060	NC_000015.10:42409996:T:C
NM_000070.3(CAPN3):c.1115+2T>C	CAPN3		not provided	Pathogenic(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000392385	15	42686541	15	42394343	392385	376404	rs1057524468	NC_000015.10:42394342:T:C
NM_000070.3(CAPN3):c.853dup (p.Glu285fs)	CAPN3		not provided	Pathogenic(Last reviewed: Sep 7, 2016)	criteria provided, single submitter	VCV000290732	15	42682197 - 42682198	15	42389999 - 42390000	290732	274969	rs761257703	NC_000015.10:42389999:GGGGG:GGGGGG
NM_000070.3(CAPN3):c.1863dup (p.Glu622fs)	CAPN3		not provided	Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	VCV000290296	15	42700470 - 42700471	15	42408272 - 42408273	290296	274533	rs886044417	NC_000015.10:42408272:A:AA
NM_000070.3(CAPN3):c.1999dup (p.Glu667fs)	CAPN3		not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000288777	15	42701989 - 42701990	15	42409791 - 42409792	288777	273014	rs886044004	NC_000015.10:42409791:GG:GGG
NM_000070.3(CAPN3):c.1373del (p.Pro458fs)	CAPN3	P410fs, P458fs	not provided	Pathogenic(Last reviewed: Apr 20, 2016)	criteria provided, single submitter	VCV000287712	15	42693855	15	42401657	287712	271949	rs886043705	NC_000015.10:42401656:CCC:CC
NM_000070.3(CAPN3):c.255_256CT[2] (p.Leu87fs)	CAPN3		not provided	Pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	VCV000286906	15	42652258 - 42652261	15	42360060 - 42360063	286906	271143	rs763649825	NC_000015.10:42360059:CTCTCTCT:CTCT
NM_000070.3(CAPN3):c.639dup (p.Gly214fs)	CAPN3		not provided	Pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	VCV000285819	15	42681131 - 42681132	15	42388933 - 42388934	285819	270056	rs886043222	NC_000015.10:42388933:T:TT
NM_000070.3(CAPN3):c.237del (p.Glu79fs)	CAPN3	E79fs	not provided	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000285684	15	42652240	15	42360042	285684	269921	rs760205277	NC_000015.10:42360041:G:
NM_000070.3(CAPN3):c.2179del (p.Trp727fs)	CAPN3	W721fs, W635fs, W215fs, W62fs, W727fs	not provided	Pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, single submitter	VCV000284870	15	42702689	15	42410491	284870	269107	rs886042964	NC_000015.10:42410490:T:
NM_000070.3(CAPN3):c.1957C>T (p.Gln653Ter)	CAPN3	Q653*, Q141*, Q561*, Q647*	not provided	Pathogenic(Last reviewed: Nov 10, 2015)	criteria provided, single submitter	VCV000284707	15	42701543	15	42409345	284707	268944	rs886042927	NC_000015.10:42409344:C:T
NM_000070.3(CAPN3):c.1611C>A (p.Tyr537Ter)	CAPN3	Y537*, Y489*, Y25*	not provided	Pathogenic(Last reviewed: Aug 11, 2015)	criteria provided, single submitter	VCV000282617	15	42695066	15	42402868	282617	266854	rs886042439	NC_000015.10:42402867:C:A
NM_000070.3(CAPN3):c.2362_2363insTC (p.Arg788fs)	CAPN3		not provided	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000281686	15	42703180 - 42703181	15	42410982 - 42410983	281686	265923	rs80338804	NC_000015.10:42410982::TC
NM_000070.3(CAPN3):c.264T>G (p.Phe88Leu)	CAPN3	F88L	not provided	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000193038	15	42652267	15	42360069	193038	190203	rs760626912	NC_000015.10:42360068:T:G
NM_000070.3(CAPN3):c.1292dup (p.Ser432fs)	CAPN3		not provided	Pathogenic(Last reviewed: Nov 4, 2017)	criteria provided, single submitter	VCV000496614	15	42691787 - 42691788	15	42399589 - 42399590	496614	488101	rs1555421856	NC_000015.10:42399589:T:TT
NM_000070.3(CAPN3):c.322_334dup (p.Ile112fs)	CAPN3		not provided	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000446980	15	42676692 - 42676693	15	42384494 - 42384495	446980	441715	rs1555420075	NC_000015.10:42384494:AATCCCCGATTTA:AATCCCCGATTTAAATCCCCGATTTA
NM_000070.3(CAPN3):c.855_864dup (p.Arg289fs)	CAPN3		not provided	Pathogenic(Last reviewed: Apr 30, 2013)	criteria provided, single submitter	VCV000092421	15	42682202 - 42682203	15	42390004 - 42390005	92421	98332	rs398123150	NC_000015.10:42390004:AGTTGATTGCA:AGTTGATTGCAGTTGATTGCA
NM_000070.3(CAPN3):c.2251_2254dup (p.Asn752fs)	CAPN3		not provided	Pathogenic(Last reviewed: Oct 4, 2013)	criteria provided, single submitter	VCV000092412	15	42702849 - 42702850	15	42410651 - 42410652	92412	98323	rs398123147	NC_000015.10:42410651:CAGTCA:CAGTCAGTCA
NM_000070.3(CAPN3):c.518G>A (p.Trp173Ter)	CAPN3	W173*	Limb-girdle muscular dystrophy, type 2A	Pathogenic	no assertion criteria provided	VCV000441261	15	42679970	15	42387772	441261	434904	rs1555420475	NC_000015.10:42387771:G:A
NC_000015.10:g.(?_92901218)_(93040513_?)del	CHD2		Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000832822	15	93444448 - 93583743			832822	820753		
NM_001271.4(CHD2):c.2425C>T (p.Arg809Ter)	CHD2	R809*	not provided|Epileptic encephalopathy, childhood-onset	Pathogenic/Likely pathogenic(Last reviewed: Feb 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000489275	15	93515567	15	92972337	489275	482084	rs146691368	NC_000015.10:92972336:C:T
NM_001271.4(CHD2):c.340C>T (p.Arg114Ter)	CHD2	R114*	Epileptic encephalopathy, childhood-onset|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372997	15	93470519	15	92927289	372997	360144	rs1057518128	NC_000015.10:92927288:C:T
NM_001271.4(CHD2):c.4921C>T (p.Gln1641Ter)	CHD2	Q1641*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000218399	15	93563256	15	93020026	218399	215123	rs864309548	NC_000015.10:93020025:C:T
NM_001271.4(CHD2):c.4233_4236del (p.Glu1412fs)	CHD2	E1412fs	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000218392	15	93545500 - 93545503	15	93002270 - 93002273	218392	215119	rs864309543	NC_000015.10:93002269:AAAGAA:AA
NM_000070.3(CAPN3):c.2230del (p.Ser744fs)	CAPN3	S232fs, S652fs, S79fs, S738fs, S744fs	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000864339	15	42702831	15	42410633	864339	842313		NC_000015.10:42410632:A:
NM_000070.3(CAPN3):c.562del (p.Gln188fs)	CAPN3	Q188fs	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000859768	15	42680014	15	42387816	859768	842301		NC_000015.10:42387815:C:
NM_000070.3(CAPN3):c.796del (p.Ile266fs)	CAPN3	I266fs	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000850654	15	42681289	15	42389091	850654	842305		NC_000015.10:42389090:A:
NM_000070.3(CAPN3):c.2162G>A (p.Trp721Ter)	CAPN3	W209*, W629*, W56*, W715*, W721*	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000849826	15	42702672	15	42410474	849826	842312		NC_000015.10:42410473:G:A
NM_000070.3(CAPN3):c.806del (p.Gly269fs)	CAPN3	G269fs	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000845509	15	42682154	15	42389956	845509	842306		NC_000015.10:42389955:GG:G
NM_000070.3(CAPN3):c.519G>A (p.Trp173Ter)	CAPN3	W173*	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000843556	15	42679971	15	42387773	843556	842300		NC_000015.10:42387772:G:A
NM_000070.3(CAPN3):c.444del (p.Ile149fs)	CAPN3	I149fs	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000837974	15	42678429	15	42386231	837974	842298		NC_000015.10:42386230:C:
NM_000070.3(CAPN3):c.2318_2321dup (p.His774fs)	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000837037	15	42703132 - 42703133	15	42410934 - 42410935	837037	842314		NC_000015.10:42410934:ACAAACA:ACAAACAAACA
NC_000015.10:g.(?_42396790)_(42404849_?)del	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000832060	15	42688988 - 42697047			832060	820698		
NM_000070.3(CAPN3):c.1106G>A (p.Trp369Ter)	CAPN3	W369*, W321*	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000813987	15	42686530	15	42394332	813987	802198		NC_000015.10:42394331:G:A
NM_000070.3(CAPN3):c.1933del (p.Asp645fs)	CAPN3	D553fs, D639fs, D645fs, D133fs	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000663070	15	42701519	15	42409321	663070	643180		NC_000015.10:42409320:G:
NM_000070.3(CAPN3):c.2118_2121del (p.Asp707fs)	CAPN3	D195fs, D42fs, D615fs, D701fs, D707fs	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000659272	15	42702628 - 42702631	15	42410430 - 42410433	659272	643183		NC_000015.10:42410429:AGAT:
NM_000070.3(CAPN3):c.1576del (p.Leu526fs)	CAPN3	L478fs, L526fs, L14fs	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000655955	15	42695030	15	42402832	655955	643178		NC_000015.10:42402831:CC:C
NC_000015.9:g.(?_42686444)_(42686549_?)del	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000648523	15	42686444 - 42686549	15	42394246 - 42394351	648523	652661		
NC_000015.9:g.(?_42651994)_(42691860_?)del	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000647946	15	42651994 - 42691860	15	42359796 - 42399662	647946	652503		
NM_000070.3(CAPN3):c.801+1G>A	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000552843	15	42681295	15	42389097	552843	548061	rs1459288402	NC_000015.10:42389096:G:A
NM_000070.3(CAPN3):c.2242C>G (p.Arg748Gly)	CAPN3	R748G, R742G, R83G, R236G, R656G	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jul 15, 2017)	criteria provided, single submitter	VCV000548138	15	42702843	15	42410645	548138	538623	rs768090444	NC_000015.10:42410644:C:G
NM_000070.3(CAPN3):c.291C>A (p.Phe97Leu)	CAPN3	F97L	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jul 15, 2017)	criteria provided, single submitter	VCV000548137	15	42652294	15	42360096	548137	538622	rs758058910	NC_000015.10:42360095:C:A
NM_000070.3(CAPN3):c.727_730delinsAT (p.Asp243fs)	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000536516	15	42681220 - 42681223	15	42389022 - 42389025	536516	529168	rs1555420642	NC_000015.10:42389021:GATG:AT
NC_000015.9:g.(?_42651698)_(42704515_?)del	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: May 23, 2016)	criteria provided, single submitter	VCV000468637	15	42651698 - 42704515	15	42359500 - 42412317	468637	463945		
NM_000070.3(CAPN3):c.1080G>C (p.Trp360Cys)	CAPN3	W312C, W360C	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000017619	15	42686504	15	42394306	17619	32658	rs267606703	NC_000015.10:42394305:G:C
NM_000070.3(CAPN3):c.257C>T (p.Ser86Phe)	CAPN3	S86F	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000017616	15	42652260	15	42360062	17616	32655	rs121434546	NC_000015.10:42360061:C:T
NC_000015.10:g.(?_42384473)_(42392732_?)del	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000832061	15	42676671 - 42684930			832061	820696		
NC_000015.9:g.(?_42651994)_(42703981_?)del	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000655755	15	42651994 - 42703981	15	42359796 - 42411783	655755	652515		
NM_000070.3(CAPN3):c.509dup (p.Tyr170Ter)	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000653660	15	42679960 - 42679961	15	42387762 - 42387763	653660	643165		NC_000015.10:42387762:A:AA
NC_000015.9:g.(?_42651994)_(42652322_?)del	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000640989	15	42651994 - 42652322	15	42359796 - 42360124	640989	652388		
NM_000070.3(CAPN3):c.741_751del (p.Met248fs)	CAPN3	M248fs	Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555260	15	42681232 - 42681242	15	42389034 - 42389044	555260	547698	rs1555420647	NC_000015.10:42389033:GACATGTACAAGA:GA
NM_000070.3(CAPN3):c.1838del (p.Lys613fs)	CAPN3	K101fs, K613fs, K607fs	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000554906	15	42700445	15	42408247	554906	547473	rs1555422832	NC_000015.10:42408246:AA:A
NM_000070.3(CAPN3):c.1524+1G>T	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000554341	15	42694009	15	42401811	554341	547493	rs1275289254	NC_000015.10:42401810:G:T
NM_000070.3(CAPN3):c.2065_2066AC[2] (p.His690fs)	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000551927	15	42702143 - 42702144	15	42409945 - 42409946	551927	547723	rs1555423046	NC_000015.10:42409944:ACACAC:ACAC
NM_000070.3(CAPN3):c.503G>A (p.Trp168Ter)	CAPN3	W168*	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000498205	15	42679955	15	42387757	498205	489629	rs1555420462	NC_000015.10:42387756:G:A
NM_000070.3(CAPN3):c.1118G>A (p.Trp373Ter)	CAPN3	W373*, W325*	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000497833	15	42689000	15	42396802	497833	489257	rs1555421523	NC_000015.10:42396801:G:A
NM_000070.3(CAPN3):c.2290del (p.Asp764fs)	CAPN3	D672fs, D764fs, D99fs, D252fs, D758fs	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000497201	15	42703108	15	42410910	497201	274910	rs886044527	NC_000015.10:42410909:G:
NM_000070.3(CAPN3):c.946-1_948del	CAPN3		Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000497002	15	42684833 - 42684836	15	42392635 - 42392638	497002	488426	rs766156798	NC_000015.10:42392634:ACAGACA:ACA
NM_000070.3(CAPN3):c.2361_2362insTC (p.Arg788fs)	CAPN3		Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000281689	15	42703179 - 42703180	15	42410981 - 42410982	281689	265926	rs761897806	NC_000015.10:42410981::TC
NM_000070.3(CAPN3):c.580del (p.Ser194fs)	CAPN3	S194fs	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092418	15	42680032	15	42387834	92418	98329	rs398123149	NC_000015.10:42387833:T:
NM_000070.3(CAPN3):c.946-1G>A	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jul 5, 2012)	no assertion criteria provided	VCV000021036	15	42684836	15	42392638	21036	33888	rs80338801	NC_000015.10:42392637:G:A
NM_001271.4(CHD2):c.628G>T (p.Glu210Ter)	CHD2	E210*	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560974	15	93482884	15	92939654	560974	552185	rs1567133726	NC_000015.10:92939653:G:T
NM_000070.3(CAPN3):c.100del (p.Ala34fs)	CAPN3	A34fs	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000861571	15	42652102	15	42359904	861571	842293		NC_000015.10:42359903:GG:G
NC_000015.9:g.(?_42682131)_(42703991_?)del	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000650702	15	42682131 - 42703991	15	42389933 - 42411793	650702	652643		
NM_000070.3(CAPN3):c.1771del (p.Asp591fs)	CAPN3	D591fs, D79fs, D543fs	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000578891	15	42695963	15	42403765	578891	568777	rs754761503	NC_000015.10:42403764:GG:G
NM_000070.3(CAPN3):c.1296_1297TG[1] (p.Val433fs)	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Jan 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557732	15	42691792 - 42691793	15	42399594 - 42399595	557732	548078	rs1293496023	NC_000015.10:42399593:TGTG:TG
NM_000070.3(CAPN3):c.59del (p.Pro20fs)	CAPN3	P20fs	Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000551104	15	42652059	15	42359861	551104	547486	rs1555417271	NC_000015.10:42359860:CCCC:CCC
NM_000070.3(CAPN3):c.742_743del (p.Met248fs)	CAPN3	M248fs	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419065	15	42681235 - 42681236	15	42389037 - 42389038	419065	409222	rs1064793620	NC_000015.10:42389036:AT:
NM_000070.3(CAPN3):c.2279dup (p.Asn760fs)	CAPN3		Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000289082	15	42703095 - 42703096	15	42410897 - 42410898	289082	273319	rs775130589	NC_000015.10:42410897:AA:AAA
NM_000070.3(CAPN3):c.402del (p.Ile135fs)	CAPN3	I135fs	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Oct 28, 2016)	criteria provided, multiple submitters, no conflicts	VCV000286591	15	42678386	15	42386188	286591	270828	rs746935735	NC_000015.10:42386187:CC:C
NM_000070.3(CAPN3):c.717del (p.Phe239fs)	CAPN3	F239fs	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000284807	15	42681205	15	42389007	284807	269044	rs776059672	NC_000015.10:42389006:TTTTTT:TTTTT
NM_000070.3(CAPN3):c.1743_1744del (p.Glu582fs)	CAPN3	E534fs, E582fs, E70fs	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000283179	15	42695198 - 42695199	15	42403000 - 42403001	283179	267416	rs886042573	NC_000015.10:42402999:TG:
NM_000070.2(CAPN3):c.439C>T	CAPN3	R147*	Limb-girdle muscular dystrophy, type 2A|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000242415	15	42678424	15	42386226	242415	226480	rs878854364	NC_000015.10:42386225:C:T
NM_000070.3(CAPN3):c.2381-2A>G	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217155	15	42703483	15	42411285	217155	213833	rs863224962	NC_000015.10:42411284:A:G
NM_000070.3(CAPN3):c.1939G>T (p.Glu647Ter)	CAPN3	E647*, E555*, E135*, E641*	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Aug 8, 2014)	criteria provided, single submitter	VCV000217153	15	42701525	15	42409327	217153	213831	rs863224960	NC_000015.10:42409326:G:T
NM_000070.3(CAPN3):c.2134C>T (p.Leu712Phe)	CAPN3	L712F, L200F, L706F, L47F, L620F	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000195450	15	42702644	15	42410446	195450	192611	rs794727318	NC_000015.10:42410445:C:T
NM_000070.3(CAPN3):c.2205_2206CA[1] (p.Thr736fs)	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000128569	15	42702805 - 42702806	15	42410607 - 42410608	128569	134018	rs587780289	NC_000015.10:42410606:ACACA:ACA
NM_002087.3(GRN):c.675_676del (p.Ser226fs)	GRN	S226fs	|not provided|Primary progressive aphasia||Ceroid lipofuscinosis, neuronal, 11	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098246	17	42428135 - 42428136	17	44350767 - 44350768	98246	104138	rs63751085	NC_000017.11:44350766:CA:
NM_001079846.1(CREBBP):c.3665+1G>A	CREBBP		Rubinstein-Taybi syndrome 1|not provided	Pathogenic(Last reviewed: Feb 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158359	16	3801726	16	3751725	158359	169243	rs587783483	NC_000016.10:3751724:C:T
NM_001271.4(CHD2):c.4909C>T (p.Arg1637Ter)	CHD2	R1637*	not provided|Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218398	15	93563244	15	93020014	218398	215122	rs864309547	NC_000015.10:93020013:C:T
NC_000015.10:g.(?_42384473)_(42390106_?)del	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Mar 9, 2019)	criteria provided, single submitter	VCV000833365	15	42676671 - 42682304			833365	820695		
NC_000015.10:g.(?_42384473)_(42394351_?)del	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000832313	15	42676671 - 42686549			832313	820697		
NM_000070.3(CAPN3):c.1079G>A (p.Trp360Ter)	CAPN3	W360*, W312*	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550578	15	42686503	15	42394305	550578	548064	rs1555421280	NC_000015.10:42394304:G:A
NM_000070.3(CAPN3):c.1524+1G>A	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000536512	15	42694009	15	42401811	536512	528794	rs1275289254	NC_000015.10:42401810:G:A
NM_000070.3(CAPN3):c.1027G>T (p.Glu343Ter)	CAPN3	E343*, E295*	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000497182	15	42684918	15	42392720	497182	488606	rs766334893	NC_000015.10:42392719:G:T
NM_000070.3(CAPN3):c.1662C>G (p.Tyr554Ter)	CAPN3	Y554*, Y506*, Y42*	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000290348	15	42695117	15	42402919	290348	274585	rs752848213	NC_000015.10:42402918:C:G
NM_000070.3(CAPN3):c.1801-1G>A	CAPN3		not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000287890	15	42700408	15	42408210	287890	272127	rs886043752	NC_000015.10:42408209:G:A
NM_000070.3(CAPN3):c.2034_2035CA[1] (p.Thr679fs)	CAPN3		not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000282536	15	42702025 - 42702026	15	42409827 - 42409828	282536	266773	rs886042418	NC_000015.10:42409826:ACACA:ACA
NM_000070.2(CAPN3):c.319G>T	CAPN3	E107*	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000242490	15	42676690	15	42384492	242490	213633	rs1801505	NC_000015.10:42384491:G:T
NM_015665.6(AAAS):c.787T>C (p.Ser263Pro)	AAAS	S263P, S230P	not provided|Glucocorticoid deficiency with achalasia|Inborn genetic diseases|Hyperreflexia|Spastic paraparesis|Babinski sign	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005045	12	53703408	12	53309624	5045	20084	rs121918550	NC_000012.12:53309623:A:G
NM_000151.4(G6PC):c.648G>T (p.Leu216=)	G6PC	G727T	not provided|Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012003	17	41063017	17	42911000	12003	27042	rs80356484	NC_000017.11:42910999:G:T
NM_001271.4(CHD2):c.1396C>T (p.Arg466Ter)	CHD2	R466*	not provided|Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092097	15	93492200	15	92948970	92097	97528	rs398123000	NC_000015.10:92948969:C:T
NM_139276.2(STAT3):c.1909G>A (p.Val637Met)	STAT3	V637M	not provided|Hyper-IgE syndrome|Hyper-IgE recurrent infection syndrome 1, autosomal dominant|STAT3 gain of function|Hyper-IgE recurrent infection syndrome 1, autosomal dominant	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000018308	17	40474492	17	42322474	18308	33347	rs113994139	NC_000017.11:42322473:C:T
NM_000070.3(CAPN3):c.946-2A>G	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000663747	15	42684835	15	42392637	663747	652729		NC_000015.10:42392636:A:G
NM_000070.3(CAPN3):c.967G>T (p.Glu323Ter)	CAPN3	E323*, E275*	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620114	15	42684858	15	42392660	620114	611794	rs750443041	NC_000015.10:42392659:G:T
NM_000070.3(CAPN3):c.2314_2317del (p.Asp772fs)	CAPN3	D107fs, D260fs, D680fs, D772fs, D766fs	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552945	15	42703130 - 42703133	15	42410932 - 42410935	552945	547506	rs764086484	NC_000015.10:42410931:CAGACA:CA
NM_000070.3(CAPN3):c.2242C>T (p.Arg748Ter)	CAPN3	R748*, R236*, R656*, R742*, R83*	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000283259	15	42702843	15	42410645	283259	267496	rs768090444	NC_000015.10:42410644:C:T
NM_000070.3(CAPN3):c.499-1G>A	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217157	15	42679950	15	42387752	217157	213822	rs863224964	NC_000015.10:42387751:G:A
NM_001079846.1(CREBBP):c.5525_5526AG[1] (p.Leu1844fs)	CREBBP		Rubinstein-Taybi syndrome 1|Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000585288	16	3779406 - 3779407	16	3729405 - 3729406	585288	576341	rs1567263114	NC_000016.10:3729404:CTCT:CT
NM_001079846.1(CREBBP):c.3718G>A (p.Glu1240Lys)	CREBBP	E1278K, E1240K	not provided|Rubinstein-Taybi syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009433	16	3799632	16	3749631	9433	24472	rs267606752	NC_000016.10:3749630:C:T
NM_001199107.2(TBC1D24):c.1008del (p.His336fs)	TBC1D24	H330fs, H336fs	Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24|DOORS syndrome|not provided	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000091398	16	2548263	16	2498262	91398	96874	rs398122967	NC_000016.10:2498261:T:
GRCh37/hg19 15q11.2(chr15:25583931-25685400)x3	UBE3A		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253397	15	25583931 - 25685400			253397	247845		
NM_004004.6(GJB2):c.238C>T (p.Gln80Ter)	GJB2	Q80*	not provided|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371685	13	20763483	13	20189344	371685	358132	rs199883710	NC_000013.11:20189343:G:A
NM_004004.6(GJB2):c.44A>C (p.Lys15Thr)	GJB2	K15T	Deafness, autosomal recessive 1A|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000044752	13	20763677	13	20189538	44752	53919	rs111033217	NC_000013.11:20189537:T:G
NM_004004.6(GJB2):c.31_68del (p.Gly11fs)	GJB2	G11fs	Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044738	13	20763653 - 20763690	13	20189514 - 20189551	44738	53905	rs397516873	NC_000013.11:20189513:ATCTTTCCAATGCTGGTGGAGTGTTTGTTCACACCCCC:
NM_000018.4(ACADVL):c.1679-6G>A	ACADVL		Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021019	17	7127955	17	7224636	21019	33871	rs113994171	NC_000017.11:7224635:G:A
NM_000018.4(ACADVL):c.1349G>A (p.Arg450His)	ACADVL	R450H, R410H, R374H, R428H, R473H	Rhabdomyolysis|Abnormality of circulating enzyme level|not provided|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001634	17	7127303	17	7223984	1634	16673	rs118204016	NC_000017.11:7223983:G:A
UBE3A, 15-BP DEL/7-BP INS, NT3240	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000030204					30204	39160		
UBE3A, 2-BP DEL, 1930AG	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Apr 30, 2004)	no assertion criteria provided	VCV000007971					7971	23010		
UBE3A, 4-BP DEL, 3093AAGA	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Apr 30, 2004)	no assertion criteria provided	VCV000007970					7970	23009		
UBE3A, IVS9, A-G, -8	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000007964					7964	23003		
UBE3A, 5-BP DUP	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000007963					7963	23002		
NM_006662.3(SRCAP):c.7376del (p.Pro2459fs)	SRCAP	P2459fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000520734	16	30748736	16	30737415	520734	512196	rs1555465942	NC_000016.10:30737414:CC:C
NM_000070.3(CAPN3):c.2050+1G>A	CAPN3		Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553754	15	42702043	15	42409845	553754	547718	rs768374736	NC_000015.10:42409844:G:A
NM_000070.3(CAPN3):c.1657G>A (p.Glu553Lys)	CAPN3	E553K, E505K, E41K	Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553020	15	42695112	15	42402914	553020	548100	rs767739787	NC_000015.10:42402913:G:A
NM_000070.3(CAPN3):c.1722del (p.Ser575fs)	CAPN3	S575fs, S63fs, S527fs	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503683	15	42695177	15	42402979	503683	495326	rs1366387924	NC_000015.10:42402978:C:
NM_000070.3(CAPN3):c.2263+1G>A	CAPN3		Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000290519	15	42702865	15	42410667	290519	274756	rs886044475	NC_000015.10:42410666:G:A
NM_000070.3(CAPN3):c.258dup (p.Leu87fs)	CAPN3		not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000284122	15	42652260 - 42652261	15	42360062 - 42360063	284122	268359	rs753360208	NC_000015.10:42360062:T:TT
NM_000070.3(CAPN3):c.2288A>G (p.Tyr763Cys)	CAPN3	Y763C, Y251C, Y757C, Y671C, Y98C	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000282681	15	42703106	15	42410908	282681	266918	rs764459544	NC_000015.10:42410907:A:G
NM_000070.3(CAPN3):c.1699G>T (p.Gly567Trp)	CAPN3	G567W, G55W, G519W	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000166791	15	42695154	15	42402956	166791	177149	rs727503839	NC_000015.10:42402955:G:T
NM_000070.3(CAPN3):c.328C>T (p.Arg110Ter)	CAPN3	R110*	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017615	15	42676699	15	42384501	17615	32654	rs121434545	NC_000015.10:42384500:C:T
NM_004572.3(PKP2):c.1903del (p.Arg635fs)	PKP2	R635fs, R591fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000518878	12	32975469	12	32822535	518878	510396	rs1555142984	NC_000012.12:32822534:GG:G
NM_004572.3(PKP2):c.795_811dup (p.Val271fs)	PKP2		Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000518538	12	33031002 - 33031003	12	32878068 - 32878069	518538	510401	rs1555148090	NC_000012.12:32878068:CCTGCCCGACAGTGAGCCCTGCC:CCTGCCCGACAGTGAGCCCTGCCCGACAGTGAGCCCTGCC
NM_004572.3(PKP2):c.1219C>T (p.Gln407Ter)	PKP2	Q407*	Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000518477	12	33003859	12	32850925	518477	510399	rs1555145520	NC_000012.12:32850924:G:A
NM_004572.3(PKP2):c.257dup (p.Tyr86Ter)	PKP2		not provided	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000452249	12	33031932 - 33031933	12	32878998 - 32878999	452249	444985	rs1555148271	NC_000012.12:32878998:T:TT
NM_004572.3(PKP2):c.1606del (p.Ser536fs)	PKP2	S536fs, S492fs	not provided	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000450580	12	32994044	12	32841110	450580	444981	rs1555144478	NC_000012.12:32841109:AAAA:AAA
NM_004572.3(PKP2):c.1202_1209del (p.Leu401fs)	PKP2	L401fs	not provided	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000449315	12	33003869 - 33003876	12	32850935 - 32850942	449315	444982	rs1555145521	NC_000012.12:32850934:GAGCTGCAGA:GA
NM_004572.3(PKP2):c.1112_1114delinsTT (p.Ser371fs)	PKP2		not provided	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000423117	12	33021917 - 33021919	12	32868983 - 32868985	423117	408645	rs1064796241	NC_000012.12:32868982:CAG:AA
NM_004572.3(PKP2):c.2489+4A>C	PKP2		not provided	Pathogenic(Last reviewed: Jul 24, 2015)	criteria provided, single submitter	VCV000419485	12	32949039	12	32796105	419485	408638	rs1064793905	NC_000012.12:32796104:T:G
NM_004572.3(PKP2):c.1147C>T (p.Gln383Ter)	PKP2	Q383*	not provided	Pathogenic(Last reviewed: May 4, 2015)	criteria provided, single submitter	VCV000379575	12	33021884	12	32868950	379575	372254	rs1057520650	NC_000012.12:32868949:G:A
NM_004572.3(PKP2):c.1687A>T (p.Arg563Ter)	PKP2	R563*, R519*	not provided	Pathogenic(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	VCV000379450	12	32993963	12	32841029	379450	373001	rs1057520597	NC_000012.12:32841028:T:A
NM_004572.3(PKP2):c.658C>T (p.Gln220Ter)	PKP2	Q220*	not provided	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000280014	12	33031156	12	32878222	280014	264612	rs886041322	NC_000012.12:32878221:G:A
NM_004572.3(PKP2):c.1511-1G>A	PKP2		not provided	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000265678	12	32994140	12	32841206	265678	260016	rs779082302	NC_000012.12:32841205:C:T
NM_004572.3(PKP2):c.1799del (p.Asp600fs)	PKP2	D556fs, D600fs	not provided	Pathogenic(Last reviewed: May 17, 2014)	criteria provided, single submitter	VCV000202020	12	32976986	12	32824052	202020	198411	rs794729128	NC_000012.12:32824051:T:
NM_004572.3(PKP2):c.1579del (p.Thr526_Leu527insTer)	PKP2		not provided	Pathogenic(Last reviewed: Nov 2, 2015)	criteria provided, single submitter	VCV000202018	12	32994071	12	32841137	202018	198419	rs794729126	NC_000012.12:32841136:G:
NM_004572.3(PKP2):c.1531_1540del (p.Ser511fs)	PKP2	S467fs, S511fs	not provided	Pathogenic(Last reviewed: Feb 11, 2014)	criteria provided, single submitter	VCV000202017	12	32994110 - 32994119	12	32841176 - 32841185	202017	198422	rs794729125	NC_000012.12:32841175:TGTCATTAGATG:TG
NM_001005242.2(PKP2):c.672_673CT[1] (p.Ser225fs)	PKP2		not provided	Pathogenic(Last reviewed: Jun 20, 2013)	criteria provided, single submitter	VCV000202014	12	33031139 - 33031140	12	32878205 - 32878206	202014	198440	rs794729123	NC_000012.12:32878204:AGAG:AG
NM_004572.3(PKP2):c.314del (p.Pro105fs)	PKP2	P105fs	not provided	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000202011	12	33031876	12	32878942	202011	198453	rs794729121	NC_000012.12:32878941:GG:G
NM_004572.3(PKP2):c.240del (p.Ser81fs)	PKP2	S81fs	not provided	Pathogenic(Last reviewed: Jan 28, 2014)	criteria provided, single submitter	VCV000202009	12	33031950	12	32879016	202009	198456	rs794729119	NC_000012.12:32879015:GG:G
NM_004572.3(PKP2):c.2385del (p.Cys796fs)	PKP2	C796fs, C752fs	not provided	Pathogenic(Last reviewed: Oct 25, 2013)	criteria provided, single submitter	VCV000202008	12	32949147	12	32796213	202008	198390	rs794729118	NC_000012.12:32796212:GG:G
NM_004572.3(PKP2):c.2301del (p.Glu769fs)	PKP2	E725fs, E769fs	not provided	Pathogenic(Last reviewed: Jun 21, 2012)	criteria provided, single submitter	VCV000202007	12	32949231	12	32796297	202007	198392	rs794729117	NC_000012.12:32796296:GG:G
NM_004572.3(PKP2):c.1804A>T (p.Lys602Ter)	PKP2	K602*, K558*	not provided	Pathogenic(Last reviewed: Apr 14, 2014)	criteria provided, single submitter	VCV000201994	12	32976981	12	32824047	201994	198409	rs794729109	NC_000012.12:32824046:T:A
NM_004572.3(PKP2):c.1767T>G (p.Tyr589Ter)	PKP2	Y589*, Y545*	not provided	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000201993	12	32977018	12	32824084	201993	198412	rs794729108	NC_000012.12:32824083:A:C
NM_004572.3(PKP2):c.1378G>C (p.Asp460His)	PKP2	D460H, G460R	not provided	Pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	VCV000201983	12	33003700	12	32850766	201983	198424	rs794729106	NC_000012.12:32850765:C:G
NM_004572.3(PKP2):c.1248T>A (p.Cys416Ter)	PKP2	C416*	not provided	Pathogenic(Last reviewed: Apr 27, 2014)	criteria provided, single submitter	VCV000201980	12	33003830	12	32850896	201980	198426	rs794729104	NC_000012.12:32850895:A:T
NM_004572.3(PKP2):c.1063C>T (p.Arg355Ter)	PKP2	R355*	not provided	Pathogenic(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	VCV000201977	12	33021968	12	32869034	201977	198433	rs754912778	NC_000012.12:32869033:G:A
NM_001005242.3(PKP2):c.1379-1998C>T	PKP2	R497*	not provided	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	VCV000078974	12	32996137	12	32843203	78974	89865	rs151212477	NC_000012.12:32843202:G:A
NM_004572.3(PKP2):c.1138G>T (p.Glu380Ter)	PKP2	E380*	Cardiovascular phenotype|Arrhythmogenic right ventricular dysplasia/cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000496253	12	33021893	12	32868959	496253	487491	rs878898365	NC_000012.12:32868958:C:A
NM_004572.3(PKP2):c.273_277del (p.His91_Leu92insTer)	PKP2		Arrhythmogenic right ventricular cardiomyopathy	Pathogenic(Last reviewed: May 31, 2016)	criteria provided, single submitter	VCV000523702	12	33031913 - 33031917	12	32878979 - 32878983	523702	514359	rs1555148259	NC_000012.12:32878978:CCAAG:
NM_001005242.3(PKP2):c.1867G>T (p.Glu623Ter)	PKP2	E667*, E623*	Arrhythmogenic right ventricular cardiomyopathy	Pathogenic(Last reviewed: May 6, 2010)	criteria provided, single submitter	VCV000045054	12	32974436	12	32821502	45054	54221	rs397517015	NC_000012.12:32821501:C:A
UBE3A, 4-BP DUP, EX10, GAGG	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jun 15, 2004)	no assertion criteria provided	VCV000007972					7972	23011		
UBE3A, 2-BP DEL, 1344GT	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000007965					7965	23004		
NM_004572.3(PKP2):c.253_256del (p.Glu85fs)	PKP2	E85fs	Sudden unexplained death|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188653	12	33031934 - 33031937	12	32879000 - 32879003	188653	186429	rs786204388	NC_000012.12:32878999:ACTCA:A
NM_001079846.1(CREBBP):c.5500A>G (p.Met1834Val)	CREBBP	M1872V, M1834V	Menke-Hennekam syndrome 1|not provided|Rubinstein-Taybi syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000209145	16	3779434	16	3729433	209145	205780	rs797045037	NC_000016.10:3729432:T:C
NM_001005242.3(PKP2):c.1003G>T (p.Glu335Ter)	PKP2	E335*	Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000860471	12	33030811	12	32877877	860471	839873		NC_000012.12:32877876:C:A
NM_001005242.3(PKP2):c.144_165del (p.Gln49fs)	PKP2	Q49fs	Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000856786	12	33049501 - 33049522	12	32896567 - 32896588	856786	839878		NC_000012.12:32896566:CCGCAGGCTCTTGACTGTCTGGCCGC:CCGC
NM_001005242.3(PKP2):c.152_153del (p.Val51fs)	PKP2	V51fs	Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000852405	12	33049513 - 33049514	12	32896579 - 32896580	852405	839879		NC_000012.12:32896578:GA:
NC_000012.12:g.(?_32841018)_(32850983_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV000833203	12	32993952 - 33003917			833203	820498		
NC_000012.12:g.(?_32877836)_(32896741_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000831873	12	33030770 - 33049675			831873	820502		
NM_004572.3(PKP2):c.2198_2202del (p.His733fs)	PKP2	H689fs, H733fs	Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Dec 1, 2018)	criteria provided, single submitter	VCV000689321	12	32955434 - 32955438	12	32802500 - 32802504	689321	676917		NC_000012.12:32802499:GGTGTG:G
NM_004572.3(PKP2):c.1978C>T (p.Gln660Ter)	PKP2	Q660*, Q616*	Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000661424	12	32974457	12	32821523	661424	641086		NC_000012.12:32821522:G:A
NM_004572.3(PKP2):c.2280_2281del (p.Leu762fs)	PKP2	L718fs, L762fs	Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000640578	12	32955355 - 32955356	12	32802421 - 32802422	640578	641082		NC_000012.12:32802420:AAA:A
NC_000012.11:g.(?_32955317)_(32955510_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000584148	12	32955317 - 32955510	12	32802383 - 32802576	584148	571154		
NC_000012.11:g.(?_32976959)_(32977116_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000583904	12	32976959 - 32977116	12	32824025 - 32824182	583904	565010		
NM_004572.3(PKP2):c.1566dup (p.Ala523fs)	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000580783	12	32994083 - 32994084	12	32841149 - 32841150	580783	568005	rs1565586921	NC_000012.12:32841149:TT:TTT
NM_004572.3(PKP2):c.224-1639_274del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000572940	12	33031916 - 33033605	12	32878982 - 32880671	572940	565438		
NM_004572.3(PKP2):c.1542del (p.Lys514fs)	PKP2	K470fs, K514fs	Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000568301	12	32994108	12	32841174	568301	571820	rs1565586958	NC_000012.12:32841173:TTT:TT
NM_004572.3(PKP2):c.951del (p.His318fs)	PKP2	H318fs	Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000533041	12	33030863	12	32877929	533041	527117	rs1555148048	NC_000012.12:32877928:C:
NM_004572.3(PKP2):c.1848C>A (p.Tyr616Ter)	PKP2	Y616*, Y572*	Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	VCV000518250	12	32975524	12	32822590	518250	508874	rs1486464304	NC_000012.12:32822589:G:T
NC_000012.11:g.(?_33003694)_(33003913_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Feb 8, 2017)	criteria provided, single submitter	VCV000464405	12	33003694 - 33003913			464405	462130		
NC_000012.11:g.(?_33030780)_(33031966_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000417386	12	33030780 - 33031966	12	32877846 - 32879032	417386	398511		
NM_004572.3(PKP2):c.1844C>T (p.Ser615Phe)	PKP2	S615F, S571F	Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000406555	12	32975528	12	32822594	406555	399698	rs1060501186	NC_000012.12:32822593:G:A
NM_001005242.2(PKP2):c.1949_1951delinsATCGCCAAAA (p.Val650fs)	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000406554	12	32974352 - 32974354	12	32821418 - 32821420	406554	399126	rs1064792929	NC_000012.12:32821417:GGA:TTTTGGCGAT
NM_004572.3(PKP2):c.1725_1728dup (p.Arg577fs)	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	VCV000406551	12	32977056 - 32977057	12	32824122 - 32824123	406551	399705	rs1555143134	NC_000012.12:32824122:CATC:CATCCATC
NM_004572.3(PKP2):c.1757del (p.Leu586fs)	PKP2	L542fs, L586fs	Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Feb 8, 2017)	criteria provided, single submitter	VCV000406545	12	32977028	12	32824094	406545	399704	rs1060501182	NC_000012.12:32824093:A:
NM_004572.3(PKP2):c.2146-?_2489+?del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000254051	12	32949043 - 32955490	12	32796109 - 32802556	254051	248509		
NM_001005242.2(PKP2):c.2066_2071delinsG (p.His689fs)	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Mar 27, 2016)	criteria provided, single submitter	VCV000239956	12	32955433 - 32955438	12	32802499 - 32802504	239956	241546	rs878854710	NC_000012.12:32802498:GGGTGT:C
NM_004572.3(PKP2):c.256dup (p.Tyr86fs)	PKP2		Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000202010	12	33031933 - 33031934	12	32878999 - 32879000	202010	198455	rs794729120	NC_000012.12:32878999:A:AA
NM_004572.3(PKP2):c.2299+1G>A	PKP2		not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000202005	12	32955336	12	32802402	202005	198395	rs794729116	NC_000012.12:32802401:C:T
NM_001005242.3(PKP2):c.1170+1G>A	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Jan 18, 2016)	criteria provided, single submitter	VCV000188657	12	33021860	12	32868926	188657	186425	rs786204392	NC_000012.12:32868925:C:T
NM_001005242.3(PKP2):c.772A>T (p.Lys258Ter)	PKP2	K258*	not provided|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2014)	criteria provided, multiple submitters, no conflicts	VCV000177984	12	33031042	12	32878108	177984	175729	rs727504430	NC_000012.12:32878107:T:A
NM_001005242.3(PKP2):c.2357+1G>T	PKP2		not provided|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000045071	12	32949042	12	32796108	45071	54238	rs111517471	NC_000012.12:32796107:C:A
NM_004572.3(PKP2):c.1760del (p.Val587fs)	PKP2	V543fs, V587fs	Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, multiple submitters, no conflicts	VCV000045046	12	32977025	12	32824091	45046	54213	rs397517009	NC_000012.12:32824090:A:
NM_001005242.3(PKP2):c.1170+2T>A	PKP2		not provided|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2013)	criteria provided, multiple submitters, no conflicts	VCV000045011	12	33021859	12	32868925	45011	54178	rs397516987	NC_000012.12:32868924:A:T
NM_004937.3(CTNS):c.589G>A (p.Gly197Arg)	CTNS	G197R	Ocular cystinosis|Juvenile nephropathic cystinosis|Ocular cystinosis|Nephropathic cystinosis|not provided|Nephropathic cystinosis	Pathogenic/Likely pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004451	17	3559997	17	3656703	4451	19490	rs113994207	NC_000017.11:3656702:G:A
NM_003119.4(SPG7):c.1053dup (p.Gly352fs)	SPG7		not provided|Hereditary spastic paraplegia 7|Hereditary spastic paraplegia	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000411675	16	89598370 - 89598371	16	89531962 - 89531963	411675	401365	rs760818649	NC_000016.10:89531962:CCCCCCC:CCCCCCCC
NM_003119.4(SPG7):c.1672A>T (p.Lys558Ter)	SPG7	K558*	not provided|Hereditary spastic paraplegia 7|Mitochondrial diseases	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188276	16	89616910	16	89550502	188276	186292	rs369227537	NC_000016.10:89550501:A:T
NM_145239.3(PRRT2):c.649del (p.Arg217fs)	PRRT2	R217fs	Paroxysmal kinesigenic dyskinesia|not provided|Episodic kinesigenic dyskinesia 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039752	16	29825016	16	29813695	39752	48351	rs587778771	NC_000016.10:29813694:CCCCCCCCC:CCCCCCCC
NM_002834.4(PTPN11):c.836A>C (p.Tyr279Ser)	PTPN11	Y279S	LEOPARD syndrome 1|Rasopathy	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000065666	12	112910827	12	112473023	65666	76574	rs121918456	NC_000012.12:112473022:A:C
NM_002834.4(PTPN11):c.1529A>G (p.Gln510Arg)	PTPN11	Q510R, Q514R	Noonan syndrome 1|LEOPARD syndrome 1|Rasopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013345	12	112926909	12	112489105	13345	28384	rs121918470	NC_000012.12:112489104:A:G
NM_002834.4(PTPN11):c.227A>C (p.Glu76Ala)	PTPN11	E76A	Squamous cell lung carcinoma|Neuroblastoma|Juvenile myelomonocytic leukemia|Neoplasm of the large intestine|Astrocytoma|not provided|Multiple myeloma	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000013339	12	112888211	12	112450407	13339	28378	rs121918465	NC_000012.12:112450406:A:C
NM_002834.4(PTPN11):c.227A>T (p.Glu76Val)	PTPN11	E76V	Juvenile myelomonocytic leukemia|Rasopathy|not provided	Pathogenic(Last reviewed: Dec 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000013337	12	112888211	12	112450407	13337	28376	rs121918465	NC_000012.12:112450406:A:T
NM_000153.4(GALC):c.1586C>T (p.Thr529Met)	GALC	T529M, T503M, T506M	Galactosylceramide beta-galactosidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370073	14	88411981	14	87945637	370073	358254	rs200960659	NC_000014.9:87945636:G:A
NM_001005242.3(PKP2):c.2062C>T (p.Gln688Ter)	PKP2	Q688*, Q732*	Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000839473	12	32955442	12	32802508	839473	839862		NC_000012.12:32802507:G:A
NC_000012.12:g.(?_32877836)_(32879042_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000832479	12	33030770 - 33031976			832479	820501		
NC_000012.12:g.(?_32824035)_(32824172_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000831856	12	32976969 - 32977106			831856	820497		
NC_000012.12:g.(?_32868917)_(32869072_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000830586	12	33021851 - 33022006			830586	820500		
NC_000012.11:g.(?_33003690)_(33003917_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000649072	12	33003690 - 33003917	12	32850756 - 32850983	649072	652645		
NC_000012.11:g.(?_33049433)_(33049675_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000646382	12	33049433 - 33049675	12	32896499 - 32896741	646382	652381		
NM_004572.3(PKP2):c.499C>T (p.Gln167Ter)	PKP2	Q167*	Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000577307	12	33031315	12	32878381	577307	566827	rs1565599473	NC_000012.12:32878380:G:A
NC_000012.11:g.(?_32945338)_(32977116_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000464403	12	32945338 - 32977116			464403	461581		
NM_004572.3(PKP2):c.929_951dup (p.His318fs)	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000406552	12	33030862 - 33030863	12	32877928 - 32877929	406552	398966	rs1064792927	NC_000012.12:32877928:CGCTCTCCTCCCGCTGGAATCCACG:CGCTCTCCTCCCGCTGGAATCCACGCTCTCCTCCCGCTGGAATCCACG
NM_004572.3(PKP2):c.397C>T (p.Gln133Ter)	PKP2	Q133*	Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided	Pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, multiple submitters, no conflicts	VCV000202027	12	33031417	12	32878483	202027	198450	rs794729132	NC_000012.12:32878482:G:A
NM_004572.3(PKP2):c.1951C>T (p.Arg651Ter)	PKP2	R651*, R607*	Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	criteria provided, single submitter	VCV000201998	12	32975421	12	32822487	201998	198401	rs751288871	NC_000012.12:32822486:G:A
NM_000070.3(CAPN3):c.1355-1G>C	CAPN3		not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000288426	15	42693838	15	42401640	288426	272663	rs747557404	NC_000015.10:42401639:G:C
NM_000070.3(CAPN3):c.483del (p.Ile162fs)	CAPN3	I162fs	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217156	15	42678466	15	42386268	217156	213821	rs863224963	NC_000015.10:42386267:GGG:GG
NM_000070.3(CAPN3):c.1992+1G>T	CAPN3		not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217154	15	42701579	15	42409381	217154	213832	rs863224961	NC_000015.10:42409380:G:T
NM_000070.2(CAPN3):c.223dup	CAPN3		not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000092411	15	42652223 - 42652224	15	42360025 - 42360026	92411	98322	rs398123146	NC_000015.10:42360025:TTT:TTTT
NM_013275.6(ANKRD11):c.7825C>T (p.Gln2609Ter)	ANKRD11	Q2609*	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 6, 2013)	criteria provided, single submitter	VCV000208708	16	89335053	16	89268645	208708	205297	rs797044900	NC_000016.10:89268644:G:A
NM_000020.2(ACVRL1):c.1121G>A (p.Arg374Gln)	ACVRL1	R374Q	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411314	12	52309892	12	51916108	411314	399783	rs1060503248	NC_000012.12:51916107:G:A
NM_004572.3(PKP2):c.390C>G (p.Tyr130Ter)	PKP2	Y130*	Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488711	12	33031424	12	32878490	488711	482018	rs763303290	NC_000012.12:32878489:G:C
NM_004572.3(PKP2):c.68del (p.Gly23fs)	PKP2	G23fs	Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided	Pathogenic(Last reviewed: Mar 26, 2017)	criteria provided, single submitter	VCV000464431	12	33049598	12	32896664	464431	462937	rs1555149975	NC_000012.12:32896663:CCC:CC
NM_004572.3(PKP2):c.2554del (p.Glu852fs)	PKP2	E852fs, E808fs	not provided|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000464426	12	32945601	12	32792667	464426	462896	rs1353074803	NC_000012.12:32792666:CC:C
NM_004572.3(PKP2):c.1689-2A>G	PKP2		not provided|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449736	12	32977098	12	32824164	449736	444980	rs1555143143	NC_000012.12:32824163:T:C
NM_004572.3(PKP2):c.1125_1132del (p.Phe376fs)	PKP2	F376fs	Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, multiple submitters, no conflicts	VCV000202016	12	33021899 - 33021906	12	32868965 - 32868972	202016	198431	rs794729124	NC_000012.12:32868964:GTATGAAAGTA:GTA
NM_004572.3(PKP2):c.623del (p.Thr208fs)	PKP2	T208fs	not provided|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000202013	12	33031191	12	32878257	202013	198442	rs794729122	NC_000012.12:32878256:G:
NM_001308211.1(EARS2):c.328G>A (p.Gly110Ser)	EARS2	G110S	Combined oxidative phosphorylation deficiency 12|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039789	16	23555992	16	23544671	39789	48388	rs201842633	NC_000016.10:23544670:C:T
NM_016239.4(MYO15A):c.1795_1798dup (p.Pro600fs)	MYO15A		not provided	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000817748	17	18023907 - 18023908	17	18120593 - 18120594	817748	805926		NC_000017.11:18120593:CGGCC:CGGCCGGCC
NM_016239.4(MYO15A):c.4581del (p.Thr1528fs)	MYO15A	T1528fs	not provided	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000817742	17	18039123	17	18135809	817742	805928		NC_000017.11:18135808:C:
NM_016239.4(MYO15A):c.9765_9766insGG (p.Ile3256fs)	MYO15A		not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000817371	17	18067130 - 18067131	17	18163816 - 18163817	817371	805930		NC_000017.11:18163816::GG
NM_016239.4(MYO15A):c.7012C>T (p.Gln2338Ter)	MYO15A	Q2338*	not provided	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000620326	17	18052585	17	18149271	620326	611843	rs1567650971	NC_000017.11:18149270:C:T
NM_016239.4(MYO15A):c.5303_5304AC[3] (p.Val1770fs)	MYO15A		not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000503775	17	18043920 - 18043921	17	18140606 - 18140607	503775	495819	rs1555544187	NC_000017.11:18140606:CACAC:CACACAC
NM_016239.4(MYO15A):c.2629G>T (p.Glu877Ter)	MYO15A	E877*	not provided	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000500057	17	18024743	17	18121429	500057	491481	rs771720649	NC_000017.11:18121428:G:T
NM_016239.4(MYO15A):c.2258_2259del (p.Ala753fs)	MYO15A	A753fs	not provided	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000498653	17	18024371 - 18024372	17	18121057 - 18121058	498653	490077	rs1555539322	NC_000017.11:18121056:GCG:G
NM_016239.4(MYO15A):c.10018C>T (p.Gln3340Ter)	MYO15A	Q3340*	not provided	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000489207	17	18070973	17	18167659	489207	482120	rs1209867958	NC_000017.11:18167658:C:T
NM_016239.4(MYO15A):c.9538_9539del (p.Gln3180fs)	MYO15A	Q3180fs	not provided	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000450989	17	18065919 - 18065920	17	18162605 - 18162606	450989	445722	rs1555547524	NC_000017.11:18162604:CA:
NM_016239.4(MYO15A):c.4176C>A (p.Tyr1392Ter)	MYO15A	Y1392*	not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000449526	17	18034815	17	18131501	449526	445716	rs1199192203	NC_000017.11:18131500:C:A
NM_016239.4(MYO15A):c.4032+1G>A	MYO15A		not provided	Pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, single submitter	VCV000421666	17	18030480	17	18127166	421666	409849	rs1064795282	NC_000017.11:18127165:G:A
NM_016239.4(MYO15A):c.4519C>T (p.Arg1507Ter)	MYO15A	R1507*	not provided	Pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, single submitter	VCV000421664	17	18039061	17	18135747	421664	409850	rs549138385	NC_000017.11:18135746:C:T
NM_016239.4(MYO15A):c.9876G>A (p.Trp3292Ter)	MYO15A	W3292*	not provided	Pathogenic(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000392810	17	18069763	17	18166449	392810	375799	rs779093807	NC_000017.11:18166448:G:A
NM_016239.4(MYO15A):c.6178-1G>A	MYO15A		not provided	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000290068	17	18047810	17	18144496	290068	274305	rs886044338	NC_000017.11:18144495:G:A
NM_016239.4(MYO15A):c.3866+1G>A	MYO15A		not provided	Pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	VCV000282299	17	18029771	17	18126457	282299	266536	rs374742590	NC_000017.11:18126456:G:A
NM_016239.4(MYO15A):c.2984_2991del (p.Glu995fs)	MYO15A	E995fs	not provided	Pathogenic(Last reviewed: Jun 26, 2015)	criteria provided, single submitter	VCV000218730	17	18025097 - 18025104	17	18121783 - 18121790	218730	215530	rs864309607	NC_000017.11:18121782:GAGCCGGGG:G
NM_016239.4(MYO15A):c.3524dup (p.Ser1176fs)	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803332	17	18025637 - 18025638	17	18122323 - 18122324	803332	791685		NC_000017.11:18122323:A:AA
NM_016239.4(MYO15A):c.1615C>T (p.Gln539Ter)	MYO15A	Q539*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803330	17	18023729	17	18120415	803330	791683		NC_000017.11:18120414:C:T
NM_016239.4(MYO15A):c.4879G>T (p.Glu1627Ter)	MYO15A	E1627*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Aug 28, 2019)	no assertion criteria provided	VCV000691339	17	18041432	17	18138118	691339	679025		NC_000017.11:18138117:G:T
NM_016239.4(MYO15A):c.4609G>T (p.Glu1537Ter)	MYO15A	E1537*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627455	17	18039743	17	18136429	627455	615824	rs1555543432	NC_000017.11:18136428:G:T
NM_016239.4(MYO15A):c.4522G>T (p.Glu1508Ter)	MYO15A	E1508*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627454	17	18039064	17	18135750	627454	615823	rs1567638693	NC_000017.11:18135749:G:T
NM_016239.4(MYO15A):c.605C>A (p.Pro202His)	MYO15A	P202H	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627453	17	18022719	17	18119405	627453	615820	rs1229200252	NC_000017.11:18119404:C:A
NM_016239.4(MYO15A):c.8524G>T (p.Glu2842Ter)	MYO15A	E2842*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627452	17	18059573	17	18156259	627452	615826	rs766250454	NC_000017.11:18156258:G:T
NM_016239.4(MYO15A):c.477G>A (p.Trp159Ter)	MYO15A	W159*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627451	17	18022591	17	18119277	627451	615819	rs1567618790	NC_000017.11:18119276:G:A
NM_016239.4(MYO15A):c.6638G>A (p.Trp2213Ter)	MYO15A	W2213*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Aug 31, 2018)	no assertion criteria provided	VCV000599164	17	18051471	17	18148157	599164	590324	rs1567649945	NC_000017.11:18148156:G:A
NM_016239.4(MYO15A):c.4570C>T (p.Gln1524Ter)	MYO15A	Q1524*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562083	17	18039112	17	18135798	562083	553270	rs1209665716	NC_000017.11:18135797:C:T
NM_016239.4(MYO15A):c.5005C>T (p.Gln1669Ter)	MYO15A	Q1669*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562078	17	18041558	17	18138244	562078	553271	rs1567641234	NC_000017.11:18138243:C:T
NM_016239.4(MYO15A):c.9083+6T>A	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Dec 6, 2017)	no assertion criteria provided	VCV000520436	17	18061958	17	18158644	520436	511041	rs1555547112	NC_000017.11:18158643:T:A
NM_016239.4(MYO15A):c.8341-2A>C	MYO15A		Rare genetic deafness	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000517420	17	18058626	17	18155312	517420	497703	rs778404517	NC_000017.11:18155311:A:C
NM_016239.4(MYO15A):c.3026del (p.Pro1009fs)	MYO15A	P1009fs	Rare genetic deafness	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000506256	17	18025137	17	18121823	506256	497269	rs1555539827	NC_000017.11:18121822:CCCC:CCC
NM_016239.4(MYO15A):c.2311del (p.Ser771fs)	MYO15A	S771fs	Rare genetic deafness	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000504879	17	18024425	17	18121111	504879	497699	rs754865266	NC_000017.11:18121110:T:
NM_016239.4(MYO15A):c.625G>T (p.Glu209Ter)	MYO15A	E209*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000417921	17	18022739	17	18119425	417921	404827	rs571594379	NC_000017.11:18119424:G:T
NM_016239.4(MYO15A):c.4240G>A (p.Glu1414Lys)	MYO15A	E1414K	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402262	17	18035800	17	18132486	402262	389249	rs1060499798	NC_000017.11:18132485:G:A
NM_016239.4(MYO15A):c.1223C>T (p.Ala408Val)	MYO15A	A408V	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402261	17	18023337	17	18120023	402261	389248	rs191710555	NC_000017.11:18120022:C:T
NM_016239.4(MYO15A):c.9572G>A (p.Arg3191His)	MYO15A	R3191H	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402260	17	18065953	17	18162639	402260	389250	rs373520843	NC_000017.11:18162638:G:A
NM_016239.4(MYO15A):c.10572dup (p.Ser3525fs)	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000375679	17	18082157 - 18082158	17	18178843 - 18178844	375679	362519	rs1057519607	NC_000017.11:18178843:CCCCCC:CCCCCCC
NM_016239.4(MYO15A):c.9229+2T>C	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000375678	17	18062663	17	18159349	375678	362518	rs1057519606	NC_000017.11:18159348:T:C
NM_016239.4(MYO15A):c.6944del (p.Gly2315fs)	MYO15A	G2315fs	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000375676	17	18052251	17	18148937	375676	362516	rs1057519604	NC_000017.11:18148936:GGGG:GGG
NM_016239.4(MYO15A):c.4528C>T (p.Gln1510Ter)	MYO15A	Q1510*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000375675	17	18039070	17	18135756	375675	362515	rs779077039	NC_000017.11:18135755:C:T
NM_016239.4(MYO15A):c.6146C>A (p.Pro2049His)	MYO15A	P2049H	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000242334	17	18047283	17	18143969	242334	243888	rs878854414	NC_000017.11:18143968:C:A
NM_016239.4(MYO15A):c.5809C>T (p.Arg1937Cys)	MYO15A	R1937C	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000242333	17	18045552	17	18142238	242333	243887	rs749465098	NC_000017.11:18142237:C:T
NM_016239.4(MYO15A):c.5335del (p.Leu1779fs)	MYO15A	L1779fs	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000242332	17	18043953	17	18140639	242332	243886	rs878854413	NC_000017.11:18140638:CC:C
NM_016239.4(MYO15A):c.4780G>C (p.Asp1594His)	MYO15A	D1594H	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000242331	17	18040898	17	18137584	242331	243885	rs878854412	NC_000017.11:18137583:G:C
NM_016239.4(MYO15A):c.3944G>A (p.Gly1315Glu)	MYO15A	G1315E	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000242329	17	18030391	17	18127077	242329	243883	rs878854410	NC_000017.11:18127076:G:A
NM_016239.4(MYO15A):c.742C>G (p.Arg248Gly)	MYO15A	R248G	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000242328	17	18022856	17	18119542	242328	243882	rs878854409	NC_000017.11:18119541:C:G
NM_016239.4(MYO15A):c.8467G>A (p.Asp2823Asn)	MYO15A	D2823N	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000236053	17	18059516	17	18156202	236053	237623	rs878853238	NC_000017.11:18156201:G:A
NC_000017.1:g.18054799_18058246delinsCTCCCCGGAACGGCTGCTGGTAC	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236039					236039	237627		
NM_016239.4(MYO15A):c.8340G>A (p.Thr2780=)	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236038	17	18058539	17	18155225	236038	237622	rs878853228	NC_000017.11:18155224:G:A
NM_016239.4(MYO15A):c.9303+1G>T	MYO15A		Rare genetic deafness	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000228374	17	18062994	17	18159680	228374	230750	rs876657708	NC_000017.11:18159679:G:T
NM_016239.4(MYO15A):c.5851del (p.Ser1951fs)	MYO15A	S1951fs	Nonsyndromic hearing loss and deafness|Rare genetic deafness	Pathogenic(Last reviewed: Mar 4, 2014)	criteria provided, single submitter	VCV000179619	17	18046095	17	18142781	179619	176463	rs727504995	NC_000017.11:18142780:A:
NM_016239.4(MYO15A):c.10136C>A (p.Ser3379Ter)	MYO15A	S3379*	Rare genetic deafness	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000179222	17	18075005	17	18171691	179222	176488	rs546575046	NC_000017.11:18171690:C:A
NM_016239.4(MYO15A):c.7893+1G>A	MYO15A		Rare genetic deafness	Pathogenic(Last reviewed: May 21, 2013)	criteria provided, single submitter	VCV000164552	17	18055266	17	18151952	164552	176477	rs727503316	NC_000017.11:18151951:G:A
NM_016239.4(MYO15A):c.5531+1G>A	MYO15A		Rare genetic deafness	Pathogenic(Last reviewed: Oct 17, 2014)	criteria provided, single submitter	VCV000164528	17	18044458	17	18141144	164528	176599	rs727503309	NC_000017.11:18141143:G:A
NM_016239.4(MYO15A):c.8100del (p.Lys2701fs)	MYO15A	K2701fs	Rare genetic deafness	Pathogenic(Last reviewed: Feb 25, 2013)	criteria provided, single submitter	VCV000045765	17	18057453	17	18154139	45765	54930	rs397517287	NC_000017.11:18154138:CCCC:CCC
NM_016239.4(MYO15A):c.7006dup (p.Gln2336fs)	MYO15A		Rare genetic deafness	Pathogenic(Last reviewed: Jan 8, 2013)	criteria provided, single submitter	VCV000045757	17	18052575 - 18052576	17	18149261 - 18149262	45757	54922	rs397517286	NC_000017.11:18149261:CCCC:CCCCC
NM_016239.4(MYO15A):c.7745_8224+177delinsCTCCCCGGAACGGCTGCTGGTAC	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000813827	17	18054799 - 18058246	17	18151485 - 18154932	813827	802078		
NM_016239.4(MYO15A):c.488C>A (p.Ser163Ter)	MYO15A	S163*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000694390	17	18022602	17	18119288	694390	682318		NC_000017.11:18119287:C:A
NM_016239.4(MYO15A):c.6503T>G (p.Leu2168Arg)	MYO15A	L2168R	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623382	17	18049415	17	18146101	623382	612317	rs1567648703	NC_000017.11:18146100:T:G
NM_016239.4(MYO15A):c.1171_1177dup (p.Tyr393fs)	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000623347	17	18023284 - 18023285	17	18119970 - 18119971	623347	612316	rs1567620939	NC_000017.11:18119970:GCCATCT:GCCATCTGCCATCT
NM_016239.4(MYO15A):c.3385C>T (p.Arg1129Ter)	MYO15A	R1129*	Rare genetic deafness	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000505802	17	18025499	17	18122185	505802	497270	rs748868741	NC_000017.11:18122184:C:T
NM_016239.4(MYO15A):c.6178-2A>G	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000242335	17	18047809	17	18144495	242335	243889	rs878854415	NC_000017.11:18144494:A:G
NM_016239.4(MYO15A):c.6340G>A (p.Val2114Met)	MYO15A	V2114M	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236040	17	18049252	17	18145938	236040	237620	rs377385081	NC_000017.11:18145937:G:A
NM_016239.4(MYO15A):c.7207G>T (p.Asp2403Tyr)	MYO15A	D2403Y	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000236037	17	18052889	17	18149575	236037	237621	rs878853227	NC_000017.11:18149574:G:T
NM_016239.4(MYO15A):c.3311dup (p.Gly1104_Glu1105insTer)	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 23, 2014)	no assertion criteria provided	VCV000203363	17	18025419 - 18025420	17	18122105 - 18122106	203363	199805	rs794729637	NC_000017.11:18122105:GGGGGG:GGGGGGG
NM_016239.4(MYO15A):c.6046+1G>A	MYO15A		Rare genetic deafness	Pathogenic(Last reviewed: Oct 17, 2014)	criteria provided, single submitter	VCV000164536	17	18047111	17	18143797	164536	176604	rs201978571	NC_000017.11:18143796:G:A
NM_016239.4(MYO15A):c.9958_9961del (p.Asp3320fs)	MYO15A	D3320fs	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000006962	17	18070911 - 18070914	17	18167597 - 18167600	6962	22001	rs1567664131	NC_000017.11:18167596:CTGACT:CT
NM_016239.4(MYO15A):c.10573del (p.Ser3525fs)	MYO15A	S3525fs	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000006961	17	18082164	17	18178850	6961	22000	rs1270302810	NC_000017.11:18178849:A:
NM_016239.4(MYO15A):c.8968-1G>C	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 15, 2007)	no assertion criteria provided	VCV000006960	17	18061836	17	18158522	6960	21999	rs746051220	NC_000017.11:18158521:G:C
NM_016239.4(MYO15A):c.5492G>T (p.Gly1831Val)	MYO15A	G1831V	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 15, 2007)	no assertion criteria provided	VCV000006959	17	18044418	17	18141104	6959	21998	rs121908972	NC_000017.11:18141103:G:T
NM_016239.4(MYO15A):c.3336del (p.Arg1113fs)	MYO15A	R1113fs	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000006958	17	18025448	17	18122134	6958	21997	rs769884586	NC_000017.11:18122133:GGG:GG
NM_016239.4(MYO15A):c.3313G>T (p.Glu1105Ter)	MYO15A	E1105*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000006957	17	18025427	17	18122113	6957	21996	rs121908971	NC_000017.11:18122112:G:T
NM_016239.4(MYO15A):c.8148G>T (p.Gln2716His)	MYO15A	Q2716H	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000006955	17	18057504	17	18154190	6955	21994	rs121908969	NC_000017.11:18154189:G:T
NM_016239.4(MYO15A):c.3756+1G>T	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000006954	17	18028546	17	18125232	6954	21993	rs748108031	NC_000017.11:18125231:G:T
NM_016239.4(MYO15A):c.3685C>T (p.Gln1229Ter)	MYO15A	Q1229*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000006953	17	18027872	17	18124558	6953	21992	rs121908968	NC_000017.11:18124557:C:T
NM_016239.4(MYO15A):c.7801A>T (p.Lys2601Ter)	MYO15A	K1300*, K2601*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: May 29, 1998)	no assertion criteria provided	VCV000006952	17	18055173	17	18151859	6952	21991	rs121908967	NC_000017.11:18151858:A:T
NM_016239.4(MYO15A):c.6331A>T (p.Asn2111Tyr)	MYO15A	N890Y, N2111Y	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: May 29, 1998)	no assertion criteria provided	VCV000006951	17	18049243	17	18145929	6951	21990	rs121908966	NC_000017.11:18145928:A:T
NM_016239.3(MYO15A):c.419dup (p.Phe141Valfs)	MYO15A		Deafness, autosomal recessive 3	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522631	17	18022527 - 18022528	17	18119213 - 18119214	522631	513367	rs750130520	NC_000017.11:18119213:AAAAAA:AAAAAAA
NM_016239.4(MYO15A):c.3505C>T (p.Arg1169Ter)	MYO15A	R1169*	not provided|Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000498654	17	18025619	17	18122305	498654	490078	rs781546107	NC_000017.11:18122304:C:T
NM_016239.4(MYO15A):c.7184_7185del (p.Leu2394_Phe2395insTer)	MYO15A		Rare genetic deafness|not provided	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000451626	17	18052865 - 18052866	17	18149551 - 18149552	451626	445719	rs1415858976	NC_000017.11:18149550:TTT:T
NM_016239.4(MYO15A):c.7226del (p.Pro2409fs)	MYO15A	P2409fs	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000164548	17	18053755	17	18150441	164548	176612	rs727503315	NC_000017.11:18150440:CC:C
NM_016239.4(MYO15A):c.8767C>T (p.Arg2923Ter)	MYO15A	R2923*	Rare genetic deafness	Pathogenic(Last reviewed: Feb 4, 2015)	criteria provided, single submitter	VCV000045771	17	18060523	17	18157209	45771	54936	rs373462792	NC_000017.11:18157208:C:T
NM_016239.4(MYO15A):c.6337A>T (p.Ile2113Phe)	MYO15A	I892F, I2113F	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: May 29, 1998)	no assertion criteria provided	VCV000006950	17	18049249	17	18145935	6950	21989	rs121908965	NC_000017.11:18145934:A:T
NC_000012.12:g.(?_32792414)_(32896741_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000832232	12	32945348 - 33049675			832232	820495		
NM_004572.3(PKP2):c.1252del (p.Ala418fs)	PKP2	A418fs	Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000464409	12	33003826	12	32850892	464409	463039	rs1555145509	NC_000012.12:32850891:CCCC:CCC
NM_004572.3(PKP2):c.1803del (p.Asp601fs)	PKP2	D601fs, D557fs	not provided|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000202021	12	32976982	12	32824048	202021	198410	rs794729129	NC_000012.12:32824047:G:
NM_004572.3(PKP2):c.1664del (p.Phe555fs)	PKP2	F511fs, F555fs	not provided|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000202019	12	32993986	12	32841052	202019	198416	rs794729127	NC_000012.12:32841051:AA:A
NM_016239.4(MYO15A):c.8714-1G>A	MYO15A		Rare genetic deafness|Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jul 22, 2014)	criteria provided, single submitter	VCV000178449	17	18060469	17	18157155	178449	176480	rs377015931	NC_000017.11:18157154:G:A
NM_016239.4(MYO15A):c.9517+2T>C	MYO15A		Deafness, autosomal recessive 3|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000666995	17	18064763	17	18161449	666995	654829		NC_000017.11:18161448:T:C
NM_016239.4(MYO15A):c.996C>G (p.Tyr332Ter)	MYO15A	Y332*	Deafness, autosomal recessive 3|Rare genetic deafness	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000505185	17	18023110	17	18119796	505185	497482	rs759523751	NC_000017.11:18119795:C:G
NM_016239.4(MYO15A):c.5896C>T (p.Arg1966Ter)	MYO15A	R1966*	Deafness, autosomal recessive 3|Rare genetic deafness	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228373	17	18046140	17	18142826	228373	230729	rs765468034	NC_000017.11:18142825:C:T
NM_016239.4(MYO15A):c.1185dup (p.Glu396fs)	MYO15A		Deafness, autosomal recessive 3|Rare genetic deafness	Pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	VCV000228372	17	18023292 - 18023293	17	18119978 - 18119979	228372	230688	rs772536599	NC_000017.11:18119978:CCCCCCC:CCCCCCCC
NM_000070.3(CAPN3):c.1043del (p.Gly348fs)	CAPN3	G300fs, G348fs	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000286813	15	42686466	15	42394268	286813	271050	rs781013226	NC_000015.10:42394267:GG:G
NM_000070.3(CAPN3):c.865C>T (p.Arg289Trp)	CAPN3	R289W	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000282646	15	42682214	15	42390016	282646	266883	rs528417986	NC_000015.10:42390015:C:T
NM_000070.3(CAPN3):c.2185-2A>G	CAPN3		Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280039	15	42702784	15	42410586	280039	264718	rs886041335	NC_000015.10:42410585:A:G
NM_000070.3(CAPN3):c.327_328dup (p.Arg110fs)	CAPN3		Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000210563	15	42676695 - 42676696	15	42384497 - 42384498	210563	208194	rs797045427	NC_000015.10:42384497:CCCC:CCCCCC
GRCh37/hg19 16p13.11(chr16:16247252-16262036)x1	ABCC6		not provided	Pathogenic(Last reviewed: Feb 16, 2018)	no assertion criteria provided	VCV000688963	16	16247252 - 16262036			688963	676555		
GRCh37/hg19 16p13.11(chr16:16247252-16258276)x1	ABCC6		not provided	Pathogenic(Last reviewed: Apr 18, 2017)	no assertion criteria provided	VCV000688630	16	16247252 - 16258276			688630	676222		
GRCh37/hg19 16p13.11(chr16:16247470-16262036)x1	ABCC6		not provided	Pathogenic(Last reviewed: Feb 28, 2018)	no assertion criteria provided	VCV000688362	16	16247470 - 16262036			688362	675954		
GRCh37/hg19 16p13.11(chr16:16247252-16258276)x1	ABCC6		not provided	Pathogenic(Last reviewed: Jun 26, 2018)	no assertion criteria provided	VCV000687897	16	16247252 - 16258276			687897	675489		
GRCh37/hg19 16p13.11(chr16:16247252-16258276)x1	ABCC6		not provided	Pathogenic(Last reviewed: Jun 28, 2017)	no assertion criteria provided	VCV000687331	16	16247252 - 16258276			687331	674923		
GRCh37/hg19 16p13.11(chr16:16248154-16262036)x1	ABCC6		not provided	Pathogenic(Last reviewed: Dec 20, 2017)	no assertion criteria provided	VCV000687229	16	16248154 - 16262036			687229	674821		
GRCh37/hg19 16p13.11(chr16:16247252-16258394)x1	ABCC6		not provided	Pathogenic(Last reviewed: Apr 28, 2017)	no assertion criteria provided	VCV000687192	16	16247252 - 16258394			687192	674784		
GRCh37/hg19 16p13.11(chr16:16258393-16295900)x1	ABCC6		not provided	Pathogenic(Last reviewed: Aug 2, 2018)	no assertion criteria provided	VCV000686810	16	16258393 - 16295900			686810	674402		
GRCh37/hg19 16p13.11(chr16:16247252-16258276)x1	ABCC6		not provided	Pathogenic(Last reviewed: Jun 20, 2018)	no assertion criteria provided	VCV000686253	16	16247252 - 16258276			686253	673845		
GRCh37/hg19 16p13.11(chr16:16247818-16262005)x1	ABCC6		not provided	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000685679	16	16247818 - 16262005			685679	673271		
GRCh37/hg19 16p13.11(chr16:16247252-16258276)x1	ABCC6		not provided	Pathogenic(Last reviewed: Jul 31, 2017)	no assertion criteria provided	VCV000685429	16	16247252 - 16258276			685429	673021		
GRCh37/hg19 16p13.11(chr16:16247470-16262036)x1	ABCC6		not provided	Pathogenic(Last reviewed: Sep 17, 2018)	no assertion criteria provided	VCV000685198	16	16247470 - 16262036			685198	672790		
NM_001171.5(ABCC6):c.196dup (p.Ser66fs)	ABCC6		not provided	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000418938	16	16315528 - 16315529	16	16221671 - 16221672	418938	409468	rs1064793538	NC_000016.10:16221671:A:AA
NM_001171.5(ABCC6):c.1675G>T (p.Glu559Ter)	ABCC6	E559*, E445*	not provided	Pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	VCV000379894	16	16282792	16	16188935	379894	377114	rs114149656	NC_000016.10:16188934:C:A
NM_001171.5(ABCC6):c.1799G>C (p.Arg600Pro)	ABCC6	R600P, R486P	not provided	Pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	VCV000379290	16	16281049	16	16187192	379290	374689	rs761433545	NC_000016.10:16187191:C:G
NM_001171.5(ABCC6):c.2814C>A (p.Tyr938Ter)	ABCC6	Y938*, Y824*	not provided	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000286408	16	16263684	16	16169827	286408	270645	rs72653704	NC_000016.10:16169826:G:T
NM_001351800.1(ABCC6):c.3270_3271CT[1] (p.Ser1091fs)	ABCC6		not provided	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000280870	16	16255313 - 16255314	16	16161456 - 16161457	280870	264654	rs745900279	NC_000016.10:16161455:AGAGA:AGA
NM_001171.5(ABCC6):c.1413del (p.Arg473fs)	ABCC6	R473fs, R359fs	Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812212	16	16286705	16	16192848	812212	800600		NC_000016.10:16192847:C:
NM_001171.5(ABCC6):c.1609del (p.Val537fs)	ABCC6	V423fs, V537fs	Pseudoxanthoma elasticum	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803224	16	16284047	16	16190190	803224	791527		NC_000016.10:16190189:CC:C
NM_001171.5(ABCC6):c.2338del (p.Leu780fs)	ABCC6	L780fs, L666fs	Pseudoxanthoma elasticum	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803223	16	16272732	16	16178875	803223	791526		NC_000016.10:16178874:GGGGG:GGGG
NM_001171.5(ABCC6):c.4254del (p.Lys1419fs)	ABCC6	K1305fs, K1419fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433526	16	16244584	16	16150727	433526	426797	rs1448934731	NC_000016.10:16150726:CC:C
NM_001171.5(ABCC6):c.3370T>C (p.Cys1124Arg)	ABCC6	C1124R, C1010R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433525	16	16256986	16	16163129	433525	426878	rs1555508972	NC_000016.10:16163128:A:G
NM_001171.5(ABCC6):c.2974G>A (p.Gly992Arg)	ABCC6	G992R, G878R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433524	16	16263524	16	16169667	433524	426902	rs72657692	NC_000016.10:16169666:C:T
NM_001171.5(ABCC6):c.2678C>G (p.Ser893Ter)	ABCC6	S893*, S779*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433523	16	16267250	16	16173393	433523	426919	rs1481200467	NC_000016.10:16173392:G:C
NM_001171.5(ABCC6):c.2306G>A (p.Arg769Lys)	ABCC6	R769K, R655K	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433522	16	16272764	16	16178907	433522	426944	rs57794451	NC_000016.10:16178906:C:T
NM_001171.5(ABCC6):c.2230A>C (p.Thr744Pro)	ABCC6	T744P, T630P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433521	16	16276286	16	16182429	433521	426959	rs1555513073	NC_000016.10:16182428:T:G
NM_001351800.1(ABCC6):c.1826_1827AG[1] (p.Arg610fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433520	16	16276343 - 16276346	16	16182486 - 16182489	433520	426963	rs1555513085	NC_000016.10:16182485:CTCTCTC:CTC
NM_001171.5(ABCC6):c.1781C>T (p.Ala594Val)	ABCC6	A594V, A480V	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433519	16	16281067	16	16187210	433519	426994	rs72653776	NC_000016.10:16187209:G:A
NM_001171.5(ABCC6):c.1519del (p.Glu507fs)	ABCC6	E393fs, E507fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433518	16	16284137	16	16190280	433518	427011	rs1555514927	NC_000016.10:16190279:CCC:CC
NM_001171.5(ABCC6):c.2387T>C (p.Ile796Thr)	ABCC6	I796T, I682T	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433517	16	16272683	16	16178826	433517	426937	rs776463091	NC_000016.10:16178825:A:G
NM_001171.5(ABCC6):c.4403+1G>T	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433516	16	16244434	16	16150577	433516	426786	rs1006994885	NC_000016.10:16150576:C:A
NM_001171.5(ABCC6):c.3876_3882+1del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433515	16	16251519 - 16251526	16	16157662 - 16157669	433515	426836	rs1297171898	NC_000016.10:16157661:CCTTCTCTCCT:CCT
NM_001171.5(ABCC6):c.2784C>T (p.Gly928=)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433497	16	16267144	16	16173287	433497	426918	rs749125777	NC_000016.10:16173286:G:A
NM_001171.5(ABCC6):c.1944-1G>C	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433496	16	16276788	16	16182931	433496	426984	rs1438851867	NC_000016.10:16182930:C:G
NM_001171.5(ABCC6):c.3475A>G (p.Arg1159Gly)	ABCC6	R1159G, R1045G	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433495	16	16256881	16	16163024	433495	426872	rs772050759	NC_000016.10:16163023:T:C
NM_001171.5(ABCC6):c.3953C>G (p.Ala1318Gly)	ABCC6	A1318G, A1204G	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433494	16	16248818	16	16154961	433494	426824	rs780887287	NC_000016.10:16154960:G:C
NM_001171.5(ABCC6):c.3816_3828dup (p.Glu1277delinsLysIleProThrTer)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433493	16	16251573 - 16251574	16	16157716 - 16157717	433493	426841	rs1555507903	NC_000016.10:16157716:AGGTCGGTATCTTAG:AGGTCGGTATCTTAGGTCGGTATCTTAG
NM_001171.5(ABCC6):c.36+1G>T	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433492	16	16317255	16	16223398	433492	427097	rs1555523841	NC_000016.10:16223397:C:A
NM_001171.5(ABCC6):c.3777G>A (p.Trp1259Ter)	ABCC6	W1259*, W1145*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433490	16	16251625	16	16157768	433490	426847	rs1555507925	NC_000016.10:16157767:C:T
NM_001171.5(ABCC6):c.2432C>G (p.Thr811Arg)	ABCC6	T811R, T697R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433489	16	16271467	16	16177610	433489	426933	rs72653796	NC_000016.10:16177609:G:C
NM_001171.5(ABCC6):c.1589T>C (p.Leu530Pro)	ABCC6	L530P, L416P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433488	16	16284067	16	16190210	433488	427004	rs774648925	NC_000016.10:16190209:A:G
NM_001171.5(ABCC6):c.3976G>T (p.Asp1326Tyr)	ABCC6	D1326Y, D1212Y	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433487	16	16248795	16	16154938	433487	426822	rs766105758	NC_000016.10:16154937:C:A
NM_001171.5(ABCC6):c.1799G>T (p.Arg600Leu)	ABCC6	R600L, R486L	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433486	16	16281049	16	16187192	433486	426992	rs761433545	NC_000016.10:16187191:C:A
NM_001171.5(ABCC6):c.3775_3776insC (p.Trp1259fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433485	16	16251626 - 16251627	16	16157769 - 16157770	433485	426848	rs1555507927	NC_000016.10:16157769::G
NM_001171.5(ABCC6):c.2659C>T (p.Arg887Cys)	ABCC6	R887C, R773C	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433484	16	16269775	16	16175918	433484	426920	rs59206042	NC_000016.10:16175917:G:A
NM_001171.5(ABCC6):c.1565T>C (p.Leu522Pro)	ABCC6	L522P, L408P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433483	16	16284091	16	16190234	433483	427006	rs1555514895	NC_000016.10:16190233:A:G
NM_001171.5(ABCC6):c.1179_1338+2del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433482	16	16291876 - 16292037	16	16198019 - 16198180	433482	427025	rs1555517253	
NM_001171.5(ABCC6):c.46C>T (p.Gln16Ter)	ABCC6	Q16*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433481	16	16315679	16	16221822	433481	427094	rs1555523535	NC_000016.10:16221821:G:A
NM_001171.5(ABCC6):c.2383del (p.Val795fs)	ABCC6	V681fs, V795fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433480	16	16272687	16	16178830	433480	426938	rs1555512419	NC_000016.10:16178829:CC:C
NM_001171.5(ABCC6):c.1978del (p.Ala660fs)	ABCC6	A546fs, A660fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433479	16	16276753	16	16182896	433479	426981	rs1555513222	NC_000016.10:16182895:CC:C
NM_001171.5(ABCC6):c.3633+1G>A	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433478	16	16255294	16	16161437	433478	426865	rs1555508604	NC_000016.10:16161436:C:T
NM_001171.5(ABCC6):c.1780-2A>G	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433477	16	16281070	16	16187213	433477	426995	rs1555514089	NC_000016.10:16187212:T:C
NM_001171.5(ABCC6):c.3119C>T (p.Pro1040Leu)	ABCC6	P1040L, P926L	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433476	16	16259667	16	16165810	433476	426896	rs1555509485	NC_000016.10:16165809:G:A
NM_001171.5(ABCC6):c.4381C>T (p.Arg1461Cys)	ABCC6	R1461C, R1347C	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433475	16	16244457	16	16150600	433475	426787	rs1030872147	NC_000016.10:16150599:G:A
NM_001171.5(ABCC6):c.333dup (p.Leu112fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433474	16	16313690 - 16313691	16	16219833 - 16219834	433474	427076	rs1555522983	NC_000016.10:16219833:CC:CCC
NM_001171.5(ABCC6):c.1465C>T (p.Arg489Trp)	ABCC6	R489W, R375W	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433473	16	16284191	16	16190334	433473	427016	rs754360599	NC_000016.10:16190333:G:A
NM_001171.5(ABCC6):c.3208G>C (p.Ala1070Pro)	ABCC6	A1070P, A956P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433472	16	16259578	16	16165721	433472	426887	rs369518454	NC_000016.10:16165720:C:G
NM_001171.5(ABCC6):c.280del (p.Ile94fs)	ABCC6	I94fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433471	16	16313744	16	16219887	433471	427077	rs1555522997	NC_000016.10:16219886:TTTT:TTT
NM_001171.5(ABCC6):c.2419C>G (p.Arg807Gly)	ABCC6	R807G, R693G	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433470	16	16271480	16	16177623	433470	426935	rs72653793	NC_000016.10:16177622:G:C
NM_001171.5(ABCC6):c.2488G>C (p.Ala830Pro)	ABCC6	A830P, A716P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433469	16	16271411	16	16177554	433469	426929	rs1555512158	NC_000016.10:16177553:C:G
NM_001171.5(ABCC6):c.3883-10C>G	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433468	16	16248898	16	16155041	433468	426833	rs965791272	NC_000016.10:16155040:G:C
NM_001171.5(ABCC6):c.1133A>C (p.Gln378Pro)	ABCC6	Q378P, Q264P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433467	16	16295901	16	16202044	433467	427038	rs1555518390	NC_000016.10:16202043:T:G
NM_001171.5(ABCC6):c.766T>C (p.Trp256Arg)	ABCC6	W256R, W142R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433466	16	16302613	16	16208756	433466	427054	rs1555520136	NC_000016.10:16208755:A:G
NM_001171.5(ABCC6):c.333G>A (p.Trp111Ter)	ABCC6	W111*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433465	16	16313691	16	16219834	433465	427075	rs1002088882	NC_000016.10:16219833:C:T
NM_001171.5(ABCC6):c.3866_3869dup (p.Ala1291fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433464	16	16251532 - 16251533	16	16157675 - 16157676	433464	426839	rs1555507893	NC_000016.10:16157675:TGGAT:TGGATGGAT
NM_001351800.1(ABCC6):c.1392_1400delinsG (p.Asn464fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433463	16	16282725 - 16282733	16	16188868 - 16188876	433463	426996	rs1555514439	NC_000016.10:16188867:TGGGCCTTG:C
NM_001171.5(ABCC6):c.600+1G>A	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433462	16	16308180	16	16214323	433462	427066	rs1187315015	NC_000016.10:16214322:C:T
NM_001171.5(ABCC6):c.3790C>T (p.Gln1264Ter)	ABCC6	Q1264*, Q1150*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433461	16	16251612	16	16157755	433461	426845	rs1311228469	NC_000016.10:16157754:G:A
NM_001171.5(ABCC6):c.2125G>A (p.Glu709Lys)	ABCC6	E709K, E595K	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433460	16	16276391	16	16182534	433460	426969	rs114303883	NC_000016.10:16182533:C:T
NM_001171.5(ABCC6):c.962del (p.Ser321fs)	ABCC6	S207fs, S321fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433459	16	16297303	16	16203446	433459	427046	rs1555518824	NC_000016.10:16203445:C:
NM_001171.5(ABCC6):c.601-2A>G	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433458	16	16306105	16	16212248	433458	427064	rs1555520991	NC_000016.10:16212247:T:C
NM_001171.5(ABCC6):c.3124G>A (p.Gly1042Ser)	ABCC6	G1042S, G928S	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433457	16	16259662	16	16165805	433457	426895	rs1555509477	NC_000016.10:16165804:C:T
NM_001171.5(ABCC6):c.713C>A (p.Ser238Ter)	ABCC6	S238*, S124*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433456	16	16302666	16	16208809	433456	427056	rs763591743	NC_000016.10:16208808:G:T
NM_001351800.1(ABCC6):c.1368_1369TC[1] (p.Leu457fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433455	16	16282754 - 16282755	16	16188897 - 16188898	433455	426997	rs1555514467	NC_000016.10:16188896:GAGAG:GAG
NM_001171.5(ABCC6):c.2125G>T (p.Glu709Ter)	ABCC6	E709*, E595*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433454	16	16276391	16	16182534	433454	426968	rs114303883	NC_000016.10:16182533:C:A
NM_001171.5(ABCC6):c.4209-2A>C	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433453	16	16244631	16	16150774	433453	426803	rs1555506740	NC_000016.10:16150773:T:G
NM_001171.5(ABCC6):c.4341G>A (p.Trp1447Ter)	ABCC6	W1447*, W1333*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433452	16	16244497	16	16150640	433452	426789	rs1333662666	NC_000016.10:16150639:C:T
NM_001171.5(ABCC6):c.3307-?_3735+?del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433451					433451	426776		
NM_001171.5(ABCC6):c.2153A>G (p.Asp718Gly)	ABCC6	D718G, D604G	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433450	16	16276363	16	16182506	433450	426966	rs1357894483	NC_000016.10:16182505:T:C
NM_001171.5(ABCC6):c.130C>G (p.Leu44Val)	ABCC6	L44V	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433449	16	16315595	16	16221738	433449	427089	rs940803158	NC_000016.10:16221737:G:C
NM_001171.5(ABCC6):c.1519G>T (p.Glu507Ter)	ABCC6	E507*, E393*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433448	16	16284137	16	16190280	433448	427010	rs368017088	NC_000016.10:16190279:C:A
NM_001171.5(ABCC6):c.1892_1943+26del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433447	16	16278790 - 16278867	16	16184933 - 16185010	433447	426985	rs1555513581	
NM_001171.5(ABCC6):c.4241G>A (p.Arg1414His)	ABCC6	R1414H, R1300H	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433446	16	16244597	16	16150740	433446	426799	rs775319351	NC_000016.10:16150739:C:T
NM_001171.5(ABCC6):c.1987G>A (p.Gly663Ser)	ABCC6	G663S, G549S	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433445	16	16276744	16	16182887	433445	426980	rs72653780	NC_000016.10:16182886:C:T
NM_001171.5(ABCC6):c.2784_2787del (p.Gly928_Arg929insTer)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433444	16	16267141 - 16267144	16	16173284 - 16173287	433444	426917	rs765405352	NC_000016.10:16173283:CCTGCC:CC
NM_001171.5(ABCC6):c.37-21_37-12del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433443	16	16315700 - 16315709	16	16221843 - 16221852	433443	427096	rs1555523540	NC_000016.10:16221842:CAAAGAGGACC:C
NM_001171.5(ABCC6):c.2996-1724_4209-478del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433442	16	16245107 - 16261514	16	16151250 - 16167657	433442	426804		
NM_001171.5(ABCC6):c.232G>A (p.Ala78Thr)	ABCC6	A78T	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433441	16	16313792	16	16219935	433441	427079	rs2856597	NC_000016.10:16219934:C:T
NM_001171.5(ABCC6):c.3307-?_3882+?del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433440					433440	426775		
NM_001171.5(ABCC6):c.2416-1_2416del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433438	16	16271483 - 16271484	16	16177626 - 16177627	433438	426936	rs111113625	NC_000016.10:16177625:TCT:T
NM_001171.5(ABCC6):c.4189G>A (p.Asp1397Asn)	ABCC6	D1397N, D1283N	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433437	16	16248504	16	16154647	433437	426808	rs749035807	NC_000016.10:16154646:C:T
NM_001171.5(ABCC6):c.2293C>T (p.Arg765Trp)	ABCC6	R765W, R651W	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433432	16	16272777	16	16178920	433432	426947	rs776513864	NC_000016.10:16178919:G:A
NM_001171.5(ABCC6):c.2279G>A (p.Arg760Gln)	ABCC6	R760Q, R646Q	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433431	16	16272791	16	16178934	433431	426948	rs769405586	NC_000016.10:16178933:C:T
NM_001171.5(ABCC6):c.998+2del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433398	16	16297265	16	16203408	433398	427045	rs72664205	NC_000016.10:16203407:A:
NM_001171.5(ABCC6):c.1868-?_1943+?del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433388					433388	426777		
NM_001171.5(ABCC6):c.4213G>A (p.Gly1405Ser)	ABCC6	G1405S, G1291S	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433380	16	16244625	16	16150768	433380	426801	rs947230593	NC_000016.10:16150767:C:T
NM_001171.5(ABCC6):c.3798del (p.Glu1266fs)	ABCC6	E1152fs, E1266fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433379	16	16251604	16	16157747	433379	426844	rs72664234	NC_000016.10:16157746:C:
NM_001171.5(ABCC6):c.1194C>G (p.Ser398Arg)	ABCC6	S398R, S284R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433377	16	16292022	16	16198165	433377	427032	rs376518465	NC_000016.10:16198164:G:C
NM_001171.5(ABCC6):c.951C>G (p.Ser317Arg)	ABCC6	S317R, S203R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433374	16	16297314	16	16203457	433374	427048	rs78678589	NC_000016.10:16203456:G:C
NM_001351800.1(ABCC6):c.-195_-187del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433371	16	16315538 - 16315546	16	16221681 - 16221689	433371	427085	rs74315110	NC_000016.10:16221680:GGTAGCCCCGG:GG
NM_001171.5(ABCC6):c.4448C>T (p.Pro1483Leu)	ABCC6	P1483L, P1369L	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433367	16	16244054	16	16150197	433367	426781	rs63750135	NC_000016.10:16150196:G:A
NM_001171.5(ABCC6):c.951C>A (p.Ser317Arg)	ABCC6	S317R, S203R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433366	16	16297314	16	16203457	433366	427049	rs78678589	NC_000016.10:16203456:G:T
NM_001171.5(ABCC6):c.4335del (p.Ser1446fs)	ABCC6	S1446fs, S1332fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433362	16	16244503	16	16150646	433362	426790	rs72664239	NC_000016.10:16150645:CCC:CC
NM_001171.5(ABCC6):c.4198G>A (p.Glu1400Lys)	ABCC6	E1400K, E1286K	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433353	16	16248495	16	16154638	433353	426806	rs63751241	NC_000016.10:16154637:C:T
NM_001171.5(ABCC6):c.4004T>A (p.Leu1335Gln)	ABCC6	L1335Q, L1221Q	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433343	16	16248767	16	16154910	433343	426819	rs63750414	NC_000016.10:16154909:A:T
NM_001171.5(ABCC6):c.4004T>C (p.Leu1335Pro)	ABCC6	L1335P, L1221P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433342	16	16248767	16	16154910	433342	426818	rs63750414	NC_000016.10:16154909:A:G
NM_001171.5(ABCC6):c.3999G>A (p.Val1333=)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433341	16	16248772	16	16154915	433341	426820	rs63750235	NC_000016.10:16154914:C:T
NM_001171.5(ABCC6):c.3971G>A (p.Trp1324Ter)	ABCC6	W1324*, W1210*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433339	16	16248800	16	16154943	433339	426823	rs72653750	NC_000016.10:16154942:C:T
NM_001171.5(ABCC6):c.3907G>C (p.Ala1303Pro)	ABCC6	A1303P, A1189P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433335	16	16248864	16	16155007	433335	426828	rs63750410	NC_000016.10:16155006:C:G
NM_001171.5(ABCC6):c.3709C>T (p.Gln1237Ter)	ABCC6	Q1237*, Q1123*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433324	16	16253365	16	16159508	433324	426857	rs72653746	NC_000016.10:16159507:G:A
NM_001171.5(ABCC6):c.3662G>A (p.Arg1221His)	ABCC6	R1221H, R1107H	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433320	16	16253412	16	16159555	433320	426862	rs63751001	NC_000016.10:16159554:C:T
NM_001171.5(ABCC6):c.3661C>T (p.Arg1221Cys)	ABCC6	R1221C, R1107C	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433319	16	16253413	16	16159556	433319	426863	rs63751215	NC_000016.10:16159555:G:A
NM_001171.5(ABCC6):c.3397G>T (p.Gly1133Cys)	ABCC6	G1133C, G1019C	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433315	16	16256959	16	16163102	433315	426875	rs63749807	NC_000016.10:16163101:C:A
NM_001171.5(ABCC6):c.3381G>A (p.Met1127Ile)	ABCC6	M1127I, M1013I	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433314	16	16256975	16	16163118	433314	426876	rs63750758	NC_000016.10:16163117:C:T
NM_001171.5(ABCC6):c.3380T>C (p.Met1127Thr)	ABCC6	M1127T, M1013T	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433313	16	16256976	16	16163119	433313	426877	rs63749998	NC_000016.10:16163118:A:G
NM_001171.5(ABCC6):c.3341G>A (p.Arg1114His)	ABCC6	R1114H, R1000H	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433308	16	16257015	16	16163158	433308	426883	rs63750427	NC_000016.10:16163157:C:T
NM_001171.5(ABCC6):c.3340C>T (p.Arg1114Cys)	ABCC6	R1114C, R1000C	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433307	16	16257016	16	16163159	433307	426884	rs63749794	NC_000016.10:16163158:G:A
NM_001171.5(ABCC6):c.724G>T (p.Glu242Ter)	ABCC6	E242*, E128*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433301	16	16302655	16	16208798	433301	427055	rs72650697	NC_000016.10:16208797:C:A
NM_001171.5(ABCC6):c.3088C>T (p.Arg1030Ter)	ABCC6	R1030*, R916*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433300	16	16259698	16	16165841	433300	426898	rs72653705	NC_000016.10:16165840:G:A
NM_001171.5(ABCC6):c.2974G>C (p.Gly992Arg)	ABCC6	G992R, G878R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433299	16	16263524	16	16169667	433299	426901	rs72657692	NC_000016.10:16169666:C:G
NM_001171.5(ABCC6):c.3823C>T (p.Arg1275Ter)	ABCC6	R1275*, R1161*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433294	16	16251579	16	16157722	433294	426842	rs72653749	NC_000016.10:16157721:G:A
NM_001171.5(ABCC6):c.3723G>C (p.Trp1241Cys)	ABCC6	W1241C, W1127C	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433287	16	16253351	16	16159494	433287	426853	rs72657701	NC_000016.10:16159493:C:G
NM_001171.5(ABCC6):c.2643G>T (p.Arg881Ser)	ABCC6	R881S, R767S	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433281	16	16269791	16	16175934	433281	426921	rs72653800	NC_000016.10:16175933:C:A
NM_001171.5(ABCC6):c.2511C>A (p.Tyr837Ter)	ABCC6	Y837*, Y723*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433277	16	16271388	16	16177531	433277	426926	rs72650702	NC_000016.10:16177530:G:T
NM_001171.5(ABCC6):c.2432C>T (p.Thr811Met)	ABCC6	T811M, T697M	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433275	16	16271467	16	16177610	433275	426932	rs72653796	NC_000016.10:16177609:G:A
NM_001171.5(ABCC6):c.2329G>A (p.Asp777Asn)	ABCC6	D777N, D663N	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433272	16	16272741	16	16178884	433272	426942	rs72653790	NC_000016.10:16178883:C:T
NM_001171.5(ABCC6):c.2304C>A (p.Tyr768Ter)	ABCC6	Y768*, Y654*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433270	16	16272766	16	16178909	433270	426945	rs66492417	NC_000016.10:16178908:G:T
NM_001171.5(ABCC6):c.2263G>A (p.Gly755Arg)	ABCC6	G755R, G641R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433267	16	16272807	16	16178950	433267	426950	rs72653787	NC_000016.10:16178949:C:T
NM_001171.5(ABCC6):c.2252T>A (p.Met751Lys)	ABCC6	M751K, M637K	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433266	16	16272818	16	16178961	433266	426952	rs72653786	NC_000016.10:16178960:A:T
NM_001171.5(ABCC6):c.2245C>T (p.Gln749Ter)	ABCC6	Q749*, Q635*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433265	16	16276271	16	16182414	433265	426957	rs66616070	NC_000016.10:16182413:G:A
NM_001171.5(ABCC6):c.2093A>C (p.Gln698Pro)	ABCC6	Q698P, Q584P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433258	16	16276423	16	16182566	433258	426971	rs72653783	NC_000016.10:16182565:T:G
NM_001171.5(ABCC6):c.1987G>T (p.Gly663Cys)	ABCC6	G663C, G549C	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433253	16	16276744	16	16182887	433253	426979	rs72653780	NC_000016.10:16182886:C:A
NM_001171.5(ABCC6):c.1388T>A (p.Leu463His)	ABCC6	L463H, L349H	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433250	16	16286730	16	16192873	433250	427020	rs72653767	NC_000016.10:16192872:A:T
NM_001171.5(ABCC6):c.1258C>G (p.Leu420Val)	ABCC6	L420V, L306V	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433249	16	16291958	16	16198101	433249	427027	rs746428588	NC_000016.10:16198100:G:C
NM_001171.5(ABCC6):c.1199C>T (p.Ser400Phe)	ABCC6	S400F, S286F	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433242	16	16292017	16	16198160	433242	427031	rs747386965	NC_000016.10:16198159:G:A
NM_001171.5(ABCC6):c.1703T>C (p.Phe568Ser)	ABCC6	F568S, F454S	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433241	16	16282764	16	16188907	433241	426998	rs66864704	NC_000016.10:16188906:A:G
NM_001171.5(ABCC6):c.1484T>A (p.Leu495His)	ABCC6	L495H, L381H	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433233	16	16284172	16	16190315	433233	427015	rs72653769	NC_000016.10:16190314:A:T
NM_001171.5(ABCC6):c.1460G>A (p.Arg487Gln)	ABCC6	R487Q, R373Q	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433232	16	16284196	16	16190339	433232	427017	rs72653768	NC_000016.10:16190338:C:T
NM_001171.5(ABCC6):c.2258T>C (p.Leu753Pro)	ABCC6	L753P, L639P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433221	16	16272812	16	16178955	433221	426951	rs1555512484	NC_000016.10:16178954:A:G
NM_001171.5(ABCC6):c.1091C>G (p.Thr364Arg)	ABCC6	T364R, T250R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433219	16	16295943	16	16202086	433219	427041	rs72653759	NC_000016.10:16202085:G:C
NM_001171.5(ABCC6):c.2248G>A (p.Gly750Ser)	ABCC6	G750S, G636S	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433217	16	16272822	16	16178965	433217	426953	rs1192373126	NC_000016.10:16178964:C:T
NM_001171.5(ABCC6):c.938dup (p.Thr315fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433213	16	16297326 - 16297327	16	16203469 - 16203470	433213	427050	rs72664216	NC_000016.10:16203469:A:AA
NM_001171.5(ABCC6):c.113G>C (p.Trp38Ser)	ABCC6	W38S	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433201	16	16315612	16	16221755	433201	427091	rs72653752	NC_000016.10:16221754:C:G
NM_001171.5(ABCC6):c.4324G>A (p.Ala1442Thr)	ABCC6	A1442T, A1328T	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433514	16	16244514	16	16150657	433514	426791	rs1462269230	NC_000016.10:16150656:C:T
NM_001171.5(ABCC6):c.3692_3693insTT (p.Ser1232fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433513	16	16253381 - 16253382	16	16159524 - 16159525	433513	426859	rs779018991	NC_000016.10:16159524:A:AAA
NM_001171.5(ABCC6):c.3306+5G>C	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433512	16	16259475	16	16165618	433512	426886	rs369806278	NC_000016.10:16165617:C:G
NM_001171.5(ABCC6):c.1635+1G>T	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433511	16	16284020	16	16190163	433511	427002	rs1264741133	NC_000016.10:16190162:C:A
NM_001171.5(ABCC6):c.3032T>C (p.Leu1011Pro)	ABCC6	L1011P, L897P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433510	16	16259754	16	16165897	433510	426900	rs1555509515	NC_000016.10:16165896:A:G
NM_001171.5(ABCC6):c.2911T>C (p.Trp971Arg)	ABCC6	W971R, W857R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433509	16	16263587	16	16169730	433509	426904	rs1555510357	NC_000016.10:16169729:A:G
NM_001171.5(ABCC6):c.118C>T (p.Pro40Ser)	ABCC6	P40S	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433507	16	16315607	16	16221750	433507	427090	rs778544828	NC_000016.10:16221749:G:A
NM_001171.5(ABCC6):c.268G>A (p.Ala90Thr)	ABCC6	A90T	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433506	16	16313756	16	16219899	433506	427078	rs957828732	NC_000016.10:16219898:C:T
NM_001171.5(ABCC6):c.26C>A (p.Ala9Glu)	ABCC6	A9E	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433505	16	16317266	16	16223409	433505	427098	rs1555523855	NC_000016.10:16223408:G:T
NM_001171.5(ABCC6):c.191G>A (p.Arg64Gln)	ABCC6	R64Q	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433504	16	16315534	16	16221677	433504	427083	rs777566074	NC_000016.10:16221676:C:T
NM_001171.5(ABCC6):c.61C>T (p.Pro21Ser)	ABCC6	P21S	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433503	16	16315664	16	16221807	433503	427093	rs1235912910	NC_000016.10:16221806:G:A
NM_001171.5(ABCC6):c.2501T>C (p.Met834Thr)	ABCC6	M834T, M720T	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433502	16	16271398	16	16177541	433502	426927	rs1355752953	NC_000016.10:16177540:A:G
NM_001171.5(ABCC6):c.2126A>G (p.Glu709Gly)	ABCC6	E709G, E595G	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433501	16	16276390	16	16182533	433501	426967	rs1555513103	NC_000016.10:16182532:T:C
NM_001171.5(ABCC6):c.2843T>C (p.Leu948Pro)	ABCC6	L948P, L834P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433500	16	16263655	16	16169798	433500	426910	rs1555510407	NC_000016.10:16169797:A:G
NM_001171.5(ABCC6):c.11C>A (p.Pro4His)	ABCC6	P4H	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433499	16	16317281	16	16223424	433499	427099	rs1555523872	NC_000016.10:16223423:G:T
NM_001171.5(ABCC6):c.1814T>C (p.Leu605Pro)	ABCC6	L605P, L491P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433498	16	16281034	16	16187177	433498	426991	rs768271196	NC_000016.10:16187176:A:G
NM_001351800.1(ABCC6):c.364_365CT[3] (p.Trp123fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433436	16	16302669 - 16302670	16	16208812 - 16208813	433436	427057	rs1343632105	NC_000016.10:16208812:AGAG:AGAGAG
NM_001171.5(ABCC6):c.3787G>A (p.Gly1263Arg)	ABCC6	G1263R, G1149R	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433435	16	16251615	16	16157758	433435	426846	rs760376992	NC_000016.10:16157757:C:T
NM_001171.5(ABCC6):c.2943G>T (p.Gln981His)	ABCC6	Q981H, Q867H	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433434	16	16263555	16	16169698	433434	426903	rs368465318	NC_000016.10:16169697:C:A
NM_001171.5(ABCC6):c.2379C>G (p.Asn793Lys)	ABCC6	N793K, N679K	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433433	16	16272691	16	16178834	433433	426939	rs1555512420	NC_000016.10:16178833:G:C
NM_001171.5(ABCC6):c.1674del (p.Glu559fs)	ABCC6	E559fs, E445fs	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433430	16	16282793	16	16188936	433430	427000	rs1313008538	NC_000016.10:16188935:GG:G
NM_001171.5(ABCC6):c.1563G>C (p.Glu521Asp)	ABCC6	E521D, E407D	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433429	16	16284093	16	16190236	433429	427007	rs1555514899	NC_000016.10:16190235:C:G
NM_001171.5(ABCC6):c.1498A>C (p.Thr500Pro)	ABCC6	T500P, T386P	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433428	16	16284158	16	16190301	433428	427013	rs1555514945	NC_000016.10:16190300:T:G
NM_001171.5(ABCC6):c.1396A>T (p.Asn466Tyr)	ABCC6	N466Y, N352Y	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433427	16	16286722	16	16192865	433427	427019	rs1555515781	NC_000016.10:16192864:T:A
NM_001171.5(ABCC6):c.1901C>T (p.Ala634Val)	ABCC6	A634V, A520V	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433426	16	16278858	16	16185001	433426	426986	rs1555513604	NC_000016.10:16185000:G:A
NM_001351800.1(ABCC6):c.-197_-193del	ABCC6	R60fs	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433425	16	16315544 - 16315548	16	16221687 - 16221691	433425	427088	rs1555523438	NC_000016.10:16221686:CCCGGCC:CC
NM_001171.5(ABCC6):c.1091_1338+3149del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433424	16	16288729 - 16295943	16	16194872 - 16202086	433424	427022		
NM_001171.5(ABCC6):c.3307-1006_3882+1582del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433423	16	16249938 - 16258055	16	16156081 - 16164198	433423	426835		
NM_001171.5(ABCC6):c.3074T>C (p.Leu1025Pro)	ABCC6	L1025P, L911P	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433422	16	16259712	16	16165855	433422	426899	rs1555509499	NC_000016.10:16165854:A:G
NM_001171.5(ABCC6):c.2237_2238ins10 (p.?)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433421	16	16276278 - 16276279	16	16182421 - 16182422	433421	426958		
NM_001171.5(ABCC6):c.3188T>C (p.Leu1063Pro)	ABCC6	L1063P, L949P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433419	16	16259598	16	16165741	433419	426891	rs72657695	NC_000016.10:16165740:A:G
NM_001171.5(ABCC6):c.3307-38_3307-3delinsAGA	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433417	16	16257052 - 16257087	16	16163195 - 16163230	433417	426885	rs1555508993	NC_000016.10:16163194:GAGAAGGATGGATGGGAGAGGGAAGAGGAGAAGCCA:TCT
NM_001171.5(ABCC6):c.3106_3108del (p.Phe1036del)	ABCC6	F1036del, F922del	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433416	16	16259678 - 16259680	16	16165821 - 16165823	433416	426897	rs72664230	NC_000016.10:16165820:AAA:
NM_001171.5(ABCC6):c.373G>T (p.Glu125Ter)	ABCC6	E125*, E11*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433415	16	16313512	16	16219655	433415	427071	rs879956688	NC_000016.10:16219654:C:A
NM_001171.5(ABCC6):c.998+2_998+3del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433414	16	16297264 - 16297265	16	16203407 - 16203408	433414	427044	rs72664204	NC_000016.10:16203406:CAC:C
NM_001171.5(ABCC6):c.3823_3870del (p.Arg1275_His1290del)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433413	16	16251532 - 16251579	16	16157675 - 16157722	433413	426840	rs74315128	NC_000016.10:16157674:GTGGATCTTGAAGGACACGCCCTGCACAGCCAGCGGGAGCTCAGGTCGGT:GT
NM_001171.5(ABCC6):c.2836_2851del (p.Leu946fs)	ABCC6	L946fs, L832fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433412	16	16263647 - 16263662	16	16169790 - 16169805	433412	426909	rs74315152	NC_000016.10:16169789:GTGCGTAGAGGCAGAGG:G
NM_001171.5(ABCC6):c.2248-2_2248-1del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433411	16	16272823 - 16272824	16	16178966 - 16178967	433411	426954	rs111113624	NC_000016.10:16178965:CT:
NM_001171.5(ABCC6):c.3544dup (p.Leu1182fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433410	16	16255383 - 16255384	16	16161526 - 16161527	433410	426867	rs1555508630	NC_000016.10:16161526:GG:GGG
NM_001171.5(ABCC6):c.595C>T (p.Gln199Ter)	ABCC6	Q199*, Q85*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433409	16	16308186	16	16214329	433409	427067	rs1474063386	NC_000016.10:16214328:G:A
NM_001171.5(ABCC6):c.2248-12_2248-11del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433407	16	16272833 - 16272834	16	16178976 - 16178977	433407	426955	rs111113623	NC_000016.10:16178975:AAAA:AA
NM_001171.5(ABCC6):c.4182G>A (p.Lys1394=)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433406	16	16248511	16	16154654	433406	426809	rs63750798	NC_000016.10:16154653:C:T
NM_001171.5(ABCC6):c.1944_1965del22	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433405	16	16276766 - 16276787	16	16182909 - 16182930	433405	426982	rs74315158	NC_000016.10:16182908:CTGGGGCACCGTGAGGTTTATTCTGG:CTGG
NM_001171.5(ABCC6):c.2996-?_4208+?del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433404					433404	426774		
NM_001171.5(ABCC6):c.179_195del (p.Arg60fs)	ABCC6	R60fs	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433403	16	16315530 - 16315546	16	16221673 - 16221689	433403	427082	rs1555523429	NC_000016.10:16221672:CATCCGGAGGTAGCCCC:
NM_001171.5(ABCC6):c.681C>G (p.Tyr227Ter)	ABCC6	Y227*, Y113*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433402	16	16302698	16	16208841	433402	427058	rs1315925055	NC_000016.10:16208840:G:C
NM_001171.5(ABCC6):c.220-1G>C	ABCC6		Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433400	16	16313805	16	16219948	433400	427081	rs72664203	NC_000016.10:16219947:C:G
NM_001171.5(ABCC6):c.4403+11C>G	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433397	16	16244424	16	16150567	433397	426785	rs72664215	NC_000016.10:16150566:G:C
NM_001171.5(ABCC6):c.3883-5G>A	ABCC6		Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433395	16	16248893	16	16155036	433395	426831	rs72664213	NC_000016.10:16155035:C:T
NM_001171.5(ABCC6):c.3634-3C>A	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433393	16	16253443	16	16159586	433393	426864	rs72664212	NC_000016.10:16159585:G:T
NM_001171.5(ABCC6):c.3506+15G>A	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433391	16	16256835	16	16162978	433391	426870	rs72664302	NC_000016.10:16162977:C:T
NM_001171.5(ABCC6):c.3506+2_3506+5del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433390	16	16256845 - 16256848	16	16162988 - 16162991	433390	426871	rs72664211	NC_000016.10:16162987:CCTACCT:CCT
NM_001171.5(ABCC6):c.795-131_795-3del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433387	16	16297473 - 16297601	16	16203616 - 16203744	433387	427052	rs1555518941	
NM_001171.5(ABCC6):c.144_795-3del	ABCC6		Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433386	16	16297473 - 16315581	16	16203616 - 16221724	433386	427053		
NM_001171.5(ABCC6):c.1432-22C>A	ABCC6		Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433384	16	16284246	16	16190389	433384	427018	rs72664297	NC_000016.10:16190388:G:T
NM_001171.5(ABCC6):c.1176+6C>T	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433381	16	16295852	16	16201995	433381	427034	rs72664295	NC_000016.10:16201994:G:A
NM_001171.5(ABCC6):c.37-1G>A	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433372	16	16315689	16	16221832	433372	427095	rs72657702	NC_000016.10:16221831:C:T
NM_001171.5(ABCC6):c.4501G>A (p.Gly1501Ser)	ABCC6	G1501S, G1387S	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433368	16	16244001	16	16150144	433368	426780	rs63750874	NC_000016.10:16150143:C:T
NM_001171.5(ABCC6):c.4434del (p.Glu1479fs)	ABCC6	E1365fs, E1479fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433365	16	16244068	16	16150211	433365	426783	rs72664280	NC_000016.10:16150210:T:
NM_001171.5(ABCC6):c.4420A>T (p.Lys1474Ter)	ABCC6	K1474*, K1360*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433364	16	16244082	16	16150225	433364	426784	rs72653751	NC_000016.10:16150224:T:A
NM_001171.5(ABCC6):c.4377C>T (p.Arg1459=)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433363	16	16244461	16	16150604	433363	426788	rs63750763	NC_000016.10:16150603:G:A
NM_001171.5(ABCC6):c.4318del (p.Met1440fs)	ABCC6	M1440fs, M1326fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433361	16	16244520	16	16150663	433361	426792	rs72664238	NC_000016.10:16150662:T:
NM_001171.5(ABCC6):c.4306_4312del (p.Thr1436fs)	ABCC6	T1322fs, T1436fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433360	16	16244526 - 16244532	16	16150669 - 16150675	433360	426793	rs74315109	NC_000016.10:16150668:GCTCCGTGC:GC
NM_001171.5(ABCC6):c.4305C>T (p.Gly1435=)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433359	16	16244533	16	16150676	433359	426794	rs72664289	NC_000016.10:16150675:G:A
NM_001171.5(ABCC6):c.4271T>C (p.Ile1424Thr)	ABCC6	I1424T, I1310T	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433358	16	16244567	16	16150710	433358	426795	rs63750295	NC_000016.10:16150709:A:G
NM_001171.5(ABCC6):c.4220_4221insGAAA (p.Gln1408fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433355	16	16244617 - 16244618	16	16150760 - 16150761	433355	426800	rs72664222	NC_000016.10:16150760:TT:TTTCTT
NM_001171.5(ABCC6):c.4209C>A (p.Ser1403Arg)	ABCC6	S1403R, S1289R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433354	16	16244629	16	16150772	433354	426802	rs63750700	NC_000016.10:16150771:G:T
NM_001171.5(ABCC6):c.4060G>C (p.Gly1354Arg)	ABCC6	G1354R, G1240R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433349	16	16248633	16	16154776	433349	426812	rs63750018	NC_000016.10:16154775:C:G
NM_001171.5(ABCC6):c.4048A>C (p.Ile1350Leu)	ABCC6	I1350L, I1236L	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433348	16	16248645	16	16154788	433348	426813	rs72664288	NC_000016.10:16154787:T:G
NM_001171.5(ABCC6):c.4041G>C (p.Gln1347His)	ABCC6	Q1347H, Q1233H	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433347	16	16248730	16	16154873	433347	426814	rs63751111	NC_000016.10:16154872:C:G
NM_001171.5(ABCC6):c.4036C>T (p.Pro1346Ser)	ABCC6	P1346S, P1232S	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433346	16	16248735	16	16154878	433346	426815	rs63751112	NC_000016.10:16154877:G:A
NM_001171.5(ABCC6):c.4025T>C (p.Ile1342Thr)	ABCC6	I1342T, I1228T	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433345	16	16248746	16	16154889	433345	426816	rs63750608	NC_000016.10:16154888:A:G
NM_001171.5(ABCC6):c.4016G>T (p.Arg1339Leu)	ABCC6	R1339L, R1225L	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433344	16	16248755	16	16154898	433344	426817	rs63750622	NC_000016.10:16154897:C:A
NM_001171.5(ABCC6):c.3932G>A (p.Gly1311Glu)	ABCC6	G1311E, G1197E	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433338	16	16248839	16	16154982	433338	426825	rs63750992	NC_000016.10:16154981:C:T
NM_001171.5(ABCC6):c.3919T>C (p.Ser1307Pro)	ABCC6	S1307P, S1193P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433337	16	16248852	16	16154995	433337	426826	rs63751318	NC_000016.10:16154994:A:G
NM_001171.5(ABCC6):c.3912del (p.Lys1305fs)	ABCC6	K1305fs, K1191fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433336	16	16248859	16	16155002	433336	426827	rs72664236	NC_000016.10:16155001:CCC:CC
NM_001171.5(ABCC6):c.3902C>T (p.Thr1301Ile)	ABCC6	T1301I, T1187I	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433334	16	16248869	16	16155012	433334	426829	rs63750494	NC_000016.10:16155011:G:A
NM_001171.5(ABCC6):c.3895G>A (p.Gly1299Ser)	ABCC6	G1299S, G1185S	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433333	16	16248876	16	16155019	433333	426830	rs63750446	NC_000016.10:16155018:C:T
NM_001171.5(ABCC6):c.3877G>A (p.Glu1293Lys)	ABCC6	E1293K, E1179K	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433332	16	16251525	16	16157668	433332	426838	rs63750625	NC_000016.10:16157667:C:T
NM_001171.5(ABCC6):c.3818G>A (p.Arg1273Lys)	ABCC6	R1273K, R1159K	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433331	16	16251584	16	16157727	433331	426843	rs63750209	NC_000016.10:16157726:C:T
NM_001171.5(ABCC6):c.3735G>A (p.Glu1245=)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433328	16	16253339	16	16159482	433328	426852	rs281865557	NC_000016.10:16159481:C:T
NM_001171.5(ABCC6):c.3735G>T (p.Glu1245Asp)	ABCC6	E1245D, E1131D	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433327	16	16253339	16	16159482	433327	426851	rs281865557	NC_000016.10:16159481:C:A
NM_001171.5(ABCC6):c.3717T>G (p.Tyr1239Ter)	ABCC6	Y1239*, Y1125*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433326	16	16253357	16	16159500	433326	426855	rs72653747	NC_000016.10:16159499:A:C
NM_001171.5(ABCC6):c.3715T>C (p.Tyr1239His)	ABCC6	Y1239H, Y1125H	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433325	16	16253359	16	16159502	433325	426856	rs63749992	NC_000016.10:16159501:A:G
NM_001171.5(ABCC6):c.3703C>T (p.Arg1235Trp)	ABCC6	R1235W, R1121W	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433323	16	16253371	16	16159514	433323	426858	rs63750402	NC_000016.10:16159513:G:A
NM_001171.5(ABCC6):c.3676C>A (p.Leu1226Ile)	ABCC6	L1226I, L1112I	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433322	16	16253398	16	16159541	433322	426860	rs63750125	NC_000016.10:16159540:G:T
NM_001171.5(ABCC6):c.3668G>A (p.Trp1223Ter)	ABCC6	W1223*, W1109*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433321	16	16253406	16	16159549	433321	426861	rs72653745	NC_000016.10:16159548:C:T
NM_001171.5(ABCC6):c.3608G>A (p.Gly1203Asp)	ABCC6	G1203D, G1089D	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433318	16	16255320	16	16161463	433318	426866	rs63750607	NC_000016.10:16161462:C:T
NM_001171.5(ABCC6):c.3427C>T (p.Gln1143Ter)	ABCC6	Q1143*, Q1029*	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433317	16	16256929	16	16163072	433317	426873	rs72653743	NC_000016.10:16163071:G:A
NM_001171.5(ABCC6):c.3413G>C (p.Arg1138Pro)	ABCC6	R1138P, R1024P	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433316	16	16256943	16	16163086	433316	426874	rs60791294	NC_000016.10:16163085:C:G
NM_001171.5(ABCC6):c.3364del (p.Ser1122fs)	ABCC6	S1122fs, S1008fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433312	16	16256992	16	16163135	433312	426879	rs72664232	NC_000016.10:16163134:A:
NM_001171.5(ABCC6):c.3362C>T (p.Ser1121Leu)	ABCC6	S1121L, S1007L	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433311	16	16256994	16	16163137	433311	426880	rs63750987	NC_000016.10:16163136:G:A
NM_001171.5(ABCC6):c.3362C>G (p.Ser1121Trp)	ABCC6	S1121W, S1007W	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433310	16	16256994	16	16163137	433310	426881	rs63750987	NC_000016.10:16163136:G:C
NM_001171.5(ABCC6):c.3343_3345del (p.Leu1115del)	ABCC6	L1115del, L1001del	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433309	16	16257011 - 16257013	16	16163154 - 16163156	433309	426882	rs72664231	NC_000016.10:16163153:CAA:
NM_001171.5(ABCC6):c.3207C>A (p.Tyr1069Ter)	ABCC6	Y1069*, Y955*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433306	16	16259579	16	16165722	433306	426888	rs60975032	NC_000016.10:16165721:G:T
NM_001171.5(ABCC6):c.3188T>G (p.Leu1063Arg)	ABCC6	L1063R, L949R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433304	16	16259598	16	16165741	433304	426890	rs72657695	NC_000016.10:16165740:A:C
NM_001171.5(ABCC6):c.3168C>A (p.Asp1056Glu)	ABCC6	D1056E, D942E	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433303	16	16259618	16	16165761	433303	426892	rs72657694	NC_000016.10:16165760:G:T
NM_001171.5(ABCC6):c.3145T>G (p.Ser1049Ala)	ABCC6	S1049A, S935A	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433302	16	16259641	16	16165784	433302	426893	rs72657693	NC_000016.10:16165783:A:C
NM_001171.5(ABCC6):c.2891G>C (p.Arg964Pro)	ABCC6	R964P, R850P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433298	16	16263607	16	16169750	433298	426905	rs72657691	NC_000016.10:16169749:C:G
NM_001171.5(ABCC6):c.2858T>A (p.Leu953His)	ABCC6	L953H, L839H	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433297	16	16263640	16	16169783	433297	426907	rs72657700	NC_000016.10:16169782:A:T
NM_001171.5(ABCC6):c.2855T>G (p.Phe952Cys)	ABCC6	F952C, F838C	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433296	16	16263643	16	16169786	433296	426908	rs72657690	NC_000016.10:16169785:A:C
NM_001171.5(ABCC6):c.2831C>T (p.Thr944Ile)	ABCC6	T944I, T830I	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433291	16	16263667	16	16169810	433291	426913	rs72653801	NC_000016.10:16169809:G:A
NM_001171.5(ABCC6):c.2820_2821insC (p.Ala941fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433290	16	16263677 - 16263678	16	16169820 - 16169821	433290	426914	rs72664219	NC_000016.10:16169820::G
NM_001171.5(ABCC6):c.2814C>G (p.Tyr938Ter)	ABCC6	Y938*, Y824*	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433288	16	16263684	16	16169827	433288	426916	rs72653704	NC_000016.10:16169826:G:C
NM_001171.5(ABCC6):c.2631C>A (p.Thr877=)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433285	16	16269803	16	16175946	433285	426922	rs72664285	NC_000016.10:16175945:G:T
NM_001171.5(ABCC6):c.2552T>C (p.Leu851Pro)	ABCC6	L851P, L737P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433284	16	16271347	16	16177490	433284	426923	rs72653799	NC_000016.10:16177489:A:G
NM_001171.5(ABCC6):c.2524C>T (p.Gln842Ter)	ABCC6	Q842*, Q728*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433282	16	16271375	16	16177518	433282	426925	rs72653703	NC_000016.10:16177517:G:A
NM_001171.5(ABCC6):c.2477T>C (p.Leu826Pro)	ABCC6	L826P, L712P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433279	16	16271422	16	16177565	433279	426930	rs72653798	NC_000016.10:16177564:A:G
NM_001171.5(ABCC6):c.2458G>C (p.Ala820Pro)	ABCC6	A820P, A706P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433278	16	16271441	16	16177584	433278	426931	rs72653797	NC_000016.10:16177583:C:G
NM_001171.5(ABCC6):c.2419C>T (p.Arg807Trp)	ABCC6	R807W, R693W	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433276	16	16271480	16	16177623	433276	426934	rs72653793	NC_000016.10:16177622:G:A
NM_001171.5(ABCC6):c.2359G>T (p.Val787Phe)	ABCC6	V787F, V673F	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433274	16	16272711	16	16178854	433274	426940	rs72653792	NC_000016.10:16178853:C:A
NM_001171.5(ABCC6):c.2342C>T (p.Ala781Val)	ABCC6	A781V, A667V	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433273	16	16272728	16	16178871	433273	426941	rs72653791	NC_000016.10:16178870:G:A
NM_001171.5(ABCC6):c.2323del (p.Leu775fs)	ABCC6	L661fs, L775fs	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433271	16	16272747	16	16178890	433271	426943	rs72664229	NC_000016.10:16178889:GG:G
NM_001171.5(ABCC6):c.2297C>A (p.Ala766Asp)	ABCC6	A766D, A652D	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433269	16	16272773	16	16178916	433269	426946	rs72653789	NC_000016.10:16178915:G:T
NM_001171.5(ABCC6):c.2177T>C (p.Leu726Pro)	ABCC6	L726P, L612P	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433263	16	16276339	16	16182482	433263	426961	rs72653785	NC_000016.10:16182481:A:G
NM_001171.5(ABCC6):c.2162G>A (p.Trp721Ter)	ABCC6	W721*, W607*	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433260	16	16276354	16	16182497	433260	426965	rs72650701	NC_000016.10:16182496:C:T
NM_001171.5(ABCC6):c.2097G>T (p.Glu699Asp)	ABCC6	E699D, E585D	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433259	16	16276419	16	16182562	433259	426970	rs72653784	NC_000016.10:16182561:C:A
NM_001171.5(ABCC6):c.2030T>C (p.Leu677Pro)	ABCC6	L677P, L563P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433257	16	16276701	16	16182844	433257	426973	rs72653782	NC_000016.10:16182843:A:G
NM_001171.5(ABCC6):c.1999del (p.Ala667fs)	ABCC6	A553fs, A667fs	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433256	16	16276732	16	16182875	433256	426974	rs72664227	NC_000016.10:16182874:CCCCC:CCCC
NM_001171.5(ABCC6):c.1996G>T (p.Gly666Trp)	ABCC6	G666W, G552W	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433255	16	16276735	16	16182878	433255	426975	rs72653781	NC_000016.10:16182877:C:A
NM_001171.5(ABCC6):c.1964A>G (p.Gln655Arg)	ABCC6	Q655R, Q541R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433248	16	16276767	16	16182910	433248	426983	rs72653779	NC_000016.10:16182909:T:C
NM_001171.5(ABCC6):c.1857dup (p.Ser620fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433245	16	16280990 - 16280991	16	16187133 - 16187134	433245	426989	rs72664218	NC_000016.10:16187133:GG:GGG
NM_001171.5(ABCC6):c.1798C>T (p.Arg600Cys)	ABCC6	R600C, R486C	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433243	16	16281050	16	16187193	433243	426993	rs72653777	NC_000016.10:16187192:G:A
NM_001171.5(ABCC6):c.1685T>C (p.Met562Thr)	ABCC6	M562T, M448T	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433240	16	16282782	16	16188925	433240	426999	rs72653775	NC_000016.10:16188924:A:G
NM_001171.5(ABCC6):c.1652T>C (p.Phe551Ser)	ABCC6	F551S, F437S	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433239	16	16282815	16	16188958	433239	427001	rs72653774	NC_000016.10:16188957:A:G
NM_001171.5(ABCC6):c.1603T>C (p.Ser535Pro)	ABCC6	S535P, S421P	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433238	16	16284053	16	16190196	433238	427003	rs72653773	NC_000016.10:16190195:A:G
NM_001171.5(ABCC6):c.1575dup (p.Arg526fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433237	16	16284080 - 16284081	16	16190223 - 16190224	433237	427005	rs72664217	NC_000016.10:16190223:C:CC
NM_001171.5(ABCC6):c.1540G>A (p.Val514Ile)	ABCC6	V514I, V400I	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433236	16	16284116	16	16190259	433236	427008	rs59157279	NC_000016.10:16190258:C:T
NM_001171.5(ABCC6):c.1505A>T (p.Lys502Met)	ABCC6	K502M, K388M	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433235	16	16284151	16	16190294	433235	427012	rs72653771	NC_000016.10:16190293:T:A
NM_001171.5(ABCC6):c.3880_3882del (p.Lys1294del)	ABCC6	K1294del, K1180del	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433231	16	16251520 - 16251522	16	16157663 - 16157665	433231	426837	rs72664235	NC_000016.10:16157662:CTTCT:CT
NM_001171.5(ABCC6):c.1363G>C (p.Ala455Pro)	ABCC6	A455P, A341P	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433230	16	16286755	16	16192898	433230	427021	rs67996819	NC_000016.10:16192897:C:G
NM_001171.5(ABCC6):c.1318T>G (p.Cys440Gly)	ABCC6	C440G, C326G	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433229	16	16291898	16	16198041	433229	427026	rs72653766	NC_000016.10:16198040:A:C
NM_001171.5(ABCC6):c.1244T>C (p.Val415Ala)	ABCC6	V415A, V301A	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433227	16	16291972	16	16198115	433227	427029	rs72653765	NC_000016.10:16198114:A:G
NM_001171.5(ABCC6):c.1192A>G (p.Ser398Gly)	ABCC6	S398G, S284G	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433225	16	16292024	16	16198167	433225	427033	rs72653764	NC_000016.10:16198166:T:C
NM_001171.5(ABCC6):c.1176G>C (p.Lys392Asn)	ABCC6	K392N, K278N	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433224	16	16295858	16	16202001	433224	427035	rs72653763	NC_000016.10:16202000:C:G
NM_001171.5(ABCC6):c.1144C>T (p.Arg382Trp)	ABCC6	R382W, R268W	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433223	16	16295890	16	16202033	433223	427036	rs72653761	NC_000016.10:16202032:G:A
NM_001171.5(ABCC6):c.1108A>G (p.Asn370Asp)	ABCC6	N370D, N256D	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433220	16	16295926	16	16202069	433220	427040	rs72653760	NC_000016.10:16202068:T:C
NM_001171.5(ABCC6):c.1087C>T (p.Gln363Ter)	ABCC6	Q363*, Q249*	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433218	16	16295947	16	16202090	433218	427042	rs72650698	NC_000016.10:16202089:G:A
NM_001171.5(ABCC6):c.1064T>G (p.Leu355Arg)	ABCC6	L355R, L241R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433216	16	16295970	16	16202113	433216	427043	rs72653758	NC_000016.10:16202112:A:C
NM_001171.5(ABCC6):c.960del (p.Ser321fs)	ABCC6	S207fs, S321fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433215	16	16297305	16	16203448	433215	427047	rs72664226	NC_000016.10:16203447:G:
NM_001171.5(ABCC6):c.373G>A (p.Glu125Lys)	ABCC6	E125K, E11K	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433214	16	16313512	16	16219655	433214	427072	rs879956688	NC_000016.10:16219654:C:T
NM_001171.5(ABCC6):c.865_889del (p.Leu289fs)	ABCC6	L289fs, L175fs	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433212	16	16297376 - 16297400	16	16203519 - 16203543	433212	427051	rs74315139	NC_000016.10:16203518:GCCACTGGCTCCCTTCTTGCCGTAGG:G
NM_001171.5(ABCC6):c.3722G>A (p.Trp1241Ter)	ABCC6	W1241*, W1127*	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433211	16	16253352	16	16159495	433211	426854	rs72653748	NC_000016.10:16159494:C:T
NM_001171.5(ABCC6):c.676G>A (p.Gly226Arg)	ABCC6	G226R, G112R	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433210	16	16302703	16	16208846	433210	427059	rs72653755	NC_000016.10:16208845:C:T
NM_001171.5(ABCC6):c.654G>T (p.Trp218Cys)	ABCC6	W218C, W104C	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433209	16	16306050	16	16212193	433209	427061	rs72653754	NC_000016.10:16212192:C:A
NM_001171.5(ABCC6):c.619G>A (p.Gly207Arg)	ABCC6	G207R, G93R	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433207	16	16306085	16	16212228	433207	427063	rs72657697	NC_000016.10:16212227:C:T
NM_001171.5(ABCC6):c.549G>A (p.Leu183=)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433206	16	16308232	16	16214375	433206	427068	rs72664281	NC_000016.10:16214374:C:T
NM_001171.5(ABCC6):c.473C>T (p.Ala158Val)	ABCC6	A158V, A44V	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433205	16	16313412	16	16219555	433205	427069	rs2606921	NC_000016.10:16219554:G:A
NM_001171.5(ABCC6):c.386G>A (p.Gly129Glu)	ABCC6	G129E, G15E	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433204	16	16313499	16	16219642	433204	427070	rs72653753	NC_000016.10:16219641:C:T
NM_001171.5(ABCC6):c.220_222del	ABCC6	V74del	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433203	16	16313802 - 16313804	16	16219945 - 16219947	433203	427080	rs72664225	NC_000016.10:16219944:CACC:C
NM_001171.5(ABCC6):c.182G>A (p.Gly61Asp)	ABCC6	G61D	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433202	16	16315543	16	16221686	433202	427087	rs72657696	NC_000016.10:16221685:C:T
NM_001351800.1(ABCC6):c.-269del	ABCC6	V37fs	Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433200	16	16315620	16	16221763	433200	427092	rs72664223	NC_000016.10:16221762:T:
NM_001171.5(ABCC6):c.3306+1del	ABCC6		Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Dec 15, 2014)	criteria provided, single submitter	VCV000208558	16	16259479	16	16165622	208558	205179	rs797045078	NC_000016.10:16165621:CC:C
NM_001171.5(ABCC6):c.450dup (p.Ala151fs)	ABCC6		Generalized arterial calcification of infancy 2	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000030340	16	16313434 - 16313435	16	16219577 - 16219578	30340	39296	rs387906860	NC_000016.10:16219577:G:GG
NG_007558.2:g.(60799_60814)_(77206_77221)del	ABCC6		Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000006573	16	16245108 - 16261530	16	16151251 - 16167673	6573	21612		
NM_001171.5(ABCC6):c.4243_4244insAGAA (p.Ala1415fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000006566	16	16244594 - 16244595	16	16150737 - 16150738	6566	21605	rs387906352	NC_000016.10:16150737::TTCT
NC_000016.10:g.(?_16157663)_(16163192_?)del	ABCC6		not provided	Pathogenic(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000830970	16	16251520 - 16257049			830970	820774		
NM_001171.5(ABCC6):c.4041G>A (p.Gln1347=)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000599399	16	16248730	16	16154873	599399	590735	rs63751111	NC_000016.10:16154872:C:T
NM_001171.5(ABCC6):c.1088_1120del (p.Gln363_Arg373del)	ABCC6		Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000433408	16	16295914 - 16295946	16	16202057 - 16202089	433408	427039	rs387906353	NC_000016.10:16202056:GCCTGTACATGTTCTGCTGCTCAAACAGCGTTTGC:GC
NM_001171.5(ABCC6):c.3883-6G>A	ABCC6		Pseudoxanthoma elasticum	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000433394	16	16248894	16	16155037	433394	426832	rs72664214	NC_000016.10:16155036:C:T
NM_001171.5(ABCC6):c.3774dup (p.Trp1259fs)	ABCC6		Pseudoxanthoma elasticum	Pathogenic	no assertion criteria provided	VCV000433330	16	16251627 - 16251628	16	16157770 - 16157771	433330	426849	rs72664220	NC_000016.10:16157770:GGGGGG:GGGGGGG
NM_001171.5(ABCC6):c.2018T>C (p.Leu673Pro)	ABCC6	L673P, L559P	Pseudoxanthoma elasticum|not provided	Pathogenic(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	VCV000379930	16	16276713	16	16182856	379930	377108	rs67470842	NC_000016.10:16182855:A:G
NM_001171.5(ABCC6):c.1132C>T (p.Gln378Ter)	ABCC6	Q378*, Q264*	Pseudoxanthoma elasticum|not provided	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000372294	16	16295902	16	16202045	372294	360232	rs72650699	NC_000016.10:16202044:G:A
NM_001171.5(ABCC6):c.3712G>C (p.Asp1238His)	ABCC6	D1238H, D1124H	Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000006581	16	16253362	16	16159505	6581	21620	rs63749796	NC_000016.10:16159504:C:G
NM_001171.5(ABCC6):c.4015C>T (p.Arg1339Cys)	ABCC6	R1339C, R1225C	Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Jun 15, 2018)	no assertion criteria provided	VCV000006576	16	16248756	16	16154899	6576	21615	rs28939702	NC_000016.10:16154898:G:A
NM_001171.5(ABCC6):c.4182del (p.Lys1394fs)	ABCC6	K1394fs, K1280fs	Pseudoxanthoma elasticum|not provided	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000433351	16	16248511	16	16154654	433351	426810	rs67791546	NC_000016.10:16154653:C:
NM_001171.5(ABCC6):c.1967_1989del (p.Gly656fs)	ABCC6	G656fs, G542fs	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433251	16	16276742 - 16276764	16	16182885 - 16182907	433251	426978	rs74315130	NC_000016.10:16182884:ACCGACAACAGCCAGCAGACAGC:
NM_001171.5(ABCC6):c.1256G>A (p.Arg419Gln)	ABCC6	R419Q, R305Q	Pseudoxanthoma elasticum|not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000430158	16	16291960	16	16198103	430158	422075	rs772434460	NC_000016.10:16198102:C:T
NM_001171.5(ABCC6):c.4081G>A (p.Asp1361Asn)	ABCC6	D1361N, D1247N	not provided|Pseudoxanthoma elasticum	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419738	16	16248612	16	16154755	419738	409463	rs58695352	NC_000016.10:16154754:C:T
NM_001171.5(ABCC6):c.4016G>A (p.Arg1339His)	ABCC6	R1339H, R1225H	Pseudoxanthoma elasticum|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, multiple submitters, no conflicts	VCV000265021	16	16248755	16	16154898	265021	260084	rs63750622	NC_000016.10:16154897:C:T
NM_001171.5(ABCC6):c.3398G>C (p.Gly1133Ala)	ABCC6	G1133A, G1019A	Pseudoxanthoma elasticum|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 17, 2015)	criteria provided, multiple submitters, no conflicts	VCV000265020	16	16256958	16	16163101	265020	260085	rs63750473	NC_000016.10:16163100:C:G
NM_001171.5(ABCC6):c.3775del (p.Trp1259fs)	ABCC6	W1259fs, W1145fs	Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000006563	16	16251627	16	16157770	6563	21602	rs72664233	NC_000016.10:16157769:A:
NM_001171.5(ABCC6):c.3341G>C (p.Arg1114Pro)	ABCC6	R1114P, R1000P	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000006562	16	16257015	16	16163158	6562	21601	rs63750427	NC_000016.10:16163157:C:G
NM_001134407.3(GRIN2A):c.1507C>T (p.Gln503Ter)	GRIN2A	Q503*	not provided	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000817517	16	9934648	16	9840791	817517	805921		NC_000016.10:9840790:G:A
NM_001134407.3(GRIN2A):c.1825dup (p.Trp609fs)	GRIN2A		not provided	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000817361	16	9923461 - 9923462	16	9829604 - 9829605	817361	805920		NC_000016.10:9829604:AAA:AAAA
NM_001134407.3(GRIN2A):c.1453del (p.His485fs)	GRIN2A	H485fs	not provided	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000498245	16	9934837	16	9840980	498245	489669	rs1555494781	NC_000016.10:9840979:G:
NM_001134407.3(GRIN2A):c.2450T>G (p.Met817Arg)	GRIN2A	M817R	not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000423745	16	9862853	16	9768996	423745	409816	rs1064796608	NC_000016.10:9768995:A:C
NM_001134407.3(GRIN2A):c.3813G>A (p.Trp1271Ter)	GRIN2A	W1271*	not provided	Pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	VCV000285528	16	9857588	16	9763731	285528	269765	rs886043129	NC_000016.10:9763730:C:T
NM_001134407.3(GRIN2A):c.2890del (p.Gln964fs)	GRIN2A	Q964fs	not provided	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	VCV000281462	16	9858511	16	9764654	281462	265699	rs886042168	NC_000016.10:9764653:GG:G
NM_001134407.3(GRIN2A):c.3701del (p.Phe1234fs)	GRIN2A	F1234fs	not provided	Pathogenic(Last reviewed: Dec 23, 2015)	criteria provided, single submitter	VCV000279995	16	9857700	16	9763843	279995	264991	rs886041308	NC_000016.10:9763842:AA:A
GRCh37/hg19 16p13.2(chr16:10031589-10051402)x1	GRIN2A		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253506	16	10031589 - 10051402			253506	247954		
GRCh37/hg19 16p13.2(chr16:9923137-9923798)x1	GRIN2A		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253382	16	9923137 - 9923798			253382	247830		
GRCh37/hg19 16p13.2(chr16:9915837-9916457)x1	GRIN2A		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253375	16	9915837 - 9916457			253375	247823		
NM_001134407.3(GRIN2A):c.627del (p.Phe210fs)	GRIN2A	F210fs	not provided	Pathogenic(Last reviewed: Oct 11, 2013)	criteria provided, single submitter	VCV000205685	16	10032196	16	9938339	205685	203373	rs796052560	NC_000016.10:9938338:GG:G
NM_001134407.3(GRIN2A):c.2449A>G (p.Met817Val)	GRIN2A	M817V	not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000205659	16	9862854	16	9768997	205659	203354	rs796052551	NC_000016.10:9768996:T:C
NM_001134407.3(GRIN2A):c.2054T>G (p.Val685Gly)	GRIN2A	V685G	not provided	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000205655	16	9916235	16	9822378	205655	203360	rs796052548	NC_000016.10:9822377:A:C
GRCh37/hg19 16p13.2(chr16:9916365-10185615)x1	GRIN2A		See cases	Pathogenic(Last reviewed: Jun 16, 2014)	no assertion criteria provided	VCV000442102	16	9916365 - 10185615			442102	435764		
NM_001134407.3(GRIN2A):c.236C>G (p.Pro79Arg)	GRIN2A	P79R	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433130	16	10274033	16	10180176	433130	426682	rs1250662891	NC_000016.10:10180175:G:C
NM_001134407.3(GRIN2A):c.692G>A (p.Cys231Tyr)	GRIN2A	C231Y	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433129	16	10032131	16	9938274	433129	426695	rs1238779318	NC_000016.10:9938273:C:T
NM_001134407.3(GRIN2A):c.1007+1G>T	GRIN2A		Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433128	16	10031815	16	9937958	433128	426694	rs397518465	NC_000016.10:9937957:C:A
NM_001134407.3(GRIN2A):c.1306T>C (p.Cys436Arg)	GRIN2A	C436R	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433127	16	9943635	16	9849778	433127	426693	rs1555496111	NC_000016.10:9849777:A:G
NM_001134407.3(GRIN2A):c.1639_1641del (p.Ser547del)	GRIN2A	S547del	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433126	16	9934514 - 9934516	16	9840657 - 9840659	433126	426692	rs1555494676	NC_000016.10:9840656:AGAAG:AG
NM_001134407.3(GRIN2A):c.2095C>T (p.Pro699Ser)	GRIN2A	P699S	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433125	16	9916194	16	9822337	433125	426691	rs1555491648	NC_000016.10:9822336:G:A
NM_001134407.3(GRIN2A):c.2200G>C (p.Val734Leu)	GRIN2A	V734L	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433123	16	9892290	16	9798433	433123	426689	rs1439688451	NC_000016.10:9798432:C:G
NM_001134407.3(GRIN2A):c.2710A>T (p.Ile904Phe)	GRIN2A	I904F	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433122	16	9858691	16	9764834	433122	426688	rs1555482933	NC_000016.10:9764833:T:A
NC_000016.10:g.(?_9890966)_(10180431_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV000831099	16	9984823 - 10274288			831099	820966		
NC_000016.10:g.(?_9829403)_(9829672_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000831053	16	9923260 - 9923529			831053	820965		
NC_000016.10:g.(?_9798257)_(9849981_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000830906	16	9892114 - 9943838			830906	820964		
NM_001134407.3(GRIN2A):c.1529dup (p.Ser511fs)	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000813782	16	9934625 - 9934626	16	9840768 - 9840769	813782	802016		NC_000016.10:9840768:CC:CCC
NM_001134407.3(GRIN2A):c.1362del (p.Lys454fs)	GRIN2A	K454fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000813772	16	9934928	16	9841071	813772	802018		NC_000016.10:9841070:TTT:TT
NC_000016.10:g.9763108_9769129del	GRIN2A		Intellectual disability	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000691259					691259	678962		
NM_001134407.3(GRIN2A):c.58_67dup (p.Pro23fs)	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000664825	16	10274201 - 10274202	16	10180344 - 10180345	664825	643763		NC_000016.10:10180344:GCGCCGGACCGCGCC:GCGCCGGACCGCGCCGGACCGCGCC
NM_001134407.3(GRIN2A):c.1648del (p.Phe549_Leu550insTer)	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000641340	16	9934507	16	9840650	641340	645259		NC_000016.10:9840649:G:
NC_000016.9:g.(?_9943593)_(9943838_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000532725	16	9943593 - 9943838	16	9849736 - 9849981	532725	529861		
NM_001134407.3(GRIN2A):c.1901G>A (p.Trp634Ter)	GRIN2A	W634*	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000532718	16	9923386	16	9829529	532718	530803	rs1555492769	NC_000016.10:9829528:C:T
NC_000016.9:g.(?_10273835)_(10274288_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000464050	16	10273835 - 10274288			464050	465388		
NM_001134407.3(GRIN2A):c.1734C>G (p.Tyr578Ter)	GRIN2A	Y578*	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000411285	16	9928005	16	9834148	411285	401471	rs1060503228	NC_000016.10:9834147:G:C
NM_001134407.3(GRIN2A):c.1954T>G (p.Phe652Val)	GRIN2A	F652V	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000088733	16	9923333	16	9829476	88733	94310	rs397518471	NC_000016.10:9829475:A:C
NM_001134407.3(GRIN2A):c.1123-2A>G	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000088731	16	9943820	16	9849963	88731	94308	rs397518469	NC_000016.10:9849962:T:C
NM_001134407.3(GRIN2A):c.2829C>G (p.Tyr943Ter)	GRIN2A	Y943*	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000088729	16	9858572	16	9764715	88729	94306	rs397518467	NC_000016.10:9764714:G:C
NM_001134407.3(GRIN2A):c.2T>C (p.Met1Thr)	GRIN2A	M1T	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000088728	16	10274267	16	10180410	88728	94305	rs397518466	NC_000016.10:10180409:A:G
NM_001134407.3(GRIN2A):c.1655C>G (p.Pro552Arg)	GRIN2A	P522R, P552R	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Oct 18, 2018)	no assertion criteria provided	VCV000039663	16	9928084	16	9834227	39663	48262	rs397518450	NC_000016.10:9834226:G:C
NM_001134407.3(GRIN2A):c.1945C>G (p.Leu649Val)	GRIN2A	L649V	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Oct 18, 2018)	no assertion criteria provided	VCV000039662	16	9923342	16	9829485	39662	48261	rs397514557	NC_000016.10:9829484:G:C
NM_001134407.3(GRIN2A):c.652C>T (p.Gln218Ter)	GRIN2A	Q218*	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000029732	16	10032171	16	9938314	29732	38687	rs387906637	NC_000016.10:9938313:G:A
NM_001844.5(COL2A1):c.258C>A (p.Cys86Ter)	COL2A1	C86*	Osteoarthritis with mild chondrodysplasia|Spondyloepiphyseal dysplasia, stanescu type||Stickler syndrome, type I, nonsyndromic ocular|Avascular necrosis of the head of femur|Spondylometaphyseal dysplasia|Kniest dysplasia|Epiphyseal dysplasia, multiple, with myopia and conductive deafness||Stickler syndrome type 1|Coxa plana|Spondyloepiphyseal dysplasia congenita|Spondyloperipheral dysplasia-short ulna syndrome||not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000195148	12	48393736	12	47999953	195148	192309	rs794727261	NC_000012.12:47999952:G:T
NM_001844.5(COL2A1):c.2710C>T (p.Arg904Cys)	COL2A1	R704C, R835C, R904C	Epiphyseal dysplasia, multiple, with myopia and conductive deafness|Myopia (disease)|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017379	12	48373317	12	47979534	17379	32418	rs121912882	NC_000012.12:47979533:G:A
NM_001134407.3(GRIN2A):c.1123-2A>T	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000813769	16	9943820	16	9849963	813769	802061		NC_000016.10:9849962:T:A
NM_001134407.3(GRIN2A):c.1447G>A (p.Gly483Arg)	GRIN2A	G483R	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000812185	16	9934843	16	9840986	812185	800674		NC_000016.10:9840985:C:T
NM_016239.4(MYO15A):c.4198G>A (p.Val1400Met)	MYO15A	V1400M	Rare genetic deafness|Deafness, autosomal recessive 3	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000632271	17	18034837	17	18131523	632271	620574	rs749136456	NC_000017.11:18131522:G:A
NM_016239.4(MYO15A):c.1137del (p.Tyr380fs)	MYO15A	Y380fs	Deafness, autosomal recessive 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000500061	17	18023248	17	18119934	500061	491485	rs769260536	NC_000017.11:18119933:CCCC:CCC
NM_001171.5(ABCC6):c.4192C>T (p.Arg1398Ter)	ABCC6	R1398*, R1284*	Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000433352	16	16248501	16	16154644	433352	426807	rs66913554	NC_000016.10:16154643:G:A
NM_001171.5(ABCC6):c.4104del (p.Asp1368fs)	ABCC6	D1254fs, D1368fs	Abnormality of the eye|Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000433350	16	16248589	16	16154732	433350	426811	rs72664237	NC_000016.10:16154731:G:
NM_001171.5(ABCC6):c.3961G>A (p.Gly1321Ser)	ABCC6	G1321S, G1207S	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000006580	16	16248810	16	16154953	6580	21619	rs63749823	NC_000016.10:16154952:C:T
NM_001171.5(ABCC6):c.3892G>T (p.Val1298Phe)	ABCC6	V1298F, V1184F	Pseudoxanthoma elasticum	Pathogenic	criteria provided, single submitter	VCV000006578	16	16248879	16	16155022	6578	21617	rs63751325	NC_000016.10:16155021:C:A
NM_001134407.3(GRIN2A):c.1123-1G>A	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: May 25, 2019)	criteria provided, single submitter	VCV000839918	16	9943819	16	9849962	839918	852151		NC_000016.10:9849961:C:T
NM_001134407.3(GRIN2A):c.1334C>A (p.Ser445Ter)	GRIN2A	S445*	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000640659	16	9934956	16	9841099	640659	645262		NC_000016.10:9841098:G:T
NC_000016.9:g.(?_9984823)_(9984977_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000532726	16	9984823 - 9984977	16	9890966 - 9891120	532726	529287		
NM_001134407.3(GRIN2A):c.2346_2356+8del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000421444	16	9892126 - 9892144	16	9798269 - 9798287	421444	409818	rs1064795143	NC_000016.10:9798268:GGTCTTACCATCACCCACA:
NM_001134407.3(GRIN2A):c.487C>T (p.Gln163Ter)	GRIN2A	Q163*	Epilepsy, focal, with speech disorder and with or without mental retardation|not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000391457	16	10032336	16	9938479	391457	378038	rs1057524089	NC_000016.10:9938478:G:A
NM_001134407.3(GRIN2A):c.2041C>T (p.Arg681Ter)	GRIN2A	R681*	not provided|Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Dec 23, 2015)	criteria provided, single submitter	VCV000088734	16	9916248	16	9822391	88734	94311	rs397518472	NC_000016.10:9822390:G:A
NM_001134407.3(GRIN2A):c.1845C>A (p.Asn615Lys)	GRIN2A	N615K	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Mar 16, 2016)	no assertion criteria provided	VCV000029733	16	9923442	16	9829585	29733	38688	rs397518447	NC_000016.10:9829584:G:T
NM_001199107.2(TBC1D24):c.724C>T (p.Arg242Cys)	TBC1D24	R242C	Early infantile epileptic encephalopathy 16|Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24|DOORS syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000091395	16	2546873	16	2496872	91395	96871	rs398122965	NC_000016.10:2496871:C:T
NM_001134407.3(GRIN2A):c.1553G>T (p.Arg518Leu)	GRIN2A	R518L	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000567708	16	9934602	16	9840745	567708	574238	rs397518470	NC_000016.10:9840744:C:A
NM_001171.5(ABCC6):c.3413G>A (p.Arg1138Gln)	ABCC6	R1138Q, R1024Q	not provided|Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000006561	16	16256943	16	16163086	6561	21600	rs60791294	NC_000016.10:16163085:C:T
NC_000012.11:g.(?_32945338)_(33049685_?)del	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000584074	12	32945338 - 33049685	12	32792404 - 32896751	584074	566286		
NM_004572.3(PKP2):c.1901del (p.Asn634fs)	PKP2	N634fs, N590fs	Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418411	12	32975471	12	32822537	418411	408642	rs1064793231	NC_000012.12:32822536:TTTT:TTT
NM_004572.3(PKP2):c.837_838del (p.Val280fs)	PKP2	V280fs	Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000202015	12	33030976 - 33030977	12	32878042 - 32878043	202015	198438	rs772220644	NC_000012.12:32878041:CG:
NM_000512.5(GALNS):c.1156C>T (p.Arg386Cys)	GALNS	R386C, R392C, R201C	Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000700	16	88891261	16	88824853	700	15739	rs118204437	NC_000016.10:88824852:G:A
NM_000086.2(CLN3):c.1213C>T (p.Arg405Trp)	CLN3	R405W, R351W, R305W, R327W, R381W	Retinal dystrophy|not provided|Retinitis pigmentosa|Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000418137	16	28488941	16	28477620	418137	409585	rs139842473	NC_000016.10:28477619:G:A
NM_000151.4(G6PC):c.248G>A (p.Arg83His)	G6PC	R83H	Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038300	17	41055965	17	42903948	38300	27048	rs1801176	NC_000017.11:42903947:G:A
NM_001171.5(ABCC6):c.1553G>A (p.Arg518Gln)	ABCC6	R518Q, R404Q	Generalized arterial calcification of infancy 2|Pseudoxanthoma elasticum, forme fruste|Pseudoxanthoma elasticum|Pseudoxanthoma elasticum|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265018	16	16284103	16	16190246	265018	260087	rs72653772	NC_000016.10:16190245:C:T
NM_001171.5(ABCC6):c.4216C>A (p.Gln1406Lys)	ABCC6	Q1406K, Q1292K	Pseudoxanthoma elasticum|Generalized arterial calcification of infancy 2	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000030338	16	16244622	16	16150765	30338	39294	rs387906859	NC_000016.10:16150764:G:T
NM_001171.5(ABCC6):c.3736-1G>A	ABCC6		Pseudoxanthoma elasticum|Generalized arterial calcification of infancy 2	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000006574	16	16251667	16	16157810	6574	21613	rs63750273	NC_000016.10:16157809:C:T
NM_001171.5(ABCC6):c.3389C>T (p.Thr1130Met)	ABCC6	T1130M, T1016M	Abnormality of the eye|Pseudoxanthoma elasticum	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000006569	16	16256967	16	16163110	6569	21608	rs63750459	NC_000016.10:16163109:G:A
NM_004004.6(GJB2):c.230G>A (p.Trp77Ter)	GJB2	W77*	Deafness, autosomal recessive 1A|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000189176	13	20763491	13	20189352	189176	186860	rs104894395	NC_000013.11:20189351:C:T
NM_000303.3(PMM2):c.484C>T (p.Arg162Trp)	PMM2	R162W	Congenital disorder of glycosylation, type Ia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007709	16	8905531	16	8811674	7709	22748	rs104894526	NC_000016.10:8811673:C:T
NM_000303.3(PMM2):c.385G>A (p.Val129Met)	PMM2	V129M	Congenital disorder of glycosylation, type Ia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007708	16	8904973	16	8811116	7708	22747	rs104894525	NC_000016.10:8811115:G:A
NM_000070.3(CAPN3):c.701G>A (p.Gly234Glu)	CAPN3	G234E	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000501754	15	42681194	15	42388996	501754	493178	rs1555420634	NC_000015.10:42388995:G:A
NM_000070.3(CAPN3):c.2051-1G>T	CAPN3		not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000281184	15	42702128	15	42409930	281184	265421	rs886042108	NC_000015.10:42409929:G:T
NM_000070.3(CAPN3):c.1981del (p.Gln660_Ile661insTer)	CAPN3		not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000194691	15	42701567	15	42409369	194691	191854	rs762471207	NC_000015.10:42409368:A:
NM_002834.5(PTPN11):c.182A>C (p.Asp61Ala)	PTPN11	D61A, D60A	Rasopathy|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000179221	12	112888166	12	112450362	179221	175539	rs121918461	NC_000012.12:112450361:A:C
NM_004572.3(PKP2):c.775G>T (p.Glu259Ter)	PKP2	E259*	Cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000464432	12	33031039	12	32878105	464432	463043	rs1425855043	NC_000012.12:32878104:C:A
NM_004572.3(PKP2):c.1440_1444del (p.Asn480fs)	PKP2	N480fs	not provided|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic/Likely pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419977	12	32996182 - 32996186	12	32843248 - 32843252	419977	408644	rs775995156	NC_000012.12:32843247:TGGGAT:T
NM_004572.3(PKP2):c.1952_1955dup (p.Ser652fs)	PKP2		Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000045051	12	32975416 - 32975417	12	32822482 - 32822483	45051	54218	rs397517013	NC_000012.12:32822482:CTTC:CTTCCTTC
NM_004572.3(PKP2):c.14del (p.Gly5fs)	PKP2	G5fs	Arrhythmogenic ventricular cardiomyopathy|not provided|Arrhythmogenic right ventricular cardiomyopathy|Cardiac arrhythmia	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000045027	12	33049652	12	32896718	45027	54194	rs397516996	NC_000012.12:32896717:CC:C
NM_001134407.3(GRIN2A):c.2146G>A (p.Ala716Thr)	GRIN2A	A716T	Epilepsy, focal, with speech disorder and with or without mental retardation|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000205656	16	9916143	16	9822286	205656	203358	rs762659685	NC_000016.10:9822285:C:T
NM_001134407.3(GRIN2A):c.1553G>A (p.Arg518His)	GRIN2A	R518H	not provided|Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000088732	16	9934602	16	9840745	88732	94309	rs397518470	NC_000016.10:9840744:C:T
NM_000053.4(ATP7B):c.3990_3993del (p.Tyr1331fs)	ATP7B	Y1220fs, Y1247fs, Y1331fs, Y1124fs, Y1253fs	not provided	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV000617988	13	52511440 - 52511443	13	51937304 - 51937307	617988	609873	rs1566441447	NC_000013.11:51937303:ATAAAT:AT
NM_000053.4(ATP7B):c.3107dup (p.Arg1038fs)	ATP7B		not provided	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000286564	13	52518380 - 52518381	13	51944244 - 51944245	286564	270801	rs886043423	NC_000013.11:51944244:A:AA
NM_000053.4(ATP7B):c.1605_1609dup (p.Ile537fs)	ATP7B		not provided	Pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, single submitter	VCV000285862	13	52542677 - 52542678	13	51968541 - 51968542	285862	270099	rs886043238	NC_000013.11:51968541:TGACCT:TGACCTGACCT
NM_000053.4(ATP7B):c.4195del (p.Gln1399fs)	ATP7B	Q1192fs, Q1288fs, Q1321fs, Q1399fs, Q1315fs	not provided	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	VCV000280040	13	52509095	13	51934959	280040	264520	rs886041336	NC_000013.11:51934958:GGG:GG
NM_000053.4(ATP7B):c.915T>A (p.Cys305Ter)	ATP7B	C305*	not provided	Pathogenic(Last reviewed: Sep 7, 2012)	criteria provided, single submitter	VCV000092391	13	52548441	13	51974305	92391	98302	rs398123137	NC_000013.11:51974304:A:T
NM_001844.5(COL2A1):c.1957C>T (p.Arg653Ter)	COL2A1	R453*, R584*, R653*	not provided|Rhegmatogenous retinal detachment, autosomal dominant|Stickler syndrome, type I, nonsyndromic ocular|Avascular necrosis of the head of femur|Stickler syndrome type 1|Epiphyseal dysplasia, multiple, with myopia and conductive deafness|Spondyloepiphyseal dysplasia, stanescu type|||Spondyloperipheral dysplasia-short ulna syndrome|Coxa plana|Kniest dysplasia|Spondyloepiphyseal dysplasia congenita|Spondylometaphyseal dysplasia||Osteoarthritis with mild chondrodysplasia|Stickler syndrome type 1	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017395	12	48377504	12	47983721	17395	32434	rs121912893	NC_000012.12:47983720:G:A
NM_001844.5(COL2A1):c.1693C>T (p.Arg565Cys)	COL2A1	R365C, R496C, R565C	Retinal dystrophy|not provided|Stickler syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017383	12	48379358	12	47985575	17383	32422	rs121912884	NC_000012.12:47985574:G:A
NM_001844.5(COL2A1):c.2965C>T (p.Arg989Cys)	COL2A1	R789C, R920C, R989C	Spondyloperipheral dysplasia-short ulna syndrome|Stickler syndrome, type I, nonsyndromic ocular|Avascular necrosis of the head of femur|Stickler syndrome type 1|Epiphyseal dysplasia, multiple, with myopia and conductive deafness|Spondyloepiphyseal dysplasia, stanescu type|||Spondyloperipheral dysplasia-short ulna syndrome|Coxa plana|Kniest dysplasia|Spondyloepiphyseal dysplasia congenita|Spondylometaphyseal dysplasia||Osteoarthritis with mild chondrodysplasia|not provided|Spondyloepiphyseal dysplasia congenita	Pathogenic(Last reviewed: May 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017366	12	48372112	12	47978329	17366	32405	rs121912874	NC_000012.12:47978328:G:A
NM_016239.4(MYO15A):c.7124_7127del (p.Asp2375fs)	MYO15A	D2375fs	Deafness, autosomal recessive 3|Rare genetic deafness|Congenital sensorineural hearing impairment	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000435919	17	18052803 - 18052806	17	18149489 - 18149492	435919	429949	rs780170125	NC_000017.11:18149488:CAGACAG:CAG
NM_000053.4(ATP7B):c.2866-2del	ATP7B		Wilson disease	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000811491	13	52520616	13	51946480	811491	799745		NC_000013.11:51946479:T:
NM_000053.4(ATP7B):c.283C>T (p.Gln95Ter)	ATP7B	Q95*	Wilson disease	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000811264	13	52549073	13	51974937	811264	799749		NC_000013.11:51974936:G:A
NM_000053.4(ATP7B):c.2230T>C (p.Ser744Pro)	ATP7B	S633P, S660P, S744P	Wilson disease	Pathogenic(Last reviewed: Sep 15, 2019)	no assertion criteria provided	VCV000800870	13	52532572	13	51958436	800870	788877		NC_000013.11:51958435:A:G
NM_000053.4(ATP7B):c.2351C>T (p.Ala784Val)	ATP7B	A784V, A673V, A700V	Wilson disease	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000590805	13	52532451	13	51958315	590805	581768	rs1566532164	NC_000013.11:51958314:G:A
NM_000053.4(ATP7B):c.3236G>T (p.Cys1079Phe)	ATP7B	C1079F, C1001F, C968F, C995F, C872F	Wilson disease	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000424618	13	52518252	13	51944116	424618	411516	rs1064797072	NC_000013.11:51944115:C:A
ATP7B, 1-BP INS, NT2487	ATP7B		Wilson disease	Pathogenic(Last reviewed: Mar 25, 2020)	no assertion criteria provided	VCV000003847					3847	18886		
ATP7B, 1-BP DEL, 2337C	ATP7B		Wilson disease	Pathogenic(Last reviewed: Mar 25, 2020)	no assertion criteria provided	VCV000003846					3846	18885		
NM_000020.2(ACVRL1):c.200G>A (p.Arg67Gln)	ACVRL1	R67Q	|not provided	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212803	12	52307021	12	51913237	212803	210224	rs863223414	NC_000012.12:51913236:G:A
NM_000053.4(ATP7B):c.2692C>T (p.Gln898Ter)	ATP7B	Q736*, Q814*, Q898*, Q787*, Q820*	Wilson disease	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000864302	13	52524181	13	51950045	864302	840990		NC_000013.11:51950044:G:A
NM_000053.4(ATP7B):c.3974del (p.Leu1325fs)	ATP7B	L1118fs, L1214fs, L1241fs, L1247fs, L1325fs	Wilson disease	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000860819	13	52511459	13	51937323	860819	840981		NC_000013.11:51937322:A:
NM_000053.4(ATP7B):c.2781del (p.Phe927fs)	ATP7B	F843fs, F927fs, F816fs, F849fs	Wilson disease	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000847147	13	52523882	13	51949746	847147	840989		NC_000013.11:51949745:AAA:AA
NM_000053.4(ATP7B):c.2157del (p.Ala718_Tyr719insTer)	ATP7B		Wilson disease	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000835191	13	52532645	13	51958509	835191	840994		NC_000013.11:51958508:G:
NM_000053.4(ATP7B):c.804dup (p.Lys269Ter)	ATP7B		Wilson disease	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000834759	13	52548551 - 52548552	13	51974415 - 51974416	834759	841004		NC_000013.11:51974415:A:AA
NM_000053.4(ATP7B):c.2009_2010AT[4] (p.Met671fs)	ATP7B		Wilson disease	Pathogenic	criteria provided, single submitter	VCV000813488	13	52534392 - 52534393	13	51960256 - 51960257	813488	801721		NC_000013.11:51960256:ATATA:ATATATATA
NM_000053.4(ATP7B):c.1158_1159del (p.Val387fs)	ATP7B	V276fs, V387fs	Wilson disease	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000663269	13	52548197 - 52548198	13	51974061 - 51974062	663269	642050		NC_000013.11:51974060:CCCC:CC
NM_000053.4(ATP7B):c.2510dup (p.Phe839fs)	ATP7B		Wilson disease	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000662996	13	52524472 - 52524473	13	51950336 - 51950337	662996	642042		NC_000013.11:51950336:CCCCC:CCCCCC
NM_000053.4(ATP7B):c.2145del (p.Phe714_Tyr715insTer)	ATP7B		Wilson disease	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000659871	13	52532657	13	51958521	659871	642046		NC_000013.11:51958520:G:
NM_000053.4(ATP7B):c.213_214del (p.Val73fs)	ATP7B	V73fs	Wilson disease	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000647773	13	52549142 - 52549143	13	51975006 - 51975007	647773	642053		NC_000013.11:51975005:AT:
NM_000053.4(ATP7B):c.2662A>C (p.Thr888Pro)	ATP7B	T726P, T810P, T888P, T777P, T804P	Wilson disease	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000642900	13	52524211	13	51950075	642900	642039		NC_000013.11:51950074:T:G
NM_000053.4(ATP7B):c.1531C>T (p.Gln511Ter)	ATP7B	Q511*, Q400*	Wilson disease	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000633071	13	52544640	13	51970504	633071	621470	rs1449610384	NC_000013.11:51970503:G:A
NM_000053.4(ATP7B):c.1708-25_1719del	ATP7B		Wilson disease	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000573285	13	52539158 - 52539194	13	51965022 - 51965058	573285	567723	rs1566560096	NC_000013.11:51965021:CATCCCTGTGATCTGCAACACAGGATGGCAAGAATCCCA:CA
NM_000053.4(ATP7B):c.2575+1G>A	ATP7B		Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557064	13	52524407	13	51950271	557064	547341	rs766149114	NC_000013.11:51950270:C:T
NM_000053.4(ATP7B):c.111dup (p.Ala38fs)	ATP7B		Wilson disease	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000554880	13	52549244 - 52549245	13	51975108 - 51975109	554880	547406	rs1555296939	NC_000013.11:51975108:AAAA:AAAAA
NM_000053.4(ATP7B):c.2478_2479delinsT (p.Gln826fs)	ATP7B		Wilson disease	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000526654	13	52524504 - 52524505	13	51950368 - 51950369	526654	527824	rs1555288808	NC_000013.11:51950367:GC:A
Single allele	ATP7B		Wilson disease	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000456550			13	51973915 - 51975188	456550	463322		
NM_000053.3(ATP7B):c.-441_-427del15	ATP7B		Wilson disease	Pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	VCV000252913	13	52585898 - 52585912	13	52011762 - 52011776	252913	247315	rs879255499	NC_000013.11:52011761:CGGTCTCGGCCACCTCG:CG
NM_000053.4(ATP7B):c.383del (p.Gly128fs)	ATP7B	G128fs	Wilson disease	Pathogenic(Last reviewed: Feb 25, 2015)	criteria provided, single submitter	VCV000208563	13	52548973	13	51974837	208563	205174	rs797045083	NC_000013.11:51974836:CC:C
NM_000053.4(ATP7B):c.4021G>A (p.Gly1341Ser)	ATP7B	G1341S, G1134S, G1230S, G1257S, G1263S	Wilson disease	Pathogenic(Last reviewed: Jul 29, 2013)	criteria provided, single submitter	VCV000157955	13	52511412	13	51937276	157955	167802	rs587783317	NC_000013.11:51937275:C:T
NM_000053.4(ATP7B):c.3011A>C (p.Gln1004Pro)	ATP7B	Q1004P, Q920P, Q893P, Q797P, Q926P	Wilson disease	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157943	13	52520469	13	51946333	157943	167790	rs587783307	NC_000013.11:51946332:T:G
ATP7B, 1-BP DEL, 2511A	ATP7B		Wilson disease	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000003858					3858	18897		
ATP7B, 3-BP DEL, 3892GTC	ATP7B		Wilson disease	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000003854					3854	18893		
NM_001171.5(ABCC6):c.2294G>A (p.Arg765Gln)	ABCC6	R765Q, R651Q	Pseudoxanthoma elasticum|Generalized arterial calcification of infancy 2	Pathogenic	criteria provided, single submitter	VCV000030337	16	16272776	16	16178919	30337	39293	rs67561842	NC_000016.10:16178918:C:T
NM_001171.5(ABCC6):c.3940C>T (p.Arg1314Trp)	ABCC6	R1314W, R1200W	not provided|Generalized arterial calcification of infancy 2|Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000006564	16	16248831	16	16154974	6564	21603	rs63750759	NC_000016.10:16154973:G:A
NM_000018.4(ACADVL):c.865G>A (p.Gly289Arg)	ACADVL	G289R, G213R, G267R, G312R	not provided|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370981	17	7125608	17	7222289	370981	358466	rs200788251	NC_000017.11:7222288:G:A
NM_000018.4(ACADVL):c.1097G>A (p.Arg366His)	ACADVL	R366H, R290H, R344H, R389H	not provided|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203580	17	7126471	17	7223152	203580	200333	rs112406105	NC_000017.11:7223151:G:A
NM_000053.4(ATP7B):c.2227del (p.Tyr743fs)	ATP7B	Y632fs, Y659fs, Y743fs	Wilson disease	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000863481	13	52532575	13	51958439	863481	840992		NC_000013.11:51958438:AAA:AA
NM_000053.4(ATP7B):c.3061-549_3081del	ATP7B		Wilson disease	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000861953	13	52518407 - 52518976	13	51944271 - 51944840	861953	851539		
NM_000053.4(ATP7B):c.2223T>A (p.Tyr741Ter)	ATP7B	Y657*, Y630*, Y741*	Wilson disease	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000861182	13	52532579	13	51958443	861182	840993		NC_000013.11:51958442:A:T
NM_000053.4(ATP7B):c.918_931del (p.Ser307fs)	ATP7B	S307fs	Wilson disease	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000861124	13	52548425 - 52548438	13	51974289 - 51974302	861124	841002		NC_000013.11:51974288:GAGCCACTGGGCTGG:G
NM_000053.4(ATP7B):c.3588dup (p.Ala1197fs)	ATP7B		Wilson disease	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000850220	13	52513297 - 52513298	13	51939161 - 51939162	850220	840985		NC_000013.11:51939161:G:GG
NC_000013.11:g.(?_51973925)_(51975178_?)del	ATP7B		Wilson disease	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000832612	13	52548061 - 52549314			832612	820587		
NM_000053.4(ATP7B):c.4006del (p.Ile1336fs)	ATP7B	I1225fs, I1258fs, I1129fs, I1252fs, I1336fs	Wilson disease	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000552929	13	52511427	13	51937291	552929	547591	rs1555283564	NC_000013.11:51937290:T:
NM_000053.4(ATP7B):c.3722C>T (p.Ala1241Val)	ATP7B	A1241V, A1130V, A1163V, A1034V, A1157V	Wilson disease	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000552915	13	52511793	13	51937657	552915	546994	rs1555283994	NC_000013.11:51937656:G:A
NM_000053.4(ATP7B):c.3036dup (p.Lys1013fs)	ATP7B		Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495410	13	52520443 - 52520444	13	51946307 - 51946308	495410	487600	rs1555287300	NC_000013.11:51946307:G:GG
NM_000053.4(ATP7B):c.388_389dup (p.Ala131fs)	ATP7B		not provided|Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000371584	13	52548966 - 52548967	13	51974830 - 51974831	371584	358240	rs1057517384	NC_000013.11:51974830:GC:GCGC
NM_000053.4(ATP7B):c.3664del (p.Asp1222fs)	ATP7B	D1222fs, D1015fs, D1138fs, D1111fs, D1144fs	Wilson disease|not provided	Pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	VCV000282915	13	52513222	13	51939086	282915	267152	rs886042519	NC_000013.11:51939085:CCCCC:CCCC
ATP7B, 15-BP DEL, NT-441	ATP7B		Wilson disease	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000003853					3853	18892		
NM_000070.3(CAPN3):c.1322del (p.Gly441fs)	CAPN3	G393fs, G441fs	not provided|Elbow flexion contracture|Arrhythmia|Muscular dystrophy|Muscle weakness|Contractures of the joints of the lower limbs|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 9, 2015)	criteria provided, multiple submitters, no conflicts	VCV000281062	15	42691815	15	42399617	281062	265299	rs1555421871	NC_000015.10:42399616:GGGG:GGG
NM_000053.4(ATP7B):c.3960G>C (p.Arg1320Ser)	ATP7B	R1209S, R1236S, R1242S, R1113S, R1320S	Wilson disease	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000835275	13	52511473	13	51937337	835275	840982		NC_000013.11:51937336:C:G
NM_000053.4(ATP7B):c.3884C>T (p.Ala1295Val)	ATP7B	A1088V, A1184V, A1211V, A1217V, A1295V	Wilson disease	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000660004	13	52511631	13	51937495	660004	642034		NC_000013.11:51937494:G:A
NM_000053.4(ATP7B):c.2795C>A (p.Ser932Ter)	ATP7B	S932*, S821*, S854*, S848*	Wilson disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633075	13	52523868	13	51949732	633075	621463	rs1566498495	NC_000013.11:51949731:G:T
NM_000053.3(ATP7B):c.-436_-422del15	ATP7B		Wilson disease	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000555936	13	52585895 - 52585909	13	52011759 - 52011773	555936	547095	rs1484840087	NC_000013.11:52011758:CCGCGGTCTCGGCCACC:CC
NM_000053.4(ATP7B):c.2145C>A (p.Tyr715Ter)	ATP7B	Y715*, Y604*, Y631*	Wilson disease	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000555174	13	52532657	13	51958521	555174	547218	rs751202110	NC_000013.11:51958520:G:T
NM_000053.4(ATP7B):c.4114C>T (p.Gln1372Ter)	ATP7B	Q1372*, Q1294*, Q1261*, Q1288*, Q1165*	Wilson disease	Pathogenic(Last reviewed: Jul 22, 2016)	criteria provided, single submitter	VCV000371170	13	52509739	13	51935603	371170	358212	rs755584106	NC_000013.11:51935602:G:A
NM_000053.4(ATP7B):c.1716del (p.Gly572_Met573insTer)	ATP7B		Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370955	13	52539161	13	51965025	370955	358231	rs1057516893	NC_000013.11:51965024:CCC:CC
ATP7B, 7-BP DEL, NT2010	ATP7B		Wilson disease	Pathogenic(Last reviewed: May 1, 1995)	no assertion criteria provided	VCV000003843					3843	18882		
NM_004572.3(PKP2):c.1511-2A>T	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000518485	12	32994141	12	32841207	518485	510397	rs1453983744	NC_000012.12:32841206:T:A
NM_004572.3(PKP2):c.1171-2A>G	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000202030	12	33003909	12	32850975	202030	198427	rs794729133	NC_000012.12:32850974:T:C
NM_004572.3(PKP2):c.275T>A (p.Leu92Ter)	PKP2	L92*	not provided|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000202026	12	33031915	12	32878981	202026	198454	rs763639737	NC_000012.12:32878980:A:T
NM_004572.3(PKP2):c.533dup (p.His179fs)	PKP2		not provided|Arrhythmogenic right ventricular cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000202012	12	33031280 - 33031281	12	32878346 - 32878347	202012	198446	rs769220833	NC_000012.12:32878346:A:AA
NM_004572.3(PKP2):c.1689-1G>C	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000201989	12	32977097	12	32824163	201989	198414	rs78897684	NC_000012.12:32824162:C:G
NM_004572.3(PKP2):c.369G>A (p.Trp123Ter)	PKP2	W123*	Arrhythmogenic right ventricular cardiomyopathy, type 9|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201970	12	33031445	12	32878511	201970	198452	rs774663443	NC_000012.12:32878510:C:T
NM_031885.4(BBS2):c.72C>G (p.Tyr24Ter)	BBS2	Y24*	Retinitis pigmentosa 74|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2|Bardet-biedl syndrome 2/6, digenic|Retinal dystrophy|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004570	16	56553703	16	56519791	4570	19609	rs121908175	NC_000016.10:56519790:G:C
NM_001171.5(ABCC6):c.3490C>T (p.Arg1164Ter)	ABCC6	R1164*, R1050*	not provided|Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006572	16	16256866	16	16163009	6572	21611	rs72653744	NC_000016.10:16163008:G:A
NM_001171.5(ABCC6):c.3412C>T (p.Arg1138Trp)	ABCC6	R1138W, R1024W	Pseudoxanthoma elasticum, forme fruste|Generalized arterial calcification of infancy 2|Pseudoxanthoma elasticum|not provided|Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006571	16	16256944	16	16163087	6571	21610	rs28939701	NC_000016.10:16163086:G:A
NM_000053.4(ATP7B):c.2924C>A (p.Ser975Tyr)	ATP7B	S768Y, S897Y, S864Y, S891Y, S975Y	Wilson disease	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000862055	13	52520556	13	51946420	862055	840987		NC_000013.11:51946419:G:T
NM_000053.4(ATP7B):c.2447+1G>T	ATP7B		Wilson disease	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000858218	13	52531651	13	51957515	858218	851979		NC_000013.11:51957514:C:A
NC_000013.10:g.(?_52518225)_(52520634_?)del	ATP7B		Wilson disease	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000654667	13	52518225 - 52520634	13	51944089 - 51946498	654667	652517		
NM_000053.4(ATP7B):c.802_808del (p.Cys268fs)	ATP7B	C268fs	not provided|Wilson disease	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000633074	13	52548548 - 52548554	13	51974412 - 51974418	633074	621474	rs1566598496	NC_000013.11:51974411:ACTTACAA:A
NM_000053.4(ATP7B):c.3083_3085delinsG (p.Lys1028fs)	ATP7B		Wilson disease	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000633073	13	52518403 - 52518405	13	51944267 - 51944269	633073	621460	rs1331370011	NC_000013.11:51944266:TCT:C
NM_000053.4(ATP7B):c.3147del (p.Thr1050fs)	ATP7B	T1050fs, T972fs, T939fs, T966fs, T843fs	Wilson disease	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000551108	13	52518341	13	51944205	551108	547022	rs762031690	NC_000013.11:51944204:GG:G
NM_000053.4(ATP7B):c.2131G>A (p.Gly711Arg)	ATP7B	G711R, G627R, G600R	Wilson disease	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000495405	13	52532671	13	51958535	495405	487606	rs1394999756	NC_000013.11:51958534:C:T
NM_000053.4(ATP7B):c.2122-8T>G	ATP7B		Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	VCV000035705	13	52532688	13	51958552	35705	44369	rs193922102	NC_000013.11:51958551:A:C
NM_000053.4(ATP7B):c.2297C>G (p.Thr766Arg)	ATP7B	T766R, T682R, T655R	Wilson disease	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000003861	13	52532505	13	51958369	3861	18900	rs121907997	NC_000013.11:51958368:G:C
NM_052867.4(NALCN):c.2563C>T (p.Arg855Ter)	NALCN	R855*, R826*, R884*	Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000489164	13	101759854	13	101107503	489164	482036	rs376152742	NC_000013.11:101107502:G:A
NM_001127701.1(SERPINA1):c.194T>C (p.Leu65Pro)	SERPINA1	L41P, L65P	Alpha-1-antitrypsin deficiency|PI M(PROCIDA)|not provided|Chronic obstructive pulmonary disease|Alpha-1-antitrypsin deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017971	14	94849381	14	94383044	17971	33010	rs28931569	NC_000014.9:94383043:A:G
NM_025137.4(SPG11):c.5769dup (p.Met1924fs)	SPG11		not provided	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000817675	15	44876108 - 44876109	15	44583910 - 44583911	817675	805826		NC_000015.10:44583910:A:AA
NM_025137.4(SPG11):c.5757_5758del (p.Glu1921fs)	SPG11	E1921fs	not provided	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000596302	15	44876120 - 44876121	15	44583922 - 44583923	596302	587363	rs771558571	NC_000015.10:44583921:CT:
NM_025137.4(SPG11):c.6971_6972del (p.Cys2324fs)	SPG11	C2211fs, C2324fs	not provided	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000546469	15	44858079 - 44858080	15	44565881 - 44565882	546469	536885	rs780301639	NC_000015.10:44565880:ACA:A
NM_025137.4(SPG11):c.3686+2T>A	SPG11		not provided	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000504377	15	44892663	15	44600465	504377	495570	rs1555451983	NC_000015.10:44600464:A:T
NM_025137.4(SPG11):c.2265del (p.Gln755fs)	SPG11	Q755fs	not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000503795	15	44914977	15	44622779	503795	495778	rs1215058780	NC_000015.10:44622778:TT:T
NM_025137.4(SPG11):c.4371G>A (p.Trp1457Ter)	SPG11	W1457*	not provided	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, single submitter	VCV000497975	15	44888344	15	44596146	497975	489399	rs886819382	NC_000015.10:44596145:C:T
NM_025137.4(SPG11):c.2068-2A>T	SPG11		not provided	Pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	VCV000449649	15	44918707	15	44626509	449649	445323	rs1555456457	NC_000015.10:44626508:T:A
NM_025137.4(SPG11):c.796C>T (p.Gln266Ter)	SPG11	Q266*	not provided	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000432638	15	44949366	15	44657168	432638	426099	rs1234882277	NC_000015.10:44657167:G:A
NM_025137.4(SPG11):c.4777del (p.Ile1593fs)	SPG11	I1593fs	not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000424590	15	44881579	15	44589381	424590	409236	rs1064797055	NC_000015.10:44589380:T:
NM_025137.4(SPG11):c.5842dup (p.Ile1948fs)	SPG11		not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000424589	15	44876035 - 44876036	15	44583837 - 44583838	424589	409234	rs1555448810	NC_000015.10:44583837:T:TT
NM_025137.4(SPG11):c.3321_3324del (p.Asn1106_Cys1107insTer)	SPG11		not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000423142	15	44900771 - 44900774	15	44608573 - 44608576	423142	409238	rs768131119	NC_000015.10:44608572:CAAACA:CA
NM_025137.4(SPG11):c.334G>T (p.Glu112Ter)	SPG11	E112*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803076	15	44952738	15	44660540	803076	791453		NC_000015.10:44660539:C:A
NM_025137.4(SPG11):c.2013_2026dup (p.Lys676fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803075	15	44920907 - 44920908	15	44628709 - 44628710	803075	791452		NC_000015.10:44628709:TGGGGACATTTTCATG:TGGGGACATTTTCATGGGGACATTTTCATG
NM_025137.4(SPG11):c.2048G>A (p.Trp683Ter)	SPG11	W683*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803074	15	44920886	15	44628688	803074	791451		NC_000015.10:44628687:C:T
NM_025137.4(SPG11):c.4434+1G>A	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803073	15	44888280	15	44596082	803073	791450		NC_000015.10:44596081:C:T
NM_025137.4(SPG11):c.3868dup (p.Tyr1290fs)	SPG11		not provided	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000448467	15	44890852 - 44890853	15	44598654 - 44598655	448467	441745	rs1555451491	NC_000015.10:44598654:A:AA
NM_025137.4(SPG11):c.3320_3321del (p.Cys1107fs)	SPG11	C1107fs	not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000448465	15	44900774 - 44900775	15	44608576 - 44608577	448465	441747	rs1366914385	NC_000015.10:44608575:ACA:A
NM_025137.4(SPG11):c.5866_5866+4del	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000858520	15	44876008 - 44876012	15	44583810 - 44583814	858520	852588		NC_000015.10:44583809:TTACT:
NM_025137.4(SPG11):c.2612dup (p.Ser871fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000856716	15	44913964 - 44913965	15	44621766 - 44621767	856716	842381		NC_000015.10:44621766:C:CC
NM_025137.4(SPG11):c.4043dup (p.Phe1349fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000848106	15	44889099 - 44889100	15	44596901 - 44596902	848106	842361		NC_000015.10:44596901:T:TT
NM_025137.4(SPG11):c.1152G>A (p.Trp384Ter)	SPG11	W384*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000846656	15	44943993	15	44651795	846656	842394		NC_000015.10:44651794:C:T
NM_025137.4(SPG11):c.4860dup (p.Lys1621fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000845182	15	44881495 - 44881496	15	44589297 - 44589298	845182	842351		NC_000015.10:44589297:CCCC:CCCCC
NM_025137.4(SPG11):c.4813del (p.Leu1605fs)	SPG11	L1605fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000837290	15	44881543	15	44589345	837290	842353		NC_000015.10:44589344:GG:G
NC_000015.10:g.(?_44595249)_(44600642_?)del	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000833140	15	44887447 - 44892840			833140	820703		
NC_000015.10:g.(?_44648856)_(44663657_?)del	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000832769	15	44941054 - 44955855			832769	820706		
NC_000015.10:g.(?_44595249)_(44663657_?)del	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000832272	15	44887447 - 44955855			832272	820704		
NM_025137.4(SPG11):c.315del (p.Ala106fs)	SPG11	A106fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000813903	15	44952757	15	44660559	813903	802202		NC_000015.10:44660558:G:
NM_025137.4(SPG11):c.925G>T (p.Gly309Ter)	SPG11	G309*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000665852	15	44944409	15	44652211	665852	643269		NC_000015.10:44652210:C:A
NC_000015.9:g.(?_44864871)_(44867249_?)del	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000659587	15	44864871 - 44867249	15	44572673 - 44575051	659587	652520		
NM_025137.4(SPG11):c.1478_1482del (p.Leu493fs)	SPG11	L493fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000657795	15	44941184 - 44941188	15	44648986 - 44648990	657795	643264		NC_000015.10:44648985:AAACAAAA:AAA
NM_025137.4(SPG11):c.2036_2037AG[3] (p.Ser680fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000655607	15	44920894 - 44920895	15	44628696 - 44628697	655607	643257		NC_000015.10:44628696:CTCTC:CTCTCTC
NM_025137.4(SPG11):c.4075del (p.Ile1359fs)	SPG11	I1359fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000653485	15	44889068	15	44596870	653485	643231		NC_000015.10:44596869:T:
NM_025137.4(SPG11):c.6724C>T (p.Gln2242Ter)	SPG11	Q2242*, Q2129*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000652217	15	44859652	15	44567454	652217	643199		NC_000015.10:44567453:G:A
NM_025137.4(SPG11):c.460_461del (p.Leu154fs)	SPG11	L154fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000651323	15	44951483 - 44951484	15	44659285 - 44659286	651323	643276		NC_000015.10:44659284:AAA:A
NM_025137.4(SPG11):c.3192del (p.Ile1065fs)	SPG11	I1065fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000650774	15	44903137	15	44610939	650774	643240		NC_000015.10:44610938:C:
NM_025137.4(SPG11):c.1818_1819del (p.Ser607fs)	SPG11	S607fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000648623	15	44921503 - 44921504	15	44629305 - 44629306	648623	643259		NC_000015.10:44629304:AAAA:AA
NM_025137.4(SPG11):c.7087_7115inv (p.Tyr2363_Leu2372delinsAsnLeuCysCysLeuAsnSerSerLysTer)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000644631	15	44856781 - 44856809	15	44564583 - 44564611	644631	643193		NC_000015.10:44564582:AACCTTTGCTGCTTAAATTCTTCCAAGTA:TACTTGGAAGAATTTAAGCAGCAAAGGTT
NM_025137.4(SPG11):c.202_203dup (p.Leu68fs)	SPG11		not provided	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000586640	15	44955642 - 44955643	15	44663444 - 44663445	586640	577393	rs773773579	NC_000015.10:44663444:AAA:AAAAA
NC_000015.9:g.(?_44864861)_(44867259_?)del	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000583568	15	44864861 - 44867259	15	44572663 - 44575061	583568	569203		
NM_025137.4(SPG11):c.5465_5477del (p.Phe1822fs)	SPG11	F1822fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000571055	15	44876401 - 44876413	15	44584203 - 44584215	571055	569372	rs1567138536	NC_000015.10:44584202:ATCTGTCGAGAAAATCTG:ATCTG
NM_025137.4(SPG11):c.4365G>A (p.Trp1455Ter)	SPG11	W1455*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000569547	15	44888350	15	44596152	569547	569384	rs138103656	NC_000015.10:44596151:C:T
NM_025137.4(SPG11):c.6418C>T (p.Gln2140Ter)	SPG11	Q2140*, Q2027*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000568554	15	44862782	15	44570584	568554	573256	rs1567129475	NC_000015.10:44570583:G:A
NM_025137.4(SPG11):c.6230_6231del (p.Thr2077fs)	SPG11	T2077fs, T1964fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000534867	15	44864993 - 44864994	15	44572795 - 44572796	534867	528815	rs1555447459	NC_000015.10:44572794:TGT:T
NM_025137.4(SPG11):c.5844del (p.Pro1949_Leu1950insTer)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000534866	15	44876034	15	44583836	534866	528826	rs1323156960	NC_000015.10:44583835:AA:A
NM_025137.4(SPG11):c.2857G>T (p.Glu953Ter)	SPG11	E953*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000534853	15	44907742	15	44615544	534853	529235	rs372906057	NC_000015.10:44615543:C:A
NM_025137.4(SPG11):c.3074_3077del (p.Lys1025fs)	SPG11	K1025fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000534850	15	44905696 - 44905699	15	44613498 - 44613501	534850	528872	rs746971952	NC_000015.10:44613497:TCTTT:T
NM_025137.4(SPG11):c.2912_2914delinsGAT (p.Ile971_Gln972delinsArgTer)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000522810	15	44907685 - 44907687	15	44615487 - 44615489	522810	513452	rs1555454508	NC_000015.10:44615486:GTA:ATC
NM_025137.4(SPG11):c.6738del (p.Ile2246fs)	SPG11	I2246fs, I2133fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000466564	15	44859638	15	44567440	466564	465042	rs1555446712	NC_000015.10:44567439:AA:A
NM_025137.4(SPG11):c.5925_5934dup (p.Val1979Ter)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000466546	15	44867171 - 44867172	15	44574973 - 44574974	466546	465073	rs749652788	NC_000015.10:44574973:TTCCAGGTTA:TTCCAGGTTATTCCAGGTTA
NM_025137.4(SPG11):c.4790G>A (p.Trp1597Ter)	SPG11	W1597*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, single submitter	VCV000466534	15	44881566	15	44589368	466534	465091	rs753920931	NC_000015.10:44589367:C:T
NM_025137.4(SPG11):c.4591C>T (p.Gln1531Ter)	SPG11	Q1531*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000466532	15	44887501	15	44595303	466532	465093	rs1362530862	NC_000015.10:44595302:G:A
NM_025137.4(SPG11):c.2737C>T (p.Gln913Ter)	SPG11	Q913*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000466515	15	44912485	15	44620287	466515	464801	rs1555455246	NC_000015.10:44620286:G:A
NM_025137.3(SPG11):c.(2244+1_2245-1)_(2620+1_2621-1)del	SPG11		Hereditary spastic paraplegia	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000424655					424655	411598		
NC_000015.9:g.(?_44862723)_(44867239_?)del	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000417384	15	44862723 - 44867239	15	44570525 - 44575041	417384	400855		
NC_000015.9:g.(?_44881450)_(44925835_?)dup	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 26, 2016)	criteria provided, single submitter	VCV000417382	15	44881450 - 44925835	15	44589252 - 44633637	417382	400532		
NC_000015.9:g.(?_44862723)_(44862856_?)del	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 11, 2016)	criteria provided, single submitter	VCV000417380	15	44862723 - 44862856	15	44570525 - 44570658	417380	400852		
NM_025137.4(SPG11):c.2990T>A (p.Leu997Ter)	SPG11	L997*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 26, 2016)	criteria provided, single submitter	VCV000406526	15	44907609	15	44615411	406526	400273	rs1060501176	NC_000015.10:44615410:A:T
NM_025137.4(SPG11):c.4811dup (p.Leu1605fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000406518	15	44881544 - 44881545	15	44589346 - 44589347	406518	400916	rs760618394	NC_000015.10:44589346:AAA:AAAA
NM_025137.4(SPG11):c.5867-1G>T	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000406505	15	44867240	15	44575042	406505	400263	rs1060501168	NC_000015.10:44575041:C:A
NM_025137.4(SPG11):c.2331del (p.Glu778fs)	SPG11	E778fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	VCV000216127	15	44914531	15	44622333	216127	213133	rs863224524	NC_000015.10:44622332:TTTT:TTT
NM_025137.4(SPG11):c.1492C>T (p.Gln498Ter)	SPG11	Q498*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041399	15	44941174	15	44648976	41399	49823	rs312262728	NC_000015.10:44648975:G:A
NM_025137.4(SPG11):c.7158_7159insACAA (p.Gln2387fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041364	15	44855492 - 44855493	15	44563294 - 44563295	41364	49788	rs312262792	NC_000015.10:44563294:TT:TTGTTT
NM_025137.4(SPG11):c.7151+4_7151+7del	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041362	15	44856738 - 44856741	15	44564540 - 44564543	41362	49786	rs312262791	NC_000015.10:44564539:TACTTACTT:TACTT
NM_025137.4(SPG11):c.7101dup (p.Lys2368Ter)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041361	15	44856794 - 44856795	15	44564596 - 44564597	41361	49785	rs312262790	NC_000015.10:44564596:AAA:AAAA
NM_025137.4(SPG11):c.7085_7088dup (p.Tyr2363Ter)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041360	15	44856807 - 44856808	15	44564609 - 44564610	41360	49784	rs312262789	NC_000015.10:44564609:TAATTAA:TAATTAATTAA
NM_025137.4(SPG11):c.7023C>A (p.Tyr2341Ter)	SPG11	Y2341*, Y2228*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041356	15	44856873	15	44564675	41356	49780	rs80338869	NC_000015.10:44564674:G:T
NM_025137.4(SPG11):c.6790dup (p.Leu2264fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041350	15	44858467 - 44858468	15	44566269 - 44566270	41350	49774	rs312262783	NC_000015.10:44566269:G:GG
NM_025137.3:c.6754+4insTG	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041349					41349	49773		
NM_025137.4(SPG11):c.654_655delinsG (p.Ser218fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041346	15	44951289 - 44951290	15	44659091 - 44659092	41346	49770	rs312262718	NC_000015.10:44659090:AA:C
NM_025137.4(SPG11):c.6477+4A>G	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041345	15	44862719	15	44570521	41345	49769	rs312262780	NC_000015.10:44570520:T:C
NM_025137.4(SPG11):c.6206-1G>C	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041342	15	44865019	15	44572821	41342	49766	rs312262778	NC_000015.10:44572820:C:G
NM_025137.4(SPG11):c.5992dup (p.Tyr1998fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041339	15	44867113 - 44867114	15	44574915 - 44574916	41339	49763	rs312262777	NC_000015.10:44574915:A:AA
NM_025137.3:c.5987_5990dupCTCT	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041337					41337	49761		
NM_025137.4(SPG11):c.5970C>G (p.Tyr1990Ter)	SPG11	Y1990*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041332	15	44867136	15	44574938	41332	49756	rs312262773	NC_000015.10:44574937:G:C
NM_025137.3:c.5898+5493_6509-491del	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041331					41331	49755		
NM_025137.4(SPG11):c.5870C>G (p.Ser1957Ter)	SPG11	S1957*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041330	15	44867236	15	44575038	41330	49754	rs312262772	NC_000015.10:44575037:G:C
NM_025137.3(SPG11):c.5867-3237_6478-451del8323	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041329	15	44862154 - 44870476	15	44569956 - 44578278	41329	49753		
NM_025137.4(SPG11):c.5798del (p.Ala1933fs)	SPG11	A1933fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041328	15	44876080	15	44583882	41328	49752	rs312262771	NC_000015.10:44583881:G:
NM_025137.4(SPG11):c.5703del (p.His1902fs)	SPG11	H1902fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041326	15	44876175	15	44583977	41326	49750	rs312262769	NC_000015.10:44583976:AAAA:AAA
NM_025137.4(SPG11):c.5532_5533del (p.Lys1845fs)	SPG11	K1845fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041325	15	44876345 - 44876346	15	44584147 - 44584148	41325	49749	rs312262768	NC_000015.10:44584146:TG:
NM_025137.4(SPG11):c.5399_5402delinsTGGAGGAG (p.Gln1800fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041322	15	44876476 - 44876479	15	44584278 - 44584281	41322	49746	rs312262765	NC_000015.10:44584277:ATCT:CTCCTCCA
NM_025137.4(SPG11):c.4846C>T (p.Gln1616Ter)	SPG11	Q1616*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041319	15	44881510	15	44589312	41319	49743	rs312262762	NC_000015.10:44589311:G:A
NM_025137.4(SPG11):c.4668T>A (p.Tyr1556Ter)	SPG11	Y1556*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041318	15	44884604	15	44592406	41318	49742	rs312262761	NC_000015.10:44592405:A:T
NM_025137.4(SPG11):c.4460_4461GT[1] (p.Val1488fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041317	15	44887629 - 44887630	15	44595431 - 44595432	41317	49741	rs587777921	NC_000015.10:44595430:ACACA:ACA
NM_025137.4(SPG11):c.408_428del (p.Glu136_Ile142del)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041314	15	44952644 - 44952664	15	44660446 - 44660466	41314	49738	rs312262714	NC_000015.10:44660445:TCAATGAGCTTTTGCAATGCCTC:TC
NM_025137.4(SPG11):c.4046T>A (p.Phe1349Tyr)	SPG11	F1349Y	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041313	15	44889097	15	44596899	41313	49737	rs312262758	NC_000015.10:44596898:A:T
NM_025137.4(SPG11):c.398del (p.Cys133fs)	SPG11	C133fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041312	15	44952674	15	44660476	41312	49736	rs312262713	NC_000015.10:44660475:C:
NM_025137.4(SPG11):c.3741dup (p.Pro1248fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041311	15	44890979 - 44890980	15	44598781 - 44598782	41311	49735	rs312262757	NC_000015.10:44598781:T:TT
NM_025137.4(SPG11):c.3717_3718TA[1] (p.Ile1240fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041310	15	44891001 - 44891002	15	44598803 - 44598804	41310	49734	rs312262756	NC_000015.10:44598802:TATA:TA
NM_025137.4(SPG11):c.3602_3603del (p.Tyr1201fs)	SPG11	Y1201fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041308	15	44892748 - 44892749	15	44600550 - 44600551	41308	49732	rs312262754	NC_000015.10:44600549:ATA:A
NM_025137.4(SPG11):c.359del (p.Asn119_Leu120insTer)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041307	15	44952713	15	44660515	41307	49731	rs312262712	NC_000015.10:44660514:AAA:AA
NM_025137.3(SPG11):c.3145_3146insCA (p.Asp1049Alafs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041303					41303	49727	rs1555453772	
NM_025137.4(SPG11):c.2842dup (p.Val948fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041300	15	44907756 - 44907757	15	44615558 - 44615559	41300	49724	rs312262750	NC_000015.10:44615558:CCCC:CCCCC
NM_025137.4(SPG11):c.2716del (p.Gln906fs)	SPG11	Q906fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041297	15	44912506	15	44620308	41297	49721	rs312262747	NC_000015.10:44620307:GGG:GG
NM_025137.4(SPG11):c.2697G>A (p.Trp899Ter)	SPG11	W899*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041296	15	44912525	15	44620327	41296	49720	rs312262746	NC_000015.10:44620326:C:T
NM_025137.4(SPG11):c.268G>T (p.Glu90Ter)	SPG11	E90*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041295	15	44952804	15	44660606	41295	49719	rs312262710	NC_000015.10:44660605:C:A
NM_025137.4(SPG11):c.2608A>G (p.Ile870Val)	SPG11	I870V	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041293	15	44913969	15	44621771	41293	49717	rs312262745	NC_000015.10:44621770:T:C
NM_025137.4(SPG11):c.2444G>T (p.Arg815Met)	SPG11	R815M	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041291	15	44914418	15	44622220	41291	49715	rs312262742	NC_000015.10:44622219:C:A
NM_025137.4(SPG11):c.2356_2357GA[1] (p.Arg788fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041289	15	44914503 - 44914504	15	44622305 - 44622306	41289	49713	rs312262741	NC_000015.10:44622304:TCTCT:TCT
NM_025137.4(SPG11):c.1845_1846del (p.Ser616fs)	SPG11	S616fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041283	15	44921476 - 44921477	15	44629278 - 44629279	41283	49707	rs312262736	NC_000015.10:44629277:ACA:A
NM_025137.4(SPG11):c.1837_1838insA (p.Leu613fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041282	15	44921484 - 44921485	15	44629286 - 44629287	41282	49706	rs312262735	NC_000015.10:44629286::T
NM_025137.4(SPG11):c.1697_1711delinsTACTCCCA (p.Asp566fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041280	15	44925727 - 44925741	15	44633529 - 44633543	41280	49704	rs312262733	NC_000015.10:44633528:AGTGATCAAACTGAT:TGGGAGTA
NM_025137.4(SPG11):c.1679C>G (p.Ser560Ter)	SPG11	S560*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041279	15	44925759	15	44633561	41279	49703	rs312262732	NC_000015.10:44633560:G:C
NM_025137.4(SPG11):c.1668del (p.Phe556fs)	SPG11	F556fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041278	15	44925770	15	44633572	41278	49702	rs312262731	NC_000015.10:44633571:AAAAA:AAAA
NM_025137.4(SPG11):c.1547_1548CT[1] (p.Cys518fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041274	15	44941116 - 44941117	15	44648918 - 44648919	41274	49698	rs312262729	NC_000015.10:44648917:AGAG:AG
NM_025137.4(SPG11):c.1457-2A>G	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041272	15	44941211	15	44649013	41272	49696	rs312262726	NC_000015.10:44649012:T:C
NM_025137.4(SPG11):c.1282A>T (p.Lys428Ter)	SPG11	K428*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041270	15	44943863	15	44651665	41270	49694	rs312262724	NC_000015.10:44651664:T:A
NM_025137.4(SPG11):c.847_851CTTAA[1] (p.Asn284fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000645925	15	44949306 - 44949310	15	44657108 - 44657112	645925	643271		NC_000015.10:44657107:TTAAGTTAAG:TTAAG
NM_025137.4(SPG11):c.5093T>A (p.Leu1698Ter)	SPG11	L1698*	not provided	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000586642	15	44877862	15	44585664	586642	577391	rs1462607878	NC_000015.10:44585663:A:T
NM_025137.4(SPG11):c.6598A>T (p.Lys2200Ter)	SPG11	K2200*, K2087*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000572602	15	44859778	15	44567580	572602	573246	rs141263564	NC_000015.10:44567579:T:A
NM_025137.4(SPG11):c.782C>A (p.Ser261Ter)	SPG11	S261*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000466570	15	44949380	15	44657182	466570	464271	rs765477482	NC_000015.10:44657181:G:T
NM_025137.4(SPG11):c.3213_3214insCCCT (p.Val1072fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000406456	15	44903115 - 44903116	15	44610917 - 44610918	406456	400104	rs767798272	NC_000015.10:44610917:A:AGGGA
NM_025137.4(SPG11):c.6828_6829AG[2] (p.Ser2278fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000041351	15	44858425 - 44858426	15	44566227 - 44566228	41351	49775	rs312262784	NC_000015.10:44566226:CTCTCT:CTCT
NM_025137.4(SPG11):c.6091C>T (p.Arg2031Ter)	SPG11	R2031*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041340	15	44865859	15	44573661	41340	49764	rs147713329	NC_000015.10:44573660:G:A
NM_025137.4(SPG11):c.5985_5988CTGT[1] (p.Leu1997fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041335	15	44867114 - 44867117	15	44574916 - 44574919	41335	49759	rs312262776	NC_000015.10:44574915:ACAGACAGA:ACAGA
NM_025137.4(SPG11):c.5977C>T (p.Gln1993Ter)	SPG11	Q1993*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041334	15	44867129	15	44574931	41334	49758	rs312262774	NC_000015.10:44574930:G:A
NM_025137.4(SPG11):c.5769del (p.Ser1923fs)	SPG11	S1923fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041327	15	44876109	15	44583911	41327	49751	rs312262770	NC_000015.10:44583910:A:
NM_025137.4(SPG11):c.5408_5409TG[1] (p.Cys1804fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided	VCV000041323	15	44876467 - 44876468	15	44584269 - 44584270	41323	49747	rs312262766	NC_000015.10:44584268:CACA:CA
NM_025137.4(SPG11):c.5255del (p.Phe1752fs)	SPG11	F1752fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041320	15	44876623	15	44584425	41320	49744	rs312262763	NC_000015.10:44584424:AAAAA:AAAA
NM_025137.4(SPG11):c.3291+1G>T	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided	VCV000041304	15	44903037	15	44610839	41304	49728	rs312262753	NC_000015.10:44610838:C:A
NM_025137.4(SPG11):c.2444+1G>C	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000041290	15	44914417	15	44622219	41290	49714	rs312262743	NC_000015.10:44622218:C:G
NM_025137.4(SPG11):c.2472_2473insT (p.Lys825Ter)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000001113	15	44914104 - 44914105	15	44621906 - 44621907	1113	16152	rs312262744	NC_000015.10:44621906::A
NM_025137.4(SPG11):c.4888G>T (p.Glu1630Ter)	SPG11	E1630*	Spastic paraplegia 11, autosomal recessive|Amyotrophic lateral sclerosis type 5	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561117	15	44881468	15	44589270	561117	552182	rs368276916	NC_000015.10:44589269:C:A
NM_025137.4(SPG11):c.3311dup (p.Asn1104fs)	SPG11		Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503939	15	44900783 - 44900784	15	44608585 - 44608586	503939	495776	rs753257469	NC_000015.10:44608585:TTTT:TTTTT
NM_025137.4(SPG11):c.5772_5781dup (p.His1928fs)	SPG11		Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423138	15	44876096 - 44876097	15	44583898 - 44583899	423138	409235	rs779321661	NC_000015.10:44583898:CAGATCCTCC:CAGATCCTCCCAGATCCTCC
NM_025137.4(SPG11):c.5158C>T (p.Gln1720Ter)	SPG11	Q1720*	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000406517	15	44876720	15	44584522	406517	400601	rs1060501173	NC_000015.10:44584521:G:A
NM_025137.4(SPG11):c.1621C>T (p.Gln541Ter)	SPG11	Q541*	Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000235891	15	44925817	15	44633619	235891	237526	rs765061840	NC_000015.10:44633618:G:A
NM_025137.4(SPG11):c.592C>T (p.Gln198Ter)	SPG11	Q198*	Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000218143	15	44951352	15	44659154	218143	214791	rs863225440	NC_000015.10:44659153:G:A
NM_025137.4(SPG11):c.6632dup (p.Pro2212fs)	SPG11		Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000218142	15	44859743 - 44859744	15	44567545 - 44567546	218142	214790	rs863225439	NC_000015.10:44567545:C:CC
NM_025137.3(SPG11):c.5456_5457del (p.Glu1819Alafs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000041368	15	44876421 - 44876422	15	44584223 - 44584224	41368	49792	rs312262764	NC_000015.10:44584222:CTCT:CT
NM_025137.4(SPG11):c.642del (p.Phe214fs)	SPG11	F214fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000041343	15	44951302	15	44659104	41343	49767	rs312262717	NC_000015.10:44659103:AAAAA:AAAA
NM_025137.4(SPG11):c.349G>T (p.Glu117Ter)	SPG11	E117*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000041306	15	44952723	15	44660525	41306	49730	rs312262711	NC_000015.10:44660524:C:A
NM_025137.4(SPG11):c.2849dup (p.Leu950fs)	SPG11		Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000041301	15	44907749 - 44907750	15	44615551 - 44615552	41301	49725	rs1470463921	NC_000015.10:44615551:AAAAAAA:AAAAAAAA
NC_000013.11:g.(?_51934746)_(51950409_?)del	ATP7B		Wilson disease	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000830995	13	52508882 - 52524545			830995	820585		
NM_000053.4(ATP7B):c.4022G>A (p.Gly1341Asp)	ATP7B	G1230D, G1257D, G1134D, G1263D, G1341D	Wilson disease	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000665925	13	52509831	13	51935695	665925	642033		NC_000013.11:51935694:C:T
NM_000053.4(ATP7B):c.1543+1G>T	ATP7B		Wilson disease	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000590806	13	52544627	13	51970491	590806	581769	rs1360279134	NC_000013.11:51970490:C:A
NM_000053.4(ATP7B):c.3061-12T>A	ATP7B		Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557116	13	52518439	13	51944303	557116	547638	rs1045194246	NC_000013.11:51944302:A:T
NM_000053.4(ATP7B):c.3904-2A>G	ATP7B		Wilson disease	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000371387	13	52511531	13	51937395	371387	358216	rs1057517233	NC_000013.11:51937394:T:C
NM_000053.4(ATP7B):c.1708-1G>A	ATP7B		Wilson disease	Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	VCV000370195	13	52539170	13	51965034	370195	358232	rs137853280	NC_000013.11:51965033:C:T
NM_000053.4(ATP7B):c.2149C>T (p.Gln717Ter)	ATP7B	Q717*, Q606*, Q633*	Wilson disease	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000225299	13	52532653	13	51958517	225299	227353	rs1085307057	NC_000013.11:51958516:G:A
NM_000053.4(ATP7B):c.524_525del (p.Lys175fs)	ATP7B	K175fs	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188995	13	52548831 - 52548832	13	51974695 - 51974696	188995	186909	rs558037268	NC_000013.11:51974694:TTT:T
NM_000053.4(ATP7B):c.2865+1G>A	ATP7B		Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, multiple submitters, no conflicts	VCV000157942	13	52523797	13	51949661	157942	167789	rs587783306	NC_000013.11:51949660:C:T
NM_025137.4(SPG11):c.3121C>T (p.Arg1041Ter)	SPG11	R1041*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000639667	15	44905652	15	44613454	639667	643245		NC_000015.10:44613453:G:A
NM_025137.4(SPG11):c.276_285del (p.Arg93fs)	SPG11	R93fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000565721	15	44952787 - 44952796	15	44660589 - 44660598	565721	569412	rs747220413	NC_000015.10:44660588:GCTGTTACGAG:G
NC_000015.9:g.(?_44862703)_(44867259_?)del	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000534912	15	44862703 - 44867259	15	44570505 - 44575061	534912	528600		
NM_025137.4(SPG11):c.5175del (p.Ala1726fs)	SPG11	A1726fs	Spastic paraplegia 11, autosomal recessive|Abnormality of brain morphology	Pathogenic/Likely pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000402197	15	44876703	15	44584505	402197	389161	rs1060499768	NC_000015.10:44584504:TT:T
NM_025137.4(SPG11):c.2877C>A (p.Cys959Ter)	SPG11	C959*	not provided|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	VCV000188250	15	44907722	15	44615524	188250	186203	rs786204176	NC_000015.10:44615523:G:T
NM_025137.4(SPG11):c.5986dup (p.Cys1996fs)	SPG11		Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000041336	15	44867119 - 44867120	15	44574921 - 44574922	41336	49760	rs312262775	NC_000015.10:44574921:A:AA
NM_025137.4(SPG11):c.1951C>T (p.Arg651Ter)	SPG11	R651*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Mar 27, 2016)	criteria provided, single submitter	VCV000041284	15	44920983	15	44628785	41284	49708	rs199588440	NC_000015.10:44628784:G:A
NM_025137.4(SPG11):c.1465_1466CT[3] (p.Leu491fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000041273	15	44941194 - 44941195	15	44648996 - 44648997	41273	49697	rs312262727	NC_000015.10:44648995:AGAGAGAG:AGAGAG
NM_025137.4(SPG11):c.7152-1G>C	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000001115	15	44855500	15	44563302	1115	16154	rs200079802	NC_000015.10:44563301:C:G
NM_004004.6(GJB2):c.224G>A (p.Arg75Gln)	GJB2	R75Q	not provided|Palmoplantar keratoderma-deafness syndrome|Rare genetic deafness|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000017027	13	20763497	13	20189358	17027	32066	rs28931593	NC_000013.11:20189357:C:T
NM_022489.4(INF2):c.658G>A (p.Glu220Lys)	INF2	E220K	Charcot-Marie-Tooth disease|not provided|Proteinuria|Renal insufficiency|Focal segmental glomerulosclerosis|Hypertensive disorder|Focal segmental glomerulosclerosis 5	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523533	14	105169782	14	104703445	523533	514037	rs530391015	NC_000014.9:104703444:G:A
NM_004572.3(PKP2):c.2013del (p.Lys672fs)	PKP2	K628fs, K672fs	not provided|Cardiac arrhythmia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000202022	12	32974422	12	32821488	202022	198400	rs764817683	NC_000012.12:32821487:GGGG:GGG
NM_004572.3(PKP2):c.2386T>C (p.Cys796Arg)	PKP2	C796R, C752R	Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000201965	12	32949146	12	32796212	201965	198389	rs794729098	NC_000012.12:32796211:A:G
NM_004572.3(PKP2):c.368G>A (p.Trp123Ter)	PKP2	W123*	not provided|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000196395	12	33031446	12	32878512	196395	193556	rs760576804	NC_000012.12:32878511:C:T
NM_000303.3(PMM2):c.338C>T (p.Pro113Leu)	PMM2	P113L	Congenital disorder of glycosylation, type Ia|Cerebral atrophy|Congenital cerebellar hypoplasia|Spasticity|Poor speech|Cerebral palsy|Cerebellar ataxia|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007723	16	8900255	16	8806398	7723	22762	rs80338700	NC_000016.10:8806397:C:T
NC_000015.10:g.(?_44595239)_(44600652_?)del	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000534914	15	44887437 - 44892850	15	44595239 - 44600652	534914	528602		
NM_025137.4(SPG11):c.3711dup (p.Tyr1238fs)	SPG11		Hereditary spastic paraplegia|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000466523	15	44891009 - 44891010	15	44598811 - 44598812	466523	465100	rs750663981	NC_000015.10:44598811:GG:GGG
NM_025137.4(SPG11):c.704_705del (p.His235fs)	SPG11	H235fs	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000041359	15	44949457 - 44949458	15	44657259 - 44657260	41359	49783	rs312262719	NC_000015.10:44657258:AT:
NM_025137.4(SPG11):c.6856C>T (p.Arg2286Ter)	SPG11	R2286*, R2173*	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000041353	15	44858195	15	44565997	41353	49777	rs312262785	NC_000015.10:44565996:G:A
NM_025137.4(SPG11):c.6739_6742del (p.Glu2247fs)	SPG11	E2134fs, E2247fs	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000041348	15	44859634 - 44859637	15	44567436 - 44567439	41348	49772	rs312262782	NC_000015.10:44567435:ACTCA:A
NM_025137.4(SPG11):c.6451del (p.Ala2151fs)	SPG11	A2038fs, A2151fs	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000041344	15	44862749	15	44570551	41344	49768	rs312262779	NC_000015.10:44570550:CC:C
NM_025137.4(SPG11):c.5470C>T (p.Arg1824Ter)	SPG11	R1824*	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000041324	15	44876408	15	44584210	41324	49748	rs312262767	NC_000015.10:44584209:G:A
NM_025137.4(SPG11):c.3664_3665insT (p.Lys1222fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000041309	15	44892686 - 44892687	15	44600488 - 44600489	41309	49733	rs312262755	NC_000015.10:44600488::A
NM_000151.4(G6PC):c.377_378TA[3] (p.Tyr128fs)	G6PC		not provided|Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011997	17	41059575 - 41059576	17	42907558 - 42907559	11997	27036	rs80356488	NC_000017.11:42907558:TATA:TATATA
NM_000070.3(CAPN3):c.1993-1G>A	CAPN3		not provided|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4|Limb-girdle muscular dystrophy, type 2A|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282494	15	42701984	15	42409786	282494	266731	rs369552114	NC_000015.10:42409785:G:A
NM_000070.3(CAPN3):c.883_886delinsCTT (p.Asp295fs)	CAPN3		Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217160	15	42682232 - 42682235	15	42390034 - 42390037	217160	213825	rs863224966	NC_000015.10:42390033:GATA:CTT
NM_000070.3(CAPN3):c.1477C>T (p.Arg493Trp)	CAPN3	R493W, R445W	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000193792	15	42693961	15	42401763	193792	190955	rs557164942	NC_000015.10:42401762:C:T
NM_001171.5(ABCC6):c.3904G>A (p.Gly1302Arg)	ABCC6	G1302R, G1188R	Pseudoxanthoma elasticum, forme fruste|Generalized arterial calcification of infancy 2|Pseudoxanthoma elasticum|not provided|Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006579	16	16248867	16	16155010	6579	21618	rs63749856	NC_000016.10:16155009:C:T
NM_002834.5(PTPN11):c.1381G>T (p.Ala461Ser)	PTPN11	A461S, A465S, A460S	Noonan syndrome with multiple lentigines|Rasopathy|not provided	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040546	12	112926248	12	112488444	40546	49016	rs121918468	NC_000012.12:112488443:G:T
NM_002834.5(PTPN11):c.228G>C (p.Glu76Asp)	PTPN11	E76D, E75D	Rasopathy|Noonan syndrome|not provided|Noonan syndrome 1	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040503	12	112888212	12	112450408	40503	48973	rs397507514	NC_000012.12:112450407:G:C
NM_002834.5(PTPN11):c.166A>G (p.Ile56Val)	PTPN11	I56V, I55V	Noonan syndrome|Noonan syndrome and Noonan-related syndrome|Rasopathy|Noonan syndrome 1|not provided	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000040485	12	112888150	12	112450346	40485	48955	rs397507504	NC_000012.12:112450345:A:G
NM_002834.5(PTPN11):c.1504T>A (p.Ser502Thr)	PTPN11	S502T, S506T, S501T	Noonan syndrome|Noonan syndrome|Juvenile myelomonocytic leukemia|Noonan syndrome 1|not provided	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013332	12	112926884	12	112489080	13332	28371	rs121918458	NC_000012.12:112489079:T:A
NM_000018.4(ACADVL):c.1376G>A (p.Arg459Gln)	ACADVL	R459Q, R482Q, R383Q, R437Q	Rhabdomyolysis|Muscular Diseases|Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203585	17	7127330	17	7224011	203585	200340	rs751995154	NC_000017.11:7224010:G:A
NM_000018.4(ACADVL):c.753-2A>C	ACADVL		not provided|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092290	17	7125494	17	7222175	92290	98201	rs398123092	NC_000017.11:7222174:A:C
NM_000018.4(ACADVL):c.520G>A (p.Val174Met)	ACADVL	V174M, V98M, V152M, V197M	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092286	17	7124899	17	7221580	92286	98197	rs369560930	NC_000017.11:7221579:G:A
NM_004937.3(CTNS):c.18_21del (p.Thr7fs)	CTNS	T7fs	Juvenile nephropathic cystinosis|Nephropathic cystinosis|Cystinosis|not provided|Ocular cystinosis|Nephropathic cystinosis|Juvenile nephropathic cystinosis	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188834	17	3543516 - 3543519	17	3640222 - 3640225	188834	186969	rs786204501	NC_000017.11:3640221:CTGACT:CT
NM_025137.4(SPG11):c.1891+1G>T	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000852519	15	44921430	15	44629232	852519	851617		NC_000015.10:44629231:C:A
NM_025137.4(SPG11):c.7029dup (p.Val2344fs)	SPG11		Spastic paraplegia 11, autosomal recessive|Amyotrophic lateral sclerosis type 5	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041358	15	44856866 - 44856867	15	44564668 - 44564669	41358	49782	rs312262788	NC_000015.10:44564668:AAAA:AAAAA
NM_025137.4(SPG11):c.6896_6897CT[1] (p.Leu2300fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000041354	15	44858152 - 44858153	15	44565954 - 44565955	41354	49778	rs312262786	NC_000015.10:44565953:AGAG:AG
NM_025137.4(SPG11):c.2198T>G (p.Leu733Ter)	SPG11	L733*	Spastic paraplegia 11, autosomal recessive|Amyotrophic lateral sclerosis type 5	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041287	15	44918575	15	44626377	41287	49711	rs312262739	NC_000015.10:44626376:A:C
NM_025137.4(SPG11):c.1203del (p.Asp402fs)	SPG11	D402fs	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000041268	15	44943942	15	44651744	41268	49692	rs312262722	NC_000015.10:44651743:TTT:TT
NM_006662.3(SRCAP):c.7727C>A (p.Ser2576Ter)	SRCAP	S2576*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521267	16	30749088	16	30737767	521267	512197	rs1555465966	NC_000016.10:30737766:C:A
NM_052845.4(MMAB):c.556C>T (p.Arg186Trp)	MMAB	R186W	not provided|Vitamin B12-responsive methylmalonic acidemia type cblB|Methylmalonic acidemia	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003095	12	109998873	12	109561068	3095	18134	rs28941784	NC_000012.12:109561067:G:A
NM_000020.2(ACVRL1):c.199C>T (p.Arg67Trp)	ACVRL1	R67W	|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000426010	12	52307020	12	51913236	426010	414382	rs1085307405	NC_000012.12:51913235:C:T
NM_000020.3(ACVRL1):c.1031G>A (p.Cys344Tyr)	ACVRL1	C344Y	|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008254	12	52309267	12	51915483	8254	23293	rs28936688	NC_000012.12:51915482:G:A
NM_000020.2(ACVRL1):c.1231C>T (p.Arg411Trp)	ACVRL1	R411W	not provided|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008251	12	52310002	12	51916218	8251	23290	rs121909287	NC_000012.12:51916217:C:T
NM_013275.6(ANKRD11):c.7569+1G>A	ANKRD11		Inborn genetic diseases|not provided	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000208695	16	89341500	16	89275092	208695	205298	rs797044890	NC_000016.10:89275091:C:T
NM_000053.4(ATP7B):c.2549C>T (p.Thr850Ile)	ATP7B	T850I, T766I, T772I, T739I, T688I	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554444	13	52524434	13	51950298	554444	547204	rs777629392	NC_000013.11:51950297:G:A
NM_000053.4(ATP7B):c.3449del (p.Asn1150fs)	ATP7B	N1039fs, N1072fs, N1066fs, N943fs, N1150fs	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000526656	13	52515324	13	51941188	526656	527794	rs1555285380	NC_000013.11:51941187:TTT:TT
NM_000053.4(ATP7B):c.1470C>A (p.Cys490Ter)	ATP7B	C490*, C379*	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370319	13	52544701	13	51970565	370319	358235	rs778675259	NC_000013.11:51970564:G:T
NM_000053.4(ATP7B):c.3263T>A (p.Leu1088Ter)	ATP7B	L1088*, L1004*, L1010*, L881*, L977*	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188886	13	52516671	13	51942535	188886	186886	rs753250853	NC_000013.11:51942534:A:T
NM_025137.4(SPG11):c.4435-2A>G	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000664569	15	44887659	15	44595461	664569	652740		NC_000015.10:44595460:T:C
NM_025137.4(SPG11):c.6899T>C (p.Leu2300Pro)	SPG11	L2300P, L2187P	not provided|Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235890	15	44858152	15	44565954	235890	237525	rs371334506	NC_000015.10:44565953:A:G
NM_025137.4(SPG11):c.869+1G>A	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000041367	15	44949292	15	44657094	41367	49791	rs312262721	NC_000015.10:44657093:C:T
NM_025137.4(SPG11):c.2833A>G (p.Arg945Gly)	SPG11	R945G	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000041298	15	44912389	15	44620191	41298	49722	rs312262748	NC_000015.10:44620190:T:C
NM_025137.4(SPG11):c.2163dup (p.Ile722fs)	SPG11		Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, multiple submitters, no conflicts	VCV000041286	15	44918609 - 44918610	15	44626411 - 44626412	41286	49710	rs312262738	NC_000015.10:44626411:AA:AAA
NM_025137.4(SPG11):c.1235C>G (p.Ser412Ter)	SPG11	S412*	Spastic paraplegia 11, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041269	15	44943910	15	44651712	41269	49693	rs312262723	NC_000015.10:44651711:G:C
NM_025137.4(SPG11):c.5623C>T (p.Gln1875Ter)	SPG11	Q1875*	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001116	15	44876255	15	44584057	1116	16155	rs141848292	NC_000015.10:44584056:G:A
NM_025137.4(SPG11):c.524_528ATATT[1] (p.Ile177fs)	SPG11		Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000001110	15	44951411 - 44951415	15	44659213 - 44659217	1110	16149	rs312262716	NC_000015.10:44659212:AATATAATAT:AATAT
NM_144997.7(FLCN):c.955_956insCCCCTGTGTTGCCAGAGAGTACAGAAAG (p.Gly319fs)	FLCN		not specified	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000812021	17	17122439 - 17122440	17	17219125 - 17219126	812021	800007		NC_000017.11:17219125:CTT:CTTTCTGTACTCTCTGGCAACACAGGGGCTT
NM_144997.7(FLCN):c.233del (p.Lys78fs)	FLCN	K78fs	not provided	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000545728	17	17131219	17	17227905	545728	536483	rs1555611377	NC_000017.11:17227904:TTTTT:TTTT
NM_144997.7(FLCN):c.780-2A>G	FLCN		not provided	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000449726	17	17124944	17	17221630	449726	445702	rs1555609514	NC_000017.11:17221629:T:C
NM_144997.7(FLCN):c.649C>T (p.Gln217Ter)	FLCN	Q217*, Q235*	not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000449402	17	17125945	17	17222631	449402	445703	rs1555609899	NC_000017.11:17222630:G:A
NM_144997.7(FLCN):c.1062+2T>C	FLCN		not provided	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000449026	17	17122331	17	17219017	449026	445701	rs886039370	NC_000017.11:17219016:A:G
NM_144997.7(FLCN):c.1301-2A>G	FLCN		not specified	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000439732	17	17118632	17	17215318	439732	433574	rs1555607296	NC_000017.11:17215317:T:C
NM_144997.7(FLCN):c.507G>A (p.Trp169Ter)	FLCN	W169*, W187*	not specified	Pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	VCV000439730	17	17127347	17	17224033	439730	433572	rs1555610290	NC_000017.11:17224032:C:T
NM_144997.7(FLCN):c.1329_1332dup (p.Ala445fs)	FLCN		not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000426738	17	17118598 - 17118599	17	17215284 - 17215285	426738	415538	rs1085307771	NC_000017.11:17215284:GGCTG:GGCTGGCTG
NM_144997.7(FLCN):c.49del (p.Arg17fs)	FLCN	R17fs	not provided	Pathogenic(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	VCV000419350	17	17131403	17	17228089	419350	409842	rs758385503	NC_000017.11:17228088:GGGGG:GGGG
NM_144997.7(FLCN):c.1300+2T>G	FLCN		not provided	Pathogenic(Last reviewed: Jun 19, 2015)	criteria provided, single submitter	VCV000419280	17	17119692	17	17216378	419280	409839	rs1064793766	NC_000017.11:17216377:A:C
NM_144997.7(FLCN):c.1285_1286insG (p.His429fs)	FLCN		not provided	Pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000418212	17	17119708 - 17119709	17	17216394 - 17216395	418212	409840	rs1555607651	NC_000017.11:17216394::C
NM_144997.7(FLCN):c.1177-2A>G	FLCN		not provided	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000379220	17	17119819	17	17216505	379220	375786	rs1057520528	NC_000017.11:17216504:T:C
NM_144997.7(FLCN):c.1227C>A (p.Tyr409Ter)	FLCN	Y409*, Y427*	not provided	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000377877	17	17119767	17	17216453	377877	375785	rs561236067	NC_000017.11:17216452:G:T
NM_144997.7(FLCN):c.241_242del (p.Met81fs)	FLCN	M81fs	not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000373020	17	17131210 - 17131211	17	17227896 - 17227897	373020	360283	rs1057518147	NC_000017.11:17227895:AT:
NM_144997.7(FLCN):c.1504C>T (p.Gln502Ter)	FLCN	Q502*, Q520*	not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000280915	17	17118333	17	17215019	280915	264994	rs886042033	NC_000017.11:17215018:G:A
NM_144997.7(FLCN):c.1227C>G (p.Tyr409Ter)	FLCN	Y409*, Y427*	not provided	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000280909	17	17119767	17	17216453	280909	265004	rs561236067	NC_000017.11:17216452:G:C
NM_144997.7(FLCN):c.1540A>T (p.Lys514Ter)	FLCN	K514*, K532*	not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000280238	17	17117169	17	17213855	280238	264669	rs886041478	NC_000017.11:17213854:T:A
NM_144997.7(FLCN):c.171dup (p.Met58fs)	FLCN		not provided	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000279810	17	17131280 - 17131281	17	17227966 - 17227967	279810	264841	rs886041203	NC_000017.11:17227966:CC:CCC
NM_144997.7(FLCN):c.1601del (p.Lys534fs)	FLCN	K534fs, K552fs	not provided	Pathogenic(Last reviewed: May 6, 2015)	criteria provided, single submitter	VCV000265155	17	17117108	17	17213794	265155	260153	rs886039371	NC_000017.11:17213793:TT:T
NM_144997.7(FLCN):c.708del (p.Asn236fs)	FLCN	N236fs, N254fs	not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000265153	17	17125886	17	17222572	265153	260155	rs886039369	NC_000017.11:17222571:G:
NM_144997.7(FLCN):c.1060C>T (p.Gln354Ter)	FLCN	Q354*, Q372*	not provided	Pathogenic(Last reviewed: Dec 27, 2012)	criteria provided, single submitter	VCV000096467	17	17122335	17	17219021	96467	102361	rs398124523	NC_000017.11:17219020:G:A
NM_144997.7(FLCN):c.490del (p.Arg164fs)	FLCN	R164fs, R182fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000825282	17	17127364	17	17224050	825282	813051		NC_000017.11:17224049:T:
NM_144997.7(FLCN):c.412G>T (p.Glu138Ter)	FLCN	E156*, E138*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000824614	17	17127442	17	17224128	824614	813053		NC_000017.11:17224127:C:A
NM_144997.7(FLCN):c.301G>T (p.Glu101Ter)	FLCN	E101*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000822598	17	17129585	17	17226271	822598	813060		NC_000017.11:17226270:C:A
Single allele	FLCN		Birt-Hogg-Dub Syndrome	Pathogenic(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635887	17	17138220 - 17146328			635887	623700		
NM_144997.7(FLCN):c.583G>T (p.Gly195Ter)	FLCN	G195*, G213*	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562464	17	17127271	17	17223957	562464	553648	rs1567819544	NC_000017.11:17223956:C:A
NM_144997.7(FLCN):c.199del (p.Ala67fs)	FLCN	A67fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000485627	17	17131253	17	17227939	485627	478608	rs1555611438	NC_000017.11:17227938:CCCCC:CCCC
NM_144997.7(FLCN):c.1286_1287dup (p.Val430fs)	FLCN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 18, 2016)	criteria provided, single submitter	VCV000485615	17	17119706 - 17119707	17	17216392 - 17216393	485615	477962	rs1555607640	NC_000017.11:17216392:GTG:GTGTG
NM_144997.7(FLCN):c.1153del (p.Gln385fs)	FLCN	Q403fs, Q385fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000485603	17	17120406	17	17217092	485603	477976	rs1555607960	NC_000017.11:17217091:GG:G
NM_144997.7(FLCN):c.44dup (p.Arg17fs)	FLCN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 8, 2015)	criteria provided, single submitter	VCV000428656	17	17131407 - 17131408	17	17228093 - 17228094	428656	420627	rs1131690839	NC_000017.11:17228093:CC:CCC
NM_144997.7(FLCN):c.838G>T (p.Glu280Ter)	FLCN	E280*, E298*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, single submitter	VCV000428653	17	17124884	17	17221570	428653	420619	rs1060502367	NC_000017.11:17221569:C:A
NM_144997.7(FLCN):c.779+1G>C	FLCN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	VCV000428652	17	17125814	17	17222500	428652	420621	rs758175953	NC_000017.11:17222499:C:G
NM_144997.7(FLCN):c.603_607del (p.Lys203fs)	FLCN	K203fs, K221fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 14, 2016)	criteria provided, single submitter	VCV000428650	17	17127247 - 17127251	17	17223933 - 17223937	428650	420623	rs1131690836	NC_000017.11:17223932:TGCCCTG:TG
NM_144997.7(FLCN):c.1098_1102dup (p.Val368fs)	FLCN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000428645	17	17120456 - 17120457	17	17217142 - 17217143	428645	420615	rs1131690831	NC_000017.11:17217142:CGTGCC:CGTGCCGTGCC
NM_144997.7(FLCN):c.919G>T (p.Glu307Ter)	FLCN	E307*, E325*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	VCV000428644	17	17122476	17	17219162	428644	420618	rs932256543	NC_000017.11:17219161:C:A
NM_144997.7(FLCN):c.1014del (p.Trp338fs)	FLCN	W356fs, W338fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000428643	17	17122381	17	17219067	428643	420617	rs1131690830	NC_000017.11:17219066:CC:C
NM_144997.7(FLCN):c.1302_1303dup (p.Phe435fs)	FLCN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 5, 2015)	criteria provided, single submitter	VCV000428642	17	17118627 - 17118628	17	17215313 - 17215314	428642	420613	rs1131690829	NC_000017.11:17215313:AC:ACAC
NM_144997.7(FLCN):c.1352del (p.Pro451fs)	FLCN	P469fs, P451fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	VCV000428640	17	17118579	17	17215265	428640	420612	rs1131690828	NC_000017.11:17215264:GGG:GG
NM_144997.7(FLCN):c.214del (p.Ser72fs)	FLCN	S72fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 7, 2014)	criteria provided, single submitter	VCV000428636	17	17131238	17	17227924	428636	420625	rs1131690824	NC_000017.11:17227923:T:
NM_144997.7(FLCN):c.1459G>T (p.Glu487Ter)	FLCN	E487*, E505*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 5, 2014)	criteria provided, single submitter	VCV000185811	17	17118378	17	17215064	185811	184480	rs786202475	NC_000017.11:17215063:C:A
NM_144997.7(FLCN):c.83dup (p.Leu29fs)	FLCN		not provided	Pathogenic(Last reviewed: Aug 27, 2012)	no assertion criteria provided	VCV000096491	17	17131368 - 17131369	17	17228054 - 17228055	96491	102385	rs398124540	NC_000017.11:17228054:GGGG:GGGGG
NM_144997.7(FLCN):c.828_829dup (p.Ala277fs)	FLCN		not provided	Pathogenic(Last reviewed: Jul 8, 2013)	no assertion criteria provided	VCV000096490	17	17124892 - 17124893	17	17221578 - 17221579	96490	102384	rs398124539	NC_000017.11:17221578:CAC:CACAC
NM_144997.5(FLCN):c.872-?_c.1740+?del	FLCN		Pneumothorax, primary spontaneous	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000003379					3379	18418		
NM_144997.7(FLCN):c.17_21del (p.Ala6fs)	FLCN	A6fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000819877	17	17131431 - 17131435	17	17228117 - 17228121	819877	813070		NC_000017.11:17228116:GAGAG:
NM_144997.7(FLCN):c.1426dup (p.Asp476fs)	FLCN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	VCV000428649	17	17118504 - 17118505	17	17215190 - 17215191	428649	420610	rs1131690835	NC_000017.11:17215190:C:CC
NM_144997.7(FLCN):c.943G>T (p.Glu315Ter)	FLCN	E315*, E333*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	criteria provided, single submitter	VCV000141706	17	17122452	17	17219138	141706	151420	rs587781952	NC_000017.11:17219137:C:A
NM_144997.7(FLCN):c.1156_1175del (p.Ser386fs)	FLCN	S404fs, S386fs	Pneumothorax, primary spontaneous	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000003375	17	17120384 - 17120403	17	17217070 - 17217089	3375	18414	rs886037610	NC_000017.11:17217069:CGAAGTACTTCAAAAGCTGAC:C
NM_144997.7(FLCN):c.404del (p.Pro135fs)	FLCN	P153fs, P135fs	Pneumothorax, primary spontaneous	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000003373	17	17127450	17	17224136	3373	18412	rs886037609	NC_000017.11:17224135:GGG:GG
NM_144997.7(FLCN):c.1533_1536del (p.Glu510_Trp511insTer)	FLCN		Pneumothorax, primary spontaneous	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000003372	17	17118301 - 17118304	17	17214987 - 17214990	3372	18411	rs886037608	NC_000017.11:17214986:CATCCA:CA
FLCN, 2-BP DEL, 1284TC AND 2-BP INS, 1284AC	FLCN		Chromophobe renal cell carcinoma	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000003368					3368	18407		
NM_144997.7(FLCN):c.1245C>A (p.Cys415Ter)	FLCN	C415*, C433*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000545980	17	17119749	17	17216435	545980	536482	rs748148728	NC_000017.11:17216434:G:T
NM_144997.7(FLCN):c.433del (p.Asp145fs)	FLCN	D163fs, D145fs	Multiple fibrofolliculomas	Pathogenic	no assertion criteria provided	VCV000431057	17	17127421	17	17224107	431057	424584	rs1135401752	NC_000017.11:17224106:C:
NM_144997.7(FLCN):c.780G>A (p.Trp260Ter)	FLCN	W260*, W278*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 11, 2014)	criteria provided, single submitter	VCV000428638	17	17124942	17	17221628	428638	420620	rs1131690826	NC_000017.11:17221627:C:T
NM_144997.7(FLCN):c.158del (p.Gln53fs)	FLCN	Q53fs	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428637	17	17131294	17	17227980	428637	420626	rs1131690825	NC_000017.11:17227979:T:
NM_144997.7(FLCN):c.1528del (p.Glu510fs)	FLCN	E510fs, E528fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000253255	17	17118309	17	17214995	253255	247649	rs879255680	NC_000017.11:17214994:CC:C
NM_144997.7(FLCN):c.1124_1139del (p.Ile375fs)	FLCN	I375fs, I393fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000253245	17	17120420 - 17120435	17	17217106 - 17217121	253245	247659	rs879255673	NC_000017.11:17217105:TCTCTGCTTTTCCAGATC:TC
NM_144997.7(FLCN):c.1098G>A (p.Trp366Ter)	FLCN	W366*, W384*	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000253244	17	17120461	17	17217147	253244	247660	rs879255672	NC_000017.11:17217146:C:T
NM_144997.7(FLCN):c.851del (p.Val284fs)	FLCN	V284fs, V302fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000253238	17	17124871	17	17221557	253238	247666	rs879255666	NC_000017.11:17221556:A:
NM_144997.7(FLCN):c.752G>A (p.Trp251Ter)	FLCN	W251*, W269*	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000253235	17	17125842	17	17222528	253235	247669	rs879255663	NC_000017.11:17222527:C:T
NM_144997.7(FLCN):c.735_738del (p.Ser246fs)	FLCN	S246fs, S264fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000253234	17	17125856 - 17125859	17	17222542 - 17222545	253234	247670	rs879255662	NC_000017.11:17222541:ACTT:
NM_144997.7(FLCN):c.453del (p.Phe152fs)	FLCN	F152fs, F170fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000253230	17	17127401	17	17224087	253230	247674	rs879255660	NC_000017.11:17224086:C:
NM_144997.7(FLCN):c.3G>C (p.Met1Ile)	FLCN	M1I	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000253226	17	17131449	17	17228135	253226	247678	rs879255658	NC_000017.11:17228134:C:G
NM_144997.7(FLCN):c.1215C>G (p.Tyr405Ter)	FLCN	Y405*, Y423*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000185892	17	17119779	17	17216465	185892	184485	rs786202541	NC_000017.11:17216464:G:C
NM_144997.7(FLCN):c.1397del (p.Val466fs)	FLCN	V466fs, V484fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000864273	17	17118534	17	17215220	864273	844748		NC_000017.11:17215219:A:
NM_144997.7(FLCN):c.1054_1055del (p.Met352fs)	FLCN	M352fs, M370fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000863926	17	17122340 - 17122341	17	17219026 - 17219027	863926	844761		NC_000017.11:17219025:AT:
NM_144997.7(FLCN):c.523_535del (p.Ile175fs)	FLCN	I175fs, I193fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000857729	17	17127319 - 17127331	17	17224005 - 17224017	857729	844777		NC_000017.11:17224004:GGTCCATCATGATGGT:GGT
NM_144997.7(FLCN):c.739_761delinsCAGCGAG (p.Asp247fs)	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000845669	17	17125833 - 17125855	17	17222519 - 17222541	845669	844772		NC_000017.11:17222518:AGGCACGCCCACAGGTTGTCATC:CTCGCTG
NM_144997.7(FLCN):c.420dup (p.Ile141fs)	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000845558	17	17127433 - 17127434	17	17224119 - 17224120	845558	844783		NC_000017.11:17224119:GGGG:GGGGG
NM_144997.7(FLCN):c.273del (p.His92fs)	FLCN	H92fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000838883	17	17129613	17	17226299	838883	844790		NC_000017.11:17226298:CCC:CC
NM_144997.7(FLCN):c.808dup (p.Thr270fs)	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000835373	17	17124913 - 17124914	17	17221599 - 17221600	835373	844771		NC_000017.11:17221599:T:TT
NC_000017.11:g.(?_17221527)_(17224153_?)del	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, single submitter	VCV000830501	17	17124841 - 17127467			830501	820990		
NM_144997.7(FLCN):c.1440del (p.Thr481fs)	FLCN	T499fs, T481fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000664632	17	17118397	17	17215083	664632	645352		NC_000017.11:17215082:GGGG:GGG
NM_144997.7(FLCN):c.942_943AG[2] (p.Ser316fs)	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000662576	17	17122448 - 17122449	17	17219134 - 17219135	662576	645372		NC_000017.11:17219133:CTCTCT:CTCT
NM_144997.7(FLCN):c.563del (p.Phe188fs)	FLCN	F188fs, F206fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000659786	17	17127291	17	17223977	659786	645379		NC_000017.11:17223976:AA:A
NM_144997.7(FLCN):c.1326del (p.His442fs)	FLCN	H442fs, H460fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000657432	17	17118605	17	17215291	657432	645360		NC_000017.11:17215290:G:
NM_144997.7(FLCN):c.312del (p.Lys105fs)	FLCN	K105fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000655361	17	17129574	17	17226260	655361	645384		NC_000017.11:17226259:AA:A
NM_144997.7(FLCN):c.167del (p.Ser56fs)	FLCN	S56fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000649905	17	17131285	17	17227971	649905	645391		NC_000017.11:17227970:C:
NM_144997.7(FLCN):c.889_890del (p.Glu297fs)	FLCN	E297fs, E315fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000643432	17	17122505 - 17122506	17	17219191 - 17219192	643432	645375		NC_000017.11:17219190:TCT:T
NC_000017.10:g.(?_17116959)_(17140502_?)del	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000642628	17	17116959 - 17140502	17	17213645 - 17237188	642628	653086		
NM_144997.7(FLCN):c.1451del (p.Asn484fs)	FLCN	N484fs, N502fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000575959	17	17118386	17	17215072	575959	568723	rs1567807238	NC_000017.11:17215071:TT:T
NM_144997.7(FLCN):c.804del (p.Arg268_Leu269insTer)	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000575582	17	17124918	17	17221604	575582	570878	rs1567816285	NC_000017.11:17221603:CC:C
NM_144997.7(FLCN):c.121C>T (p.Gln41Ter)	FLCN	Q41*	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000571073	17	17131331	17	17228017	571073	568752	rs1254608489	NC_000017.11:17228016:G:A
NM_144997.7(FLCN):c.365_372del (p.Arg122fs)	FLCN	R122fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000565562	17	17129514 - 17129521	17	17226200 - 17226207	565562	568740	rs1567822638	NC_000017.11:17226199:GGCCTGGCGG:GG
NM_144997.7(FLCN):c.1358_1374del (p.Gly453fs)	FLCN	G453fs, G471fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000529992	17	17118557 - 17118573	17	17215243 - 17215259	529992	531115	rs1555607179	NC_000017.11:17215242:CTGGTCATCCTCACACCC:C
NM_144997.7(FLCN):c.1359del (p.Cys454fs)	FLCN	C454fs, C472fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Oct 8, 2017)	criteria provided, single submitter	VCV000529979	17	17118572	17	17215258	529979	531133	rs1555607212	NC_000017.11:17215257:CCCC:CCC
NM_144997.7(FLCN):c.979dup (p.Ala327fs)	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000460642	17	17122415 - 17122416	17	17219101 - 17219102	460642	467323	rs1555608552	NC_000017.11:17219101:CC:CCC
NM_144997.7(FLCN):c.1451_1458dup (p.Glu487fs)	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000460596	17	17118378 - 17118379	17	17215064 - 17215065	460596	467434	rs757197845	NC_000017.11:17215064:AATCTTAT:AATCTTATAATCTTAT
NC_000017.10:g.(?_17116047)_(17118400_?)del	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000460576	17	17116047 - 17118400			460576	467070		
NM_144997.7(FLCN):c.3del (p.Met1fs)	FLCN	M1fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000428655	17	17131449	17	17228135	428655	420629	rs1131690838	NC_000017.11:17228134:C:
NM_144997.7(FLCN):c.1062+1G>A	FLCN		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	VCV000428646	17	17122332	17	17219018	428646	420616	rs1131690832	NC_000017.11:17219017:C:T
NM_144997.7(FLCN):c.239del (p.Asp80fs)	FLCN	D80fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: May 20, 2016)	criteria provided, single submitter	VCV000409393	17	17131213	17	17227899	409393	402055	rs1060502371	NC_000017.11:17227898:T:
NM_144997.7(FLCN):c.202del (p.Ser68fs)	FLCN	S68fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Apr 9, 2016)	criteria provided, single submitter	VCV000409389	17	17131250	17	17227936	409389	402066	rs1060502370	NC_000017.11:17227935:T:
NM_144997.7(FLCN):c.987del (p.Ser330fs)	FLCN	S348fs, S330fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Nov 2, 2015)	criteria provided, single submitter	VCV000241933	17	17122408	17	17219094	241933	242602	rs878855221	NC_000017.11:17219093:GG:G
NM_144997.7(FLCN):c.828delinsAGA (p.Ala277fs)	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000241931	17	17124894	17	17221580	241931	242603	rs878855220	NC_000017.11:17221579:A:TCT
FLCN, 2-BP DEL/2-BP INS, NT610	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000003378					3378	18417		
NM_001110219.3(GJB6):c.31G>A (p.Gly11Arg)	GJB6	G11R	Deafness, autosomal dominant 3b|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Deafness, X-linked 2|Hidrotic ectodermal dysplasia syndrome|not provided|Deafness, autosomal dominant 3b|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Hidrotic ectodermal dysplasia syndrome|Hidrotic ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005544	13	20797589	13	20223450	5544	20583	rs104894415	NC_000013.11:20223449:C:T
NC_000017.11:g.(?_17216370)_(17228161_?)del	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000831982	17	17119684 - 17131475			831982	820989		
NM_144997.7(FLCN):c.1177-169_1538del	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000638865	17	17118299 - 17119986	17	17214985 - 17216672	638865	652894		
NM_144997.7(FLCN):c.887C>G (p.Ser296Ter)	FLCN	S296*, S314*	Multiple fibrofolliculomas	Pathogenic(Last reviewed: May 20, 2018)	criteria provided, single submitter	VCV000571069	17	17122508	17	17219194	571069	570802	rs1490424623	NC_000017.11:17219193:G:C
NM_144997.7(FLCN):c.510C>A (p.Tyr170Ter)	FLCN	Y170*, Y188*	Multiple fibrofolliculomas	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000565561	17	17127344	17	17224030	565561	570809	rs1567819834	NC_000017.11:17224029:G:T
NC_000017.10:g.(?_17124845)_(17131457_?)del	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Nov 18, 2017)	criteria provided, single submitter	VCV000530024	17	17124845 - 17131457	17	17221531 - 17228143	530024	530829		
NM_144997.7(FLCN):c.991_992TC[3] (p.Ser333fs)	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000529991	17	17122397 - 17122398	17	17219083 - 17219084	529991	530779	rs1555608515	NC_000017.11:17219082:GAGAGAGAG:GAGAGAG
NM_144997.7(FLCN):c.49dup (p.Arg17fs)	FLCN		not provided|Multiple fibrofolliculomas	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429820	17	17131402 - 17131403	17	17228088 - 17228089	429820	422146	rs758385503	NC_000017.11:17228088:GGGGG:GGGGGG
NM_144997.7(FLCN):c.932_933del (p.Pro311fs)	FLCN	P329fs, P311fs	not provided|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000373895	17	17122462 - 17122463	17	17219148 - 17219149	373895	360794	rs1555608614	NC_000017.11:17219147:AG:
NM_144997.7(FLCN):c.1532G>A (p.Trp511Ter)	FLCN	W511*, W529*	Multiple fibrofolliculomas|not provided	Pathogenic(Last reviewed: Feb 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000253257	17	17118305	17	17214991	253257	247647	rs879255682	NC_000017.11:17214990:C:T
NM_144997.7(FLCN):c.1525_1527GAG[1] (p.Glu510del)	FLCN	E510del	Multiple fibrofolliculomas|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000253256	17	17118307 - 17118309	17	17214993 - 17214995	253256	247648	rs879255681	NC_000017.11:17214992:CTCCTCCT:CTCCT
NM_144997.7(FLCN):c.1300+1G>A	FLCN		Multiple fibrofolliculomas|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000253248	17	17119693	17	17216379	253248	247656	rs879255676	NC_000017.11:17216378:C:T
NM_144997.7(FLCN):c.1036_1043del (p.Phe346fs)	FLCN	F346fs, F364fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000253242	17	17122352 - 17122359	17	17219038 - 17219045	253242	247662	rs879255670	NC_000017.11:17219037:GACTTGAAGACT:GACT
NM_144997.7(FLCN):c.853C>T (p.Gln285Ter)	FLCN	Q285*, Q303*	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, multiple submitters, no conflicts	VCV000253239	17	17124869	17	17221555	253239	247665	rs879255667	NC_000017.11:17221554:G:A
NM_144997.7(FLCN):c.634C>T (p.Gln212Ter)	FLCN	Q212*, Q230*	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000253232	17	17125960	17	17222646	253232	247672	rs558699420	NC_000017.11:17222645:G:A
NM_022041.3(GAN):c.806G>A (p.Arg269Gln)	GAN	R269Q	Giant axonal neuropathy 1|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000521988	16	81390562	16	81356957	521988	512228	rs759581558	NC_000016.10:81356956:G:A
NM_020988.3(GNAO1):c.736G>A (p.Glu246Lys)	GNAO1	E246K	Neurodevelopmental disorder with involuntary movements|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208777	16	56385308	16	56351396	208777	205294	rs797044951	NC_000016.10:56351395:G:A
NM_004960.3(FUS):c.1574C>T (p.Pro525Leu)	FUS	P525L, P521L, P524L	not provided|Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280110	16	31202752	16	31191431	280110	264787	rs886041390	NC_000016.10:31191430:C:T
NM_144997.7(FLCN):c.237_240dup (p.Met81fs)	FLCN		Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000645451	17	17131211 - 17131212	17	17227897 - 17227898	645451	645386		NC_000017.11:17227897:GTCCG:GTCCGTCCG
NM_144997.7(FLCN):c.1188del (p.Val397fs)	FLCN	V397fs, V415fs	not specified|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618131	17	17119806	17	17216492	618131	610059	rs1567809782	NC_000017.11:17216491:GGG:GG
NM_144997.7(FLCN):c.1318del (p.Glu440fs)	FLCN	E440fs, E458fs	Multiple fibrofolliculomas	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000529989	17	17118613	17	17215299	529989	530765	rs1555607273	NC_000017.11:17215298:CC:C
NM_144997.7(FLCN):c.1300G>T (p.Glu434Ter)	FLCN	E434*, E452*	not provided|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488811	17	17119694	17	17216380	488811	482118	rs1266098984	NC_000017.11:17216379:C:A
NM_144997.7(FLCN):c.1357_1363del (p.Gly453fs)	FLCN	G453fs, G471fs	Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428658	17	17118568 - 17118574	17	17215254 - 17215260	428658	420611	rs1131690841	NC_000017.11:17215253:CACACCCCACA:CACA
NM_144997.7(FLCN):c.1213dup (p.Tyr405fs)	FLCN		Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428651	17	17119780 - 17119781	17	17216466 - 17216467	428651	420614	rs1131690837	NC_000017.11:17216466:A:AA
NM_144997.7(FLCN):c.521_527del (p.Thr174fs)	FLCN	T174fs, T192fs	not provided|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426160	17	17127327 - 17127333	17	17224013 - 17224019	426160	415539	rs1085307478	NC_000017.11:17224012:ATGATGG:
NM_144997.7(FLCN):c.780-1G>T	FLCN		not provided|Multiple fibrofolliculomas	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2016)	criteria provided, multiple submitters, no conflicts	VCV000409407	17	17124943	17	17221629	409407	401569	rs878855218	NC_000017.11:17221628:C:A
NM_144997.7(FLCN):c.503_518delinsATCAG (p.Arg168fs)	FLCN		Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000409385	17	17127336 - 17127351	17	17224022 - 17224037	409385	402289	rs1064792959	NC_000017.11:17224021:ATGATGCTGTACCAGC:CTGAT
NM_001005242.3(PKP2):c.1378+1G>C	PKP2		Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000045022	12	33003699	12	32850765	45022	54189	rs397516994	NC_000012.12:32850764:C:G
NM_004572.3(PKP2):c.2028G>A (p.Trp676Ter)	PKP2	W676*, W632*	not provided|Arrhythmogenic right ventricular cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036682	12	32974407	12	32821473	36682	45343	rs193922673	NC_000012.12:32821472:C:T
NM_001134407.3(GRIN2A):c.1841A>G (p.Asn614Ser)	GRIN2A	N614S	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 6, 2014)	criteria provided, single submitter	VCV000224990	16	9923446	16	9829589	224990	226960	rs869312916	NC_000016.10:9829588:T:C
NM_025137.4(SPG11):c.1085G>A (p.Trp362Ter)	SPG11	W362*	Charcot-Marie-Tooth disease, axonal type 2X|Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive|not provided|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488833	15	44944060	15	44651862	488833	482070	rs140385286	NC_000015.10:44651861:C:T
NM_025137.4(SPG11):c.5974C>T (p.Arg1992Ter)	SPG11	R1992*	not provided|Spastic paraplegia 11, autosomal recessive|Amyotrophic lateral sclerosis type 5	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000041333	15	44867132	15	44574934	41333	49757	rs200793464	NC_000015.10:44574933:G:A
NM_025137.4(SPG11):c.2316+1G>A	SPG11		Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000041288	15	44914925	15	44622727	41288	49712	rs312262740	NC_000015.10:44622726:C:T
NC_000017.11:g.(?_17214975)_(17215326_?)del	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000832607	17	17118289 - 17118640			832607	820988		
NC_000017.10:g.(?_17140226)_(17140502_?)del	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000583955	17	17140226 - 17140502	17	17236912 - 17237188	583955	568571		
NM_144997.7(FLCN):c.1389C>A (p.Tyr463Ter)	FLCN	Y463*, Y481*	Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000253250	17	17118542	17	17215228	253250	247654	rs137852929	NC_000017.11:17215227:G:T
NM_144997.7(FLCN):c.1286dup (p.His429fs)	FLCN		Multiple fibrofolliculomas|not provided	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000253247	17	17119707 - 17119708	17	17216393 - 17216394	253247	247657	rs879255675	NC_000017.11:17216393:T:TT
NM_144997.7(FLCN):c.927dup (p.Ala310fs)	FLCN		Multiple fibrofolliculomas|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000253241	17	17122467 - 17122468	17	17219153 - 17219154	253241	247663	rs879255669	NC_000017.11:17219153:TTT:TTTT
NM_144997.7(FLCN):c.1219del (p.Ser407fs)	FLCN	S425fs, S407fs	Multiple fibrofolliculomas|not provided	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000241915	17	17119775	17	17216461	241915	242600	rs878855213	NC_000017.11:17216460:T:
NM_144997.7(FLCN):c.113del (p.Ser38fs)	FLCN	S38fs	Multiple fibrofolliculomas|not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000241913	17	17131339	17	17228025	241913	242612	rs878855212	NC_000017.11:17228024:C:
NM_000053.4(ATP7B):c.2866-2A>G	ATP7B		Wilson disease	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000623292	13	52520616	13	51946480	623292	612356	rs1377418826	NC_000013.11:51946479:T:C
NM_000053.4(ATP7B):c.2072G>T (p.Gly691Val)	ATP7B	G691V, G580V	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555245	13	52534333	13	51960197	555245	547225	rs1555291801	NC_000013.11:51960196:C:A
NM_000053.4(ATP7B):c.994G>T (p.Glu332Ter)	ATP7B	E332*	Wilson disease	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553388	13	52548362	13	51974226	553388	547394	rs761084829	NC_000013.11:51974225:C:A
NM_000053.4(ATP7B):c.1924G>T (p.Asp642Tyr)	ATP7B	D642Y, D531Y	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000526655	13	52535995	13	51961859	526655	527826	rs72552285	NC_000013.11:51961858:C:A
NM_000053.4(ATP7B):c.1782del (p.Thr593_Tyr594insTer)	ATP7B		Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189091	13	52539095	13	51964959	189091	186904	rs780327716	NC_000013.11:51964958:A:
NM_000053.4(ATP7B):c.3556+1G>A	ATP7B		Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189055	13	52515216	13	51941080	189055	186880	rs184388696	NC_000013.11:51941079:C:T
NM_000053.4(ATP7B):c.2009_2015del (p.Ile669_Tyr670insTer)	ATP7B		Wilson disease	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188862	13	52534390 - 52534396	13	51960254 - 51960260	188862	186902	rs779904655	NC_000013.11:51960253:AGCATATAG:AG
NM_000070.3(CAPN3):c.1381C>T (p.Arg461Cys)	CAPN3	R461C, R413C	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000501440	15	42693865	15	42401667	501440	492864	rs1274808359	NC_000015.10:42401666:C:T
NM_000070.3(CAPN3):c.1309C>T (p.Arg437Cys)	CAPN3	R437C, R389C	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000285470	15	42691805	15	42399607	285470	269707	rs777483913	NC_000015.10:42399606:C:T
NM_000070.3(CAPN3):c.1250C>T (p.Thr417Met)	CAPN3	T417M, T369M	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000281505	15	42691746	15	42399548	281505	265742	rs200646556	NC_000015.10:42399547:C:T
NM_015087.5(SPART):c.364_365del (p.Met122fs)	SPART	M122fs	Inborn genetic diseases|Troyer syndrome	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	VCV000003458	13	36909603 - 36909604	13	36335466 - 36335467	3458	18497	rs775736341	NC_000013.11:36335465:AT:
NM_144997.7(FLCN):c.619-1G>A	FLCN		Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428657	17	17125976	17	17222662	428657	420622	rs1131690840	NC_000017.11:17222661:C:T
NM_144997.7(FLCN):c.33C>A (p.Cys11Ter)	FLCN	C11*	not provided|Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Mar 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428641	17	17131419	17	17228105	428641	420628	rs754616167	NC_000017.11:17228104:G:T
NM_144997.7(FLCN):c.632_633delinsC (p.Glu211fs)	FLCN		not provided|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000253231	17	17125961 - 17125962	17	17222647 - 17222648	253231	247673	rs879255661	NC_000017.11:17222646:CT:G
NM_144997.7(FLCN):c.189del (p.Ala64fs)	FLCN	A64fs	not provided|Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233744	17	17131263	17	17227949	233744	235488	rs876660611	NC_000017.11:17227948:GGGG:GGG
NM_144997.7(FLCN):c.557G>A (p.Trp186Ter)	FLCN	W186*, W204*	Multiple fibrofolliculomas|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000230137	17	17127297	17	17223983	230137	235486	rs876658409	NC_000017.11:17223982:C:T
NM_144997.7(FLCN):c.59del (p.Phe20fs)	FLCN	F20fs	Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas|not provided	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000230104	17	17131393	17	17228079	230104	235492	rs876658390	NC_000017.11:17228078:AA:A
NM_144997.7(FLCN):c.250-1G>A	FLCN		Multiple fibrofolliculomas|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000185318	17	17129637	17	17226323	185318	184491	rs786202081	NC_000017.11:17226322:C:T
NM_144997.7(FLCN):c.779G>A (p.Trp260Ter)	FLCN	W260*, W278*	Multiple fibrofolliculomas|Pneumothorax, primary spontaneous	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000161246	17	17125815	17	17222501	161246	171188	rs368778627	NC_000017.11:17222500:C:T
NM_144997.7(FLCN):c.1203dup (p.Ile402fs)	FLCN		not provided|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096473	17	17119790 - 17119791	17	17216476 - 17216477	96473	102367	rs398124526	NC_000017.11:17216476:G:GG
NM_025137.4(SPG11):c.1348dup (p.Ile450fs)	SPG11		Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000241590	15	44943796 - 44943797	15	44651598 - 44651599	241590	242051	rs312262725	NC_000015.10:44651598:T:TT
NM_025137.4(SPG11):c.267G>A (p.Trp89Ter)	SPG11	W89*	Spastic paraplegia 11, autosomal recessive|Amyotrophic lateral sclerosis type 5	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000041294	15	44952805	15	44660607	41294	49718	rs312262709	NC_000015.10:44660606:C:T
NM_025137.4(SPG11):c.2146C>T (p.Gln716Ter)	SPG11	Q716*	not provided|Spastic paraplegia 11, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041285	15	44918627	15	44626429	41285	49709	rs312262737	NC_000015.10:44626428:G:A
NM_024312.5(GNPTAB):c.3565C>T (p.Arg1189Ter)	GNPTAB	R1189*	|Pseudo-Hurler polydystrophy|not provided|Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002764	12	102147187	12	101753409	2764	17803	rs137852897	NC_000012.12:101753408:G:A
NM_000018.4(ACADVL):c.1837C>T (p.Arg613Trp)	ACADVL	R613W, R591W, R537W, R636W	not provided|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001623	17	7128285	17	7224966	1623	16662	rs118204014	NC_000017.11:7224965:C:T
NM_004004.6(GJB2):c.439G>A (p.Glu147Lys)	GJB2	E147K	not specified|not provided|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371709	13	20763282	13	20189143	371709	358131	rs767178508	NC_000013.11:20189142:C:T
NM_004004.6(GJB2):c.508_511dup (p.Ala171fs)	GJB2		Deafness, autosomal recessive 1A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189070	13	20763209 - 20763210	13	20189070 - 20189071	189070	186855	rs773528125	NC_000013.11:20189070:CGTT:CGTTCGTT
NM_144997.7(FLCN):c.1021del (p.Arg341fs)	FLCN	R359fs, R341fs	Multiple fibrofolliculomas|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000409378	17	17122374	17	17219060	409378	402022	rs1060502368	NC_000017.11:17219059:GGGG:GGG
NM_144997.7(FLCN):c.875T>G (p.Leu292Ter)	FLCN	L292*, L310*	Multiple fibrofolliculomas|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000253240	17	17122520	17	17219206	253240	247664	rs879255668	NC_000017.11:17219205:A:C
NM_144997.7(FLCN):c.610_611delinsTA (p.Ala204Ter)	FLCN		not provided|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000096488	17	17127243 - 17127244	17	17223929 - 17223930	96488	102382	rs398124538	NC_000017.11:17223928:GC:TA
NM_144997.7(FLCN):c.1305del (p.Phe435fs)	FLCN	F435fs, F453fs	not provided|Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096475	17	17118626	17	17215312	96475	102369	rs398124527	NC_000017.11:17215311:AAA:AA
NM_144997.7(FLCN):c.1179del (p.Met394fs)	FLCN	M394fs, M412fs	not provided|Multiple fibrofolliculomas|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096471	17	17119815	17	17216501	96471	102365	rs398124525	NC_000017.11:17216500:GG:G
NM_000231.2(SGCG):c.525del (p.Phe175fs)	SGCG	F175fs	not provided|Severe autosomal recessive muscular dystrophy of childhood - North African type	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189243	13	23869569	13	23295430	189243	187121	rs786204786	NC_000013.11:23295429:TTTTT:TTTT
NM_002834.5(PTPN11):c.174C>A (p.Asn58Lys)	PTPN11	N58K, N57K	Rasopathy|not provided|Noonan syndrome|Noonan syndrome 3	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040488	12	112888158	12	112450354	40488	48958	rs397507506	NC_000012.12:112450353:C:A
NM_002834.5(PTPN11):c.124A>G (p.Thr42Ala)	PTPN11	T42A	Rasopathy|Noonan syndrome|not provided	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040482	12	112884189	12	112446385	40482	48952	rs397507501	NC_000012.12:112446384:A:G
NM_001171.5(ABCC6):c.2787+1G>T	ABCC6		Pseudoxanthoma elasticum, forme fruste|Generalized arterial calcification of infancy 2|Pseudoxanthoma elasticum|not provided|Generalized arterial calcification of infancy 2|Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006560	16	16267140	16	16173283	6560	21599	rs72664209	NC_000016.10:16173282:C:A
NM_000153.4(GALC):c.857G>A (p.Gly286Asp)	GALC	G286D, G260D, G263D	not provided|Galactosylceramide beta-galactosidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030619	14	88434730	14	87968386	30619	39576	rs199847983	NC_000014.9:87968385:C:T
NM_000053.4(ATP7B):c.1145_1151del (p.Ser382fs)	ATP7B	S382fs, S271fs	not provided|Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000523941	13	52548205 - 52548211	13	51974069 - 51974075	523941	514657	rs1176709391	NC_000013.11:51974068:AGTTGGGAG:AG
NM_000053.4(ATP7B):c.3182G>A (p.Gly1061Glu)	ATP7B	G1061E, G854E, G983E, G977E, G950E	Wilson disease|not specified	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000312383	13	52518306	13	51944170	312383	328532	rs764131178	NC_000013.11:51944169:C:T
NM_000053.4(ATP7B):c.2165dup (p.Arg723fs)	ATP7B		Wilson disease	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000210483	13	52532636 - 52532637	13	51958500 - 51958501	210483	208048	rs768729972	NC_000013.11:51958500:A:AA
NM_000053.4(ATP7B):c.1772G>A (p.Gly591Asp)	ATP7B	G591D, G480D	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000210482	13	52539105	13	51964969	210482	208049	rs797045402	NC_000013.11:51964968:C:T
NM_000053.4(ATP7B):c.3895C>T (p.Leu1299Phe)	ATP7B	L1299F, L1221F, L1092F, L1188F, L1215F	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189149	13	52511620	13	51937484	189149	186875	rs749472361	NC_000013.11:51937483:G:A
NM_000053.4(ATP7B):c.778dup (p.Gln260fs)	ATP7B		Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188938	13	52548577 - 52548578	13	51974441 - 51974442	188938	186908	rs786204570	NC_000013.11:51974441:GG:GGG
NM_000053.4(ATP7B):c.4058G>A (p.Trp1353Ter)	ATP7B	W1353*, W1242*, W1269*, W1146*, W1275*	Wilson disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035729	13	52509795	13	51935659	35729	44393	rs193922110	NC_000013.11:51935658:C:T
NM_004572.3(PKP2):c.1677dup (p.Gly560Trpfs)	PKP2		Cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000517335	12	32993972 - 32993973	12	32841038 - 32841039	517335	497223	rs1555144459	NC_000012.12:32841038:A:AA
NM_004572.3(PKP2):c.1162C>T (p.Arg388Trp)	PKP2	R388W	Arrhythmogenic right ventricular cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201979	12	33021869	12	32868935	201979	198430	rs766209297	NC_000012.12:32868934:G:A
NM_001005242.3(PKP2):c.1556+1G>A	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000045038	12	32993961	12	32841027	45038	54205	rs397517003	NC_000012.12:32841026:C:T
NM_001005242.3(PKP2):c.2071C>T (p.Arg691Ter)	PKP2	R735*, R691*	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006755	12	32955433	12	32802499	6755	21794	rs121434421	NC_000012.12:32802498:G:A
NM_000020.2(ACVRL1):c.430C>T (p.Arg144Ter)	ACVRL1	R144*	|not provided|Primary pulmonary hypertension	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212804	12	52307459	12	51913675	212804	210228	rs758683062	NC_000012.12:51913674:C:T
NM_025137.4(SPG11):c.442+1G>C	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000001114	15	44952629	15	44660431	1114	16153	rs312262715	NC_000015.10:44660430:C:G
NM_025137.4(SPG11):c.118C>T (p.Gln40Ter)	SPG11	Q40*	Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive|Amyotrophic lateral sclerosis type 5	Pathogenic(Last reviewed: Nov 10, 2015)	no assertion criteria provided	VCV000001111	15	44955728	15	44663530	1111	16150	rs267607084	NC_000015.10:44663529:G:A
NM_144997.7(FLCN):c.1483_1486CTGT[3] (p.Asp498fs)	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000253254	17	17118346 - 17118347	17	17215032 - 17215033	253254	247650	rs879255679	NC_000017.11:17215032:ACAGACAG:ACAGACAGACAG
NM_144997.7(FLCN):c.346C>T (p.Gln116Ter)	FLCN	Q116*	Multiple fibrofolliculomas|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096484	17	17129540	17	17226226	96484	102378	rs398124536	NC_000017.11:17226225:G:A
NM_144997.7(FLCN):c.1433-2A>G	FLCN		Hereditary cancer-predisposing syndrome|not provided|Multiple fibrofolliculomas	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096476	17	17118406	17	17215092	96476	102370	rs398124528	NC_000017.11:17215091:T:C
NM_144997.7(FLCN):c.1117C>T (p.Gln373Ter)	FLCN	Q373*, Q391*	Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas|not provided	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096469	17	17120442	17	17217128	96469	102363	rs398124524	NC_000017.11:17217127:G:A
NM_000070.3(CAPN3):c.133G>A (p.Ala45Thr)	CAPN3	A45T	Limb-girdle muscular dystrophy, type 2A|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217148	15	42652136	15	42359938	217148	213819	rs774048743	NC_000015.10:42359937:G:A
NM_000070.3(CAPN3):c.1194-9A>G	CAPN3		not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217146	15	42691681	15	42399483	217146	213827	rs374665929	NC_000015.10:42399482:A:G
NM_014363.6(SACS):c.8340del (p.His2781fs)	SACS	H2634fs, H2781fs	not provided	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000817704	13	23909675	13	23335536	817704	805769		NC_000013.11:23335535:AAA:AA
NM_014363.6(SACS):c.2775_2776del (p.Phe927fs)	SACS	F780fs, F927fs	Spastic paraplegia	Pathogenic	no assertion criteria provided	VCV000689580	13	23915239 - 23915240	13	23341100 - 23341101	689580	677244		NC_000013.11:23341099:TT:
NM_014363.6(SACS):c.4265_4274dup (p.Ile1426_Pro1427insAlaTer)	SACS		not provided	Pathogenic(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	VCV000419617	13	23913740 - 23913741	13	23339601 - 23339602	419617	408807	rs1555252433	NC_000013.11:23339601:TCCTCATGCA:TCCTCATGCATCCTCATGCA
NM_014363.6(SACS):c.12028C>T (p.Gln4010Ter)	SACS	Q4010*, Q3863*	not provided	Pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	VCV000287692	13	23905987	13	23331848	287692	271929	rs148297332	NC_000013.11:23331847:G:A
NM_014363.6(SACS):c.4598C>G (p.Ser1533Ter)	SACS	S1533*, S1386*	not provided	Pathogenic(Last reviewed: May 31, 2016)	criteria provided, single submitter	VCV000280645	13	23913417	13	23339278	280645	264733	rs886041813	NC_000013.11:23339277:G:C
NM_014363.6(SACS):c.382_383del (p.Glu128fs)	SACS	E128fs	Spastic paraplegia	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000856558	13	23939379 - 23939380	13	23365240 - 23365241	856558	840616		NC_000013.11:23365239:TCT:T
NM_014363.6(SACS):c.1201C>T (p.Arg401Ter)	SACS	R401*, R254*	Spastic paraplegia	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000843602	13	23929550	13	23355411	843602	840614		NC_000013.11:23355410:G:A
NM_014363.6(SACS):c.1940del (p.Lys647fs)	SACS	K500fs, K647fs	Spastic paraplegia	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000666207	13	23928811	13	23354672	666207	641619		NC_000013.11:23354671:TTTT:TTT
NM_014363.6(SACS):c.517C>T (p.Gln173Ter)	SACS	Q26*, Q173*	Spastic paraplegia	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000663248	13	23932561	13	23358422	663248	641626		NC_000013.11:23358421:G:A
NM_014363.6(SACS):c.1707G>A (p.Trp569Ter)	SACS	W422*, W569*	Spastic paraplegia	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000657319	13	23929044	13	23354905	657319	641621		NC_000013.11:23354904:C:T
NM_014363.6(SACS):c.187A>T (p.Lys63Ter)	SACS	K63*	Spastic paraplegia	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000652757	13	23945289	13	23371150	652757	641629		NC_000013.11:23371149:T:A
NM_014363.6(SACS):c.1004C>A (p.Ser335Ter)	SACS	S188*, S335*	Spastic paraplegia	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000648026	13	23929747	13	23355608	648026	641624		NC_000013.11:23355607:G:T
NM_014363.6(SACS):c.1441G>T (p.Glu481Ter)	SACS	E334*, E481*	Spastic paraplegia	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000647530	13	23929310	13	23355171	647530	641622		NC_000013.11:23355170:C:A
NM_014363.6(SACS):c.12908T>A (p.Leu4303Ter)	SACS	L4303*, L4156*	Spastic paraplegia	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000583073	13	23905107	13	23330968	583073	565869	rs1566055368	NC_000013.11:23330967:A:T
NM_014363.6(SACS):c.1869del (p.Arg624fs)	SACS	R624fs, R477fs	Spastic paraplegia	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000580619	13	23928882	13	23354743	580619	567223	rs1006060877	NC_000013.11:23354742:C:
NM_014363.6(SACS):c.10939G>T (p.Glu3647Ter)	SACS	E3647*, E3500*	Spastic paraplegia	Pathogenic(Last reviewed: Feb 5, 2017)	criteria provided, single submitter	VCV000458251	13	23907076	13	23332937	458251	462618	rs1156566314	NC_000013.11:23332936:C:A
NM_014363.6(SACS):c.9561_9564del (p.Leu3187_Phe3188insTer)	SACS		Spastic paraplegia	Pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, single submitter	VCV000411690	13	23908451 - 23908454	13	23334312 - 23334315	411690	399266	rs1060503431	NC_000013.11:23334311:AAACAA:AA
NM_014363.6(SACS):c.7272C>A (p.Cys2424Ter)	SACS	C2277*, C2424*	Spastic paraplegia	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000857156	13	23910743	13	23336604	857156	840601		NC_000013.11:23336603:G:T
NM_014363.6(SACS):c.11941C>T (p.Gln3981Ter)	SACS	Q3834*, Q3981*		Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802912	13	23906074	13	23331935	802912	791295		NC_000013.11:23331934:G:A
NM_014363.6(SACS):c.5428C>T (p.Gln1810Ter)	SACS	Q1663*, Q1810*	Spastic paraplegia	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000838309	13	23912587	13	23338448	838309	840606		NC_000013.11:23338447:G:A
NM_014363.6(SACS):c.9956_9957dup (p.Val3320fs)	SACS		Spastic paraplegia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000836040	13	23908057 - 23908058	13	23333918 - 23333919	836040	840593		NC_000013.11:23333918:TTT:TTTTT
NM_014363.6(SACS):c.8454G>A (p.Trp2818Ter)	SACS	W2818*, W2671*	Spastic paraplegia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000835299	13	23909561	13	23335422	835299	840598		NC_000013.11:23335421:C:T
NM_014363.6(SACS):c.2938_2939del (p.Met980fs)	SACS	M980fs, M833fs		Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689783	13	23915076 - 23915077	13	23340937 - 23340938	689783	677443		NC_000013.11:23340936:AT:
NM_014363.6(SACS):c.6434T>A (p.Leu2145Ter)	SACS	L1998*, L2145*		Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689782	13	23911581	13	23337442	689782	677442		NC_000013.11:23337441:A:T
NM_014363.6(SACS):c.10847G>A (p.Trp3616Ter)	SACS	W3469*, W3616*	Spastic paraplegia	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000663762	13	23907168	13	23333029	663762	641593		NC_000013.11:23333028:C:T
NM_014363.6(SACS):c.9233del (p.Asn3078fs)	SACS	N3078fs, N2931fs	Spastic paraplegia	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000662301	13	23908782	13	23334643	662301	641596		NC_000013.11:23334642:TT:T
NM_014363.6(SACS):c.6623del (p.Ala2208fs)	SACS	A2061fs, A2208fs	Spastic paraplegia	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000641897	13	23911392	13	23337253	641897	641604		NC_000013.11:23337252:G:
NM_014363.6(SACS):c.2713A>T (p.Lys905Ter)	SACS	K905*, K758*	Spastic paraplegia	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000641094	13	23915302	13	23341163	641094	641615		NC_000013.11:23341162:T:A
NM_014363.6(SACS):c.3055A>G (p.Asn1019Asp)	SACS	N1019D, N872D		Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623396	13	23914960	13	23340821	623396	612301	rs1566071225	NC_000013.11:23340820:T:C
NM_014363.6(SACS):c.4103G>T (p.Ser1368Ile)	SACS	S1368I, S1221I		Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623395	13	23913912	13	23339773	623395	612300	rs1566069517	NC_000013.11:23339772:C:A
NM_014363.6(SACS):c.13454T>C (p.Leu4485Ser)	SACS	L4485S, L4338S		Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623376	13	23904561	13	23330422	623376	612299	rs1566054340	NC_000013.11:23330421:A:G
NM_014363.6(SACS):c.10933del (p.Phe3644_Leu3645insTer)	SACS		Spastic paraplegia	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000574684	13	23907082	13	23332943	574684	565876	rs1566058677	NC_000013.11:23332942:G:
NM_014363.6(SACS):c.262C>T (p.Arg88Ter)	SACS	R88*		Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	VCV000559870	13	23942624	13	23368485	559870	550624	rs1555255676	NC_000013.11:23368484:G:A
NM_014363.6(SACS):c.6338_6341del (p.Leu2113fs)	SACS	L1966fs, L2113fs		Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	VCV000559869	13	23911674 - 23911677	13	23337535 - 23337538	559869	550623	rs1555251822	NC_000013.11:23337534:ATCAATC:ATC
NM_014363.6(SACS):c.1672C>T (p.Gln558Ter)	SACS	Q558*, Q411*	Spastic paraplegia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523854	13	23929079	13	23354940	523854	514654	rs923921184	NC_000013.11:23354939:G:A
NM_014363.6(SACS):c.10813A>T (p.Lys3605Ter)	SACS	K3605*, K3458*		Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522647	13	23907202	13	23333063	522647	513328	rs1360298758	NC_000013.11:23333062:T:A
NM_014363.6(SACS):c.4585C>T (p.Gln1529Ter)	SACS	Q1529*, Q1382*		Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522627	13	23913430	13	23339291	522627	513330	rs1555252345	NC_000013.11:23339290:G:A
NM_014363.6(SACS):c.10644del (p.Phe3548fs)	SACS	F3401fs, F3548fs		Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522626	13	23907371	13	23333232	522626	513329	rs1555250160	NC_000013.11:23333231:AAAAA:AAAA
NM_014363.6(SACS):c.7205_7206del (p.Leu2402fs)	SACS	L2255fs, L2402fs	Spastic paraplegia	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000458274	13	23910809 - 23910810	13	23336670 - 23336671	458274	463488	rs773182375	NC_000013.11:23336669:AA:
NM_014363.6(SACS):c.1917_1918AC[1] (p.His640fs)	SACS			Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000212111	13	23928831 - 23928832	13	23354692 - 23354693	212111	208022	rs797045937	NC_000013.11:23354691:GTGTG:GTG
NM_014363.6(SACS):c.13527dup (p.Glu4510fs)	SACS			Pathogenic(Last reviewed: Aug 13, 2014)	criteria provided, single submitter	VCV000212110	13	23904487 - 23904488	13	23330348 - 23330349	212110	208015	rs797045936	NC_000013.11:23330348:T:TT
SACS, 1-BP DEL, 31760T	SACS			Pathogenic(Last reviewed: Apr 11, 2006)	no assertion criteria provided	VCV000005522					5522	20561		
SACS, 10-BP DEL, NT32627	SACS			Pathogenic(Last reviewed: Apr 11, 2006)	no assertion criteria provided	VCV000005521					5521	20560		
NM_014363.6(SACS):c.3161T>C (p.Phe1054Ser)	SACS	F304S, F1054S, F907S		Pathogenic(Last reviewed: Jun 28, 2005)	no assertion criteria provided	VCV000005520	13	23914854	13	23340715	5520	20559	rs137853019	NC_000013.11:23340714:A:G
NM_014363.6(SACS):c.9742T>C (p.Trp3248Arg)	SACS	W2498R, W3101R, W3248R		Pathogenic(Last reviewed: Jan 13, 2004)	no assertion criteria provided	VCV000005519	13	23908273	13	23334134	5519	20558	rs137853018	NC_000013.11:23334133:A:G
NM_014363.6(SACS):c.4033dup (p.Gln1345fs)	SACS			Pathogenic(Last reviewed: Jan 13, 2004)	no assertion criteria provided	VCV000005518	13	23913981 - 23913982	13	23339842 - 23339843	5518	20557	rs606231163	NC_000013.11:23339842:GG:GGG
NM_014363.6(SACS):c.5836T>C (p.Trp1946Arg)	SACS	W1196R, W1799R, W1946R		Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000005517	13	23912179	13	23338040	5517	20556	rs137853017	NC_000013.11:23338039:A:G
SACS, 1-BP INS, 1155A	SACS			Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000005516					5516	20555		
SACS, 1-BP DEL, 1411T	SACS			Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000005515					5515	20554		
NM_014363.6(SACS):c.12220G>C (p.Ala4074Pro)	SACS	A3324P, A3927P, A4074P		Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000005514	13	23905795	13	23331656	5514	20553	rs137853016	NC_000013.11:23331655:C:G
NM_014363.6(SACS):c.8471C>G (p.Ser2824Ter)	SACS	S2677*, S2824*	Spastic paraplegia	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000858884	13	23909544	13	23335405	858884	840597		NC_000013.11:23335404:G:C
NM_014363.6(SACS):c.13252_13253del (p.Glu4418fs)	SACS	E4271fs, E4418fs	Spastic paraplegia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000848193	13	23904762 - 23904763	13	23330623 - 23330624	848193	840587		NC_000013.11:23330622:TCT:T
NM_014363.6(SACS):c.7250_7254del (p.Thr2417fs)	SACS	T2417fs, T2270fs	Spastic paraplegia	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000847067	13	23910761 - 23910765	13	23336622 - 23336626	847067	840602		NC_000013.11:23336621:TTCTGTT:TT
NM_014363.6(SACS):c.7764_7767dup (p.Val2590fs)	SACS		Spastic paraplegia	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000843447	13	23910247 - 23910248	13	23336108 - 23336109	843447	840600		NC_000013.11:23336108:ACAAA:ACAAACAAA
NM_014363.6(SACS):c.4259_4263del (p.Ile1420fs)	SACS	I1420fs, I1273fs	Spastic paraplegia	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000837100	13	23913752 - 23913756	13	23339613 - 23339617	837100	840609		NC_000013.11:23339612:CAAAA:
NM_014363.6(SACS):c.11633_11634AG[2] (p.Arg3879fs)	SACS			Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689784	13	23906377 - 23906378	13	23332238 - 23332239	689784	677441		NC_000013.11:23332237:CTCTCT:CTCT
NM_014363.6(SACS):c.434C>G (p.Ser145Ter)	SACS	S145*	Spastic paraplegia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000661678	13	23939328	13	23365189	661678	641627		NC_000013.11:23365188:G:C
NM_014363.6(SACS):c.10822_10823del (p.Ser3608fs)	SACS	S3461fs, S3608fs	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557443	13	23907192 - 23907193	13	23333053 - 23333054	557443	547173	rs1555250082	NC_000013.11:23333052:CT:
NM_014363.6(SACS):c.5719C>T (p.Arg1907Ter)	SACS	R1907*, R1760*		Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000556533	13	23912296	13	23338157	556533	547475	rs1485209013	NC_000013.11:23338156:G:A
NM_014363.6(SACS):c.961C>T (p.Arg321Ter)	SACS	R321*, R174*		Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000555502	13	23929790	13	23355651	555502	546943	rs1175545518	NC_000013.11:23355650:G:A
NM_014363.6(SACS):c.6172del (p.Ser2058fs)	SACS	S2058fs, S1911fs		Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000552153	13	23911843	13	23337704	552153	546864	rs1214399996	NC_000013.11:23337703:AAAAAAA:AAAAAA
NM_014363.6(SACS):c.11263_11264AT[1] (p.Ile3755fs)	SACS			Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000550274	13	23906749 - 23906750	13	23332610 - 23332611	550274	547028	rs1400601705	NC_000013.11:23332609:ATAT:AT
NM_014363.6(SACS):c.5063_5064AG[1] (p.Ser1689fs)	SACS		|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496950	13	23912949 - 23912950	13	23338810 - 23338811	496950	488374	rs1372213267	NC_000013.11:23338809:CTCT:CT
NM_014363.6(SACS):c.5125C>T (p.Gln1709Ter)	SACS	Q1709*, Q1562*		Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000371484	13	23912890	13	23338751	371484	358182	rs1057517311	NC_000013.11:23338750:G:A
NM_014363.6(SACS):c.4877_4880del (p.Gly1626fs)	SACS	G1479fs, G1626fs	not provided|	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000280236	13	23913135 - 23913138	13	23338996 - 23338999	280236	264725	rs757872635	NC_000013.11:23338995:CAGCCA:CA
NM_014363.6(SACS):c.7641dup (p.Glu2548fs)	SACS		Autosomal recessive spastic ataxia	Pathogenic(Last reviewed: Aug 8, 2015)	criteria provided, single submitter	VCV000228393	13	23910373 - 23910374	13	23336234 - 23336235	228393	230439	rs876657720	NC_000013.11:23336234:TTT:TTTT
NM_030665.4(RAI1):c.1670_1671del (p.Ser557fs)	RAI1	S557fs	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000522051	17	17697931 - 17697932	17	17794617 - 17794618	522051	512258	rs1555565243	NC_000017.11:17794616:TCT:T
NM_030665.4(RAI1):c.2234_2237del (p.Ala745fs)	RAI1	A745fs	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000521229	17	17698494 - 17698497	17	17795180 - 17795183	521229	512259	rs1555565426	NC_000017.11:17795179:TGCCTG:TG
NM_000321.2(RB1):c.2525_2526del (p.Thr841_Ser842insTer)	RB1		not provided	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000618345	13	49050840 - 49050841	13	48476704 - 48476705	618345	609871	rs1566240909	NC_000013.11:48476703:TCT:T
NM_000321.2(RB1):c.889del (p.Ile297fs)	RB1	I297fs	not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000545733	13	48939057	13	48364921	545733	536445	rs1555285133	NC_000013.11:48364920:A:
NM_000321.2(RB1):c.2488_2489+7del	RB1		not provided	Pathogenic(Last reviewed: Feb 7, 2013)	criteria provided, single submitter	VCV000496901	13	49039503 - 49039511	13	48465367 - 48465375	496901	488325	rs1555294634	NC_000013.11:48465366:AGGTGTGTG:
NM_000321.2(RB1):c.861+2del	RB1		not provided	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000421686	13	48937095	13	48362959	421686	409031	rs1064795296	NC_000013.11:48362958:T:
NM_000321.2(RB1):c.396del (p.Phe132fs)	RB1	F132fs	not provided	Pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	VCV000286124	13	48919229	13	48345093	286124	270361	rs886043313	NC_000013.11:48345092:TTT:TT
NM_000321.2(RB1):c.2548C>T (p.Gln850Ter)	RB1	Q850*	not provided	Pathogenic(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	VCV000284733	13	49050864	13	48476728	284733	268970	rs886042935	NC_000013.11:48476727:C:T
NM_000321.2(RB1):c.2370C>A (p.Tyr790Ter)	RB1	Y790*	not provided	Pathogenic(Last reviewed: Jul 28, 2014)	criteria provided, single submitter	VCV000195726	13	49039385	13	48465249	195726	192887	rs794727372	NC_000013.11:48465248:C:A
NM_000321.2(RB1):c.1402_1412dup (p.Gln471Hisfs)	RB1		not provided	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000194469	13	48954199 - 48954200	13	48380063 - 48380064	194469	191632	rs797044649	NC_000013.11:48380063:ATTATCCATTCA:ATTATCCATTCATTATCCATTCA
NM_000321.2(RB1):c.1191del (p.Glu398fs)	RB1	E398fs	not provided	Pathogenic(Last reviewed: Mar 4, 2014)	criteria provided, single submitter	VCV000167565	13	48947604	13	48373468	167565	178001	rs727504121	NC_000013.11:48373467:A:
NM_000321.2(RB1):c.54_79del (p.Glu19fs)	RB1	E19fs	not provided	Pathogenic(Last reviewed: Mar 19, 2014)	criteria provided, single submitter	VCV000167564	13	48878094 - 48878119	13	48303958 - 48303983	167564	178000	rs727504120	NC_000013.11:48303957:GCCGCCGCGGAACCCCCGGCACCGCCGCCGCCGC:GCCGCCGC
NM_000321.2(RB1):c.2067_2079delinsCAC (p.Gln689fs)	RB1		not provided	Pathogenic(Last reviewed: Jul 25, 2013)	criteria provided, single submitter	VCV000092841	13	49033930 - 49033942	13	48459794 - 48459806	92841	98748	rs398123333	NC_000013.11:48459793:GAATGAGTATGAA:CAC
NM_000321.3(RB1):c.2363_2384dup (p.Arg798_Ile799insGlnValSerTerProLeu)	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000821155	13	49039377 - 49039378	13	48465241 - 48465242	821155	811884		NC_000013.11:48465241:GCCCTTACAAGTTTCCTAGTTC:GCCCTTACAAGTTTCCTAGTTCGCCCTTACAAGTTTCCTAGTTC
NM_000321.3(RB1):c.1338C>A (p.Tyr446Ter)	RB1	Y446*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000818972	13	48953735	13	48379599	818972	811853		NC_000013.11:48379598:C:A
NM_000321.3(RB1):c.118del (p.Glu40fs)	RB1	E40fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000818546	13	48878165	13	48304029	818546	811824		NC_000013.11:48304028:GG:G
NM_000321.2(RB1):c.1421+1del	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000486293	13	48954220	13	48380084	486293	477632	rs1555286576	NC_000013.11:48380083:GG:G
NM_000321.2(RB1):c.862-2A>C	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 30, 2014)	criteria provided, single submitter	VCV000428744	13	48939028	13	48364892	428744	420533	rs1131690914	NC_000013.11:48364891:A:C
NM_000321.2(RB1):c.106del (p.Asp36fs)	RB1	D36fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000428741	13	48878153	13	48304017	428741	420505	rs1131690913	NC_000013.11:48304016:GG:G
NM_000321.2(RB1):c.434del (p.Asp145fs)	RB1	D145fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000428740	13	48919269	13	48345133	428740	420515	rs1131690912	NC_000013.11:48345132:A:
NM_000321.2(RB1):c.1447del (p.His483fs)	RB1	H483fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000428737	13	48954326	13	48380190	428737	420552	rs1131690910	NC_000013.11:48380189:C:
NM_000321.2(RB1):c.681del (p.Lys228fs)	RB1	K228fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000428732	13	48934225	13	48360089	428732	420524	rs1131690905	NC_000013.11:48360088:TT:T
NM_000321.2(RB1):c.2014G>T (p.Glu672Ter)	RB1	E672*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000428728	13	49033877	13	48459741	428728	420566	rs1131690903	NC_000013.11:48459740:G:T
NM_000321.2(RB1):c.1814+2T>G	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 29, 2015)	criteria provided, single submitter	VCV000428724	13	49027249	13	48453113	428724	420562	rs1131690899	NC_000013.11:48453112:T:G
NM_000321.2(RB1):c.1229del (p.Asn410fs)	RB1	N410fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	VCV000428722	13	48951066	13	48376930	428722	420543	rs1131690897	NC_000013.11:48376929:AA:A
NM_000321.2(RB1):c.2128_2132del (p.Gly710fs)	RB1	G710fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	VCV000428721	13	49037886 - 49037890	13	48463750 - 48463754	428721	420572	rs1131690896	NC_000013.11:48463749:ATGGCAT:AT
NM_000321.2(RB1):c.964G>T (p.Glu322Ter)	RB1	E322*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000428719	13	48941654	13	48367518	428719	420536	rs776534331	NC_000013.11:48367517:G:T
NM_000321.2(RB1):c.2299_2302del (p.Asn767fs)	RB1	N767fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	VCV000428717	13	49039220 - 49039223	13	48465084 - 48465087	428717	420574	rs1131690894	NC_000013.11:48465083:AAATA:A
NM_000321.2(RB1):c.1811del (p.Asp604fs)	RB1	D604fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 15, 2015)	criteria provided, single submitter	VCV000428716	13	49027244	13	48453108	428716	420561	rs1131690893	NC_000013.11:48453107:A:
NM_000321.2(RB1):c.731_732delinsATC (p.Ile244fs)	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	VCV000428713	13	48936963 - 48936964	13	48362827 - 48362828	428713	420528	rs1131690890	NC_000013.11:48362826:TA:ATC
NM_000321.2(RB1):c.9_42dup (p.Ala15fs)	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000428711	13	48878050 - 48878051	13	48303914 - 48303915	428711	420501	rs1555279195	NC_000013.11:48303914:GCCGCCCAAAACCCCCCGAAAAACGGCCGCCACCGCCGCC:GCCGCCCAAAACCCCCCGAAAAACGGCCGCCACCGCCGCCCAAAACCCCCCGAAAAACGGCCGCCACCGCCGCC
NM_000321.2(RB1):c.549del (p.Glu184fs)	RB1	E184fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 7, 2015)	criteria provided, single submitter	VCV000428710	13	48923101	13	48348965	428710	420520	rs1131690887	NC_000013.11:48348964:T:
NM_000321.2(RB1):c.500+1G>T	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000428702	13	48919336	13	48345200	428702	420518	rs1131690880	NC_000013.11:48345199:G:T
NM_000321.2(RB1):c.702del (p.Leu234fs)	RB1	L234fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 21, 2014)	criteria provided, single submitter	VCV000428700	13	48934247	13	48360111	428700	420525	rs1131690878	NC_000013.11:48360110:G:
NM_000321.2(RB1):c.1575del (p.Phe526fs)	RB1	F526fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000428697	13	48955458	13	48381322	428697	420557	rs1131690876	NC_000013.11:48381321:CC:C
NM_000321.2(RB1):c.1321dup (p.Ile441fs)	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000428696	13	48951156 - 48951157	13	48377020 - 48377021	428696	420545	rs1131690875	NC_000013.11:48377020:AAA:AAAA
NM_000321.2(RB1):c.496G>T (p.Glu166Ter)	RB1	E166*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 22, 2014)	criteria provided, single submitter	VCV000428695	13	48919331	13	48345195	428695	420517	rs1131690874	NC_000013.11:48345194:G:T
NM_000321.2(RB1):c.1027del (p.Leu343fs)	RB1	L343fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 16, 2014)	criteria provided, single submitter	VCV000428694	13	48941717	13	48367581	428694	420537	rs1131690873	NC_000013.11:48367580:C:
NM_000321.2(RB1):c.1072_1074delinsGG (p.Arg358fs)	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 16, 2014)	criteria provided, single submitter	VCV000428693	13	48942685 - 48942687	13	48368549 - 48368551	428693	420539	rs1131690872	NC_000013.11:48368548:CGA:GG
NM_000321.2(RB1):c.539del (p.Ser179_Ser180insTer)	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 5, 2014)	criteria provided, single submitter	VCV000428690	13	48921999	13	48347863	428690	420519	rs1131690871	NC_000013.11:48347862:C:
NM_000321.2(RB1):c.1695+3A>C	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 13, 2014)	criteria provided, single submitter	VCV000428689	13	48955582	13	48381446	428689	420559	rs1131690870	NC_000013.11:48381445:A:C
NM_000321.2(RB1):c.443del (p.Met148fs)	RB1	M148fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 17, 2015)	criteria provided, single submitter	VCV000428685	13	48919278	13	48345142	428685	420516	rs1131690867	NC_000013.11:48345141:T:
NM_000321.2(RB1):c.2465del (p.Pro822fs)	RB1	P822fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 11, 2013)	criteria provided, single submitter	VCV000428684	13	49039479	13	48465343	428684	420580	rs1131690866	NC_000013.11:48465342:CC:C
NM_000321.2(RB1):c.2104C>T (p.Gln702Ter)	RB1	Q702*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 18, 2013)	criteria provided, single submitter	VCV000428683	13	49033967	13	48459831	428683	420569	rs1131690865	NC_000013.11:48459830:C:T
NM_000321.2(RB1):c.281dup (p.Lys95fs)	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 10, 2013)	criteria provided, single submitter	VCV000428680	13	48916747 - 48916748	13	48342611 - 48342612	428680	420511	rs1131690862	NC_000013.11:48342611:AAAA:AAAAA
NM_000321.2(RB1):c.1062_1063GA[1] (p.Arg355fs)	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 4, 2013)	criteria provided, single submitter	VCV000428679	13	48942674 - 48942675	13	48368538 - 48368539	428679	420538	rs1131690861	NC_000013.11:48368537:AGAGA:AGA
NM_000321.2(RB1):c.2105A>G (p.Gln702Arg)	RB1	Q702R	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 31, 2013)	criteria provided, single submitter	VCV000428675	13	49033968	13	48459832	428675	420570	rs1131690857	NC_000013.11:48459831:A:G
NM_000321.2(RB1):c.1502_1514del (p.Ser501fs)	RB1	S501fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 8, 2013)	criteria provided, single submitter	VCV000428674	13	48955383 - 48955395	13	48381247 - 48381259	428674	420555	rs1131690856	NC_000013.11:48381246:GAAGTACATCTCAGAA:GAA
NM_000321.2(RB1):c.137+1G>T	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 30, 2013)	criteria provided, single submitter	VCV000428673	13	48878186	13	48304050	428673	420506	rs1131690855	NC_000013.11:48304049:G:T
NM_000321.2(RB1):c.846del (p.Glu282fs)	RB1	E282fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 23, 2012)	criteria provided, single submitter	VCV000428667	13	48937077	13	48362941	428667	420531	rs1131690849	NC_000013.11:48362940:AA:A
NM_000321.2(RB1):c.735del (p.Ile246fs)	RB1	I246fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 14, 2012)	criteria provided, single submitter	VCV000428665	13	48936965	13	48362829	428665	420529	rs1131690847	NC_000013.11:48362828:CCC:CC
NM_000321.2(RB1):c.19_21delinsGG (p.Arg7fs)	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000428663	13	48878067 - 48878069	13	48303931 - 48303933	428663	420502	rs1131690845	NC_000013.11:48303930:CGA:GG
NM_000321.2(RB1):c.2055del (p.Gln685fs)	RB1	Q685fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 16, 2011)	criteria provided, single submitter	VCV000428662	13	49033918	13	48459782	428662	420567	rs1131690844	NC_000013.11:48459781:G:
NM_000321.2(RB1):c.1510C>T (p.Gln504Ter)	RB1	Q504*	not provided	Pathogenic(Last reviewed: Jan 28, 2016)	criteria provided, single submitter	VCV000285896	13	48955394	13	48381258	285896	270133	rs886043247	NC_000013.11:48381257:C:T
NM_000321.2(RB1):c.1696-1G>A	RB1		not provided	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000194811	13	49027128	13	48452992	194811	191974	rs794727199	NC_000013.11:48452991:G:A
NM_000321.2(RB1):c.1585dup (p.Tyr529fs)	RB1		not provided	Pathogenic(Last reviewed: Aug 30, 2013)	criteria provided, single submitter	VCV000092840	13	48955464 - 48955465	13	48381328 - 48381329	92840	98747	rs398123332	NC_000013.11:48381328:TTTTT:TTTTTT
NM_000321.2(RB1):c.2107-2A>G	RB1		Bladder cancer, somatic	Pathogenic(Last reviewed: Jan 29, 2018)	no assertion criteria provided	VCV000013077	13	49037865	13	48463729	13077	28116		NC_000013.11:48463728:A:G
NM_014363.6(SACS):c.9249del (p.Leu3083_Ile3084insTer)	SACS		Spastic paraplegia	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000841237	13	23908766	13	23334627	841237	840594		NC_000013.11:23334626:AA:A
NM_014363.4(SACS):c.7276C>T	SACS	R2426*, R2279*	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189175	13	23910739	13	23336600	189175	186869	rs786204750	NC_000013.11:23336599:G:A
NM_000321.2(RB1):c.277C>T (p.Gln93Ter)	RB1	Q93*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 9, 2015)	criteria provided, single submitter	VCV000428746	13	48916747	13	48342611	428746	420510	rs1131690915	NC_000013.11:48342610:C:T
NM_000321.2(RB1):c.1960+5G>C	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 9, 2015)	criteria provided, single submitter	VCV000428745	13	49030490	13	48456354	428745	420564	rs587778871	NC_000013.11:48456353:G:C
NM_000321.2(RB1):c.2513C>A (p.Ser838Ter)	RB1	S838*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000428735	13	49047519	13	48473383	428735	420583	rs1131690908	NC_000013.11:48473382:C:A
NM_000321.2(RB1):c.2501C>A (p.Ser834Ter)	RB1	S834*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000428733	13	49047507	13	48473371	428733	420582	rs1131690906	NC_000013.11:48473370:C:A
NM_000321.2(RB1):c.2439T>G (p.Tyr813Ter)	RB1	Y813*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000428718	13	49039454	13	48465318	428718	420579	rs774744607	NC_000013.11:48465317:T:G
NM_000321.2(RB1):c.1128-2A>G	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 18, 2015)	criteria provided, single submitter	VCV000428715	13	48947539	13	48373403	428715	420540	rs1131690892	NC_000013.11:48373402:A:G
NM_000321.2(RB1):c.1251_1252del (p.Arg418fs)	RB1	R418fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	VCV000428712	13	48951087 - 48951088	13	48376951 - 48376952	428712	420544	rs1131690889	NC_000013.11:48376950:AAAA:AA
NM_000321.2(RB1):c.2007_2010TCTG[1] (p.Glu672fs)	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000428707	13	49033870 - 49033873	13	48459734 - 48459737	428707	420565	rs1131690885	NC_000013.11:48459733:TCTGTCTG:TCTG
NM_000321.2(RB1):c.1372G>T (p.Glu458Ter)	RB1	E458*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 14, 2015)	criteria provided, single submitter	VCV000428706	13	48953769	13	48379633	428706	420548	rs1131690884	NC_000013.11:48379632:G:T
NM_000321.2(RB1):c.2439T>A (p.Tyr813Ter)	RB1	Y813*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000428692	13	49039454	13	48465318	428692	420578	rs774744607	NC_000013.11:48465317:T:A
NM_000321.2(RB1):c.2413_2420del (p.Tyr805fs)	RB1	Y805fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 17, 2014)	criteria provided, single submitter	VCV000428686	13	49039426 - 49039433	13	48465290 - 48465297	428686	420577	rs1131690868	NC_000013.11:48465289:TCTATATTTC:TC
NM_000321.2(RB1):c.709G>T (p.Glu237Ter)	RB1	E237*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 13, 2016)	criteria provided, single submitter	VCV000428731	13	48934254	13	48360118	428731	420526	rs1131690904	NC_000013.11:48360117:G:T
NM_000321.2(RB1):c.380+1G>A	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	VCV000428727	13	48916851	13	48342715	428727	420514	rs1131690902	NC_000013.11:48342714:G:A
NM_000321.2(RB1):c.1389+5G>A	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000428677	13	48953791	13	48379655	428677	420550	rs1131690859	NC_000013.11:48379654:G:A
NM_000321.2(RB1):c.2489+1G>A	RB1		not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428742	13	49039505	13	48465369	428742	420581	rs764754259	NC_000013.11:48465368:G:A
NM_000321.2(RB1):c.264+1G>A	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000428734	13	48881543	13	48307407	428734	420508	rs1131690907	NC_000013.11:48307406:G:A
NM_000321.2(RB1):c.1147C>T (p.Gln383Ter)	RB1	Q383*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000428664	13	48947560	13	48373424	428664	420541	rs1131690846	NC_000013.11:48373423:C:T
NM_014363.6(SACS):c.5707_5708del (p.Asp1903fs)	SACS	D1903fs, D1756fs	Spastic paraplegia	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000646225	13	23912307 - 23912308	13	23338168 - 23338169	646225	641609		NC_000013.11:23338167:TCT:T
NM_014363.6(SACS):c.2881C>T (p.Arg961Ter)	SACS	R814*, R961*	Spastic paraplegia	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000640122	13	23915134	13	23340995	640122	641614		NC_000013.11:23340994:G:A
NM_014363.6(SACS):c.6355C>T (p.Arg2119Ter)	SACS	R2119*, R1972*		Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556270	13	23911660	13	23337521	556270	547227	rs766711286	NC_000013.11:23337520:G:A
NM_014363.6(SACS):c.10136T>G (p.Leu3379Ter)	SACS	L3379*, L3232*	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371410	13	23907879	13	23333740	371410	358151	rs1057517250	NC_000013.11:23333739:A:C
NM_014363.6(SACS):c.9305T>A (p.Leu3102Ter)	SACS	L3102*, L2955*	|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280809	13	23908710	13	23334571	280809	264664	rs886041949	NC_000013.11:23334570:A:T
NM_014363.6(SACS):c.2439_2440del (p.Val815fs)	SACS	V815fs, V668fs	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188856	13	23915575 - 23915576	13	23341436 - 23341437	188856	186871	rs775059063	NC_000013.11:23341435:AT:
NM_000321.2(RB1):c.297G>A (p.Trp99Ter)	RB1	W99*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000196251	13	48916767	13	48342631	196251	193412	rs794727481	NC_000013.11:48342630:G:A
NM_000080.3(CHRNE):c.1327delG (p.Glu443LysfsTer64)	CHRNE		Myasthenic syndrome, congenital, 4a, slow-channel|not provided|Congenital myasthenic syndrome 4C|Congenital myasthenic syndrome	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000243031	17	4802186	17	4898891	243031	244116	rs763258280	NC_000017.11:4898890:CC:C
NM_000053.4(ATP7B):c.3694A>C (p.Thr1232Pro)	ATP7B	T1232P, T1148P, T1025P, T1121P, T1154P	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555144	13	52513192	13	51939056	555144	547000	rs568009639	NC_000013.11:51939055:T:G
NM_000053.4(ATP7B):c.1745_1746del (p.Ile582fs)	ATP7B	I471fs, I582fs	Wilson disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189112	13	52539131 - 52539132	13	51964995 - 51964996	189112	186905	rs753962912	NC_000013.11:51964994:TAT:T
NM_000053.4(ATP7B):c.3244-2A>G	ATP7B		Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: May 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188953	13	52516692	13	51942556	188953	186887	rs786204584	NC_000013.11:51942555:T:C
NM_000321.2(RB1):c.2489+1G>C	RB1		not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000287433	13	49039505	13	48465369	287433	271670	rs764754259	NC_000013.11:48465368:G:C
NM_000321.2(RB1):c.2242G>T (p.Glu748Ter)	RB1	E748*	Neoplasm|Small cell lung cancer	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000013078	13	49039164	13	48465028	13078	28117	rs121913297	NC_000013.11:48465027:G:T
NM_014363.6(SACS):c.9508C>T (p.Arg3170Ter)	SACS	R3170*, R3023*	|not provided	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280094	13	23908507	13	23334368	280094	264659	rs202199411	NC_000013.11:23334367:G:A
NM_000086.2(CLN3):c.597C>A (p.Tyr199Ter)	CLN3	Y199*, Y145*, Y121*, Y99*, Y175*	Neuronal ceroid lipofuscinosis|not provided|Juvenile neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis, neuronal, 3, protracted	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003557	16	28497748	16	28486427	3557	18596	rs267606737	NC_000016.10:28486426:G:T
NM_001329943.3(KIAA0586):c.392del (p.Arg131fs)	KIAA0586	R131fs, R143fs, R116fs, R46fs	Rod-cone dystrophy|Intellectual disability|Congenital cerebellar hypoplasia|Joubert syndrome 23|Short-rib thoracic dysplasia 14 with polydactyly|Joubert syndrome 23|not provided|Retinal dystrophy|Joubert syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204593	14	58899157	14	58432439	204593	200983	rs534542684	NC_000014.9:58432438:G:
NM_001134407.3(GRIN2A):c.1007+1G>A	GRIN2A		Rolandic epilepsy|not provided|Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000088727	16	10031815	16	9937958	88727	94304	rs397518465	NC_000016.10:9937957:C:T
NM_144997.7(FLCN):c.1062+2T>G	FLCN		Multiple fibrofolliculomas|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265154	17	17122331	17	17219017	265154	260154	rs886039370	NC_000017.11:17219016:A:C
NM_144997.7(FLCN):c.1318_1334dup (p.Leu449fs)	FLCN		Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas|not provided	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000253249	17	17118596 - 17118597	17	17215282 - 17215283	253249	247655	rs879255677	NC_000017.11:17215282:GCGGCTGCGTGGACCTC:GCGGCTGCGTGGACCTCGCGGCTGCGTGGACCTC
NM_144997.7(FLCN):c.1252del (p.Leu418fs)	FLCN	L418fs, L436fs	Multiple fibrofolliculomas|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220767	17	17119742	17	17216428	220767	222560	rs864622651	NC_000017.11:17216427:GG:G
NM_144997.7(FLCN):c.1522_1524del (p.Lys508del)	FLCN	K508del, K526del	not provided|Multiple fibrofolliculomas	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096477	17	17118313 - 17118315	17	17214999 - 17215001	96477	102371	rs398124529	NC_000017.11:17214998:CTT:
NM_144997.7(FLCN):c.235_238del (p.Ser79fs)	FLCN	S79fs	Hereditary cancer-predisposing syndrome|not provided|Pneumothorax, primary spontaneous|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003371	17	17131214 - 17131217	17	17227900 - 17227903	3371	18410	rs750146811	NC_000017.11:17227899:CCGAC:C
NM_025137.4(SPG11):c.3075dup (p.Glu1026fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001117	15	44905697 - 44905698	15	44613499 - 44613500	1117	16156	rs312262752	NC_000015.10:44613499:TTTTTTTT:TTTTTTTTT
NM_201525.4(ADGRG1):c.286C>T (p.Arg96Ter)	ADGRG1	R96*, R101*, R44*	Inborn genetic diseases|Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Nov 17, 2015)	criteria provided, multiple submitters, no conflicts	VCV000158629	16	57685333	16	57651421	158629	169276	rs146278035	NC_000016.10:57651420:C:T
NM_000321.2(RB1):c.2447C>A (p.Ser816Ter)	RB1	S816*	Retinoblastoma	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802990	13	49039462	13	48465326	802990	791373		NC_000013.11:48465325:C:A
NM_000321.2(RB1):c.1216-2A>G	RB1		Retinoblastoma	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802970	13	48951052	13	48376916	802970	791353		NC_000013.11:48376915:A:G
NM_000321.2(RB1):c.649del (p.Gln217fs)	RB1	Q217fs	Retinoblastoma	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802967	13	48934194	13	48360058	802967	791350		NC_000013.11:48360057:C:
NM_000321.2(RB1):c.606del (p.Glu204fs)	RB1	E204fs	Retinoblastoma	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802965	13	48923156	13	48349020	802965	791348		NC_000013.11:48349019:AAA:AA
NM_000321.2(RB1):c.2520+3_2520+6del	RB1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000428676	13	49047527 - 49047530	13	48473391 - 48473394	428676	420586	rs1131690858	NC_000013.11:48473390:GTGAGT:GT
NM_000321.2(RB1):c.1907del (p.Phe636fs)	RB1	F636fs	Retinoblastoma	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000139570	13	49030431	13	48456295	139570	143200	rs587781257	NC_000013.11:48456294:TT:T
NM_000321.2(RB1):c.227_228dup (p.Thr77Ter)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126845	13	48881504 - 48881505	13	48307368 - 48307369	126845	132355	rs587778824	NC_000013.11:48307368:TA:TATA
NM_000321.2(RB1):c.217del (p.Arg73fs)	RB1	R73fs	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126843	13	48881495	13	48307359	126843	132353	rs587778840	NC_000013.11:48307358:A:
NM_000321.2(RB1):c.1695+1G>A	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126842	13	48955580	13	48381444	126842	132352	rs587778857	NC_000013.11:48381443:G:A
NM_000321.2(RB1):c.1688G>A (p.Trp563Ter)	RB1	W563*	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126841	13	48955572	13	48381436	126841	132351	rs587778863	NC_000013.11:48381435:G:A
NM_000321.2(RB1):c.1456_1457del (p.Leu486fs)	RB1	L486fs	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126838	13	48954334 - 48954335	13	48380198 - 48380199	126838	132348	rs587778832	NC_000013.11:48380197:TTT:T
NM_000321.2(RB1):c.1346G>T (p.Gly449Val)	RB1	G449V	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126836	13	48953743	13	48379607	126836	132346	rs587778847	NC_000013.11:48379606:G:T
NM_000321.2(RB1):c.1332+1G>T	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126835	13	48951171	13	48377035	126835	132345	rs587778846	NC_000013.11:48377034:G:T
NM_000321.2(RB1):c.1216-1G>A	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126833	13	48951053	13	48376917	126833	132343	rs587778831	NC_000013.11:48376916:G:A
NM_000321.2(RB1):c.1166T>A (p.Leu389Ter)	RB1	L389*	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126831	13	48947579	13	48373443	126831	132341	rs587778845	NC_000013.11:48373442:T:A
NM_000321.2(RB1):c.1147dup (p.Gln383fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126830	13	48947558 - 48947559	13	48373422 - 48373423	126830	132340	rs587778830	NC_000013.11:48373422:CC:CCC
NM_000321.2(RB1):c.1021A>T (p.Lys341Ter)	RB1	K341*	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126825	13	48941711	13	48367575	126825	132335	rs587778855	NC_000013.11:48367574:A:T
NM_000321.2(RB1):c.937G>T (p.Glu313Ter)	RB1	E313*	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126823	13	48939105	13	48364969	126823	132333	rs587778843	NC_000013.11:48364968:G:T
NM_000321.2(RB1):c.884dup (p.Asn295fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126822	13	48939047 - 48939048	13	48364911 - 48364912	126822	132332	rs587778828	NC_000013.11:48364911:AAAAA:AAAAAA
NM_000321.2(RB1):c.795del (p.Lys265fs)	RB1	K265fs	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126821	13	48937024	13	48362888	126821	132331	rs587778827	NC_000013.11:48362887:AAAA:AAA
NM_000321.2(RB1):c.113_115delinsCT (p.Gly38fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126819	13	48878161 - 48878163	13	48304025 - 48304027	126819	132329	rs886037649	NC_000013.11:48304024:GCC:CT
NM_000321.2(RB1):c.103C>T (p.Gln35Ter)	RB1	Q35*	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126818	13	48878151	13	48304015	126818	132328	rs587778869	NC_000013.11:48304014:C:T
NG_009009.1:g.5168-?_5303+?(2)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126815					126815	132325		
NM_000321.2(RB1):c.508G>T (p.Glu170Ter)	RB1	E170*	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126814	13	48921968	13	48347832	126814	132324	rs587778826	NC_000013.11:48347831:G:T
NM_000321.2(RB1):c.463dup (p.Tyr155fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126813	13	48919297 - 48919298	13	48345161 - 48345162	126813	132323	rs587778854	NC_000013.11:48345161:T:TT
NM_000321.2(RB1):c.446C>G (p.Ser149Ter)	RB1	S149*	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126812	13	48919281	13	48345145	126812	132322	rs587778870	NC_000013.11:48345144:C:G
NM_000321.2(RB1):c.438_441del (p.Asn146fs)	RB1	N146fs	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126811	13	48919273 - 48919276	13	48345137 - 48345140	126811	132321	rs587778841	NC_000013.11:48345136:TGCT:
NM_000321.2(RB1):c.2663+2T>C	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126807	13	49050981	13	48476845	126807	132317	rs587778839	NC_000013.11:48476844:T:C
NM_000321.2(RB1):c.2525dup (p.Ser842_Glu843insTer)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126806	13	49050840 - 49050841	13	48476704 - 48476705	126806	132316	rs587778851	NC_000013.11:48476704:C:CC
NM_000321.2(RB1):c.2490-1G>A	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126804	13	49047495	13	48473359	126804	132314	rs587778838	NC_000013.11:48473358:G:A
NM_000321.2(RB1):c.2453del (p.Gly818fs)	RB1	G818fs	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126803	13	49039467	13	48465331	126803	132313	rs587778837	NC_000013.11:48465330:GG:G
NG_009009.1:g.166501C>G	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126802					126802	132312		
NM_000321.2(RB1):c.2247T>A (p.Tyr749Ter)	RB1	Y749*	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126801	13	49039169	13	48465033	126801	132311	rs587778861	NC_000013.11:48465032:T:A
NM_000321.2(RB1):c.2228_2231dup (p.Lys745fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126800	13	49039148 - 49039149	13	48465012 - 48465013	126800	132310	rs587778836	NC_000013.11:48465012:TTGAT:TTGATTGAT
NG_009009.1:g.1662319T>A	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126799					126799	132309		
NM_000321.2(RB1):c.2209G>T (p.Glu737Ter)	RB1	E737*	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126798	13	49037969	13	48463833	126798	132308	rs587778868	NC_000013.11:48463832:G:T
NM_000321.2(RB1):c.2197C>T (p.His733Tyr)	RB1	H733Y	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126797	13	49037957	13	48463821	126797	132307	rs587778835	NC_000013.11:48463820:C:T
NM_000321.2(RB1):c.2107-1G>C	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126795	13	49037866	13	48463730	126795	132305	rs587778860	NC_000013.11:48463729:G:C
NM_000321.2(RB1):c.2101G>A (p.Asp701Asn)	RB1	D701N	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126794	13	49033964	13	48459828	126794	132304	rs587778859	NC_000013.11:48459827:G:A
NM_000321.2(RB1):c.1961-2A>T	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126792	13	49033822	13	48459686	126792	132302	rs587778867	NC_000013.11:48459685:A:T
NM_000321.2(RB1):c.1927A>G (p.Lys643Glu)	RB1	K643E	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126790	13	49030452	13	48456316	126790	132300	rs587778866	NC_000013.11:48456315:A:G
NM_000321.2(RB1):c.1925T>A (p.Leu642Ter)	RB1	L642*	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126789	13	49030450	13	48456314	126789	132299	rs587778865	NC_000013.11:48456313:T:A
NM_000321.2(RB1):c.1909C>T (p.Gln637Ter)	RB1	Q637*	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126788	13	49030434	13	48456298	126788	132298	rs587778833	NC_000013.11:48456297:C:T
NG_009009.1:g.154289dupA	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126787					126787	132297	rs1566233014	
NM_000321.2(RB1):c.1738G>T (p.Glu580Ter)	RB1	E580*	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126786	13	49027171	13	48453035	126786	132296	rs587778858	NC_000013.11:48453034:G:T
NM_000321.2(RB1):c.1723C>T (p.Gln575Ter)	RB1	Q575*	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126784	13	49027156	13	48453020	126784	132294	rs587778864	NC_000013.11:48453019:C:T
NM_031885.4(BBS2):c.311A>C (p.Asp104Ala)	BBS2	D104A	Retinitis pigmentosa 74|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 2|Retinitis pigmentosa 74|Bardet-biedl syndrome 1/2, digenic|Bardet-Biedl syndrome|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004577	16	56548399	16	56514487	4577	19616	rs121908179	NC_000016.10:56514486:T:G
NM_002693.3(POLG):c.3156_3157CA[1] (p.Thr1053fs)	POLG		not provided	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000817632	15	89862276 - 89862277	15	89319045 - 89319046	817632	805850		NC_000015.10:89319044:TGTG:TG
NM_002693.2(POLG):c.160C>T (p.Gln54Ter)	POLG	Q54*	not provided	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000598699	15	89876826	15	89333595	598699	589760	rs774768199	NC_000015.10:89333594:G:A
NM_002693.2(POLG):c.1073del (p.Glu358fs)	POLG	E358fs	not provided	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000596511	15	89872013	15	89328782	596511	587572	rs763418954	NC_000015.10:89328781:T:
NM_002693.2(POLG):c.1024-1G>C	POLG		not provided	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000595458	15	89872063	15	89328832	595458	586520	rs1567192203	NC_000015.10:89328831:C:G
NM_002693.2(POLG):c.3358_3361dup (p.Glu1121delinsValTer)	POLG		not provided	Pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	VCV000419336	15	89861892 - 89861893	15	89318661 - 89318662	419336	409369	rs1064793800	NC_000015.10:89318661:CAAACA:CAAACAAACA
NM_002693.2(POLG):c.2982-1G>C	POLG		not provided	Pathogenic(Last reviewed: Apr 15, 2015)	criteria provided, single submitter	VCV000418876	15	89862582	15	89319351	418876	409373	rs1064793493	NC_000015.10:89319350:C:G
NM_002693.2(POLG):c.694C>T (p.Arg232Cys)	POLG	R232C	not provided	Pathogenic(Last reviewed: May 18, 2015)	criteria provided, single submitter	VCV000379796	15	89873473	15	89330242	379796	376803	rs770115219	NC_000015.10:89330241:G:A
NM_002693.2(POLG):c.823C>T (p.Arg275Ter)	POLG	R275*	not provided	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000372472	15	89873344	15	89330113	372472	360124	rs1057517803	NC_000015.10:89330112:G:A
NM_002693.2(POLG):c.3609_3612dup (p.Gly1205fs)	POLG		not provided	Pathogenic(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	VCV000285869	15	89860637 - 89860638	15	89317406 - 89317407	285869	270106	rs886043241	NC_000015.10:89317406:AGTT:AGTTAGTT
NM_002693.2(POLG):c.2800_2801del (p.Lys934fs)	POLG	K934fs	not provided	Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	VCV000206607	15	89864177 - 89864178	15	89320946 - 89320947	206607	202953	rs796052907	NC_000015.10:89320945:TT:
NM_002693.2(POLG):c.1808T>C (p.Met603Thr)	POLG	M603T	not provided	Pathogenic(Last reviewed: Jul 26, 2013)	criteria provided, single submitter	VCV000206602	15	89868822	15	89325591	206602	203000	rs367610201	NC_000015.10:89325590:A:G
NM_002693.2(POLG):c.1716G>A (p.Trp572Ter)	POLG	W572*	not provided	Pathogenic(Last reviewed: Apr 16, 2014)	criteria provided, single submitter	VCV000206600	15	89868914	15	89325683	206600	203002	rs767709505	NC_000015.10:89325682:C:T
NM_002693.2(POLG):c.3313G>C (p.Ala1105Pro)	POLG	A1105P	not provided	Pathogenic(Last reviewed: Apr 1, 2013)	criteria provided, single submitter	VCV000206560	15	89861941	15	89318710	206560	202923	rs753410045	NC_000015.10:89318709:C:G
NM_002693.2(POLG):c.3287G>T (p.Arg1096Leu)	POLG	R1096L	not provided	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000206559	15	89861967	15	89318736	206559	202924	rs368435864	NC_000015.10:89318735:C:A
NM_002693.2(POLG):c.2840A>G (p.Lys947Arg)	POLG	K947R	not provided	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000206536	15	89864138	15	89320907	206536	202950	rs796052891	NC_000015.10:89320906:T:C
NM_002693.2(POLG):c.2515del (p.Ala839fs)	POLG	A839fs	Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000807660	15	89865050	15	89321819	807660	798691		NC_000015.10:89321818:CCCC:CCC
NM_002693.2(POLG):c.3570_3573GAAG[1] (p.Lys1191_Glu1192insTer)	POLG		Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000807659	15	89860673 - 89860676	15	89317442 - 89317445	807659	798690		NC_000015.10:89317441:CTTCCTTCCT:CTTCCT
NM_002693.2(POLG):c.1140dup (p.Thr381fs)	POLG		mitochondrial hepatopathy	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000694428	15	89871945 - 89871946	15	89328714 - 89328715	694428	682361		NC_000015.10:89328714:G:GG
NM_002693.2(POLG):c.3630C>A (p.Tyr1210Ter)	POLG	Y1210*	Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000694430	15	89860620	15	89317389	694430	682355		NC_000015.10:89317388:G:T
NM_002693.2(POLG):c.409C>T (p.Gln137Ter)	POLG	Q137*	not provided|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372622	15	89876577	15	89333346	372622	360223	rs1057517891	NC_000015.10:89333345:G:A
NM_002693.2(POLG):c.3014_3057del (p.Val1005fs)	POLG	V1005fs	not provided|Seizures	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000279948	15	89862506 - 89862549	15	89319275 - 89319318	279948	264576	rs886041276	NC_000015.10:89319274:CCAGCCACCCTCAGTCCTGTCCACTGGGAGGTTCAACTCCCTCACCAGCCAC:CCAGCCAC
NM_002693.2(POLG):c.2591A>G (p.Asn864Ser)	POLG	N864S	Mitochondrial DNA depletion syndrome 4B, MNGIE type	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000013506	15	89864974	15	89321743	13506	28545	rs121918050	NC_000015.10:89321742:T:C
NM_002693.2(POLG):c.1879C>T (p.Arg627Trp)	POLG	R627W	Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000013499	15	89868751	15	89325520	13499	28538	rs121918046	NC_000015.10:89325519:G:A
NM_002693.2(POLG):c.8G>C (p.Arg3Pro)	POLG	R3P	Cerebellar ataxia infantile with progressive external ophthalmoplegia	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000013498	15	89876978	15	89333747	13498	28537	rs121918045	NC_000015.10:89333746:C:G
NM_002693.3(POLG):c.2884dup (p.Ala962fs)	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000845148	15	89864093 - 89864094	15	89320862 - 89320863	845148	842779		NC_000015.10:89320862:C:CC
NM_002693.2(POLG):c.75G>A (p.Trp25Ter)	POLG	W25*	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000694427	15	89876911	15	89333680	694427	682363		NC_000015.10:89333679:C:T
NM_002693.2(POLG):c.951_961dup (p.Lys321fs)	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000694426	15	89872235 - 89872236	15	89329004 - 89329005	694426	682362		NC_000015.10:89329004:TGTGTTTGCCCTG:TGTGTTTGCCCTGTGTTTGCCCTG
NM_002693.2(POLG):c.660G>A (p.Trp220Ter)	POLG	W220*	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000648373	15	89873507	15	89330276	648373	643617		NC_000015.10:89330275:C:T
NM_001126131.2(POLG):c.3255dup (p.Ser1086fs)	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000640935	15	89862179 - 89862180	15	89318948 - 89318949	640935	643599		NC_000015.10:89318948:GGG:GGGG
NM_002693.2(POLG):c.1562del (p.Pro521fs)	POLG	P521fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619448	15	89870166	15	89326935	619448	610774	rs1567191094	NC_000015.10:89326934:GGGG:GGG
NM_002693.2(POLG):c.2851T>A (p.Tyr951Asn)	POLG	Y951N	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619425	15	89864127	15	89320896	619425	610734	rs1567186591	NC_000015.10:89320895:A:T
NM_002693.2(POLG):c.2669A>C (p.Asp890Ala)	POLG	D890A	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619422	15	89864421	15	89321190	619422	610742	rs1567186779	NC_000015.10:89321189:T:G
NM_002693.2(POLG):c.2564T>C (p.Val855Ala)	POLG	V855A	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619420	15	89865001	15	89321770	619420	610748	rs963553787	NC_000015.10:89321769:A:G
NM_002693.2(POLG):c.1289T>C (p.Met430Thr)	POLG	M430T	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619407	15	89870542	15	89327311	619407	610780	rs1567191474	NC_000015.10:89327310:A:G
NM_002693.2(POLG):c.698dup (p.Tyr233Ter)	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619403	15	89873468 - 89873469	15	89330237 - 89330238	619403	610791	rs1567192884	NC_000015.10:89330237:T:TT
NM_001126131.2(POLG):c.3490_3493dup (p.Ala1165fs)	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619402	15	89860756 - 89860757	15	89317525 - 89317526	619402	610707	rs778115255	NC_000015.10:89317525:CAAACA:CAAACAAACA
NM_002693.2(POLG):c.2543_2544dup (p.Thr849fs)	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619401	15	89865020 - 89865021	15	89321789 - 89321790	619401	610752	rs1567187103	NC_000015.10:89321789:GC:GCGC
NM_002693.2(POLG):c.2480+1G>A	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619400	15	89865192	15	89321961	619400	610841	rs1567187326	NC_000015.10:89321960:C:T
NM_002693.2(POLG):c.2426+1G>C	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619399	15	89865972	15	89322741	619399	610847	rs1567187745	NC_000015.10:89322740:C:G
NM_002693.2(POLG):c.2143C>T (p.Gln715Ter)	POLG	Q715*	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619398	15	89867060	15	89323829	619398	610760	rs1254855971	NC_000015.10:89323828:G:A
NM_002693.2(POLG):c.2070+1G>A	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619397	15	89867337	15	89324106	619397	610859	rs1567188588	NC_000015.10:89324105:C:T
NM_002693.2(POLG):c.2038del (p.Leu680fs)	POLG	L680fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619396	15	89867370	15	89324139	619396	610764	rs1567188632	NC_000015.10:89324138:GG:G
NM_002693.2(POLG):c.3572A>G (p.Lys1191Arg)	POLG	K1191R	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619340	15	89860678	15	89317447	619340	610704	rs1567183988	NC_000015.10:89317446:T:C
NM_002693.2(POLG):c.2662G>A (p.Gly888Ser)	POLG	G888S	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619332	15	89864428	15	89321197	619332	610743	rs1567186787	NC_000015.10:89321196:C:T
NM_002693.2(POLG):c.3447dup (p.Ala1150fs)	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619312	15	89861806 - 89861807	15	89318575 - 89318576	619312	610710	rs1567185026	NC_000015.10:89318575:A:AA
NM_001126131.2(POLG):c.3430_3433dup (p.Asp1145fs)	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619311	15	89861820 - 89861821	15	89318589 - 89318590	619311	610711	rs1567185048	NC_000015.10:89318589:CCTCC:CCTCCCTCC
NM_002693.2(POLG):c.3241C>T (p.Arg1081Ter)	POLG	R1081*	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619310	15	89862194	15	89318963	619310	610719	rs767708989	NC_000015.10:89318962:G:A
NM_002693.2(POLG):c.3149del (p.Lys1050fs)	POLG	K1050fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619309	15	89862286	15	89319055	619309	610724	rs1567185603	NC_000015.10:89319054:TT:T
NM_002693.2(POLG):c.3104+1G>A	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619308	15	89862458	15	89319227	619308	610829	rs138917386	NC_000015.10:89319226:C:T
NM_002693.2(POLG):c.3067C>T (p.Gln1023Ter)	POLG	Q1023*	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619307	15	89862496	15	89319265	619307	610726	rs1567185770	NC_000015.10:89319264:G:A
NM_001126131.2(POLG):c.2674dup (p.Asp892fs)	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619306	15	89864415 - 89864416	15	89321184 - 89321185	619306	610741	rs1283198587	NC_000015.10:89321184:CC:CCC
NM_002693.2(POLG):c.1345C>T (p.Gln449Ter)	POLG	Q449*	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619305	15	89870486	15	89327255	619305	610778	rs1567191417	NC_000015.10:89327254:G:A
NM_002693.2(POLG):c.2217_2230dup (p.Ile744fs)	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000577990	15	89866669 - 89866670	15	89323438 - 89323439	577990	569207	rs1282521429	NC_000015.10:89323438:TGTCCACGTCGTTGT:TGTCCACGTCGTTGTGTCCACGTCGTTGT
NM_002693.2(POLG):c.646del (p.Ser216fs)	POLG	S216fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000567927	15	89876340	15	89333109	567927	573580	rs1567193844	NC_000015.10:89333108:A:
NM_002693.2(POLG):c.3523C>T (p.Gln1175Ter)	POLG	Q1175*	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000566733	15	89860727	15	89317496	566733	569643	rs1567184117	NC_000015.10:89317495:G:A
NM_002693.2(POLG):c.3155dup (p.Thr1053fs)	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Mar 4, 2017)	criteria provided, single submitter	VCV000458711	15	89862279 - 89862280	15	89319048 - 89319049	458711	465354	rs1447799185	NC_000015.10:89319048:CCCCCC:CCCCCCC
NM_001126131.2(POLG):c.3087_3088GA[2] (p.Glu1031fs)	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, single submitter	VCV000458710	15	89862471 - 89862472	15	89319240 - 89319241	458710	465356	rs1555452607	NC_000015.10:89319239:TCTCTCT:TCTCT
NM_002693.2(POLG):c.3630dup (p.Gly1211fs)	POLG		Mitochondrial diseases	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021315	15	89860619 - 89860620	15	89317388 - 89317389	21315	34167	rs113994101	NC_000015.10:89317388:G:GG
NM_002693.2(POLG):c.3488T>G (p.Met1163Arg)	POLG	M1163R	Mitochondrial diseases	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021314	15	89860762	15	89317531	21314	34166	rs113994100	NC_000015.10:89317530:A:C
NM_002693.2(POLG):c.1532G>A (p.Ser511Asn)	POLG	S511N	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000013514	15	89870196	15	89326965	13514	28553	rs121918055	NC_000015.10:89326964:C:T
NM_002693.2(POLG):c.3057G>A (p.Trp1019Ter)	POLG	W1020*, W1019*	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Nov 8, 2005)	no assertion criteria provided	VCV000013511	15	89862506	15	89319275	13511	28550	rs1567185775	NC_000015.10:89319274:C:T
NM_002693.2(POLG):c.2869G>T (p.Ala957Ser)	POLG	A957S	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000013508	15	89864109	15	89320878	13508	28547	rs121918051	NC_000015.10:89320877:C:A
NM_002693.2(POLG):c.2617G>T (p.Glu873Ter)	POLG	E873*	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	VCV000013504	15	89864473	15	89321242	13504	28543	rs121918047	NC_000015.10:89321241:C:A
NM_002693.2(POLG):c.2157+5_2157+6delinsAG	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619500	15	89867040 - 89867041	15	89323809 - 89323810	619500	610897		NC_000015.10:89323808:GC:CT
NM_002693.2(POLG):c.1120C>T (p.Arg374Ter)	POLG	R374*	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619394	15	89871966	15	89328735	619394	610782	rs960142425	NC_000015.10:89328734:G:A
NM_002693.2(POLG):c.705G>A (p.Trp235Ter)	POLG	W235*	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619303	15	89873462	15	89330231	619303	610790	rs1567192879	NC_000015.10:89330230:C:T
NM_014363.6(SACS):c.2903_2906del (p.Asp968fs)	SACS	D821fs, D968fs	|Spastic paraplegia	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000549687	13	23915109 - 23915112	13	23340970 - 23340973	549687	540460	rs1259615333	NC_000013.11:23340969:CTGTCT:CT
NM_014363.6(SACS):c.5151dup (p.Ser1718fs)	SACS		not provided|Spastic paraplegia	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448205	13	23912863 - 23912864	13	23338724 - 23338725	448205	441616	rs754439135	NC_000013.11:23338724:TTTTTTTTT:TTTTTTTTTT
NM_014363.6(SACS):c.7273C>T (p.Arg2425Ter)	SACS	R2425*, R2278*	|Spastic paraplegia|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370415	13	23910742	13	23336603	370415	358168	rs145766983	NC_000013.11:23336602:G:A
NM_014363.6(SACS):c.11374C>T (p.Arg3792Ter)	SACS	R3792*, R3645*		Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000370283	13	23906641	13	23332502	370283	358141	rs565203731	NC_000013.11:23332501:G:A
NM_014363.6(SACS):c.8542_8543del (p.Phe2848fs)	SACS	F2701fs, F2848fs	Autosomal recessive spastic ataxia|	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228394	13	23909472 - 23909473	13	23335333 - 23335334	228394	230438	rs876657721	NC_000013.11:23335332:AAAA:AA
NM_014363.6(SACS):c.7504C>T (p.Arg2502Ter)	SACS	R2502*, R2355*		Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	VCV000005513	13	23910511	13	23336372	5513	20552	rs281865118	NC_000013.11:23336371:G:A
NM_002693.2(POLG):c.2563G>T (p.Val855Leu)	POLG	V855L	not provided|Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000619419	15	89865002	15	89321771	619419	610749	rs771254207	NC_000015.10:89321770:C:A
NM_002693.2(POLG):c.3483-4_3497del	POLG		Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000619313	15	89860753 - 89860771	15	89317522 - 89317540	619313	610813	rs756325504	NC_000015.10:89317521:TAGGCAAACATGCACCTGA:
NM_002693.2(POLG):c.2827C>T (p.Arg943Cys)	POLG	R943C	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619301	15	89864151	15	89320920	619301	610737	rs1567186614	NC_000015.10:89320919:G:A
NM_002693.2(POLG):c.3483-2A>G	POLG		not provided|Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372866	15	89860769	15	89317538	372866	360211	rs1057518035	NC_000015.10:89317537:T:C
NM_002693.2(POLG):c.202C>T (p.Gln68Ter)	POLG	Q68*	Progressive sclerosing poliodystrophy|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279988	15	89876784	15	89333553	279988	264592	rs202039305	NC_000015.10:89333552:G:A
NM_001126131.2(POLG):c.2395del (p.Ser799fs)	POLG	S799fs	not provided|Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206632	15	89866004	15	89322773	206632	202969	rs796052919	NC_000015.10:89322772:AAA:AA
NM_002693.2(POLG):c.2558G>A (p.Arg853Gln)	POLG	R853Q	Progressive sclerosing poliodystrophy|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206529	15	89865007	15	89321776	206529	202959	rs796052888	NC_000015.10:89321775:C:T
NM_002693.2(POLG):c.695G>A (p.Arg232His)	POLG	R232H	not provided|Mitochondrial diseases	Pathogenic(Last reviewed: Nov 17, 2016)	criteria provided, single submitter	VCV000021319	15	89873472	15	89330241	21319	34171	rs113994093	NC_000015.10:89330240:C:T
NM_001127701.1(SERPINA1):c.187C>T (p.Arg63Cys)	SERPINA1	R39C, R63C	Alpha-1-antitrypsin deficiency|PI I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017974	14	94849388	14	94383051	17974	33013	rs28931570	NC_000014.9:94383050:G:A
NM_000321.3(RB1):c.1567_1568dup (p.Leu523fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000860929	13	48955449 - 48955450	13	48381313 - 48381314	860929	840938		NC_000013.11:48381313:TTT:TTTTT
NM_000321.3(RB1):c.1053del (p.Phe351fs)	RB1	F351fs	Retinoblastoma	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000859870	13	48942663	13	48368527	859870	840923		NC_000013.11:48368526:TTTT:TTT
NM_000321.3(RB1):c.2435del (p.Pro812fs)	RB1	P812fs	Retinoblastoma	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000858931	13	49039449	13	48465313	858931	840955		NC_000013.11:48465312:CC:C
NM_000321.3(RB1):c.1275_1279dup (p.Lys427fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000856059	13	48951112 - 48951113	13	48376976 - 48376977	856059	840926		NC_000013.11:48376976:CTTTA:CTTTACTTTA
NM_000321.3(RB1):c.1584_1585insCACTT (p.Tyr529fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000849407	13	48955466 - 48955467	13	48381330 - 48381331	849407	840939		NC_000013.11:48381330:TT:TTCACTT
NM_000321.3(RB1):c.1346dup (p.Val450fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV000849175	13	48953741 - 48953742	13	48379605 - 48379606	849175	840929		NC_000013.11:48379605:GG:GGG
NM_000321.3(RB1):c.1257del (p.Lys420fs)	RB1	K420fs	Retinoblastoma	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000837403	13	48951095	13	48376959	837403	840925		NC_000013.11:48376958:G:
NM_000321.3(RB1):c.2408del (p.Asn803fs)	RB1	N803fs	Retinoblastoma	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000836098	13	49039422	13	48465286	836098	840953		NC_000013.11:48465285:AA:A
NM_000321.3(RB1):c.526_532del (p.Gln176fs)	RB1	Q176fs	Retinoblastoma	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000834926	13	48921984 - 48921990	13	48347848 - 48347854	834926	840913		NC_000013.11:48347847:CACAACCCA:CA
NM_000321.2(RB1):c.1331_1332dup (p.Arg445fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000662634	13	48951168 - 48951169	13	48377032 - 48377033	662634	641978		NC_000013.11:48377032:AG:AGAG
NM_000321.2(RB1):c.2339C>G (p.Ser780Ter)	RB1	S780*	Retinoblastoma	Pathogenic(Last reviewed: Nov 18, 2018)	criteria provided, single submitter	VCV000661686	13	49039354	13	48465218	661686	642011		NC_000013.11:48465217:C:G
NC_000013.10:g.(?_48934143)_(48942750_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000660144	13	48934143 - 48942750	13	48360007 - 48368614	660144	652793		
NM_000321.2(RB1):c.272_276del (p.Tyr91fs)	RB1	Y91fs	Retinoblastoma	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000659122	13	48916740 - 48916744	13	48342604 - 48342608	659122	641956		NC_000013.11:48342603:TTATATT:TT
NM_000321.2(RB1):c.1686dup (p.Trp563fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000657941	13	48955569 - 48955570	13	48381433 - 48381434	657941	641993		NC_000013.11:48381433:A:AA
NM_000321.2(RB1):c.2405_2414del (p.Gly802fs)	RB1	G802fs	Retinoblastoma	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000655598	13	49039420 - 49039429	13	48465284 - 48465293	655598	642013		NC_000013.11:48465283:GGAACATCTA:
NM_000321.2(RB1):c.726dup (p.Val243fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 1, 2018)	criteria provided, single submitter	VCV000654420	13	48936957 - 48936958	13	48362821 - 48362822	654420	641963		NC_000013.11:48362821:T:TT
NM_000321.2(RB1):c.1512_1513del (p.Asn505fs)	RB1	N505fs	Retinoblastoma	Pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, single submitter	VCV000653571	13	48955395 - 48955396	13	48381259 - 48381260	653571	641986		NC_000013.11:48381258:AGA:A
NM_000321.2(RB1):c.2160_2167delinsC (p.Lys720fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000653255	13	49037920 - 49037927	13	48463784 - 48463791	653255	642005		NC_000013.11:48463783:ATTCAAAA:C
NM_000321.2(RB1):c.1978_1996del (p.Leu660fs)	RB1	L660fs	Retinoblastoma	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000652191	13	49033840 - 49033858	13	48459704 - 48459722	652191	642001		NC_000013.11:48459703:TCTCCGGCTAAATACACTTT:T
NM_000321.2(RB1):c.859G>T (p.Glu287Ter)	RB1	E287*	Retinoblastoma	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000651486	13	48937091	13	48362955	651486	641967		NC_000013.11:48362954:G:T
NC_000013.10:g.(?_48951044)_(48954230_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000650696	13	48951044 - 48954230	13	48376908 - 48380094	650696	652797		
NM_000321.2(RB1):c.1950_1953del (p.Phe650fs)	RB1	F650fs	Retinoblastoma	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000648404	13	49030474 - 49030477	13	48456338 - 48456341	648404	642000		NC_000013.11:48456337:TTTAT:T
NM_000321.2(RB1):c.2473dup (p.Met825fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000647483	13	49039483 - 49039484	13	48465347 - 48465348	647483	642014		NC_000013.11:48465347:AAAAA:AAAAAA
NM_000321.2(RB1):c.2284C>T (p.Gln762Ter)	RB1	Q762*	Retinoblastoma	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000647382	13	49039206	13	48465070	647382	642009		NC_000013.11:48465069:C:T
NC_000013.10:g.(?_48878039)_(48881552_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Aug 11, 2018)	criteria provided, single submitter	VCV000645883	13	48878039 - 48881552	13	48303903 - 48307416	645883	652514		
NM_000321.2(RB1):c.1625T>A (p.Leu542Ter)	RB1	L542*	Retinoblastoma	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000645660	13	48955509	13	48381373	645660	641987		NC_000013.11:48381372:T:A
NM_000321.2(RB1):c.2131dup (p.Ile711fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000645440	13	49037890 - 49037891	13	48463754 - 48463755	645440	642004		NC_000013.11:48463754:A:AA
NM_000321.2(RB1):c.849_856del (p.Cys283_Asp286delinsTer)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000640850	13	48937080 - 48937087	13	48362944 - 48362951	640850	641965		NC_000013.11:48362943:GTAATATAG:G
NM_000321.2(RB1):c.2206C>T (p.Gln736Ter)	RB1	Q736*	Retinoblastoma	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000640755	13	49037966	13	48463830	640755	642006		NC_000013.11:48463829:C:T
NM_000321.2(RB1):c.1294A>T (p.Lys432Ter)	RB1	K432*	Retinoblastoma	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000590847	13	48951132	13	48376996	590847	581786	rs1566197747	NC_000013.11:48376995:A:T
NM_000321.2(RB1):c.92dup (p.Asp32fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Aug 5, 2016)	criteria provided, single submitter	VCV000590845	13	48878139 - 48878140	13	48304003 - 48304004	590845	581783	rs1566174147	NC_000013.11:48304003:A:AA
NM_000321.2(RB1):c.381-1G>A	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	VCV000590844	13	48919215	13	48345079	590844	581785	rs1566186836	NC_000013.11:48345078:G:A
NM_000321.2(RB1):c.1789C>T (p.Gln597Ter)	RB1	Q597*	Retinoblastoma	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000582300	13	49027222	13	48453086	582300	572573	rs1566233076	NC_000013.11:48453085:C:T
NM_000321.2(RB1):c.465_468dup (p.Val157Ter)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000581661	13	48919299 - 48919300	13	48345163 - 48345164	581661	568559	rs1566186889	NC_000013.11:48345163:TGAT:TGATTGAT
NM_000321.2(RB1):c.36del (p.Ala13fs)	RB1	A13fs	Retinoblastoma	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000580945	13	48878083	13	48303947	580945	572492	rs1566174065	NC_000013.11:48303946:CC:C
NM_000321.2(RB1):c.83del (p.Pro28fs)	RB1	P28fs	Retinoblastoma	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000580564	13	48878127	13	48303991	580564	572494	rs1276653645	NC_000013.11:48303990:CCCCC:CCCC
NM_000321.2(RB1):c.297_298insA (p.Gly100fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000580262	13	48916767 - 48916768	13	48342631 - 48342632	580262	568556	rs1566186087	NC_000013.11:48342631::A
NM_000321.2(RB1):c.2172dup (p.Val725fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000573547	13	49037930 - 49037931	13	48463794 - 48463795	573547	566163	rs1566237098	NC_000013.11:48463794:TT:TTT
NM_000321.2(RB1):c.388A>T (p.Lys130Ter)	RB1	K130*	Retinoblastoma	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000569968	13	48919223	13	48345087	569968	568558	rs1566186840	NC_000013.11:48345086:A:T
NM_000321.2(RB1):c.45_70dup (p.Pro24fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000567591	13	48878088 - 48878089	13	48303952 - 48303953	567591	568554	rs1566174074	NC_000013.11:48303952:CCGCTGCCGCCGCGGAACCCCCGGCACCGC:CCGCTGCCGCCGCGGAACCCCCGGCACCGCTGCCGCCGCGGAACCCCCGGCACCGC
NM_000321.2(RB1):c.800del (p.Leu267fs)	RB1	L267fs	Retinoblastoma	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000565386	13	48937032	13	48362896	565386	572510	rs1566192557	NC_000013.11:48362895:T:
NM_000321.2(RB1):c.2247_2248insAA (p.Asp750fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000527930	13	49039169 - 49039170	13	48465033 - 48465034	527930	528146	rs1555294600	NC_000013.11:48465033::AA
NM_000321.2(RB1):c.1633_1640del (p.Glu545fs)	RB1	E545fs	Retinoblastoma	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000527913	13	48955517 - 48955524	13	48381381 - 48381388	527913	527766	rs1555286695	NC_000013.11:48381380:GAAATGAT:
NM_000321.2(RB1):c.1239_1240del (p.Ser414fs)	RB1	S414fs	Retinoblastoma	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000527910	13	48951076 - 48951077	13	48376940 - 48376941	527910	528302	rs1555286220	NC_000013.11:48376939:AAA:A
NM_000321.2(RB1):c.2450_2453delinsTTT (p.Glu817fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000527909	13	49039465 - 49039468	13	48465329 - 48465332	527909	527806	rs1555294626	NC_000013.11:48465328:AAGG:TTT
NM_000321.2(RB1):c.510del (p.Glu170fs)	RB1	E170fs	Retinoblastoma	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000527905	13	48921969	13	48347833	527905	527778	rs1555283482	NC_000013.11:48347832:AA:A
NM_000321.2(RB1):c.597_601dup (p.Ala201delinsAspTer)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523357	13	48923148 - 48923149	13	48349012 - 48349013	523357	514031	rs1555283670	NC_000013.11:48349012:ATTAG:ATTAGATTAG
NM_000321.2(RB1):c.861G>C (p.Glu287Asp)	RB1	E287D	Retinoblastoma	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000458186	13	48937093	13	48362957	458186	462925	rs1555284956	NC_000013.11:48362956:G:C
NM_000321.2(RB1):c.54_73dup (p.Pro25fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000458171	13	48878094 - 48878095	13	48303958 - 48303959	458171	463855	rs1555279212	NC_000013.11:48303958:CCGCCGCGGAACCCCCGGCACCGCCGC:CCGCCGCGGAACCCCCGGCACCGCCGCGGAACCCCCGGCACCGCCGC
NM_000321.2(RB1):c.1333-2A>G	RB1		Retinoblastoma	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000458120	13	48953728	13	48379592	458120	463899	rs1555286503	NC_000013.11:48379591:A:G
NM_000321.2(RB1):c.1278dup (p.Lys427Ter)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	VCV000458116	13	48951113 - 48951114	13	48376977 - 48376978	458116	463672	rs1555286236	NC_000013.11:48376977:TTT:TTTT
NC_000013.10:g.(?_48881410)_(48923165_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000458111	13	48881410 - 48923165	13	48307274 - 48349029	458111	463437		
NC_000013.10:g.(?_48916735)_(48919335_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000417540	13	48916735 - 48919335	13	48342599 - 48345199	417540	399102		
NM_000321.2(RB1):c.37_65del (p.Ala13fs)	RB1	A13fs	Retinoblastoma	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000410951	13	48878084 - 48878112	13	48303948 - 48303976	410951	400193	rs1064792974	NC_000013.11:48303947:CGCCGCCGCTGCCGCCGCGGAACCCCCGGC:C
NM_000321.2(RB1):c.1696-12T>G	RB1		Retinoblastoma	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	VCV000410940	13	49027117	13	48452981	410940	399469	rs1060503088	NC_000013.11:48452980:T:G
NM_000321.2(RB1):c.1673_1674dup (p.Glu559fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000410928	13	48955556 - 48955557	13	48381420 - 48381421	410928	399538	rs1555286707	NC_000013.11:48381420:TG:TGTG
NM_000321.2(RB1):c.2194_2197del (p.Pro732fs)	RB1	P732fs	Retinoblastoma	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000410922	13	49037954 - 49037957	13	48463818 - 48463821	410922	399482	rs1060503075	NC_000013.11:48463817:CCTC:
NM_000321.2(RB1):c.2029G>T (p.Glu677Ter)	RB1	E677*	Retinoblastoma	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000410885	13	49033892	13	48459756	410885	399479	rs1060503067	NC_000013.11:48459755:G:T
NM_000321.2(RB1):c.1154T>G (p.Leu385Ter)	RB1	L385*	Retinoblastoma	Pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, single submitter	VCV000237659	13	48947567	13	48373431	237659	241751	rs878853947	NC_000013.11:48373430:T:G
NM_000321.2(RB1):c.305_306del (p.Cys102fs)	RB1	C102fs	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	VCV000126809	13	48916774 - 48916775	13	48342638 - 48342639	126809	132319	rs587778825	NC_000013.11:48342637:TGT:T
NM_000321.2(RB1):c.43_65dup (p.Pro23fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000013095	13	48878089 - 48878090	13	48303953 - 48303954	13095	28134	rs587776790	NC_000013.11:48303953:CGCTGCCGCCGCGGAACCCCCGGC:CGCTGCCGCCGCGGAACCCCCGGCGCTGCCGCCGCGGAACCCCCGGC
NM_000321.2(RB1):c.1818T>A (p.Tyr606Ter)	RB1	Y606*	Retinoblastoma	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000013094	13	49030343	13	48456207	13094	28133	rs137853297	NC_000013.11:48456206:T:A
NM_000321.2(RB1):c.2211G>A (p.Glu737=)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000013089	13	49037971	13	48463835	13089	28128	rs587776787	NC_000013.11:48463834:G:A
NM_000321.2(RB1):c.2023G>T (p.Glu675Ter)	RB1	Q675*, E675*	Retinoblastoma	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000013088	13	49033886	13	48459750	13088	28127	rs137853295	NC_000013.11:48459749:G:T
NM_000321.2(RB1):c.-189G>T	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 5, 1991)	no assertion criteria provided	VCV000013085	13	48877860	13	48303724	13085	28124	rs387906520	NC_000013.11:48303723:G:T
NM_000321.2(RB1):c.2212-1G>A	RB1		Retinoblastoma	Pathogenic(Last reviewed: Nov 1, 1989)	no assertion criteria provided	VCV000013084	13	49039133	13	48464997	13084	28123	rs587776786	NC_000013.11:48464996:G:A
NM_000321.2(RB1):c.1949_1957del (p.Phe650_Lys653delinsTer)	RB1	F650*	Retinoblastoma	Pathogenic(Last reviewed: Nov 1, 1989)	no assertion criteria provided	VCV000013083	13	49030474 - 49030482	13	48456338 - 48456346	13083	28122	rs587776785	NC_000013.11:48456337:TTTATAAAA:
NM_000321.2(RB1):c.1760_1769del (p.Glu587fs)	RB1	E587fs	Retinoblastoma	Pathogenic(Last reviewed: Nov 1, 1989)	no assertion criteria provided	VCV000013082	13	49027189 - 49027198	13	48453053 - 48453062	13082	28121	rs587776784	NC_000013.11:48453052:CTTGAATCTGCTTG:CTTG
NM_000321.2(RB1):c.979_1033dup (p.Thr345delinsLysLysTer)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Nov 1, 1989)	no assertion criteria provided	VCV000013081	13	48941668 - 48941669	13	48367532 - 48367533	13081	28120	rs1555285429	
RB1, 5-BP DEL, EX8	RB1		Retinoblastoma	Pathogenic(Last reviewed: Nov 1, 1989)	no assertion criteria provided	VCV000013080					13080	28119		
NM_000321.2(RB1):c.1049+1G>T	RB1		Retinoblastoma	Pathogenic(Last reviewed: Dec 21, 1989)	no assertion criteria provided	VCV000013075	13	48941740	13	48367604	13075	28114	rs587776782	NC_000013.11:48367603:G:T
NM_000321.2(RB1):c.2244del (p.Glu748fs)	RB1	E748fs	Retinoblastoma	Pathogenic(Last reviewed: Dec 21, 1989)	no assertion criteria provided	VCV000013074	13	49039166	13	48465030	13074	28113	rs587776781	NC_000013.11:48465029:G:
NM_000321.2(RB1):c.1700C>T (p.Ser567Leu)	RB1	S567L	Retinoblastoma	Pathogenic(Last reviewed: Dec 21, 1989)	no assertion criteria provided	VCV000013072	13	49027133	13	48452997	13072	28111	rs137853292	NC_000013.11:48452996:C:T
NM_000321.2(RB1):c.1960+2T>C	RB1		Retinoblastoma	Pathogenic(Last reviewed: Dec 21, 1989)	no assertion criteria provided	VCV000013070	13	49030487	13	48456351	13070	28109	rs587776780	NC_000013.11:48456350:T:C
NM_000321.2(RB1):c.2520+1del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Dec 21, 1989)	no assertion criteria provided	VCV000013069	13	49047524	13	48473388	13069	28108	rs587776779	NC_000013.11:48473387:GGGG:GGG
NM_002693.2(POLG):c.2551A>G (p.Thr851Ala)	POLG	T851A	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619395	15	89865014	15	89321783	619395	610751	rs775445970	NC_000015.10:89321782:T:C
NM_002693.2(POLG):c.1721G>A (p.Arg574Gln)	POLG	R574Q	POLG-related disorders|Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000619321	15	89868909	15	89325678	619321	610770	rs764287987	NC_000015.10:89325677:C:T
NM_002693.2(POLG):c.1874C>T (p.Pro625Leu)	POLG	P625L	not provided|Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419975	15	89868756	15	89325525	419975	409376	rs1064794214	NC_000015.10:89325524:G:A
NM_002693.2(POLG):c.1789C>T (p.Arg597Trp)	POLG	R597W	Progressive sclerosing poliodystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381520	15	89868841	15	89325610	381520	374507	rs139717885	NC_000015.10:89325609:G:A
NM_002693.2(POLG):c.2125C>T (p.Arg709Ter)	POLG	R709*	Progressive sclerosing poliodystrophy|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381519	15	89867078	15	89323847	381519	374842	rs867038717	NC_000015.10:89323846:G:A
NM_004004.6(GJB2):c.334_335del (p.Lys112fs)	GJB2	K112fs	Hearing loss|Deafness, autosomal recessive 1A|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189051	13	20763386 - 20763387	13	20189247 - 20189248	189051	186857	rs756484720	NC_000013.11:20189246:TTT:T
NM_002834.5(PTPN11):c.181G>T (p.Asp61Tyr)	PTPN11	D61Y, D60Y	Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Feb 6, 2015)	criteria provided, single submitter	VCV000228392	12	112888165	12	112450361	228392	230257	rs397507510	NC_000012.12:112450360:G:T
NM_002693.2(POLG):c.3643+2T>C	POLG		not provided|Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000597808	15	89860605	15	89317374	597808	588869	rs1335880349	NC_000015.10:89317373:A:G
NM_002693.2(POLG):c.3573G>T (p.Lys1191Asn)	POLG	K1191N	Progressive sclerosing poliodystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426681	15	89860677	15	89317446	426681	415454	rs1085307741	NC_000015.10:89317445:C:A
NM_002693.2(POLG):c.3409dup (p.Val1137fs)	POLG		not provided|not specified|Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423899	15	89861844 - 89861845	15	89318613 - 89318614	423899	409368	rs1555452461	NC_000015.10:89318613:CC:CCC
NM_002693.2(POLG):c.2870C>T (p.Ala957Val)	POLG	A957V	not provided|Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280016	15	89864108	15	89320877	280016	264637	rs753160398	NC_000015.10:89320876:G:A
NM_002693.2(POLG):c.2794C>T (p.His932Tyr)	POLG	H932Y	Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome|Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000013500	15	89864184	15	89320953	13500	28539	rs121918048	NC_000015.10:89320952:G:A
NM_014363.6(SACS):c.4232T>G (p.Leu1411Ter)	SACS	L1411*, L1264*	Spastic paraplegia|not provided|	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000450250	13	23913783	13	23339644	450250	445130	rs867249938	NC_000013.11:23339643:A:C
NM_014363.6(SACS):c.2182C>T (p.Arg728Ter)	SACS	R728*, R581*	Abnormality of brain morphology||not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280095	13	23927927	13	23353788	280095	264512	rs752059006	NC_000013.11:23353787:G:A
NM_000070.3(CAPN3):c.2120A>G (p.Asp707Gly)	CAPN3	D707G, D195G, D42G, D615G, D701G	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000468648	15	42702630	15	42410432	468648	465015	rs200379491	NC_000015.10:42410431:A:G
NM_000070.3(CAPN3):c.1435A>G (p.Ser479Gly)	CAPN3	S479G, S431G	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092405	15	42693919	15	42401721	92405	98316	rs201736037	NC_000015.10:42401720:A:G
GRCh37/hg19 16q24.3(chr16:89828385-89858029)x1	FANCA		not provided	Pathogenic(Last reviewed: Mar 15, 2018)	no assertion criteria provided	VCV000686854	16	89828385 - 89858029			686854	674446		
NM_000135.4(FANCA):c.793-1G>A	FANCA		not provided	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000596588	16	89866047	16	89799639	596588	587649	rs1567642367	NC_000016.10:89799638:C:T
NM_000135.4(FANCA):c.236_239del (p.Asp79fs)	FANCA	D79fs	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803294	16	89880972 - 89880975	16	89814564 - 89814567	803294	791664		NC_000016.10:89814563:CAGTCA:CA
NM_000135.4(FANCA):c.275C>G (p.Ser92Ter)	FANCA	S92*	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803293	16	89880936	16	89814528	803293	791663		NC_000016.10:89814527:G:C
NM_000135.4(FANCA):c.427A>T (p.Lys143Ter)	FANCA	K143*	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000488514	16	89877210	16	89810802	488514	481382	rs539460201	NC_000016.10:89810801:T:A
NG_011706.1:g.10587_63081del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Feb 1, 2017)	no assertion criteria provided	VCV000632556	16	89824985 - 89877479	16	89758580 - 89811074	632556	620942		
NG_011706.1:g.13291_71928del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Feb 1, 2017)	no assertion criteria provided	VCV000632555	16	89816138 - 89874775	16	89749731 - 89808368	632555	620941		
NM_000135.4(FANCA):c.3241_3626+1del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Feb 1, 2017)	no assertion criteria provided	VCV000632554	16	89811366 - 89815174	16	89744958 - 89748766	632554	620940		
NM_000135.4(FANCA):c.1472_1566+1del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Feb 1, 2017)	no assertion criteria provided	VCV000632553	16	89849414 - 89849509	16	89783006 - 89783101	632553	620943	rs1567628967	
NM_000135.4(FANCA):c.2529_2530CT[2] (p.Leu845fs)	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000623181	16	89833614 - 89833617	16	89767206 - 89767209	623181	612196		NC_000016.10:89767205:AGAGAGAG:AGAG
NM_000135.4(FANCA):c.2317-2A>G	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	VCV000619960	16	89836434	16	89770026	619960	611365	rs1567618264	NC_000016.10:89770025:T:C
NM_000135.4(FANCA):c.1359+1G>C	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000556465	16	89857810	16	89791402	556465	547961	rs1555561294	NC_000016.10:89791401:C:G
NM_000135.4(FANCA):c.2172dup (p.Ser725fs)	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000554995	16	89837021 - 89837022	16	89770613 - 89770614	554995	547918	rs1555547955	NC_000016.10:89770613:C:CC
NM_000135.4(FANCA):c.549G>A (p.Trp183Ter)	FANCA	W183*, W151*	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Sep 24, 2017)	criteria provided, single submitter	VCV000554024	16	89874749	16	89808341	554024	547960	rs758528624	NC_000016.10:89808340:C:T
NM_000135.4(FANCA):c.100A>T (p.Lys34Ter)	FANCA	K34*	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000553243	16	89882374	16	89815966	553243	548263	rs772858764	NC_000016.10:89815965:T:A
NM_000135.4(FANCA):c.718C>T (p.Gln240Ter)	FANCA	Q240*, Q208*	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000551354	16	89869741	16	89803333	551354	547985	rs1184639006	NC_000016.10:89803332:G:A
NM_000135.4(FANCA):c.1340C>G (p.Ser447Ter)	FANCA	S447*	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000435132	16	89857830	16	89791422	435132	429903	rs149551759	NC_000016.10:89791421:G:C
NM_000135.4(FANCA):c.2151+1G>A	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000435130	16	89838085	16	89771677	435130	429900	rs1555548428	NC_000016.10:89771676:C:T
NM_000135.4(FANCA):c.2601+1G>T	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000435128	16	89833548	16	89767140	435128	429897	rs1188581065	NC_000016.10:89767139:C:A
NM_000135.4(FANCA):c.154C>T (p.Arg52Ter)	FANCA	R52*	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000371668	16	89882320	16	89815912	371668	358392	rs773159223	NC_000016.10:89815911:G:A
NM_000135.4(FANCA):c.295C>T (p.Gln99Ter)	FANCA	Q99*	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000370361	16	89877468	16	89811060	370361	358391	rs1057516430	NC_000016.10:89811059:G:A
FANCA, IVS7DS, G-A, +5	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Jul 2, 2009)	no assertion criteria provided	VCV000192385					192385	190172		
NM_000135.4(FANCA):c.513G>A (p.Trp171Ter)	FANCA	W171*	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000003447	16	89877124	16	89810716	3447	18486	rs121907930	NC_000016.10:89810715:C:T
NM_000135.4(FANCA):c.1606del (p.Ser536fs)	FANCA	S536fs	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000003446	16	89849287	16	89782879	3446	18485	rs587776570	NC_000016.10:89782878:A:
NM_000135.2(FANCA):c.1007_3066del	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: May 8, 2001)	no assertion criteria provided	VCV000003445	16	89817632 - 89861789	16	89751224 - 89795381	3445	18484		
NM_000135.2(FANCA):c.894_1006del113 (p.Trp298Cysfs)	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000003442					3442	18481		
NM_000135.2:c.1471_1626del	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000003441					3441	18480		
NM_000135.2:c.1627_1900del	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000003439					3439	18478		
NM_004448.3(ERBB2):c.2524G>A (p.Val842Ile)	ERBB2	V812I, V827I, V842I	Neoplasm of the breast|Adenocarcinoma of stomach|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of gallbladder|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375994	17	37881332	17	39725079	375994	362873	rs1057519738	NC_000017.11:39725078:G:A
NM_000135.4(FANCA):c.1433C>G (p.Ser478Ter)	FANCA	S478*	Fanconi anemia	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000864301	16	89851299	16	89784891	864301	844565		NC_000016.10:89784890:G:C
NM_000135.4(FANCA):c.1202del (p.Pro401fs)	FANCA	P401fs	Fanconi anemia	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000863457	16	89858358	16	89791950	863457	844571		NC_000016.10:89791949:GG:G
NM_000135.4(FANCA):c.319del (p.Val107fs)	FANCA	V107fs	Fanconi anemia	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000860635	16	89877444	16	89811036	860635	844595		NC_000016.10:89811035:CCCCC:CCCC
NM_000135.4(FANCA):c.2600del (p.Lys867fs)	FANCA	K867fs	Fanconi anemia	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000859024	16	89833550	16	89767142	859024	844540		NC_000016.10:89767141:TTTTT:TTTT
NM_000135.4(FANCA):c.3264_3267del (p.Val1089fs)	FANCA	V1089fs	Fanconi anemia	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000853433	16	89815148 - 89815151	16	89748740 - 89748743	853433	844523		NC_000016.10:89748739:GACAGAC:GAC
NM_000135.4(FANCA):c.207T>A (p.Cys69Ter)	FANCA	C69*	Fanconi anemia	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000852815	16	89881004	16	89814596	852815	844598		NC_000016.10:89814595:A:T
NM_000135.4(FANCA):c.91A>T (p.Lys31Ter)	FANCA	K31*	Fanconi anemia	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000848634	16	89882383	16	89815975	848634	844600		NC_000016.10:89815974:T:A
NM_000135.4(FANCA):c.418G>T (p.Glu140Ter)	FANCA	E140*	Fanconi anemia	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000842534	16	89877345	16	89810937	842534	844592		NC_000016.10:89810936:C:A
NM_000135.4(FANCA):c.664G>T (p.Glu222Ter)	FANCA	E190*, E222*	Fanconi anemia	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000841981	16	89871733	16	89805325	841981	844585		NC_000016.10:89805324:C:A
NM_000135.4(FANCA):c.217_218TC[2] (p.Leu74fs)	FANCA		Fanconi anemia	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000841482	16	89880989 - 89880990	16	89814581 - 89814582	841482	844597		NC_000016.10:89814580:GAGAGA:GAGA
NM_000135.4(FANCA):c.2786del (p.Tyr929fs)	FANCA	Y929fs	Fanconi anemia	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000838509	16	89828423	16	89762015	838509	844534		NC_000016.10:89762014:T:
NM_000135.4(FANCA):c.1318G>T (p.Glu440Ter)	FANCA	E440*	Fanconi anemia	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000836439	16	89857852	16	89791444	836439	844569		NC_000016.10:89791443:C:A
NC_000016.10:g.(?_89803249)_(89811081_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000833108	16	89869657 - 89877489			833108	820951		
NC_000016.10:g.(?_89761939)_(89816616_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000832647	16	89828347 - 89883024			832647	820933		
NC_000016.10:g.(?_89748649)_(89758715_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, single submitter	VCV000832641	16	89815057 - 89825123			832641	820925		
NC_000016.10:g.(?_89791393)_(89811081_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV000831816	16	89857801 - 89877489			831816	820945		
NC_000016.10:g.(?_89758567)_(89784974_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000831544	16	89824975 - 89851382			831544	820929		
NC_000016.10:g.(?_89748641)_(89758720_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000831147	16	89815049 - 89825128			831147	820923		
NM_000135.4(FANCA):c.3521G>A (p.Trp1174Ter)	FANCA	W1174*	Fanconi anemia	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000664975	16	89811472	16	89745064	664975	645165		NC_000016.10:89745063:C:T
NM_000135.4(FANCA):c.1630dup (p.His544fs)	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000664949	16	89846361 - 89846362	16	89779953 - 89779954	664949	645187		NC_000016.10:89779953:GGGG:GGGGG
NM_000135.4(FANCA):c.1824dup (p.Arg609fs)	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000657429	16	89845210 - 89845211	16	89778802 - 89778803	657429	645184		NC_000016.10:89778802:C:CC
NM_000135.4(FANCA):c.2314C>T (p.Gln772Ter)	FANCA	Q772*	Fanconi anemia	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000656626	16	89836576	16	89770168	656626	645176		NC_000016.10:89770167:G:A
NC_000016.9:g.(?_89842140)_(89874785_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000654678	16	89842140 - 89874785	16	89775732 - 89808377	654678	652890		
NC_000016.9:g.(?_89831215)_(89871810_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000653531	16	89831215 - 89871810	16	89764807 - 89805402	653531	652492		
NM_000135.4(FANCA):c.548G>A (p.Trp183Ter)	FANCA	W151*, W183*	Fanconi anemia	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000648397	16	89874750	16	89808342	648397	645207		NC_000016.10:89808341:C:T
NM_000135.4(FANCA):c.2735_2736CA[2] (p.His913fs)	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000647752	16	89831336 - 89831337	16	89764928 - 89764929	647752	645174		NC_000016.10:89764927:TGTGTGT:TGTGT
NM_000135.4(FANCA):c.1158G>A (p.Trp386Ter)	FANCA	W386*	Fanconi anemia	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000647127	16	89858402	16	89791994	647127	645196		NC_000016.10:89791993:C:T
NM_000135.4(FANCA):c.294_295delinsTT (p.Leu98_Gln99delinsPheTer)	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000644950	16	89877468 - 89877469	16	89811060 - 89811061	644950	645213		NC_000016.10:89811059:GC:AA
NC_000016.9:g.(?_89831288)_(89839802_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000644835	16	89831288 - 89839802	16	89764880 - 89773394	644835	653193		
NM_000135.4(FANCA):c.1979T>C (p.Leu660Pro)	FANCA	L660P	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000623180	16	89839714	16	89773306	623180	612197	rs1567621042	NC_000016.10:89773305:A:G
NC_000016.9:g.(?_89824979)_(89851378_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000583996	16	89824979 - 89851378	16	89758571 - 89784970	583996	569431		
NM_000135.4(FANCA):c.3634dup (p.Ser1212fs)	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000579823	16	89809338 - 89809339	16	89742930 - 89742931	579823	570649	rs1374769712	NC_000016.10:89742930:A:AA
NM_000135.4(FANCA):c.2587_2588dup (p.Leu864fs)	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000572341	16	89833561 - 89833562	16	89767153 - 89767154	572341	568499	rs1567616135	NC_000016.10:89767153:CC:CCCC
NM_000135.4(FANCA):c.1378C>T (p.Arg460Ter)	FANCA	R460*	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000552305	16	89851354	16	89784946	552305	548721	rs1438828232	NC_000016.10:89784945:G:A
NM_000135.4(FANCA):c.641_642TG[1] (p.Cys215fs)	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000456134	16	89871753 - 89871754	16	89805345 - 89805346	456134	467206	rs1338138752	NC_000016.10:89805344:CACA:CA
NM_000135.4(FANCA):c.3316G>T (p.Glu1106Ter)	FANCA	E1106*	Fanconi anemia	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000456112	16	89815099	16	89748691	456112	466116	rs777825824	NC_000016.10:89748690:C:A
NM_000135.4(FANCA):c.3085G>T (p.Glu1029Ter)	FANCA	E1029*	Fanconi anemia	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000456108	16	89816292	16	89749884	456108	466907	rs1555538740	NC_000016.10:89749883:C:A
NM_000135.4(FANCA):c.1812_1813AG[1] (p.Glu605fs)	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000456085	16	89845220 - 89845221	16	89778812 - 89778813	456085	466935	rs759899153	NC_000016.10:89778811:CTCT:CT
NM_000135.4(FANCA):c.1809dup (p.Ile604fs)	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000456084	16	89845225 - 89845226	16	89778817 - 89778818	456084	466913	rs1343140664	NC_000016.10:89778817:AAA:AAAA
Single allele	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000456072			16	89791397 - 89792553	456072	464849		
Single allele	FANCA		Fanconi anemia	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000456071			16	89782853 - 89784970	456071	465462		
NC_000016.9:g.(?_89831292)_(89833651_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000456068	16	89831292 - 89833651			456068	465557		
NM_000135.4(FANCA):c.2398G>T (p.Glu800Ter)	FANCA	E800*	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000435129	16	89836351	16	89769943	435129	429898	rs1555547474	NC_000016.10:89769942:C:A
NC_000016.9:g.(?_89818546)_(89858955_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000417423	16	89818546 - 89858955	16	89752138 - 89792547	417423	400659		
NM_000135.4(FANCA):c.1981A>T (p.Arg661Ter)	FANCA	R661*	Fanconi anemia	Pathogenic(Last reviewed: Dec 4, 2016)	criteria provided, single submitter	VCV000408180	16	89839712	16	89773304	408180	401399	rs1060501878	NC_000016.10:89773303:T:A
NM_000135.4(FANCA):c.3755_3756AG[3] (p.Glu1254fs)	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000370466	16	89809211 - 89809212	16	89742803 - 89742804	370466	358389	rs868273545	NC_000016.10:89742802:CTCTCTCTC:CTCTCTC
NM_000135.4(FANCA):c.2722_2723CT[4] (p.Trp911fs)	FANCA		Fanconi anemia	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000237042	16	89831345 - 89831346	16	89764937 - 89764938	237042	242543	rs878853663	NC_000016.10:89764936:AGAGAGAGAG:AGAGAGAG
NM_000135.4(FANCA):c.1074_1075del (p.Tyr359fs)	FANCA	Y359fs	Fanconi anemia	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000237032	16	89858887 - 89858888	16	89792479 - 89792480	237032	242551	rs878853660	NC_000016.10:89792478:ACA:A
NM_000135.4(FANCA):c.414_415TG[1] (p.Val139fs)	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	VCV000219633	16	89877346 - 89877347	16	89810938 - 89810939	219633	222543	rs864622188	NC_000016.10:89810937:CACA:CA
NM_000135.4(FANCA):c.3400_3402TTC[1] (p.Phe1135del)	FANCA	F1135del	Fanconi anemia	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000188384	16	89813242 - 89813244	16	89746834 - 89746836	188384	186234	rs786204246	NC_000016.10:89746833:GAAGAAG:GAAG
NM_000135.4(FANCA):c.97del (p.Glu33fs)	FANCA	E33fs	Fanconi anemia	Pathogenic(Last reviewed: Dec 26, 2014)	criteria provided, single submitter	VCV000188362	16	89882377	16	89815969	188362	186237	rs786204238	NC_000016.10:89815968:CCC:CC
NM_000135.4(FANCA):c.283+3A>C	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Dec 5, 2014)	criteria provided, single submitter	VCV000188302	16	89880925	16	89814517	188302	186236	rs786204204	NC_000016.10:89814516:T:G
NM_000135.4(FANCA):c.3720_3724del (p.Glu1240fs)	FANCA	E1240fs	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000003448	16	89809249 - 89809253	16	89742841 - 89742845	3448	18487	rs794726660	NC_000016.10:89742840:TGTTTT:T
NM_000321.3(RB1):c.1891C>T (p.Gln631Ter)	RB1	Q631*	Retinoblastoma	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000860313	13	49030416	13	48456280	860313	840946		NC_000013.11:48456279:C:T
NM_000321.3(RB1):c.2027T>G (p.Leu676Ter)	RB1	L676*	Retinoblastoma	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000858699	13	49033890	13	48459754	858699	840949		NC_000013.11:48459753:T:G
NM_000321.3(RB1):c.1454_1457del (p.Ser485fs)	RB1	S485fs	Retinoblastoma	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000847352	13	48954332 - 48954335	13	48380196 - 48380199	847352	840936		NC_000013.11:48380195:TCTTT:T
NM_000321.3(RB1):c.98dup (p.Glu34fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000845216	13	48878143 - 48878144	13	48304007 - 48304008	845216	840901		NC_000013.11:48304007:CCC:CCCC
NC_000013.11:g.(?_48342589)_(48368614_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000831768	13	48916725 - 48942750			831768	820577		
NC_000013.11:g.(?_48342589)_(48345209_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000830665	13	48916725 - 48919345			830665	820576		
NC_000013.11:g.(?_48303701)_(48304059_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000830533	13	48877837 - 48878195			830533	820572		
NM_000321.2(RB1):c.45_76del (p.Ala17fs)	RB1	A17fs	Retinoblastoma	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000659361	13	48878081 - 48878112	13	48303945 - 48303976	659361	641946		NC_000013.11:48303944:CACCGCCGCCGCTGCCGCCGCGGAACCCCCGGCACCGCCGCCGC:CACCGCCGCCGC
NM_000321.2(RB1):c.1659T>A (p.Cys553Ter)	RB1	C553*	Retinoblastoma	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000659061	13	48955543	13	48381407	659061	641990		NC_000013.11:48381406:T:A
NC_000013.10:g.(?_48881406)_(48923169_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000654679	13	48881406 - 48923169	13	48307270 - 48349033	654679	652281		
NM_000321.2(RB1):c.1389+1G>C	RB1		Retinoblastoma	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000649139	13	48953787	13	48379651	649139	652396		NC_000013.11:48379650:G:C
NM_000321.2(RB1):c.1960_1960+1insC	RB1		Retinoblastoma	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000645082	13	49030485 - 49030486	13	48456349 - 48456350	645082	652402		NC_000013.11:48456349::C
NM_000321.2(RB1):c.1629_1630del (p.Glu545fs)	RB1	E545fs	Retinoblastoma	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000640295	13	48955513 - 48955514	13	48381377 - 48381378	640295	641988		NC_000013.11:48381376:AA:
NM_000321.2(RB1):c.1499-2A>C	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000583225	13	48955381	13	48381245	583225	572567	rs1258442224	NC_000013.11:48381244:A:C
NM_000321.2(RB1):c.2513C>G (p.Ser838Ter)	RB1	S838*	Retinoblastoma	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000579093	13	49047519	13	48473383	579093	567688	rs1131690908	NC_000013.11:48473382:C:G
NM_000321.2(RB1):c.1445_1446del (p.Phe482fs)	RB1	F482fs	Retinoblastoma	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000576526	13	48954321 - 48954322	13	48380185 - 48380186	576526	566149	rs1566199059	NC_000013.11:48380184:TTTTT:TTT
NM_000321.2(RB1):c.1183C>T (p.Gln395Ter)	RB1	Q395*	Retinoblastoma	Pathogenic(Last reviewed: Jan 27, 2018)	criteria provided, single submitter	VCV000575444	13	48947596	13	48373460	575444	572539	rs1566196458	NC_000013.11:48373459:C:T
NM_000321.2(RB1):c.2106+2T>C	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000574925	13	49033971	13	48459835	574925	568600	rs1566235515	NC_000013.11:48459834:T:C
NM_000321.2(RB1):c.2065C>T (p.Gln689Ter)	RB1	Q689*	Retinoblastoma	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000572110	13	49033928	13	48459792	572110	567670	rs1566235470	NC_000013.11:48459791:C:T
NM_000321.2(RB1):c.951_954del (p.Ser318fs)	RB1	S318fs	Retinoblastoma	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000566571	13	48941638 - 48941641	13	48367502 - 48367505	566571	572516	rs1566194323	NC_000013.11:48367501:TCTTTCT:TCT
NC_000013.10:g.(?_49039128)_(49039510_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000527954	13	49039128 - 49039510	13	48464992 - 48465374	527954	527722		
NM_000321.2(RB1):c.283A>T (p.Lys95Ter)	RB1	K95*	Retinoblastoma	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527906	13	48916753	13	48342617	527906	527746	rs1555282775	NC_000013.11:48342616:A:T
NM_000321.2(RB1):c.380+3A>T	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000527904	13	48916853	13	48342717	527904	528090	rs1555282811	NC_000013.11:48342716:A:T
NM_000321.2(RB1):c.1458del (p.Leu486fs)	RB1	L486fs	Retinoblastoma	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000458123	13	48954337	13	48380201	458123	463325	rs1555286611	NC_000013.11:48380200:A:
NM_000321.2(RB1):c.2490-1398A>G	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jan 29, 2018)	no assertion criteria provided	VCV000013096	13	49046098	13	48471962	13096	28135	rs587776791	NC_000013.11:48471961:A:G
NM_144997.7(FLCN):c.584del (p.Gly195fs)	FLCN	G195fs, G213fs	Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas|not provided	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000241927	17	17127270	17	17223956	241927	242607	rs878855217	NC_000017.11:17223955:CCCC:CCC
NM_144997.7(FLCN):c.1597C>T (p.Gln533Ter)	FLCN	Q533*, Q551*	Multiple fibrofolliculomas|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096480	17	17117112	17	17213798	96480	102374	rs398124532	NC_000017.11:17213797:G:A
NM_144997.7(FLCN):c.236C>G (p.Ser79Trp)	FLCN	S79W	Carcinoma of colon	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000003369	17	17131216	17	17227902	3369	18408	rs137852930	NC_000017.11:17227901:G:C
NM_000135.4(FANCA):c.1027C>T (p.Gln343Ter)	FANCA	Q343*	Fanconi anemia	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000857881	16	89858935	16	89792527	857881	844576		NC_000016.10:89792526:G:A
NM_000135.4(FANCA):c.3629dup (p.Leu1211fs)	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000842590	16	89809343 - 89809344	16	89742935 - 89742936	842590	844519		NC_000016.10:89742935:AAA:AAAA
NM_000135.4(FANCA):c.2638C>T (p.Arg880Ter)	FANCA	R880*	Fanconi anemia	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000836893	16	89831438	16	89765030	836893	844539		NC_000016.10:89765029:G:A
NC_000016.10:g.(?_89758567)_(89808377_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000833420	16	89824975 - 89874785			833420	820930		
NC_000016.10:g.(?_89799156)_(89799648_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000833217	16	89865564 - 89866056			833217	820949		
NC_000016.10:g.(?_89778791)_(89779967_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000833216	16	89845199 - 89846375			833216	820939		
NC_000016.10:g.(?_89815867)_(89816625_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000832894	16	89882275 - 89883033			832894	820958		
NC_000016.10:g.(?_89814510)_(89816625_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000832886	16	89880918 - 89883033			832886	820957		
NC_000016.10:g.(?_89761939)_(89762032_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000832813	16	89828347 - 89828440			832813	820931		
NC_000016.10:g.(?_89778791)_(89816625_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000832674	16	89845199 - 89883033			832674	820940		
NC_000016.10:g.(?_89798246)_(89799648_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000832376	16	89864654 - 89866056			832376	820948		
NC_000016.10:g.(?_89752128)_(89808377_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000832273	16	89818536 - 89874785			832273	820927		
NC_000016.10:g.(?_89808284)_(89816616_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000831679	16	89874692 - 89883024			831679	820953		
NC_000016.10:g.(?_89761939)_(89765076_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000831136	16	89828347 - 89831484			831136	820932		
NC_000016.10:g.(?_89808284)_(89816625_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, single submitter	VCV000831124	16	89874692 - 89883033			831124	820954		
NC_000016.10:g.(?_89803249)_(89816625_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000830869	16	89869657 - 89883033			830869	820952		
NC_000016.9:g.(?_89849257)_(89862436_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000657390	16	89849257 - 89862436	16	89782849 - 89796028	657390	652501		
NM_000135.4(FANCA):c.258T>A (p.Tyr86Ter)	FANCA	Y86*	Fanconi anemia	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000645709	16	89880953	16	89814545	645709	645214		NC_000016.10:89814544:A:T
NM_000135.4(FANCA):c.2910del (p.Gly972fs)	FANCA	G972fs	not provided|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558147	16	89825056	16	89758648	558147	548197	rs1278836130	NC_000016.10:89758647:T:
NM_000135.4(FANCA):c.2602-2A>T	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000555572	16	89831476	16	89765068	555572	548205	rs1555545592	NC_000016.10:89765067:T:A
NM_000135.4(FANCA):c.3348+1G>A	FANCA		Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000553239	16	89815066	16	89748658	553239	547886	rs751266148	NC_000016.10:89748657:C:T
NM_000135.4(FANCA):c.2870G>A (p.Trp957Ter)	FANCA	W957*	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000552462	16	89825096	16	89758688	552462	547925	rs927630499	NC_000016.10:89758687:C:T
NM_000135.4(FANCA):c.238del (p.Cys80fs)	FANCA	C80fs	Fanconi anemia	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000219632	16	89880973	16	89814565	219632	222544	rs864622187	NC_000016.10:89814564:A:
NM_001077401.2(ACVRL1):c.1232G>A (p.Arg411Gln)	ACVRL1	R411Q	|not specified|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided	Pathogenic(Last reviewed: Aug 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008243	12	52310003	12	51916219	8243	23282	rs121909284	NC_000012.12:51916218:G:A
NM_000053.4(ATP7B):c.3784G>T (p.Val1262Phe)	ATP7B	V1262F, V1055F, V1151F, V1184F, V1178F	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550902	13	52511731	13	51937595	550902	547171	rs769484789	NC_000013.11:51937594:C:A
NM_000053.4(ATP7B):c.3247C>T (p.Leu1083Phe)	ATP7B	L1083F, L876F, L1005F, L972F, L999F	Wilson disease	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000495412	13	52516687	13	51942551	495412	487755	rs1286080173	NC_000013.11:51942550:G:A
NM_000053.4(ATP7B):c.2810del (p.Val937fs)	ATP7B	V826fs, V853fs, V937fs, V859fs	Wilson disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370632	13	52523853	13	51949717	370632	358225	rs1057516643	NC_000013.11:51949716:A:
NM_000053.4(ATP7B):c.2304del (p.Met769fs)	ATP7B	M658fs, M685fs, M769fs	Wilson disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000088957	13	52532498	13	51958362	88957	94514	rs137853287	NC_000013.11:51958361:GGGGGG:GGGGG
NM_002693.2(POLG):c.3104+3A>T	POLG		Progressive sclerosing poliodystrophy|Seizures	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000587863	15	89862456	15	89319225	587863	580246	rs778573169	NC_000015.10:89319224:T:A
NM_002693.2(POLG):c.925C>T (p.Arg309Cys)	POLG	R309C	Progressive sclerosing poliodystrophy|not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280375	15	89872272	15	89329041	280375	264743	rs886041592	NC_000015.10:89329040:G:A
NM_002693.2(POLG):c.915C>G (p.Ser305Arg)	POLG	S305R	Cerebellar ataxia infantile with progressive external ophthalmoplegia|Progressive sclerosing poliodystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206588	15	89872282	15	89329051	206588	203028	rs769410130	NC_000015.10:89329050:G:C
NM_001018005.2(TPM1):c.284T>C (p.Val95Ala)	TPM1	V95A, V137A, V59A	Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 3|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012457	15	63349227	15	63057028	12457	27496	rs104894504	NC_000015.10:63057027:T:C
NM_000135.4(FANCA):c.2641C>T (p.Gln881Ter)	FANCA	Q881*	Fanconi anemia	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000860918	16	89831435	16	89765027	860918	844538		NC_000016.10:89765026:G:A
NC_000016.9:g.89871693_89878808del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000850409					850409	852847		
NM_000135.4(FANCA):c.710-5T>C	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Mar 10, 2019)	criteria provided, single submitter	VCV000848504	16	89869754	16	89803346	848504	852687		NC_000016.10:89803345:A:G
NM_000135.4(FANCA):c.793-1G>C	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000835280	16	89866047	16	89799639	835280	852145		NC_000016.10:89799638:C:G
NC_000016.10:g.(?_89784844)_(89784974_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000833513	16	89851252 - 89851382			833513	820942		
NC_000016.10:g.(?_89791403)_(89796018_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000832197	16	89857811 - 89862426			832197	820946		
NC_000016.10:g.(?_89767131)_(89799648_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000831984	16	89833539 - 89866056			831984	820938		
NC_000016.10:g.(?_89764807)_(89773394_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000831133	16	89831215 - 89839802			831133	820934		
NM_000135.4(FANCA):c.3239+1dup	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000663982	16	89816136 - 89816137	16	89749728 - 89749729	663982	653319		NC_000016.10:89749728:CC:CCC
NC_000016.9:g.(?_89818536)_(89858965_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000660690	16	89818536 - 89858965	16	89752128 - 89792557	660690	652887		
NM_000135.4(FANCA):c.790C>T (p.Gln264Ter)	FANCA	Q232*, Q264*	Fanconi anemia	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000648985	16	89869669	16	89803261	648985	645201		NC_000016.10:89803260:G:A
NM_000135.4(FANCA):c.2529C>A (p.Tyr843Ter)	FANCA	Y843*	Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556394	16	89833621	16	89767213	556394	547940	rs1247378731	NC_000016.10:89767212:G:T
NM_000135.4(FANCA):c.3188G>A (p.Trp1063Ter)	FANCA	W1063*	Fanconi anemia	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000526315	16	89816189	16	89749781	526315	530419	rs1166286386	NC_000016.10:89749780:C:T
NC_000016.9:g.(?_89842144)_(89842229_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000456070	16	89842144 - 89842229	16	89775736 - 89775821	456070	465458		
NM_000135.4(FANCA):c.2749C>T (p.Arg917Ter)	FANCA	R917*	Fanconi anemia	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000408188	16	89831327	16	89764919	408188	402169	rs1060501880	NC_000016.10:89764918:G:A
NM_000151.4(G6PC):c.1039C>T (p.Gln347Ter)	G6PC	Q347*	Glycogen storage disease|not provided|Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012000	17	41063408	17	42911391	12000	27039	rs80356487	NC_000017.11:42911390:C:T
NM_001171.5(ABCC6):c.1552C>T (p.Arg518Ter)	ABCC6	R518*, R404*	not provided|Pseudoxanthoma elasticum|Pseudoxanthoma elasticum, forme fruste|Pseudoxanthoma elasticum|Generalized arterial calcification of infancy 2	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030339	16	16284104	16	16190247	30339	39295	rs72650700	NC_000016.10:16190246:G:A
NM_014363.6(SACS):c.4744G>A (p.Asp1582Asn)	SACS	D1582N, D1435N	Spastic paraplegia|	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000458265	13	23913271	13	23339132	458265	462633	rs1160357920	NC_000013.11:23339131:C:T
NM_014363.6(SACS):c.10906C>T (p.Arg3636Ter)	SACS	R3636*, R3489*	|Spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212108	13	23907109	13	23332970	212108	208017	rs780247476	NC_000013.11:23332969:G:A
NC_000016.10:g.(?_89791393)_(89796028_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000832475	16	89857801 - 89862436			832475	820943		
NC_000016.10:g.(?_89744949)_(89767247_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000832351	16	89811357 - 89833655			832351	820922		
NC_000016.10:g.(?_89748641)_(89765076_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000832294	16	89815049 - 89831484			832294	820924		
NC_000016.10:g.(?_89810697)_(89816616_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000831925	16	89877105 - 89883024			831925	820955		
NC_000016.10:g.(?_89748649)_(89765076_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000830952	16	89815057 - 89831484			830952	820926		
NC_000016.10:g.(?_89764807)_(89775825_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000830595	16	89831215 - 89842233			830595	820935		
NM_000135.4(FANCA):c.912_913AC[2] (p.Thr306fs)	FANCA		Fanconi anemia, complementation group A|Fanconi anemia	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000456141	16	89862403 - 89862404	16	89795995 - 89795996	456141	466953	rs764122657	NC_000016.10:89795994:GTGTGT:GTGT
NM_000135.4(FANCA):c.2839dup (p.Ser947fs)	FANCA		Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000188383	16	89828369 - 89828370	16	89761961 - 89761962	188383	186235	rs756367276	NC_000016.10:89761961:AAA:AAAA
NM_000321.3(RB1):c.1960+1G>C	RB1		Retinoblastoma	Pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000862582	13	49030486	13	48456350	862582	851531		NC_000013.11:48456349:G:C
NM_000321.3(RB1):c.2326-2A>G	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000853216	13	49039339	13	48465203	853216	852542		NC_000013.11:48465202:A:G
NM_000321.3(RB1):c.245C>A (p.Ser82Ter)	RB1	S82*	Retinoblastoma	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000837710	13	48881523	13	48307387	837710	840905		NC_000013.11:48307386:C:A
NC_000013.11:g.(?_48459678)_(48459843_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Sep 14, 2019)	criteria provided, single submitter	VCV000831231	13	49033814 - 49033979			831231	820582		
NC_000013.10:g.(?_48919206)_(48919345_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000657375	13	48919206 - 48919345	13	48345070 - 48345209	657375	652364		
NM_000321.2(RB1):c.2490-1_2490del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000641355	13	49047494 - 49047495	13	48473358 - 48473359	641355	652295		NC_000013.11:48473357:AGA:A
NM_000321.2(RB1):c.371_372del (p.Ile124fs)	RB1	I124fs	Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000590846	13	48916840 - 48916841	13	48342704 - 48342705	590846	581784	rs1566186125	NC_000013.11:48342703:ATA:A
NC_000013.10:g.(?_49050827)_(49051550_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000584131	13	49050827 - 49051550	13	48476691 - 48477414	584131	565827		
NC_000013.10:g.(?_48919210)_(48919341_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000583949	13	48919210 - 48919341	13	48345074 - 48345205	583949	568225		
NM_000321.2(RB1):c.2520+5G>T	RB1		Retinoblastoma	Pathogenic(Last reviewed: Mar 3, 2018)	criteria provided, single submitter	VCV000567155	13	49047531	13	48473395	567155	567692	rs1131690881	NC_000013.11:48473394:G:T
NM_000321.2(RB1):c.1422-1G>A	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000527931	13	48954300	13	48380164	527931	527758	rs1461382798	NC_000013.11:48380163:G:A
NM_000321.2(RB1):c.1332G>C (p.Gln444His)	RB1	Q444H	Retinoblastoma	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000527917	13	48951170	13	48377034	527917	528109	rs1555286250	NC_000013.11:48377033:G:C
NM_000321.2(RB1):c.1706del (p.Leu569fs)	RB1	L569fs	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000428659	13	49027137	13	48453001	428659	420560	rs1131690842	NC_000013.11:48453000:TTT:TT
NM_000321.2(RB1):c.1960G>C (p.Val654Leu)	RB1	V654L	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000410929	13	49030485	13	48456349	410929	399549	rs483352690	NC_000013.11:48456348:G:C
NM_000321.2(RB1):c.376del (p.Ile126fs)	RB1	I126fs	not provided|Retinoblastoma	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000282251	13	48916844	13	48342708	282251	266488	rs886042357	NC_000013.11:48342707:AAA:AA
NM_000321.2(RB1):c.2053C>T (p.Gln685Ter)	RB1	Q685*	Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Mar 6, 2016)	criteria provided, multiple submitters, no conflicts	VCV000237668	13	49033916	13	48459780	237668	241759	rs878853949	NC_000013.11:48459779:C:T
NM_000321.2(RB1):c.1332+1G>A	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000126834	13	48951171	13	48377035	126834	132344	rs587778846	NC_000013.11:48377034:G:A
NM_000321.2(RB1):c.2164A>T (p.Lys722Ter)	RB1	K722*	Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000126796	13	49037924	13	48463788	126796	132306	rs587778849	NC_000013.11:48463787:A:T
NM_002693.2(POLG):c.3285C>G (p.Ser1095Arg)	POLG	S1095R	POLG-related disorders|Progressive sclerosing poliodystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381517	15	89861969	15	89318738	381517	376748	rs761649878	NC_000015.10:89318737:G:C
NM_002693.2(POLG):c.1433+1G>A	POLG		Progressive sclerosing poliodystrophy|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280017	15	89870397	15	89327166	280017	264590	rs771623994	NC_000015.10:89327165:C:T
NM_002693.2(POLG):c.1943C>G (p.Pro648Arg)	POLG	P648R	not provided|Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206606	15	89868687	15	89325456	206606	202994	rs796052906	NC_000015.10:89325455:G:C
NM_001009944.3(PKD1):c.2781_2782insAG (p.Ala928fs)	PKD1		not provided	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000817248	16	2164242 - 2164243	16	2114241 - 2114242	817248	805872		NC_000016.10:2114241:C:CTC
NM_001009944.3(PKD1):c.11783G>A (p.Trp3928Ter)	PKD1	W3927*, W3928*	not provided	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000816944	16	2141105	16	2091104	816944	805870		NC_000016.10:2091103:C:T
NM_001009944.3(PKD1):c.4070del (p.Leu1357fs)	PKD1	L1357fs	not provided	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000636886	16	2161098	16	2111097	636886	624591		NC_000016.10:2111096:A:
NM_001009944.3(PKD1):c.7915C>T (p.Arg2639Ter)	PKD1	R2639*	not provided	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000636809	16	2155424	16	2105423	636809	624571		NC_000016.10:2105422:G:A
NM_001009944.3(PKD1):c.4616G>A (p.Trp1539Ter)	PKD1	W1539*	not provided	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000636799	16	2160552	16	2110551	636799	624586		NC_000016.10:2110550:C:T
NM_001009944.3(PKD1):c.4957C>T (p.Gln1653Ter)	PKD1	Q1653*	not provided	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000636665	16	2160211	16	2110210	636665	624583		NC_000016.10:2110209:G:A
NM_001009944.3(PKD1):c.12061C>T (p.Arg4021Ter)	PKD1	R4021*, R4020*	not provided	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000636627	16	2140752	16	2090751	636627	624545		NC_000016.10:2090750:G:A
NM_001009944.3(PKD1):c.6586C>T (p.Gln2196Ter)	PKD1	Q2196*	not provided	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000620104	16	2158582	16	2108581	620104	611820	rs1567192286	NC_000016.10:2108580:G:A
NM_001009944.3(PKD1):c.7751_7754del (p.Leu2584fs)	PKD1	L2584fs	not provided	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000618822	16	2155975 - 2155978	16	2105974 - 2105977	618822	609978	rs1567183784	NC_000016.10:2105973:GTGAG:G
NM_001009944.3(PKD1):c.8590G>T (p.Glu2864Ter)	PKD1	E2864*	not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000618820	16	2153468	16	2103467	618820	609973	rs374629549	NC_000016.10:2103466:C:A
NM_001009944.3(PKD1):c.5552_5553del (p.His1851fs)	PKD1	H1851fs	not provided	Pathogenic(Last reviewed: Sep 10, 2017)	criteria provided, single submitter	VCV000618815	16	2159615 - 2159616	16	2109614 - 2109615	618815	609992	rs1567196314	NC_000016.10:2109613:AT:
NM_001009944.3(PKD1):c.4177C>T (p.Gln1393Ter)	PKD1	Q1393*	not provided	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000618796	16	2160991	16	2110990	618796	609998	rs1567201083	NC_000016.10:2110989:G:A
NM_001009944.3(PKD1):c.1400_1410del (p.Trp467fs)	PKD1	W467fs	not provided	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000618794	16	2167030 - 2167040	16	2117029 - 2117039	618794	610014	rs1567215697	NC_000016.10:2117028:GAAGCCGATCC:
NM_001009944.3(PKD1):c.7666C>T (p.Gln2556Ter)	PKD1	Q2556*	not provided	Pathogenic(Last reviewed: Feb 25, 2018)	criteria provided, single submitter	VCV000618320	16	2156129	16	2106128	618320	609979	rs1567184366	NC_000016.10:2106127:G:A
NM_001009944.3(PKD1):c.7987C>T (p.Gln2663Ter)	PKD1	Q2663*	not provided	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000618315	16	2155352	16	2105351	618315	609977	rs1567182193	NC_000016.10:2105350:G:A
NM_001009944.3(PKD1):c.3932del (p.Ala1311fs)	PKD1	A1311fs	not provided	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000618313	16	2161236	16	2111235	618313	610001	rs1567201999	NC_000016.10:2111234:G:
NM_001009944.3(PKD1):c.8560C>T (p.Gln2854Ter)	PKD1	Q2854*	not provided	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000618310	16	2153498	16	2103497	618310	609974	rs1364976535	NC_000016.10:2103496:G:A
NM_001009944.3(PKD1):c.1198C>T (p.Arg400Ter)	PKD1	R400*	not provided	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000618300	16	2167795	16	2117794	618300	610016	rs774453006	NC_000016.10:2117793:G:A
NM_001009944.3(PKD1):c.12354C>A (p.Tyr4118Ter)	PKD1	Y4117*, Y4118*	not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000618297	16	2140376	16	2090375	618297	609955	rs1188292999	NC_000016.10:2090374:G:T
NM_001009944.3(PKD1):c.1772del (p.Thr591fs)	PKD1	T591fs	not provided	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000618289	16	2166070	16	2116069	618289	610010	rs1567213901	NC_000016.10:2116068:G:
NM_001009944.3(PKD1):c.6806C>G (p.Ser2269Ter)	PKD1	S2269*	not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000590791	16	2158362	16	2108361	590791	581730	rs1567191179	NC_000016.10:2108360:G:C
NM_001009944.3(PKD1):c.12278_12279del (p.Leu4093fs)	PKD1	L4093fs, L4092fs	not provided	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000504231	16	2140451 - 2140452	16	2090450 - 2090451	504231	495786	rs1555444648	NC_000016.10:2090449:CA:
NM_001009944.3(PKD1):c.6398dup (p.Val2134fs)	PKD1		not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000503935	16	2158769 - 2158770	16	2108768 - 2108769	503935	495792	rs1555454467	NC_000016.10:2108768:AA:AAA
NM_001009944.3(PKD1):c.6549dup (p.Glu2184Ter)	PKD1		not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000451918	16	2158618 - 2158619	16	2108617 - 2108618	451918	445533	rs1555454373	NC_000016.10:2108617:A:AA
NM_001009944.3(PKD1):c.6583_6589del (p.Cys2195fs)	PKD1	C2195fs	not specified	Pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000440136	16	2158579 - 2158585	16	2108578 - 2108584	440136	433199	rs1555454353	NC_000016.10:2108577:GCTGGCAGCTGGC:GCTGGC
NM_001009944.3(PKD1):c.2152C>T (p.Gln718Ter)	PKD1	Q718*	not specified	Pathogenic(Last reviewed: Mar 25, 2017)	criteria provided, single submitter	VCV000440133	16	2164872	16	2114871	440133	433220	rs1555458032	NC_000016.10:2114870:G:A
NM_001009944.3(PKD1):c.11912del (p.Pro3971fs)	PKD1	P3970fs, P3971fs	not specified	Pathogenic(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000440124	16	2140976	16	2090975	440124	433159	rs1555445123	NC_000016.10:2090974:GGG:GG
NM_001009944.3(PKD1):c.2932C>T (p.Gln978Ter)	PKD1	Q978*	not specified	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000440123	16	2163215	16	2113214	440123	433217	rs1555457446	NC_000016.10:2113213:G:A
NM_001009944.3(PKD1):c.9994del (p.Val3332fs)	PKD1	V3332fs	not specified	Pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000440118	16	2149701	16	2099700	440118	433177	rs1555449235	NC_000016.10:2099699:CC:C
NM_001009944.3(PKD1):c.4258G>T (p.Glu1420Ter)	PKD1	E1420*	not specified	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000440112	16	2160910	16	2110909	440112	433207	rs1555456139	NC_000016.10:2110908:C:A
NM_001009944.3(PKD1):c.1305_1306GT[1] (p.Cys436fs)	PKD1		not specified	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000440100	16	2167567 - 2167568	16	2117566 - 2117567	440100	433226	rs1555458891	NC_000016.10:2117565:ACAC:AC
NM_001009944.3(PKD1):c.3285C>A (p.Tyr1095Ter)	PKD1	Y1095*	not specified	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000440095	16	2162351	16	2112350	440095	433212	rs558648661	NC_000016.10:2112349:G:T
NM_001009944.3(PKD1):c.8905C>T (p.Gln2969Ter)	PKD1	Q2969*	not specified	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000440091	16	2152858	16	2102857	440091	433182	rs200520583	NC_000016.10:2102856:G:A
NM_001009944.3(PKD1):c.215+1G>C	PKD1		not provided	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000432433	16	2185475	16	2135474	432433	426163	rs1555462433	NC_000016.10:2135473:C:G
NM_001009944.3(PKD1):c.7818dup (p.His2607fs)	PKD1		Polycystic kidney dysplasia	Pathogenic	no assertion criteria provided	VCV000427767	16	2155910 - 2155911	16	2105909 - 2105910	427767	417656	rs1555452653	NC_000016.10:2105909:C:CC
NM_001009944.3(PKD1):c.8898_8911dup (p.Ala2971fs)	PKD1		not provided	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000424364	16	2152851 - 2152852	16	2102850 - 2102851	424364	409503	rs1555450672	NC_000016.10:2102850:CACCCTGGAGTGAC:CACCCTGGAGTGACCACCCTGGAGTGAC
NM_001009944.3(PKD1):c.12310_12313dup (p.Ile4105fs)	PKD1		not provided	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	VCV000423181	16	2140416 - 2140417	16	2090415 - 2090416	423181	409500	rs1555444602	NC_000016.10:2090415:TAAC:TAACTAAC
NM_001009944.3(PKD1):c.1687C>T (p.Gln563Ter)	PKD1	Q563*	not provided	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000419961	16	2166565	16	2116564	419961	409508	rs1064794207	NC_000016.10:2116563:G:A
NM_001009944.3(PKD1):c.6913C>T (p.Gln2305Ter)	PKD1	Q2305*	not provided	Pathogenic(Last reviewed: Jul 24, 2015)	criteria provided, single submitter	VCV000419272	16	2158255	16	2108254	419272	409506	rs1064793762	NC_000016.10:2108253:G:A
NM_001009944.3(PKD1):c.5086C>T (p.Gln1696Ter)	PKD1	Q1696*	Polycystic kidney dysplasia	Pathogenic(Last reviewed: Jun 8, 2016)	no assertion criteria provided	VCV000373937	16	2160082	16	2110081	373937	360990	rs1057518783	NC_000016.10:2110080:G:A
NM_001009944.3(PKD1):c.8369del (p.Pro2790fs)	PKD1	P2790fs	not provided	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000373776	16	2153689	16	2103688	373776	360270	rs1057518604	NC_000016.10:2103687:GGG:GG
NM_001009944.3(PKD1):c.1722+2T>C	PKD1		not provided	Pathogenic(Last reviewed: Jun 23, 2016)	criteria provided, single submitter	VCV000280669	16	2166528	16	2116527	280669	264693	rs886041836	NC_000016.10:2116526:A:G
NM_001009944.3(PKD1):c.322G>T (p.Glu108Ter)	PKD1	E108*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Apr 30, 2019)	no assertion criteria provided	VCV000829954	16	2169152	16	2119151	829954	818323		NC_000016.10:2119150:C:A
NM_001009944.3(PKD1):c.12391G>T (p.Glu4131Ter)	PKD1	E4130*, E4131*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828104	16	2140339	16	2090338	828104	816483		NC_000016.10:2090337:C:A
GRCh37/hg19 16p13.3(chr16:2140675-2140809)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000813320	16	2140675 - 2140809			813320	801569		
NM_001009944.3(PKD1):c.9824dup (p.Thr3276fs)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000812069	16	2149960 - 2149961	16	2099959 - 2099960	812069	799880		NC_000016.10:2099959:AAA:AAAA
NM_001009944.3(PKD1):c.166_167insGCGGGCC (p.Leu56fs)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000811887	16	2185524 - 2185525	16	2135523 - 2135524	811887	799949		NC_000016.10:2135523:G:GGCCCGCG
NM_001009944.3(PKD1):c.3792C>A (p.Tyr1264Ter)	PKD1	Y1264*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jan 6, 2019)	criteria provided, single submitter	VCV000811875	16	2161376	16	2111375	811875	799928		NC_000016.10:2111374:G:T
NM_001009944.3(PKD1):c.10163del (p.Ala3388fs)	PKD1	A3388fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000811856	16	2147873	16	2097872	811856	799879		NC_000016.10:2097871:G:
NM_001009944.3(PKD1):c.9585G>A (p.Trp3195Ter)	PKD1	W3195*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Nov 23, 2018)	criteria provided, single submitter	VCV000811842	16	2150294	16	2100293	811842	799883		NC_000016.10:2100292:C:T
NM_001009944.3(PKD1):c.2085del (p.Ala696fs)	PKD1	A696fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000811793	16	2165391	16	2115390	811793	799940		NC_000016.10:2115389:GGGGGG:GGGGG
NM_001009944.3(PKD1):c.12381C>G (p.Tyr4127Ter)	PKD1	Y4126*, Y4127*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000811724	16	2140349	16	2090348	811724	799862		NC_000016.10:2090347:G:C
NM_001009944.3(PKD1):c.3346C>T (p.Gln1116Ter)	PKD1	Q1116*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000811713	16	2161822	16	2111821	811713	799931		NC_000016.10:2111820:G:A
NM_001009944.3(PKD1):c.1930_1932delinsTG (p.Gly644fs)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000811428	16	2165544 - 2165546	16	2115543 - 2115545	811428	799941		NC_000016.10:2115542:TCC:CA
NM_001009944.3(PKD1):c.4796dup (p.Tyr1599Ter)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000811426	16	2160371 - 2160372	16	2110370 - 2110371	811426	799925		NC_000016.10:2110370:T:TT
NM_001009944.3(PKD1):c.5141del (p.Phe1714fs)	PKD1	F1714fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000811337	16	2160027	16	2110026	811337	799922		NC_000016.10:2110025:AA:A
NM_001009944.3(PKD1):c.8239_8242del (p.Met2747fs)	PKD1	M2747fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000811277	16	2153816 - 2153819	16	2103815 - 2103818	811277	799899		NC_000016.10:2103814:CCATCC:CC
NM_001009944.3(PKD1):c.6795C>A (p.Tyr2265Ter)	PKD1	Y2265*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000811234	16	2158373	16	2108372	811234	799916		NC_000016.10:2108371:G:T
NM_001009944.3(PKD1):c.5921del (p.Leu1974fs)	PKD1	L1974fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Nov 23, 2018)	criteria provided, single submitter	VCV000811212	16	2159247	16	2109246	811212	799920		NC_000016.10:2109245:A:
NM_001009944.3(PKD1):c.9885del (p.Asn3295fs)	PKD1	N3295fs	not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000805196	16	2149900	16	2099899	805196	793586		NC_000016.10:2099898:G:
NM_001009944.3(PKD1):c.9202-10_9218del	PKD1		not provided	Pathogenic(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV000805191	16	2152241 - 2152267	16	2102240 - 2102266	805191	794056		NC_000016.10:2102239:ACATCCGCTGTCGGCTCCTGTGAGGACACA:ACA
NM_001009944.3(PKD1):c.5481dup (p.Gln1828fs)	PKD1		not provided	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000805170	16	2159686 - 2159687	16	2109685 - 2109686	805170	793608		NC_000016.10:2109685:CCCCC:CCCCCC
NM_001009944.3(PKD1):c.5018del (p.Gly1673fs)	PKD1	G1673fs	not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000805168	16	2160150	16	2110149	805168	793610		NC_000016.10:2110148:CCCC:CCC
NM_001009944.3(PKD1):c.10233del (p.Trp3411fs)	PKD1	W3410fs, W3411fs	not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000805133	16	2147492	16	2097491	805133	793584		NC_000016.10:2097490:CC:C
NM_001009944.3(PKD1):c.1931del (p.Gly644fs)	PKD1	G644fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803173	16	2165545	16	2115544	803173	791557		NC_000016.10:2115543:CCCCC:CCCC
NM_001009944.3(PKD1):c.2048G>A (p.Trp683Ter)	PKD1	W683*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803172	16	2165428	16	2115427	803172	791556		NC_000016.10:2115426:C:T
NM_001009944.3(PKD1):c.2828_2831del (p.Ala943fs)	PKD1	A943fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803170	16	2164193 - 2164196	16	2114192 - 2114195	803170	791554		NC_000016.10:2114191:CGGGC:C
NM_001009944.3(PKD1):c.4243del (p.Asp1415fs)	PKD1	D1415fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803168	16	2160925	16	2110924	803168	791552		NC_000016.10:2110923:CCC:CC
NM_001009944.3(PKD1):c.4906C>T (p.Gln1636Ter)	PKD1	Q1636*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803166	16	2160262	16	2110261	803166	791550		NC_000016.10:2110260:G:A
NM_001009944.3(PKD1):c.8767C>T (p.Gln2923Ter)	PKD1	Q2923*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803161	16	2153291	16	2103290	803161	791545		NC_000016.10:2103289:G:A
NM_001009944.3(PKD1):c.12004-7_12012dup	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803160	16	2140800 - 2140801	16	2090799 - 2090800	803160	791544		NC_000016.10:2090799:CTGGGCAGCCTGCGGAC:CTGGGCAGCCTGCGGACTGGGCAGCCTGCGGAC
NM_001009944.3(PKD1):c.4832_4836dup (p.Ala1613fs)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Nov 26, 2018)	no assertion criteria provided	VCV000635522	16	2160331 - 2160332	16	2110330 - 2110331	635522	623334		NC_000016.10:2110330:CGTGACG:CGTGACGTGACG
NM_001009944.3(PKD1):c.5830G>T (p.Gly1944Ter)	PKD1	G1944*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Nov 26, 2018)	no assertion criteria provided	VCV000635520	16	2159338	16	2109337	635520	623333		NC_000016.10:2109336:C:A
NM_001009944.3(PKD1):c.12490del (p.Arg4164fs)	PKD1	R4163fs, R4164fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Oct 12, 2018)	no assertion criteria provided	VCV000635498	16	2140150	16	2090149	635498	623324		NC_000016.10:2090148:G:
NM_001009944.3(PKD1):c.12348del (p.Glu4116fs)	PKD1	E4116fs, E4115fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Feb 21, 2019)	no assertion criteria provided	VCV000635487	16	2140382	16	2090381	635487	623325		NC_000016.10:2090380:C:
NM_001009944.3(PKD1):c.3482G>A (p.Trp1161Ter)	PKD1	W1161*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Oct 31, 2018)	no assertion criteria provided	VCV000635437	16	2161686	16	2111685	635437	623336		NC_000016.10:2111684:C:T
NM_001009944.3(PKD1):c.5366C>G (p.Ser1789Ter)	PKD1	S1789*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jan 17, 2019)	no assertion criteria provided	VCV000617551	16	2159802	16	2109801	617551	608920	rs1377414968	NC_000016.10:2109800:G:C
NM_001009944.3(PKD1):c.1347_1356delinsAC (p.Ser449fs)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jul 17, 2018)	no assertion criteria provided	VCV000599151	16	2167519 - 2167528	16	2117518 - 2117527	599151	590320	rs1567216323	NC_000016.10:2117517:CACGGCGGGA:GT
NM_001009944.3(PKD1):c.404G>A (p.Trp135Ter)	PKD1	W135*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Apr 9, 2018)	no assertion criteria provided	VCV000599102	16	2168802	16	2118801	599102	590321	rs1567219111	NC_000016.10:2118800:C:T
NM_001009944.3(PKD1):c.3850del (p.Ala1284fs)	PKD1	A1284fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Mar 12, 2018)	no assertion criteria provided	VCV000599092	16	2161318	16	2111317	599092	590317	rs1567202350	NC_000016.10:2111316:CC:C
NM_001009944.3(PKD1):c.8873C>A (p.Ser2958Ter)	PKD1	S2958*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Mar 12, 2018)	no assertion criteria provided	VCV000599089	16	2152890	16	2102889	599089	590315	rs750780241	NC_000016.10:2102888:G:T
NM_001009944.3(PKD1):c.10092dup (p.Leu3365fs)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jan 23, 2018)	no assertion criteria provided	VCV000599073	16	2147943 - 2147944	16	2097942 - 2097943	599073	590313	rs1567165997	NC_000016.10:2097942:C:CC
NM_001009944.3(PKD1):c.3071delinsCCC (p.Val1024fs)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jan 17, 2018)	no assertion criteria provided	VCV000599067	16	2162879	16	2112878	599067	590319	rs1567206904	NC_000016.10:2112877:A:GGG
NM_001009944.3(PKD1):c.12217_12221del (p.Thr4073fs)	PKD1	T4073fs, T4072fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jan 16, 2018)	no assertion criteria provided	VCV000599066	16	2140509 - 2140513	16	2090508 - 2090512	599066	590311	rs1567146946	NC_000016.10:2090507:AGGGTAG:AG
NM_001009944.3(PKD1):c.9412dup (p.Val3138fs)	PKD1		not provided	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000586306	16	2150552 - 2150553	16	2100551 - 2100552	586306	577480	rs1567171493	NC_000016.10:2100551:C:CC
NM_001009944.3(PKD1):c.8333del (p.Gly2778fs)	PKD1	G2778fs	not provided	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000586302	16	2153725	16	2103724	586302	577484	rs1567178000	NC_000016.10:2103723:CCC:CC
NM_001009944.3(PKD1):c.7782_7783TG[3] (p.Leu2596fs)	PKD1		not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000586298	16	2155943 - 2155944	16	2105942 - 2105943	586298	577488	rs1567183633	NC_000016.10:2105942:CACAC:CACACAC
NM_001009944.3(PKD1):c.3G>A (p.Met1Ile)	PKD1	M1I	not provided	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000586273	16	2185688	16	2135687	586273	577535	rs1567233098	NC_000016.10:2135686:C:T
NM_001009944.3(PKD1):c.3601_3620del (p.Ala1201fs)	PKD1	A1201fs	not provided	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000586270	16	2161548 - 2161567	16	2111547 - 2111566	586270	577514	rs778028967	NC_000016.10:2111546:CGCACATCCGCCTGGGCCGCCGCAC:CGCAC
NM_001009944.3(PKD1):c.3296-1G>C	PKD1		not provided	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000586268	16	2161873	16	2111872	586268	577516	rs1567204631	NC_000016.10:2111871:C:G
NM_001009944.3(PKD1):c.3247_3253del (p.Ala1083fs)	PKD1	A1083fs	not provided	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000586267	16	2162383 - 2162389	16	2112382 - 2112388	586267	577517	rs1567205637	NC_000016.10:2112381:CCTGGGCC:C
NM_001009944.3(PKD1):c.2867dup (p.Val957fs)	PKD1		not provided	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000586264	16	2163279 - 2163280	16	2113278 - 2113279	586264	577520	rs1567208136	NC_000016.10:2113278:A:AA
NM_001009944.3(PKD1):c.10417_10419delinsT (p.Ile3473fs)	PKD1		not provided	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000586239	16	2147229 - 2147231	16	2097228 - 2097230	586239	577472	rs1567164013	NC_000016.10:2097227:GAT:A
NM_001009944.3(PKD1):c.10026dup (p.Leu3343fs)	PKD1		not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000586236	16	2149668 - 2149669	16	2099667 - 2099668	586236	577475	rs1567169118	NC_000016.10:2099667:AAAAA:AAAAAA
NM_001009944.3(PKD1):c.2098-1G>C	PKD1		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562361	16	2164927	16	2114926	562361	553545	rs1567211807	NC_000016.10:2114925:C:G
NM_001009944.3(PKD1):c.9912_9913CT[1] (p.Ser3305fs)	PKD1		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562331	16	2149870 - 2149871	16	2099869 - 2099870	562331	553515	rs1567169638	NC_000016.10:2099868:AGAG:AG
NM_001009944.3(PKD1):c.5824del (p.Arg1942fs)	PKD1	R1942fs	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562327	16	2159344	16	2109343	562327	553511	rs1567195285	NC_000016.10:2109342:GGGGG:GGGG
NM_001009944.3(PKD1):c.1723-2A>G	PKD1		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562319	16	2166121	16	2116120	562319	553503	rs1567214052	NC_000016.10:2116119:T:C
NM_001009944.3(PKD1):c.1206_1207del (p.His403fs)	PKD1	H403fs	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562317	16	2167668 - 2167669	16	2117667 - 2117668	562317	553501	rs1567216675	NC_000016.10:2117666:GC:
NM_001009944.3(PKD1):c.7490-2A>T	PKD1		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562314	16	2156307	16	2106306	562314	553498	rs1567185163	NC_000016.10:2106305:T:A
NM_001009944.3(PKD1):c.2298_2308del (p.Cys767fs)	PKD1	C767fs	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562310	16	2164716 - 2164726	16	2114715 - 2114725	562310	553494	rs1567211181	NC_000016.10:2114714:GCAGGGCACAGGCAGGGCA:GCAGGGCA
NM_001009944.3(PKD1):c.1286G>T (p.Trp429Leu)	PKD1	W429L	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562303	16	2167589	16	2117588	562303	553487	rs1567216472	NC_000016.10:2117587:C:A
NM_001009944.3(PKD1):c.7493G>A (p.Trp2498Ter)	PKD1	W2498*	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562300	16	2156302	16	2106301	562300	553484	rs1567185138	NC_000016.10:2106300:C:T
NM_001009944.3(PKD1):c.5878C>T (p.Gln1960Ter)	PKD1	Q1960*	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562298	16	2159290	16	2109289	562298	553482	rs1567195059	NC_000016.10:2109288:G:A
NM_001009944.3(PKD1):c.755dup (p.Pro253fs)	PKD1		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562290	16	2168237 - 2168238	16	2118236 - 2118237	562290	553474	rs1352019198	NC_000016.10:2118236:GGGGGG:GGGGGGG
NM_001009944.3(PKD1):c.2494dup (p.Arg832fs)	PKD1		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562288	16	2164529 - 2164530	16	2114528 - 2114529	562288	553472	rs1567210630	NC_000016.10:2114528:GGGGGG:GGGGGGG
NM_001009944.3(PKD1):c.1722+1G>A	PKD1		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562275	16	2166529	16	2116528	562275	553459	rs1567214706	NC_000016.10:2116527:C:T
NM_001009944.3(PKD1):c.8698C>T (p.Gln2900Ter)	PKD1	Q2900*	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562271	16	2153360	16	2103359	562271	553455	rs1567176750	NC_000016.10:2103358:G:A
NM_001009944.3(PKD1):c.8427del (p.Glu2810fs)	PKD1	E2810fs	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562269	16	2153631	16	2103630	562269	553453	rs1567177760	NC_000016.10:2103629:GGGG:GGG
NM_001009944.3(PKD1):c.2966_2967insCC (p.Ala990fs)	PKD1		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562265	16	2163180 - 2163181	16	2113179 - 2113180	562265	553449	rs1567207841	NC_000016.10:2113179:G:GGG
NM_001009944.3(PKD1):c.5707C>T (p.Gln1903Ter)	PKD1	Q1903*	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562264	16	2159461	16	2109460	562264	553448	rs942694907	NC_000016.10:2109459:G:A
NM_001009944.3(PKD1):c.4861C>T (p.Gln1621Ter)	PKD1	Q1621*	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562258	16	2160307	16	2110306	562258	553442	rs1264176877	NC_000016.10:2110305:G:A
NM_001009944.3(PKD1):c.10151C>G (p.Ser3384Ter)	PKD1	S3384*	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562255	16	2147885	16	2097884	562255	553439	rs1383556063	NC_000016.10:2097883:G:C
NM_001009944.3(PKD1):c.3128del (p.Val1043fs)	PKD1	V1043fs	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562254	16	2162822	16	2112821	562254	553438	rs1567206632	NC_000016.10:2112820:A:
NM_001009944.3(PKD1):c.9547C>T (p.Arg3183Ter)	PKD1	R3183*	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562249	16	2150418	16	2100417	562249	553433	rs1485297878	NC_000016.10:2100416:G:A
NM_001009944.3(PKD1):c.9240_9241del (p.Ala3082fs)	PKD1	A3082fs	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562246	16	2152218 - 2152219	16	2102217 - 2102218	562246	553430	rs1567173924	NC_000016.10:2102216:AT:
NM_001009944.3(PKD1):c.964_965dup (p.His323fs)	PKD1		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562244	16	2168027 - 2168028	16	2118026 - 2118027	562244	553428	rs1567217428	NC_000016.10:2118026:GAG:GAGAG
NM_001009944.3(PKD1):c.384del (p.Glu128fs)	PKD1	E128fs	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562243	16	2168822	16	2118821	562243	553427	rs1567219155	NC_000016.10:2118820:C:
NM_001009944.3(PKD1):c.7925_7926del (p.Ile2642fs)	PKD1	I2642fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000549710	16	2155413 - 2155414	16	2105412 - 2105413	549710	540477	rs1555452400	NC_000016.10:2105411:TAT:T
NM_001009944.3(PKD1):c.5896_5898GTG[1] (p.Val1967del)	PKD1	V1967del	Polycystic liver disease 1|Polycystic kidney dysplasia|Cystic renal dysplasia|Multicystic kidney dysplasia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523387	16	2159267 - 2159269	16	2109266 - 2109268	523387	514058	rs1555454847	NC_000016.10:2109265:CACCAC:CAC
NM_001009944.3(PKD1):c.1584C>A (p.Tyr528Ter)	PKD1	Y528*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Oct 13, 2017)	no assertion criteria provided	VCV000522520	16	2166856	16	2116855	522520	513125	rs1401015526	NC_000016.10:2116854:G:T
NM_001009944.3(PKD1):c.1078_1088del (p.Glu360fs)	PKD1	E360fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Oct 13, 2017)	no assertion criteria provided	VCV000522519	16	2167905 - 2167915	16	2117904 - 2117914	522519	513126	rs1555459001	NC_000016.10:2117903:CACACGAGCTCCA:CA
NM_001009944.3(PKD1):c.4709del (p.Thr1570fs)	PKD1	T1570fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522490	16	2160459	16	2110458	522490	513121	rs1555455797	NC_000016.10:2110457:G:
Single allele	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522444	16	2163763 - 2179490	16	2113762 - 2129489	522444	513124		
NM_001009944.3(PKD1):c.7861G>T (p.Glu2621Ter)	PKD1	E2621*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522439	16	2155868	16	2105867	522439	513117	rs762003393	NC_000016.10:2105866:C:A
NM_001009944.3(PKD1):c.9867C>A (p.Cys3289Ter)	PKD1	C3289*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522410	16	2149918	16	2099917	522410	513113	rs1420757773	NC_000016.10:2099916:G:T
NM_001009944.3(PKD1):c.6911_6912CA[1] (p.Gln2305fs)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522403	16	2158254 - 2158255	16	2108253 - 2108254	522403	513118	rs1555454075	NC_000016.10:2108252:TGTGT:TGT
NM_001009944.3(PKD1):c.10348G>T (p.Glu3450Ter)	PKD1	E3450*, E3449*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2016)	no assertion criteria provided	VCV000488408	16	2147377	16	2097376	488408	481262	rs780009030	NC_000016.10:2097375:C:A
NM_001009944.3(PKD1):c.1148C>A (p.Ser383Ter)	PKD1	S383*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2016)	no assertion criteria provided	VCV000488407	16	2167845	16	2117844	488407	481261	rs1286585831	NC_000016.10:2117843:G:T
NM_001009944.3(PKD1):c.5809del (p.Ser1937fs)	PKD1	S1937fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000488406	16	2159359	16	2109358	488406	481260	rs1555454915	NC_000016.10:2109357:A:
NM_001009944.3(PKD1):c.10487del (p.Leu3496fs)	PKD1	L3495fs, L3496fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000488344	16	2147161	16	2097160	488344	481173	rs1555448106	NC_000016.10:2097159:A:
NM_001009944.3(PKD1):c.8998dup (p.Arg3000fs)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000488185	16	2152584 - 2152585	16	2102583 - 2102584	488185	481144	rs1555450475	NC_000016.10:2102583:GG:GGG
NM_001009944.3(PKD1):c.12499del (p.Arg4167fs)	PKD1	R4166fs, R4167fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2016)	no assertion criteria provided	VCV000488184	16	2140141	16	2090140	488184	481143	rs1555444249	NC_000016.10:2090139:T:
NM_001009944.3(PKD1):c.924_948delinsTGGAT (p.Asp309fs)	PKD1		not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000448026	16	2168045 - 2168069	16	2118044 - 2118068	448026	441879	rs1555459056	NC_000016.10:2118043:GGCATCCACCTCGGCGGAGCCGTCT:ATCCA
NM_001009944.3(PKD1):c.7704-2_7712del	PKD1		not provided	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000448007	16	2156017 - 2156027	16	2106016 - 2106026	448007	441843	rs1555452738	NC_000016.10:2106015:GCCAAAGACCT:
NM_001009944.3(PKD1):c.6193del (p.Ala2065fs)	PKD1	A2065fs	not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000447993	16	2158975	16	2108974	447993	441855	rs1555454620	NC_000016.10:2108973:CC:C
NM_001009944.3(PKD1):c.11713-2A>G	PKD1		not provided	Pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, single submitter	VCV000447955	16	2141177	16	2091176	447955	441810	rs1555445274	NC_000016.10:2091175:T:C
NM_001009944.3(PKD1):c.7428C>A (p.Cys2476Ter)	PKD1	C2476*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000438680	16	2156460	16	2106459	438680	432325	rs1453883641	NC_000016.10:2106458:G:T
NM_001009944.3(PKD1):c.3503dup (p.Val1169fs)	PKD1		Polycystic kidney disease, adult type	Pathogenic	no assertion criteria provided	VCV000433550	16	2161664 - 2161665	16	2111663 - 2111664	433550	427122	rs1555456661	NC_000016.10:2111663:GGGG:GGGGG
NM_001009944.3(PKD1):c.5021del (p.Pro1674fs)	PKD1	P1674fs	Polycystic kidney disease, adult type	Pathogenic	no assertion criteria provided	VCV000433540	16	2160147	16	2110146	433540	427114	rs1555455453	NC_000016.10:2110145:GGG:GG
NM_001009944.3(PKD1):c.10220+2_10220+3del	PKD1		Polycystic kidney disease, adult type	Pathogenic	no assertion criteria provided	VCV000427741	16	2147726 - 2147727	16	2097725 - 2097726	427741	417443	rs1114167366	NC_000016.10:2097724:CAC:C
NM_001009944.3(PKD1):c.12310_12311del (p.Val4104fs)	PKD1	V4103fs, V4104fs	Polycystic kidney disease, adult type	Pathogenic	no assertion criteria provided	VCV000397614	16	2140419 - 2140420	16	2090418 - 2090419	397614	384492	rs1060499718	NC_000016.10:2090417:ACA:A
NM_001009944.3(PKD1):c.6424del (p.Gln2142fs)	PKD1	Q2142fs	Polycystic kidney disease, adult type	Pathogenic	no assertion criteria provided	VCV000397591	16	2158744	16	2108743	397591	384496	rs1060499702	NC_000016.10:2108742:GG:G
NM_001009944.3(PKD1):c.6299C>A (p.Ser2100Ter)	PKD1	S2100*	Polycystic kidney disease, adult type	Pathogenic	no assertion criteria provided	VCV000397586	16	2158869	16	2108868	397586	384497	rs539793378	NC_000016.10:2108867:G:T
NM_001009944.3(PKD1):c.2079dup (p.Pro694fs)	PKD1		Hepatic cysts|Dilatation of the cerebral artery|Stage 5 chronic kidney disease	Pathogenic(Last reviewed: Jan 28, 2015)	criteria provided, single submitter	VCV000374141	16	2165396 - 2165397	16	2115395 - 2115396	374141	360995	rs1057518923	NC_000016.10:2115395:CCCC:CCCCC
NM_001009944.3(PKD1):c.3520C>T (p.Gln1174Ter)	PKD1	Q1174*	Polycystic kidney dysplasia|Hypertensive disorder	Pathogenic(Last reviewed: Jun 11, 2015)	criteria provided, single submitter	VCV000374102	16	2161648	16	2111647	374102	360993	rs1057518899	NC_000016.10:2111646:G:A
NM_001009944.3(PKD1):c.3543T>A (p.Tyr1181Ter)	PKD1	Y1181*	Polycystic kidney disease, adult type	Pathogenic	no assertion criteria provided	VCV000369967	16	2161625	16	2111624	369967	354175	rs1057516206	NC_000016.10:2111623:A:T
NM_001009944.3(PKD1):c.11900_11925delinsAAGCTAGTGA (p.Val3967fs)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Aug 29, 2016)	no assertion criteria provided	VCV000267265	16	2140963 - 2140988	16	2090962 - 2090987	267265	262268	rs886040959	NC_000016.10:2090961:AGTGAAGCGGCGCGGGCGGCCGCGCA:TCACTAGCTT
NM_001009944.3(PKD1):c.445del (p.Gln149fs)	PKD1	Q149fs	Polycystic kidney disease, adult type	Pathogenic	no assertion criteria provided	VCV000208064	16	2168761	16	2118760	208064	204343	rs796052133	NC_000016.10:2118759:G:
NM_001009944.3(PKD1):c.7833C>G (p.Tyr2611Ter)	PKD1	Y2611*	not provided	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000805184	16	2155896	16	2105895	805184	793596		NC_000016.10:2105894:G:C
NM_001009944.3(PKD1):c.7045del (p.Glu2349fs)	PKD1	E2349fs	not provided	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000805176	16	2157904	16	2107903	805176	793602		NC_000016.10:2107902:CC:C
NM_001009944.3(PKD1):c.6565_6566GT[3] (p.Tyr2190fs)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000637996	16	2158599 - 2158600	16	2108598 - 2108599	637996	625819		NC_000016.10:2108598:ACAC:ACACAC
NM_001009944.3(PKD1):c.7111del (p.Val2371fs)	PKD1	V2371fs	Polycystic kidney disease 3	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000620580	16	2156904	16	2106903	620580	611980	rs1567187420	NC_000016.10:2106902:C:
NM_001009944.3(PKD1):c.8972dup (p.Tyr2991Ter)	PKD1		not provided	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000586305	16	2152610 - 2152611	16	2102609 - 2102610	586305	577481	rs1567174997	NC_000016.10:2102609:T:TT
NM_001009944.3(PKD1):c.2085dup (p.Ala696fs)	PKD1		not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000562308	16	2165390 - 2165391	16	2115389 - 2115390	562308	553492	rs1567212531	NC_000016.10:2115389:GGGGGG:GGGGGGG
NM_001009944.3(PKD1):c.8447T>C (p.Leu2816Pro)	PKD1	L2816P	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, single submitter	VCV000562235	16	2153611	16	2103610	562235	553419	rs1567177684	NC_000016.10:2103609:A:G
NM_001009944.3(PKD1):c.2622_2626CCCTG[3] (p.Val878fs)	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000448969	16	2164392 - 2164393	16	2114391 - 2114392	448969	442561	rs1555457807	NC_000016.10:2114391:CAGGGCAGGGCAG:CAGGGCAGGGCAGGGCAG
NM_001009944.3(PKD1):c.8162-1G>A	PKD1		not provided	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000448014	16	2153897	16	2103896	448014	441837	rs1555451430	NC_000016.10:2103895:C:T
NM_001009944.3(PKD1):c.8017-1dup	PKD1		not provided	Pathogenic(Last reviewed: Aug 11, 2016)	criteria provided, single submitter	VCV000448012	16	2154640 - 2154641	16	2104639 - 2104640	448012	441839	rs1555452047	NC_000016.10:2104639:CCCC:CCCCC
NM_001009944.3(PKD1):c.7164C>G (p.Tyr2388Ter)	PKD1	Y2388*	not provided	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000448000	16	2156851	16	2106850	448000	441848	rs1555453372	NC_000016.10:2106849:G:C
NM_001009944.3(PKD1):c.11944C>T (p.Gln3982Ter)	PKD1	Q3981*, Q3982*	not provided	Pathogenic(Last reviewed: Feb 6, 2015)	criteria provided, single submitter	VCV000447959	16	2140944	16	2090943	447959	441807	rs1161012209	NC_000016.10:2090942:G:A
PKD1, 3-BP DEL, EX20 AND 8-BP DEL, EX21	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000008210					8210	23249		
NM_001009944.3(PKD1):c.12420G>A (p.Trp4140Ter)	PKD1	W4139*, W4140*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000008209	16	2140310	16	2090309	8209	23248	rs199476102	NC_000016.10:2090308:C:T
PKD1, 2-BP DEL, 5224AG	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Aug 7, 2017)	no assertion criteria provided	VCV000008208					8208	23247		
NM_001009944.3(PKD1):c.5764C>T (p.Gln1922Ter)	PKD1	Q1922*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000008207	16	2159404	16	2109403	8207	23246	rs199476101	NC_000016.10:2109402:G:A
NM_001009944.3(PKD1):c.3296-1G>A	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000008204	16	2161873	16	2111872	8204	23243	rs1567204631	NC_000016.10:2111871:C:T
NM_001009944.3(PKD1):c.6440_6467del (p.Arg2147fs)	PKD1	R2147fs	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000008203	16	2158701 - 2158728	16	2108700 - 2108727	8203	23242	rs1567192790	NC_000016.10:2108699:GGCAGGACCACGTCCACCTCCGGCTCCCGGCAGG:GGCAGG
NM_001009944.3(PKD1):c.12036G>A (p.Trp4012Ter)	PKD1	W4012*, W4011*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000008202	16	2140777	16	2090776	8202	23241	rs1218054241	NC_000016.10:2090775:C:T
NM_001009944.3(PKD1):c.12261T>A (p.Cys4087Ter)	PKD1	C4086*, C4087*	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000008200	16	2140469	16	2090468	8200	23239	rs199476097	NC_000016.10:2090467:A:T
PKD1, IVSDS, G-C, +1	PKD1		Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jun 17, 1994)	no assertion criteria provided	VCV000008195					8195	23234		
NM_001009944.3(PKD1):c.6736C>T (p.Gln2246Ter)	PKD1	Q2246*	Polycystic kidney disease, adult type|not provided	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000618317	16	2158432	16	2108431	618317	609989	rs1567191534	NC_000016.10:2108430:G:A
NM_001009944.3(PKD1):c.7107_7108GT[3] (p.Ser2372fs)	PKD1		not provided	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000586292	16	2156901 - 2156902	16	2106900 - 2106901	586292	577494	rs1567187389	NC_000016.10:2106899:ACACACAC:ACACAC
NM_001009944.3(PKD1):c.4444C>T (p.Gln1482Ter)	PKD1	Q1482*	not provided	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000586276	16	2160724	16	2110723	586276	577509	rs1567200117	NC_000016.10:2110722:G:A
NM_001009944.3(PKD1):c.10167+25_10167+43del	PKD1		not provided	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000586238	16	2147826 - 2147844	16	2097825 - 2097843	586238	577473	rs1197421698	NC_000016.10:2097824:CAGGACCCCCAGCCCAGCCCAGGACCCCCAG:CAGGACCCCCAG
NM_001009944.3(PKD1):c.12691C>T (p.Gln4231Ter)	PKD1	Q4231*, Q4230*	not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000562326	16	2139949	16	2089948	562326	553510	rs755496450	NC_000016.10:2089947:G:A
NM_001009944.3(PKD1):c.7622del (p.Pro2541fs)	PKD1	P2541fs	Polycystic kidney disease, autosomal dominant	Pathogenic	no assertion criteria provided	VCV000559836	16	2156173	16	2106172	559836	550558	rs1555452849	NC_000016.10:2106171:GGGGG:GGGG
NM_001009944.3(PKD1):c.12035G>A (p.Trp4012Ter)	PKD1	W4012*, W4011*	not provided|Polycystic kidney dysplasia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523384	16	2140778	16	2090777	523384	514054	rs777269070	NC_000016.10:2090776:C:T
NM_001009944.3(PKD1):c.8218G>T (p.Gly2740Ter)	PKD1	G2740*	not provided	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	VCV000448015	16	2153840	16	2103839	448015	441836	rs1555451368	NC_000016.10:2103838:C:A
NM_001009944.3(PKD1):c.7126C>T (p.Gln2376Ter)	PKD1	Q2376*	not provided	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000447999	16	2156889	16	2106888	447999	441849	rs1555453395	NC_000016.10:2106887:G:A
NM_001009944.3(PKD1):c.11798_11810del (p.Leu3933fs)	PKD1	L3933fs, L3932fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, single submitter	VCV000434005	16	2141078 - 2141090	16	2091077 - 2091089	434005	427447	rs1555445192	NC_000016.10:2091076:GCCCAGGCTCCGAGCC:GCC
NM_001009944.3(PKD1):c.9074_9076delinsA (p.Trp3025_Arg3026delinsTer)	PKD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000433996	16	2152507 - 2152509	16	2102506 - 2102508	433996	427456	rs1555450424	NC_000016.10:2102505:GCC:T
NM_001009944.3(PKD1):c.7174del (p.Arg2392fs)	PKD1	R2392fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000433978	16	2156841	16	2106840	433978	427474	rs1555453360	NC_000016.10:2106839:GG:G
NM_001009944.3(PKD1):c.7137C>G (p.Tyr2379Ter)	PKD1	Y2379*	Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000433977	16	2156878	16	2106877	433977	427475	rs752114168	NC_000016.10:2106876:G:C
NM_001009944.3(PKD1):c.6987_6993GCTGGCG[3] (p.Val2334fs)	PKD1		Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000433976	16	2157948 - 2157949	16	2107947 - 2107948	433976	427476	rs1555453872	NC_000016.10:2107947:CGCCAGCCGCCAGCCGC:CGCCAGCCGCCAGCCGCCAGCCGC
NM_001009944.3(PKD1):c.6307C>T (p.Gln2103Ter)	PKD1	Q2103*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, single submitter	VCV000433971	16	2158861	16	2108860	433971	427481	rs1555454512	NC_000016.10:2108859:G:A
NM_001009944.3(PKD1):c.4461del (p.Ser1488fs)	PKD1	S1488fs	Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000433962	16	2160707	16	2110706	433962	427490	rs1555455998	NC_000016.10:2110705:G:
NM_001009944.2:c.8949-?_9397+?del	PKD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	VCV000433595	16	2152062 - 2152634			433595	427600		
NM_001009944.2:c.6468-?_10050+?del	PKD1		Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jul 27, 2016)	criteria provided, single submitter	VCV000433593	16	2149645 - 2158700			433593	427599		
NM_001009944.3(PKD1):c.10420C>T (p.Gln3474Ter)	PKD1	Q3474*, Q3473*	not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419960	16	2147228	16	2097227	419960	409502	rs1064794206	NC_000016.10:2097226:G:A
NC_000016.10:g.(?_89767131)_(89784974_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000830942	16	89833539 - 89851382			830942	820937		
NC_000016.9:g.(?_89849257)_(89851382_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000649628	16	89849257 - 89851382	16	89782849 - 89784974	649628	652896		
NM_000135.4(FANCA):c.401dup (p.Val135fs)	FANCA		Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558097	16	89877361 - 89877362	16	89810953 - 89810954	558097	548743	rs1555575253	NC_000016.10:89810953:GGG:GGGG
NM_000135.4(FANCA):c.283+1G>T	FANCA		Fanconi anemia, complementation group A|Fanconi anemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555413	16	89880927	16	89814519	555413	548260	rs1232171121	NC_000016.10:89814518:C:A
NM_000135.4(FANCA):c.2107C>T (p.Gln703Ter)	FANCA	Q703*	Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552483	16	89838130	16	89771722	552483	547947	rs1555548512	NC_000016.10:89771721:G:A
NM_001009944.3(PKD1):c.4797C>A (p.Tyr1599Ter)	PKD1	Y1599*	Polycystic kidney disease, adult type|not provided	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000805167	16	2160371	16	2110370	805167	793611		NC_000016.10:2110369:G:T
NM_001009944.3(PKD1):c.6727C>T (p.Gln2243Ter)	PKD1	Q2243*	not provided	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000586289	16	2158441	16	2108440	586289	577497	rs1567191609	NC_000016.10:2108439:G:A
NM_001009944.3(PKD1):c.2677_2678del (p.Leu893fs)	PKD1	L893fs	not provided|Polycystic kidney disease, adult type	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000586262	16	2164346 - 2164347	16	2114345 - 2114346	586262	577522	rs1567210080	NC_000016.10:2114344:AG:
NM_001009944.3(PKD1):c.10084C>T (p.Gln3362Ter)	PKD1	Q3362*	not provided	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000586237	16	2147952	16	2097951	586237	577474	rs1567166045	NC_000016.10:2097950:G:A
NM_001009944.3(PKD1):c.7327G>T (p.Gly2443Ter)	PKD1	G2443*	Polycystic kidney disease, adult type|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000562312	16	2156561	16	2106560	562312	553496	rs1567186165	NC_000016.10:2106559:C:A
NM_001009944.3(PKD1):c.8017-2A>G	PKD1		not provided	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000562279	16	2154645	16	2104644	562279	553463	rs1567180640	NC_000016.10:2104643:T:C
NM_001009944.3(PKD1):c.7288C>T (p.Arg2430Ter)	PKD1	R2430*	Polycystic kidney disease, adult type|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000562262	16	2156600	16	2106599	562262	553446	rs2432403	NC_000016.10:2106598:G:A
NM_001009944.3(PKD1):c.849_855TCTGGCC[1] (p.Ser286_Gly287insTer)	PKD1		not provided	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000448020	16	2168131 - 2168137	16	2118130 - 2118136	448020	441880	rs1555459108	NC_000016.10:2118129:GGCCAGAGGCCAGAGG:GGCCAGAGG
NM_001009944.3(PKD1):c.165_171del (p.Leu56fs)	PKD1	L56fs	not provided	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000447976	16	2185520 - 2185526	16	2135519 - 2135525	447976	441885	rs1555462438	NC_000016.10:2135518:CCGCAGCCCGC:CCGC
NM_001009944.3(PKD1):c.8704C>T (p.Gln2902Ter)	PKD1	Q2902*	Polycystic kidney disease, adult type|not provided	Pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000441260	16	2153354	16	2103353	441260	434903	rs1555450968	NC_000016.10:2103352:G:A
NM_001009944.3(PKD1):c.11713-1G>A	PKD1		not provided|not specified	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000440137	16	2141176	16	2091175	440137	433161	rs867092741	NC_000016.10:2091174:C:T
NM_001009944.3(PKD1):c.12514del (p.Ser4172fs)	PKD1	S4171fs, S4172fs	Autosomal recessive polycystic kidney disease	Pathogenic	criteria provided, single submitter	VCV000434009	16	2140126	16	2090125	434009	427443	rs1555444225	NC_000016.10:2090124:A:
NM_001009944.3(PKD1):c.8095C>T (p.Gln2699Ter)	PKD1	Q2699*	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, single submitter	VCV000433984	16	2154565	16	2104564	433984	427468	rs1222094213	NC_000016.10:2104563:G:A
NM_001009944.3(PKD1):c.12682C>T (p.Arg4228Ter)	PKD1	R4227*, R4228*	Polycystic kidney disease, adult type|not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000008198	16	2139958	16	2089957	8198	23237	rs199476095	NC_000016.10:2089956:G:A
NM_004572.3(PKP2):c.663C>A (p.Tyr221Ter)	PKP2	Y221*	Arrhythmogenic right ventricular cardiomyopathy, type 9|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000201976	12	33031151	12	32878217	201976	198441	rs767987619	NC_000012.12:32878216:G:T
NM_001009944.3(PKD1):c.1723-1G>A	PKD1		Polycystic kidney disease, adult type|not provided	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000805152	16	2166120	16	2116119	805152	794058		NC_000016.10:2116118:C:T
NM_001009944.3(PKD1):c.8754_8758del (p.Gly2919fs)	PKD1	G2919fs	not provided|Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000638007	16	2153300 - 2153304	16	2103299 - 2103303	638007	625817		NC_000016.10:2103298:GCCCGGCC:GCC
NM_001009944.3(PKD1):c.8017-2_8017-1del	PKD1		not provided	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000586300	16	2154644 - 2154645	16	2104643 - 2104644	586300	577486	rs1567180636	NC_000016.10:2104642:CT:
NM_001009944.3(PKD1):c.6725_6726CA[1] (p.Gln2243fs)	PKD1		not provided	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000586288	16	2158440 - 2158441	16	2108439 - 2108440	586288	577496	rs1567191601	NC_000016.10:2108438:TGTGT:TGT
NM_001009944.3(PKD1):c.6031C>T (p.Gln2011Ter)	PKD1	Q2011*	not provided|Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523776	16	2159137	16	2109136	523776	514690	rs1555454739	NC_000016.10:2109135:G:A
NM_001009944.3(PKD1):c.2215C>T (p.Arg739Trp)	PKD1	Q739*, R739W	Autosomal recessive polycystic kidney disease|Polycystic kidney dysplasia|Polycystic liver disease 1	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000433952	16	2164809	16	2114808	433952	427500	rs747483368	NC_000016.10:2114807:G:A
NM_001009944.3(PKD1):c.12124C>T (p.Gln4042Ter)	PKD1	Q1273*, Q4041*, Q4042*	Polycystic kidney disease, adult type|not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000008196	16	2140689	16	2090688	8196	23235	rs199476094	NC_000016.10:2090687:G:A
NM_001127713.1(ATL1):c.1483C>T (p.Arg495Trp)	ATL1	R495W	Inborn genetic diseases|Hereditary spastic paraplegia 3A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000219827	14	51095112	14	50628394	219827	222374	rs864622269	NC_000014.9:50628393:C:T
NM_001009944.3(PKD1):c.7204C>T (p.Arg2402Ter)	PKD1	R2402*	not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000586294	16	2156811	16	2106810	586294	577492	rs1567186946	NC_000016.10:2106809:G:A
NM_001009944.3(PKD1):c.12712C>T (p.Gln4238Ter)	PKD1	Q4238*, Q4237*	not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000434010	16	2139928	16	2089927	434010	427442	rs1045675831	NC_000016.10:2089926:G:A
NM_001009944.3(PKD1):c.8545del (p.Ala2849fs)	PKD1	A2849fs	not provided|Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000433992	16	2153513	16	2103512	433992	427460	rs1555451093	NC_000016.10:2103511:CC:C
NM_001009944.3(PKD1):c.6199C>T (p.Gln2067Ter)	PKD1	Q2067*	not provided|Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000433970	16	2158969	16	2108968	433970	427482	rs1555454604	NC_000016.10:2108967:G:A
NM_001009944.3(PKD1):c.1583A>G (p.Tyr528Cys)	PKD1	Y528C	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	VCV000433946	16	2166857	16	2116856	433946	427506	rs750798165	NC_000016.10:2116855:T:C
NC_000017.10:g.(?_17116959)_(17117180_?)del	FLCN		Multiple fibrofolliculomas	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000664451	17	17116959 - 17117180	17	17213645 - 17213866	664451	653332		
NM_144997.7(FLCN):c.347dup (p.Leu117fs)	FLCN		Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas|not specified|not provided	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000241922	17	17129538 - 17129539	17	17226224 - 17226225	241922	242611	rs776896550	NC_000017.11:17226224:T:TT
NM_144997.7(FLCN):c.319_320delinsCAC (p.Val107fs)	FLCN		not provided|Multiple fibrofolliculomas|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096483	17	17129566 - 17129567	17	17226252 - 17226253	96483	102377	rs398124535	NC_000017.11:17226251:AC:GTG
NM_144997.7(FLCN):c.296del (p.Asp99fs)	FLCN	D99fs	not provided|Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096482	17	17129590	17	17226276	96482	102376	rs398124534	NC_000017.11:17226275:T:
NM_144997.7(FLCN):c.1533G>A (p.Trp511Ter)	FLCN	W511*, W529*	Multiple fibrofolliculomas|not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000096478	17	17118304	17	17214990	96478	102372	rs398124530	NC_000017.11:17214989:C:T
NM_000018.4(ACADVL):c.779C>T (p.Thr260Met)	ACADVL	T260M, T238M, T184M, T283M	not provided|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021024	17	7125522	17	7222203	21024	33876	rs113994168	NC_000017.11:7222202:C:T
NM_000018.4(ACADVL):c.1322G>A (p.Gly441Asp)	ACADVL	G401D, G441D, G365D, G464D, G419D	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021016	17	7127184	17	7223865	21016	33868	rs2309689	NC_000017.11:7223864:G:A
NM_002693.2(POLG):c.2897T>G (p.Leu966Arg)	POLG	L966R	not provided|Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372473	15	89864081	15	89320850	372473	360215	rs142347031	NC_000015.10:89320849:A:C
NM_000135.4(FANCA):c.1028_1029AG[3] (p.Glu345fs)	FANCA		Fanconi anemia, complementation group A|Fanconi anemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558653	16	89858927 - 89858928	16	89792519 - 89792520	558653	548730	rs769580546	NC_000016.10:89792518:CTCTCTCT:CTCTCT
NM_000135.4(FANCA):c.2026C>T (p.Gln676Ter)	FANCA	Q676*	Fanconi anemia, complementation group A|Fanconi anemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558070	16	89838211	16	89771803	558070	548660	rs1448463647	NC_000016.10:89771802:G:A
NM_000135.4(FANCA):c.856C>T (p.Gln286Ter)	FANCA	Q286*, Q254*	Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552738	16	89865611	16	89799203	552738	548733	rs1291524243	NC_000016.10:89799202:G:A
NM_001009944.3(PKD1):c.12448C>T (p.Arg4150Cys)	PKD1	R4149C, R4150C	not provided	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000805147	16	2140192	16	2090191	805147	793574		NC_000016.10:2090190:G:A
NM_001009944.3(PKD1):c.4306C>T (p.Arg1436Ter)	PKD1	R1436*	not provided	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000562236	16	2160862	16	2110861	562236	553420	rs1567200516	NC_000016.10:2110860:G:A
NM_000321.3(RB1):c.1448_1449AT[1] (p.Met484fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000855427	13	48954327 - 48954328	13	48380191 - 48380192	855427	840934		NC_000013.11:48380190:ATAT:AT
NC_000013.11:g.(?_48452983)_(48480081_?)del	RB1		Retinoblastoma	Pathogenic(Last reviewed: Apr 7, 2019)	criteria provided, single submitter	VCV000830414	13	49027119 - 49054217			830414	820581		
NM_000321.2(RB1):c.772_776del (p.Asn258fs)	RB1	N258fs	Retinoblastoma	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000576809	13	48937001 - 48937005	13	48362865 - 48362869	576809	567612	rs1566192530	NC_000013.11:48362864:CAGAACAG:CAG
NM_000321.2(RB1):c.607+2dup	RB1		Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428720	13	48923160 - 48923161	13	48349024 - 48349025	428720	420522	rs1131690895	NC_000013.11:48349024:T:TT
NM_000321.2(RB1):c.54_76dup (p.Pro26fs)	RB1		Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428668	13	48878093 - 48878094	13	48303957 - 48303958	428668	420504	rs1555279210	NC_000013.11:48303957:GCCGCCGCGGAACCCCCGGCACCGCCGCCGC:GCCGCCGCGGAACCCCCGGCACCGCCGCCGCGGAACCCCCGGCACCGCCGCCGC
NM_000321.2(RB1):c.1328C>A (p.Ser443Ter)	RB1	S443*	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000410927	13	48951166	13	48377030	410927	399513	rs1060503079	NC_000013.11:48377029:C:A
NM_000321.2(RB1):c.1024del (p.Thr342fs)	RB1	T342fs	Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000126826	13	48941711	13	48367575	126826	132336	rs587778844	NC_000013.11:48367574:AAAA:AAA
NM_025137.4(SPG11):c.4307_4308del (p.Gln1436fs)	SPG11	Q1436fs	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041315	15	44888407 - 44888408	15	44596209 - 44596210	41315	49739	rs312262759	NC_000015.10:44596208:TT:
NM_001376.5(DYNC1H1):c.10348G>A (p.Glu3450Lys)	DYNC1H1	E3450K	not provided	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000453004	14	102499756	14	102033419	453004	445176	rs1555411399	NC_000014.9:102033418:G:A
NM_001376.5(DYNC1H1):c.10420C>T (p.Arg3474Trp)	DYNC1H1	R3474W	not provided	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000246393	14	102500319	14	102033982	246393	244887	rs757725348	NC_000014.9:102033981:C:T
NM_001376.5(DYNC1H1):c.3370C>T (p.His1124Tyr)	DYNC1H1	H1124Y	not provided	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000246228	14	102461359	14	101995022	246228	244865	rs879254164	NC_000014.9:101995021:C:T
NM_001376.5(DYNC1H1):c.9092C>T (p.Thr3031Met)	DYNC1H1	T3031M	not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000245807	14	102493999	14	102027662	245807	244884	rs879253956	NC_000014.9:102027661:C:T
NM_001376.5(DYNC1H1):c.5884C>T (p.Arg1962Cys)	DYNC1H1	R1962C	not provided	Pathogenic(Last reviewed: Oct 3, 2015)	criteria provided, single submitter	VCV000245597	14	102474581	14	102008244	245597	244873	rs879253881	NC_000014.9:102008243:C:T
NM_001376.5(DYNC1H1):c.1738G>A (p.Glu580Lys)	DYNC1H1	E580K	Abnormality of neuronal migration	Pathogenic(Last reviewed: Oct 31, 2014)	no assertion criteria provided	VCV000208862	14	102452300	14	101985963	208862	205474	rs863223361	NC_000014.9:101985962:G:A
NM_001376.5(DYNC1H1):c.1706G>C (p.Arg569Pro)	DYNC1H1	R569P	Mental retardation, autosomal dominant 13	Pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000209108	14	102452268	14	101985931	209108	205704	rs797045178	NC_000014.9:101985930:G:C
NM_001376.5(DYNC1H1):c.3603G>T (p.Arg1201Ser)	DYNC1H1	R1201S	Mental retardation, autosomal dominant 13|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant	Pathogenic(Last reviewed: Nov 24, 2014)	no assertion criteria provided	VCV000180211	14	102463410	14	101997073	180211	178391	rs727505393	NC_000014.9:101997072:G:T
NM_001376.5(DYNC1H1):c.10031G>A (p.Arg3344Gln)	DYNC1H1	R3344Q	Mental retardation, autosomal dominant 13	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000055855	14	102498756	14	102032419	55855	70509	rs397509412	NC_000014.9:102032418:G:A
NM_001376.5(DYNC1H1):c.10151G>A (p.Arg3384Gln)	DYNC1H1	R3384Q	Mental retardation, autosomal dominant 13	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000055854	14	102499473	14	102033136	55854	70508	rs397509411	NC_000014.9:102033135:G:A
NM_001376.5(DYNC1H1):c.10008G>T (p.Lys3336Asn)	DYNC1H1	K3336N	Mental retardation, autosomal dominant 13	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000055853	14	102498733	14	102032396	55853	70507	rs397509410	NC_000014.9:102032395:G:T
NM_001376.5(DYNC1H1):c.2909A>G (p.Tyr970Cys)	DYNC1H1	Y970C	Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant	Pathogenic(Last reviewed: May 29, 2012)	no assertion criteria provided	VCV000030034	14	102457904	14	101991567	30034	38989	rs387906743	NC_000014.9:101991566:A:G
NM_001376.5(DYNC1H1):c.2011A>G (p.Lys671Glu)	DYNC1H1	K671E	Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant	Pathogenic(Last reviewed: May 29, 2012)	no assertion criteria provided	VCV000030033	14	102452573	14	101986236	30033	38988	rs387906742	NC_000014.9:101986235:A:G
NM_001376.5(DYNC1H1):c.4552G>A (p.Glu1518Lys)	DYNC1H1	E1518K	Mental retardation, autosomal dominant 13	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000030031	14	102468883	14	102002546	30031	38986	rs387906740	NC_000014.9:102002545:G:A
NM_001376.5(DYNC1H1):c.874C>T (p.Arg292Trp)	DYNC1H1	R292W	Mental retardation, autosomal dominant 13	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000800542	14	102446800	14	101980463	800542	789143		NC_000014.9:101980462:C:T
NM_001376.5(DYNC1H1):c.10573C>T (p.Arg3525Cys)	DYNC1H1	R3525C	not provided|Mental retardation, autosomal dominant 13	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224130	14	102500472	14	102034135	224130	225860	rs869312693	NC_000014.9:102034134:C:T
NM_001376.5(DYNC1H1):c.11465A>C (p.His3822Pro)	DYNC1H1	H3822P	Mental retardation, autosomal dominant 13	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000030030	14	102505753	14	102039416	30030	38985	rs387906739	NC_000014.9:102039415:A:C
NM_000070.3(CAPN3):c.1333G>A (p.Gly445Arg)	CAPN3	G445R, G397R	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000284515	15	42691829	15	42399631	284515	268752	rs773827877	NC_000015.10:42399630:G:A
NM_000070.3(CAPN3):c.802-9G>A	CAPN3		Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280037	15	42682142	15	42389944	280037	264570	rs761211705	NC_000015.10:42389943:G:A
NM_000053.4(ATP7B):c.813C>A (p.Cys271Ter)	ATP7B	C271*	not provided|Wilson disease	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188930	13	52548543	13	51974407	188930	186907	rs572147914	NC_000013.11:51974406:G:T
NM_000053.4(ATP7B):c.845del (p.Leu282fs)	ATP7B	L282fs	Wilson disease	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035735	13	52548511	13	51974375	35735	44399	rs193922111	NC_000013.11:51974374:A:
NM_000053.4(ATP7B):c.2293G>A (p.Asp765Asn)	ATP7B	D765N, D654N, D681N	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000003855	13	52532509	13	51958373	3855	18894	rs28942075	NC_000013.11:51958372:C:T
NM_000875.5(IGF1R):c.2904del (p.Asn969fs)	IGF1R	N969fs, N968fs	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	VCV000521203	15	99473479	15	98930250	521203	512172	rs1555463008	NC_000015.10:98930249:GGGG:GGG
NM_000875.5(IGF1R):c.1931A>G (p.Tyr644Cys)	IGF1R	Y644C	Inborn genetic diseases	Pathogenic(Last reviewed: May 17, 2016)	criteria provided, single submitter	VCV000521118	15	99459295	15	98916066	521118	512171	rs1555460702	NC_000015.10:98916065:A:G
NM_001376.5(DYNC1H1):c.791G>T (p.Arg264Leu)	DYNC1H1	R264L	Spinal muscular atrophy	Pathogenic(Last reviewed: Jun 21, 2013)	criteria provided, single submitter	VCV000162033	14	102446717	14	101980380	162033	171752	rs713993043	NC_000014.9:101980379:G:T
NM_003482.4(KMT2D):c.1616del (p.Pro539fs)	KMT2D	P539fs	not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000817953	12	49445850	12	49052067	817953	805748		NC_000012.12:49052066:GG:G
NM_003482.4(KMT2D):c.858dup (p.Lys287Ter)	KMT2D		not provided	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000817588	12	49447085 - 49447086	12	49053302 - 49053303	817588	805749		NC_000012.12:49053302:A:AA
NM_003482.4(KMT2D):c.12944_12945del (p.Gln4315fs)	KMT2D	Q4315fs	not provided	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000817336	12	49425543 - 49425544	12	49031760 - 49031761	817336	805745		NC_000012.12:49031759:TT:
NM_003482.4(KMT2D):c.12066_12067insTCAG (p.Gly4023fs)	KMT2D		not provided	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000817297	12	49426421 - 49426422	12	49032638 - 49032639	817297	805746		NC_000012.12:49032638:C:CTGAC
NM_003482.4(KMT2D):c.16209_16222del (p.Ser5404fs)	KMT2D	S5404fs	not provided	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000817217	12	49416489 - 49416502	12	49022706 - 49022719	817217	805743		NC_000012.12:49022705:CCTGGATACGGGAGC:C
NM_003482.4(KMT2D):c.14867del (p.Pro4956fs)	KMT2D	P4956fs	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000817144	12	49420882	12	49027099	817144	805744		NC_000012.12:49027098:GGGG:GGG
NM_003482.4(KMT2D):c.8826del (p.Asn2943fs)	KMT2D	N2943fs	not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000817121	12	49432313	12	49038530	817121	805747		NC_000012.12:49038529:C:
NM_003482.3(KMT2D):c.12778C>T (p.Gln4260Ter)	KMT2D	Q4260*	not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000620436	12	49425710	12	49031927	620436	611772	rs1565773662	NC_000012.12:49031926:G:A
NM_003482.3(KMT2D):c.16018C>T (p.Arg5340Ter)	KMT2D	R5340*	not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000620151	12	49418395	12	49024612	620151	611771	rs1565756115	NC_000012.12:49024611:G:A
NM_003482.3(KMT2D):c.8214del (p.Phe2739fs)	KMT2D	F2739fs	not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000618192	12	49433233	12	49039450	618192	609834	rs1565790685	NC_000012.12:49039449:GGGGG:GGGG
NM_003482.3(KMT2D):c.8792_8793CA[1] (p.Gln2932fs)	KMT2D		not provided	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000596807	12	49432344 - 49432345	12	49038561 - 49038562	596807	587868	rs1565788703	NC_000012.12:49038560:TGTG:TG
NM_003482.3(KMT2D):c.5998C>T (p.Gln2000Ter)	KMT2D	Q2000*	not provided	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000594690	12	49435983	12	49042200	594690	585752	rs1565798715	NC_000012.12:49042199:G:A
NM_003482.3(KMT2D):c.11519dup (p.Ala3841fs)	KMT2D		not provided	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000524044	12	49426968 - 49426969	12	49033185 - 49033186	524044	514641	rs1555188651	NC_000012.12:49033185:A:AA
NM_003482.3(KMT2D):c.2141C>A (p.Ser714Ter)	KMT2D	S714*	not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000523867	12	49445325	12	49051542	523867	514642	rs747636808	NC_000012.12:49051541:G:T
NM_003482.3(KMT2D):c.2624_2625delinsAGGCCAAAA (p.Pro875fs)	KMT2D		not provided	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000500704	12	49444841 - 49444842	12	49051058 - 49051059	500704	492128	rs1555196720	NC_000012.12:49051057:AG:TTTTGGCCT
NM_003482.3(KMT2D):c.9937_9939delinsA (p.Leu3313fs)	KMT2D		not provided	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000500630	12	49431200 - 49431202	12	49037417 - 49037419	500630	492054	rs1555190224	NC_000012.12:49037416:AAG:T
NM_003482.3(KMT2D):c.9265dup (p.Val3089fs)	KMT2D		not provided	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000497970	12	49431873 - 49431874	12	49038090 - 49038091	497970	489394	rs1333678798	NC_000012.12:49038090:CCCCCC:CCCCCCC
NM_003482.3(KMT2D):c.11214del (p.Gln3738fs)	KMT2D	Q3738fs	not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000496887	12	49427274	12	49033491	496887	488311	rs1555188885	NC_000012.12:49033490:C:
NM_003482.3(KMT2D):c.6664C>T (p.Gln2222Ter)	KMT2D	Q2222*	not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000489063	12	49434889	12	49041106	489063	482025	rs1555192676	NC_000012.12:49041105:G:A
NM_003482.3(KMT2D):c.12730C>T (p.Gln4244Ter)	KMT2D	Q4244*	not provided	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000489008	12	49425758	12	49031975	489008	482023	rs1555187899	NC_000012.12:49031974:G:A
NM_003482.3(KMT2D):c.12667C>T (p.Gln4223Ter)	KMT2D	Q4223*	not provided	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000488744	12	49425821	12	49032038	488744	482024	rs1555187956	NC_000012.12:49032037:G:A
NM_003482.3(KMT2D):c.7325del (p.Pro2442fs)	KMT2D	P2442fs	not provided	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000453212	12	49434228	12	49040445	453212	445026	rs1555192192	NC_000012.12:49040444:GGGG:GGG
NM_003482.3(KMT2D):c.3109_3110del (p.Ser1037fs)	KMT2D	S1037fs	not provided	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000453057	12	49444261 - 49444262	12	49050478 - 49050479	453057	445029	rs1555196415	NC_000012.12:49050477:GAG:G
NM_003482.3(KMT2D):c.14194C>T (p.Gln4732Ter)	KMT2D	Q4732*	not provided	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000451416	12	49422901	12	49029118	451416	445021	rs1555186520	NC_000012.12:49029117:G:A
NM_003482.3(KMT2D):c.3900_3906+1delinsGAAACAGT	KMT2D		not provided	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000450549	12	49443464 - 49443471	12	49049681 - 49049688	450549	445028	rs1555195933	NC_000012.12:49049680:CCTGTTTG:ACTGTTTC
NM_003482.3(KMT2D):c.303dup (p.Ser102fs)	KMT2D		not provided	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000450365	12	49448407 - 49448408	12	49054624 - 49054625	450365	445032	rs797045661	NC_000012.12:49054624:CCCCCC:CCCCCCC
NM_003482.3(KMT2D):c.401-2A>T	KMT2D		not provided	Pathogenic(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	VCV000449579	12	49448201	12	49054418	449579	445031	rs1555198655	NC_000012.12:49054417:T:A
NM_003482.3(KMT2D):c.6546dup (p.Tyr2183fs)	KMT2D		not provided	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000439851	12	49435006 - 49435007	12	49041223 - 49041224	439851	433655	rs1555192788	NC_000012.12:49041223:GG:GGG
NM_003482.3(KMT2D):c.10367_10368CT[1] (p.Leu3457fs)	KMT2D		not provided	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000432931	12	49428435 - 49428436	12	49034652 - 49034653	432931	425984	rs1555189455	NC_000012.12:49034651:AGAGA:AGA
NM_003482.3(KMT2D):c.11749C>T (p.Gln3917Ter)	KMT2D	Q3917*	not provided	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000432835	12	49426739	12	49032956	432835	425983	rs1555188515	NC_000012.12:49032955:G:A
NM_003482.3(KMT2D):c.1940dup (p.Pro648fs)	KMT2D		not provided	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000432829	12	49445525 - 49445526	12	49051742 - 49051743	432829	425987	rs770315135	NC_000012.12:49051742:GGGGGGG:GGGGGGGG
NM_003482.3(KMT2D):c.12466C>T (p.Gln4156Ter)	KMT2D	Q4156*	not provided	Pathogenic(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	VCV000430069	12	49426022	12	49032239	430069	421925	rs1131691768	NC_000012.12:49032238:G:A
NM_003482.3(KMT2D):c.2713del (p.Glu905fs)	KMT2D	E905fs	not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000424486	12	49444753	12	49050970	424486	408680	rs1064796995	NC_000012.12:49050969:CCCC:CCC
NM_003482.3(KMT2D):c.9099del (p.Asn3034fs)	KMT2D	N3034fs	not provided	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000424198	12	49432040	12	49038257	424198	408675	rs1064796855	NC_000012.12:49038256:GG:G
NM_003482.3(KMT2D):c.13652_13660del (p.Leu4551_Gln4554delinsTer)	KMT2D		not provided	Pathogenic(Last reviewed: Feb 11, 2017)	criteria provided, single submitter	VCV000423216	12	49424687 - 49424695	12	49030904 - 49030912	423216	408672	rs1064796300	NC_000012.12:49030903:GTTTCAGCA:
NM_003482.3(KMT2D):c.2164del (p.Glu722fs)	KMT2D	E722fs	not provided	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000423172	12	49445302	12	49051519	423172	408681	rs1064796275	NC_000012.12:49051518:CC:C
NM_003482.3(KMT2D):c.5278_5279del (p.Lys1760fs)	KMT2D	K1760fs	not provided	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000422853	12	49437691 - 49437692	12	49043908 - 49043909	422853	408677	rs1064796043	NC_000012.12:49043907:TT:
NM_003482.3(KMT2D):c.4148G>A (p.Cys1383Tyr)	KMT2D	C1383Y	not provided	Pathogenic(Last reviewed: Aug 3, 2015)	criteria provided, single submitter	VCV000419661	12	49441836	12	49048053	419661	408678	rs1064794026	NC_000012.12:49048052:C:T
NM_003482.3(KMT2D):c.3730del (p.Val1244fs)	KMT2D	V1244fs	not provided	Pathogenic(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	VCV000419636	12	49443641	12	49049858	419636	408679	rs1064794007	NC_000012.12:49049857:CCCCC:CCCC
NM_003482.3(KMT2D):c.5467+5_5467+8del	KMT2D		not provided	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000419457	12	49437410 - 49437413	12	49043627 - 49043630	419457	408676	rs1064793884	NC_000012.12:49043626:TAACTAAC:TAAC
NM_003482.3(KMT2D):c.709del (p.Glu237fs)	KMT2D	E237fs	not provided	Pathogenic(Last reviewed: Jun 9, 2015)	criteria provided, single submitter	VCV000419107	12	49447389	12	49053606	419107	408683	rs1064793649	NC_000012.12:49053605:CCCC:CCC
NM_003482.3(KMT2D):c.2317C>T (p.Gln773Ter)	KMT2D	Q773*	not provided	Pathogenic(Last reviewed: Dec 15, 2016)	criteria provided, single submitter	VCV000392140	12	49445149	12	49051366	392140	373303	rs758555274	NC_000012.12:49051365:G:A
NM_003482.3(KMT2D):c.4271G>C (p.Cys1424Ser)	KMT2D	C1424S	not provided	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000379810	12	49440539	12	49046756	379810	372335	rs1057520740	NC_000012.12:49046755:C:G
NM_003482.3(KMT2D):c.5319+1G>T	KMT2D		not provided	Pathogenic(Last reviewed: May 22, 2015)	criteria provided, single submitter	VCV000379742	12	49437650	12	49043867	379742	373097	rs1057520722	NC_000012.12:49043866:C:A
NM_003482.3(KMT2D):c.16522-1G>A	KMT2D		not provided	Pathogenic(Last reviewed: May 1, 2015)	criteria provided, single submitter	VCV000379611	12	49415656	12	49021873	379611	373295	rs1057520667	NC_000012.12:49021872:C:T
NM_003482.3(KMT2D):c.1259-2A>G	KMT2D		not provided	Pathogenic(Last reviewed: Apr 2, 2015)	criteria provided, single submitter	VCV000379327	12	49446209	12	49052426	379327	375162	rs1057520573	NC_000012.12:49052425:T:C
NM_003482.3(KMT2D):c.8696del (p.Gly2899fs)	KMT2D	G2899fs	not provided	Pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, single submitter	VCV000373065	12	49432443	12	49038660	373065	360117	rs1057518186	NC_000012.12:49038659:CCC:CC
NM_003482.3(KMT2D):c.8366+1G>A	KMT2D		not provided	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000373023	12	49433004	12	49039221	373023	359965	rs1057518149	NC_000012.12:49039220:C:T
NM_003482.3(KMT2D):c.13324del (p.Ala4442fs)	KMT2D	A4442fs	not provided	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000286874	12	49425164	12	49031381	286874	271111	rs886043505	NC_000012.12:49031380:CCCC:CCC
NM_003482.3(KMT2D):c.7643dup (p.Pro2549fs)	KMT2D		not provided	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000286832	12	49433909 - 49433910	12	49040126 - 49040127	286832	271069	rs886043495	NC_000012.12:49040126:TTT:TTTT
NM_003482.3(KMT2D):c.5104C>T (p.Arg1702Ter)	KMT2D	R1702*	not provided	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000286527	12	49438067	12	49044284	286527	270764	rs886043414	NC_000012.12:49044283:G:A
NM_003482.3(KMT2D):c.9041_9042del (p.Leu3014fs)	KMT2D	L3014fs	not provided	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000285922	12	49432097 - 49432098	12	49038314 - 49038315	285922	270159	rs886043252	NC_000012.12:49038313:CA:
NM_003482.3(KMT2D):c.1966del (p.Leu656fs)	KMT2D	L656fs	not provided	Pathogenic(Last reviewed: Jul 22, 2015)	criteria provided, single submitter	VCV000282014	12	49445500	12	49051717	282014	266251	rs886042284	NC_000012.12:49051716:GGGGGG:GGGGG
NM_003482.3(KMT2D):c.11713C>T (p.Gln3905Ter)	KMT2D	Q3905*	not provided	Pathogenic(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	VCV000281884	12	49426775	12	49032992	281884	266121	rs886042253	NC_000012.12:49032991:G:A
NM_003482.3(KMT2D):c.13999+1G>A	KMT2D		not provided	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000280605	12	49424062	12	49030279	280605	264685	rs886041779	NC_000012.12:49030278:C:T
NM_003482.3(KMT2D):c.15708_15717delinsTA (p.Gly5237fs)	KMT2D		not provided	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000280456	12	49420032 - 49420041	12	49026249 - 49026258	280456	264529	rs886041660	NC_000012.12:49026248:CGGCCGCCCG:TA
NM_003482.3(KMT2D):c.5139del (p.Pro1714fs)	KMT2D	P1714fs	not provided	Pathogenic(Last reviewed: Mar 6, 2016)	criteria provided, single submitter	VCV000280416	12	49438032	12	49044249	280416	264485	rs886041627	NC_000012.12:49044248:CCCC:CCC
NM_003482.3(KMT2D):c.16184G>A (p.Trp5395Ter)	KMT2D	W5395*	not provided	Pathogenic(Last reviewed: Feb 28, 2016)	criteria provided, single submitter	VCV000280332	12	49416527	12	49022744	280332	264681	rs886041558	NC_000012.12:49022743:C:T
NM_003482.3(KMT2D):c.8650dup (p.Val2884fs)	KMT2D		not provided	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000280330	12	49432488 - 49432489	12	49038705 - 49038706	280330	264687	rs886041556	NC_000012.12:49038705:C:CC
NM_003482.3(KMT2D):c.16469_16472del (p.Lys5490fs)	KMT2D	K5490fs	not provided	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000280263	12	49415875 - 49415878	12	49022092 - 49022095	280263	264483	rs886041499	NC_000012.12:49022091:TCTTT:T
NM_003482.3(KMT2D):c.9367del (p.Glu3123fs)	KMT2D	E3123fs	not provided	Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	VCV000280154	12	49431772	12	49037989	280154	264630	rs886041416	NC_000012.12:49037988:CC:C
NM_003482.3(KMT2D):c.401-3A>G	KMT2D		not provided	Pathogenic(Last reviewed: Feb 20, 2016)	criteria provided, single submitter	VCV000280136	12	49448202	12	49054419	280136	264642	rs886041408	NC_000012.12:49054418:T:C
NM_003482.3(KMT2D):c.1300del (p.Pro433_Leu434insTer)	KMT2D		not provided	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000280135	12	49446166	12	49052383	280135	264632	rs398123715	NC_000012.12:49052382:GGGGGG:GGGGG
NM_003482.3(KMT2D):c.4693+1G>T	KMT2D		not provided	Pathogenic(Last reviewed: Dec 28, 2015)	criteria provided, single submitter	VCV000280134	12	49439847	12	49046064	280134	264691	rs886041406	NC_000012.12:49046063:C:A
NM_003482.3(KMT2D):c.5707C>T (p.Arg1903Ter)	KMT2D	R1903*	not provided	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000280133	12	49436599	12	49042816	280133	264689	rs886041405	NC_000012.12:49042815:G:A
NM_003482.3(KMT2D):c.1634del (p.Leu545fs)	KMT2D	L545fs	not provided	Pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, single submitter	VCV000265213	12	49445832	12	49052049	265213	260020	rs886039399	NC_000012.12:49052048:A:
NM_003482.3(KMT2D):c.16412+1G>T	KMT2D		not provided	Pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	VCV000197935	12	49416062	12	49022279	197935	195096	rs794727752	NC_000012.12:49022278:C:A
NM_003482.3(KMT2D):c.15172del (p.Val5058fs)	KMT2D	V5058fs	not provided	Pathogenic(Last reviewed: Oct 3, 2014)	criteria provided, single submitter	VCV000197588	12	49420577	12	49026794	197588	194749	rs794727689	NC_000012.12:49026793:CCC:CC
NM_003482.3(KMT2D):c.14885dup (p.Pro4963fs)	KMT2D		not provided	Pathogenic(Last reviewed: Jan 29, 2015)	criteria provided, single submitter	VCV000197587	12	49420863 - 49420864	12	49027080 - 49027081	197587	194748	rs797044744	NC_000012.12:49027080:TT:TTT
NM_003482.3(KMT2D):c.13780dup (p.Ala4594fs)	KMT2D		not provided	Pathogenic(Last reviewed: Jun 6, 2014)	criteria provided, single submitter	VCV000197432	12	49424442 - 49424443	12	49030659 - 49030660	197432	194593	rs797044740	NC_000012.12:49030659:CCCCCC:CCCCCCC
NM_003482.3(KMT2D):c.12481del (p.Glu4161fs)	KMT2D	E4161fs	not provided	Pathogenic(Last reviewed: Feb 11, 2015)	criteria provided, single submitter	VCV000197075	12	49426007	12	49032224	197075	194236	rs794727611	NC_000012.12:49032223:C:
NM_003482.3(KMT2D):c.11939del (p.Gln3980fs)	KMT2D	Q3980fs	not provided	Pathogenic(Last reviewed: Nov 4, 2014)	criteria provided, single submitter	VCV000197074	12	49426549	12	49032766	197074	194235	rs794727610	NC_000012.12:49032765:T:
NM_003482.3(KMT2D):c.7375_7376del (p.Ser2459fs)	KMT2D	S2459fs	not provided	Pathogenic(Last reviewed: Sep 10, 2014)	criteria provided, single submitter	VCV000196691	12	49434177 - 49434178	12	49040394 - 49040395	196691	193852	rs794727548	NC_000012.12:49040393:GA:
NM_003482.3(KMT2D):c.177-12_177-2delGTGTGTCCACA	KMT2D		not provided	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000196364	12	49448536 - 49448546	12	49054750 - 49054760	196364	193525	rs794727497	
NM_003482.3(KMT2D):c.5677C>T (p.Gln1893Ter)	KMT2D	Q1893*	not provided	Pathogenic(Last reviewed: Dec 29, 2014)	criteria provided, single submitter	VCV000195960	12	49436629	12	49042846	195960	193121	rs794727420	NC_000012.12:49042845:G:A
NM_003482.3(KMT2D):c.5423del (p.Gly1808fs)	KMT2D	G1808fs	not provided	Pathogenic(Last reviewed: Oct 7, 2014)	criteria provided, single submitter	VCV000195747	12	49437462	12	49043679	195747	192908	rs794727379	NC_000012.12:49043678:CCC:CC
NM_003482.3(KMT2D):c.5131A>T (p.Lys1711Ter)	KMT2D	K1711*	not provided	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	VCV000195594	12	49438040	12	49044257	195594	192755	rs794727342	NC_000012.12:49044256:T:A
NM_003482.3(KMT2D):c.4485C>G (p.Tyr1495Ter)	KMT2D	Y1495*	not provided	Pathogenic(Last reviewed: Mar 5, 2015)	criteria provided, single submitter	VCV000194629	12	49440141	12	49046358	194629	191792	rs574622908	NC_000012.12:49046357:G:C
NM_003482.3(KMT2D):c.4265G>A (p.Trp1422Ter)	KMT2D	W1422*	not provided	Pathogenic(Last reviewed: Apr 22, 2015)	criteria provided, single submitter	VCV000194500	12	49440545	12	49046762	194500	191663	rs794727143	NC_000012.12:49046761:C:T
NM_003482.3(KMT2D):c.4168dup (p.Ala1390fs)	KMT2D		not provided	Pathogenic(Last reviewed: Mar 27, 2015)	criteria provided, single submitter	VCV000194381	12	49441815 - 49441816	12	49048032 - 49048033	194381	191544	rs756471180	NC_000012.12:49048032:CCCCCC:CCCCCCC
NM_003482.3(KMT2D):c.3582dup (p.Thr1195fs)	KMT2D		not provided	Pathogenic(Last reviewed: Nov 17, 2014)	criteria provided, single submitter	VCV000193864	12	49443788 - 49443789	12	49050005 - 49050006	193864	191027	rs796065328	NC_000012.12:49050005:GGGGG:GGGGGG
NM_003482.3(KMT2D):c.2747_2748delinsAGCTGAGCCATCC (p.Pro916fs)	KMT2D		not provided	Pathogenic(Last reviewed: Jun 18, 2014)	criteria provided, single submitter	VCV000193655	12	49444718 - 49444719	12	49050935 - 49050936	193655	190818	rs797044630	NC_000012.12:49050934:CG:GGATGGCTCAGCT
NM_003482.3(KMT2D):c.133del (p.Ser45fs)	KMT2D	S45fs	not provided	Pathogenic(Last reviewed: Apr 17, 2014)	criteria provided, single submitter	VCV000167234	12	49448726	12	49054943	167234	177805	rs727503990	NC_000012.12:49054942:T:
NM_003482.3(KMT2D):c.1812_1813AG[1] (p.Glu605fs)	KMT2D		not provided	Pathogenic(Last reviewed: Jan 9, 2014)	criteria provided, single submitter	VCV000167230	12	49445651 - 49445652	12	49051868 - 49051869	167230	177802	rs727503989	NC_000012.12:49051867:CTCT:CT
NM_003482.3(KMT2D):c.2797+1G>A	KMT2D		not provided	Pathogenic(Last reviewed: Jan 17, 2014)	criteria provided, single submitter	VCV000167229	12	49444668	12	49050885	167229	177801	rs727503988	NC_000012.12:49050884:C:T
NM_003482.3(KMT2D):c.4009G>T (p.Glu1337Ter)	KMT2D	E1337*	not provided	Pathogenic(Last reviewed: Mar 3, 2014)	criteria provided, single submitter	VCV000167226	12	49442899	12	49049116	167226	177272	rs727503986	NC_000012.12:49049115:C:A
NM_003482.3(KMT2D):c.7140del (p.Gln2380fs)	KMT2D	Q2380fs	not provided	Pathogenic(Last reviewed: Dec 18, 2012)	criteria provided, single submitter	VCV000094246	12	49434413	12	49040630	94246	100146	rs398123758	NC_000012.12:49040629:C:
NM_003482.3(KMT2D):c.7066C>T (p.Gln2356Ter)	KMT2D	Q2356*	not provided	Pathogenic(Last reviewed: Nov 30, 2012)	criteria provided, single submitter	VCV000094245	12	49434487	12	49040704	94245	100145	rs398123757	NC_000012.12:49040703:G:A
NM_003482.3(KMT2D):c.5645-2A>G	KMT2D		not provided	Pathogenic(Last reviewed: May 28, 2013)	criteria provided, single submitter	VCV000094230	12	49436663	12	49042880	94230	100130	rs398123750	NC_000012.12:49042879:T:C
NM_003482.3(KMT2D):c.3834_3846del (p.Ile1279fs)	KMT2D	I1279fs	not provided	Pathogenic(Last reviewed: Nov 7, 2013)	criteria provided, single submitter	VCV000094212	12	49443525 - 49443537	12	49049742 - 49049754	94212	100112	rs398123743	NC_000012.12:49049741:GCCTCCGCTGATAGC:GC
NM_003482.3(KMT2D):c.3532C>T (p.Gln1178Ter)	KMT2D	Q1178*	not provided	Pathogenic(Last reviewed: Aug 7, 2012)	criteria provided, single submitter	VCV000094210	12	49443839	12	49050056	94210	100110	rs398123741	NC_000012.12:49050055:G:A
NM_003482.3(KMT2D):c.16306_16322delinsC (p.Ala5436fs)	KMT2D		not provided	Pathogenic(Last reviewed: Sep 11, 2013)	criteria provided, single submitter	VCV000094192	12	49416389 - 49416405	12	49022606 - 49022622	94192	100092	rs398123735	NC_000012.12:49022605:TTCTCCCGCCGGTTGGC:G
NM_003482.3(KMT2D):c.16109del (p.Gly5370fs)	KMT2D	G5370fs	not provided	Pathogenic(Last reviewed: Nov 12, 2013)	criteria provided, single submitter	VCV000094190	12	49416602	12	49022819	94190	100090	rs398123733	NC_000012.12:49022818:CC:C
NM_003482.3(KMT2D):c.15949_15952TATT[1] (p.Leu5318fs)	KMT2D		not provided	Pathogenic(Last reviewed: Jul 10, 2013)	criteria provided, single submitter	VCV000094188	12	49418457 - 49418460	12	49024674 - 49024677	94188	100088	rs398123732	NC_000012.12:49024673:AATAAATA:AATA
NM_003482.3(KMT2D):c.12430C>T (p.Gln4144Ter)	KMT2D	Q4144*	not provided	Pathogenic(Last reviewed: May 7, 2013)	criteria provided, single submitter	VCV000094157	12	49426058	12	49032275	94157	100057	rs398123712	NC_000012.12:49032274:G:A
NM_003482.3(KMT2D):c.12406C>T (p.Gln4136Ter)	KMT2D	Q4136*	not provided	Pathogenic(Last reviewed: Nov 19, 2012)	criteria provided, single submitter	VCV000094156	12	49426082	12	49032299	94156	100056	rs398123711	NC_000012.12:49032298:G:A
NM_003482.3(KMT2D):c.11201_11202del (p.Leu3734fs)	KMT2D	L3734fs	not provided	Pathogenic(Last reviewed: Dec 11, 2012)	criteria provided, single submitter	VCV000094148	12	49427286 - 49427287	12	49033503 - 49033504	94148	100048	rs398123706	NC_000012.12:49033502:CA:
NM_003482.3(KMT2D):c.11149C>T (p.Gln3717Ter)	KMT2D	Q3717*	not provided	Pathogenic(Last reviewed: Apr 11, 2013)	criteria provided, single submitter	VCV000094146	12	49427339	12	49033556	94146	100046	rs398123704	NC_000012.12:49033555:G:A
NM_003482.3(KMT2D):c.10834C>T (p.Gln3612Ter)	KMT2D	Q3612*	not provided	Pathogenic(Last reviewed: Aug 6, 2013)	criteria provided, single submitter	VCV000094141	12	49427654	12	49033871	94141	100041	rs398123702	NC_000012.12:49033870:G:A
NM_003482.3(KMT2D):c.10819C>T (p.Gln3607Ter)	KMT2D	Q3607*	not provided	Pathogenic(Last reviewed: May 9, 2013)	criteria provided, single submitter	VCV000094140	12	49427669	12	49033886	94140	100040	rs398123701	NC_000012.12:49033885:G:A
NM_003482.3(KMT2D):c.10623_10629delinsCGCAAGTCACG (p.Leu3542fs)	KMT2D		not provided	Pathogenic(Last reviewed: Aug 14, 2012)	criteria provided, single submitter	VCV000094137	12	49427961 - 49427967	12	49034178 - 49034184	94137	100037	rs398123699	NC_000012.12:49034177:ACACAGA:CGTGACTTGCG
NC_000012.12:g.49050297del	KMT2D	M1098fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV000813317	12	49444079	12	49050296	813317	801550		NC_000012.12:49050295:TT:T
NC_000012.12:g.49054899C>T	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802855	12	49448682	12	49054899	802855	791252		NC_000012.12:49054898:C:T
NC_000012.12:g.49040749G>A	KMT2D	Q2341*	Kabuki syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802854	12	49434532	12	49040749	802854	791251		NC_000012.12:49040748:G:A
NC_000012.12:g.49039359C>T	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802852	12	49433142	12	49039359	802852	791249		NC_000012.12:49039358:C:T
NC_000012.12:g.49033929del	KMT2D	A3593fs	Kabuki syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802851	12	49427711	12	49033928	802851	791248		NC_000012.12:49033927:CC:C
NC_000012.12:g.49026990del	KMT2D	L4993fs	Kabuki syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802847	12	49420773	12	49026990	802847	791244		NC_000012.12:49026989:C:
NM_003482.3(KMT2D):c.9964C>T (p.Gln3322Ter)	KMT2D	Q3322*	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 28, 2018)	no assertion criteria provided	VCV000635527	12	49431175	12	49037392	635527	623310		NC_000012.12:49037391:G:A
NM_003482.3(KMT2D):c.595_604del (p.Thr199fs)	KMT2D	T199fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 22, 2018)	no assertion criteria provided	VCV000635515	12	49447830 - 49447839	12	49054047 - 49054056	635515	623311		NC_000012.12:49054046:CGCTGGCAGTCGC:CGC
NM_003482.3(KMT2D):c.16294C>T (p.Arg5432Trp)	KMT2D	R5432W	not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000633524	12	49416417	12	49022634	633524	621973	rs1565753611	NC_000012.12:49022633:G:A
NM_003482.3(KMT2D):c.8626del (p.Gln2876fs)	KMT2D	Q2876fs	Complement component c1s deficiency	Pathogenic	criteria provided, single submitter	VCV000549852	12	49432513	12	49038730	549852	540577	rs1565789104	NC_000012.12:49038729:GGG:GG
NM_003482.3(KMT2D):c.15641G>C (p.Arg5214Pro)	KMT2D	R5214P	Kabuki syndrome 1	Pathogenic	no assertion criteria provided	VCV000523665	12	49420108	12	49026325	523665	514313	rs398123729	NC_000012.12:49026324:C:G
NM_003482.3(KMT2D):c.11093dup (p.Phe3699fs)	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000488541	12	49427394 - 49427395	12	49033611 - 49033612	488541	481409	rs35493001	NC_000012.12:49033611:CCCCC:CCCCCC
NM_003482.3(KMT2D):c.8841_8844del (p.His2947fs)	KMT2D	H2947fs	not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000445997	12	49432295 - 49432298	12	49038512 - 49038515	445997	439269	rs1555190924	NC_000012.12:49038511:TGGATG:TG
NM_003482.3(KMT2D):c.1845dup (p.Pro616fs)	KMT2D		not provided	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000445762	12	49445620 - 49445621	12	49051837 - 49051838	445762	439034	rs1555197320	NC_000012.12:49051837:A:AA
NM_003482.3(KMT2D):c.10810C>T (p.Gln3604Ter)	KMT2D	Q3604*	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 1, 2017)	no assertion criteria provided	VCV000417814	12	49427678	12	49033895	417814	404699	rs1060499552	NC_000012.12:49033894:G:A
NM_003482.3(KMT2D):c.5852del (p.Pro1951fs)	KMT2D	P1951fs	Kabuki syndrome 1	Pathogenic	no assertion criteria provided	VCV000403721	12	49436359	12	49042576	403721	390698	rs1060499724	NC_000012.12:49042575:GGGG:GGG
NM_003482.3(KMT2D):c.466G>T (p.Glu156Ter)	KMT2D	E156*	Kabuki syndrome 1	Pathogenic(Last reviewed: Jan 17, 2017)	no assertion criteria provided	VCV000375574	12	49448134	12	49054351	375574	362384	rs1057519422	NC_000012.12:49054350:C:A
NM_003482.3(KMT2D):c.10252G>T (p.Glu3418Ter)	KMT2D	E3418*	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000254202	12	49428698	12	49034915	254202	248717	rs1114167348	NC_000012.12:49034914:C:A
NM_003482.3(KMT2D):c.15030dup (p.Glu5011fs)	KMT2D		not provided	Pathogenic(Last reviewed: Aug 30, 2013)	criteria provided, single submitter	VCV000094177	12	49420718 - 49420719	12	49026935 - 49026936	94177	100077	rs398123722	NC_000012.12:49026935:T:TT
NM_003482.3(KMT2D):c.14580dup (p.Asp4861Ter)	KMT2D		not provided	Pathogenic(Last reviewed: Dec 18, 2012)	criteria provided, single submitter	VCV000094175	12	49421648 - 49421649	12	49027865 - 49027866	94175	100075	rs398123720	NC_000012.12:49027865:AAA:AAAA
NM_003482.3(KMT2D):c.13032del (p.Lys4345fs)	KMT2D	K4345fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000094164	12	49425456	12	49031673	94164	100064	rs398123716	NC_000012.12:49031672:GGGGG:GGGG
NM_003482.3(KMT2D):c.1300dup (p.Leu434fs)	KMT2D		not provided	Pathogenic(Last reviewed: Jan 23, 2013)	criteria provided, single submitter	VCV000094163	12	49446165 - 49446166	12	49052382 - 49052383	94163	100063	rs398123715	NC_000012.12:49052382:GGGGGG:GGGGGGG
NM_003482.4(KMT2D):c.5149C>T (p.Gln1717Ter)	KMT2D	Q1717*	Kabuki syndrome	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000860555	12	49438022	12	49044239	860555	839988		NC_000012.12:49044238:G:A
NM_003482.4(KMT2D):c.9136G>T (p.Glu3046Ter)	KMT2D	E3046*	Kabuki syndrome	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000860101	12	49432003	12	49038220	860101	839982		NC_000012.12:49038219:C:A
NM_003482.4(KMT2D):c.11769del (p.Gln3923fs)	KMT2D	Q3923fs	Kabuki syndrome	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000856284	12	49426719	12	49032936	856284	839977		NC_000012.12:49032935:TT:T
NM_003482.4(KMT2D):c.544_548del (p.Ile182fs)	KMT2D	I182fs	Kabuki syndrome	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000853584	12	49447886 - 49447890	12	49054103 - 49054107	853584	839992		NC_000012.12:49054102:GGGATGG:GG
NM_003482.4(KMT2D):c.1748del (p.Pro583fs)	KMT2D	P583fs	Kabuki syndrome	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000848635	12	49445718	12	49051935	848635	839991		NC_000012.12:49051934:GGGG:GGG
NM_003482.4(KMT2D):c.15171G>A (p.Trp5057Ter)	KMT2D	W5057*	Kabuki syndrome	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000844389	12	49420578	12	49026795	844389	839974		NC_000012.12:49026794:C:T
NM_003482.4(KMT2D):c.1762_1763del (p.Ser588fs)	KMT2D	S588fs	Kabuki syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000843792	12	49445703 - 49445704	12	49051920 - 49051921	843792	839990		NC_000012.12:49051919:GA:
NM_003482.4(KMT2D):c.6293_6296ACCG[3] (p.Ala2101fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000842599	12	49435252 - 49435253	12	49041469 - 49041470	842599	839987		NC_000012.12:49041469:CGGTCGGTC:CGGTCGGTCGGTC
NM_003482.4(KMT2D):c.16441_16442TG[2] (p.Val5482fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000836929	12	49415901 - 49415902	12	49022118 - 49022119	836929	839970		NC_000012.12:49022117:CACACA:CACA
NM_003482.4(KMT2D):c.166C>T (p.Gln56Ter)	KMT2D	Q56*	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000829800	12	49448693	12	49054910	829800	818144		NC_000012.12:49054909:G:A
NM_003482.3(KMT2D):c.9223dup (p.Ser3075fs)	KMT2D		Kabuki syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694724	12	49431915 - 49431916	12	49038132 - 49038133	694724	682822		NC_000012.12:49038132:A:AA
NM_003482.3(KMT2D):c.5869G>T (p.Glu1957Ter)	KMT2D	E1957*	Kabuki syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694715	12	49436112	12	49042329	694715	682823		NC_000012.12:49042328:C:A
NM_003482.3(KMT2D):c.5278A>T (p.Lys1760Ter)	KMT2D	K1760*	Kabuki syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694711	12	49437692	12	49043909	694711	682824		NC_000012.12:49043908:T:A
NM_003482.3(KMT2D):c.15834del (p.Asp5279fs)	KMT2D	D5279fs	Kabuki syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694684	12	49418680	12	49024897	694684	682821		NC_000012.12:49024896:A:
NM_003482.3(KMT2D):c.3968dup (p.Gly1323_Arg1324insTer)	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000692057	12	49442939 - 49442940	12	49049156 - 49049157	692057	679789		NC_000012.12:49049156:CC:CCC
NM_003482.3(KMT2D):c.14753del (p.Pro4918fs)	KMT2D	P4918fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000692044	12	49420996	12	49027213	692044	679787		NC_000012.12:49027212:GGGGG:GGGG
NM_003482.3(KMT2D):c.6010C>T (p.Gln2004Ter)	KMT2D	Q2004*	Kabuki syndrome 1	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000692015	12	49435971	12	49042188	692015	679788		NC_000012.12:49042187:G:A
NM_003482.3(KMT2D):c.13895dup (p.Ser4633fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000664811	12	49424166 - 49424167	12	49030383 - 49030384	664811	641152		NC_000012.12:49030383:GGGGG:GGGGGG
NM_003482.3(KMT2D):c.7183_7214delinsACT (p.Cys2395fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000664096	12	49434339 - 49434370	12	49040556 - 49040587	664096	641164		NC_000012.12:49040555:GAGGGCAGTGAGCGAGGGGGCAGAGCACAGCA:AGT
NM_003482.3(KMT2D):c.15050dup (p.Thr5018fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Sep 9, 2018)	criteria provided, single submitter	VCV000661403	12	49420698 - 49420699	12	49026915 - 49026916	661403	641150		NC_000012.12:49026915:CC:CCC
NM_003482.3(KMT2D):c.1529C>G (p.Ser510Ter)	KMT2D	S510*	Kabuki syndrome	Pathogenic(Last reviewed: Sep 9, 2018)	criteria provided, single submitter	VCV000661208	12	49445937	12	49052154	661208	641177		NC_000012.12:49052153:G:C
NM_003482.3(KMT2D):c.6114G>A (p.Trp2038Ter)	KMT2D	W2038*	Kabuki syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000659178	12	49435769	12	49041986	659178	641169		NC_000012.12:49041985:C:T
NM_003482.3(KMT2D):c.8953A>T (p.Lys2985Ter)	KMT2D	K2985*	Kabuki syndrome	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000658862	12	49432186	12	49038403	658862	641161		NC_000012.12:49038402:T:A
NM_003482.3(KMT2D):c.8044C>T (p.Gln2682Ter)	KMT2D	Q2682*	Kabuki syndrome	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000658825	12	49433509	12	49039726	658825	641163		NC_000012.12:49039725:G:A
NM_003482.3(KMT2D):c.6991dup (p.Leu2331fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000653354	12	49434561 - 49434562	12	49040778 - 49040779	653354	641165		NC_000012.12:49040778:GGGGGG:GGGGGGG
NM_003482.3(KMT2D):c.12715C>T (p.Gln4239Ter)	KMT2D	Q4239*	Kabuki syndrome	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000652230	12	49425773	12	49031990	652230	641154		NC_000012.12:49031989:G:A
NM_003482.3(KMT2D):c.1825del (p.Ser609fs)	KMT2D	S609fs	Kabuki syndrome	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000651533	12	49445641	12	49051858	651533	641176		NC_000012.12:49051857:A:
NM_003482.3(KMT2D):c.10704_10705AG[3] (p.Gln3570fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000650671	12	49427882 - 49427883	12	49034099 - 49034100	650671	641159		NC_000012.12:49034099:CTCT:CTCTCT
NM_003482.3(KMT2D):c.1468_1471del (p.Glu490fs)	KMT2D	E490fs	Kabuki syndrome	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000649945	12	49445995 - 49445998	12	49052212 - 49052215	649945	641178		NC_000012.12:49052211:CCTCC:C
NM_003482.3(KMT2D):c.4400del (p.Gly1467fs)	KMT2D	G1467fs	Kabuki syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000649906	12	49440410	12	49046627	649906	641172		NC_000012.12:49046626:CCC:CC
NM_003482.3(KMT2D):c.11968C>T (p.Gln3990Ter)	KMT2D	Q3990*	Kabuki syndrome	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000649558	12	49426520	12	49032737	649558	641158		NC_000012.12:49032736:G:A
NM_003482.3(KMT2D):c.12807_12810ACAG[1] (p.Thr4271fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000649491	12	49425674 - 49425677	12	49031891 - 49031894	649491	641153		NC_000012.12:49031890:CTGTCTGT:CTGT
NM_003482.3(KMT2D):c.5199_5206dup (p.Pro1736fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000647911	12	49437763 - 49437764	12	49043980 - 49043981	647911	641170		NC_000012.12:49043980:GCAGGTCAGCAGGT:GCAGGTCAGCAGGTCAGCAGGT
NM_003482.3(KMT2D):c.11971C>T (p.Gln3991Ter)	KMT2D	Q3991*	Kabuki syndrome	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000646335	12	49426517	12	49032734	646335	641157		NC_000012.12:49032733:G:A
NM_003482.3(KMT2D):c.3788C>G (p.Ser1263Ter)	KMT2D	S1263*	Kabuki syndrome	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000645513	12	49443583	12	49049800	645513	641173		NC_000012.12:49049799:G:C
NM_003482.3(KMT2D):c.6508del (p.Gln2170fs)	KMT2D	Q2170fs	Kabuki syndrome	Pathogenic(Last reviewed: Sep 2, 2018)	criteria provided, single submitter	VCV000644609	12	49435045	12	49041262	644609	641167		NC_000012.12:49041261:GGG:GG
NM_003482.3(KMT2D):c.6705_6706AC[3] (p.Gln2237fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000644536	12	49434844 - 49434845	12	49041061 - 49041062	644536	641166		NC_000012.12:49041061:GTGT:GTGTGT
NM_003482.3(KMT2D):c.14823_14825delinsTGTT (p.Leu4941fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000643443	12	49420924 - 49420926	12	49027141 - 49027143	643443	641151		NC_000012.12:49027140:GCC:AACA
NM_003482.3(KMT2D):c.9947del (p.Gly3316fs)	KMT2D	G3316fs	Kabuki syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000643374	12	49431192	12	49037409	643374	641160		NC_000012.12:49037408:CCC:CC
NM_003482.3(KMT2D):c.713del (p.Leu238fs)	KMT2D	L238fs	Kabuki syndrome	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000642765	12	49447385	12	49053602	642765	641180		NC_000012.12:49053601:AA:A
NM_003482.3(KMT2D):c.6496C>T (p.Gln2166Ter)	KMT2D	Q2166*	Kabuki syndrome	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000642660	12	49435057	12	49041274	642660	641168		NC_000012.12:49041273:G:A
NM_003482.3(KMT2D):c.2579del (p.Leu860fs)	KMT2D	L860fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000637044	12	49444887	12	49051104	637044	624859		NC_000012.12:49051103:A:
NM_003482.3(KMT2D):c.8229+1G>A	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000637040	12	49433217	12	49039434	637040	624876		NC_000012.12:49039433:C:T
NM_003482.3(KMT2D):c.8366+1G>T	KMT2D		Kabuki syndrome 1	Pathogenic	criteria provided, single submitter	VCV000634818	12	49433004	12	49039221	634818	622692	rs1057518149	NC_000012.12:49039220:C:A
NM_003482.3(KMT2D):c.14568G>A (p.Trp4856Ter)	KMT2D	W4856*	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000620058	12	49421661	12	49027878	620058	611412	rs1565763192	NC_000012.12:49027877:C:T
NM_003482.3(KMT2D):c.945del (p.Ser314_Trp315insTer)	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000620017	12	49446999	12	49053216	620017	611415	rs1565822457	NC_000012.12:49053215:CC:C
NM_003482.3(KMT2D):c.12878_12893del (p.Pro4293fs)	KMT2D	P4293fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000619211	12	49425595 - 49425610	12	49031812 - 49031827	619211	610610	rs1565773113	NC_000012.12:49031811:GTAGATAAGGCTCCTGGT:GT
NM_003482.3(KMT2D):c.11881C>T (p.Gln3961Ter)	KMT2D	Q3961*	Kabuki syndrome	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000581886	12	49426607	12	49032824	581886	568060	rs1565776616	NC_000012.12:49032823:G:A
NM_003482.3(KMT2D):c.5263C>T (p.Gln1755Ter)	KMT2D	Q1755*	Kabuki syndrome	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000581592	12	49437707	12	49043924	581592	568071	rs1565802369	NC_000012.12:49043923:G:A
NM_003482.3(KMT2D):c.13361del (p.Pro4454fs)	KMT2D	P4454fs	Kabuki syndrome	Pathogenic(Last reviewed: Sep 2, 2017)	criteria provided, single submitter	VCV000580374	12	49425127	12	49031344	580374	565488	rs1565771606	NC_000012.12:49031343:GGG:GG
NM_003482.3(KMT2D):c.10570C>T (p.Gln3524Ter)	KMT2D	Q3524*	Kabuki syndrome	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000579500	12	49428020	12	49034237	579500	566849	rs1565780936	NC_000012.12:49034236:G:A
NM_003482.3(KMT2D):c.8478_8488del (p.Thr2827fs)	KMT2D	T2827fs	Kabuki syndrome	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000577069	12	49432651 - 49432661	12	49038868 - 49038878	577069	568067	rs1565789522	NC_000012.12:49038867:GCATGGAGGTTGC:GC
NM_003482.3(KMT2D):c.3704del (p.Gly1235fs)	KMT2D	G1235fs	Kabuki syndrome	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000573747	12	49443667	12	49049884	573747	565521	rs1364500207	NC_000012.12:49049883:CCCCCC:CCCCC
NM_003482.3(KMT2D):c.2317dup (p.Gln773fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000570717	12	49445148 - 49445149	12	49051365 - 49051366	570717	568085	rs1565817210	NC_000012.12:49051365:GGGGGG:GGGGGGG
NM_003482.3(KMT2D):c.3903del (p.Lys1301fs)	KMT2D	K1301fs	Kabuki syndrome	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000569278	12	49443468	12	49049685	569278	568075	rs1565812092	NC_000012.12:49049684:TTT:TT
NM_003482.3(KMT2D):c.14069_14075+1del	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Apr 26, 2018)	no assertion criteria provided	VCV000559648	12	49423183 - 49423190	12	49029400 - 49029407	559648	550365	rs1555186619	NC_000012.12:49029399:CCTGACATCCT:CCT
NM_003482.3(KMT2D):c.16437del (p.Asn5480fs)	KMT2D	N5480fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547510	12	49415910	12	49022127	547510	537901	rs1555184635	NC_000012.12:49022126:A:
NM_003482.3(KMT2D):c.15640C>T (p.Arg5214Cys)	KMT2D	R5214C	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547505	12	49420109	12	49026326	547505	537906	rs398123728	NC_000012.12:49026325:G:A
NM_003482.3(KMT2D):c.14878C>T (p.Arg4960Ter)	KMT2D	R4960*	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547499	12	49420871	12	49027088	547499	537912	rs1555185969	NC_000012.12:49027087:G:A
NM_003482.3(KMT2D):c.4379del (p.Pro1460fs)	KMT2D	P1460fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547420	12	49440431	12	49046648	547420	537991	rs1240601136	NC_000012.12:49046647:GGGGGG:GGGGG
NM_003482.3(KMT2D):c.1301del (p.Leu434fs)	KMT2D	L434fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547402	12	49446165	12	49052382	547402	538009	rs1555197738	NC_000012.12:49052381:A:
NM_003482.3(KMT2D):c.11812C>T (p.Gln3938Ter)	KMT2D	Q3938*	Kabuki syndrome	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000531890	12	49426676	12	49032893	531890	527188	rs1350605713	NC_000012.12:49032892:G:A
NM_003482.3(KMT2D):c.2533del (p.Arg845fs)	KMT2D	R845fs	Kabuki syndrome	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000531886	12	49444933	12	49051150	531886	527750	rs767415197	NC_000012.12:49051149:GGGGGG:GGGGG
NM_003482.3(KMT2D):c.14700del (p.Leu4901fs)	KMT2D	L4901fs	Kabuki syndrome	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000531885	12	49421049	12	49027266	531885	527177	rs1555186066	NC_000012.12:49027265:A:
NM_003482.3(KMT2D):c.13818C>G (p.Tyr4606Ter)	KMT2D	Y4606*	Kabuki syndrome 1	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000523017	12	49424405	12	49030622	523017	513611	rs1555187117	NC_000012.12:49030621:G:C
NM_003482.3(KMT2D):c.9703_9704del (p.Lys3235fs)	KMT2D	K3235fs	Kabuki syndrome	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000463025	12	49431435 - 49431436	12	49037652 - 49037653	463025	462484	rs1555190324	NC_000012.12:49037651:TT:
NM_003482.3(KMT2D):c.8207_8210dup (p.Pro2738fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, single submitter	VCV000463022	12	49433236 - 49433237	12	49039453 - 49039454	463022	462207	rs1555191521	NC_000012.12:49039453:GTCTG:GTCTGTCTG
NM_003482.3(KMT2D):c.6673dup (p.Glu2225fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000463020	12	49434879 - 49434880	12	49041096 - 49041097	463020	463002	rs1555192667	NC_000012.12:49041096:CCCC:CCCCC
NM_003482.3(KMT2D):c.6264del (p.Lys2089fs)	KMT2D	K2089fs	Kabuki syndrome	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000463019	12	49435289	12	49041506	463019	462494	rs1555192996	NC_000012.12:49041505:GG:G
NM_003482.3(KMT2D):c.4812dup (p.Met1605fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Jan 22, 2017)	criteria provided, single submitter	VCV000463017	12	49438677 - 49438678	12	49044894 - 49044895	463017	462216	rs1555194510	NC_000012.12:49044894:GG:GGG
NM_003482.3(KMT2D):c.4204C>T (p.Gln1402Ter)	KMT2D	Q1402*	Kabuki syndrome	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000463015	12	49441780	12	49047997	463015	463004	rs1555195442	NC_000012.12:49047996:G:A
NM_003482.3(KMT2D):c.16052G>A (p.Arg5351Gln)	KMT2D	R5351Q	Kabuki syndrome	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000463012	12	49418361	12	49024578	463012	463112	rs1555185217	NC_000012.12:49024577:C:T
NM_003482.3(KMT2D):c.14688C>A (p.Tyr4896Ter)	KMT2D	Y4896*	Kabuki syndrome	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000463010	12	49421061	12	49027278	463010	462191	rs1555186079	NC_000012.12:49027277:G:T
NM_003482.3(KMT2D):c.14358_14359CA[1] (p.Thr4787fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000463008	12	49422632 - 49422633	12	49028849 - 49028850	463008	462194	rs1555186436	NC_000012.12:49028848:TGTG:TG
NM_003482.3(KMT2D):c.13833_13837dup (p.Lys4613fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000463007	12	49424385 - 49424386	12	49030602 - 49030603	463007	462197	rs1555187105	NC_000012.12:49030602:TGGTA:TGGTATGGTA
NM_003482.3(KMT2D):c.1345_1346del (p.Leu449fs)	KMT2D	L449fs	Kabuki syndrome	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000463006	12	49446120 - 49446121	12	49052337 - 49052338	463006	462237	rs1555197682	NC_000012.12:49052336:AG:
NM_003482.3(KMT2D):c.12985C>T (p.Gln4329Ter)	KMT2D	Q4329*	Kabuki syndrome	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000463004	12	49425503	12	49031720	463004	462482	rs1555187758	NC_000012.12:49031719:G:A
NM_003482.3(KMT2D):c.12019C>T (p.Gln4007Ter)	KMT2D	Q4007*	Kabuki syndrome	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000463003	12	49426469	12	49032686	463003	462205	rs188017299	NC_000012.12:49032685:G:A
NM_003482.3(KMT2D):c.11755C>T (p.Gln3919Ter)	KMT2D	Q3919*	Kabuki syndrome	Pathogenic(Last reviewed: Jul 9, 2016)	criteria provided, single submitter	VCV000463002	12	49426733	12	49032950	463002	463113	rs1555188501	NC_000012.12:49032949:G:A
NM_003482.3(KMT2D):c.603_604dup (p.Gly202fs)	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000435671	12	49447829 - 49447830	12	49054046 - 49054047	435671	429427	rs1555198491	NC_000012.12:49054046:CGC:CGCGC
NM_003482.3(KMT2D):c.4209C>A (p.Cys1403Ter)	KMT2D	C1403*	Kabuki syndrome 1	Pathogenic(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	VCV000435670	12	49441775	12	49047992	435670	429425	rs1555195441	NC_000012.12:49047991:G:T
NM_003482.3(KMT2D):c.5269C>T (p.Arg1757Ter)	KMT2D	R1757*	Kabuki syndrome 1	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000435669	12	49437701	12	49043918	435669	429423	rs1555194045	NC_000012.12:49043917:G:A
NM_003482.3(KMT2D):c.14843C>G (p.Ser4948Ter)	KMT2D	S4948*	Kabuki syndrome 1	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000433190	12	49420906	12	49027123	433190	426746	rs940178682	NC_000012.12:49027122:G:C
NM_003482.3(KMT2D):c.11515C>T (p.Gln3839Ter)	KMT2D	Q3839*	Kabuki syndrome 1	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000433189	12	49426973	12	49033190	433189	426747	rs1555188653	NC_000012.12:49033189:G:A
NM_003482.3(KMT2D):c.12661C>T (p.Gln4221Ter)	KMT2D	Q4221*	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	VCV000397538	12	49425827	12	49032044	397538	384441	rs1060499669	NC_000012.12:49032043:G:A
NM_003482.3(KMT2D):c.11471_11474ACAG[1] (p.Gln3826fs)	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Dec 15, 2016)	criteria provided, single submitter	VCV000375267	12	49427010 - 49427013	12	49033227 - 49033230	375267	361970	rs1057519067	NC_000012.12:49033226:CTGTCTGT:CTGT
NM_003482.3(KMT2D):c.11770C>T (p.Gln3924Ter)	KMT2D	Q3924*	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	VCV000279603	12	49426718	12	49032935	279603	263871	rs886041106	NC_000012.12:49032934:G:A
NM_003482.3(KMT2D):c.11275C>T (p.Gln3759Ter)	KMT2D	Q3759*	Kabuki syndrome 1	Pathogenic(Last reviewed: Jun 17, 2014)	criteria provided, single submitter	VCV000216954	12	49427213	12	49033430	216954	213621	rs863224890	NC_000012.12:49033429:G:A
NM_003482.3(KMT2D):c.9540del (p.Glu3181fs)	KMT2D	E3181fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	VCV000211334	12	49431599	12	49037816	211334	207955	rs797045672	NC_000012.12:49037815:A:
NM_003482.3(KMT2D):c.8445_8475dup (p.Ala2826fs)	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211333	12	49432663 - 49432664	12	49038880 - 49038881	211333	207956	rs797045671	NC_000012.12:49038880:TGCTGTTGCCTGTTGTTGCTGCCACAGTTGTTGCTGTTGC:TGCTGTTGCCTGTTGTTGCTGCCACAGTTGTTGCTGTTGCCTGTTGTTGCTGCCACAGTTGTTGCTGTTGC
NM_003482.3(KMT2D):c.836dup (p.Cys279fs)	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211332	12	49447261 - 49447262	12	49053478 - 49053479	211332	207968	rs797045670	NC_000012.12:49053478:C:CC
NM_003482.3(KMT2D):c.6171dup (p.Ala2058fs)	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Mar 8, 2013)	criteria provided, single submitter	VCV000211330	12	49435711 - 49435712	12	49041928 - 49041929	211330	207958	rs797045668	NC_000012.12:49041928:TTT:TTTT
NM_003482.3(KMT2D):c.4981dup (p.Glu1661fs)	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 28, 2014)	criteria provided, single submitter	VCV000211329	12	49438287 - 49438288	12	49044504 - 49044505	211329	207959	rs797045667	NC_000012.12:49044504:CC:CCC
NM_003482.3(KMT2D):c.3591del (p.Thr1198fs)	KMT2D	T1198fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Jun 24, 2015)	criteria provided, single submitter	VCV000211325	12	49443780	12	49049997	211325	207962	rs797045663	NC_000012.12:49049996:GGG:GG
NM_003482.3(KMT2D):c.303del (p.Ser102fs)	KMT2D	S102fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	VCV000211323	12	49448408	12	49054625	211323	207970	rs797045661	NC_000012.12:49054624:CCCCCC:CCCCC
NM_003482.3(KMT2D):c.2954_2955insT (p.Pro986fs)	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	VCV000211321	12	49444416 - 49444417	12	49050633 - 49050634	211321	207965	rs797045660	NC_000012.12:49050633::A
NM_003482.3(KMT2D):c.11845C>T (p.Gln3949Ter)	KMT2D	Q3949*	Kabuki syndrome 1	Pathogenic(Last reviewed: Jun 6, 2014)	criteria provided, single submitter	VCV000211317	12	49426643	12	49032860	211317	207952	rs797045658	NC_000012.12:49032859:G:A
NM_003482.3(KMT2D):c.4237-2A>C	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Jan 22, 2014)	no assertion criteria provided	VCV000208484	12	49440575	12	49046792	208484	205016	rs797045001	NC_000012.12:49046791:T:G
NM_003482.3(KMT2D):c.7903C>T (p.Arg2635Ter)	KMT2D	R2635*	not provided	Pathogenic(Last reviewed: Oct 1, 2014)	criteria provided, single submitter	VCV000196692	12	49433650	12	49039867	196692	193853	rs794727549	NC_000012.12:49039866:G:A
NM_003482.3(KMT2D):c.6670_6674del (p.Gly2224fs)	KMT2D	G2224fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Apr 30, 2014)	criteria provided, single submitter	VCV000158778	12	49434879 - 49434883	12	49041096 - 49041100	158778	168945	rs587783725	NC_000012.12:49041095:TCCCCT:T
NM_003482.3(KMT2D):c.6126C>A (p.Cys2042Ter)	KMT2D	C2042*	Kabuki syndrome 1	Pathogenic(Last reviewed: Jun 25, 2013)	criteria provided, single submitter	VCV000158776	12	49435757	12	49041974	158776	168947	rs556669370	NC_000012.12:49041973:G:T
NM_003482.3(KMT2D):c.6086del (p.Pro2029fs)	KMT2D	P2029fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158775	12	49435895	12	49042112	158775	168948	rs587783723	NC_000012.12:49042111:GG:G
NM_003482.3(KMT2D):c.4739del (p.Pro1580fs)	KMT2D	P1580fs	Kabuki syndrome 1	Pathogenic(Last reviewed: May 8, 2013)	criteria provided, single submitter	VCV000158771	12	49439705	12	49045922	158771	168952	rs587783719	NC_000012.12:49045921:GG:G
NM_003482.3(KMT2D):c.4221del (p.Cys1408fs)	KMT2D	C1408fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158767	12	49441763	12	49047980	158767	168956	rs587783715	NC_000012.12:49047979:G:
NM_003482.3(KMT2D):c.400+1G>C	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158763	12	49448310	12	49054527	158763	168977	rs587783714	NC_000012.12:49054526:C:G
NM_003482.3(KMT2D):c.3695del (p.Pro1232fs)	KMT2D	P1232fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158760	12	49443676	12	49049893	158760	168962	rs587783713	NC_000012.12:49049892:GGG:GG
NM_003482.3(KMT2D):c.3553C>T (p.Gln1185Ter)	KMT2D	Q1185*	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158759	12	49443818	12	49050035	158759	168963	rs587783712	NC_000012.12:49050034:G:A
NM_003482.3(KMT2D):c.256G>T (p.Glu86Ter)	KMT2D	E86*	Kabuki syndrome 1	Pathogenic(Last reviewed: Aug 5, 2013)	criteria provided, single submitter	VCV000158755	12	49448455	12	49054672	158755	168979	rs587783708	NC_000012.12:49054671:C:A
NM_003482.3(KMT2D):c.1813G>T (p.Glu605Ter)	KMT2D	E605*	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158746	12	49445653	12	49051870	158746	168974	rs587783705	NC_000012.12:49051869:C:A
NM_003482.3(KMT2D):c.15943C>T (p.Gln5315Ter)	KMT2D	Q5315*	Kabuki syndrome 1	Pathogenic(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	VCV000158740	12	49418470	12	49024687	158740	168903	rs587783699	NC_000012.12:49024686:G:A
NM_003482.3(KMT2D):c.15844C>T (p.Arg5282Ter)	KMT2D	R5282*	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158739	12	49418670	12	49024887	158739	168904	rs587783698	NC_000012.12:49024886:G:A
NM_003482.3(KMT2D):c.15791G>A (p.Trp5264Ter)	KMT2D	W5264*	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158738	12	49418723	12	49024940	158738	168905	rs587783697	NC_000012.12:49024939:C:T
NM_003482.3(KMT2D):c.15195G>A (p.Trp5065Ter)	KMT2D	W5065*	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158735	12	49420554	12	49026771	158735	168908	rs587783696	NC_000012.12:49026770:C:T
NM_003482.3(KMT2D):c.13518del (p.Ser4507fs)	KMT2D	S4507fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	VCV000158730	12	49424970	12	49031187	158730	168913	rs587783691	NC_000012.12:49031186:GGGGG:GGGG
NM_003482.3(KMT2D):c.12962C>A (p.Ser4321Ter)	KMT2D	S4321*	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158726	12	49425526	12	49031743	158726	168916	rs587783688	NC_000012.12:49031742:G:T
NM_003482.3(KMT2D):c.12954_12955GA[1] (p.Arg4319fs)	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158725	12	49425531 - 49425532	12	49031748 - 49031749	158725	168917	rs587783687	NC_000012.12:49031747:TCTCT:TCT
NM_003482.3(KMT2D):c.11263C>T (p.Gln3755Ter)	KMT2D	Q3755*	Kabuki syndrome 1	Pathogenic(Last reviewed: Dec 2, 2013)	criteria provided, single submitter	VCV000158715	12	49427225	12	49033442	158715	168927	rs587783681	NC_000012.12:49033441:G:A
NM_003482.3(KMT2D):c.13579A>T (p.Lys4527Ter)	KMT2D	K4527*	Kabuki syndrome 1	Pathogenic(Last reviewed: Sep 1, 2010)	no assertion criteria provided	VCV000007537	12	49424768	12	49030985	7537	22576	rs267607240	NC_000012.12:49030984:T:A
NM_003482.4(KMT2D):c.15289C>T (p.Arg5097Ter)	KMT2D	R5097*	Kabuki syndrome	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000851272	12	49420460	12	49026677	851272	839972		NC_000012.12:49026676:G:A
NM_003482.4(KMT2D):c.15185G>A (p.Cys5062Tyr)	KMT2D	C5062Y	Kabuki syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000840772	12	49420564	12	49026781	840772	839973		NC_000012.12:49026780:C:T
NM_003482.3(KMT2D):c.1029_1030CT[2] (p.Leu345fs)	KMT2D		Kabuki syndrome 1	Pathogenic	criteria provided, single submitter	VCV000635198	12	49446774 - 49446777	12	49052991 - 49052994	635198	623031		NC_000012.12:49052990:AGAGAGAG:AGAG
NM_003482.3(KMT2D):c.3315_3325CCCCAGCCCTG[1] (p.Ala1109fs)	KMT2D		Kabuki syndrome	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000582622	12	49444035 - 49444045	12	49050252 - 49050262	582622	568084	rs1565813691	NC_000012.12:49050251:CAGGGCTGGGGCAGGGCTGGGG:CAGGGCTGGGG
NM_003482.3(KMT2D):c.15902_15903del (p.Val5301fs)	KMT2D	V5301fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561046	12	49418611 - 49418612	12	49024828 - 49024829	561046	552162	rs1565756561	NC_000012.12:49024827:CAC:C
NM_003482.3(KMT2D):c.7933C>T (p.Arg2645Ter)	KMT2D	R2645*	Kabuki syndrome 1	Pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547450	12	49433620	12	49039837	547450	537961	rs1555191740	NC_000012.12:49039836:G:A
NM_003482.3(KMT2D):c.5627_5630del (p.Asp1876fs)	KMT2D	D1876fs	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547432	12	49436873 - 49436876	12	49043090 - 49043093	547432	537979	rs1555193738	NC_000012.12:49043089:CTGTCT:CT
NM_003482.3(KMT2D):c.6594del (p.Tyr2199fs)	KMT2D	Y2199fs	Kabuki syndrome	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000531891	12	49434959	12	49041176	531891	527189	rs1555192751	NC_000012.12:49041175:GGGGGG:GGGGG
NM_003482.3(KMT2D):c.12304C>T (p.Gln4102Ter)	KMT2D	Q4102*	Kabuki syndrome 1	Pathogenic	criteria provided, single submitter	VCV000430816	12	49426184	12	49032401	430816	424359	rs1555188129	NC_000012.12:49032400:G:A
NM_003482.3(KMT2D):c.13207_13208del (p.Asn4403fs)	KMT2D	N4403fs	Kabuki syndrome 1	Pathogenic	criteria provided, single submitter	VCV000430815	12	49425280 - 49425281	12	49031497 - 49031498	430815	424358	rs1555187577	NC_000012.12:49031496:TT:
NM_003482.3(KMT2D):c.14075+1G>A	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 24, 2014)	criteria provided, single submitter	VCV000369674	12	49423183	12	49029400	369674	353905	rs1057516039	NC_000012.12:49029399:C:T
NM_003482.3(KMT2D):c.13884del (p.Thr4629fs)	KMT2D	T4629fs	Kabuki syndrome 1	Pathogenic(Last reviewed: Jun 23, 2016)	criteria provided, single submitter	VCV000267267	12	49424178	12	49030395	267267	262270	rs886040960	NC_000012.12:49030394:GGGGGG:GGGGG
NM_003482.3(KMT2D):c.3754C>T (p.Arg1252Ter)	KMT2D	R1252*	Kabuki syndrome 1|not provided	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000167228	12	49443617	12	49049834	167228	177140	rs727503987	NC_000012.12:49049833:G:A
NM_000295.5(SERPINA1):c.221_223TCT[2] (p.Phe76del)	SERPINA1	F76del, F52del	not provided|Alpha-1-antitrypsin deficiency|PI M(MALTON)	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000315028	14	94849346 - 94849348	14	94383009 - 94383011	315028	321860	rs775982338	NC_000014.9:94383008:AGAAGAAGA:AGAAGA
NM_003482.3(KMT2D):c.8200C>T (p.Arg2734Ter)	KMT2D	R2734*	Kabuki syndrome	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000653606	12	49433247	12	49039464	653606	641162		NC_000012.12:49039463:G:A
NM_003482.3(KMT2D):c.4525_4528del (p.Ile1509fs)	KMT2D	I1509fs	Kabuki syndrome|not provided	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000652440	12	49440098 - 49440101	12	49046315 - 49046318	652440	641171		NC_000012.12:49046314:AGATAG:AG
NM_003482.3(KMT2D):c.8401C>T (p.Arg2801Ter)	KMT2D	R2801*	not provided|Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547454	12	49432738	12	49038955	547454	537957	rs1555191203	NC_000012.12:49038954:G:A
NM_003482.3(KMT2D):c.1940del (p.Pro647fs)	KMT2D	P647fs	Kabuki syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000547404	12	49445526	12	49051743	547404	538007	rs770315135	NC_000012.12:49051742:GGGGGGG:GGGGGG
NM_003482.3(KMT2D):c.14713C>T (p.Gln4905Ter)	KMT2D	Q4905*	not provided|Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000504375	12	49421036	12	49027253	504375	495537	rs1555186053	NC_000012.12:49027252:G:A
NM_003482.3(KMT2D):c.8311C>T (p.Arg2771Ter)	KMT2D	R2771*	not provided|Kabuki syndrome 1	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503723	12	49433060	12	49039277	503723	495553	rs1251778848	NC_000012.12:49039276:G:A
NM_003482.3(KMT2D):c.8059C>T (p.Arg2687Ter)	KMT2D	R2687*	Kabuki syndrome 1|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449562	12	49433388	12	49039605	449562	445025	rs1555191598	NC_000012.12:49039604:G:A
NM_003482.3(KMT2D):c.1143del (p.Thr382fs)	KMT2D	T382fs	Kabuki syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, multiple submitters, no conflicts	VCV000422962	12	49446462	12	49052679	422962	408682	rs1064796125	NC_000012.12:49052678:GGGGG:GGGG
NM_003482.3(KMT2D):c.6172del (p.Ala2058fs)	KMT2D	A2058fs	Kabuki syndrome 1|not provided	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211331	12	49435711	12	49041928	211331	207957	rs797045669	NC_000012.12:49041927:C:
NM_003482.3(KMT2D):c.3585dup (p.Pro1196fs)	KMT2D		Kabuki syndrome 1	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000211324	12	49443785 - 49443786	12	49050002 - 49050003	211324	207963	rs797045662	NC_000012.12:49050002:T:TT
NM_003482.3(KMT2D):c.8171_8175del (p.Pro2724fs)	KMT2D	P2724fs	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158788	12	49433272 - 49433276	12	49039489 - 49039493	158788	168935	rs587783728	NC_000012.12:49039488:GCTGGGCT:GCT
NM_003482.3(KMT2D):c.8053C>T (p.Arg2685Ter)	KMT2D	R2685*	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158787	12	49433394	12	49039611	158787	168936	rs587783727	NC_000012.12:49039610:G:A
NM_003482.3(KMT2D):c.3121C>T (p.Gln1041Ter)	KMT2D	Q1041*	not provided|Kabuki syndrome 1	Pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, multiple submitters, no conflicts	VCV000158758	12	49444250	12	49050467	158758	168964	rs587783711	NC_000012.12:49050466:G:A
NM_003482.3(KMT2D):c.13996_13997del (p.Arg4666fs)	KMT2D	R4666fs	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158732	12	49424065 - 49424066	12	49030282 - 49030283	158732	168911	rs587783693	NC_000012.12:49030281:CTC:C
NM_003482.3(KMT2D):c.12896del (p.Gly4299fs)	KMT2D	G4299fs	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158724	12	49425592	12	49031809	158724	168918	rs587783686	NC_000012.12:49031808:CC:C
NM_003482.3(KMT2D):c.11290C>T (p.Gln3764Ter)	KMT2D	Q3764*	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158716	12	49427198	12	49033415	158716	168926	rs587783682	NC_000012.12:49033414:G:A
NM_003482.3(KMT2D):c.5908_5915del (p.Asp1970fs)	KMT2D	D1970fs	not provided|Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 8, 2012)	criteria provided, single submitter	VCV000094232	12	49436066 - 49436073	12	49042283 - 49042290	94232	100132	rs398123751	NC_000012.12:49042282:GGGCTGTCGGGCT:GGGCT
NM_003482.3(KMT2D):c.15641G>A (p.Arg5214His)	KMT2D	R5214H	Kabuki syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000094185	12	49420108	12	49026325	94185	100085	rs398123729	NC_000012.12:49026324:C:T
NM_003482.3(KMT2D):c.11692C>T (p.Gln3898Ter)	KMT2D	Q3898*	Kabuki syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000094151	12	49426796	12	49033013	94151	100051	rs398123708	NC_000012.12:49033012:G:A
NM_003482.3(KMT2D):c.16360C>T (p.Arg5454Ter)	KMT2D	R5454*	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000007538	12	49416115	12	49022332	7538	22577	rs267607239	NC_000012.12:49022331:G:A
NM_003482.3(KMT2D):c.10999C>T (p.Gln3667Ter)	KMT2D	Q3667*	Kabuki syndrome 1|Kabuki syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000547470	12	49427489	12	49033706	547470	537941	rs1555189038	NC_000012.12:49033705:G:A
NM_003482.3(KMT2D):c.11422del (p.Ala3808fs)	KMT2D	A3808fs	Kabuki syndrome|Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000531881	12	49427066	12	49033283	531881	527741	rs1555188704	NC_000012.12:49033282:CC:C
NM_003482.3(KMT2D):c.7411C>T (p.Arg2471Ter)	KMT2D	R2471*	not provided|Kabuki syndrome	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000373723	12	49434142	12	49040359	373723	359967	rs1057518571	NC_000012.12:49040358:G:A
NM_003482.3(KMT2D):c.5120_5121AC[2] (p.Arg1709fs)	KMT2D		not provided|Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, multiple submitters, no conflicts	VCV000286876	12	49438046 - 49438047	12	49044263 - 49044264	286876	271113	rs886043506	NC_000012.12:49044262:GTGTGTG:GTGTG
NM_003482.3(KMT2D):c.15143G>A (p.Arg5048His)	KMT2D	R5048H	Kabuki syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280132	12	49420606	12	49026823	280132	264683	rs886041404	NC_000012.12:49026822:C:T
NM_003482.3(KMT2D):c.15079C>T (p.Arg5027Ter)	KMT2D	R5027*	Kabuki syndrome 1|not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000211319	12	49420670	12	49026887	211319	207951	rs797045659	NC_000012.12:49026886:G:A
NM_003482.3(KMT2D):c.8488C>T (p.Arg2830Ter)	KMT2D	R2830*	Kabuki syndrome|not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167222	12	49432651	12	49038868	167222	177403	rs727503983	NC_000012.12:49038867:G:A
NM_003482.3(KMT2D):c.15256C>T (p.Arg5086Ter)	KMT2D	R5086*	not provided|Kabuki syndrome 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000167218	12	49420493	12	49026710	167218	177139	rs727503979	NC_000012.12:49026709:G:A
NM_003482.3(KMT2D):c.1329_1332del (p.Pro444fs)	KMT2D	P444fs	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	VCV000158728	12	49446134 - 49446137	12	49052351 - 49052354	158728	168975	rs587783689	NC_000012.12:49052350:AGGT:
NM_003482.3(KMT2D):c.11386del (p.Gln3796fs)	KMT2D	Q3796fs	Kabuki syndrome|Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158717	12	49427102	12	49033319	158717	168925	rs587783683	NC_000012.12:49033318:GGGG:GGG
NM_004004.6(GJB2):c.223C>T (p.Arg75Trp)	GJB2	R75W	Rare genetic deafness|Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Sep 29, 2014)	criteria provided, single submitter	VCV000017011	13	20763498	13	20189359	17011	32050	rs104894402	NC_000013.11:20189358:G:A
NM_000359.3(TGM1):c.919C>G (p.Arg307Gly)	TGM1	R307G	Lamellar ichthyosis|not provided|Autosomal recessive congenital ichthyosis 1	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372534	14	24728975	14	24259769	372534	360047	rs121918731	NC_000014.9:24259768:G:C
NM_002834.5(PTPN11):c.317A>C (p.Asp106Ala)	PTPN11	D106A, D105A	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040506	12	112888301	12	112450497	40506	48976	rs397507517	NC_000012.12:112450496:A:C
NC_000016.10:g.(?_89803249)_(89808377_?)del	FANCA		Fanconi anemia	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000830873	16	89869657 - 89874785			830873	820950		
NM_000135.4(FANCA):c.3349-1G>A	FANCA		Fanconi anemia, complementation group A|Fanconi anemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000623165	16	89813299	16	89746891	623165	612134	rs769862233	NC_000016.10:89746890:C:T
NM_000135.4(FANCA):c.3755_3756AG[5] (p.Glu1255fs)	FANCA		Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555285	16	89809210 - 89809211	16	89742802 - 89742803	555285	547871	rs868273545	NC_000016.10:89742802:CTCTCTCTC:CTCTCTCTCTC
NM_000135.4(FANCA):c.1304G>A (p.Arg435His)	FANCA	R435H	Fanconi anemia	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000408183	16	89857866	16	89791458	408183	401450	rs1060501879	NC_000016.10:89791457:C:T
NM_000135.4(FANCA):c.1615del (p.Asp539fs)	FANCA	D539fs	Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000003443	16	89849278	16	89782870	3443	18482	rs778507965	NC_000016.10:89782869:CCCC:CCC
NM_003482.3(KMT2D):c.11743C>T (p.Gln3915Ter)	KMT2D	Q3915*	Kabuki syndrome|Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000531880	12	49426745	12	49032962	531880	527191	rs1555188518	NC_000012.12:49032961:G:A
NM_003482.3(KMT2D):c.8743C>T (p.Arg2915Ter)	KMT2D	R2915*	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158790	12	49432396	12	49038613	158790	168933	rs587783729	NC_000012.12:49038612:G:A
NM_006009.4(TUBA1A):c.959G>A (p.Arg320His)	TUBA1A	R320H, R285H	Tubulinopathies|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521647	12	49579190	12	49185407	521647	512021	rs1555162323	NC_000012.12:49185406:C:T
NM_006009.4(TUBA1A):c.424G>A (p.Gly142Ser)	TUBA1A	G142S, G107S	Tubulinopathies|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520702	12	49579725	12	49185942	520702	512022	rs1555162407	NC_000012.12:49185941:C:T
NM_006009.4(TUBA1A):c.283G>T (p.Gly95Cys)	TUBA1A	G95C, G60C	Tubulinopathies|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520585	12	49580185	12	49186402	520585	512023	rs1555162486	NC_000012.12:49186401:C:A
NM_000303.3(PMM2):c.691G>A (p.Val231Met)	PMM2	V231M	Congenital disorder of glycosylation, type Ia|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007719	16	8941632	16	8847775	7719	22758	rs80338707	NC_000016.10:8847774:G:A
NM_001009944.3(PKD1):c.12031C>T (p.Gln4011Ter)	PKD1	Q4010*, Q4011*	Polycystic kidney disease, adult type|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447961	16	2140782	16	2090781	447961	441805	rs1555444985	NC_000016.10:2090780:G:A
NM_001009944.3(PKD1):c.12010C>T (p.Gln4004Ter)	PKD1	Q4004*, Q4003*	not provided|Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Aug 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000434006	16	2140803	16	2090802	434006	427446	rs766551411	NC_000016.10:2090801:G:A
NM_001009944.3(PKD1):c.9829C>T (p.Arg3277Cys)	PKD1	R3277C	Polycystic kidney disease, adult type|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000192320	16	2149956	16	2099955	192320	190113	rs148812376	NC_000016.10:2099954:G:A
NM_014363.6(SACS):c.8793del (p.Lys2931fs)	SACS	K2784fs, K2931fs	not provided|Spastic paraplegia|	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449517	13	23909222	13	23335083	449517	445128	rs767871841	NC_000013.11:23335082:TTTTTTT:TTTTTT
NM_003482.3(KMT2D):c.16342C>T (p.Arg5448Ter)	KMT2D	R5448*	Kabuki syndrome|Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000531888	12	49416133	12	49022350	531888	527445	rs1422752351	NC_000012.12:49022349:G:A
NM_003482.3(KMT2D):c.16501C>T (p.Arg5501Ter)	KMT2D	R5501*	Kabuki syndrome 1|not provided|Kabuki syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280126	12	49415846	12	49022063	280126	264679	rs886041398	NC_000012.12:49022062:G:A
NM_003482.3(KMT2D):c.15061C>T (p.Arg5021Ter)	KMT2D	R5021*	not provided|Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158734	12	49420688	12	49026905	158734	168909	rs587783695	NC_000012.12:49026904:G:A
NM_000321.2(RB1):c.861G>A (p.Glu287=)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000527929	13	48937093	13	48362957	527929	528097	rs1555284956	NC_000013.11:48362956:G:A
NM_000321.2(RB1):c.1390-2A>G	RB1		not specified|Retinoblastoma	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495816	13	48954187	13	48380051	495816	487737	rs1555286568	NC_000013.11:48380050:A:G
NM_000321.2(RB1):c.869del (p.Asn290fs)	RB1	N290fs	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428726	13	48939033	13	48364897	428726	420534	rs1131690901	NC_000013.11:48364896:AAAAA:AAAA
NM_000321.2(RB1):c.940-1G>A	RB1		Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Jan 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428678	13	48941629	13	48367493	428678	420535	rs1131690860	NC_000013.11:48367492:G:A
NM_000321.2(RB1):c.1345G>A (p.Gly449Arg)	RB1	G449R	Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428669	13	48953742	13	48379606	428669	420546	rs1131690851	NC_000013.11:48379605:G:A
NM_000321.2(RB1):c.967G>T (p.Glu323Ter)	RB1	E323*	Retinoblastoma	Pathogenic(Last reviewed: Mar 31, 2019)	criteria provided, single submitter	VCV000410924	13	48941657	13	48367521	410924	400209	rs1060503077	NC_000013.11:48367520:G:T
NM_144997.7(FLCN):c.1432+1G>A	FLCN		Hereditary cancer-predisposing syndrome|not specified|Multiple fibrofolliculomas|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000253252	17	17118498	17	17215184	253252	247652	rs755959303	NC_000017.11:17215183:C:T
NM_144997.7(FLCN):c.250-2A>G	FLCN		not provided|Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096481	17	17129638	17	17226324	96481	102375	rs398124533	NC_000017.11:17226323:T:C
NM_001005242.3(PKP2):c.1780C>T (p.Gln594Ter)	PKP2	Q638*, Q594*	Arrhythmogenic right ventricular cardiomyopathy|not provided|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000045049	12	32975460	12	32822526	45049	54216	rs397517012	NC_000012.12:32822525:G:A
NM_003482.3(KMT2D):c.2994del (p.Pro998_Met999insTer)	KMT2D		Kabuki syndrome|Kabuki syndrome 1	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000375634	12	49444377	12	49050594	375634	362446	rs1057519595	NC_000012.12:49050593:A:
NM_003482.3(KMT2D):c.12844C>T (p.Arg4282Ter)	KMT2D	R4282*	not provided|Multiple myeloma|Kabuki syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372805	12	49425644	12	49031861	372805	359952	rs1057517992	NC_000012.12:49031860:G:A
NM_000135.4(FANCA):c.2778+1G>A	FANCA		Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000635518	16	89831297	16	89764889	635518	623342		NC_000016.10:89764888:C:T
NM_000135.4(FANCA):c.2840C>G (p.Ser947Ter)	FANCA	S947*	Fanconi anemia, complementation group A|Fanconi anemia	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558253	16	89828369	16	89761961	558253	548200	rs745568821	NC_000016.10:89761960:G:C
NM_000135.4(FANCA):c.2524del (p.Ser842fs)	FANCA	S842fs	Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555088	16	89833626	16	89767218	555088	547941	rs1205909298	NC_000016.10:89767217:AAA:AA
NM_000135.4(FANCA):c.2529_2530CT[3] (p.Cys846fs)	FANCA		Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Oct 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550840	16	89833614 - 89833615	16	89767206 - 89767207	550840	548210	rs763378933	NC_000016.10:89767205:AGAGAGAG:AGAGAG
NM_000135.4(FANCA):c.3517_3519TGG[1] (p.Trp1174del)	FANCA	W1174del	Fanconi anemia	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000456115	16	89811471 - 89811473	16	89745063 - 89745065	456115	466877	rs1555536446	NC_000016.10:89745062:CCACCAC:CCAC
NM_000135.4(FANCA):c.1827-1G>A	FANCA		Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000408199	16	89842224	16	89775816	408199	402186	rs555449842	NC_000016.10:89775815:C:T
NM_000135.4(FANCA):c.2546del (p.Ser849fs)	FANCA	S849fs	Fanconi anemia	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000408166	16	89833604	16	89767196	408166	402171	rs1060501876	NC_000016.10:89767195:G:
NM_000430.4(PAFAH1B1):c.701_702GA[1] (p.Glu235fs)	PAFAH1B1		Inborn genetic diseases|Lissencephaly due to LIS1 mutation|not provided	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211829	17	2577382 - 2577383	17	2674088 - 2674089	211829	208381	rs797045865	NC_000017.11:2674087:AGAGA:AGA
NM_001126108.2(SLC12A3):c.179C>T (p.Thr60Met)	SLC12A3	T60M	not provided|Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000101514	16	56899326	16	56865414	101514	107257	rs371443644	NC_000016.10:56865413:C:T
NM_001376.5(DYNC1H1):c.2327C>T (p.Pro776Leu)	DYNC1H1	P776L	Charcot-Marie-Tooth disease, axonal, type 2O|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372934	14	102452889	14	101986552	372934	360017	rs1057518083	NC_000014.9:101986551:C:T
NM_001126131.2(POLG):c.1268_1269CT[1] (p.Leu424fs)	POLG		Obesity|Global developmental delay|Generalized epilepsy|not provided|Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206608	15	89870560 - 89870561	15	89327329 - 89327330	206608	203022	rs796052908	NC_000015.10:89327328:AGAG:AG
NM_002693.2(POLG):c.2420G>A (p.Arg807His)	POLG	R807H	Progressive sclerosing poliodystrophy|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206523	15	89865979	15	89322748	206523	202968	rs796052887	NC_000015.10:89322747:C:T
NM_000057.4(BLM):c.205G>T (p.Glu69Ter)	BLM	E69*	not provided	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000489300	15	91292703	15	90749473	489300	482082	rs746195311	NC_000015.10:90749472:G:T
NM_000057.4(BLM):c.829G>T (p.Glu277Ter)	BLM	E277*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 14, 2019)	criteria provided, single submitter	VCV000827564	15	91295046	15	90751816	827564	812282		NC_000015.10:90751815:G:T
NM_000057.4(BLM):c.700_713del (p.Asp234fs)	BLM	D234fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000826769	15	91293198 - 91293211	15	90749968 - 90749981	826769	812278		NC_000015.10:90749967:GATGTGATTTGCAT:
NM_000057.4(BLM):c.670C>T (p.Gln224Ter)	BLM	Q224*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000826568	15	91293168	15	90749938	826568	812277		NC_000015.10:90749937:C:T
NM_000057.4(BLM):c.3679A>T (p.Lys1227Ter)	BLM	K852*, K1227*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000824060	15	91347517	15	90804287	824060	812398		NC_000015.10:90804286:A:T
NM_000057.4(BLM):c.3055_3058del (p.His1019fs)	BLM	H1019fs, H644fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000822737	15	91337429 - 91337432	15	90794199 - 90794202	822737	812376		NC_000015.10:90794198:ACTCACT:ACT
NM_000057.4(BLM):c.1784C>G (p.Ser595Ter)	BLM	S220*, S595*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000820081	15	91304387	15	90761157	820081	812332		NC_000015.10:90761156:C:G
NM_000057.4(BLM):c.1440dup (p.Ala481fs)	BLM		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000819226	15	91304042 - 91304043	15	90760812 - 90760813	819226	812313		NC_000015.10:90760812:T:TT
NM_000057.4(BLM):c.1173_1180dup (p.Leu394Ter)	BLM		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000818492	15	91303460 - 91303461	15	90760230 - 90760231	818492	812300		NC_000015.10:90760230:TGAAACTTT:TGAAACTTTGAAACTTT
NM_000057.4(BLM):c.1500del (p.Phe500fs)	BLM	F500fs, F125fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000485348	15	91304101	15	90760871	485348	477857	rs1555419889	NC_000015.10:90760870:TTT:TT
NM_000057.4(BLM):c.1385del (p.Ser462fs)	BLM	S462fs, S87fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 18, 2014)	criteria provided, single submitter	VCV000182060	15	91303988	15	90760758	182060	180705	rs730881429	NC_000015.10:90760757:C:
NM_000057.4(BLM):c.3564del (p.Phe1189fs)	BLM	F1189fs, F814fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000823933	15	91347402	15	90804172	823933	812393		NC_000015.10:90804171:C:
NM_000057.4(BLM):c.1701G>A (p.Trp567Ter)	BLM	W192*, W567*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000819865	15	91304304	15	90761074	819865	812326		NC_000015.10:90761073:G:A
NM_000057.4(BLM):c.1624del (p.Asp542fs)	BLM	D542fs, D167fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000819694	15	91304227	15	90760997	819694	812325		NC_000015.10:90760996:G:
NM_000057.4(BLM):c.2308-2A>G	BLM		not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449542	15	91312361	15	90769131	449542	445471	rs1248548542	NC_000015.10:90769130:A:G
NM_019066.5(MAGEL2):c.3122del (p.Val1041fs)	MAGEL2	V1041fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	VCV000520706	15	23889768	15	23644621	520706	512115	rs1555374117	NC_000015.10:23644620:A:
NM_000053.4(ATP7B):c.2294A>G (p.Asp765Gly)	ATP7B	D765G, D654G, D681G	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495406	13	52532508	13	51958372	495406	487525	rs1555291147	NC_000013.11:51958371:T:C
NM_000053.4(ATP7B):c.525dup (p.Val176fs)	ATP7B		Wilson disease	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370306	13	52548830 - 52548831	13	51974694 - 51974695	370306	358239	rs558037268	NC_000013.11:51974694:TTT:TTTT
NM_000057.4(BLM):c.2207_2209del (p.Tyr736del)	BLM	Y736del, Y361del	Bloom syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803132	15	91310153 - 91310155	15	90766923 - 90766925	803132	791509		NC_000015.10:90766922:ATC:
NM_000057.4(BLM):c.2005A>T (p.Arg669Ter)	BLM	R294*, R669*	Bloom syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803130	15	91306318	15	90763088	803130	791507		NC_000015.10:90763087:A:T
NM_000057.4(BLM):c.2258T>A (p.Leu753Ter)	BLM	L753*, L378*	Bloom syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584888	15	91310204	15	90766974	584888	575944	rs1400231534	NC_000015.10:90766973:T:A
NM_002755.3(MAP2K1):c.370C>T (p.Pro124Ser)	MAP2K1	P124S	Neoplasm of the large intestine|Noonan syndrome|Malignant melanoma of skin|Cutaneous melanoma|Transitional cell carcinoma of the bladder|not provided|Cardiofaciocutaneous syndrome 3|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000375981	15	66729162	15	66436824	375981	362860	rs1057519732	NC_000015.10:66436823:C:T
NM_000057.4(BLM):c.842del (p.His281fs)	BLM	H281fs	Bloom syndrome	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000857211	15	91295059	15	90751829	857211	842828		NC_000015.10:90751828:A:
NM_000057.4(BLM):c.1632_1635del (p.Arg545fs)	BLM	R170fs, R545fs	Bloom syndrome	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000856945	15	91304232 - 91304235	15	90761002 - 90761005	856945	842839		NC_000015.10:90761001:AGAAAGA:AGA
NM_000057.4(BLM):c.2409G>A (p.Trp803Ter)	BLM	W803*, W428*	Bloom syndrome	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000854209	15	91312670	15	90769440	854209	842863		NC_000015.10:90769439:G:A
NM_000057.4(BLM):c.2448del (p.Met816fs)	BLM	M441fs, M816fs	Bloom syndrome	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000854016	15	91312709	15	90769479	854016	842866		NC_000015.10:90769478:G:
NM_000057.4(BLM):c.2801G>A (p.Trp934Ter)	BLM	W559*, W934*	Bloom syndrome	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000850920	15	91328289	15	90785059	850920	842875		NC_000015.10:90785058:G:A
NM_000057.4(BLM):c.3087C>G (p.Tyr1029Ter)	BLM	Y1029*, Y654*	Bloom syndrome	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000846968	15	91337464	15	90794234	846968	842881		NC_000015.10:90794233:C:G
NM_000057.4(BLM):c.2347_2348CT[1] (p.Leu783_Tyr784insTer)	BLM		Bloom syndrome	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000845042	15	91312401 - 91312402	15	90769171 - 90769172	845042	842860		NC_000015.10:90769170:TCTCT:TCT
NM_000057.4(BLM):c.371_372AC[2] (p.Pro126fs)	BLM		Bloom syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000835407	15	91292869 - 91292870	15	90749639 - 90749640	835407	842811		NC_000015.10:90749638:ACACAC:ACAC
NC_000015.10:g.(?_90754801)_(90754948_?)del	BLM		Bloom syndrome	Pathogenic(Last reviewed: Oct 5, 2019)	criteria provided, single submitter	VCV000832970	15	91298031 - 91298178			832970	820745		
NC_000015.10:g.(?_90747393)_(90815279_?)del	BLM		Bloom syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000832791	15	91290623 - 91358509			832791	820743		
NC_000015.10:g.(?_90782812)_(90785091_?)del	BLM		Bloom syndrome	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000831051	15	91326042 - 91328321			831051	820747		
NC_000015.10:g.(?_90749357)_(90765424_?)del	BLM		Bloom syndrome	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000830859	15	91292587 - 91308654			830859	820744		
NM_000057.4(BLM):c.2809C>T (p.Gln937Ter)	BLM	Q562*, Q937*	Bloom syndrome	Pathogenic	no assertion criteria provided	VCV000694003	15	91328297	15	90785067	694003	681831		NC_000015.10:90785066:C:T
NM_000057.4(BLM):c.2650_2651del (p.Lys884fs)	BLM	K509fs, K884fs	Bloom syndrome	Pathogenic	no assertion criteria provided	VCV000694002	15	91326145 - 91326146	15	90782915 - 90782916	694002	681830		NC_000015.10:90782914:AAA:A
NM_000057.4(BLM):c.1546G>T (p.Glu516Ter)	BLM	E141*, E516*	Bloom syndrome	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000665277	15	91304149	15	90760919	665277	643664		NC_000015.10:90760918:G:T
NM_000057.4(BLM):c.709del (p.Cys237fs)	BLM	C237fs	Bloom syndrome	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000664539	15	91293205	15	90749975	664539	643649		NC_000015.10:90749974:TTT:TT
NM_000057.4(BLM):c.600_603AACA[1] (p.Asn202fs)	BLM		Bloom syndrome	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000661923	15	91293098 - 91293101	15	90749868 - 90749871	661923	643646		NC_000015.10:90749867:AACAAACA:AACA
NC_000015.9:g.(?_91290613)_(91295186_?)del	BLM		Bloom syndrome	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000658981	15	91290613 - 91295186	15	90747383 - 90751956	658981	652720		
NC_000015.9:g.(?_91290613)_(91308654_?)del	BLM		Bloom syndrome	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000658444	15	91290613 - 91308654	15	90747383 - 90765424	658444	652544		
NM_000057.4(BLM):c.3496C>T (p.Gln1166Ter)	BLM	Q791*, Q1166*	Bloom syndrome	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000653629	15	91346888	15	90803658	653629	643715		NC_000015.10:90803657:C:T
NM_000057.4(BLM):c.2208_2213delinsGATATGT (p.Tyr736_Thr738delinsTer)	BLM		Bloom syndrome	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000644219	15	91310154 - 91310159	15	90766924 - 90766929	644219	643681		NC_000015.10:90766923:TCTGAC:GATATGT
NM_000057.4(BLM):c.619del (p.Asp207fs)	BLM	D207fs	Bloom syndrome	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000643228	15	91293117	15	90749887	643228	643647		NC_000015.10:90749886:G:
NC_000015.9:g.(?_91354425)_(91354646_?)del	BLM		Bloom syndrome	Pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000583481	15	91354425 - 91354646	15	90811195 - 90811416	583481	568608		
NM_000057.4(BLM):c.835G>T (p.Glu279Ter)	BLM	E279*	Bloom syndrome	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000582201	15	91295052	15	90751822	582201	567364	rs1567036566	NC_000015.10:90751821:G:T
NM_000057.4(BLM):c.2506del (p.Arg836fs)	BLM	R461fs, R836fs	Bloom syndrome	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000581302	15	91312767	15	90769537	581302	569305	rs1567045531	NC_000015.10:90769536:A:
NM_000057.4(BLM):c.3569delinsAA (p.Met1190fs)	BLM		Bloom syndrome	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000580708	15	91347407	15	90804177	580708	569350	rs1567063125	NC_000015.10:90804176:T:AA
NM_000057.4(BLM):c.1462G>T (p.Glu488Ter)	BLM	E488*, E113*	Bloom syndrome	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000577769	15	91304065	15	90760835	577769	573614	rs1477193473	NC_000015.10:90760834:G:T
NM_000057.4(BLM):c.839_888del (p.Glu279_Leu280insTer)	BLM		Bloom syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000576209	15	91295054 - 91295103	15	90751824 - 90751873	576209	567367	rs1567036579	NC_000015.10:90751823:ATTACATTCAACTGAGAAAGTTCCATGTATTGAATTTGATGATGATGATTAT:AT
NM_000057.4(BLM):c.2353_2354insTT (p.Glu785fs)	BLM		Bloom syndrome	Pathogenic(Last reviewed: May 20, 2018)	criteria provided, single submitter	VCV000574253	15	91312408 - 91312409	15	90769178 - 90769179	574253	573621	rs1567045130	NC_000015.10:90769178::TT
NM_000057.4(BLM):c.2851_2857del (p.Met951fs)	BLM	M576fs, M951fs	Bloom syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000573132	15	91333903 - 91333909	15	90790673 - 90790679	573132	567395	rs1309932713	NC_000015.10:90790672:GGAATGGGGA:GGA
NM_000057.4(BLM):c.3960dup (p.Val1321fs)	BLM		Bloom syndrome	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000565336	15	91354517 - 91354518	15	90811287 - 90811288	565336	569355	rs1567066891	NC_000015.10:90811287:CCC:CCCC
NM_000057.4(BLM):c.1985_1986del (p.Lys662fs)	BLM	K287fs, K662fs	Bloom syndrome	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000553499	15	91306294 - 91306295	15	90763064 - 90763065	553499	548377	rs762804291	NC_000015.10:90763063:AAAAAA:AAAA
NC_000015.9:g.(?_91298035)_(91298174_?)del	BLM		Bloom syndrome	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000524848	15	91298035 - 91298174	15	90754805 - 90754944	524848	528583		
NM_000057.4(BLM):c.2539del (p.Ile847fs)	BLM	I847fs, I472fs	Bloom syndrome	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000524795	15	91312800	15	90769570	524795	529189	rs770751979	NC_000015.10:90769569:A:
NM_000057.4(BLM):c.1295dup (p.Pro432_Asp433insTer)	BLM		Bloom syndrome	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000454074	15	91303896 - 91303897	15	90760666 - 90760667	454074	465528	rs1555419806	NC_000015.10:90760666:CC:CCC
NM_000057.4(BLM):c.1129del (p.Glu377fs)	BLM	E2fs, E377fs	Bloom syndrome	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000454063	15	91303417	15	90760187	454063	465281	rs1555419710	NC_000015.10:90760186:GG:G
NM_000057.4(BLM):c.2580_2581del (p.His860fs)	BLM	H485fs, H860fs	Bloom syndrome	Pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	VCV000220018	15	91326075 - 91326076	15	90782845 - 90782846	220018	222437	rs864622347	NC_000015.10:90782844:ATA:A
NM_000057.4(BLM):c.1358T>G (p.Leu453Ter)	BLM	L453*, L78*	Bloom syndrome	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000182059	15	91303961	15	90760731	182059	180704	rs730881428	NC_000015.10:90760730:T:G
NM_000057.4(BLM):c.3107G>T (p.Cys1036Phe)	BLM	C1036F, C661F	Bloom syndrome	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	VCV000005457	15	91337484	15	90794254	5457	20496	rs137853153	NC_000015.10:90794253:G:T
NM_000086.2(CLN3):c.1000C>T (p.Arg334Cys)	CLN3	R334C, R256C, R234C, R280C, R310C	Juvenile neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056243	16	28493482	16	28482161	56243	70882	rs386833694	NC_000016.10:28482160:G:A
NM_014363.6(SACS):c.12160C>T (p.Gln4054Ter)	SACS	Q4054*, Q3907*	not provided|Spastic paraplegia|	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038458	13	23905855	13	23331716	38458	47016	rs281865120	NC_000013.11:23331715:G:A
NM_000070.3(CAPN3):c.1318C>T (p.Arg440Trp)	CAPN3	R440W, R392W	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000283991	15	42691814	15	42399616	283991	268228	rs777323132	NC_000015.10:42399615:C:T
NM_000070.3(CAPN3):c.2305C>T (p.Arg769Trp)	CAPN3	R769W, R677W, R257W, R763W, R104W	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282411	15	42703123	15	42410925	282411	266648	rs868791726	NC_000015.10:42410924:C:T
NM_000070.3(CAPN3):c.2338G>C (p.Asp780His)	CAPN3	D780H, D774H, D115H, D268H, D688H	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000195641	15	42703156	15	42410958	195641	192802	rs778768583	NC_000015.10:42410957:G:C
NC_000015.10:g.(?_90790639)_(90790854_?)del	BLM		Bloom syndrome	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000831439	15	91333869 - 91334084			831439	820749		
NC_000015.10:g.(?_90769123)_(90769596_?)del	BLM		Bloom syndrome	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000830916	15	91312353 - 91312826			830916	820746		
NM_000057.4(BLM):c.1043dup (p.Met348fs)	BLM		Bloom syndrome	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000584884	15	91298123 - 91298124	15	90754893 - 90754894	584884	575940	rs1567038003	NC_000015.10:90754893:T:TT
NM_000057.4(BLM):c.1316del (p.Met439fs)	BLM	M439fs, M64fs	Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554680	15	91303919	15	90760689	554680	547647	rs1555419829	NC_000015.10:90760688:T:
NM_000057.4(BLM):c.3589del (p.Ser1197fs)	BLM	S1197fs, S822fs	Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551725	15	91347427	15	90804197	551725	547968	rs1555424376	NC_000015.10:90804196:A:
NC_000015.9:g.(?_91333873)_(91334080_?)del	BLM		Bloom syndrome	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000524847	15	91333873 - 91334080	15	90790643 - 90790850	524847	528609		
NM_000057.4(BLM):c.213_214del (p.Ser72fs)	BLM	S72fs	Bloom syndrome	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000454095	15	91292709 - 91292710	15	90749479 - 90749480	454095	465245	rs960430492	NC_000015.10:90749478:TTTT:TT
NM_000057.4(BLM):c.2341_2342GA[3] (p.Asn782fs)	BLM		Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000405291	15	91312395 - 91312396	15	90769165 - 90769166	405291	400447	rs1555420842	NC_000015.10:90769165:GAGA:GAGAGA
NM_000057.4(BLM):c.3305_3306del (p.His1102fs)	BLM	H727fs, H1102fs	Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000370126	15	91341514 - 91341515	15	90798284 - 90798285	370126	358359	rs1057516253	NC_000015.10:90798283:AT:
NM_000057.2(BLM):c.2308-953_2555+4719del	BLM		Bloom syndrome	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000042069	15	91311410 - 91317535	15	90768180 - 90774305	42069	51235		
NM_000321.3(RB1):c.2211+1G>T	RB1		Retinoblastoma	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000852375	13	49037972	13	48463836	852375	851535		NC_000013.11:48463835:G:T
NM_000321.2(RB1):c.1959dup (p.Val654fs)	RB1		Retinoblastoma	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000575455	13	49030478 - 49030479	13	48456342 - 48456343	575455	566160	rs1566234123	NC_000013.11:48456342:AAAAAA:AAAAAAA
NM_000321.2(RB1):c.2211G>T (p.Glu737Asp)	RB1	E737D	Retinoblastoma	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000527898	13	49037971	13	48463835	527898	528138	rs587776787	NC_000013.11:48463834:G:T
NM_000321.2(RB1):c.2489+2T>C	RB1		Retinoblastoma	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000458151	13	49039506	13	48465370	458151	463693	rs1555294636	NC_000013.11:48465369:T:C
NM_000321.2(RB1):c.644C>A (p.Ser215Ter)	RB1	S215*	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428743	13	48934189	13	48360053	428743	420523	rs768305224	NC_000013.11:48360052:C:A
NM_000321.2(RB1):c.19dup (p.Arg7fs)	RB1		Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428670	13	48878061 - 48878062	13	48303925 - 48303926	428670	420503	rs1131690852	NC_000013.11:48303925:CCCCCC:CCCCCCC
NM_000321.2(RB1):c.2520+1G>T	RB1		Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428660	13	49047527	13	48473391	428660	420585	rs587778850	NC_000013.11:48473390:G:T
NM_000321.3(RB1):c.607+1G>A	RB1		Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal cancer type 4	Pathogenic(Last reviewed: Jan 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000419970	13	48923160	13	48349024	419970	409030	rs587776789	NC_000013.11:48349023:G:A
NM_000321.2(RB1):c.211_212AG[4] (p.Arg73fs)	RB1		Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000126844	13	48881489 - 48881490	13	48307353 - 48307354	126844	132354	rs587778862	NC_000013.11:48307352:AGAGAGAGAG:AGAGAGAG
NM_000321.2(RB1):c.1058_1059CA[1] (p.Gln354fs)	RB1		Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000126828	13	48942670 - 48942671	13	48368534 - 48368535	126828	132338	rs587778829	NC_000013.11:48368533:ACACA:ACA
NM_000321.2(RB1):c.-198G>A	RB1		Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000013086	13	48877851	13	48303715	13086	28125	rs387906521	NC_000013.11:48303714:G:A
NM_001009944.3(PKD1):c.5014_5015del (p.Arg1672fs)	PKD1	R1672fs	Polycystic kidney disease, adult type|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447985	16	2160153 - 2160154	16	2110152 - 2110153	447985	441862	rs1555455457	NC_000016.10:2110151:CT:
NM_000057.4(BLM):c.2268del (p.Asp757fs)	BLM	D757fs, D382fs	Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000803135	15	91310208	15	90766978	803135	791512		NC_000015.10:90766977:AAAAAAA:AAAAAA
NM_000057.4(BLM):c.3508del (p.Tyr1170fs)	BLM	Y1170fs, Y795fs	Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558254	15	91346899	15	90803669	558254	548393	rs1555424311	NC_000015.10:90803668:TT:T
NM_000057.4(BLM):c.3499del (p.Ala1167fs)	BLM	A1167fs, A792fs	Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550553	15	91346890	15	90803660	550553	547950	rs1555424305	NC_000015.10:90803659:GG:G
NM_000057.4(BLM):c.2875C>T (p.Arg959Ter)	BLM	R959*, R584*	Bloom syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000405266	15	91333930	15	90790700	405266	400610	rs762354041	NC_000015.10:90790699:C:T
NM_000057.4(BLM):c.581_582del (p.Phe193_Phe194insTer)	BLM		Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189032	15	91293075 - 91293076	15	90749845 - 90749846	189032	186946	rs367543026	NC_000015.10:90749844:TTTTTT:TTTT
NM_000057.4(BLM):c.3847C>T (p.Gln1283Ter)	BLM	Q1283*, Q908*, Q1152*	Bloom syndrome	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000042089	15	91352462	15	90809232	42089	51255	rs367543031	NC_000015.10:90809231:C:T
NM_000135.4(FANCA):c.3558dup (p.Arg1187fs)	FANCA		Fanconi anemia, complementation group A|Fanconi anemia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003444	16	89811434 - 89811435	16	89745026 - 89745027	3444	18483	rs747851434	NC_000016.10:89745026:CC:CCC
NM_003482.3(KMT2D):c.16438_16441del (p.Asn5480fs)	KMT2D	N5480fs	Kabuki syndrome|not provided|Kabuki syndrome 1	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158744	12	49415906 - 49415909	12	49022123 - 49022126	158744	168899	rs587783703	NC_000012.12:49022122:AGTTAG:AG
NM_003482.3(KMT2D):c.13606C>T (p.Arg4536Ter)	KMT2D	R4536*	Kabuki syndrome|not provided|Kabuki syndrome 1	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158731	12	49424741	12	49030958	158731	168912	rs587783692	NC_000012.12:49030957:G:A
NM_144997.7(FLCN):c.1375_1376TC[2] (p.Leu460fs)	FLCN		Multiple fibrofolliculomas|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418213	17	17118551 - 17118552	17	17215237 - 17215238	418213	409838	rs1064793128	NC_000017.11:17215236:GAGAGA:GAGA
NM_144997.7(FLCN):c.1579C>T (p.Arg527Ter)	FLCN	R527*, R545*	Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000253258	17	17117130	17	17213816	253258	247646	rs879255683	NC_000017.11:17213815:G:A
NM_144997.7(FLCN):c.499C>T (p.Gln167Ter)	FLCN	Q167*, Q185*	Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141865	17	17127355	17	17224041	141865	151579	rs587782069	NC_000017.11:17224040:G:A
NM_024685.4(BBS10):c.1091del (p.Asn364fs)	BBS10	N364fs	Bardet-Biedl syndrome|Bardet-Biedl syndrome 10|not provided|Bardet-Biedl syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000166723	12	76740674	12	76346894	166723	177505	rs727503818	NC_000012.12:76346893:TT:T
NM_000057.4(BLM):c.2193+1G>A	BLM		Hereditary cancer-predisposing syndrome|Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000694326	15	91308645	15	90765415	694326	682218		NC_000015.10:90765414:G:A
NM_000057.4(BLM):c.3439A>T (p.Lys1147Ter)	BLM	K1147*, K772*	Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000562196	15	91346831	15	90803601	562196	553392	rs770311534	NC_000015.10:90803600:A:T
NM_000057.4(BLM):c.2488dup (p.Thr830fs)	BLM		Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042178	15	91312748 - 91312749	15	90769518 - 90769519	42178	51344	rs367543019	NC_000015.10:90769518:A:AA
NM_002834.5(PTPN11):c.855T>G (p.Phe285Leu)	PTPN11	F285L, F284L	Noonan syndrome 3|Rasopathy|Noonan syndrome|not provided	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044615	12	112915456	12	112477652	44615	53782	rs397516810	NC_000012.12:112477651:T:G
NM_002834.5(PTPN11):c.1493G>T (p.Arg498Leu)	PTPN11	R498L, R502L, R497L	Rasopathy|Noonan syndrome|Noonan syndrome with multiple lentigines|not provided|LEOPARD syndrome 1|Cafe-au-lait spot|Specific learning disability|Abnormal facial shape|Intellectual disability, mild|Scoliosis|Noonan syndrome 1	Pathogenic(Last reviewed: Nov 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040554	12	112926873	12	112489069	40554	49024	rs397507542	NC_000012.12:112489068:G:T
NM_002834.5(PTPN11):c.767A>G (p.Gln256Arg)	PTPN11	Q256R, Q255R	not specified|Rasopathy|Noonan syndrome|Noonan syndrome with multiple lentigines|not provided|Noonan syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040518	12	112910758	12	112472954	40518	48988	rs397507523	NC_000012.12:112472953:A:G
NM_002834.5(PTPN11):c.5C>T (p.Thr2Ile)	PTPN11	T2I	Noonan syndrome|Noonan syndrome 1|Rasopathy|not provided|Metachondromatosis	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013349	12	112856920	12	112419116	13349	28388	rs267606990	NC_000012.12:112419115:C:T
NM_002693.2(POLG):c.3286C>T (p.Arg1096Cys)	POLG	R1096C	Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Cerebellar ataxia infantile with progressive external ophthalmoplegia|not provided|Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206556	15	89861968	15	89318737	206556	202926	rs201732356	NC_000015.10:89318736:G:A
NM_152594.3(SPRED1):c.493dup (p.Ser165fs)	SPRED1		Inborn genetic diseases	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000521350	15	38632006 - 38632007	15	38339805 - 38339806	521350	512137	rs1555392032	NC_000015.10:38339805:A:AA
NM_005902.4(SMAD3):c.859C>T (p.Arg287Trp)	SMAD3	R287W, R182W, R92W, R243W	not provided|Loeys-Dietz syndrome 3|Cardiovascular phenotype|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030306	15	67473779	15	67181441	30306	39262	rs387906850	NC_000015.10:67181440:C:T
NM_001005242.3(PKP2):c.337-2A>T	PKP2		not provided|Arrhythmogenic right ventricular cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 9|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188654	12	33031479	12	32878545	188654	186427	rs786204389	NC_000012.12:32878544:T:A
NM_006009.4(TUBA1A):c.5G>A (p.Arg2His)	TUBA1A	R2H	not provided|Decreased head circumference|Seizures|Global developmental delay|Tubulinopathies|Inborn genetic diseases|Lissencephaly 3	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000160161	12	49580615	12	49186832	160161	169007	rs587784491	NC_000012.12:49186831:C:T
NM_000303.3(PMM2):c.710C>G (p.Thr237Arg)	PMM2	T237R	Congenital disorder of glycosylation, type Ia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007716	16	8941651	16	8847794	7716	22755	rs80338708	NC_000016.10:8847793:C:G
NM_000057.4(BLM):c.2289_2290AT[1] (p.Tyr764fs)	BLM		Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557764	15	91310234 - 91310235	15	90767004 - 90767005	557764	547654	rs1555420602	NC_000015.10:90767003:TATAT:TAT
NM_000057.4(BLM):c.1301C>G (p.Ser434Ter)	BLM	S434*, S59*	Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555723	15	91303904	15	90760674	555723	547927	rs754203833	NC_000015.10:90760673:C:G
NM_000057.4(BLM):c.3261del (p.Phe1087fs)	BLM	F1087fs, F712fs	Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000454132	15	91341468	15	90798238	454132	465592	rs1319786857	NC_000015.10:90798237:TTT:TT
NM_000057.4(BLM):c.1081_1082TG[1] (p.Cys361_Asp362delinsTer)	BLM		Hereditary cancer-predisposing syndrome|Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371130	15	91298162 - 91298163	15	90754932 - 90754933	371130	358347	rs1057517030	NC_000015.10:90754931:TGTG:TG
NM_000057.4(BLM):c.1479_1480del (p.Thr494fs)	BLM	T119fs, T494fs	Hereditary cancer-predisposing syndrome|Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371108	15	91304081 - 91304082	15	90760851 - 90760852	371108	358349	rs746244182	NC_000015.10:90760850:ATA:A
NM_000057.4(BLM):c.557_559del (p.Ser186_Lys187delinsTer)	BLM	S186*	Bloom syndrome	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005455	15	91293055 - 91293057	15	90749825 - 90749827	5455	20494	rs367543035	NC_000015.10:90749824:CAA:
NM_003482.3(KMT2D):c.9602dup (p.Ser3202fs)	KMT2D		not provided|Kabuki syndrome 1|CHARGE association	Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000424021	12	49431536 - 49431537	12	49037753 - 49037754	424021	408674	rs1555190375	NC_000012.12:49037753:A:AA
NM_003482.3(KMT2D):c.14710C>T (p.Arg4904Ter)	KMT2D	R4904*	Kabuki syndrome|Kabuki syndrome 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094176	12	49421039	12	49027256	94176	100076	rs398123721	NC_000012.12:49027255:G:A
NM_001009944.3(PKD1):c.9561_9563CAA[1] (p.Asn3188del)	PKD1	N3188del	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 7, 2013)	criteria provided, single submitter	VCV000225056	16	2150399 - 2150401	16	2100398 - 2100400	225056	226951	rs869312944	NC_000016.10:2100397:TTGTTGT:TTGT
NM_002474.3(MYH11):c.1669C>T (p.Gln557Ter)	MYH11	Q564*, Q557*	Aortic aneurysm, familial thoracic 4	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000846364	16	15850278	16	15756421	846364	843185		NC_000016.10:15756420:G:A
NM_002474.3(MYH11):c.3376del (p.Asp1126fs)	MYH11	D1126fs, D1133fs	Aortic aneurysm, familial thoracic 4	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000838001	16	15829353	16	15735496	838001	843172		NC_000016.10:15735495:CC:C
NM_002474.3(MYH11):c.3422_3470del (p.Lys1141fs)	MYH11	K1148fs, K1141fs	Aortic aneurysm, familial thoracic 4	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000211548	16	15829259 - 15829307	16	15735402 - 15735450	211548	208248	rs797045725	NC_000016.10:15735401:TCTTCCAGCTCTGTCTTTAGGGCCTCCAGCTCCTCGCCGAGGTCTCGCTTCT:TCT
NM_002474.3(MYH11):c.2809_2810del (p.Arg937fs)	MYH11	R944fs, R937fs	Aortic aneurysm, familial thoracic 4	Pathogenic(Last reviewed: Jun 22, 2015)	criteria provided, single submitter	VCV000211547	16	15835369 - 15835370	16	15741512 - 15741513	211547	208249	rs749497185	NC_000016.10:15741511:CT:
NM_000321.2(RB1):c.2325+1G>A	RB1		Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428709	13	49039248	13	48465112	428709	420575	rs1131690882	NC_000013.11:48465111:G:A
NM_000053.4(ATP7B):c.1708-5T>G	ATP7B		Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495402	13	52539174	13	51965038	495402	487771	rs770829226	NC_000013.11:51965037:A:C
NM_000053.4(ATP7B):c.51+4A>T	ATP7B		Wilson disease	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000312401	13	52585419	13	52011283	312401	328547	rs369488210	NC_000013.11:52011282:T:A
NM_000053.4(ATP7B):c.314C>A (p.Ser105Ter)	ATP7B	S105*	Wilson disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189193	13	52549042	13	51974906	189193	186911	rs753236073	NC_000013.11:51974905:G:T
NM_000053.4(ATP7B):c.3818C>T (p.Pro1273Leu)	ATP7B	P1273L, P1189L, P1195L, P1066L, P1162L	Wilson disease	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189139	13	52511697	13	51937561	189139	186876	rs758355520	NC_000013.11:51937560:G:A
NM_000053.4(ATP7B):c.2123T>C (p.Leu708Pro)	ATP7B	L708P, L624P, L597P	Wilson disease|not specified|not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003865	13	52532679	13	51958543	3865	18904	rs121908000	NC_000013.11:51958542:A:G
NM_000053.4(ATP7B):c.865C>T (p.Gln289Ter)	ATP7B	Q289*	Wilson disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003864	13	52548491	13	51974355	3864	18903	rs121907999	NC_000013.11:51974354:G:A
NM_000053.4(ATP7B):c.3796G>A (p.Gly1266Arg)	ATP7B	G1267R, G1266R, G1059R, G1155R, G1182R, G1188R	Wilson disease	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003849	13	52511719	13	51937583	3849	18888	rs121907992	NC_000013.11:51937582:C:T
NM_000135.4(FANCA):c.2534T>C (p.Leu845Pro)	FANCA	L845P	Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556016	16	89833616	16	89767208	556016	548654	rs1173704265	NC_000016.10:89767207:A:G
NM_000135.4(FANCA):c.2738A>C (p.His913Pro)	FANCA	H913P	Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555969	16	89831338	16	89764930	555969	547892	rs1302083447	NC_000016.10:89764929:T:G
NM_000135.4(FANCA):c.2812_2830dup (p.Asp944delinsGlyAsnSerThrTer)	FANCA		Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552489	16	89828378 - 89828379	16	89761970 - 89761971	552489	548201	rs1283284704	NC_000016.10:89761970:CAGCTTCAGGTTGAATTTCCAGCT:CAGCTTCAGGTTGAATTTCCAGCTTCAGGTTGAATTTCCAGCT
NM_000135.4(FANCA):c.1226-2A>G	FANCA		not specified|Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Feb 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439688	16	89857946	16	89791538	439688	433544	rs773906241	NC_000016.10:89791537:T:C
NM_000135.4(FANCA):c.862G>T (p.Glu288Ter)	FANCA	E288*, E256*	Fanconi anemia, complementation group A|Fanconi anemia|not specified	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000134239	16	89865605	16	89799197	134239	137978	rs148100796	NC_000016.10:89799196:C:A
NM_002474.3(MYH11):c.3722_3793del (p.Arg1241_Leu1264del)	MYH11		Aortic aneurysm, familial thoracic 4	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000014132	16	15820770 - 15820841	16	15726913 - 15726984	14132	29171	rs1555554098	
NM_000057.4(BLM):c.1544del (p.Asn515fs)	BLM	N140fs, N515fs	Bloom syndrome	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374315	15	91304139	15	90760909	374315	361217	rs367543043	NC_000015.10:90760908:AAAAAAAAA:AAAAAAAA
NM_000057.4(BLM):c.1284G>A (p.Trp428Ter)	BLM	W428*, W53*	Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371048	15	91303887	15	90760657	371048	358348	rs1057516964	NC_000015.10:90760656:G:A
NM_000057.4(BLM):c.2206dup (p.Tyr736fs)	BLM		Bloom syndrome	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000317406	15	91310151 - 91310152	15	90766921 - 90766922	317406	340082	rs886051551	NC_000015.10:90766921:T:TT
NM_000057.4(BLM):c.2407dup (p.Trp803fs)	BLM		Bloom syndrome|not provided	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000042177	15	91312667 - 91312668	15	90769437 - 90769438	42177	51343	rs367543012	NC_000015.10:90769437:T:TT
NM_000057.4(BLM):c.2506_2507del (p.Arg836fs)	BLM	R836fs, R461fs	Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042071	15	91312767 - 91312768	15	90769537 - 90769538	42071	51237	rs367543024	NC_000015.10:90769536:AG:
NM_001126108.2(SLC12A3):c.1925G>A (p.Arg642His)	SLC12A3	R642H, R641H	not provided|Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000319909	16	56919276	16	56885364	319909	343464	rs147901432	NC_000016.10:56885363:G:A
NM_016239.4(MYO15A):c.406_407insAGTT (p.Trp136Ter)	MYO15A		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000522086	17	18022519 - 18022520	17	18119205 - 18119206	522086	512262	rs1555537955	NC_000017.11:18119205:T:TAGTT
NM_016239.4(MYO15A):c.1661dup (p.Leu555fs)	MYO15A		Inborn genetic diseases	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000521500	17	18023771 - 18023772	17	18120457 - 18120458	521500	512263	rs1245338270	NC_000017.11:18120457:GGGG:GGGGG
NM_016239.4(MYO15A):c.6440dup (p.Trp2148fs)	MYO15A		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 25, 2016)	criteria provided, single submitter	VCV000520965	17	18049348 - 18049349	17	18146034 - 18146035	520965	512265	rs1555545225	NC_000017.11:18146034:GGGG:GGGGG
NM_000070.3(CAPN3):c.1817C>T (p.Ser606Leu)	CAPN3	S606L, S600L, S94L	Limb-girdle muscular dystrophy, type 2A|not provided|Limb-girdle muscular dystrophy, type 2A|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000289372	15	42700425	15	42408227	289372	273609	rs199806879	NC_000015.10:42408226:C:T
NM_000070.2(CAPN3):c.643_663del(p.Ser215_Gly221del)	CAPN3		Limb-girdle muscular dystrophy, type 2A|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4|not provided	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217159	15	42681133 - 42681153	15	42388935 - 42388955	217159	213824	rs863224965	NC_000015.10:42388934:GGTTCCTACGAAGCTCTGAAAGGT:GGT
NM_000070.3(CAPN3):c.1465C>T (p.Arg489Trp)	CAPN3	R489W, R441W	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217150	15	42693949	15	42401751	217150	213829	rs863224957	NC_000015.10:42401750:C:T
NM_000070.3(CAPN3):c.145C>T (p.Arg49Cys)	CAPN3	R49C	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000193037	15	42652148	15	42359950	193037	190202	rs794726871	NC_000015.10:42359949:C:T
NM_000070.3(CAPN3):c.1795dup (p.Thr599fs)	CAPN3		Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017620	15	42698129 - 42698130	15	42405931 - 42405932	17620	32659	rs80338803	NC_000015.10:42405931:AAAAAAA:AAAAAAAA
NM_001376.5(DYNC1H1):c.10033G>A (p.Glu3345Lys)	DYNC1H1	E3345K	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 20, 2013)	criteria provided, single submitter	VCV000208747	14	102498758	14	102032421	208747	205282	rs797044928	NC_000014.9:102032420:G:A
NM_001376.5(DYNC1H1):c.9754_9756AAG[2] (p.Lys3254del)	DYNC1H1	K3254del	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	VCV000208734	14	102496267 - 102496269	14	102029930 - 102029932	208734	205281	rs797044918	NC_000014.9:102029929:AAGAAGAAG:AAGAAG
NM_144997.7(FLCN):c.890_893del (p.Glu297fs)	FLCN	E315fs, E297fs	not provided|Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096492	17	17122502 - 17122505	17	17219188 - 17219191	96492	102386	rs398124541	NC_000017.11:17219187:CTTTCT:CT
NM_002693.2(POLG):c.3550G>A (p.Asp1184Asn)	POLG	D1184N	not provided|Progressive sclerosing poliodystrophy|Mitochondrial diseases	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426100	15	89860700	15	89317469	426100	414709	rs1131691575	NC_000015.10:89317468:C:T
NM_003482.3(KMT2D):c.4135_4136del (p.Met1379fs)	KMT2D	M1379fs	Kabuki syndrome|Kabuki syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094216	12	49441848 - 49441849	12	49048065 - 49048066	94216	100116	rs398123744	NC_000012.12:49048064:AT:
NM_003482.3(KMT2D):c.15536G>A (p.Arg5179His)	KMT2D	R5179H	not provided|Kabuki syndrome 1|Kabuki syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007536	12	49420213	12	49026430	7536	22575	rs267607237	NC_000012.12:49026429:C:T
NM_001009944.3(PKD1):c.6487C>T (p.Arg2163Ter)	PKD1	R2163*	Autosomal recessive polycystic kidney disease|not specified|not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000433972	16	2158681	16	2108680	433972	427480	rs1555454411	NC_000016.10:2108679:G:A
NM_000057.4(BLM):c.296_297CA[1] (p.Gln100fs)	BLM		Hereditary cancer-predisposing syndrome|Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371569	15	91292793 - 91292794	15	90749563 - 90749564	371569	358343	rs745807085	NC_000015.10:90749562:ACACA:ACA
NM_000057.4(BLM):c.3028del (p.Asp1010fs)	BLM	D1010fs, D635fs	Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189048	15	91337405	15	90794175	189048	186950	rs780379121	NC_000015.10:90794174:G:
NM_000057.4(BLM):c.991_995del (p.Lys331fs)	BLM	K331fs	Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188870	15	91298069 - 91298073	15	90754839 - 90754843	188870	186947	rs786204524	NC_000015.10:90754838:AGAAAAGA:AGA
NM_000057.4(BLM):c.2250_2251insAAAT (p.Leu751fs)	BLM		Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188790	15	91310196 - 91310197	15	90766966 - 90766967	188790	186949	rs786204471	NC_000015.10:90766966::AAAT
NM_000057.4(BLM):c.768_769CT[2] (p.Leu258fs)	BLM		Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042092	15	91293266 - 91293267	15	90750036 - 90750037	42092	51258	rs367543013	NC_000015.10:90750035:CTCTCT:CTCT
NM_000875.5(IGF1R):c.3348_3366dup (p.Met1123fs)	IGF1R		Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000431965	15	99482476 - 99482477	15	98939247 - 98939248	431965	426143	rs1322503729	NC_000015.10:98939247:GGCCGGAGAGATTGCAGACGGC:GGCCGGAGAGATTGCAGACGGCCGGAGAGATTGCAGACGGC
NM_024312.5(GNPTAB):c.1959_1960del (p.Pro655fs)	GNPTAB	P655fs	MUCOLIPIDOSIS III ALPHA/BETA|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520752	12	102158735 - 102158736	12	101764957 - 101764958	520752	511952	rs1429181351	NC_000012.12:101764956:TA:
NM_000135.4(FANCA):c.2851C>T (p.Arg951Trp)	FANCA	R951W	Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000408196	16	89828358	16	89761950	408196	401422	rs755546887	NC_000016.10:89761949:G:A
NM_000135.4(FANCA):c.3349A>G (p.Arg1117Gly)	FANCA	R1117G	Fanconi anemia, complementation group A|not provided|Fanconi anemia	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000219752	16	89813298	16	89746890	219752	222542	rs149277003	NC_000016.10:89746889:T:C
NC_000016.9:g.(?_15917092)_(15932129_?)del	MYH11		Aortic aneurysm, familial thoracic 4	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000465704			16	15823235 - 15838272	465704	465523		
NM_002474.3(MYH11):c.3791T>C (p.Leu1264Pro)	MYH11	L1264P, L1271P	Cardiovascular phenotype|not provided|Aortic aneurysm, familial thoracic 4	Pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, multiple submitters, no conflicts	VCV000088953	16	15820772	16	15726915	88953	94510	rs201831933	NC_000016.10:15726914:A:G
NM_004572.3(PKP2):c.1821dup (p.Val608fs)	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9|Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000045047	12	32975550 - 32975551	12	32822616 - 32822617	45047	54214	rs397517010	NC_000012.12:32822616:A:AA
NM_002834.5(PTPN11):c.1505C>T (p.Ser502Leu)	PTPN11	S502L, S506L, S501L	not provided|Rasopathy|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040557	12	112926885	12	112489081	40557	49027	rs397507544	NC_000012.12:112489080:C:T
NM_004004.6(GJB2):c.250G>T (p.Val84Leu)	GJB2	V84L	not specified|not provided|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: May 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167134	13	20763471	13	20189332	167134	177744	rs104894409	NC_000013.11:20189331:C:A
NM_004004.6(GJB2):c.95G>A (p.Arg32His)	GJB2	R32H	Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Rare genetic deafness	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000044766	13	20763626	13	20189487	44766	53933	rs111033190	NC_000013.11:20189486:C:T
NM_003482.3(KMT2D):c.15461G>A (p.Arg5154Gln)	KMT2D	R5154Q	Kabuki syndrome|not provided|Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000286834	12	49420288	12	49026505	286834	271071	rs886043497	NC_000012.12:49026504:C:T
NM_000512.5(GALNS):c.122T>A (p.Met41Lys)	GALNS	M41K, M47K	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	VCV000520822	16	88909236	16	88842828	520822	512234	rs1555523411	NC_000016.10:88842827:A:T
NM_000053.4(ATP7B):c.2333G>A (p.Arg778Gln)	ATP7B	R778Q, R667Q, R694Q	Wilson disease	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550914	13	52532469	13	51958333	550914	547360	rs28942074	NC_000013.11:51958332:C:T
NM_000053.4(ATP7B):c.3305T>C (p.Ile1102Thr)	ATP7B	I1102T, I1018T, I1024T, I991T, I895T	Wilson disease	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000430725	13	52516629	13	51942493	430725	424263	rs560952220	NC_000013.11:51942492:A:G
NM_000053.4(ATP7B):c.2383C>T (p.Leu795Phe)	ATP7B	L795F, L711F, L717F, L633F, L684F	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188814	13	52531716	13	51957580	188814	186900	rs751710854	NC_000013.11:51957579:G:A
NM_000053.4(ATP7B):c.2336G>A (p.Trp779Ter)	ATP7B	W779*, W668*, W695*	Wilson disease|not specified|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156284	13	52532466	13	51958330	156284	166064	rs137853283	NC_000013.11:51958329:C:T
NM_002693.2(POLG):c.1880G>A (p.Arg627Gln)	POLG	R627Q	not provided|Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000436359	15	89868750	15	89325519	436359	429734	rs375305567	NC_000015.10:89325518:C:T
NM_001126131.2(POLG):c.3218C>T (p.Pro1073Leu)	POLG	P1073L	Progressive sclerosing poliodystrophy|not provided|Mitochondrial DNA depletion syndrome 4B, MNGIE type	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013516	15	89862217	15	89318986	13516	28555	rs267606959	NC_000015.10:89318985:G:A
NM_000057.4(BLM):c.98+1G>C	BLM		Hereditary cancer-predisposing syndrome|Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000667391	15	91290721	15	90747491	667391	654784		NC_000015.10:90747490:G:C
NM_000057.4(BLM):c.1968dup (p.Lys657fs)	BLM		Hereditary cancer-predisposing syndrome|Bloom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495425	15	91306280 - 91306281	15	90763050 - 90763051	495425	487898	rs772785079	NC_000015.10:90763050:G:GG
NM_139276.2(STAT3):c.2144C>T (p.Pro715Leu)	STAT3	P715L, P714L	not provided|Inherited Immunodeficiency Diseases|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000421171	17	40469200	17	42317182	421171	409927	rs1064794957	NC_000017.11:42317181:G:A
NM_000431.4(MVK):c.803T>C (p.Ile268Thr)	MVK	I268T, I216T	not specified|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever||Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|not provided	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011932	12	110029080	12	109591275	11932	26971	rs104895304	NC_000012.12:109591274:T:C
NM_001271.4(CHD2):c.5035C>T (p.Arg1679Ter)	CHD2	R1679*	not provided|Inborn genetic diseases|Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208725	15	93563370	15	93020140	208725	205288	rs797044912	NC_000015.10:93020139:C:T
NM_000151.4(G6PC):c.79del (p.Gln27fs)	G6PC	Q27fs	not provided|Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021062	17	41052970	17	42900953	21062	33914	rs80356479	NC_000017.11:42900952:CCC:CC
NM_000070.3(CAPN3):c.1343G>A (p.Arg448His)	CAPN3	R448H, R400H	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217149	15	42691839	15	42399641	217149	213828	rs863224956	NC_000015.10:42399640:G:A
NM_000070.2(CAPN3):c.1319G>A	CAPN3	R440Q, R392Q	Limb-girdle muscular dystrophy, type 2A|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4|not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217147	15	42691815	15	42399617	217147	213634	rs376107921	NC_000015.10:42399616:G:A
NM_000070.3(CAPN3):c.598_612del (p.Phe200_Leu204del)	CAPN3		not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000166786	15	42680049 - 42680063	15	42387851 - 42387865	166786	177545	rs727503837	NC_000015.10:42387850:GTTCTGGAGTGCTCTG:G
NM_000070.3(CAPN3):c.2393C>A (p.Ala798Glu)	CAPN3	A798E, A133E, A706E, A792E, A286E	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092414	15	42703497	15	42411299	92414	98325	rs149095128	NC_000015.10:42411298:C:A
NM_014336.5(AIPL1):c.834G>A (p.Trp278Ter)	AIPL1	W278*, W256*, W218*, W254*, W215*, W239*, W266*	AIPL1-Related Disorders|Retinal dystrophy|Leber congenital amaurosis|not provided|Leber congenital amaurosis 4	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005565	17	6329101	17	6425781	5565	20604	rs62637014	NC_000017.11:6425780:C:T
NM_000135.4(FANCA):c.1771C>T (p.Arg591Ter)	FANCA	R591*	Fanconi anemia, complementation group A|Fanconi anemia	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557990	16	89845356	16	89778948	557990	547958	rs753980264	NC_000016.10:89778947:G:A
NM_000135.4(FANCA):c.2852G>A (p.Arg951Gln)	FANCA	R951Q	Fanconi anemia, complementation group A|Fanconi anemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000526433	16	89828357	16	89761949	526433	530933	rs755922289	NC_000016.10:89761948:C:T
NM_000135.4(FANCA):c.709+5G>A	FANCA		Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000408169	16	89871683	16	89805275	408169	402204	rs759877008	NC_000016.10:89805274:C:T
NM_000135.4(FANCA):c.2557C>T (p.Arg853Ter)	FANCA	R853*	Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000192384	16	89833593	16	89767185	192384	190171	rs752160950	NC_000016.10:89767184:G:A
NM_013382.5(POMT2):c.1997A>G (p.Tyr666Cys)	POMT2	Y666C	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|not provided|Muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003221	14	77745107	14	77278764	3221	18260	rs200198778	NC_000014.9:77278763:T:C
NM_001376.5(DYNC1H1):c.4700G>A (p.Arg1567Gln)	DYNC1H1	R1567Q	not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000208709	14	102469031	14	102002694	208709	205280	rs797044901	NC_000014.9:102002693:G:A
NM_000057.4(BLM):c.3415C>T (p.Arg1139Ter)	BLM	R1139*, R764*	Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156484	15	91346807	15	90803577	156484	166249	rs587783037	NC_000015.10:90803576:C:T
NM_000057.4(BLM):c.2923del (p.Gln975fs)	BLM	Q600fs, Q975fs	Bloom syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042076	15	91333977	15	90790747	42076	51242	rs367543014	NC_000015.10:90790746:CC:C
NM_001009944.3(PKD1):c.2534T>C (p.Leu845Ser)	PKD1	L845S	not provided|Polycystic kidney disease, adult type|Polycystic kidney disease 3	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008206	16	2164490	16	2114489	8206	23245	rs199476100	NC_000016.10:2114488:A:G
NM_002693.2(POLG):c.679C>T (p.Arg227Trp)	POLG	R227W	Progressive sclerosing poliodystrophy|Abnormality of corpus callosum|not provided|Mitochondrial DNA depletion syndrome 4B, MNGIE type	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013515	15	89873488	15	89330257	13515	28554	rs121918056	NC_000015.10:89330256:G:A
NM_000053.4(ATP7B):c.4090_4091GT[1] (p.Ser1365fs)	ATP7B		Wilson disease	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371438	13	52509760 - 52509761	13	51935624 - 51935625	371438	358213	rs771603301	NC_000013.11:51935623:ACACA:ACA
NM_000053.4(ATP7B):c.3104G>T (p.Gly1035Val)	ATP7B	G1035V, G828V, G951V, G957V, G924V	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371021	13	52518384	13	51944248	371021	358223	rs753594031	NC_000013.11:51944247:C:A
NM_000053.4(ATP7B):c.4051C>T (p.Gln1351Ter)	ATP7B	Q1351*, Q1144*, Q1240*, Q1267*, Q1273*	not provided|Wilson disease	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188947	13	52509802	13	51935666	188947	186874	rs786204578	NC_000013.11:51935665:G:A
NM_000053.4(ATP7B):c.3556G>A (p.Gly1186Ser)	ATP7B	G1186S, G1075S, G1102S, G1108S, G979S	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000188900	13	52515217	13	51941081	188900	186881	rs786204547	NC_000013.11:51941080:C:T
NM_000053.4(ATP7B):c.2731-2A>G	ATP7B		Wilson disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188725	13	52523934	13	51949798	188725	186894	rs367956522	NC_000013.11:51949797:T:C
NM_003119.4(SPG7):c.347C>A (p.Ser116Ter)	SPG7	S116*	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000521196	16	89579416	16	89513008	521196	512250	rs149474131	NC_000016.10:89513007:C:A
NM_002834.5(PTPN11):c.205G>C (p.Glu69Gln)	PTPN11	E69Q, E68Q	Rasopathy|Noonan syndrome|not provided	Pathogenic(Last reviewed: Dec 5, 2019)	reviewed by expert panel	VCV000040498	12	112888189	12	112450385	40498	48968	rs397507511	NC_000012.12:112450384:G:C
NM_002834.5(PTPN11):c.172A>G (p.Asn58Asp)	PTPN11	N58D, N57D	Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Noonan syndrome 1|Metachondromatosis|Rasopathy|not provided|Noonan syndrome	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040487	12	112888156	12	112450352	40487	48957	rs397507505	NC_000012.12:112450351:A:G
NM_002834.4(PTPN11):c.226G>A (p.Glu76Lys)	PTPN11	E76K	Squamous cell lung carcinoma|Noonan syndrome|Juvenile myelomonocytic leukemia|Rasopathy|Neoplasm of the large intestine|Astrocytoma|not provided|Neuroblastoma|Multiple myeloma	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013336	12	112888210	12	112450406	13336	28375	rs121918464	NC_000012.12:112450405:G:A
NM_144997.7(FLCN):c.1389C>G (p.Tyr463Ter)	FLCN	Y463*, Y481*	Hereditary cancer-predisposing syndrome|not provided|Pneumothorax, primary spontaneous|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003367	17	17118542	17	17215228	3367	18406	rs137852929	NC_000017.11:17215227:G:C
NM_000137.3(FAH):c.554-1G>T	FAH		Tyrosinemia type I|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011874	15	80460605	15	80168263	11874	26913	rs80338895	NC_000015.10:80168262:G:T
NM_002474.3(MYH11):c.2135G>A (p.Arg712Gln)	MYH11	R712Q, R719Q	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014135	16	15841949	16	15748092	14135	29174	rs267606902	NC_000016.10:15748091:C:T
NM_000057.4(BLM):c.3210+2del	BLM		Bloom syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127497	15	91337589	15	90794359	127497	132954	rs587779886	NC_000015.10:90794358:T:
NM_000057.4(BLM):c.2098C>T (p.Gln700Ter)	BLM	Q700*, Q325*	Bloom syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042067	15	91308549	15	90765319	42067	51233	rs367543028	NC_000015.10:90765318:C:T
NM_014363.6(SACS):c.8844del (p.Ile2949fs)	SACS	I2802fs, I2949fs	not provided|Spastic paraplegia|	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005512	13	23909171	13	23335032	5512	20551	rs281865117	NC_000013.11:23335031:A:
NM_000070.3(CAPN3):c.756_758GAA[1] (p.Lys254del)	CAPN3	K254del	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197624	15	42681249 - 42681251	15	42389051 - 42389053	197624	194785	rs794727697	NC_000015.10:42389050:GAAGAA:GAA
NM_000070.3(CAPN3):c.1715G>A (p.Arg572Gln)	CAPN3	R572Q, R524Q, R60Q	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017614	15	42695170	15	42402972	17614	32653	rs121434544	NC_000015.10:42402971:G:A
NM_000321.2(RB1):c.409G>T (p.Glu137Ter)	RB1	E137*	Neoplasm|Retinoblastoma	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000126810	13	48919244	13	48345108	126810	132320	rs121913296	NC_000013.11:48345107:G:T
NM_005249.5(FOXG1):c.859A>T (p.Lys287Ter)	FOXG1	K287*	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000521962	14	29237344	14	28768138	521962	512091	rs1555321367	NC_000014.9:28768137:A:T
NM_005249.5(FOXG1):c.717C>G (p.Phe239Leu)	FOXG1	F239L	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 17, 2016)	criteria provided, single submitter	VCV000520962	14	29237202	14	28767996	520962	512089	rs1555321339	NC_000014.9:28767995:C:G
NM_005249.5(FOXG1):c.732_741del (p.His245fs)	FOXG1	H245fs	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 25, 2015)	criteria provided, single submitter	VCV000520758	14	29237217 - 29237226	14	28768011 - 28768020	520758	512090	rs1555321345	NC_000014.9:28768010:CCACTACGAC:
NM_005249.5(FOXG1):c.1082dup (p.Leu362fs)	FOXG1		Inborn genetic diseases	Pathogenic(Last reviewed: May 6, 2015)	criteria provided, single submitter	VCV000520665	14	29237565 - 29237566	14	28768359 - 28768360	520665	512093	rs1555321405	NC_000014.9:28768359:GG:GGG
NM_001126108.2(SLC12A3):c.1315G>A (p.Gly439Ser)	SLC12A3	G439S, G438S	not provided|Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000586601	16	56913119	16	56879207	586601	577552	rs759377924	NC_000016.10:56879206:G:A
NM_015335.4(MED13L):c.1858_1860delinsCTCGAACA (p.Gly620fs)	MED13L		Inborn genetic diseases	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000521718	12	116446358 - 116446360	12	116008553 - 116008555	521718	511971	rs1555247853	NC_000012.12:116008552:CCC:TGTTCGAG
NM_015335.4(MED13L):c.6331C>T (p.Gln2111Ter)	MED13L	Q2111*	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000521384	12	116403943	12	115966138	521384	511964	rs1555240361	NC_000012.12:115966137:G:A
NM_015335.4(MED13L):c.2239-2A>G	MED13L		Inborn genetic diseases	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000521269	12	116444218	12	116006413	521269	511970	rs1555247469	NC_000012.12:116006412:T:C
NM_015335.4(MED13L):c.6336G>A (p.Trp2112Ter)	MED13L	W2112*	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000521253	12	116403938	12	115966133	521253	511963	rs1555240359	NC_000012.12:115966132:C:T
NM_015335.4(MED13L):c.1690C>T (p.Arg564Ter)	MED13L	R564*	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000521154	12	116446528	12	116008723	521154	511972	rs1555247936	NC_000012.12:116008722:G:A
NM_015335.4(MED13L):c.1361C>G (p.Ser454Ter)	MED13L	S454*	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000520839	12	116446857	12	116009052	520839	511974	rs1555248020	NC_000012.12:116009051:G:C
NM_015335.4(MED13L):c.6280C>A (p.Pro2094Thr)	MED13L	P2094T	Inborn genetic diseases	Pathogenic(Last reviewed: May 21, 2015)	criteria provided, single submitter	VCV000520657	12	116403994	12	115966189	520657	511965	rs1555240376	NC_000012.12:115966188:G:T
NM_002755.4(MAP2K1):c.371C>T (p.Pro124Leu)	MAP2K1	P124L	Neoplasm of the large intestine|Malignant melanoma of skin|Malignant neoplasm of body of uterus|Cutaneous melanoma|Cardio-facio-cutaneous syndrome|Transitional cell carcinoma of the bladder|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040744	15	66729163	15	66436825	40744	49214	rs397516792	NC_000015.10:66436824:C:T
NM_000053.4(ATP7B):c.3818C>A (p.Pro1273Gln)	ATP7B	P1273Q, P1195Q, P1066Q, P1162Q, P1189Q	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553360	13	52511697	13	51937561	553360	547279	rs758355520	NC_000013.11:51937560:G:T
NM_000053.4(ATP7B):c.2828G>A (p.Gly943Asp)	ATP7B	G943D, G832D, G865D, G859D	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189058	13	52523835	13	51949699	189058	186892	rs779323689	NC_000013.11:51949698:C:T
NM_000053.4(ATP7B):c.2519C>T (p.Pro840Leu)	ATP7B	P840L, P762L, P729L, P756L, P678L	Wilson disease|not provided	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000188879	13	52524464	13	51950328	188879	186898	rs768671894	NC_000013.11:51950327:G:A
NM_000053.4(ATP7B):c.122A>G (p.Asn41Ser)	ATP7B	N41S	Wilson disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000157928	13	52549234	13	51975098	157928	167775	rs201738967	NC_000013.11:51975097:T:C
NM_000057.4(BLM):c.98+1G>T	BLM		Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370200	15	91290721	15	90747491	370200	358342	rs750293380	NC_000015.10:90747490:G:T
NM_000135.4(FANCA):c.3163C>T (p.Arg1055Trp)	FANCA	R1055W	Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555008	16	89816214	16	89749806	555008	548634	rs753063086	NC_000016.10:89749805:G:A
NM_000135.4(FANCA):c.983_986TCAC[1] (p.His330fs)	FANCA		Fanconi anemia, complementation group A|not provided|Fanconi anemia	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208580	16	89862330 - 89862333	16	89795922 - 89795925	208580	205183	rs772359099	NC_000016.10:89795921:GTGAGTGAGT:GTGAGT
NM_000135.4(FANCA):c.1111_1114TTGG[1] (p.Val372fs)	FANCA		Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003440	16	89858442 - 89858445	16	89792034 - 89792037	3440	18479	rs397507552	NC_000016.10:89792033:CCAACCAAC:CCAAC
NM_001089.3(ABCA3):c.875A>T (p.Glu292Val)	ABCA3	E292V	Pulmonary arterial hypertension|Respiratory insufficiency|Pulmonary insufficiency|Surfactant metabolism dysfunction, pulmonary, 3|Primary interstitial lung disease specific to childhood due to pulmonary surfactant protein anomalies|Diffuse interstitial pulmonary fibrosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203381	16	2367764	16	2317763	203381	199803	rs149989682	NC_000016.10:2317762:T:A
NM_002834.5(PTPN11):c.1391G>C (p.Gly464Ala)	PTPN11	G464A, G468A, G463A	Rasopathy|Noonan syndrome with multiple lentigines|Noonan syndrome|not provided|LEOPARD syndrome 1	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013343	12	112926258	12	112488454	13343	28382	rs121918469	NC_000012.12:112488453:G:C
NM_004004.6(GJB2):c.269dup (p.Val91fs)	GJB2		Hearing loss|not provided|Rare genetic deafness|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177737	13	20763451 - 20763452	13	20189312 - 20189313	177737	175904	rs730880338	NC_000013.11:20189312:A:AA
NM_004004.6(GJB2):c.647_650del (p.Arg216fs)	GJB2	R216fs	Hearing impairment|not specified|not provided|Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158609	13	20763071 - 20763074	13	20188932 - 20188935	158609	169009	rs587783647	NC_000013.11:20188931:TATCTA:TA
NM_000321.2(RB1):c.1654C>T (p.Arg552Ter)	RB1	R552*	Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Jan 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000126840	13	48955538	13	48381402	126840	132350	rs121913303	NC_000013.11:48381401:C:T
NM_000321.2(RB1):c.1436_1438ACA[1] (p.Asn480del)	RB1	N480del	Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013091	13	48954315 - 48954317	13	48380179 - 48380181	13091	28130	rs587776788	NC_000013.11:48380178:ACAACA:ACA
NM_144599.5(NIPA1):c.316G>A (p.Gly106Arg)	NIPA1	G106R, G31R	Hereditary spastic paraplegia 6|Spastic paraplegia|not provided|Hereditary spastic paraplegia	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002523	15	23060816	15	22812252	2523	17562	rs104894490	NC_000015.10:22812251:G:A
NM_001077401.2(ACVRL1):c.1451G>A (p.Arg484Gln)	ACVRL1	R484Q	not provided|Pulmonary arterial hypertension|Epistaxis|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia||Pulmonary arterial hypertension|not specified	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212796	12	52314616	12	51920832	212796	210238	rs863223408	NC_000012.12:51920831:G:A
NM_001199107.2(TBC1D24):c.475del (p.Leu159fs)	TBC1D24	L159fs	Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207507	16	2546623	16	2496622	207507	203229	rs796053403	NC_000016.10:2496621:CC:C
NM_000303.3(PMM2):c.470T>C (p.Phe157Ser)	PMM2	F157S	Congenital disorder of glycosylation, type Ia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188763	16	8905517	16	8811660	188763	186953	rs190521996	NC_000016.10:8811659:T:C
NM_004448.3(ERBB2):c.2263_2264delinsCC (p.Leu755Pro)	ERBB2	L755P	Lung adenocarcinoma|Transitional cell carcinoma of the bladder|Malignant melanoma of skin|Papillary renal cell carcinoma, sporadic|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Neoplasm of the large intestine|Neoplasm of the breast	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000013877	17	37880219 - 37880220	17	39723966 - 39723967	13877	28916	rs121913469	NC_000017.11:39723965:TT:CC
NM_000070.3(CAPN3):c.1466G>A (p.Arg489Gln)	CAPN3	R489Q, R441Q	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000289644	15	42693950	15	42401752	289644	273881	rs147764579	NC_000015.10:42401751:G:A
NM_000070.3(CAPN3):c.245C>T (p.Pro82Leu)	CAPN3	P82L	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282783	15	42652248	15	42360050	282783	267020	rs886042478	NC_000015.10:42360049:C:T
NM_000070.3(CAPN3):c.1063C>T (p.Arg355Trp)	CAPN3	R355W, R307W	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000281254	15	42686487	15	42394289	281254	265491	rs749099493	NC_000015.10:42394288:C:T
NM_000070.3(CAPN3):c.2306G>A (p.Arg769Gln)	CAPN3	R769Q, R257Q, R677Q, R104Q, R763Q	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017613	15	42703124	15	42410926	17613	32652	rs80338802	NC_000015.10:42410925:G:A
NM_000257.4(MYH7):c.1810A>G (p.Thr604Ala)	MYH7	T604A	not provided	Pathogenic(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	VCV000429741	14	23896872	14	23427663	429741	421983	rs1131691562	NC_000014.9:23427662:T:C
NM_000257.4(MYH7):c.2783A>T (p.Asp928Val)	MYH7	D928V	not provided	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	VCV000181379	14	23893255	14	23424046	181379	179578	rs727504558	NC_000014.9:23424045:T:A
NM_000257.4(MYH7):c.1234A>T (p.Thr412Ser)	MYH7	T412S	not provided	Pathogenic(Last reviewed: Aug 25, 2014)	criteria provided, single submitter	VCV000181340	14	23898461	14	23429252	181340	179657	rs730880869	NC_000014.9:23429251:T:A
NM_000257.4(MYH7):c.1048T>C (p.Tyr350His)	MYH7	Y350H	not provided	Pathogenic(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	VCV000181334	14	23899074	14	23429865	181334	179666	rs730880863	NC_000014.9:23429864:A:G
NM_000257.4(MYH7):c.730T>C (p.Phe244Leu)	MYH7	F244L	not provided	Pathogenic(Last reviewed: Aug 21, 2013)	criteria provided, single submitter	VCV000181319	14	23900796	14	23431587	181319	179684	rs730880849	NC_000014.9:23431586:A:G
NM_000257.4(MYH7):c.5507C>G (p.Ser1836Trp)	MYH7	S1836W	not provided	Pathogenic(Last reviewed: Apr 23, 2012)	criteria provided, single submitter	VCV000181284	14	23884256	14	23415047	181284	179475	rs727503242	NC_000014.9:23415046:G:C
NM_000257.4(MYH7):c.5410G>A (p.Ala1804Thr)	MYH7	A1804T	not provided	Pathogenic(Last reviewed: Dec 10, 2012)	criteria provided, single submitter	VCV000181280	14	23884353	14	23415144	181280	179479	rs730880818	NC_000014.9:23415143:C:T
NM_000257.4(MYH7):c.3620T>A (p.Ile1207Asn)	MYH7	I1207N	not provided	Pathogenic(Last reviewed: Aug 7, 2013)	criteria provided, single submitter	VCV000181229	14	23889160	14	23419951	181229	179549	rs730880780	NC_000014.9:23419950:A:T
NM_000257.4(MYH7):c.2347C>T (p.Arg783Cys)	MYH7	R783C	not provided	Pathogenic(Last reviewed: May 5, 2014)	criteria provided, single submitter	VCV000181182	14	23894567	14	23425358	181182	179614	rs727503258	NC_000014.9:23425357:G:A
NM_000257.4(MYH7):c.1073A>T (p.His358Leu)	MYH7	H358L	Familial cardiomyopathy	Pathogenic	no assertion criteria provided	VCV000132933	14	23899049	14	23429840	132933	136682	rs606231316	NC_000014.9:23429839:T:A
NM_000257.4(MYH7):c.1151C>A (p.Ser384Tyr)	MYH7	S384Y	Familial cardiomyopathy	Pathogenic	no assertion criteria provided	VCV000132930	14	23898544	14	23429335	132930	136679	rs606231319	NC_000014.9:23429334:G:T
NM_000257.4(MYH7):c.1530C>A (p.Phe510Leu)	MYH7	F510L	Familial cardiomyopathy	Pathogenic	no assertion criteria provided	VCV000132926	14	23897757	14	23428548	132926	136675	rs606231323	NC_000014.9:23428547:G:T
NM_000257.4(MYH7):c.1952A>G (p.His651Arg)	MYH7	H651R	Familial cardiomyopathy	Pathogenic	no assertion criteria provided	VCV000132921	14	23896453	14	23427244	132921	136670	rs606231328	NC_000014.9:23427243:T:C
NM_000257.4(MYH7):c.1956+2T>G	MYH7		Familial cardiomyopathy	Pathogenic	no assertion criteria provided	VCV000132920	14	23896447	14	23427238	132920	136669	rs606231329	NC_000014.9:23427237:A:C
NM_000257.4(MYH7):c.2028del (p.Asn676fs)	MYH7	N676K, N676fs	Familial cardiomyopathy	Pathogenic	no assertion criteria provided	VCV000132917	14	23896002	14	23426793	132917	136666	rs606231331	NC_000014.9:23426792:A:
NM_000257.4(MYH7):c.2051T>G (p.Met684Arg)	MYH7	M684R	Familial cardiomyopathy	Pathogenic	no assertion criteria provided	VCV000132916	14	23895284	14	23426075	132916	136665	rs606231332	NC_000014.9:23426074:A:C
NM_000257.4(MYH7):c.2163-1G>A	MYH7		Familial cardiomyopathy	Pathogenic	no assertion criteria provided	VCV000132914	14	23895028	14	23425819	132914	136663	rs606231334	NC_000014.9:23425818:C:T
NM_000257.4(MYH7):c.2366del (p.Gln789fs)	MYH7	Q789R, Q789fs	Familial cardiomyopathy	Pathogenic	no assertion criteria provided	VCV000132911	14	23894548	14	23425339	132911	136660	rs606231337	NC_000014.9:23425338:T:
NM_000257.4(MYH7):c.2686G>A (p.Asp896Asn)	MYH7	D896N	Familial cardiomyopathy	Pathogenic	no assertion criteria provided	VCV000132908	14	23893352	14	23424143	132908	136657	rs606231340	NC_000014.9:23424142:C:T
NM_000257.4(MYH7):c.195T>G (p.Tyr65Ter)	MYH7	Y65*	MYH7-Related Disorders	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634543	14	23902747	14	23433538	634543	622424	rs934278063	NC_000014.9:23433537:A:C
NM_000257.4(MYH7):c.1400T>A (p.Ile467Asn)	MYH7	I467N	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000619263	14	23898171	14	23428962	619263	610672	rs730880872	NC_000014.9:23428961:A:T
NM_000257.4(MYH7):c.1963C>A (p.Leu655Met)	MYH7	L655M	Dilated cardiomyopathy 1S	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000619177	14	23896067	14	23426858	619177	610572		NC_000014.9:23426857:G:T
NM_000257.4(MYH7):c.2333A>T (p.Asp778Val)	MYH7	D778V	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000454354	14	23894581	14	23425372	454354	463668	rs121913634	NC_000014.9:23425371:T:A
NM_000257.4(MYH7):c.2631G>T (p.Met877Ile)	MYH7	M877I	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 18, 2017)	no assertion criteria provided	VCV000417718	14	23894026	14	23424817	417718	404619	rs1060505018	NC_000014.9:23424816:C:A
NM_000257.4(MYH7):c.761C>A (p.Ala254Glu)	MYH7	A254E	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000237444	14	23900662	14	23431453	237444	241824	rs878853842	NC_000014.9:23431452:G:T
NM_000257.4(MYH7):c.5566G>A (p.Glu1856Lys)	MYH7	E1856K	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000190403	14	23883305	14	23414096	190403	188227	rs797044598	NC_000014.9:23414095:C:T
NM_000257.4(MYH7):c.1325G>A (p.Arg442His)	MYH7	R442H	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181342	14	23898246	14	23429037	181342	179653	rs730880870	NC_000014.9:23429036:C:T
NM_000257.4(MYH7):c.2163G>T (p.Arg721Ser)	MYH7	R721S	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181175	14	23895027	14	23425818	181175	179624	rs730880734	NC_000014.9:23425817:C:A
NM_000257.4(MYH7):c.5754C>R (p.Asn1918Lys)	MYH7	N1918K	Left ventricular noncompaction 5	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000066082	14	23883004	14	23413795	66082	76984	rs138110910	NC_000014.9:23413794:G:Y
NM_000257.4(MYH7):c.847T>G (p.Tyr283Asp)	MYH7	Y283D	Left ventricular noncompaction 5	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000066081	14	23900158	14	23430949	66081	76983	rs397515482	NC_000014.9:23430948:A:C
NM_000257.4(MYH7):c.5296G>A (p.Ala1766Thr)	MYH7	A1766T	Left ventricular noncompaction 5	Pathogenic(Last reviewed: Jun 3, 2008)	no assertion criteria provided	VCV000014128	14	23884467	14	23415258	14128	29167	rs267606909	NC_000014.9:23415257:C:T
NM_000257.4(MYH7):c.667G>A (p.Ala223Thr)	MYH7	A223T	Dilated cardiomyopathy 1S	Pathogenic(Last reviewed: Oct 18, 2002)	no assertion criteria provided	VCV000014112	14	23900859	14	23431650	14112	29151	rs121913645	NC_000014.9:23431649:C:T
NM_000257.4(MYH7):c.2292C>G (p.Phe764Leu)	MYH7	F764L	Dilated cardiomyopathy 1S	Pathogenic(Last reviewed: Dec 7, 2000)	no assertion criteria provided	VCV000014109	14	23894622	14	23425413	14109	29148	rs121913643	NC_000014.9:23425412:G:C
NM_000257.4(MYH7):c.2459C>A (p.Ala820Asp)	MYH7	A820D	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000657112	14	23894198	14	23424989	657112	642293		NC_000014.9:23424988:G:T
NM_000257.4(MYH7):c.732+1G>C	MYH7		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000849269	14	23900793	14	23431584	849269	851991		NC_000014.9:23431583:C:G
NM_000257.4(MYH7):c.1801C>T (p.Leu601Phe)	MYH7	L601F	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jun 24, 2018)	criteria provided, single submitter	VCV000574861	14	23896881	14	23427672	574861	567932	rs1131691685	NC_000014.9:23427671:G:A
NM_000257.4(MYH7):c.2411T>C (p.Leu804Pro)	MYH7	L804P	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000525035	14	23894503	14	23425294	525035	528116	rs1555337794	NC_000014.9:23425293:A:G
NM_000257.4(MYH7):c.2464A>G (p.Met822Val)	MYH7	M822V	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000525013	14	23894193	14	23424984	525013	528064	rs730880742	NC_000014.9:23424983:T:C
NM_000257.4(MYH7):c.5655G>A (p.Ala1885=)	MYH7		not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000378215	14	23883216	14	23414007	378215	373755	rs753392652	NC_000014.9:23414006:C:T
NM_000257.4(MYH7):c.5655+5G>C	MYH7		Primary dilated cardiomyopathy|Congenital myopathy	Pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000694311	14	23883211	14	23414002	694311	682183		NC_000014.9:23414001:C:G
NM_000257.4(MYH7):c.2135G>A (p.Arg712His)	MYH7	R712H	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jun 16, 2018)	criteria provided, single submitter	VCV000575575	14	23895200	14	23425991	575575	567931	rs1224554825	NC_000014.9:23425990:C:T
NM_000257.4(MYH7):c.1618T>C (p.Phe540Leu)	MYH7	F540L	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000407186	14	23897064	14	23427855	407186	400185	rs1060501443	NC_000014.9:23427854:A:G
NM_000257.4(MYH7):c.5378_5380del (p.Leu1793del)	MYH7	L1793del	Myopathy, distal, 1|Dilated cardiomyopathy 1S|Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000143218	14	23884383 - 23884385	14	23415174 - 23415176	143218	152936	rs587779396	NC_000014.9:23415173:GCAG:G
NM_000257.4(MYH7):c.5702A>T (p.His1901Leu)	MYH7	H1904L, H1901L	Myosin storage myopathy	Pathogenic(Last reviewed: Apr 14, 2009)	no assertion criteria provided	VCV000014117	14	23883056	14	23413847	14117	29156	rs121913649	NC_000014.9:23413846:T:A
NM_000257.4(MYH7):c.2198G>A (p.Gly733Glu)	MYH7	G733E	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	VCV000177628	14	23894992	14	23425783	177628	175482	rs727504241	NC_000014.9:23425782:C:T
NM_025137.4(SPG11):c.6100C>T (p.Arg2034Ter)	SPG11	R2034*	Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive|not provided|Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001109	15	44865850	15	44573652	1109	16148	rs118203963	NC_000015.10:44573651:G:A
NM_000257.4(MYH7):c.2594A>G (p.Lys865Arg)	MYH7	K865R	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 9, 2019)	criteria provided, single submitter	VCV000524996	14	23894063	14	23424854	524996	528112	rs758891557	NC_000014.9:23424853:T:C
NM_000257.4(MYH7):c.842G>C (p.Arg281Thr)	MYH7	R281T	not provided|Left ventricular noncompaction	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000181327	14	23900163	14	23430954	181327	179675	rs730880856	NC_000014.9:23430953:C:G
NM_000257.4(MYH7):c.2593A>G (p.Lys865Glu)	MYH7	K865E	Hypertrophic cardiomyopathy|not provided|not specified	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181195	14	23894064	14	23424855	181195	179593	rs730880749	NC_000014.9:23424854:T:C
NM_000257.4(MYH7):c.2513C>T (p.Pro838Leu)	MYH7	P838L	not provided|Restrictive cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000042910	14	23894144	14	23424935	42910	52080	rs397516153	NC_000014.9:23424934:G:A
NM_000257.4(MYH7):c.2129C>A (p.Pro710His)	MYH7	P710H	Hypertrophic cardiomyopathy|not specified	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000177734	14	23895206	14	23425997	177734	175629	rs727504272	NC_000014.9:23425996:G:T
NM_000257.4(MYH7):c.2644C>G (p.Gln882Glu)	MYH7	Q882E	Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042921	14	23894013	14	23424804	42921	52091	rs397516160	NC_000014.9:23424803:G:C
NM_000257.4(MYH7):c.2803G>A (p.Glu935Lys)	MYH7	E935K	Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Apr 15, 1994)	no assertion criteria provided	VCV000014106	14	23893235	14	23424026	14106	29145	rs121913639	NC_000014.9:23424025:C:T
NM_000257.4(MYH7):c.2333A>G (p.Asp778Gly)	MYH7	D778G	Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Jul 30, 1993)	no assertion criteria provided	VCV000014100	14	23894581	14	23425372	14100	29139	rs121913634	NC_000014.9:23425371:T:C
nsv513807	MYH7		Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000014096					14096	29135		
NM_004572.3(PKP2):c.1211dup (p.Val406fs)	PKP2		Arrhythmogenic right ventricular cardiomyopathy|Cardiac arrhythmia|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000045015	12	33003866 - 33003867	12	32850932 - 32850933	45015	54182	rs397516989	NC_000012.12:32850932:A:AA
NM_000135.4(FANCA):c.1303C>T (p.Arg435Cys)	FANCA	R435C	Fanconi anemia|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555603	16	89857867	16	89791459	555603	548728	rs148473140	NC_000016.10:89791458:G:A
NM_001127713.1(ATL1):c.1243C>T (p.Arg415Trp)	ATL1	R415W	Inborn genetic diseases|Hereditary spastic paraplegia 3A	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004352	14	51094872	14	50628154	4352	19391	rs119476050	NC_000014.9:50628153:C:T
NM_000053.4(ATP7B):c.1847G>A (p.Arg616Gln)	ATP7B	R616Q, R505Q	Wilson disease	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552606	13	52539030	13	51964894	552606	547709	rs752850609	NC_000013.11:51964893:C:T
NM_000053.4(ATP7B):c.2532del (p.Val845fs)	ATP7B	V761fs, V767fs, V845fs, V683fs, V734fs	not provided|Wilson disease	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188883	13	52524451	13	51950315	188883	186897	rs755709270	NC_000013.11:51950314:TTT:TT
NM_000053.4(ATP7B):c.2906G>A (p.Arg969Gln)	ATP7B	R969Q, R762Q, R858Q, R885Q, R891Q	Wilson disease|not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003860	13	52520574	13	51946438	3860	18899	rs121907996	NC_000013.11:51946437:C:T
NM_144997.7(FLCN):c.466_468TTC[1] (p.Phe157del)	FLCN	F157del	Pneumothorax, primary spontaneous|Hereditary cancer-predisposing syndrome|not provided|Multiple fibrofolliculomas	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186785	17	17127383 - 17127385	17	17224069 - 17224071	186785	184490	rs786203218	NC_000017.11:17224068:GAAGAAG:GAAG
NM_000257.4(MYH7):c.2302G>C (p.Gly768Arg)	MYH7	G768R	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181180	14	23894612	14	23425403	181180	179617	rs727503260	NC_000014.9:23425402:C:G
NM_000257.4(MYH7):c.596C>T (p.Ala199Val)	MYH7	A199V	not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000177692	14	23901013	14	23431804	177692	175511	rs727504283	NC_000014.9:23431803:G:A
NM_000257.4(MYH7):c.1538T>G (p.Phe513Cys)	MYH7	F513C	Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000014103	14	23897749	14	23428540	14103	29142	rs121913636	NC_000014.9:23428539:A:C
NM_031885.4(BBS2):c.1895G>C (p.Arg632Pro)	BBS2	R632P	Bardet-Biedl syndrome 2|BBS2-Related Disorders|Retinitis pigmentosa 74|Retinal dystrophy|Retinitis pigmentosa|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004578	16	56530894	16	56496982	4578	19617	rs138043021	NC_000016.10:56496981:C:G
NM_002834.5(PTPN11):c.1517A>C (p.Gln506Pro)	PTPN11	Q506P, Q510P, Q505P	Rasopathy|LEOPARD syndrome 1|Noonan syndrome with multiple lentigines|not provided	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040563	12	112926897	12	112489093	40563	49033	rs397507548	NC_000012.12:112489092:A:C
NM_002834.5(PTPN11):c.211T>C (p.Phe71Leu)	PTPN11	F71L, F70L	not provided|Rasopathy|Noonan syndrome|Noonan syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040499	12	112888195	12	112450391	40499	48969	rs397507512	NC_000012.12:112450390:T:C
NM_002834.5(PTPN11):c.174C>G (p.Asn58Lys)	PTPN11	N58K, N57K	Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Noonan syndrome 1|Metachondromatosis|not provided|Rasopathy|Noonan syndrome 1|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040489	12	112888158	12	112450354	40489	48959	rs397507506	NC_000012.12:112450353:C:G
NM_004004.6(GJB2):c.596C>T (p.Ser199Phe)	GJB2	S199F	not provided|Deafness, autosomal recessive 1A|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189183	13	20763125	13	20188986	189183	186854	rs771748289	NC_000013.11:20188985:G:A
NM_004004.6(GJB2):c.428G>A (p.Arg143Gln)	GJB2	R143Q	not provided|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000017017	13	20763293	13	20189154	17017	32056	rs104894401	NC_000013.11:20189153:C:T
NM_001289910.1(IDH2):c.263G>A (p.Arg88Gln)	IDH2	R140Q, R88Q, R10Q	Multiple myeloma|Squamous cell carcinoma of the head and neck|Myelodysplastic syndrome|Acute myeloid leukemia|D-2-hydroxyglutaric aciduria 2|Neoplasm of the large intestine|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014716	15	90631934	15	90088702	14716	29755	rs121913502	NC_000015.10:90088701:C:T
NM_000257.4(MYH7):c.2191C>T (p.Pro731Ser)	MYH7	P731S	not provided|Familial hypertrophic cardiomyopathy 1	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2012)	criteria provided, multiple submitters, no conflicts	VCV000181176	14	23894999	14	23425790	181176	179623	rs727504299	NC_000014.9:23425789:G:A
NM_000257.4(MYH7):c.1436A>G (p.Asn479Ser)	MYH7	N479S	Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177623	14	23897851	14	23428642	177623	175641	rs727504236	NC_000014.9:23428641:T:C
NM_006009.4(TUBA1A):c.1264C>T (p.Arg422Cys)	TUBA1A	R422C, R387C	not provided|Inborn genetic diseases|Tubulinopathies|Lissencephaly 3	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007076	12	49578885	12	49185102	7076	22115	rs137853049	NC_000012.12:49185101:G:A
NM_000070.3(CAPN3):c.1342C>T (p.Arg448Cys)	CAPN3	R448C, R400C	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280038	15	42691838	15	42399640	280038	264572	rs776043976	NC_000015.10:42399639:C:T
NM_000057.4(BLM):c.1933C>T (p.Gln645Ter)	BLM	Q645*, Q270*	Hereditary cancer-predisposing syndrome|Bloom syndrome	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000454091	15	91306246	15	90763016	454091	464682	rs373525781	NC_000015.10:90763015:C:T
NM_000057.4(BLM):c.3164G>C (p.Cys1055Ser)	BLM	C1055S, C680S	Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042078	15	91337541	15	90794311	42078	51244	rs367543029	NC_000015.10:90794310:G:C
NM_003384.3(VRK1):c.1072C>T (p.Arg358Ter)	VRK1	R358*	Multiple congenital anomalies|not provided|Inborn genetic diseases|Spinal muscular atrophy|Pontocerebellar hypoplasia type 1|Pontocerebellar hypoplasia type 1A	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007497	14	97342370	14	96876033	7497	22536	rs137853063	NC_000014.9:96876032:C:T
NM_005249.5(FOXG1):c.561C>G (p.Asn187Lys)	FOXG1	N187K	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, multiple submitters, no conflicts	VCV000265363	14	29237046	14	28767840	265363	260056	rs796052462	NC_000014.9:28767839:C:G
NM_000257.4(MYH7):c.5533C>T (p.Arg1845Trp)	MYH7	R1845W	Hypertrophic cardiomyopathy|Myosin storage myopathy|MYH7-related late-onset scapuloperoneal muscular dystrophy	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000014114	14	23884230	14	23415021	14114	29153	rs28933098	NC_000014.9:23415020:G:A
NM_000257.4(MYH7):c.1208G>T (p.Arg403Leu)	MYH7	R403L	not provided|Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000014101	14	23898487	14	23429278	14101	29140	rs121913624	NC_000014.9:23429277:C:A
NM_015335.4(MED13L):c.6418C>T (p.Gln2140Ter)	MED13L	Q2140*	not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000452776	12	116401294	12	115963489	452776	444924	rs1555239936	NC_000012.12:115963488:G:A
NM_000053.4(ATP7B):c.3517G>A (p.Glu1173Lys)	ATP7B	E1173K, E966K, E1062K, E1089K, E1095K	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189050	13	52515256	13	51941120	189050	186883	rs756029120	NC_000013.11:51941119:C:T
NM_001127713.1(ATL1):c.715C>T (p.Arg239Cys)	ATL1	R239C	Spastic paraplegia|Hereditary spastic paraplegia 3A|Hereditary spastic paraplegia 3A|Hereditary sensory neuropathy type 1D|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004346	14	51080061	14	50613343	4346	19385	rs119476046	NC_000014.9:50613342:C:T
NM_144997.7(FLCN):c.927_954dup (p.Gly319fs)	FLCN		not provided|Hereditary cancer-predisposing syndrome|Pneumothorax, primary spontaneous|Multiple fibrofolliculomas	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096493	17	17122440 - 17122441	17	17219126 - 17219127	96493	102387	rs398124542	NC_000017.11:17219126:TTCTGTACTCTCTGGCAACACAGGGGCTTTCT:TTCTGTACTCTCTGGCAACACAGGGGCTTTCTGTACTCTCTGGCAACACAGGGGCTTTCT
NM_030621.4(DICER1):c.1234del (p.Trp412fs)	DICER1	W412fs	not provided	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000449993	14	95590675	14	95124338	449993	445263	rs1555374679	NC_000014.9:95124337:A:
NM_177438.3(DICER1):c.556del (p.Tyr186fs)	DICER1	Y186fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000825837	14	95596412	14	95130075	825837	812209		NC_000014.9:95130074:A:
NM_177438.3(DICER1):c.4636_4638delinsGA (p.Tyr1546fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000825058	14	95562619 - 95562621	14	95096282 - 95096284	825058	811976		NC_000014.9:95096281:GTA:TC
NM_177438.3(DICER1):c.4346_4347AT[1] (p.Ile1450fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000824812	14	95562908 - 95562909	14	95096571 - 95096572	824812	811987		NC_000014.9:95096570:ATAT:AT
NM_177438.3(DICER1):c.3888_3891del (p.Ile1297fs)	DICER1	I1297fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000824338	14	95569842 - 95569845	14	95103505 - 95103508	824338	812010		NC_000014.9:95103504:AATAA:A
NM_177438.3(DICER1):c.3045_3054del (p.Ser1015fs)	DICER1	S1015fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000822714	14	95572054 - 95572063	14	95105717 - 95105726	822714	812073		NC_000014.9:95105716:CTCAGCACTGCT:CT
NM_177438.3(DICER1):c.256_257del (p.Arg86fs)	DICER1	R86fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000821478	14	95598902 - 95598903	14	95132565 - 95132566	821478	812236		NC_000014.9:95132564:CT:
NM_177438.3(DICER1):c.1910_1911insGA (p.Tyr637Ter)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000820321	14	95579558 - 95579559	14	95113221 - 95113222	820321	812138		NC_000014.9:95113221:T:TCT
NM_177438.3(DICER1):c.1686del (p.Met562fs)	DICER1	M562fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000819817	14	95582856	14	95116519	819817	812152		NC_000014.9:95116518:C:
NM_177438.3(DICER1):c.1532_1533del (p.His511fs)	DICER1	H511fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000819478	14	95583009 - 95583010	14	95116672 - 95116673	819478	812158		NC_000014.9:95116671:AT:
NM_030621.4(DICER1):c.5125G>A (p.Asp1709Asn)	DICER1	D1709N	not provided	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000690480	14	95560464	14	95094127	690480	678128		NC_000014.9:95094126:C:T
NM_030621.4(DICER1):c.1306dup (p.Ser436fs)	DICER1		not provided	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000690459	14	95590602 - 95590603	14	95124265 - 95124266	690459	678155		NC_000014.9:95124265:AA:AAA
NM_030621.4(DICER1):c.1196_1197dup (p.Trp400fs)	DICER1		not provided	Pathogenic(Last reviewed: Apr 17, 2014)	criteria provided, single submitter	VCV000690436	14	95590711 - 95590712	14	95124374 - 95124375	690436	678156		NC_000014.9:95124374:CTC:CTCTC
DICER1, ASP1709TYR	DICER1	D1709Y	Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome	Pathogenic(Last reviewed: Jan 8, 2019)	no assertion criteria provided	VCV000599262					599262	590483		
DICER1, ASP1713VAL	DICER1	D1713V	Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome	Pathogenic(Last reviewed: Jan 8, 2019)	no assertion criteria provided	VCV000599261					599261	590482		
NM_030621.4(DICER1):c.3450_3451TG[1] (p.Val1151fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000485534	14	95570280 - 95570281	14	95103943 - 95103944	485534	477119	rs1555369632	NC_000014.9:95103942:CACA:CA
NM_030621.4(DICER1):c.1726del (p.Thr578fs)	DICER1	T578fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000479658	14	95582816	14	95116479	479658	477147	rs1555372838	NC_000014.9:95116478:GG:G
NM_030621.4(DICER1):c.1749_1753del (p.Glu583fs)	DICER1	E583fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000429165	14	95582790 - 95582794	14	95116453 - 95116457	429165	421131	rs1131691232	NC_000014.9:95116452:CTTTTC:C
NM_177438.2(DICER1):c.2256+1G>A	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000429164	14	95577653	14	95111316	429164	421125	rs1131691231	NC_000014.9:95111315:C:T
NM_030621.4(DICER1):c.948_961del (p.Trp316fs)	DICER1	W316fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000429163	14	95590948 - 95590961	14	95124611 - 95124624	429163	421140	rs1555374817	NC_000014.9:95124610:CTTTATCTGCACACC:C
NM_030621.4(DICER1):c.4657dup (p.Cys1553fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 15, 2015)	criteria provided, single submitter	VCV000429161	14	95562599 - 95562600	14	95096262 - 95096263	429161	421099	rs1131691229	NC_000014.9:95096262:A:AA
NM_030621.4(DICER1):c.2399del (p.Arg800fs)	DICER1	R800fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 4, 2014)	criteria provided, single submitter	VCV000429160	14	95574698	14	95108361	429160	421123	rs1131691228	NC_000014.9:95108360:C:
NM_030621.4(DICER1):c.3516_3525delinsA (p.Thr1173_Ile1175del)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 8, 2013)	criteria provided, single submitter	VCV000429158	14	95570208 - 95570217	14	95103871 - 95103880	429158	421117	rs1555369579	NC_000014.9:95103870:AATTGCTGTA:T
NM_030621.4(DICER1):c.4044del (p.Ser1348fs)	DICER1	S1348fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 26, 2011)	criteria provided, single submitter	VCV000429156	14	95569689	14	95103352	429156	421112	rs1131691224	NC_000014.9:95103351:G:
NM_001195573.1(DICER1):c.5365-197_5365-189dup	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 27, 2012)	criteria provided, single submitter	VCV000429155	14	95557634 - 95557635	14	95091297 - 95091298	429155	421092	rs1131691223	NC_000014.9:95091297:ATATCCCCCAT:ATATCCCCCATATCCCCCAT
NM_030621.4(DICER1):c.4285del (p.Trp1429fs)	DICER1	W1429fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000429153	14	95562972	14	95096635	429153	421105	rs1131691222	NC_000014.9:95096634:A:
NM_030621.4(DICER1):c.4637dup (p.Tyr1546Ter)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 28, 2016)	criteria provided, single submitter	VCV000429152	14	95562619 - 95562620	14	95096282 - 95096283	429152	421101	rs1131691221	NC_000014.9:95096282:T:TT
NM_177438.2(DICER1):c.1246G>T (p.Glu416Ter)	DICER1	E416*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000429151	14	95590663	14	95124326	429151	421137	rs1131691220	NC_000014.9:95124325:C:A
NM_177438.2(DICER1):c.1356C>G (p.Tyr452Ter)	DICER1	Y452*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	VCV000429150	14	95590553	14	95124216	429150	421135	rs1131691219	NC_000014.9:95124215:G:C
NM_030621.4(DICER1):c.1024del (p.Arg342fs)	DICER1	R342fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	VCV000429149	14	95590885	14	95124548	429149	421139	rs1131691218	NC_000014.9:95124547:T:
NM_030621.4(DICER1):c.4071dup (p.Arg1358fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, single submitter	VCV000429147	14	95566251 - 95566252	14	95099914 - 95099915	429147	421111	rs1131691216	NC_000014.9:95099914:A:AA
NM_030621.4(DICER1):c.3345dup (p.Ala1116fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 31, 2016)	criteria provided, single submitter	VCV000429145	14	95570387 - 95570388	14	95104050 - 95104051	429145	421118	rs1131691215	NC_000014.9:95104050:T:TT
NM_030621.4(DICER1):c.3987_3988AT[1] (p.Tyr1330fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000429144	14	95569743 - 95569744	14	95103406 - 95103407	429144	421113	rs1131691214	NC_000014.9:95103405:ATAT:AT
NM_030621.4(DICER1):c.2181_2187dup (p.Asp730delinsPheAlaTer)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 29, 2016)	criteria provided, single submitter	VCV000429143	14	95577722 - 95577723	14	95111385 - 95111386	429143	421126	rs1131691213	NC_000014.9:95111385:ATGCAAA:ATGCAAAATGCAAA
NM_030621.4(DICER1):c.937dup (p.Leu313fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 24, 2016)	criteria provided, single submitter	VCV000429142	14	95590971 - 95590972	14	95124634 - 95124635	429142	421141	rs1131691212	NC_000014.9:95124634:G:GG
NM_177438.2(DICER1):c.4853C>A (p.Ser1618Ter)	DICER1	S1618*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 28, 2016)	criteria provided, single submitter	VCV000429140	14	95562404	14	95096067	429140	421097	rs377205344	NC_000014.9:95096066:G:T
NM_177438.2(DICER1):c.2350G>T (p.Glu784Ter)	DICER1	E784*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000429139	14	95574747	14	95108410	429139	421124	rs1131691210	NC_000014.9:95108409:C:A
NM_030621.4(DICER1):c.1462dup (p.Gln488fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 27, 2015)	criteria provided, single submitter	VCV000429138	14	95584005 - 95584006	14	95117668 - 95117669	429138	421133	rs1131691209	NC_000014.9:95117668:G:GG
NM_030621.4(DICER1):c.1839del (p.Tyr614fs)	DICER1	Y614fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	VCV000429135	14	95582072	14	95115735	429135	421130	rs1131691207	NC_000014.9:95115734:T:
NM_177438.2(DICER1):c.4533T>A (p.Tyr1511Ter)	DICER1	Y1511*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000429134	14	95562724	14	95096387	429134	421103	rs1131691206	NC_000014.9:95096386:A:T
NM_030621.4(DICER1):c.1400_1401del (p.Gln467fs)	DICER1	Q467fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	VCV000429131	14	95584067 - 95584068	14	95117730 - 95117731	429131	421134	rs1131691203	NC_000014.9:95117729:TT:
NM_030621.4(DICER1):c.4264dup (p.Glu1422fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	VCV000429130	14	95562992 - 95562993	14	95096655 - 95096656	429130	421106	rs1131691202	NC_000014.9:95096655:C:CC
NM_177438.2(DICER1):c.4812C>A (p.Cys1604Ter)	DICER1	C1604*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	VCV000429128	14	95562445	14	95096108	429128	421098	rs1131691201	NC_000014.9:95096107:G:T
NM_030621.4(DICER1):c.4923_4926del (p.Gly1640_Cys1641insTer)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 25, 2013)	criteria provided, single submitter	VCV000429127	14	95562331 - 95562334	14	95095994 - 95095997	429127	421096	rs1131691200	NC_000014.9:95095993:CAAACAA:CAA
NM_177438.2(DICER1):c.3726C>G (p.Tyr1242Ter)	DICER1	Y1242*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 2, 2013)	criteria provided, single submitter	VCV000429126	14	95570007	14	95103670	429126	421114	rs886037708	NC_000014.9:95103669:G:C
NM_030621.4(DICER1):c.5235del (p.Phe1745fs)	DICER1	F1745fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 12, 2012)	criteria provided, single submitter	VCV000429124	14	95560354	14	95094017	429124	421094	rs1131691199	NC_000014.9:95094016:AAA:AA
NM_030621.4(DICER1):c.877del (p.Arg293fs)	DICER1	R293fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000429123	14	95592943	14	95126606	429123	421142	rs1131691198	NC_000014.9:95126605:TTT:TT
NM_030621.4(DICER1):c.4984del (p.Ile1663fs)	DICER1	I1663fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 18, 2012)	criteria provided, single submitter	VCV000429121	14	95562273	14	95095936	429121	421095	rs1131691196	NC_000014.9:95095935:GG:G
NM_030621.4(DICER1):c.4085dup (p.Lys1363fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 31, 2014)	criteria provided, single submitter	VCV000429120	14	95566237 - 95566238	14	95099900 - 95099901	429120	421110	rs1131691195	NC_000014.9:95099900:TTTTTT:TTTTTTT
NM_030621.4(DICER1):c.4555del (p.Glu1519fs)	DICER1	E1519fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000429119	14	95562702	14	95096365	429119	421102	rs1131691194	NC_000014.9:95096364:C:
NM_177438.2(DICER1):c.3135_3137delATCins10 (p.?)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 20, 2012)	criteria provided, single submitter	VCV000429118	14	95571540 - 95571542	14	95105203 - 95105205	429118	421119		
NM_030621.4(DICER1):c.1732dup (p.Thr578fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 6, 2012)	criteria provided, single submitter	VCV000429117	14	95582809 - 95582810	14	95116472 - 95116473	429117	421132	rs1131691193	NC_000014.9:95116472:TTTT:TTTTT
NM_030621.4(DICER1):c.3531_3534TCTT[1] (p.Ser1179fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 31, 2013)	criteria provided, single submitter	VCV000429115	14	95570195 - 95570198	14	95103858 - 95103861	429115	421116	rs1131691191	NC_000014.9:95103857:AAGAAAGA:AAGA
NM_030621.4(DICER1):c.1325dup (p.Leu442fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 30, 2012)	criteria provided, single submitter	VCV000429114	14	95590583 - 95590584	14	95124246 - 95124247	429114	421136	rs1131691190	NC_000014.9:95124246:AAAA:AAAAA
NM_177438.2(DICER1):c.1498A>T (p.Lys500Ter)	DICER1	K500*	Pineoblastoma	Pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	VCV000225886	14	95583970	14	95117633	225886	227701	rs875989782	NC_000014.9:95117632:T:A
NM_030621.4(DICER1):c.3611_3616delinsT (p.Tyr1204fs)	DICER1		Rhabdomyosarcoma, embryonal, 2	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000066096	14	95570117 - 95570122	14	95103780 - 95103785	66096	76998	rs886037651	NC_000014.9:95103779:TGTAGT:A
NM_030621.4(DICER1):c.3905_3906CT[1] (p.Leu1303fs)	DICER1		Rhabdomyosarcoma, embryonal, 2	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000066095	14	95569825 - 95569826	14	95103488 - 95103489	66095	76997	rs886037650	NC_000014.9:95103487:AGAG:AG
NM_177438.3(DICER1):c.2119G>T (p.Glu707Ter)	DICER1	E707*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000864427	14	95577791	14	95111454	864427	842011		NC_000014.9:95111453:C:A
NM_177438.3(DICER1):c.2166T>G (p.Tyr722Ter)	DICER1	Y722*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000864081	14	95577744	14	95111407	864081	842010		NC_000014.9:95111406:A:C
NM_177438.3(DICER1):c.4049del (p.Lys1350fs)	DICER1	K1350fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, single submitter	VCV000862376	14	95569684	14	95103347	862376	841957		NC_000014.9:95103346:TTTTT:TTTT
NM_177438.3(DICER1):c.5247dup (p.Val1750fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000861255	14	95560341 - 95560342	14	95094004 - 95094005	861255	841925		NC_000014.9:95094004:A:AA
NM_177438.3(DICER1):c.4005C>G (p.Tyr1335Ter)	DICER1	Y1335*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000859818	14	95569728	14	95103391	859818	841960		NC_000014.9:95103390:G:C
NM_177438.3(DICER1):c.3315del (p.Lys1105fs)	DICER1	K1105fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, single submitter	VCV000858879	14	95570418	14	95104081	858879	841983		NC_000014.9:95104080:TTT:TT
NM_177438.3(DICER1):c.3300dup (p.Ser1101fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Jun 30, 2019)	criteria provided, single submitter	VCV000858569	14	95570432 - 95570433	14	95104095 - 95104096	858569	841984		NC_000014.9:95104095:TTTTTT:TTTTTTT
NM_177438.3(DICER1):c.200del (p.Gly67fs)	DICER1	G67fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000858162	14	95598959	14	95132622	858162	842062		NC_000014.9:95132621:CC:C
NM_177438.3(DICER1):c.4035_4039del (p.Tyr1345_Arg1347delinsTer)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000852550	14	95569694 - 95569698	14	95103357 - 95103361	852550	841958		NC_000014.9:95103356:TCATAT:T
NM_177438.3(DICER1):c.1236G>A (p.Trp412Ter)	DICER1	W412*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000849778	14	95590673	14	95124336	849778	842028		NC_000014.9:95124335:C:T
NM_177438.3(DICER1):c.2370dup (p.Lys791fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000847987	14	95574726 - 95574727	14	95108389 - 95108390	847987	842006		NC_000014.9:95108389:CC:CCC
NM_177438.3(DICER1):c.3747del (p.Lys1249fs)	DICER1	K1249fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000845108	14	95569986	14	95103649	845108	841970		NC_000014.9:95103648:TTT:TT
NM_177438.3(DICER1):c.5234_5235del (p.Phe1745fs)	DICER1	F1745fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000841359	14	95560354 - 95560355	14	95094017 - 95094018	841359	841926		NC_000014.9:95094016:AAA:A
NM_177438.3(DICER1):c.4007del (p.Pro1336fs)	DICER1	P1336fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000837809	14	95569726	14	95103389	837809	841959		NC_000014.9:95103388:GGG:GG
NM_030621.4(DICER1):c.3402del (p.Gln1135fs)	DICER1	Q1135fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Sep 23, 2018)	criteria provided, single submitter	VCV000663671	14	95570331	14	95103994	663671	642863		NC_000014.9:95103993:A:
NM_177438.2(DICER1):c.2018C>G (p.Ser673Ter)	DICER1	S673*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Dec 25, 2018)	criteria provided, single submitter	VCV000663618	14	95579451	14	95113114	663618	642901		NC_000014.9:95113113:G:C
NM_030621.4(DICER1):c.1280_1283del (p.Lys427fs)	DICER1	K427fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000658250	14	95590626 - 95590629	14	95124289 - 95124292	658250	642923		NC_000014.9:95124288:TCTTT:T
NM_030621.4(DICER1):c.3909_3910del (p.Ser1304fs)	DICER1	S1304fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000652078	14	95569823 - 95569824	14	95103486 - 95103487	652078	642845		NC_000014.9:95103485:ACA:A
NM_177438.2(DICER1):c.1501C>T (p.Gln501Ter)	DICER1	Q501*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000643405	14	95583967	14	95117630	643405	642919		NC_000014.9:95117629:G:A
NM_177438.2(DICER1):c.4031C>G (p.Ser1344Ter)	DICER1	S1344*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000582884	14	95569702	14	95103365	582884	573017	rs1566766572	NC_000014.9:95103364:G:C
NM_001195573.1(DICER1):c.5365-117_5365-114del	DICER1	Y1835fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000582239	14	95557560 - 95557563	14	95091223 - 95091226	582239	569083	rs1566746106	NC_000014.9:95091222:GGAT:
NM_177438.2(DICER1):c.5261_5364+79del	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000580813	14	95560146 - 95560328	14	95093809 - 95093991	580813	572981	rs1566749829	
NM_177438.2(DICER1):c.3688C>T (p.Gln1230Ter)	DICER1	Q1230*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000576876	14	95570045	14	95103708	576876	566707	rs1566767799	NC_000014.9:95103707:G:A
NM_177438.2(DICER1):c.3591C>A (p.Cys1197Ter)	DICER1	C1197*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000576410	14	95570142	14	95103805	576410	573025	rs1566768212	NC_000014.9:95103804:G:T
NM_177438.2(DICER1):c.1847T>A (p.Leu616Ter)	DICER1	L616*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000574836	14	95582064	14	95115727	574836	566766	rs771634025	NC_000014.9:95115726:A:T
NM_030621.4(DICER1):c.4762del (p.Gly1587_Leu1588insTer)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000570976	14	95562495	14	95096158	570976	566697	rs1566754840	NC_000014.9:95096157:G:
NM_030621.4(DICER1):c.2370_2373dup (p.Leu792fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000543649	14	95574723 - 95574724	14	95108386 - 95108387	543649	528883	rs1555370915	NC_000014.9:95108386:CTTCC:CTTCCTTCC
NM_030621.4(DICER1):c.2955delinsTT (p.Gln985fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000543648	14	95572410	14	95106073	543648	528423	rs1555370268	NC_000014.9:95106072:C:AA
NM_030621.4(DICER1):c.4212del (p.Asp1405fs)	DICER1	D1405fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000543615	14	95563045	14	95096708	543615	528430	rs1555367927	NC_000014.9:95096707:TTTT:TTT
NM_177438.2(DICER1):c.4999G>T (p.Glu1667Ter)	DICER1	E1667*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000543602	14	95562258	14	95095921	543602	528421	rs1555367522	NC_000014.9:95095920:C:A
NM_177438.2(DICER1):c.100C>T (p.Gln34Ter)	DICER1	Q34*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000543565	14	95599696	14	95133359	543565	528551	rs1555376548	NC_000014.9:95133358:G:A
NM_030621.4(DICER1):c.757dup (p.Ile253fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000543554	14	95593062 - 95593063	14	95126725 - 95126726	543554	528568	rs1555375356	NC_000014.9:95126725:T:TT
NM_177438.2(DICER1):c.901C>T (p.Gln301Ter)	DICER1	Q301*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000477292	14	95592919	14	95126582	477292	464728	rs781144010	NC_000014.9:95126581:G:A
NM_177438.2(DICER1):c.823G>T (p.Glu275Ter)	DICER1	E275*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000477290	14	95592997	14	95126660	477290	464722	rs1555375333	NC_000014.9:95126659:C:A
NM_030621.4(DICER1):c.535del (p.Ala180fs)	DICER1	A180fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000477257	14	95596433	14	95130096	477257	464482	rs1555375946	NC_000014.9:95130095:G:
NM_177438.2(DICER1):c.4638C>A (p.Tyr1546Ter)	DICER1	Y1546*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000477210	14	95562619	14	95096282	477210	463659	rs773822569	NC_000014.9:95096281:G:T
NM_030621.4(DICER1):c.459dup (p.Val154fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000477209	14	95596508 - 95596509	14	95130171 - 95130172	477209	464736	rs1555375978	NC_000014.9:95130171:A:AA
NM_030621.4(DICER1):c.282_283dup (p.Arg95fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000477120	14	95598875 - 95598876	14	95132538 - 95132539	477120	464762	rs1555376368	NC_000014.9:95132538:TTTTT:TTTTTTT
NM_030621.4(DICER1):c.256del (p.Arg86fs)	DICER1	R86fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000477107	14	95598903	14	95132566	477107	464750	rs1555376375	NC_000014.9:95132565:T:
NM_030621.4(DICER1):c.2245_2248dup (p.Pro750fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000477093	14	95577661 - 95577662	14	95111324 - 95111325	477093	463789	rs1555371565	NC_000014.9:95111324:GGTAG:GGTAGGTAG
NM_030621.4(DICER1):c.2197_2198GA[3] (p.Thr734fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000477091	14	95577709 - 95577710	14	95111372 - 95111373	477091	463794	rs1555371596	NC_000014.9:95111372:TCTCT:TCTCTCT
NM_030621.4(DICER1):c.1694del (p.Asp565fs)	DICER1	D565fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000477053	14	95582848	14	95116511	477053	464423	rs1555372851	NC_000014.9:95116510:T:
NM_030621.4(DICER1):c.1417del (p.Tyr473fs)	DICER1	Y473fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000477039	14	95584051	14	95117714	477039	463889	rs1555373228	NC_000014.9:95117713:AA:A
NM_030621.4(DICER1):c.1137del (p.Lys379fs)	DICER1	K379fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000477023	14	95590772	14	95124435	477023	464690	rs1555374734	NC_000014.9:95124434:TTT:TT
NM_177438.2(DICER1):c.3675C>G (p.Tyr1225Ter)	DICER1	Y1225*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000429129	14	95570058	14	95103721	429129	421115	rs184830847	NC_000014.9:95103720:G:C
NM_030621.4(DICER1):c.1706_1710del (p.Ile569fs)	DICER1	I569fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Jul 16, 2016)	criteria provided, single submitter	VCV000412198	14	95582832 - 95582836	14	95116495 - 95116499	412198	400460	rs1060503665	NC_000014.9:95116494:TTTTATTTT:TTTT
NM_030621.4(DICER1):c.1767del (p.Lys589fs)	DICER1	K589fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000412191	14	95582144	14	95115807	412191	399942	rs1060503662	NC_000014.9:95115806:C:
NM_030621.4(DICER1):c.1747del (p.Glu583fs)	DICER1	E583fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Oct 9, 2016)	criteria provided, single submitter	VCV000412131	14	95582795	14	95116458	412131	399944	rs1060503633	NC_000014.9:95116457:C:
NM_030621.4(DICER1):c.2507_2508del (p.Phe836fs)	DICER1	F836fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, single submitter	VCV000412123	14	95574359 - 95574360	14	95108022 - 95108023	412123	400095	rs1060503628	NC_000014.9:95108021:GA:
NM_030621.4(DICER1):c.2953del (p.Gln985fs)	DICER1	Q985fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000412122	14	95572412	14	95106075	412122	400693	rs1060503627	NC_000014.9:95106074:GG:G
NM_177438.2(DICER1):c.3349G>T (p.Glu1117Ter)	DICER1	E1117*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Apr 4, 2016)	criteria provided, single submitter	VCV000412104	14	95570384	14	95104047	412104	400657	rs1060503617	NC_000014.9:95104046:C:A
NM_177438.2(DICER1):c.2233C>T (p.Arg745Ter)	DICER1	R745*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000412038	14	95577677	14	95111340	412038	400415	rs1060503584	NC_000014.9:95111339:G:A
NM_177438.2(DICER1):c.5494C>T (p.Gln1832Ter)	DICER1	Q1832*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000412037	14	95557573	14	95091236	412037	400557	rs1060503583	NC_000014.9:95091235:G:A
NM_030621.4(DICER1):c.4004dup (p.Tyr1335Ter)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: May 2, 2016)	criteria provided, single submitter	VCV000242098	14	95569728 - 95569729	14	95103391 - 95103392	242098	241938	rs878855262	NC_000014.9:95103391:T:TT
NM_177438.2(DICER1):c.489C>G (p.Tyr163Ter)	DICER1	Y163*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	VCV000220675	14	95596479	14	95130142	220675	222414	rs864622626	NC_000014.9:95130141:G:C
NM_000321.2(RB1):c.2520+1G>A	RB1		Retinoblastoma	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000126805	13	49047527	13	48473391	126805	132315	rs587778850	NC_000013.11:48473390:G:A
NM_000321.2(RB1):c.1399C>T (p.Arg467Ter)	RB1	R467*	Retinoblastoma|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000092839	13	48954198	13	48380062	92839	98746	rs398123331	NC_000013.11:48380061:C:T
NM_177438.3(DICER1):c.4401_4402CT[1] (p.Ser1468fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV000854090	14	95562851 - 95562854	14	95096514 - 95096517	854090	841944		NC_000014.9:95096513:AGAGAGA:AGA
NM_177438.3(DICER1):c.3581_3582GA[1] (p.Asp1195fs)	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000823956	14	95570149 - 95570150	14	95103812 - 95103813	823956	812031		NC_000014.9:95103811:TCTCT:TCT
NM_177438.2(DICER1):c.2040+1G>A	DICER1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 3, 2015)	criteria provided, single submitter	VCV000429162	14	95579428	14	95113091	429162	421128	rs886037683	NC_000014.9:95113090:C:T
NM_177438.2(DICER1):c.3019C>T (p.Gln1007Ter)	DICER1	Q1007*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429113	14	95572089	14	95105752	429113	421121	rs1131691189	NC_000014.9:95105751:G:A
NM_177438.2(DICER1):c.996C>A (p.Tyr332Ter)	DICER1	Y332*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254356	14	95590913	14	95124576	254356	248882	rs757094384	NC_000014.9:95124575:G:T
NM_177438.2(DICER1):c.832C>T (p.Leu278Phe)	DICER1	L278F	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254354	14	95592988	14	95126651	254354	248884	rs768248216	NC_000014.9:95126650:G:A
NM_177438.2(DICER1):c.745C>T (p.Gln249Ter)	DICER1	Q249*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 11, 2014)	criteria provided, single submitter	VCV000254353	14	95593075	14	95126738	254353	248885	rs886037732	NC_000014.9:95126737:G:A
NM_177438.2(DICER1):c.735-1_741delinsA	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254352	14	95593079 - 95593086	14	95126742 - 95126749	254352	248886	rs886037731	NC_000014.9:95126741:AGTATACC:T
NM_177438.2(DICER1):c.629T>G (p.Leu210Ter)	DICER1	L210*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254351	14	95595914	14	95129577	254351	248887	rs886037730	NC_000014.9:95129576:A:C
NM_177438.2(DICER1):c.5465A>T (p.Asp1822Val)	DICER1	D1822V	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254350	14	95557602	14	95091265	254350	248816	rs886037729	NC_000014.9:95091264:T:A
NM_001195573.1(DICER1):c.5365-227del	DICER1	E1799fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254349	14	95557673	14	95091336	254349	248817	rs886037728	NC_000014.9:95091335:TTT:TT
NM_030621.4(DICER1):c.5251_5255del (p.Lys1751fs)	DICER1	K1751fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254347	14	95560334 - 95560338	14	95093997 - 95094001	254347	248820	rs886037726	NC_000014.9:95093996:TACTTTAC:TAC
NM_030621.4(DICER1):c.5194dup (p.Leu1732fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254346	14	95560394 - 95560395	14	95094057 - 95094058	254346	248821	rs886037725	NC_000014.9:95094057:GG:GGG
NM_177438.2(DICER1):c.5123G>A (p.Gly1708Glu)	DICER1	G1708E	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254345	14	95560466	14	95094129	254345	248822	rs886037724	NC_000014.9:95094128:C:T
NM_177438.2(DICER1):c.5096-498_5364+356del	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254343	14	95559869 - 95560991	14	95093532 - 95094654	254343	248818		
NM_177438.2(DICER1):c.5095+1G>C	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254342	14	95562161	14	95095824	254342	248824	rs886037722	NC_000014.9:95095823:C:G
NM_177438.2(DICER1):c.5053C>T (p.Gln1685Ter)	DICER1	Q1685*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254341	14	95562204	14	95095867	254341	248825	rs886037721	NC_000014.9:95095866:G:A
NM_030621.4(DICER1):c.4626del (p.Gln1542fs)	DICER1	Q1542fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254339	14	95562631	14	95096294	254339	248827	rs886037719	NC_000014.9:95096293:C:
NM_030621.4(DICER1):c.4511del (p.Ser1504fs)	DICER1	S1504fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254335	14	95562746	14	95096409	254335	248831	rs886037715	NC_000014.9:95096408:C:
NM_177438.2(DICER1):c.4426_4427insT (p.Asp1476fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254334	14	95562830 - 95562831	14	95096493 - 95096494	254334	248832	rs886037714	NC_000014.9:95096493::A
NM_030621.4(DICER1):c.3875_3878del (p.Pro1292fs)	DICER1	P1292fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254330	14	95569855 - 95569858	14	95103518 - 95103521	254330	248836	rs886037710	NC_000014.9:95103517:TTGG:
NM_177438.2(DICER1):c.3676G>T (p.Glu1226Ter)	DICER1	E1226*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254327	14	95570057	14	95103720	254327	248839	rs748087536	NC_000014.9:95103719:C:A
NM_030621.4(DICER1):c.3579_3580del (p.Asn1193fs)	DICER1	N1193fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254324	14	95570153 - 95570154	14	95103816 - 95103817	254324	248842	rs886037705	NC_000014.9:95103815:TGT:T
NM_177438.2(DICER1):c.3534_3535insAA (p.Ser1179fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254321	14	95570198 - 95570199	14	95103861 - 95103862	254321	248845	rs886037702	NC_000014.9:95103861::TT
NM_030621.4(DICER1):c.3175dup (p.Tyr1059fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254316	14	95571501 - 95571502	14	95105164 - 95105165	254316	248850	rs886037697	NC_000014.9:95105164:AAA:AAAA
NM_030621.4(DICER1):c.3135_3137delinsTGAACTCATG (p.Ser1046fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254315	14	95571540 - 95571542	14	95105203 - 95105205	254315	248851	rs886037696	NC_000014.9:95105202:GAT:CATGAGTTCA
NM_030621.4(DICER1):c.2863del (p.Thr955fs)	DICER1	T955fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254312	14	95572502	14	95106165	254312	248854	rs886037693	NC_000014.9:95106164:T:
NM_177438.2(DICER1):c.2243_2244insACTA (p.Cys748Ter)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254307	14	95577666 - 95577667	14	95111329 - 95111330	254307	248889	rs886037688	NC_000014.9:95111329::TAGT
NM_177438.2(DICER1):c.2236A>G (p.Arg746Gly)	DICER1	R746G	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254305	14	95577674	14	95111337	254305	248859	rs886037686	NC_000014.9:95111336:T:C
NM_177438.2(DICER1):c.2040+1G>T	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254302	14	95579428	14	95113091	254302	248862	rs886037683	NC_000014.9:95113090:C:A
NM_030621.4(DICER1):c.1910dup (p.Tyr637Ter)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254300	14	95579558 - 95579559	14	95113221 - 95113222	254300	248864	rs886037682	NC_000014.9:95113221:T:TT
NM_177438.2(DICER1):c.1907+1del	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254299	14	95582003	14	95115666	254299	248865	rs886037681	NC_000014.9:95115665:CC:C
NM_177438.2(DICER1):c.1752+1del	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254294	14	95582789	14	95116452	254294	248870	rs886037677	NC_000014.9:95116451:CC:C
NM_030621.4(DICER1):c.1716del (p.Phe572fs)	DICER1	F572fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254292	14	95582826	14	95116489	254292	248872	rs886037676	NC_000014.9:95116488:AAAA:AAA
NM_030621.4(DICER1):c.1695_1696del (p.Thr566fs)	DICER1	T566fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254291	14	95582846 - 95582847	14	95116509 - 95116510	254291	248873	rs886037675	NC_000014.9:95116508:TAT:T
NM_177438.2(DICER1):c.1651G>T (p.Gly551Ter)	DICER1	G551*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254289	14	95582891	14	95116554	254289	248875	rs886037673	NC_000014.9:95116553:C:A
NM_177438.2(DICER1):c.1376+1G>T	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254286	14	95590532	14	95124195	254286	248878	rs886037670	NC_000014.9:95124194:C:A
NM_030621.4(DICER1):c.1202dup (p.Tyr401Ter)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000254285	14	95590706 - 95590707	14	95124369 - 95124370	254285	248879	rs886037669	NC_000014.9:95124369:T:TT
NM_030621.4(DICER1):c.2516C>T (p.Ser839Phe)	DICER1	S839F	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	Pathogenic(Last reviewed: Jan 5, 2011)	no assertion criteria provided	VCV000030566	14	95574351	14	95108014	30566	39523	rs387906934	NC_000014.9:95108013:G:A
NM_030621.4(DICER1):c.2457C>G (p.Tyr819Ter)	DICER1	Y819*	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	Pathogenic(Last reviewed: Jan 5, 2011)	no assertion criteria provided	VCV000030565	14	95574410	14	95108073	30565	39522		NC_000014.9:95108072:G:C
NM_177438.2(DICER1):c.2805-1G>T	DICER1		Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	Pathogenic(Last reviewed: Jan 5, 2011)	no assertion criteria provided	VCV000030564	14	95572561	14	95106224	30564	39521		NC_000014.9:95106223:C:A
NM_030621.4(DICER1):c.873_877del (p.Glu292fs)	DICER1	E292fs	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	Pathogenic(Last reviewed: Jan 5, 2011)	no assertion criteria provided	VCV000030563	14	95592943 - 95592947	14	95126606 - 95126610	30563	39520		NC_000014.9:95126605:TTTCTTTT:TTT
DICER1, 1-BP INS, 2574A	DICER1		Pulmonary blastoma	Pathogenic(Last reviewed: Aug 21, 2009)	no assertion criteria provided	VCV000004471					4471	19510		
NM_177438.2(DICER1):c.2988-20_2988del	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000660444	14	95572120 - 95572140	14	95105783 - 95105803	660444	652995		NC_000014.9:95105782:TCTGTAAGAATTCCAAAACAAT:T
NC_000014.8:g.(?_95556825)_(95599805_?)del	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000655753	14	95556825 - 95599805	14	95090488 - 95133468	655753	652566		
NM_177438.2(DICER1):c.3073G>T (p.Glu1025Ter)	DICER1	E1025*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429157	14	95572035	14	95105698	429157	421120	rs1131691225	NC_000014.9:95105697:C:A
NM_030621.4(DICER1):c.1907+1G>A	DICER1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429148	14	95582003	14	95115666	429148	421129	rs1131691217	NC_000014.9:95115665:C:T
NM_030621.4(DICER1):c.1174C>T (p.Arg392Ter)	DICER1	R392*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429141	14	95590735	14	95124398	429141	421138	rs1131691211	NC_000014.9:95124397:G:A
NM_030621.4(DICER1):c.4654C>T (p.Gln1552Ter)	DICER1	Q1552*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, multiple submitters, no conflicts	VCV000429137	14	95562603	14	95096266	429137	421100	rs1131691208	NC_000014.9:95096265:G:A
NM_030621.4(DICER1):c.4140G>A (p.Trp1380Ter)	DICER1	W1380*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2015)	criteria provided, multiple submitters, no conflicts	VCV000429133	14	95566183	14	95099846	429133	421109	rs1131691205	NC_000014.9:95099845:C:T
NM_030621.4(DICER1):c.4633dup (p.Ser1545fs)	DICER1		Pineoblastoma|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 24, 2016)	criteria provided, multiple submitters, no conflicts	VCV000225885	14	95562623 - 95562624	14	95096286 - 95096287	225885	227698	rs875989781	NC_000014.9:95096286:AAA:AAAA
NM_030621.4(DICER1):c.5103C>A (p.Tyr1701Ter)	DICER1	Y1701*	Pineoblastoma|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, multiple submitters, no conflicts	VCV000225884	14	95560486	14	95094149	225884	227696	rs875989780	NC_000014.9:95094148:G:T
NM_177438.3(DICER1):c.2437-1G>A	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000841517	14	95574431	14	95108094	841517	852578		NC_000014.9:95108093:C:T
NM_030621.4(DICER1):c.3957dup (p.Asp1320fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000575211	14	95569775 - 95569776	14	95103438 - 95103439	575211	569097	rs1566766788	NC_000014.9:95103438:G:GG
NM_177438.2(DICER1):c.1376+1G>A	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000573393	14	95590532	14	95124195	573393	568501	rs886037670	NC_000014.9:95124194:C:T
NM_030621.4(DICER1):c.947G>A (p.Trp316Ter)	DICER1	W316*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000543605	14	95590962	14	95124625	543605	528920	rs1555374839	NC_000014.9:95124624:C:T
NM_177438.2(DICER1):c.5103C>G (p.Tyr1701Ter)	DICER1	Y1701*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523888	14	95560486	14	95094149	523888	514664	rs875989780	NC_000014.9:95094148:G:C
NM_030621.4(DICER1):c.1029dup (p.Phe344fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000477022	14	95590879 - 95590880	14	95124542 - 95124543	477022	464467	rs1555374772	NC_000014.9:95124542:TTT:TTTT
NM_030621.4(DICER1):c.4130del (p.Pro1377fs)	DICER1	P1377fs	Hereditary cancer-predisposing syndrome|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000412050	14	95566193	14	95099856	412050	400635	rs34678453	NC_000014.9:95099855:GGGGG:GGGG
NM_030621.4(DICER1):c.2867_2869delinsAA (p.Pro956fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000254313	14	95572496 - 95572498	14	95106159 - 95106161	254313	248853	rs886037694	NC_000014.9:95106158:GTG:TT
NM_177438.2(DICER1):c.2650+1G>T	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, multiple submitters, no conflicts	VCV000254310	14	95574216	14	95107879	254310	248856	rs886037691	NC_000014.9:95107878:C:A
NM_030621.4(DICER1):c.1684_1685del (p.Met562fs)	DICER1	M562fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000254290	14	95582857 - 95582858	14	95116520 - 95116521	254290	248874	rs886037674	NC_000014.9:95116519:AT:
NM_177438.2(DICER1):c.559C>T (p.Arg187Ter)	DICER1	R187*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Oct 20, 2015)	criteria provided, multiple submitters, no conflicts	VCV000220676	14	95596409	14	95130072	220676	222413	rs763801533	NC_000014.9:95130071:G:A
NM_001195573.1(DICER1):c.5365-144C>A	DICER1	S1826*	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors|Pulmonary blastoma	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030562	14	95557590	14	95091253	30562	39519		NC_000014.9:95091252:G:T
NM_000257.4(MYH7):c.727C>T (p.Arg243Cys)	MYH7	R243C	Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043101	14	23900799	14	23431590	43101	52271	rs397516265	NC_000014.9:23431589:G:A
NM_000257.4(MYH7):c.438G>T (p.Lys146Asn)	MYH7	K146N	Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2013)	criteria provided, multiple submitters, no conflicts	VCV000043013	14	23901912	14	23432703	43013	52183	rs397516212	NC_000014.9:23432702:C:A
NM_000257.4(MYH7):c.1447G>A (p.Glu483Lys)	MYH7	E483K	Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000014119	14	23897840	14	23428631	14119	29158	rs121913651	NC_000014.9:23428630:C:T
NM_030621.4(DICER1):c.4401_4402CT[2] (p.Leu1469fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000422631	14	95562851 - 95562852	14	95096514 - 95096515	422631	409178	rs1064795904	NC_000014.9:95096513:AGAGAGA:AGAGA
NM_030621.4(DICER1):c.3007C>T (p.Arg1003Ter)	DICER1	R1003*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000412077	14	95572101	14	95105764	412077	400386	rs1060503605	NC_000014.9:95105763:G:A
NM_030621.4(DICER1):c.878_881del (p.Arg293fs)	DICER1	R293fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254355	14	95592939 - 95592942	14	95126602 - 95126605	254355	248883	rs886037733	NC_000014.9:95126601:TCTCT:T
NM_030621.4(DICER1):c.5299del (p.His1767fs)	DICER1	H1767fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254348	14	95560290	14	95093953	254348	248819	rs886037727	NC_000014.9:95093952:GG:G
NM_030621.4(DICER1):c.4960_4961dup (p.Asp1654fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254340	14	95562295 - 95562296	14	95095958 - 95095959	254340	248826	rs886037720	NC_000014.9:95095958:TCT:TCTCT
NM_177438.2(DICER1):c.4621A>T (p.Lys1541Ter)	DICER1	K1541*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254338	14	95562636	14	95096299	254338	248828	rs886037718	NC_000014.9:95096298:T:A
NM_177438.2(DICER1):c.4517G>A (p.Trp1506Ter)	DICER1	W1506*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254336	14	95562740	14	95096403	254336	248830	rs886037716	NC_000014.9:95096402:C:T
NM_030621.4(DICER1):c.4407_4408del (p.Pro1471fs)	DICER1	P1471fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254333	14	95562849 - 95562850	14	95096512 - 95096513	254333	248833	rs886037713	NC_000014.9:95096511:AAA:A
NM_177438.2(DICER1):c.4190G>A (p.Trp1397Ter)	DICER1	W1397*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254331	14	95566133	14	95099796	254331	248835	rs886037711	NC_000014.9:95099795:C:T
NM_030621.4(DICER1):c.3777dup (p.Val1260fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000254329	14	95569955 - 95569956	14	95103618 - 95103619	254329	248837	rs886037709	NC_000014.9:95103618:GG:GGG
NM_177438.2(DICER1):c.3726C>A (p.Tyr1242Ter)	DICER1	Y1242*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254328	14	95570007	14	95103670	254328	248838	rs886037708	NC_000014.9:95103669:G:T
NM_177438.2(DICER1):c.3658C>T (p.Gln1220Ter)	DICER1	Q1220*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254326	14	95570075	14	95103738	254326	248840	rs886037707	NC_000014.9:95103737:G:A
NM_030621.4(DICER1):c.3538_3539del (p.Tyr1180fs)	DICER1	Y1180fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254322	14	95570194 - 95570195	14	95103857 - 95103858	254322	248844	rs886037703	NC_000014.9:95103856:TA:
NM_030621.4(DICER1):c.3515_3525delinsA (p.Leu1172fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254320	14	95570208 - 95570218	14	95103871 - 95103881	254320	248846	rs886037701	NC_000014.9:95103870:AATTGCTGTAA:T
NM_030621.4(DICER1):c.3300del (p.Lys1100fs)	DICER1	K1100fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254319	14	95570433	14	95104096	254319	248847	rs886037700	NC_000014.9:95104095:TTTTTT:TTTTT
NM_030621.4(DICER1):c.3277_3280del (p.Pro1092_Asn1093insTer)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254318	14	95570453 - 95570456	14	95104116 - 95104119	254318	248848	rs886037699	NC_000014.9:95104115:AGTTAG:AG
NM_177438.2(DICER1):c.3273C>G (p.Tyr1091Ter)	DICER1	Y1091*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000254317	14	95570460	14	95104123	254317	248849	rs886037698	NC_000014.9:95104122:G:C
NM_030621.4(DICER1):c.2888_2889del (p.Pro963fs)	DICER1	P963fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254314	14	95572476 - 95572477	14	95106139 - 95106140	254314	248852	rs886037695	NC_000014.9:95106138:AG:
NM_177438.2(DICER1):c.2749G>T (p.Glu917Ter)	DICER1	E917*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254311	14	95574000	14	95107663	254311	248855	rs886037692	NC_000014.9:95107662:C:A
NM_030621.4(DICER1):c.2392dup (p.Thr798fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254309	14	95574704 - 95574705	14	95108367 - 95108368	254309	248857	rs886037690	NC_000014.9:95108367:T:TT
NM_030621.4(DICER1):c.2243_2244delinsAA (p.Cys748Ter)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254306	14	95577666 - 95577667	14	95111329 - 95111330	254306	248888	rs886037687	NC_000014.9:95111328:GC:TT
NM_030621.4(DICER1):c.2158_2159del (p.Thr719_Val720insTer)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254304	14	95577751 - 95577752	14	95111414 - 95111415	254304	248860	rs886037685	NC_000014.9:95111413:ACA:A
NM_177438.2(DICER1):c.1827_1828insAG (p.Val610fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254296	14	95582083 - 95582084	14	95115746 - 95115747	254296	248868	rs886037679	NC_000014.9:95115746::CT
NM_030621.4(DICER1):c.1787del (p.Thr596fs)	DICER1	T596fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254295	14	95582124	14	95115787	254295	248869	rs886037678	NC_000014.9:95115786:G:
NM_177438.2(DICER1):c.1408G>T (p.Glu470Ter)	DICER1	E470*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254287	14	95584060	14	95117723	254287	248877	rs886037671	NC_000014.9:95117722:C:A
NM_030621.4(DICER1):c.1185_1187delinsC (p.Glu396fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254284	14	95590722 - 95590724	14	95124385 - 95124387	254284	248880	rs886037668	NC_000014.9:95124384:TCA:G
NM_177438.2(DICER1):c.1144G>T (p.Glu382Ter)	DICER1	E382*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000254283	14	95590765	14	95124428	254283	248881	rs886037667	NC_000014.9:95124427:C:A
NM_177438.2(DICER1):c.4754C>G (p.Ser1585Ter)	DICER1	S1585*	Pineoblastoma|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	VCV000225883	14	95562503	14	95096166	225883	227697	rs875989779	NC_000014.9:95096165:G:C
NM_177438.2(DICER1):c.4748T>G (p.Leu1583Arg)	DICER1	L1583R	Pulmonary blastoma|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000004468	14	95562509	14	95096172	4468	19507	rs137852976	NC_000014.9:95096171:A:C
NM_002834.5(PTPN11):c.1381G>A (p.Ala461Thr)	PTPN11	A461T, A465T, A460T	not specified|Rasopathy|not provided|Noonan syndrome with multiple lentigines|Noonan syndrome 3|LEOPARD syndrome 1	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013342	12	112926248	12	112488444	13342	28381	rs121918468	NC_000012.12:112488443:G:A
NM_177438.2(DICER1):c.2988-1G>T	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429116	14	95572121	14	95105784	429116	421122	rs1131691192	NC_000014.9:95105783:C:A
NM_030621.4(DICER1):c.3589del (p.Cys1197fs)	DICER1	C1197fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, multiple submitters, no conflicts	VCV000254325	14	95570144	14	95103807	254325	248841	rs886037706	NC_000014.9:95103806:AAAA:AAA
NM_177438.2(DICER1):c.5315_5316del (p.Phe1772fs)	DICER1	F1772fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000242134	14	95560273 - 95560274	14	95093936 - 95093937	242134	241906	rs878855274	NC_000014.9:95093935:AAA:A
NM_030621.4(DICER1):c.4050+1G>A	DICER1		Hereditary cancer-predisposing syndrome|not provided|Pineoblastoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, multiple submitters, no conflicts	VCV000225887	14	95569682	14	95103345	225887	227700	rs875989783	NC_000014.9:95103344:C:T
NM_004004.6(GJB2):c.176_191del (p.Gly59fs)	GJB2	G59fs	Deafness, autosomal recessive 1A|not specified|not provided	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000284906	13	20763530 - 20763545	13	20189391 - 20189406	284906	269143	rs750188782	NC_000013.11:20189390:CACACGTTCTTGCAGCC:C
NM_002693.2(POLG):c.2828G>A (p.Arg943His)	POLG	R943H	Progressive sclerosing poliodystrophy|not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000619302	15	89864150	15	89320919	619302	610736	rs1567186613	NC_000015.10:89320918:C:T
NM_000512.5(GALNS):c.268C>T (p.Arg90Trp)	GALNS	R90W, R96W	Mucopolysaccharidosis, MPS-IV-A|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520618	16	88908356	16	88841948	520618	512232	rs1028668536	NC_000016.10:88841947:G:A
NM_001271.4(CHD2):c.4767_4768CT[2] (p.Leu1591fs)	CHD2		Inborn genetic diseases	Pathogenic(Last reviewed: Nov 29, 2016)	criteria provided, single submitter	VCV000521424	15	93558000 - 93558001	15	93014770 - 93014771	521424	512167	rs1555445685	NC_000015.10:93014769:CTCTCT:CTCT
NM_006009.4(TUBA1A):c.790C>T (p.Arg264Cys)	TUBA1A	R264C, R229C	Inborn genetic diseases|Tubulinopathies|Lissencephaly 3	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007070	12	49579359	12	49185576	7070	22109	rs137853043	NC_000012.12:49185575:G:A
NM_000020.2(ACVRL1):c.1120C>T (p.Arg374Trp)	ACVRL1	R374W	not provided|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008249	12	52309891	12	51916107	8249	23288	rs28936401	NC_000012.12:51916106:C:T
NM_177438.2(DICER1):c.5104C>T (p.Gln1702Ter)	DICER1	Q1702*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000254344	14	95560485	14	95094148	254344	248823	rs886037723	NC_000014.9:95094147:G:A
NM_177438.2(DICER1):c.2247C>A (p.Tyr749Ter)	DICER1	Y749*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000254308	14	95577663	14	95111326	254308	248858	rs886037689	NC_000014.9:95111325:G:T
NM_030621.4(DICER1):c.1880_1883del (p.Ile627fs)	DICER1	I627fs	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000254298	14	95582028 - 95582031	14	95115691 - 95115694	254298	248866	rs886037680	NC_000014.9:95115690:TTGATTG:TTG
NM_000135.4(FANCA):c.65G>A (p.Trp22Ter)	FANCA	W22*	Fanconi anemia, complementation group A|Fanconi anemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000550541	16	89882959	16	89816551	550541	547975	rs761341952	NC_000016.10:89816550:C:T
NM_000135.4(FANCA):c.3391A>G (p.Thr1131Ala)	FANCA	T1131A	Fanconi anemia|not provided|Fanconi anemia, complementation group A	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237048	16	89813256	16	89746848	237048	242537	rs574034197	NC_000016.10:89746847:T:C
NM_030621.4(DICER1):c.4458dup (p.Ser1487fs)	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429122	14	95562798 - 95562799	14	95096461 - 95096462	429122	421104	rs1131691197	NC_000014.9:95096461:TTTTTT:TTTTTTT
NM_030621.4(DICER1):c.5441C>T (p.Ser1814Leu)	DICER1	S1814L	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Rhabdomyosarcoma, embryonal, 2|Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000412119	14	95557626	14	95091289	412119	399958	rs1060503625	NC_000014.9:95091288:G:A
NM_030621.4(DICER1):c.4603_4604TG[1] (p.Cys1535fs)	DICER1		Hereditary cancer-predisposing syndrome|not provided|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Feb 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000254337	14	95562651 - 95562652	14	95096314 - 95096315	254337	248829	rs886037717	NC_000014.9:95096313:CACA:CA
NM_177438.2(DICER1):c.2830C>T (p.Arg944Ter)	DICER1	R934*, R944*	Pulmonary blastoma|Hereditary cancer-predisposing syndrome|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000004470	14	95572535	14	95106198	4470	19509	rs137852978	NC_000014.9:95106197:G:A
NM_000430.4(PAFAH1B1):c.569-10T>C	PAFAH1B1		not provided|Inborn genetic diseases|Lissencephaly due to LIS1 mutation	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021182	17	2575939	17	2672645	21182	34034	rs113994202	NC_000017.11:2672644:T:C
NM_001844.5(COL2A1):c.1388_1996-108del	COL2A1		Inborn genetic diseases	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV000521694	12	48377329 - 48380649	12	47983546 - 47986866	521694	511999		
NM_001844.5(COL2A1):c.3879G>A (p.Trp1293Ter)	COL2A1	W1293*, W1224*	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000521248	12	48369107	12	47975324	521248	511995	rs1555164672	NC_000012.12:47975323:C:T
NM_001844.5(COL2A1):c.3265G>A (p.Gly1089Arg)	COL2A1	G1089R, G1020R	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	VCV000520992	12	48371111	12	47977328	520992	511996	rs1555165183	NC_000012.12:47977327:C:T
NM_000053.4(ATP7B):c.3191A>C (p.Glu1064Ala)	ATP7B	E1064A, E980A, E857A, E953A, E986A	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370081	13	52518297	13	51944161	370081	358222	rs374094065	NC_000013.11:51944160:T:G
NM_000053.4(ATP7B):c.3121C>T (p.Arg1041Trp)	ATP7B	R1041W, R834W, R930W, R957W, R963W	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000312384	13	52518367	13	51944231	312384	319974	rs746485916	NC_000013.11:51944230:G:A
NM_000053.4(ATP7B):c.3007G>A (p.Ala1003Thr)	ATP7B	A1003T, A796T, A925T, A919T, A892T	Epileptic encephalopathy|Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188802	13	52520473	13	51946337	188802	186890	rs201497300	NC_000013.11:51946336:C:T
NM_000053.4(ATP7B):c.3443T>C (p.Ile1148Thr)	ATP7B	I1148T, I1037T, I1070T, I1064T, I941T	Wilson disease|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000037122	13	52515330	13	51941194	37122	18902	rs60431989	NC_000013.11:51941193:A:G
NM_020988.3(GNAO1):c.625C>T (p.Arg209Cys)	GNAO1	R209C	Movement disorder|Early infantile epileptic encephalopathy|Neurodevelopmental disorder with involuntary movements|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265350	16	56370674	16	56336762	265350	260118	rs886039494	NC_000016.10:56336761:C:T
NM_030621.4(DICER1):c.4206+1G>T	DICER1		DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429136	14	95566116	14	95099779	429136	421108	rs765059994	NC_000014.9:95099778:C:A
NM_000321.2(RB1):c.1735C>T (p.Arg579Ter)	RB1	R579*	Hereditary cancer-predisposing syndrome|not provided|Retinoblastoma	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000126785	13	49027168	13	48453032	126785	132295	rs121913305	NC_000013.11:48453031:C:T
NM_000321.2(RB1):c.607+1G>T	RB1		Hereditary cancer-predisposing syndrome|not provided|Retinoblastoma	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013093	13	48923160	13	48349024	13093	28132	rs587776789	NC_000013.11:48349023:G:T
NM_000321.2(RB1):c.2134T>C (p.Cys712Arg)	RB1	C712R	Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013092	13	49037894	13	48463758	13092	28131	rs137853296	NC_000013.11:48463757:T:C
NM_001009944.3(PKD1):c.2180T>C (p.Leu727Pro)	PKD1	L727P	Polycystic kidney disease 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000562302	16	2164844	16	2114843	562302	553486	rs1616940	NC_000016.10:2114842:A:G
NM_000257.4(MYH7):c.2334C>A (p.Asp778Glu)	MYH7	D778E	not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188615	14	23894580	14	23425371	188615	186494	rs2069544	NC_000014.9:23425370:G:T
NM_000257.4(MYH7):c.602T>C (p.Ile201Thr)	MYH7	I201T	Cardiovascular phenotype|not provided|Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043093	14	23901007	14	23431798	43093	52263	rs397516258	NC_000014.9:23431797:A:G
NM_002693.2(POLG):c.2864A>G (p.Tyr955Cys)	POLG	Y955C	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Progressive sclerosing poliodystrophy|not provided|Mitochondrial diseases	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000013495	15	89864114	15	89320883	13495	28534	rs113994099	NC_000015.10:89320882:T:C
NM_003119.4(SPG7):c.1045G>A (p.Gly349Ser)	SPG7	G349S	not provided|Hereditary spastic paraplegia 7	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006819	16	89598369	16	89531961	6819	21858	rs141659620	NC_000016.10:89531960:G:A
NM_002834.4(PTPN11):c.182A>T (p.Asp61Val)	PTPN11	D61V	Rasopathy	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000040496	12	112888166	12	112450362	40496	48966	rs121918461	NC_000012.12:112450361:A:T
NM_002834.5(PTPN11):c.172A>C (p.Asn58His)	PTPN11	N58H, N57H	Noonan syndrome|Rasopathy|not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040486	12	112888156	12	112450352	40486	48956	rs397507505	NC_000012.12:112450351:A:C
NM_177438.2(DICER1):c.1507G>T (p.Glu503Ter)	DICER1	E493*, E503*	Pulmonary blastoma|Hereditary cancer-predisposing syndrome|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004469	14	95583961	14	95117624	4469	19508	rs137852977	NC_000014.9:95117623:C:A
NM_001171.5(ABCC6):c.3421C>T (p.Arg1141Ter)	ABCC6	R1141*, R1027*	Pseudoxanthoma elasticum, forme fruste|Generalized arterial calcification of infancy 2|Pseudoxanthoma elasticum|not provided|Generalized arterial calcification of infancy 2|Cutis laxa|Papule|Pseudoxanthoma elasticum	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006559	16	16256935	16	16163078	6559	21598	rs72653706	NC_000016.10:16163077:G:A
NM_000070.3(CAPN3):c.1714C>T (p.Arg572Trp)	CAPN3	R572W, R524W, R60W	not provided|Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217152	15	42695169	15	42402971	217152	213830	rs863224959	NC_000015.10:42402970:C:T
NM_000070.3(CAPN3):c.2362_2363delinsTCATCT (p.Arg788fs)	CAPN3		Limb-girdle muscular dystrophy, type 2A|Myositis, eosinophilic|not provided	Pathogenic(Last reviewed: Jun 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017618	15	42703180 - 42703181	15	42410982 - 42410983	17618	32657	rs1555423217	NC_000015.10:42410981:AG:TCATCT
NM_000020.2(ACVRL1):c.1435C>T (p.Arg479Ter)	ACVRL1	R479*	Hereditary hemorrhagic telangiectasia type 1||Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372722	12	52314600	12	51920816	372722	360048	rs1057517944	NC_000012.12:51920815:C:T
NM_001018005.2(TPM1):c.688G>A (p.Asp230Asn)	TPM1	D230N, D194N, D272N	Primary dilated cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 3|Dilated cardiomyopathy 1Y	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031884	15	63354462	15	63062263	31884	40544	rs199476317	NC_000015.10:63062262:G:A
NM_177438.2(DICER1):c.3540C>A (p.Tyr1180Ter)	DICER1	Y1180*	not provided|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000254323	14	95570193	14	95103856	254323	248843	rs886037704	NC_000014.9:95103855:G:T
NM_177438.2(DICER1):c.2062C>T (p.Arg688Ter)	DICER1	R688*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000254303	14	95578563	14	95112226	254303	248861	rs886037684	NC_000014.9:95112225:G:A
NM_030621.4(DICER1):c.1870C>T (p.Arg624Ter)	DICER1	R624*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000254297	14	95582041	14	95115704	254297	248867	rs754818927	NC_000014.9:95115703:G:A
NM_030621.4(DICER1):c.2026C>T (p.Arg676Ter)	DICER1	R676*	Hereditary cancer-predisposing syndrome|not provided|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000242054	14	95579443	14	95113106	242054	241976	rs878855246	NC_000014.9:95113105:G:A
NM_030621.4(DICER1):c.1630C>T (p.Arg544Ter)	DICER1	R534*, R544*	Pulmonary blastoma|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004472	14	95582912	14	95116575	4472	19511	rs137852979	NC_000014.9:95116574:G:A
NM_030621.4(DICER1):c.1966C>T (p.Arg656Ter)	DICER1	R656*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000254301	14	95579503	14	95113166	254301	248863	rs754081635	NC_000014.9:95113165:G:A
NM_177438.2(DICER1):c.4407_4410del (p.Ser1470fs)	DICER1	S1470fs	Hereditary cancer-predisposing syndrome|Pineoblastoma|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225888	14	95562847 - 95562850	14	95096510 - 95096513	225888	227699	rs875989784	NC_000014.9:95096509:AGAAAGA:AGA
NM_002834.5(PTPN11):c.1507G>C (p.Gly503Arg)	PTPN11	G503R, G507R, G502R	Rasopathy|Noonan syndrome 1|Noonan syndrome|not provided|Juvenile myelomonocytic leukemia|Noonan syndrome|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|LEOPARD syndrome 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040558	12	112926887	12	112489083	40558	49028	rs397507545	NC_000012.12:112489082:G:C
NM_002834.5(PTPN11):c.417G>T (p.Glu139Asp)	PTPN11	E139D, E138D	Rasopathy|Juvenile myelomonocytic leukemia|Noonan syndrome|Noonan syndrome 1|not provided	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040512	12	112891083	12	112453279	40512	48982	rs397507520	NC_000012.12:112453278:G:T
NM_002834.5(PTPN11):c.179G>C (p.Gly60Ala)	PTPN11	G60A, G59A	not provided|Rasopathy|Noonan syndrome 1|Noonan syndrome	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040493	12	112888163	12	112450359	40493	48963	rs397507509	NC_000012.12:112450358:G:C
NM_002834.5(PTPN11):c.1529A>C (p.Gln510Pro)	PTPN11	Q510P, Q514P, Q509P	Noonan syndrome with multiple lentigines|LEOPARD syndrome 1|Rasopathy|Noonan syndrome with multiple lentigines|Noonan syndrome|not provided|Noonan syndrome 3	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013344	12	112926909	12	112489105	13344	28383	rs121918470	NC_000012.12:112489104:A:C
NM_002834.5(PTPN11):c.227A>G (p.Glu76Gly)	PTPN11	E76G, E75G	Squamous cell lung carcinoma|Juvenile myelomonocytic leukemia|Neoplasm of the large intestine|Astrocytoma|not provided|Neuroblastoma|Multiple myeloma	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013338	12	112888211	12	112450407	13338	28377	rs121918465	NC_000012.12:112450406:A:G
NM_001271.4(CHD2):c.3937C>T (p.Arg1313Ter)	CHD2	R1313*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521625	15	93541780	15	92998550	521625	512165	rs1555444702	NC_000015.10:92998549:C:T
NM_002087.4(GRN):c.1477C>T (p.Arg493Ter)	GRN	R493*	not provided||Ceroid lipofuscinosis, neuronal, 11|	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016014	17	42429772	17	44352404	16014	31053	rs63751294	NC_000017.11:44352403:C:T
NM_000257.4(MYH7):c.2146G>C (p.Gly716Arg)	MYH7	G716R	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000847327	14	23895189	14	23425980	847327	841298		NC_000014.9:23425979:C:G
NM_000257.4(MYH7):c.2334C>G (p.Asp778Glu)	MYH7	D778E	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265252	14	23894580	14	23425371	265252	260053	rs2069544	NC_000014.9:23425370:G:C
NM_000257.4(MYH7):c.2081G>A (p.Arg694His)	MYH7	R694H	not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000264068	14	23895254	14	23426045	264068	258806	rs886039030	NC_000014.9:23426044:C:T
NM_000257.4(MYH7):c.2543A>G (p.Glu848Gly)	MYH7	E848G	Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177758	14	23894114	14	23424905	177758	175473	rs727504311	NC_000014.9:23424904:T:C
NM_000257.4(MYH7):c.2782G>A (p.Asp928Asn)	MYH7	D928N	not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000164313	14	23893256	14	23424047	164313	175611	rs727503252	NC_000014.9:23424046:C:T
NM_006662.3(SRCAP):c.7330C>T (p.Arg2444Ter)	SRCAP	R2444*	not provided|Floating-Harbor syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030908	16	30748691	16	30737370	30908	39865	rs199469464	NC_000016.10:30737369:C:T
NM_005249.5(FOXG1):c.577G>A (p.Ala193Thr)	FOXG1	A193T	Inborn genetic diseases|Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189616	14	29237062	14	28767856	189616	187405	rs786205005	NC_000014.9:28767855:G:A
NM_030621.4(DICER1):c.4309_4312del (p.Asp1437fs)	DICER1	D1437fs	not provided|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000254332	14	95562945 - 95562948	14	95096608 - 95096611	254332	248834	rs886037712	NC_000014.9:95096607:AGTCAG:AG
NM_030621.4(DICER1):c.1525C>T (p.Arg509Ter)	DICER1	R509*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000254288	14	95583017	14	95116680	254288	248876	rs886037672	NC_000014.9:95116679:G:A
NM_000053.4(ATP7B):c.3646G>A (p.Val1216Met)	ATP7B	V1216M, V1105M, V1132M, V1138M, V1009M	not provided|Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188859	13	52513240	13	51939104	188859	186878	rs776280797	NC_000013.11:51939103:C:T
NM_000053.4(ATP7B):c.2975C>T (p.Pro992Leu)	ATP7B	P992L, P881L, P908L, P914L, P785L	Wilson disease|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188831	13	52520505	13	51946369	188831	186891	rs201038679	NC_000013.11:51946368:G:A
NM_002693.2(POLG):c.911T>G (p.Leu304Arg)	POLG	L304R	Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Progressive sclerosing poliodystrophy|Cerebellar ataxia infantile with progressive external ophthalmoplegia|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Cerebellar ataxia infantile with progressive external ophthalmoplegia|not provided|Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013497	15	89872286	15	89329055	13497	28536	rs121918044	NC_000015.10:89329054:A:C
NM_024685.4(BBS10):c.39_46del (p.Ala14fs)	BBS10	A14fs	Bardet-Biedl syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521411	12	76742093 - 76742100	12	76348313 - 76348320	521411	512038	rs1555202806	NC_000012.12:76348312:GCAACGCCGC:GC
NM_000257.4(MYH7):c.1573G>A (p.Glu525Lys)	MYH7	I524K, E525K	Left ventricular noncompaction cardiomyopathy|not provided|Left ventricular noncompaction|Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S|Hypertrophic cardiomyopathy|Familial cardiomyopathy	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000132925	14	23897714	14	23428505	132925	136674	rs606231324	NC_000014.9:23428504:C:T
NM_000257.4(MYH7):c.732+1G>A	MYH7		Hypertrophic cardiomyopathy|Left ventricular noncompaction 5|not provided|Left ventricular noncompaction|Cardiomyopathy, left ventricular noncompaction	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000014127	14	23900793	14	23431584	14127	29166	rs730880850	NC_000014.9:23431583:C:T
NM_003482.3(KMT2D):c.6595del (p.Tyr2199fs)	KMT2D	Y2199fs	Kabuki syndrome|Kabuki syndrome 1|not provided	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094239	12	49434958	12	49041175	94239	100139	rs398123753	NC_000012.12:49041174:A:
NM_002834.5(PTPN11):c.1471C>T (p.Pro491Ser)	PTPN11	P491S, P495S, P490S	Rasopathy|not provided|Noonan syndrome|not specified|Noonan syndrome 1	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040550	12	112926851	12	112489047	40550	49020	rs397507539	NC_000012.12:112489046:C:T
NM_004004.6(GJB2):c.169C>T (p.Gln57Ter)	GJB2	Q57*	Deafness, autosomal recessive 1A|not provided|Rare genetic deafness|Hearing loss	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044725	13	20763552	13	20189413	44725	53892	rs111033297	NC_000013.11:20189412:G:A
NM_004004.6(GJB2):c.250G>A (p.Val84Met)	GJB2	V84M	not provided|Progressive sensorineural hearing impairment|Rare genetic deafness|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000017036	13	20763471	13	20189332	17036	32075	rs104894409	NC_000013.11:20189331:C:T
NM_001844.5(COL2A1):c.1636G>A (p.Gly546Ser)	COL2A1	G546S, G477S	Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000290774	12	48379555	12	47985772	290774	275011	rs886044555	NC_000012.12:47985771:C:T
NM_000138.5(FBN1):c.2768dup (p.Asn923fs)	FBN1		not provided	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000817238	15	48784743 - 48784744	15	48492546 - 48492547	817238	805832		NC_000015.10:48492546:TTTTT:TTTTTT
NM_000138.4(FBN1):c.2613A>C (p.Leu871Phe)	FBN1	L871F	Congenital scoliosis	Pathogenic(Last reviewed: Jun 12, 2019)	no assertion criteria provided	VCV000667457	15	48787384	15	48495187	667457	655014		NC_000015.10:48495186:T:G
NM_000138.4(FBN1):c.1589-9T>A	FBN1		not provided	Pathogenic(Last reviewed: Nov 23, 2018)	criteria provided, single submitter	VCV000636865	15	48802375	15	48510178	636865	624802		NC_000015.10:48510177:A:T
NM_000138.4(FBN1):c.4224C>A (p.Cys1408Ter)	FBN1	C1408*	Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000633218	15	48764860	15	48472663	633218	621507	rs1566905978	NC_000015.10:48472662:G:T
NM_000138.4(FBN1):c.633_634CA[1] (p.Thr212fs)	FBN1		not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000618651	15	48829908 - 48829909	15	48537711 - 48537712	618651	609929	rs1566922422	NC_000015.10:48537710:TGTG:TG
NM_000138.4(FBN1):c.163G>T (p.Gly55Ter)	FBN1	G55*	not specified	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000618122	15	48936804	15	48644607	618122	609931	rs1566944812	NC_000015.10:48644606:C:A
NM_000138.4(FBN1):c.8275_8291del (p.Glu2759fs)	FBN1	E2759fs	Marfan lipodystrophy syndrome	Pathogenic(Last reviewed: Aug 18, 2018)	no assertion criteria provided	VCV000617941	15	48703512 - 48703528	15	48411315 - 48411331	617941	609338	rs1566888718	NC_000015.10:48411314:AAGATGGCTGTCTTCTCAA:AA
NM_000138.4(FBN1):c.7016_7031dup (p.Gln2345fs)	FBN1		not provided	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000595071	15	48719936 - 48719937	15	48427739 - 48427740	595071	586133	rs1566893502	NC_000015.10:48427739:AGCACCTCTGTGAAGCAG:AGCACCTCTGTGAAGCAGCACCTCTGTGAAGCAG
NM_000138.4(FBN1):c.4721del (p.Cys1574fs)	FBN1	C1574fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 3, 2013)	criteria provided, single submitter	VCV000520243	15	48760161	15	48467964	520243	510583	rs1555397148	NC_000015.10:48467963:C:
NM_000138.4(FBN1):c.412A>T (p.Lys138Ter)	FBN1	K138*	Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 28, 2013)	criteria provided, single submitter	VCV000520241	15	48892366	15	48600169	520241	510643	rs886038937	NC_000015.10:48600168:T:A
NM_000138.4(FBN1):c.3269del (p.Pro1090fs)	FBN1	P1090fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 24, 2013)	criteria provided, single submitter	VCV000520240	15	48780378	15	48488181	520240	510602	rs35656954	NC_000015.10:48488180:GGGG:GGG
NM_000138.4(FBN1):c.1512T>A (p.Cys504Ter)	FBN1	C504*	Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000519798	15	48805822	15	48513625	519798	510629	rs1555400285	NC_000015.10:48513624:A:T
NM_000138.4(FBN1):c.2665del (p.Leu889fs)	FBN1	L889fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000519793	15	48787332	15	48495135	519793	510613	rs1555399147	NC_000015.10:48495134:GGG:GG
NM_000138.4(FBN1):c.3400G>T (p.Gly1134Ter)	FBN1	G1134*	Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000519789	15	48779572	15	48487375	519789	510600	rs372404949	NC_000015.10:48487374:C:A
NM_000138.4(FBN1):c.7780dup (p.Gln2594fs)	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000519788	15	48712922 - 48712923	15	48420725 - 48420726	519788	510536	rs1555394146	NC_000015.10:48420725:GGGGG:GGGGGG
NM_000138.4(FBN1):c.8051_8051+1delinsT	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000519784	15	48707732 - 48707733	15	48415535 - 48415536	519784	510529	rs1555393823	NC_000015.10:48415534:CC:A
NM_000138.4(FBN1):c.6609_6610del (p.Thr2203_Cys2204insTer)	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000519777	15	48726797 - 48726798	15	48434600 - 48434601	519777	510553	rs1555395002	NC_000015.10:48434599:AT:
NM_000138.4(FBN1):c.6268G>T (p.Glu2090Ter)	FBN1	E2090*	Cardiovascular phenotype	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV000519776	15	48730010	15	48437813	519776	510560	rs1304643689	NC_000015.10:48437812:C:A
NM_000138.4(FBN1):c.3947del (p.Gly1316fs)	FBN1	G1316fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000519763	15	48773869	15	48481672	519763	510595	rs1555398143	NC_000015.10:48481671:CC:C
NM_000138.4(FBN1):c.6313G>T (p.Glu2105Ter)	FBN1	E2105*	Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000519755	15	48729965	15	48437768	519755	510559	rs794728247	NC_000015.10:48437767:C:A
NM_000138.4(FBN1):c.7412del (p.Pro2471fs)	FBN1	P2471fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000519747	15	48717607	15	48425410	519747	510541	rs1555394396	NC_000015.10:48425409:GGG:GG
NM_000138.4(FBN1):c.4704dup (p.Ala1569fs)	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 17, 2016)	criteria provided, single submitter	VCV000519746	15	48760177 - 48760178	15	48467980 - 48467981	519746	510584	rs1555397154	NC_000015.10:48467980:TTT:TTTT
NM_000138.4(FBN1):c.2899_2900dup (p.Thr968fs)	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000519738	15	48782229 - 48782230	15	48490032 - 48490033	519738	510607	rs1555398828	NC_000015.10:48490032:CAC:CACAC
NM_000138.4(FBN1):c.4888del (p.Gln1630fs)	FBN1	Q1630fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, single submitter	VCV000519728	15	48757819	15	48465622	519728	510580	rs1555397000	NC_000015.10:48465621:GG:G
NM_000138.4(FBN1):c.6740-1G>A	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000519724	15	48723000	15	48430803	519724	510550	rs1555394781	NC_000015.10:48430802:C:T
NM_000138.4(FBN1):c.6146_6150del (p.Ser2049fs)	FBN1	S2049fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, single submitter	VCV000519719	15	48733931 - 48733935	15	48441734 - 48441738	519719	510562	rs1555395461	NC_000015.10:48441733:TCCACT:T
NM_000138.4(FBN1):c.558T>A (p.Cys186Ter)	FBN1	C186*	Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000519718	15	48829986	15	48537789	519718	510638	rs1555401699	NC_000015.10:48537788:A:T
NM_000138.4(FBN1):c.3815del (p.Ser1272fs)	FBN1	S1272fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000519709	15	48776038	15	48483841	519709	510596	rs1555398272	NC_000015.10:48483840:G:
NM_000138.4(FBN1):c.258_260delinsCT (p.His87fs)	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 1, 2016)	criteria provided, single submitter	VCV000519706	15	48903011 - 48903013	15	48610814 - 48610816	519706	510647	rs1555405534	NC_000015.10:48610813:TGC:AG
NM_000138.4(FBN1):c.4813del (p.Glu1605fs)	FBN1	E1605fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000519703	15	48757990	15	48465793	519703	510582	rs1555397016	NC_000015.10:48465792:CC:C
NM_000138.4(FBN1):c.7120del (p.His2374fs)	FBN1	H2374fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000519701	15	48719848	15	48427651	519701	510547	rs1555394566	NC_000015.10:48427650:GGGG:GGG
NM_000138.4(FBN1):c.111del (p.Arg38fs)	FBN1	R38fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000519700	15	48936856	15	48644659	519700	510651	rs1555407416	NC_000015.10:48644658:GG:G
NM_000138.4(FBN1):c.1852dup (p.Glu618fs)	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Feb 7, 2016)	criteria provided, single submitter	VCV000519567	15	48797329 - 48797330	15	48505132 - 48505133	519567	510626	rs1555399835	NC_000015.10:48505132:C:CC
NM_000138.4(FBN1):c.1839_1840delinsGAAGGT (p.Asp613fs)	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	VCV000519559	15	48797342 - 48797343	15	48505145 - 48505146	519559	510627	rs1555399839	NC_000015.10:48505144:TG:ACCTTC
NM_000138.4(FBN1):c.5672-1G>C	FBN1		not provided	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000504315	15	48739020	15	48446823	504315	495344	rs1555395849	NC_000015.10:48446822:C:G
NM_000138.4(FBN1):c.6450_6454del (p.Cys2151fs)	FBN1	C2151fs	not provided	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000503977	15	48729200 - 48729204	15	48437003 - 48437007	503977	495341	rs1555395193	NC_000015.10:48437002:CGCAGCG:CG
NM_000138.4(FBN1):c.1880_1881del (p.Arg627fs)	FBN1	R627fs	not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000503860	15	48797301 - 48797302	15	48505104 - 48505105	503860	495353	rs1555399827	NC_000015.10:48505103:AC:
NM_000138.4(FBN1):c.8543_8544del (p.Lys2848fs)	FBN1	K2848fs	not provided	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000503785	15	48703259 - 48703260	15	48411062 - 48411063	503785	495578	rs794728323	NC_000015.10:48411061:TTT:T
NM_000138.4(FBN1):c.2668T>A (p.Cys890Ser)	FBN1	C890S	not provided	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000453168	15	48787329	15	48495132	453168	445365	rs1555399145	NC_000015.10:48495131:A:T
NM_000138.4(FBN1):c.7507del (p.Thr2503fs)	FBN1	T2503fs	not provided	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000453088	15	48714212	15	48422015	453088	445340	rs1555394242	NC_000015.10:48422014:T:
NM_000138.4(FBN1):c.2816del (p.Ser939fs)	FBN1	S939fs	not provided	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000452698	15	48784696	15	48492499	452698	445364	rs1555398976	NC_000015.10:48492498:C:
NM_000138.4(FBN1):c.2854+1G>T	FBN1		not provided	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000452451	15	48784657	15	48492460	452451	445363	rs112809590	NC_000015.10:48492459:C:A
NM_000138.4(FBN1):c.4531_4534del (p.Cys1511fs)	FBN1	C1511fs	not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000451806	15	48760657 - 48760660	15	48468460 - 48468463	451806	445354	rs1555397206	NC_000015.10:48468459:CACA:
NM_000138.4(FBN1):c.3253C>T (p.Gln1085Ter)	FBN1	Q1085*	not provided	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000449815	15	48780394	15	48488197	449815	445359	rs1555398640	NC_000015.10:48488196:G:A
NM_000138.4(FBN1):c.1532A>G (p.Tyr511Cys)	FBN1	Y511C	not specified	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, single submitter	VCV000439720	15	48805802	15	48513605	439720	433562	rs1555400281	NC_000015.10:48513604:T:C
NM_000138.4(FBN1):c.5783G>A (p.Cys1928Tyr)	FBN1	C1928Y	not provided	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000439719	15	48738908	15	48446711	439719	433561	rs587782947	NC_000015.10:48446710:C:T
NM_000138.4(FBN1):c.3856del (p.Asp1285_Leu1286insTer)	FBN1		not specified	Pathogenic(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000439716	15	48773960	15	48481763	439716	433140	rs1555398170	NC_000015.10:48481762:GG:G
NM_000138.4(FBN1):c.1961-2A>G	FBN1		not specified	Pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000439714	15	48796138	15	48503941	439714	433146	rs1555399779	NC_000015.10:48503940:T:C
NM_000138.4(FBN1):c.3839_3846del (p.Asp1280fs)	FBN1	D1280fs	not specified	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000439711	15	48773970 - 48773977	15	48481773 - 48481780	439711	433141	rs113603747	NC_000015.10:48481772:ATTGACAT:
NM_000138.4(FBN1):c.3221G>A (p.Cys1074Tyr)	FBN1	C1074Y	not provided	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000439705	15	48780426	15	48488229	439705	433555	rs1555398645	NC_000015.10:48488228:C:T
NM_000138.4(FBN1):c.6087C>A (p.Cys2029Ter)	FBN1	C2029*	not specified	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000439704	15	48733994	15	48441797	439704	433138	rs1555395475	NC_000015.10:48441796:G:T
NM_000138.4(FBN1):c.3091G>A (p.Glu1031Lys)	FBN1	E1031K	not provided	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000432343	15	48780682	15	48488485	432343	426111	rs1555398685	NC_000015.10:48488484:C:T
NM_000138.4(FBN1):c.6549_6550TG[3] (p.Ile2185Ter)	FBN1		not provided	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000432254	15	48726854 - 48726855	15	48434657 - 48434658	432254	426104	rs1555395009	NC_000015.10:48434657:CACA:CACACA
NM_000138.4(FBN1):c.6296G>T (p.Cys2099Phe)	FBN1	C2099F	not provided	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000430149	15	48729982	15	48437785	430149	422025	rs1131691803	NC_000015.10:48437784:C:A
NM_000138.4(FBN1):c.2814del (p.Ser939fs)	FBN1	S939fs	not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000430067	15	48784698	15	48492501	430067	422040	rs1131691766	NC_000015.10:48492500:GGG:GG
NM_000138.4(FBN1):c.6997+2T>C	FBN1		not provided	Pathogenic(Last reviewed: Sep 27, 2015)	criteria provided, single submitter	VCV000430009	15	48720541	15	48428344	430009	422022	rs1131691730	NC_000015.10:48428343:A:G
NM_000138.4(FBN1):c.4429G>T (p.Glu1477Ter)	FBN1	E1477*	not provided	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000429983	15	48762861	15	48470664	429983	422031	rs869025407	NC_000015.10:48470663:C:A
NM_000138.4(FBN1):c.7037dup (p.Asn2346fs)	FBN1		not provided	Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	VCV000429895	15	48719930 - 48719931	15	48427733 - 48427734	429895	422021	rs1131691656	NC_000015.10:48427733:TTTT:TTTTT
NM_000138.4(FBN1):c.3713-2A>T	FBN1		not provided	Pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	VCV000429807	15	48776142	15	48483945	429807	422036	rs1131691604	NC_000015.10:48483944:T:A
NM_000138.4(FBN1):c.3757C>T (p.Gln1253Ter)	FBN1	Q1253*	not provided	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000429308	15	48776096	15	48483899	429308	422035	rs1131691311	NC_000015.10:48483898:G:A
NM_000138.4(FBN1):c.3258del (p.Cys1086fs)	FBN1	C1086fs	not provided	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000426761	15	48780389	15	48488192	426761	415430	rs1085307786	NC_000015.10:48488191:A:
NM_000138.4(FBN1):c.466_469del (p.Asn156fs)	FBN1	N156fs	not provided	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000426193	15	48888549 - 48888552	15	48596352 - 48596355	426193	415437	rs1085307490	NC_000015.10:48596351:CATT:
NM_000138.4(FBN1):c.2050_2054dup (p.Ala686fs)	FBN1		not provided	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000423245	15	48796042 - 48796043	15	48503845 - 48503846	423245	409290	rs1555399762	NC_000015.10:48503845:CAACA:CAACACAACA
NM_000138.4(FBN1):c.6872-2A>G	FBN1		not provided	Pathogenic(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	VCV000419834	15	48720670	15	48428473	419834	409259	rs1064794139	NC_000015.10:48428472:T:C
NM_000138.4(FBN1):c.2179T>C (p.Cys727Arg)	FBN1	C727R	not provided	Pathogenic(Last reviewed: Aug 5, 2015)	criteria provided, single submitter	VCV000419660	15	48789577	15	48497380	419660	409289	rs1064794025	NC_000015.10:48497379:A:G
NM_000138.4(FBN1):c.6005del (p.Pro2002fs)	FBN1	P2002fs	not provided	Pathogenic(Last reviewed: Sep 5, 2015)	criteria provided, single submitter	VCV000419612	15	48736770	15	48444573	419612	409266	rs1064793989	NC_000015.10:48444572:GG:G
NM_000138.4(FBN1):c.2712del (p.Gly905fs)	FBN1	G905fs	not provided	Pathogenic(Last reviewed: Jul 23, 2015)	criteria provided, single submitter	VCV000419548	15	48786417	15	48494220	419548	409284	rs1064793946	NC_000015.10:48494219:TTT:TT
NM_000138.4(FBN1):c.2294-1G>T	FBN1		not provided	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000419500	15	48788423	15	48496226	419500	409286	rs1064793914	NC_000015.10:48496225:C:A
NM_000138.4(FBN1):c.2902_2920del (p.Thr968fs)	FBN1	T968fs	not provided	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000419285	15	48782210 - 48782228	15	48490013 - 48490031	419285	409283	rs1064793770	NC_000015.10:48490012:GGCCAGCAATAGGCAGGGTG:G
NM_000138.4(FBN1):c.1361_1371del (p.Gln454fs)	FBN1	Q454fs	not provided	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	VCV000419210	15	48807681 - 48807691	15	48515484 - 48515494	419210	409295	rs1064793723	NC_000015.10:48515483:GCGGACCAACTG:G
NM_000138.4(FBN1):c.5789-8_5793del	FBN1		not provided	Pathogenic(Last reviewed: May 22, 2015)	criteria provided, single submitter	VCV000419100	15	48737697 - 48737709	15	48445500 - 48445512	419100	409267	rs1064793643	NC_000015.10:48445499:AACATCTGCAGAAAA:AA
NM_000138.4(FBN1):c.5735del (p.Phe1912fs)	FBN1	F1912fs	not provided	Pathogenic(Last reviewed: May 15, 2015)	criteria provided, single submitter	VCV000419086	15	48738956	15	48446759	419086	409268	rs1064793633	NC_000015.10:48446758:AA:A
NM_000138.4(FBN1):c.3265del (p.Thr1089fs)	FBN1	T1089fs	not provided	Pathogenic(Last reviewed: May 1, 2015)	criteria provided, single submitter	VCV000418900	15	48780382	15	48488185	418900	409281	rs1064793510	NC_000015.10:48488184:T:
NM_000138.4(FBN1):c.8256del (p.Ala2754fs)	FBN1	A2754fs	not provided	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	VCV000418893	15	48703547	15	48411350	418893	409255	rs1064793503	NC_000015.10:48411349:A:
NM_000138.4(FBN1):c.5219_5224+1dup	FBN1		not provided	Pathogenic(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	VCV000418868	15	48755277 - 48755278	15	48463080 - 48463081	418868	409271	rs1555396754	NC_000015.10:48463080:CCTGTAC:CCTGTACCCTGTAC
NM_000138.4(FBN1):c.4222dup (p.Cys1408fs)	FBN1		not provided	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000418767	15	48764861 - 48764862	15	48472664 - 48472665	418767	409275	rs1555397562	NC_000015.10:48472664:A:AA
NM_000138.4(FBN1):c.2003_2007dup (p.Cys670fs)	FBN1		not provided	Pathogenic(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	VCV000418751	15	48796089 - 48796090	15	48503892 - 48503893	418751	409291	rs1555399769	NC_000015.10:48503892:CTGGCCT:CTGGCCTGGCCT
NM_000138.4(FBN1):c.5686del (p.Glu1896fs)	FBN1	E1896fs	not provided	Pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	VCV000418697	15	48739005	15	48446808	418697	409269	rs1064793374	NC_000015.10:48446807:C:
NM_000138.4(FBN1):c.2810G>A (p.Cys937Tyr)	FBN1	C937Y	not provided	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000389041	15	48784702	15	48492505	389041	374193	rs113602180	NC_000015.10:48492504:C:T
NM_000138.4(FBN1):c.7465T>C (p.Cys2489Arg)	FBN1	C2489R	not provided	Pathogenic(Last reviewed: May 18, 2015)	criteria provided, single submitter	VCV000379778	15	48714254	15	48422057	379778	374156	rs1057520728	NC_000015.10:48422056:A:G
NM_000138.4(FBN1):c.6379+2T>C	FBN1		not provided	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000379519	15	48729517	15	48437320	379519	373484	rs113453570	NC_000015.10:48437319:A:G
NM_000138.4(FBN1):c.5595C>A (p.Cys1865Ter)	FBN1	C1865*	not provided	Pathogenic(Last reviewed: Apr 27, 2015)	criteria provided, single submitter	VCV000379460	15	48741041	15	48448844	379460	374557	rs1057520601	NC_000015.10:48448843:G:T
NM_000138.4(FBN1):c.6800A>T (p.Asn2267Ile)	FBN1	N2267I	Myopia (disease)|Dilatation of the ascending aorta|Pes planus|Mitral valve prolapse|Dolichocephaly|Scoliosis|High palate	Pathogenic(Last reviewed: Mar 24, 2016)	no assertion criteria provided	VCV000373981	15	48722939	15	48430742	373981	360974	rs1057518812	NC_000015.10:48430741:T:A
NM_000138.4(FBN1):c.2254del (p.Ser752fs)	FBN1	S752fs	not provided	Pathogenic(Last reviewed: Nov 29, 2016)	criteria provided, single submitter	VCV000373697	15	48789502	15	48497305	373697	360084	rs1057518554	NC_000015.10:48497304:AA:A
NM_000138.4(FBN1):c.4759del (p.Ile1587fs)	FBN1	I1587fs	not provided	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000373067	15	48758044	15	48465847	373067	360076	rs1057518188	NC_000015.10:48465846:TTTT:TTT
NM_000138.4(FBN1):c.6682dup (p.Tyr2228fs)	FBN1		not provided	Pathogenic(Last reviewed: Sep 7, 2016)	criteria provided, single submitter	VCV000290735	15	48725119 - 48725120	15	48432922 - 48432923	290735	274972	rs886044547	NC_000015.10:48432922:A:AA
NM_000138.4(FBN1):c.2598_2601dup (p.Gly868fs)	FBN1		not provided	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000280865	15	48787395 - 48787396	15	48495198 - 48495199	280865	264729	rs1555399159	NC_000015.10:48495198:ATTGAT:ATTGATTGAT
NM_000138.4(FBN1):c.6625G>T (p.Glu2209Ter)	FBN1	E2209*	not provided	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000280702	15	48725177	15	48432980	280702	264721	rs886041859	NC_000015.10:48432979:C:A
NM_000138.4(FBN1):c.1179_1180dup (p.Val394fs)	FBN1		not provided	Pathogenic(Last reviewed: Sep 9, 2016)	criteria provided, single submitter	VCV000280570	15	48808526 - 48808527	15	48516329 - 48516330	280570	264869	rs886041751	NC_000015.10:48516329:CC:CCCC
NM_000138.4(FBN1):c.2T>G (p.Met1Arg)	FBN1	M1R	not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000280307	15	48936965	15	48644768	280307	264741	rs886041536	NC_000015.10:48644767:A:C
NM_000138.4(FBN1):c.5917+1G>A	FBN1		not provided	Pathogenic(Last reviewed: Jan 25, 2016)	criteria provided, single submitter	VCV000280287	15	48737572	15	48445375	280287	264850	rs363808	NC_000015.10:48445374:C:T
NM_000138.4(FBN1):c.539-1G>T	FBN1		not provided	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000280279	15	48830006	15	48537809	280279	264871	rs794728161	NC_000015.10:48537808:C:A
NM_000138.4(FBN1):c.6380-2A>C	FBN1		not provided	Pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	VCV000280242	15	48729276	15	48437079	280242	264840	rs886041482	NC_000015.10:48437078:T:G
NM_000138.4(FBN1):c.6186T>G (p.Tyr2062Ter)	FBN1	Y2062*	not provided	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000280057	15	48730092	15	48437895	280057	264842	rs764144407	NC_000015.10:48437894:A:C
NM_000138.4(FBN1):c.3238del (p.Leu1080fs)	FBN1	L1080fs	not provided	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000265445	15	48780409	15	48488212	265445	260072	rs886039549	NC_000015.10:48488211:GG:G
NM_000138.4(FBN1):c.3834T>G (p.Cys1278Trp)	FBN1	C1278W	not provided	Pathogenic(Last reviewed: Aug 5, 2016)	criteria provided, single submitter	VCV000265347	15	48776019	15	48483822	265347	260071	rs886039492	NC_000015.10:48483821:A:C
NM_000138.4(FBN1):c.2094del (p.Cys699fs)	FBN1	C699fs	not provided	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000265141	15	48796003	15	48503806	265141	260074	rs886039360	NC_000015.10:48503805:C:
NM_000138.4(FBN1):c.3669T>A (p.Cys1223Ter)	FBN1	C1223*	Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 25, 2015)	criteria provided, single submitter	VCV000264578	15	48777614	15	48485417	264578	258881	rs886039196	NC_000015.10:48485416:A:T
NM_000138.4(FBN1):c.5536del (p.Gln1846fs)	FBN1	Q1846fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000264473	15	48744768	15	48452571	264473	258861	rs886039167	NC_000015.10:48452570:G:
NM_000138.4(FBN1):c.6611G>A (p.Cys2204Tyr)	FBN1	C2204Y	Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	VCV000264438	15	48726796	15	48434599	264438	258840	rs886039158	NC_000015.10:48434598:C:T
NM_000138.4(FBN1):c.2906del (p.Leu969fs)	FBN1	L969fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Sep 25, 2015)	criteria provided, single submitter	VCV000264427	15	48782224	15	48490027	264427	258893	rs886039154	NC_000015.10:48490026:A:
NM_000138.4(FBN1):c.3159C>A (p.Cys1053Ter)	FBN1	C1053*	Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	VCV000264131	15	48780614	15	48488417	264131	258892	rs886039054	NC_000015.10:48488416:G:T
NM_000138.4(FBN1):c.841_842insT (p.Glu281fs)	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	VCV000264076	15	48826297 - 48826298	15	48534100 - 48534101	264076	258918	rs886039034	NC_000015.10:48534100::A
NM_000138.4(FBN1):c.4956del (p.Cys1652fs)	FBN1	C1652fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	VCV000263927	15	48756205	15	48464008	263927	258864	rs886038979	NC_000015.10:48464007:A:
NM_000138.4(FBN1):c.7792C>T (p.Gln2598Ter)	FBN1	Q2598*	Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	VCV000263920	15	48712911	15	48420714	263920	258822	rs886038975	NC_000015.10:48420713:G:A
NM_000138.4(FBN1):c.2127_2130delACTCins11 (p.?)	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 6, 2015)	criteria provided, single submitter	VCV000263918	15	48791219 - 48791222	15	48499022 - 48499025	263918	258908		
NM_000138.4(FBN1):c.1191dup (p.Arg398fs)	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Feb 16, 2015)	criteria provided, single submitter	VCV000263912	15	48808515 - 48808516	15	48516318 - 48516319	263912	258916	rs886038972	NC_000015.10:48516318:CCC:CCCC
NM_000138.4(FBN1):c.4135_4141del (p.Asp1379fs)	FBN1	D1379fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	VCV000263907	15	48766521 - 48766527	15	48474324 - 48474330	263907	258872	rs886038970	NC_000015.10:48474323:TGCAGTCTGCA:TGCA
NM_000138.4(FBN1):c.1807C>T (p.Gln603Ter)	FBN1	Q603*	Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	VCV000263880	15	48800809	15	48508612	263880	258920	rs886038963	NC_000015.10:48508611:G:A
NM_000138.4(FBN1):c.6492T>A (p.Cys2164Ter)	FBN1	C2164*	Cardiovascular phenotype	Pathogenic(Last reviewed: Sep 29, 2014)	criteria provided, single submitter	VCV000263864	15	48729162	15	48436965	263864	258850	rs886038957	NC_000015.10:48436964:A:T
NM_000138.4(FBN1):c.3209-1G>C	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Sep 22, 2014)	criteria provided, single submitter	VCV000263860	15	48780439	15	48488242	263860	258884	rs886038956	NC_000015.10:48488241:C:G
NM_000138.4(FBN1):c.7092_7093del (p.Cys2364fs)	FBN1	C2364fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Sep 22, 2014)	criteria provided, single submitter	VCV000263859	15	48719875 - 48719876	15	48427678 - 48427679	263859	258832	rs886038955	NC_000015.10:48427677:AG:
NM_000138.4(FBN1):c.2524A>T (p.Lys842Ter)	FBN1	K842*	Cardiovascular phenotype	Pathogenic(Last reviewed: May 2, 2014)	criteria provided, single submitter	VCV000263834	15	48787681	15	48495484	263834	258900	rs886038941	NC_000015.10:48495483:T:A
NM_000138.4(FBN1):c.5825G>C (p.Cys1942Ser)	FBN1	C1942S	Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000263804	15	48737665	15	48445468	263804	258853	rs794728241	NC_000015.10:48445467:C:G
NM_000138.4(FBN1):c.1211dup (p.Pro405fs)	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: May 2, 2013)	criteria provided, single submitter	VCV000263585	15	48808495 - 48808496	15	48516298 - 48516299	263585	258913	rs112289537	NC_000015.10:48516298:GGGGG:GGGGGG
NM_000138.4(FBN1):c.4412_4415del (p.Glu1471fs)	FBN1	E1471fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000263556	15	48762875 - 48762878	15	48470678 - 48470681	263556	258866	rs886038846	NC_000015.10:48470677:CACTCAC:CAC
NM_000138.4(FBN1):c.5067_5073delTATGAGA	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000263488	15	48755430 - 48755436	15	48463233 - 48463239	263488	258863	rs886038823	NC_000015.10:48463232:TCTCATATCT:TCT
NM_000138.4(FBN1):c.2725del (p.Glu909fs)	FBN1	E909fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 5, 2012)	criteria provided, single submitter	VCV000263434	15	48786404	15	48494207	263434	258897	rs886038804	NC_000015.10:48494206:C:
NM_000138.4(FBN1):c.5789-2A>G	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Sep 7, 2012)	criteria provided, single submitter	VCV000263403	15	48737703	15	48445506	263403	258858	rs886038790	NC_000015.10:48445505:T:C
NM_000138.4(FBN1):c.2227del (p.Arg743fs)	FBN1	R743fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 5, 2015)	criteria provided, single submitter	VCV000263335	15	48789529	15	48497332	263335	258903	rs886038769	NC_000015.10:48497331:G:
NM_000138.4(FBN1):c.526C>T (p.Gln176Ter)	FBN1	Q176*	Cardiovascular phenotype	Pathogenic(Last reviewed: Feb 1, 2013)	criteria provided, single submitter	VCV000263325	15	48888492	15	48596295	263325	258921	rs886038766	NC_000015.10:48596294:G:A
NM_000138.4(FBN1):c.8064del (p.Gly2689fs)	FBN1	G2689fs	not provided	Pathogenic(Last reviewed: Oct 23, 2014)	criteria provided, single submitter	VCV000200207	15	48704928	15	48412731	200207	197584	rs794728344	NC_000015.10:48412730:A:
NM_000138.4(FBN1):c.3773del (p.Pro1258fs)	FBN1	P1258fs	not provided	Pathogenic(Last reviewed: Sep 23, 2014)	criteria provided, single submitter	VCV000200206	15	48776080	15	48483883	200206	197720	rs794728343	NC_000015.10:48483882:GGG:GG
NM_000138.4(FBN1):c.1297_1300dup (p.Tyr434Ter)	FBN1		not provided	Pathogenic(Last reviewed: Oct 6, 2014)	criteria provided, single submitter	VCV000200204	15	48808406 - 48808407	15	48516209 - 48516210	200204	197801	rs794728341	NC_000015.10:48516209:ATTC:ATTCATTC
NM_000138.4(FBN1):c.225del (p.Gly76fs)	FBN1	G76fs	not provided	Pathogenic(Last reviewed: Mar 7, 2014)	criteria provided, single submitter	VCV000200176	15	48905229	15	48613032	200176	197825	rs794728324	NC_000015.10:48613031:A:
NM_000138.4(FBN1):c.8544del (p.Lys2848fs)	FBN1	K2848fs	not provided	Pathogenic(Last reviewed: Dec 7, 2012)	criteria provided, single submitter	VCV000200175	15	48703259	15	48411062	200175	197572	rs794728323	NC_000015.10:48411061:TTT:TT
NM_000138.4(FBN1):c.7599del (p.Leu2534fs)	FBN1	L2534fs	not provided	Pathogenic(Last reviewed: Aug 18, 2014)	criteria provided, single submitter	VCV000200172	15	48713855	15	48421658	200172	197599	rs794728320	NC_000015.10:48421657:A:
NM_000138.4(FBN1):c.6722_6725dup (p.Arg2243fs)	FBN1		not provided	Pathogenic(Last reviewed: Mar 2, 2014)	criteria provided, single submitter	VCV000200170	15	48725076 - 48725077	15	48432879 - 48432880	200170	197629	rs794728318	NC_000015.10:48432879:CGGTC:CGGTCGGTC
NM_000138.4(FBN1):c.6406_6407dup (p.Cys2137fs)	FBN1		not provided	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000200169	15	48729246 - 48729247	15	48437049 - 48437050	200169	197648	rs794728317	NC_000015.10:48437049:ACA:ACACA
NM_000138.4(FBN1):c.6129del (p.Ser2045fs)	FBN1	S2045fs	not provided	Pathogenic(Last reviewed: May 9, 2014)	criteria provided, single submitter	VCV000200166	15	48733952	15	48441755	200166	197659	rs794728314	NC_000015.10:48441754:CCC:CC
NM_000138.4(FBN1):c.5957dup (p.Gly1987fs)	FBN1		not provided	Pathogenic(Last reviewed: Jun 9, 2014)	criteria provided, single submitter	VCV000200165	15	48736817 - 48736818	15	48444620 - 48444621	200165	197663	rs794728313	NC_000015.10:48444620:GG:GGG
NM_000138.4(FBN1):c.5893del (p.Ala1965fs)	FBN1	A1965fs	not provided	Pathogenic(Last reviewed: Jun 27, 2014)	criteria provided, single submitter	VCV000200164	15	48737597	15	48445400	200164	197666	rs794728312	NC_000015.10:48445399:CC:C
NM_000138.4(FBN1):c.5817del (p.Asn1940fs)	FBN1	N1940fs	not provided	Pathogenic(Last reviewed: Jul 31, 2014)	criteria provided, single submitter	VCV000200163	15	48737673	15	48445476	200163	197668	rs794728311	NC_000015.10:48445475:CCC:CC
NM_000138.4(FBN1):c.4429dup (p.Glu1477fs)	FBN1		not provided	Pathogenic(Last reviewed: Feb 16, 2014)	criteria provided, single submitter	VCV000200162	15	48762860 - 48762861	15	48470663 - 48470664	200162	197699	rs794728310	NC_000015.10:48470663:C:CC
NM_000138.4(FBN1):c.4425del (p.Tyr1476fs)	FBN1	Y1476fs	not provided	Pathogenic(Last reviewed: Mar 14, 2013)	criteria provided, single submitter	VCV000200161	15	48762865	15	48470668	200161	197700	rs794728309	NC_000015.10:48470667:G:
NM_000138.4(FBN1):c.2712_2716del (p.Lys904fs)	FBN1	K904fs	not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000200156	15	48786413 - 48786417	15	48494216 - 48494220	200156	197751	rs794728304	NC_000015.10:48494215:TTCCTTT:TT
NM_000138.4(FBN1):c.2701del (p.Ser901fs)	FBN1	S901fs	not provided	Pathogenic(Last reviewed: Jun 19, 2013)	criteria provided, single submitter	VCV000200155	15	48786428	15	48494231	200155	197752	rs794728303	NC_000015.10:48494230:A:
NM_000138.4(FBN1):c.2601dup (p.Gly868fs)	FBN1		not provided	Pathogenic(Last reviewed: Aug 6, 2014)	criteria provided, single submitter	VCV000200154	15	48787395 - 48787396	15	48495198 - 48495199	200154	197758	rs794728302	NC_000015.10:48495198:A:AA
NM_000138.4(FBN1):c.2569_2570del (p.Val857fs)	FBN1	V857fs	not provided	Pathogenic(Last reviewed: Nov 27, 2012)	criteria provided, single submitter	VCV000200153	15	48787427 - 48787428	15	48495230 - 48495231	200153	197761	rs794728301	NC_000015.10:48495229:ACA:A
NM_000138.4(FBN1):c.2262_2263del (p.Tyr754_Glu755delinsTer)	FBN1		not provided	Pathogenic(Last reviewed: Jun 2, 2013)	criteria provided, single submitter	VCV000200152	15	48789493 - 48789494	15	48497296 - 48497297	200152	197768	rs794728300	NC_000015.10:48497295:CA:
NM_000138.4(FBN1):c.2180dup (p.Cys727fs)	FBN1		not provided	Pathogenic(Last reviewed: Aug 5, 2013)	criteria provided, single submitter	VCV000200151	15	48789575 - 48789576	15	48497378 - 48497379	200151	197772	rs794728299	NC_000015.10:48497378:C:CC
NM_000138.4(FBN1):c.1679dup (p.Phe561fs)	FBN1		not provided	Pathogenic(Last reviewed: Feb 18, 2013)	criteria provided, single submitter	VCV000200149	15	48802275 - 48802276	15	48510078 - 48510079	200149	197790	rs794728297	NC_000015.10:48510078:CCC:CCCC
NM_000138.4(FBN1):c.1624_1634del (p.Asn542fs)	FBN1	N542fs	not provided	Pathogenic(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	VCV000200148	15	48802321 - 48802331	15	48510124 - 48510134	200148	197792	rs794728296	NC_000015.10:48510123:CGTCCATTATT:
NM_000138.4(FBN1):c.212G>C (p.Trp71Ser)	FBN1	W71S	not provided	Pathogenic(Last reviewed: May 3, 2014)	criteria provided, single submitter	VCV000200139	15	48905242	15	48613045	200139	197826	rs794728289	NC_000015.10:48613044:C:G
NM_000138.4(FBN1):c.8010C>G (p.Tyr2670Ter)	FBN1	Y2670*	not provided	Pathogenic(Last reviewed: Dec 27, 2013)	criteria provided, single submitter	VCV000200126	15	48707774	15	48415577	200126	197586	rs794728282	NC_000015.10:48415576:G:C
NM_000138.4(FBN1):c.7775G>A (p.Cys2592Tyr)	FBN1	C2592Y	not provided	Pathogenic(Last reviewed: Jan 15, 2013)	criteria provided, single submitter	VCV000200120	15	48712928	15	48420731	200120	197595	rs112118237	NC_000015.10:48420730:C:T
NM_000138.4(FBN1):c.7267G>T (p.Gly2423Ter)	FBN1	G2423*	not provided	Pathogenic(Last reviewed: Oct 17, 2013)	criteria provided, single submitter	VCV000200111	15	48717999	15	48425802	200111	197607	rs794728271	NC_000015.10:48425801:C:A
NM_000138.4(FBN1):c.6871G>A (p.Asp2291Asn)	FBN1	D2291N	not provided	Pathogenic(Last reviewed: Feb 18, 2015)	criteria provided, single submitter	VCV000200094	15	48722868	15	48430671	200094	197627	rs794728257	NC_000015.10:48430670:C:T
NM_000138.4(FBN1):c.6752G>A (p.Cys2251Tyr)	FBN1	C2251Y	not provided	Pathogenic(Last reviewed: Aug 13, 2014)	criteria provided, single submitter	VCV000200093	15	48722987	15	48430790	200093	197628	rs794728256	NC_000015.10:48430789:C:T
NM_000138.4(FBN1):c.6453C>G (p.Cys2151Trp)	FBN1	C2151W	not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000200086	15	48729201	15	48437004	200086	197642	rs794728251	NC_000015.10:48437003:G:C
NM_000138.4(FBN1):c.6274T>C (p.Trp2092Arg)	FBN1	W2092R	not provided	Pathogenic(Last reviewed: May 3, 2014)	criteria provided, single submitter	VCV000200079	15	48730004	15	48437807	200079	197652	rs794728246	NC_000015.10:48437806:A:G
NM_000138.4(FBN1):c.6251G>T (p.Cys2084Phe)	FBN1	C2084F	not provided	Pathogenic(Last reviewed: Jun 13, 2013)	criteria provided, single submitter	VCV000200078	15	48730027	15	48437830	200078	197653	rs794728245	NC_000015.10:48437829:C:A
NM_000138.4(FBN1):c.6630T>A (p.Cys2210Ter)	FBN1	C2210*	not provided	Pathogenic(Last reviewed: Jul 31, 2014)	criteria provided, single submitter	VCV000200077	15	48725172	15	48432975	200077	197635	rs397515836	NC_000015.10:48432974:A:T
NM_000138.4(FBN1):c.6164-2A>T	FBN1		not provided	Pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, single submitter	VCV000200075	15	48730116	15	48437919	200075	197656	rs794728244	NC_000015.10:48437918:T:A
NM_000138.4(FBN1):c.5801G>A (p.Cys1934Tyr)	FBN1	C1934Y	not provided	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000200069	15	48737689	15	48445492	200069	197669	rs794728240	NC_000015.10:48445491:C:T
NM_000138.4(FBN1):c.5746T>C (p.Cys1916Arg)	FBN1	C1916R	not provided	Pathogenic(Last reviewed: Feb 9, 2014)	criteria provided, single submitter	VCV000200067	15	48738945	15	48446748	200067	197671	rs794728238	NC_000015.10:48446747:A:G
NM_000138.4(FBN1):c.5700T>A (p.Cys1900Ter)	FBN1	C1900*	not provided	Pathogenic(Last reviewed: May 14, 2014)	criteria provided, single submitter	VCV000200062	15	48738991	15	48446794	200062	197673	rs794728236	NC_000015.10:48446793:A:T
NM_000138.4(FBN1):c.5197T>G (p.Cys1733Gly)	FBN1	C1733G	not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000200061	15	48755306	15	48463109	200061	197679	rs794728235	NC_000015.10:48463108:A:C
NM_000138.4(FBN1):c.5021G>T (p.Cys1674Phe)	FBN1	C1674F	not provided	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	VCV000200058	15	48756140	15	48463943	200058	197682	rs794728233	NC_000015.10:48463942:C:A
NM_000138.4(FBN1):c.4062G>A (p.Trp1354Ter)	FBN1	W1354*	not provided	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000200033	15	48766750	15	48474553	200033	197712	rs794728215	NC_000015.10:48474552:C:T
NM_000138.4(FBN1):c.4050C>A (p.Cys1350Ter)	FBN1	C1350*	not provided	Pathogenic(Last reviewed: May 10, 2014)	criteria provided, single submitter	VCV000200032	15	48766762	15	48474565	200032	197713	rs201058219	NC_000015.10:48474564:G:T
NM_000138.4(FBN1):c.3964+1G>A	FBN1		not provided	Pathogenic(Last reviewed: Mar 30, 2014)	criteria provided, single submitter	VCV000200028	15	48773851	15	48481654	200028	197716	rs794728212	NC_000015.10:48481653:C:T
NM_000138.4(FBN1):c.3839-1G>T	FBN1		not provided	Pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, single submitter	VCV000200026	15	48773978	15	48481781	200026	197718	rs794728211	NC_000015.10:48481780:C:A
NM_000138.4(FBN1):c.3712+1G>A	FBN1		not provided	Pathogenic(Last reviewed: Aug 8, 2014)	criteria provided, single submitter	VCV000200023	15	48777570	15	48485373	200023	197722	rs794728209	NC_000015.10:48485372:C:T
NM_000138.4(FBN1):c.3513C>A (p.Cys1171Ter)	FBN1	C1171*	not provided	Pathogenic(Last reviewed: Oct 27, 2015)	criteria provided, single submitter	VCV000200019	15	48779348	15	48487151	200019	197728	rs775417975	NC_000015.10:48487150:G:T
NM_000138.4(FBN1):c.3173G>T (p.Gly1058Val)	FBN1	G1058V	not provided	Pathogenic(Last reviewed: Aug 18, 2014)	criteria provided, single submitter	VCV000200013	15	48780600	15	48488403	200013	197737	rs794728202	NC_000015.10:48488402:C:A
NM_000138.4(FBN1):c.2806C>T (p.Gln936Ter)	FBN1	Q936*	not provided	Pathogenic(Last reviewed: May 28, 2014)	criteria provided, single submitter	VCV000200003	15	48784706	15	48492509	200003	197747	rs794728197	NC_000015.10:48492508:G:A
NM_000138.4(FBN1):c.2671C>T (p.Gln891Ter)	FBN1	Q891*	not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000200002	15	48787326	15	48495129	200002	197754	rs794728196	NC_000015.10:48495128:G:A
NM_000138.4(FBN1):c.2201G>T (p.Cys734Phe)	FBN1	C734F	not provided	Pathogenic(Last reviewed: May 21, 2014)	criteria provided, single submitter	VCV000199992	15	48789555	15	48497358	199992	197770	rs794728187	NC_000015.10:48497357:C:A
NM_000138.4(FBN1):c.1890C>A (p.Asn630Lys)	FBN1	N630K	not provided	Pathogenic(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	VCV000199983	15	48797292	15	48505095	199983	197782	rs794728179	NC_000015.10:48505094:G:T
NM_000138.4(FBN1):c.1889A>T (p.Asn630Ile)	FBN1	N630I	not provided	Pathogenic(Last reviewed: Nov 2, 2012)	criteria provided, single submitter	VCV000199982	15	48797293	15	48505096	199982	197783	rs794728178	NC_000015.10:48505095:T:A
NM_000138.4(FBN1):c.2055C>A (p.Cys685Ter)	FBN1	C685*	not provided	Pathogenic(Last reviewed: Jun 27, 2014)	criteria provided, single submitter	VCV000199980	15	48796042	15	48503845	199980	197778	rs140603	NC_000015.10:48503844:G:T
NM_000138.4(FBN1):c.1817C>A (p.Ser606Ter)	FBN1	S606*	not provided	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000199979	15	48800799	15	48508602	199979	197785	rs794728176	NC_000015.10:48508601:G:T
NM_000138.4(FBN1):c.1664G>T (p.Cys555Phe)	FBN1	C555F	not provided	Pathogenic(Last reviewed: Feb 28, 2013)	criteria provided, single submitter	VCV000199974	15	48802291	15	48510094	199974	197791	rs794728172	NC_000015.10:48510093:C:A
NM_000138.4(FBN1):c.1583G>A (p.Cys528Tyr)	FBN1	C528Y	not provided	Pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	VCV000199972	15	48805751	15	48513554	199972	197794	rs794728170	NC_000015.10:48513553:C:T
NM_000138.4(FBN1):c.1468+2T>C	FBN1		not provided	Pathogenic(Last reviewed: Apr 4, 2013)	criteria provided, single submitter	VCV000199969	15	48807582	15	48515385	199969	197797	rs794728167	NC_000015.10:48515384:A:G
NM_000138.4(FBN1):c.1421G>A (p.Cys474Tyr)	FBN1	C474Y	not provided	Pathogenic(Last reviewed: Feb 9, 2014)	criteria provided, single submitter	VCV000199967	15	48807631	15	48515434	199967	197800	rs794728166	NC_000015.10:48515433:C:T
NM_000138.4(FBN1):c.1148-2A>C	FBN1		not provided	Pathogenic(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	VCV000199965	15	48808561	15	48516364	199965	197805	rs397515756	NC_000015.10:48516363:T:G
NM_000138.4(FBN1):c.539-1G>A	FBN1		not provided	Pathogenic(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	VCV000199955	15	48830006	15	48537809	199955	197818	rs794728161	NC_000015.10:48537808:C:T
NM_000138.5(FBN1):c.5666G>A (p.Cys1889Tyr)	FBN1	C1889Y	not provided	Pathogenic	criteria provided, single submitter	VCV000684790	15	48740970	15	48448773	684790	672441		NC_000015.10:48448772:C:T
NM_000138.4(FBN1):c.8405dup (p.Phe2803fs)	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	VCV000520233	15	48703397 - 48703398	15	48411200 - 48411201	520233	510526	rs1555393539	NC_000015.10:48411200:CC:CCC
NM_000138.4(FBN1):c.6410G>C (p.Cys2137Ser)	FBN1	C2137S	Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000519770	15	48729244	15	48437047	519770	510557	rs1555395206	NC_000015.10:48437046:C:G
NM_000138.4(FBN1):c.2168-2A>G	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	VCV000519725	15	48789590	15	48497393	519725	510621	rs1555399388	NC_000015.10:48497392:T:C
NM_000138.4(FBN1):c.6641_6645CTCTG[1] (p.Leu2216fs)	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	VCV000519694	15	48725152 - 48725156	15	48432955 - 48432959	519694	510552	rs1555394927	NC_000015.10:48432954:CAGAGCAGAG:CAGAG
NM_000138.4(FBN1):c.4337-1G>A	FBN1		Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, single submitter	VCV000495608	15	48762954	15	48470757	495608	487570	rs1555397424	NC_000015.10:48470756:C:T
NM_000138.4(FBN1):c.8516_8519AGAA[1] (p.Lys2840fs)	FBN1		not provided	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000445483	15	48703280 - 48703283	15	48411083 - 48411086	445483	438755	rs1555393513	NC_000015.10:48411082:TTCTTTCTTT:TTCTTT
NM_000138.4(FBN1):c.6037+1G>A	FBN1		not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000423795	15	48736737	15	48444540	423795	409265	rs1064796636	NC_000015.10:48444539:C:T
NM_000138.4(FBN1):c.3563C>A (p.Ser1188Ter)	FBN1	S1188*	not provided	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000377280	15	48779298	15	48487101	377280	364158	rs1057520181	NC_000015.10:48487100:G:T
NM_000138.4(FBN1):c.1786T>G (p.Cys596Gly)	FBN1	C596G	not provided	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000377096	15	48800830	15	48508633	377096	363974	rs1057520131	NC_000015.10:48508632:A:C
NM_000138.4(FBN1):c.1949_1950GT[4] (p.Cys652_Val653insTer)	FBN1		not provided	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280059	15	48797224 - 48797225	15	48505027 - 48505028	280059	264739	rs886041350	NC_000015.10:48505026:ACACACACAC:ACACACAC
NM_000138.4(FBN1):c.3082+1G>C	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000263975	15	48782047	15	48489850	263975	258889	rs886038996	NC_000015.10:48489849:C:G
NM_000138.4(FBN1):c.5720del (p.Asn1907fs)	FBN1	N1907fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 1, 2014)	criteria provided, single submitter	VCV000263866	15	48738971	15	48446774	263866	258854	rs886038959	NC_000015.10:48446773:TT:T
NM_000138.4(FBN1):c.7939C>T (p.Gln2647Ter)	FBN1	Q2647*	Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000263644	15	48707845	15	48415648	263644	258820	rs886038870	NC_000015.10:48415647:G:A
NM_000138.4(FBN1):c.2964_2971del (p.Trp988_Glu991delinsTer)	FBN1		not provided	Pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, single submitter	VCV000235697	15	48782159 - 48782166	15	48489962 - 48489969	235697	237377	rs878853095	NC_000015.10:48489961:CAGTACCCCAG:CAG
NM_000138.4(FBN1):c.8175_8182del (p.Arg2726fs)	FBN1	R2726fs	Marfan lipodystrophy syndrome	Pathogenic(Last reviewed: Feb 27, 2019)	no assertion criteria provided	VCV000225628	15	48704810 - 48704817	15	48412613 - 48412620	225628	227462	rs876657410	NC_000015.10:48412612:TGCCCCGTT:T
NM_000138.4(FBN1):c.5015G>A (p.Cys1672Tyr)	FBN1	C1672Y	not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000200187	15	48756146	15	48463949	200187	197683	rs140627	NC_000015.10:48463948:C:T
GRCh38/hg38 15q21.1(chr15:48436038-48501606)x3	FBN1		See cases	Pathogenic(Last reviewed: May 27, 2010)	no assertion criteria provided	VCV000144202	15	48728235 - 48793803	15	48436038 - 48501606	144202	153953		
NM_000138.4(FBN1):c.8156_8175del (p.Lys2719fs)	FBN1	K2719fs	Marfan lipodystrophy syndrome	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000040244	15	48704817 - 48704836	15	48412620 - 48412639	40244	48728	rs398122832	NC_000015.10:48412619:TTTGGGGTAGCCATTGATCTT:T
NM_000138.4(FBN1):c.8155_8156del (p.Lys2719fs)	FBN1	K2719fs	Marfan lipodystrophy syndrome	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000040243	15	48704836 - 48704837	15	48412639 - 48412640	40243	48727	rs398122831	NC_000015.10:48412638:TT:
NM_000138.4(FBN1):c.5202_5204dup (p.Gln1735dup)	FBN1		Acromicric dysplasia	Pathogenic(Last reviewed: Jan 4, 2018)	no assertion criteria provided	VCV000029702	15	48755298 - 48755299	15	48463101 - 48463102	29702	38657	rs587776863	NC_000015.10:48463101:TGTT:TGTTGTT
NM_000138.4(FBN1):c.5250T>G (p.Ser1750Arg)	FBN1	S1750R	Acromicric dysplasia	Pathogenic(Last reviewed: Jan 4, 2018)	no assertion criteria provided	VCV000029700	15	48752489	15	48460292	29700	38655	rs1131692052	NC_000015.10:48460291:A:C
NM_000138.4(FBN1):c.4729T>G (p.Cys1577Gly)	FBN1	C1577G	Stiff skin syndrome	Pathogenic(Last reviewed: Nov 12, 2001)	no assertion criteria provided	VCV000016472	15	48760153	15	48467956	16472	31511	rs267606801	NC_000015.10:48467955:A:C
NM_000138.4(FBN1):c.3257G>A (p.Cys1086Tyr)	FBN1	C1086Y	Marfan syndrome, neonatal	Pathogenic(Last reviewed: Apr 15, 2007)	no assertion criteria provided	VCV000016465	15	48780390	15	48488193	16465	31504	rs137854484	NC_000015.10:48488192:C:T
NM_000138.4(FBN1):c.3391A>T (p.Asn1131Tyr)	FBN1	N1131Y	Marfan syndrome, neonatal	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000016447	15	48779581	15	48487384	16447	31486	rs137854473	NC_000015.10:48487383:T:A
NM_000138.4(FBN1):c.3128A>G (p.Lys1043Arg)	FBN1	K1043R	Marfan syndrome, neonatal	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000016446	15	48780645	15	48488448	16446	31485	rs137854472	NC_000015.10:48488447:T:C
NM_000138.4(FBN1):c.3965-2A>T	FBN1		Marfan syndrome, neonatal	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000016441	15	48766849	15	48474652	16441	31480	rs387906547	NC_000015.10:48474651:T:A
NM_000138.4(FBN1):c.5243G>T (p.Cys1748Phe)	FBN1	C1748F	Geleophysic dysplasia 2	Pathogenic(Last reviewed: Oct 27, 2018)	no assertion criteria provided	VCV000590974	15	48752496	15	48460299	590974	581917	rs1566902569	NC_000015.10:48460298:C:A
NM_000138.4(FBN1):c.7330+1G>A	FBN1		Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000519742	15	48717935	15	48425738	519742	510545	rs1555394433	NC_000015.10:48425737:C:T
NM_000138.4(FBN1):c.650G>A (p.Trp217Ter)	FBN1	W217*	Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000519741	15	48829894	15	48537697	519741	510637	rs1555401686	NC_000015.10:48537696:C:T
NM_000138.4(FBN1):c.5874C>A (p.Cys1958Ter)	FBN1	C1958*	Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|not specified	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495630	15	48737616	15	48445419	495630	487832	rs1555395750	NC_000015.10:48445418:G:T
NM_000138.4(FBN1):c.840_843del (p.Asn280fs)	FBN1	N280fs	Tall stature|Inguinal hernia|Pectus excavatum|Myopia (disease)|Joint hypermobility	Pathogenic(Last reviewed: Feb 24, 2015)	criteria provided, single submitter	VCV000374115	15	48826296 - 48826299	15	48534099 - 48534102	374115	360978	rs1057518909	NC_000015.10:48534098:TTCATT:TT
NM_000138.4(FBN1):c.3G>T (p.Met1Ile)	FBN1	M1I	Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	VCV000264175	15	48936964	15	48644767	264175	258926	rs886039072	NC_000015.10:48644766:C:A
NM_000138.4(FBN1):c.4562del (p.Pro1521fs)	FBN1	P1521fs	Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000264077	15	48760629	15	48468432	264077	258876	rs886039035	NC_000015.10:48468431:GGG:GG
NM_000138.4(FBN1):c.7C>T (p.Arg3Ter)	FBN1	R3*	Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000263416	15	48936960	15	48644763	263416	258931	rs886038797	NC_000015.10:48644762:G:A
NM_000138.4(FBN1):c.8226+1G>T	FBN1		Marfan lipodystrophy syndrome	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000040245	15	48704765	15	48412568	40245	48729	rs398122833	NC_000015.10:48412567:C:A
NM_000138.4(FBN1):c.5087A>G (p.Tyr1696Cys)	FBN1	Y1696C	Geleophysic dysplasia 2	Pathogenic(Last reviewed: Jan 4, 2018)	no assertion criteria provided	VCV000029699	15	48755416	15	48463219	29699	38654	rs387906625	NC_000015.10:48463218:T:C
NM_000138.4(FBN1):c.4691G>C (p.Cys1564Ser)	FBN1	C1564S	Stiff skin syndrome	Pathogenic(Last reviewed: Nov 12, 2001)	no assertion criteria provided	VCV000016471	15	48760191	15	48467994	16471	31510	rs267606800	NC_000015.10:48467993:C:G
NM_000138.4(FBN1):c.4710G>C (p.Trp1570Cys)	FBN1	W1570C	Stiff skin syndrome	Pathogenic(Last reviewed: Nov 12, 2001)	no assertion criteria provided	VCV000016470	15	48760172	15	48467975	16470	31509	rs267606799	NC_000015.10:48467974:C:G
NM_000138.4(FBN1):c.4710G>T (p.Trp1570Cys)	FBN1	W1570C	Stiff skin syndrome	Pathogenic(Last reviewed: Nov 12, 2001)	no assertion criteria provided	VCV000016469	15	48760172	15	48467975	16469	31508	rs267606799	NC_000015.10:48467974:C:A
NM_000138.4(FBN1):c.5074_5097del (p.Arg1692_Tyr1699del)	FBN1		Weill-Marchesani syndrome 2	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000016459	15	48755406 - 48755429	15	48463209 - 48463232	16459	31498	rs1555396783	NC_000015.10:48463208:GTAGTTTCTGTAGCACAAACTTCT:
NM_000138.4(FBN1):c.2954G>A (p.Gly985Glu)	FBN1	G985E	Marfan syndrome, atypical	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000016453	15	48782176	15	48489979	16453	31492	rs137854477	NC_000015.10:48489978:C:T
NM_000138.4(FBN1):c.3220T>C (p.Cys1074Arg)	FBN1	C1074R	Marfan syndrome, neonatal	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000016438	15	48780427	15	48488230	16438	31477	rs137854465	NC_000015.10:48488229:A:G
NM_000138.4(FBN1):c.3410G>C (p.Arg1137Pro)	FBN1	R1137P	Marfan syndrome, severe classic	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000016421	15	48779562	15	48487365	16421	31460	rs137854456	NC_000015.10:48487364:C:G
NM_000138.4(FBN1):c.6827G>A (p.Cys2276Tyr)	FBN1	C2276Y	Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000632805	15	48722912	15	48430715	632805	621496	rs1566894262	NC_000015.10:48430714:C:T
NM_000138.4(FBN1):c.7956T>A (p.Cys2652Ter)	FBN1	C2652*	Thoracic aortic aneurysm and aortic dissection	Pathogenic	no assertion criteria provided	VCV000517125	15	48707828	15	48415631	517125	508716	rs1555393856	NC_000015.10:48415630:A:T
NM_000138.4(FBN1):c.2554_2555dup (p.Cys853fs)	FBN1		Thoracic aortic aneurysm and aortic dissection	Pathogenic	no assertion criteria provided	VCV000517123	15	48787441 - 48787442	15	48495244 - 48495245	517123	508722	rs1555399166	NC_000015.10:48495244:GTG:GTGTG
NM_000138.4(FBN1):c.2896G>T (p.Glu966Ter)	FBN1	E966*	Thoracic aortic aneurysm and aortic dissection	Pathogenic	no assertion criteria provided	VCV000517122	15	48782234	15	48490037	517122	508721	rs1555398830	NC_000015.10:48490036:C:A
NM_000138.4(FBN1):c.6402dup (p.Asp2135fs)	FBN1		Thoracic aortic aneurysm and aortic dissection	Pathogenic	no assertion criteria provided	VCV000517117	15	48729251 - 48729252	15	48437054 - 48437055	517117	508718	rs1555395209	NC_000015.10:48437054:GGG:GGGG
NM_000138.4(FBN1):c.5235_5236dup (p.Thr1746fs)	FBN1		Thoracic aortic aneurysm and aortic dissection	Pathogenic	no assertion criteria provided	VCV000517116	15	48752502 - 48752503	15	48460305 - 48460306	517116	508720	rs1555396638	NC_000015.10:48460305:TA:TATA
NM_000138.4(FBN1):c.6904T>A (p.Cys2302Ser)	FBN1	C2302S	Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000264235	15	48720636	15	48428439	264235	258839	rs886039092	NC_000015.10:48428438:A:T
NM_000138.4(FBN1):c.3424_3427dup (p.Gly1143fs)	FBN1		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	VCV000200158	15	48779544 - 48779545	15	48487347 - 48487348	200158	197732	rs794728306	NC_000015.10:48487347:CAGGC:CAGGCAGGC
NM_000138.4(FBN1):c.2786_2789dup (p.Arg930delinsSerTer)	FBN1		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 20, 2013)	criteria provided, single submitter	VCV000200157	15	48784722 - 48784723	15	48492525 - 48492526	200157	197748	rs794728305	NC_000015.10:48492525:CTAG:CTAGCTAG
NM_000138.5(FBN1):c.5134_5137dup (p.Asn1713fs)	FBN1		MASS syndrome	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000016434	15	48755365 - 48755366	15	48463168 - 48463169	16434	31473	rs1131692049	NC_000015.10:48463168:TGAAT:TGAATGAAT
NM_000138.4(FBN1):c.236dup (p.Cys80fs)	FBN1		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000628893	15	48905217 - 48905218	15	48613020 - 48613021	628893	618275	rs1566938153	NC_000015.10:48613020:T:TT
NM_000138.4(FBN1):c.5423-2A>G	FBN1		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000626595	15	48744883	15	48452686	626595	615225	rs1566900540	NC_000015.10:48452685:T:C
NM_000138.4(FBN1):c.7582T>C (p.Cys2528Arg)	FBN1	C2528R	Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000625127	15	48713872	15	48421675	625127	613464	rs1566891701	NC_000015.10:48421674:A:G
NM_000138.4(FBN1):c.5182G>A (p.Ala1728Thr)	FBN1	A1728T	Geleophysic dysplasia 2|Acromicric dysplasia	Pathogenic(Last reviewed: Jan 4, 2018)	no assertion criteria provided	VCV000029698	15	48755321	15	48463124	29698	38653	rs387906624	NC_000015.10:48463123:C:T
NM_000138.4(FBN1):c.5096A>G (p.Tyr1699Cys)	FBN1	Y1699C	Geleophysic dysplasia 2|Acromicric dysplasia	Pathogenic(Last reviewed: Jan 4, 2018)	no assertion criteria provided	VCV000029696	15	48755407	15	48463210	29696	38651	rs387906622	NC_000015.10:48463209:T:C
NM_000053.4(ATP7B):c.2804C>T (p.Thr935Met)	ATP7B	T935M, T824M, T851M, T857M	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188713	13	52523859	13	51949723	188713	186893	rs750019452	NC_000013.11:51949722:G:A
NM_000053.4(ATP7B):c.2827G>A (p.Gly943Ser)	ATP7B	G943S, G859S, G865S, G832S	Wilson disease	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003856	13	52523836	13	51949700	3856	18895	rs28942076	NC_000013.11:51949699:C:T
NM_000053.4(ATP7B):c.1708-1G>C	ATP7B		Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003850	13	52539170	13	51965034	3850	18889	rs137853280	NC_000013.11:51965033:C:G
NM_001005242.3(PKP2):c.1132C>T (p.Gln378Ter)	PKP2	Q378*	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000045010	12	33021899	12	32868965	45010	54177	rs397516986	NC_000012.12:32868964:G:A
NM_000138.4(FBN1):c.5099A>G (p.Tyr1700Cys)	FBN1	Y1700C	Acromicric dysplasia|not provided	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000029701	15	48755404	15	48463207	29701	38656	rs387906626	NC_000015.10:48463206:T:C
NM_000257.4(MYH7):c.2788G>A (p.Glu930Lys)	MYH7	E930K	Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042933	14	23893250	14	23424041	42933	52103	rs397516171	NC_000014.9:23424040:C:T
NM_000257.4(MYH7):c.5378T>C (p.Leu1793Pro)	MYH7	L1793P	Familial hypertrophic cardiomyopathy 1|Left ventricular noncompaction 5|Myosin storage myopathy|not provided	Pathogenic(Last reviewed: Mar 20, 2014)	criteria provided, single submitter	VCV000014123	14	23884385	14	23415176	14123	29162	rs121913654	NC_000014.9:23415175:A:G
NM_002834.5(PTPN11):c.854T>C (p.Phe285Ser)	PTPN11	F285S, F284S	Noonan syndrome 1|Early T cell progenitor acute lymphoblastic leukemia|Rasopathy|not provided|Noonan syndrome	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013335	12	112915455	12	112477651	13335	28374	rs121918463	NC_000012.12:112477650:T:C
NM_000138.4(FBN1):c.2723G>A (p.Cys908Tyr)	FBN1	C908Y	Cardiovascular phenotype|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519733	15	48786406	15	48494209	519733	510611	rs1057523406	NC_000015.10:48494208:C:T
NM_000138.4(FBN1):c.5183C>T (p.Ala1728Val)	FBN1	A1728V	Wide mouth|Wide nasal bridge|Short stature|Relative macrocephaly|Metaphyseal chondrodysplasia|Geleophysic dysplasia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000430150	15	48755320	15	48463123	430150	422029	rs1131691804	NC_000015.10:48463122:G:A
NM_013275.6(ANKRD11):c.3334dup (p.Ser1112fs)	ANKRD11		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000522161	16	89349615 - 89349616	16	89283207 - 89283208	522161	512242	rs1555528558	NC_000016.10:89283207:TTTT:TTTTT
NM_013275.6(ANKRD11):c.7303del (p.Ala2435fs)	ANKRD11	A2435fs	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000522113	16	89345647	16	89279239	522113	512236	rs1555524870	NC_000016.10:89279238:CCC:CC
NM_013275.6(ANKRD11):c.4114G>T (p.Glu1372Ter)	ANKRD11	E1372*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000522112	16	89348836	16	89282428	522112	512241	rs146474985	NC_000016.10:89282427:C:A
NM_013275.6(ANKRD11):c.7327C>T (p.Gln2443Ter)	ANKRD11	Q2443*	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000522007	16	89345623	16	89279215	522007	512235	rs1555524861	NC_000016.10:89279214:G:A
NM_013275.6(ANKRD11):c.2494del (p.Ser832fs)	ANKRD11	S832fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000521944	16	89350456	16	89284048	521944	512243	rs1555529052	NC_000016.10:89284047:T:
NM_013275.6(ANKRD11):c.5537del (p.Leu1846fs)	ANKRD11	L1846fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000521906	16	89347413	16	89281005	521906	512238	rs1555526796	NC_000016.10:89281004:AA:A
NM_013275.6(ANKRD11):c.2130G>A (p.Trp710Ter)	ANKRD11	W710*	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000521867	16	89350820	16	89284412	521867	512244	rs1555529297	NC_000016.10:89284411:C:T
NM_013275.6(ANKRD11):c.4902del (p.Leu1635fs)	ANKRD11	L1635fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000521846	16	89348048	16	89281640	521846	512239	rs1555527497	NC_000016.10:89281639:A:
NM_013275.6(ANKRD11):c.1381_1382del (p.Glu461fs)	ANKRD11	E461fs	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000521650	16	89351568 - 89351569	16	89285160 - 89285161	521650	512248	rs1555529734	NC_000016.10:89285159:TCT:T
NM_013275.6(ANKRD11):c.1389del (p.Gly464fs)	ANKRD11	G464fs	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000521317	16	89351561	16	89285153	521317	512247	rs1555529726	NC_000016.10:89285152:TTTT:TTT
NM_013275.6(ANKRD11):c.6792dup (p.Ala2265fs)	ANKRD11		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000521294	16	89346157 - 89346158	16	89279749 - 89279750	521294	512237	rs878855327	NC_000016.10:89279749:GGGGGGG:GGGGGGGG
NM_013275.6(ANKRD11):c.4140C>G (p.Tyr1380Ter)	ANKRD11	Y1380*	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000521022	16	89348810	16	89282402	521022	512240	rs1555528040	NC_000016.10:89282401:G:C
NM_013275.6(ANKRD11):c.1623_1630del (p.His542fs)	ANKRD11	H542fs	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 13, 2014)	criteria provided, single submitter	VCV000520579	16	89351320 - 89351327	16	89284912 - 89284919	520579	512245	rs1555529572	NC_000016.10:89284911:TGGTGTGCTGGT:TGGT
NM_001142279.2(RNASEH2B):c.529G>A (p.Ala177Thr)	RNASEH2B	A177T	Aicardi Goutieres syndrome|not provided|Aicardi Goutieres syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001262	13	51519581	13	50945445	1262	16301	rs75184679	NC_000013.11:50945444:G:A
NM_144997.7(FLCN):c.1285del (p.His429fs)	FLCN	H447fs, H429fs	Hereditary cancer-predisposing syndrome|not provided|Multiple fibrofolliculomas|not specified	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003364	17	17119709	17	17216395	3364	18403	rs80338682	NC_000017.11:17216394:GGGGGGGG:GGGGGGG
NM_000257.4(MYH7):c.2555T>C (p.Met852Thr)	MYH7	M852T	Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042916	14	23894102	14	23424893	42916	52086	rs397516157	NC_000014.9:23424892:A:G
NM_000257.4(MYH7):c.1594T>C (p.Ser532Pro)	MYH7	S532P	Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy|Dilated cardiomyopathy 1S	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014108	14	23897088	14	23427879	14108	29147	rs121913642	NC_000014.9:23427878:A:G
NM_000321.2(RB1):c.958C>T (p.Arg320Ter)	RB1	R320*	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000126824	13	48941648	13	48367512	126824	132334	rs121913300	NC_000013.11:48367511:C:T
NM_000321.2(RB1):c.763C>T (p.Arg255Ter)	RB1	R255*	Hereditary cancer-predisposing syndrome|Retinoblastoma|not provided	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000126820	13	48936995	13	48362859	126820	132330	rs587778842	NC_000013.11:48362858:C:T
NM_000053.4(ATP7B):c.2332C>G (p.Arg778Gly)	ATP7B	R778G, R694G, R667G	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156283	13	52532470	13	51958334	156283	166063	rs137853284	NC_000013.11:51958333:G:C
NM_000053.4(ATP7B):c.2755C>G (p.Arg919Gly)	ATP7B	R919G, R808G, R841G, R835G	Wilson disease	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003857	13	52523908	13	51949772	3857	18896	rs121907993	NC_000013.11:51949771:G:C
NM_000138.5(FBN1):c.1759T>C (p.Cys587Arg)	FBN1	C587R	Marfan syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803095	15	48800857	15	48508660	803095	791472		NC_000015.10:48508659:A:G
NM_000138.5(FBN1):c.2130dup (p.Cys711fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803094	15	48791218 - 48791219	15	48499021 - 48499022	803094	791471		NC_000015.10:48499021:G:GG
NM_000138.5(FBN1):c.3217G>T (p.Glu1073Ter)	FBN1	E1073*	Marfan syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803093	15	48780430	15	48488233	803093	791470		NC_000015.10:48488232:C:A
NM_000138.5(FBN1):c.3375dup (p.Gly1126fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803092	15	48779596 - 48779597	15	48487399 - 48487400	803092	791469		NC_000015.10:48487399:T:TT
NM_000138.5(FBN1):c.3545G>A (p.Cys1182Tyr)	FBN1	C1182Y	Marfan syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803091	15	48779316	15	48487119	803091	791468		NC_000015.10:48487118:C:T
NM_000138.5(FBN1):c.5125G>T (p.Glu1709Ter)	FBN1	E1709*	Marfan syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803085	15	48755378	15	48463181	803085	791462		NC_000015.10:48463180:C:A
NM_000138.5(FBN1):c.5244_5247dup (p.Ser1750fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803084	15	48752491 - 48752492	15	48460294 - 48460295	803084	791461		NC_000015.10:48460294:TCCA:TCCATCCA
NM_000138.5(FBN1):c.5675_5676del (p.Ile1892fs)	FBN1	I1892fs	Marfan syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803083	15	48739015 - 48739016	15	48446818 - 48446819	803083	791460		NC_000015.10:48446817:TAT:T
NM_000138.5(FBN1):c.6149del (p.Gly2050fs)	FBN1	G2050fs	Marfan syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803081	15	48733932	15	48441735	803081	791458		NC_000015.10:48441734:CC:C
NM_000138.5(FBN1):c.7820-1G>C	FBN1		Marfan syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803080	15	48707965	15	48415768	803080	791457		NC_000015.10:48415767:C:G
NM_000138.5(FBN1):c.6067del (p.Ile2023fs)	FBN1	I2023fs	Marfan syndrome	Pathogenic	no assertion criteria provided	VCV000800490	15	48734014	15	48441817	800490	789089		NC_000015.10:48441816:TTT:TT
NC_000015.10:g.48472568del	FBN1	D1440fs	Marfan syndrome	Pathogenic	no assertion criteria provided	VCV000691636	15	48764765	15	48472568	691636	679355		NC_000015.10:48472567:T:
NM_000138.4(FBN1):c.7570+5G>A	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	VCV000633778	15	48714144	15	48421947	633778	622211	rs1566891797	NC_000015.10:48421946:C:T
NM_000138.4(FBN1):c.7785del (p.Tyr2596fs)	FBN1	Y2596fs	Marfan syndrome	Pathogenic(Last reviewed: Aug 18, 2018)	no assertion criteria provided	VCV000617943	15	48712918	15	48420721	617943	609339	rs1566891406	NC_000015.10:48420720:G:
NM_000138.4(FBN1):c.1793G>C (p.Cys598Ser)	FBN1	C598S	Marfan syndrome	Pathogenic(Last reviewed: Jan 18, 2019)	no assertion criteria provided	VCV000617616	15	48800823	15	48508626	617616	609012	rs1555399955	NC_000015.10:48508625:C:G
NM_000138.4(FBN1):c.960C>A (p.Tyr320Ter)	FBN1	Y320*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549474	15	48818355	15	48526158	549474	539909	rs1555401004	NC_000015.10:48526157:G:T
NM_000138.4(FBN1):c.8536G>T (p.Glu2846Ter)	FBN1	E2846*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549468	15	48703267	15	48411070	549468	539479	rs1555393508	NC_000015.10:48411069:C:A
NM_000138.4(FBN1):c.7813dup (p.Cys2605fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549431	15	48712889 - 48712890	15	48420692 - 48420693	549431	539516	rs1555394138	NC_000015.10:48420692:A:AA
NM_000138.4(FBN1):c.7780del (p.Gln2594fs)	FBN1	Q2594fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549430	15	48712923	15	48420726	549430	539518	rs1555394146	NC_000015.10:48420725:GGGGG:GGGG
NM_000138.4(FBN1):c.7780C>T (p.Gln2594Ter)	FBN1	Q2594*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549429	15	48712923	15	48420726	549429	539517	rs1555394144	NC_000015.10:48420725:G:A
NM_000138.4(FBN1):c.772C>T (p.Gln258Ter)	FBN1	Q258*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549425	15	48826367	15	48534170	549425	539915	rs146348130	NC_000015.10:48534169:G:A
NM_000138.4(FBN1):c.7448G>C (p.Cys2483Ser)	FBN1	C2483S	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549411	15	48717571	15	48425374	549411	539534	rs1555394390	NC_000015.10:48425373:C:G
NM_000138.4(FBN1):c.7432G>T (p.Glu2478Ter)	FBN1	E2478*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549409	15	48717587	15	48425390	549409	539536	rs537570299	NC_000015.10:48425389:C:A
NM_000138.4(FBN1):c.7398C>A (p.Tyr2466Ter)	FBN1	Y2466*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549405	15	48717621	15	48425424	549405	539540	rs1555394402	NC_000015.10:48425423:G:T
NM_000138.4(FBN1):c.7323del (p.Cys2442fs)	FBN1	C2442fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549399	15	48717943	15	48425746	549399	539545	rs1555394436	NC_000015.10:48425745:GG:G
NM_000138.4(FBN1):c.7058del (p.Ser2353fs)	FBN1	S2353fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549387	15	48719910	15	48427713	549387	539557	rs1555394574	NC_000015.10:48427712:C:
NM_000138.4(FBN1):c.6886del (p.Gln2296fs)	FBN1	Q2296fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549375	15	48720654	15	48428457	549375	539569	rs1555394641	NC_000015.10:48428456:G:
NM_000138.4(FBN1):c.680_690del (p.Gln227fs)	FBN1	Q227fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549369	15	48829854 - 48829864	15	48537657 - 48537667	549369	539917	rs1555401671	NC_000015.10:48537656:GGGGTGAGGCTGGG:GGG
NM_000138.4(FBN1):c.6761del (p.Gly2254fs)	FBN1	G2254fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549364	15	48722978	15	48430781	549364	539579	rs1555394780	NC_000015.10:48430780:CCC:CC
NM_000138.4(FBN1):c.6693del (p.Lys2231fs)	FBN1	K2231fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549361	15	48725109	15	48432912	549361	539581	rs1555394901	NC_000015.10:48432911:TTT:TT
NM_000138.4(FBN1):c.6583G>T (p.Gly2195Ter)	FBN1	G2195*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549351	15	48726824	15	48434627	549351	539590	rs886038976	NC_000015.10:48434626:C:A
NM_000138.4(FBN1):c.6496+2T>G	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549347	15	48729156	15	48436959	549347	539594	rs1555395187	NC_000015.10:48436958:A:C
NM_000138.4(FBN1):c.6388G>T (p.Glu2130Ter)	FBN1	E2130*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549342	15	48729266	15	48437069	549342	539599	rs794728334	NC_000015.10:48437068:C:A
NM_000138.4(FBN1):c.6160C>T (p.Gln2054Ter)	FBN1	Q2054*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549331	15	48733921	15	48441724	549331	539608	rs1555395456	NC_000015.10:48441723:G:A
NM_000138.4(FBN1):c.6064G>T (p.Glu2022Ter)	FBN1	E2022*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549329	15	48734017	15	48441820	549329	539610	rs1555395482	NC_000015.10:48441819:C:A
NM_000138.4(FBN1):c.5961dup (p.Thr1988fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549321	15	48736813 - 48736814	15	48444616 - 48444617	549321	539618	rs1555395653	NC_000015.10:48444616:A:AA
NM_000138.4(FBN1):c.5898del (p.Asp1967fs)	FBN1	D1967fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549313	15	48737592	15	48445395	549313	539625	rs1555395747	NC_000015.10:48445394:T:
NM_000138.4(FBN1):c.5863del (p.Gln1955fs)	FBN1	Q1955fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549312	15	48737627	15	48445430	549312	539626	rs1555395753	NC_000015.10:48445429:GG:G
NM_000138.4(FBN1):c.5809G>T (p.Gly1937Ter)	FBN1	G1937*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549309	15	48737681	15	48445484	549309	539629	rs1555395766	NC_000015.10:48445483:C:A
NM_000138.4(FBN1):c.5699G>T (p.Cys1900Phe)	FBN1	C1900F	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549298	15	48738992	15	48446795	549298	539639	rs794728237	NC_000015.10:48446794:C:A
NM_000138.4(FBN1):c.5688_5689del (p.Asp1898fs)	FBN1	D1898fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549297	15	48739002 - 48739003	15	48446805 - 48446806	549297	539640	rs1555395843	NC_000015.10:48446804:TTT:T
NM_000138.4(FBN1):c.5684del (p.Cys1895fs)	FBN1	C1895fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549296	15	48739007	15	48446810	549296	539641	rs1555395846	NC_000015.10:48446809:C:
NM_000138.4(FBN1):c.5635_5636del (p.Gly1879fs)	FBN1	G1879fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549293	15	48741000 - 48741001	15	48448803 - 48448804	549293	539644	rs1555395978	NC_000015.10:48448802:CC:
NM_000138.4(FBN1):c.5612_5613del (p.Ser1871fs)	FBN1	S1871fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549292	15	48741023 - 48741024	15	48448826 - 48448827	549292	539645	rs1555395981	NC_000015.10:48448825:GC:
NM_000138.4(FBN1):c.5558G>C (p.Cys1853Ser)	FBN1	C1853S	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549290	15	48741078	15	48448881	549290	539647	rs1555395989	NC_000015.10:48448880:C:G
NM_000138.4(FBN1):c.5557T>A (p.Cys1853Ser)	FBN1	C1853S	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549289	15	48741079	15	48448882	549289	539648	rs1555395990	NC_000015.10:48448881:A:T
NM_000138.4(FBN1):c.5520del (p.Phe1841fs)	FBN1	F1841fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549285	15	48744784	15	48452587	549285	539651	rs1555396188	NC_000015.10:48452586:G:
NM_000138.4(FBN1):c.5493C>G (p.Tyr1831Ter)	FBN1	Y1831*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549280	15	48744811	15	48452614	549280	539656	rs1555396201	NC_000015.10:48452613:G:C
NM_000138.4(FBN1):c.5470_5483dup (p.Gly1829fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549279	15	48744820 - 48744821	15	48452623 - 48452624	549279	539657	rs1555396202	NC_000015.10:48452623:GCAGTGTTGATGCA:GCAGTGTTGATGCAGCAGTGTTGATGCA
NM_000138.4(FBN1):c.538+2T>C	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549276	15	48888478	15	48596281	549276	539925	rs1555404799	NC_000015.10:48596280:A:G
NM_000138.4(FBN1):c.5377T>A (p.Cys1793Ser)	FBN1	C1793S	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549275	15	48748879	15	48456682	549275	539660	rs1555396424	NC_000015.10:48456681:A:T
NM_000138.4(FBN1):c.5373T>G (p.Cys1791Trp)	FBN1	C1791W	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549274	15	48748883	15	48456686	549274	539661	rs1555396426	NC_000015.10:48456685:A:C
NM_000138.4(FBN1):c.5297-1G>A	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549269	15	48748960	15	48456763	549269	539664	rs1555396435	NC_000015.10:48456762:C:T
NM_000138.4(FBN1):c.5225_5249del	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549265	15	48752490 - 48752514	15	48460293 - 48460317	549265	539666	rs1555396635	NC_000015.10:48460292:CTTCCACAGAGTGTAGCAAACTCATCT:CT
NM_000138.4(FBN1):c.5208_5212TCCCA[1] (p.Ile1738fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549264	15	48755286 - 48755290	15	48463089 - 48463093	549264	539669	rs1555396757	NC_000015.10:48463088:TGGGATGGGA:TGGGA
NM_000138.4(FBN1):c.5015G>C (p.Cys1672Ser)	FBN1	C1672S	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549257	15	48756146	15	48463949	549257	539675	rs140627	NC_000015.10:48463948:C:G
NM_000138.4(FBN1):c.4972_4973TG[1] (p.Cys1658fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549256	15	48756186 - 48756187	15	48463989 - 48463990	549256	539676	rs1555396858	NC_000015.10:48463988:CACA:CA
NM_000138.4(FBN1):c.4926_4927del (p.Arg1644fs)	FBN1	R1644fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549255	15	48757780 - 48757781	15	48465583 - 48465584	549255	539677	rs1555396990	NC_000015.10:48465582:TAT:T
NM_000138.4(FBN1):c.4914C>A (p.Tyr1638Ter)	FBN1	Y1638*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549254	15	48757793	15	48465596	549254	539678	rs1555396991	NC_000015.10:48465595:G:T
NM_000138.4(FBN1):c.4770_4771del (p.Gly1591fs)	FBN1	G1591fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549247	15	48758032 - 48758033	15	48465835 - 48465836	549247	539682	rs1555397022	NC_000015.10:48465834:CA:
NM_000138.4(FBN1):c.4665_4668del (p.Gly1556fs)	FBN1	G1556fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549244	15	48760214 - 48760217	15	48468017 - 48468020	549244	539685	rs1555397160	NC_000015.10:48468016:ACCAAC:AC
NM_000138.4(FBN1):c.4582+2T>G	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549241	15	48760607	15	48468410	549241	539688	rs1555397193	NC_000015.10:48468409:A:C
NM_000138.4(FBN1):c.4501_4511del (p.Asn1501fs)	FBN1	N1501fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549238	15	48760680 - 48760690	15	48468483 - 48468493	549238	539691	rs1555397210	NC_000015.10:48468482:TTGACACAGTT:
NM_000138.4(FBN1):c.4490G>C (p.Cys1497Ser)	FBN1	C1497S	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549237	15	48760701	15	48468504	549237	539692	rs1555397212	NC_000015.10:48468503:C:G
NM_000138.4(FBN1):c.443del (p.Pro148fs)	FBN1	P148fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549230	15	48888575	15	48596378	549230	539929	rs1555404820	NC_000015.10:48596377:G:
NM_000138.4(FBN1):c.4349G>A (p.Cys1450Tyr)	FBN1	C1450Y	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549227	15	48762941	15	48470744	549227	539701	rs1555397419	NC_000015.10:48470743:C:T
NM_000138.4(FBN1):c.4287T>G (p.Cys1429Trp)	FBN1	C1429W	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549218	15	48764797	15	48472600	549218	539710	rs1555397543	NC_000015.10:48472599:A:C
NM_000138.4(FBN1):c.4285T>A (p.Cys1429Ser)	FBN1	C1429S	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549215	15	48764799	15	48472602	549215	539712	rs1555397546	NC_000015.10:48472601:A:T
NM_000138.4(FBN1):c.4099T>C (p.Cys1367Arg)	FBN1	C1367R	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549209	15	48766563	15	48474366	549209	539717	rs1555397670	NC_000015.10:48474365:A:G
NM_000138.4(FBN1):c.408C>A (p.Cys136Ter)	FBN1	C136*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549208	15	48892370	15	48600173	549208	539932	rs1555405039	NC_000015.10:48600172:G:T
NM_000138.4(FBN1):c.4049G>A (p.Cys1350Tyr)	FBN1	C1350Y	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549203	15	48766763	15	48474566	549203	539720	rs1555397718	NC_000015.10:48474565:C:T
NM_000138.4(FBN1):c.3849del (p.Glu1283fs)	FBN1	E1283fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549191	15	48773967	15	48481770	549191	539731	rs1555398174	NC_000015.10:48481769:C:
NM_000138.4(FBN1):c.3623del (p.Cys1208fs)	FBN1	C1208fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549177	15	48777660	15	48485463	549177	539744	rs1555398407	NC_000015.10:48485462:C:
NM_000138.4(FBN1):c.3589+1G>T	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549175	15	48779271	15	48487074	549175	539746	rs1555398501	NC_000015.10:48487073:C:A
NM_000138.4(FBN1):c.3559dup (p.His1187fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549174	15	48779301 - 48779302	15	48487104 - 48487105	549174	539747	rs1555398508	NC_000015.10:48487104:GG:GGG
NM_000138.4(FBN1):c.3539G>A (p.Cys1180Tyr)	FBN1	C1180Y	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549172	15	48779322	15	48487125	549172	539749	rs1555398513	NC_000015.10:48487124:C:T
NM_000138.4(FBN1):c.3388del (p.His1130fs)	FBN1	H1130fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549162	15	48779584	15	48487387	549162	539759	rs1555398572	NC_000015.10:48487386:GG:G
NM_000138.4(FBN1):c.3347_3348del (p.Glu1116fs)	FBN1	E1116fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549160	15	48779624 - 48779625	15	48487427 - 48487428	549160	539761	rs1555398580	NC_000015.10:48487426:CTC:C
NM_000138.4(FBN1):c.3303T>A (p.Tyr1101Ter)	FBN1	Y1101*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549155	15	48780344	15	48488147	549155	539766	rs1555398624	NC_000015.10:48488146:A:T
NM_000138.4(FBN1):c.3256T>C (p.Cys1086Arg)	FBN1	C1086R	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549147	15	48780391	15	48488194	549147	539773	rs1555398637	NC_000015.10:48488193:A:G
NM_000138.4(FBN1):c.3235_3239del (p.Asp1079fs)	FBN1	D1079fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549146	15	48780408 - 48780412	15	48488211 - 48488215	549146	539774	rs1555398642	NC_000015.10:48488210:AGGTCAGG:AGG
NM_000138.4(FBN1):c.3132C>A (p.Cys1044Ter)	FBN1	C1044*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549130	15	48780641	15	48488444	549130	539790	rs1555398677	NC_000015.10:48488443:G:T
NM_000138.4(FBN1):c.305_306delinsAA (p.Cys102Ter)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549126	15	48902965 - 48902966	15	48610768 - 48610769	549126	539937	rs1555405530	NC_000015.10:48610767:GC:TT
NM_000138.4(FBN1):c.2849G>T (p.Cys950Phe)	FBN1	C950F	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549117	15	48784663	15	48492466	549117	539800	rs1555398974	NC_000015.10:48492465:C:A
NM_000138.4(FBN1):c.2657_2667del (p.Pro886fs)	FBN1	P886fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549099	15	48787330 - 48787340	15	48495133 - 48495143	549099	539817	rs1555399146	NC_000015.10:48495132:TAGGGTGCACG:
NM_000138.4(FBN1):c.2586dup (p.Glu863Ter)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549098	15	48787410 - 48787411	15	48495213 - 48495214	549098	539818	rs1555399160	NC_000015.10:48495213:A:AA
NM_000138.4(FBN1):c.255C>A (p.Cys85Ter)	FBN1	C85*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549095	15	48903016	15	48610819	549095	539940	rs1555405536	NC_000015.10:48610818:G:T
NM_000138.4(FBN1):c.2489G>A (p.Cys830Tyr)	FBN1	C830Y	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549090	15	48787716	15	48495519	549090	539825	rs397515774	NC_000015.10:48495518:C:T
NM_000138.4(FBN1):c.247+1G>T	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549086	15	48905206	15	48613009	549086	539942	rs25404	NC_000015.10:48613008:C:A
NM_000138.4(FBN1):c.2446T>C (p.Cys816Arg)	FBN1	C816R	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549084	15	48787759	15	48495562	549084	539829	rs1555399206	NC_000015.10:48495561:A:G
NM_000138.4(FBN1):c.2434G>T (p.Glu812Ter)	FBN1	E812*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549083	15	48787771	15	48495574	549083	539830	rs201778577	NC_000015.10:48495573:C:A
NM_000138.4(FBN1):c.2433C>G (p.Cys811Trp)	FBN1	C811W	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549082	15	48787772	15	48495575	549082	539831	rs193921256	NC_000015.10:48495574:G:C
NM_000138.4(FBN1):c.2341T>A (p.Cys781Ser)	FBN1	C781S	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549074	15	48788375	15	48496178	549074	539838	rs397515766	NC_000015.10:48496177:A:T
NM_000138.4(FBN1):c.2327G>A (p.Cys776Tyr)	FBN1	C776Y	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549073	15	48788389	15	48496192	549073	539839	rs1555399273	NC_000015.10:48496191:C:T
NM_000138.4(FBN1):c.2243del (p.Cys748fs)	FBN1	C748fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549069	15	48789513	15	48497316	549069	539843	rs1555399371	NC_000015.10:48497315:C:
NM_000138.4(FBN1):c.2114-1G>C	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549064	15	48791236	15	48499039	549064	539846	rs1555399484	NC_000015.10:48499038:C:G
NM_000138.4(FBN1):c.1837+2T>C	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549051	15	48800777	15	48508580	549051	539856	rs1555399940	NC_000015.10:48508579:A:G
NM_000138.4(FBN1):c.1837+1G>A	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549050	15	48800778	15	48508581	549050	539857	rs397515762	NC_000015.10:48508580:C:T
NM_000138.4(FBN1):c.1801G>T (p.Gly601Ter)	FBN1	G601*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549046	15	48800815	15	48508618	549046	539861	rs1555399953	NC_000015.10:48508617:C:A
NM_000138.4(FBN1):c.1715-1G>A	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549036	15	48800902	15	48508705	549036	539870	rs1555399977	NC_000015.10:48508704:C:T
NM_000138.4(FBN1):c.1709G>A (p.Cys570Tyr)	FBN1	C570Y	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549035	15	48802246	15	48510049	549035	539871	rs1555400049	NC_000015.10:48510048:C:T
NM_000138.4(FBN1):c.164+1del	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549031	15	48936802	15	48644605	549031	539951	rs1555407399	NC_000015.10:48644604:CCC:CC
NM_000138.4(FBN1):c.1579G>T (p.Glu527Ter)	FBN1	E527*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549027	15	48805755	15	48513558	549027	539877	rs1555400267	NC_000015.10:48513557:C:A
NM_000138.4(FBN1):c.1575del (p.Thr526fs)	FBN1	T526fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549026	15	48805759	15	48513562	549026	539878	rs1555400268	NC_000015.10:48513561:CC:C
NM_000138.4(FBN1):c.1552G>T (p.Gly518Ter)	FBN1	G518*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549023	15	48805782	15	48513585	549023	539881	rs794728168	NC_000015.10:48513584:C:A
NM_000138.4(FBN1):c.1511G>A (p.Cys504Tyr)	FBN1	C504Y	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549021	15	48805823	15	48513626	549021	539883	rs1156747241	NC_000015.10:48513625:C:T
NM_000138.4(FBN1):c.1422del (p.Cys474fs)	FBN1	C474fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549016	15	48807630	15	48515433	549016	539888	rs1555400379	NC_000015.10:48515432:A:
NM_000138.4(FBN1):c.1360C>T (p.Gln454Ter)	FBN1	Q454*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549012	15	48807692	15	48515495	549012	539892	rs1555400387	NC_000015.10:48515494:G:A
NM_000138.4(FBN1):c.1318G>T (p.Glu440Ter)	FBN1	E440*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549010	15	48808389	15	48516192	549010	539894	rs1555400406	NC_000015.10:48516191:C:A
NM_000138.4(FBN1):c.1270C>T (p.Gln424Ter)	FBN1	Q424*	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549009	15	48808437	15	48516240	549009	539895	rs1439533354	NC_000015.10:48516239:G:A
NM_000138.4(FBN1):c.124del (p.Ala42fs)	FBN1	A42fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549008	15	48936843	15	48644646	549008	539952	rs1555407414	NC_000015.10:48644645:CCC:CC
NM_000138.4(FBN1):c.4088-2A>C	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Oct 23, 2014)	no assertion criteria provided	VCV000492829	15	48766576	15	48474379	492829	485758	rs1555397671	NC_000015.10:48474378:T:G
NM_000138.4(FBN1):c.3081del (p.Asp1028fs)	FBN1	D1028fs	Marfan syndrome	Pathogenic(Last reviewed: Oct 31, 2014)	no assertion criteria provided	VCV000492827	15	48782049	15	48489852	492827	485760	rs1555398774	NC_000015.10:48489851:TTT:TT
NM_000138.4(FBN1):c.1883G>T (p.Cys628Phe)	FBN1	C628F	Marfan syndrome	Pathogenic	no assertion criteria provided	VCV000446121	15	48797299	15	48505102	446121	439468	rs1555399825	NC_000015.10:48505101:C:A
NM_000138.4(FBN1):c.2563C>T (p.Gln855Ter)	FBN1	Q855*	Marfan syndrome	Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	VCV000375466	15	48787434	15	48495237	375466	362231	rs1057519502	NC_000015.10:48495236:G:A
NM_000138.4(FBN1):c.5783G>T (p.Cys1928Phe)	FBN1	C1928F	Marfan syndrome	Pathogenic(Last reviewed: Apr 25, 2014)	no assertion criteria provided	VCV000155794	15	48738908	15	48446711	155794	165546	rs587782947	NC_000015.10:48446710:C:A
NM_000138.4(FBN1):c.385T>G (p.Cys129Gly)	FBN1	C129G	Marfan syndrome	Pathogenic	no assertion criteria provided	VCV000126960	15	48892393	15	48600196	126960	132473	rs199474693	NC_000015.10:48600195:A:C
NM_000138.4(FBN1):c.6662G>C (p.Cys2221Ser)	FBN1	C2221S	Marfan syndrome	Pathogenic(Last reviewed: Dec 7, 2016)	no assertion criteria provided	VCV000016427	15	48725140	15	48432943	16427	31466	rs137854460	NC_000015.10:48432942:C:G
NM_000138.4(FBN1):c.4987T>C (p.Cys1663Arg)	FBN1	C1663R	Marfan syndrome	Pathogenic(Last reviewed: Dec 7, 2016)	no assertion criteria provided	VCV000016426	15	48756174	15	48463977	16426	31465	rs137854459	NC_000015.10:48463976:A:G
NM_000138.4(FBN1):c.3746G>C (p.Cys1249Ser)	FBN1	C1249S	Marfan syndrome	Pathogenic(Last reviewed: Dec 7, 2016)	no assertion criteria provided	VCV000016425	15	48776107	15	48483910	16425	31464	rs137854458	NC_000015.10:48483909:C:G
NM_002834.5(PTPN11):c.1472C>T (p.Pro491Leu)	PTPN11	P491L, P495L, P490L	not specified|Rasopathy|not provided|Noonan syndrome 1|Noonan syndrome	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040552	12	112926852	12	112489048	40552	49022	rs397507540	NC_000012.12:112489047:C:T
NM_004004.6(GJB2):c.229T>C (p.Trp77Arg)	GJB2	W77R	Deafness, autosomal recessive 1A|not provided|Rare genetic deafness|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017003	13	20763492	13	20189353	17003	32042	rs104894397	NC_000013.11:20189352:A:G
NM_000138.5(FBN1):c.3159C>G (p.Cys1053Trp)	FBN1	C1053W	Marfan syndrome	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000864854	15	48780614	15	48488417	864854	855103		NC_000015.10:48488416:G:C
NC_000015.10:g.48534128delinsAAGTTTGTGTCCAGCAGGGCATTGTGTCCA	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000695028	15	48826325	15	48534128	695028	683146		NC_000015.10:48534127:T:AAGTTTGTGTCCAGCAGGGCATTGTGTCCA
NM_000138.4(FBN1):c.5471G>T (p.Cys1824Phe)	FBN1	C1824F	Marfan syndrome	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000689491	15	48744833	15	48452636	689491	677128		NC_000015.10:48452635:C:A
NM_000138.4(FBN1):c.5627G>C (p.Cys1876Ser)	FBN1	C1876S	Marfan syndrome	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000689478	15	48741009	15	48448812	689478	677071		NC_000015.10:48448811:C:G
NM_000138.4(FBN1):c.2415T>G (p.Cys805Trp)	FBN1	C805W	Marfan syndrome	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000684779	15	48788301	15	48496104	684779	672370		NC_000015.10:48496103:A:C
NM_000138.4(FBN1):c.859G>T (p.Glu287Ter)	FBN1	E287*	Marfan syndrome	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000684778	15	48826280	15	48534083	684778	672369		NC_000015.10:48534082:C:A
NM_000138.4(FBN1):c.5378G>A (p.Cys1793Tyr)	FBN1	C1793Y	Marfan syndrome	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000684777	15	48748878	15	48456681	684777	672368		NC_000015.10:48456680:C:T
NM_000138.5(FBN1):c.6834del (p.Tyr2280fs)	FBN1	Y2280fs	Marfan syndrome	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000684766	15	48722905	15	48430708	684766	672361		NC_000015.10:48430707:GGG:GG
NM_000138.5(FBN1):c.4219G>T (p.Glu1407Ter)	FBN1	E1407*	Marfan syndrome	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000684765	15	48764865	15	48472668	684765	672360		NC_000015.10:48472667:C:A
NM_000138.5(FBN1):c.3535C>T (p.Gln1179Ter)	FBN1	Q1179*	Marfan syndrome	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000684764	15	48779326	15	48487129	684764	672359		NC_000015.10:48487128:G:A
NM_000138.5(FBN1):c.5187G>A (p.Trp1729Ter)	FBN1	W1729*	Marfan syndrome	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000684761	15	48755316	15	48463119	684761	672356		NC_000015.10:48463118:C:T
NM_000138.4(FBN1):c.3284G>C (p.Cys1095Ser)	FBN1	C1095S	Marfan syndrome	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000684730	15	48780363	15	48488166	684730	672322		NC_000015.10:48488165:C:G
NM_000138.4(FBN1):c.7951G>T (p.Glu2651Ter)	FBN1	E2651*	Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684611	15	48707833	15	48415636	684611	672158		NC_000015.10:48415635:C:A
NM_000138.4(FBN1):c.7559del (p.Thr2520fs)	FBN1	T2520fs	Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684610	15	48714160	15	48421963	684610	672159		NC_000015.10:48421962:G:
NM_000138.4(FBN1):c.7099G>T (p.Gly2367Ter)	FBN1	G2367*	Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684609	15	48719869	15	48427672	684609	672160		NC_000015.10:48427671:C:A
NM_000138.4(FBN1):c.6804del (p.Ile2269fs)	FBN1	I2269fs	Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684606	15	48722935	15	48430738	684606	672162		NC_000015.10:48430737:G:
NM_000138.4(FBN1):c.6740-1G>T	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684605	15	48723000	15	48430803	684605	672196		NC_000015.10:48430802:C:A
NM_000138.4(FBN1):c.6701dup (p.Tyr2236fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684604	15	48725100 - 48725101	15	48432903 - 48432904	684604	672163		NC_000015.10:48432903:A:AA
NM_000138.4(FBN1):c.6496+1del	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684602	15	48729157	15	48436960	684602	672197		NC_000015.10:48436959:CC:C
NM_000138.4(FBN1):c.6380-1G>T	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684601	15	48729275	15	48437078	684601	672198		NC_000015.10:48437077:C:A
NM_000138.4(FBN1):c.5093del (p.Asn1698fs)	FBN1	N1698fs	Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684595	15	48755410	15	48463213	684595	672170		NC_000015.10:48463212:TTT:TT
NM_000138.4(FBN1):c.5057del (p.Asn1686fs)	FBN1	N1686fs	Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684594	15	48756104	15	48463907	684594	672171		NC_000015.10:48463906:TT:T
NM_000138.4(FBN1):c.3396_3397AG[1] (p.Glu1133fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684593	15	48779573 - 48779574	15	48487376 - 48487377	684593	672172		NC_000015.10:48487375:CTCT:CT
NM_000138.4(FBN1):c.3372_3376del (p.Cys1124fs)	FBN1	C1124fs	Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684592	15	48779596 - 48779600	15	48487399 - 48487403	684592	672173		NC_000015.10:48487398:CTCGGC:C
NM_000138.4(FBN1):c.3096C>A (p.Cys1032Ter)	FBN1	C1032*	Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684591	15	48780677	15	48488480	684591	672174		NC_000015.10:48488479:G:T
NM_000138.4(FBN1):c.2886C>A (p.Tyr962Ter)	FBN1	Y962*	Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684589	15	48782244	15	48490047	684589	672176		NC_000015.10:48490046:G:T
NM_000138.4(FBN1):c.2561G>A (p.Trp854Ter)	FBN1	W854*	Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684587	15	48787436	15	48495239	684587	672178		NC_000015.10:48495238:C:T
NM_000138.4(FBN1):c.2539+2T>G	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684586	15	48787664	15	48495467	684586	672199		NC_000015.10:48495466:A:C
NM_000138.4(FBN1):c.2419+2T>G	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684585	15	48788295	15	48496098	684585	672200		NC_000015.10:48496097:A:C
NM_000138.4(FBN1):c.1646_1649delinsGT (p.Thr549fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684578	15	48802306 - 48802309	15	48510109 - 48510112	684578	672183		NC_000015.10:48510108:TCTG:AC
NM_000138.4(FBN1):c.376G>T (p.Gly126Ter)	FBN1	G126*	Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684572	15	48892402	15	48600205	684572	672189		NC_000015.10:48600204:C:A
NM_000138.4(FBN1):c.176del (p.Cys59fs)	FBN1	C59fs	Marfan syndrome	Pathogenic(Last reviewed: Jun 6, 2019)	no assertion criteria provided	VCV000684568	15	48905278	15	48613081	684568	672193		NC_000015.10:48613080:C:
NM_000138.5(FBN1):c.543C>G (p.Tyr181Ter)	FBN1	Y181*	Marfan syndrome	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000666551	15	48830001	15	48537804	666551	654111		NC_000015.10:48537803:G:C
NM_000138.4(FBN1):c.2849G>C (p.Cys950Ser)	FBN1	C950S	Marfan syndrome	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000638676	15	48784663	15	48492466	638676	626451		NC_000015.10:48492465:C:G
NM_000138.4(FBN1):c.40_49del (p.Phe13_Thr14insTer)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000638668	15	48936918 - 48936927	15	48644721 - 48644730	638668	626444		NC_000015.10:48644720:AAAGCACGGTAAA:AAA
NM_000138.4(FBN1):c.2438C>G (p.Ser813Ter)	FBN1	S813*	Marfan syndrome	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000638667	15	48787767	15	48495570	638667	626443		NC_000015.10:48495569:G:C
NM_000138.4(FBN1):c.2761T>C (p.Cys921Arg)	FBN1	C921R	Marfan syndrome	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000638643	15	48784751	15	48492554	638643	626416		NC_000015.10:48492553:A:G
NM_000138.4(FBN1):c.2217T>G (p.Cys739Trp)	FBN1	C739W	Marfan syndrome	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000638563	15	48789539	15	48497342	638563	626350		NC_000015.10:48497341:A:C
NM_000138.4(FBN1):c.1558C>T (p.Gln520Ter)	FBN1	Q520*	Marfan syndrome	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000638556	15	48805776	15	48513579	638556	626346		NC_000015.10:48513578:G:A
NM_000138.5(FBN1):c.6751del (p.Cys2251fs)	FBN1	C2251fs	Marfan syndrome	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000638264	15	48722988	15	48430791	638264	626020		NC_000015.10:48430790:A:
NM_000138.4(FBN1):c.8512A>T (p.Lys2838Ter)	FBN1	K2838*	Marfan syndrome	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000638158	15	48703291	15	48411094	638158	625979		NC_000015.10:48411093:T:A
NM_000138.4(FBN1):c.7694G>A (p.Cys2565Tyr)	FBN1	C2565Y	Marfan syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000625128	15	48713760	15	48421563	625128	613463	rs1566891645	NC_000015.10:48421562:C:T
NM_000138.5(FBN1):c.6613dup (p.Glu2205fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000625126	15	48726793 - 48726794	15	48434596 - 48434597	625126	613465	rs1566895225	NC_000015.10:48434596:C:CC
NM_000138.5(FBN1):c.5905del (p.Arg1969fs)	FBN1	R1969fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000625124	15	48737585	15	48445388	625124	613467	rs1566898399	NC_000015.10:48445387:T:
NM_000138.5(FBN1):c.4781del (p.Gly1594fs)	FBN1	G1594fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000625122	15	48758022	15	48465825	625122	613468	rs1566904011	NC_000015.10:48465824:CC:C
NM_000138.4(FBN1):c.4036T>G (p.Phe1346Val)	FBN1	F1346V	Marfan syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000625121	15	48766776	15	48474579	625121	613469	rs1566906537	NC_000015.10:48474578:A:C
NM_000138.4(FBN1):c.3332G>A (p.Cys1111Tyr)	FBN1	C1111Y	Marfan syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000625119	15	48780315	15	48488118	625119	613471	rs1566909766	NC_000015.10:48488117:C:T
NM_000138.4(FBN1):c.2557T>C (p.Cys853Arg)	FBN1	C853R	Marfan syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000625118	15	48787440	15	48495243	625118	613472	rs1555399165	NC_000015.10:48495242:A:G
NM_000138.4(FBN1):c.974_983del (p.Gly325fs)	FBN1	G325fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000625116	15	48818332 - 48818341	15	48526135 - 48526144	625116	613473	rs1566919599	NC_000015.10:48526134:CATCTGGTACCATCTGG:CATCTGG
NM_000138.4(FBN1):c.7649G>A (p.Cys2550Tyr)	FBN1	C2550Y	Marfan syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000590852	15	48713805	15	48421608	590852	581791	rs1555394196	NC_000015.10:48421607:C:T
NM_000138.4(FBN1):c.1659del (p.His554fs)	FBN1	H554fs	Marfan syndrome	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000562234	15	48802296	15	48510099	562234	553418	rs1566915277	NC_000015.10:48510098:AAAA:AAA
NC_000015.9:g.48703187_48748959del45773	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000560348	15	48703187 - 48748959	15	48410990 - 48456762	560348	551394		
NM_000138.4(FBN1):c.6038_6163del	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000560347	15	48733918 - 48734043	15	48441721 - 48441846	560347	551397	rs1566897376	
NM_000138.4(FBN1):c.6497_6616del	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000560346	15	48726791 - 48726910	15	48434594 - 48434713	560346	551396	rs1566895223	
NM_000138.4(FBN1):c.6740_6871del	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000560345	15	48722868 - 48722999	15	48430671 - 48430802	560345	551395	rs1566894226	
NM_000138.4(FBN1):c.1956T>G (p.Cys652Trp)	FBN1	C652W	Marfan syndrome	Pathogenic(Last reviewed: Jun 1, 2018)	no assertion criteria provided	VCV000560218	15	48797226	15	48505029	560218	551268	rs1566913974	NC_000015.10:48505028:A:C
NM_000138.4(FBN1):c.4337-1G>T	FBN1		Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000549222	15	48762954	15	48470757	549222	539705	rs1555397424	NC_000015.10:48470756:C:A
NM_000138.4(FBN1):c.1960+1G>C	FBN1		Marfan syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000549056	15	48797221	15	48505024	549056	539851	rs1555399804	NC_000015.10:48505023:C:G
NM_000138.4(FBN1):c.1794C>G (p.Cys598Trp)	FBN1	C598W	Marfan syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000549045	15	48800822	15	48508625	549045	539862	rs1555399954	NC_000015.10:48508624:G:C
NM_000138.4(FBN1):c.7498T>C (p.Cys2500Arg)	FBN1	C2500R	Marfan syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547346	15	48714221	15	48422024	547346	538034	rs363810	NC_000015.10:48422023:A:G
NM_000138.4(FBN1):c.7015T>C (p.Cys2339Arg)	FBN1	C2339R	Marfan syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547343	15	48719953	15	48427756	547343	538037	rs1555394581	NC_000015.10:48427755:A:G
NM_000138.4(FBN1):c.5826C>A (p.Cys1942Ter)	FBN1	C1942*	Marfan syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547334	15	48737664	15	48445467	547334	538046	rs363806	NC_000015.10:48445466:G:T
NM_000138.4(FBN1):c.5788G>A (p.Asp1930Asn)	FBN1	D1930N	Marfan syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547333	15	48738903	15	48446706	547333	538047	rs1555395820	NC_000015.10:48446705:C:T
NM_000138.4(FBN1):c.5021G>A (p.Cys1674Tyr)	FBN1	C1674Y	Marfan syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547326	15	48756140	15	48463943	547326	538054	rs794728233	NC_000015.10:48463942:C:T
NM_000138.4(FBN1):c.4490G>A (p.Cys1497Tyr)	FBN1	C1497Y	Marfan syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547321	15	48760701	15	48468504	547321	538059	rs1555397212	NC_000015.10:48468503:C:T
NM_000138.4(FBN1):c.3703T>C (p.Ser1235Pro)	FBN1	S1235P	Marfan syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547313	15	48777580	15	48485383	547313	538067	rs1555398382	NC_000015.10:48485382:A:G
NM_000138.4(FBN1):c.2678-15C>A	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 24, 2017)	no assertion criteria provided	VCV000446494	15	48786466	15	48494269	446494	440009	rs181681840	NC_000015.10:48494268:G:T
NM_000138.4(FBN1):c.3895dup (p.Thr1299fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, single submitter	VCV000406373	15	48773920 - 48773921	15	48481723 - 48481724	406373	400677	rs1555398160	NC_000015.10:48481723:T:TT
NM_000138.4(FBN1):c.1572del (p.Arg525fs)	FBN1	R525fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 26, 2016)	criteria provided, single submitter	VCV000406370	15	48805762	15	48513565	406370	401031	rs1060501096	NC_000015.10:48513564:C:
NM_000138.4(FBN1):c.6159C>A (p.Cys2053Ter)	FBN1	C2053*	Marfan syndrome	Pathogenic(Last reviewed: Oct 6, 2016)	criteria provided, single submitter	VCV000406369	15	48733922	15	48441725	406369	400640	rs1060501095	NC_000015.10:48441724:G:T
NM_000138.4(FBN1):c.978del (p.Arg327fs)	FBN1	R327fs	Marfan syndrome	Pathogenic(Last reviewed: Jun 13, 2016)	criteria provided, single submitter	VCV000406368	15	48818337	15	48526140	406368	400243	rs1060501094	NC_000015.10:48526139:GG:G
NM_000138.4(FBN1):c.3893del (p.Asn1298fs)	FBN1	N1298fs	Marfan syndrome	Pathogenic(Last reviewed: Dec 24, 2016)	criteria provided, single submitter	VCV000406363	15	48773923	15	48481726	406363	400383	rs869025425	NC_000015.10:48481725:TTTT:TTT
NM_000138.4(FBN1):c.5823_5824del (p.Cys1942fs)	FBN1	C1942fs	Marfan syndrome	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000406362	15	48737666 - 48737667	15	48445469 - 48445470	406362	400644	rs1060501089	NC_000015.10:48445468:AAA:A
NM_000138.4(FBN1):c.1982G>A (p.Cys661Tyr)	FBN1	C661Y	Marfan syndrome	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000406359	15	48796115	15	48503918	406359	400712	rs1060501086	NC_000015.10:48503917:C:T
NM_000138.4(FBN1):c.3973dup (p.Glu1325fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000406358	15	48766838 - 48766839	15	48474641 - 48474642	406358	401002	rs1555397743	NC_000015.10:48474641:C:CC
NM_000138.4(FBN1):c.1915T>A (p.Cys639Ser)	FBN1	C639S	Marfan syndrome	Pathogenic(Last reviewed: May 18, 2016)	criteria provided, single submitter	VCV000406351	15	48797267	15	48505070	406351	400407	rs1060501078	NC_000015.10:48505069:A:T
NM_000138.4(FBN1):c.7466G>A (p.Cys2489Tyr)	FBN1	C2489Y	Marfan syndrome	Pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	VCV000406349	15	48714253	15	48422056	406349	400143	rs1060501077	NC_000015.10:48422055:C:T
NM_000138.4(FBN1):c.4468G>T (p.Glu1490Ter)	FBN1	E1490*	Marfan syndrome	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000406348	15	48760723	15	48468526	406348	400670	rs1060501076	NC_000015.10:48468525:C:A
NM_000138.4(FBN1):c.7729dup (p.Cys2577fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000406337	15	48712973 - 48712974	15	48420776 - 48420777	406337	400326	rs1555394151	NC_000015.10:48420776:A:AA
NM_000138.4(FBN1):c.2638G>C (p.Gly880Arg)	FBN1	G880R	Marfan syndrome	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000406335	15	48787359	15	48495162	406335	401022	rs794728194	NC_000015.10:48495161:C:G
NM_000138.4(FBN1):c.7852G>T (p.Gly2618Ter)	FBN1	G2618*	Marfan syndrome	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000406331	15	48707932	15	48415735	406331	400140	rs141133182	NC_000015.10:48415734:C:A
NM_000138.4(FBN1):c.4145dup (p.Asn1382fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Sep 4, 2016)	criteria provided, single submitter	VCV000406330	15	48766516 - 48766517	15	48474319 - 48474320	406330	400194	rs1555397663	NC_000015.10:48474319:TT:TTT
NM_000138.4(FBN1):c.6541del (p.Cys2181fs)	FBN1	C2181fs	Marfan syndrome	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000406323	15	48726866	15	48434669	406323	400972	rs1060501059	NC_000015.10:48434668:A:
NM_000138.4(FBN1):c.2369G>T (p.Cys790Phe)	FBN1	C790F	Marfan syndrome	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000406322	15	48788347	15	48496150	406322	401026	rs193922188	NC_000015.10:48496149:C:A
NM_000138.4(FBN1):c.1888_1889delinsC (p.Asn630fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000406320	15	48797293 - 48797294	15	48505096 - 48505097	406320	400714	rs1060501058	NC_000015.10:48505095:TT:G
NM_000138.4(FBN1):c.7228_7232dup (p.Val2412fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000406319	15	48718033 - 48718034	15	48425836 - 48425837	406319	400146	rs1555394445	NC_000015.10:48425836:TCGTG:TCGTGTCGTG
NM_000138.4(FBN1):c.5672-2A>G	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000406314	15	48739021	15	48446824	406314	400172	rs1060501053	NC_000015.10:48446823:T:C
NM_000138.4(FBN1):c.6963del (p.Phe2322fs)	FBN1	F2322fs	Marfan syndrome	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000406311	15	48720577	15	48428380	406311	400358	rs1060501051	NC_000015.10:48428379:CCC:CC
NM_000138.4(FBN1):c.801del (p.Ser268fs)	FBN1	S268fs	Marfan syndrome	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000406310	15	48826338	15	48534141	406310	401044	rs1060501050	NC_000015.10:48534140:CCC:CC
NM_000138.4(FBN1):c.6164-1G>A	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, single submitter	VCV000406308	15	48730115	15	48437918	406308	400634	rs1060501048	NC_000015.10:48437917:C:T
NM_000138.4(FBN1):c.409C>T (p.Gln137Ter)	FBN1	Q137*	Marfan syndrome	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000406307	15	48892369	15	48600172	406307	401053	rs1060501047	NC_000015.10:48600171:G:A
NM_000138.4(FBN1):c.4367_4368GT[1] (p.Val1457fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Dec 3, 2016)	criteria provided, single submitter	VCV000406301	15	48762920 - 48762921	15	48470723 - 48470724	406301	400189	rs1060501043	NC_000015.10:48470722:ACACA:ACA
NM_000138.4(FBN1):c.7650_7651insA (p.Glu2551fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	VCV000406300	15	48713803 - 48713804	15	48421606 - 48421607	406300	400946	rs1060501042	NC_000015.10:48421606::T
NM_000138.4(FBN1):c.3165T>A (p.Cys1055Ter)	FBN1	C1055*	Marfan syndrome	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000406294	15	48780608	15	48488411	406294	400396	rs1060501040	NC_000015.10:48488410:A:T
NM_000138.4(FBN1):c.592C>T (p.Gln198Ter)	FBN1	Q198*	Marfan syndrome	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000406287	15	48829952	15	48537755	406287	400257	rs1060501035	NC_000015.10:48537754:G:A
NM_000138.4(FBN1):c.6471T>A (p.Tyr2157Ter)	FBN1	Y2157*	Marfan syndrome	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000406286	15	48729183	15	48436986	406286	400162	rs1060501034	NC_000015.10:48436985:A:T
NM_000138.4(FBN1):c.5094del (p.Tyr1699fs)	FBN1	Y1699fs	Marfan syndrome	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000406282	15	48755409	15	48463212	406282	400176	rs1060501031	NC_000015.10:48463211:G:
NM_000138.4(FBN1):c.2028_2029insA (p.Ala677fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000406278	15	48796068 - 48796069	15	48503871 - 48503872	406278	401030	rs1060501027	NC_000015.10:48503871::T
NM_000138.4(FBN1):c.4166G>C (p.Cys1389Ser)	FBN1	C1389S	Marfan syndrome	Pathogenic(Last reviewed: May 30, 2016)	criteria provided, single submitter	VCV000406277	15	48766496	15	48474299	406277	400991	rs1060501026	NC_000015.10:48474298:C:G
NM_000138.4(FBN1):c.6948T>A (p.Cys2316Ter)	FBN1	C2316*	Marfan syndrome	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000406266	15	48720592	15	48428395	406266	400157	rs1060501016	NC_000015.10:48428394:A:T
NM_000138.4(FBN1):c.3166del (p.Asp1056fs)	FBN1	D1056fs	Marfan syndrome	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000406261	15	48780607	15	48488410	406261	400395	rs1060501013	NC_000015.10:48488409:C:
NM_000138.4(FBN1):c.5416del (p.Cys1806fs)	FBN1	C1806fs	Marfan syndrome	Pathogenic(Last reviewed: Apr 2, 2015)	criteria provided, single submitter	VCV000374118	15	48748840	15	48456643	374118	360975	rs1057518912	NC_000015.10:48456642:AAA:AA
NM_000138.4(FBN1):c.5423-?_*2684+?del	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jan 2, 2016)	criteria provided, single submitter	VCV000237097					237097	242025		
NM_000138.4(FBN1):c.5038C>T (p.Gln1680Ter)	FBN1	Q1680*	Marfan syndrome	Pathogenic(Last reviewed: Jan 16, 2016)	criteria provided, single submitter	VCV000237094	15	48756123	15	48463926	237094	242068	rs878853685	NC_000015.10:48463925:G:A
NM_000138.4(FBN1):c.4210+1G>A	FBN1		Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000180359	15	48766451	15	48474254	180359	178696	rs730880106	NC_000015.10:48474253:C:T
NM_000138.4(FBN1):c.660del (p.Cys221fs)	FBN1	C221fs	Marfan syndrome	Pathogenic(Last reviewed: Sep 30, 2014)	criteria provided, single submitter	VCV000179992	15	48829884	15	48537687	179992	176133	rs727505269	NC_000015.10:48537686:GGGG:GGG
NM_000138.4(FBN1):c.1335dup (p.Pro446fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Sep 17, 2013)	criteria provided, single submitter	VCV000179300	15	48807716 - 48807717	15	48515519 - 48515520	179300	176132	rs730880356	NC_000015.10:48515519:C:CC
NM_000138.5(FBN1):c.8265_8266delinsAGGA (p.Ser2755fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jul 18, 2013)	criteria provided, single submitter	VCV000179129	15	48703537 - 48703538	15	48411340 - 48411341	179129	175978	rs727504651	NC_000015.10:48411339:AA:TCCT
NM_000138.5(FBN1):c.3546C>A (p.Cys1182Ter)	FBN1	C1182*	Marfan syndrome	Pathogenic(Last reviewed: Nov 3, 2010)	criteria provided, single submitter	VCV000177940	15	48779315	15	48487118	177940	175986	rs727504411	NC_000015.10:48487117:G:T
NM_000138.4(FBN1):c.1156_1167del (p.Asn386_Cys389del)	FBN1		Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000162038	15	48808540 - 48808551	15	48516343 - 48516354	162038	171763	rs672601352	NC_000015.10:48516342:GCACAGCTTGTTG:G
NM_000138.4(FBN1):c.958dup (p.Tyr320fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jan 30, 2012)	criteria provided, single submitter	VCV000042448	15	48818356 - 48818357	15	48526159 - 48526160	42448	51618	rs397515867	NC_000015.10:48526159:AAAAA:AAAAAA
NM_000138.5(FBN1):c.5066-1G>C	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Mar 1, 2012)	criteria provided, single submitter	VCV000042378	15	48755438	15	48463241	42378	51548	rs397515819	NC_000015.10:48463240:C:G
NM_000138.4(FBN1):c.3274del (p.Asp1092fs)	FBN1	D1092fs	Marfan syndrome	Pathogenic(Last reviewed: Oct 18, 2012)	criteria provided, single submitter	VCV000042329	15	48780373	15	48488176	42329	51499	rs397515788	NC_000015.10:48488175:CCCC:CCC
NM_000138.5(FBN1):c.2855-1G>A	FBN1		Marfan syndrome	Pathogenic(Last reviewed: May 2, 2012)	criteria provided, single submitter	VCV000042318	15	48782276	15	48490079	42318	51488	rs112202622	NC_000015.10:48490078:C:T
NM_000138.5(FBN1):c.2407A>T (p.Lys803Ter)	FBN1	K803*	Marfan syndrome	Pathogenic(Last reviewed: Nov 2, 2007)	criteria provided, single submitter	VCV000042303	15	48788309	15	48496112	42303	51473	rs397515768	NC_000015.10:48496111:T:A
NM_000138.5(FBN1):c.1192A>T (p.Arg398Ter)	FBN1	R398*	Marfan syndrome	Pathogenic(Last reviewed: Sep 12, 2011)	criteria provided, single submitter	VCV000042281	15	48808515	15	48516318	42281	51451	rs397515754	NC_000015.10:48516317:T:A
NM_000138.4(FBN1):c.4253_4259del (p.Gly1418fs)	FBN1	G1418fs	Marfan syndrome	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000041409	15	48764825 - 48764831	15	48472628 - 48472634	41409	49841	rs398122934	NC_000015.10:48472627:CACTGGCCA:CA
FBN1, EX13-49DEL	FBN1		Marfan syndrome	Pathogenic(Last reviewed: May 15, 2008)	no assertion criteria provided	VCV000016468					16468	31507		
NM_000138.4(FBN1):c.3662G>A (p.Cys1221Tyr)	FBN1	C1221Y	Marfan syndrome	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000016464	15	48777621	15	48485424	16464	31503	rs137854483	NC_000015.10:48485423:C:T
NM_000138.4(FBN1):c.3386G>A (p.Cys1129Tyr)	FBN1	C1129Y	Marfan syndrome	Pathogenic(Last reviewed: Aug 19, 1999)	no assertion criteria provided	VCV000016463	15	48779586	15	48487389	16463	31502	rs137854482	NC_000015.10:48487388:C:T
NM_000138.4(FBN1):c.5788+1G>A	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000016456	15	48738902	15	48446705	16456	31495	rs1555395819	NC_000015.10:48446704:C:T
NM_000138.4(FBN1):c.3793T>C (p.Cys1265Arg)	FBN1	C1265R	Marfan syndrome	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000016450	15	48776060	15	48483863	16450	31489	rs137854474	NC_000015.10:48483862:A:G
NM_000138.4(FBN1):c.3192del (p.Glu1065fs)	FBN1	E1065fs	Marfan syndrome	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000016448	15	48780581	15	48488384	16448	31487	rs1131692050	NC_000015.10:48488383:TT:T
NM_000138.4(FBN1):c.2168A>C (p.Asp723Ala)	FBN1	D723A	Marfan syndrome	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000016433	15	48789588	15	48497391	16433	31472	rs137854463	NC_000015.10:48497390:T:G
NM_000138.4(FBN1):c.3350G>A (p.Cys1117Tyr)	FBN1	C1117Y	Marfan syndrome	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000016428	15	48779622	15	48487425	16428	31467	rs137854470	NC_000015.10:48487424:C:T
NM_000138.4(FBN1):c.8268G>A (p.Trp2756Ter)	FBN1	W2756*	Marfan syndrome	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000016424	15	48703535	15	48411338	16424	31463	rs267606796	NC_000015.10:48411337:C:T
NM_000138.4(FBN1):c.7455_7821del	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000016423					16423	31462		
NM_000057.4(BLM):c.2695C>T (p.Arg899Ter)	BLM	R899*, R524*	Hereditary cancer-predisposing syndrome|Bloom syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127491	15	91328183	15	90784953	127491	132948	rs587779884	NC_000015.10:90784952:C:T
NM_001009944.3(PKD1):c.2854-2A>G	PKD1		Inborn genetic diseases	Pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	VCV000521112	16	2163295	16	2113294	521112	512185	rs1555457488	NC_000016.10:2113293:T:C
NM_001009944.3(PKD1):c.8311G>A (p.Glu2771Lys)	PKD1	E2771K	Polycystic kidney disease, adult type|not provided|Multiple renal cysts|Hypertensive disorder	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374097	16	2153747	16	2103746	374097	360989	rs1057518897	NC_000016.10:2103745:C:T
NM_019066.5(MAGEL2):c.1996dup (p.Gln666fs)	MAGEL2		Schaaf-yang syndrome|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000190122	15	23890893 - 23890894	15	23645746 - 23645747	190122	187954	rs770374710	NC_000015.10:23645746:GGGGGGG:GGGGGGGG
NM_000321.2(RB1):c.751C>T (p.Arg251Ter)	RB1	R251*	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428681	13	48936983	13	48362847	428681	420530	rs1131690863	NC_000013.11:48362846:C:T
NM_004572.3(PKP2):c.1643del (p.Gly548fs)	PKP2	G504fs, G548fs	Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy|not provided|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000202035	12	32994007	12	32841073	202035	198417	rs794729137	NC_000012.12:32841072:CC:C
NM_000138.5(FBN1):c.5189del (p.Asn1730fs)	FBN1	N1730fs	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000864422	15	48755314	15	48463117	864422	842474		NC_000015.10:48463116:TT:T
NM_000138.5(FBN1):c.6139del (p.Ser2047fs)	FBN1	S2047fs	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000864324	15	48733942	15	48441745	864324	842462		NC_000015.10:48441744:A:
NM_000138.5(FBN1):c.5846_5850dup (p.Val1951fs)	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000863319	15	48737639 - 48737640	15	48445442 - 48445443	863319	842469		NC_000015.10:48445442:TGTATT:TGTATTGTATT
NM_000138.5(FBN1):c.6716_6717GA[1] (p.Glu2240fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000862538	15	48725083 - 48725084	15	48432886 - 48432887	862538	842455		NC_000015.10:48432885:TCTCT:TCT
NM_000138.5(FBN1):c.2986dup (p.Cys996fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000860255	15	48782143 - 48782144	15	48489946 - 48489947	860255	842496		NC_000015.10:48489946:A:AA
NM_000138.5(FBN1):c.5157C>A (p.Cys1719Ter)	FBN1	C1719*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 20, 2019)	criteria provided, single submitter	VCV000858650	15	48755346	15	48463149	858650	842475		NC_000015.10:48463148:G:T
NM_000138.5(FBN1):c.5912del (p.Cys1971fs)	FBN1	C1971fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000857721	15	48737578	15	48445381	857721	842466		NC_000015.10:48445380:C:
NM_000138.5(FBN1):c.4660G>T (p.Gly1554Ter)	FBN1	G1554*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000857210	15	48760222	15	48468025	857210	842480		NC_000015.10:48468024:C:A
NM_000138.5(FBN1):c.616A>T (p.Lys206Ter)	FBN1	K206*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000855231	15	48829928	15	48537731	855231	842535		NC_000015.10:48537730:T:A
NM_000138.5(FBN1):c.5860_5863dup (p.Gln1955fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000851202	15	48737626 - 48737627	15	48445429 - 48445430	851202	842468		NC_000015.10:48445429:GGAA:GGAAGGAA
NM_000138.5(FBN1):c.6121_6130del (p.Pro2041fs)	FBN1	P2041fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000850747	15	48733951 - 48733960	15	48441754 - 48441763	850747	842464		NC_000015.10:48441753:ACCCTTCTGGAC:AC
NM_000138.5(FBN1):c.831del (p.His277fs)	FBN1	H277fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000850708	15	48826308	15	48534111	850708	842528		NC_000015.10:48534110:G:
NM_000138.5(FBN1):c.7851C>A (p.Cys2617Ter)	FBN1	C2617*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000850223	15	48707933	15	48415736	850223	842438		NC_000015.10:48415735:G:T
NM_000138.5(FBN1):c.748_749insCC (p.Cys250fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000850087	15	48826390 - 48826391	15	48534193 - 48534194	850087	842532		NC_000015.10:48534193::GG
NM_000138.5(FBN1):c.7249G>T (p.Glu2417Ter)	FBN1	E2417*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000849713	15	48718017	15	48425820	849713	842448		NC_000015.10:48425819:C:A
NM_000138.5(FBN1):c.362_363dup (p.Arg122fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000848459	15	48892414 - 48892415	15	48600217 - 48600218	848459	842540		NC_000015.10:48600217:AA:AAAA
NM_000138.5(FBN1):c.2745del (p.Val916fs)	FBN1	V916fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV000848243	15	48784767	15	48492570	848243	842499		NC_000015.10:48492569:TT:T
NM_000138.5(FBN1):c.465del (p.Asn156fs)	FBN1	N156fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000845299	15	48888553	15	48596356	845299	842539		NC_000015.10:48596355:G:
NM_000138.5(FBN1):c.4410dup (p.Glu1471Ter)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000844338	15	48762879 - 48762880	15	48470682 - 48470683	844338	842482		NC_000015.10:48470682:A:AA
NM_000138.5(FBN1):c.905del (p.Gly302fs)	FBN1	G302fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000844121	15	48818410	15	48526213	844121	842527		NC_000015.10:48526212:CCCCC:CCCC
NM_000138.5(FBN1):c.3109_3112dup (p.Leu1038fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000843388	15	48780660 - 48780661	15	48488463 - 48488464	843388	842494		NC_000015.10:48488463:GGCTGG:GGCTGGCTGG
NM_000138.5(FBN1):c.198C>G (p.Tyr66Ter)	FBN1	Y66*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000841972	15	48905256	15	48613059	841972	842543		NC_000015.10:48613058:G:C
NM_000138.5(FBN1):c.3091G>T (p.Glu1031Ter)	FBN1	E1031*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000840727	15	48780682	15	48488485	840727	842495		NC_000015.10:48488484:C:A
NM_000138.5(FBN1):c.1570_1571del (p.Thr524fs)	FBN1	T524fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000838980	15	48805763 - 48805764	15	48513566 - 48513567	838980	842518		NC_000015.10:48513565:GTG:G
NM_000138.5(FBN1):c.491del (p.Asn164fs)	FBN1	N164fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000837896	15	48888527	15	48596330	837896	842538		NC_000015.10:48596329:TTT:TT
NC_000015.10:g.(?_48613000)_(48644779_?)del	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000831524	15	48905197 - 48936976			831524	820719		
NC_000015.10:g.(?_48644596)_(48644779_?)del	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000831123	15	48936793 - 48936976			831123	820720		
NC_000015.10:g.(?_48503777)_(48613102_?)del	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000830585	15	48795974 - 48905299			830585	820716		
NM_000138.4(FBN1):c.6872-1G>T	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000684607	15	48720669	15	48428472	684607	672195		NC_000015.10:48428471:C:A
NM_000138.4(FBN1):c.189T>G (p.Tyr63Ter)	FBN1	Y63*	Marfan syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000684569	15	48905265	15	48613068	684569	672192		NC_000015.10:48613067:A:C
NM_000138.4(FBN1):c.8092G>T (p.Glu2698Ter)	FBN1	E2698*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000665604	15	48704900	15	48412703	665604	643304		NC_000015.10:48412702:C:A
NM_000138.4(FBN1):c.6668_6669AC[1] (p.Thr2224fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000665490	15	48725131 - 48725132	15	48432934 - 48432935	665490	643333		NC_000015.10:48432933:GTGT:GT
NM_000138.5(FBN1):c.6954dup (p.Asn2319Ter)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000663913	15	48720585 - 48720586	15	48428388 - 48428389	663913	643328		NC_000015.10:48428388:A:AA
NM_000138.5(FBN1):c.1400dup (p.Thr468fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000663648	15	48807651 - 48807652	15	48515454 - 48515455	663648	643408		NC_000015.10:48515454:GG:GGG
NC_000015.9:g.(?_48707358)_(48707974_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000663422	15	48707358 - 48707974	15	48415161 - 48415777	663422	653005		
NC_000015.9:g.(?_48888470)_(48905299_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000662847	15	48888470 - 48905299	15	48596273 - 48613102	662847	652674		
NM_000138.5(FBN1):c.1537dup (p.Cys513fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000662516	15	48805796 - 48805797	15	48513599 - 48513600	662516	643405		NC_000015.10:48513599:A:AA
NM_000138.5(FBN1):c.3945dup (p.Gly1316fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 2, 2018)	criteria provided, single submitter	VCV000661986	15	48773870 - 48773871	15	48481673 - 48481674	661986	643370		NC_000015.10:48481673:TTTTTT:TTTTTTT
NM_000138.5(FBN1):c.2099del (p.Pro700fs)	FBN1	P700fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000661223	15	48795998	15	48503801	661223	643399		NC_000015.10:48503800:GG:G
NM_000138.5(FBN1):c.2379dup (p.Lys794fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000659391	15	48788336 - 48788337	15	48496139 - 48496140	659391	643395		NC_000015.10:48496139:GGGG:GGGGG
NM_000138.5(FBN1):c.3349del (p.Cys1117fs)	FBN1	C1117fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000659088	15	48779623	15	48487426	659088	643379		NC_000015.10:48487425:A:
NM_000138.5(FBN1):c.6090dup (p.Asn2031Ter)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000658886	15	48733990 - 48733991	15	48441793 - 48441794	658886	643341		NC_000015.10:48441793:A:AA
NM_000138.4(FBN1):c.3374_3379delinsAAAGT (p.Arg1125fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 2, 2018)	criteria provided, single submitter	VCV000657850	15	48779593 - 48779598	15	48487396 - 48487401	657850	643378		NC_000015.10:48487395:CACCTC:ACTTT
NM_000138.4(FBN1):c.7801C>T (p.Gln2601Ter)	FBN1	Q2601*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000657481	15	48712902	15	48420705	657481	643313		NC_000015.10:48420704:G:A
NM_000138.4(FBN1):c.3052G>T (p.Glu1018Ter)	FBN1	E1018*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000656145	15	48782078	15	48489881	656145	643384		NC_000015.10:48489880:C:A
NM_000138.4(FBN1):c.7119_7120insGGAC (p.His2374fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000655877	15	48719848 - 48719849	15	48427651 - 48427652	655877	643324		NC_000015.10:48427651:G:GTCCG
NM_000138.4(FBN1):c.7655_7656del (p.Cys2552fs)	FBN1	C2552fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000655510	15	48713798 - 48713799	15	48421601 - 48421602	655510	643317		NC_000015.10:48421600:GC:
NM_000138.4(FBN1):c.7221_7225del (p.Lys2407fs)	FBN1	K2407fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000653553	15	48718041 - 48718045	15	48425844 - 48425848	653553	643322		NC_000015.10:48425843:TAACCT:T
NM_000138.5(FBN1):c.7959del (p.Ser2654fs)	FBN1	S2654fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000653418	15	48707825	15	48415628	653418	643309		NC_000015.10:48415627:G:
NM_000138.5(FBN1):c.8259del (p.Ala2754fs)	FBN1	A2754fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000651909	15	48703544	15	48411347	651909	643300		NC_000015.10:48411346:AA:A
NM_000138.4(FBN1):c.2719C>T (p.Gln907Ter)	FBN1	Q907*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000650262	15	48786410	15	48494213	650262	643389		NC_000015.10:48494212:G:A
NM_000138.5(FBN1):c.3874del (p.Cys1291_Leu1292insTer)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000650082	15	48773942	15	48481745	650082	643371		NC_000015.10:48481744:GG:G
NM_000138.4(FBN1):c.2143_2161del (p.Pro715fs)	FBN1	P715fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000648195	15	48791188 - 48791206	15	48498991 - 48499009	648195	643397		NC_000015.10:48498990:CTGCTGACGTCATTCCTGGC:C
NM_000138.4(FBN1):c.8145T>A (p.Cys2715Ter)	FBN1	C2715*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000648036	15	48704847	15	48412650	648036	643301		NC_000015.10:48412649:A:T
NM_000138.5(FBN1):c.4639dup (p.Thr1547fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000647831	15	48760242 - 48760243	15	48468045 - 48468046	647831	643363		NC_000015.10:48468045:T:TT
NM_000138.4(FBN1):c.5493C>A (p.Tyr1831Ter)	FBN1	Y1831*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000647484	15	48744811	15	48452614	647484	643352		NC_000015.10:48452613:G:T
NM_000138.4(FBN1):c.6623_6627del (p.Asn2208fs)	FBN1	N2208fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000647381	15	48725175 - 48725179	15	48432978 - 48432982	647381	643334		NC_000015.10:48432977:TTCATTT:TT
NM_000138.5(FBN1):c.6699del (p.Val2234fs)	FBN1	V2234fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000647136	15	48725103	15	48432906	647136	643332		NC_000015.10:48432905:GGG:GG
NM_000138.4(FBN1):c.6584G>T (p.Gly2195Val)	FBN1	G2195V	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000647088	15	48726823	15	48434626	647088	643337		NC_000015.10:48434625:C:A
NM_000138.5(FBN1):c.6266del (p.Gly2089fs)	FBN1	G2089fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 16, 2019)	criteria provided, single submitter	VCV000646717	15	48730012	15	48437815	646717	643340		NC_000015.10:48437814:CCC:CC
NM_000138.4(FBN1):c.8101_8102del (p.Val2701fs)	FBN1	V2701fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000646300	15	48704890 - 48704891	15	48412693 - 48412694	646300	643303		NC_000015.10:48412692:ACA:A
NM_000138.4(FBN1):c.4893C>A (p.Cys1631Ter)	FBN1	C1631*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000646299	15	48757814	15	48465617	646299	643360		NC_000015.10:48465616:G:T
NM_000138.5(FBN1):c.7080dup (p.Ser2361fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000646120	15	48719887 - 48719888	15	48427690 - 48427691	646120	643327		NC_000015.10:48427690:TTT:TTTT
NM_000138.4(FBN1):c.916_919del (p.Asn306fs)	FBN1	N306fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000645004	15	48818396 - 48818399	15	48526199 - 48526202	645004	643416		NC_000015.10:48526198:TGTTTGT:TGT
NM_000138.5(FBN1):c.3211del (p.Ile1071fs)	FBN1	I1071fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000643962	15	48780436	15	48488239	643962	643380		NC_000015.10:48488238:T:
NM_000138.5(FBN1):c.7178dup (p.Arg2394fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000643850	15	48719789 - 48719790	15	48427592 - 48427593	643850	643323		NC_000015.10:48427592:CC:CCC
NM_000138.5(FBN1):c.2410dup (p.Thr804fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000643068	15	48788305 - 48788306	15	48496108 - 48496109	643068	643394		NC_000015.10:48496108:TTTTT:TTTTTT
NM_000138.5(FBN1):c.5571del (p.Asn1858fs)	FBN1	N1858fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000641710	15	48741065	15	48448868	641710	643350		NC_000015.10:48448867:GGGG:GGG
NM_000138.5(FBN1):c.5311dup (p.Arg1771fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000641406	15	48748944 - 48748945	15	48456747 - 48456748	641406	643357		NC_000015.10:48456747:GG:GGG
NM_000138.4(FBN1):c.4829_4838dup (p.Leu1616fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000641341	15	48757868 - 48757869	15	48465671 - 48465672	641341	643361		NC_000015.10:48465671:AGCTCCTGGCA:AGCTCCTGGCAGCTCCTGGCA
NC_000015.9:g.(?_48888470)_(48936976_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000639879	15	48888470 - 48936976	15	48596273 - 48644779	639879	652523		
NM_000138.4(FBN1):c.7655_7656delinsAA (p.Cys2552Ter)	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000638929	15	48713798 - 48713799	15	48421601 - 48421602	638929	643318		NC_000015.10:48421600:GC:TT
NM_000138.4(FBN1):c.5966G>T (p.Cys1989Phe)	FBN1	C1989F	Marfan syndrome	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000638559	15	48736809	15	48444612	638559	626347		NC_000015.10:48444611:C:A
NC_000015.9:g.(?_48905187)_(48936986_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000584085	15	48905187 - 48936986	15	48612990 - 48644789	584085	569208		
NC_000015.9:g.(?_48888460)_(48936986_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000583422	15	48888460 - 48936986	15	48596263 - 48644789	583422	573121		
NM_000138.4(FBN1):c.2340del (p.Gln780fs)	FBN1	Q780fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000583257	15	48788376	15	48496179	583257	568978	rs1566911942	NC_000015.10:48496178:TT:T
NM_000138.4(FBN1):c.6800del (p.Asn2267fs)	FBN1	N2267fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000582882	15	48722939	15	48430742	582882	568915	rs1566894288	NC_000015.10:48430741:TT:T
NM_000138.4(FBN1):c.5688_5691del (p.Arg1897fs)	FBN1	R1897fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, single submitter	VCV000581732	15	48739000 - 48739003	15	48446803 - 48446806	581732	573343	rs1566898828	NC_000015.10:48446802:TCTTTC:TC
NM_000138.4(FBN1):c.4911C>A (p.Tyr1637Ter)	FBN1	Y1637*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000581702	15	48757796	15	48465599	581702	568943	rs1566903921	NC_000015.10:48465598:G:T
NM_000138.4(FBN1):c.1948del (p.Arg650fs)	FBN1	R650fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000581142	15	48797234	15	48505037	581142	569518	rs1566913982	NC_000015.10:48505036:GG:G
NM_000138.4(FBN1):c.3595_3608dup (p.Ile1203fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000581002	15	48777674 - 48777675	15	48485477 - 48485478	581002	567151	rs1566908947	NC_000015.10:48485477:ATGCTGCATTCATCA:ATGCTGCATTCATCATGCTGCATTCATCA
NM_000138.4(FBN1):c.2471_2474delinsAATAAA (p.Ser824_Pro825delinsLysTer)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000580859	15	48787731 - 48787734	15	48495534 - 48495537	580859	568973	rs1566911724	NC_000015.10:48495533:GGGC:TTTATT
NM_000138.4(FBN1):c.5536C>T (p.Gln1846Ter)	FBN1	Q1846*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000580013	15	48744768	15	48452571	580013	569482	rs1566900473	NC_000015.10:48452570:G:A
NM_000138.4(FBN1):c.3624T>A (p.Cys1208Ter)	FBN1	C1208*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000579992	15	48777659	15	48485462	579992	567149	rs765842423	NC_000015.10:48485461:A:T
NM_000138.4(FBN1):c.7822G>T (p.Glu2608Ter)	FBN1	E2608*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, single submitter	VCV000579718	15	48707962	15	48415765	579718	573323	rs1566890005	NC_000015.10:48415764:C:A
NM_000138.4(FBN1):c.4224_4225CT[1] (p.Cys1408_Ser1409insTer)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000578961	15	48764857 - 48764858	15	48472660 - 48472661	578961	567146	rs1566905976	NC_000015.10:48472659:AGAG:AG
NM_000138.4(FBN1):c.5362_5364delinsGACT (p.Ser1788fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000576668	15	48748892 - 48748894	15	48456695 - 48456697	576668	569485	rs1566901605	NC_000015.10:48456694:GCT:AGTC
NM_000138.4(FBN1):c.2384del (p.Gly795fs)	FBN1	G795fs	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000575476	15	48788332	15	48496135	575476	567159	rs1566911908	NC_000015.10:48496134:CCC:CC
NM_000138.4(FBN1):c.7549C>T (p.Gln2517Ter)	FBN1	Q2517*	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000574342	15	48714170	15	48421973	574342	569429	rs1566891808	NC_000015.10:48421972:G:A
NM_000138.4(FBN1):c.3432dup (p.Gln1145fs)	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000573107	15	48779539 - 48779540	15	48487342 - 48487343	573107	569497	rs1566909483	NC_000015.10:48487342:A:AA
NM_000138.4(FBN1):c.3952dup (p.Thr1318fs)	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000572235	15	48773863 - 48773864	15	48481666 - 48481667	572235	569493	rs1566908063	NC_000015.10:48481666:TTTTT:TTTTTT
NM_000138.4(FBN1):c.5296+5G>C	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000571937	15	48752438	15	48460241	571937	567138	rs1566902515	NC_000015.10:48460240:C:G
NM_000138.4(FBN1):c.3073_3074insA (p.Phe1025fs)	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000571557	15	48782056 - 48782057	15	48489859 - 48489860	571557	573365	rs1566910251	NC_000015.10:48489859::T
NM_000138.4(FBN1):c.1302T>A (p.Tyr434Ter)	FBN1	Y434*	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000571414	15	48808405	15	48516208	571414	568987	rs1566916969	NC_000015.10:48516207:A:T
NM_000138.4(FBN1):c.3518A>T (p.Asn1173Ile)	FBN1	N1173I	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000570671	15	48779343	15	48487146	570671	569496	rs1555398520	NC_000015.10:48487145:T:A
NM_000138.4(FBN1):c.7251dup (p.Cys2418fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000570130	15	48718014 - 48718015	15	48425817 - 48425818	570130	568899	rs1566892906	NC_000015.10:48425817:TT:TTT
NM_000138.4(FBN1):c.7398C>G (p.Tyr2466Ter)	FBN1	Y2466*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000569834	15	48717621	15	48425424	569834	573328	rs1555394402	NC_000015.10:48425423:G:C
NM_000138.4(FBN1):c.6757G>T (p.Glu2253Ter)	FBN1	E2253*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000566067	15	48722982	15	48430785	566067	569442	rs1245476075	NC_000015.10:48430784:C:A
NM_000138.4(FBN1):c.5225_5296del	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000560344	15	48752443 - 48752514	15	48460246 - 48460317	560344	551398	rs1566902526	
NM_000138.4(FBN1):c.1760G>A (p.Cys587Tyr)	FBN1	C587Y	Marfan syndrome	Pathogenic	criteria provided, single submitter	VCV000549040	15	48800856	15	48508659	549040	539866	rs1555399963	NC_000015.10:48508658:C:T
NM_000138.4(FBN1):c.8416dup (p.Ile2806fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547349	15	48703386 - 48703387	15	48411189 - 48411190	547349	538031	rs1555393538	NC_000015.10:48411189:TTTT:TTTTT
NC_000015.9:g.(?_48902905)_(48905309_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000527237	15	48902905 - 48905309	15	48610708 - 48613112	527237	529020		
NM_000138.4(FBN1):c.2003delinsTGTAT (p.Gly668fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000527214	15	48796094	15	48503897	527214	528993	rs1555399770	NC_000015.10:48503896:C:ATACA
NM_000138.4(FBN1):c.5756del (p.Gly1919fs)	FBN1	G1919fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000527213	15	48738935	15	48446738	527213	529441	rs1555395825	NC_000015.10:48446737:CC:C
NM_000138.4(FBN1):c.6023del (p.Asn2008fs)	FBN1	N2008fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000527212	15	48736752	15	48444555	527212	528935	rs1555395640	NC_000015.10:48444554:TTTT:TTT
NM_000138.4(FBN1):c.406dup (p.Cys136fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 8, 2017)	criteria provided, single submitter	VCV000527211	15	48892371 - 48892372	15	48600174 - 48600175	527211	529368	rs1555405042	NC_000015.10:48600174:A:AA
NM_000138.4(FBN1):c.5062del (p.Met1688fs)	FBN1	M1688fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527196	15	48756099	15	48463902	527196	528956	rs1555396837	NC_000015.10:48463901:T:
NM_000138.4(FBN1):c.5590C>T (p.Gln1864Ter)	FBN1	Q1864*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000527195	15	48741046	15	48448849	527195	528899	rs1555395985	NC_000015.10:48448848:G:A
NM_000138.4(FBN1):c.4188del (p.Gly1397fs)	FBN1	G1397fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000527190	15	48766474	15	48474277	527190	529328	rs1555397652	NC_000015.10:48474276:T:
NM_000138.4(FBN1):c.6966del (p.Phe2322fs)	FBN1	F2322fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000527184	15	48720574	15	48428377	527184	528912	rs1555394623	NC_000015.10:48428376:AAA:AA
NM_000138.4(FBN1):c.3793_3799del (p.Cys1265fs)	FBN1	C1265fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000527172	15	48776054 - 48776060	15	48483857 - 48483863	527172	528972	rs1555398276	NC_000015.10:48483856:CATAACACA:CA
NM_000138.4(FBN1):c.8173A>T (p.Lys2725Ter)	FBN1	K2725*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000527171	15	48704819	15	48412622	527171	529425	rs1555393652	NC_000015.10:48412621:T:A
NM_000138.4(FBN1):c.7092C>A (p.Cys2364Ter)	FBN1	C2364*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000527162	15	48719876	15	48427679	527162	529435	rs1555394569	NC_000015.10:48427678:G:T
NM_000138.4(FBN1):c.2887_2893del (p.Glu963fs)	FBN1	E963fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000527161	15	48782237 - 48782243	15	48490040 - 48490046	527161	528919	rs1555398832	NC_000015.10:48490039:CGTCCTC:
NM_000138.4(FBN1):c.2857dup (p.Ile953fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000527157	15	48782272 - 48782273	15	48490075 - 48490076	527157	529493	rs1555398837	NC_000015.10:48490075:T:TT
NM_000138.4(FBN1):c.3656dup (p.Tyr1219Ter)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000527156	15	48777626 - 48777627	15	48485429 - 48485430	527156	528915	rs1555398395	NC_000015.10:48485429:T:TT
NM_000138.4(FBN1):c.4003_4004insCACAACTCTGGCA (p.Lys1335fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000527146	15	48766808 - 48766809	15	48474611 - 48474612	527146	529459	rs1555397733	NC_000015.10:48474611:TGCCA:TGCCAGAGTTGTGTGCCA
NM_000138.4(FBN1):c.4965del (p.Gly1656fs)	FBN1	G1656fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000527139	15	48756196	15	48463999	527139	528902	rs1555396861	NC_000015.10:48463998:A:
NM_000138.4(FBN1):c.3795T>A (p.Cys1265Ter)	FBN1	C1265*	Marfan syndrome|not provided	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000523795	15	48776058	15	48483861	523795	514674	rs1555398278	NC_000015.10:48483860:A:T
NM_000138.4(FBN1):c.4164_4167CTGT[1] (p.Leu1390fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000517371	15	48766491 - 48766494	15	48474294 - 48474297	517371	497067	rs1555397655	NC_000015.10:48474293:ACAGACAG:ACAG
NM_000138.4(FBN1):c.5861del (p.Phe1954fs)	FBN1	F1954fs	Marfan syndrome	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000505296	15	48737629	15	48445432	505296	497682	rs1555395756	NC_000015.10:48445431:AAA:AA
NM_000138.4(FBN1):c.7999G>T (p.Glu2667Ter)	FBN1	E2667*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000457266	15	48707785	15	48415588	457266	465150	rs149062442	NC_000015.10:48415587:C:A
NM_000138.4(FBN1):c.6616+1G>C	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000457247	15	48726790	15	48434593	457247	464335	rs1064793980	NC_000015.10:48434592:C:G
NM_000138.4(FBN1):c.6391T>A (p.Cys2131Ser)	FBN1	C2131S	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000457245	15	48729263	15	48437066	457245	464879	rs1555395210	NC_000015.10:48437065:A:T
NM_000138.4(FBN1):c.6327del (p.Ile2110fs)	FBN1	I2110fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000457243	15	48729571	15	48437374	457243	465096	rs1555395228	NC_000015.10:48437373:C:
NM_000138.4(FBN1):c.6038-1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000457238	15	48734044	15	48441847	457238	465177	rs1555395489	NC_000015.10:48441846:C:T
NM_000138.4(FBN1):c.4821delinsCA (p.Asp1608fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 10, 2017)	criteria provided, single submitter	VCV000457226	15	48757886	15	48465689	457226	464352	rs1555397007	NC_000015.10:48465688:A:TG
NM_000138.4(FBN1):c.4582+1G>T	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000457217	15	48760608	15	48468411	457217	464359	rs1555397195	NC_000015.10:48468410:C:A
NM_000138.4(FBN1):c.4555del (p.Glu1518_Leu1519insTer)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000457216	15	48760636	15	48468439	457216	465112	rs1555397199	NC_000015.10:48468438:G:
NM_000138.4(FBN1):c.3962dup (p.Asp1322fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000457200	15	48773853 - 48773854	15	48481656 - 48481657	457200	464934	rs1555398137	NC_000015.10:48481656:G:GG
NM_000138.4(FBN1):c.336dup (p.Ser113fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000457193	15	48902934 - 48902935	15	48610737 - 48610738	457193	464394	rs1555405528	NC_000015.10:48610737:G:GG
NM_000138.4(FBN1):c.3098del (p.Lys1033fs)	FBN1	K1033fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000457188	15	48780675	15	48488478	457188	464937	rs1555398683	NC_000015.10:48488477:TT:T
NM_000138.4(FBN1):c.3061_3082+172del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000457187	15	48781876 - 48782069	15	48489679 - 48489872	457187	465219	rs1555398753	
NM_000138.4(FBN1):c.2682_2692delinsTTTACC (p.Ile895fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	VCV000457176	15	48786437 - 48786447	15	48494240 - 48494250	457176	464381	rs1555399095	NC_000015.10:48494239:TACCACATATG:GGTAAA
NM_000138.4(FBN1):c.1983C>G (p.Cys661Trp)	FBN1	C661W	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000457168	15	48796114	15	48503917	457168	465139	rs765018527	NC_000015.10:48503916:G:C
NM_000138.4(FBN1):c.1410del (p.Ser471fs)	FBN1	S471fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000457161	15	48807642	15	48515445	457161	465248	rs1555400383	NC_000015.10:48515444:CCC:CC
NM_000138.4(FBN1):c.1287dup (p.Pro430fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000457159	15	48808419 - 48808420	15	48516222 - 48516223	457159	464974	rs1555400410	NC_000015.10:48516222:T:TT
Single allele	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000457155			15	48508562 - 48516382	457155	464780		
Single allele	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000457154			15	48503767 - 48510189	457154	464532		
NC_000015.9:g.(?_48707358)_(48760751_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000457153	15	48707358 - 48760751	15	48415161 - 48468554	457153	463948		
NC_000015.9:g.(?_48703167)_(48789608_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000457150	15	48703167 - 48789608	15	48410970 - 48497411	457150	463946		
NM_000138.4(FBN1):c.871G>T (p.Glu291Ter)	FBN1	E291*	Marfan syndrome	Pathogenic(Last reviewed: May 30, 2016)	criteria provided, single submitter	VCV000453293	15	48818444	15	48526247	453293	446890	rs1232880706	NC_000015.10:48526246:C:A
NM_000138.4(FBN1):c.6313+2T>C	FBN1		Marfan syndrome|not provided	Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	VCV000449672	15	48729963	15	48437766	449672	445348	rs1555395257	NC_000015.10:48437765:A:G
NM_000138.4(FBN1):c.6953G>A (p.Cys2318Tyr)	FBN1	C2318Y	Marfan syndrome|not provided	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000449436	15	48720587	15	48428390	449436	445344	rs1555394626	NC_000015.10:48428389:C:T
NM_000138.4(FBN1):c.2669G>A (p.Cys890Tyr)	FBN1	C890Y	not provided|Marfan syndrome	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000431935	15	48787328	15	48495131	431935	426112	rs1555399144	NC_000015.10:48495130:C:T
NM_000138.4(FBN1):c.3412T>C (p.Cys1138Arg)	FBN1	C1138R	Marfan syndrome|not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000430152	15	48779560	15	48487363	430152	422037	rs1131691806	NC_000015.10:48487362:A:G
NM_000138.4(FBN1):c.7819+1G>A	FBN1		Marfan syndrome|not provided	Pathogenic(Last reviewed: Sep 27, 2015)	criteria provided, single submitter	VCV000430010	15	48712883	15	48420686	430010	422019	rs112907302	NC_000015.10:48420685:C:T
NM_000138.4(FBN1):c.799_805del (p.Gly267fs)	FBN1	G267fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000406374	15	48826334 - 48826340	15	48534137 - 48534143	406374	400747	rs1060501100	NC_000015.10:48534136:AAGACCCAA:AA
NM_000138.4(FBN1):c.7331A>G (p.Asp2444Gly)	FBN1	D2444G	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000406366	15	48717688	15	48425491	406366	400144	rs1060501093	NC_000015.10:48425490:T:C
NM_000138.4(FBN1):c.2089C>T (p.Gln697Ter)	FBN1	Q697*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000406355	15	48796008	15	48503811	406355	400216	rs1060501082	NC_000015.10:48503810:G:A
NM_000138.4(FBN1):c.7974dup (p.Cys2659fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Apr 4, 2016)	criteria provided, single submitter	VCV000406354	15	48707809 - 48707810	15	48415612 - 48415613	406354	400324	rs1555393848	NC_000015.10:48415612:GGGGG:GGGGGG
NM_000138.4(FBN1):c.2213dup (p.Cys739fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000406340	15	48789542 - 48789543	15	48497345 - 48497346	406340	400214	rs1555399379	NC_000015.10:48497345:A:AA
NM_000138.4(FBN1):c.7881dup (p.Ser2628fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000406338	15	48707902 - 48707903	15	48415705 - 48415706	406338	400138	rs1060501067	NC_000015.10:48415705:CCCC:CCCCC
NM_000138.4(FBN1):c.4061G>A (p.Trp1354Ter)	FBN1	W1354*	Marfan syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000406293	15	48766751	15	48474554	406293	400674	rs1060501039	NC_000015.10:48474553:C:T
NM_000138.4(FBN1):c.2305T>C (p.Cys769Arg)	FBN1	C769R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000406272	15	48788411	15	48496214	406272	400702	rs1060501022	NC_000015.10:48496213:A:G
NM_000138.4(FBN1):c.6772T>C (p.Cys2258Arg)	FBN1	C2258R	not provided|Marfan syndrome	Pathogenic(Last reviewed: Apr 17, 2015)	criteria provided, single submitter	VCV000379489	15	48722967	15	48430770	379489	374549	rs1057520617	NC_000015.10:48430769:A:G
NM_000138.4(FBN1):c.8149G>T (p.Glu2717Ter)	FBN1	E2717*	Marfan syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 8, 2012)	criteria provided, single submitter	VCV000263433	15	48704843	15	48412646	263433	258819	rs187553035	NC_000015.10:48412645:C:A
NM_000138.4(FBN1):c.732T>A (p.Cys244Ter)	FBN1	C244*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000237104	15	48829812	15	48537615	237104	242083	rs878853689	NC_000015.10:48537614:A:T
NM_000138.4(FBN1):c.434G>A (p.Cys145Tyr)	FBN1	C145Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 16, 2017)	criteria provided, single submitter	VCV000237091	15	48892344	15	48600147	237091	242084	rs878853682	NC_000015.10:48600146:C:T
NM_000138.4(FBN1):c.8154dup (p.Lys2719Ter)	FBN1		Marfan syndrome|not provided	Pathogenic(Last reviewed: Jul 23, 2014)	criteria provided, single submitter	VCV000200173	15	48704837 - 48704838	15	48412640 - 48412641	200173	197582	rs794728321	NC_000015.10:48412640:A:AA
NM_000138.4(FBN1):c.4405del (p.Arg1469fs)	FBN1	R1469fs	Marfan syndrome|not provided	Pathogenic(Last reviewed: Oct 22, 2013)	criteria provided, single submitter	VCV000200160	15	48762885	15	48470688	200160	197701	rs794728308	NC_000015.10:48470687:GG:G
NM_000138.4(FBN1):c.7624C>T (p.Gln2542Ter)	FBN1	Q2542*	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000200119	15	48713830	15	48421633	200119	197596	rs794728276	NC_000015.10:48421632:G:A
NM_000138.4(FBN1):c.6496G>A (p.Asp2166Asn)	FBN1	D2166N	Marfan syndrome|not provided	Pathogenic(Last reviewed: Oct 25, 2012)	criteria provided, single submitter	VCV000200087	15	48729158	15	48436961	200087	197640	rs794728252	NC_000015.10:48436960:C:T
NM_000138.4(FBN1):c.5208T>A (p.Cys1736Ter)	FBN1	C1736*	Marfan syndrome|not provided	Pathogenic(Last reviewed: Mar 30, 2014)	criteria provided, single submitter	VCV000200060	15	48755295	15	48463098	200060	197678	rs794728234	NC_000015.10:48463097:A:T
NM_000138.4(FBN1):c.4888C>T (p.Gln1630Ter)	FBN1	Q1630*	Marfan syndrome|not provided	Pathogenic(Last reviewed: Apr 1, 2014)	criteria provided, single submitter	VCV000200056	15	48757819	15	48465622	200056	197686	rs794728231	NC_000015.10:48465621:G:A
NM_000138.5(FBN1):c.6886C>T (p.Gln2296Ter)	FBN1	Q2296*	Marfan syndrome	Pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	VCV000177938	15	48720654	15	48428457	177938	176124	rs727504410	NC_000015.10:48428456:G:A
NM_000138.5(FBN1):c.8267G>A (p.Trp2756Ter)	FBN1	W2756*	Marfan syndrome	Pathogenic(Last reviewed: Jul 1, 2010)	criteria provided, single submitter	VCV000042441	15	48703536	15	48411339	42441	51611	rs397515861	NC_000015.10:48411338:C:T
NM_000138.5(FBN1):c.3463+1G>T	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Jul 5, 2011)	criteria provided, single submitter	VCV000042336	15	48779508	15	48487311	42336	51506	rs397515792	NC_000015.10:48487310:C:A
NM_000138.4(FBN1):c.1211del (p.Pro404fs)	FBN1	P404fs	Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000036033	15	48808496	15	48516299	36033	44697	rs112289537	NC_000015.10:48516298:GGGGG:GGGG
NM_000138.4(FBN1):c.3037G>C (p.Gly1013Arg)	FBN1	G1013R	Marfan syndrome	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000016455	15	48782093	15	48489896	16455	31494	rs140593	NC_000015.10:48489895:C:G
NM_000138.4(FBN1):c.6739+1G>C	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000016436	15	48725062	15	48432865	16436	31475	rs869025419	NC_000015.10:48432864:C:G
NM_000137.4(FAH):c.1062+5G>A	FAH		Tyrosinemia type I|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011870	15	80472572	15	80180230	11870	26909	rs80338901	NC_000015.10:80180229:G:A
NM_004004.6(GJB2):c.1A>G (p.Met1Val)	GJB2	M1V	not provided|Deafness, autosomal recessive 1A|Knuckle pads, deafness AND leukonychia syndrome|Hystrix-like ichthyosis with deafness|Palmoplantar keratoderma-deafness syndrome|Deafness, X-linked 2|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Mutilating keratoderma|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Rare genetic deafness|not specified	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044729	13	20763720	13	20189581	44729	53896	rs111033293	NC_000013.11:20189580:T:C
NM_004004.6(GJB2):c.19C>T (p.Gln7Ter)	GJB2	Q7*	Deafness, autosomal recessive 1A|Rare genetic deafness|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000044728	13	20763702	13	20189563	44728	53895	rs111033451	NC_000013.11:20189562:G:A
NM_001079846.1(CREBBP):c.3841C>T (p.Arg1281Ter)	CREBBP	R1319*, R1281*	Inborn genetic diseases	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000521081	16	3794922	16	3744921	521081	512208	rs1555475250	NC_000016.10:3744920:G:A
NM_001079846.1(CREBBP):c.3314del (p.Asp1105fs)	CREBBP	D1143fs, D1105fs	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	VCV000521003	16	3807991	16	3757990	521003	512210	rs1555478331	NC_000016.10:3757989:T:
NM_001079846.1(CREBBP):c.90del (p.Phe30fs)	CREBBP	F30fs	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 3, 2016)	criteria provided, single submitter	VCV000520877	16	3901006	16	3851005	520877	512211	rs1555496732	NC_000016.10:3851004:AAAA:AAA
NM_001079846.1(CREBBP):c.4234T>C (p.Tyr1412His)	CREBBP	Y1450H, Y1412H	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 8, 2015)	criteria provided, single submitter	VCV000520695	16	3788606	16	3738605	520695	512207	rs1555473499	NC_000016.10:3738604:A:G
NM_001079846.1(CREBBP):c.5015G>A (p.Cys1672Tyr)	CREBBP	C1710Y, C1672Y	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 26, 2015)	criteria provided, single submitter	VCV000520650	16	3781236	16	3731235	520650	512205	rs1555471813	NC_000016.10:3731234:C:T
NM_001079846.1(CREBBP):c.4295A>G (p.His1432Arg)	CREBBP	H1470R, H1432R	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 30, 2014)	criteria provided, single submitter	VCV000208655	16	3786802	16	3736801	208655	205291	rs797044860	NC_000016.10:3736800:T:C
NM_013275.6(ANKRD11):c.3702_3705del (p.Lys1235fs)	ANKRD11	K1235fs	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000432304	16	89349245 - 89349248	16	89282837 - 89282840	432304	426193	rs1555528357	NC_000016.10:89282836:TTTATTT:TTT
NM_000138.5(FBN1):c.755_762del (p.Ala252fs)	FBN1	A252fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000862810	15	48826377 - 48826384	15	48534180 - 48534187	862810	842531		NC_000015.10:48534179:GGGGATGG:
NM_000138.5(FBN1):c.6837del (p.Tyr2280fs)	FBN1	Y2280fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000862646	15	48722902	15	48430705	862646	842451		NC_000015.10:48430704:CCC:CC
NM_000138.5(FBN1):c.4177del (p.Glu1393fs)	FBN1	E1393fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000862320	15	48766485	15	48474288	862320	842484		NC_000015.10:48474287:CC:C
NM_000138.5(FBN1):c.6735C>A (p.Cys2245Ter)	FBN1	C2245*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000853202	15	48725067	15	48432870	853202	842454		NC_000015.10:48432869:G:T
NM_000138.5(FBN1):c.8477_8478insATAG (p.Tyr2827_Ser2828insTer)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000849975	15	48703325 - 48703326	15	48411128 - 48411129	849975	842430		NC_000015.10:48411128::CTAT
NM_000138.5(FBN1):c.7974del (p.Cys2659fs)	FBN1	C2659fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000848010	15	48707810	15	48415613	848010	842436		NC_000015.10:48415612:GGGGG:GGGG
NM_000138.5(FBN1):c.1981dup (p.Cys661fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000847743	15	48796115 - 48796116	15	48503918 - 48503919	847743	842512		NC_000015.10:48503918:A:AA
NM_000138.5(FBN1):c.679C>T (p.Gln227Ter)	FBN1	Q227*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000844924	15	48829865	15	48537668	844924	842533		NC_000015.10:48537667:G:A
NM_000138.5(FBN1):c.6180C>G (p.Tyr2060Ter)	FBN1	Y2060*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000837810	15	48730098	15	48437901	837810	842461		NC_000015.10:48437900:G:C
NM_000138.5(FBN1):c.1875_1876inv (p.Gly626Arg)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000836639	15	48797306 - 48797307	15	48505109 - 48505110	836639	842515		NC_000015.10:48505108:CA:TG
NM_000138.5(FBN1):c.7760del (p.Gly2587fs)	FBN1	G2587fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000653146	15	48712943	15	48420746	653146	643315		NC_000015.10:48420745:CCCCC:CCCC
NM_000138.4(FBN1):c.2305_2315del (p.Cys769fs)	FBN1	C769fs	Marfan syndrome|Ectopia lentis, isolated, autosomal dominant|Marfan lipodystrophy syndrome|Geleophysic dysplasia 2|Acromicric dysplasia|Stiff skin syndrome|MASS syndrome|Weill-Marchesani syndrome 2	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000625943	15	48788401 - 48788411	15	48496204 - 48496214	625943	614400	rs1566911957	NC_000015.10:48496203:TTCAGTACACATTCA:TTCA
NM_000138.4(FBN1):c.5613del (p.Tyr1873fs)	FBN1	Y1873fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000582223	15	48741023	15	48448826	582223	567137	rs1566899541	NC_000015.10:48448825:G:
NM_000138.4(FBN1):c.3013G>T (p.Glu1005Ter)	FBN1	E1005*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000581386	15	48782117	15	48489920	581386	569509	rs564713154	NC_000015.10:48489919:C:A
NM_000138.4(FBN1):c.6940_6943dup (p.Thr2315fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000581318	15	48720596 - 48720597	15	48428399 - 48428400	581318	568912	rs1566893738	NC_000015.10:48428399:TGTA:TGTATGTA
NM_000138.4(FBN1):c.126del (p.Lys43fs)	FBN1	K43fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000568779	15	48936841	15	48644644	568779	569531	rs1566944839	NC_000015.10:48644643:GG:G
NM_000138.4(FBN1):c.2506del (p.Ser836fs)	FBN1	S836fs	Marfan syndrome|MASS syndrome	Pathogenic(Last reviewed: Jun 1, 2018)	no assertion criteria provided	VCV000560217	15	48787699	15	48495502	560217	551267	rs1566911709	NC_000015.10:48495501:TTT:TT
NM_000138.4(FBN1):c.5242_5243TG[1] (p.Cys1748fs)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000549267	15	48752494 - 48752495	15	48460297 - 48460298	549267	539667	rs1555396636	NC_000015.10:48460296:CACA:CA
NM_000138.4(FBN1):c.4460A>G (p.Asp1487Gly)	FBN1	D1487G	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000527205	15	48760731	15	48468534	527205	529312	rs1555397216	NC_000015.10:48468533:T:C
NM_000138.4(FBN1):c.3408C>A (p.Tyr1136Ter)	FBN1	Y1136*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000527176	15	48779564	15	48487367	527176	528918	rs1555398564	NC_000015.10:48487366:G:T
NM_000138.4(FBN1):c.2216G>A (p.Cys739Tyr)	FBN1	C739Y	Marfan syndrome|not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000520498	15	48789540	15	48497343	520498	511130	rs1555399378	NC_000015.10:48497342:C:T
NM_000138.4(FBN1):c.5345G>A (p.Cys1782Tyr)	FBN1	C1782Y	Cardiovascular phenotype|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000519757	15	48748911	15	48456714	519757	510572	rs1555396429	NC_000015.10:48456713:C:T
NM_000138.4(FBN1):c.347-2A>G	FBN1		Cardiovascular phenotype|Marfan syndrome	Pathogenic(Last reviewed: Jul 23, 2017)	criteria provided, single submitter	VCV000519716	15	48892433	15	48600236	519716	510646	rs1555405056	NC_000015.10:48600235:T:C
NM_000138.4(FBN1):c.4816+1G>T	FBN1		Cardiovascular phenotype|Marfan syndrome	Pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	VCV000519695	15	48757986	15	48465789	519695	510581	rs1555397014	NC_000015.10:48465788:C:A
NM_000138.4(FBN1):c.2647T>C (p.Trp883Arg)	FBN1	W883R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000457174	15	48787350	15	48495153	457174	465136	rs1555399150	NC_000015.10:48495152:A:G
NM_000138.4(FBN1):c.762del (p.Leu256fs)	FBN1	L256fs	not provided|Marfan syndrome	Pathogenic(Last reviewed: May 11, 2015)	criteria provided, single submitter	VCV000418977	15	48826377	15	48534180	418977	409300	rs1064793559	NC_000015.10:48534179:GGGG:GGG
NM_000138.4(FBN1):c.2080G>T (p.Glu694Ter)	FBN1	E694*	Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000406275	15	48796017	15	48503820	406275	400711	rs1060501024	NC_000015.10:48503819:C:A
NM_000138.4(FBN1):c.6784C>T (p.Gln2262Ter)	FBN1	Q2262*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000406274	15	48722955	15	48430758	406274	400968	rs1060501023	NC_000015.10:48430757:G:A
NM_000138.4(FBN1):c.6164-2A>G	FBN1		Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, multiple submitters, no conflicts	VCV000373085	15	48730116	15	48437919	373085	360174	rs794728244	NC_000015.10:48437918:T:C
NM_000138.4(FBN1):c.439C>T (p.Gln147Ter)	FBN1	Q147*	Marfan syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000264081	15	48892339	15	48600142	264081	258925	rs886039036	NC_000015.10:48600141:G:A
NM_000138.4(FBN1):c.1571del (p.Thr524fs)	FBN1	T524fs	Marfan syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 14, 2012)	criteria provided, single submitter	VCV000263469	15	48805763	15	48513566	263469	258914	rs886038817	NC_000015.10:48513565:G:
NM_000138.4(FBN1):c.8226+5G>A	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000200129	15	48704761	15	48412564	200129	197579	rs193922243	NC_000015.10:48412563:C:T
NM_000138.4(FBN1):c.7205-1G>A	FBN1		not provided|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, multiple submitters, no conflicts	VCV000200106	15	48718062	15	48425865	200106	197610	rs794728266	NC_000015.10:48425864:C:T
NM_000138.4(FBN1):c.1726T>G (p.Cys576Gly)	FBN1	C576G	Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000199977	15	48800890	15	48508693	199977	197787	rs794728174	NC_000015.10:48508692:A:C
NM_000138.5(FBN1):c.4937G>A (p.Cys1646Tyr)	FBN1	C1646Y	not provided|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000042372	15	48757770	15	48465573	42372	51542	rs397515814	NC_000015.10:48465572:C:T
NM_000138.5(FBN1):c.4367G>C (p.Cys1456Ser)	FBN1	C1456S	Marfan syndrome	Pathogenic(Last reviewed: Jun 3, 2011)	criteria provided, single submitter	VCV000042360	15	48762923	15	48470726	42360	51530	rs397515805	NC_000015.10:48470725:C:G
NM_000138.5(FBN1):c.3337+1G>A	FBN1		Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042331	15	48780309	15	48488112	42331	51501	rs397515789	NC_000015.10:48488111:C:T
NM_000138.4(FBN1):c.6920G>C (p.Cys2307Ser)	FBN1	C2307S	Marfan syndrome, mild variable|Marfan syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000016422	15	48720620	15	48428423	16422	31461	rs137854457	NC_000015.10:48428422:C:G
NM_000018.4(ACADVL):c.848T>C (p.Val283Ala)	ACADVL	V283A, V207A, V306A, V261A	not provided|Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021025	17	7125591	17	7222272	21025	33877	rs113994167	NC_000017.11:7222271:T:C
NM_000057.4(BLM):c.320dup (p.Leu107fs)	BLM		Bloom syndrome|Hereditary breast and ovarian cancer syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000405281	15	91292816 - 91292817	15	90749586 - 90749587	405281	400922	rs781221411	NC_000015.10:90749586:TT:TTT
NM_001005242.3(PKP2):c.1237C>T (p.Arg413Ter)	PKP2	R413*	Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|not provided|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045016	12	33003841	12	32850907	45016	54183	rs372827156	NC_000012.12:32850906:G:A
NM_001330504.1(ALG1):c.440C>T (p.Ser147Leu)	ALG1	S258L, S147L	Finnish congenital nephrotic syndrome|Inborn genetic diseases|Congenital disorder of glycosylation|ALG1-CDG|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004724	16	5128790	16	5078789	4724	19763	rs28939378	NC_000016.10:5078788:C:T
NM_000138.5(FBN1):c.6496+1G>T	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000863764	15	48729157	15	48436960	863764	852047		NC_000015.10:48436959:C:A
NM_000138.5(FBN1):c.4011del (p.Val1338fs)	FBN1	V1338fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000854447	15	48766801	15	48474604	854447	842486		NC_000015.10:48474603:A:
NM_000138.5(FBN1):c.7032_7054del (p.Asn2346fs)	FBN1	N2346fs	not specified|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000811334	15	48719914 - 48719936	15	48427717 - 48427739	811334	799801		NC_000015.10:48427716:AGCCGATCTGACACATGTTTTGTAGC:AGC
NM_000138.4(FBN1):c.2649G>A (p.Trp883Ter)	FBN1	W883*	Congenital scoliosis|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000654218	15	48787348	15	48495151	654218	643390		NC_000015.10:48495150:C:T
NM_000138.4(FBN1):c.6871+1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000653360	15	48722867	15	48430670	653360	653045		NC_000015.10:48430669:C:T
NM_000138.4(FBN1):c.3173G>A (p.Gly1058Asp)	FBN1	G1058D	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000646221	15	48780600	15	48488403	646221	643382		NC_000015.10:48488402:C:T
NM_000138.4(FBN1):c.2113G>A (p.Ala705Thr)	FBN1	A705T	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000642750	15	48795984	15	48503787	642750	643398		NC_000015.10:48503786:C:T
NM_000138.4(FBN1):c.165-2A>C	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000642384	15	48905291	15	48613094	642384	652419		NC_000015.10:48613093:T:G
NM_000138.4(FBN1):c.5015G>T (p.Cys1672Phe)	FBN1	C1672F	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000640108	15	48756146	15	48463949	640108	643359		NC_000015.10:48463948:C:A
NM_000138.4(FBN1):c.5672-2_5674delinsTGACT	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000582085	15	48739017 - 48739021	15	48446820 - 48446824	582085	569476	rs1566898852	NC_000015.10:48446819:TGTCT:AGTCA
NM_000138.4(FBN1):c.2113+1G>T	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000580926	15	48795983	15	48503786	580926	569516	rs1566913670	NC_000015.10:48503785:C:A
NM_000138.4(FBN1):c.3337+1del	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000574182	15	48780309	15	48488112	574182	568953	rs1566909762	NC_000015.10:48488111:CCC:CC
NM_000138.4(FBN1):c.530G>A (p.Cys177Tyr)	FBN1	C177Y	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Mar 31, 2018)	criteria provided, single submitter	VCV000574053	15	48888488	15	48596291	574053	567192	rs113695103	NC_000015.10:48596290:C:T
NM_000138.4(FBN1):c.4177_4199del (p.Glu1393fs)	FBN1	E1393fs	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not provided	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000572456	15	48766463 - 48766485	15	48474266 - 48474288	572456	569490	rs1566906389	NC_000015.10:48474265:AAGCCATCACCTGTGTATCCTTC:
NM_000138.4(FBN1):c.4942+1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000570762	15	48757764	15	48465567	570762	567140	rs1566903907	NC_000015.10:48465566:C:T
NM_000138.4(FBN1):c.7921C>T (p.Gln2641Ter)	FBN1	Q2641*	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000549441	15	48707863	15	48415666	549441	539506	rs1555393866	NC_000015.10:48415665:G:A
NM_000138.4(FBN1):c.7371dup (p.Ile2458fs)	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000549404	15	48717647 - 48717648	15	48425450 - 48425451	549404	539541	rs1555394407	NC_000015.10:48425450:AAAA:AAAAA
NM_000138.4(FBN1):c.7082C>A (p.Ser2361Ter)	FBN1	S2361*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000549389	15	48719886	15	48427689	549389	539555	rs397515844	NC_000015.10:48427688:G:T
NM_000138.4(FBN1):c.2793del (p.Ser932fs)	FBN1	S932fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000549113	15	48784719	15	48492522	549113	539804	rs778900586	NC_000015.10:48492521:CCCCC:CCCC
NM_000138.4(FBN1):c.2737G>T (p.Glu913Ter)	FBN1	E913*	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000549108	15	48784775	15	48492578	549108	539809	rs1555398996	NC_000015.10:48492577:C:A
NM_000138.4(FBN1):c.2562G>A (p.Trp854Ter)	FBN1	W854*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000549096	15	48787435	15	48495238	549096	539820	rs1555399164	NC_000015.10:48495237:C:T
NM_000138.4(FBN1):c.1462_1468+17delins17	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 25, 2017)	criteria provided, single submitter	VCV000527169	15	48807567 - 48807590	15	48515370 - 48515393	527169	528921		
NM_000138.4(FBN1):c.3778G>T (p.Glu1260Ter)	FBN1	E1260*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000527164	15	48776075	15	48483878	527164	529474	rs1555398283	NC_000015.10:48483877:C:A
NM_000138.4(FBN1):c.5626T>C (p.Cys1876Arg)	FBN1	C1876R	Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000520499	15	48741010	15	48448813	520499	511124	rs1555395980	NC_000015.10:48448812:A:G
NM_000138.4(FBN1):c.5203dup (p.Gln1735fs)	FBN1		Cardiovascular phenotype|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519739	15	48755299 - 48755300	15	48463102 - 48463103	519739	510573	rs1555396760	NC_000015.10:48463102:G:GG
NM_000138.4(FBN1):c.4082G>A (p.Cys1361Tyr)	FBN1	C1361Y	Cardiovascular phenotype|Marfan syndrome	Pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, single submitter	VCV000519726	15	48766730	15	48474533	519726	510592	rs1555397704	NC_000015.10:48474532:C:T
NM_000138.4(FBN1):c.6645del (p.Leu2216fs)	FBN1	L2216fs	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 27, 2017)	criteria provided, single submitter	VCV000457249	15	48725157	15	48432960	457249	464872	rs1555394928	NC_000015.10:48432959:C:
NM_000138.4(FBN1):c.4293C>G (p.Cys1431Trp)	FBN1	C1431W	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Mar 26, 2017)	criteria provided, single submitter	VCV000457207	15	48764791	15	48472594	457207	464910	rs112375043	NC_000015.10:48472593:G:C
NM_000138.4(FBN1):c.406T>G (p.Cys136Gly)	FBN1	C136G	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000457203	15	48892372	15	48600175	457203	465161	rs1555405041	NC_000015.10:48600174:A:C
NM_000138.4(FBN1):c.4293C>A (p.Cys1431Ter)	FBN1	C1431*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000457201	15	48764791	15	48472594	457201	464912	rs112375043	NC_000015.10:48472593:G:T
NM_000138.4(FBN1):c.3458G>A (p.Cys1153Tyr)	FBN1	C1153Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	VCV000457194	15	48779514	15	48487317	457194	465123	rs140599	NC_000015.10:48487316:C:T
NM_000138.4(FBN1):c.917del (p.Asn306fs)	FBN1	N306fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000419091	15	48818398	15	48526201	419091	409297	rs1064793637	NC_000015.10:48526200:TTT:TT
NM_000138.4(FBN1):c.7421del (p.Tyr2474fs)	FBN1	Y2474fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000406324	15	48717598	15	48425401	406324	400960	rs1060501060	NC_000015.10:48425400:T:
NM_000138.4(FBN1):c.5593_5594dup (p.Ile1866fs)	FBN1		not provided|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000287723	15	48741041 - 48741042	15	48448844 - 48448845	287723	271960	rs886043709	NC_000015.10:48448844:CAC:CACAC
NM_000138.4(FBN1):c.2019_2022TTTG[1] (p.Phe675fs)	FBN1		not provided|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280058	15	48796071 - 48796074	15	48503874 - 48503877	280058	264737	rs886041349	NC_000015.10:48503873:CAAACAAA:CAAA
NM_000138.4(FBN1):c.7125T>A (p.Cys2375Ter)	FBN1	C2375*	not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000200105	15	48719843	15	48427646	200105	197613	rs794728265	NC_000015.10:48427645:A:T
NM_000138.4(FBN1):c.6871+1G>T	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000200095	15	48722867	15	48430670	200095	197626	rs794728258	NC_000015.10:48430669:C:A
NM_000138.4(FBN1):c.6418G>A (p.Gly2140Arg)	FBN1	G2140R	not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000200083	15	48729236	15	48437039	200083	197646	rs794728249	NC_000015.10:48437038:C:T
NM_000138.4(FBN1):c.5097C>G (p.Tyr1699Ter)	FBN1	Y1699*	not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000200059	15	48755406	15	48463209	200059	197681	rs368979510	NC_000015.10:48463208:G:C
NM_000138.4(FBN1):c.(?_5475)_(5542_?)del	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Mar 1, 2012)	criteria provided, single submitter	VCV000163458	15	48744762 - 48744829	15	48452565 - 48452632	163458	175953		
NM_000138.4(FBN1):c.(?_4473)_(8280_?)del	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Sep 7, 2011)	criteria provided, single submitter	VCV000163457	15	48703523 - 48760718	15	48411326 - 48468521	163457	175772		
NM_000138.5(FBN1):c.6379+1G>A	FBN1		Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042400	15	48729518	15	48437321	42400	51570	rs397515833	NC_000015.10:48437320:C:T
NM_000138.5(FBN1):c.4955G>A (p.Cys1652Tyr)	FBN1	C1652Y	Marfan syndrome	Pathogenic(Last reviewed: Apr 29, 2009)	criteria provided, single submitter	VCV000042376	15	48756206	15	48464009	42376	51546	rs397515817	NC_000015.10:48464008:C:T
NM_000138.4(FBN1):c.2412_2413del (p.Thr804_Cys805insTer)	FBN1		Marfan syndrome	Pathogenic(Last reviewed: Mar 24, 2009)	criteria provided, single submitter	VCV000042304	15	48788303 - 48788304	15	48496106 - 48496107	42304	51474	rs397515769	NC_000015.10:48496105:AT:
NM_000138.5(FBN1):c.2341T>C (p.Cys781Arg)	FBN1	C781R	Marfan syndrome	Pathogenic(Last reviewed: Mar 5, 2009)	criteria provided, single submitter	VCV000042301	15	48788375	15	48496178	42301	51471	rs397515766	NC_000015.10:48496177:A:G
NM_000138.4(FBN1):c.4087+1G>A	FBN1		Marfan syndrome|Marfan syndrome, neonatal	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000016442	15	48766724	15	48474527	16442	31481	rs387906548	NC_000015.10:48474526:C:T
NM_004004.6(GJB2):c.551G>A (p.Arg184Gln)	GJB2	R184Q	not provided|Deafness, autosomal dominant 3a|Hearing impairment|Rare genetic deafness|Hearing loss|not specified	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000029662	13	20763170	13	20189031	29662	38617	rs80338950	NC_000013.11:20189030:C:T
NM_002834.5(PTPN11):c.228G>T (p.Glu76Asp)	PTPN11	E76D, E75D	Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Noonan syndrome 1|Metachondromatosis|not provided|Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040502	12	112888212	12	112450408	40502	48972	rs397507514	NC_000012.12:112450407:G:T
NM_000257.4(MYH7):c.767G>A (p.Gly256Glu)	MYH7	G256E	not provided|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014099	14	23900656	14	23431447	14099	29138	rs121913633	NC_000014.9:23431446:C:T
NM_000138.5(FBN1):c.2539+1G>C	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000860190	15	48787665	15	48495468	860190	852775		NC_000015.10:48495467:C:G
NM_000138.5(FBN1):c.7454-2A>G	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000856210	15	48714267	15	48422070	856210	852592		NC_000015.10:48422069:T:C
NM_000138.5(FBN1):c.6997+1G>C	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000852129	15	48720542	15	48428345	852129	851619		NC_000015.10:48428344:C:G
NM_000138.5(FBN1):c.1468+2T>G	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000846428	15	48807582	15	48515385	846428	852599		NC_000015.10:48515384:A:C
NM_000138.5(FBN1):c.6997+1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000841704	15	48720542	15	48428345	841704	852767		NC_000015.10:48428344:C:T
NM_000138.5(FBN1):c.8338dup (p.Leu2780fs)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000839703	15	48703464 - 48703465	15	48411267 - 48411268	839703	842432		NC_000015.10:48411267:G:GG
NM_000138.5(FBN1):c.3463+1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000837133	15	48779508	15	48487311	837133	851625		NC_000015.10:48487310:C:T
NM_000138.5(FBN1):c.7205-1G>C	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000836625	15	48718062	15	48425865	836625	852596		NC_000015.10:48425864:C:G
NM_000138.4(FBN1):c.6634C>T (p.Gln2212Ter)	FBN1	Q2212*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000684603	15	48725168	15	48432971	684603	672164		NC_000015.10:48432970:G:A
NM_000138.4(FBN1):c.5671+1G>T	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000648091	15	48740964	15	48448767	648091	653049		NC_000015.10:48448766:C:A
NM_000138.5(FBN1):c.1782del (p.Phe594fs)	FBN1	F594fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000646896	15	48800834	15	48508637	646896	643403		NC_000015.10:48508636:AAAA:AAA
NM_000138.5(FBN1):c.661del (p.Cys221fs)	FBN1	C221fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000638265	15	48829883	15	48537686	638265	626021		NC_000015.10:48537685:A:
NC_000015.9:g.(?_48762811)_(48791255_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 18, 2018)	criteria provided, single submitter	VCV000584214	15	48762811 - 48791255	15	48470614 - 48499058	584214	568573		
NM_000138.4(FBN1):c.7663G>A (p.Gly2555Arg)	FBN1	G2555R	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000567107	15	48713791	15	48421594	567107	568887	rs1566891655	NC_000015.10:48421593:C:T
NM_000138.4(FBN1):c.660_661del (p.Pro220_Cys221insTer)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: May 20, 2018)	criteria provided, single submitter	VCV000549352	15	48829883 - 48829884	15	48537686 - 48537687	549352	539919	rs1555401679	NC_000015.10:48537685:AG:
NM_000138.4(FBN1):c.6244G>T (p.Glu2082Ter)	FBN1	E2082*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547337	15	48730034	15	48437837	547337	538043	rs1052480459	NC_000015.10:48437836:C:A
NM_000138.4(FBN1):c.441del (p.Gln147fs)	FBN1	Q147fs	Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000527202	15	48892337	15	48600140	527202	529534	rs1555405028	NC_000015.10:48600139:TT:T
NM_000138.4(FBN1):c.3337+1G>T	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000527150	15	48780309	15	48488112	527150	529483	rs397515789	NC_000015.10:48488111:C:A
NM_000138.4(FBN1):c.4388A>G (p.Asn1463Ser)	FBN1	N1463S	Myxomatous mitral valve degeneration|High palate|Mitral valve prolapse|Lumbar scoliosis|Disproportionate tall stature|Geleophysic dysplasia 2|Stiff skin syndrome|Marfan syndrome|Ectopia lentis, isolated, autosomal dominant|Marfan lipodystrophy syndrome|MASS syndrome|Acromicric dysplasia|Weill-Marchesani syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523334	15	48762902	15	48470705	523334	514051	rs1555397413	NC_000015.10:48470704:T:C
NM_000138.4(FBN1):c.7977C>A (p.Cys2659Ter)	FBN1	C2659*	Cardiovascular phenotype|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Mar 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519801	15	48707807	15	48415610	519801	510532	rs1555393844	NC_000015.10:48415609:G:T
NM_000138.4(FBN1):c.7112G>A (p.Trp2371Ter)	FBN1	W2371*	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000457257	15	48719856	15	48427659	457257	464311	rs1555394567	NC_000015.10:48427658:C:T
NM_000138.4(FBN1):c.4337-2A>T	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000457210	15	48762955	15	48470758	457210	465115	rs794728216	NC_000015.10:48470757:T:A
NM_000138.4(FBN1):c.503G>T (p.Cys168Phe)	FBN1	C168F	Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449282	15	48888515	15	48596318	449282	445378	rs1555404803	NC_000015.10:48596317:C:A
NM_000138.4(FBN1):c.2858del (p.Ile953fs)	FBN1	I953fs	Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|not specified	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000439703	15	48782272	15	48490075	439703	433143	rs1555398836	NC_000015.10:48490074:A:
NM_000138.4(FBN1):c.6487G>T (p.Glu2163Ter)	FBN1	E2163*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000432112	15	48729167	15	48436970	432112	426105	rs1555395191	NC_000015.10:48436969:C:A
NM_000138.4(FBN1):c.164+1G>A	FBN1		Marfan syndrome|not provided	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000200030	15	48936802	15	48644605	200030	197827	rs794728213	NC_000015.10:48644604:C:T
NM_000138.4(FBN1):c.1496G>A (p.Cys499Tyr)	FBN1	C499Y	Marfan syndrome	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000155791	15	48805838	15	48513641	155791	165543	rs587782944	NC_000015.10:48513640:C:T
NM_000138.5(FBN1):c.5863C>T (p.Gln1955Ter)	FBN1	Q1955*	not provided|Marfan syndrome	Pathogenic(Last reviewed: Jul 2, 2013)	criteria provided, multiple submitters, no conflicts	VCV000042393	15	48737627	15	48445430	42393	51563	rs363807	NC_000015.10:48445429:G:A
NM_000138.5(FBN1):c.5504G>A (p.Cys1835Tyr)	FBN1	C1835Y	Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2014)	criteria provided, multiple submitters, no conflicts	VCV000042385	15	48744800	15	48452603	42385	51555	rs111929350	NC_000015.10:48452602:C:T
NM_000138.5(FBN1):c.368G>A (p.Cys123Tyr)	FBN1	C123Y	Marfan syndrome	Pathogenic(Last reviewed: Jun 3, 2011)	criteria provided, single submitter	VCV000042340	15	48892410	15	48600213	42340	51510	rs397515794	NC_000015.10:48600212:C:T
NM_000138.4(FBN1):c.7806G>A (p.Trp2602Ter)	FBN1	W2602*	Cardiovascular phenotype|not provided|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, multiple submitters, no conflicts	VCV000036119	15	48712897	15	48420700	36119	44783	rs193922236	NC_000015.10:48420699:C:T
NM_000138.4(FBN1):c.510C>G (p.Tyr170Ter)	FBN1	Y170*	not provided|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, multiple submitters, no conflicts	VCV000036085	15	48888508	15	48596311	36085	44749	rs111671429	NC_000015.10:48596310:G:C
NM_000138.4(FBN1):c.3095G>A (p.Cys1032Tyr)	FBN1	C1032Y	Marfan syndrome, neonatal|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000016462	15	48780678	15	48488481	16462	31501	rs137854481	NC_000015.10:48488480:C:T
NM_000138.4(FBN1):c.2261A>G (p.Tyr754Cys)	FBN1	Y754C	Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000016460	15	48789495	15	48497298	16460	31499	rs137854479	NC_000015.10:48497297:T:C
NM_000138.4(FBN1):c.3668G>A (p.Cys1223Tyr)	FBN1	C1223Y	Marfan syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 9, 2012)	criteria provided, single submitter	VCV000016444	15	48777615	15	48485418	16444	31483	rs137854469	NC_000015.10:48485417:C:T
NM_000321.2(RB1):c.1666C>T (p.Arg556Ter)	RB1	R556*	Hereditary cancer-predisposing syndrome|Neoplasm|Retinoblastoma, trilateral|Retinoblastoma	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013090	13	48955550	13	48381414	13090	28129	rs121913304	NC_000013.11:48381413:C:T
NM_000321.2(RB1):c.1072C>T (p.Arg358Ter)	RB1	R358*	Hereditary cancer-predisposing syndrome|not provided|Retinoblastoma	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013076	13	48942685	13	48368549	13076	28115	rs121913301	NC_000013.11:48368548:C:T
NM_000321.2(RB1):c.2359C>T (p.Arg787Ter)	RB1	R787*	Hereditary cancer-predisposing syndrome|not provided|Retinoblastoma	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013073	13	49039374	13	48465238	13073	28112	rs137853293	NC_000013.11:48465237:C:T
NM_000053.4(ATP7B):c.3659C>T (p.Thr1220Met)	ATP7B	T1220M, T1142M, T1013M, T1136M, T1109M	Wilson disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035725	13	52513227	13	51939091	35725	44389	rs193922107	NC_000013.11:51939090:G:A
NM_004004.6(GJB2):c.231G>A (p.Trp77Ter)	GJB2	W77*	Deafness, autosomal recessive 1A|not provided|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Deafness, X-linked 2|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Rare genetic deafness|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017001	13	20763490	13	20189351	17001	32040	rs80338944	NC_000013.11:20189350:C:T
NM_001271.4(CHD2):c.4971G>A (p.Trp1657Ter)	CHD2	W1657*	Inborn genetic diseases|Epileptic encephalopathy, childhood-onset|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092095	15	93563306	15	93020076	92095	97526	rs398122998	NC_000015.10:93020075:G:A
NM_025137.4(SPG11):c.733_734del (p.Met245fs)	SPG11	M245fs	Hereditary spastic paraplegia|Spastic paraplegia 11, autosomal recessive|Amyotrophic lateral sclerosis type 5|not provided	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001112	15	44949428 - 44949429	15	44657230 - 44657231	1112	16151	rs312262720	NC_000015.10:44657229:AT:
NM_000070.3(CAPN3):c.1469G>A (p.Arg490Gln)	CAPN3	R490Q, R442Q	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017622	15	42693953	15	42401755	17622	32661	rs121434548	NC_000015.10:42401754:G:A
NM_000257.4(MYH7):c.2788G>C (p.Glu930Gln)	MYH7	E930Q	Myopathy, myosin storage, autosomal recessive|Myopathy, distal, 1|Myosin storage myopathy|Dilated cardiomyopathy 1S|Congenital myopathy with fiber type disproportion|MYH7-related late-onset scapuloperoneal muscular dystrophy|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000164312	14	23893250	14	23424041	164312	175610	rs397516171	NC_000014.9:23424040:C:G
NM_000138.5(FBN1):c.6164-3_6164-1del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000858908	15	48730115 - 48730117	15	48437918 - 48437920	858908	852769		NC_000015.10:48437917:CTGC:C
NM_000138.5(FBN1):c.5671+1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000845016	15	48740964	15	48448767	845016	852051		NC_000015.10:48448766:C:T
NM_000138.5(FBN1):c.6037+2T>C	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000843770	15	48736736	15	48444539	843770	851623		NC_000015.10:48444538:A:G
NC_000015.10:g.(?_48508572)_(48510179_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000833378	15	48800769 - 48802376			833378	820717		
NC_000015.10:g.(?_48503777)_(48516372_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000832352	15	48795974 - 48808569			832352	820715		
NC_000015.10:g.(?_48428336)_(48474660_?)del	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000831780	15	48720533 - 48766857			831780	820712		
NC_000015.10:g.(?_48425359)_(48441856_?)del	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV000831289	15	48717556 - 48734053			831289	820711		
NC_000015.10:g.(?_48446696)_(48446910_?)del	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000831226	15	48738893 - 48739107			831226	820714		
NC_000015.10:g.(?_48434584)_(48437927_?)del	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000830996	15	48726781 - 48730124			830996	820713		
NC_000015.10:g.(?_48410980)_(48465868_?)del	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000830994	15	48703177 - 48758065			830994	820710		
NM_000138.5(FBN1):c.1679G>T (p.Gly560Val)	FBN1	G560V	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000803096	15	48802276	15	48510079	803096	791473		NC_000015.10:48510078:C:A
NM_000138.4(FBN1):c.6393C>G (p.Cys2131Trp)	FBN1	C2131W	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000664437	15	48729261	15	48437064	664437	643339		NC_000015.10:48437063:G:C
NC_000015.9:g.(?_48784648)_(48784793_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000663944	15	48784648 - 48784793	15	48492451 - 48492596	663944	653008		
NM_000138.4(FBN1):c.7988G>A (p.Cys2663Tyr)	FBN1	C2663Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000661431	15	48707796	15	48415599	661431	643308		NC_000015.10:48415598:C:T
NM_000138.4(FBN1):c.6866G>A (p.Cys2289Tyr)	FBN1	C2289Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000653363	15	48722873	15	48430676	653363	643330		NC_000015.10:48430675:C:T
NM_000138.4(FBN1):c.7937G>A (p.Cys2646Tyr)	FBN1	C2646Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000653296	15	48707847	15	48415650	653296	643310		NC_000015.10:48415649:C:T
NC_000015.9:g.(?_48726781)_(48726920_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000651834	15	48726781 - 48726920	15	48434584 - 48434723	651834	652390		
NM_000138.4(FBN1):c.203G>A (p.Cys68Tyr)	FBN1	C68Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000649153	15	48905251	15	48613054	649153	643417		NC_000015.10:48613053:C:T
NC_000015.9:g.(?_48736728)_(48741100_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000647456	15	48736728 - 48741100	15	48444531 - 48448903	647456	652394		
NM_000138.4(FBN1):c.2495G>C (p.Cys832Ser)	FBN1	C832S	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000647275	15	48787710	15	48495513	647275	643392		NC_000015.10:48495512:C:G
NM_000138.4(FBN1):c.2053T>A (p.Cys685Ser)	FBN1	C685S	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000646759	15	48796044	15	48503847	646759	643400		NC_000015.10:48503846:A:T
NM_000138.4(FBN1):c.5918-1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000644021	15	48736858	15	48444661	644021	652418		NC_000015.10:48444660:C:T
NM_000138.4(FBN1):c.2623T>A (p.Cys875Ser)	FBN1	C875S	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000642667	15	48787374	15	48495177	642667	643391		NC_000015.10:48495176:A:T
NC_000015.9:g.(?_48752423)_(48791255_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000641001	15	48752423 - 48791255	15	48460226 - 48499058	641001	652668		
NM_000138.4(FBN1):c.3958T>C (p.Cys1320Arg)	FBN1	C1320R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000639403	15	48773858	15	48481661	639403	643369		NC_000015.10:48481660:A:G
NC_000015.9:g.(?_48703167)_(48704960_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000584073	15	48703167 - 48704960	15	48410970 - 48412763	584073	573113		
NC_000015.9:g.(?_48752423)_(48752534_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000583489	15	48752423 - 48752534	15	48460226 - 48460337	583489	566875		
NM_000138.4(FBN1):c.7664G>T (p.Gly2555Val)	FBN1	G2555V	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000572714	15	48713790	15	48421593	572714	567115	rs1566891654	NC_000015.10:48421592:C:A
NM_000138.4(FBN1):c.5918-1G>C	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000567577	15	48736858	15	48444661	567577	573340	rs1566898144	NC_000015.10:48444660:C:G
NM_000138.4(FBN1):c.3338A>G (p.Asp1113Gly)	FBN1	D1113G	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000549158	15	48779634	15	48487437	549158	539763	rs140597	NC_000015.10:48487436:T:C
NM_000138.4(FBN1):c.1727G>A (p.Cys576Tyr)	FBN1	C576Y	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000549038	15	48800889	15	48508692	549038	539868	rs1555399974	NC_000015.10:48508691:C:T
NM_000138.4(FBN1):c.1915T>C (p.Cys639Arg)	FBN1	C639R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000527206	15	48797267	15	48505070	527206	528999	rs1060501078	NC_000015.10:48505069:A:G
NM_000138.4(FBN1):c.1589-1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000527198	15	48802367	15	48510170	527198	529520	rs1555400077	NC_000015.10:48510169:C:T
NM_000138.4(FBN1):c.6998-2A>T	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000527142	15	48719972	15	48427775	527142	529437	rs1555394585	NC_000015.10:48427774:T:A
NM_000138.4(FBN1):c.3623G>T (p.Cys1208Phe)	FBN1	C1208F	Cardiovascular phenotype|Marfan syndrome	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, single submitter	VCV000519748	15	48777660	15	48485463	519748	510599	rs1555398406	NC_000015.10:48485462:C:A
NM_000138.4(FBN1):c.1A>C (p.Met1Leu)	FBN1	M1L	Marfan syndrome|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000495569	15	48936966	15	48644769	495569	487865	rs730880097	NC_000015.10:48644768:T:G
NM_000138.4(FBN1):c.6325C>T (p.Gln2109Ter)	FBN1	Q2109*	not provided|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488820	15	48729573	15	48437376	488820	482071	rs1555395229	NC_000015.10:48437375:G:A
NM_000138.4(FBN1):c.5431G>T (p.Glu1811Ter)	FBN1	E1811*	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457230	15	48744873	15	48452676	457230	465105	rs761857514	NC_000015.10:48452675:C:A
NM_000138.4(FBN1):c.4043G>A (p.Cys1348Tyr)	FBN1	C1348Y	Cardiovascular phenotype|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000457202	15	48766769	15	48474572	457202	464927	rs1555397720	NC_000015.10:48474571:C:T
NM_000138.4(FBN1):c.7656C>A (p.Cys2552Ter)	FBN1	C2552*	Marfan syndrome|Familial thoracic aortic aneurysm|Acute aortic dissection|not provided	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439701	15	48713798	15	48421601	439701	433137	rs1555394195	NC_000015.10:48421600:G:T
NM_000138.4(FBN1):c.7402T>C (p.Cys2468Arg)	FBN1	C2468R	Marfan syndrome|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000427179	15	48717617	15	48425420	427179	415425	rs1085308004	NC_000015.10:48425419:A:G
NM_000138.4(FBN1):c.2114-2A>C	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280189	15	48791237	15	48499040	280189	264731	rs886041440	NC_000015.10:48499039:T:G
NM_000138.4(FBN1):c.7141C>T (p.Gln2381Ter)	FBN1	Q2381*	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000222612	15	48719827	15	48427630	222612	224485	rs869025414	NC_000015.10:48427629:G:A
NM_000138.4(FBN1):c.2728+1G>C	FBN1		not provided|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000200174	15	48786400	15	48494203	200174	197750	rs794728322	NC_000015.10:48494202:C:G
NM_000138.4(FBN1):c.7531T>C (p.Cys2511Arg)	FBN1	C2511R	not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000200115	15	48714188	15	48421991	200115	197602	rs794728272	NC_000015.10:48421990:A:G
NM_000138.4(FBN1):c.5699G>A (p.Cys1900Tyr)	FBN1	C1900Y	Marfan syndrome|not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000200066	15	48738992	15	48446795	200066	197674	rs794728237	NC_000015.10:48446794:C:T
NM_000138.5(FBN1):c.4505G>A (p.Cys1502Tyr)	FBN1	C1502Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000042363	15	48760686	15	48468489	42363	51533	rs397515810	NC_000015.10:48468488:C:T
NM_000138.5(FBN1):c.1148-2A>G	FBN1		Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042283	15	48808561	15	48516364	42283	51453	rs397515756	NC_000015.10:48516363:T:C
NM_000321.2(RB1):c.1363C>T (p.Arg455Ter)	RB1	R455*	not provided|Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000126837	13	48953760	13	48379624	126837	132347	rs121913302	NC_000013.11:48379623:C:T
NM_000321.2(RB1):c.1215+1G>A	RB1		Hereditary cancer-predisposing syndrome|Osteosarcoma|Bladder cancer, somatic|Small cell lung cancer|Retinoblastoma|Retinoblastoma	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000126832	13	48947629	13	48373493	126832	132342	rs587776783	NC_000013.11:48373492:G:A
NM_000321.2(RB1):c.1333C>T (p.Arg445Ter)	RB1	R445*	Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013071	13	48953730	13	48379594	13071	28110	rs3092891	NC_000013.11:48379593:C:T
NM_000303.3(PMM2):c.442G>A (p.Asp148Asn)	PMM2	D148N	Inborn genetic diseases|not provided|Congenital disorder of glycosylation, type Ia	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197659	16	8905030	16	8811173	197659	194820	rs148032587	NC_000016.10:8811172:G:A
NM_002693.2(POLG):c.2740A>C (p.Thr914Pro)	POLG	T914P	Progressive sclerosing poliodystrophy|POLG-Related Spectrum Disorders|not provided|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4B, MNGIE type	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279961	15	89864238	15	89321007	279961	264890	rs139590686	NC_000015.10:89321006:T:G
NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn)	MAP2K1	D67N	not provided|Cutaneous melanoma|Noonan syndrome|Cardio-facio-cutaneous syndrome|Cardio-facio-cutaneous syndrome|Rasopathy|Non-small cell lung cancer|Autism spectrum disorder|Cardiofaciocutaneous syndrome 3	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000040781	15	66727483	15	66435145	40781	49251	rs727504317	NC_000015.10:66435144:G:A
NM_000138.5(FBN1):c.8014T>C (p.Cys2672Arg)	FBN1	C2672R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000857658	15	48707770	15	48415573	857658	842435		NC_000015.10:48415572:A:G
NM_000138.5(FBN1):c.2584T>C (p.Cys862Arg)	FBN1	C862R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000857483	15	48787413	15	48495216	857483	842502		NC_000015.10:48495215:A:G
NM_000138.5(FBN1):c.6905G>A (p.Cys2302Tyr)	FBN1	C2302Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000856730	15	48720635	15	48428438	856730	842450		NC_000015.10:48428437:C:T
NM_000138.5(FBN1):c.4582+1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000850911	15	48760608	15	48468411	850911	852771		NC_000015.10:48468410:C:T
NM_000138.5(FBN1):c.5065+1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000848649	15	48756095	15	48463898	848649	852055		NC_000015.10:48463897:C:T
NM_000138.5(FBN1):c.502T>C (p.Cys168Arg)	FBN1	C168R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000841509	15	48888516	15	48596319	841509	842537		NC_000015.10:48596318:A:G
NM_000138.5(FBN1):c.1954T>C (p.Cys652Arg)	FBN1	C652R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000839687	15	48797228	15	48505031	839687	842514		NC_000015.10:48505030:A:G
NM_000138.5(FBN1):c.3083-2A>C	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000834974	15	48780692	15	48488495	834974	852598		NC_000015.10:48488494:T:G
NM_000138.5(FBN1):c.4816+2T>C	FBN1		not specified|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000811710	15	48757985	15	48465788	811710	799807		NC_000015.10:48465787:A:G
NM_000138.4(FBN1):c.5471G>A (p.Cys1824Tyr)	FBN1	C1824Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000660084	15	48744833	15	48452636	660084	643354		NC_000015.10:48452635:C:T
NC_000015.9:g.(?_48736728)_(48736867_?)del	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000639375	15	48736728 - 48736867	15	48444531 - 48444670	639375	652392		
NM_000138.4(FBN1):c.1A>T (p.Met1Leu)	FBN1	M1L	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000577426	15	48936966	15	48644769	577426	569532	rs730880097	NC_000015.10:48644768:T:A
NM_000138.4(FBN1):c.6751T>C (p.Cys2251Arg)	FBN1	C2251R	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000573034	15	48722988	15	48430791	573034	569443	rs112836174	NC_000015.10:48430790:A:G
NM_000138.4(FBN1):c.671G>A (p.Cys224Tyr)	FBN1	C224Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, single submitter	VCV000570805	15	48829873	15	48537676	570805	568994	rs1566922396	NC_000015.10:48537675:C:T
NM_000138.4(FBN1):c.2113+1G>C	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000568188	15	48795983	15	48503786	568188	573368	rs1566913670	NC_000015.10:48503785:C:G
NM_000138.4(FBN1):c.7399C>T (p.Gln2467Ter)	FBN1	Q2467*	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not specified	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000566434	15	48717620	15	48425423	566434	573324	rs1566892727	NC_000015.10:48425422:G:A
NM_000138.4(FBN1):c.7605C>A (p.Cys2535Ter)	FBN1	C2535*	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000527183	15	48713849	15	48421652	527183	529273	rs113544411	NC_000015.10:48421651:G:T
NM_000138.4(FBN1):c.3G>A (p.Met1Ile)	FBN1	M1I	not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488792	15	48936964	15	48644767	488792	482072	rs886039072	NC_000015.10:48644766:C:T
NM_000138.4(FBN1):c.7605C>G (p.Cys2535Trp)	FBN1	C2535W	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000457264	15	48713849	15	48421652	457264	464853	rs113544411	NC_000015.10:48421651:G:C
NM_000138.4(FBN1):c.4539C>G (p.Cys1513Trp)	FBN1	C1513W	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000457215	15	48760652	15	48468455	457215	464906	rs1555397203	NC_000015.10:48468454:G:C
NM_000138.4(FBN1):c.2269del (p.Asp757fs)	FBN1	D757fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided|Marfan syndrome	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419089	15	48789487	15	48497290	419089	409287	rs1064793636	NC_000015.10:48497289:CC:C
NM_000138.4(FBN1):c.8488C>T (p.Gln2830Ter)	FBN1	Q2830*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000263414	15	48703315	15	48411118	263414	258815	rs886038795	NC_000015.10:48411117:G:A
NM_000138.4(FBN1):c.2539+1G>A	FBN1		Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000199998	15	48787665	15	48495468	199998	197762	rs794728192	NC_000015.10:48495467:C:T
NM_000138.4(FBN1):c.6339T>G (p.Tyr2113Ter)	FBN1	Y2113*	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 4, 2018)	criteria provided, single submitter	VCV000016430	15	48729559	15	48437362	16430	31469	rs267606797	NC_000015.10:48437361:A:C
NM_001042492.3(NF1):c.5901del (p.Lys1967fs)	NF1	K1967fs, K1946fs	not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000817915	17	29661942	17	31334924	817915	805942		NC_000017.11:31334923:AAA:AA
NM_001042492.3(NF1):c.6388del (p.Ile2130fs)	NF1	I2130fs, I2109fs	not provided	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000817894	17	29663893	17	31336875	817894	805943		NC_000017.11:31336874:A:
NM_001042492.3(NF1):c.1785_1786del (p.Glu595fs)	NF1	E595fs	not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000817846	17	29550524 - 29550525	17	31223506 - 31223507	817846	805938		NC_000017.11:31223505:AAA:A
NM_001042492.3(NF1):c.926del (p.Gly309fs)	NF1	G309fs	not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000817817	17	29527476	17	31200458	817817	805934		NC_000017.11:31200457:GG:G
NM_001042492.3(NF1):c.67del (p.Pro22_Ile23insTer)	NF1		not provided	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000817575	17	29483006	17	31155988	817575	805932		NC_000017.11:31155987:AA:A
NM_001042492.3(NF1):c.3007_3008delinsTA (p.Gly1003Ter)	NF1		not provided	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000817565	17	29557294 - 29557295	17	31230276 - 31230277	817565	805940		NC_000017.11:31230275:GG:TA
NM_001042492.3(NF1):c.5806_5812del (p.Lys1936fs)	NF1	K1915fs, K1936fs	not provided	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000817404	17	29657510 - 29657516	17	31330492 - 31330498	817404	805941		NC_000017.11:31330491:AAATCTA:
NM_001042492.3(NF1):c.339del (p.Leu113fs)	NF1	L113fs	not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000817346	17	29490254	17	31163236	817346	805933		NC_000017.11:31163235:G:
NM_001042492.3(NF1):c.2207del (p.Asn736fs)	NF1	N736fs	not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000817311	17	29553657	17	31226639	817311	805939		NC_000017.11:31226638:AA:A
NM_001042492.3(NF1):c.1608dup (p.His537fs)	NF1		not provided	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000817295	17	29546102 - 29546103	17	31219084 - 31219085	817295	805936		NC_000017.11:31219084:A:AA
NM_001042492.3(NF1):c.1711del (p.Trp571fs)	NF1	W571fs	not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000817039	17	29548934	17	31221916	817039	805937		NC_000017.11:31221915:TTTT:TTT
NM_001042492.3(NF1):c.1399dup (p.Thr467fs)	NF1		not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000817038	17	29541474 - 29541475	17	31214456 - 31214457	817038	805935		NC_000017.11:31214456:A:AA
NM_001042492.3(NF1):c.7505_7508dup (p.Tyr2503Ter)	NF1		not provided	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000817011	17	29679321 - 29679322	17	31352303 - 31352304	817011	805945		NC_000017.11:31352303:GATA:GATAGATA
NM_001042492.3(NF1):c.6596T>A (p.Leu2199Ter)	NF1	L2178*, L2199*	not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000816958	17	29664554	17	31337536	816958	805944		NC_000017.11:31337535:T:A
NM_001042492.3(NF1):c.792dup (p.Ala265fs)	NF1		not specified	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000811981	17	29509586 - 29509587	17	31182568 - 31182569	811981	800010		NC_000017.11:31182568:A:AA
NM_001042492.3(NF1):c.1532del (p.Pro511fs)	NF1	P511fs	not specified	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000811921	17	29546026	17	31219008	811921	800012		NC_000017.11:31219007:CC:C
NM_001042492.3(NF1):c.7040del (p.Ser2347fs)	NF1	S2326fs, S2347fs	not specified	Pathogenic(Last reviewed: Feb 9, 2019)	criteria provided, single submitter	VCV000811904	17	29667641	17	31340623	811904	800023		NC_000017.11:31340622:G:
NM_001042492.3(NF1):c.3217_3218delinsTTCC (p.Met1073fs)	NF1		not specified	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000811815	17	29559110 - 29559111	17	31232092 - 31232093	811815	800014		NC_000017.11:31232091:AT:TTCC
NM_001042492.3(NF1):c.6246del (p.Arg2083fs)	NF1	R2062fs, R2083fs	not specified	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000811798	17	29663751	17	31336733	811798	800021		NC_000017.11:31336732:A:
NM_001042492.3(NF1):c.338del (p.Leu113fs)	NF1	L113fs	not specified	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000811776	17	29490252	17	31163234	811776	800009		NC_000017.11:31163233:TT:T
NM_001042492.3(NF1):c.4015_4028del (p.Asn1338_Leu1339insTer)	NF1		not specified	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000811453	17	29576040 - 29576053	17	31249022 - 31249035	811453	800017		NC_000017.11:31249021:ACCTCCTTCAGATGAC:AC
NM_001042492.3(NF1):c.7090dup (p.Arg2364fs)	NF1		not specified	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000811261	17	29670052 - 29670053	17	31343034 - 31343035	811261	800024		NC_000017.11:31343034:CC:CCC
NM_001042492.3(NF1):c.4669del (p.Thr1557fs)	NF1	T1536fs, T1557fs	not specified	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000811165	17	29588820	17	31261802	811165	800018		NC_000017.11:31261801:A:
NM_001042492.3(NF1):c.2553C>A (p.Cys851Ter)	NF1	C851*	not specified	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000811157	17	29556186	17	31229168	811157	800013		NC_000017.11:31229167:C:A
NM_000267.3(NF1):c.7385_7394del (p.Pro2462fs)	NF1	P2462fs, P2483fs	Neurofibroma	Pathogenic	no assertion criteria provided	VCV000638015	17	29677327 - 29677336	17	31350309 - 31350318	638015	625836		NC_000017.11:31350308:CTTCCTATAG:
NM_001042492.3(NF1):c.2619_2622dup (p.Gly875Ter)	NF1		Neurofibromas	Pathogenic	no assertion criteria provided	VCV000637012	17	29556250 - 29556251	17	31229232 - 31229233	637012	624836		NC_000017.11:31229232:GTAAG:GTAAGTAAG
NM_001042492.3(NF1):c.2388del (p.Ala797fs)	NF1	A797fs	Neurofibroma	Pathogenic(Last reviewed: Jun 29, 2019)	no assertion criteria provided	VCV000635819	17	29554600	17	31227582	635819	623636		NC_000017.11:31227581:AAAA:AAA
NM_000267.3(NF1):c.7395-1G>C	NF1		Neurofibroma	Pathogenic(Last reviewed: Jun 29, 2019)	no assertion criteria provided	VCV000635818	17	29679274	17	31352256	635818	623638		NC_000017.11:31352255:G:C
NM_000267.3(NF1):c.3106A>T (p.Lys1036Ter)	NF1	K1036*	not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000620488	17	29557393	17	31230375	620488	611848	rs1567849891	NC_000017.11:31230374:A:T
NM_000267.3(NF1):c.4735A>T (p.Lys1579Ter)	NF1	K1579*, K1600*	not provided	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000620441	17	29592320	17	31265302	620441	611849	rs1567865056	NC_000017.11:31265301:A:T
NM_000267.3(NF1):c.2142T>A (p.Cys714Ter)	NF1	C714*	not provided	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000620413	17	29553593	17	31226575	620413	611847	rs141382637	NC_000017.11:31226574:T:A
NM_000267.3(NF1):c.121G>T (p.Glu41Ter)	NF1	E41*	not provided	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000620401	17	29483061	17	31156043	620401	611846	rs1567814497	NC_000017.11:31156042:G:T
NM_000267.3(NF1):c.4761T>A (p.Tyr1587Ter)	NF1	Y1587*, Y1608*	not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000620127	17	29592346	17	31265328	620127	611850	rs1567865089	NC_000017.11:31265327:T:A
NM_000267.3(NF1):c.1672del (p.Ile558fs)	NF1	I558fs	not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000618759	17	29548898	17	31221880	618759	610073	rs1567845057	NC_000017.11:31221879:A:
NM_000267.3(NF1):c.5792G>A (p.Trp1931Ter)	NF1	W1931*, W1952*	not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000618754	17	29661898	17	31334880	618754	610078	rs1567615766	NC_000017.11:31334879:G:A
NM_000267.3(NF1):c.1467T>A (p.Tyr489Ter)	NF1	Y489*	not provided	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000618252	17	29541543	17	31214525	618252	610071	rs1567841799	NC_000017.11:31214524:T:A
NM_000267.3(NF1):c.5875del (p.Thr1959fs)	NF1	T1959fs, T1980fs	not provided	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000618250	17	29661980	17	31334962	618250	610079	rs1567615852	NC_000017.11:31334961:AA:A
NM_000267.3(NF1):c.2842C>T (p.Gln948Ter)	NF1	Q948*	not provided	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000618249	17	29556475	17	31229457	618249	610075	rs1567849237	NC_000017.11:31229456:C:T
NM_000267.3(NF1):c.5054_5055insA (p.Val1686fs)	NF1		not provided	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000618248	17	29653119 - 29653120	17	31326101 - 31326102	618248	610076	rs1567611534	NC_000017.11:31326101::A
NM_000267.3(NF1):c.2149del (p.Ala717fs)	NF1	A717fs	not provided	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000561975	17	29553600	17	31226582	561975	552920	rs1567847540	NC_000017.11:31226581:G:
NM_000267.3(NF1):c.3677dup (p.Leu1227fs)	NF1		not provided	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000561974	17	29560199 - 29560200	17	31233181 - 31233182	561974	552942	rs1567851501	NC_000017.11:31233181:C:CC
NM_000267.3(NF1):c.479+1G>T	NF1		not provided	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000561965	17	29490395	17	31163377	561965	552878	rs1555606137	NC_000017.11:31163376:G:T
NM_000267.3(NF1):c.1754T>G (p.Leu585Ter)	NF1	L585*	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000561952	17	29550494	17	31223476	561952	552915	rs775670722	NC_000017.11:31223475:T:G
NM_000267.3(NF1):c.2990+1G>T	NF1		not provided	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000561950	17	29556993	17	31229975	561950	552933	rs1135402836	NC_000017.11:31229974:G:T
NM_000267.3(NF1):c.5368_5386del (p.Thr1790fs)	NF1	T1811fs, T1790fs	not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000561944	17	29654679 - 29654697	17	31327661 - 31327679	561944	552966	rs1567612488	NC_000017.11:31327660:ACCTTCATGCACCAGGAGT:
NM_000267.3(NF1):c.6688_6691del (p.Val2230fs)	NF1	V2230fs, V2251fs	not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000561927	17	29665088 - 29665091	17	31338070 - 31338073	561927	552986	rs1567617877	NC_000017.11:31338069:TGTCT:T
NM_000267.3(NF1):c.6367G>T (p.Glu2123Ter)	NF1	E2123*, E2144*	not provided	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000561889	17	29664388	17	31337370	561889	552983	rs1567617371	NC_000017.11:31337369:G:T
NM_000267.3(NF1):c.6756+2T>A	NF1		not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000561509	17	29665159	17	31338141	561509	552988	rs1135402894	NC_000017.11:31338140:T:A
NM_000267.3(NF1):c.480-2A>G	NF1		not provided	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000561503	17	29496907	17	31169889	561503	552883	rs1567820688	NC_000017.11:31169888:A:G
NM_000267.3(NF1):c.6733C>T (p.Gln2245Ter)	NF1	Q2245*, Q2266*	not provided	Pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, single submitter	VCV000545966	17	29665134	17	31338116	545966	536488	rs1555534955	NC_000017.11:31338115:C:T
NM_000267.3(NF1):c.200del (p.Asn67fs)	NF1	N67fs	not provided	Pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	VCV000545870	17	29483139	17	31156121	545870	536485	rs1555604942	NC_000017.11:31156120:AA:A
NM_000267.3(NF1):c.422_437del (p.Val141fs)	NF1	V141fs	not provided	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000524035	17	29490336 - 29490351	17	31163318 - 31163333	524035	514711	rs1555606098	NC_000017.11:31163317:GTTTTATTTTCTCTCAG:G
NM_000267.3(NF1):c.7193_7194del (p.Leu2398fs)	NF1	L2398fs, L2419fs	not provided	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000524017	17	29676204 - 29676205	17	31349186 - 31349187	524017	514716	rs1555536027	NC_000017.11:31349185:TG:
NM_000267.3(NF1):c.4373dup (p.Leu1459fs)	NF1		not provided	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000523966	17	29587387 - 29587388	17	31260369 - 31260370	523966	514715	rs1555618803	NC_000017.11:31260369:TTTTT:TTTTTT
NM_000267.3(NF1):c.3261dup (p.Glu1088Ter)	NF1		not provided	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000523917	17	29559153 - 29559154	17	31232135 - 31232136	523917	514713	rs1555614851	NC_000017.11:31232135:T:TT
NM_000267.3(NF1):c.5594T>A (p.Leu1865Ter)	NF1	L1865*, L1886*	not provided	Pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	VCV000504446	17	29657361	17	31330343	504446	495673	rs1555533853	NC_000017.11:31330342:T:A
NM_000267.3(NF1):c.663del (p.Phe220_Trp221insTer)	NF1		not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000504215	17	29508735	17	31181717	504215	495830	rs1555608736	NC_000017.11:31181716:GG:G
NM_000267.3(NF1):c.4197_4198del (p.Pro1400fs)	NF1	P1400fs, P1421fs	not provided	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000503798	17	29585447 - 29585448	17	31258429 - 31258430	503798	495664	rs1555618536	NC_000017.11:31258428:CAC:C
NM_000267.3(NF1):c.6162G>A (p.Trp2054Ter)	NF1	W2054*, W2075*	not provided	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000489188	17	29663730	17	31336712	489188	482129	rs1555534677	NC_000017.11:31336711:G:A
NM_000267.3(NF1):c.5817C>A (p.Cys1939Ter)	NF1	C1939*, C1960*	not provided	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000488978	17	29661923	17	31334905	488978	482127	rs1462287670	NC_000017.11:31334904:C:A
NM_000267.3(NF1):c.5793G>A (p.Trp1931Ter)	NF1	W1931*, W1952*	not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000488816	17	29661899	17	31334881	488816	482126	rs1555534393	NC_000017.11:31334880:G:A
NM_000267.3(NF1):c.731-1G>A	NF1		not provided	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000488814	17	29509525	17	31182507	488814	482122	rs1555608928	NC_000017.11:31182506:G:A
NM_000267.3(NF1):c.1642-1G>T	NF1		not provided	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000453127	17	29548867	17	31221849	453127	445733	rs1555613185	NC_000017.11:31221848:G:T
NM_000267.3(NF1):c.2135_2136dup (p.Leu713fs)	NF1		not provided	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000453012	17	29553584 - 29553585	17	31226566 - 31226567	453012	445734	rs1555613810	NC_000017.11:31226566:CAC:CACAC
NM_000267.3(NF1):c.6025dup (p.Val2009fs)	NF1		not provided	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000452757	17	29663430 - 29663431	17	31336412 - 31336413	452757	445752	rs1555534609	NC_000017.11:31336412:GG:GGG
NM_000267.3(NF1):c.6650_6652del (p.Phe2217_Gln2218delinsTer)	NF1		not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000451371	17	29665051 - 29665053	17	31338033 - 31338035	451371	445753	rs1555534948	NC_000017.11:31338032:TCC:
NM_000267.3(NF1):c.5257_5261dup (p.Ser1755fs)	NF1		not provided	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000451369	17	29654566 - 29654567	17	31327548 - 31327549	451369	445747	rs1555533562	NC_000017.11:31327548:AGGGCA:AGGGCAGGGCA
NM_000267.3(NF1):c.6971T>G (p.Leu2324Ter)	NF1	L2324*, L2345*	not provided	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000451275	17	29667635	17	31340617	451275	445754	rs1555535195	NC_000017.11:31340616:T:G
NM_000267.3(NF1):c.3737dup (p.Phe1247fs)	NF1		not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000450458	17	29562656 - 29562657	17	31235638 - 31235639	450458	445741	rs1555615445	NC_000017.11:31235638:T:TT
NM_000267.3(NF1):c.372_373insTT (p.Arg125fs)	NF1		not provided	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV000449973	17	29490286 - 29490287	17	31163268 - 31163269	449973	445728	rs1555606080	NC_000017.11:31163268:T:TTT
NM_000267.3(NF1):c.4367+2T>G	NF1		not provided	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000449930	17	29586149	17	31259131	449930	445743	rs1555618693	NC_000017.11:31259130:T:G
NM_000267.3(NF1):c.5759T>A (p.Leu1920Ter)	NF1	L1920*, L1941*	not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000449431	17	29661865	17	31334847	449431	445751	rs1555534375	NC_000017.11:31334846:T:A
NM_000267.3(NF1):c.4773-2A>C	NF1		not provided	Pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, single submitter	VCV000449428	17	29652836	17	31325818	449428	445744	rs1555533265	NC_000017.11:31325817:A:C
NM_000267.3(NF1):c.5234C>G (p.Ser1745Ter)	NF1	S1745*, S1766*	not provided	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000449426	17	29654545	17	31327527	449426	445746	rs1555533555	NC_000017.11:31327526:C:G
NM_000267.3(NF1):c.84del (p.Asn29fs)	NF1	N29fs	Spinal neurofibromas	Pathogenic	no assertion criteria provided	VCV000446473	17	29483024	17	31156006	446473	439929	rs1555604877	NC_000017.11:31156005:G:
NM_000267.3(NF1):c.3537del (p.Phe1179fs)	NF1	F1179fs	not specified	Pathogenic(Last reviewed: Apr 8, 2017)	criteria provided, single submitter	VCV000440004	17	29560058	17	31233040	440004	433250	rs1555615026	NC_000017.11:31233039:TTT:TT
NM_000267.3(NF1):c.1178del (p.His393fs)	NF1	H393fs	not specified	Pathogenic(Last reviewed: Mar 25, 2017)	criteria provided, single submitter	VCV000440003	17	29528170	17	31201152	440003	433242	rs1555611037	NC_000017.11:31201151:A:
NM_000267.3(NF1):c.5702_5703del (p.Leu1901fs)	NF1	L1901fs, L1922fs	not specified	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000440000	17	29657468 - 29657469	17	31330450 - 31330451	440000	433259	rs1555533880	NC_000017.11:31330449:CTC:C
NM_000267.3(NF1):c.7225G>T (p.Glu2409Ter)	NF1	E2409*, E2430*	not specified	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000439999	17	29676236	17	31349218	439999	433264	rs1555536035	NC_000017.11:31349217:G:T
NM_000267.3(NF1):c.7411C>T (p.Gln2471Ter)	NF1	Q2471*, Q2492*	not specified	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000439998	17	29679291	17	31352273	439998	433265	rs1555536340	NC_000017.11:31352272:C:T
NM_000267.3(NF1):c.1009G>T (p.Glu337Ter)	NF1	E337*	not specified	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000439994	17	29527560	17	31200542	439994	433240	rs747241884	NC_000017.11:31200541:G:T
NM_000267.3(NF1):c.2331G>A (p.Trp777Ter)	NF1	W777*	not specified	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000439992	17	29554546	17	31227528	439992	433247	rs1555613983	NC_000017.11:31227527:G:A
NM_000267.3(NF1):c.5270_5271del (p.Phe1757fs)	NF1	F1757fs, F1778fs	not specified	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000439991	17	29654580 - 29654581	17	31327562 - 31327563	439991	433258	rs1555533566	NC_000017.11:31327561:TTT:T
NM_000267.3(NF1):c.2077_2078del (p.Met693fs)	NF1	M693fs	not specified	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000439988	17	29553528 - 29553529	17	31226510 - 31226511	439988	433246	rs1555613795	NC_000017.11:31226509:AT:
NM_000267.3(NF1):c.3790G>T (p.Glu1264Ter)	NF1	E1264*	not specified	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000439986	17	29562710	17	31235692	439986	433254	rs863224660	NC_000017.11:31235691:G:T
NM_000267.3(NF1):c.6310_6313del (p.Leu2104fs)	NF1	L2104fs, L2125fs	not specified	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000439985	17	29663878 - 29663881	17	31336860 - 31336863	439985	433261	rs1555534755	NC_000017.11:31336859:CTGG:
NM_000267.3(NF1):c.551del (p.Asn184fs)	NF1	N184fs	not specified	Pathogenic(Last reviewed: Oct 23, 2016)	criteria provided, single submitter	VCV000439984	17	29496979	17	31169961	439984	433235	rs1555607102	NC_000017.11:31169960:AA:A
NM_000267.3(NF1):c.3757_3797del (p.Leu1253fs)	NF1	L1253fs	not specified	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000439983	17	29562676 - 29562716	17	31235658 - 31235698	439983	433253	rs1555615447	NC_000017.11:31235657:ACTCTACCAACTGCTCTGGAACATGTTTTCTAAAGAAGTAGA:A
NM_000267.3(NF1):c.731-1_731del	NF1		not specified	Pathogenic(Last reviewed: Sep 24, 2016)	criteria provided, single submitter	VCV000439978	17	29509524 - 29509525	17	31182506 - 31182507	439978	433238	rs1555608925	NC_000017.11:31182505:AGA:A
NM_000267.3(NF1):c.4829T>G (p.Leu1610Ter)	NF1	L1610*, L1631*	not specified	Pathogenic(Last reviewed: Sep 25, 2016)	criteria provided, single submitter	VCV000439977	17	29652894	17	31325876	439977	433257	rs1555533292	NC_000017.11:31325875:T:G
NM_000267.3(NF1):c.7907+1G>A	NF1		not specified	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000439967	17	29684388	17	31357370	439967	433268	rs1555536773	NC_000017.11:31357369:G:A
NM_000267.3(NF1):c.950_953dup (p.Glu318fs)	NF1		not provided	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000432551	17	29527498 - 29527499	17	31200480 - 31200481	432551	426211	rs1555610879	NC_000017.11:31200480:GACAGA:GACAGACAGA
NM_000267.3(NF1):c.1039C>T (p.Gln347Ter)	NF1	Q347*	not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000431975	17	29527590	17	31200572	431975	426212	rs1555610910	NC_000017.11:31200571:C:T
NM_000267.3(NF1):c.1863del (p.Cys622fs)	NF1	C622fs	not provided	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000430095	17	29552129	17	31225111	430095	422158	rs1131691777	NC_000017.11:31225110:CC:C
NM_000267.3(NF1):c.1453G>T (p.Glu485Ter)	NF1	E485*	not provided	Pathogenic(Last reviewed: Sep 18, 2015)	criteria provided, single submitter	VCV000429817	17	29541529	17	31214511	429817	422157	rs1131691610	NC_000017.11:31214510:G:T
NM_000267.3(NF1):c.1243dup (p.His415fs)	NF1		not provided	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000426651	17	29528484 - 29528485	17	31201466 - 31201467	426651	415543	rs1085307728	NC_000017.11:31201466:CC:CCC
NM_001042492.2(NF1):c.1969_1970TC[2] (p.Leu658fs)	NF1		not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000424182	17	29552235 - 29552236	17	31225217 - 31225218	424182	409864	rs1064796843	NC_000017.11:31225216:CTCTCTC:CTCTC
NM_000267.3(NF1):c.5466dup (p.Lys1823fs)	NF1		not provided	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000423917	17	29654775 - 29654776	17	31327757 - 31327758	423917	409876	rs1555533628	NC_000017.11:31327757:CC:CCC
NM_000267.3(NF1):c.4534A>T (p.Arg1512Ter)	NF1	R1512*, R1533*	not provided	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000423790	17	29588748	17	31261730	423790	409874	rs1064796633	NC_000017.11:31261729:A:T
NM_000267.3(NF1):c.5478_5484del (p.Lys1827fs)	NF1	K1827fs, K1848fs	not provided	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000423787	17	29654789 - 29654795	17	31327771 - 31327777	423787	409877	rs1064796631	NC_000017.11:31327770:AAAAGAT:
NM_000267.3(NF1):c.5943_5943+1delinsAA	NF1		not provided	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000422898	17	29662049 - 29662050	17	31335031 - 31335032	422898	409878	rs1064796077	NC_000017.11:31335030:GG:AA
NM_000267.3(NF1):c.7709del (p.Pro2570fs)	NF1	P2570fs, P2591fs	not provided	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000421434	17	29684009	17	31356991	421434	409885	rs1064795136	NC_000017.11:31356990:CCC:CC
NM_000267.3(NF1):c.2545G>T (p.Gly849Ter)	NF1	G849*	not provided	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000420077	17	29556178	17	31229160	420077	409866	rs1064794275	NC_000017.11:31229159:G:T
NM_000267.3(NF1):c.3563A>C (p.Gln1188Pro)	NF1	Q1188P	not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000419549	17	29560086	17	31233068	419549	409870	rs758419553	NC_000017.11:31233067:A:C
NM_000267.3(NF1):c.311T>G (p.Leu104Ter)	NF1	L104*	not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000381605	17	29490226	17	31163208	381605	374910	rs1057521097	NC_000017.11:31163207:T:G
NM_000267.3(NF1):c.5779T>G (p.Tyr1927Asp)	NF1	Y1927D, Y1948D	not provided	Pathogenic(Last reviewed: Apr 3, 2015)	criteria provided, single submitter	VCV000379330	17	29661885	17	31334867	379330	375854	rs1057520575	NC_000017.11:31334866:T:G
NM_000267.3(NF1):c.5999del (p.Gly2000fs)	NF1	G2000fs, G2021fs	not provided	Pathogenic(Last reviewed: Nov 29, 2016)	criteria provided, single submitter	VCV000373546	17	29663405	17	31336387	373546	360420	rs1057518475	NC_000017.11:31336386:GG:G
NM_000267.3(NF1):c.587-2A>T	NF1		not provided	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000373342	17	29508438	17	31181420	373342	360285	rs1057518360	NC_000017.11:31181419:A:T
NM_000267.3(NF1):c.3911T>A (p.Leu1304Ter)	NF1	L1304*	not provided	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000373284	17	29562976	17	31235958	373284	360330	rs761512189	NC_000017.11:31235957:T:A
NM_000267.3(NF1):c.1591C>T (p.Gln531Ter)	NF1	Q531*	not provided	Pathogenic(Last reviewed: Sep 2, 2016)	criteria provided, single submitter	VCV000373005	17	29546086	17	31219068	373005	360229	rs1057518134	NC_000017.11:31219067:C:T
NM_000267.3(NF1):c.4270-2del	NF1		not provided	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000280419	17	29586048	17	31259030	280419	264764	rs886041630	NC_000017.11:31259029:A:
NM_000267.3(NF1):c.4317dup (p.Met1440fs)	NF1		not provided	Pathogenic(Last reviewed: Dec 18, 2015)	criteria provided, single submitter	VCV000280182	17	29586096 - 29586097	17	31259078 - 31259079	280182	264671	rs886041435	NC_000017.11:31259078:T:TT
NM_001042492.3(NF1):c.7908del (p.Gln2636fs)	NF1	Q2636fs, Q2615fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 30, 2018)	criteria provided, single submitter	VCV000827284	17	29684324	17	31357306	827284	813506		NC_000017.11:31357305:AA:A
NM_001042492.3(NF1):c.7838del (p.Pro2613fs)	NF1	P2592fs, P2613fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000827252	17	29684076	17	31357058	827252	813501		NC_000017.11:31357057:CC:C
NM_001042492.3(NF1):c.7249del (p.Leu2416_Leu2417insTer)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000826893	17	29676197	17	31349179	826893	813471		NC_000017.11:31349178:C:
NM_001042492.3(NF1):c.706dup (p.Gln236fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000826813	17	29508777 - 29508778	17	31181759 - 31181760	826813	813105		NC_000017.11:31181759:CC:CCC
NM_001042492.3(NF1):c.6906del (p.Gln2302fs)	NF1	Q2281fs, Q2302fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000826662	17	29665808	17	31338790	826662	813447		NC_000017.11:31338789:G:
NM_001042492.3(NF1):c.6303del (p.Tyr2102fs)	NF1	Y2102fs, Y2081fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000826263	17	29663806	17	31336788	826263	813412		NC_000017.11:31336787:CCC:CC
NM_001042492.3(NF1):c.6149_6150delinsGGC (p.Val2050fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000826176	17	29663654 - 29663655	17	31336636 - 31336637	826176	813408		NC_000017.11:31336635:TT:GGC
NM_001042492.3(NF1):c.6013del (p.Asp2005fs)	NF1	D2005fs, D1984fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000826076	17	29663357	17	31336339	826076	813403		NC_000017.11:31336338:G:
NM_001042492.3(NF1):c.6009del (p.Thr2004fs)	NF1	T1983fs, T2004fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000826071	17	29663352	17	31336334	826071	813401		NC_000017.11:31336333:TT:T
NM_001042492.3(NF1):c.5829_5830insTG (p.Leu1944fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000825950	17	29661872 - 29661873	17	31334854 - 31334855	825950	813393		NC_000017.11:31334854::TG
NM_001042492.3(NF1):c.5737A>T (p.Lys1913Ter)	NF1	K1892*, K1913*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000825886	17	29657441	17	31330423	825886	813390		NC_000017.11:31330422:A:T
NM_001042492.3(NF1):c.5376C>A (p.Cys1792Ter)	NF1	C1771*, C1792*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000825640	17	29654624	17	31327606	825640	813371		NC_000017.11:31327605:C:A
NM_001042492.3(NF1):c.5364del (p.Ile1788fs)	NF1	I1767fs, I1788fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000825627	17	29654611	17	31327593	825627	813370		NC_000017.11:31327592:TT:T
NM_001042492.3(NF1):c.517del (p.Asp173fs)	NF1	D173fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000825512	17	29496946	17	31169928	825512	813099		NC_000017.11:31169927:G:
NM_001042492.3(NF1):c.5076T>A (p.Tyr1692Ter)	NF1	Y1692*, Y1671*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000825371	17	29653078	17	31326060	825371	813353		NC_000017.11:31326059:T:A
NM_001042492.3(NF1):c.5013C>G (p.Tyr1671Ter)	NF1	Y1650*, Y1671*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000825318	17	29653015	17	31325997	825318	813350		NC_000017.11:31325996:C:G
NM_001042492.3(NF1):c.4977dup (p.Ser1660fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000825285	17	29652978 - 29652979	17	31325960 - 31325961	825285	813348		NC_000017.11:31325960:C:CC
NM_001042492.3(NF1):c.4821T>G (p.Tyr1607Ter)	NF1	Y1607*, Y1586*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000825148	17	29592343	17	31265325	825148	813336		NC_000017.11:31265324:T:G
NM_001042492.3(NF1):c.4333del (p.Ile1445fs)	NF1	I1424fs, I1445fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000824743	17	29586050	17	31259032	824743	813312		NC_000017.11:31259031:A:
NM_001042492.3(NF1):c.365_366AC[1] (p.Thr123fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000824053	17	29490279 - 29490280	17	31163261 - 31163262	824053	813089		NC_000017.11:31163260:CACAC:CAC
NM_001042492.3(NF1):c.3604del (p.Ala1202fs)	NF1	A1202fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000823979	17	29560126	17	31233108	823979	813257		NC_000017.11:31233107:GG:G
NM_001042492.3(NF1):c.3227dup (p.Val1077fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000823237	17	29559119 - 29559120	17	31232101 - 31232102	823237	813239		NC_000017.11:31232101:T:TT
NM_001042492.3(NF1):c.93dup (p.Thr32fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000823217	17	29483032 - 29483033	17	31156014 - 31156015	823217	813075		NC_000017.11:31156014:T:TT
NM_001042492.3(NF1):c.875del (p.Asn292fs)	NF1	N292fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000822712	17	29509667	17	31182649	822712	813113		NC_000017.11:31182648:AAAA:AAA
NM_001042492.3(NF1):c.284del (p.Ala95fs)	NF1	A95fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000821902	17	29486107	17	31159089	821902	813082		NC_000017.11:31159088:C:
NM_001042492.3(NF1):c.2820_2826del (p.Ile941fs)	NF1	I941fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000821855	17	29556452 - 29556458	17	31229434 - 31229440	821855	813221		NC_000017.11:31229433:CCATCAGC:C
NM_001042492.3(NF1):c.2429_2493del (p.Lys810fs)	NF1	K810fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000821257	17	29556058 - 29556122	17	31229040 - 31229104	821257	813198		
NM_001042492.3(NF1):c.2047_2057dup (p.Leu687fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000820581	17	29553494 - 29553495	17	31226476 - 31226477	820581	813179		NC_000017.11:31226476:CAAGCCCAGACCAA:CAAGCCCAGACCAAGCCCAGACCAA
NM_001042492.3(NF1):c.1955del (p.Arg652fs)	NF1	R652fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000820408	17	29552222	17	31225204	820408	813171		NC_000017.11:31225203:G:
NM_001042492.3(NF1):c.1954del (p.Arg652fs)	NF1	R652fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000820406	17	29552221	17	31225203	820406	813170		NC_000017.11:31225202:C:
NM_001042492.3(NF1):c.1876del (p.Leu626fs)	NF1	L626fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, single submitter	VCV000820244	17	29552142	17	31225124	820244	813161		NC_000017.11:31225123:CC:C
NM_001042492.3(NF1):c.1307_1316del (p.Ser436fs)	NF1	S436fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000818872	17	29533301 - 29533310	17	31206283 - 31206292	818872	813136		NC_000017.11:31206282:ACTCGGTTGAACT:ACT
NM_001042492.3(NF1):c.1121_1122del (p.Asp374fs)	NF1	D374fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000818359	17	29528113 - 29528114	17	31201095 - 31201096	818359	813126		NC_000017.11:31201094:AT:
NM_001042492.2(NF1):c.2351_2352delinsC (p.Trp784fs)	NF1		Optic nerve glioma	Pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	VCV000590843	17	29554566 - 29554567	17	31227548 - 31227549	590843	581787	rs1567848147	NC_000017.11:31227547:GG:C
NM_000267.3(NF1):c.6103A>T (p.Lys2035Ter)	NF1	K2035*, K2056*	Pilocytic astrocytoma	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000590842	17	29663671	17	31336653	590842	581788	rs1555534667	NC_000017.11:31336652:A:T
NM_000267.3(NF1):c.7715del (p.Leu2572fs)	NF1	L2572fs, L2593fs	not provided	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000586173	17	29684015	17	31356997	586173	577626	rs1567626919	NC_000017.11:31356996:TTT:TT
NM_000267.3(NF1):c.6641+2del	NF1		Inguinal freckling|Axillary freckling|Neurofibromas|Multiple cafe-au-lait spots	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523350	17	29664900	17	31337882	523350	514081	rs1555534929	NC_000017.11:31337881:T:
NM_000267.3(NF1):c.4812C>G (p.Tyr1604Ter)	NF1	Y1604*, Y1625*	Axillary freckling|Neurofibromas|Multiple cafe-au-lait spots	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523344	17	29652877	17	31325859	523344	514077	rs1555533285	NC_000017.11:31325858:C:G
NM_000267.3(NF1):c.4200del (p.Tyr1401fs)	NF1	Y1422fs, Y1401fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, single submitter	VCV000484152	17	29585451	17	31258433	484152	478186	rs1555618542	NC_000017.11:31258432:G:
NM_000267.3(NF1):c.5531_5532del (p.Ser1843_Ser1844insTer)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000484147	17	29654841 - 29654842	17	31327823 - 31327824	484147	478246	rs1555533650	NC_000017.11:31327822:TCT:T
NM_000267.3(NF1):c.7446C>A (p.Tyr2482Ter)	NF1	Y2482*, Y2503*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000484140	17	29679326	17	31352308	484140	478356	rs1555536359	NC_000017.11:31352307:C:A
NM_000267.3(NF1):c.2136_2142del (p.His712fs)	NF1	H712fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000484138	17	29553587 - 29553593	17	31226569 - 31226575	484138	478173	rs1555613811	NC_000017.11:31226568:CCTCTGT:
NM_000267.3(NF1):c.2388dup (p.Ala797fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000484131	17	29554599 - 29554600	17	31227581 - 31227582	484131	478202	rs1555614011	NC_000017.11:31227581:AAAA:AAAAA
NM_000267.3(NF1):c.6157dup (p.Met2053fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000484109	17	29663724 - 29663725	17	31336706 - 31336707	484109	478298	rs1555534673	NC_000017.11:31336706:A:AA
NM_000267.3(NF1):c.3778_3782del (p.Met1260fs)	NF1	M1260fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 29, 2016)	criteria provided, single submitter	VCV000484084	17	29562698 - 29562702	17	31235680 - 31235684	484084	478273	rs1555615462	NC_000017.11:31235679:ATGTT:
NM_000267.3(NF1):c.6795_6796del (p.Asn2265fs)	NF1	N2265fs, N2286fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	VCV000484074	17	29665759 - 29665760	17	31338741 - 31338742	484074	478321	rs1555535044	NC_000017.11:31338740:ACA:A
NM_000267.3(NF1):c.6073dup (p.Val2025fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000484070	17	29663478 - 29663479	17	31336460 - 31336461	484070	478962	rs1555534618	NC_000017.11:31336460:GG:GGG
NM_000267.3(NF1):c.6271del (p.Ala2091fs)	NF1	A2091fs, A2112fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 4, 2016)	criteria provided, single submitter	VCV000484028	17	29663839	17	31336821	484028	478424	rs1555534735	NC_000017.11:31336820:G:
NM_000267.3(NF1):c.3948dup (p.Val1317fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, single submitter	VCV000484026	17	29563012 - 29563013	17	31235994 - 31235995	484026	478140	rs1555615559	NC_000017.11:31235994:T:TT
NM_000267.3(NF1):c.5451_5454del (p.Ile1818fs)	NF1	I1818fs, I1839fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000482001	17	29654760 - 29654763	17	31327742 - 31327745	482001	478254	rs1555533621	NC_000017.11:31327741:TCTATC:TC
NM_000267.3(NF1):c.6930_6945del (p.Ser2311fs)	NF1	S2332fs, S2311fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000481987	17	29667593 - 29667608	17	31340575 - 31340590	481987	478328	rs1555535177	NC_000017.11:31340574:ATTCAGCAGGTACCGCA:A
NM_000267.3(NF1):c.2934del (p.Ser979fs)	NF1	S979fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000481979	17	29556936	17	31229918	481979	478118	rs1555614448	NC_000017.11:31229917:C:
NM_000267.3(NF1):c.191del (p.Asn64fs)	NF1	N64fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000481972	17	29483130	17	31156112	481972	478021	rs1555604941	NC_000017.11:31156111:AA:A
NM_000267.3(NF1):c.955del (p.Ser319fs)	NF1	S319fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000481958	17	29527504	17	31200486	481958	477957	rs876660931	NC_000017.11:31200485:AAA:AA
NM_000267.3(NF1):c.3074_3096dup (p.Gln1033fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000481944	17	29557360 - 29557361	17	31230342 - 31230343	481944	478099	rs1555614527	NC_000017.11:31230342:GGAGAGATGACCTCTCATTTTGC:GGAGAGATGACCTCTCATTTTGCGGAGAGATGACCTCTCATTTTGC
NM_000267.3(NF1):c.1255del (p.Thr419fs)	NF1	T419fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, single submitter	VCV000481904	17	29528498	17	31201480	481904	478707	rs1555611105	NC_000017.11:31201479:A:
NM_000267.3(NF1):c.7047_7048del (p.His2349fs)	NF1	H2349fs, H2370fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000481903	17	29670074 - 29670075	17	31343056 - 31343057	481903	478336	rs1555535416	NC_000017.11:31343055:CT:
NM_000267.3(NF1):c.2237del (p.Asn746fs)	NF1	N746fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000480107	17	29553687	17	31226669	480107	478037	rs1555613838	NC_000017.11:31226668:AA:A
NM_000267.3(NF1):c.2952del (p.Gln985fs)	NF1	Q985fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 4, 2016)	criteria provided, single submitter	VCV000480089	17	29556952	17	31229934	480089	478123	rs1555614453	NC_000017.11:31229933:GGG:GG
NM_000267.3(NF1):c.7901_7902ins11 (p.?)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, single submitter	VCV000429018	17	29684381 - 29684382	17	31357363 - 31357364	429018	420836		
NM_000267.3(NF1):c.6295_6296insTTTAA (p.Ala2099delinsValTer)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	VCV000429017	17	29663863 - 29663864	17	31336845 - 31336846	429017	420817	rs1131691133	NC_000017.11:31336845::TTTAA
NM_000267.3(NF1):c.5264del (p.Gln1754_Ser1755insTer)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000429011	17	29654575	17	31327557	429011	420810	rs1131691128	NC_000017.11:31327556:C:
NM_000267.3(NF1):c.6244del (p.Leu2082fs)	NF1	L2103fs, L2082fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	VCV000429005	17	29663811	17	31336793	429005	420816	rs1131691125	NC_000017.11:31336792:CC:C
NM_000267.3(NF1):c.7543_7552+1del	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, single submitter	VCV000429000	17	29679422 - 29679432	17	31352404 - 31352414	429000	420833	rs1131691120	NC_000017.11:31352403:GAAGTTGCTTGG:G
NM_000267.3(NF1):c.421del (p.Val141fs)	NF1	V141fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000428999	17	29490333	17	31163315	428999	420764	rs1131691119	NC_000017.11:31163314:GGGG:GGG
NM_000267.3(NF1):c.7259del (p.Ala2420fs)	NF1	A2420fs, A2441fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000428993	17	29677201	17	31350183	428993	420831	rs1131691113	NC_000017.11:31350182:C:
NM_000267.3(NF1):c.1961del (p.Pro654fs)	NF1	P654fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 12, 2016)	criteria provided, single submitter	VCV000428988	17	29552227	17	31225209	428988	420779	rs1131691108	NC_000017.11:31225208:CC:C
NM_000267.3(NF1):c.7359dup (p.Thr2454fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000428986	17	29677300 - 29677301	17	31350282 - 31350283	428986	420832	rs1131691107	NC_000017.11:31350282:T:TT
NM_000267.3(NF1):c.7132del (p.Arg2378fs)	NF1	R2399fs, R2378fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 13, 2016)	criteria provided, single submitter	VCV000428981	17	29676143	17	31349125	428981	420830	rs1131691102	NC_000017.11:31349124:A:
NM_000267.3(NF1):c.653dup (p.Ala219fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	VCV000428973	17	29508502 - 29508503	17	31181484 - 31181485	428973	420765	rs1131691094	NC_000017.11:31181484:AAAA:AAAAA
NM_000267.3(NF1):c.6652C>T (p.Gln2218Ter)	NF1	Q2218*, Q2239*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2015)	criteria provided, single submitter	VCV000428972	17	29665053	17	31338035	428972	420823	rs1131691093	NC_000017.11:31338034:C:T
NM_000267.3(NF1):c.4564del (p.Ala1523fs)	NF1	A1523fs, A1544fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000428966	17	29588778	17	31261760	428966	420805	rs1131691088	NC_000017.11:31261759:C:
NM_000267.3(NF1):c.4064C>G (p.Ser1355Ter)	NF1	S1355*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000428965	17	29576091	17	31249073	428965	420800	rs1131691087	NC_000017.11:31249072:C:G
NM_000267.3(NF1):c.6965_6968del (p.His2322fs)	NF1	H2322fs, H2343fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000428960	17	29667628 - 29667631	17	31340610 - 31340613	428960	420827	rs1131691083	NC_000017.11:31340609:CATAC:C
NM_000267.3(NF1):c.7039del (p.Glu2347fs)	NF1	E2347fs, E2368fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	VCV000428959	17	29670065	17	31343047	428959	420829	rs1131691082	NC_000017.11:31343046:GG:G
NM_000267.3(NF1):c.5562_5567delinsG (p.Asn1854fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 6, 2015)	criteria provided, single submitter	VCV000428958	17	29657329 - 29657334	17	31330311 - 31330316	428958	420813	rs1131691081	NC_000017.11:31330310:TCTTCT:G
NM_000267.3(NF1):c.2753del (p.Lys918fs)	NF1	K918fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 15, 2014)	criteria provided, single submitter	VCV000428954	17	29556385	17	31229367	428954	420788	rs1131691078	NC_000017.11:31229366:AA:A
NM_000267.3(NF1):c.6506_6507del (p.Gly2169fs)	NF1	G2169fs, G2190fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 2, 2014)	criteria provided, single submitter	VCV000428952	17	29664527 - 29664528	17	31337509 - 31337510	428952	420820	rs1131691076	NC_000017.11:31337508:GC:
NM_000267.3(NF1):c.6462_6474del (p.Ile2155fs)	NF1	I2155fs, I2176fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 10, 2014)	criteria provided, single submitter	VCV000428945	17	29664481 - 29664493	17	31337463 - 31337475	428945	420818	rs1131691071	NC_000017.11:31337462:GTCATTGCCTTCCGT:GT
NM_000267.3(NF1):c.2483del (p.Leu828fs)	NF1	L828fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 17, 2013)	criteria provided, single submitter	VCV000428943	17	29556114	17	31229096	428943	420787	rs1131691069	NC_000017.11:31229095:TTT:TT
NM_000267.3(NF1):c.1551_1564del (p.Glu517fs)	NF1	E517fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 7, 2013)	criteria provided, single submitter	VCV000428942	17	29546045 - 29546058	17	31219027 - 31219040	428942	420774	rs1131691068	NC_000017.11:31219026:AAACCCAAGGCAGTA:A
NM_000267.3(NF1):c.6849_6853del (p.Leu2283_Leu2284insTer)	NF1		not provided	Pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	VCV000235382	17	29665814 - 29665818	17	31338796 - 31338800	235382	237068	rs878853025	NC_000017.11:31338795:TCTTA:
NM_000267.3(NF1):c.4958_4959TC[1] (p.Ser1654fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	criteria provided, single submitter	VCV000233245	17	29653023 - 29653024	17	31326005 - 31326006	233245	235716	rs876660286	NC_000017.11:31326004:TCTC:TC
NM_000267.3(NF1):c.4203dup (p.Glu1402Ter)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	VCV000232744	17	29585453 - 29585454	17	31258435 - 31258436	232744	235680	rs876659964	NC_000017.11:31258435:T:TT
NM_000267.3(NF1):c.6243_6244insT (p.Leu2082fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 25, 2015)	criteria provided, single submitter	VCV000231976	17	29663811 - 29663812	17	31336793 - 31336794	231976	235768	rs876659471	NC_000017.11:31336793::T
NM_000267.3(NF1):c.5749+1G>A	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	VCV000230938	17	29657517	17	31330499	230938	235752	rs876658854	NC_000017.11:31330498:G:A
NM_000267.3(NF1):c.1584del (p.Leu529fs)	NF1	L529fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	VCV000230660	17	29546077	17	31219059	230660	235558	rs876658693	NC_000017.11:31219058:GGG:GG
NM_000267.3(NF1):c.629T>G (p.Leu210Ter)	NF1	L210*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000230444	17	29508482	17	31181464	230444	235519	rs876658570	NC_000017.11:31181463:T:G
NM_000267.3(NF1):c.4756dup (p.Tyr1586fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 3, 2015)	criteria provided, single submitter	VCV000230301	17	29592335 - 29592336	17	31265317 - 31265318	230301	235704	rs876658492	NC_000017.11:31265317:TTTTTT:TTTTTTT
NM_000267.3(NF1):c.7171del (p.Ile2391fs)	NF1	I2412fs, I2391fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 5, 2015)	criteria provided, single submitter	VCV000229876	17	29676181	17	31349163	229876	235807	rs876658245	NC_000017.11:31349162:AA:A
NM_000267.3(NF1):c.3941G>A (p.Trp1314Ter)	NF1	W1314*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 16, 2015)	criteria provided, single submitter	VCV000229852	17	29563006	17	31235988	229852	235666	rs876658235	NC_000017.11:31235987:G:A
NM_000267.3(NF1):c.2589_2592del (p.Ser864fs)	NF1	S864fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 5, 2015)	criteria provided, single submitter	VCV000229804	17	29556222 - 29556225	17	31229204 - 31229207	229804	235603	rs876658207	NC_000017.11:31229203:TAGC:
NM_000267.3(NF1):c.6457_6475del (p.Ala2153fs)	NF1	A2174fs, A2153fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 23, 2014)	criteria provided, single submitter	VCV000187533	17	29664477 - 29664495	17	31337459 - 31337477	187533	184721	rs786203806	NC_000017.11:31337458:TGCTGTCATTGCCTTCCGTT:T
NM_000267.3(NF1):c.3902_3903insTTATTACGAATTG (p.Asp1302fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	VCV000187137	17	29562967 - 29562968	17	31235949 - 31235950	187137	184646	rs786203500	NC_000017.11:31235949::TTATTACGAATTG
NM_000267.3(NF1):c.8032C>T (p.Gln2678Ter)	NF1	Q2678*, Q2699*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 3, 2014)	criteria provided, single submitter	VCV000187064	17	29685622	17	31358604	187064	184781	rs786203443	NC_000017.11:31358603:C:T
NM_000267.3(NF1):c.2178del (p.Ser727fs)	NF1	S727fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 6, 2014)	criteria provided, single submitter	VCV000186442	17	29553629	17	31226611	186442	184585	rs786202954	NC_000017.11:31226610:G:
NM_000267.3(NF1):c.3208C>T (p.Gln1070Ter)	NF1	Q1070*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 18, 2014)	criteria provided, single submitter	VCV000185239	17	29559101	17	31232083	185239	184620	rs786202023	NC_000017.11:31232082:C:T
GRCh38/hg38 17q11.2(chr17:31206265-31261713)x1	NF1		See cases	Pathogenic(Last reviewed: May 7, 2012)	no assertion criteria provided	VCV000151017	17	29533283 - 29588731	17	31206265 - 31261713	151017	160768		
NM_000267.3(NF1):c.2589T>G (p.Tyr863Ter)	NF1	Y863*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 1, 2014)	criteria provided, single submitter	VCV000142911	17	29556222	17	31229204	142911	152625	rs587782814	NC_000017.11:31229203:T:G
NM_000267.3(NF1):c.2622_2623insA (p.Gly875fs)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 30, 2014)	criteria provided, single submitter	VCV000141682	17	29556255 - 29556256	17	31229237 - 31229238	141682	151396	rs587781933	NC_000017.11:31229237::A
NM_000267.3(NF1):c.4841_4842insAAT (p.Tyr1614Ter)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	VCV000141480	17	29652906 - 29652907	17	31325888 - 31325889	141480	151194	rs587781780	NC_000017.11:31325888::AAT
GRCh38/hg38 17q11.2(chr17:31223174-31246335)x1	NF1		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059585	17	29550192 - 29573353	17	31223174 - 31246335	59585	74180		
NM_000267.3(NF1):c.4095_4096insTG (p.His1366fs)	NF1		Neurofibromatosis-Noonan syndrome	Pathogenic(Last reviewed: May 15, 2003)	no assertion criteria provided	VCV000000365	17	29576122 - 29576123	17	31249104 - 31249105	365	15404	rs267606608	NC_000017.11:31249104::TG
NM_000267.3(NF1):c.6200T>C (p.Leu2067Pro)	NF1	L2067P, L2088P	Neurofibromatosis, familial spinal	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000000358	17	29663768	17	31336750	358	15397	rs137854561	NC_000017.11:31336749:T:C
NM_000267.3(NF1):c.8042dup (p.Tyr2681Ter)	NF1		Neurofibromatosis, familial spinal	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000000349	17	29685631 - 29685632	17	31358613 - 31358614	349	15388	rs267606601	NC_000017.11:31358613:A:AA
NF1, 80-KB DEL	NF1		Caf-au-lait macules with pulmonary stenosis	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000000342					342	15381		
NF1, 42-BP DUP	NF1		Caf-au-lait macules with pulmonary stenosis	Pathogenic(Last reviewed: Jul 1, 1993)	no assertion criteria provided	VCV000000341					341	15380		
NM_001042492.3(NF1):c.6687G>A (p.Trp2229Ter)	NF1	W2229*, W2208*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000826516	17	29664881	17	31337863	826516	813432		NC_000017.11:31337862:G:A
NM_001042492.3(NF1):c.2851-1G>T	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV000821889	17	29556852	17	31229834	821889	815652		NC_000017.11:31229833:G:T
NM_001042492.3(NF1):c.1392+2del	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000819072	17	29533391	17	31206373	819072	815648		NC_000017.11:31206372:T:
NM_001042492.3(NF1):c.1182dup (p.Lys395Ter)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000818520	17	29528171 - 29528172	17	31201153 - 31201154	818520	813128		NC_000017.11:31201153:TTT:TTTT
NM_000267.3(NF1):c.731-2A>G	NF1		not provided	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000805084	17	29509524	17	31182506	805084	794063		NC_000017.11:31182505:A:G
NM_001042492.3(NF1):c.147del (p.Lys48_Tyr49insTer)	NF1		not provided	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000805082	17	29483087	17	31156069	805082	793658		NC_000017.11:31156068:C:
NM_000267.3(NF1):c.2410-1G>C	NF1		not provided	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000586171	17	29556042	17	31229024	586171	577624	rs1057518792	NC_000017.11:31229023:G:C
NM_000267.3(NF1):c.1721+1G>C	NF1	R574S	not provided	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000586169	17	29548948	17	31221930	586169	577622	rs1131691096	NC_000017.11:31221929:G:C
NM_000267.3(NF1):c.1062G>C (p.Lys354Asn)	NF1	K354N	not provided	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000586168	17	29527613	17	31200595	586168	577621	rs1131691118	NC_000017.11:31200594:G:C
NM_000267.3(NF1):c.2455del (p.His819fs)	NF1	H819fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000584470	17	29556086	17	31229068	584470	575604	rs1567848761	NC_000017.11:31229067:CCC:CC
NM_000267.3(NF1):c.1224T>A (p.Tyr408Ter)	NF1	Y408*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000485979	17	29528467	17	31201449	485979	478022	rs1555611089	NC_000017.11:31201448:T:A
NM_000267.3(NF1):c.1302T>A (p.Cys434Ter)	NF1	C434*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000485971	17	29533299	17	31206281	485971	478110	rs1555611570	NC_000017.11:31206280:T:A
NM_000267.3(NF1):c.1811T>A (p.Leu604Ter)	NF1	L604*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000484114	17	29550551	17	31223533	484114	478023	rs1555613427	NC_000017.11:31223532:T:A
NM_000267.3(NF1):c.82C>T (p.Gln28Ter)	NF1	Q28*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 11, 2015)	criteria provided, single submitter	VCV000429015	17	29483022	17	31156004	429015	420761	rs771764281	NC_000017.11:31156003:C:T
NM_000267.3(NF1):c.1796G>A (p.Trp599Ter)	NF1	W599*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000429013	17	29550536	17	31223518	429013	420776	rs1131691130	NC_000017.11:31223517:G:A
NM_000267.3(NF1):c.3111del (p.Phe1037fs)	NF1	F1037fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000429008	17	29557396	17	31230378	429008	420793	rs1131691127	NC_000017.11:31230377:TTT:TT
NM_000267.3(NF1):c.6859-1G>C	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 14, 2016)	criteria provided, single submitter	VCV000428995	17	29667522	17	31340504	428995	420825	rs1131691115	NC_000017.11:31340503:G:C
NM_000267.3(NF1):c.154del (p.Ser52fs)	NF1	S52fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	VCV000428989	17	29483091	17	31156073	428989	420762	rs1131691109	NC_000017.11:31156072:TTTT:TTT
NM_000267.3(NF1):c.2088G>A (p.Trp696Ter)	NF1	W696*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000428978	17	29553539	17	31226521	428978	420782	rs1131691099	NC_000017.11:31226520:G:A
NM_000267.3(NF1):c.4702del (p.Thr1568fs)	NF1	T1589fs, T1568fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 9, 2015)	criteria provided, single submitter	VCV000428977	17	29592284	17	31265266	428977	420807	rs1131691098	NC_000017.11:31265265:AAAA:AAA
NM_000267.3(NF1):c.6494C>G (p.Ser2165Ter)	NF1	S2165*, S2186*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 3, 2015)	criteria provided, single submitter	VCV000428969	17	29664515	17	31337497	428969	420819	rs1131691091	NC_000017.11:31337496:C:G
NM_000267.3(NF1):c.1278G>A (p.Trp426Ter)	NF1	W426*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 13, 2015)	criteria provided, single submitter	VCV000428962	17	29533275	17	31206257	428962	420771	rs1131691085	NC_000017.11:31206256:G:A
NM_000267.3(NF1):c.3870+1G>A	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	VCV000428951	17	29562791	17	31235773	428951	420798	rs1131691075	NC_000017.11:31235772:G:A
NM_000267.3(NF1):c.7946C>A (p.Ser2649Ter)	NF1	S2649*, S2670*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	VCV000428950	17	29685536	17	31358518	428950	420838	rs1131691074	NC_000017.11:31358517:C:A
NM_000267.3(NF1):c.3514del (p.Asp1172fs)	NF1	D1172fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 31, 2015)	criteria provided, single submitter	VCV000233696	17	29560036	17	31233018	233696	235644	rs876660580	NC_000017.11:31233017:GG:G
NM_000267.3(NF1):c.1299T>A (p.Tyr433Ter)	NF1	Y433*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 15, 2015)	criteria provided, single submitter	VCV000232960	17	29533296	17	31206278	232960	235546	rs876660099	NC_000017.11:31206277:T:A
NM_000267.3(NF1):c.7126+3A>C	NF1		Neurofibromatosis, familial spinal	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000000369	17	29670156	17	31343138	369	15408	rs267606610	NC_000017.11:31343137:A:C
NF1, IVS34, G-A, +18	NF1		Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Jun 12, 1997)	no assertion criteria provided	VCV000000351					351	15390		
NM_001042492.3(NF1):c.3380del (p.Thr1127fs)	NF1	T1127fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000823694	17	29559783	17	31232765	823694	813249		NC_000017.11:31232764:C:
NM_001042492.3(NF1):c.2621_2634dup (p.Ser879delinsArgValLeuTer)	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000821585	17	29556253 - 29556254	17	31229235 - 31229236	821585	813214		NC_000017.11:31229235:AGGGTTCTATGATT:AGGGTTCTATGATTAGGGTTCTATGATT
NM_001042492.3(NF1):c.4700C>G (p.Ser1567Ter)	NF1	S1546*, S1567*	not specified|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000811172	17	29588851	17	31261833	811172	800019		NC_000017.11:31261832:C:G
NM_000267.3(NF1):c.7267_7268insAA (p.Thr2423fs)	NF1		not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000504361	17	29677208 - 29677209	17	31350190 - 31350191	504361	495839	rs1064794278	NC_000017.11:31350190:A:AAA
NM_000267.3(NF1):c.7702C>T (p.Gln2568Ter)	NF1	Q2589*, Q2568*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000484156	17	29684004	17	31356986	484156	478369	rs1555536689	NC_000017.11:31356985:C:T
NM_001042492.2(NF1):c.240_241TC[2] (p.Ser82_Gln83insTer)	NF1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000484139	17	29486063 - 29486066	17	31159045 - 31159048	484139	477908	rs771115661	NC_000017.11:31159044:TCTCTCTC:TCTC
NM_000267.3(NF1):c.663G>A (p.Trp221Ter)	NF1	W221*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000484076	17	29508736	17	31181718	484076	477936	rs1555608737	NC_000017.11:31181717:G:A
NM_000267.3(NF1):c.3367G>T (p.Glu1123Ter)	NF1	E1123*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000481993	17	29559770	17	31232752	481993	478232	rs1555614940	NC_000017.11:31232751:G:T
NM_000267.3(NF1):c.5944-1G>C	NF1		not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000431977	17	29663350	17	31336332	431977	426217	rs1555534596	NC_000017.11:31336331:G:C
NM_000267.3(NF1):c.662G>A (p.Trp221Ter)	NF1	W221*	not specified|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429007	17	29508735	17	31181717	429007	420766	rs1131691126	NC_000017.11:31181716:G:A
NM_000267.3(NF1):c.319del (p.Thr107fs)	NF1	T107fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428996	17	29490232	17	31163214	428996	420763	rs1131691116	NC_000017.11:31163213:AAA:AA
NM_000267.3(NF1):c.6514_6515GA[3] (p.Glu2174fs)	NF1		not specified|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428961	17	29664535 - 29664538	17	31337517 - 31337520	428961	420821	rs1131691084	NC_000017.11:31337516:GAGAGAGAGA:GAGAGA
NM_000267.3(NF1):c.4572C>A (p.Tyr1524Ter)	NF1	Y1524*, Y1545*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, single submitter	VCV000428949	17	29588786	17	31261768	428949	420806	rs754023358	NC_000017.11:31261767:C:A
NM_000267.3(NF1):c.4132C>T (p.Gln1378Ter)	NF1	Q1378*, Q1399*	not specified|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, multiple submitters, no conflicts	VCV000428946	17	29585383	17	31258365	428946	420801	rs1131691072	NC_000017.11:31258364:C:T
NM_000267.3(NF1):c.1572del (p.Glu524fs)	NF1	E524fs	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000426130	17	29546066	17	31219048	426130	415544	rs1085307461	NC_000017.11:31219047:AA:A
NM_000267.3(NF1):c.2409+2T>G	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 23, 2015)	criteria provided, single submitter	VCV000234062	17	29554626	17	31227608	234062	235595	rs876660826	NC_000017.11:31227607:T:G
NM_000267.3(NF1):c.705C>G (p.Tyr235Ter)	NF1	Y235*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 26, 2014)	criteria provided, single submitter	VCV000186943	17	29508778	17	31181760	186943	184519	rs769048538	NC_000017.11:31181759:C:G
NM_000267.3(NF1):c.4078C>T (p.Gln1360Ter)	NF1	Q1360*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000480204	17	29576105	17	31249087	480204	478856	rs1555617368	NC_000017.11:31249086:C:T
NM_000267.3(NF1):c.2410-1G>A	NF1		Hereditary cancer-predisposing syndrome|Multiple cafe-au-lait spots	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000373947	17	29556042	17	31229024	373947	361011	rs1057518792	NC_000017.11:31229023:G:A
NM_013275.6(ANKRD11):c.1458_1459AG[2] (p.Ser488fs)	ANKRD11		Inborn genetic diseases|KBG syndrome	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000522136	16	89351487 - 89351488	16	89285079 - 89285080	522136	512246	rs1555529645	NC_000016.10:89285078:CTCTCT:CTCT
NM_013275.6(ANKRD11):c.6847C>T (p.Gln2283Ter)	ANKRD11	Q2283*	Inborn genetic diseases|KBG syndrome	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000441154	16	89346103	16	89279695	441154	434772	rs1221781038	NC_000016.10:89279694:G:A
NM_013275.6(ANKRD11):c.2197C>T (p.Arg733Ter)	ANKRD11	R733*	KBG syndrome|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280620	16	89350753	16	89284345	280620	264834	rs886041791	NC_000016.10:89284344:G:A
NM_001042492.3(NF1):c.7923del (p.Glu2641fs)	NF1	E2641fs, E2620fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803378	17	29684339	17	31357321	803378	791731		NC_000017.11:31357320:AA:A
NM_001042492.3(NF1):c.7724_7725dup (p.Asp2576fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803377	17	29683585 - 29683586	17	31356567 - 31356568	803377	791730		NC_000017.11:31356567:CT:CTCT
NM_001042492.3(NF1):c.7458-2_7459del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803376	17	29679273 - 29679276	17	31352255 - 31352258	803376	791729		NC_000017.11:31352254:AGGA:
NM_001042492.3(NF1):c.7062+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803375	17	29667664	17	31340646	803375	791728		NC_000017.11:31340645:G:T
NM_001042492.3(NF1):c.6546C>G (p.Tyr2182Ter)	NF1	Y2182*, Y2161*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803373	17	29664504	17	31337486	803373	791726		NC_000017.11:31337485:C:G
NM_001042492.3(NF1):c.6360_6363dup (p.Thr2122fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803372	17	29663863 - 29663864	17	31336845 - 31336846	803372	791725		NC_000017.11:31336845:CTTCC:CTTCCTTCC
NM_001042492.3(NF1):c.5379_5380dup (p.Val1794fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803367	17	29654626 - 29654627	17	31327608 - 31327609	803367	791720		NC_000017.11:31327608:AG:AGAG
NM_001042492.3(NF1):c.5046dup (p.Asn1683Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803365	17	29653047 - 29653048	17	31326029 - 31326030	803365	791718		NC_000017.11:31326029:T:TT
NM_001042492.3(NF1):c.4463del (p.Thr1488fs)	NF1	T1488fs, T1467fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803360	17	29587419	17	31260401	803360	791713		NC_000017.11:31260400:C:
NM_001042492.3(NF1):c.4431-1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803359	17	29587386	17	31260368	803359	791712		NC_000017.11:31260367:G:T
NM_001042492.3(NF1):c.4381dup (p.Met1461fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803358	17	29586097 - 29586098	17	31259079 - 31259080	803358	791711		NC_000017.11:31259079:A:AA
NM_001042492.3(NF1):c.3381_3382del (p.Gly1128fs)	NF1	G1128fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803353	17	29559784 - 29559785	17	31232766 - 31232767	803353	791706		NC_000017.11:31232765:AG:
NM_001042492.3(NF1):c.2244dup (p.Ser749fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803346	17	29553694 - 29553695	17	31226676 - 31226677	803346	791699		NC_000017.11:31226676:G:GG
NM_001042492.3(NF1):c.1989del (p.Asn664fs)	NF1	N664fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803345	17	29552254	17	31225236	803345	791698		NC_000017.11:31225235:GGG:GG
NM_001042492.3(NF1):c.1950del (p.Leu650fs)	NF1	L650fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803344	17	29552217	17	31225199	803344	791697		NC_000017.11:31225198:A:
NM_001042492.3(NF1):c.1854del (p.Asp618fs)	NF1	D618fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803343	17	29552121	17	31225103	803343	791696		NC_000017.11:31225102:T:
NM_001042492.3(NF1):c.1186-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803341	17	29528428	17	31201410	803341	791694		NC_000017.11:31201409:G:A
NM_001042492.3(NF1):c.333del (p.Lys111fs)	NF1	K111fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803338	17	29490246	17	31163228	803338	791691		NC_000017.11:31163227:AAA:AA
NM_001042492.3(NF1):c.5269-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584932	17	29654515	17	31327497	584932	575981	rs1555533548	NC_000017.11:31327496:A:T
NM_000267.3(NF1):c.2545_2546dup (p.Val850fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584928	17	29556174 - 29556175	17	31229156 - 31229157	584928	575977	rs1567848878	NC_000017.11:31229156:GGGGG:GGGGGGG
NM_000267.3(NF1):c.7442del (p.Gly2481fs)	NF1	G2502fs, G2481fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522466	17	29679321	17	31352303	522466	513135	rs1555536358	NC_000017.11:31352302:GG:G
NM_000267.3(NF1):c.8021del (p.Pro2674fs)	NF1	P2695fs, P2674fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 16, 2015)	no assertion criteria provided	VCV000492890	17	29685608	17	31358590	492890	485782	rs1555536928	NC_000017.11:31358589:CCCC:CCC
NM_000267.3(NF1):c.7748del (p.Leu2583fs)	NF1	L2583fs, L2604fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 29, 2016)	no assertion criteria provided	VCV000492889	17	29684050	17	31357032	492889	485781	rs1555536701	NC_000017.11:31357031:T:
NM_000267.3(NF1):c.7089dup (p.Asn2364Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 21, 2016)	no assertion criteria provided	VCV000492888	17	29670115 - 29670116	17	31343097 - 31343098	492888	485780	rs1555535434	NC_000017.11:31343097:T:TT
NM_000267.3(NF1):c.5254dup (p.Leu1752fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 23, 2014)	no assertion criteria provided	VCV000492885	17	29654563 - 29654564	17	31327545 - 31327546	492885	485777	rs1555533561	NC_000017.11:31327545:CC:CCC
NM_000267.3(NF1):c.5232_5233del (p.Ala1746fs)	NF1	A1767fs, A1746fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 8, 2017)	no assertion criteria provided	VCV000492884	17	29654543 - 29654544	17	31327525 - 31327526	492884	485776	rs1555533552	NC_000017.11:31327524:TT:
NM_000267.3(NF1):c.4842T>G (p.Tyr1614Ter)	NF1	Y1614*, Y1635*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000492883	17	29652907	17	31325889	492883	485775	rs948982039	NC_000017.11:31325888:T:G
NM_000267.3(NF1):c.3111dup (p.Arg1038Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 22, 2016)	no assertion criteria provided	VCV000492880	17	29557395 - 29557396	17	31230377 - 31230378	492880	485772	rs1131691127	NC_000017.11:31230377:TTT:TTTT
NM_000267.3(NF1):c.2511G>A (p.Trp837Ter)	NF1	W837*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 30, 2015)	no assertion criteria provided	VCV000492879	17	29556144	17	31229126	492879	485771	rs1555614211	NC_000017.11:31229125:G:A
NM_000267.3(NF1):c.2251+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2014)	no assertion criteria provided	VCV000492878	17	29553703	17	31226685	492878	485770	rs1555613843	NC_000017.11:31226684:G:A
NM_000267.3(NF1):c.1400_1415del (p.Thr467fs)	NF1	T467fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 7, 2015)	no assertion criteria provided	VCV000492876	17	29541476 - 29541491	17	31214458 - 31214473	492876	485769	rs1555612270	NC_000017.11:31214457:CATTTAAAGAAAAAGT:
NM_000267.3(NF1):c.282del (p.Ala95fs)	NF1	A95fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 8, 2015)	no assertion criteria provided	VCV000492873	17	29486104	17	31159086	492873	485765	rs1555605404	NC_000017.11:31159085:TT:T
NM_000267.3(NF1):c.125_126dup (p.Leu43fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 13, 2015)	no assertion criteria provided	VCV000492872	17	29483063 - 29483064	17	31156045 - 31156046	492872	485764	rs1555604897	NC_000017.11:31156045:TGT:TGTGT
NM_000267.3(NF1):c.4755_4759del (p.Phe1585fs)	NF1	F1585fs, F1606fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000488562	17	29592338 - 29592342	17	31265320 - 31265324	488562	481430	rs1555619413	NC_000017.11:31265319:TTTTATT:TT
NM_000267.3(NF1):c.7699C>T (p.Gln2567Ter)	NF1	Q2588*, Q2567*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000484056	17	29684001	17	31356983	484056	479071	rs1555536687	NC_000017.11:31356982:C:T
NM_000267.3(NF1):c.7806+1G>A	NF1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480091	17	29684109	17	31357091	480091	478383	rs1329683225	NC_000017.11:31357090:G:A
NM_000267.3(NF1):c.7719del (p.Val2575fs)	NF1	V2596fs, V2575fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431694	17	29684021	17	31357003	431694	425199	rs1135402908	NC_000017.11:31357002:T:
NM_000267.3(NF1):c.7320del (p.Leu2441fs)	NF1	L2441fs, L2462fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431691	17	29677261	17	31350243	431691	425196	rs1135402905	NC_000017.11:31350242:TT:T
NM_000267.3(NF1):c.7274_7275del (p.Val2424_Ser2425insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431690	17	29677215 - 29677216	17	31350197 - 31350198	431690	425195	rs1135402904	NC_000017.11:31350196:TCT:T
NM_000267.3(NF1):c.7197dup (p.Asn2400Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431687	17	29676206 - 29676207	17	31349188 - 31349189	431687	425192	rs1135402901	NC_000017.11:31349188:TT:TTT
NM_000267.3(NF1):c.6967del (p.Thr2323fs)	NF1	T2323fs, T2344fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431683	17	29667631	17	31340613	431683	425188	rs1135402897	NC_000017.11:31340612:A:
NM_000267.3(NF1):c.6815del (p.Ala2272fs)	NF1	A2293fs, A2272fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431681	17	29665780	17	31338762	431681	425186	rs1135402895	NC_000017.11:31338761:C:
NM_000267.3(NF1):c.6514G>T (p.Glu2172Ter)	NF1	E2172*, E2193*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431676	17	29664535	17	31337517	431676	425181	rs1135402891	NC_000017.11:31337516:G:T
NM_000267.3(NF1):c.6483_6487del (p.Tyr2161_Asp2163delinsTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431675	17	29664504 - 29664508	17	31337486 - 31337490	431675	425180	rs1135402890	NC_000017.11:31337485:CCGGG:
NM_000267.3(NF1):c.6482del (p.Tyr2161fs)	NF1	Y2161fs, Y2182fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431674	17	29664503	17	31337485	431674	425179	rs1135402889	NC_000017.11:31337484:A:
NM_000267.3(NF1):c.6389_6393delinsA (p.Leu2130fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431672	17	29664410 - 29664414	17	31337392 - 31337396	431672	425177	rs1135402887	NC_000017.11:31337391:TCAGT:A
NM_000267.3(NF1):c.6263del (p.Phe2088fs)	NF1	F2109fs, F2088fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431669	17	29663829	17	31336811	431669	425174	rs1135402885	NC_000017.11:31336810:TTT:TT
NM_000267.3(NF1):c.6148C>T (p.Gln2050Ter)	NF1	Q2050*, Q2071*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431668	17	29663716	17	31336698	431668	425173	rs1135402884	NC_000017.11:31336697:C:T
NM_000267.3(NF1):c.6134del (p.Thr2045fs)	NF1	T2045fs, T2066fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431667	17	29663702	17	31336684	431667	425172	rs1135402883	NC_000017.11:31336683:C:
NM_000267.3(NF1):c.5780dup (p.Tyr1927Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431665	17	29661885 - 29661886	17	31334867 - 31334868	431665	425170	rs1135402881	NC_000017.11:31334867:A:AA
NM_000267.3(NF1):c.5609dup (p.Leu1871fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431662	17	29657375 - 29657376	17	31330357 - 31330358	431662	425167	rs1135402878	NC_000017.11:31330357:A:AA
NM_000267.3(NF1):c.5574del (p.Ala1858_Leu1859insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431661	17	29657340	17	31330322	431661	425166	rs1135402877	NC_000017.11:31330321:CC:C
NM_000267.3(NF1):c.5508_5509delinsT (p.Ala1837fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431659	17	29654819 - 29654820	17	31327801 - 31327802	431659	425163	rs1135402875	NC_000017.11:31327800:CG:T
NM_000267.3(NF1):c.5483_5490del (p.Asp1828fs)	NF1	D1828fs, D1849fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431657	17	29654794 - 29654801	17	31327776 - 31327783	431657	425162	rs1135402873	NC_000017.11:31327775:ATGTCCCT:
NM_000267.3(NF1):c.4999G>T (p.Glu1667Ter)	NF1	E1667*, E1688*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431652	17	29653064	17	31326046	431652	425157	rs1135402869	NC_000017.11:31326045:G:T
NM_000267.3(NF1):c.4935dup (p.Pro1646fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431650	17	29652995 - 29652996	17	31325977 - 31325978	431650	425155	rs1135402867	NC_000017.11:31325977:TTTTT:TTTTTT
NM_000267.3(NF1):c.4756del (p.Tyr1586fs)	NF1	Y1607fs, Y1586fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431648	17	29592336	17	31265318	431648	425153	rs876658492	NC_000017.11:31265317:TTTTTT:TTTTT
NM_000267.3(NF1):c.4397del (p.Pro1466fs)	NF1	P1487fs, P1466fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431643	17	29587415	17	31260397	431643	425148	rs1135402861	NC_000017.11:31260396:CC:C
NM_000267.3(NF1):c.4316_4317AT[3] (p.Met1440fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431640	17	29586095 - 29586096	17	31259077 - 31259078	431640	425145	rs1135402859	NC_000017.11:31259077:ATAT:ATATAT
NM_000267.3(NF1):c.4261del (p.Met1421fs)	NF1	M1421fs, M1442fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431636	17	29585511	17	31258493	431636	425141	rs1135402856	NC_000017.11:31258492:AA:A
NM_000267.3(NF1):c.4191del (p.Ile1397fs)	NF1	I1397fs, I1418fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431635	17	29585441	17	31258423	431635	425140	rs1135402855	NC_000017.11:31258422:TT:T
NM_000267.3(NF1):c.4000del (p.Glu1334fs)	NF1	E1334fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431631	17	29576026	17	31249008	431631	425136	rs1135402851	NC_000017.11:31249007:GG:G
NM_000267.3(NF1):c.3732dup (p.Thr1245fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431629	17	29562650 - 29562651	17	31235632 - 31235633	431629	425134	rs1135402849	NC_000017.11:31235632:TT:TTT
NM_000267.3(NF1):c.3692_3708del (p.Val1231fs)	NF1	V1231fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431628	17	29560211 - 29560227	17	31233193 - 31233209	431628	425133	rs1135402848	NC_000017.11:31233192:GTGGTTCCTTGTTCTCAGTGG:GTGG
NM_000267.3(NF1):c.3591dup (p.Glu1198fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431624	17	29560113 - 29560114	17	31233095 - 31233096	431624	425129	rs1135402844	NC_000017.11:31233095:A:AA
NM_000267.3(NF1):c.3429_3432dup (p.Thr1145fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431621	17	29559831 - 29559832	17	31232813 - 31232814	431621	425126	rs1135402842	NC_000017.11:31232813:CTGT:CTGTCTGT
NM_000267.3(NF1):c.3189T>A (p.Cys1063Ter)	NF1	C1063*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431620	17	29557935	17	31230917	431620	425125	rs1135402841	NC_000017.11:31230916:T:A
NM_000267.3(NF1):c.3048T>A (p.Cys1016Ter)	NF1	C1016*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431617	17	29557335	17	31230317	431617	425122	rs1135402840	NC_000017.11:31230316:T:A
NM_000267.3(NF1):c.3040A>T (p.Lys1014Ter)	NF1	K1014*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431616	17	29557327	17	31230309	431616	425121	rs1135402839	NC_000017.11:31230308:A:T
NM_000267.3(NF1):c.3027del (p.Gln1010fs)	NF1	Q1010fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431614	17	29557313	17	31230295	431614	425119	rs1135402837	NC_000017.11:31230294:TT:T
NM_000267.3(NF1):c.2848del (p.Gln950fs)	NF1	Q950fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431610	17	29556481	17	31229463	431610	425115	rs1135402833	NC_000017.11:31229462:C:
NM_000267.3(NF1):c.2790T>G (p.Tyr930Ter)	NF1	Y930*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431609	17	29556423	17	31229405	431609	425114	rs1135402832	NC_000017.11:31229404:T:G
NM_000267.3(NF1):c.2349del (p.Lys783fs)	NF1	K783fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431606	17	29554561	17	31227543	431606	425111	rs1135402829	NC_000017.11:31227542:AAAA:AAA
NM_000267.3(NF1):c.2338_2343del (p.Thr780_His781del)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431605	17	29554551 - 29554556	17	31227533 - 31227538	431605	425110	rs1135402828	NC_000017.11:31227532:ATACACAT:AT
NM_000267.3(NF1):c.2218G>T (p.Glu740Ter)	NF1	E740*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431604	17	29553669	17	31226651	431604	425109	rs1135402827	NC_000017.11:31226650:G:T
NM_000267.3(NF1):c.1949T>A (p.Leu650Ter)	NF1	L650*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431603	17	29552216	17	31225198	431603	425108	rs1135402826	NC_000017.11:31225197:T:A
NM_000267.3(NF1):c.1918dup (p.Thr640fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431602	17	29552184 - 29552185	17	31225166 - 31225167	431602	425107	rs1135402825	NC_000017.11:31225166:A:AA
NM_000267.3(NF1):c.1883_1885delinsCC (p.Tyr628fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431600	17	29552150 - 29552152	17	31225132 - 31225134	431600	425105	rs1135402823	NC_000017.11:31225131:ACG:CC
NM_000267.3(NF1):c.1866T>A (p.Cys622Ter)	NF1	C622*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431599	17	29552133	17	31225115	431599	425104	rs753245823	NC_000017.11:31225114:T:A
NM_000267.3(NF1):c.1683G>A (p.Trp561Ter)	NF1	W561*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431596	17	29548909	17	31221891	431596	425101	rs1135402820	NC_000017.11:31221890:G:A
NM_000267.3(NF1):c.1667_1670del (p.Asp556fs)	NF1	D556fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431595	17	29548890 - 29548893	17	31221872 - 31221875	431595	425100	rs1135402819	NC_000017.11:31221871:TAGATAG:TAG
NM_000267.3(NF1):c.1613del (p.Met538fs)	NF1	M538fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431593	17	29546108	17	31219090	431593	425098	rs1135402817	NC_000017.11:31219089:T:
NM_000267.3(NF1):c.1561del (p.Ser521fs)	NF1	S521fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431590	17	29546056	17	31219038	431590	425095	rs1135402814	NC_000017.11:31219037:A:
NM_000267.3(NF1):c.1525dup (p.Cys509fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431588	17	29541598 - 29541599	17	31214580 - 31214581	431588	425093	rs1135402813	NC_000017.11:31214580:TTT:TTTT
NM_000267.3(NF1):c.1469_1472del (p.Lys490fs)	NF1	K490fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431586	17	29541543 - 29541546	17	31214525 - 31214528	431586	425091	rs1135402811	NC_000017.11:31214524:TAAGTA:TA
NM_000267.3(NF1):c.1462del (p.Ser488fs)	NF1	S488fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431585	17	29541537	17	31214519	431585	425090	rs1135402810	NC_000017.11:31214518:AA:A
NM_000267.3(NF1):c.1400del (p.Thr467fs)	NF1	T467fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431583	17	29541476	17	31214458	431583	425088	rs1135402808	NC_000017.11:31214457:C:
NM_000267.3(NF1):c.1374dup (p.Ala459fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431581	17	29533370 - 29533371	17	31206352 - 31206353	431581	425086	rs1135402806	NC_000017.11:31206352:A:AA
NM_000267.3(NF1):c.1322_1323AT[1] (p.Met442fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431580	17	29533319 - 29533320	17	31206301 - 31206302	431580	425085	rs1135402805	NC_000017.11:31206300:ATAT:AT
NM_000267.3(NF1):c.1280_1292del (p.Pro427fs)	NF1	P427fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431579	17	29533275 - 29533287	17	31206257 - 31206269	431579	425084	rs1135402804	NC_000017.11:31206256:GCCTAAGATTGATGC:GC
NM_000267.3(NF1):c.1152del (p.Arg385fs)	NF1	R385fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431578	17	29528142	17	31201124	431578	425083	rs1135402803	NC_000017.11:31201123:TTT:TT
NM_000267.3(NF1):c.1041_1045del (p.Gln347fs)	NF1	Q347fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431575	17	29527590 - 29527594	17	31200572 - 31200576	431575	425080	rs1135402800	NC_000017.11:31200571:CAGTCCA:CA
NM_000267.3(NF1):c.792del (p.Ala265fs)	NF1	A265fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431570	17	29509587	17	31182569	431570	425075	rs1135402796	NC_000017.11:31182568:A:
NM_000267.3(NF1):c.789del (p.Ala264fs)	NF1	A264fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431569	17	29509582	17	31182564	431569	425074	rs1135402795	NC_000017.11:31182563:AAA:AA
NM_000267.3(NF1):c.610dup (p.Leu204fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431567	17	29508460 - 29508461	17	31181442 - 31181443	431567	425072	rs1135402793	NC_000017.11:31181442:CCC:CCCC
NM_000267.3(NF1):c.603del (p.Phe201fs)	NF1	F201fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431566	17	29508454	17	31181436	431566	425071	rs1135402792	NC_000017.11:31181435:TTT:TT
NM_000267.3(NF1):c.538_541del (p.Leu180fs)	NF1	L180fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431563	17	29496967 - 29496970	17	31169949 - 31169952	431563	425068	rs1135402789	NC_000017.11:31169948:TTAC:
NM_000267.3(NF1):c.332_335del (p.Lys111fs)	NF1	K111fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431561	17	29490245 - 29490248	17	31163227 - 31163230	431561	425066	rs1135402787	NC_000017.11:31163226:CAAACA:CA
NM_000267.3(NF1):c.1722-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	VCV000430965	17	29550460	17	31223442	430965	424506	rs763983337	NC_000017.11:31223441:A:G
NM_000267.3(NF1):c.2850+1G>T	NF1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429002	17	29556484	17	31229466	429002	420790	rs1131691122	NC_000017.11:31229465:G:T
NM_001042492.3(NF1):c.7212dup (p.Ile2405fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000864530	17	29676159 - 29676160	17	31349141 - 31349142	864530	845145		NC_000017.11:31349141:T:TT
NM_001042492.3(NF1):c.2369_2370dup (p.Ile791Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000864452	17	29554583 - 29554584	17	31227565 - 31227566	864452	844943		NC_000017.11:31227565:TA:TATA
NM_001042492.3(NF1):c.6407_6408del (p.Cys2136fs)	NF1	C2136fs, C2115fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000864428	17	29663911 - 29663912	17	31336893 - 31336894	864428	845100		NC_000017.11:31336892:TGT:T
NM_001042492.3(NF1):c.7247_7250dup (p.Leu2419fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000864134	17	29676194 - 29676195	17	31349176 - 31349177	864134	845149		NC_000017.11:31349176:TACT:TACTTACT
NM_001042492.3(NF1):c.5629dup (p.Leu1877fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000864001	17	29657332 - 29657333	17	31330314 - 31330315	864001	845076		NC_000017.11:31330314:C:CC
NM_001042492.3(NF1):c.439_445dup (p.Asn149fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000863925	17	29490353 - 29490354	17	31163335 - 31163336	863925	844863		NC_000017.11:31163335:TGCAACA:TGCAACATGCAACA
NM_001042492.3(NF1):c.6186_6187insG (p.Leu2063fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000863626	17	29663691 - 29663692	17	31336673 - 31336674	863626	845094		NC_000017.11:31336673::G
NM_001042492.3(NF1):c.7231A>T (p.Arg2411Ter)	NF1	R2411*, R2390*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000863490	17	29676179	17	31349161	863490	845147		NC_000017.11:31349160:A:T
NM_001042492.3(NF1):c.4275dup (p.Ile1426fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000863229	17	29585460 - 29585461	17	31258442 - 31258443	863229	845032		NC_000017.11:31258442:GGG:GGGG
NM_001042492.3(NF1):c.2810del (p.Lys936_Leu937insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000862987	17	29556442	17	31229424	862987	844958		NC_000017.11:31229423:TT:T
NM_001042492.3(NF1):c.3926del (p.Ile1309fs)	NF1	I1309fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000862782	17	29562991	17	31235973	862782	845010		NC_000017.11:31235972:T:
NM_001042492.3(NF1):c.1607_1608CA[2] (p.Met538fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000862340	17	29546102 - 29546103	17	31219084 - 31219085	862340	844909		NC_000017.11:31219083:CACACA:CACA
NM_001042492.3(NF1):c.7465A>T (p.Lys2489Ter)	NF1	K2468*, K2489*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000861961	17	29679282	17	31352264	861961	845164		NC_000017.11:31352263:A:T
NM_001042492.3(NF1):c.7509C>G (p.Tyr2503Ter)	NF1	Y2482*, Y2503*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000861417	17	29679326	17	31352308	861417	845167		NC_000017.11:31352307:C:G
NM_001042492.3(NF1):c.5639dup (p.Leu1880fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000861337	17	29657341 - 29657342	17	31330323 - 31330324	861337	845077		NC_000017.11:31330323:TT:TTT
NM_001042492.3(NF1):c.7184dup (p.Leu2395fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000861173	17	29670144 - 29670145	17	31343126 - 31343127	861173	845144		NC_000017.11:31343126:TTTT:TTTTT
NM_001042492.3(NF1):c.6515C>G (p.Ser2172Ter)	NF1	S2151*, S2172*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000860326	17	29664473	17	31337455	860326	845110		NC_000017.11:31337454:C:G
NM_001042492.3(NF1):c.7120dup (p.Met2374fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000860110	17	29670081 - 29670082	17	31343063 - 31343064	860110	845137		NC_000017.11:31343063:AAA:AAAA
NM_001042492.3(NF1):c.2679del (p.Lys893fs)	NF1	K893fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000859970	17	29556310	17	31229292	859970	844952		NC_000017.11:31229291:AAA:AA
NM_001042492.3(NF1):c.2276del (p.Val759fs)	NF1	V759fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000859969	17	29554260	17	31227242	859969	844939		NC_000017.11:31227241:T:
NM_001042492.3(NF1):c.903_913del (p.Asp301fs)	NF1	D301fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000859342	17	29527453 - 29527463	17	31200435 - 31200445	859342	844878		NC_000017.11:31200434:ACAGTCTACGAA:A
NM_001042492.3(NF1):c.6307dup (p.Leu2103fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000859025	17	29663810 - 29663811	17	31336792 - 31336793	859025	845098		NC_000017.11:31336792:CC:CCC
NM_001042492.3(NF1):c.5314_5339del (p.Lys1771_Val1772insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV000858878	17	29654559 - 29654584	17	31327541 - 31327566	858878	845061		NC_000017.11:31327540:AAAGTCCTAGGGCAATCAGTCTTTCTAAA:AAA
NM_001042492.3(NF1):c.7114_7133del (p.Lys2372fs)	NF1	K2351fs, K2372fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000858867	17	29670078 - 29670097	17	31343060 - 31343079	858867	845136		NC_000017.11:31343059:AAGCAAATGGATCATTTTGT:
NM_001042492.3(NF1):c.1564dup (p.Thr522fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000858595	17	29546058 - 29546059	17	31219040 - 31219041	858595	844906		NC_000017.11:31219040:A:AA
NM_001042492.3(NF1):c.8295_8296del (p.Leu2766fs)	NF1	L2766fs, L2745fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000858470	17	29687638 - 29687639	17	31360620 - 31360621	858470	845197		NC_000017.11:31360619:CAC:C
NM_001042492.3(NF1):c.7608del (p.Lys2536fs)	NF1	K2536fs, K2515fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000858274	17	29679425	17	31352407	858274	845174		NC_000017.11:31352406:G:
NM_001042492.3(NF1):c.338T>A (p.Leu113Ter)	NF1	L113*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000857599	17	29490253	17	31163235	857599	844853		NC_000017.11:31163234:T:A
NM_001042492.3(NF1):c.6486C>G (p.Tyr2162Ter)	NF1	Y2162*, Y2141*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000857333	17	29664444	17	31337426	857333	845106		NC_000017.11:31337425:C:G
NM_001042492.3(NF1):c.1477_1481del (p.Leu493fs)	NF1	L493fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000857230	17	29541549 - 29541553	17	31214531 - 31214535	857230	844900		NC_000017.11:31214530:TCTTCTCTT:TCTT
NM_001042492.3(NF1):c.3051del (p.Gln1017fs)	NF1	Q1017fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000856218	17	29557337	17	31230319	856218	844972		NC_000017.11:31230318:AA:A
NM_001042492.3(NF1):c.7531_7532del (p.Val2511fs)	NF1	V2490fs, V2511fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000856137	17	29679347 - 29679348	17	31352329 - 31352330	856137	845168		NC_000017.11:31352328:TGT:T
NM_001042492.3(NF1):c.7573_7574insT (p.Asp2525fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000855778	17	29679390 - 29679391	17	31352372 - 31352373	855778	845171		NC_000017.11:31352372::T
NM_001042492.3(NF1):c.1522del (p.Leu508fs)	NF1	L508fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000855655	17	29541598	17	31214580	855655	844903		NC_000017.11:31214579:C:
NM_001042492.3(NF1):c.3243del (p.Gly1082fs)	NF1	G1082fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000855008	17	29559136	17	31232118	855008	844982		NC_000017.11:31232117:T:
NM_001042492.3(NF1):c.1153del (p.Arg385fs)	NF1	R385fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000854268	17	29528145	17	31201127	854268	844889		NC_000017.11:31201126:C:
NM_001042492.3(NF1):c.5049_5059del (p.Asn1683fs)	NF1	N1662fs, N1683fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 12, 2020)	criteria provided, single submitter	VCV000853045	17	29653050 - 29653060	17	31326032 - 31326042	853045	845055		NC_000017.11:31326031:ACTCCTGGGTCA:A
NM_001042492.3(NF1):c.4065del (p.Glu1356fs)	NF1	E1356fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000852526	17	29576092	17	31249074	852526	845020		NC_000017.11:31249073:A:
NM_001042492.3(NF1):c.7157_7158dup (p.Asn2387fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000851908	17	29670119 - 29670120	17	31343101 - 31343102	851908	845140		NC_000017.11:31343101:TTT:TTTTT
NM_001042492.3(NF1):c.1896dup (p.Asp633Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000851537	17	29552162 - 29552163	17	31225144 - 31225145	851537	844922		NC_000017.11:31225144:T:TT
NM_001042492.3(NF1):c.6892dup (p.Leu2298fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000851532	17	29665793 - 29665794	17	31338775 - 31338776	851532	845125		NC_000017.11:31338775:C:CC
NM_001042492.3(NF1):c.6802del (p.Ile2268fs)	NF1	I2268fs, I2247fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000851106	17	29665139	17	31338121	851106	845121		NC_000017.11:31338120:AA:A
NM_001042492.3(NF1):c.6939del (p.Ala2314fs)	NF1	A2314fs, A2293fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000850595	17	29667538	17	31340520	850595	845127		NC_000017.11:31340519:AAA:AA
NM_001042492.3(NF1):c.2765del (p.Gly922fs)	NF1	G922fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000850578	17	29556396	17	31229378	850578	844957		NC_000017.11:31229377:GGG:GG
NM_001042492.3(NF1):c.6486C>A (p.Tyr2162Ter)	NF1	Y2162*, Y2141*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000850401	17	29664444	17	31337426	850401	845105		NC_000017.11:31337425:C:A
NM_001042492.3(NF1):c.7262del (p.Asn2421fs)	NF1	N2421fs, N2400fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000849953	17	29676209	17	31349191	849953	845151		NC_000017.11:31349190:AA:A
NM_001042492.3(NF1):c.8074del (p.Glu2692fs)	NF1	E2692fs, E2671fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000849177	17	29685601	17	31358583	849177	845191		NC_000017.11:31358582:G:
NM_001042492.3(NF1):c.6950G>A (p.Trp2317Ter)	NF1	W2296*, W2317*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000848870	17	29667551	17	31340533	848870	845129		NC_000017.11:31340532:G:A
NM_001042492.3(NF1):c.5662del (p.Ile1888fs)	NF1	I1888fs, I1867fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000848857	17	29657362	17	31330344	848857	845079		NC_000017.11:31330343:AAAAA:AAAA
NM_001042492.3(NF1):c.3869del (p.Lys1290fs)	NF1	K1290fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000848632	17	29562788	17	31235770	848632	845005		NC_000017.11:31235769:AA:A
NM_001042492.3(NF1):c.1639dup (p.Glu547fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000848456	17	29546132 - 29546133	17	31219114 - 31219115	848456	844911		NC_000017.11:31219114:GG:GGG
NM_001042492.3(NF1):c.7262_7266del (p.Asn2421fs)	NF1	N2400fs, N2421fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000848332	17	29676209 - 29676213	17	31349191 - 31349195	848332	845152		NC_000017.11:31349190:AACAAA:A
NM_001042492.3(NF1):c.3884_3887del (p.Thr1295fs)	NF1	T1295fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000848117	17	29562946 - 29562949	17	31235928 - 31235931	848117	845006		NC_000017.11:31235927:CTACCTA:CTA
NM_001042492.3(NF1):c.1759_1760insTAGTT (p.Ser587fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000848008	17	29550499 - 29550500	17	31223481 - 31223482	848008	844916		NC_000017.11:31223481::TAGTT
NM_001042492.3(NF1):c.4068del (p.Glu1356fs)	NF1	E1356fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000847979	17	29576094	17	31249076	847979	845021		NC_000017.11:31249075:AA:A
NM_001042492.3(NF1):c.7018C>T (p.Gln2340Ter)	NF1	Q2340*, Q2319*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000847696	17	29667619	17	31340601	847696	845131		NC_000017.11:31340600:C:T
NM_001042492.3(NF1):c.2049_2083del (p.Gln684fs)	NF1	Q684fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000847553	17	29553499 - 29553533	17	31226481 - 31226515	847553	844930		NC_000017.11:31226480:CCCAGACCAAACTAGAAGTGGCCCTGTACATGTTTC:C
NM_001042492.3(NF1):c.4042del (p.His1348fs)	NF1	H1348fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000847279	17	29576068	17	31249050	847279	845019		NC_000017.11:31249049:CC:C
NM_001042492.3(NF1):c.2292_2293GC[1] (p.Arg765fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000846756	17	29554276 - 29554277	17	31227258 - 31227259	846756	844940		NC_000017.11:31227257:GCGC:GC
NM_001042492.3(NF1):c.7059_7062dup (p.Ser2355fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000846444	17	29667659 - 29667660	17	31340641 - 31340642	846444	845133		NC_000017.11:31340641:CAAG:CAAGCAAG
NM_001042492.3(NF1):c.7534_7537dup (p.Gln2513fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 19, 2020)	criteria provided, single submitter	VCV000846377	17	29679349 - 29679350	17	31352331 - 31352332	846377	845169		NC_000017.11:31352331:CGGCC:CGGCCGGCC
NM_001042492.3(NF1):c.1868del (p.His623fs)	NF1	H623fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000846196	17	29552135	17	31225117	846196	844920		NC_000017.11:31225116:A:
NM_001042492.3(NF1):c.1849_1850delinsTA (p.Ala617Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000846124	17	29552116 - 29552117	17	31225098 - 31225099	846124	844919		NC_000017.11:31225097:GC:TA
NM_001042492.3(NF1):c.6096del (p.Asp2033fs)	NF1	D2012fs, D2033fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000845972	17	29663440	17	31336422	845972	845092		NC_000017.11:31336421:A:
NM_001042492.3(NF1):c.4888del (p.Thr1630fs)	NF1	T1630fs, T1609fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000845544	17	29652890	17	31325872	845544	845050		NC_000017.11:31325871:A:
NM_001042492.3(NF1):c.1955_1956del (p.Arg652fs)	NF1	R652fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000845519	17	29552222 - 29552223	17	31225204 - 31225205	845519	844925		NC_000017.11:31225203:GT:
NM_001042492.3(NF1):c.4436del (p.Phe1479fs)	NF1	F1458fs, F1479fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000845258	17	29587388	17	31260370	845258	845041		NC_000017.11:31260369:TTTTT:TTTT
NM_001042492.3(NF1):c.8074G>T (p.Glu2692Ter)	NF1	E2671*, E2692*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000845204	17	29685601	17	31358583	845204	845192		NC_000017.11:31358582:G:T
NM_001042492.3(NF1):c.3058del (p.Glu1020fs)	NF1	E1020fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000844702	17	29557345	17	31230327	844702	844973		NC_000017.11:31230326:G:
NM_001042492.3(NF1):c.3380dup (p.Gly1128fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000844681	17	29559782 - 29559783	17	31232764 - 31232765	844681	844988		NC_000017.11:31232764:C:CC
NM_001042492.3(NF1):c.6322dup (p.Thr2108fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000844156	17	29663826 - 29663827	17	31336808 - 31336809	844156	845099		NC_000017.11:31336808:A:AA
NM_001042492.3(NF1):c.4963A>T (p.Lys1655Ter)	NF1	K1634*, K1655*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000843916	17	29652965	17	31325947	843916	845053		NC_000017.11:31325946:A:T
NM_001042492.3(NF1):c.4298del (p.Pro1433fs)	NF1	P1433fs, P1412fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000843416	17	29585485	17	31258467	843416	845033		NC_000017.11:31258466:CC:C
NM_001042492.3(NF1):c.3331del (p.Phe1110_Met1111insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000842681	17	29559734	17	31232716	842681	844987		NC_000017.11:31232715:A:
NM_001042492.3(NF1):c.1884del (p.Phe627_Tyr628insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000842649	17	29552151	17	31225133	842649	844921		NC_000017.11:31225132:C:
NM_001042492.3(NF1):c.4590del (p.Val1531fs)	NF1	V1510fs, V1531fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000842480	17	29588741	17	31261723	842480	845045		NC_000017.11:31261722:T:
NM_001042492.3(NF1):c.3276del (p.Val1093fs)	NF1	V1093fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000841871	17	29559169	17	31232151	841871	844985		NC_000017.11:31232150:T:
NM_001042492.3(NF1):c.1103dup (p.Ser368fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000841815	17	29528094 - 29528095	17	31201076 - 31201077	841815	844888		NC_000017.11:31201076:G:GG
NM_001042492.3(NF1):c.4216G>T (p.Gly1406Ter)	NF1	G1406*, G1385*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000841676	17	29585404	17	31258386	841676	845027		NC_000017.11:31258385:G:T
NM_001042492.3(NF1):c.3755T>A (p.Leu1252Ter)	NF1	L1252*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000841346	17	29562675	17	31235657	841346	845001		NC_000017.11:31235656:T:A
NM_001042492.3(NF1):c.4239del (p.Phe1413fs)	NF1	F1392fs, F1413fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000841064	17	29585425	17	31258407	841064	845029		NC_000017.11:31258406:TTT:TT
NM_001042492.3(NF1):c.403del (p.Arg135fs)	NF1	R135fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV000840878	17	29490318	17	31163300	840878	844858		NC_000017.11:31163299:C:
NM_001042492.3(NF1):c.4034del (p.Lys1345fs)	NF1	K1345fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000840335	17	29576058	17	31249040	840335	845018		NC_000017.11:31249039:AAAA:AAA
NM_001042492.3(NF1):c.2199del (p.Asn734fs)	NF1	N734fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000840160	17	29553648	17	31226630	840160	844935		NC_000017.11:31226629:CCC:CC
NM_001042492.3(NF1):c.7142dup (p.Asn2381fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000839973	17	29670104 - 29670105	17	31343086 - 31343087	839973	845139		NC_000017.11:31343086:AA:AAA
NM_001042492.3(NF1):c.2481_2491del (p.Leu828fs)	NF1	L828fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000839727	17	29556113 - 29556123	17	31229095 - 31229105	839727	844945		NC_000017.11:31229094:ATTTGTCTGACA:A
NM_001042492.3(NF1):c.3058G>T (p.Glu1020Ter)	NF1	E1020*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000839592	17	29557345	17	31230327	839592	844974		NC_000017.11:31230326:G:T
NM_001042492.3(NF1):c.6524_6525insAA (p.Ile2176fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000839327	17	29664482 - 29664483	17	31337464 - 31337465	839327	845112		NC_000017.11:31337464::AA
NM_001042492.3(NF1):c.2276_2280del (p.Val759fs)	NF1	V759fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000839187	17	29554259 - 29554263	17	31227241 - 31227245	839187	844938		NC_000017.11:31227240:GTGATG:G
NM_001042492.3(NF1):c.2900dup (p.Met968fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000839014	17	29556901 - 29556902	17	31229883 - 31229884	839014	844963		NC_000017.11:31229883:T:TT
NM_001042492.3(NF1):c.7114A>T (p.Lys2372Ter)	NF1	K2351*, K2372*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000838652	17	29670078	17	31343060	838652	845135		NC_000017.11:31343059:A:T
NM_001042492.3(NF1):c.6410C>A (p.Ser2137Ter)	NF1	S2116*, S2137*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000838504	17	29663915	17	31336897	838504	845101		NC_000017.11:31336896:C:A
NM_001042492.3(NF1):c.8030del (p.Leu2677fs)	NF1	L2677fs, L2656fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000838455	17	29685555	17	31358537	838455	845188		NC_000017.11:31358536:TTT:TT
NM_001042492.3(NF1):c.2064del (p.Val689fs)	NF1	V689fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000838146	17	29553514	17	31226496	838146	844931		NC_000017.11:31226495:AA:A
NM_001042492.3(NF1):c.2596_2600dup (p.Met867fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000837844	17	29556228 - 29556229	17	31229210 - 31229211	837844	844949		NC_000017.11:31229210:CCCAT:CCCATCCCAT
NM_001042492.3(NF1):c.7646C>A (p.Ser2549Ter)	NF1	S2528*, S2549*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000837583	17	29683508	17	31356490	837583	845176		NC_000017.11:31356489:C:A
NM_001042492.3(NF1):c.3262_3263del (p.Glu1088fs)	NF1	E1088fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000837482	17	29559155 - 29559156	17	31232137 - 31232138	837482	844984		NC_000017.11:31232136:GA:
NM_001042492.3(NF1):c.2842del (p.Gln948fs)	NF1	Q948fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000837151	17	29556473	17	31229455	837151	844962		NC_000017.11:31229454:CCC:CC
NM_001042492.3(NF1):c.1753_1759del (p.Leu585fs)	NF1	L585fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000836939	17	29550492 - 29550498	17	31223474 - 31223480	836939	844914		NC_000017.11:31223473:ATTAACTA:A
NM_001042492.3(NF1):c.3305T>G (p.Leu1102Ter)	NF1	L1102*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000836913	17	29559198	17	31232180	836913	844986		NC_000017.11:31232179:T:G
NM_001042492.3(NF1):c.6488T>A (p.Leu2163Ter)	NF1	L2163*, L2142*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000836119	17	29664446	17	31337428	836119	845107		NC_000017.11:31337427:T:A
NM_001042492.3(NF1):c.3207_3208delinsTT (p.Gln1070Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV000835546	17	29559100 - 29559101	17	31232082 - 31232083	835546	844980		NC_000017.11:31232081:CC:TT
NM_001042492.3(NF1):c.1192del (p.Leu398fs)	NF1	L398fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000835175	17	29528434	17	31201416	835175	844890		NC_000017.11:31201415:CC:C
NM_001042492.3(NF1):c.997dup (p.Tyr333fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000834888	17	29527546 - 29527547	17	31200528 - 31200529	834888	844883		NC_000017.11:31200528:TT:TTT
NM_001042492.3(NF1):c.3034A>T (p.Lys1012Ter)	NF1	K1012*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000834887	17	29557321	17	31230303	834887	844971		NC_000017.11:31230302:A:T
NM_001042492.3(NF1):c.2824del (p.Ser942fs)	NF1	S942fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000834401	17	29556457	17	31229439	834401	844960		NC_000017.11:31229438:A:
NC_000017.11:g.(?_31218985)_(31222471_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000833276	17	29546003 - 29549489			833276	821017		
NC_000017.11:g.(?_31181402)_(31253278_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000833000	17	29508420 - 29580296			833000	821012		
NC_000017.11:g.(?_31155973)_(31265349_?)dup	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 2, 2019)	criteria provided, single submitter	VCV000831854	17	29482991 - 29592367			831854	821004		
NC_000017.11:g.(?_31225075)_(31236281_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000831764	17	29552093 - 29563299			831764	821019		
NC_000017.11:g.(?_31095030)_(31170007_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000831619	17	29422048 - 29497025			831619	820997		
NC_000017.11:g.(?_31327479)_(31327859_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 9, 2019)	criteria provided, single submitter	VCV000830566	17	29654497 - 29654877			830566	821026		
NM_001042492.3(NF1):c.7847_7850del (p.Gln2616fs)	NF1	Q2595fs, Q2616fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 16, 2020)	criteria provided, single submitter	VCV000827764	17	29684085 - 29684088	17	31357067 - 31357070	827764	815962		NC_000017.11:31357066:CAGGC:C
NM_001042492.3(NF1):c.5404del (p.Thr1802fs)	NF1	T1781fs, T1802fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000805931	17	29654651	17	31327633	805931	794261		NC_000017.11:31327632:AA:A
NM_001042492.3(NF1):c.979_997del (p.Leu327fs)	NF1	L327fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000800651	17	29527530 - 29527548	17	31200512 - 31200530	800651	789249		NC_000017.11:31200511:CTGTGTAAAGCAAGTACTT:
NM_001042492.3(NF1):c.7186A>T (p.Lys2396Ter)	NF1	K2375*, K2396*	Neurofibromatosis, type 1|Ewing's sarcoma	Pathogenic(Last reviewed: Sep 4, 2018)	no assertion criteria provided	VCV000690368	17	29670150	17	31343132	690368	678053		NC_000017.11:31343131:A:T
NM_000267.3(NF1):c.97A>T (p.Lys33Ter)	NF1	K33*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000666183	17	29483037	17	31156019	666183	645439		NC_000017.11:31156018:A:T
NM_000267.3(NF1):c.3158C>G (p.Ser1053Ter)	NF1	S1053*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000665851	17	29557904	17	31230886	665851	645576		NC_000017.11:31230885:C:G
NM_000267.3(NF1):c.7089_7090insTT (p.Asn2364fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000665552	17	29670115 - 29670116	17	31343097 - 31343098	665552	645731		NC_000017.11:31343097:T:TTT
NM_001042492.3(NF1):c.1066del (p.Leu356fs)	NF1	L356fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000664219	17	29528057	17	31201039	664219	645489		NC_000017.11:31201038:CC:C
NM_000267.3(NF1):c.3732_3742del (p.Thr1245fs)	NF1	T1245fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000664141	17	29562652 - 29562662	17	31235634 - 31235644	664141	645603		NC_000017.11:31235633:TACTCTGTTTG:
NM_001042492.3(NF1):c.964del (p.Ile322fs)	NF1	I322fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000663019	17	29527514	17	31200496	663019	645483		NC_000017.11:31200495:AA:A
NM_000267.3(NF1):c.6772_6773dup (p.Leu2258fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 29, 2018)	criteria provided, single submitter	VCV000662994	17	29665736 - 29665737	17	31338718 - 31338719	662994	645720		NC_000017.11:31338718:TT:TTTT
NM_000267.3(NF1):c.972T>A (p.Cys324Ter)	NF1	C324*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000662589	17	29527523	17	31200505	662589	645484		NC_000017.11:31200504:T:A
NM_000267.3(NF1):c.1238C>A (p.Ser413Ter)	NF1	S413*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000662203	17	29528481	17	31201463	662203	645497		NC_000017.11:31201462:C:A
NM_000267.3(NF1):c.5406_5407insTT (p.Ile1803fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000662174	17	29654716 - 29654717	17	31327698 - 31327699	662174	645670		NC_000017.11:31327698:T:TTT
NM_000267.3(NF1):c.4809dup (p.Tyr1604fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000662034	17	29652873 - 29652874	17	31325855 - 31325856	662034	645649		NC_000017.11:31325855:A:AA
NM_000267.3(NF1):c.4068_4069del (p.Glu1356fs)	NF1	E1356fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000661607	17	29576095 - 29576096	17	31249077 - 31249078	661607	645616		NC_000017.11:31249076:AT:
NM_001042492.3(NF1):c.1895del (p.Cys632fs)	NF1	C632fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 21, 2018)	criteria provided, single submitter	VCV000660981	17	29552162	17	31225144	660981	645524		NC_000017.11:31225143:G:
NM_000267.3(NF1):c.1095_1096del (p.Gly367fs)	NF1	G367fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000660347	17	29528087 - 29528088	17	31201069 - 31201070	660347	645491		NC_000017.11:31201068:AA:
NM_000267.3(NF1):c.7854_7855insA (p.Tyr2619fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000660273	17	29684334 - 29684335	17	31357316 - 31357317	660273	645767		NC_000017.11:31357316::A
NM_000267.3(NF1):c.8142_8151del (p.Asp2715fs)	NF1	D2715fs, D2736fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000660162	17	29687549 - 29687558	17	31360531 - 31360540	660162	645784		NC_000017.11:31360530:TGATGCCTTG:
NM_001042492.3(NF1):c.1804dup (p.Glu602fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000659891	17	29550541 - 29550542	17	31223523 - 31223524	659891	645516		NC_000017.11:31223523:GGG:GGGG
NM_001042492.3(NF1):c.2293del (p.Arg765fs)	NF1	R765fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000659735	17	29554277	17	31227259	659735	645539		NC_000017.11:31227258:C:
NM_001042492.3(NF1):c.4631del (p.Ala1544fs)	NF1	A1544fs, A1523fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000659661	17	29588782	17	31261764	659661	645640		NC_000017.11:31261763:C:
NM_001042492.2(NF1):c.7301_7302AG[1] (p.Ser2435fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000659543	17	29676249 - 29676250	17	31349231 - 31349232	659543	645742		NC_000017.11:31349230:AGAG:AG
NM_001042492.2(NF1):c.8052_8053TG[1] (p.Val2685fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000659542	17	29685579 - 29685580	17	31358561 - 31358562	659542	645778		NC_000017.11:31358560:TGTG:TG
NM_000267.3(NF1):c.8021_8026delinsA (p.Pro2674fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000659275	17	29685611 - 29685616	17	31358593 - 31358598	659275	645780		NC_000017.11:31358592:CACCAC:A
NM_001042492.3(NF1):c.4062del (p.Ser1355fs)	NF1	S1355fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000658776	17	29576088	17	31249070	658776	645615		NC_000017.11:31249069:CC:C
NM_000267.3(NF1):c.2045_2049dup (p.Gln684fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000658682	17	29553494 - 29553495	17	31226476 - 31226477	658682	645528		NC_000017.11:31226476:CAAGCC:CAAGCCAAGCC
NM_000267.3(NF1):c.2947_2948del (p.Leu983fs)	NF1	L983fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000658369	17	29556948 - 29556949	17	31229930 - 31229931	658369	645560		NC_000017.11:31229929:TCT:T
NM_000267.3(NF1):c.4432delinsTG (p.Ile1478fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000658301	17	29587451	17	31260433	658301	645636		NC_000017.11:31260432:A:TG
NM_001042492.3(NF1):c.7325dup (p.Leu2442fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 3, 2018)	criteria provided, single submitter	VCV000658066	17	29677201 - 29677202	17	31350183 - 31350184	658066	645743		NC_000017.11:31350183:TTT:TTTT
NM_001042492.3(NF1):c.3212del (p.Ala1071fs)	NF1	A1071fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000657966	17	29559105	17	31232087	657966	645580		NC_000017.11:31232086:C:
NM_000267.3(NF1):c.6670C>T (p.Gln2224Ter)	NF1	Q2224*, Q2245*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 21, 2018)	criteria provided, single submitter	VCV000657256	17	29665071	17	31338053	657256	645718		NC_000017.11:31338052:C:T
NM_000267.3(NF1):c.7128delG	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000657065	17	29676137	17	31349119	657065	652773		NC_000017.11:31349118:GGG:GG
NM_001042492.3(NF1):c.3456dup (p.Leu1153fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000656975	17	29559858 - 29559859	17	31232840 - 31232841	656975	645591		NC_000017.11:31232840:A:AA
NM_001042492.2(NF1):c.5727_5728CT[1] (p.Ser1910fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000656660	17	29657430 - 29657431	17	31330412 - 31330413	656660	645685		NC_000017.11:31330411:TCTCT:TCT
NM_000267.3(NF1):c.681T>G (p.Tyr227Ter)	NF1	Y227*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000656641	17	29508754	17	31181736	656641	645468		NC_000017.11:31181735:T:G
NC_000017.10:g.(?_29556843)_(29592367_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000655758	17	29556843 - 29592367	17	31229825 - 31265349	655758	652798		
NM_000267.3(NF1):c.3402_3405dup (p.Arg1136fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000655579	17	29559803 - 29559804	17	31232785 - 31232786	655579	645588		NC_000017.11:31232785:TGTCT:TGTCTGTCT
NM_001042492.3(NF1):c.7393del (p.Asp2465fs)	NF1	D2465fs, D2444fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000655473	17	29677272	17	31350254	655473	645748		NC_000017.11:31350253:G:
NM_000267.3(NF1):c.5606_5627del (p.Gly1869fs)	NF1	G1869fs, G1890fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000654611	17	29657370 - 29657391	17	31330352 - 31330373	654611	645682		NC_000017.11:31330351:AGGGCCAGTTACTAGAGACATCAGG:AGG
NM_000267.3(NF1):c.2695_2738dup (p.Arg914_Thr915insCysProTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000654522	17	29556327 - 29556328	17	31229309 - 31229310	654522	645550		NC_000017.11:31229309:TTGTCCTTAATGGTGTGTAACCATGAGAAAGTGGGACTTCAAAT:TTGTCCTTAATGGTGTGTAACCATGAGAAAGTGGGACTTCAAATTTGTCCTTAATGGTGTGTAACCATGAGAAAGTGGGACTTCAAAT
NM_000267.3(NF1):c.279T>A (p.Cys93Ter)	NF1	C93*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000654518	17	29486102	17	31159084	654518	645449		NC_000017.11:31159083:T:A
NM_001042492.3(NF1):c.4404del (p.Ser1470fs)	NF1	S1470fs, S1449fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000654170	17	29586121	17	31259103	654170	645629		NC_000017.11:31259102:G:
NM_001042492.3(NF1):c.370del (p.Cys124fs)	NF1	C124fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000653825	17	29490285	17	31163267	653825	645453		NC_000017.11:31163266:T:
NM_000267.3(NF1):c.5617G>T (p.Glu1873Ter)	NF1	E1894*, E1873*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000653673	17	29657384	17	31330366	653673	645684		NC_000017.11:31330365:G:T
NM_001042492.3(NF1):c.3186dup (p.Cys1063fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000653648	17	29557928 - 29557929	17	31230910 - 31230911	653648	645578		NC_000017.11:31230910:AAAA:AAAAA
NM_001042492.2(NF1):c.7324_7327TTAC[1] (p.Leu2443fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000653486	17	29677203 - 29677206	17	31350185 - 31350188	653486	645744		NC_000017.11:31350184:TTACTTAC:TTAC
NM_001042492.3(NF1):c.3461dup (p.Asn1154fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000653419	17	29559862 - 29559863	17	31232844 - 31232845	653419	645592		NC_000017.11:31232844:AA:AAA
NM_000267.3(NF1):c.4675_4682delinsAAAAAGG (p.Glu1559fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000653392	17	29592260 - 29592267	17	31265242 - 31265249	653392	645643		NC_000017.11:31265241:GAAAAAGA:AAAAAGG
NM_001042492.3(NF1):c.2158dup (p.Arg720fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000652458	17	29553607 - 29553608	17	31226589 - 31226590	652458	645532		NC_000017.11:31226589:CC:CCC
NM_000267.3(NF1):c.7721_7722del (p.Lys2574fs)	NF1	K2595fs, K2574fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000652439	17	29684022 - 29684023	17	31357004 - 31357005	652439	645760		NC_000017.11:31357003:AAA:A
NM_000267.3(NF1):c.4786_4790delinsATATCAG (p.Gln1596fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000651932	17	29652851 - 29652855	17	31325833 - 31325837	651932	645648		NC_000017.11:31325832:CAAAT:ATATCAG
NM_001042492.3(NF1):c.4618del (p.Ala1540fs)	NF1	A1519fs, A1540fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000651837	17	29588768	17	31261750	651837	645639		NC_000017.11:31261749:GG:G
NM_001042492.3(NF1):c.3370dup (p.Ser1124fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000650810	17	29559770 - 29559771	17	31232752 - 31232753	650810	645586		NC_000017.11:31232752:AAA:AAAA
NM_000267.3(NF1):c.6585C>A (p.Cys2195Ter)	NF1	C2195*, C2216*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000649614	17	29664842	17	31337824	649614	645714		NC_000017.11:31337823:C:A
NM_000267.3(NF1):c.6278_6279del (p.Gly2093fs)	NF1	G2114fs, G2093fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000649391	17	29663846 - 29663847	17	31336828 - 31336829	649391	645703		NC_000017.11:31336827:GT:
NM_001042492.3(NF1):c.2525del (p.Gly842fs)	NF1	G842fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000649295	17	29556157	17	31229139	649295	645547		NC_000017.11:31229138:GG:G
NM_001042492.3(NF1):c.6538del (p.Ser2180fs)	NF1	S2159fs, S2180fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000649128	17	29664495	17	31337477	649128	645709		NC_000017.11:31337476:TT:T
NM_000267.3(NF1):c.4769_4771delinsAC (p.Arg1590fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000649126	17	29592354 - 29592356	17	31265336 - 31265338	649126	645646		NC_000017.11:31265335:GGA:AC
NM_000267.3(NF1):c.480delG	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000648269	17	29496908	17	31169890	648269	652908		NC_000017.11:31169889:GG:G
NM_001042492.3(NF1):c.7131del (p.Phe2377fs)	NF1	F2377fs, F2356fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000648010	17	29670092	17	31343074	648010	645730		NC_000017.11:31343073:TTTT:TTT
NC_000017.10:g.(?_29559081)_(29576147_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 15, 2018)	criteria provided, single submitter	VCV000647943	17	29559081 - 29576147	17	31232063 - 31249129	647943	653089		
NM_000267.3(NF1):c.221_222dup (p.Ala75fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	VCV000647297	17	29486043 - 29486044	17	31159025 - 31159026	647297	645442		NC_000017.11:31159025:CT:CTCT
NM_000267.3(NF1):c.4894_4901del (p.Arg1632fs)	NF1	R1632fs, R1653fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000646596	17	29652959 - 29652966	17	31325941 - 31325948	646596	645654		NC_000017.11:31325940:CGCTTTAA:
NM_001042492.3(NF1):c.2458del (p.His819_Val820insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000646475	17	29556091	17	31229073	646475	645545		NC_000017.11:31229072:G:
NM_001042492.3(NF1):c.790del (p.Ala264fs)	NF1	A264fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000646450	17	29509585	17	31182567	646450	645475		NC_000017.11:31182566:G:
NM_001042492.3(NF1):c.2122del (p.Ser708fs)	NF1	S708fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000646410	17	29553573	17	31226555	646410	645530		NC_000017.11:31226554:T:
NM_001042492.3(NF1):c.1861del (p.Ser621fs)	NF1	S621fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000645426	17	29552127	17	31225109	645426	645520		NC_000017.11:31225108:TT:T
NM_000267.3(NF1):c.7694_7695dup (p.Ser2566fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000645292	17	29683995 - 29683996	17	31356977 - 31356978	645292	645759		NC_000017.11:31356977:CA:CACA
NM_001042492.3(NF1):c.5494del (p.Glu1832fs)	NF1	E1811fs, E1832fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000645159	17	29654740	17	31327722	645159	645673		NC_000017.11:31327721:GGG:GG
NM_000267.3(NF1):c.4312G>T (p.Glu1438Ter)	NF1	E1438*, E1459*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000645094	17	29586092	17	31259074	645094	645627		NC_000017.11:31259073:G:T
NM_000267.3(NF1):c.5749+4A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000644875	17	29657520	17	31330502	644875	652762		NC_000017.11:31330501:A:T
NM_000267.3(NF1):c.3447_3448dup (p.Ser1150fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000644537	17	29559848 - 29559849	17	31232830 - 31232831	644537	645590		NC_000017.11:31232830:TGT:TGTGT
NM_000267.3(NF1):c.7392T>A (p.Tyr2464Ter)	NF1	Y2464*, Y2485*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000644466	17	29677334	17	31350316	644466	645753		NC_000017.11:31350315:T:A
NM_001042492.3(NF1):c.5802del (p.Phe1934fs)	NF1	F1934fs, F1913fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000643961	17	29657504	17	31330486	643961	645688		NC_000017.11:31330485:TTT:TT
NM_000267.3(NF1):c.5908_5915del (p.Ile1971fs)	NF1	I1992fs, I1971fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000643803	17	29662012 - 29662019	17	31334994 - 31335001	643803	645694		NC_000017.11:31334993:CATCTATTCA:CA
NM_000267.3(NF1):c.5223_5226del (p.Val1741_Gln1742insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000643507	17	29654534 - 29654537	17	31327516 - 31327519	643507	645664		NC_000017.11:31327515:CCAA:
NM_000267.3(NF1):c.7892_7893del (p.Lys2631fs)	NF1	K2631fs, K2652fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000642977	17	29684371 - 29684372	17	31357353 - 31357354	642977	645772		NC_000017.11:31357352:AAA:A
NM_000267.3(NF1):c.8095A>T (p.Lys2699Ter)	NF1	K2720*, K2699*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000642603	17	29686031	17	31359013	642603	645783		NC_000017.11:31359012:A:T
NC_000017.10:g.(?_29527420)_(29592377_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000642049	17	29527420 - 29592377	17	31200402 - 31265359	642049	653088		
NM_000267.3(NF1):c.1984A>T (p.Lys662Ter)	NF1	K662*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000641164	17	29552251	17	31225233	641164	645526		NC_000017.11:31225232:A:T
NM_001042492.3(NF1):c.7612del (p.Gly2539fs)	NF1	G2539fs, G2518fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000640820	17	29679429	17	31352411	640820	645755		NC_000017.11:31352410:C:
NM_001042492.3(NF1):c.4481del (p.His1494fs)	NF1	H1473fs, H1494fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000640494	17	29587437	17	31260419	640494	645634		NC_000017.11:31260418:A:
NM_001042492.3(NF1):c.5533dup (p.Ile1845fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000640360	17	29654780 - 29654781	17	31327762 - 31327763	640360	645675		NC_000017.11:31327762:A:AA
NM_000267.3(NF1):c.1174C>T (p.Gln392Ter)	NF1	Q392*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000640314	17	29528166	17	31201148	640314	645495		NC_000017.11:31201147:C:T
NM_000267.3(NF1):c.2272A>T (p.Arg758Ter)	NF1	R758*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000639102	17	29554256	17	31227238	639102	645535		NC_000017.11:31227237:A:T
NM_001042492.3(NF1):c.6794del (p.Lys2265fs)	NF1	K2244fs, K2265fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000638554	17	29665130	17	31338112	638554	626344		NC_000017.11:31338111:AAA:AA
NM_000267.3(NF1):c.7215T>A (p.Cys2405Ter)	NF1	C2405*, C2426*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 9, 2019)	criteria provided, single submitter	VCV000627518	17	29676226	17	31349208	627518	615874	rs1567623508	NC_000017.11:31349207:T:A
NM_000267.3(NF1):c.7919T>A (p.Leu2640Ter)	NF1	L2640*, L2661*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000617614	17	29685509	17	31358491	617614	609010	rs1567627709	NC_000017.11:31358490:T:A
NM_000267.3(NF1):c.4269+1del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000599036	17	29585520	17	31258502	599036	590165	rs1567862095	NC_000017.11:31258501:GG:G
NM_001042492.3(NF1):c.1392+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000585289	17	29533390	17	31206372	585289	576342	rs267604791	NC_000017.11:31206371:G:C
NC_000017.10:g.(?_29527430)_(29592367_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000584096	17	29527430 - 29592367	17	31200412 - 31265349	584096	570772		
NM_000267.3(NF1):c.6637C>T (p.Gln2213Ter)	NF1	Q2213*, Q2234*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000583019	17	29664894	17	31337876	583019	571179	rs1567617727	NC_000017.11:31337875:C:T
NM_000267.3(NF1):c.6253_6296dup (p.Ser2100_Thr2101insLeuLeuLeuSerTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000582963	17	29663819 - 29663820	17	31336801 - 31336802	582963	571027	rs1567617045	NC_000017.11:31336801:CGTTGTTACTTTCTTAGTAGCCACAGGTCCGCTCTCCCTTAGAGC:CGTTGTTACTTTCTTAGTAGCCACAGGTCCGCTCTCCCTTAGAGCGTTGTTACTTTCTTAGTAGCCACAGGTCCGCTCTCCCTTAGAGC
NM_000267.3(NF1):c.7954C>T (p.Gln2652Ter)	NF1	Q2673*, Q2652*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000582838	17	29685544	17	31358526	582838	574434	rs1567627751	NC_000017.11:31358525:C:T
NM_000267.3(NF1):c.1857_1863del (p.Arg619fs)	NF1	R619fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000582772	17	29552124 - 29552130	17	31225106 - 31225112	582772	571000	rs1567846634	NC_000017.11:31225105:AAGTTCC:
NM_000267.3(NF1):c.2322_2323del (p.Glu775fs)	NF1	E775fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000582698	17	29554306 - 29554307	17	31227288 - 31227289	582698	568844	rs1567847962	NC_000017.11:31227287:TG:
NM_000267.3(NF1):c.1680del (p.Leu560fs)	NF1	L560fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000582154	17	29548906	17	31221888	582154	570966	rs1567845069	NC_000017.11:31221887:G:
NM_000267.3(NF1):c.607del (p.Ala203fs)	NF1	A203fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000581692	17	29508460	17	31181442	581692	570942	rs1567825887	NC_000017.11:31181441:G:
NM_000267.3(NF1):c.3497delG	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000581647	17	29560019	17	31233001	581647	570956	rs1567851231	NC_000017.11:31233000:GG:G
NM_000267.3(NF1):c.5582dup (p.Cys1861fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000581320	17	29657348 - 29657349	17	31330330 - 31330331	581320	571144	rs1567613604	NC_000017.11:31330330:G:GG
NM_000267.3(NF1):c.1815del (p.Cys606fs)	NF1	C606fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000581113	17	29550555	17	31223537	581113	574379	rs1567845935	NC_000017.11:31223536:C:
NM_000267.3(NF1):c.882_885del (p.Met294fs)	NF1	M294fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000581086	17	29509675 - 29509678	17	31182657 - 31182660	581086	574360	rs1567826819	NC_000017.11:31182656:ATGAAT:AT
NM_000267.3(NF1):c.2424del (p.His809fs)	NF1	H809fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000580980	17	29556056	17	31229038	580980	574389	rs1567848731	NC_000017.11:31229037:TT:T
NM_000267.3(NF1):c.4393del (p.Cys1465fs)	NF1	C1465fs, C1486fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000580782	17	29587411	17	31260393	580782	571112	rs1567862860	NC_000017.11:31260392:TT:T
NM_000267.3(NF1):c.4680dup (p.Glu1561fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000580651	17	29592260 - 29592261	17	31265242 - 31265243	580651	570998	rs1567864972	NC_000017.11:31265242:AAAAA:AAAAAA
NM_000267.3(NF1):c.5313_5316dup (p.Val1773fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000580268	17	29654623 - 29654624	17	31327605 - 31327606	580268	571013	rs1567612435	NC_000017.11:31327605:CCTA:CCTACCTA
NM_000267.3(NF1):c.1618G>T (p.Glu540Ter)	NF1	E540*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000579731	17	29546113	17	31219095	579731	570884	rs1567843930	NC_000017.11:31219094:G:T
NM_000267.3(NF1):c.4044del (p.His1348fs)	NF1	H1348fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000579586	17	29576071	17	31249053	579586	570973	rs1567858344	NC_000017.11:31249052:T:
NM_000267.3(NF1):c.6659dup (p.Asn2220fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000579219	17	29665058 - 29665059	17	31338040 - 31338041	579219	574423	rs1567617849	NC_000017.11:31338040:AA:AAA
NM_000267.3(NF1):c.7863C>G (p.Tyr2621Ter)	NF1	Y2621*, Y2642*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000579176	17	29684343	17	31357325	579176	574433	rs1567627217	NC_000017.11:31357324:C:G
NM_000267.3(NF1):c.3361G>T (p.Glu1121Ter)	NF1	E1121*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000577899	17	29559764	17	31232746	577899	571066	rs1567851029	NC_000017.11:31232745:G:T
NM_000267.3(NF1):c.4020del (p.Gln1341fs)	NF1	Q1341fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000577224	17	29576046	17	31249028	577224	574405	rs1567858318	NC_000017.11:31249027:TT:T
NM_000267.3(NF1):c.298del (p.Asp100fs)	NF1	D100fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000576707	17	29490212	17	31163194	576707	568763	rs1567817841	NC_000017.11:31163193:GG:G
NM_001042492.2(NF1):c.2148_2159delinsTGAAGTGTCT (p.Glu716fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000575987	17	29553599 - 29553610	17	31226581 - 31226592	575987	568833	rs1567847538	NC_000017.11:31226580:AGCAGATATCCG:TGAAGTGTCT
NM_000267.3(NF1):c.4648G>T (p.Glu1550Ter)	NF1	E1550*, E1571*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000575667	17	29588862	17	31261844	575667	571124	rs1567863648	NC_000017.11:31261843:G:T
NM_000267.3(NF1):c.3384del (p.Gly1129fs)	NF1	G1129fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000575579	17	29559787	17	31232769	575579	571069	rs1567851054	NC_000017.11:31232768:T:
NM_001042492.2(NF1):c.7662_7664delinsAG (p.Lys2555fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000575440	17	29683524 - 29683526	17	31356506 - 31356508	575440	571228	rs1567626632	NC_000017.11:31356505:TAA:AG
NM_000267.3(NF1):c.2434del (p.Ile812fs)	NF1	I812fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000574941	17	29556067	17	31229049	574941	570925	rs1567848739	NC_000017.11:31229048:A:
NM_000267.3(NF1):c.2034del (p.Ile679fs)	NF1	I679fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000574937	17	29553485	17	31226467	574937	570903	rs1567847384	NC_000017.11:31226466:G:
NM_000267.3(NF1):c.3695del (p.Pro1232fs)	NF1	P1232fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000574642	17	29560217	17	31233199	574642	570962	rs1567851532	NC_000017.11:31233198:CC:C
NM_000267.3(NF1):c.2041del (p.Arg681fs)	NF1	R681fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000574512	17	29553491	17	31226473	574512	570906	rs1567847398	NC_000017.11:31226472:CC:C
NM_000267.3(NF1):c.4554_4567dup (p.Ala1523fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000574435	17	29588767 - 29588768	17	31261749 - 31261750	574435	571119	rs1567863580	NC_000017.11:31261749:GGCAACACTTCTTG:GGCAACACTTCTTGGGCAACACTTCTTG
NM_000267.3(NF1):c.449del (p.Phe150fs)	NF1	F150fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000574327	17	29490363	17	31163345	574327	570855	rs1567817974	NC_000017.11:31163344:TT:T
NM_000267.3(NF1):c.7970del (p.Leu2656_Leu2657insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000574267	17	29685559	17	31358541	574267	571247	rs1567627755	NC_000017.11:31358540:TT:T
NM_000267.3(NF1):c.3657dup (p.Glu1220fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000573205	17	29560179 - 29560180	17	31233161 - 31233162	573205	571084	rs1567851445	NC_000017.11:31233161:A:AA
NM_000267.3(NF1):c.4922G>A (p.Trp1641Ter)	NF1	W1641*, W1662*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000573015	17	29652987	17	31325969	573015	568925	rs1567611375	NC_000017.11:31325968:G:A
NM_000267.3(NF1):c.5129T>A (p.Leu1710Ter)	NF1	L1710*, L1731*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000572862	17	29653194	17	31326176	572862	571008	rs1567611604	NC_000017.11:31326175:T:A
NM_000267.3(NF1):c.5660_5679del (p.Ile1887fs)	NF1	I1908fs, I1887fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000572845	17	29657426 - 29657445	17	31330408 - 31330427	572845	574419	rs1567613682	NC_000017.11:31330407:ATTGTCTCTATTAGTAAGACA:A
NM_000267.3(NF1):c.2380del (p.Tyr794fs)	NF1	Y794fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000572818	17	29554595	17	31227577	572818	570921	rs1567848178	NC_000017.11:31227576:T:
NM_000267.3(NF1):c.1818C>A (p.Cys606Ter)	NF1	C606*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000572601	17	29550558	17	31223540	572601	570899	rs1567845937	NC_000017.11:31223539:C:A
NM_000267.3(NF1):c.988_995del (p.Ala330fs)	NF1	A330fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000571225	17	29527539 - 29527546	17	31200521 - 31200528	571225	568790	rs1567835161	NC_000017.11:31200520:GCAAGTAC:
NM_000267.3(NF1):c.4199del (p.Pro1400fs)	NF1	P1400fs, P1421fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000571036	17	29585449	17	31258431	571036	568901	rs1567861977	NC_000017.11:31258430:CC:C
NM_000267.3(NF1):c.5284del (p.Tyr1762fs)	NF1	Y1783fs, Y1762fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000570774	17	29654593	17	31327575	570774	571011	rs1567612415	NC_000017.11:31327574:TTT:TT
NM_000267.3(NF1):c.5364dup (p.Leu1789fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 18, 2018)	criteria provided, single submitter	VCV000570687	17	29654674 - 29654675	17	31327656 - 31327657	570687	571138	rs1567612483	NC_000017.11:31327656:G:GG
NM_000267.3(NF1):c.592del (p.Ala198fs)	NF1	A198fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000570686	17	29508445	17	31181427	570686	570938	rs1567825858	NC_000017.11:31181426:G:
NM_000267.3(NF1):c.1344dup (p.Lys449Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000570222	17	29533340 - 29533341	17	31206322 - 31206323	570222	570876	rs1567838311	NC_000017.11:31206322:T:TT
NM_000267.3(NF1):c.4686del (p.Glu1562fs)	NF1	E1562fs, E1583fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000569717	17	29592270	17	31265252	569717	574411	rs1567864983	NC_000017.11:31265251:AA:A
NM_000267.3(NF1):c.2622_2629del (p.Lys874fs)	NF1	K874fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000569716	17	29556254 - 29556261	17	31229236 - 31229243	569716	574391	rs1567848976	NC_000017.11:31229235:AGGGTTCTA:A
NM_001042492.2(NF1):c.87_88CA[2] (p.His31fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000569660	17	29483026 - 29483027	17	31156008 - 31156009	569660	570927	rs1567814432	NC_000017.11:31156007:ACACACA:ACACA
NM_000267.3(NF1):c.5398del (p.Val1800fs)	NF1	V1821fs, V1800fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000569647	17	29654709	17	31327691	569647	574415	rs1567612531	NC_000017.11:31327690:G:
NM_000267.3(NF1):c.1331del (p.Gly444fs)	NF1	G444fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000569133	17	29533327	17	31206309	569133	574370	rs1567838293	NC_000017.11:31206308:GG:G
NM_000267.3(NF1):c.1724C>G (p.Ser575Ter)	NF1	S575*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000568718	17	29550464	17	31223446	568718	570898	rs915463951	NC_000017.11:31223445:C:G
NM_000267.3(NF1):c.6798_6801dup (p.Val2268fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, single submitter	VCV000568552	17	29665762 - 29665763	17	31338744 - 31338745	568552	571191	rs1567618250	NC_000017.11:31338744:TCAA:TCAATCAA
NM_000267.3(NF1):c.4463del (p.Arg1488fs)	NF1	R1488fs, R1509fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000568205	17	29587482	17	31260464	568205	570988	rs1567862956	NC_000017.11:31260463:G:
NM_001042492.2(NF1):c.5039_5041delinsT (p.Tyr1680fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000567655	17	29653041 - 29653043	17	31326023 - 31326025	567655	568927	rs1567611457	NC_000017.11:31326022:ATA:T
NM_000267.3(NF1):c.1619del (p.Glu540fs)	NF1	E540fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000567071	17	29546114	17	31219096	567071	570963	rs1567843934	NC_000017.11:31219095:A:
NM_000267.3(NF1):c.4000G>T (p.Glu1334Ter)	NF1	E1334*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000565647	17	29576027	17	31249009	565647	568894	rs878853892	NC_000017.11:31249008:G:T
NM_000267.3(NF1):c.7858del (p.Glu2620fs)	NF1	E2641fs, E2620fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000565583	17	29684338	17	31357320	565583	571241	rs1567627210	NC_000017.11:31357319:G:
NM_000267.3(NF1):c.5880del (p.Met1960fs)	NF1	M1981fs, M1960fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000565500	17	29661986	17	31334968	565500	571145	rs1567615872	NC_000017.11:31334967:G:
NM_000267.3(NF1):c.6111del (p.Ile2037fs)	NF1	I2058fs, I2037fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000565403	17	29663678	17	31336660	565403	568948	rs1567616894	NC_000017.11:31336659:TT:T
NM_000267.3(NF1):c.5472del (p.Arg1825fs)	NF1	R1825fs, R1846fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000565311	17	29654782	17	31327764	565311	574417	rs1567612647	NC_000017.11:31327763:TT:T
NM_000267.3(NF1):c.6858+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547687	17	29665824	17	31338806	547687	538223	rs1060500355	NC_000017.11:31338805:G:T
NM_000267.3(NF1):c.6641+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547681	17	29664900	17	31337882	547681	538218	rs1555534928	NC_000017.11:31337881:T:G
NM_000267.3(NF1):c.5944-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547672	17	29663349	17	31336331	547672	538208	rs1555534595	NC_000017.11:31336330:A:G
NM_000267.3(NF1):c.5749+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547669	17	29657518	17	31330500	547669	538206	rs1555533887	NC_000017.11:31330499:T:C
NM_000267.3(NF1):c.5613dup (p.Leu1872fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547666	17	29657379 - 29657380	17	31330361 - 31330362	547666	538203	rs1475358670	NC_000017.11:31330361:A:AA
NM_000267.3(NF1):c.5485_5486del (p.Val1829fs)	NF1	V1829fs, V1850fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547661	17	29654795 - 29654796	17	31327777 - 31327778	547661	538198	rs1555533636	NC_000017.11:31327776:TGT:T
NM_000267.3(NF1):c.5206-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547657	17	29654515	17	31327497	547657	538194	rs1555533548	NC_000017.11:31327496:A:G
NM_000267.3(NF1):c.4772+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547652	17	29592358	17	31265340	547652	538189	rs1085307819	NC_000017.11:31265339:G:A
NM_000267.3(NF1):c.4720del (p.Gln1574fs)	NF1	Q1574fs, Q1595fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547650	17	29592304	17	31265286	547650	538187	rs1555619404	NC_000017.11:31265285:CC:C
NM_000267.3(NF1):c.4523A>G (p.Lys1508Arg)	NF1	K1508R, K1529R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547646	17	29588737	17	31261719	547646	538183	rs1555619001	NC_000017.11:31261718:A:G
NM_000267.3(NF1):c.2786T>C (p.Leu929Pro)	NF1	L929P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547614	17	29556419	17	31229401	547614	538151	rs1555614338	NC_000017.11:31229400:T:C
NM_000267.3(NF1):c.2356C>T (p.Gln786Ter)	NF1	Q786*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547610	17	29554571	17	31227553	547610	538147	rs1555613999	NC_000017.11:31227552:C:T
NM_000267.3(NF1):c.2252-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547607	17	29554234	17	31227216	547607	538143	rs1131691105	NC_000017.11:31227215:A:C
NM_000267.3(NF1):c.1642-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547599	17	29548867	17	31221849	547599	538136	rs1555613185	NC_000017.11:31221848:G:A
NM_000267.3(NF1):c.1607C>A (p.Ser536Ter)	NF1	S536*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547596	17	29546102	17	31219084	547596	538133	rs1555612859	NC_000017.11:31219083:C:A
NM_000267.3(NF1):c.1540C>T (p.Gln514Ter)	NF1	Q514*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547594	17	29546035	17	31219017	547594	538131	rs1316926587	NC_000017.11:31219016:C:T
NM_000267.3(NF1):c.1237T>C (p.Ser413Pro)	NF1	S413P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547584	17	29528480	17	31201462	547584	538121	rs1555611093	NC_000017.11:31201461:T:C
NM_000267.3(NF1):c.586+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547567	17	29497016	17	31169998	547567	538104	rs1555607126	NC_000017.11:31169997:G:A
NM_000267.3(NF1):c.5094del (p.Ile1698fs)	NF1	I1698fs, I1719fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000545724	17	29653159	17	31326141	545724	536216	rs1555533382	NC_000017.11:31326140:A:
NC_000017.10:g.(?_29587367)_(29592377_?)dup	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000527684	17	29587367 - 29592377	17	31260349 - 31265359	527684	530834		
NC_000017.10:g.(?_29661850)_(29662055_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000527681	17	29661850 - 29662055	17	31334832 - 31335037	527681	531012		
NM_000267.3(NF1):c.1549G>T (p.Glu517Ter)	NF1	E517*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527597	17	29546044	17	31219026	527597	530901	rs587778548	NC_000017.11:31219025:G:T
NM_000267.3(NF1):c.5498del (p.Leu1833fs)	NF1	L1833fs, L1854fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000527589	17	29654809	17	31327791	527589	531008	rs1555533644	NC_000017.11:31327790:T:
NM_000267.3(NF1):c.2062G>T (p.Glu688Ter)	NF1	E688*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000527588	17	29553513	17	31226495	527588	531222	rs1555613784	NC_000017.11:31226494:G:T
NM_000267.3(NF1):c.4707_4714del (p.Leu1569fs)	NF1	L1590fs, L1569fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000527574	17	29592290 - 29592297	17	31265272 - 31265279	527574	531302	rs1555619402	NC_000017.11:31265271:TTAAGTATTT:TT
NM_000267.3(NF1):c.594del (p.Phe199fs)	NF1	F199fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000527567	17	29508447	17	31181429	527567	530673	rs1555608647	NC_000017.11:31181428:A:
NM_000267.3(NF1):c.181dup (p.Ile61fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000527552	17	29483120 - 29483121	17	31156102 - 31156103	527552	530914	rs1555604935	NC_000017.11:31156102:A:AA
NM_001042492.2(NF1):c.920_921delinsA (p.Leu307fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000527551	17	29527471 - 29527472	17	31200453 - 31200454	527551	530873	rs1555610860	NC_000017.11:31200452:TT:A
NM_000267.3(NF1):c.3043del (p.Leu1015fs)	NF1	L1015fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000527530	17	29557330	17	31230312	527530	531235	rs1555614514	NC_000017.11:31230311:C:
NM_000267.3(NF1):c.6212del (p.Asn2071fs)	NF1	N2092fs, N2071fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000527500	17	29663779	17	31336761	527500	531356	rs1555534697	NC_000017.11:31336760:AA:A
NM_001042492.2(NF1):c.4983_4985delinsCTTA (p.Lys1661fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000527499	17	29652985 - 29652987	17	31325967 - 31325969	527499	530867	rs1555533326	NC_000017.11:31325966:GTG:CTTA
NM_000267.3(NF1):c.4070del (p.Phe1357fs)	NF1	F1357fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000527483	17	29576096	17	31249078	527483	530818	rs1555617354	NC_000017.11:31249077:TT:T
NM_000267.3(NF1):c.5723del (p.Glu1908fs)	NF1	E1908fs, E1929fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000527475	17	29657490	17	31330472	527475	531344	rs1555533883	NC_000017.11:31330471:A:
NM_000267.3(NF1):c.529dup (p.Ile177fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000527453	17	29496957 - 29496958	17	31169939 - 31169940	527453	530842	rs1555607093	NC_000017.11:31169939:A:AA
NM_000267.3(NF1):c.2668_2677del (p.Pro890fs)	NF1	P890fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000527452	17	29556299 - 29556308	17	31229281 - 31229290	527452	531232	rs1555614293	NC_000017.11:31229280:CACCTGTCAGCA:CA
NM_000267.3(NF1):c.8049_8050del (p.Ser2684fs)	NF1	S2684fs, S2705fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000527440	17	29685638 - 29685639	17	31358620 - 31358621	527440	530934	rs1555536947	NC_000017.11:31358619:AAA:A
NM_000267.3(NF1):c.1912G>T (p.Gly638Ter)	NF1	G638*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000527439	17	29552179	17	31225161	527439	531214	rs1555613567	NC_000017.11:31225160:G:T
NM_000267.3(NF1):c.3094dup (p.Cys1032fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000527429	17	29557377 - 29557378	17	31230359 - 31230360	527429	530953	rs1555614535	NC_000017.11:31230359:TTTT:TTTTT
NM_000267.3(NF1):c.6663_6664insGGAAA (p.Ser2222fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527428	17	29665063 - 29665064	17	31338045 - 31338046	527428	531363	rs1555534950	NC_000017.11:31338045:A:AGGAAA
NM_000267.3(NF1):c.7013_7039del (p.Val2338_Leu2346del)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000522586	17	29670039 - 29670065	17	31343021 - 31343047	522586	513200	rs1555535403	NC_000017.11:31343020:GTATTTATGGCAATCCGGAATCCTCTGG:G
NM_000267.3(NF1):c.5024del (p.Leu1675fs)	NF1	L1696fs, L1675fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000488453	17	29653089	17	31326071	488453	481323	rs1555533368	NC_000017.11:31326070:T:
NM_000267.3(NF1):c.996_999del (p.Tyr333fs)	NF1	Y333fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 16, 2017)	criteria provided, single submitter	VCV000457882	17	29527544 - 29527547	17	31200526 - 31200529	457882	467543	rs1555610900	NC_000017.11:31200525:TACTTAC:TAC
NM_000267.3(NF1):c.952del (p.Glu318fs)	NF1	E318fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000457877	17	29527503	17	31200485	457877	467412	rs1555610881	NC_000017.11:31200484:G:
NM_000267.3(NF1):c.908del (p.Leu303fs)	NF1	L303fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000457876	17	29527459	17	31200441	457876	466417	rs1555610848	NC_000017.11:31200440:T:
NM_000267.3(NF1):c.8003del (p.Val2668fs)	NF1	V2668fs, V2689fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 14, 2017)	criteria provided, single submitter	VCV000457864	17	29685593	17	31358575	457864	467786	rs1555536923	NC_000017.11:31358574:T:
NM_000267.3(NF1):c.7893dup (p.Val2632fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000457861	17	29684370 - 29684371	17	31357352 - 31357353	457861	467913	rs1555536765	NC_000017.11:31357352:AAA:AAAA
NM_000267.3(NF1):c.7682dup (p.Arg2562fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000457853	17	29683983 - 29683984	17	31356965 - 31356966	457853	467569	rs1555536683	NC_000017.11:31356965:A:AA
NM_000267.3(NF1):c.731-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000457836	17	29509524	17	31182506	457836	467242	rs1555608924	NC_000017.11:31182505:A:T
NM_000267.3(NF1):c.7175T>A (p.Leu2392Ter)	NF1	L2413*, L2392*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000457827	17	29676186	17	31349168	457827	467748	rs775181940	NC_000017.11:31349167:T:A
NM_000267.3(NF1):c.6971_6978del (p.Leu2324fs)	NF1	L2324fs, L2345fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000457815	17	29667634 - 29667641	17	31340616 - 31340623	457815	467733	rs1555535192	NC_000017.11:31340615:TTAGATAGT:T
NM_000267.3(NF1):c.6837dup (p.Leu2280fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 19, 2017)	criteria provided, single submitter	VCV000457811	17	29665799 - 29665800	17	31338781 - 31338782	457811	467879	rs1555535050	NC_000017.11:31338781:AAA:AAAA
NM_000267.3(NF1):c.6792del (p.Thr2263_Tyr2264insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 14, 2017)	criteria provided, single submitter	VCV000457810	17	29665757	17	31338739	457810	467726	rs1555535042	NC_000017.11:31338738:C:
NM_000267.3(NF1):c.6604del (p.Cys2202fs)	NF1	C2223fs, C2202fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000457800	17	29664861	17	31337843	457800	467521	rs1555534917	NC_000017.11:31337842:T:
NM_000267.3(NF1):c.6302_6303insGG (p.His2102fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000457791	17	29663870 - 29663871	17	31336852 - 31336853	457791	466667	rs1555534751	NC_000017.11:31336852::GG
NM_000267.3(NF1):c.6027dup (p.Met2010fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000457779	17	29663433 - 29663434	17	31336415 - 31336416	457779	467678	rs1555534611	NC_000017.11:31336415:G:GG
NM_000267.3(NF1):c.5523del (p.Gly1842fs)	NF1	G1842fs, G1863fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000457754	17	29654834	17	31327816	457754	467627	rs1555533648	NC_000017.11:31327815:A:
NM_000267.3(NF1):c.5206-41_5228del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000457747	17	29654473 - 29654536	17	31327455 - 31327518	457747	466649	rs1555533543	
NM_000267.3(NF1):c.5115del (p.Pro1706fs)	NF1	P1706fs, P1727fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000457741	17	29653180	17	31326162	457741	467828	rs1555533393	NC_000017.11:31326161:A:
NM_000267.3(NF1):c.4950_4954dup (p.Asn1652fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000457734	17	29653013 - 29653014	17	31325995 - 31325996	457734	467484	rs1555533336	NC_000017.11:31325995:ACGACA:ACGACACGACA
NM_000267.3(NF1):c.4904_4905del (p.Thr1635fs)	NF1	T1635fs, T1656fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000457728	17	29652968 - 29652969	17	31325950 - 31325951	457728	467480	rs1555533323	NC_000017.11:31325949:ACA:A
NM_000267.3(NF1):c.4854T>A (p.Tyr1618Ter)	NF1	Y1618*, Y1639*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000457726	17	29652919	17	31325901	457726	467825	rs1555533297	NC_000017.11:31325900:T:A
NM_000267.3(NF1):c.4829del (p.Thr1609_Leu1610insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000457725	17	29652892	17	31325874	457725	467589	rs1555533290	NC_000017.11:31325873:TTT:TT
NM_000267.3(NF1):c.4808_4809TA[3] (p.His1605fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000457724	17	29652871 - 29652872	17	31325853 - 31325854	457724	467822	rs1555533284	NC_000017.11:31325853:ATATA:ATATATA
NM_000267.3(NF1):c.4640del (p.Lys1547fs)	NF1	K1568fs, K1547fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000457711	17	29588852	17	31261834	457711	467791	rs1555619052	NC_000017.11:31261833:AAA:AA
NM_000267.3(NF1):c.4515-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000457705	17	29588727	17	31261709	457705	466618	rs1555618996	NC_000017.11:31261708:A:G
NM_000267.3(NF1):c.4166del (p.Phe1389fs)	NF1	F1410fs, F1389fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000457685	17	29585416	17	31258398	457685	467763	rs1555618511	NC_000017.11:31258397:TT:T
NM_000267.3(NF1):c.3484dup (p.Met1162fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000457651	17	29559886 - 29559887	17	31232868 - 31232869	457651	467504	rs1555614977	NC_000017.11:31232868:A:AA
NM_000267.3(NF1):c.3214dup (p.Ser1072fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000457634	17	29559105 - 29559106	17	31232087 - 31232088	457634	467405	rs1555614825	NC_000017.11:31232087:AA:AAA
NM_000267.3(NF1):c.3144G>A (p.Trp1048Ter)	NF1	W1048*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 16, 2017)	criteria provided, single submitter	VCV000457626	17	29557890	17	31230872	457626	466532	rs1555614635	NC_000017.11:31230871:G:A
NM_000267.3(NF1):c.3075del (p.Arg1026fs)	NF1	R1026fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 22, 2017)	criteria provided, single submitter	VCV000457620	17	29557361	17	31230343	457620	467683	rs1555614526	NC_000017.11:31230342:GG:G
NM_000267.3(NF1):c.2969_2970dup (p.Met991fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000457609	17	29556969 - 29556970	17	31229951 - 31229952	457609	467653	rs1555614458	NC_000017.11:31229951:ACA:ACACA
NM_000267.3(NF1):c.2866dup (p.Thr956fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000457604	17	29556867 - 29556868	17	31229849 - 31229850	457604	466513	rs1555614418	NC_000017.11:31229849:A:AA
NM_000267.3(NF1):c.2802del (p.Phe934fs)	NF1	F934fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000457601	17	29556433	17	31229415	457601	467646	rs1555614343	NC_000017.11:31229414:TTT:TT
NM_000267.3(NF1):c.2710dup (p.Cys904fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000457590	17	29556342 - 29556343	17	31229324 - 31229325	457590	467635	rs1555614310	NC_000017.11:31229324:T:TT
NM_000267.3(NF1):c.2411del (p.Ala804fs)	NF1	A804fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000457584	17	29556044	17	31229026	457584	467462	rs1555614180	NC_000017.11:31229025:C:
NM_001042492.2(NF1):c.2208_2209CA[1] (p.Thr737fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000457571	17	29553658 - 29553659	17	31226640 - 31226641	457571	467603	rs1555613831	NC_000017.11:31226639:ACACA:ACA
NM_000267.3(NF1):c.2064dup (p.Val689fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000457561	17	29553513 - 29553514	17	31226495 - 31226496	457561	466477	rs1555613786	NC_000017.11:31226495:AA:AAA
NM_000267.3(NF1):c.1882dup (p.Tyr628fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000457553	17	29552143 - 29552144	17	31225125 - 31225126	457553	467285	rs1555613558	NC_000017.11:31225125:TTTTTT:TTTTTTT
NM_000267.3(NF1):c.1514del (p.Lys505fs)	NF1	K505fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000457535	17	29541588	17	31214570	457535	467281	rs1555612289	NC_000017.11:31214569:AAA:AA
NC_000017.10:g.(?_29652832)_(29665163_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000457508	17	29652832 - 29665163	17	31325814 - 31338145	457508	467089		
NC_000017.10:g.(?_29486022)_(29533395_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000457503	17	29486022 - 29533395			457503	467009		
NM_000267.3(NF1):c.3250C>A (p.Pro1084Thr)	NF1	P1084T	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000437407	17	29559143	17	31232125	437407	430967	rs1555614848	NC_000017.11:31232124:C:A
NM_000267.3(NF1):c.7126G>A (p.Gly2376Arg)	NF1	G2376R, G2397R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000431686	17	29670153	17	31343135	431686	425191	rs1135402900	NC_000017.11:31343134:G:A
NC_000017.10:g.(?_29490204)_(29497015_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000417339	17	29490204 - 29497015	17	31163186 - 31169997	417339	401506		
NC_000017.10:g.(?_29670027)_(29670153_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 15, 2016)	criteria provided, single submitter	VCV000417337	17	29670027 - 29670153	17	31343009 - 31343135	417337	401483		
NC_000017.10:g.(?_29654517)_(29654857_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 15, 2016)	criteria provided, single submitter	VCV000417335	17	29654517 - 29654857	17	31327499 - 31327839	417335	402236		
NC_000017.10:g.(?_29490204)_(29490394_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 4, 2016)	criteria provided, single submitter	VCV000417334	17	29490204 - 29490394	17	31163186 - 31163376	417334	401502		
NM_000267.3(NF1):c.1343dup (p.His448fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 24, 2016)	criteria provided, single submitter	VCV000404616	17	29533339 - 29533340	17	31206321 - 31206322	404616	401641	rs1555611584	NC_000017.11:31206321:A:AA
NM_000267.3(NF1):c.7251C>G (p.Tyr2417Ter)	NF1	Y2438*, Y2417*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 24, 2016)	criteria provided, single submitter	VCV000404615	17	29676262	17	31349244	404615	401832	rs1060500385	NC_000017.11:31349243:C:G
NM_000267.3(NF1):c.3623T>A (p.Leu1208Ter)	NF1	L1208*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000404596	17	29560146	17	31233128	404596	401748	rs1060500374	NC_000017.11:31233127:T:A
NM_000267.3(NF1):c.2071del (p.Leu691fs)	NF1	L691fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000404582	17	29553520	17	31226502	404582	402173	rs1060500364	NC_000017.11:31226501:CCC:CC
NM_000267.3(NF1):c.6952G>T (p.Glu2318Ter)	NF1	E2318*, E2339*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000404576	17	29667616	17	31340598	404576	402522	rs1060500359	NC_000017.11:31340597:G:T
NM_000267.3(NF1):c.5845_5846insTA (p.Arg1949fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000404569	17	29661950 - 29661951	17	31334932 - 31334933	404569	401828	rs1060500354	NC_000017.11:31334932:A:ATA
NM_000267.3(NF1):c.5636del (p.Ile1879fs)	NF1	I1900fs, I1879fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 3, 2016)	criteria provided, single submitter	VCV000404568	17	29657403	17	31330385	404568	401812	rs1060500353	NC_000017.11:31330384:T:
NM_000267.3(NF1):c.4511dup (p.Asn1504fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000404564	17	29587528 - 29587529	17	31260510 - 31260511	404564	401757	rs1555618862	NC_000017.11:31260510:AA:AAA
NM_000267.3(NF1):c.5862del (p.Asp1955fs)	NF1	D1976fs, D1955fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 1, 2016)	criteria provided, single submitter	VCV000404562	17	29661967	17	31334949	404562	401833	rs1060500349	NC_000017.11:31334948:TT:T
NM_000267.3(NF1):c.5020_5021dup (p.Leu1675fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000404561	17	29653083 - 29653084	17	31326065 - 31326066	404561	401805	rs1555533366	NC_000017.11:31326065:GCG:GCGCG
NM_000267.3(NF1):c.6424_6425del (p.Leu2142fs)	NF1	L2142fs, L2163fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 14, 2016)	criteria provided, single submitter	VCV000404549	17	29664445 - 29664446	17	31337427 - 31337428	404549	402343	rs1060500338	NC_000017.11:31337426:TT:
NM_000267.3(NF1):c.7310del (p.Arg2437fs)	NF1	R2458fs, R2437fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	VCV000404546	17	29677252	17	31350234	404546	401907	rs1060500335	NC_000017.11:31350233:G:
NM_000267.3(NF1):c.5668_5671dup (p.Ser1891delinsAsnTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 10, 2016)	criteria provided, single submitter	VCV000404545	17	29657434 - 29657435	17	31330416 - 31330417	404545	401825	rs1555533871	NC_000017.11:31330416:ATTA:ATTAATTA
NM_000267.3(NF1):c.7857T>G (p.Tyr2619Ter)	NF1	Y2619*, Y2640*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000404544	17	29684337	17	31357319	404544	401910	rs1060500333	NC_000017.11:31357318:T:G
NM_000267.3(NF1):c.7544del (p.Lys2515fs)	NF1	K2515fs, K2536fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000404533	17	29679423	17	31352405	404533	402384	rs1060500327	NC_000017.11:31352404:AA:A
NM_000267.3(NF1):c.4684_4685dup (p.Phe1563fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000404532	17	29592267 - 29592268	17	31265249 - 31265250	404532	401784	rs1555619397	NC_000017.11:31265249:AGA:AGAGA
NM_000267.3(NF1):c.7127-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000404526	17	29676136	17	31349118	404526	402535	rs772348111	NC_000017.11:31349117:A:G
NM_000267.3(NF1):c.206_207delGA	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000404525	17	29486026 - 29486027	17	31159008 - 31159009	404525	401595	rs1060500321	NC_000017.11:31159007:AGAGA:AGA
NM_000267.3(NF1):c.99del (p.Val34fs)	NF1	V34fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000404524	17	29483037	17	31156019	404524	401600	rs1060500320	NC_000017.11:31156018:AAA:AA
NM_000267.3(NF1):c.3986C>A (p.Ser1329Ter)	NF1	S1329*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000404521	17	29576013	17	31248995	404521	402247	rs1060500319	NC_000017.11:31248994:C:A
NM_000267.3(NF1):c.1469_1470insTTAT (p.Lys490fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	VCV000404503	17	29541545 - 29541546	17	31214527 - 31214528	404503	401642	rs1060500307	NC_000017.11:31214527::TTAT
NM_000267.3(NF1):c.924_927del (p.Gly309fs)	NF1	G309fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000404496	17	29527473 - 29527476	17	31200455 - 31200458	404496	402117	rs1060500301	NC_000017.11:31200454:GCTGGC:GC
NM_000267.3(NF1):c.7257del (p.Ala2420fs)	NF1	A2420fs, A2441fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 27, 2016)	criteria provided, single submitter	VCV000404495	17	29676268	17	31349250	404495	401835	rs1060500300	NC_000017.11:31349249:A:
NM_000267.3(NF1):c.4535del (p.Arg1512fs)	NF1	R1533fs, R1512fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 9, 2016)	criteria provided, single submitter	VCV000404484	17	29588749	17	31261731	404484	402468	rs1060500292	NC_000017.11:31261730:G:
NM_000267.3(NF1):c.7044G>A (p.Trp2348Ter)	NF1	W2348*, W2369*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000404475	17	29670071	17	31343053	404475	401885	rs1060500286	NC_000017.11:31343052:G:A
NM_000267.3(NF1):c.2729dup (p.Leu911fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 15, 2016)	criteria provided, single submitter	VCV000404466	17	29556359 - 29556360	17	31229341 - 31229342	404466	401697	rs1555614313	NC_000017.11:31229341:GGG:GGGG
NM_000267.3(NF1):c.730+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	VCV000404459	17	29508804	17	31181786	404459	402099	rs1060500274	NC_000017.11:31181785:G:C
NM_000267.3(NF1):c.3567del (p.Gly1190fs)	NF1	G1190fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 4, 2016)	criteria provided, single submitter	VCV000404456	17	29560089	17	31233071	404456	402231	rs1060500271	NC_000017.11:31233070:AA:A
NM_000267.3(NF1):c.6636del (p.Gln2213fs)	NF1	Q2213fs, Q2234fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 7, 2016)	criteria provided, single submitter	VCV000404452	17	29664893	17	31337875	404452	401863	rs1060500268	NC_000017.11:31337874:T:
NM_000267.3(NF1):c.4950C>A (p.Tyr1650Ter)	NF1	Y1650*, Y1671*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 10, 2016)	criteria provided, single submitter	VCV000404434	17	29653015	17	31325997	404434	401802	rs1060500255	NC_000017.11:31325996:C:A
NM_000267.3(NF1):c.4230_4231dup (p.Pro1411fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 19, 2016)	criteria provided, single submitter	VCV000404424	17	29585479 - 29585480	17	31258461 - 31258462	404424	402276	rs1555618552	NC_000017.11:31258461:CAC:CACAC
NM_000267.3(NF1):c.3250_3251dup (p.Gln1086fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000404423	17	29559141 - 29559142	17	31232123 - 31232124	404423	401710	rs1555614845	NC_000017.11:31232123:CCC:CCCCC
NM_000267.3(NF1):c.129_130ins568 (p.?)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000254097	17	29483069 - 29483070	17	31156051 - 31156052	254097	248528		
NM_000267.3(NF1):c.7868dup (p.Glu2624fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000237600	17	29684347 - 29684348	17	31357329 - 31357330	237600	242711	rs878853918	NC_000017.11:31357329:C:CC
NM_000267.3(NF1):c.649G>T (p.Glu217Ter)	NF1	E217*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000237587	17	29508502	17	31181484	237587	242626	rs878853909	NC_000017.11:31181483:G:T
NM_000267.3(NF1):c.5608C>T (p.Gln1870Ter)	NF1	Q1870*, Q1891*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000237577	17	29657375	17	31330357	237577	242695	rs878853904	NC_000017.11:31330356:C:T
NM_000267.3(NF1):c.4420dup (p.Ser1474fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 13, 2016)	criteria provided, single submitter	VCV000237568	17	29587438 - 29587439	17	31260420 - 31260421	237568	242686	rs878853896	NC_000017.11:31260420:A:AA
NM_000267.3(NF1):c.4255A>G (p.Lys1419Glu)	NF1	K1419E, K1440E	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 17, 2016)	criteria provided, single submitter	VCV000237561	17	29585506	17	31258488	237561	242679	rs199474790	NC_000017.11:31258487:A:G
NM_000267.3(NF1):c.397del (p.Glu133fs)	NF1	E133fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, single submitter	VCV000237559	17	29490312	17	31163294	237559	242621	rs878853891	NC_000017.11:31163293:G:
NM_000267.3(NF1):c.3064del (p.Val1021_Met1022insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	VCV000237545	17	29557350	17	31230332	237545	242665	rs878853881	NC_000017.11:31230331:AA:A
NM_000267.3(NF1):c.2604dup (p.Pro869fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 13, 2018)	criteria provided, single submitter	VCV000237538	17	29556236 - 29556237	17	31229218 - 31229219	237538	242658	rs878853877	NC_000017.11:31229218:T:TT
NM_000267.3(NF1):c.2352G>A (p.Trp784Ter)	NF1	W784*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	VCV000237535	17	29554567	17	31227549	237535	242655	rs199474778	NC_000017.11:31227548:G:A
NM_000267.3(NF1):c.1595T>G (p.Leu532Arg)	NF1	L532R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	VCV000237521	17	29546090	17	31219072	237521	242642	rs199474737	NC_000017.11:31219071:T:G
NM_000267.3(NF1):c.4368-?_5943+?del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 13, 2015)	criteria provided, single submitter	VCV000224941					224941	226809		
NM_000267.3(NF1):c.6889dup (p.Val2297fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000223148	17	29667550 - 29667551	17	31340532 - 31340533	223148	224875	rs1057519369	NC_000017.11:31340532:GGG:GGGG
NM_000267.3(NF1):c.5458C>T (p.Gln1820Ter)	NF1	Q1841*, Q1820*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000220317	17	29654769	17	31327751	220317	222618	rs786203570	NC_000017.11:31327750:C:T
NM_000267.3(NF1):c.1094C>A (p.Ser365Ter)	NF1	S365*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 9, 2015)	criteria provided, single submitter	VCV000219467	17	29528086	17	31201068	219467	222571	rs864622107	NC_000017.11:31201067:C:A
NM_000267.3(NF1):c.7907+149_8097+723dup	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217114	17	29684536 - 29686756	17	31357518 - 31359738	217114	213737		
NM_000267.3(NF1):c.3496+57_4772+2639dup	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217111	17	29559956 - 29594996	17	31232938 - 31267978	217111	213710		
NM_000267.3(NF1):c.2851-151_2990+121dup	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217110	17	29556697 - 29556698	17	31229679 - 31229680	217110	213709	rs1555614386	
NM_001042492.3(NF1):c.2252-70_2326-39dup	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217109	17	29554163 - 29554164	17	31227145 - 31227146	217109	213707	rs1555613896	
NM_000267.3(NF1):c.1527+443_3709-761dup	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217108	17	29542046 - 29561868	17	31215028 - 31234850	217108	213700		
NM_000267.3(NF1):c.1393-1905_2251+85dup	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217107	17	29539564 - 29553787	17	31212546 - 31226769	217107	213699		
NM_000267.3(NF1):c.7884_8315-5528del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217104	17	29684364 - 29695503	17	31357346 - 31368485	217104	213736		
NM_000267.3:c.7566_8314+3321_delinsCGCCACGGC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217103					217103	213758		
NM_000267.3(NF1):c.5943+448_7127-414del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217099	17	29662497 - 29675724	17	31335479 - 31348706	217099	213732		
NM_000267.3(NF1):c.5943+265_7000-999delins15	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217098	17	29662314 - 29669028	17	31335296 - 31342010	217098	213731		
NM_000267.3(NF1):c.5749+189_6999+1035del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217097	17	29657705 - 29668698	17	31330687 - 31341680	217097	213725		
NM_000267.3(NF1):c.5749+6_6858+633delins130	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217096	17	29657522 - 29666456	17	31330504 - 31339438	217096	213724		
NM_000267.3(NF1):c.5750-1748_6184delinsCTA	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217095	17	29660108 - 29663752	17	31333090 - 31336734	217095	213727		
NM_000267.3(NF1):c.5750-374_5944-176del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217094	17	29661481 - 29663174	17	31334463 - 31336156	217094	213730		
NM_000267.3(NF1):c.5750-1086_5943+244del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217093	17	29660768 - 29662291	17	31333750 - 31335273	217093	213728		
NM_000267.3(NF1):c.5749+750_5943+244del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217092	17	29658266 - 29662293	17	31331248 - 31335275	217092	213726		
NM_000267.3(NF1):c.5750-460_5943+244del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217091	17	29661395 - 29662292	17	31334377 - 31335274	217091	213729	rs1555534307	
NM_000267.3:c.5547-961+5943+244del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217090					217090	213757		
NM_000267.3(NF1):c.5546+336_5943+244del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217089	17	29655193 - 29662293	17	31328175 - 31335275	217089	213723		
NM_000267.3(NF1):c.4773-23713_7907+14del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217088					217088	213756		
NM_000267.3(NF1):c.4941_7127-2901del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217087	17	29653006 - 29673237	17	31325988 - 31346219	217087	213722		
NM_000267.3(NF1):c.4773-2116_7127-1817delinsAGTTACC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217086	17	29650722 - 29674321	17	31323704 - 31347303	217086	213720		
NM_000267.3(NF1):c.4515-343_8314+3380del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217084					217084	213755		
NM_000267.3(NF1):c.4661+1660_4773-8837del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217083					217083	213754		
NM_000267.3(NF1):c.4662-1076_4772+1300delins260	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217081	17	29591171 - 29593657	17	31264153 - 31266639	217081	213717		
NM_000267.3(NF1):c.4368-391_4515-122delins105	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217080	17	29586996 - 29588607	17	31259978 - 31261589	217080	213716		
NM_000267.3:c.3975-364_4515-510indel810	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217079					217079	213753		
NM_000267.3(NF1):c.3975-1922_4111-2448delinsTTTACTTAGGT	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217078	17	29574080 - 29582914	17	31247062 - 31255896	217078	213713		
NM_000267.3:c.3975-1046_4110+902deins333	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217077					217077	213752		
NM_000267.3(NF1):c.3709-266_7259-397delinsCAG	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217076					217076	213751		
NM_000267.3(NF1):c.3708+598_4772+16224del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217075	17	29560829 - 29608581	17	31233811 - 31281563	217075	213711		
NM_000267.3(NF1):c.3709-941_3974+2711del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217074	17	29561688 - 29565750	17	31234670 - 31238732	217074	213712		
NM_000267.3(NF1):c.2410-110_2850+65delinsAAAA	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217073	17	29555933 - 29556548	17	31228915 - 31229530	217073	213708	rs1555614169	
NM_000267.3(NF1):c.2048_5041del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217072					217072	213750		
NM_000267.3(NF1):c.1846-613_4773-1009delinsTTAGGTTTAT	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217071					217071	213749		
NM_000267.3(NF1):c.1845+537_4661+331del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217070	17	29551122 - 29589206	17	31224104 - 31262188	217070	213704		
NM_000267.3(NF1):c.1988_2410-218delinsTGTC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217069	17	29552255 - 29555825	17	31225237 - 31228807	217069	213706		
NM_000267.3(NF1):c.1846-496_2410-645delinsTAGC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217068	17	29551617 - 29555398	17	31224599 - 31228380	217068	213705		
NM_000267.3(NF1):c.1641+156_3975-2222del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217067	17	29546292 - 29573780	17	31219274 - 31246762	217067	213703		
NM_000267.3(NF1):c.1528-960_1761del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217066	17	29545063 - 29550501	17	31218045 - 31223483	217066	213702		
NM_000267.3(NF1):c.1527+1509_1641+1137del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217065	17	29543112 - 29547273	17	31216094 - 31220255	217065	213701		
NM_000267.3(NF1):c.1393-3329_3975-6377del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217064	17	29538140 - 29569625	17	31211122 - 31242607	217064	213696		
NM_000267.3(NF1):c.1393-2488_1642-648delinsAATAG	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217063	17	29538981 - 29548220	17	31211963 - 31221202	217063	213698		
NM_000267.3(NF1):c.1393-2652_1528-892del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217062	17	29538817 - 29545131	17	31211799 - 31218113	217062	213697		
NM_000267.3(NF1):c.1260+220_7553-1095del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217061					217061	213748		
NM_000267.3(NF1):c.889-1633_7395-667del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217060					217060	213747		
NM_000267.3(NF1):c.889-8381_6757-5del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217059					217059	213746		
NM_000267.3(NF1):c.888+3798_5750-2053del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217058					217058	213745		
NM_000267.3(NF1):c.888+8334_1721+34delinsTC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217057	17	29518017 - 29548981	17	31190999 - 31221963	217057	213692		
NM_000267.3(NF1):c.889-894_1261-284del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217056	17	29526546 - 29532974	17	31199528 - 31205956	217056	213694		
NM_000267.3(NF1):c.889-8107_1261-278del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217055	17	29519333 - 29532980	17	31192315 - 31205962	217055	213693		
NM_000267.3(NF1):c.888+5515_1261-1635del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217054	17	29515198 - 29531623	17	31188180 - 31204605	217054	213691		
NM_000267.3(NF1):c.889-453_908del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217053	17	29526983 - 29527455	17	31199965 - 31200437	217053	213695	rs1555610774	
NM_000267.3(NF1):c.731-302_8314+3681del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217052					217052	213744		
NM_000267.3(NF1):c.587-282_8315-3687del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217050					217050	213743		
NM_000267.3(NF1):c.586+1209_1845+35del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217049					217049	213742		
NM_000267.3(NF1):c.480-134_8315-6206del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217045					217045	213741		
NM_000267.3(NF1):c.480-2989_586+3445del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217043	17	29493920 - 29500460	17	31166902 - 31173442	217043	213685		
NM_000267.3(NF1):c.204+155_2990+53del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217038					217038	213740		
NM_000267.3(NF1):c.60+3120_3975-326del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217036					217036	213739		
NM_000267.3(NF1):c.60+24136_587-5022del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217035					217035	213738		
NM_000267.3(NF1):c.7734dup (p.Glu2579Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000216867	17	29684035 - 29684036	17	31357017 - 31357018	216867	213299	rs863224837	NC_000017.11:31357017:T:TT
NM_000267.3(NF1):c.3139_3140del (p.Asp1047fs)	NF1	D1047fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 28, 2015)	criteria provided, single submitter	VCV000216063	17	29557884 - 29557885	17	31230866 - 31230867	216063	213265	rs863224490	NC_000017.11:31230865:AGA:A
NM_000267.3(NF1):c.1059del (p.Lys354fs)	NF1	K354fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 29, 2015)	criteria provided, single submitter	VCV000216060	17	29527609	17	31200591	216060	213248	rs863224488	NC_000017.11:31200590:TT:T
NM_000267.3(NF1):c.5425C>A (p.Arg1809Ser)	NF1	R1809S, R1830S	Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000208856	17	29654736	17	31327718	208856	205414	rs797045139	NC_000017.11:31327717:C:A
NM_000267.3(NF1):c.5426G>C (p.Arg1809Pro)	NF1	R1809P, R1830P	Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000208855	17	29654737	17	31327719	208855	205417	rs771529172	NC_000017.11:31327718:G:C
NM_000267.3(NF1):c.3500T>G (p.Leu1167Ter)	NF1	L1167*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	VCV000188394	17	29560023	17	31233005	188394	186251	rs786204253	NC_000017.11:31233004:T:G
NM_000267.3(NF1):c.2298_2304del (p.Glu767fs)	NF1	E767fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 5, 2014)	criteria provided, single submitter	VCV000188217	17	29554278 - 29554284	17	31227260 - 31227266	188217	186248	rs786204154	NC_000017.11:31227259:GCATTGAGCAT:GCAT
NM_000267.3(NF1):c.5710G>T (p.Glu1904Ter)	NF1	E1904*, E1925*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000000372	17	29657477	17	31330459	372	15411	rs137854565	NC_000017.11:31330458:G:T
NF1, 1-BP DEL, 4071C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000000370					370	15409		
NF1, DEL	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000000360					360	15399		
NM_000267.3(NF1):c.1523T>C (p.Leu508Pro)	NF1	L508P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000000355	17	29541599	17	31214581	355	15394	rs137854558	NC_000017.11:31214580:T:C
NM_000267.3(NF1):c.6511T>A (p.Tyr2171Asn)	NF1	Y2213N, Y2171N, Y2192N	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000000340	17	29664532	17	31337514	340	15379	rs267606598	NC_000017.11:31337513:T:A
NM_000267.3(NF1):c.6427C>A (p.Leu2143Met)	NF1	L2143M, L2164M	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000000339	17	29664448	17	31337430	339	15378	rs137854551	NC_000017.11:31337429:C:A
NM_000267.3(NF1):c.5465_5466insT (p.Lys1823fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000000338	17	29654776 - 29654777	17	31327758 - 31327759	338	15377	rs267606597	NC_000017.11:31327758::T
NM_000267.3(NF1):c.5448dup (p.Ser1817fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000000337	17	29654758 - 29654759	17	31327740 - 31327741	337	15376	rs267606596	NC_000017.11:31327740:C:CC
NF1, ALU INS	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 31, 1991)	no assertion criteria provided	VCV000000332					332	15371		
NM_001042492.3(NF1):c.5639T>G (p.Leu1880Ter)	NF1	L1859*, L1880*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000863800	17	29657343	17	31330325	863800	845078		NC_000017.11:31330324:T:G
NM_001042492.3(NF1):c.952_953del (p.Glu318fs)	NF1	E318fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000863185	17	29527502 - 29527503	17	31200484 - 31200485	863185	844880		NC_000017.11:31200483:AGA:A
NM_001042492.3(NF1):c.7725_7726del (p.Asp2576fs)	NF1	D2576fs, D2555fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000862093	17	29683587 - 29683588	17	31356569 - 31356570	862093	845180		NC_000017.11:31356568:TG:
NM_001042492.3(NF1):c.6590_6591del (p.Phe2197fs)	NF1	F2197fs, F2176fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000861239	17	29664546 - 29664547	17	31337528 - 31337529	861239	845115		NC_000017.11:31337527:TTTT:TT
NM_001042492.3(NF1):c.7453dup (p.Tyr2485fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000860235	17	29677331 - 29677332	17	31350313 - 31350314	860235	845161		NC_000017.11:31350313:T:TT
NM_001042492.3(NF1):c.3892C>T (p.Gln1298Ter)	NF1	Q1298*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000859602	17	29562957	17	31235939	859602	845007		NC_000017.11:31235938:C:T
NM_001042492.3(NF1):c.5172_5173del (p.Lys1725fs)	NF1	K1725fs, K1704fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000859473	17	29653173 - 29653174	17	31326155 - 31326156	859473	845058		NC_000017.11:31326154:AGA:A
NM_001042492.3(NF1):c.5494G>T (p.Glu1832Ter)	NF1	E1811*, E1832*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000859126	17	29654742	17	31327724	859126	845066		NC_000017.11:31327723:G:T
NM_001042492.3(NF1):c.7271_7272del (p.Arg2424fs)	NF1	R2424fs, R2403fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000856570	17	29676218 - 29676219	17	31349200 - 31349201	856570	845153		NC_000017.11:31349199:AGA:A
NM_001042492.3(NF1):c.1555del (p.Gln519fs)	NF1	Q519fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000856397	17	29546048	17	31219030	856397	844904		NC_000017.11:31219029:CCC:CC
NM_001042492.3(NF1):c.6841G>T (p.Gly2281Ter)	NF1	G2260*, G2281*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000856272	17	29665743	17	31338725	856272	845123		NC_000017.11:31338724:G:T
NM_001042492.3(NF1):c.4521dup (p.His1508fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000856053	17	29587476 - 29587477	17	31260458 - 31260459	856053	845043		NC_000017.11:31260458:A:AA
NM_001042492.3(NF1):c.5785G>T (p.Glu1929Ter)	NF1	E1908*, E1929*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000852822	17	29657489	17	31330471	852822	845083		NC_000017.11:31330470:G:T
NM_001042492.3(NF1):c.5503C>T (p.Gln1835Ter)	NF1	Q1814*, Q1835*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000852381	17	29654751	17	31327733	852381	845067		NC_000017.11:31327732:C:T
NM_001042492.3(NF1):c.349del (p.Ile117fs)	NF1	I117fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000851792	17	29490262	17	31163244	851792	844854		NC_000017.11:31163243:AAA:AA
NM_001042492.3(NF1):c.6576T>A (p.Tyr2192Ter)	NF1	Y2171*, Y2192*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000851779	17	29664534	17	31337516	851779	845114		NC_000017.11:31337515:T:A
NM_001042492.3(NF1):c.7325del (p.Leu2442fs)	NF1	L2442fs, L2421fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000851770	17	29677202	17	31350184	851770	845156		NC_000017.11:31350183:TTT:TT
NM_001042492.3(NF1):c.688G>T (p.Glu230Ter)	NF1	E230*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000851567	17	29508761	17	31181743	851567	844869		NC_000017.11:31181742:G:T
NM_001042492.3(NF1):c.7113C>A (p.Cys2371Ter)	NF1	C2350*, C2371*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000849556	17	29670077	17	31343059	849556	845134		NC_000017.11:31343058:C:A
NM_001042492.3(NF1):c.4107C>G (p.Tyr1369Ter)	NF1	Y1369*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000848486	17	29576134	17	31249116	848486	845024		NC_000017.11:31249115:C:G
NM_001042492.3(NF1):c.2546dup (p.Val850fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000848118	17	29556174 - 29556175	17	31229156 - 31229157	848118	844946		NC_000017.11:31229156:GGGGG:GGGGGG
NM_001042492.3(NF1):c.6902T>G (p.Leu2301Ter)	NF1	L2301*, L2280*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000844773	17	29665804	17	31338786	844773	845126		NC_000017.11:31338785:T:G
NM_001042492.3(NF1):c.4076dup (p.Gln1360fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000844453	17	29576097 - 29576098	17	31249079 - 31249080	844453	845022		NC_000017.11:31249079:CCCCCC:CCCCCCC
NM_001042492.3(NF1):c.3662T>G (p.Leu1221Arg)	NF1	L1221R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000843506	17	29560185	17	31233167	843506	844999		NC_000017.11:31233166:T:G
NM_001042492.3(NF1):c.5521dup (p.Gln1841fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000842214	17	29654764 - 29654765	17	31327746 - 31327747	842214	845068		NC_000017.11:31327746:CCCCC:CCCCCC
NM_001042492.3(NF1):c.1712G>A (p.Trp571Ter)	NF1	W571*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 12, 2020)	criteria provided, single submitter	VCV000842188	17	29548938	17	31221920	842188	844913		NC_000017.11:31221919:G:A
NM_001042492.3(NF1):c.3215_3216del (p.Ser1072fs)	NF1	S1072fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000841847	17	29559108 - 29559109	17	31232090 - 31232091	841847	844981		NC_000017.11:31232089:GC:
NM_001042492.3(NF1):c.968C>A (p.Ala323Asp)	NF1	A323D	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000839743	17	29527519	17	31200501	839743	844882		NC_000017.11:31200500:C:A
NM_001042492.3(NF1):c.1555C>T (p.Gln519Ter)	NF1	Q519*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000837847	17	29546050	17	31219032	837847	844905		NC_000017.11:31219031:C:T
NM_001042492.3(NF1):c.7582C>T (p.Gln2528Ter)	NF1	Q2507*, Q2528*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000836626	17	29679399	17	31352381	836626	845172		NC_000017.11:31352380:C:T
NM_001042492.3(NF1):c.2728_2729del (p.Gly910fs)	NF1	G910fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000836581	17	29556360 - 29556361	17	31229342 - 31229343	836581	844956		NC_000017.11:31229341:GGG:G
NM_001042492.3(NF1):c.5787_5788GT[1] (p.Cys1930fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000835683	17	29657491 - 29657492	17	31330473 - 31330474	835683	845084		NC_000017.11:31330472:GTGT:GT
NM_001042492.3(NF1):c.5629_5630del (p.Leu1877fs)	NF1	L1856fs, L1877fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000835556	17	29657332 - 29657333	17	31330314 - 31330315	835556	845075		NC_000017.11:31330313:TCT:T
NM_001042492.3(NF1):c.3810_3820del (p.Met1271fs)	NF1	M1271fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000835230	17	29562722 - 29562732	17	31235704 - 31235714	835230	845002		NC_000017.11:31235703:GCAGACTCCATGCAGACTC:GCAGACTC
NM_001042492.3(NF1):c.2810T>A (p.Leu937Ter)	NF1	L937*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000834980	17	29556443	17	31229425	834980	844959		NC_000017.11:31229424:T:A
NM_001042492.3(NF1):c.5861C>G (p.Ser1954Ter)	NF1	S1933*, S1954*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000834435	17	29661904	17	31334886	834435	845085		NC_000017.11:31334885:C:G
NC_000017.11:g.(?_31342999)_(31374165_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000833495	17	29670017 - 29701183			833495	821031		
NC_000017.11:g.(?_31169881)_(31183454_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000833181	17	29496899 - 29510472			833181	821008		
NC_000017.11:g.(?_31181402)_(31182685_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000832814	17	29508420 - 29509703			832814	821011		
NC_000017.11:g.(?_31352247)_(31352424_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000832737	17	29679265 - 29679442			832737	821032		
NC_000017.11:g.(?_31200402)_(31206391_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 24, 2019)	criteria provided, single submitter	VCV000832511	17	29527420 - 29533409			832511	821014		
NC_000017.11:g.(?_31095030)_(31095379_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000831526	17	29422048 - 29422397			831526	820995		
NC_000017.11:g.(?_31095290)_(31095389_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000831072	17	29422308 - 29422407			831072	821000		
NC_000017.11:g.(?_31181408)_(31183454_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000830815	17	29508426 - 29510472			830815	821013		
NM_001042492.3(NF1):c.6399_6400GT[1] (p.Cys2134fs)	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818199	17	29663903 - 29663904	17	31336885 - 31336886	818199	806402		NC_000017.11:31336884:TGTGT:TGT
NM_001042492.3(NF1):c.5980_5983del (p.Ala1994fs)	NF1	A1973fs, A1994fs	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818198	17	29662020 - 29662023	17	31335002 - 31335005	818198	806401		NC_000017.11:31335001:CAAGCAA:CAA
NM_001042492.3(NF1):c.5697T>A (p.Cys1899Ter)	NF1	C1878*, C1899*	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818197	17	29657401	17	31330383	818197	806400		NC_000017.11:31330382:T:A
NM_001042492.3(NF1):c.5392C>T (p.Gln1798Ter)	NF1	Q1777*, Q1798*	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818196	17	29654640	17	31327622	818196	806399		NC_000017.11:31327621:C:T
NM_001042492.3(NF1):c.5199dup (p.Glu1734fs)	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818195	17	29653200 - 29653201	17	31326182 - 31326183	818195	806398		NC_000017.11:31326182:A:AA
NM_001042492.3(NF1):c.5130del (p.Cys1711fs)	NF1	C1711fs, C1690fs	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818194	17	29653132	17	31326114	818194	806397		NC_000017.11:31326113:C:
NM_001042492.3(NF1):c.5046delinsGGTTAC (p.Cys1682fs)	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818193	17	29653048	17	31326030	818193	806396		NC_000017.11:31326029:T:GGTTAC
NM_001042492.3(NF1):c.4756_4772del (p.Ala1586fs)	NF1	A1586fs, A1565fs	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818192	17	29592275 - 29592291	17	31265257 - 31265273	818192	806395		NC_000017.11:31265256:AAGGCTTTGAAAACGTTAAG:AAG
NM_001042492.3(NF1):c.3187_3188insTA (p.Cys1063fs)	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818191	17	29557933 - 29557934	17	31230915 - 31230916	818191	806394		NC_000017.11:31230915::TA
NM_001042492.3(NF1):c.2947del (p.His982_Leu983insTer)	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818190	17	29556949	17	31229931	818190	806393		NC_000017.11:31229930:C:
NM_001042492.3(NF1):c.289C>T (p.Gln97Ter)	NF1	Q97*	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818189	17	29490204	17	31163186	818189	806386		NC_000017.11:31163185:C:T
NM_001042492.3(NF1):c.7898del (p.Glu2633fs)	NF1	E2612fs, E2633fs	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818188	17	29684315	17	31357297	818188	806403		NC_000017.11:31357296:A:
NM_001042492.3(NF1):c.6819+2_6826del	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818187	17	29665158 - 29665727	17	31338140 - 31338709	818187	806404		
NM_001042492.3(NF1):c.2044C>T (p.Gln682Ter)	NF1	Q682*	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818186	17	29553495	17	31226477	818186	806392		NC_000017.11:31226476:C:T
NM_001042492.3(NF1):c.2019C>A (p.Cys673Ter)	NF1	C673*	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818185	17	29553470	17	31226452	818185	806391		NC_000017.11:31226451:C:A
NM_001042492.3(NF1):c.1992dup (p.Ser665fs)	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818184	17	29552258 - 29552259	17	31225240 - 31225241	818184	806390		NC_000017.11:31225240:C:CC
NM_001042492.3(NF1):c.1198C>T (p.Gln400Ter)	NF1	Q400*	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818183	17	29528441	17	31201423	818183	806389		NC_000017.11:31201422:C:T
NM_001042492.3(NF1):c.786_787insTT (p.Lys263fs)	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818182	17	29509580 - 29509581	17	31182562 - 31182563	818182	806388		NC_000017.11:31182562:T:TTT
NM_001042492.3(NF1):c.731-2A>C	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818181	17	29509524	17	31182506	818181	806405		NC_000017.11:31182505:A:C
NM_001042492.3(NF1):c.643del (p.Ser215fs)	NF1	S215fs	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818180	17	29508496	17	31181478	818180	806387		NC_000017.11:31181477:A:
NM_001042492.3(NF1):c.8161-3C>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816777	17	29687502	17	31360484	816777	804980		NC_000017.11:31360483:C:G
NM_001042492.3(NF1):c.7063-3T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816776	17	29670024	17	31343006	816776	804974		NC_000017.11:31343005:T:G
NM_001042492.3(NF1):c.6428-3C>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816775	17	29664383	17	31337365	816775	804967		NC_000017.11:31337364:C:G
NM_001042492.3(NF1):c.3114-3T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816774	17	29557857	17	31230839	816774	804952		NC_000017.11:31230838:T:G
NM_001042492.3(NF1):c.1063-3T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816773	17	29528052	17	31201034	816773	804933		NC_000017.11:31201033:T:G
NM_001042492.3(NF1):c.7870-3C>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816772	17	29684284	17	31357266	816772	804979		NC_000017.11:31357265:C:G
NM_001042492.3(NF1):c.7739-3C>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816771	17	29683975	17	31356957	816771	804977		NC_000017.11:31356956:C:G
NM_001042492.3(NF1):c.6428-3del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816770	17	29664383	17	31337365	816770	804968		NC_000017.11:31337364:C:
NM_001042492.3(NF1):c.6148-3C>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816769	17	29663650	17	31336632	816769	804966		NC_000017.11:31336631:C:A
NM_001042492.3(NF1):c.4578-3T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816768	17	29588726	17	31261708	816768	804960		NC_000017.11:31261707:T:G
NM_001042492.3(NF1):c.4578-3del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816767	17	29588726	17	31261708	816767	804961		NC_000017.11:31261707:T:
NM_001042492.3(NF1):c.3315-3C>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816766	17	29559715	17	31232697	816766	804954		NC_000017.11:31232696:C:G
NM_001042492.3(NF1):c.2410-3T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816765	17	29556040	17	31229022	816765	804949		NC_000017.11:31229021:T:G
NM_001042492.3(NF1):c.1722-3C>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816764	17	29550459	17	31223441	816764	804942		NC_000017.11:31223440:C:A
NM_001042492.3(NF1):c.4431-9T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816763	17	29587378	17	31260360	816763	804957		NC_000017.11:31260359:T:G
NM_001042492.3(NF1):c.3975-11T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816762	17	29575991	17	31248973	816762	804956		NC_000017.11:31248972:T:G
NM_001042492.3(NF1):c.3114-8T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816761	17	29557852	17	31230834	816761	804951		NC_000017.11:31230833:T:G
NM_001042492.3(NF1):c.2991-11del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816760	17	29557267	17	31230249	816760	804950		NC_000017.11:31230248:T:
NM_001042492.3(NF1):c.2410-9T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816759	17	29556034	17	31229016	816759	804948		NC_000017.11:31229015:T:A
NM_001042492.3(NF1):c.2410-14A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816758	17	29556029	17	31229011	816758	804947		NC_000017.11:31229010:A:G
NM_001042492.3(NF1):c.2410-15A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816757	17	29556028	17	31229010	816757	804946		NC_000017.11:31229009:A:G
NM_001042492.3(NF1):c.1642-7A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816756	17	29548861	17	31221843	816756	804938		NC_000017.11:31221842:A:G
NM_001042492.3(NF1):c.1642-10A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816755	17	29548858	17	31221840	816755	804937		NC_000017.11:31221839:A:G
NM_001042492.3(NF1):c.1261-13T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816754	17	29533245	17	31206227	816754	804936		NC_000017.11:31206226:T:A
NM_001042492.3(NF1):c.1261-21T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816752	17	29533237	17	31206219	816752	804934		NC_000017.11:31206218:T:G
NM_001042492.3(NF1):c.1063-14T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816751	17	29528041	17	31201023	816751	804932		NC_000017.11:31201022:T:A
NM_001042492.3(NF1):c.205-6T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816750	17	29486022	17	31159004	816750	804925		NC_000017.11:31159003:T:A
NM_001042492.3(NF1):c.7870-24_7870-19delinsTTTTAG	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816749	17	29684263 - 29684268	17	31357245 - 31357250	816749	804978		NC_000017.11:31357244:GTTTAC:TTTTAG
NM_001042492.3(NF1):c.5813-12_5813-9del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816748	17	29661843 - 29661846	17	31334825 - 31334828	816748	804963		NC_000017.11:31334824:TATTT:T
NM_001042492.3(NF1):c.4578-20_4578-18del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816747	17	29588709 - 29588711	17	31261691 - 31261693	816747	804959		NC_000017.11:31261690:AAG:
NM_001042492.3(NF1):c.2252-33_2252-8del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816746	17	29554202 - 29554227	17	31227184 - 31227209	816746	804943		NC_000017.11:31227183:TGCAGTAACTTGATTTGCTGTTGTATT:T
NM_001042492.3(NF1):c.1722-8_1722-3delinsAAAA	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816745	17	29550454 - 29550459	17	31223436 - 31223441	816745	804941		NC_000017.11:31223435:TACTGC:AAAA
NM_001042492.3(NF1):c.1722-20_1722-17del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816744	17	29550440 - 29550443	17	31223422 - 31223425	816744	804940		NC_000017.11:31223421:AATGAA:AA
NM_001042492.3(NF1):c.655-12_655-9del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816743	17	29508714 - 29508717	17	31181696 - 31181699	816743	804929		NC_000017.11:31181695:TTCTTT:TT
NM_001042492.3(NF1):c.587-15_587-14del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816742	17	29508425 - 29508426	17	31181407 - 31181408	816742	804927		NC_000017.11:31181406:TT:
NM_001042492.3(NF1):c.7190-12T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816741	17	29676126	17	31349108	816741	804976		NC_000017.11:31349107:T:A
NM_001042492.3(NF1):c.7190-20T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816740	17	29676118	17	31349100	816740	804975		NC_000017.11:31349099:T:A
NM_001042492.3(NF1):c.7063-10T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816739	17	29670017	17	31342999	816739	804973		NC_000017.11:31342998:T:G
NM_001042492.3(NF1):c.6820-9T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816738	17	29665713	17	31338695	816738	804972		NC_000017.11:31338694:T:G
NM_001042492.3(NF1):c.6820-10T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816737	17	29665712	17	31338694	816737	804971		NC_000017.11:31338693:T:G
NM_001042492.3(NF1):c.6705-6T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816736	17	29665037	17	31338019	816736	804969		NC_000017.11:31338018:T:G
NM_001042492.3(NF1):c.6705-5T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816735	17	29665038	17	31338020	816735	804970		NC_000017.11:31338019:T:G
NM_001042492.3(NF1):c.6148-13T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816734	17	29663640	17	31336622	816734	804965		NC_000017.11:31336621:T:A
NM_001042492.3(NF1):c.6148-16T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816733	17	29663637	17	31336619	816733	804964		NC_000017.11:31336618:T:G
NM_001042492.3(NF1):c.5269-19C>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816732	17	29654498	17	31327480	816732	804962		NC_000017.11:31327479:C:A
NM_001042492.3(NF1):c.4578-21T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816731	17	29588708	17	31261690	816731	804958		NC_000017.11:31261689:T:C
NM_001042492.3(NF1):c.3871-13T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816730	17	29562923	17	31235905	816730	804955		NC_000017.11:31235904:T:A
NM_001042492.3(NF1):c.3315-8T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816729	17	29559710	17	31232692	816729	804953		NC_000017.11:31232691:T:G
NM_001042492.3(NF1):c.2326-6T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816728	17	29554535	17	31227517	816728	804945		NC_000017.11:31227516:T:G
NM_001042492.3(NF1):c.2252-13T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816727	17	29554223	17	31227205	816727	804944		NC_000017.11:31227204:T:A
NM_001042492.3(NF1):c.1722-26T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816726	17	29550436	17	31223418	816726	804939		NC_000017.11:31223417:T:C
NM_001042492.3(NF1):c.889-21C>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816725	17	29527419	17	31200401	816725	804931		NC_000017.11:31200400:C:A
NM_001042492.3(NF1):c.731-14T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816724	17	29509512	17	31182494	816724	804930		NC_000017.11:31182493:T:G
NM_001042492.3(NF1):c.587-14T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816723	17	29508426	17	31181408	816723	804928		NC_000017.11:31181407:T:A
NM_001042492.3(NF1):c.480-8C>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816722	17	29496901	17	31169883	816722	804926		NC_000017.11:31169882:C:G
NM_001042492.3(NF1):c.205-19T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816721	17	29486009	17	31158991	816721	804924		NC_000017.11:31158990:T:A
NM_001042492.3(NF1):c.2536G>C (p.Ala846Pro)	NF1	A846P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000694607	17	29556169	17	31229151	694607	682680		NC_000017.11:31229150:G:C
NM_001042492.3(NF1):c.2524_2531delinsAGCTTCCA (p.Gly842_Leu844delinsSerPheHis)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000694606	17	29556157 - 29556164	17	31229139 - 31229146	694606	682678		NC_000017.11:31229138:GGCTTCCT:AGCTTCCA
NM_001042492.3(NF1):c.2531T>A (p.Leu844His)	NF1	L844H	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000694605	17	29556164	17	31229146	694605	682679		NC_000017.11:31229145:T:A
NM_001042492.3(NF1):c.4581del (p.His1528fs)	NF1	H1528fs, H1507fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000665381	17	29588732	17	31261714	665381	645638		NC_000017.11:31261713:T:
NM_000267.3(NF1):c.3053T>A (p.Leu1018Ter)	NF1	L1018*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000664969	17	29557340	17	31230322	664969	645569		NC_000017.11:31230321:T:A
NM_000267.3(NF1):c.6376C>T (p.Gln2126Ter)	NF1	Q2147*, Q2126*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000664810	17	29664397	17	31337379	664810	645707		NC_000017.11:31337378:C:T
NM_001042492.2(NF1):c.3045_3046GT[1] (p.Cys1016fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000663702	17	29557331 - 29557332	17	31230313 - 31230314	663702	645567		NC_000017.11:31230312:TGTGT:TGT
NM_000267.3(NF1):c.7352del (p.Pro2451fs)	NF1	P2451fs, P2472fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000663189	17	29677293	17	31350275	663189	645749		NC_000017.11:31350274:CC:C
NM_001042492.3(NF1):c.6540del (p.Ser2181fs)	NF1	S2160fs, S2181fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000659910	17	29664497	17	31337479	659910	645710		NC_000017.11:31337478:CC:C
NM_000267.3(NF1):c.2702T>G (p.Leu901Ter)	NF1	L901*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000659214	17	29556335	17	31229317	659214	645551		NC_000017.11:31229316:T:G
NM_000267.3(NF1):c.715C>T (p.Gln239Ter)	NF1	Q239*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000658113	17	29508788	17	31181770	658113	645471		NC_000017.11:31181769:C:T
NM_001042492.3(NF1):c.4108del (p.Gln1370fs)	NF1	Q1370fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000657584	17	29576134	17	31249116	657584	645618		NC_000017.11:31249115:CC:C
NC_000017.10:g.(?_29527440)_(29592357_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000657376	17	29527440 - 29592357	17	31200422 - 31265339	657376	652627		
NM_000267.3(NF1):c.1783G>T (p.Glu595Ter)	NF1	E595*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000655568	17	29550523	17	31223505	655568	645515		NC_000017.11:31223504:G:T
NM_000267.3(NF1):c.5305G>T (p.Glu1769Ter)	NF1	E1790*, E1769*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000654733	17	29654616	17	31327598	654733	645666		NC_000017.11:31327597:G:T
NM_001042492.3(NF1):c.653del (p.Lys218fs)	NF1	K218fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000653602	17	29508503	17	31181485	653602	645466		NC_000017.11:31181484:AAAA:AAA
NM_001042492.3(NF1):c.7959del (p.Pro2655fs)	NF1	P2634fs, P2655fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000651321	17	29684376	17	31357358	651321	645773		NC_000017.11:31357357:C:
NM_000267.3(NF1):c.412G>C (p.Ala138Pro)	NF1	A138P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000651033	17	29490327	17	31163309	651033	645456		NC_000017.11:31163308:G:C
NM_001042492.3(NF1):c.7158del (p.Phe2386fs)	NF1	F2365fs, F2386fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000650764	17	29670120	17	31343102	650764	645733		NC_000017.11:31343101:TTT:TT
NM_000267.3(NF1):c.2325G>T (p.Glu775Asp)	NF1	E775D	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 21, 2018)	criteria provided, single submitter	VCV000650391	17	29554309	17	31227291	650391	645540		NC_000017.11:31227290:G:T
NM_000267.3(NF1):c.4720C>T (p.Gln1574Ter)	NF1	Q1595*, Q1574*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000649568	17	29592305	17	31265287	649568	645644		NC_000017.11:31265286:C:T
NM_000267.3(NF1):c.999C>G (p.Tyr333Ter)	NF1	Y333*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000647719	17	29527550	17	31200532	647719	645487		NC_000017.11:31200531:C:G
NM_000267.3(NF1):c.5438C>G (p.Ser1813Ter)	NF1	S1834*, S1813*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000647087	17	29654749	17	31327731	647087	645674		NC_000017.11:31327730:C:G
NM_000267.3(NF1):c.248A>C (p.Gln83Pro)	NF1	Q83P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000641956	17	29486071	17	31159053	641956	645448		NC_000017.11:31159052:A:C
NM_000267.3(NF1):c.6373A>T (p.Lys2125Ter)	NF1	K2125*, K2146*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000639020	17	29664394	17	31337376	639020	645706		NC_000017.11:31337375:A:T
NC_000017.10:g.(?_29661846)_(29662059_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000583626	17	29661846 - 29662059	17	31334828 - 31335041	583626	568579		
NC_000017.10:g.(?_29527430)_(29533399_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000583529	17	29527430 - 29533399	17	31200412 - 31206381	583529	570758		
NM_000267.3(NF1):c.7125del (p.Tyr2377fs)	NF1	Y2398fs, Y2377fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000580631	17	29670149	17	31343131	580631	571052	rs777872719	NC_000017.11:31343130:AAAA:AAA
NM_000267.3(NF1):c.681T>A (p.Tyr227Ter)	NF1	Y227*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000580256	17	29508754	17	31181736	580256	568771	rs745804540	NC_000017.11:31181735:T:A
NM_000267.3(NF1):c.1797G>A (p.Trp599Ter)	NF1	W599*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000580246	17	29550537	17	31223519	580246	568806	rs1567845906	NC_000017.11:31223518:G:A
NM_000267.3(NF1):c.3089C>G (p.Ser1030Ter)	NF1	S1030*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000580002	17	29557376	17	31230358	580002	574399	rs1567849864	NC_000017.11:31230357:C:G
NM_000267.3(NF1):c.1525del (p.Cys509fs)	NF1	C509fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000579706	17	29541599	17	31214581	579706	570880	rs1135402813	NC_000017.11:31214580:TTT:TT
NM_000267.3(NF1):c.204+3_204+6del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000578995	17	29483145 - 29483148	17	31156127 - 31156130	578995	574346	rs1567814632	NC_000017.11:31156126:GTGAGT:GT
NM_000267.3(NF1):c.2449dup (p.Met817fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000578345	17	29556080 - 29556081	17	31229062 - 31229063	578345	568849	rs1567848755	NC_000017.11:31229062:AA:AAA
NM_000267.3(NF1):c.4640dup (p.Phe1548fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000576754	17	29588851 - 29588852	17	31261833 - 31261834	576754	574410	rs1555619052	NC_000017.11:31261833:AAA:AAAA
NM_000267.3(NF1):c.58C>T (p.Gln20Ter)	NF1	Q20*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000576465	17	29422385	17	31095367	576465	574343	rs1567786905	NC_000017.11:31095366:C:T
NM_000267.3(NF1):c.4600del (p.Ala1534fs)	NF1	A1534fs, A1555fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000573251	17	29588813	17	31261795	573251	568913	rs1567863614	NC_000017.11:31261794:GG:G
NM_001042492.2(NF1):c.997del (p.Tyr333fs)	NF1	Y333fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000572921	17	29527547	17	31200529	572921	568794	rs1567835183	NC_000017.11:31200528:TT:T
NM_000267.3(NF1):c.328del (p.Val110fs)	NF1	V110fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000571592	17	29490242	17	31163224	571592	568765	rs1567817865	NC_000017.11:31163223:GG:G
NM_000267.3(NF1):c.4926del (p.Phe1642fs)	NF1	F1642fs, F1663fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000569882	17	29652989	17	31325971	569882	571005	rs1567611380	NC_000017.11:31325970:TTT:TT
NM_000267.3(NF1):c.2167del (p.Val723fs)	NF1	V723fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000569878	17	29553615	17	31226597	569878	570917	rs1567847571	NC_000017.11:31226596:GGGG:GGG
NM_000267.3(NF1):c.2338dup (p.Thr780fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000569066	17	29554552 - 29554553	17	31227534 - 31227535	569066	574386	rs1567848129	NC_000017.11:31227534:A:AA
NM_000267.3(NF1):c.750del (p.Phe250fs)	NF1	F250fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000567780	17	29509543	17	31182525	567780	568786	rs1567826633	NC_000017.11:31182524:TTT:TT
NM_000267.3(NF1):c.4903del (p.Thr1635fs)	NF1	T1656fs, T1635fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000566482	17	29652965	17	31325947	566482	571002	rs1567611351	NC_000017.11:31325946:AAAA:AAA
NM_000267.3(NF1):c.2850+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547617	17	29556484	17	31229466	547617	538154	rs1131691122	NC_000017.11:31229465:G:A
NC_000017.10:g.(?_29527434)_(29533395_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000527686	17	29527434 - 29533395	17	31200416 - 31206377	527686	531005		
NM_000267.3(NF1):c.3431_3432dup (p.Thr1145fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000527598	17	29559832 - 29559833	17	31232814 - 31232815	527598	530783	rs1555614966	NC_000017.11:31232814:TGT:TGTGT
NM_000267.3(NF1):c.7365T>A (p.Tyr2455Ter)	NF1	Y2455*, Y2476*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000527542	17	29677307	17	31350289	527542	530918	rs181397225	NC_000017.11:31350288:T:A
NM_000267.3(NF1):c.3773G>A (p.Trp1258Ter)	NF1	W1258*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000527540	17	29562693	17	31235675	527540	531033	rs1555615458	NC_000017.11:31235674:G:A
NM_000267.3(NF1):c.2870del (p.Asn957fs)	NF1	N957fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000527526	17	29556871	17	31229853	527526	530761	rs1555614423	NC_000017.11:31229852:AA:A
NM_000267.3(NF1):c.1423dup (p.Leu475fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000527489	17	29541497 - 29541498	17	31214479 - 31214480	527489	530708	rs1555612274	NC_000017.11:31214479:CC:CCC
NM_000267.3(NF1):c.3707G>A (p.Trp1236Ter)	NF1	W1236*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000527476	17	29560230	17	31233212	527476	531256	rs1252674239	NC_000017.11:31233211:G:A
NM_000267.3(NF1):c.4030G>T (p.Glu1344Ter)	NF1	E1344*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000527464	17	29576057	17	31249039	527464	531042	rs1555617328	NC_000017.11:31249038:G:T
NM_000267.3(NF1):c.1354C>T (p.Gln452Ter)	NF1	Q452*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000527463	17	29533351	17	31206333	527463	531201	rs1555611590	NC_000017.11:31206332:C:T
NM_000267.3(NF1):c.4375del (p.Asp1460fs)	NF1	D1460fs, D1481fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000527443	17	29587393	17	31260375	527443	531289	rs1555618806	NC_000017.11:31260374:CC:C
NM_000267.3(NF1):c.6339T>A (p.Cys2113Ter)	NF1	C2113*, C2134*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	VCV000527417	17	29663907	17	31336889	527417	531026	rs1555534766	NC_000017.11:31336888:T:A
NM_000267.3(NF1):c.5767del (p.Leu1923fs)	NF1	L1944fs, L1923fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000492886	17	29661872	17	31334854	492886	485778	rs1555534378	NC_000017.11:31334853:CC:C
NM_000267.3(NF1):c.4992G>A (p.Trp1664Ter)	NF1	W1664*, W1685*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000457738	17	29653057	17	31326039	457738	466633	rs1555533354	NC_000017.11:31326038:G:A
NM_000267.3(NF1):c.4419_4420del (p.His1473fs)	NF1	H1494fs, H1473fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000457702	17	29587437 - 29587438	17	31260419 - 31260420	457702	467779	rs1555618821	NC_000017.11:31260418:ATA:A
NC_000017.10:g.(?_29508434)_(29509689_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000457506	17	29508434 - 29509689			457506	467016		
NM_000267.3(NF1):c.5717del (p.Leu1906fs)	NF1	L1906fs, L1927fs	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000431664	17	29657480	17	31330462	431664	425169	rs1135402880	NC_000017.11:31330461:TTTTT:TTTT
NM_000267.3(NF1):c.5429G>A (p.Trp1810Ter)	NF1	W1810*, W1831*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000431656	17	29654740	17	31327722	431656	425161	rs1135402872	NC_000017.11:31327721:G:A
NM_000267.3(NF1):c.3665del (p.Pro1222fs)	NF1	P1222fs	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000431627	17	29560186	17	31233168	431627	425132	rs867391752	NC_000017.11:31233167:CCC:CC
NM_000267.3(NF1):c.2034delinsCA (p.Ile679fs)	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000423262	17	29553485	17	31226467	423262	409865	rs1064796331	NC_000017.11:31226466:G:CA
NM_000267.3(NF1):c.3897del (p.Lys1299fs)	NF1	K1299fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000237558	17	29562958	17	31235940	237558	242677	rs878853890	NC_000017.11:31235939:AAAAA:AAAA
NM_000267.3(NF1):c.1738dup (p.Tyr580fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000188397	17	29550472 - 29550473	17	31223454 - 31223455	188397	186245	rs786204255	NC_000017.11:31223454:TTTTTT:TTTTTTT
NM_000267.3(NF1):c.4661+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000374	17	29588876	17	31261858	374	15413	rs1555619056	NC_000017.11:31261857:G:C
NM_000267.3(NF1):c.3784del (p.Ser1262fs)	NF1	S1262fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000000367	17	29562701	17	31235683	367	15406	rs1567852567	NC_000017.11:31235682:TTTT:TTT
NM_000267.3(NF1):c.5845A>T (p.Arg1949Ter)	NF1	R365*, R1949*, R1970*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000000335	17	29661951	17	31334933	335	15374	rs267606595	NC_000017.11:31334932:A:T
NF1, 5-BP DEL	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000000333					333	15372		
NM_144997.7(FLCN):c.779+1G>T	FLCN		not specified|Pneumothorax, primary spontaneous|Multiple fibrofolliculomas|Renal cell carcinoma, nonpapillary|Potocki-Lupski syndrome|Carcinoma of colon|Hereditary cancer-predisposing syndrome|not provided|Multiple fibrofolliculomas	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231274	17	17125814	17	17222500	231274	235483	rs758175953	NC_000017.11:17222499:C:A
NM_000053.4(ATP7B):c.2332C>T (p.Arg778Trp)	ATP7B	R778W, R694W, R667W	Wilson disease	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000456553	13	52532470	13	51958334	456553	462961	rs137853284	NC_000013.11:51958333:G:A
NM_001005242.2(PKP2):c.148_151del (p.Thr50fs)	PKP2	T50fs	not provided|Cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000045028	12	33049515 - 33049518	12	32896581 - 32896584	45028	54195	rs397516997	NC_000012.12:32896580:CTGTCTG:CTG
NM_001042492.3(NF1):c.4577+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000864398	17	29587535	17	31260517	864398	852181		NC_000017.11:31260516:T:G
NM_001042492.3(NF1):c.5609+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000858870	17	29654859	17	31327841	858870	852183		NC_000017.11:31327840:T:G
NM_001042492.3(NF1):c.5687C>A (p.Ser1896Ter)	NF1	S1875*, S1896*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000857730	17	29657391	17	31330373	857730	845080		NC_000017.11:31330372:C:A
NM_001042492.3(NF1):c.5493G>A (p.Trp1831Ter)	NF1	W1810*, W1831*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000856332	17	29654741	17	31327723	856332	845064		NC_000017.11:31327722:G:A
NM_001042492.3(NF1):c.4340_4341delinsCA (p.Gln1447Pro)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000854788	17	29586057 - 29586058	17	31259039 - 31259040	854788	845035		NC_000017.11:31259038:AG:CA
NM_001042492.3(NF1):c.2271_2272del (p.Arg758fs)	NF1	R758fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000849296	17	29554253 - 29554254	17	31227235 - 31227236	849296	844937		NC_000017.11:31227234:AAAA:AA
NM_001042492.3(NF1):c.1224T>G (p.Tyr408Ter)	NF1	Y408*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000844580	17	29528467	17	31201449	844580	844892		NC_000017.11:31201448:T:G
NM_001042492.3(NF1):c.6705-1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000836704	17	29665042	17	31338024	836704	851709		NC_000017.11:31338023:G:T
NM_001042492.3(NF1):c.8161-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000835670	17	29687503	17	31360485	835670	852733		NC_000017.11:31360484:A:T
NM_001042492.3(NF1):c.5013del (p.Ala1670_Tyr1671insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000834483	17	29653015	17	31325997	834483	845054		NC_000017.11:31325996:C:
NM_001042492.3(NF1):c.4865del (p.Leu1622fs)	NF1	L1622fs, L1601fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000834344	17	29652865	17	31325847	834344	845049		NC_000017.11:31325846:TTT:TT
NC_000017.11:g.(?_31155973)_(31156136_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000833279	17	29482991 - 29483154			833279	821003		
NC_000017.11:g.(?_31232063)_(31236281_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000833234	17	29559081 - 29563299			833234	821021		
NC_000017.11:g.(?_31160230)_(31163386_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV000832872	17	29487248 - 29490404			832872	821007		
NM_001042492.3(NF1):c.2410-13A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000804167	17	29556030	17	31229012	804167	792537		NC_000017.11:31229011:A:G
NM_001042492.3(NF1):c.4331A>T (p.Lys1444Met)	NF1	K1423M, K1444M	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000694609	17	29585519	17	31258501	694609	682682		NC_000017.11:31258500:A:T
NM_001042492.3(NF1):c.3827G>T (p.Arg1276Leu)	NF1	R1276L	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000694608	17	29562747	17	31235729	694608	682681		NC_000017.11:31235728:G:T
NM_000267.3(NF1):c.808C>T (p.Gln270Ter)	NF1	Q270*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000664218	17	29509603	17	31182585	664218	645476		NC_000017.11:31182584:C:T
NM_000267.3(NF1):c.1642-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000661992	17	29548866	17	31221848	661992	652722		NC_000017.11:31221847:A:T
NM_001042492.2(NF1):c.7253_7254CT[1] (p.Leu2419fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000661667	17	29676201 - 29676202	17	31349183 - 31349184	661667	645738		NC_000017.11:31349182:CTCT:CT
NM_000267.3(NF1):c.5543T>G (p.Leu1848Ter)	NF1	L1848*, L1869*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000661533	17	29654854	17	31327836	661533	645679		NC_000017.11:31327835:T:G
NM_000267.3(NF1):c.3315-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000657669	17	29559717	17	31232699	657669	653242		NC_000017.11:31232698:G:A
NM_000267.3(NF1):c.236T>G (p.Leu79Ter)	NF1	L79*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000655362	17	29486059	17	31159041	655362	645444		NC_000017.11:31159040:T:G
NM_000267.3(NF1):c.581T>C (p.Leu194Pro)	NF1	L194P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000653665	17	29497010	17	31169992	653665	645462		NC_000017.11:31169991:T:C
NM_000267.3(NF1):c.205-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, single submitter	VCV000652752	17	29486026	17	31159008	652752	652701		NC_000017.11:31159007:A:G
NM_000267.3(NF1):c.6641+1del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000651367	17	29664898	17	31337880	651367	653264		NC_000017.11:31337879:GG:G
NM_000267.3(NF1):c.5708T>A (p.Leu1903Ter)	NF1	L1924*, L1903*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000649928	17	29657475	17	31330457	649928	645687		NC_000017.11:31330456:T:A
NM_000267.3(NF1):c.2409+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000648121	17	29554625	17	31227607	648121	653416		NC_000017.11:31227606:G:A
NM_000267.3(NF1):c.4276C>G (p.Gln1426Glu)	NF1	Q1447E, Q1426E	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000639280	17	29586056	17	31259038	639280	645626		NC_000017.11:31259037:C:G
NM_000267.3(NF1):c.4253T>A (p.Leu1418Ter)	NF1	L1418*, L1439*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000623196	17	29585504	17	31258486	623196	612164	rs1567862071	NC_000017.11:31258485:T:A
NM_000267.3(NF1):c.7901del (p.Pro2634fs)	NF1	P2634fs, P2655fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000618756	17	29684380	17	31357362	618756	610081	rs1567627268	NC_000017.11:31357361:CC:C
NM_000267.3(NF1):c.668G>A (p.Trp223Ter)	NF1	W223*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000579648	17	29508741	17	31181723	579648	568769	rs1567826110	NC_000017.11:31181722:G:A
NM_000267.3(NF1):c.7727C>A (p.Ser2576Ter)	NF1	S2576*, S2597*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000579517	17	29684029	17	31357011	579517	574431	rs1567626945	NC_000017.11:31357010:C:A
NM_001042492.2(NF1):c.6393_6394CT[2] (p.Leu2133fs)	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000577771	17	29663898 - 29663899	17	31336880 - 31336881	577771	571175	rs1567617129	NC_000017.11:31336879:CTCTCT:CTCT
NM_000267.3(NF1):c.7202_7205del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000575475	17	29676209 - 29676212	17	31349191 - 31349194	575475	571223	rs1567623480	NC_000017.11:31349190:AACAAACA:AACA
NM_000267.3(NF1):c.1765C>T (p.Gln589Ter)	NF1	Q589*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000573696	17	29550505	17	31223487	573696	568805	rs1282299543	NC_000017.11:31223486:C:T
NM_000267.3(NF1):c.479+5G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000565507	17	29490399	17	31163381	565507	570933	rs1567818033	NC_000017.11:31163380:G:A
NM_000267.3(NF1):c.3315-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000565393	17	29559717	17	31232699	565393	574400	rs1567850984	NC_000017.11:31232698:G:C
NM_000267.3(NF1):c.2510G>A (p.Trp837Ter)	NF1	W837*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000561498	17	29556143	17	31229125	561498	552926	rs1348129244	NC_000017.11:31229124:G:A
NM_000267.3(NF1):c.3686del (p.Asn1229fs)	NF1	N1229fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547633	17	29560208	17	31233190	547633	538170	rs1555615103	NC_000017.11:31233189:AA:A
NM_000267.3(NF1):c.1660C>T (p.Gln554Ter)	NF1	Q554*	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000547601	17	29548886	17	31221868	547601	538138	rs953440640	NC_000017.11:31221867:C:T
NM_000267.3(NF1):c.667T>C (p.Trp223Arg)	NF1	W223R	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547570	17	29508740	17	31181722	547570	538107	rs1555608740	NC_000017.11:31181721:T:C
NM_000267.3(NF1):c.288+2T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 23, 2017)	criteria provided, single submitter	VCV000527581	17	29486113	17	31159095	527581	530916	rs1555605406	NC_000017.11:31159094:T:A
NM_000267.3(NF1):c.7126+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000527538	17	29670154	17	31343136	527538	531045	rs1555535455	NC_000017.11:31343135:G:A
NM_000267.3(NF1):c.7926dup (p.Lys2643Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 26, 2017)	criteria provided, single submitter	VCV000527531	17	29685515 - 29685516	17	31358497 - 31358498	527531	531142	rs1555536882	NC_000017.11:31358497:T:TT
NM_000267.3(NF1):c.7528C>T (p.Gln2510Ter)	NF1	Q2510*, Q2531*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000527484	17	29679408	17	31352390	527484	530926	rs1555536372	NC_000017.11:31352389:C:T
NM_000267.3(NF1):c.569del (p.Lys189_Leu190insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000527450	17	29496997	17	31169979	527450	530671	rs1555607110	NC_000017.11:31169978:TT:T
NM_000267.3(NF1):c.3703C>T (p.Gln1235Ter)	NF1	Q1235*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523788	17	29560226	17	31233208	523788	514714	rs1555615109	NC_000017.11:31233207:C:T
NM_000267.3(NF1):c.4935del (p.Pro1646fs)	NF1	P1646fs, P1667fs	Cafe-au-lait spot|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000523347	17	29652996	17	31325978	523347	514078	rs1135402867	NC_000017.11:31325977:TTTTT:TTTT
NM_000267.3(NF1):c.3060del (p.Glu1020_Val1021insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000517397	17	29557346	17	31230328	517397	497565	rs1555614521	NC_000017.11:31230327:AA:A
NM_000267.3(NF1):c.7211del (p.Asn2404fs)	NF1	N2425fs, N2404fs	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504241	17	29676220	17	31349202	504241	495684	rs1555536030	NC_000017.11:31349201:AAA:AA
NM_000267.3(NF1):c.5206delG	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503953	17	29654516	17	31327498	503953	495413	rs1555533549	NC_000017.11:31327497:GG:G
NM_000267.3(NF1):c.3197+1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503702	17	29557944	17	31230926	503702	495410	rs1555614653	NC_000017.11:31230925:G:A
NM_000267.3(NF1):c.2163T>A (p.Cys721Ter)	NF1	C721*	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488882	17	29553614	17	31226596	488882	482124	rs1555613816	NC_000017.11:31226595:T:A
NM_000267.3(NF1):c.6611G>A (p.Trp2204Ter)	NF1	W2204*, W2225*	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488819	17	29664868	17	31337850	488819	482131	rs1193716348	NC_000017.11:31337849:G:A
NM_000267.3(NF1):c.560del (p.Cys187fs)	NF1	C187fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 28, 2016)	criteria provided, single submitter	VCV000480102	17	29496989	17	31169971	480102	477928	rs1555607107	NC_000017.11:31169970:G:
NM_001042492.2(NF1):c.981_982GT[1] (p.Leu327_Cys328insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000457880	17	29527531 - 29527532	17	31200513 - 31200514	457880	466422	rs1555610893	NC_000017.11:31200512:TGTGT:TGT
NM_001042492.2(NF1):c.6577_6578GA[4] (p.Glu2195fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000457797	17	29664535 - 29664536	17	31337517 - 31337518	457797	466672	rs1131691084	NC_000017.11:31337516:GAGAGAGAGA:GAGAGAGA
NM_000267.3(NF1):c.5749+5G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000457764	17	29657521	17	31330503	457764	467501	rs1555533889	NC_000017.11:31330502:G:A
NM_001042492.2(NF1):c.3299_3300CA[1] (p.Gln1101fs)	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457639	17	29559192 - 29559193	17	31232174 - 31232175	457639	467717	rs1555614866	NC_000017.11:31232173:CACA:CA
NM_000267.3(NF1):c.288+5G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000457605	17	29486116	17	31159098	457605	466402	rs1555605409	NC_000017.11:31159097:G:T
NM_000267.3(NF1):c.1139T>C (p.Leu380Pro)	NF1	L380P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000457516	17	29528131	17	31201113	457516	467415	rs1555611004	NC_000017.11:31201112:T:C
NM_000267.3(NF1):c.2890del (p.Thr964fs)	NF1	T964fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000451156	17	29556890	17	31229872	451156	445737	rs1555614437	NC_000017.11:31229871:AAA:AA
NM_000267.3(NF1):c.1541del (p.Gln514fs)	NF1	Q514fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449422	17	29546036	17	31219018	449422	445732	rs1555612815	NC_000017.11:31219017:A:
NM_000267.3(NF1):c.7054C>T (p.Gln2352Ter)	NF1	Q2352*, Q2373*	Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000440001	17	29670081	17	31343063	440001	433263	rs1555535417	NC_000017.11:31343062:C:T
NM_000267.3(NF1):c.334C>T (p.Gln112Ter)	NF1	Q112*	Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439975	17	29490249	17	31163231	439975	433234	rs1555606061	NC_000017.11:31163230:C:T
NM_000267.3(NF1):c.7684_7685del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000431693	17	29683984 - 29683985	17	31356966 - 31356967	431693	425198	rs1135402907	NC_000017.11:31356965:AGAG:AG
NM_000267.3(NF1):c.7346dup (p.Asn2449fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000431692	17	29677284 - 29677285	17	31350266 - 31350267	431692	425197	rs1135402906	NC_000017.11:31350266:AAAA:AAAAA
NM_000267.3(NF1):c.4457T>G (p.Leu1486Ter)	NF1	L1486*, L1507*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000431645	17	29587476	17	31260458	431645	425150	rs1135402863	NC_000017.11:31260457:T:G
NM_000267.3(NF1):c.3834C>G (p.Asn1278Lys)	NF1	N1278K	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000431630	17	29562754	17	31235736	431630	425135	rs1135402850	NC_000017.11:31235735:C:G
NM_000267.3(NF1):c.886A>T (p.Lys296Ter)	NF1	K296*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000431572	17	29509681	17	31182663	431572	425077	rs1135402798	NC_000017.11:31182662:A:T
NM_000267.3(NF1):c.1299T>G (p.Tyr433Ter)	NF1	Y433*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404617	17	29533296	17	31206278	404617	402352	rs876660099	NC_000017.11:31206277:T:G
NM_000267.3(NF1):c.5587T>C (p.Phe1863Leu)	NF1	F1884L, F1863L	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000404601	17	29657354	17	31330336	404601	402477	rs1060500378	NC_000017.11:31330335:T:C
NM_000267.3(NF1):c.288+1del	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000404591	17	29486109	17	31159091	404591	401612	rs1057519370	NC_000017.11:31159090:GGGG:GGG
NM_000267.3(NF1):c.1063-2A>G	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404575	17	29528053	17	31201035	404575	401633	rs1060500358	NC_000017.11:31201034:A:G
NM_000267.3(NF1):c.2848C>T (p.Gln950Ter)	NF1	Q950*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000404574	17	29556481	17	31229463	404574	402194	rs1060500357	NC_000017.11:31229462:C:T
NM_000267.3(NF1):c.2619dup (p.Lys874Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000404563	17	29556251 - 29556252	17	31229233 - 31229234	404563	401668	rs1555614284	NC_000017.11:31229233:T:TT
NM_000267.3(NF1):c.3763C>T (p.Gln1255Ter)	NF1	Q1255*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000404504	17	29562683	17	31235665	404504	401707	rs1060500308	NC_000017.11:31235664:C:T
NM_000267.3(NF1):c.2325+3A>G	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372550	17	29554312	17	31227294	372550	360327	rs1057517848	NC_000017.11:31227293:A:G
NM_000267.3(NF1):c.2665dup (p.Thr889fs)	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280056	17	29556297 - 29556298	17	31229279 - 31229280	280056	265014	rs886041348	NC_000017.11:31229279:A:AA
NM_000267.3(NF1):c.2409+2del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000237536	17	29554626	17	31227608	237536	242656	rs878853875	NC_000017.11:31227607:T:
NM_000267.3(NF1):c.4483G>T (p.Glu1495Ter)	NF1	E1495*, E1516*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000216064	17	29587502	17	31260484	216064	213276	rs786203390	NC_000017.11:31260483:G:T
NM_000267.3(NF1):c.3494T>A (p.Ile1165Lys)	NF1	I1165K	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000188312	17	29559897	17	31232879	188312	186250	rs786204211	NC_000017.11:31232878:T:A
NM_000267.3(NF1):c.1783_1784del (p.Glu595fs)	NF1	E595fs	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188086	17	29550522 - 29550523	17	31223504 - 31223505	188086	186246	rs786204059	NC_000017.11:31223503:AGA:A
NM_000267.3(NF1):c.5938G>A (p.Gly1980Arg)	NF1	G1980R, G2001R	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 4, 2014)	no assertion criteria provided	VCV000068358	17	29662044	17	31335026	68358	79249	rs199474751	NC_000017.11:31335025:G:A
NM_000267.3(NF1):c.945_946delinsAA (p.Leu316Met)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000000366	17	29527496 - 29527497	17	31200478 - 31200479	366	15405	rs267606609	NC_000017.11:31200477:GC:AA
NM_000267.3(NF1):c.4021C>T (p.Gln1341Ter)	NF1	Q1341*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 2, 2015)	criteria provided, single submitter	VCV000000357	17	29576048	17	31249030	357	15396	rs137854559	NC_000017.11:31249029:C:T
NM_004004.6(GJB2):c.617A>G (p.Asn206Ser)	GJB2	N206S	Deafness, autosomal recessive 1A|Rare genetic deafness|Deafness, autosomal recessive 1A|Knuckle pads, deafness AND leukonychia syndrome|Hystrix-like ichthyosis with deafness|Palmoplantar keratoderma-deafness syndrome|Deafness, X-linked 2|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Mutilating keratoderma|Deafness, autosomal dominant 3a|not provided|Hearing impairment|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|not specified	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000044763	13	20763104	13	20188965	44763	53930	rs111033294	NC_000013.11:20188964:T:C
NM_004004.6(GJB2):c.283G>A (p.Val95Met)	GJB2	V95M	Deafness, autosomal recessive 1A|Knuckle pads, deafness AND leukonychia syndrome|Hystrix-like ichthyosis with deafness|Palmoplantar keratoderma-deafness syndrome|Deafness, X-linked 2|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Mutilating keratoderma|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Hearing impairment|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044735	13	20763438	13	20189299	44735	53902	rs111033299	NC_000013.11:20189298:C:T
NM_002834.5(PTPN11):c.214G>A (p.Ala72Thr)	PTPN11	A72T, A71T	not provided|Rasopathy|Chronic lymphocytic leukemia|Neuroblastoma|Acute myeloid leukemia|Neoplasm of brain|Noonan syndrome|Juvenile myelomonocytic leukemia|Noonan syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177754	12	112888198	12	112450394	177754	175540	rs121918453	NC_000012.12:112450393:G:A
NM_002834.5(PTPN11):c.236A>G (p.Gln79Arg)	PTPN11	Q79R, Q78R	Noonan syndrome 1|Noonan syndrome|Noonan syndrome 3|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|Rasopathy|not provided	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013340	12	112888220	12	112450416	13340	28379	rs121918466	NC_000012.12:112450415:A:G
NM_000138.5(FBN1):c.1955G>A (p.Cys652Tyr)	FBN1	C652Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000858022	15	48797227	15	48505030	858022	842513		NC_000015.10:48505029:C:T
NM_000138.5(FBN1):c.4689C>G (p.Cys1563Trp)	FBN1	C1563W	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000857217	15	48760193	15	48467996	857217	842478		NC_000015.10:48467995:G:C
NM_000138.5(FBN1):c.6296G>A (p.Cys2099Tyr)	FBN1	C2099Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000855800	15	48729982	15	48437785	855800	842460		NC_000015.10:48437784:C:T
NM_000138.5(FBN1):c.4688G>A (p.Cys1563Tyr)	FBN1	C1563Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000847866	15	48760194	15	48467997	847866	842479		NC_000015.10:48467996:C:T
NM_000138.5(FBN1):c.3850T>C (p.Cys1284Arg)	FBN1	C1284R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000847403	15	48773966	15	48481769	847403	842488		NC_000015.10:48481768:A:G
NM_000138.5(FBN1):c.7865G>C (p.Cys2622Ser)	FBN1	C2622S	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000844728	15	48707919	15	48415722	844728	842437		NC_000015.10:48415721:C:G
NM_000138.4(FBN1):c.2113+1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 29, 2018)	criteria provided, single submitter	VCV000582881	15	48795983	15	48503786	582881	573369	rs1566913670	NC_000015.10:48503785:C:T
NM_000138.4(FBN1):c.8056T>C (p.Cys2686Arg)	FBN1	C2686R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000582674	15	48704936	15	48412739	582674	567107	rs1566889188	NC_000015.10:48412738:A:G
NM_000138.4(FBN1):c.3143T>C (p.Ile1048Thr)	FBN1	I1048T	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000549131	15	48780630	15	48488433	549131	539789	rs1555398673	NC_000015.10:48488432:A:G
NM_000138.4(FBN1):c.5065+1G>C	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547327	15	48756095	15	48463898	547327	538053	rs1296209846	NC_000015.10:48463897:C:G
NM_000138.4(FBN1):c.3012C>A (p.Tyr1004Ter)	FBN1	Y1004*	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000527177	15	48782118	15	48489921	527177	529345	rs397515784	NC_000015.10:48489920:G:T
NM_000138.4(FBN1):c.1837+5G>A	FBN1		Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000527158	15	48800774	15	48508577	527158	529507	rs1445085747	NC_000015.10:48508576:C:T
NM_000138.4(FBN1):c.5014T>G (p.Cys1672Gly)	FBN1	C1672G	Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495617	15	48756147	15	48463950	495617	487784	rs112930491	NC_000015.10:48463949:A:C
NM_000138.4(FBN1):c.6662G>A (p.Cys2221Tyr)	FBN1	C2221Y	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000492830	15	48725140	15	48432943	492830	485757	rs137854460	NC_000015.10:48432942:C:T
NM_000138.4(FBN1):c.6048_6056del (p.Cys2017_Glu2019del)	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000457239	15	48734025 - 48734033	15	48441828 - 48441836	457239	464883	rs1555395483	NC_000015.10:48441827:TCGACACACTC:TC
NM_000138.4(FBN1):c.4691G>A (p.Cys1564Tyr)	FBN1	C1564Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000457221	15	48760191	15	48467994	457221	464356	rs267606800	NC_000015.10:48467993:C:T
NM_000138.4(FBN1):c.2626T>C (p.Cys876Arg)	FBN1	C876R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000457173	15	48787371	15	48495174	457173	464955	rs1555399158	NC_000015.10:48495173:A:G
NM_000138.4(FBN1):c.3851G>A (p.Cys1284Tyr)	FBN1	C1284Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449441	15	48773965	15	48481768	449441	445356	rs1555398173	NC_000015.10:48481767:C:T
NM_000138.4(FBN1):c.5371T>C (p.Cys1791Arg)	FBN1	C1791R	Marfan syndrome|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449439	15	48748885	15	48456688	449439	445350	rs1555396427	NC_000015.10:48456687:A:G
NM_000138.4(FBN1):c.1570dup (p.Thr524fs)	FBN1		not provided|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431982	15	48805763 - 48805764	15	48513566 - 48513567	431982	426115	rs1555400274	NC_000015.10:48513566:T:TT
NM_000138.4(FBN1):c.6616+1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided|Marfan syndrome	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419595	15	48726790	15	48434593	419595	409261	rs1064793980	NC_000015.10:48434592:C:T
NM_000138.4(FBN1):c.2945G>C (p.Cys982Ser)	FBN1	C982S	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000392364	15	48782185	15	48489988	392364	374188	rs1057524458	NC_000015.10:48489987:C:G
NM_000138.5(FBN1):c.8226+1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan lipodystrophy syndrome	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000225629	15	48704765	15	48412568	225629	227463	rs398122833	NC_000015.10:48412567:C:T
NM_000138.4(FBN1):c.2180G>A (p.Cys727Tyr)	FBN1	C727Y	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000199991	15	48789576	15	48497379	199991	197771		NC_000015.10:48497378:C:T
NM_000138.4(FBN1):c.3725G>A (p.Cys1242Tyr)	FBN1	C1242Y	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000016429	15	48776128	15	48483931	16429	31468	rs137854471	NC_000015.10:48483930:C:T
NM_001042492.3(NF1):c.7945_7946GT[1] (p.Phe2650fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000862375	17	29684361 - 29684362	17	31357343 - 31357344	862375	845185		NC_000017.11:31357342:TGTGT:TGT
NM_001042492.3(NF1):c.1275G>A (p.Trp425Ter)	NF1	W425*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000855972	17	29533272	17	31206254	855972	844893		NC_000017.11:31206253:G:A
NM_001042492.3(NF1):c.205-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000852374	17	29486027	17	31159009	852374	852163		NC_000017.11:31159008:G:A
NM_001042492.3(NF1):c.6147+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000851432	17	29663492	17	31336474	851432	852868		NC_000017.11:31336473:G:T
NM_001042492.3(NF1):c.998dup (p.Tyr333Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000850603	17	29527548 - 29527549	17	31200530 - 31200531	850603	844884		NC_000017.11:31200530:A:AA
NM_001042492.3(NF1):c.3942G>A (p.Trp1314Ter)	NF1	W1314*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000849712	17	29563007	17	31235989	849712	845012		NC_000017.11:31235988:G:A
NM_001042492.3(NF1):c.8161-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000849315	17	29687504	17	31360486	849315	852734		NC_000017.11:31360485:G:A
NM_001042492.3(NF1):c.480-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000845305	17	29496908	17	31169890	845305	852857		NC_000017.11:31169889:G:A
NM_001042492.3(NF1):c.7400C>A (p.Ser2467Ter)	NF1	S2446*, S2467*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000836114	17	29677279	17	31350261	836114	845159		NC_000017.11:31350260:C:A
NM_001042492.3(NF1):c.4431-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000835743	17	29587386	17	31260368	835743	852720		NC_000017.11:31260367:G:A
NM_001042492.3(NF1):c.3496+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000835181	17	29559900	17	31232882	835181	852711		NC_000017.11:31232881:G:C
NC_000017.11:g.(?_31095290)_(31183409_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000831422	17	29422308 - 29510427			831422	821001		
NC_000017.11:g.(?_31248974)_(31265349_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000830849	17	29575992 - 29592367			830849	821024		
NC_000017.11:g.(?_31248964)_(31265359_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000830506	17	29575982 - 29592377			830506	821022		
NM_001042492.3(NF1):c.6503del (p.Ser2168fs)	NF1	S2168fs, S2147fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000826407	17	29664461	17	31337443	826407	813423		NC_000017.11:31337442:G:
NM_001042492.3(NF1):c.1408G>T (p.Glu470Ter)	NF1	E470*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000819135	17	29541484	17	31214466	819135	813143		NC_000017.11:31214465:G:T
NM_000267.3(NF1):c.2329T>C (p.Trp777Arg)	NF1	W777R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000652361	17	29554544	17	31227526	652361	645541		NC_000017.11:31227525:T:C
NM_000267.3(NF1):c.3709-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000647016	17	29562627	17	31235609	647016	652926		NC_000017.11:31235608:A:T
NM_000267.3(NF1):c.288+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000642767	17	29486112	17	31159094	642767	653217		NC_000017.11:31159093:G:C
NM_000267.3(NF1):c.288+5G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000642764	17	29486116	17	31159098	642764	652705		NC_000017.11:31159097:G:A
NM_000267.3(NF1):c.4367+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000640358	17	29586148	17	31259130	640358	653430		NC_000017.11:31259129:G:A
NM_000267.3(NF1):c.2542G>A (p.Gly848Arg)	NF1	G848R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000640216	17	29556175	17	31229157	640216	645548		NC_000017.11:31229156:G:A
NM_001042492.3(NF1):c.338dup (p.Leu113fs)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000640096	17	29490251 - 29490252	17	31163233 - 31163234	640096	645450		NC_000017.11:31163233:TT:TTT
NM_000267.3(NF1):c.844C>T (p.Gln282Ter)	NF1	Q282*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000637000	17	29509639	17	31182621	637000	624623		NC_000017.11:31182620:C:T
NM_000267.3(NF1):c.5896C>T (p.Gln1966Ter)	NF1	Q1966*, Q1987*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620128	17	29662002	17	31334984	620128	611851	rs876659070	NC_000017.11:31334983:C:T
NM_000267.3(NF1):c.2827A>T (p.Lys943Ter)	NF1	K943*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585292	17	29556460	17	31229442	585292	576343	rs1567849199	NC_000017.11:31229441:A:T
NM_000267.3(NF1):c.288+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000581065	17	29486113	17	31159095	581065	570850	rs1555605406	NC_000017.11:31159094:T:C
NM_000267.3(NF1):c.1845+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000579615	17	29550586	17	31223568	579615	568808	rs1567845945	NC_000017.11:31223567:G:A
NM_000267.3(NF1):c.4514+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000576239	17	29587534	17	31260516	576239	570994	rs1279529138	NC_000017.11:31260515:G:T
NM_000267.3(NF1):c.2325+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000575838	17	29554310	17	31227292	575838	574384	rs1555613933	NC_000017.11:31227291:G:T
NM_000267.3(NF1):c.6999+1_6999+5del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000572463	17	29667661 - 29667665	17	31340643 - 31340647	572463	571216	rs1567619134	NC_000017.11:31340642:AAGGTAAG:AAG
NM_000267.3(NF1):c.2407C>T (p.Gln803Ter)	NF1	Q803*	Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000565792	17	29554622	17	31227604	565792	574387	rs1567848213	NC_000017.11:31227603:C:T
NM_000267.3(NF1):c.5904C>G (p.Tyr1968Ter)	NF1	Y1968*, Y1989*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000561857	17	29662010	17	31334992	561857	552978	rs1567615902	NC_000017.11:31334991:C:G
NM_000267.3(NF1):c.7638dup (p.Lys2547fs)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547695	17	29683557 - 29683558	17	31356539 - 31356540	547695	538232	rs1060500295	NC_000017.11:31356539:CCCCCC:CCCCCCC
NM_000267.3(NF1):c.4168C>G (p.Leu1390Val)	NF1	L1390V, L1411V	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547642	17	29585419	17	31258401	547642	538179	rs199474789	NC_000017.11:31258400:C:G
NM_000267.3(NF1):c.3911del (p.Leu1304fs)	NF1	L1304fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547639	17	29562974	17	31235956	547639	538176	rs1555615549	NC_000017.11:31235955:TTT:TT
NM_000267.3(NF1):c.1020dup (p.Val341fs)	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000545745	17	29527570 - 29527571	17	31200552 - 31200553	545745	536487	rs1555610905	NC_000017.11:31200552:T:TT
NM_000267.3(NF1):c.311_312del (p.Arg103_Leu104insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000527507	17	29490226 - 29490227	17	31163208 - 31163209	527507	530917	rs1555606053	NC_000017.11:31163207:TA:
NM_000267.3(NF1):c.3709-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527473	17	29562628	17	31235610	527473	531027	rs1555615431	NC_000017.11:31235609:G:A
NM_000267.3(NF1):c.4621del (p.Asn1542fs)	NF1	N1563fs, N1542fs	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000504235	17	29588834	17	31261816	504235	495668	rs1555619041	NC_000017.11:31261815:CC:C
NM_000267.3(NF1):c.541C>T (p.Gln181Ter)	NF1	Q181*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000492874	17	29496970	17	31169952	492874	485766	rs753529924	NC_000017.11:31169951:C:T
NM_000267.3(NF1):c.3161_3165del (p.Asn1054fs)	NF1	N1054fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000485960	17	29557904 - 29557908	17	31230886 - 31230890	485960	478117	rs1555614642	NC_000017.11:31230885:CAAACCAA:CAA
NM_000267.3(NF1):c.7433del (p.Gly2478fs)	NF1	G2478fs, G2499fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000480793	17	29679312	17	31352294	480793	478346	rs1555536352	NC_000017.11:31352293:GG:G
NM_000267.3(NF1):c.4171A>G (p.Arg1391Gly)	NF1	R1391G, R1412G	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457686	17	29585422	17	31258404	457686	467765	rs1555618515	NC_000017.11:31258403:A:G
NM_000267.3(NF1):c.3277G>A (p.Val1093Met)	NF1	V1093M	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000457638	17	29559170	17	31232152	457638	467714	rs1555614858	NC_000017.11:31232151:G:A
NM_000267.3(NF1):c.3113+5G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000457622	17	29557405	17	31230387	457622	467386	rs1555614549	NC_000017.11:31230386:G:A
NM_000267.3(NF1):c.1884C>A (p.Tyr628Ter)	NF1	Y628*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457554	17	29552151	17	31225133	457554	467287	rs555635097	NC_000017.11:31225132:C:A
NM_000267.3(NF1):c.3376C>T (p.Gln1126Ter)	NF1	Q1126*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449424	17	29559779	17	31232761	449424	445739	rs1555614947	NC_000017.11:31232760:C:T
NM_000267.3(NF1):c.1094C>G (p.Ser365Ter)	NF1	S365*	Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439995	17	29528086	17	31201068	439995	433241	rs864622107	NC_000017.11:31201067:C:G
NM_000267.3(NF1):c.654+1G>A	NF1		Tibial pseudoarthrosis|Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439982	17	29508508	17	31181490	439982	433236	rs1060500245	NC_000017.11:31181489:G:A
NM_000267.3(NF1):c.3076A>T (p.Arg1026Ter)	NF1	R1026*	Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Oct 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439974	17	29557363	17	31230345	439974	433248	rs1555614529	NC_000017.11:31230344:A:T
NM_000267.3(NF1):c.3449C>G (p.Ser1150Ter)	NF1	S1150*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432961	17	29559852	17	31232834	432961	426216	rs1555614972	NC_000017.11:31232833:C:G
NM_000267.3(NF1):c.7224del (p.Phe2408fs)	NF1	F2429fs, F2408fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000431688	17	29676233	17	31349215	431688	425193	rs1135402902	NC_000017.11:31349214:TTT:TT
NM_000267.3(NF1):c.3037del (p.Thr1013fs)	NF1	T1013fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000431615	17	29557320	17	31230302	431615	425120	rs1135402838	NC_000017.11:31230301:AAAAA:AAAA
NM_000267.3(NF1):c.2990+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000431613	17	29556993	17	31229975	431613	425118	rs1135402836	NC_000017.11:31229974:G:A
NM_000267.3(NF1):c.7775dup (p.Lys2593fs)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000429012	17	29684075 - 29684076	17	31357057 - 31357058	429012	420835	rs1131691129	NC_000017.11:31357057:CC:CCC
NM_000267.3(NF1):c.79C>T (p.Gln27Ter)	NF1	Q27*	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000404581	17	29483019	17	31156001	404581	402309	rs1060500363	NC_000017.11:31156000:C:T
NM_000267.3(NF1):c.7638del (p.Lys2547_Met2548insTer)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404488	17	29683558	17	31356540	404488	402387	rs1060500295	NC_000017.11:31356539:CCCCCC:CCCCC
NM_000267.3(NF1):c.1726C>T (p.Gln576Ter)	NF1	Q576*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404467	17	29550466	17	31223448	404467	401648	rs1060500278	NC_000017.11:31223447:C:T
NM_000267.3(NF1):c.4495C>T (p.Gln1499Ter)	NF1	Q1520*, Q1499*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000404417	17	29587514	17	31260496	404417	402465	rs1060500242	NC_000017.11:31260495:C:T
NM_000267.3(NF1):c.2252-3T>G	NF1		Axillary freckling|Cafe-au-lait spot|Multiple cafe-au-lait spots|Inguinal freckling|Neurofibromas|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374022	17	29554233	17	31227215	374022	361010	rs1057518842	NC_000017.11:31227214:T:G
NM_000267.3(NF1):c.4773-1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 11, 2016)	criteria provided, multiple submitters, no conflicts	VCV000373285	17	29652837	17	31325819	373285	360299	rs1057518326	NC_000017.11:31325818:G:A
NM_000267.3(NF1):c.7518del (p.Gln2507fs)	NF1	Q2507fs, Q2528fs	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000237598	17	29679395	17	31352377	237598	242710	rs878853917	NC_000017.11:31352376:GGGG:GGG
NM_001042492.2(NF1):c.7267_7268CA[1] (p.His2423fs)	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000237592	17	29676214 - 29676215	17	31349196 - 31349197	237592	242705	rs878853913	NC_000017.11:31349195:ACACA:ACA
NM_000267.3(NF1):c.955dup (p.Ser319fs)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000234213	17	29527503 - 29527504	17	31200485 - 31200486	234213	235533	rs876660931	NC_000017.11:31200485:AAA:AAAA
NM_000267.3(NF1):c.2887C>T (p.Gln963Ter)	NF1	Q963*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000233495	17	29556889	17	31229871	233495	235619	rs876660444	NC_000017.11:31229870:C:T
NM_000267.3(NF1):c.1714del (p.Glu572fs)	NF1	E572fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000233017	17	29548938	17	31221920	233017	235561	rs876660135	NC_000017.11:31221919:GGG:GG
NM_000267.3(NF1):c.3790G>A (p.Glu1264Lys)	NF1	E1264K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216402	17	29562710	17	31235692	216402	213269	rs863224660	NC_000017.11:31235691:G:A
NM_000267.3(NF1):c.7419G>A (p.Trp2473Ter)	NF1	W2473*, W2494*	Neurofibromatosis, type 1|Inguinal hernia|Cafe-au-lait spot|Familial predisposition|Axillary freckling|Inguinal freckling|Delayed speech and language development|Specific learning disability	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000216067	17	29679299	17	31352281	216067	213298	rs863224493	NC_000017.11:31352280:G:A
NM_000267.3(NF1):c.1713G>A (p.Trp571Ter)	NF1	W571*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000216061	17	29548939	17	31221921	216061	213253	rs863224489	NC_000017.11:31221920:G:A
NM_000267.3(NF1):c.3821dup (p.Phe1275fs)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187286	17	29562740 - 29562741	17	31235722 - 31235723	187286	184641	rs786203614	NC_000017.11:31235722:T:TT
NM_000267.3(NF1):c.7329del (p.Asp2444fs)	NF1	D2444fs, D2465fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000185448	17	29677271	17	31350253	185448	184751	rs786202180	NC_000017.11:31350252:T:
NM_000267.3(NF1):c.1595T>C (p.Leu532Pro)	NF1	L532P	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Nov 11, 2014)	criteria provided, single submitter	VCV000068302	17	29546090	17	31219072	68302	79193	rs199474737	NC_000017.11:31219071:T:C
NM_000070.3(CAPN3):c.2243G>A (p.Arg748Gln)	CAPN3	R748Q, R742Q, R236Q, R656Q, R83Q	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000128570	15	42702844	15	42410646	128570	134019	rs587780290	NC_000015.10:42410645:G:A
NM_000257.4(MYH7):c.2221G>A (p.Gly741Arg)	MYH7	G741R	Hypertrophic cardiomyopathy|Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042890	14	23894969	14	23425760	42890	52060	rs121913632	NC_000014.9:23425759:C:T
NM_019066.5(MAGEL2):c.1912C>T (p.Gln638Ter)	MAGEL2	Q638*	Prader-Willi syndrome|Schaaf-yang syndrome|Schaaf-yang syndrome|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208684	15	23890978	15	23645831	208684	205286	rs797044883	NC_000015.10:23645830:G:A
NM_001042492.3(NF1):c.3870+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000863762	17	29562791	17	31235773	863762	852713		NC_000017.11:31235772:G:C
NM_001042492.3(NF1):c.1845+2T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000859076	17	29550587	17	31223569	859076	852173		NC_000017.11:31223568:T:A
NM_001042492.3(NF1):c.1260+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000848717	17	29528504	17	31201486	848717	852699		NC_000017.11:31201485:G:C
NM_000267.3:c.1491_4110+4407del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000845037					845037	852690		
NM_001042492.3(NF1):c.1261-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000835846	17	29533256	17	31206238	835846	852858		NC_000017.11:31206237:A:T
NM_001042492.3(NF1):c.1261-19G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000816753	17	29533239	17	31206221	816753	804935		NC_000017.11:31206220:G:A
NM_001042492.3(NF1):c.888+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000803340	17	29509684	17	31182666	803340	791693		NC_000017.11:31182665:G:T
NM_000267.3(NF1):c.3974+1G>A	NF1		Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000661977	17	29563040	17	31236022	661977	653248		NC_000017.11:31236021:G:A
NM_000267.3(NF1):c.2734C>T (p.Gln912Ter)	NF1	Q912*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000654419	17	29556367	17	31229349	654419	645552		NC_000017.11:31229348:C:T
NM_000267.3(NF1):c.2990G>A (p.Arg997Lys)	NF1	R997K	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000654334	17	29556992	17	31229974	654334	645562		NC_000017.11:31229973:G:A
NM_000267.3(NF1):c.1393_1394delAG	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000653570	17	29541467 - 29541468	17	31214449 - 31214450	653570	652717		NC_000017.11:31214448:AGAG:AG
NM_000267.3(NF1):c.6974_6977del (p.Asp2325fs)	NF1	D2325fs, D2346fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000644855	17	29667635 - 29667638	17	31340617 - 31340620	644855	645727		NC_000017.11:31340616:TAGATAG:TAG
NM_000267.3(NF1):c.4110+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000582401	17	29576138	17	31249120	582401	574406	rs1555617383	NC_000017.11:31249119:G:T
NM_000267.3(NF1):c.889-2del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000581747	17	29527438	17	31200420	581747	570959	rs1567834983	NC_000017.11:31200419:A:
NM_000267.3(NF1):c.1603C>T (p.Gln535Ter)	NF1	Q535*	Tibial pseudoarthrosis|Neurofibromatosis, type 1|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000571976	17	29546098	17	31219080	571976	574378	rs1567843917	NC_000017.11:31219079:C:T
NM_000267.3(NF1):c.4480C>T (p.Gln1494Ter)	NF1	Q1494*, Q1515*	Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Caf-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000570950	17	29587499	17	31260481	570950	570990	rs1567862991	NC_000017.11:31260480:C:T
NM_000267.3(NF1):c.1260+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000570670	17	29528504	17	31201486	570670	570960	rs267606603	NC_000017.11:31201485:G:T
NM_000267.3(NF1):c.7843C>T (p.Gln2615Ter)	NF1	Q2615*, Q2636*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547698	17	29684323	17	31357305	547698	538235	rs567988442	NC_000017.11:31357304:C:T
NM_000267.3(NF1):c.4243G>T (p.Glu1415Ter)	NF1	E1415*, E1436*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547643	17	29585494	17	31258476	547643	538180	rs876660428	NC_000017.11:31258475:G:T
NM_000267.3(NF1):c.4120C>T (p.Gln1374Ter)	NF1	Q1374*, Q1395*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547641	17	29585371	17	31258353	547641	538178	rs1555618494	NC_000017.11:31258352:C:T
NM_000267.3(NF1):c.2560C>T (p.Gln854Ter)	NF1	Q854*	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547612	17	29556193	17	31229175	547612	538149	rs1555614261	NC_000017.11:31229174:C:T
NM_000267.3(NF1):c.1496T>G (p.Leu499Arg)	NF1	L499R	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547592	17	29541572	17	31214554	547592	538129	rs1555612288	NC_000017.11:31214553:T:G
NM_000267.3(NF1):c.1627C>T (p.Gln543Ter)	NF1	Q543*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000485943	17	29546122	17	31219104	485943	478042	rs894292181	NC_000017.11:31219103:C:T
NM_000267.3(NF1):c.6756+3A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000457805	17	29665160	17	31338142	457805	467709	rs1555534966	NC_000017.11:31338141:A:G
NM_000267.3(NF1):c.5770del (p.Cys1924fs)	NF1	C1945fs, C1924fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457765	17	29661874	17	31334856	457765	467670	rs1555534379	NC_000017.11:31334855:TTT:TT
NM_000267.3(NF1):c.479+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457722	17	29490395	17	31163377	457722	466407	rs1555606137	NC_000017.11:31163376:G:A
NM_000267.3(NF1):c.2537C>A (p.Ala846Asp)	NF1	A846D	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457588	17	29556170	17	31229152	457588	467630	rs1555614229	NC_000017.11:31229151:C:A
NM_000267.3(NF1):c.569T>G (p.Leu190Ter)	NF1	L190*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000431974	17	29496998	17	31169980	431974	426210	rs1555607112	NC_000017.11:31169979:T:G
NM_000267.3(NF1):c.6365-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000431671	17	29664384	17	31337366	431671	425176	rs1060500312	NC_000017.11:31337365:A:C
NM_000267.3(NF1):c.4267A>C (p.Lys1423Gln)	NF1	K1423Q, K1444Q	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431637	17	29585518	17	31258500	431637	425142	rs137854550	NC_000017.11:31258499:A:C
NM_000267.3(NF1):c.4076del (p.Pro1359fs)	NF1	P1359fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431632	17	29576098	17	31249080	431632	425137	rs1135402852	NC_000017.11:31249079:CCCCCC:CCCCC
NM_000267.3(NF1):c.1570G>T (p.Glu524Ter)	NF1	E524*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000431591	17	29546065	17	31219047	431591	425096	rs1135402815	NC_000017.11:31219046:G:T
NM_000267.3(NF1):c.1218del (p.His407fs)	NF1	H407fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428985	17	29528459	17	31201441	428985	420769	rs1131691106	NC_000017.11:31201440:TTT:TT
NM_000267.3(NF1):c.3097C>T (p.Gln1033Ter)	NF1	Q1033*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428983	17	29557384	17	31230366	428983	420792	rs1131691104	NC_000017.11:31230365:C:T
NM_000267.3(NF1):c.7697C>G (p.Ser2566Ter)	NF1	S2566*, S2587*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000428968	17	29683999	17	31356981	428968	420834	rs1131691090	NC_000017.11:31356980:C:G
NM_000267.3(NF1):c.2534G>A (p.Cys845Tyr)	NF1	C845Y	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404587	17	29556167	17	31229149	404587	401689	rs1060500367	NC_000017.11:31229148:G:A
NM_000267.3(NF1):c.3712G>T (p.Glu1238Ter)	NF1	E1238*	Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404559	17	29562632	17	31235614	404559	402450	rs1060500346	NC_000017.11:31235613:G:T
NM_000267.3(NF1):c.6365-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 21, 2019)	criteria provided, single submitter	VCV000404510	17	29664384	17	31337366	404510	402492	rs1060500312	NC_000017.11:31337365:A:G
NM_000267.3(NF1):c.1062+3A>G	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000381606	17	29527616	17	31200598	381606	378108	rs1057521098	NC_000017.11:31200597:A:G
NM_000267.3(NF1):c.5498T>G (p.Leu1833Arg)	NF1	L1833R, L1854R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237576	17	29654809	17	31327791	237576	242694	rs878853903	NC_000017.11:31327790:T:G
NM_000267.3(NF1):c.3565C>T (p.Gln1189Ter)	NF1	Q1189*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237551	17	29560088	17	31233070	237551	242671	rs878853884	NC_000017.11:31233069:C:T
NM_000267.3(NF1):c.3046T>C (p.Cys1016Arg)	NF1	C1016R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000237543	17	29557333	17	31230315	237543	242663	rs878853880	NC_000017.11:31230314:T:C
NM_000267.3(NF1):c.5667dup (p.Ile1890fs)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000233126	17	29657433 - 29657434	17	31330415 - 31330416	233126	235750	rs876660212	NC_000017.11:31330415:T:TT
NM_000267.3(NF1):c.5205+5G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000220498	17	29653275	17	31326257	220498	222614	rs864622551	NC_000017.11:31326256:G:A
NM_000267.3(NF1):c.6999+1G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 28, 2016)	criteria provided, multiple submitters, no conflicts	VCV000216066	17	29667664	17	31340646	216066	213294	rs863224492	NC_000017.11:31340645:G:A
NM_000267.3(NF1):c.5719G>T (p.Glu1907Ter)	NF1	E1907*, E1928*	Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Caf-au-lait macules with pulmonary stenosis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000187652	17	29657486	17	31330468	187652	184701	rs786203896	NC_000017.11:31330467:G:T
NM_000267.3(NF1):c.625C>T (p.Gln209Ter)	NF1	Q209*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, multiple submitters, no conflicts	VCV000187069	17	29508478	17	31181460	187069	184516	rs786203448	NC_000017.11:31181459:C:T
NM_000267.3(NF1):c.5776G>T (p.Glu1926Ter)	NF1	E1926*, E1947*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141892	17	29661882	17	31334864	141892	151606	rs587782088	NC_000017.11:31334863:G:T
NM_000267.3(NF1):c.2531T>C (p.Leu844Pro)	NF1	L844P	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000068322	17	29556164	17	31229146	68322	79213	rs137854566	NC_000017.11:31229145:T:C
NM_000267.3(NF1):c.1260+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000000356	17	29528504	17	31201486	356	15395	rs267606603	NC_000017.11:31201485:G:A
NM_001844.5(COL2A1):c.1510G>A (p.Gly504Ser)	COL2A1	G504S, G435S	not provided|Inborn genetic diseases|Spondyloperipheral dysplasia-short ulna syndrome	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000195742	12	48380136	12	47986353	195742	192903	rs121912880	NC_000012.12:47986352:C:T
NM_004004.6(GJB2):c.94C>T (p.Arg32Cys)	GJB2	R32C	not specified|Deafness, autosomal recessive 1A|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188758	13	20763627	13	20189488	188758	186863	rs371024165	NC_000013.11:20189487:G:A
NM_004004.6(GJB2):c.298C>T (p.His100Tyr)	GJB2	H100Y	not provided|Deafness, autosomal recessive 1A|Hearing impairment|not specified|Rare genetic deafness|Hearing loss	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158607	13	20763423	13	20189284	158607	169011	rs143343083	NC_000013.11:20189283:G:A
NM_004004.6(GJB2):c.365A>T (p.Lys122Ile)	GJB2	K122I	Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|not specified|not provided|Hearing impairment|Rare genetic deafness|Hearing loss	Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044742	13	20763356	13	20189217	44742	53909	rs111033295	NC_000013.11:20189216:T:A
NM_004004.6(GJB2):c.250G>C (p.Val84Leu)	GJB2	V84L	not provided|Rare genetic deafness|Hearing impairment|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017032	13	20763471	13	20189332	17032	32071	rs104894409	NC_000013.11:20189331:C:G
NM_001363711.2(DUOX2):c.2895_2898del (p.Phe966fs)	DUOX2	F966fs	Familial thyroid dyshormonogenesis|Nongoitrous Euthyroid Hyperthyrotropinemia|not provided|Congenital hypothyroidism|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189229	15	45393426 - 45393429	15	45101228 - 45101231	189229	187125	rs530719719	NC_000015.10:45101227:GAACGA:GA
NM_002834.5(PTPN11):c.1507G>A (p.Gly503Arg)	PTPN11	G503R, G507R, G502R	Rasopathy|not provided|Noonan syndrome|Juvenile myelomonocytic leukemia|Noonan syndrome|Cardiovascular phenotype|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040559	12	112926887	12	112489083	40559	49029	rs397507545	NC_000012.12:112489082:G:A
NM_002834.5(PTPN11):c.214G>T (p.Ala72Ser)	PTPN11	A72S, A71S	Noonan syndrome|Noonan syndrome 1|LEOPARD syndrome 1|Noonan syndrome 1|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|Rasopathy|not provided	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013324	12	112888198	12	112450394	13324	28363	rs121918453	NC_000012.12:112450393:G:T
NM_014249.4(NR2E3):c.932G>A (p.Arg311Gln)	NR2E3	R311Q	NR2E3-Related Disorders|Enhanced s-cone syndrome|Retinitis pigmentosa 37|Retinal dystrophy|Retinitis pigmentosa|not provided|Enhanced s-cone syndrome|Goldmann-Favre syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005532	15	72105913	15	71813573	5532	20571	rs28937873	NC_000015.10:71813572:G:A
NM_000138.5(FBN1):c.2051G>A (p.Cys684Tyr)	FBN1	C684Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000854113	15	48796046	15	48503849	854113	842511		NC_000015.10:48503848:C:T
NM_000138.5(FBN1):c.5911T>C (p.Cys1971Arg)	FBN1	C1971R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000852975	15	48737579	15	48445382	852975	842467		NC_000015.10:48445381:A:G
NM_000138.5(FBN1):c.1495T>A (p.Cys499Ser)	FBN1	C499S	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000846906	15	48805839	15	48513642	846906	842519		NC_000015.10:48513641:A:T
NM_000138.5(FBN1):c.203G>T (p.Cys68Phe)	FBN1	C68F	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000841878	15	48905251	15	48613054	841878	842542		NC_000015.10:48613053:C:A
NM_000138.4(FBN1):c.2414G>A (p.Cys805Tyr)	FBN1	C805Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000656190	15	48788302	15	48496105	656190	643393		NC_000015.10:48496104:C:T
NM_000138.4(FBN1):c.5434T>C (p.Cys1812Arg)	FBN1	C1812R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000655979	15	48744870	15	48452673	655979	643355		NC_000015.10:48452672:A:G
NM_000138.4(FBN1):c.1510T>A (p.Cys504Ser)	FBN1	C504S	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000653004	15	48805824	15	48513627	653004	643406		NC_000015.10:48513626:A:T
NM_000138.4(FBN1):c.5377T>C (p.Cys1793Arg)	FBN1	C1793R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000647812	15	48748879	15	48456682	647812	643356		NC_000015.10:48456681:A:G
NM_000138.4(FBN1):c.7325G>A (p.Cys2442Tyr)	FBN1	C2442Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000646261	15	48717941	15	48425744	646261	643321		NC_000015.10:48425743:C:T
NM_000138.4(FBN1):c.5066-1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000625123	15	48755438	15	48463241	625123	613478	rs397515819	NC_000015.10:48463240:C:T
NM_000138.4(FBN1):c.626G>T (p.Cys209Phe)	FBN1	C209F	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000579559	15	48829918	15	48537721	579559	573391	rs1555401687	NC_000015.10:48537720:C:A
NM_000138.4(FBN1):c.6883T>C (p.Cys2295Arg)	FBN1	C2295R	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000567978	15	48720657	15	48428460	567978	573329	rs1555394644	NC_000015.10:48428459:A:G
NM_000138.4(FBN1):c.7954T>C (p.Cys2652Arg)	FBN1	C2652R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527194	15	48707830	15	48415633	527194	529429	rs1555393858	NC_000015.10:48415632:A:G
NM_000138.4(FBN1):c.6158G>A (p.Cys2053Tyr)	FBN1	C2053Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000527145	15	48733923	15	48441726	527145	529295	rs363805	NC_000015.10:48441725:C:T
NM_000138.4(FBN1):c.1904A>G (p.Tyr635Cys)	FBN1	Y635C	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520493	15	48797278	15	48505081	520493	511131	rs1555399816	NC_000015.10:48505080:T:C
NM_000138.4(FBN1):c.6650G>A (p.Cys2217Tyr)	FBN1	C2217Y	not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200090	15	48725152	15	48432955	200090	197634	rs794728254	NC_000015.10:48432954:C:T
NM_000138.4(FBN1):c.4337-2A>G	FBN1		Marfan syndrome|Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000200034	15	48762955	15	48470758	200034	197703	rs794728216	NC_000015.10:48470757:T:C
NM_000138.4(FBN1):c.3344A>G (p.Asp1115Gly)	FBN1	D1115G	not provided|Cardiovascular phenotype|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200015	15	48779628	15	48487431	200015	197735	rs794728203	NC_000015.10:48487430:T:C
NM_000138.5(FBN1):c.3012C>G (p.Tyr1004Ter)	FBN1	Y1004*	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042324	15	48782118	15	48489921	42324	51494	rs397515784	NC_000015.10:48489920:G:C
NM_000138.4(FBN1):c.2433C>A (p.Cys811Ter)	FBN1	C811*	Cardiovascular phenotype|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|not provided|Marfan syndrome	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036049	15	48787772	15	48495575	36049	44713	rs193921256	NC_000015.10:48495574:G:T
NM_000267.3(NF1):c.4269+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000663586	17	29585521	17	31258503	663586	652754		NC_000017.11:31258502:G:T
NM_000267.3(NF1):c.1062+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000660278	17	29527614	17	31200596	660278	652918		NC_000017.11:31200595:G:A
NM_000267.3(NF1):c.3047_3048insSVAelement	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000646558	17	29557334 - 29557335	17	31230316 - 31230317	646558	645568		
NM_000267.3(NF1):c.247C>T (p.Gln83Ter)	NF1	Q83*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000642883	17	29486070	17	31159052	642883	645447		NC_000017.11:31159051:C:T
NM_000267.3(NF1):c.7000-2A>G	NF1		Neurofibroma|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 8, 2019)	criteria provided, single submitter	VCV000635820	17	29670025	17	31343007	635820	623637		NC_000017.11:31343006:A:G
NM_000267.3(NF1):c.1238C>G (p.Ser413Ter)	NF1	S413*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000570504	17	29528481	17	31201463	570504	574368	rs1241533665	NC_000017.11:31201462:C:G
NM_000267.3(NF1):c.6084+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547673	17	29663493	17	31336475	547673	538210	rs1555534621	NC_000017.11:31336474:T:C
NM_000267.3(NF1):c.4572C>G (p.Tyr1524Ter)	NF1	Y1524*, Y1545*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Sep 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547647	17	29588786	17	31261768	547647	538184	rs754023358	NC_000017.11:31261767:C:G
NM_000267.3(NF1):c.888+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547573	17	29509684	17	31182666	547573	538110	rs1135402799	NC_000017.11:31182665:G:A
NM_000267.3(NF1):c.655-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547569	17	29508726	17	31181708	547569	538106	rs1555608734	NC_000017.11:31181707:A:C
NM_000267.3(NF1):c.205-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547564	17	29486027	17	31159009	547564	538101	rs1555605362	NC_000017.11:31159008:G:C
NM_000267.3(NF1):c.3644T>G (p.Met1215Arg)	NF1	M1215R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000527596	17	29560167	17	31233149	527596	531252	rs1555615071	NC_000017.11:31233148:T:G
NM_000267.3(NF1):c.2503C>T (p.Gln835Ter)	NF1	Q835*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523904	17	29556136	17	31229118	523904	514712	rs1555614207	NC_000017.11:31229117:C:T
NM_000267.3(NF1):c.7552+1G>T	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000489226	17	29679433	17	31352415	489226	482132	rs1555536380	NC_000017.11:31352414:G:T
NM_000267.3(NF1):c.3315-2A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484086	17	29559716	17	31232698	484086	478125	rs1555614914	NC_000017.11:31232697:A:G
NM_000267.3(NF1):c.6642-3C>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481981	17	29665040	17	31338022	481981	478971	rs1131691079	NC_000017.11:31338021:C:A
NM_000267.3(NF1):c.61-2A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457782	17	29482999	17	31155981	457782	466393	rs1131691100	NC_000017.11:31155980:A:G
NM_000267.3(NF1):c.2991-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000457613	17	29557277	17	31230259	457613	467376	rs1060500273	NC_000017.11:31230258:G:C
NM_000267.3(NF1):c.724dup (p.Met242fs)	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449421	17	29508796 - 29508797	17	31181778 - 31181779	449421	445731	rs1555608763	NC_000017.11:31181778:A:AA
NM_000267.3(NF1):c.5624C>G (p.Ser1875Ter)	NF1	S1875*, S1896*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431663	17	29657391	17	31330373	431663	425168	rs1135402879	NC_000017.11:31330372:C:G
NM_000267.3(NF1):c.4973_4978del	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431651	17	29653032 - 29653037	17	31326014 - 31326019	431651	425156	rs1135402868	NC_000017.11:31326013:TCTATATCTATA:TCTATA
NM_000267.3(NF1):c.1845+1_1845+5del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000431598	17	29550582 - 29550586	17	31223564 - 31223568	431598	425103	rs1135402822	NC_000017.11:31223563:TAAGGTAAG:TAAG
NM_000267.3(NF1):c.1527+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000431589	17	29541604	17	31214586	431589	425094	rs1060500331	NC_000017.11:31214585:G:C
NM_000267.3(NF1):c.496_497del (p.Val166fs)	NF1	V166fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431562	17	29496924 - 29496925	17	31169906 - 31169907	431562	425067	rs1135402788	NC_000017.11:31169905:TGT:T
NM_001042492.2(NF1):c.2033del (p.Pro678fs)	NF1	P678fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428991	17	29553478	17	31226460	428991	420780	rs587781807	NC_000017.11:31226459:CCCCCCC:CCCCCC
NM_000267.3(NF1):c.4277A>C (p.Gln1426Pro)	NF1	Q1426P, Q1447P	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000428987	17	29586057	17	31259039	428987	420804	rs786204157	NC_000017.11:31259038:A:C
NM_000267.3(NF1):c.1721+1G>T	NF1	R574S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428975	17	29548948	17	31221930	428975	420775	rs1131691096	NC_000017.11:31221929:G:T
NM_000267.3(NF1):c.3198-2A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000428967	17	29559089	17	31232071	428967	420794	rs1131691089	NC_000017.11:31232070:A:G
NM_000267.3(NF1):c.5406dup (p.Ile1803fs)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428957	17	29654716 - 29654717	17	31327698 - 31327699	428957	420811	rs267606605	NC_000017.11:31327698:T:TT
NM_000267.3(NF1):c.6801A>G (p.Gln2267=)	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420870	17	29665766	17	31338748	420870	409881	rs1064794756	NC_000017.11:31338747:A:G
NM_000267.3(NF1):c.5749+332A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216065	17	29657848	17	31330830	216065	213285	rs863224491	NC_000017.11:31330829:A:G
NM_000267.3(NF1):c.4277A>G (p.Gln1426Arg)	NF1	Q1426R, Q1447R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000188220	17	29586057	17	31259039	188220	186253	rs786204157	NC_000017.11:31259038:A:G
NM_000267.3(NF1):c.647T>C (p.Leu216Pro)	NF1	L216P	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000068360	17	29508500	17	31181482	68360	79251	rs199474756	NC_000017.11:31181481:T:C
NM_000267.3(NF1):c.1646T>C (p.Leu549Pro)	NF1	L549P	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068303	17	29548872	17	31221854	68303	79194	rs199474758	NC_000017.11:31221853:T:C
NM_013275.6(ANKRD11):c.3770_3771del (p.Lys1257fs)	ANKRD11	K1257fs	not provided|KBG syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265324	16	89349179 - 89349180	16	89282771 - 89282772	265324	260139	rs886039477	NC_000016.10:89282770:TTT:T
NM_000257.4(MYH7):c.2711G>A (p.Arg904His)	MYH7	R904H	Hypertrophic cardiomyopathy|Familial dilated cardiomyopathy|not provided|Cardiomyopathy|Primary dilated cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042926	14	23893327	14	23424118	42926	52096	rs397516165	NC_000014.9:23424117:C:T
NM_001042492.3(NF1):c.288+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000863797	17	29486112	17	31159094	863797	852165		NC_000017.11:31159093:G:A
NM_001042492.3(NF1):c.1261-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000855635	17	29533256	17	31206238	855635	851699		NC_000017.11:31206237:A:G
NM_001042492.3(NF1):c.2991-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV000843158	17	29557276	17	31230258	843158	851701		NC_000017.11:31230257:A:T
NM_001042492.3(NF1):c.1185+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000840905	17	29528179	17	31201161	840905	852696		NC_000017.11:31201160:T:C
NM_001042492.3(NF1):c.6921+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000835698	17	29665824	17	31338806	835698	852185		NC_000017.11:31338805:G:C
NM_000267.3(NF1):c.2410-16A>G	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000572474	17	29556027	17	31229009	572474	571021	rs1567848704	NC_000017.11:31229008:A:G
NM_000267.3(NF1):c.6364+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000566355	17	29663934	17	31336916	566355	568957	rs1567617158	NC_000017.11:31336915:T:G
NM_000267.3(NF1):c.3447G>C (p.Met1149Ile)	NF1	M1149I	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000566155	17	29559850	17	31232832	566155	570952	rs1064794277	NC_000017.11:31232831:G:C
NM_000267.3(NF1):c.943C>T (p.Gln315Ter)	NF1	Q315*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547574	17	29527494	17	31200476	547574	538111	rs766011053	NC_000017.11:31200475:C:T
NM_000267.3(NF1):c.730+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547571	17	29508804	17	31181786	547571	538108	rs1060500274	NC_000017.11:31181785:G:T
NM_000267.3(NF1):c.909_910delinsTT (p.Arg304Ter)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000527594	17	29527460 - 29527461	17	31200442 - 31200443	527594	530942	rs1555610854	NC_000017.11:31200441:AC:TT
NM_001042492.2(NF1):c.240_241TC[3] (p.Gln83fs)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000527470	17	29486063 - 29486064	17	31159045 - 31159046	527470	530668	rs771115661	NC_000017.11:31159044:TCTCTCTC:TCTCTC
NM_000267.3(NF1):c.4269+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000492881	17	29585521	17	31258503	492881	485773	rs1555618572	NC_000017.11:31258502:G:A
NM_000267.3(NF1):c.3822_3823del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457670	17	29562738 - 29562739	17	31235720 - 31235721	457670	466588	rs1555615472	NC_000017.11:31235719:CTCTCT:CTCT
NM_001042492.3(NF1):c.1721+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457545	17	29548948	17	31221930	457545	467579	rs1131691096	NC_000017.11:31221929:G:A
NM_000267.3(NF1):c.5546+1G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428997	17	29654858	17	31327840	428997	420812	rs1131691117	NC_000017.11:31327839:G:A
NM_000267.3(NF1):c.7000-1G>T	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428994	17	29670026	17	31343008	428994	420828	rs1131691114	NC_000017.11:31343007:G:T
NM_000267.3(NF1):c.3871-2A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428953	17	29562934	17	31235916	428953	420799	rs1131691077	NC_000017.11:31235915:A:G
NM_000267.3(NF1):c.4269G>C (p.Lys1423Asn)	NF1	K1444N, K1423N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404485	17	29585520	17	31258502	404485	401735	rs199474750	NC_000017.11:31258501:G:C
NM_000267.3(NF1):c.2533T>C (p.Cys845Arg)	NF1	C845R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404431	17	29556166	17	31229148	404431	401687	rs1060500254	NC_000017.11:31229147:T:C
NM_000267.3(NF1):c.669G>A (p.Trp223Ter)	NF1	W223*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372756	17	29508742	17	31181724	372756	360415	rs1057517967	NC_000017.11:31181723:G:A
NM_000267.3(NF1):c.3113+2T>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000231169	17	29557402	17	31230384	231169	235627	rs876658997	NC_000017.11:31230383:T:G
NM_001042492.3(NF1):c.1392+1G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000080403	17	29533390	17	31206372	80403	91294	rs267604791	NC_000017.11:31206371:G:A
NM_000267.3(NF1):c.2084T>C (p.Leu695Pro)	NF1	L695P	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000068309	17	29553535	17	31226517	68309	79200	rs199474761	NC_000017.11:31226516:T:C
NM_000267.3(NF1):c.1070T>C (p.Leu357Pro)	NF1	L357P	Neurofibromatosis, familial spinal|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000000368	17	29528062	17	31201044	368	15407	rs137854563	NC_000017.11:31201043:T:C
NM_000267.3(NF1):c.1642-8A>G	NF1		Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000000352	17	29548860	17	31221842	352	15391	rs267606602	NC_000017.11:31221841:A:G
NM_000267.3(NF1):c.4614G>A (p.Trp1538Ter)	NF1	W1538*, W1559*	not provided|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000350	17	29588828	17	31261810	350	15389	rs137854555	NC_000017.11:31261809:G:A
NM_001005242.3(PKP2):c.1481G>A (p.Trp494Ter)	PKP2	W538*, W494*	not provided|Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036680	12	32994037	12	32841103	36680	45341	rs193922672	NC_000012.12:32841102:C:T
NM_144997.7(FLCN):c.1429C>T (p.Arg477Ter)	FLCN	R477*, R495*	Hereditary cancer-predisposing syndrome|Potocki-Lupski syndrome|Pneumothorax, primary spontaneous|Multiple fibrofolliculomas|Carcinoma of colon|Renal cell carcinoma, nonpapillary|not specified|Multiple fibrofolliculomas|not provided	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000253251	17	17118502	17	17215188	253251	247653	rs879255678	NC_000017.11:17215187:G:A
NM_000053.4(ATP7B):c.2128G>A (p.Gly710Ser)	ATP7B	G710S, G599S, G626S	Wilson disease|not provided	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156281	13	52532674	13	51958538	156281	166061	rs137853285	NC_000013.11:51958537:C:T
NM_000053.3(ATP7B):c.3809A>G	ATP7B	N1270S, N915S, N1186S, N1063S, N1192S, N1159S	Wilson disease|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003859	13	52511706	13	51937570	3859	18898	rs121907990	NC_000013.11:51937569:T:C
NM_000138.4(FBN1):c.5579G>A (p.Cys1860Tyr)	FBN1	C1860Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000645309	15	48741057	15	48448860	645309	643349		NC_000015.10:48448859:C:T
NM_000138.4(FBN1):c.7987T>C (p.Cys2663Arg)	FBN1	C2663R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000576623	15	48707797	15	48415600	576623	567110	rs1566889870	NC_000015.10:48415599:A:G
NM_000138.4(FBN1):c.7342T>C (p.Cys2448Arg)	FBN1	C2448R	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000574697	15	48717677	15	48425480	574697	568893	rs1566892757	NC_000015.10:48425479:A:G
NM_000138.4(FBN1):c.7410C>G (p.Cys2470Trp)	FBN1	C2470W	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000549408	15	48717609	15	48425412	549408	539537	rs1555394397	NC_000015.10:48425411:G:C
NM_000138.4(FBN1):c.626G>C (p.Cys209Ser)	FBN1	C209S	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000549338	15	48829918	15	48537721	549338	539920	rs1555401687	NC_000015.10:48537720:C:G
NM_000138.4(FBN1):c.5156G>A (p.Cys1719Tyr)	FBN1	C1719Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000549263	15	48755347	15	48463150	549263	539670	rs1555396769	NC_000015.10:48463149:C:T
NM_000138.4(FBN1):c.479G>A (p.Cys160Tyr)	FBN1	C160Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000549250	15	48888539	15	48596342	549250	539928	rs1555404810	NC_000015.10:48596341:C:T
NM_000138.4(FBN1):c.4286G>A (p.Cys1429Tyr)	FBN1	C1429Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000549216	15	48764798	15	48472601	549216	539711	rs1555397545	NC_000015.10:48472600:C:T
NM_000138.4(FBN1):c.4016G>A (p.Cys1339Tyr)	FBN1	C1339Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000549200	15	48766796	15	48474599	549200	539723	rs397515798	NC_000015.10:48474598:C:T
NM_000138.4(FBN1):c.3302A>G (p.Tyr1101Cys)	FBN1	Y1101C	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000549154	15	48780345	15	48488148	549154	539767	rs1555398625	NC_000015.10:48488147:T:C
NM_000138.4(FBN1):c.1510T>C (p.Cys504Arg)	FBN1	C504R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000549020	15	48805824	15	48513627	549020	539884	rs1555400288	NC_000015.10:48513626:A:G
NM_000138.4(FBN1):c.4988G>T (p.Cys1663Phe)	FBN1	C1663F	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547325	15	48756173	15	48463976	547325	538055	rs1555396853	NC_000015.10:48463975:C:A
NM_000138.4(FBN1):c.6695G>A (p.Cys2232Tyr)	FBN1	C2232Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000406315	15	48725107	15	48432910	406315	400627	rs1060501054	NC_000015.10:48432909:C:T
NM_000138.4(FBN1):c.5627G>A (p.Cys1876Tyr)	FBN1	C1876Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000406296	15	48741009	15	48448812	406296	400648	rs112728248	NC_000015.10:48448811:C:T
NM_000138.4(FBN1):c.6739+1G>A	FBN1		Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000222618	15	48725062	15	48432865	222618	224489	rs869025419	NC_000015.10:48432864:C:T
NM_000138.4(FBN1):c.7165_7166CT[1] (p.Cys2390fs)	FBN1		Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|not provided|Marfan syndrome	Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000042420	15	48719800 - 48719801	15	48427603 - 48427604	42420	51590	rs397515846	NC_000015.10:48427602:AGAG:AG
NM_000138.5(FBN1):c.2495G>A (p.Cys832Tyr)	FBN1	C832Y	Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042311	15	48787710	15	48495513	42311	51481	rs397515775	NC_000015.10:48495512:C:T
NM_000138.4(FBN1):c.3193del (p.Glu1065fs)	FBN1	E1065fs	Thoracic aortic aneurysm and aortic dissection|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036064	15	48780580	15	48488383	36064	44728	rs193922198	NC_000015.10:48488382:C:
NM_001018005.2(TPM1):c.574G>A (p.Glu192Lys)	TPM1	E192K, E156K, E234K	Familial hypertrophic cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Left ventricular noncompaction 9	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031882	15	63353922	15	63061723	31882	40542	rs199476315	NC_000015.10:63061722:G:A
NM_001042492.3(NF1):c.6704+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000856149	17	29664899	17	31337881	856149	852730		NC_000017.11:31337880:G:C
NM_000267.3(NF1):c.5941C>T (p.Gln1981Ter)	NF1	Q2002*, Q1981*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000578868	17	29662047	17	31335029	578868	574420	rs1567615941	NC_000017.11:31335028:C:T
NM_000267.3(NF1):c.2266C>T (p.Gln756Ter)	NF1	Q756*	Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Caf-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal	Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000576444	17	29554250	17	31227232	576444	570918	rs1567847905	NC_000017.11:31227231:C:T
NM_000267.3(NF1):c.288+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000571198	17	29486112	17	31159094	571198	568760	rs1567816131	NC_000017.11:31159093:G:T
NM_000267.3(NF1):c.3870+1G>T	NF1		Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Caf-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000565498	17	29562791	17	31235773	565498	574403	rs1131691075	NC_000017.11:31235772:G:T
NM_000267.3(NF1):c.2850G>A (p.Gln950=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000561684	17	29556483	17	31229465	561684	552930	rs863224446	NC_000017.11:31229464:G:A
NM_000267.3(NF1):c.2325+2T>C	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000561504	17	29554311	17	31227293	561504	552923	rs1567847972	NC_000017.11:31227292:T:C
NM_000267.3(NF1):c.233del (p.Asn78fs)	NF1	N78fs	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000545744	17	29486050	17	31159032	545744	536486	rs1438566555	NC_000017.11:31159031:AAAAAAA:AAAAAA
NM_000267.3(NF1):c.1527+1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503701	17	29541604	17	31214586	503701	495835	rs1060500331	NC_000017.11:31214585:G:A
NM_000267.3(NF1):c.730+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503700	17	29508804	17	31181786	503700	495833	rs1060500274	NC_000017.11:31181785:G:A
NM_000267.3(NF1):c.889-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000492875	17	29527439	17	31200421	492875	485767	rs587781517	NC_000017.11:31200420:G:C
NM_000267.3(NF1):c.484C>T (p.Gln162Ter)	NF1	Q162*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481882	17	29496913	17	31169895	481882	478065	rs1555607073	NC_000017.11:31169894:C:T
NM_000267.3(NF1):c.2326-2A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480183	17	29554539	17	31227521	480183	478174	rs1555613975	NC_000017.11:31227520:A:G
NM_000267.3(NF1):c.4661+1G>A	NF1		Neurofibromatosis, type 1|Neurofibromas|Dilatation|not specified	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457713	17	29588876	17	31261858	457713	467795	rs1555619056	NC_000017.11:31261857:G:A
NM_000267.3(NF1):c.4110+1G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457679	17	29576138	17	31249120	457679	466602	rs1555617383	NC_000017.11:31249119:G:A
NM_000267.3(NF1):c.3447G>T (p.Met1149Ile)	NF1	M1149I	Neurofibromatosis, type 1|Caf-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457650	17	29559850	17	31232832	457650	466548	rs1064794277	NC_000017.11:31232831:G:T
NM_000267.3(NF1):c.6399dup (p.Glu2134fs)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431673	17	29664419 - 29664420	17	31337401 - 31337402	431673	425178	rs1135402888	NC_000017.11:31337401:A:AA
NM_000267.3(NF1):c.503C>G (p.Ser168Ter)	NF1	S168*	Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudoarthrosis|not provided	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000430497	17	29496932	17	31169914	430497	422155	rs1131691994	NC_000017.11:31169913:C:G
NM_000267.3(NF1):c.2125T>C (p.Cys709Arg)	NF1	C709R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428974	17	29553576	17	31226558	428974	420783	rs1131691095	NC_000017.11:31226557:T:C
NM_000267.3(NF1):c.6907C>T (p.Gln2303Ter)	NF1	Q2303*, Q2324*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Caf-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428948	17	29667571	17	31340553	428948	420826	rs1131691073	NC_000017.11:31340552:C:T
NM_000267.3(NF1):c.7994_7995AG[1] (p.Ser2666fs)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404618	17	29685584 - 29685585	17	31358566 - 31358567	404618	402548	rs1060500387	NC_000017.11:31358565:AGAG:AG
NM_000267.3(NF1):c.6579+1G>T	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404558	17	29664601	17	31337583	404558	402348	rs1060500345	NC_000017.11:31337582:G:T
NM_000267.3(NF1):c.5206-1G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000233026	17	29654516	17	31327498	233026	235732	rs876660141	NC_000017.11:31327497:G:A
NM_000267.3(NF1):c.5844_5845del (p.Arg1949fs)	NF1	R1949fs, R1970fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216865	17	29661949 - 29661950	17	31334931 - 31334932	216865	213287	rs863224835	NC_000017.11:31334930:AAA:A
NM_000267.3(NF1):c.3113+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000216062	17	29557401	17	31230383	216062	213264	rs267606599	NC_000017.11:31230382:G:T
NM_000267.3(NF1):c.2693T>C (p.Leu898Pro)	NF1	L898P	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068326	17	29556326	17	31229308	68326	79217	rs199474786	NC_000017.11:31229307:T:C
NM_000257.4(MYH7):c.1954A>G (p.Arg652Gly)	MYH7	R652G	not provided|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000177626	14	23896451	14	23427242	177626	175632	rs727504239	NC_000014.9:23427241:T:C
NM_014249.4(NR2E3):c.119-2A>C	NR2E3		Enhanced s-cone syndrome|Retinitis pigmentosa 37|NR2E3-Related Disorders|not specified|Retinitis pigmentosa 37|Enhanced s-cone syndrome|not provided|Retinal dystrophy|Retinitis pigmentosa|Cone-rod dystrophy|Retinal dystrophy|Visual impairment|Abnormality of color vision|Horizontal nystagmus	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000191059	15	72103821	15	71811481	191059	188865	rs2723341	NC_000015.10:71811480:A:C
NM_004004.6(GJB2):c.299_300del (p.His100fs)	GJB2	H100fs	Deafness, autosomal recessive 1A|not specified|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044736	13	20763421 - 20763422	13	20189282 - 20189283	44736	53903	rs111033204	NC_000013.11:20189281:AT:
NM_000267.3(NF1):c.989C>T (p.Ala330Val)	NF1	A330V	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547578	17	29527540	17	31200522	547578	538115	rs1555610898	NC_000017.11:31200521:C:T
NM_000267.3(NF1):c.2325+1G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified|not provided	Pathogenic(Last reviewed: Sep 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000546100	17	29554310	17	31227292	546100	536933	rs1555613933	NC_000017.11:31227291:G:A
NM_000267.3(NF1):c.6579+1G>A	NF1		not provided|Neurofibromatosis, type 1|Cafe-au-lait spot	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523343	17	29664601	17	31337583	523343	514080	rs1060500345	NC_000017.11:31337582:G:A
NM_000267.3(NF1):c.4606dup (p.Thr1536fs)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503769	17	29588819 - 29588820	17	31261801 - 31261802	503769	495672	rs1555619033	NC_000017.11:31261801:A:AA
NM_000267.3(NF1):c.2002-1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488815	17	29553452	17	31226434	488815	482123	rs1555613743	NC_000017.11:31226433:G:A
NM_000267.3(NF1):c.4111-2A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481997	17	29585360	17	31258342	481997	478184	rs1555618489	NC_000017.11:31258341:A:G
NM_000267.3(NF1):c.1185+2T>G	NF1		Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439976	17	29528179	17	31201161	439976	433243	rs1555611043	NC_000017.11:31201160:T:G
NM_000267.3(NF1):c.1658A>G (p.His553Arg)	NF1	H553R	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420076	17	29548884	17	31221866	420076	409863	rs1064794274	NC_000017.11:31221865:A:G
NM_000267.3(NF1):c.2531T>G (p.Leu844Arg)	NF1	L844R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000373	17	29556164	17	31229146	373	15412	rs137854566	NC_000017.11:31229145:T:G
NM_014363.6(SACS):c.1706G>A (p.Trp569Ter)	SACS	W569*, W422*	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 17, 2015)	criteria provided, single submitter	VCV000520634	13	23929045	13	23354906	520634	512062	rs1555254256	NC_000013.11:23354905:C:T
NM_000053.4(ATP7B):c.3955C>T (p.Arg1319Ter)	ATP7B	R1319*, R1112*, R1208*, R1235*, R1241*	not provided|Wilson disease	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035728	13	52511478	13	51937342	35728	44392	rs193922109	NC_000013.11:51937341:G:A
NM_000053.4(ATP7B):c.2305A>G (p.Met769Val)	ATP7B	M769V, M685V, M658V	Wilson disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035706	13	52532497	13	51958361	35706	44370	rs193922103	NC_000013.11:51958360:T:C
NM_144997.7(FLCN):c.1285dup (p.His429fs)	FLCN		Hereditary cancer-predisposing syndrome|not provided|Pneumothorax, primary spontaneous|Multiple fibrofolliculomas|not specified	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003363	17	17119708 - 17119709	17	17216394 - 17216395	3363	18402	rs80338682	NC_000017.11:17216394:GGGGGGGG:GGGGGGGGG
NM_000057.4(BLM):c.1544dup (p.Asn515fs)	BLM		Bloom syndrome|Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042064	15	91304138 - 91304139	15	90760908 - 90760909	42064	51230	rs367543043	NC_000015.10:90760908:AAAAAAAAA:AAAAAAAAAA
NM_000138.5(FBN1):c.503G>A (p.Cys168Tyr)	FBN1	C168Y	not specified|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: May 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000812041	15	48888515	15	48596318	812041	799811		NC_000015.10:48596317:C:T
NM_000138.4(FBN1):c.5666G>T (p.Cys1889Phe)	FBN1	C1889F	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000576709	15	48740970	15	48448773	576709	569481	rs1566899500	NC_000015.10:48448772:C:A
NM_000138.4(FBN1):c.4348T>C (p.Cys1450Arg)	FBN1	C1450R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000576549	15	48762942	15	48470745	576549	568947	rs1555397421	NC_000015.10:48470744:A:G
NM_000138.4(FBN1):c.5801G>C (p.Cys1934Ser)	FBN1	C1934S	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000565697	15	48737689	15	48445492	565697	569473	rs794728240	NC_000015.10:48445491:C:G
NM_000138.4(FBN1):c.5503T>A (p.Cys1835Ser)	FBN1	C1835S	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000549282	15	48744801	15	48452604	549282	539654	rs1555396198	NC_000015.10:48452603:A:T
NM_000138.4(FBN1):c.3959G>C (p.Cys1320Ser)	FBN1	C1320S	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000549196	15	48773857	15	48481660	549196	539727	rs113393517	NC_000015.10:48481659:C:G
NM_000138.4(FBN1):c.3202T>C (p.Cys1068Arg)	FBN1	C1068R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Mar 31, 2019)	criteria provided, single submitter	VCV000549137	15	48780571	15	48488374	549137	539783	rs1293095681	NC_000015.10:48488373:A:G
NM_000138.4(FBN1):c.1849T>C (p.Cys617Arg)	FBN1	C617R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000549054	15	48797333	15	48505136	549054	539853	rs1060501017	NC_000015.10:48505135:A:G
NM_000138.4(FBN1):c.1463G>A (p.Cys488Tyr)	FBN1	C488Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000549017	15	48807589	15	48515392	549017	539887	rs1555400372	NC_000015.10:48515391:C:T
NM_000138.4(FBN1):c.4205G>A (p.Cys1402Tyr)	FBN1	C1402Y	Cardiovascular phenotype|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519799	15	48766457	15	48474260	519799	510591	rs1555397646	NC_000015.10:48474259:C:T
NM_000138.4(FBN1):c.2248T>C (p.Cys750Arg)	FBN1	C750R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000492826	15	48789508	15	48497311	492826	485761	rs1555399368	NC_000015.10:48497310:A:G
NM_000138.4(FBN1):c.5993G>A (p.Cys1998Tyr)	FBN1	C1998Y	not provided|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426268	15	48736782	15	48444585	426268	415427	rs1085307531	NC_000015.10:48444584:C:T
NM_000138.4(FBN1):c.1670G>A (p.Cys557Tyr)	FBN1	C557Y	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000381611	15	48802285	15	48510088	381611	373562	rs1057521102	NC_000015.10:48510087:C:T
NM_000138.4(FBN1):c.7769G>A (p.Cys2590Tyr)	FBN1	C2590Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000222614	15	48712934	15	48420737	222614	224481	rs869025416	NC_000015.10:48420736:C:T
NM_000138.4(FBN1):c.6453C>T (p.Cys2151=)	FBN1		not provided|Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000200193	15	48729201	15	48437004	200193	197641	rs794728251	NC_000015.10:48437003:G:A
NM_000138.4(FBN1):c.6425G>A (p.Cys2142Tyr)	FBN1	C2142Y	Marfan syndrome|not provided|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200192	15	48729229	15	48437032	200192	197645	rs794728335	NC_000015.10:48437031:C:T
NM_000138.4(FBN1):c.4453T>C (p.Cys1485Arg)	FBN1	C1485R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000180354	15	48762837	15	48470640	180354	178694	rs730880101	NC_000015.10:48470639:A:G
NM_000138.5(FBN1):c.493C>T (p.Arg165Ter)	FBN1	R165*	not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042373	15	48888525	15	48596328	42373	51543	rs113905529	NC_000015.10:48596327:G:A
NM_001376.5(DYNC1H1):c.3278T>C (p.Phe1093Ser)	DYNC1H1	F1093S	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449962	14	102461131	14	101994794	449962	445168	rs1555408829	NC_000014.9:101994793:T:C
NM_001134407.3(GRIN2A):c.96dup (p.Ala33fs)	GRIN2A		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000522057	16	10274172 - 10274173	16	10180315 - 10180316	522057	512175	rs1555491538	NC_000016.10:10180315:GGGGGG:GGGGGGG
NM_000267.3(NF1):c.2970_2971del (p.Met991fs)	NF1	M991fs	Juvenile myelomonocytic leukemia|Cafe-au-lait spot|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000663010	17	29556972 - 29556973	17	31229954 - 31229955	663010	645561		NC_000017.11:31229953:AA:
NM_000267.3(NF1):c.3974+1G>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000571920	17	29563040	17	31236022	571920	570971	rs1567852849	NC_000017.11:31236021:G:C
NM_000267.3(NF1):c.5547-1G>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000561746	17	29657313	17	31330295	561746	552971	rs1567613569	NC_000017.11:31330294:G:C
NM_000267.3(NF1):c.4270-2A>G	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449427	17	29586048	17	31259030	449427	445742	rs1555618634	NC_000017.11:31259029:A:G
NM_000267.3(NF1):c.2409+1G>T	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449423	17	29554625	17	31227607	449423	445735	rs1555614022	NC_000017.11:31227606:G:T
NM_000267.3(NF1):c.889-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431574	17	29527439	17	31200421	431574	425079	rs587781517	NC_000017.11:31200420:G:A
NM_000267.3(NF1):c.2252-2A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428984	17	29554234	17	31227216	428984	420784	rs1131691105	NC_000017.11:31227215:A:G
NM_000267.3(NF1):c.1260+1604A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428941	17	29530107	17	31203089	428941	420770	rs1131691067	NC_000017.11:31203088:A:G
NM_000267.3(NF1):c.7267dup (p.Thr2423fs)	NF1		not provided|not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420081	17	29677208 - 29677209	17	31350190 - 31350191	420081	409883	rs1064794278	NC_000017.11:31350190:A:AA
NM_000267.3(NF1):c.3447G>A (p.Met1149Ile)	NF1	M1149I	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420079	17	29559850	17	31232832	420079	409869	rs1064794277	NC_000017.11:31232831:G:A
NM_000267.3(NF1):c.2991-1G>A	NF1		not specified|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404458	17	29557277	17	31230259	404458	401699	rs1060500273	NC_000017.11:31230258:G:A
NM_000267.3(NF1):c.4306A>G (p.Lys1436Glu)	NF1	K1436E, K1457E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237563	17	29586086	17	31259068	237563	242681	rs878853893	NC_000017.11:31259067:A:G
NM_000267.3(NF1):c.1185+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219572	17	29528178	17	31201160	219572	222572	rs864622161	NC_000017.11:31201159:G:A
NM_000267.3(NF1):c.4269+2T>C	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188306	17	29585522	17	31258504	188306	186252	rs786204207	NC_000017.11:31258503:T:C
NM_000267.3(NF1):c.4168C>T (p.Leu1390Phe)	NF1	L1390F, L1411F	Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030992	17	29585419	17	31258401	30992	39949	rs199474789	NC_000017.11:31258400:C:T
NM_001005242.2(PKP2):c.2065_2070delinsG (p.His689fs)	PKP2		Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|not provided|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000045063	12	32955434 - 32955439	12	32802500 - 32802505	45063	54230	rs397517021	NC_000012.12:32802499:GGTGTG:C
NM_000138.4(FBN1):c.386G>A (p.Cys129Tyr)	FBN1	C129Y	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000574616	15	48892392	15	48600195	574616	573402	rs1566935517	NC_000015.10:48600194:C:T
NM_000138.4(FBN1):c.4292G>A (p.Cys1431Tyr)	FBN1	C1431Y	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000549219	15	48764792	15	48472595	549219	539708	rs1555397540	NC_000015.10:48472594:C:T
NM_000138.4(FBN1):c.2051G>T (p.Cys684Phe)	FBN1	C684F	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547301	15	48796046	15	48503849	547301	538079	rs1555399763	NC_000015.10:48503848:C:A
NM_000138.4(FBN1):c.2777G>A (p.Cys926Tyr)	FBN1	C926Y	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000527216	15	48784735	15	48492538	527216	529359	rs1555398989	NC_000015.10:48492537:C:T
NM_000138.4(FBN1):c.6610T>C (p.Cys2204Arg)	FBN1	C2204R	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527154	15	48726797	15	48434600	527154	529438	rs1555395001	NC_000015.10:48434599:A:G
NM_000138.4(FBN1):c.3977G>A (p.Cys1326Tyr)	FBN1	C1326Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432123	15	48766835	15	48474638	432123	426109	rs1555397738	NC_000015.10:48474637:C:T
NM_000138.4(FBN1):c.8525_8529del (p.Leu2842fs)	FBN1	L2842fs	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided|Marfan syndrome	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419823	15	48703274 - 48703278	15	48411077 - 48411081	419823	409254	rs1064794130	NC_000015.10:48411076:GTTAAGTT:GTT
NM_000138.4(FBN1):c.2722T>C (p.Cys908Arg)	FBN1	C908R	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000406271	15	48786407	15	48494210	406271	401013	rs1060501021	NC_000015.10:48494209:A:G
NM_000138.4(FBN1):c.5372G>A (p.Cys1791Tyr)	FBN1	C1791Y	Cardiovascular phenotype|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000263568	15	48748884	15	48456687	263568	258859	rs886038848	NC_000015.10:48456686:C:T
NM_000138.4(FBN1):c.2638G>A (p.Gly880Ser)	FBN1	G880S	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200000	15	48787359	15	48495162	200000	197756	rs794728194	NC_000015.10:48495161:C:T
NM_000138.4(FBN1):c.1759T>G (p.Cys587Gly)	FBN1	C587G	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000199978	15	48800857	15	48508660	199978	197786	rs1555399968	NC_000015.10:48508659:A:C
NM_000138.5(FBN1):c.2489G>C (p.Cys830Ser)	FBN1	C830S	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042310	15	48787716	15	48495519	42310	51480	rs397515774	NC_000015.10:48495518:C:G
NM_000267.3(NF1):c.3445A>G (p.Met1149Val)	NF1	M1149V	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527517	17	29559848	17	31232830	527517	530962	rs1187097568	NC_000017.11:31232829:A:G
NM_000267.3(NF1):c.2409+1G>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000484037	17	29554625	17	31227607	484037	478205	rs1555614022	NC_000017.11:31227606:G:C
NM_000267.3(NF1):c.4514+1G>A	NF1		Neurofibromatosis, type 1|not provided|Optic nerve glioma|Midaortic syndrome|not specified	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000439997	17	29587534	17	31260516	439997	433256	rs1279529138	NC_000017.11:31260515:G:A
NM_000267.3(NF1):c.4914_4917del	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426127	17	29652976 - 29652979	17	31325958 - 31325961	426127	415548	rs1085307459	NC_000017.11:31325957:TCTCTCT:TCT
NM_000267.3(NF1):c.801G>A (p.Trp267Ter)	NF1	W267*	Hereditary cancer-predisposing syndrome|not provided|not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420075	17	29509596	17	31182578	420075	409860	rs1064794273	NC_000017.11:31182577:G:A
NM_000267.3(NF1):c.6641+1G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404599	17	29664899	17	31337881	404599	402353	rs1060500376	NC_000017.11:31337880:G:A
NM_000267.3(NF1):c.2709G>A (p.Val903=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000373958	17	29556342	17	31229324	373958	361012	rs771820789	NC_000017.11:31229323:G:A
NM_000267.3(NF1):c.5928G>A (p.Trp1976Ter)	NF1	W1976*, W1997*	Neurofibromatosis, familial spinal|Caf-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000233869	17	29662034	17	31335016	233869	235758	rs876660696	NC_000017.11:31335015:G:A
NM_000267.3(NF1):c.3975-2A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220232	17	29576000	17	31248982	220232	222596	rs864622431	NC_000017.11:31248981:A:G
NM_000267.3(NF1):c.2288T>G (p.Leu763Arg)	NF1	L763R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216396	17	29554272	17	31227254	216396	213257	rs199474762	NC_000017.11:31227253:T:G
NM_000267.3(NF1):c.4268A>G (p.Lys1423Arg)	NF1	K1423R, K1444R	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000068344	17	29585519	17	31258501	68344	79235	rs199474781	NC_000017.11:31258500:A:G
NM_000267.3(NF1):c.2543G>A (p.Gly848Glu)	NF1	G848E	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068324	17	29556176	17	31229158	68324	79215	rs199474748	NC_000017.11:31229157:G:A
NM_000303.3(PMM2):c.710C>T (p.Thr237Met)	PMM2	T237M	not provided|Congenital disorder of glycosylation, type Ia|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021145	16	8941651	16	8847794	21145	33997	rs80338708	NC_000016.10:8847793:C:T
NM_000257.4(MYH7):c.1491G>T (p.Glu497Asp)	MYH7	E497D	Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014124	14	23897796	14	23428587	14124	29163	rs267606911	NC_000014.9:23428586:C:A
NM_001005242.2(PKP2):c.2377del (p.Ser793fs)	PKP2	S793fs, S837fs	Ventricular tachycardia|Arrhythmogenic right ventricular cardiomyopathy, type 9|Cardiovascular phenotype|not provided|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177995	12	32945646	12	32792712	177995	175861	rs727504432	NC_000012.12:32792711:TT:T
NM_000138.4(FBN1):c.2369G>A (p.Cys790Tyr)	FBN1	C790Y	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000549076	15	48788347	15	48496150	549076	539836	rs193922188	NC_000015.10:48496149:C:T
NM_000138.4(FBN1):c.2342G>A (p.Cys781Tyr)	FBN1	C781Y	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000527217	15	48788374	15	48496177	527217	528983	rs1555399271	NC_000015.10:48496176:C:T
NM_000138.4(FBN1):c.400T>C (p.Cys134Arg)	FBN1	C134R	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000527141	15	48892378	15	48600181	527141	529016	rs1555405044	NC_000015.10:48600180:A:G
NM_000138.4(FBN1):c.401G>A (p.Cys134Tyr)	FBN1	C134Y	Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495602	15	48892377	15	48600180	495602	487628	rs1555405043	NC_000015.10:48600179:C:T
NM_000138.4(FBN1):c.6049T>C (p.Cys2017Arg)	FBN1	C2017R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457240	15	48734032	15	48441835	457240	464340	rs1555395486	NC_000015.10:48441834:A:G
NM_000138.4(FBN1):c.7708G>A (p.Glu2570Lys)	FBN1	E2570K	not provided|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000263398	15	48712995	15	48420798	263398	258830	rs886038786	NC_000015.10:48420797:C:T
NM_000138.4(FBN1):c.6169C>T (p.Arg2057Ter)	FBN1	R2057*	Cardiovascular phenotype|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200076	15	48730109	15	48437912	200076	197655	rs763091520	NC_000015.10:48437911:G:A
NM_001042492.3(NF1):c.6704+1G>T	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547680	17	29664899	17	31337881	547680	538217	rs1060500376	NC_000017.11:31337880:G:T
NM_000267.3(NF1):c.5943+1G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Caf-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488817	17	29662050	17	31335032	488817	482128	rs1555534433	NC_000017.11:31335031:G:A
NM_000267.3(NF1):c.2953C>T (p.Gln985Ter)	NF1	Q985*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457608	17	29556955	17	31229937	457608	467482	rs1555614455	NC_000017.11:31229936:C:T
NM_000267.3(NF1):c.6084+1G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404489	17	29663492	17	31336474	404489	401837	rs1060500296	NC_000017.11:31336473:G:A
NM_000267.3(NF1):c.6841C>T (p.Gln2281Ter)	NF1	Q2281*, Q2302*	Hereditary cancer-predisposing syndrome|Multiple cafe-au-lait spots|Subcutaneous neurofibromas|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000373973	17	29665806	17	31338788	373973	361014	rs1057518807	NC_000017.11:31338787:C:T
NM_000267.3(NF1):c.5791T>C (p.Trp1931Arg)	NF1	W1931R, W1952R	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068357	17	29661897	17	31334879	68357	79248	rs199474791	NC_000017.11:31334878:T:C
NM_000267.3(NF1):c.3610C>T (p.Arg1204Trp)	NF1	R1204W	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068338	17	29560133	17	31233115	68338	79229	rs199474732	NC_000017.11:31233114:C:T
NM_000432.4(MYL2):c.173G>A (p.Arg58Gln)	MYL2	R58Q	not provided|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014067	12	111352091	12	110914287	14067	29106	rs104894369	NC_000012.12:110914286:C:T
NM_000151.4(G6PC):c.247C>T (p.Arg83Cys)	G6PC	R83C	Glycogen storage disease|Hypoglycemia|Short stature|not provided|Glycogen storage disease due to glucose-6-phosphatase deficiency type IA	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011998	17	41055964	17	42903947	11998	27037	rs1801175	NC_000017.11:42903946:C:T
NM_004004.6(GJB2):c.35G>T (p.Gly12Val)	GJB2	G12V	not provided|Rare genetic deafness|Deafness, autosomal dominant 3a|Hearing impairment|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021387	13	20763686	13	20189547	21387	34239	rs1801002	NC_000013.11:20189546:C:A
NM_002834.5(PTPN11):c.182A>G (p.Asp61Gly)	PTPN11	D61G, D60G	Noonan syndrome|Juvenile myelomonocytic leukemia|Noonan syndrome|Noonan syndrome 1|not provided|Rasopathy|Short stature|Abnormality of cardiovascular system morphology	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013330	12	112888166	12	112450362	13330	28369	rs121918461	NC_000012.12:112450361:A:G
NM_000257.4(MYH7):c.4135G>A (p.Ala1379Thr)	MYH7	A1379T	Familial hypertrophic cardiomyopathy 1|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042993	14	23887453	14	23418244	42993	52163	rs397516202	NC_000014.9:23418243:C:T
NM_001005242.3(PKP2):c.235C>T (p.Arg79Ter)	PKP2	R79*	Arrhythmogenic right ventricular cardiomyopathy, type 9|Cardiovascular phenotype|not provided|Arrhythmogenic right ventricular cardiomyopathy|Cardiac arrhythmia	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006754	12	33031955	12	32879021	6754	21793	rs121434420	NC_000012.12:32879020:G:A
NM_000053.4(ATP7B):c.3402del (p.Ala1135fs)	ATP7B	A1057fs, A1135fs, A1024fs, A1051fs, A928fs	not provided|Wilson disease	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000088958	13	52516532	13	51942396	88958	94515	rs137853281	NC_000013.11:51942395:GGG:GG
NM_000267.3(NF1):c.2540T>G (p.Leu847Arg)	NF1	L847R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000573019	17	29556173	17	31229155	573019	571033	rs199474747	NC_000017.11:31229154:T:G
NM_000267.3(NF1):c.2674del (p.Ser892fs)	NF1	S892fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided|not specified	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481923	17	29556307	17	31229289	481923	478216	rs1555614296	NC_000017.11:31229288:A:
NM_000267.3(NF1):c.1721G>A (p.Ser574Asn)	NF1	S574N, R574K	Multiple cafe-au-lait spots|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431976	17	29548947	17	31221929	431976	426213	rs1555613206	NC_000017.11:31221928:G:A
NM_000267.3(NF1):c.1246C>T (p.Arg416Ter)	NF1	R416*	not specified|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Nov 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404597	17	29528489	17	31201471	404597	402141	rs764079291	NC_000017.11:31201470:C:T
NM_000267.3(NF1):c.204+1G>A	NF1		not specified|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265442	17	29483145	17	31156127	265442	260163	rs886039548	NC_000017.11:31156126:G:A
NM_000267.3(NF1):c.4402A>G (p.Ser1468Gly)	NF1	S1468G, S1489G	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068351	17	29587421	17	31260403	68351	79242	rs199474743	NC_000017.11:31260402:A:G
NM_000267.3(NF1):c.1748A>G (p.Lys583Arg)	NF1	K583R	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068306	17	29550488	17	31223470	68306	79197	rs199474760	NC_000017.11:31223469:A:G
NM_014363.6(SACS):c.11707C>T (p.Arg3903Ter)	SACS	R3903*, R3756*	Inborn genetic diseases|Spastic paraplegia	Pathogenic(Last reviewed: May 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000411691	13	23906308	13	23332169	411691	399614	rs774906736	NC_000013.11:23332168:G:A
NM_000138.4(FBN1):c.266G>A (p.Cys89Tyr)	FBN1	C89Y	Marfan syndrome|Cardiovascular phenotype|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000200141	15	48903005	15	48610808	200141	197823	rs112660651	NC_000015.10:48610807:C:T
NM_000138.4(FBN1):c.4096G>A (p.Glu1366Lys)	FBN1	E1366K	Marfan syndrome|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|not provided|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000200036	15	48766566	15	48474369	200036	197710	rs763449629	NC_000015.10:48474368:C:T
NM_000138.4(FBN1):c.3463G>A (p.Asp1155Asn)	FBN1	D1155N	not provided|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200017	15	48779509	15	48487312	200017	197731	rs794728204	NC_000015.10:48487311:C:T
NM_000138.4(FBN1):c.2306G>A (p.Cys769Tyr)	FBN1	C769Y	Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000199995	15	48788410	15	48496213	199995	197765	rs794728190	NC_000015.10:48496212:C:T
NM_000138.4(FBN1):c.1285C>T (p.Arg429Ter)	FBN1	R429*	not provided|Cardiovascular phenotype|Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000180351	15	48808422	15	48516225	180351	178700	rs112645512	NC_000015.10:48516224:G:A
NM_000138.5(FBN1):c.643C>T (p.Arg215Ter)	FBN1	R215*	not specified|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000042401	15	48829901	15	48537704	42401	51571	rs111687884	NC_000015.10:48537703:G:A
NM_000138.4(FBN1):c.6431A>G (p.Asn2144Ser)	FBN1	N2144S	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016431	15	48729223	15	48437026	16431	31470	rs137854461	NC_000015.10:48437025:T:C
NM_000057.4(BLM):c.1642C>T (p.Gln548Ter)	BLM	Q548*, Q173*	Bloom syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127478	15	91304245	15	90761015	127478	132935	rs200389141	NC_000015.10:90761014:C:T
NM_000303.3(PMM2):c.722G>C (p.Cys241Ser)	PMM2	C241S	Congenital disorder of glycosylation, type Ia|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007717	16	8941663	16	8847806	7717	22756	rs80338709	NC_000016.10:8847805:G:C
NM_004004.6(GJB2):c.313_326del (p.Lys105fs)	GJB2	K105fs	not specified|Deafness, autosomal recessive 1A|Rare genetic deafness|Hearing impairment|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Hearing loss|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044737	13	20763395 - 20763408	13	20189256 - 20189269	44737	53904	rs111033253	NC_000013.11:20189255:CCCTTGATGAACTTCC:CC
NM_000070.3(CAPN3):c.1468C>T (p.Arg490Trp)	CAPN3	R490W, R442W	not provided|Limb-girdle muscular dystrophy, type 2A|Limb-girdle muscular dystrophy, type 2A|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000166790	15	42693952	15	42401754	166790	177281	rs141656719	NC_000015.10:42401753:C:T
NM_024685.4(BBS10):c.145C>T (p.Arg49Trp)	BBS10	R49W	Bardet-Biedl syndrome 10|Retinal dystrophy|Retinal dystrophy|Postaxial hand polydactyly|Foot polydactyly|Intellectual disability|High-frequency hearing impairment|Macular degeneration|Inborn genetic diseases|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225010	12	76741994	12	76348214	225010	226933	rs768933093	NC_000012.12:76348213:G:A
NM_000257.4(MYH7):c.1358G>A (p.Arg453His)	MYH7	R453H	Hypertrophic cardiomyopathy|not provided|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000042838	14	23898213	14	23429004	42838	52008	rs397516101	NC_000014.9:23429003:C:T
NM_000053.4(ATP7B):c.2930C>T (p.Thr977Met)	ATP7B	T977M, T899M, T866M, T770M, T893M	Wilson disease|not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000035710	13	52520550	13	51946414	35710	44374	rs72552255	NC_000013.11:51946413:G:A
NM_000267.3(NF1):c.3525_3526del (p.Arg1176fs)	NF1	R1176fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428971	17	29560048 - 29560049	17	31233030 - 31233031	428971	420797	rs1131691092	NC_000017.11:31233029:AA:
NM_001042492.3(NF1):c.2288T>C (p.Leu763Pro)	NF1	L763P	Hereditary cancer-predisposing syndrome|not provided|not specified|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068312	17	29554272	17	31227254	68312	79203	rs199474762	NC_000017.11:31227253:T:C
NM_000138.4(FBN1):c.5930G>A (p.Cys1977Tyr)	FBN1	C1977Y	Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000527152	15	48736845	15	48444648	527152	529300	rs1555395663	NC_000015.10:48444647:C:T
NM_000138.4(FBN1):c.7240C>T (p.Arg2414Ter)	FBN1	R2414*	Cardiovascular phenotype|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000519729	15	48718026	15	48425829	519729	510546	rs112550005	NC_000015.10:48425828:G:A
NM_000138.4(FBN1):c.6661T>C (p.Cys2221Arg)	FBN1	C2221R	not provided|Geleophysic dysplasia 2|Acromicric dysplasia|Weill-Marchesani syndrome 2|MASS syndrome|Marfan syndrome|Ectopia lentis, isolated, autosomal dominant|Stiff skin syndrome|Marfan lipodystrophy syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439708	15	48725141	15	48432944	439708	433558	rs113543334	NC_000015.10:48432943:A:G
NM_000138.4(FBN1):c.1426T>G (p.Cys476Gly)	FBN1	C476G	Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|not provided	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200179	15	48807626	15	48515429	200179	197799	rs794728326	NC_000015.10:48515428:A:C
NM_000138.5(FBN1):c.7180C>T (p.Arg2394Ter)	FBN1	R2394*	not provided|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042422	15	48719788	15	48427591	42422	51592	rs397515848	NC_000015.10:48427590:G:A
NM_000138.5(FBN1):c.4222T>C (p.Cys1408Arg)	FBN1	C1408R	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042351	15	48764862	15	48472665	42351	51521	rs397515802	NC_000015.10:48472664:A:G
NM_000138.5(FBN1):c.2055C>G (p.Cys685Trp)	FBN1	C685W	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036043	15	48796042	15	48503845	36043	44707	rs140603	NC_000015.10:48503844:G:C
NM_002834.5(PTPN11):c.184T>G (p.Tyr62Asp)	PTPN11	Y62D, Y61D	Patent ductus arteriosus|Secundum atrial septal defect|Tricuspid regurgitation|Failure to thrive|Dysplastic pulmonary valve|Right ventricular hypertrophy|Noonan syndrome|Juvenile myelomonocytic leukemia|Noonan syndrome|Noonan syndrome 1|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|not provided|Rasopathy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013329	12	112888168	12	112450364	13329	28368	rs121918460	NC_000012.12:112450363:T:G
NM_001042492.3(NF1):c.768del (p.Phe256fs)	NF1	F256fs	Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000827194	17	29509560	17	31182542	827194	813107		NC_000017.11:31182541:TTTT:TTT
NM_001128147.3(NF1):c.1017_1018CT[1] (p.Ser340fs)	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547579	17	29527568 - 29527569	17	31200550 - 31200551	547579	538116	rs1555610903	NC_000017.11:31200549:CTCT:CT
NM_000267.3(NF1):c.2542G>C (p.Gly848Arg)	NF1	G848R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404588	17	29556175	17	31229157	404588	402419	rs1060500368	NC_000017.11:31229156:G:C
NM_000267.3(NF1):c.3826C>G (p.Arg1276Gly)	NF1	R1276G	not provided|not specified|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068340	17	29562746	17	31235728	68340	79231	rs199474742	NC_000017.11:31235727:C:G
NM_000267.3(NF1):c.3610C>G (p.Arg1204Gly)	NF1	R1204G	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068337	17	29560133	17	31233115	68337	79228	rs199474732	NC_000017.11:31233114:C:G
NM_000267.3(NF1):c.2339C>A (p.Thr780Lys)	NF1	T780K	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068316	17	29554554	17	31227536	68316	79207	rs199474746	NC_000017.11:31227535:C:A
NM_000267.3(NF1):c.3827G>C (p.Arg1276Pro)	NF1	R1276P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000353	17	29562747	17	31235729	353	15392	rs137854556	NC_000017.11:31235728:G:C
NM_000257.4(MYH7):c.715G>A (p.Asp239Asn)	MYH7	D239N	MYH7-related late-onset scapuloperoneal muscular dystrophy|Congenital myopathy with fiber type disproportion|Myopathy, myosin storage, autosomal recessive|Dilated cardiomyopathy 1S|Myopathy, distal, 1|Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043100	14	23900811	14	23431602	43100	52270	rs397516264	NC_000014.9:23431601:C:T
NM_000257.4(MYH7):c.2167C>G (p.Arg723Gly)	MYH7	R723G	not provided|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000042885	14	23895023	14	23425814	42885	52055	rs121913630	NC_000014.9:23425813:G:C
NM_000257.4(MYH7):c.1063G>A (p.Ala355Thr)	MYH7	A355T	Cardiovascular phenotype|not provided|Cardiomyopathy|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000042820	14	23899059	14	23429850	42820	51990	rs397516088	NC_000014.9:23429849:C:T
NM_002834.5(PTPN11):c.1528C>G (p.Gln510Glu)	PTPN11	Q510E, Q514E, Q509E	Rasopathy|Noonan syndrome|Noonan syndrome with multiple lentigines|LEOPARD syndrome 1|not provided|Cardiovascular phenotype|Noonan syndrome 1|Noonan syndrome 3	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040566	12	112926908	12	112489104	40566	49036	rs397507549	NC_000012.12:112489103:C:G
NM_002834.5(PTPN11):c.215C>G (p.Ala72Gly)	PTPN11	A72G, A71G	Noonan syndrome|Noonan syndrome 1|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|Rasopathy|not provided|Noonan syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013325	12	112888199	12	112450395	13325	28364	rs121918454	NC_000012.12:112450394:C:G
NM_000057.4(BLM):c.2207_2212delinsTAGATTC (p.Tyr736fs)	BLM	Y735fs	Bloom syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005454	15	91310153 - 91310158	15	90766923 - 90766928	5454	20493	rs113993962	NC_000015.10:90766922:ATCTGA:TAGATTC
NM_000138.4(FBN1):c.2860C>T (p.Arg954Cys)	FBN1	R954C	not provided|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495582	15	48782270	15	48490073	495582	487591	rs1555398835	NC_000015.10:48490072:G:A
NM_000138.4(FBN1):c.6884G>A (p.Cys2295Tyr)	FBN1	C2295Y	Cardiovascular phenotype|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000263849	15	48720656	15	48428459	263849	258845	rs886038949	NC_000015.10:48428458:C:T
NM_000138.4(FBN1):c.8038C>T (p.Arg2680Cys)	FBN1	R2680C	not provided|Cardiovascular phenotype|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200127	15	48707746	15	48415549	200127	197585	rs794728283	NC_000015.10:48415548:G:A
NM_000138.4(FBN1):c.7916A>G (p.Tyr2639Cys)	FBN1	Y2639C	Cardiovascular phenotype|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Thoracic aortic aneurysm and aortic dissection|not provided|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000200123	15	48707868	15	48415671	200123	197590	rs794728280	NC_000015.10:48415670:T:C
NM_000138.5(FBN1):c.3164G>A (p.Cys1055Tyr)	FBN1	C1055Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042327	15	48780609	15	48488412	42327	51497	rs397515786	NC_000015.10:48488411:C:T
NM_003482.3(KMT2D):c.4485C>A (p.Tyr1495Ter)	KMT2D	Y1495*	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000521871	12	49440141	12	49046358	521871	512015	rs574622908	NC_000012.12:49046357:G:T
NM_003482.3(KMT2D):c.13986_13993dup (p.Leu4665fs)	KMT2D		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000521654	12	49424068 - 49424069	12	49030285 - 49030286	521654	512005	rs1555186842	NC_000012.12:49030285:GTGCCCTT:GTGCCCTTGTGCCCTT
NM_003482.3(KMT2D):c.4941del (p.Asp1648fs)	KMT2D	D1648fs	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000521326	12	49438549	12	49044766	521326	512014	rs1555194443	NC_000012.12:49044765:GG:G
NM_003482.3(KMT2D):c.13411_13412del (p.Asn4471fs)	KMT2D	N4471fs	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000521231	12	49425076 - 49425077	12	49031293 - 49031294	521231	512006	rs1555187440	NC_000012.12:49031292:TT:
NM_003482.3(KMT2D):c.11944C>T (p.Arg3982Ter)	KMT2D	R3982*	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	VCV000520944	12	49426544	12	49032761	520944	512009	rs1555188379	NC_000012.12:49032760:G:A
NM_003482.3(KMT2D):c.16336dup (p.Gln5446fs)	KMT2D		Inborn genetic diseases	Pathogenic(Last reviewed: Jul 22, 2015)	criteria provided, single submitter	VCV000520704	12	49416374 - 49416375	12	49022591 - 49022592	520704	512003	rs1555184787	NC_000012.12:49022591:G:GG
NM_003482.3(KMT2D):c.11547_11557dup (p.Val3853fs)	KMT2D		Inborn genetic diseases	Pathogenic(Last reviewed: May 21, 2015)	criteria provided, single submitter	VCV000520680	12	49426930 - 49426931	12	49033147 - 49033148	520680	512010	rs1555188623	NC_000012.12:49033147:CCAGCCTGTGTCC:CCAGCCTGTGTCCAGCCTGTGTCC
NM_004004.6(GJB2):c.355_357GAG[1] (p.Glu120del)	GJB2	E118del, E120del	Deafness, autosomal recessive 1A|not provided|Rare genetic deafness|Hearing impairment|Hearing loss	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017006	13	20763361 - 20763363	13	20189222 - 20189224	17006	32045	rs80338947	NC_000013.11:20189221:CTCCTC:CTC
NM_000267.3(NF1):c.6791dup (p.Tyr2264Ter)	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228382	17	29665755 - 29665756	17	31338737 - 31338738	228382	230771	rs876657715	NC_000017.11:31338737:A:AA
NM_000267.3(NF1):c.4666C>T (p.Gln1556Ter)	NF1	Q1556*, Q1577*	Inborn genetic diseases|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000208766	17	29592251	17	31265233	208766	205301	rs797044942	NC_000017.11:31265232:C:T
NM_000267.3(NF1):c.7285C>T (p.Arg2429Ter)	NF1	R2429*, R2450*	Neurofibromatosis, type 1|Lisch nodules|Subcutaneous neurofibromas|not specified|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185789	17	29677227	17	31350209	185789	184747	rs786202457	NC_000017.11:31350208:C:T
NM_000267.3(NF1):c.2530C>T (p.Leu844Phe)	NF1	L844F	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068321	17	29556163	17	31229145	68321	79212	rs199474785	NC_000017.11:31229144:C:T
NM_000267.3(NF1):c.5944-5A>G	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000359	17	29663346	17	31336328	359	15398	rs267606604	NC_000017.11:31336327:A:G
NM_000257.4(MYH7):c.2302G>A (p.Gly768Arg)	MYH7	G768R	Familial hypertrophic cardiomyopathy 1|Restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000164337	14	23894612	14	23425403	164337	175624	rs727503260	NC_000014.9:23425402:C:T
NM_000138.4(FBN1):c.1462T>C (p.Cys488Arg)	FBN1	C488R	Marfan syndrome|Ectopia lentis, isolated, autosomal dominant|MASS syndrome|Geleophysic dysplasia 2|Marfan syndrome|Acromicric dysplasia|Stiff skin syndrome|Weill-Marchesani syndrome 2|Marfan lipodystrophy syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457162	15	48807590	15	48515393	457162	465146	rs1555400373	NC_000015.10:48515392:A:G
NM_000138.4(FBN1):c.640G>A (p.Gly214Ser)	FBN1	G214S	Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000199956	15	48829904	15	48537707	199956	197817	rs794728162	NC_000015.10:48537706:C:T
NM_000138.5(FBN1):c.4567C>T (p.Arg1523Ter)	FBN1	R1523*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not provided|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042365	15	48760624	15	48468427	42365	51535	rs397515812	NC_000015.10:48468426:G:A
NM_000138.5(FBN1):c.4259G>A (p.Cys1420Tyr)	FBN1	C1420Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042354	15	48764825	15	48472628	42354	51524	rs397515804	NC_000015.10:48472627:C:T
NM_000138.5(FBN1):c.1546C>T (p.Arg516Ter)	FBN1	R516*	Marfan syndrome|not specified|not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042285	15	48805788	15	48513591	42285	51455	rs113812345	NC_000015.10:48513590:G:A
NM_000138.4(FBN1):c.8326C>T (p.Arg2776Ter)	FBN1	R2776*	Marfan syndrome|not provided|Cardiovascular phenotype|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016439	15	48703477	15	48411280	16439	31478	rs137854466	NC_000015.10:48411279:G:A
NM_001042492.3(NF1):c.204+1G>T	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449419	17	29483145	17	31156127	449419	445726	rs886039548	NC_000017.11:31156126:G:T
NM_000321.2(RB1):c.1981C>T (p.Arg661Trp)	RB1	R661W	Hereditary cancer-predisposing syndrome|not provided|Vulvar adenocarcinoma of mammary gland type|Osteosarcoma|Retinoblastoma|Bladder cancer, somatic|Small cell lung cancer|Retinoblastoma	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013087	13	49033844	13	48459708	13087	28126	rs137853294	NC_000013.11:48459707:C:T
NM_000138.4(FBN1):c.2243G>A (p.Cys748Tyr)	FBN1	C748Y	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420086	15	48789513	15	48497316	420086	409288	rs1064794282	NC_000015.10:48497315:C:T
NM_000138.5(FBN1):c.8080C>T (p.Arg2694Ter)	FBN1	R2694*	not specified|Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided	Pathogenic(Last reviewed: Aug 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000163461	15	48704912	15	48412715	163461	176122	rs200309328	NC_000015.10:48412714:G:A
NM_000138.4(FBN1):c.7726C>T (p.Arg2576Cys)	FBN1	R2576C	Marfan syndrome, autosomal recessive|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not provided	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036118	15	48712977	15	48420780	36118	44782	rs147195031	NC_000015.10:48420779:G:A
NM_000138.4(FBN1):c.7339G>A (p.Glu2447Lys)	FBN1	E2447K	Connective tissue disease|not provided|Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Ectopia lentis, isolated, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016437	15	48717680	15	48425483	16437	31476	rs137854464	NC_000015.10:48425482:C:T
NM_002834.5(PTPN11):c.181G>A (p.Asp61Asn)	PTPN11	D61N, D60N	Rasopathy|Noonan syndrome 3|LEOPARD syndrome 1|Noonan syndrome 1|not provided|Noonan syndrome	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040495	12	112888165	12	112450361	40495	48965	rs397507510	NC_000012.12:112450360:G:A
NM_014363.6(SACS):c.7139del (p.Asn2380fs)	SACS	N2380fs, N2233fs	Inborn genetic diseases|Spastic paraplegia|	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370689	13	23910876	13	23336737	370689	358169	rs1057516689	NC_000013.11:23336736:TTTTT:TTTT
NM_000303.3(PMM2):c.357C>A (p.Phe119Leu)	PMM2	F119L	Congenital disorder of glycosylation, type Ia|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007711	16	8904945	16	8811088	7711	22750	rs80338701	NC_000016.10:8811087:C:A
NM_000267.3(NF1):c.889-2A>G	NF1		Hereditary cancer-predisposing syndrome|not specified|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237610	17	29527438	17	31200420	237610	242629	rs878853922	NC_000017.11:31200419:A:G
NM_000267.3(NF1):c.910C>T (p.Arg304Ter)	NF1	R304*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187722	17	29527461	17	31200443	187722	184531	rs786203950	NC_000017.11:31200442:C:T
NM_004004.6(GJB2):c.131G>A (p.Trp44Ter)	GJB2	W44*	Deafness, autosomal recessive 1A|not provided|Inborn genetic diseases|Deafness, autosomal recessive 1A|Knuckle pads, deafness AND leukonychia syndrome|Hystrix-like ichthyosis with deafness|Mutilating keratoderma|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Deafness, X-linked 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188830	13	20763590	13	20189451	188830	186861	rs104894413	NC_000013.11:20189450:C:T
NM_000257.4(MYH7):c.2146G>A (p.Gly716Arg)	MYH7	G716R	not provided|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014105	14	23895189	14	23425980	14105	29144	rs121913638	NC_000014.9:23425979:C:T
NM_003482.3(KMT2D):c.15535C>T (p.Arg5179Cys)	KMT2D	R5179C	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000197586	12	49420214	12	49026431	197586	194747	rs794727688	NC_000012.12:49026430:G:A
NM_000138.5(FBN1):c.3037G>A (p.Gly1013Arg)	FBN1	G1013R	not provided|Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000177648	15	48782093	15	48489896	177648	175987	rs140593	NC_000015.10:48489895:C:T
NM_000138.4(FBN1):c.4460-8G>A	FBN1		Marfan syndrome|not provided|Marfan lipodystrophy syndrome|Weill-Marchesani syndrome 2|Geleophysic dysplasia 2|Marfan syndrome|Stiff skin syndrome|MASS syndrome|Ectopia lentis, isolated, autosomal dominant|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not specified	Pathogenic/Likely pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036075	15	48760739	15	48468542	36075	44739	rs193922204	NC_000015.10:48468541:C:T
NM_000138.4(FBN1):c.1643A>T (p.Asn548Ile)	FBN1	N548I	Marfan syndrome	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000016432	15	48802312	15	48510115	16432	31471	rs137854462	NC_000015.10:48510114:T:A
NM_000053.4(ATP7B):c.2333G>T (p.Arg778Leu)	ATP7B	R778L, R667L, R694L	Wilson disease|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003852	13	52532469	13	51958333	3852	18891	rs28942074	NC_000013.11:51958332:C:A
NM_000267.3(NF1):c.6792C>G (p.Tyr2264Ter)	NF1	Y2264*, Y2285*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439973	17	29665757	17	31338739	439973	433262	rs772295894	NC_000017.11:31338738:C:G
NM_000267.3(NF1):c.1381C>T (p.Arg461Ter)	NF1	R461*	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237514	17	29533378	17	31206360	237514	242637	rs878853865	NC_000017.11:31206359:C:T
NM_000267.3(NF1):c.1318C>T (p.Arg440Ter)	NF1	R440*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Caf-au-lait macules with pulmonary stenosis|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230673	17	29533315	17	31206297	230673	235548	rs778405030	NC_000017.11:31206296:C:T
NM_000267.3(NF1):c.6709C>T (p.Arg2237Ter)	NF1	R2237*, R2258*	Tibial pseudoarthrosis|Neurofibromatosis, type 1|not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230389	17	29665110	17	31338092	230389	235788	rs876658541	NC_000017.11:31338091:C:T
NM_001042492.2(NF1):c.7153_7158AACTTT[1] (p.2385_2386NF[1])	NF1		Tibial pseudoarthrosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220715	17	29670116 - 29670121	17	31343098 - 31343103	220715	222630	rs864622639	NC_000017.11:31343097:TAACTTTAACTTT:TAACTTT
NM_000267.3(NF1):c.5426G>T (p.Arg1809Leu)	NF1	R1809L, R1830L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Caf-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208854	17	29654737	17	31327719	208854	205418	rs771529172	NC_000017.11:31327718:G:T
NM_000267.3(NF1):c.3457_3460del (p.Leu1153fs)	NF1	L1153fs	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185963	17	29559859 - 29559862	17	31232841 - 31232844	185963	184625	rs1321848637	NC_000017.11:31232840:ACTCA:A
NM_000267.3(NF1):c.2033dup (p.Ile679fs)	NF1		Tibial pseudoarthrosis|Neurofibromatosis, type 1|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141513	17	29553477 - 29553478	17	31226459 - 31226460	141513	151227	rs587781807	NC_000017.11:31226459:CCCCCCC:CCCCCCCC
NM_000257.4(MYH7):c.1750G>A (p.Gly584Ser)	MYH7	G584S	Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042862	14	23896932	14	23427723	42862	52032	rs121913626	NC_000014.9:23427722:C:T
NM_003482.3(KMT2D):c.13450C>T (p.Arg4484Ter)	KMT2D	R4484*	Inborn genetic diseases|Kabuki syndrome 1	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158729	12	49425038	12	49031255	158729	168914	rs587783690	NC_000012.12:49031254:G:A
NM_000138.4(FBN1):c.7828G>A (p.Glu2610Lys)	FBN1	E2610K	Cardiovascular phenotype|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Geleophysic dysplasia 2|Marfan lipodystrophy syndrome|Marfan syndrome|MASS syndrome|Ectopia lentis, isolated, autosomal dominant|Acromicric dysplasia|Stiff skin syndrome|Weill-Marchesani syndrome 2|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000264272	15	48707956	15	48415759	264272	258823	rs111984349	NC_000015.10:48415758:C:T
NM_000138.4(FBN1):c.1693C>T (p.Arg565Ter)	FBN1	R565*	not specified|not provided|Marfan syndrome|Cardiovascular phenotype|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000199975	15	48802262	15	48510065	199975	197789	rs113422242	NC_000015.10:48510064:G:A
NM_000138.5(FBN1):c.7606G>A (p.Gly2536Arg)	FBN1	G2536R	not provided|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042429	15	48713848	15	48421651	42429	51599	rs397515854	NC_000015.10:48421650:C:T
NM_000138.5(FBN1):c.5368C>T (p.Arg1790Ter)	FBN1	R1790*	not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Marfan syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042382	15	48748888	15	48456691	42382	51552	rs113249837	NC_000015.10:48456690:G:A
NM_000138.4(FBN1):c.2920C>T (p.Arg974Cys)	FBN1	R974C	not provided|Cardiovascular phenotype|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Ectopia lentis, isolated, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000039667	15	48782210	15	48490013	39667	48266	rs397514558	NC_000015.10:48490012:G:A
NM_000267.3(NF1):c.3826C>T (p.Arg1276Ter)	NF1	R1276*	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237556	17	29562746	17	31235728	237556	242675	rs199474742	NC_000017.11:31235727:C:T
NM_000267.3(NF1):c.3113+1G>A	NF1		not provided|Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudoarthrosis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000345	17	29557401	17	31230383	345	15384	rs267606599	NC_000017.11:31230382:G:A
NM_000267.3(NF1):c.4084C>T (p.Arg1362Ter)	NF1	R1362*	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000344	17	29576111	17	31249093	344	15383	rs137854560	NC_000017.11:31249092:C:T
NM_000257.4(MYH7):c.788T>C (p.Ile263Thr)	MYH7	I263T	Cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|not provided|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000043106	14	23900635	14	23431426	43106	52276	rs397516269	NC_000014.9:23431425:A:G
NM_000053.4(ATP7B):c.3207C>A (p.His1069Gln)	ATP7B	H1069Q, H714Q, H958Q, H862Q, H991Q, H985Q	Wilson disease|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003848	13	52518281	13	51944145	3848	18887	rs76151636	NC_000013.11:51944144:G:T
NM_000138.4(FBN1):c.2953G>A (p.Gly985Arg)	FBN1	G985R	Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Cardiovascular phenotype|Marfan syndrome|not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200008	15	48782177	15	48489980	200008	197742	rs794728199	NC_000015.10:48489979:C:T
NM_000138.5(FBN1):c.247+1G>A	FBN1		Marfan syndrome|not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042307	15	48905206	15	48613009	42307	51477	rs25404	NC_000015.10:48613008:C:T
NM_000138.4(FBN1):c.1948C>T (p.Arg650Cys)	FBN1	R650C	not specified|Marfan syndrome|Marfan lipodystrophy syndrome|Weill-Marchesani syndrome 2|Geleophysic dysplasia 2|Marfan syndrome|Stiff skin syndrome|MASS syndrome|Ectopia lentis, isolated, autosomal dominant|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036042	15	48797234	15	48505037	36042	44706	rs193922185	NC_000015.10:48505036:G:A
NM_000267.3(NF1):c.5425C>T (p.Arg1809Cys)	NF1	R1809C, R1830C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Caf-au-lait macules with pulmonary stenosis|Neurofibromatosis-Noonan syndrome	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208853	17	29654736	17	31327718	208853	205416	rs797045139	NC_000017.11:31327717:C:T
NM_000267.3(NF1):c.1541_1542del (p.Gln514fs)	NF1	Q514fs	not provided|Neurofibromatosis, type 1|not specified|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000346	17	29546036 - 29546037	17	31219018 - 31219019	346	15385	rs267606600	NC_000017.11:31219017:AG:
NM_002755.4(MAP2K1):c.389A>G (p.Tyr130Cys)	MAP2K1	Y130C	Inborn genetic diseases|Noonan syndrome 1|Cardiofaciocutaneous syndrome 3|Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 3|Rasopathy|not provided	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000013351	15	66729181	15	66436843	13351	28390	rs121908595	NC_000015.10:66436842:A:G
NM_003482.3(KMT2D):c.6295C>T (p.Arg2099Ter)	KMT2D	R2099*	Inborn genetic diseases|Kabuki syndrome 1|not provided	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521015	12	49435258	12	49041475	521015	512013	rs1452715535	NC_000012.12:49041474:G:A
NM_002834.5(PTPN11):c.218C>T (p.Thr73Ile)	PTPN11	T73I, T72I	Noonan syndrome 1|Noonan syndrome|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|Rasopathy|not provided	Pathogenic(Last reviewed: Apr 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013334	12	112888202	12	112450398	13334	28373	rs121918462	NC_000012.12:112450397:C:T
NM_000138.4(FBN1):c.6388G>A (p.Glu2130Lys)	FBN1	E2130K	Cardiovascular phenotype|Marfan syndrome|not provided|Geleophysic dysplasia 2|Marfan syndrome|Stiff skin syndrome|Ectopia lentis, isolated, autosomal dominant|Marfan lipodystrophy syndrome|Acromicric dysplasia|MASS syndrome|Weill-Marchesani syndrome 2|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200191	15	48729266	15	48437069	200191	197650	rs794728334	NC_000015.10:48437068:C:T
NM_000138.5(FBN1):c.3373C>T (p.Arg1125Ter)	FBN1	R1125*	not provided|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000179632	15	48779599	15	48487402	179632	176130	rs727505006	NC_000015.10:48487401:G:A
NM_001005242.3(PKP2):c.2357+1G>A	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9|Cardiovascular phenotype|not provided|Aborted sudden cardiac death|Arrhythmogenic ventricular cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006757	12	32949042	12	32796108	6757	21796	rs111517471	NC_000012.12:32796107:C:T
NM_002834.5(PTPN11):c.794G>A (p.Arg265Gln)	PTPN11	R265Q, R264Q	Metachondromatosis|Inborn genetic diseases|not provided|PTPN11-related disorder|Rasopathy|Noonan syndrome 1|Noonan syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040522	12	112910785	12	112472981	40522	48992	rs376607329	NC_000012.12:112472980:G:A
NM_000257.4(MYH7):c.1750G>C (p.Gly584Arg)	MYH7	G584R	not provided|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014090	14	23896932	14	23427723	14090	29129	rs121913626	NC_000014.9:23427722:C:G
NM_000267.3(NF1):c.3916C>T (p.Arg1306Ter)	NF1	R1306*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudoarthrosis|not provided	Pathogenic(Last reviewed: Feb 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404592	17	29562981	17	31235963	404592	401712	rs376576925	NC_000017.11:31235962:C:T
NM_000267.3(NF1):c.7486C>T (p.Arg2496Ter)	NF1	R2496*, R2517*	not specified|Neurofibromatosis, type 1|Neurofibromas|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230467	17	29679366	17	31352348	230467	235823	rs866445127	NC_000017.11:31352347:C:T
NM_000267.3(NF1):c.1756_1759del (p.Thr586fs)	NF1	T586fs	Neurofibroma|not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186215	17	29550494 - 29550497	17	31223476 - 31223479	186215	184559	rs786202782	NC_000017.11:31223475:TAACTA:TA
NM_000138.5(FBN1):c.4615C>T (p.Arg1539Ter)	FBN1	R1539*	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042366	15	48760267	15	48468070	42366	51536	rs111231312	NC_000015.10:48468069:G:A
NM_000138.5(FBN1):c.184C>T (p.Arg62Cys)	FBN1	R62C	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042295	15	48905270	15	48613073	42295	51465	rs25403	NC_000015.10:48613072:G:A
NM_000138.4(FBN1):c.1585C>T (p.Arg529Ter)	FBN1	R529*	not specified|Marfan syndrome|not provided|Thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016452	15	48805749	15	48513552	16452	31491	rs137854476	NC_000015.10:48513551:G:A
NM_004004.6(GJB2):c.416G>A (p.Ser139Asn)	GJB2	S139N	Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1A|Knuckle pads, deafness AND leukonychia syndrome|Hystrix-like ichthyosis with deafness|Palmoplantar keratoderma-deafness syndrome|Deafness, X-linked 2|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Mutilating keratoderma|Deafness, autosomal dominant 3a|Hearing impairment|Rare genetic deafness|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Hearing loss|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044749	13	20763305	13	20189166	44749	53916	rs76434661	NC_000013.11:20189165:C:T
NM_000257.4(MYH7):c.2221G>T (p.Gly741Trp)	MYH7	G741W	Hypertrophic cardiomyopathy|not provided|Familial hypertrophic cardiomyopathy 1|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000177665	14	23894969	14	23425760	177665	175480	rs121913632	NC_000014.9:23425759:C:A
NM_000257.4(MYH7):c.2681A>G (p.Glu894Gly)	MYH7	E894G	Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|not provided|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000042922	14	23893357	14	23424148	42922	52092	rs397516161	NC_000014.9:23424147:T:C
NM_024312.5(GNPTAB):c.3501_3502TC[1] (p.Leu1168fs)	GNPTAB		|Inborn genetic diseases|GNPTAB-Related Disorders|Pseudo-Hurler polydystrophy|not provided|Pseudo-Hurler polydystrophy|	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002771	12	102147248 - 102147249	12	101753470 - 101753471	2771	17810	rs34002892	NC_000012.12:101753469:GAGA:GA
NM_003119.3(SPG7):c.1454_1462delGGCGGGAGA (p.Arg485_Glu487del)	SPG7		not provided|Hereditary spastic paraplegia 7|Hereditary spastic paraplegia|Distal spinal muscular atrophy|Inborn genetic diseases|Seizures|Memory impairment|Gait ataxia|Spastic paraplegia|Gait ataxia|Spastic paraparesis|Cerebral cortical atrophy|Dysarthria	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411680	16	89613065 - 89613073	16	89546657 - 89546665	411680	402131	rs768823392	NC_000016.10:89546656:GGAGAGGCGGGAGA:GGAGA
NM_000267.3(NF1):c.2041C>T (p.Arg681Ter)	NF1	R681*	not provided|Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1|Axillary freckling|Optic nerve glioma|Cafe-au-lait spot	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188280	17	29553492	17	31226474	188280	186247	rs768638173	NC_000017.11:31226473:C:T
NM_000243.2(MEFV):c.2040G>C (p.Met680Ile)	MEFV	M680I	Familial mediterranean fever, autosomal dominant|Familial Mediterranean fever|Familial Mediterranean fever|not provided|not specified	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036507	16	3293447	16	3243447	36507	45169	rs28940580	NC_000016.10:3243446:C:G
NM_000138.4(FBN1):c.4621C>T (p.Arg1541Ter)	FBN1	R1541*	not provided|Thoracic aortic aneurysm and aortic dissection|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000200052	15	48760261	15	48468064	200052	197690	rs794728228	NC_000015.10:48468063:G:A
NM_000138.5(FBN1):c.6354C>T (p.Ile2118=)	FBN1	I2118I	Marfan syndrome|not provided|Cardiovascular phenotype|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016449	15	48729544	15	48437347	16449	31488	rs112989722	NC_000015.10:48437346:G:A
NM_013275.6(ANKRD11):c.1898_1902AAACA[1] (p.Lys635fs)	ANKRD11		not provided|Delayed speech and language development|Conductive hearing impairment|Seizures|Global developmental delay|Abnormal facial shape|KBG syndrome|Short foot|Intellectual disability|Short palm|Conductive hearing impairment|Global developmental delay|Ptosis|Clinodactyly of the 5th finger|Unilateral cryptorchidism|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279678	16	89351043 - 89351047	16	89284635 - 89284639	279678	264749	rs886041125	NC_000016.10:89284634:TGTTTTGTTTT:TGTTTT
NM_004004.6(GJB2):c.235del (p.Leu79fs)	GJB2	L79fs	not specified|not provided|Rare genetic deafness|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Deafness, digenic, GJB2/GJB3|Hearing impairment|Hearing loss|Nonsyndromic hearing loss and deafness|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Sep 14, 2018)	reviewed by expert panel	VCV000017014	13	20763486	13	20189347	17014	32053	rs80338943	NC_000013.11:20189346:GGG:GG
NM_004004.6(GJB2):c.551G>C (p.Arg184Pro)	GJB2	R184P	not specified|Deafness, autosomal recessive 1A|not provided|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Deafness, X-linked 2|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Rare genetic deafness|Hearing loss	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017007	13	20763170	13	20189031	17007	32046	rs80338950	NC_000013.11:20189030:C:G
NM_000267.3(NF1):c.2446C>T (p.Arg816Ter)	NF1	R816*	Neurofibromatosis, type 1|Caf-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Inguinal freckling|Large cafe-au-lait macules with irregular margins|Delayed fine motor development|Lisch nodules|Multiple cafe-au-lait spots|Axillary freckling|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280055	17	29556079	17	31229061	280055	264844	rs886041347	NC_000017.11:31229060:C:T
NM_001042492.3(NF1):c.5305C>T (p.Arg1769Ter)	NF1	R1748*, R1769*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228381	17	29654553	17	31327535	228381	230767	rs876657714	NC_000017.11:31327534:C:T
NM_001042492.2(NF1):c.6852_6855del (p.Tyr2285fs)	NF1	Y2264fs, Y2285fs	Neurofibromatosis, type 1|Ganglioglioma|Hereditary cancer-predisposing syndrome|not specified|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216866	17	29665752 - 29665755	17	31338734 - 31338737	216866	213290	rs1555535032	NC_000017.11:31338733:ACTTAC:AC
NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn)	TPM1	D175N, D139N, D217N	Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 3|not provided|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012456	15	63353098	15	63060899	12456	27495	rs104894503	NC_000015.10:63060898:G:A
NM_002834.5(PTPN11):c.1492C>T (p.Arg498Trp)	PTPN11	R498W, R502W, R497W	Inborn genetic diseases|Noonan syndrome|Noonan syndrome with multiple lentigines|Noonan syndrome 1|not provided|LEOPARD syndrome 1|Rasopathy	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040553	12	112926872	12	112489068	40553	49023	rs397507541	NC_000012.12:112489067:C:T
NM_000138.5(FBN1):c.4786C>T (p.Arg1596Ter)	FBN1	R1596*	Marfan syndrome|not provided|Marfan lipodystrophy syndrome|Weill-Marchesani syndrome 2|Geleophysic dysplasia 2|Marfan syndrome|Stiff skin syndrome|MASS syndrome|Ectopia lentis, isolated, autosomal dominant|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036082	15	48758017	15	48465820	36082	44746	rs113871094	NC_000015.10:48465819:G:A
NM_000257.4(MYH7):c.1207C>T (p.Arg403Trp)	MYH7	R403W	MYH7-related late-onset scapuloperoneal muscular dystrophy|Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Dilated cardiomyopathy 1S|Myopathy, distal, 1|Myopathy, myosin storage, autosomal recessive|Congenital myopathy with fiber type disproportion|not provided|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014102	14	23898488	14	23429279	14102	29141	rs3218714	NC_000014.9:23429278:G:A
NM_000267.3(NF1):c.5546G>A (p.Arg1849Gln)	NF1	R1849Q, R1870Q	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Caf-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185354	17	29654857	17	31327839	185354	184694	rs786202112	NC_000017.11:31327838:G:A
NM_000267.3(NF1):c.1466A>G (p.Tyr489Cys)	NF1	Y489C	not provided|Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudoarthrosis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000354	17	29541542	17	31214524	354	15393	rs137854557	NC_000017.11:31214523:A:G
NM_000070.3(CAPN3):c.550del (p.Thr184fs)	CAPN3	T184fs	Limb-Girdle Muscular Dystrophy, Recessive|Muscular dystrophy|Shoulder girdle muscle weakness|Limb-girdle muscle weakness|Muscular dystrophy|Muscular Diseases|Absent Achilles reflex|Muscle weakness|Progressive spinal muscular atrophy|Paresthesia|Positive Romberg sign|Difficulty walking|EMG: neuropathic changes|Migraine|Absent muscle fiber calpain-3|Elevated serum creatine phosphokinase|Arrhythmia|Muscle weakness|Contractures of the joints of the lower limbs|Muscular dystrophy|Elbow flexion contracture|Shoulder girdle muscle weakness|Calf muscle hypertrophy|Shoulder girdle muscle weakness|EMG: myopathic abnormalities|Limb-girdle muscular dystrophy, type 2A|not provided|Congenital muscular dystrophy	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017621	15	42680001	15	42387803	17621	32660	rs80338800	NC_000015.10:42387802:AA:A
NM_000138.4(FBN1):c.3217G>A (p.Glu1073Lys)	FBN1	E1073K	Marfan syndrome|not provided|Loeys-Dietz syndrome|Marfan syndrome, neonatal|Cardiovascular phenotype|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016457	15	48780430	15	48488233	16457	31496	rs137854478	NC_000015.10:48488232:C:T
NM_000257.4(MYH7):c.2207T>C (p.Ile736Thr)	MYH7	I736T	Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000164342	14	23894983	14	23425774	164342	175481	rs727503261	NC_000014.9:23425773:A:G
NM_002693.3(POLG):c.2209G>C (p.Gly737Arg)	POLG	G737R	Cerebellar ataxia infantile with progressive external ophthalmoplegia|Progressive sclerosing poliodystrophy|Mitochondrial diseases|Seizures|POLG-Related Spectrum Disorders|not provided|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Progressive sclerosing poliodystrophy|Cerebellar ataxia infantile with progressive external ophthalmoplegia|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome|Mitochondrial DNA depletion syndrome 4B, MNGIE type	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013513	15	89866691	15	89323460	13513	28552	rs121918054	NC_000015.10:89323459:C:G
NM_003482.3(KMT2D):c.12592C>T (p.Arg4198Ter)	KMT2D	R4198*	Inborn genetic diseases|Kabuki syndrome|Kabuki syndrome 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158722	12	49425896	12	49032113	158722	168920	rs587783685	NC_000012.12:49032112:G:A
NM_000053.4(ATP7B):c.2304dup (p.Met769fs)	ATP7B		Wilson disease|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000456552	13	52532497 - 52532498	13	51958361 - 51958362	456552	463941	rs137853287	NC_000013.11:51958361:GGGGGG:GGGGGGG
NM_000267.3(NF1):c.2540T>C (p.Leu847Pro)	NF1	L847P	Hereditary cancer-predisposing syndrome|not provided|Midaortic syndrome|not specified|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068323	17	29556173	17	31229155	68323	79214	rs199474747	NC_000017.11:31229154:T:C
NM_000257.4(MYH7):c.2221G>C (p.Gly741Arg)	MYH7	G741R	not provided|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014098	14	23894969	14	23425760	14098	29137	rs121913632	NC_000014.9:23425759:C:G
NM_000257.4(MYH7):c.2722C>G (p.Leu908Val)	MYH7	L908V	not provided|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014097	14	23893316	14	23424107	14097	29136	rs121913631	NC_000014.9:23424106:G:C
NM_000138.4(FBN1):c.4930C>T (p.Arg1644Ter)	FBN1	R1644*	Cardiovascular phenotype|Marfan syndrome|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000200186	15	48757777	15	48465580	200186	197685	rs140630	NC_000015.10:48465579:G:A
NM_024685.4(BBS10):c.271dup (p.Cys91fs)	BBS10		Bardet-Biedl syndrome 10|Bardet-biedl syndrome 6/10, digenic|Retinal dystrophy|Bardet-Biedl syndrome 1|Inborn genetic diseases|not provided|Retinitis pigmentosa|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001328	12	76741493 - 76741494	12	76347713 - 76347714	1328	16367	rs549625604	NC_000012.12:76347713:AAA:AAAA
NM_000257.4(MYH7):c.2167C>T (p.Arg723Cys)	MYH7	R723C	not provided|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014095	14	23895023	14	23425814	14095	29134	rs121913630	NC_000014.9:23425813:G:A
NM_000257.4(MYH7):c.2770G>A (p.Glu924Lys)	MYH7	E924K	MYH7-related late-onset scapuloperoneal muscular dystrophy|Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Dilated cardiomyopathy 1S|Myopathy, distal, 1|Myopathy, myosin storage, autosomal recessive|Congenital myopathy with fiber type disproportion|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014092	14	23893268	14	23424059	14092	29131	rs121913628	NC_000014.9:23424058:C:T
NM_000267.3(NF1):c.1721+3A>G	NF1	Y575C	Hereditary cancer-predisposing syndrome|Optic nerve glioma|Multiple cafe-au-lait spots|Neurofibromatosis, type 1|Multiple cafe-au-lait spots|Neurofibromas|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374108	17	29548950	17	31221932	374108	361009	rs1057518904	NC_000017.11:31221931:A:G
NM_000267.3(NF1):c.2970_2972del (p.Met992del)	NF1	M992del	not provided|Neurofibromatosis-Noonan syndrome|Caf-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000363	17	29556972 - 29556974	17	31229954 - 31229956	363	15402	rs267606606	NC_000017.11:31229953:AAT:
NM_002834.5(PTPN11):c.844A>G (p.Ile282Val)	PTPN11	I282V, I281V	Inborn genetic diseases|not provided|Rasopathy|Noonan syndrome|Noonan syndrome with multiple lentigines	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040525	12	112910835	12	112473031	40525	48995	rs397507529	NC_000012.12:112473030:A:G
NM_001127701.1(SERPINA1):c.863A>T (p.Glu288Val)	SERPINA1	E264V, E288V	Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|Alpha-1-antitrypsin deficiency|Cystic fibrosis|PI S|not provided	Pathogenic, other(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017969	14	94847262	14	94380925	17969	33008	rs17580	NC_000014.9:94380924:T:A
NM_000138.5(FBN1):c.1879C>T (p.Arg627Cys)	FBN1	R627C	Marfan syndrome|Stiff skin syndrome|Weill-Marchesani syndrome 2|Geleophysic dysplasia 2|Acromicric dysplasia|Marfan syndrome|Ectopia lentis, isolated, autosomal dominant|MASS syndrome|Marfan lipodystrophy syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000163480	15	48797303	15	48505106	163480	175988	rs727503057	NC_000015.10:48505105:G:A
NM_004004.6(GJB2):c.139G>T (p.Glu47Ter)	GJB2	E47*	not specified|Deafness, autosomal recessive 1A|not provided|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Deafness, X-linked 2|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Rare genetic deafness|Hearing impairment|Hearing loss	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017005	13	20763582	13	20189443	17005	32044	rs104894398	NC_000013.11:20189442:C:A
NM_001376.5(DYNC1H1):c.1792C>T (p.Arg598Cys)	DYNC1H1	R598C	not provided|Charcot-Marie-Tooth disease, axonal, type 2O|Mental retardation, autosomal dominant 13|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Hereditary motor and sensory neuropathy|Charcot-Marie-Tooth disease, axonal, type 2O|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000139652	14	102452354	14	101986017	139652	143271	rs587780564	NC_000014.9:101986016:C:T
NM_002834.5(PTPN11):c.923A>G (p.Asn308Ser)	PTPN11	N308S, N307S	not specified|Noonan syndrome 3|Noonan syndrome|Noonan syndrome 1|LEOPARD syndrome 1|Noonan syndrome 1|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|not provided|Rasopathy	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013327	12	112915524	12	112477720	13327	28366	rs121918455	NC_000012.12:112477719:A:G
NM_000138.4(FBN1):c.7039_7040del (p.Met2347fs)	FBN1	M2347fs	Cardiovascular phenotype|Marfan syndrome|Familial thoracic aortic aneurysm|Acute aortic dissection|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200171	15	48719928 - 48719929	15	48427731 - 48427732	200171	197619	rs794728319	NC_000015.10:48427730:AT:
NM_004004.6(GJB2):c.269T>C (p.Leu90Pro)	GJB2	L90P	not specified|not provided|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Deafness, X-linked 2|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Hearing impairment|Short palpebral fissure|Congenital omphalocele|Horseshoe kidney|Rare genetic deafness|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Hearing impairment|Hearing loss|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017016	13	20763452	13	20189313	17016	32055	rs80338945	NC_000013.11:20189312:A:G
NM_000257.4(MYH7):c.2717A>G (p.Asp906Gly)	MYH7	D906G	MYH7-related late-onset scapuloperoneal muscular dystrophy|Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Dilated cardiomyopathy 1S|Myopathy, distal, 1|Myopathy, myosin storage, autosomal recessive|Congenital myopathy with fiber type disproportion|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|not provided|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014125	14	23893321	14	23424112	14125	29164	rs267606908	NC_000014.9:23424111:T:C
NM_002834.5(PTPN11):c.853T>C (p.Phe285Leu)	PTPN11	F285L, F284L	Noonan syndrome|Inborn genetic diseases|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Noonan syndrome 1|Metachondromatosis|not provided|Rasopathy|Noonan syndrome 1|Noonan syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040528	12	112910844	12	112473040	40528	48998	rs397507531	NC_000012.12:112473039:T:C
NM_004004.6(GJB2):c.-23+1G>A	GJB2		not specified|not provided|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Deafness, X-linked 2|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Rare genetic deafness|Hearing impairment|Hearing loss|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017029	13	20766921	13	20192782	17029	32068	rs80338940	NC_000013.11:20192781:C:T
NM_000138.4(FBN1):c.7006G>T (p.Glu2336Ter)	FBN1	E2336*	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000521084	15	48719962	15	48427765	521084	512142	rs1199524458	NC_000015.10:48427764:C:A
NM_000138.4(FBN1):c.8206dup (p.Thr2736fs)	FBN1		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	VCV000520767	15	48704785 - 48704786	15	48412588 - 48412589	520767	512141	rs1555393647	NC_000015.10:48412588:TTT:TTTT
NM_000138.4(FBN1):c.2645C>T (p.Ala882Val)	FBN1	A882V	Thoracic aortic aneurysm and aortic dissection|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|not specified|Geleophysic dysplasia 2|Stiff skin syndrome|Marfan lipodystrophy syndrome|Weill-Marchesani syndrome 2|Ectopia lentis, isolated, autosomal dominant|Acromicric dysplasia|Marfan syndrome|MASS syndrome|Cardiovascular phenotype|not provided|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200001	15	48787352	15	48495155	200001	197755	rs794728195	NC_000015.10:48495154:G:A
NM_000267.3(NF1):c.7846C>T (p.Arg2616Ter)	NF1	R2616*, R2637*	Tibial pseudoarthrosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Caf-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184261	17	29684326	17	31357308	184261	184776	rs786201367	NC_000017.11:31357307:C:T
NM_000267.3(NF1):c.574C>T (p.Arg192Ter)	NF1	R192*	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromas|Multiple cafe-au-lait spots|Axillary freckling|Focal T2 hyperintense basal ganglia lesion	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040093	17	29497003	17	31169985	40093	48599	rs397514641	NC_000017.11:31169984:C:T
NM_004004.6(GJB2):c.167del (p.Leu56fs)	GJB2	L56fs	not specified|Keratitis ichthyosis and deafness syndrome|Nonsyndromic Hearing Loss, Dominant|not provided|Hystrix-like ichthyosis with deafness|GJB2-Related Disorders|Rare genetic deafness|Mutilating keratoderma|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Hearing impairment|Hearing loss|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Sep 19, 2018)	reviewed by expert panel	VCV000017010	13	20763554	13	20189415	17010	32049	rs80338942	NC_000013.11:20189414:A:
NM_000138.5(FBN1):c.1468+5G>A	FBN1		Thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype|Marfan syndrome|Geleophysic dysplasia 2|Stiff skin syndrome|Marfan syndrome|Ectopia lentis, isolated, autosomal dominant|Acromicric dysplasia|Marfan lipodystrophy syndrome|MASS syndrome|Weill-Marchesani syndrome 2|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042284	15	48807579	15	48515382	42284	51454	rs397515757	NC_000015.10:48515381:C:T
NM_000138.5(FBN1):c.6806T>C (p.Ile2269Thr)	FBN1	I2269T	Cardiovascular phenotype|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|not provided|Marfan syndrome|Marfan lipodystrophy syndrome|Weill-Marchesani syndrome 2|Geleophysic dysplasia 2|Marfan syndrome|Stiff skin syndrome|MASS syndrome|Ectopia lentis, isolated, autosomal dominant|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036107	15	48722933	15	48430736	36107	44771	rs193922228	NC_000015.10:48430735:A:G
NM_002834.5(PTPN11):c.188A>G (p.Tyr63Cys)	PTPN11	Y63C, Y62C	Noonan syndrome|Noonan syndrome 3|Noonan syndrome 1|B lymphoblastic leukemia lymphoma, no ICD-O subtype|Lymphoma|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|Rasopathy|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013333	12	112888172	12	112450368	13333	28372	rs121918459	NC_000012.12:112450367:A:G
NM_000257.4(MYH7):c.1987C>T (p.Arg663Cys)	MYH7	R663C	MYH7-related late-onset scapuloperoneal muscular dystrophy|Congenital myopathy with fiber type disproportion|Myopathy, myosin storage, autosomal recessive|Dilated cardiomyopathy 1S|Myopathy, distal, 1|Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042874	14	23896043	14	23426834	42874	52044	rs397516127	NC_000014.9:23426833:G:A
NM_000257.4(MYH7):c.2609G>A (p.Arg870His)	MYH7	R870H	Hypertrophic cardiomyopathy|Chest pain|not provided|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014120	14	23894048	14	23424839	14120	29159	rs36211715	NC_000014.9:23424838:C:T
NM_000267.3(NF1):c.4537C>T (p.Arg1513Ter)	NF1	R1534*, R1513*	not specified|Tibial pseudoarthrosis|Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Subcutaneous neurofibromas|Thoracic scoliosis|Multiple cafe-au-lait spots	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220152	17	29588751	17	31261733	220152	222607	rs760703505	NC_000017.11:31261732:C:T
NM_000303.3(PMM2):c.422G>A (p.Arg141His)	PMM2	R141H	Cerebral atrophy|Congenital cerebellar hypoplasia|Spasticity|Poor speech|Cerebral palsy|Cerebellar ataxia|Congenital cerebellar hypoplasia|Diabetes mellitus|Cerebellar ataxia|Muscular dystrophy|Cerebellar ataxia|Congenital disorder of glycosylation, type Ia|Inborn genetic diseases|not provided|Congenital disorder of glycosylation	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007706	16	8905010	16	8811153	7706	22745	rs28936415	NC_000016.10:8811152:G:A
NM_000138.4(FBN1):c.2581C>T (p.Arg861Ter)	FBN1	R861*	not specified|Thoracic aortic aneurysm and aortic dissection|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Geleophysic dysplasia 2|Marfan lipodystrophy syndrome|Marfan syndrome|MASS syndrome|Ectopia lentis, isolated, autosomal dominant|Acromicric dysplasia|Stiff skin syndrome|Weill-Marchesani syndrome 2|Cardiovascular phenotype|not provided|Marfan syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265401	15	48787416	15	48495219	265401	260073	rs140583	NC_000015.10:48495218:G:A
NM_001042492.3(NF1):c.4330A>G (p.Lys1444Glu)	NF1	K1423E, K1444E	not provided|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Caf-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Optic nerve glioma|Neurofibromas|Multiple cafe-au-lait spots|Axillary freckling|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000336	17	29585518	17	31258500	336	15375	rs137854550	NC_000017.11:31258499:A:G
NM_002834.5(PTPN11):c.836A>G (p.Tyr279Cys)	PTPN11	Y279C, Y278C	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia|not specified|LEOPARD syndrome 1|Noonan syndrome|Noonan syndrome 1|Cardiovascular phenotype|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|not provided|Rasopathy|Noonan syndrome with multiple lentigines|Noonan syndrome|LEOPARD syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013328	12	112910827	12	112473023	13328	28367	rs121918456	NC_000012.12:112473022:A:G
NM_001126131.2(POLG):c.2542G>A (p.Gly848Ser)	POLG	G848S	Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Progressive sclerosing poliodystrophy|Cerebellar ataxia infantile with progressive external ophthalmoplegia|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Cerebellar ataxia infantile with progressive external ophthalmoplegia|POLG- Related Disorder|POLG-Related Spectrum Disorders|not provided|Progressive sclerosing poliodystrophy|Progressive sclerosing poliodystrophy|Cerebellar ataxia infantile with progressive external ophthalmoplegia|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013502	15	89865023	15	89321792	13502	28541	rs113994098	NC_000015.10:89321791:C:T
NM_000257.4(MYH7):c.2156G>A (p.Arg719Gln)	MYH7	R719Q	not provided|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014107	14	23895179	14	23425970	14107	29146	rs121913641	NC_000014.9:23425969:C:T
NM_000267.3(NF1):c.5839C>T (p.Arg1947Ter)	NF1	R1947*, R1968*	not provided|Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudoarthrosis|Neurofibromatosis, familial spinal|Caf-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000343	17	29661945	17	31334927	343	15382	rs137854552	NC_000017.11:31334926:C:T
NM_001005242.3(PKP2):c.2014-1G>C	PKP2		Arrhythmogenic right ventricular cardiomyopathy, type 9|Cardiovascular phenotype|not provided|Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006756	12	32955491	12	32802557	6756	21795	rs193922674	NC_000012.12:32802556:C:G
NM_000267.3(NF1):c.6792C>A (p.Tyr2264Ter)	NF1	Y2264*, Y2285*	Ewing's sarcoma|Neurofibromatosis, type 1|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Caf-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185082	17	29665757	17	31338739	185082	184734	rs772295894	NC_000017.11:31338738:C:A
NM_000257.4(MYH7):c.1816G>A (p.Val606Met)	MYH7	V606M	not provided|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014091	14	23896866	14	23427657	14091	29130	rs121913627	NC_000014.9:23427656:C:T
NM_000138.4(FBN1):c.5284G>A (p.Gly1762Ser)	FBN1	G1762S	Geleophysic dysplasia 2|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000029697	15	48752455	15	48460258	29697	38652	rs387906623	NC_000015.10:48460257:C:T
NM_002834.5(PTPN11):c.417G>C (p.Glu139Asp)	PTPN11	E139D, E138D	Inborn genetic diseases|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Noonan syndrome 1|Metachondromatosis|Global developmental delay|Ptosis|Brachycephaly|Microcephaly|Pectus excavatum|Rasopathy|Juvenile myelomonocytic leukemia|Noonan syndrome|Cardiovascular phenotype|not specified|Hypertrophic cardiomyopathy|Noonan syndrome 1|not provided|Noonan syndrome|Noonan syndrome 3	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040513	12	112891083	12	112453279	40513	48983	rs397507520	NC_000012.12:112453278:G:C
NM_004004.6(GJB2):c.427C>T (p.Arg143Trp)	GJB2	R143W	not provided|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Deafness, X-linked 2|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Rare genetic deafness|Hearing impairment|Hearing loss|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017009	13	20763294	13	20189155	17009	32048	rs80338948	NC_000013.11:20189154:G:A
NM_004004.6(GJB2):c.71G>A (p.Trp24Ter)	GJB2	W24*	Deafness, autosomal recessive 1A|not provided|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Deafness, X-linked 2|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Rare genetic deafness|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Hearing impairment|Hearing loss|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Sep 17, 2018)	reviewed by expert panel	VCV000017002	13	20763650	13	20189511	17002	32041	rs104894396	NC_000013.11:20189510:C:T
NM_000138.5(FBN1):c.5788+5G>A	FBN1		Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|not provided|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Ischemic stroke|Cutaneous melanoma|Ectopia lentis|Severe Myopia|Melanoma|Aortic root dilatation|Arachnodactyly|Dissecting aortic dilatation	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042394	15	48738898	15	48446701	42394	51564	rs193922219	NC_000015.10:48446700:C:T
NM_000138.5(FBN1):c.4588C>T (p.Arg1530Cys)	FBN1	R1530C	Cardiovascular phenotype|Marfan lipodystrophy syndrome|Weill-Marchesani syndrome 2|Geleophysic dysplasia 2|Marfan syndrome|Stiff skin syndrome|MASS syndrome|Ectopia lentis, isolated, autosomal dominant|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not provided|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036078	15	48760294	15	48468097	36078	44742	rs111401431	NC_000015.10:48468096:G:A
NM_000267.3(NF1):c.1885G>A (p.Gly629Arg)	NF1	G629R	not provided|Tibial pseudoarthrosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068308	17	29552152	17	31225134	68308	79199	rs199474738	NC_000017.11:31225133:G:A
NM_145239.3(PRRT2):c.649dup (p.Arg217fs)	PRRT2		Infantile convulsions and choreoathetosis|Seizures, benign familial infantile, 2|Episodic kinesigenic dyskinesia 1|not provided|History of neurodevelopmental disorder|Paroxysmal kinesigenic dyskinesia|Paroxysmal nonkinesigenic dyskinesia 1|Seizures|Episodic kinesigenic dyskinesia 1|Infantile convulsions and choreoathetosis|Seizures, benign familial infantile, 2	Pathogenic/Likely pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000065758	16	29825015 - 29825016	16	29813694 - 29813695	65758	76666	rs587778771	NC_000016.10:29813694:CCCCCCCCC:CCCCCCCCCC
NM_000257.4(MYH7):c.746G>A (p.Arg249Gln)	MYH7	R249Q	MYH7-related late-onset scapuloperoneal muscular dystrophy|Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Dilated cardiomyopathy 1S|Myopathy, distal, 1|Myopathy, myosin storage, autosomal recessive|Congenital myopathy with fiber type disproportion|not provided|Cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014088	14	23900677	14	23431468	14088	29127	rs3218713	NC_000014.9:23431467:C:T
NM_002834.5(PTPN11):c.1510A>G (p.Met504Val)	PTPN11	M504V, M508V, M503V	Rasopathy|Inborn genetic diseases|not specified|not provided|Noonan syndrome|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome 1|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome 1	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040562	12	112926890	12	112489086	40562	49032	rs397507547	NC_000012.12:112489085:A:G
NM_000257.4(MYH7):c.1357C>T (p.Arg453Cys)	MYH7	R453C	not provided|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014089	14	23898214	14	23429005	14089	29128	rs121913625	NC_000014.9:23429004:G:A
NM_000267.3(NF1):c.5772T>A (p.Cys1924Ter)	NF1	C1924*, C1945*	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000522060	17	29661878	17	31334860	522060	512272	rs1555534380	NC_000017.11:31334859:T:A
NM_000267.3(NF1):c.6852_6853dup (p.Asn2285fs)	NF1		Inborn genetic diseases	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000521721	17	29665816 - 29665817	17	31338798 - 31338799	521721	512273	rs1555535052	NC_000017.11:31338798:TA:TATA
NM_000267.3(NF1):c.5556dup (p.Tyr1853fs)	NF1		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	VCV000520771	17	29657321 - 29657322	17	31330303 - 31330304	520771	512271	rs1555533842	NC_000017.11:31330303:CC:CCC
NM_000138.4(FBN1):c.364C>T (p.Arg122Cys)	FBN1	R122C	not specified|not provided|Marfan syndrome|Marfan syndrome, atypical|Cardiovascular phenotype|High palate|Aortic dissection|Lens subluxation|Arachnodactyly	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016440	15	48892414	15	48600217	16440	31479	rs137854467	NC_000015.10:48600216:G:A
NM_001127701.1(SERPINA1):c.1096G>A (p.Glu366Lys)	SERPINA1	E342K, E366K	Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|Alpha-1-antitrypsin deficiency|PI Z(AUGSBURG)|PI Z(TUN)|PI Z|Inborn genetic diseases|not provided|FRAXE	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017967	14	94844947	14	94378610	17967	33006	rs28929474	NC_000014.9:94378609:C:T
NM_000138.5(FBN1):c.718C>T (p.Arg240Cys)	FBN1	R240C	not provided|Geleophysic dysplasia 2|MASS syndrome|Weill-Marchesani syndrome 2|Acromicric dysplasia|Ectopia lentis, isolated, autosomal dominant|Stiff skin syndrome|Marfan syndrome|Marfan lipodystrophy syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Ectopia lentis, isolated, autosomal dominant|Marfan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016461	15	48829826	15	48537629	16461	31500	rs137854480	NC_000015.10:48537628:G:A
NM_000257.4(MYH7):c.2389G>A (p.Ala797Thr)	MYH7	A797T	MYH7-related late-onset scapuloperoneal muscular dystrophy|Congenital myopathy with fiber type disproportion|Myopathy, myosin storage, autosomal recessive|Dilated cardiomyopathy 1S|Myopathy, distal, 1|Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Congenital combined immunodeficiency|Severe combined immunodeficiency disease|Immunodeficiency|Abnormality of cellular immune system|Lymphopenia|Abnormality of T cell physiology|Familial dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042901	14	23894525	14	23425316	42901	52071	rs3218716	NC_000014.9:23425315:C:T
NM_001042492.3(NF1):c.3827G>A (p.Arg1276Gln)	NF1	R1276Q	Hereditary cancer-predisposing syndrome|Caf-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Caf-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068341	17	29562747	17	31235729	68341	79232	rs137854556	NC_000017.11:31235728:G:A
NM_004004.6(GJB2):c.109G>A (p.Val37Ile)	GJB2	V37I	not specified|not provided|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Deafness, X-linked 2|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Rare genetic deafness|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Hearing impairment|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Jun 24, 2019)	reviewed by expert panel	VCV000017023	13	20763612	13	20189473	17023	32062	rs72474224	NC_000013.11:20189472:C:T
NM_000257.4(MYH7):c.2155C>T (p.Arg719Trp)	MYH7	R719W	not provided|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014104	14	23895180	14	23425971	14104	29143	rs121913637	NC_000014.9:23425970:G:A
NM_000138.4(FBN1):c.1633C>T (p.Arg545Cys)	FBN1	R545C	not provided|Cardiovascular phenotype|Stiff skin syndrome|Geleophysic dysplasia 2|Acromicric dysplasia|Marfan lipodystrophy syndrome|Weill-Marchesani syndrome 2|MASS syndrome|Marfan syndrome|Ectopia lentis, isolated, autosomal dominant|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180352	15	48802322	15	48510125	180352	178699	rs730880099	NC_000015.10:48510124:G:A
NM_000138.5(FBN1):c.7754T>C (p.Ile2585Thr)	FBN1	I2585T	not specified|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Stiff skin syndrome|Weill-Marchesani syndrome 2|Geleophysic dysplasia 2|Acromicric dysplasia|Marfan syndrome|Ectopia lentis, isolated, autosomal dominant|MASS syndrome|Marfan lipodystrophy syndrome|Cardiovascular phenotype|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Tall stature|Scoliosis|Aortic aneurysm|Severe Myopia|Joint hypermobility|Dilatation of ascending aorta|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000163462	15	48712949	15	48420752	163462	175979	rs727503054	NC_000015.10:48420751:A:G
NM_002834.5(PTPN11):c.1403C>T (p.Thr468Met)	PTPN11	T468M, T472M, T467M	Inborn genetic diseases|not specified|Noonan syndrome|Noonan syndrome 1|Hypertrophic cardiomyopathy|PTPN11-related disorder|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|Rasopathy|not provided|Noonan syndrome with multiple lentigines|LEOPARD syndrome 1	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013331	12	112926270	12	112488466	13331	28370	rs121918457	NC_000012.12:112488465:C:T
NM_000257.4(MYH7):c.1208G>A (p.Arg403Gln)	MYH7	R403Q	not provided|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014087	14	23898487	14	23429278	14087	29126	rs121913624	NC_000014.9:23429277:C:T
NM_002834.5(PTPN11):c.922A>G (p.Asn308Asp)	PTPN11	N308D, N307D	Inborn genetic diseases|not specified|Noonan syndrome|Noonan syndrome 1|Cardiovascular phenotype|LEOPARD syndrome 1|Noonan syndrome 1|Rasopathy|LEOPARD syndrome 1|Noonan syndrome 1|Metachondromatosis|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013326	12	112915523	12	112477719	13326	28365	rs28933386	NC_000012.12:112477718:A:G
NM_000257.4(MYH7):c.1988G>A (p.Arg663His)	MYH7	R663H	Familial hypertrophic cardiomyopathy 1|MYH7-related late-onset scapuloperoneal muscular dystrophy|Congenital myopathy with fiber type disproportion|Myopathy, myosin storage, autosomal recessive|Dilated cardiomyopathy 1S|Myopathy, distal, 1|Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|MYH7-related late-onset scapuloperoneal muscular dystrophy|Myopathy, myosin storage, autosomal recessive|Dilated cardiomyopathy 1S|Myopathy, distal, 1|Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000042875	14	23896042	14	23426833	42875	52045	rs371898076	NC_000014.9:23426832:C:T
NM_004004.6(GJB2):c.101T>C (p.Met34Thr)	GJB2	M34T	not specified|Deafness, autosomal recessive 1A|Keratitis ichthyosis and deafness syndrome|Nonsyndromic Hearing Loss, Dominant|not provided|Rare genetic deafness|Mutilating keratoderma|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Hystrix-like ichthyosis with deafness|Hearing loss|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Jun 24, 2019)	reviewed by expert panel	VCV000017000	13	20763620	13	20189481	17000	32039	rs35887622	NC_000013.11:20189480:A:G
NM_000138.5(FBN1):c.6658C>T (p.Arg2220Ter)	FBN1	R2220*	Inborn genetic diseases|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|not specified|Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042407	15	48725144	15	48432947	42407	51577	rs113001196	NC_000015.10:48432946:G:A
NM_002693.3(POLG):c.1399G>A (p.Ala467Thr)	POLG	A467T	Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Progressive sclerosing poliodystrophy|Cerebellar ataxia infantile with progressive external ophthalmoplegia|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Progressive sclerosing poliodystrophy|Cerebellar ataxia infantile with progressive external ophthalmoplegia|Myoclonic epilepsy myopathy sensory ataxia|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome|Seizures|POLG- Related Disorders|POLG-Related Spectrum Disorders|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4B, MNGIE type|not provided|Mitochondrial diseases|POLG-related condition	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013496	15	89870432	15	89327201	13496	28535	rs113994095	NC_000015.10:89327200:C:T
NM_000267.3(NF1):c.3739_3742del (p.Phe1247fs)	NF1	F1247fs	Hereditary cancer-predisposing syndrome|Inborn genetic diseases|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420078	17	29562657 - 29562660	17	31235639 - 31235642	420078	409871	rs1064794276	NC_000017.11:31235638:TGTTTG:TG
NM_000267.3(NF1):c.3721C>T (p.Arg1241Ter)	NF1	R1241*	not provided|Neurofibromatosis, type 1|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000361	17	29562641	17	31235623	361	15400	rs137854562	NC_000017.11:31235622:C:T
NM_004004.6(GJB2):c.35del (p.Gly12fs)	GJB2	G12fs	not specified|Deafness, autosomal recessive 1A|Nonsyndromic Hearing Loss, Recessive|not provided|Severe sensorineural hearing impairment|Hearing impairment|Bilateral conductive hearing impairment|Bilateral sensorineural hearing impairment|Hearing impairment|Rare genetic deafness|Inborn genetic diseases|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Deafness, digenic, GJB2/GJB6|Bilateral sensorineural hearing impairment|Hearing impairment|Deafness|Hearing loss|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Sep 20, 2018)	reviewed by expert panel	VCV000017004	13	20763686	13	20189547	17004	32043	rs80338939	NC_000013.11:20189546:CCCCCC:CCCCC
NM_000267.3(NF1):c.499_502del	NF1		not provided|Tibial pseudoarthrosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185021	17	29496924 - 29496927	17	31169906 - 31169909	185021	184512	rs786201874	NC_000017.11:31169905:TGTTTGTT:TGTT
